Citrus Sinensis ID: 043425

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-----
Protein Sequence
MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKYTTSSAPVPIIGATNSKISHIGSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH
Secondary Structure (PSIPRED)
cccccccccEEEcEEEEEEEEccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEcccccHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEEEEEEEEccccEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHccccccEccEEEEEEcccEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEEcccccccEEEccccccEEcccccEEEEEEccHHHccHHHHcccEEcHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccHHHHccccHHHHHHHHccccccHHHcccHHHHHHcHHHHccccccccccHcccHHHHccHHcccccccEEcccccHHHccccHHHHHccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccEEEEcccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccc
Coil and Loop (DISEMBL)
msqatgrgrvvGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKrinhphiirlhdiievPGKLHLILEYCkggdlsmyiqrhgcvpeETAKHFMKQLAAGLQvlrdnnlihrdlkpqnlllctdddnAALKIADfgfarslqprglaetlcgsplymapeimqlqkYDAKADLWSVGAILFQLvtgktpftgsnQIQLLQNIVKAtelhfppdakilSADCKDLCQKLlrrnpverltfeeffnhpflsqtqpdqvfrsrmfsrsaddfpfyesksvrdvaessqddclpffldddssgpegspsfskrrssmkstygfsvdakhgreaTSSALNNLdlrygnkldntnlrhdsyklsdenlneppkclDQRLAntrskvgdsldlvdqdyvlvsgppmdtsssstsvskpthiprtserplisvpkyttssapvpiigatnskishigslesqssapgtslgstdmgdaleqpsthcmTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTqaasamdgspsgestrlrssrkkh
Flexible Loop (DISEMBL)
msqatgrgrvvgdylvgrQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFgfarslqprGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTfeeffnhpflsqtqpdqVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFfldddssgpegspsfskrrssmKSTYGfsvdakhgreATSSALNNLDLRYGNKLDNTNLRHDSyklsdenlneppkcLDQRLANTrskvgdsldlvDQDYVLVSGppmdtsssstsvskpthiprtserplisvpkyttssapvPIIGATNSKISHIGSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQaasamdgspsgestrlrssrkkh
Low Complexity Region (SEG)
MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLdddssgpegspsfsKRRSSMKSTYGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVsgppmdtsssstsvskptHIPRTSERPLISVPKYTTSSAPVPIIGATNSKISHIGSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH
Disordered region (IsUnstruct)
********RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ***************************************************************************************************************************************LVDQDYVL***********************************************************************************HCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQ***********************
Disordered Region (DISOPRED)
************DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM**L*******LMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP*******************************************************************************************************************************************************************************************************************************************ACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICH*************************
Disordered Region (DISEMBL)
MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYES**********QDDCLPFFLDDD********************YGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVSGPP*****************RTSERPLISVPKYTTSSAPVPIIGATNSKISHIGS*************STDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQA**********************
Disordered Region (DISPRO)
********RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEG*P*FSKR*********FSVD***********************DNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVSGP************************************************************************ALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQAASAM******************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKYTTSSAPVPIIGATNSKISHIGSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	575	2.2.26 [Sep-21-2011]
Q52EB3	982	Serine/threonine-protein	N/A	no	0.533	0.312	0.411	7e-74
Q3ZDQ4	941	Serine/threonine-protein	yes	no	0.518	0.316	0.392	9e-72
Q7RX99	932	Serine/threonine-protein	N/A	no	0.469	0.289	0.421	1e-71
Q0CLX3	964	Serine/threonine-protein	N/A	no	0.460	0.274	0.453	8e-71
P87248	675	Serine/threonine-protein	N/A	no	0.506	0.431	0.422	2e-70
A1CHL6	928	Serine/threonine-protein	N/A	no	0.460	0.285	0.451	2e-70
A7KAL2	960	Serine/threonine-protein	yes	no	0.492	0.294	0.428	3e-70
Q4WPF2	973	Serine/threonine-protein	yes	no	0.476	0.281	0.438	5e-70
Q6C7U0	710	Serine/threonine-protein	yes	no	0.539	0.436	0.403	7e-70
A1CX69	950	Serine/threonine-protein	N/A	no	0.467	0.283	0.444	2e-69

>sp|Q52EB3|ATG1_MAGO7 Serine/threonine-protein kinase ATG1 OS=Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) GN=ATG1 PE=1 SV=1

 Score =  278 bits (712), Expect = 7e-74,   Method: Compositional matrix adjust.
 Identities = 153/372 (41%), Positives = 215/372 (57%), Gaps = 65/372 (17%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           VG +++G +IG GSF+ V+  +H+V G  VA+K + + RLNKKL+E+L  EI ILK + H
Sbjct: 16  VGQFVIGAEIGKGSFAQVYMGKHKVSGAAVAIKSVELARLNKKLKENLYGEINILKTLRH 75

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR----------------HGCVP----- 109
           PHI+ LHD +E    ++L++EYC+ GDLS++I++                +  VP     
Sbjct: 76  PHIVALHDCVESATHINLMMEYCELGDLSLFIKKREKLSTNPATHDMARKYPNVPNSGLN 135

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL-----------------CTDDDNAA 152
           E   +HF+KQL++ L+ LR++NL+HRD+KPQNLLL                     D+  
Sbjct: 136 EVVIRHFLKQLSSALKFLRESNLVHRDVKPQNLLLLPSPEFREVNKLARPILTASQDSLV 195

Query: 153 ----------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
                     LK+ADFGFAR L    LAETLCGSPLYMAPEI++ ++YDAKADLWSVG +
Sbjct: 196 PVAGLASLPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYERYDAKADLWSVGTV 255

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
           LF+++ G+ PF  SN ++LL+ I  A ++   P    +S++ K L + LL+RNPVER++F
Sbjct: 256 LFEMIVGRPPFRASNHVELLRKIEAAEDVIKFPRETTISSEMKGLTRALLKRNPVERISF 315

Query: 263 EEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSG 322
           E FF HP +  + P  V          DD P  E+   R    SS  D       DD   
Sbjct: 316 ENFFAHPVIISSIPGLV---------EDDIPKPEASEQR----SSSKDTRAASKSDD--- 359

Query: 323 PEGSP-SFSKRR 333
           P  SP  +S RR
Sbjct: 360 PIASPRKYSFRR 371

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Autophagy is essential to fungal development, production of appressorium turgor, and pathogenicity in rice blast disease.
Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (taxid: 242507)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q3ZDQ4|ATG1_PODAS Serine/threonine-protein kinase atg1 OS=Podospora anserina GN=ATG1 PE=2 SV=1

 Score =  271 bits (694), Expect = 9e-72,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 211/372 (56%), Gaps = 74/372 (19%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           VG +++ ++IG GSF+ V+  RH+V G  VA+K + + RLNKKL+E+L  EI ILK + H
Sbjct: 23  VGQFVIDKEIGKGSFAQVYSGRHKVTGALVAIKSVELSRLNKKLKENLYGEIKILKTLRH 82

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR---------------------HGCVP 109
           PHI+ LHD +E    ++LI+EYC+ GDLS++I++                     +  + 
Sbjct: 83  PHIVALHDCVESATHINLIMEYCELGDLSLFIKKREKLITHSATRDIARRYPIEHNQGLH 142

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT-----DDDNAA------------ 152
           E   +HF+KQLA+ L+ LR+ N +HRD+KPQNLLL       +  ++A            
Sbjct: 143 EVITRHFLKQLASALKFLREGNFVHRDVKPQNLLLLPSPLFRETHHSAKQILSASYDSLM 202

Query: 153 ----------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
                     LK+ADFGFAR L    LAETLCGSPLYMAPEI++ ++YDAKADLWSVG +
Sbjct: 203 PAAGLPSLPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYERYDAKADLWSVGTV 262

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
           L+++ TG+ PF   N ++LL+ I  A +    P   ++S + K L + LL+RNPVER++F
Sbjct: 263 LYEMATGRPPFRAGNHVELLRKIEAAEDQVKFPRESVVSPELKSLVRALLKRNPVERISF 322

Query: 263 EEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSG 322
            +FFNH  ++   P+            DD P  E + V++                    
Sbjct: 323 ADFFNHTVITGPIPNL---------HEDDLPKPEPQQVKETVR----------------- 356

Query: 323 PEGSPSFSKRRS 334
           PEGS S S+R S
Sbjct: 357 PEGSLSLSRRDS 368

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Podospora anserina (taxid: 5145)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7RX99|ATG1_NEUCR Serine/threonine-protein kinase atg-1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=atg-1 PE=3 SV=1

 Score =  271 bits (692), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 134/318 (42%), Positives = 194/318 (61%), Gaps = 48/318 (15%)

Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
            +G +++ ++IG GSF+ V+  RH+V G  VA+K + + RLNKKL+E+L  EI ILK + 
Sbjct: 20  AIGSFVIDQEIGKGSFAKVYLGRHKVTGALVAVKSVELARLNKKLKENLYGEIQILKTLR 79

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR---------------------HGCV 108
           HPHI+ LHD +E    ++LI+EYC+ GDLS++I++                     +  +
Sbjct: 80  HPHIVALHDCVESSTHINLIMEYCELGDLSLFIKKRDKLITNPYTHDLARKYPVYPNAGL 139

Query: 109 PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---------------- 152
            E   +HF+KQLA+ LQ LR  + +HRD+KPQNLLL       A                
Sbjct: 140 NEVVTRHFLKQLASALQFLRAGDFVHRDVKPQNLLLLPSPHMMANNKTAKHIMSGSYDSF 199

Query: 153 -----------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGA 201
                      LK+ADFGFAR L    LAETLCGSPLYMAPEI++ +KYDAKADLWSVG 
Sbjct: 200 TPAAGLASAPMLKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGT 259

Query: 202 ILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLT 261
           +L+++VTG+ PF  SN ++LL+ I  + ++       ++S + K L + LL++NPVER++
Sbjct: 260 VLYEMVTGRPPFKASNHVELLRKIESSGDVIKFTRESVVSQEMKGLIRALLKKNPVERIS 319

Query: 262 FEEFFNHPFLSQTQPDQV 279
           FE+ FNHP +++  P  V
Sbjct: 320 FEDLFNHPVVTEPIPGLV 337

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) (taxid: 367110)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1

 Score =  268 bits (685), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 143/315 (45%), Positives = 184/315 (58%), Gaps = 50/315 (15%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           VG Y    QIG GSF+ V+   H    T VA+K + + +LNKKL+E+L SEI ILK + H
Sbjct: 23  VGRYTRLGQIGKGSFATVYQGVHTKSRTYVAIKSVNLSQLNKKLKENLFSEIHILKGLYH 82

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ---------------------RHGCVP 109
           PHI+ L D  E    +HL++EYC  GDLS +I+                     R G + 
Sbjct: 83  PHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRNTLGEHRYTRDMIAKYPNPRGGALN 142

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD---------------------- 147
           E   +HF+KQLA+ L+ LRD NLIHRD+KPQNLLLC                        
Sbjct: 143 EVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLCPSPTSYRAGVAQIVPFKGSEDSFS 202

Query: 148 -----DDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
                D    LKIADFGFARSL    LAETLCGSPLYMAPEI++ +KYDAKADLWSVG +
Sbjct: 203 PATGLDSLPMLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 262

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLT 261
           L+++V GK PF  SN ++LL+ I +  + + FPP+    S D K L + LL+RNPVER+ 
Sbjct: 263 LYEMVVGKPPFRASNHVELLRRIERGEDNIKFPPE-NPASDDIKALIRMLLKRNPVERMN 321

Query: 262 FEEFFNHPFLSQTQP 276
           F +FF    ++   P
Sbjct: 322 FADFFESNVITSPIP 336

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P87248|ATG1_COLLN Serine/threonine-protein kinase ATG1 OS=Colletotrichum lindemuthianum GN=ATG1 PE=3 SV=1

 Score =  267 bits (683), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 150/355 (42%), Positives = 210/355 (59%), Gaps = 64/355 (18%)

Query: 2   SQATGRGR-----VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE 56
           S ++GR R      +G++++G +IG GSF+ V+   H+     VA+K + MGRLN KL+E
Sbjct: 8   STSSGRRRRDGDASIGEFVIGGEIGKGSFAQVYSGHHKNSKAAVAIKSVEMGRLNNKLRE 67

Query: 57  SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ---RHGC------ 107
           +L  EI ILK + HPHI+ LHD +E    ++L++EYC+ GDLS +I+   RHG       
Sbjct: 68  NLYGEIQILKTLRHPHIVALHDCVESATHINLVMEYCELGDLSFFIKKRDRHGTNAATED 127

Query: 108 ------------VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL----------- 144
                       + E   +HF++QLA+ L+ LR+ N +HRD+KPQNLLL           
Sbjct: 128 MARKYPVTPGSGLHEVVTRHFLQQLASALKFLREKNYVHRDVKPQNLLLLPSPGFRKENS 187

Query: 145 -----CTDDD---NAAL------KIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
                 ++D    NA L      K+ADFGFAR L    LA+TLCGSPLYMAPEI++ ++Y
Sbjct: 188 RPILTASNDSLIPNAGLASLPMLKLADFGFARVLPSTSLADTLCGSPLYMAPEILRYERY 247

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--LHFPPDAKILSADCKDLC 248
           DAKADLWSVG +L++++TG+ PF   N ++LL+ I +ATE  + +P DA ++S D   L 
Sbjct: 248 DAKADLWSVGTVLYEMITGRPPFRARNHVELLRKI-EATEDKVKYPKDA-VVSKDLVKLI 305

Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDV 303
            KLL RNPVER+ FE+FFN         D V    +     DD P  E K  RD+
Sbjct: 306 GKLLTRNPVERMRFEDFFN---------DPVVVGPIPGVVEDDIPKVEQKPSRDL 351

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Colletotrichum lindemuthianum (taxid: 290576)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A1CHL6|ATG1_ASPCL Serine/threonine-protein kinase atg1 OS=Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1) GN=atg1 PE=3 SV=1

 Score =  266 bits (681), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 144/319 (45%), Positives = 187/319 (58%), Gaps = 54/319 (16%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G Y    +IG GSF+ V+   H   GT VA+K + + +LNKKL+E+L SEI ILK + H
Sbjct: 3   LGRYTRLDEIGRGSFATVYQGVHTKTGTYVAIKSVNLSKLNKKLKENLSSEIHILKGLYH 62

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------------------GCVP 109
           PHI+ L D  E    +HL++EYC  GDLS++I+R                      G + 
Sbjct: 63  PHIVALIDCQETSSHIHLVMEYCALGDLSLFIKRRDTLGDHRYTRDMIAKYPNPPGGALN 122

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC-----------------------T 146
           E   +HF+KQL++ L+ LRD NLIHRD+KPQNLLLC                        
Sbjct: 123 EVVVRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLCPSPSSYRSGAGSGAATVVPFKGCE 182

Query: 147 DDDNAA--------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWS 198
           D  N A        LKIADFGFARSL    LAETLCGSPLYMAPEI++ +KYDAKADLWS
Sbjct: 183 DSFNPATGVDSLPLLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLWS 242

Query: 199 VGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPV 257
           VG +L+++V GK PF  +N ++LL+ I K  + + FP D     A  K L + LL+RNPV
Sbjct: 243 VGTVLYEMVVGKPPFRATNHVELLRKIEKGEDRIKFPEDNPASDA-IKALIRALLKRNPV 301

Query: 258 ERLTFEEFFNHPFLSQTQP 276
           ERL F EFF +  ++   P
Sbjct: 302 ERLNFPEFFENEVITGPIP 320

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1) (taxid: 344612)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1

 Score =  266 bits (680), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 147/343 (42%), Positives = 197/343 (57%), Gaps = 60/343 (17%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G Y    +IG GSF+ V+   H    T VA+K + + +LNKKL+E+L SEI ILK ++H
Sbjct: 19  IGRYTRLDEIGRGSFATVYQGVHTKSKTYVAIKSVNLSKLNKKLKENLSSEIDILKGLHH 78

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------------------GCVP 109
           PHI+ L D  E    +HL++EYC  GDLS++I+R                      G + 
Sbjct: 79  PHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRDTLGSHKYTRDMIAKYPNPPGGSLN 138

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-----------------DDN-- 150
           E   +HF+KQL++ L+ LRD NLIHRD+KPQNLLLC                   DD+  
Sbjct: 139 EVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLCPSPSSYRSGHAQVMPYKGSDDSYE 198

Query: 151 --------AALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
                     LKIADFGFARSL    LAETLCGSPLYMAPEI++ +KYDAKADLWSVG +
Sbjct: 199 PTTGLESLPMLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 258

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLT 261
           L+++V G+ PF  +N ++LL+ I K  + + FP D    S D K L + LL+RNPVERL 
Sbjct: 259 LYEMVVGRPPFRATNHVELLRKIEKGEDRIRFPED-NPASDDIKKLIRGLLKRNPVERLN 317

Query: 262 FEEFFNHPFLSQ----------TQPDQVFRSRMFSRSADDFPF 294
           F EFF++  ++             P Q  R R     A++ P+
Sbjct: 318 FPEFFSNNVINDPIPGLLADDAPGPPQSPRPRQLVGKAEESPY 360

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q4WPF2|ATG1_ASPFU Serine/threonine-protein kinase atg1 OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) GN=atg1 PE=3 SV=1

 Score =  265 bits (678), Expect = 5e-70,   Method: Compositional matrix adjust.
 Identities = 145/331 (43%), Positives = 190/331 (57%), Gaps = 57/331 (17%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G Y    +IG GSF+ V+   H    T VA+K + + +LNKKL+++L SEI ILK + H
Sbjct: 20  IGRYTRLDEIGRGSFATVYQGVHTKTRTYVAIKSVNLSKLNKKLKDNLSSEIHILKGLYH 79

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------------------GCVP 109
           PHI+ L D  E    +HL++EYC  GDLS++I+R                      G + 
Sbjct: 80  PHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRDTLGDHRYTRDMIAKYPNPPGGALN 139

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC-------------------TDDDN 150
           E   +HF+KQLA+ L+ LRD NLIHRD+KPQNLLLC                    D  N
Sbjct: 140 EVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLCPSPSSYRSGVTQVVPFKGSEDSFN 199

Query: 151 AA--------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
            A        LKIADFGFARSL    LAETLCGSPLYMAPEI++ +KYDAKADLWSVG +
Sbjct: 200 PATGLESLPLLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 259

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
           L+++V GK PF  +N ++LL+ I K  +    P+    S + K L + LL+RNPVERL F
Sbjct: 260 LYEMVVGKPPFRATNHVELLRKIEKGEDRIKFPEENPASDEIKALIRALLKRNPVERLNF 319

Query: 263 EEFFNHPFLSQTQPDQVFRSRMFSRSADDFP 293
            +FF +  ++   P  V         ADD P
Sbjct: 320 PDFFQNGVITSPIPGLV---------ADDLP 341

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (taxid: 330879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6C7U0|ATG1_YARLI Serine/threonine-protein kinase ATG1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) GN=ATG1 PE=3 SV=1

 Score =  265 bits (677), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 149/369 (40%), Positives = 212/369 (57%), Gaps = 59/369 (15%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +  Y +G ++G GSF+ V+   H   G+ VA+K +   +LN+KL E+L SEI ILK++ H
Sbjct: 4   IKSYTIGNELGRGSFATVYKGEHVASGSPVAIKSVLRAKLNRKLLENLGSEISILKQMKH 63

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVP----------------- 109
           PH++ L D  E P   HL++EYC  GDLS ++++       +P                 
Sbjct: 64  PHVVELLDFQETPTHFHLVMEYCSLGDLSFFLKKKKELSETLPLVASLLRRYPSNTRGLH 123

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC------TDDDNA---------ALK 154
           EE  +HF+ QL+A L+ LR  NL+HRD+KPQNLLLC       D  NA          LK
Sbjct: 124 EELVRHFVHQLSAALEFLRQKNLVHRDIKPQNLLLCPPSLSEMDAQNANLYGRWELPILK 183

Query: 155 IADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT 214
           IADFGFAR L    LAETLCGSPLYMAPEI++ +KY+AKADLWSVGA+ +++V GK PF 
Sbjct: 184 IADFGFARILPASALAETLCGSPLYMAPEILRYEKYNAKADLWSVGAVTYEMVVGKPPFK 243

Query: 215 GSNQIQLLQNIVKATEL----HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
            +N ++LL+ I ++ ++      PP     S D +D  + LL++NP +R+ F+E+F HP 
Sbjct: 244 ANNYVELLKTIEQSNDVIGFGREPP-----SEDMQDFVRCLLKKNPADRIGFKEYFEHPI 298

Query: 271 LSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFS 330
           ++  Q   +       RS  D   Y       ++E  Q+  LP  LD D        SFS
Sbjct: 299 IANKQ--VIGSGEELDRSQLDPRMY-------ISEYIQEADLP-KLDLDRE----MDSFS 344

Query: 331 KRRSSMKST 339
           ++RS+ KS+
Sbjct: 345 QKRSTQKSS 353

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Yarrowia lipolytica (strain CLIB 122 / E 150) (taxid: 284591)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A1CX69|ATG1_NEOFI Serine/threonine-protein kinase atg1 OS=Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / FGSC A1164 / NRRL 181) GN=atg1 PE=3 SV=1

 Score =  264 bits (674), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 141/317 (44%), Positives = 186/317 (58%), Gaps = 48/317 (15%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G Y    +IG GSF+ V+   H    T VA+K + + +LNKKL+++L SEI ILK + H
Sbjct: 3   IGRYTRLDEIGRGSFATVYQGVHTKTRTYVAIKSVNLSKLNKKLKDNLSSEIHILKGLYH 62

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------------------GCVP 109
           PHI+ L D  E    +HL++EYC  GDLS++I+R                      G + 
Sbjct: 63  PHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRDTLGDHRYTRDMIAKYPNPPGGALN 122

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC-------------------TDDDN 150
           E   +HF+KQLA+ L+ LRD NLIHRD+KPQNLLLC                    D  N
Sbjct: 123 EVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLCPSPSSYRSGVTQVVPFKGSEDSFN 182

Query: 151 AA--------LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI 202
            A        LKIADFGFARSL    LAETLCGSPLYMAPEI++ +KYDAKADLWSVG +
Sbjct: 183 PATGLESLPLLKIADFGFARSLPATSLAETLCGSPLYMAPEILRYEKYDAKADLWSVGTV 242

Query: 203 LFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
           L+++V GK PF  +N ++LL+ I K  +    P+    S + K L + LL+RNPVERL F
Sbjct: 243 LYEMVVGKPPFRATNHVELLRKIEKGEDRIKFPEENPASDEIKALIRALLKRNPVERLNF 302

Query: 263 EEFFNHPFLSQTQPDQV 279
            +FF +  ++   P  V
Sbjct: 303 PDFFENGVITSPIPGLV 319

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / FGSC A1164 / NRRL 181) (taxid: 331117)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	575
297740304	716	unnamed protein product [Vitis vinifera]	1.0	0.803	0.750	0.0
225440496	732	PREDICTED: serine/threonine-protein kina	1.0	0.785	0.750	0.0
224090827	724	predicted protein [Populus trichocarpa]	0.973	0.773	0.739	0.0
224140327	727	predicted protein [Populus trichocarpa]	0.979	0.774	0.743	0.0
255577981	694	serine/threonine-protein kinase, putativ	0.994	0.824	0.738	0.0
356504236	732	PREDICTED: uncharacterized protein LOC10	0.994	0.781	0.688	0.0
356494830	720	PREDICTED: uncharacterized protein LOC10	0.984	0.786	0.685	0.0
449439966	725	PREDICTED: uncharacterized protein LOC10	0.989	0.784	0.659	0.0
297823655	733	kinase family protein [Arabidopsis lyrat	0.996	0.781	0.677	0.0
30687274	733	unc51-like kinase [Arabidopsis thaliana]	0.996	0.781	0.675	0.0

>gi|297740304|emb|CBI30486.3| unnamed protein product [Vitis vinifera]

 Score =  870 bits (2249), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/585 (75%), Positives = 487/585 (83%), Gaps = 10/585 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+Q   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVA+KEI  GRLNKKLQESLMS
Sbjct: 1   MAQTPSRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEIVTGRLNKKLQESLMS 60

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EIFILK+INHP+IIRLHDIIEVPGK+HL+LEYC+GGDLSMYIQ +  VPE TAKHFM+QL
Sbjct: 61  EIFILKKINHPNIIRLHDIIEVPGKIHLVLEYCRGGDLSMYIQSYVRVPEATAKHFMQQL 120

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           AAGLQVLRDNNLIHRDLKPQNLLL T+D+N+ LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct: 121 AAGLQVLRDNNLIHRDLKPQNLLLSTNDNNSVLKIADFGFARSLQPRGLAETLCGSPLYM 180

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG+NQIQLLQNIVK++ELHFPPD   L
Sbjct: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNNQIQLLQNIVKSSELHFPPDNNDL 240

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS+ QPD+   SR  SR  D FP  E   V
Sbjct: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSRKQPDEALSSRRSSRIIDGFPLSECNPV 300

Query: 301 RDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK-HGREATSSALNN 359
           R+  ESSQ+DC+PF LDDDSSGPEGSPSF +RRSSMKSTYGFS+D K   RE   +  NN
Sbjct: 301 RNTEESSQEDCMPFPLDDDSSGPEGSPSFLRRRSSMKSTYGFSLDKKVDRRETIFNTPNN 360

Query: 360 LDL--RY---GNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSL-DLVDQD 413
           +DL  +Y    +K + T  R DS + SDEN+ EP K ++QR   + S+V DSL +LVDQD
Sbjct: 361 MDLASKYSSASHKPEITGFRIDSLRPSDENVKEPLKSMEQRPMRSCSRVVDSLEELVDQD 420

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIP-RTSERPLISVPKYTTSSAPVPIIGATNSKISHIG 472
           YV VSGPPMD SSSS   SKP+H   R+   PL SV   T SSAP+PI GA  +   + G
Sbjct: 421 YVFVSGPPMDVSSSSAIASKPSHSQCRSGSAPLTSVNMKTKSSAPMPIAGAGITNTFYTG 480

Query: 473 SLESQSSAP-GTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEG 531
           SLES SSAP GTS GS D+GDALEQPSTHCMTRIKSL++CA  ITELVNEKI AGK LE 
Sbjct: 481 SLESHSSAPSGTSQGSMDIGDALEQPSTHCMTRIKSLQQCASVITELVNEKIEAGKQLEA 540

Query: 532 FSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRL-RSSRKKH 575
           FSIQLVILAIWKQALHICHTQAASAM+GSP+ E++RL RS+ KKH
Sbjct: 541 FSIQLVILAIWKQALHICHTQAASAMEGSPTQETSRLRRSTDKKH 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225440496|ref|XP_002273930.1| PREDICTED: serine/threonine-protein kinase atg-1 [Vitis vinifera]

 Score =  869 bits (2246), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/585 (75%), Positives = 487/585 (83%), Gaps = 10/585 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+Q   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVA+KEI  GRLNKKLQESLMS
Sbjct: 1   MAQTPSRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEIVTGRLNKKLQESLMS 60

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EIFILK+INHP+IIRLHDIIEVPGK+HL+LEYC+GGDLSMYIQ +  VPE TAKHFM+QL
Sbjct: 61  EIFILKKINHPNIIRLHDIIEVPGKIHLVLEYCRGGDLSMYIQSYVRVPEATAKHFMQQL 120

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           AAGLQVLRDNNLIHRDLKPQNLLL T+D+N+ LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct: 121 AAGLQVLRDNNLIHRDLKPQNLLLSTNDNNSVLKIADFGFARSLQPRGLAETLCGSPLYM 180

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG+NQIQLLQNIVK++ELHFPPD   L
Sbjct: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNNQIQLLQNIVKSSELHFPPDNNDL 240

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS+ QPD+   SR  SR  D FP  E   V
Sbjct: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSRKQPDEALSSRRSSRIIDGFPLSECNPV 300

Query: 301 RDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK-HGREATSSALNN 359
           R+  ESSQ+DC+PF LDDDSSGPEGSPSF +RRSSMKSTYGFS+D K   RE   +  NN
Sbjct: 301 RNTEESSQEDCMPFPLDDDSSGPEGSPSFLRRRSSMKSTYGFSLDKKVDRRETIFNTPNN 360

Query: 360 LDL--RYGN---KLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSL-DLVDQD 413
           +DL  +Y +   K + T  R DS + SDEN+ EP K ++QR   + S+V DSL +LVDQD
Sbjct: 361 MDLASKYSSASHKPEITGFRIDSLRPSDENVKEPLKSMEQRPMRSCSRVVDSLEELVDQD 420

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIP-RTSERPLISVPKYTTSSAPVPIIGATNSKISHIG 472
           YV VSGPPMD SSSS   SKP+H   R+   PL SV   T SSAP+PI GA  +   + G
Sbjct: 421 YVFVSGPPMDVSSSSAIASKPSHSQCRSGSAPLTSVNMKTKSSAPMPIAGAGITNTFYTG 480

Query: 473 SLESQSSAP-GTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEG 531
           SLES SSAP GTS GS D+GDALEQPSTHCMTRIKSL++CA  ITELVNEKI AGK LE 
Sbjct: 481 SLESHSSAPSGTSQGSMDIGDALEQPSTHCMTRIKSLQQCASVITELVNEKIEAGKQLEA 540

Query: 532 FSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRL-RSSRKKH 575
           FSIQLVILAIWKQALHICHTQAASAM+GSP+ E++RL RS+ KKH
Sbjct: 541 FSIQLVILAIWKQALHICHTQAASAMEGSPTQETSRLRRSTDKKH 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090827|ref|XP_002309098.1| predicted protein [Populus trichocarpa] gi|222855074|gb|EEE92621.1| predicted protein [Populus trichocarpa]

 Score =  842 bits (2174), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/573 (73%), Positives = 472/573 (82%), Gaps = 13/573 (2%)

Query: 1   MSQATGR-GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM 59
           M+QA+GR GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVA+KEI   RLNKKLQESLM
Sbjct: 1   MAQASGRSGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEIVTNRLNKKLQESLM 60

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           SEIFILKRINHP+IIRLHDII+VPG++ ++LEYC+GGDLSMYIQRHG VPE  AKHFM+Q
Sbjct: 61  SEIFILKRINHPNIIRLHDIIKVPGRILIVLEYCEGGDLSMYIQRHGKVPEAIAKHFMQQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LAAGLQ+LRDNNLIHRDLKPQNLLL T D+NA LKIADFGFARSLQPRGLAETLCGSPLY
Sbjct: 121 LAAGLQILRDNNLIHRDLKPQNLLLSTSDNNAVLKIADFGFARSLQPRGLAETLCGSPLY 180

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP+TG+NQIQLLQNIVK+ EL FP D K 
Sbjct: 181 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPYTGNNQIQLLQNIVKSAELQFPFDNKD 240

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKS 299
           LSA CKDLC+KLL  NPVERLTFEEFFNHPFLSQ + D++ RS   SRS D FPF  S  
Sbjct: 241 LSAGCKDLCRKLLCCNPVERLTFEEFFNHPFLSQRKKDELLRS---SRSVDGFPFSGSNP 297

Query: 300 VRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK-HGREATSSALN 358
            R+  ++SQ+DCLPF LDDDSS PEGSPS SKR S MKSTYGFS+D++  GR+ATS+  N
Sbjct: 298 ARNADDNSQEDCLPFLLDDDSSCPEGSPSVSKRMSPMKSTYGFSLDSRIGGRDATSNVFN 357

Query: 359 NLDL--RYGN---KLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQD 413
           N+DL  RY +    L+N + R    K SDENLNEPPK +DQR  N RS+V DSLDL+DQD
Sbjct: 358 NVDLTSRYSSARQNLENASFRPGINKASDENLNEPPKSIDQRSVNIRSRVVDSLDLIDQD 417

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKYTTS--SAPVPIIGATNSKISHI 471
           YVLVSGPP++ SSS+ S  KP + P  SE P  +   YT +  S PVPII   N+     
Sbjct: 418 YVLVSGPPLNVSSSTASTYKPGNAPYKSEGPSQAF-TYTNTRLSIPVPIIDTANNNPCRF 476

Query: 472 GSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEG 531
           GSLE  +SAPGTS GS DMGDALEQPSTHCMTRIKSL+ CA AI ELV EKI AG+ LE 
Sbjct: 477 GSLEIPASAPGTSEGSLDMGDALEQPSTHCMTRIKSLQHCASAIMELVVEKIKAGRQLEA 536

Query: 532 FSIQLVILAIWKQALHICHTQAASAMDGSPSGE 564
           FSIQLVILAIWKQ LHICHTQAASA++GSPS E
Sbjct: 537 FSIQLVILAIWKQVLHICHTQAASAIEGSPSQE 569

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224140327|ref|XP_002323534.1| predicted protein [Populus trichocarpa] gi|222868164|gb|EEF05295.1| predicted protein [Populus trichocarpa]

 Score =  840 bits (2169), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/573 (74%), Positives = 474/573 (82%), Gaps = 10/573 (1%)

Query: 1   MSQATGR-GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM 59
           M+QATGR GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVA+KEI   RLNKKLQESLM
Sbjct: 1   MAQATGRNGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEIVTNRLNKKLQESLM 60

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           SEIFILKRINHP+IIRLHDIIE PG++H++LEYCKGGDLSMYIQRHG VPE  A HFM+Q
Sbjct: 61  SEIFILKRINHPNIIRLHDIIEAPGRIHIVLEYCKGGDLSMYIQRHGRVPEAIANHFMQQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LAAGLQ+LRDNNLIHRDLKPQNLLL T D NA LKIADFGFARSLQPRGLAETLCGSPLY
Sbjct: 121 LAAGLQILRDNNLIHRDLKPQNLLLSTSDGNAVLKIADFGFARSLQPRGLAETLCGSPLY 180

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG+NQIQLLQNIVK+T+L FP D K 
Sbjct: 181 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGNNQIQLLQNIVKSTQLQFPLDNKD 240

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKS 299
           LSADCKDLCQKLLRR+PVERLTFEEFFNHPFLSQ + D+    R  SRS D FPF ES  
Sbjct: 241 LSADCKDLCQKLLRRSPVERLTFEEFFNHPFLSQRKKDESLSRRRSSRSVDGFPFSESNL 300

Query: 300 VRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK-HGREATSSALN 358
            R+  ++SQ+DCLPF LDDDSSG E SP  SKR S MKSTYGFS+D++  GR+ATS+ LN
Sbjct: 301 GRNADDNSQEDCLPFLLDDDSSGLECSPFVSKRMSPMKSTYGFSLDSRVGGRDATSNVLN 360

Query: 359 NLDL--RYGN---KLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQD 413
           ++D   RY +    L+N + R    K  DE+LNEPPK ++QR AN RS+V DSL+L++QD
Sbjct: 361 DVDFTSRYDSARQNLENASFRPGINKALDESLNEPPKSINQRSANLRSRVVDSLELIEQD 420

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKY--TTSSAPVPIIGATNSKISHI 471
           YV+VSGPP+D SSS+ S SKP++    SE P    P Y  TT S P+PII   N  +   
Sbjct: 421 YVIVSGPPLDVSSSTASTSKPSNAQCKSESP-SRAPAYINTTPSVPMPIISTANKNLCLF 479

Query: 472 GSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEG 531
           GSLE  SSAPGTS GS D+GDALEQPSTHCMTRIKSL++CA AITELV EKI A K LE 
Sbjct: 480 GSLEIPSSAPGTSEGSVDLGDALEQPSTHCMTRIKSLQQCASAITELVLEKIKASKLLEA 539

Query: 532 FSIQLVILAIWKQALHICHTQAASAMDGSPSGE 564
           FSIQLVILAIWKQALHICHTQAASA++GSPS E
Sbjct: 540 FSIQLVILAIWKQALHICHTQAASAIEGSPSLE 572

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577981|ref|XP_002529862.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223530638|gb|EEF32512.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  837 bits (2161), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/582 (73%), Positives = 493/582 (84%), Gaps = 10/582 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+QA GRGRVVG+YLVGRQIGSGSFSVVWHARHRVHGTEVA+KEIA  RLNKKLQESLMS
Sbjct: 1   MAQAPGRGRVVGEYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEIATSRLNKKLQESLMS 60

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EIFILKRINHP+II LHDIIEVPG++++ILEYCKGGDLSMYIQRHG VPE  AK+FM+QL
Sbjct: 61  EIFILKRINHPNIICLHDIIEVPGRINIILEYCKGGDLSMYIQRHGKVPEAIAKNFMQQL 120

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           AAGLQ+LRDNNLIHRDLKPQNLLL T D NA LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct: 121 AAGLQILRDNNLIHRDLKPQNLLLSTTDSNAVLKIADFGFARSLQPRGLAETLCGSPLYM 180

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG+NQIQLLQNIVK+TEL FP D+K L
Sbjct: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGNNQIQLLQNIVKSTELQFPSDSKDL 240

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           SA+CKDLCQKLLRRNPVERLTF+EFFNH FLSQ   D+  R+R F++S + FP  ES S 
Sbjct: 241 SAECKDLCQKLLRRNPVERLTFDEFFNHSFLSQKNVDESLRNRRFAKSVESFPLCESNSE 300

Query: 301 RDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK-HGREATSSALNN 359
           R++ + S +DCLPFFLDDDSSGP+GSPSFS+RRSSMKSTYGFS+D +  G+EA S+ LNN
Sbjct: 301 RNMEDISPEDCLPFFLDDDSSGPDGSPSFSRRRSSMKSTYGFSLDTRVDGKEAKSNVLNN 360

Query: 360 LDLRYG-----NKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDY 414
            D  +      N L+NT+L+ +  K  D+NL+EPPK ++QR  N RS+V DSL+L+DQDY
Sbjct: 361 TDFAHTYSSTRNNLENTSLKPEISKFPDDNLHEPPKFMNQRSINARSRVVDSLELIDQDY 420

Query: 415 VLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKYTTSSAPVPIIGATNSKISHIGSL 474
           VLVSGPP+D SSSS S SKP+HIP     P  ++     ++AP+PI    NS + H+GSL
Sbjct: 421 VLVSGPPLDGSSSSASASKPSHIPSKLPSPQATI---NLNTAPMPITCTVNSNMCHVGSL 477

Query: 475 ESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSI 534
           +S SSAPGTS GSTD+GD LEQPSTHCMTRIKSL++CA AI+ELV+EK+ +GK LE FSI
Sbjct: 478 DSPSSAPGTSHGSTDIGDVLEQPSTHCMTRIKSLQQCAAAISELVHEKVESGKQLEAFSI 537

Query: 535 QLVILAIWKQALHICHTQAASAMDGSPSGESTRL-RSSRKKH 575
           QLVILAIWKQALHICHT+AASA++ S S ESTRL RS  KKH
Sbjct: 538 QLVILAIWKQALHICHTRAASAIEDSSSQESTRLRRSGSKKH 579

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504236|ref|XP_003520903.1| PREDICTED: uncharacterized protein LOC100791596 [Glycine max]

 Score =  794 bits (2050), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/585 (68%), Positives = 468/585 (80%), Gaps = 13/585 (2%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+QA GR RVVGDY+VG+QIG+GSFSVVWH RH+VHGTEVA+KEIA  RLNKKLQESLMS
Sbjct: 1   MAQAAGRSRVVGDYVVGKQIGAGSFSVVWHGRHKVHGTEVAIKEIATLRLNKKLQESLMS 60

Query: 61  EIFILKRINHPHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           EIFILKRINHP+II LHDII +V GK+HL+LEYCKGGDLS+YIQRHG VPE TAKHFM Q
Sbjct: 61  EIFILKRINHPNIISLHDIINQVHGKIHLVLEYCKGGDLSLYIQRHGKVPEATAKHFMLQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LAAGLQVLRDNNLIHRDLKPQNLLL  +D+ + LKIADFGFARSLQPRGLAETLCGSPLY
Sbjct: 121 LAAGLQVLRDNNLIHRDLKPQNLLLSRNDEKSVLKIADFGFARSLQPRGLAETLCGSPLY 180

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG+NQIQLLQNI+K+TEL FP D++ 
Sbjct: 181 MAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNNQIQLLQNIMKSTELQFPSDSQS 240

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKS 299
           LS +CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ Q +Q    R   R    F    S  
Sbjct: 241 LSFECKDLCQKLLRRNPVERLTFEEFFNHPFLSQKQTEQDEPLRSSPRLVGGFCSTGSDP 300

Query: 300 VRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGREATSSAL-N 358
           +R   E+ Q+DCLPF LDDDSSGPEGSPSFS+++SSMKSTYGF ++AK  +  +SS + N
Sbjct: 301 LRRTEENYQEDCLPFMLDDDSSGPEGSPSFSRKKSSMKSTYGFDLNAKLDKAESSSPISN 360

Query: 359 NLDLRYG-----NKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSK-VGDSLDLVDQ 412
           N++   G      + +NT  R D++K+S  NL  P +  +Q   +   K V DSL+ +DQ
Sbjct: 361 NINHTSGFGSVTQRSENTTKRLDNHKIS-RNLTNPLESPEQLFTSPYPKAVTDSLENIDQ 419

Query: 413 DYVLVSGPPMDTSSSSTSVSKPTHIP-RTSERPLISVPKYTTSSAPVPIIGATNSKISHI 471
           +YVLVSGPP+D SSSS   S+P+H P R+   P  S    T  S P+PI+G  ++ I  I
Sbjct: 420 EYVLVSGPPIDVSSSSVGASRPSHTPYRSGSLPQESSSTITRLSVPMPIVGVPSNSICQI 479

Query: 472 GSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEG 531
           GS  SQ SAPGTSLGS D GD  EQPS HCMTR+KSL++CA +ITELVNEK+ AGKHLE 
Sbjct: 480 GSSGSQDSAPGTSLGSMDTGD--EQPSAHCMTRVKSLQQCASSITELVNEKMEAGKHLEA 537

Query: 532 FSIQLVILAIWKQALHICHTQAASAMDGSPSGESTRL-RSSRKKH 575
           FSIQLVILAIWKQALHICHTQAASAM+GSP+ E++R  RS+ +KH
Sbjct: 538 FSIQLVILAIWKQALHICHTQAASAMEGSPNQETSRYRRSTSRKH 582

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356494830|ref|XP_003516286.1| PREDICTED: uncharacterized protein LOC100789255 [Glycine max]

 Score =  764 bits (1973), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/579 (68%), Positives = 464/579 (80%), Gaps = 13/579 (2%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+QA GR RVVGDY+VG+QIG+GSFSVVWH RH+VHGTEVA+KEIA  RLNKKLQESLMS
Sbjct: 1   MAQAAGRSRVVGDYVVGKQIGAGSFSVVWHGRHKVHGTEVAIKEIATLRLNKKLQESLMS 60

Query: 61  EIFILKRINHPHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           EIFILKRINHP+II LHDII +VPGK+HL+LEYCKGGDLS+YIQRHG VPE TAKHFM+Q
Sbjct: 61  EIFILKRINHPNIISLHDIINQVPGKIHLVLEYCKGGDLSLYIQRHGRVPEATAKHFMQQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LAAGLQVLRDNNLIHRDLKPQNLLL  +D+ + LKIADFGFARSLQPRGLAETLCGSPLY
Sbjct: 121 LAAGLQVLRDNNLIHRDLKPQNLLLSRNDEKSVLKIADFGFARSLQPRGLAETLCGSPLY 180

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG+NQIQLLQNI+K+TEL FP D+  
Sbjct: 181 MAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNNQIQLLQNIMKSTELQFPSDSPS 240

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKS 299
           LS +CKDLCQK+LRRNPVERLTFEEFFNHPFL+Q Q +     R  S S  D  F  + S
Sbjct: 241 LSFECKDLCQKMLRRNPVERLTFEEFFNHPFLAQKQTE-----RDESSSRMDGGFCSTVS 295

Query: 300 -VRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGREATSSALN 358
            +R   E+ Q+DCLPF LDDDSSGPEGS SFS+++SSMKSTYGF ++AK  +  +SS ++
Sbjct: 296 DLRRTEENYQEDCLPFMLDDDSSGPEGSSSFSRKKSSMKSTYGFDLNAKLDKAESSSPIS 355

Query: 359 NLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLVS 418
                   + +NT  R D++ +S  NL +P +  +Q  A+   KV DSL+ +DQ+YVLVS
Sbjct: 356 GFG-SMTQRSENTTKRLDNHTIS-RNLTDPLESPEQLFASPYPKVMDSLENIDQEYVLVS 413

Query: 419 GPPMDTSSSSTSVSKPTHIP-RTSERPLISVPKYTTSSAPVPIIGATNSKISHIGSLESQ 477
           GP +D SS S   S+P H P R+   P  S    T  SAP+PI+G   + +  IGS  SQ
Sbjct: 414 GPTIDVSSLSVGASRPIHTPSRSGSLPQESSSTITRLSAPMPIVGVPTNSVCQIGSSGSQ 473

Query: 478 SSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQLV 537
            SAPGTSLGS D GD  EQPS HCMTR+KSL++CA +ITELVNEK+ AGKHLE FSIQLV
Sbjct: 474 DSAPGTSLGSMDTGD--EQPSAHCMTRVKSLQQCASSITELVNEKMEAGKHLEAFSIQLV 531

Query: 538 ILAIWKQALHICHTQAASAMDGSPSGESTRL-RSSRKKH 575
           ILAIWKQALHICHTQAASAM+GSP+ E++R  RS+ +KH
Sbjct: 532 ILAIWKQALHICHTQAASAMEGSPNQETSRYRRSTSRKH 570

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439966|ref|XP_004137756.1| PREDICTED: uncharacterized protein LOC101221608 [Cucumis sativus] gi|449483421|ref|XP_004156586.1| PREDICTED: uncharacterized protein LOC101228985 [Cucumis sativus]

 Score =  745 bits (1923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/581 (65%), Positives = 448/581 (77%), Gaps = 12/581 (2%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+ +TGR RVV DYLVGRQIGSGSFSVVWHARHRVHGTEVA+KEI+M RL+KKLQ+SLMS
Sbjct: 1   MAHSTGRTRVVADYLVGRQIGSGSFSVVWHARHRVHGTEVAIKEISMSRLSKKLQDSLMS 60

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQ 119
           EIFILKRINHP+IIRL DIIEVPGK+HL+LEYC+GGDLS YIQ RHG +PE  AKHF++Q
Sbjct: 61  EIFILKRINHPNIIRLFDIIEVPGKIHLVLEYCRGGDLSFYIQQRHGRIPEAIAKHFLQQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LAAGL++LRDNNLIHRDLKPQNLLL T ++++ LKIADFGFARSLQPRGLAETLCGSPLY
Sbjct: 121 LAAGLKILRDNNLIHRDLKPQNLLLSTSEEHSVLKIADFGFARSLQPRGLAETLCGSPLY 180

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG+NQIQLLQNIVK+ ELHFP D   
Sbjct: 181 MAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNNQIQLLQNIVKSNELHFPLDIND 240

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKS 299
           LS DCKDLC+KLLRRNPVERLTFEEFF HPFL   Q D+  RS+  SR  D+FPF ES  
Sbjct: 241 LSNDCKDLCRKLLRRNPVERLTFEEFFKHPFLCANQADESLRSKRSSRLLDEFPFSESDP 300

Query: 300 VRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK--HGREATSSAL 357
              + E+SQD+ LPF LDDDSSGPEGSPS  +R SS KSTYGFS D K   G   TS   
Sbjct: 301 ASKMEENSQDEYLPFSLDDDSSGPEGSPSL-RRMSSTKSTYGFSPDKKVDRGTRGTSRHS 359

Query: 358 NNLD-LRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVL 416
           +  D +     + +T ++ +    SD +LN   + ++ R  N R +V DSL+ +DQDYV+
Sbjct: 360 SVPDKMESATLISDTRVQLERDVHSDRSLNSVLRSVNPRSVNNRPRVVDSLESIDQDYVI 419

Query: 417 VSGPPMDTSSSS-TSVSKPTHIPRTSERPLISVPKYTTSSAPVPIIG-ATNSKISH-IGS 473
           VSGPP+D  SS+  S S+P    ++   P  S+   T  +AP+PIIG AT +  S+ +GS
Sbjct: 420 VSGPPIDDPSSTLASASRPIPSHKSQSPPQTSISLGTALTAPMPIIGRATTTTSSYRMGS 479

Query: 474 LESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFS 533
           L SQSSAP    GS D+ D LEQPS +C  R+KSL++ A  ITELV EKI AG+ LE FS
Sbjct: 480 LGSQSSAP----GSMDIEDTLEQPSANCRARVKSLQQSASTITELVKEKITAGRQLEAFS 535

Query: 534 IQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKK 574
           IQLVILAIWK+AL ICHTQAASA++GSP   S   R S  K
Sbjct: 536 IQLVILAIWKKALDICHTQAASALEGSPGQGSAEFRRSLSK 576

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297823655|ref|XP_002879710.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297325549|gb|EFH55969.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  743 bits (1917), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/583 (67%), Positives = 459/583 (78%), Gaps = 10/583 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+Q TGR  VVGDYLVGRQIGSGSFSVVW ARHRV GTEVA+KEIAM RLNKKLQESLMS
Sbjct: 1   MAQFTGR--VVGDYLVGRQIGSGSFSVVWEARHRVDGTEVAIKEIAMDRLNKKLQESLMS 58

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EIFIL+RINHP+IIR+ D+I+ PGK+HL+LEYCKGGDLS+Y+QRHG VPE TAK+FM+QL
Sbjct: 59  EIFILRRINHPNIIRMIDMIKSPGKVHLVLEYCKGGDLSVYVQRHGIVPEATAKYFMQQL 118

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           AAGLQVLRDNN+IHRDLKPQNLLL TD+++A LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct: 119 AAGLQVLRDNNIIHRDLKPQNLLLSTDENDADLKIADFGFARSLQPRGLAETLCGSPLYM 178

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG++QIQLLQNI+++T LHFP D + L
Sbjct: 179 APEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTGLHFPGDCRDL 238

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           S DC DLCQKLLRRNPVERLTFEEFFNHPFLS  Q     RSR+  R+ D F    S   
Sbjct: 239 SLDCIDLCQKLLRRNPVERLTFEEFFNHPFLSDRQSYDFSRSRLGLRTMDGFLSSGSSPS 298

Query: 301 RDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGR-EATSSALNN 359
           R++ ESSQDDCLPF LD DSSGPEGSPS+ K+ SSMKS+ GF VD K  R EA SS L  
Sbjct: 299 RNMEESSQDDCLPFLLDYDSSGPEGSPSYLKKTSSMKSSSGFKVDTKIERKEAESSPLKY 358

Query: 360 LDLRYG-----NKLDNTNLRHDSYKLSD-ENLNEPPKCLDQRLANTRSKVGDSLDLVDQD 413
            +   G      K++N   R ++   SD  N  EP    D R       V DS D +DQD
Sbjct: 359 TEFTSGYSSVDQKVENNRFRFETQINSDRRNRREPTGLTDSRSLIAPGGVDDSQDSMDQD 418

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISV-PKYTTSSAPVPIIGATNSKISHIG 472
           +VLVSGPP+D  SSS+S SKP + P  S+ P + +  +  +S+AP+PIIGAT + I   G
Sbjct: 419 FVLVSGPPVDMPSSSSSSSKPYNFPFKSQSPPVELFNRSISSTAPMPIIGATGNSIGRFG 478

Query: 473 SLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGF 532
           SL+SQ+SAP TS GS D+GDA EQPSTH +TRI+SL++CA +I ELV+E+I + KHLE F
Sbjct: 479 SLDSQNSAPSTSHGSLDLGDAFEQPSTHSLTRIRSLRKCAASIAELVHERIESDKHLEAF 538

Query: 533 SIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH 575
           SIQL ILAIWKQALHICHTQA S ++GSPS +  +LRSS  KH
Sbjct: 539 SIQLAILAIWKQALHICHTQAISGLEGSPSQDINKLRSSSLKH 581

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30687274|ref|NP_850285.1| unc51-like kinase [Arabidopsis thaliana] gi|330254361|gb|AEC09455.1| unc51-like kinase [Arabidopsis thaliana]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/583 (67%), Positives = 459/583 (78%), Gaps = 10/583 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M+Q TGR  VVGDYLVGRQIGSGSFSVVW ARHRV GTEVA+KEIAM RLNKKLQESLMS
Sbjct: 1   MAQFTGR--VVGDYLVGRQIGSGSFSVVWEARHRVDGTEVAIKEIAMDRLNKKLQESLMS 58

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EIFIL+RINHP+IIRL D+I+ PGK+HL+LEYCKGGDLS+Y+QRHG VPE TAKHFM+QL
Sbjct: 59  EIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHGIVPEATAKHFMQQL 118

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           AAGLQVLRDNN+IHRDLKPQNLLL T++++A LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct: 119 AAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQPRGLAETLCGSPLYM 178

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG++QIQLLQNI+++TELHFP D + L
Sbjct: 179 APEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTELHFPGDCRDL 238

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           S DC DLCQKLLRRNPVERLTFEEFFNHPFLS  Q     RSR+  R+ D F    S   
Sbjct: 239 SLDCIDLCQKLLRRNPVERLTFEEFFNHPFLSDRQSYDFSRSRLGLRTMDGFLSSGSSPS 298

Query: 301 RDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAKHGR-EATSSALNN 359
           R++ ESSQ+DCLPF LDDDSSGPEGSPS+ K+ SSMKS+ G  VD +  R E  SS L +
Sbjct: 299 RNMEESSQEDCLPFLLDDDSSGPEGSPSYLKKTSSMKSSSGIKVDTRIERKEVESSPLKH 358

Query: 360 LDLRYG-----NKLDNTNLRHDSYKLSD-ENLNEPPKCLDQRLANTRSKVGDSLDLVDQD 413
            +L  G      K++N   R ++   SD  N  EP    D R      +V DS D +DQD
Sbjct: 359 TELTSGYSSFNQKVENDRFRFETQINSDRRNRREPTGLTDSRSLIAPGRVDDSQDSMDQD 418

Query: 414 YVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISV-PKYTTSSAPVPIIGATNSKISHIG 472
           +VLVSGPP+D  SSS+S SKP + P  S+ P + +  +  +S+AP+PIIGAT++ I   G
Sbjct: 419 FVLVSGPPVDMPSSSSSSSKPYNFPFKSQSPPVELFNRSISSTAPMPIIGATSNSIGQFG 478

Query: 473 SLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGF 532
           SL+SQ SAP TS GS D+GDA EQPSTH +TRI+SL++ A  I ELV E+I + KHLE F
Sbjct: 479 SLDSQYSAPSTSHGSLDLGDAFEQPSTHSLTRIRSLRKYAATIAELVYERIESDKHLEAF 538

Query: 533 SIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH 575
           SIQL ILAIWKQALHICHTQA S ++GSPS +  +LRSS  KH
Sbjct: 539 SIQLAILAIWKQALHICHTQAISGLEGSPSQDINKLRSSSLKH 581

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	575
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.996	0.781	0.634	5.8e-185
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.963	0.778	0.637	2e-182
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.467	0.429	0.628	9.7e-99
UNIPROTKB|Q52EB3	982	ATG1 "Serine/threonine-protein	0.219	0.128	0.546	1.6e-62
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.476	0.671	0.448	3.8e-62
CGD|CAL0002062	834	orf19.3841 [Candida albicans (	0.288	0.199	0.5	3.6e-59
UNIPROTKB|E1BH35	1037	ULK2 "Uncharacterized protein"	0.521	0.289	0.410	8.1e-58
FB|FBgn0037679	520	CG8866 [Drosophila melanogaste	0.464	0.513	0.420	5.9e-57
UNIPROTKB|F1RFR1	1055	ULK1 "Uncharacterized protein"	0.459	0.250	0.444	7.7e-57
POMBASE|SPCC63.08c	830	atg1 "autophagy and CVT pathwa	0.273	0.189	0.494	1.3e-56

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 1794 (636.6 bits), Expect = 5.8e-185, P = 5.8e-185
 Identities = 370/583 (63%), Positives = 432/583 (74%)

Query:     1 MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
             M+Q TGR  VVGDYLVGRQIGSGSFSVVW ARHRV GTEVA+KEIAM RLNKKLQESLMS
Sbjct:     1 MAQFTGR--VVGDYLVGRQIGSGSFSVVWEARHRVDGTEVAIKEIAMDRLNKKLQESLMS 58

Query:    61 EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
             EIFIL+RINHP+IIRL D+I+ PGK+HL+LEYCKGGDLS+Y+QRHG VPE TAKHFM+QL
Sbjct:    59 EIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHGIVPEATAKHFMQQL 118

Query:   121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
             AAGLQVLRDNN+IHRDLKPQNLLL T++++A LKIADFGFARSLQPRGLAETLCGSPLYM
Sbjct:   119 AAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQPRGLAETLCGSPLYM 178

Query:   181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
             APEIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG++QIQLLQNI+++TELHFP D + L
Sbjct:   179 APEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTELHFPGDCRDL 238

Query:   241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
             S DC DLCQKLLRRNPVERLTFEEFFNHPFLS  Q     RSR+  R+ D F    S   
Sbjct:   239 SLDCIDLCQKLLRRNPVERLTFEEFFNHPFLSDRQSYDFSRSRLGLRTMDGFLSSGSSPS 298

Query:   301 RDVAESSQDDCLPFFLXXXXXXXXXXXXXXKRRSSMKSTYGFSVDAKHGR-EATSSALNN 359
             R++ ESSQ+DCLPF L              K+ SSMKS+ G  VD +  R E  SS L +
Sbjct:   299 RNMEESSQEDCLPFLLDDDSSGPEGSPSYLKKTSSMKSSSGIKVDTRIERKEVESSPLKH 358

Query:   360 LDLRYG-----NKLDNTNLRHDSYKLSDE-NLNEPPKCLDQRLANTRSKVGDSLDLVDQD 413
              +L  G      K++N   R ++   SD  N  EP    D R      +V DS D +DQD
Sbjct:   359 TELTSGYSSFNQKVENDRFRFETQINSDRRNRREPTGLTDSRSLIAPGRVDDSQDSMDQD 418

Query:   414 YVLVXXXXXXXXXXXXXXXXXXHIPRTSERPLISV-PKYTTSSAPVPIIGATNSKISHIG 472
             +VLV                  + P  S+ P + +  +  +S+AP+PIIGAT++ I   G
Sbjct:   419 FVLVSGPPVDMPSSSSSSSKPYNFPFKSQSPPVELFNRSISSTAPMPIIGATSNSIGQFG 478

Query:   473 SLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGF 532
             SL+SQ SAP TS GS D+GDA EQPSTH +TRI+SL++ A  I ELV E+I + KHLE F
Sbjct:   479 SLDSQYSAPSTSHGSLDLGDAFEQPSTHSLTRIRSLRKYAATIAELVYERIESDKHLEAF 538

Query:   533 SIQLVILAIWKQALHICHTQAASAMDGSPSGESTRLRSSRKKH 575
             SIQL ILAIWKQALHICHTQA S ++GSPS +  +LRSS  KH
Sbjct:   539 SIQLAILAIWKQALHICHTQAISGLEGSPSQDINKLRSSSLKH 581

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1770 (628.1 bits), Expect = 2.0e-182, P = 2.0e-182
 Identities = 360/565 (63%), Positives = 421/565 (74%)

Query:     4 ATGR-GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEI 62
             A GR GRV+GDY VGRQIGSGSFSVVW  RH VHGT VA+KEIAM RLNKKLQESLMSEI
Sbjct:     9 AAGRSGRVIGDYAVGRQIGSGSFSVVWEGRHLVHGTVVAIKEIAMARLNKKLQESLMSEI 68

Query:    63 FILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
              IL++INHP+IIR  D+IE PGK++L+LEYCKGGDLSMYI +HG VPE TAKHFM QLAA
Sbjct:    69 IILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHGSVPEATAKHFMLQLAA 128

Query:   123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
             GLQVLRDNN+IHRDLKPQNLLL TDD++AALKIADFGFARSLQPRGLAETLCGSPLYMAP
Sbjct:   129 GLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQPRGLAETLCGSPLYMAP 188

Query:   183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
             EIMQLQKYDAKADLWSVGAILFQLVTG+TPFTG++QIQLLQNI+++TELHFP D + LS 
Sbjct:   189 EIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNIIRSTELHFPADCRDLST 248

Query:   243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRD 302
             DCKDLCQKLLRRNPVERLTFEEFF+HPFLS  Q     RSR+ SR+ +DF    S   R+
Sbjct:   249 DCKDLCQKLLRRNPVERLTFEEFFHHPFLSDKQSYDFTRSRLDSRTMNDFHSSGSSPSRN 308

Query:   303 VAESSQDDCLPFFLXXXXXXXXXXXXXXKRRSSMKSTYGFSVDAKHGREATSSALNNLDL 362
             + E SQ+D LPFFL              K  S MKS+YGFSV+    REA  S L N+DL
Sbjct:   309 IEEISQEDGLPFFLDDDSSGPEGSPSSFKHTSPMKSSYGFSVER---REAALSPLKNMDL 365

Query:   363 --RYG---NKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSLDLVDQDYVLV 417
               RY    ++ +  N + + ++LSD +  +P    D R  +T+ +VGDS D +DQDYVL+
Sbjct:   366 SSRYSRVSHRAETNNFKFEGHRLSDRSQFKPSSLPDSRSFSTQGRVGDSPDSMDQDYVLI 425

Query:   418 XXXXXXXXXXXXXXXXXXHIPRTSERPLISVPK--YTTSSAPVPIIGATNSKISHIGSLE 475
                               + P  S  P +   K   T  +AP+PI  AT + +S  GSLE
Sbjct:   426 SGPPVDIPSSSSGSPKPFNYPFKSHSPPVEFIKRNVTNLTAPMPIASATGNNLSRFGSLE 485

Query:   476 SQSSAPGTSLGSTDMGDALEQPSTHCMTRIKSLKRCACAITELVNEKIVAGKHLEGFSIQ 535
             SQ+  PGTS GS D+ DA EQPST+ +TRI+SL++CA AI ELV+E+   GKHLE FSIQ
Sbjct:   486 SQNCIPGTSHGSLDLVDAFEQPSTNSLTRIRSLQKCAAAIAELVHERGENGKHLEAFSIQ 545

Query:   536 LVILAIWKQALHICHTQAASAMDGS 560
             LVILAIW QALHICHTQA S ++GS
Sbjct:   546 LVILAIWNQALHICHTQAVSGIEGS 570

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 9.7e-99, Sum P(2) = 9.7e-99
 Identities = 171/272 (62%), Positives = 208/272 (76%)

Query:     9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
             R+VGDY +G +IGSGSF+VVW A+HR  G EVA+KEI    L+ K++++L+ EI IL  I
Sbjct:     5 RLVGDYALGPRIGSGSFAVVWLAKHRSSGLEVAVKEIDKKLLSPKVRDNLLKEISILSTI 64

Query:    69 NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
             +HP+IIR ++ IE   ++ L+LEYC GGDL+ YI RHG VPE  AKHFM+QLA GLQVL+
Sbjct:    65 DHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGKVPEAVAKHFMRQLALGLQVLQ 124

Query:   129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + + IHRDLKPQNLLL + +    LKI DFGFARSL P  +AET CGSPLYMAPEI++ Q
Sbjct:   125 EKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPESMAETFCGSPLYMAPEIIRNQ 184

Query:   189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSADCKDL 247
             KYDAKADLWS GAILFQLVTGK PF G+N IQL  NIV+ TEL FP D +  +  DC DL
Sbjct:   185 KYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVRDTELKFPEDTRNEIHPDCVDL 244

Query:   248 CQKLLRRNPVERLTFEEFFNHPFLSQTQ--PD 277
             C+ LLRRNP+ERLTF EFFNH FL + +  PD
Sbjct:   245 CRSLLRRNPIERLTFREFFNHMFLREPRQIPD 276

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q52EB3 ATG1 "Serine/threonine-protein kinase ATG1" [Magnaporthe oryzae 70-15 (taxid:242507)]

 Score = 365 (133.5 bits), Expect = 1.6e-62, Sum P(3) = 1.6e-62
 Identities = 70/128 (54%), Positives = 94/128 (73%)

Query:   153 LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP 212
             LK+ADFGFAR L    LAETLCGSPLYMAPEI++ ++YDAKADLWSVG +LF+++ G+ P
Sbjct:   206 LKLADFGFARVLPSTSLAETLCGSPLYMAPEILRYERYDAKADLWSVGTVLFEMIVGRPP 265

Query:   213 FTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
             F  SN ++LL+ I  A + + FP +  I S++ K L + LL+RNPVER++FE FF HP +
Sbjct:   266 FRASNHVELLRKIEAAEDVIKFPRETTI-SSEMKGLTRALLKRNPVERISFENFFAHPVI 324

Query:   272 SQTQPDQV 279
               + P  V
Sbjct:   325 ISSIPGLV 332

GO:0004674 "protein serine/threonine kinase activity" evidence=IMP

GO:0005575 "cellular_component" evidence=ND

GO:0009405 "pathogenesis" evidence=IMP

GO:0009847 "spore germination" evidence=IMP

GO:0044409 "entry into host" evidence=IMP

GO:0048102 "autophagic cell death" evidence=IMP

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 635 (228.6 bits), Expect = 3.8e-62, P = 3.8e-62
 Identities = 125/279 (44%), Positives = 182/279 (65%)

Query:    10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
             ++ DY+   ++     S VW A+H++ G E  MK   + +LN+ L++ L +E+  L  ++
Sbjct:     3 MLDDYIAKSKLSESLTSTVWLAKHKLTGEEAVMKCFDLSKLNRNLRDCLNNELEFLSSVD 62

Query:    70 HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
             HP+IIRL  + +    L ++LEYC GG LS YIQR+G V E+ AK FMKQ+ AGL+++ D
Sbjct:    63 HPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYGRVEEDIAKRFMKQIGAGLEIIHD 122

Query:   130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
             N++IHRDLKP+N+L+    D+  LKIADF  AR L P    ET+CGSP YMAPE++Q Q+
Sbjct:   123 NHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHPGKYLETVCGSPFYMAPEVLQFQR 182

Query:   190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILSADCKDLC 248
             Y+ KAD+WSVGAILF+L+ G  PF G+N +Q+L+NI  +T L F     + +  DC D+C
Sbjct:   183 YNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIKSSTALPFSRLILQQMHPDCIDVC 242

Query:   249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF-RSRMFS 286
              +LL  NP   L  E+F   PFL + +  +V+ +   FS
Sbjct:   243 SRLLSINPAATLGIEDF---PFLGRIKNSRVWVKDTTFS 278

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

CGD|CAL0002062 orf19.3841 [Candida albicans (taxid:5476)]

 Score = 434 (157.8 bits), Expect = 3.6e-59, Sum P(3) = 3.6e-59
 Identities = 92/184 (50%), Positives = 122/184 (66%)

Query:   105 HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT---------DDDNAA--- 152
             HG + E    HF++QL++ LQ LRD +L+HRD+KPQNLLLC          D +      
Sbjct:   174 HG-LNEVLVLHFLRQLSSALQFLRDKSLVHRDIKPQNLLLCPPVHSKQEFIDGEFVGMWE 232

Query:   153 ---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG 209
                LKIADFGFAR L    +AETLCGSPLYMAPEI++ +KY+AKADLWSVGA+L+++  G
Sbjct:   233 LPILKIADFGFARFLPSTSMAETLCGSPLYMAPEILRYEKYNAKADLWSVGAVLYEMTVG 292

Query:   210 KTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
             K PF   N I+LL+NI KA + + FP  A++     K L + LL+ NP ER++F EFFN 
Sbjct:   293 KPPFKAGNHIELLKNIEKANDKIKFPSAAQV-PEPLKQLIRSLLKYNPTERISFNEFFND 351

Query:   269 PFLS 272
               ++
Sbjct:   352 SLIT 355

GO:0005634 "nucleus" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0000407 "pre-autophagosomal structure" evidence=IEA

GO:0034273 "Atg1p signaling complex" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0032258 "CVT pathway" evidence=IEA

GO:0000747 "conjugation with cellular fusion" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0000422 "mitochondrion degradation" evidence=IEA

GO:0034727 "piecemeal microautophagy of nucleus" evidence=IEA

GO:0006995 "cellular response to nitrogen starvation" evidence=IEA

GO:0000045 "autophagic vacuole assembly" evidence=IEA

UNIPROTKB|E1BH35 ULK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 570 (205.7 bits), Expect = 8.1e-58, Sum P(3) = 8.1e-58
 Identities = 128/312 (41%), Positives = 183/312 (58%)

Query:    10 VVGDYLVGRQ--IGSGSFSVVWHARHRVHGT-EVAMKEIAMGRLNKKLQESLMSEIFILK 66
             VVGD+   ++  +G G+F+VV+  RHR     EVA+K I    L+K  Q  L  EI ILK
Sbjct:     3 VVGDFEYSKRDLVGHGAFAVVFRGRHRQKTDWEVAIKSINKKNLSKS-QILLGKEIKILK 61

Query:    67 RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              + H +I+ L+D+ E+P  + L++EYC GGDL+ Y+Q  G + E+T + F+ Q+AA +++
Sbjct:    62 ELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRI 121

Query:   127 LRDNNLIHRDLKPQNLLLC------TDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
             L    +IHRDLKPQN+LL       +      +KIADFGFAR L    +A TLCGSP+YM
Sbjct:   122 LHSKGIIHRDLKPQNILLSYASRKKSSVSGIRIKIADFGFARYLHSNMMAATLCGSPMYM 181

Query:   181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
             APE++  Q YDAKADLWS+G +++Q + GK PF  +N  Q L+   +      P   +  
Sbjct:   182 APEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQQANSPQDLRMFYEKNRNLMPSIPRET 241

Query:   241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV--FRSRMFSRSADDFPFYESK 298
             S    +L   LL+RN  +R+ FE FF+HPFL Q    +       M++ SA    +  S 
Sbjct:   242 SPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQVPAKKSCPVPVPMYAGSASGGSYGSSP 301

Query:   299 SVRDVAESSQDD 310
             S R V+  S  D
Sbjct:   302 SCRFVSPPSLPD 313

GO:0048675 "axon extension" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042594 "response to starvation" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

FB|FBgn0037679 CG8866 [Drosophila melanogaster (taxid:7227)]

 Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
 Identities = 113/269 (42%), Positives = 179/269 (66%)

Query:    11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
             + D+ +  ++G+GS++ V+ ARH+   T  A+K + M  L++  +E+L++EI +L+ + H
Sbjct:     6 ITDFEILEKLGAGSYATVYKARHKKQRTYHAIKYVEMSTLSQTSRENLITEIRLLRELKH 65

Query:    71 PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
              +I+ L D       ++++LEYC  G+LS +I+    +PE T ++F++QLAA +Q +R N
Sbjct:    66 KYIVTLQDFFWDDKNIYIVLEYCNAGNLSAFIRTKKALPESTCRYFLRQLAAAVQYMRAN 125

Query:   131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
             ++ H DLKPQNLLL    +N +LK+ADFGFA+ L+   + + L GSPLYMAPEI++  +Y
Sbjct:   126 DVSHFDLKPQNLLLTRGANNVSLKVADFGFAQHLKLGEINQQLKGSPLYMAPEIVRKHQY 185

Query:   191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
             DAKADLWS+G IL++ + GK P++     +LL  I KA  +  PP+A+I S +C DL  +
Sbjct:   186 DAKADLWSIGVILYECLFGKAPYSSRTIEELLLRIRKAEAITLPPNARI-SNECHDLLHR 244

Query:   251 LLRRNPVERLTFEEFFNHPFLS-QTQPDQ 278
             LL   P  R++F +FF HPFL  +T P +
Sbjct:   245 LLAHEPTARISFADFFAHPFLDLKTFPTE 273

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1RFR1 ULK1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 561 (202.5 bits), Expect = 7.7e-57, Sum P(3) = 7.7e-57
 Identities = 123/277 (44%), Positives = 173/277 (62%)

Query:     6 GRG--RVVGDYLVGRQ--IGSGSFSVVWHARHRV-HGTEVAMKEIAMGRLNKKLQESLMS 60
             GRG   VVG +   R+  IG G+F+VV+  RHR  H  EVA+K I    L K  Q  L  
Sbjct:     4 GRGGLEVVGKFEFSRKDLIGHGAFAVVFKGRHREKHDLEVAVKCINKKNLAKS-QTLLGK 62

Query:    61 EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
             EI ILK + H +I+ L+D  E+   ++L++EYC GGDL+ Y+     + E+T + F++Q+
Sbjct:    63 EIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHTMRTLSEDTIRLFLQQI 122

Query:   121 AAGLQVLRDNNLIHRDLKPQNLLLCT------DDDNAALKIADFGFARSLQPRGLAETLC 174
             A  +++L    +IHRDLKPQN+LL        + +N  +KIADFGFAR LQ   +A TLC
Sbjct:   123 AGAMRLLHSKGIIHRDLKPQNILLSNPGGRRANPNNIRVKIADFGFARYLQSNMMAATLC 182

Query:   175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP 234
             GSP+YMAPE++  Q YD KADLWS+G I++Q +TGK PF  S+  Q L+   +  +   P
Sbjct:   183 GSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSP-QDLRLFYEKNKTLVP 241

Query:   235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                +  SA  + L   LL+RN  +R+ F+EFF+HPFL
Sbjct:   242 TIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFL 278

GO:0070969 "ULK1-ATG13-FIP200 complex" evidence=IEA

GO:0051386 "regulation of neurotrophin TRK receptor signaling pathway" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043005 "neuron projection" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

GO:0032403 "protein complex binding" evidence=IEA

GO:0031623 "receptor internalization" evidence=IEA

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA

GO:0021933 "radial glia guided migration of cerebellar granule cell" evidence=IEA

GO:0021707 "cerebellar granule cell differentiation" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0017137 "Rab GTPase binding" evidence=IEA

GO:0016239 "positive regulation of macroautophagy" evidence=IEA

GO:0008104 "protein localization" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005776 "autophagic vacuole" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000045 "autophagic vacuole assembly" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

POMBASE|SPCC63.08c atg1 "autophagy and CVT pathway serine/threonine protein kinase Atg1" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 404 (147.3 bits), Expect = 1.3e-56, Sum P(2) = 1.3e-56
 Identities = 86/174 (49%), Positives = 114/174 (65%)

Query:   110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA---------------ALK 154
             E   +HF +QLA+ LQ LR  +LIHRD+KPQNLLL      A                LK
Sbjct:   131 ETLVRHFTQQLASALQFLRSRSLIHRDVKPQNLLLQPPPTAAYLEEHPQFVGSPKLPMLK 190

Query:   155 IADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT 214
             +ADFGFAR LQ   +AETLCGSPLYMAPEI++ +KYDAKADLWSVGA+L+++  GK PF 
Sbjct:   191 LADFGFARYLQTSSMAETLCGSPLYMAPEILRYEKYDAKADLWSVGAVLYEMAVGKPPFK 250

Query:   215 GSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN 267
               N ++LL+ I KA + + FP +A  +  D K L   LL++NP +R+ ++ FF+
Sbjct:   251 APNHVELLRRIQKAKDVIKFPEEA-FIHPDIKTLICALLKQNPADRIDYDGFFS 303

GO:0000747 "conjugation with cellular fusion" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=ISM

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=ISM

GO:0006914 "autophagy" evidence=IMP

GO:0006995 "cellular response to nitrogen starvation" evidence=IMP

GO:0007165 "signal transduction" evidence=IC

GO:0016236 "macroautophagy" evidence=IC

GO:0016239 "positive regulation of macroautophagy" evidence=ISO

GO:0032258 "CVT pathway" evidence=NAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	575
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-105
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-89
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-83
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-73
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-71
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-70
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-65
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-62
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-60
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-60
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-58
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-58
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-57
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-56
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-55
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-55
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-54
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-53
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-52
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-51
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-50
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-48
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-48
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-47
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-46
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-46
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-46
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-46
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-45
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-45
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-45
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-44
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-44
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-44
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-44
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-43
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-43
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-43
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-43
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-42
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-42
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-41
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-41
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-41
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-40
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-40
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-40
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-40
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-39
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-39
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-39
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-39
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-39
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-38
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-38
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-38
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-38
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-38
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-38
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-38
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-37
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-37
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-37
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-37
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-36
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-36
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-36
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-36
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-35
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-35
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-35
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-35
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-35
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-34
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-34
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-34
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-34
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-34
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-33
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-33
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-33
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-33
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-33
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-33
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-33
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-33
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-33
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-33
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-32
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-32
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-32
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-32
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-32
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-32
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-32
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-32
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-32
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-32
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-32
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-31
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-31
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-31
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-31
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-31
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-31
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-31
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-31
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-31
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-31
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-31
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-30
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-30
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-30
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-30
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-30
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-30
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-30
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-30
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-29
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-29
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-29
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-29
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-29
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-29
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-29
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-28
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-28
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-28
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-28
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-27
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-27
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-27
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-27
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-27
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-27
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-27
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-27
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-27
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-27
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-27
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-27
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-27
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-26
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-26
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-26
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-26
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-26
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-26
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-26
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-26
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-25
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-25
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-25
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-25
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-24
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-24
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-24
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-24
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-23
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-23
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-23
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-22
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-22
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-22
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-22
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-22
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-22
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-21
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-21
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-21
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-21
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-20
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-18
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-15
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  315 bits (809), Expect = e-105
 Identities = 105/258 (40%), Positives = 165/258 (63%), Gaps = 4/258 (1%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +  ++G GSF  V+ AR +  G  VA+K I   ++ K  +E ++ EI ILK++ HP+I
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNI 59

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +RL+D+ E   KL+L++EYC+GGDL   +++ G + E+ A+ +++Q+ + L+ L    ++
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           HRDLKP+N+LL   D++  +K+ADFG AR L P     T  G+P YMAPE++  + Y   
Sbjct: 120 HRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D+WS+G IL++L+TGK PF G +Q+  L   +   +  FPP    +S + KDL +KLL 
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 254 RNPVERLTFEEFFNHPFL 271
           ++P +RLT EE   HPF 
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  276 bits (708), Expect = 2e-89
 Identities = 107/263 (40%), Positives = 155/263 (58%), Gaps = 8/263 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + R++GSGSF  V+ A+H+  G  VA+K +       K  ++   EI IL+R++HP+I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +RL D  E    L+L++EYC+GGDL  Y+ R G + E+ AK    Q+  GL+ L  N +I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK-YD 191
           HRDLKP+N+LL  +     +KIADFG A+ L +      T  G+P YMAPE++     Y 
Sbjct: 121 HRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA--TELHFPPDAKIL-SADCKDLC 248
            K D+WS+G IL++L+TGK PF+G N +  LQ I +     L F        S + KDL 
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 249 QKLLRRNPVERLTFEEFFNHPFL 271
           +K L ++P +R T EE   HP+ 
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  261 bits (669), Expect = 1e-83
 Identities = 93/264 (35%), Positives = 157/264 (59%), Gaps = 11/264 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y + +QIG GSF  V+  R +  G    +KEI +  +++K +E  ++E+ ILK++NHP+
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV----PEETAKHFMKQLAAGLQVLR 128
           II+ ++  E  GKL +++EY  GGDLS  I++        PEE    +  QL   L+ L 
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQL 187
              ++HRD+KPQN+ L ++     +K+ DFG ++ L     LA+T+ G+P Y++PE+ Q 
Sbjct: 121 SRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           + Y+ K+D+WS+G +L++L T K PF G N ++L   I+K     +PP     S++ ++L
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG---QYPPIPSQYSSELRNL 234

Query: 248 CQKLLRRNPVERLTFEEFFNHPFL 271
              LL+++P ER +  +    PF+
Sbjct: 235 VSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  233 bits (596), Expect = 7e-73
 Identities = 93/256 (36%), Positives = 146/256 (57%), Gaps = 12/256 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +G GSF  V   R +  G   AMK +   + + +K  E  ++E  IL RINHP I++LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +   KL+L+LEY  GG+L  ++ + G   EE A+ +  ++   L+ L    +I+RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           P+N+LL   D +  +K+ DFG A+ L   G    T CG+P Y+APE++  + Y    D W
Sbjct: 121 PENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
           S+G +L++++TGK PF   ++ ++ + I+K   L FP     LS + +DL   LL+++P 
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRFPEF---LSPEARDLISGLLQKDPT 233

Query: 258 ERLT---FEEFFNHPF 270
           +RL     EE   HPF
Sbjct: 234 KRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  229 bits (586), Expect = 3e-71
 Identities = 89/266 (33%), Positives = 148/266 (55%), Gaps = 13/266 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           ++  G  +G GSF  V+ A  +  G  +A+K + +   +++  E+L  EI IL  + HP+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 73  IIRL--HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           I+R    +  E    L++ LEY  GG LS  +++ G +PE   + + +Q+  GL  L  N
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---TLCGSPLYMAPEIMQL 187
            ++HRD+K  N+L+ +D     +K+ADFG A+ L      E   ++ G+P +MAPE+++ 
Sbjct: 121 GIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELH-FPPDAKILSADCK 245
           ++Y   AD+WS+G  + ++ TGK P++   N +  L  I  + E    P     LS + K
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH---LSEEAK 234

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D  +K LRR+P +R T +E   HPFL
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  225 bits (577), Expect = 9e-70
 Identities = 94/290 (32%), Positives = 148/290 (51%), Gaps = 44/290 (15%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL--QESLMSEIFILKRI-- 68
           D+  G+ IG GSFS V  A+ +    E A+K      L+K+   +E  +  + I K +  
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIK-----ILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 69  ---NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
               HP II+L+   +    L+ +LEY   G+L  YI+++G + E+  + +  ++   L+
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-------------- 171
            L    +IHRDLKP+N+LL   D +  +KI DFG A+ L P    E              
Sbjct: 117 YLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 172 -------TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN 224
                  +  G+  Y++PE++  +     +DLW++G I++Q++TGK PF GSN+    Q 
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233

Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFF----NHPF 270
           I+K  E  FPP+      D KDL +KLL  +P +RL   E +     HPF
Sbjct: 234 ILK-LEYSFPPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  212 bits (542), Expect = 2e-65
 Identities = 86/253 (33%), Positives = 139/253 (54%), Gaps = 41/253 (16%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G F  V+ AR +  G +VA+K I     +  L E L+ EI ILK++NHP+I++L+ +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            E    L+L++EYC+GG L   ++ + G + E+     + Q+  GL+ L  N +IHRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 139 PQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIM-QLQKYDAKADL 196
           P+N+LL  D DN  +K+ADFG ++ L   + L +T+ G+P YMAPE++     Y  K+D+
Sbjct: 120 PENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS+G IL++L                                    + KDL +K+L+++P
Sbjct: 178 WSLGVILYEL-----------------------------------PELKDLIRKMLQKDP 202

Query: 257 VERLTFEEFFNHP 269
            +R + +E   H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  207 bits (528), Expect = 2e-62
 Identities = 89/282 (31%), Positives = 154/282 (54%), Gaps = 25/282 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK------KLQESLMSEIFILK 66
           D+   + +G+GSF  V   RH+  G   A+K      L+K      K  E +++E  IL+
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALK-----ILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            I HP ++ L+   +    L+L++EY  GG+L  ++++ G  PE  A+ +  Q+   L+ 
Sbjct: 57  SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           L   ++++RDLKP+NLLL   D +  +KI DFGFA+ ++ R    TLCG+P Y+APEI+ 
Sbjct: 117 LHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIIL 171

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            + Y    D W++G ++++++ G  PF   N IQ+ + I++  ++ FP      S D KD
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFP---SFFSPDAKD 227

Query: 247 LCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSR 283
           L + LL+ +  +RL        +  NHP+ +      + + +
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRK 269

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  200 bits (511), Expect = 3e-60
 Identities = 92/271 (33%), Positives = 142/271 (52%), Gaps = 18/271 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG GSF  V   R +  G  +  KEI  G + +K ++ L+SE+ IL+ + HP+
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQ- 125
           I+R +D I       L++++EYC+GGDL+  IQ+       + EE     + QL   L  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 126 ----VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYM 180
                   N ++HRDLKP N+ L   D N  +K+ DFG A+ L      A+T  G+P YM
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE +    YD K+D+WS+G ++++L     PFT  NQ+QL   I    E  F       
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI---KEGKFRRIPYRY 234

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           S++  ++ + +L  +P +R + EE    P +
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  200 bits (511), Expect = 4e-60
 Identities = 94/296 (31%), Positives = 145/296 (48%), Gaps = 52/296 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y    ++G G++ VV+ AR +  G  VA+K+I +    + +  + + EI +LK + HP+I
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++L D+I    KL+L+ EYC   DL  Y+ +  G +     K  M QL  GL     + +
Sbjct: 61  VKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMA 181
           +HRDLKPQN+L+   + +  LK+ADFG AR+           G PL           Y A
Sbjct: 120 LHRDLKPQNILI---NRDGVLKLADFGLARA----------FGIPLRTYTHEVVTLWYRA 166

Query: 182 PEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----ATE------ 230
           PEI +  + Y    D+WSVG I  +++TGK  F G ++I  L  I +     TE      
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226

Query: 231 -------LHFP-----PDAKILSA---DCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                    FP        K+L     +  DL  K+L+ NP +R++ +E   HP+ 
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  195 bits (497), Expect = 2e-58
 Identities = 82/260 (31%), Positives = 141/260 (54%), Gaps = 7/260 (2%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y +G  IG G+F VV+   +   G  VA+K+I++ ++ ++  +S+M EI +LK + HP+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I++    IE    L++ILEY + G L   I++ G  PE     ++ Q+  GL  L +  +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQKYD 191
           IHRD+K  N+L  T D     K+ADFG A  L        ++ G+P +MAPE++++    
Sbjct: 121 IHRDIKAANILT-TKDGVV--KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
             +D+WS+G  + +L+TG  P+   N +  L  IV+      P      S + KD   + 
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGI---SPELKDFLMQC 234

Query: 252 LRRNPVERLTFEEFFNHPFL 271
            +++P  R T ++   HP++
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  194 bits (494), Expect = 7e-58
 Identities = 83/266 (31%), Positives = 144/266 (54%), Gaps = 18/266 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHD 78
           I  G++  V+ A+ +  G   A+K I    +  K   + +++E  IL +   P++++L+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +    L+L++EY  GGDL+  ++  G + E+ A+ ++ ++   L+ L  N +IHRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 139 PQNLLLCTDDDNAALKIADFGFAR-SLQPRGL--------AETLCGSPLYMAPEIMQLQK 189
           P N+L+   D N  LK+ DFG ++  L  R +         + + G+P Y+APE++  Q 
Sbjct: 121 PDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           +    D WS+G IL++ + G  PF G    ++ QNI+   ++ +P D   +S +  DL  
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-KIEWPED-VEVSDEAIDLIS 235

Query: 250 KLLRRNPVERL---TFEEFFNHPFLS 272
           KLL  +P +RL   + EE  NHPF  
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  192 bits (491), Expect = 2e-57
 Identities = 86/262 (32%), Positives = 142/262 (54%), Gaps = 15/262 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHD 78
           +G G F  V   + +      A+K +    +     QE + SE  IL+  NHP I++L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +    +++++EYC GG+L   ++  G   E TA+ ++  +    + L +  +I+RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWS 198
           P+NLLL   D N  +K+ DFGFA+ L+      T CG+P Y+APEI+  + YD   D WS
Sbjct: 121 PENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Query: 199 VGAILFQLVTGKTPFTGSN--QIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRN 255
           +G +L++L+TG+ PF   +   +++  +I+K    L FP     +    KDL ++LLRRN
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP---NYIDKAAKDLIKQLLRRN 234

Query: 256 PVERL-----TFEEFFNHPFLS 272
           P ERL       ++   H + +
Sbjct: 235 PEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  189 bits (481), Expect = 5e-56
 Identities = 88/259 (33%), Positives = 141/259 (54%), Gaps = 9/259 (3%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES---LMSEIFILKRINHPHI 73
           G  +GSGSF  V+   +   G   A+KE+++    +  QE+   L  EI +L ++ HP+I
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++          L++ LE   GG L+  ++++G  PE   + + +Q+  GL+ L D N +
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQLQKYDA 192
           HRD+K  N+L+   D N  +K+ADFG A+ +     A++  GSP +MAPE I Q   Y  
Sbjct: 125 HRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
            AD+WS+G  + ++ TGK P++    +  +  I ++ EL  PP    LS + KD   K L
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPIPDHLSDEAKDFILKCL 239

Query: 253 RRNPVERLTFEEFFNHPFL 271
           +R+P  R T  E   HPF+
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  187 bits (477), Expect = 2e-55
 Identities = 87/262 (33%), Positives = 143/262 (54%), Gaps = 13/262 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHP 71
            + +  +IG G F  V+ ARH+  G EVA+K I   +L  K  +E +++EI ILK+  HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDN 130
           +I++ +       +L +++E+C GG L   ++  +  + E    +  K+L  GL+ L  N
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRD+K  N+LL +D     +K+ DFG +  L       T+ G+P +MAPE++  + Y
Sbjct: 118 GIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP--PDAKILSADCKDLC 248
           D KAD+WS+G    +L  GK P++    ++ L  I        P   + +  S + KD  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFL 231

Query: 249 QKLLRRNPVERLTFEEFFNHPF 270
           +K L++NP +R T E+   HPF
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  187 bits (477), Expect = 2e-55
 Identities = 81/263 (30%), Positives = 141/263 (53%), Gaps = 11/263 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D+ V +++G GS+  V+  +        A+KE+ +G +++K +E  ++EI IL  +NHP+
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC----VPEETAKHFMKQLAAGLQVLR 128
           II   +      KL +++EY   GDLS  I +       +PE+       QL  GLQ L 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
           +  ++HRDLK  N+LL  +D    +KI D G ++ L+ + +A+T  G+P YMAPE+ + +
Sbjct: 121 EQKILHRDLKSANILLVANDL---VKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGR 176

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
            Y  K+D+WS+G +L+++ T   PF   +   L   + +     +PP   I S D ++  
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK---YPPIPPIYSQDLQNFI 233

Query: 249 QKLLRRNPVERLTFEEFFNHPFL 271
           + +L+  P  R   ++    P +
Sbjct: 234 RSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  185 bits (471), Expect = 2e-54
 Identities = 81/269 (30%), Positives = 136/269 (50%), Gaps = 13/269 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHP 71
           D    + +G GS  VV+  RH+  G   A+K+I + G    + Q  L+ E+  L+    P
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCESP 59

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL-RDN 130
           ++++ +      G++ ++LEY  GG L+  +++ G +PE    +  +Q+  GL  L    
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK 189
           ++IHRD+KP NLL+ +      +KIADFG ++ L        T  G+  YM+PE +Q + 
Sbjct: 120 HIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQ---IQLLQNIVKATELHFPPDAKILSADCKD 246
           Y   AD+WS+G  L +   GK PF    Q    +L+Q I         P A+  S + +D
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLP-AEEFSPEFRD 234

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                L+++P +R +  E   HPF+ +  
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  181 bits (461), Expect = 4e-53
 Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 13/264 (4%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPH 72
           + + R IG G+F  V   + R      AMK +   + + K    ++++E  IL+ +NHP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++ L    +    ++L+++   GGDL  ++ +     EE  K ++ ++   L+ L    +
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           IHRD+KP N+LL   D+   + I DF  A  + P  L  +  G+P YMAPE++  Q Y  
Sbjct: 122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178

Query: 193 KADLWSVGAILFQLVTGKTPFTG-SNQI--QLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             D WS+G   ++ + GK P+ G S  I  Q+      A  L+    +     +  D   
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST----EAIDAIN 234

Query: 250 KLLRRNPVERL--TFEEFFNHPFL 271
           KLL R+P +RL    ++  NHP+ 
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  180 bits (459), Expect = 2e-52
 Identities = 93/290 (32%), Positives = 138/290 (47%), Gaps = 36/290 (12%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y +  +IG G+  +V+ A+ R  G  VA+K++A+ RL   +    + EI  L+   HP+
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +++L D+        L++EY    DLS  ++     +PE   K +M+ L  G+  +  N 
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAETLCGSPLYMAPEIM-QLQ 188
           ++HRDLKP NLL+  D     LKIADFG AR    +   L      +  Y APE++   +
Sbjct: 120 IMHRDLKPANLLISADGV---LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----------ELHFPPDA- 237
           KYD   DLW+VG I  +L+ G   F G N I+ L  IV  T           L   PD  
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL-AIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 238 KILSADCK----------------DLCQKLLRRNPVERLTFEEFFNHPFL 271
           KI   + K                DL + LL  +P +RL+  E   HP+ 
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  175 bits (445), Expect = 6e-51
 Identities = 79/250 (31%), Positives = 140/250 (56%), Gaps = 9/250 (3%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D+ +  +IG GSF VV+    +      AMK+I + ++N++ +E  + E  +L +++  +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           IIR ++     GKL++++EY + GDL   +  QR   +PE+    F  Q+  GL  L   
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQK 189
            ++HRD+K  NL L   D+   +KI D G A+ L      A T+ G+P Y++PE+ + + 
Sbjct: 121 KILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           Y+ K+D+W++G +L++  TGK PF  +NQ  L+  I++     FPP +++ S     L  
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---FPPVSQMYSQQLAQLID 234

Query: 250 KLLRRNPVER 259
           + L ++  +R
Sbjct: 235 QCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  175 bits (447), Expect = 1e-50
 Identities = 88/283 (31%), Positives = 143/283 (50%), Gaps = 33/283 (11%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG G++ VV+ AR ++ G  VA+K+I +   ++ + ++ + EI +LK +NHP+II+L 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           D+    G L+L+ E+    DL   I+     +PE   K ++ QL  GL     + ++HRD
Sbjct: 65  DVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-YMAPEIMQLQK-YDAKA 194
           LKP+NLL+ T+     LK+ADFG ARS        T       Y APE++   K Y    
Sbjct: 124 LKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQI-QL-----------------LQNIVKATELHFPPD 236
           D+WSVG I  +L++ +  F G ++I QL                   ++ +  +  FP  
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 237 AKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           A +         S    DL  ++L  +P +R+T E+   HP+ 
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 2e-48
 Identities = 89/294 (30%), Positives = 146/294 (49%), Gaps = 45/294 (15%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y    QIG G++  V+ AR++  G  VA+K+I M    +    + + EI +L+++ HP+I
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDN 130
           +RL +I+   GK  ++++ EY    DL+  +        E   K +MKQL  GLQ L  N
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE------TLCGSPLYMAPEI 184
            ++HRD+K  N+L+   +++  LK+ADFG AR    R  A+      TL     Y  PE+
Sbjct: 120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITL----WYRPPEL 172

Query: 185 -MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHFP----- 234
            +   +Y  + D+WSVG IL +L  GK  F GS +++ L+ I +     T+ ++P     
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 235 PDAKIL------------------SADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
           P  + L                       DL  KLL  +P +R++ ++   H +
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  168 bits (427), Expect = 3e-48
 Identities = 85/267 (31%), Positives = 140/267 (52%), Gaps = 19/267 (7%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           G +IG G+F  V+ A +   G  +A+KEI +   + K  + +  E+ +L+ + HP++++ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 77  HDIIEVP-GKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNNLIH 134
           + + EV   K+++ +EYC GG L   +  HG +  E   + +  QL  GL  L  + ++H
Sbjct: 65  YGV-EVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-----ETLCGSPLYMAPEIMQLQK 189
           RD+KP N+ L   D N  +K+ DFG A  L+          ++L G+P YMAPE++   K
Sbjct: 123 RDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 190 YDAK---ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP--PDAKILSADC 244
                  AD+WS+G ++ ++ TGK P+  S      Q +      H P  PD+  LS + 
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFL 271
           KD   + L  +P +R T  E   HPF+
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  169 bits (429), Expect = 9e-48
 Identities = 83/262 (31%), Positives = 138/262 (52%), Gaps = 17/262 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSE--IFILKRINHPHII 74
           + +G GSF  V  A  +      A+K +    + +    E  M+E  +  L    HP + 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLT 59

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +   +L  ++EY  GGDL  +IQR G   E  A+ +  ++  GLQ L +  +I+
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N+LL   D    +KIADFG  +  +       T CG+P Y+APEI+  Q Y   
Sbjct: 120 RDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA 176

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D W++G +L++++ G++PF G ++ +L Q+I++  E+ +P   + LS + K + +  L 
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-DEVRYP---RWLSKEAKSILKSFLT 232

Query: 254 RNPVERL-----TFEEFFNHPF 270
           +NP +RL       ++   HPF
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  171 bits (432), Expect = 9e-48
 Identities = 100/362 (27%), Positives = 158/362 (43%), Gaps = 31/362 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHP 71
            Y + R++G GSF  V+ AR R     VA+K +A    +K K  E  + EI IL  +NHP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 72  -HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI---QRHGCVPEETAKHFMKQLAAGLQVL 127
            +I++L+D  +  G L+L++EY  GG L   +    R G + E  A   + Q+ + L+ L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-------QPRGLAETLCGSPLYM 180
               +IHRD+KP+N+LL  D D   +K+ DFG A+ L           L  T  G+P YM
Sbjct: 118 HSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 181 APEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           APE++    L    + +D+WS+G  L++L+TG  PF G          +K       P  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 238 KI---------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ--TQPDQVFRSRMFS 286
                      +S    DL +KLL ++P  RL+     +H  L+    +   +       
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 287 RSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDA 346
            SA             ++  +        L  D S      + +   SS  ++    +  
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLST 355

Query: 347 KH 348
             
Sbjct: 356 AS 357

Length = 384

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  167 bits (425), Expect = 4e-47
 Identities = 102/311 (32%), Positives = 164/311 (52%), Gaps = 26/311 (8%)

Query: 18  RQIGSGSFSVVWHARHRVHGTE----VAMKEI--AMGRLNKKLQESLMSEIFILKRINHP 71
           + +G G +  V+  R +V G +     AMK +  A    N+K      +E  IL+ + HP
Sbjct: 2   KVLGKGGYGKVFQVR-KVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            I+ L    +  GKL+LILEY  GG+L M+++R G   E+TA  ++ +++  L+ L    
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLKP+N+LL   D    +K+ DFG  + S+    +  T CG+  YMAPEI+    +
Sbjct: 121 IIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D WS+GA+++ ++TG  PFT  N+ + +  I+K  +L+ PP    L+ + +DL +K
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLNLPP---YLTPEARDLLKK 233

Query: 251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFS------RSADDFPFYESKS 299
           LL+RNP  RL        E  +HPF      D +   ++        +S +D   ++SK 
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKF 293

Query: 300 VRDVAESSQDD 310
            R     S DD
Sbjct: 294 TRQTPVDSPDD 304

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  165 bits (419), Expect = 1e-46
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 51/296 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRIN-HP 71
           Y V +Q+G G+F  V+ AR++  G  VA+K+  M +     +E + + E+  L+++N HP
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDN 130
           +I++L ++     +L+ + EY +G    +   R G    E   +  + Q+  GL  +  +
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------YMAP 182
              HRDLKP+NLL+   +    +KIADFG AR ++ R         P         Y AP
Sbjct: 119 GFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSR--------PPYTDYVSTRWYRAP 167

Query: 183 EI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---------------- 225
           EI ++   Y +  D+W++G I+ +L T +  F GS++I  L  I                
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 226 --VKATELHFPPDAKIL--------SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                    FP  A           S +  DL + +LR +P +R T  +   HP+ 
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  166 bits (422), Expect = 2e-46
 Identities = 92/310 (29%), Positives = 143/310 (46%), Gaps = 48/310 (15%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-----QESL-MSEIFIL 65
            D+ V + IG G+F  VW  R +  G   AMK      L K       Q +   +E  IL
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK-----VLRKSDMIKRNQIAHVRAERDIL 55

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
              + P I++L+   +    L+L++EY  GGDL   + R    PEETA+ ++ +L   L 
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--------------------- 164
            +     IHRD+KP N+L+   D +  +K+ADFG  + +                     
Sbjct: 116 SVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 165 ---------QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG 215
                    Q R  A +  G+P Y+APE+++   Y  + D WS+G IL++++ G  PF  
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232

Query: 216 SNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLT-FEEFFNHPFLSQ 273
               +    I+   E L FPPD  + S +  DL  +LL   P +RL  FEE  +HPF   
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPPV-SPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290

Query: 274 TQPDQVFRSR 283
              + +  ++
Sbjct: 291 IDWENLRETK 300

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  164 bits (417), Expect = 2e-46
 Identities = 84/263 (31%), Positives = 146/263 (55%), Gaps = 11/263 (4%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y    +IG G+   V+ A  R  G EVA+K++   RL K+ +E +++EI I+K   HP+I
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNI 77

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNL 132
           +  +D   V  +L +++EY  GG L+  I ++   + E    +  +++  GL+ L   N+
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQKYD 191
           IHRD+K  N+LL  D     +K+ADFGFA  L + +    ++ G+P +MAPE+++ + Y 
Sbjct: 138 IHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQK 250
            K D+WS+G +  ++  G+ P+     ++ L  I   T+ +    + +  S + KD   K
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TTKGIPPLKNPEKWSPEFKDFLNK 252

Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
            L ++P +R + EE   HPFL +
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  162 bits (412), Expect = 4e-46
 Identities = 87/261 (33%), Positives = 145/261 (55%), Gaps = 8/261 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + ++IG GSF  ++ A+ +       +KEI + ++  K +E+   E+ +L ++ HP+I
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCV-PEETAKHFMKQLAAGLQVLRDNN 131
           +      +  G+L +++EYC GGDL   I R  G +  E+    +  Q++ GL+ + D  
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKY 190
           ++HRD+K QN+ L  +   A  K+ DFG AR L     LA T  G+P Y++PEI Q + Y
Sbjct: 122 ILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           + K D+WS+G +L++L T K PF G+N  QL+  I +    +F P +   S D + L  +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG---YFAPISPNFSRDLRSLISQ 236

Query: 251 LLRRNPVERLTFEEFFNHPFL 271
           L + +P +R +       PFL
Sbjct: 237 LFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  163 bits (414), Expect = 1e-45
 Identities = 88/272 (32%), Positives = 146/272 (53%), Gaps = 14/272 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSE-IFILKRINHPHIIRLH 77
           IG GSF  V  A+H+  G   A+K +     L KK Q+ +M+E   +LK + HP ++ LH
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   KL+ +L+Y  GG+L  ++QR    PE  A+ +  ++A+ L  L   N+I+RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           KP+N+LL   D    + + DFG  +  ++      T CG+P Y+APE+++ Q YD   D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +GA+L++++ G  PF   +  ++  NI+    L   P+   +S   + L + LL+++ 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-KPLRLKPN---ISVSARHLLEGLLQKDR 235

Query: 257 VERL----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL     F E  NH F S    D +   ++
Sbjct: 236 TKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  160 bits (406), Expect = 2e-45
 Identities = 81/261 (31%), Positives = 144/261 (55%), Gaps = 9/261 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+  ++IG GSF      + +  G +  +KEI + +++ K +E    E+ +L  + HP+I
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++  +  E  G L+++++YC+GGDL   I  QR    PE+    +  Q+   L+ + D  
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           ++HRD+K QN+ L  D     +K+ DFG AR L     LA T  G+P Y++PEI + + Y
Sbjct: 122 ILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPY 178

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           + K+D+W++G +L+++ T K  F   N   L+  I++ +   +PP +   S D ++L  +
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS---YPPVSSHYSYDLRNLVSQ 235

Query: 251 LLRRNPVERLTFEEFFNHPFL 271
           L +RNP +R +        F+
Sbjct: 236 LFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 4e-45
 Identities = 90/293 (30%), Positives = 139/293 (47%), Gaps = 41/293 (13%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NH 70
           Y    +IG G++  V+ AR    G  VA+K++ +    + +  S + EI +LK++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 71  PHIIRLHDIIEVPG-----KLHLILEYCKGGDLSMYIQRH---GCVPEETAKHFMKQLAA 122
           P+I+RL D+   P      KL L+ E+    DL+ Y+ +    G +P ET K  M+QL  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPETIKDLMRQLLR 118

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-YMA 181
           G+  L  + ++HRDLKPQN+L+ +D     +KIADFG AR      +A T     L Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLARIYS-FEMALTSVVVTLWYRA 174

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL---------- 231
           PE++    Y    D+WSVG I  +L   +  F G+++   L  I     L          
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234

Query: 232 -----HFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                 FP             +  +  DL +K+L  NP +R++  E   HP+ 
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  158 bits (402), Expect = 1e-44
 Identities = 77/254 (30%), Positives = 136/254 (53%), Gaps = 7/254 (2%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           R +G G+F +V   R +     V +K+I + ++ K  + +  +E  +LK ++HP+II  +
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +       L +++EY  GG L+ YIQ+     + E+T  HF  Q+   L  +    ++HR
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
           DLK QN+LL  D     +KI DFG ++ L  +  A T+ G+P Y++PE+ + + Y+ K+D
Sbjct: 126 DLKTQNILL--DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
           +W++G +L++L + K  F  +N   L+  I+  T   F P +   S D + L   +L  +
Sbjct: 184 IWALGCVLYELASLKRAFEAANLPALVLKIMSGT---FAPISDRYSPDLRQLILSMLNLD 240

Query: 256 PVERLTFEEFFNHP 269
           P +R    +    P
Sbjct: 241 PSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  159 bits (404), Expect = 2e-44
 Identities = 90/272 (33%), Positives = 144/272 (52%), Gaps = 14/272 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSE-IFILKRINHPHIIRLH 77
           IG GSF  V  A+ +  G+  A+K +     L KK Q  +M+E   +LK + HP ++ LH
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   KL+ +L+Y  GG+L  ++QR  C  E  A+ +  ++A+ +  L   N+I+RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           KP+N+LL   D    + + DFG  +  ++P     T CG+P Y+APE+++ + YD   D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +GA+L++++ G  PF   +  Q+  NI+    L  P    +  A C DL   LL ++ 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPLQLPGGKTV--AAC-DLLVGLLHKDQ 235

Query: 257 VERL----TFEEFFNHPFLSQTQPDQVFRSRM 284
             RL     F E  NH F S    D ++  R+
Sbjct: 236 RRRLGAKADFLEIKNHVFFSPINWDDLYHKRI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  160 bits (406), Expect = 2e-44
 Identities = 89/303 (29%), Positives = 145/303 (47%), Gaps = 53/303 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL--MSEIFILKRINHP 71
           Y + + IGSG++ VV  A  +  G +VA+K+I    +   L ++   + EI +L+ + H 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHE 59

Query: 72  HIIRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +II L DI+  P       ++++ E     DL   I+    + ++  ++F+ Q+  GL+ 
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-------- 178
           L   N+IHRDLKP N+L+   + N  LKI DFG AR + P    +      L        
Sbjct: 119 LHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP----DEDEKGFLTEYVVTRW 171

Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIV-------- 226
           Y APE++    +Y    D+WSVG I  +L+T K  F G    +Q+ L+  ++        
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 227 ------KATE--LHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                 KA       P   K          S +  DL +K+L  +P +R+T +E   HP+
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 271 LSQ 273
           L+Q
Sbjct: 292 LAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  159 bits (403), Expect = 3e-44
 Identities = 98/304 (32%), Positives = 158/304 (51%), Gaps = 26/304 (8%)

Query: 18  RQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           + +G GSF  V+  R       G   AMK +    L  + +     E  IL  +NHP I+
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA  L  L    +I+
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           RDLKP+N+LL   D+   +K+ DFG ++ S+     A + CG+  YMAPE++  + +   
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           AD WS G ++F+++TG  PF G ++ + +  I+KA +L  P   + LS + + L + L +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-KLGMP---QFLSPEAQSLLRALFK 234

Query: 254 RNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSADDFPF---YESK 298
           RNP  RL       EE   HPF S    ++++R  +         R  D F F   + S+
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSR 294

Query: 299 SVRD 302
           + +D
Sbjct: 295 TPKD 298

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  156 bits (395), Expect = 1e-43
 Identities = 89/269 (33%), Positives = 141/269 (52%), Gaps = 16/269 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRI 68
           ++L G+Q+G+G+FS  + AR    GT +A+K++   R     Q    E+L  EI ++ R+
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           NHPHIIR+          +L +E+  GG +S  + ++G   E    ++ +QL  GL  L 
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPE 183
           +N +IHRD+K  NLL+  D     L+IADFG A  L  +G         L G+  +MAPE
Sbjct: 121 ENQIIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTG---SNQIQLLQNIVKATELHFPPDAKIL 240
           +++ ++Y    D+WSVG ++ ++ T K P+     SN + L+  I  AT    P   + L
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEHL 236

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHP 269
           S   +D+  + L   P +R    E   HP
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  155 bits (394), Expect = 2e-43
 Identities = 73/260 (28%), Positives = 136/260 (52%), Gaps = 22/260 (8%)

Query: 17  GRQIGSGSFSVVWHARHRV----HGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRIN 69
           G+++G G+F  V+    +       T+VA   +KE A     ++ +E  + E  I+K+++
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS----EEEREEFLEEASIMKKLS 59

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLR 128
           HP+I+RL  +      L+++ EY  GGDL  ++++HG  +  +       Q+A G++ L 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIM 185
             N +HRDL  +N L+    +N  +KI+DFG +R +          G  L   +MAPE +
Sbjct: 120 SKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
           +  K+ +K+D+WS G +L+++ T G+ P+ G +  ++L+ +     L  P +      + 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENC---PDEL 233

Query: 245 KDLCQKLLRRNPVERLTFEE 264
            +L  +    +P +R TF E
Sbjct: 234 YELMLQCWAYDPEDRPTFSE 253

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (394), Expect = 2e-43
 Identities = 73/257 (28%), Positives = 137/257 (53%), Gaps = 16/257 (6%)

Query: 17  GRQIGSGSFSVVWHARHR----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           G+++G G+F  V+    +        EVA+K +      ++++E  + E  I+++++HP+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDN 130
           I++L  +      L +++EY  GGDL  Y++++    +       F  Q+A G++ L   
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG-SPL-YMAPEIMQLQ 188
           N IHRDL  +N L+    +N  +KI+DFG +R L      +   G  P+ +MAPE ++  
Sbjct: 123 NFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G +L+++ T G+ P+ G +  ++L+ + K   L  PP+      +   L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC---PPELYKL 236

Query: 248 CQKLLRRNPVERLTFEE 264
             +    +P +R TF E
Sbjct: 237 MLQCWAEDPEDRPTFSE 253

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  156 bits (396), Expect = 4e-43
 Identities = 87/272 (31%), Positives = 147/272 (54%), Gaps = 14/272 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEI-AMGRLNKKLQESLMSEI-FILKRINHPHIIRLH 77
           IG GSF  V  ARH+      A+K +     L KK ++ +MSE   +LK + HP ++ LH
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   KL+ +L+Y  GG+L  ++QR  C  E  A+ +  ++A+ L  L   N+++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           KP+N+LL   D    + + DFG  + +++  G   T CG+P Y+APE++  Q YD   D 
Sbjct: 123 KPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +GA+L++++ G  PF   N  ++  NI+    L   P+   ++   + L + LL+++ 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-KPLQLKPN---ITNSARHLLEGLLQKDR 235

Query: 257 VERLTFEEFF----NHPFLSQTQPDQVFRSRM 284
            +RL  ++ F    NH F S    D +   ++
Sbjct: 236 TKRLGAKDDFMEIKNHIFFSPINWDDLINKKI 267

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  154 bits (390), Expect = 5e-43
 Identities = 77/257 (29%), Positives = 137/257 (53%), Gaps = 9/257 (3%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           R +G G+F      R     + V  KE+ + RL++K +   ++EI IL  + HP+II  +
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +       L + +EY  GG L   I  Q+     EE    ++ Q+ + +  +    ++HR
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKYDAKA 194
           D+K  N+ L        +K+ DFG ++ L     +AET+ G+P YM+PE+ Q  KY+ K+
Sbjct: 126 DIKTLNIFLTKAG---LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D+W++G +L++L+T K  F  +N + L+  IV+    ++ P   + S++   L   LL++
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG---NYTPVVSVYSSELISLVHSLLQQ 239

Query: 255 NPVERLTFEEFFNHPFL 271
           +P +R T +E  + P L
Sbjct: 240 DPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (391), Expect = 5e-43
 Identities = 73/256 (28%), Positives = 139/256 (54%), Gaps = 15/256 (5%)

Query: 17  GRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           G+++G G+F  V+  + +  G     EVA+K +     +++  E  + E  I+++++HP+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +++L  +      L++++EY +GGDL  Y++++   +       F  Q+A G++ L   N
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG-SPL-YMAPEIMQLQK 189
            IHRDL  +N L+    +N  +KI+DFG +R L          G  P+ +MAPE ++  K
Sbjct: 123 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + +K+D+WS G +L+++ T G+ P+ G +  ++L+ +     L  PP+      +  DL 
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC---PPELYDLM 236

Query: 249 QKLLRRNPVERLTFEE 264
            +    +P +R TF E
Sbjct: 237 LQCWAEDPEDRPTFSE 252

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  153 bits (389), Expect = 8e-43
 Identities = 67/262 (25%), Positives = 130/262 (49%), Gaps = 14/262 (5%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ---ESLMSEIFILKRINHPHI 73
           G+ +G G+F  V+       G E+A+K++     + + +    +L  EI +LK + H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ +  +     L + +EY  GG +   ++ +G + E   + + +Q+  G++ L  N ++
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK 189
           HRD+K  N+L    D    +K+ DFG ++ LQ         +++ G+P +M+PE++  + 
Sbjct: 127 HRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA-TELHFPPDAKILSADCKDLC 248
           Y  KAD+WSVG  + +++T K P+     +  +  I    T    P     +S D ++  
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH---VSPDARNFL 240

Query: 249 QKLLRRNPVERLTFEEFFNHPF 270
           ++    N  +R + EE   H F
Sbjct: 241 RRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  153 bits (388), Expect = 1e-42
 Identities = 76/257 (29%), Positives = 132/257 (51%), Gaps = 16/257 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G GS+  V+ A H+  G  VA+K + +        + ++ EI ILK+ + P+I++ +  
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL----QEIIKEISILKQCDSPYIVKYYGS 66

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                 L +++EYC  G +S  ++  +  + EE     + Q   GL+ L  N  IHRD+K
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL   ++    K+ADFG +  L        T+ G+P +MAPE++Q   Y+ KAD+W
Sbjct: 127 AGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLCQKLLRR 254
           S+G    ++  GK P++  + ++ +  I        PP   D +  S +  D  +K L +
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP----PPTLSDPEKWSPEFNDFVKKCLVK 239

Query: 255 NPVERLTFEEFFNHPFL 271
           +P ER +  +   HPF+
Sbjct: 240 DPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  152 bits (386), Expect = 8e-42
 Identities = 95/305 (31%), Positives = 141/305 (46%), Gaps = 59/305 (19%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE----SLMSEIFILKRIN 69
           Y  G+++G G+++VV+ AR +  G  VA+K+I +G   K+ ++    + + EI +L+ + 
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGER-KEAKDGINFTALREIKLLQELK 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHFMKQLAAGLQVL 127
           HP+II L D+      ++L+ E+    DL   I+    V  P +  K +M     GL+ L
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADI-KSYMLMTLRGLEYL 118

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP---------- 177
             N ++HRDLKP NLL+     +  LK+ADFG ARS           GSP          
Sbjct: 119 HSNWILHRDLKPNNLLI---ASDGVLKLADFGLARS----------FGSPNRKMTHQVVT 165

Query: 178 -LYMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------- 228
             Y APE+    + Y    D+WSVG I  +L+       G + I  L  I +A       
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225

Query: 229 -----TEL-------HFPPDA-----KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                T L        FPP          S D  DL Q+LL  NP +R+T  +   HP+ 
Sbjct: 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Query: 272 SQTQP 276
           S   P
Sbjct: 286 S-NDP 289

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 4e-41
 Identities = 79/261 (30%), Positives = 127/261 (48%), Gaps = 24/261 (9%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES------LMSEIFILKRINHPHI 73
           IG GSF  V+ A  +     VA+K I        L+E+      +  EI  L +   P+I
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVI-------DLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
            + +       KL +I+EYC GG     + + G + E      ++++  GL+ L +   I
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKI 120

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQLQKYDA 192
           HRD+K  N+LL  + D   +K+ADFG +  L        T  G+P +MAPE+++   YD 
Sbjct: 121 HRDIKAANILLSEEGD---VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP--DAKILSADCKDLCQK 250
           KAD+WS+G    +L  G+ P +  + +++L  I K    + PP  +    S   KD    
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NNPPSLEGNKFSKPFKDFVSL 233

Query: 251 LLRRNPVERLTFEEFFNHPFL 271
            L ++P ER + +E   H F+
Sbjct: 234 CLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 5e-41
 Identities = 77/289 (26%), Positives = 140/289 (48%), Gaps = 46/289 (15%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G++ VV   R++  G  VA+K+      ++ ++++ + E+ +L+++ H +I+ L + 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
               G+L+L+ EY +   L +     G +P +  + ++ QL   +     +N+IHRD+KP
Sbjct: 69  FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKP 128

Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------YMAPEIM-QLQKY 190
           +N+L+    ++  LK+ DFGFAR+L+ R        SPL        Y APE++     Y
Sbjct: 129 ENILV---SESGVLKLCDFGFARALRARP------ASPLTDYVATRWYRAPELLVGDTNY 179

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------------TELH 232
               D+W++G I+ +L+ G+  F G + I  L  I K                     + 
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 233 FPPDAKILSADCK----------DLCQKLLRRNPVERLTFEEFFNHPFL 271
           FP  ++  S + +          D  +  LR +P ERLT +E   HP+ 
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  149 bits (379), Expect = 5e-41
 Identities = 88/289 (30%), Positives = 145/289 (50%), Gaps = 50/289 (17%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-----SEIFILKRIN-HPH 72
           +IG G+FS V  A+ R  G   A+K      + K  + SL       EI  L+R++ HP+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFK-SLEQVNNLREIQALRRLSPHPN 59

Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMY--IQ-RHGCVPEETAKHFMKQLAAGLQVL 127
           I+RL +++     G+L L+ E     D+++Y  I+ R   +PE+  K +M QL   L  +
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQ 186
             N + HRD+KP+N+L+   DD   LK+ADFG  R +  +        +  Y APE ++ 
Sbjct: 117 HRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIV--------------KAT 229
              Y  K D+W+VG + F++++    F G+N   QI  + +++              +  
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232

Query: 230 ELHFPPD-----AKIL---SADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
             +FP        K+L   SA+  DL +KLL  +P ER+T ++   HP+
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  148 bits (377), Expect = 5e-41
 Identities = 73/268 (27%), Positives = 136/268 (50%), Gaps = 25/268 (9%)

Query: 18  RQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           +++G G+F  V+  + +      TEVA+K +     +++ ++  + E  ++K++ HP+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK---------HFMKQLAAGLQ 125
           RL  +      L+L+LEY +GGDL  Y+++   V     K          F  Q+A G++
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAP 182
            L     +HRDL  +N L+    ++  +KI+DFG +R +          G  L   +MAP
Sbjct: 120 YLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHFPPDAKIL 240
           E ++   + +K+D+WS G +L+++ T G TP+ G SN+ ++L+ + K   L  P      
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLRKGYRLPKPEYC--- 232

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNH 268
             +  +L     + +P +R TF E    
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  148 bits (376), Expect = 1e-40
 Identities = 91/292 (31%), Positives = 143/292 (48%), Gaps = 55/292 (18%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+++ V+  R+R  G  VA+KEI +    +    + + EI ++K + H +I+RLHD
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +I    KL L+ EY    DL  Y+  HG    +   T K F  QL  G+    +N ++HR
Sbjct: 66  VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMAPEI 184
           DLKPQNLL+   +    LK+ADFG AR+           G P+           Y AP++
Sbjct: 125 DLKPQNLLI---NKRGELKLADFGLARAF----------GIPVNTFSNEVVTLWYRAPDV 171

Query: 185 -MQLQKYDAKADLWSVGAILFQLVTGKTPFTGS-NQIQLLQ--NIV-KATELHFP----- 234
            +  + Y    D+WSVG I+ +++TG+  F G+ N+ QLL+   I+   TE  +P     
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 235 PDAKILSADCK----------------DLCQKLLRRNPVERLTFEEFFNHPF 270
           P+ K                       DL  +LL+ NP  R++  +   HP+
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 1e-40
 Identities = 78/242 (32%), Positives = 135/242 (55%), Gaps = 10/242 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +G+G+F  V   R R+     A+K +A+   +  K ++ + +E  +LK ++HP IIRL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                  L++++EY  GG+L  Y++  G     T   +  ++   L+ L    +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWS 198
           P+N+LL   D    +K+ DFGFA+ L+ R    TLCG+P Y+APE++Q + ++   D W+
Sbjct: 129 PENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWA 183

Query: 199 VGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVE 258
           +G ++++++ G  PF   N   + + I+ A +L FP   + L    KDL +KLL  +   
Sbjct: 184 LGILIYEMLVGYPPFFDDNPFGIYEKIL-AGKLEFP---RHLDLYAKDLIKKLLVVDRTR 239

Query: 259 RL 260
           RL
Sbjct: 240 RL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  149 bits (378), Expect = 2e-40
 Identities = 83/278 (29%), Positives = 146/278 (52%), Gaps = 23/278 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMK-----EIAMGRLNKKLQESLMSEIFILKR 67
           D+ +G  +G+GSF  V  A+H+  G   A+K     EI    L  K  + +  E  IL  
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI----LKMKQVQHVAQEKSILME 74

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           ++HP I+ +    +   +++ +LE+  GG+L  ++++ G  P + AK +  +L    + L
Sbjct: 75  LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
              ++I+RDLKP+NLLL   D+   +K+ DFGFA+ +  R    TLCG+P Y+APE++Q 
Sbjct: 135 HSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVIQS 189

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           + +    D W++G +L++ + G  PF      ++ + I+ A  L FP          +DL
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKFP---NWFDGRARDL 245

Query: 248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVF 280
            + LL+ +  +RL        +  NHP+      D+++
Sbjct: 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283

Length = 329

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  147 bits (372), Expect = 3e-40
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 23/273 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY +   IG G+ +VV+ A    +  +VA+K I + +    + + L  E+  + + NHP+
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGG---DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +++ +    V  +L L++ Y  GG   D+       G + E      +K++  GL+ L  
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-----QPRGLAETLCGSPLYMAPEI 184
           N  IHRD+K  N+LL  D    ++KIADFG + SL     + R + +T  G+P +MAPE+
Sbjct: 121 NGQIHRDIKAGNILLGED---GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 185 M-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP------DA 237
           M Q+  YD KAD+WS G    +L TG  P++    +++L   ++    + PP      D 
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----NDPPSLETGADY 233

Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
           K  S   + +    L+++P +R T EE   H F
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  146 bits (370), Expect = 7e-40
 Identities = 94/291 (32%), Positives = 142/291 (48%), Gaps = 53/291 (18%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++  V+ A++R     VA+K + +   ++ +  S + EI +LK + H +I+RL+D
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
           ++    KL L+ EYC   DL  Y    +G +  E  K FM QL  GL     +N++HRDL
Sbjct: 67  VLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMAPEIMQ 186
           KPQNLL+   + N  LK+ADFG AR+           G P+           Y  P+++ 
Sbjct: 126 KPQNLLI---NKNGELKLADFGLARAF----------GIPVRCYSAEVVTLWYRPPDVLF 172

Query: 187 LQK-YDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVKA----TELHFP-----P 235
             K Y    D+WS G I  +L     P F G++    L+ I +     TE  +P     P
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 236 DAKI----------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
           D K                 L++  +DL Q LL  NPV+R++ EE   HP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  144 bits (364), Expect = 2e-39
 Identities = 82/250 (32%), Positives = 136/250 (54%), Gaps = 10/250 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y V R +G GSF      +H     + AMKEI + + +  +++S   E  +L ++ HP+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPN 59

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           I+   +  E  G L++++EYC GGDL   I  QR    PE+T   +  Q+  G+Q + + 
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK 189
            ++HRD+K +N+ L     N  +K+ DFG AR L  P   A T  G+P Y+ PEI +   
Sbjct: 120 RVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           Y+ K+D+WS+G IL++L T K PF  ++   L+  + + +   + P     S + + L +
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS---YKPLPSHYSYELRSLIK 233

Query: 250 KLLRRNPVER 259
           ++ +RNP  R
Sbjct: 234 QMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  144 bits (365), Expect = 2e-39
 Identities = 75/266 (28%), Positives = 139/266 (52%), Gaps = 15/266 (5%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN 69
           +G++ + ++IG G FSVV+ A   + G  VA+K++ +  + + K ++  + EI +LK+++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQ 125
           HP++I+         +L+++LE    GDLS  I+        +PE T   +  QL + L+
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEI 184
            +    ++HRD+KP N+ +        +K+ D G  R    +   A +L G+P YM+PE 
Sbjct: 121 HMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGS--NQIQLLQNIVKATELHFPP-DAKILS 241
           +    Y+ K+D+WS+G +L+++   ++PF G   N   L + I K     +PP  A   S
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---DYPPLPADHYS 234

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFN 267
            + +DL  + +  +P +R        
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  144 bits (365), Expect = 3e-39
 Identities = 84/271 (30%), Positives = 137/271 (50%), Gaps = 18/271 (6%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
            D     ++G+G+  VV    HR  G  +A+K I +  +N+ +Q+ ++ E+ IL + N P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSP 59

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDN 130
           +I+  +      G + + +EY  GG L   ++   G +PE         +  GL  L + 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 131 -NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
             +IHRD+KP N+L+   +    +K+ DFG +  L    LA+T  G+  YMAPE +Q   
Sbjct: 120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGND 175

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQ-----IQLLQNIVKATELHFPP--DAKILSA 242
           Y  K+D+WS+G  L +L TG+ P+   N       +LLQ IV       PP   +   S 
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----PPRLPSGKFSP 231

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           D +D     L ++P ER +++E   HPF+ +
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  145 bits (367), Expect = 5e-39
 Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 14/260 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEI-FILKRINHPHIIRLH 77
           IG GSF  V  A+ ++ G   A+K +     LN+K Q+ +M+E   +LK + HP ++ LH
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   KL+ +L++  GG+L  ++QR    PE  A+ +  ++A+ L  L   N+++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           KP+N+LL   D    + + DFG  +  +       T CG+P Y+APE+++ Q YD   D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +GA+L++++ G  PF   +  ++  NI+    L   P A   S     + ++LL ++ 
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-KPLVLRPGA---SLTAWSILEELLEKDR 235

Query: 257 VERLTFEEFF----NHPFLS 272
             RL  +E F     HPF  
Sbjct: 236 QRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 5e-39
 Identities = 88/292 (30%), Positives = 141/292 (48%), Gaps = 53/292 (18%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR ++ G  VA+K+I +   ++ +  + + EI +LK +NHP+I+RL D
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++    KL+L+ E+    DL  Y+             K ++ QL  G+     + ++HRD
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMAPEIM 185
           LKPQNLL+   D   ALK+ADFG AR+           G P+           Y APEI+
Sbjct: 125 LKPQNLLI---DREGALKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEIL 171

Query: 186 QLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------TEL- 231
              + Y    D+WS+G I  ++V  +  F G ++I  L  I +             T L 
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231

Query: 232 ----HFP-----PDAKI---LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                FP       +K+   L  D  DL  K+L  +P +R++ +    HP+ 
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  142 bits (361), Expect = 2e-38
 Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 62/303 (20%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY    +IG G++ VV+  R++  G  VAMK+I +    + +  + + EI +LK + HP+
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-------GCVPEETAKHFMKQLAAGLQ 125
           I+ L D++    +L+LI E+     LSM ++++         +  E  K ++ Q+  G+ 
Sbjct: 61  IVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL------- 178
                 ++HRDLKPQNLL+   D+   +K+ADFG AR+           G P+       
Sbjct: 116 FCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAF----------GIPVRVYTHEV 162

Query: 179 ----YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----T 229
               Y APE+ +   +Y    D+WS+G I  ++ T K  F G ++I  L  I +     T
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT 222

Query: 230 ELHFP-----PDAKI----------------LSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           E  +P     PD K                 L  D  DL +K+L  +P +R++ ++  NH
Sbjct: 223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282

Query: 269 PFL 271
           P+ 
Sbjct: 283 PYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  143 bits (361), Expect = 2e-38
 Identities = 85/259 (32%), Positives = 135/259 (52%), Gaps = 12/259 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRLHD 78
           IG GSF  V   R R      A+K I    +  + +    ++E  +L ++N P I+ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             + P KL+L+L +  GG+L  ++QR G      A+ +  +L   L+ L   N+I+RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 139 PQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           P+N+LL   D    + + DFG  + +++      T CG+P Y+APE++    Y    D W
Sbjct: 121 PENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
           ++G +L++++TG  PF   N  ++ + I++   L FP        D KDL   LL R+P 
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQ-EPLRFPDG---FDRDAKDLLIGLLSRDPT 233

Query: 258 ERLTF---EEFFNHPFLSQ 273
            RL +   +E  NHPF SQ
Sbjct: 234 RRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  142 bits (361), Expect = 3e-38
 Identities = 82/275 (29%), Positives = 136/275 (49%), Gaps = 18/275 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSE--IF-ILKRINHPHIIR 75
           +G G F  V  A ++  G   A+K +  G  + +   ESLM E  IF       HP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           L    +    +  ++EY  GGDL M+I       E  A  +   +  GLQ L +N +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           DLK  NLLL T+     +KIADFG  +  +       T CG+P ++APE++    Y    
Sbjct: 126 DLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D W +G ++++++ G++PF G ++ ++  +IV   E+ +P   + LS +   + ++LLRR
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-NDEVRYP---RFLSREAISIMRRLLRR 238

Query: 255 NPVERLTF-----EEFFNHPFLSQTQPDQVFRSRM 284
           NP  RL       E+    PF      D +   ++
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKI 273

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  141 bits (358), Expect = 3e-38
 Identities = 90/291 (30%), Positives = 146/291 (50%), Gaps = 53/291 (18%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 79  IIEVPGKLHLILEYCKGGDLSMY--IQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  +        +P    K ++ QL  GL     + ++HRD
Sbjct: 67  VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMAPEIM 185
           LKPQNLL+   +   A+K+ADFG AR+           G P+           Y APEI+
Sbjct: 126 LKPQNLLI---NTEGAIKLADFGLARAF----------GVPVRTYTHEVVTLWYRAPEIL 172

Query: 186 QLQKYDAKA-DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHFP-----P 235
              KY + A D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     P
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 236 DAK----------------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
           D K                 L  D +DL  ++L  +P +R++ +    HPF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 5e-38
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 33/269 (12%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-----SLMSEIFILKRINHPHI 73
           +IGSG++  V+ AR    G  VA+K I       KL+       +  EI +LK   HP+I
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVI-------KLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSM-YIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           +          KL +++EYC GG L   Y    G + E    +  ++   GL  L +   
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEIMQLQ 188
           IHRD+K  N+LL  D D   +K+ADFG +     ++  R   ++  G+P +MAPE+  ++
Sbjct: 123 IHRDIKGANILLTEDGD---VKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVAAVE 176

Query: 189 K---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP----DAKILS 241
           +   YD K D+W++G    +L   + P    + ++ L  I K+    FPP    D +  S
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN---FPPPKLKDKEKWS 233

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
               D  +K L ++P +R T  +   HPF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 7e-38
 Identities = 77/265 (29%), Positives = 137/265 (51%), Gaps = 21/265 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINH-----P 71
           + I  G+F  V+ A+ R  G   A+K +    +  K Q  ++ +E    + I       P
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESP 57

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++ +L+   +    L+L++EY  GGD +  I+  G +PE+ AK ++ ++  G++ L    
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRD+KP+NLL+   D    LK+ DFG +R+       +   G+P Y+APE +     D
Sbjct: 118 IIHRDIKPENLLI---DQTGHLKLTDFGLSRNGL---ENKKFVGTPDYLAPETILGVGDD 171

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQK 250
             +D WS+G ++F+ + G  PF       +  NI+ +  +++P + K   S +  DL  +
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-SRRINWPEEVKEFCSPEAVDLINR 230

Query: 251 LLRRNPVERL---TFEEFFNHPFLS 272
           LL  +P +RL    ++E  +HPF  
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  142 bits (359), Expect = 8e-38
 Identities = 87/306 (28%), Positives = 139/306 (45%), Gaps = 59/306 (19%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y     IGSG++ VV  A     G +VA+K+I        L +  + E+ IL+   H +I
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 74  IRLHDIIEVPGKL----HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           I + DI+  PG      +++++     DL   I     + EE  ++F+ QL  GL+ +  
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----------- 178
            N+IHRDLKP NLL+   +++  L+I DFG AR L           SP            
Sbjct: 126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL---------SSSPTEHKYFMTEYVA 173

Query: 179 ---YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKATEL 231
              Y APE++  L +Y    D+WSVG I  +++  +  F G N   Q++L+ +++ +   
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233

Query: 232 HF----------------------PPDAKILSADCK--DLCQKLLRRNPVERLTFEEFFN 267
                                   P       A  +  DL  ++L+ +P ER+T E+   
Sbjct: 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293

Query: 268 HPFLSQ 273
           HPFL+Q
Sbjct: 294 HPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 9e-38
 Identities = 80/272 (29%), Positives = 135/272 (49%), Gaps = 22/272 (8%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL------MSEIFIL 65
            D+ +  Q+G G +  V+ A+ +  G  VA+K     R+ K L   L      ++E  IL
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALK-----RMKKSLLFKLNEVRHVLTERDIL 55

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
                  +++L    +    L+L +EY  GGD    +   G + E+ A+ +M ++   + 
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            L +   IHRDLKP+N L+   D +  +K+ DFG ++ +     A ++ GSP YMAPE++
Sbjct: 116 ALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY--ANSVVGSPDYMAPEVL 170

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----HFPPDAKILS 241
           + + YD   D WS+G +L++ + G  PF+GS   +  +N+    E      +      LS
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230

Query: 242 ADCKDLCQKLLRRNPVERL-TFEEFFNHPFLS 272
            +  DL  KL+  +P  R  + E+  NHPF  
Sbjct: 231 DEAWDLITKLI-NDPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  140 bits (355), Expect = 2e-37
 Identities = 86/261 (32%), Positives = 137/261 (52%), Gaps = 23/261 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRI-----NHP 71
           +G GSF  V  A  +      A+K +      KK   L++  +    + +R+      HP
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKAL------KKDVVLEDDDVECTMVERRVLALAWEHP 56

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +    L  ++EY  GGDL  +IQ  G   E  A+ +  ++  GLQ L    
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLK  N+LL   D +  +KIADFG  + ++   G A T CG+P Y+APEI++ QKY
Sbjct: 117 IIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +   D WS G +L++++ G++PF G ++ +L  +I+     HFP   + +S + KD   K
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-HFP---RWISKEAKDCLSK 229

Query: 251 LLRRNPVERLTFE-EFFNHPF 270
           L  R+P +RL  + +   HPF
Sbjct: 230 LFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  139 bits (351), Expect = 2e-37
 Identities = 79/272 (29%), Positives = 142/272 (52%), Gaps = 20/272 (7%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-------KKLQESLMSEIFILK 66
           ++ G  IGSGSF  V+   +   G  +A+K++ +  ++       + + ++L  EI +LK
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            + H +I++          L++ LEY  GG ++  +  +G   E   ++F++Q+  GL  
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-------LCGSPLY 179
           L +  +IHRD+K  N+L+   D+   +KI+DFG ++ L+   L+         L GS  +
Sbjct: 122 LHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPE+++   Y  KAD+WS+G ++ +++TGK PF    Q+Q +  I +      P +   
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI-- 236

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
            S++  D  +K    +  +R T  E   HPFL
Sbjct: 237 -SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  140 bits (356), Expect = 2e-37
 Identities = 95/301 (31%), Positives = 148/301 (49%), Gaps = 50/301 (16%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI--AMGRLNKKLQESLMSEIFILKRI-NH 70
           Y + +++G G++ +VW A  R     VA+K+I  A    N    +    EI  L+ + +H
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDH 66

Query: 71  PHIIRLHDII--EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           P+I++L ++I  E    ++L+ EY +  DL   I R   + +   ++ M QL   L+ + 
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYIH 124

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------YM 180
             N+IHRDLKP N+LL   + +  +K+ADFG ARSL    L E      L        Y 
Sbjct: 125 SGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSE--LEENPENPVLTDYVATRWYR 179

Query: 181 APEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--------- 230
           APEI+    +Y    D+WSVG IL +++ GK  F G++ +  L+ I++            
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239

Query: 231 LHFPPDAKIL------------------SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +  P  A +L                  S D  DL +KLL  NP +RLT EE   HP+++
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 273 Q 273
           Q
Sbjct: 300 Q 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  138 bits (350), Expect = 4e-37
 Identities = 78/262 (29%), Positives = 134/262 (51%), Gaps = 17/262 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRLHD 78
           +G G F  V   + +  G   A K++   RL K+  E + ++E  IL++++   I+ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
             E    L L++    GGDL  +I   G    PE  A  +  Q+  GL+ L    +++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+N+LL   DD+  ++I+D G A  L+     +   G+P YMAPE++Q + YD   D 
Sbjct: 121 LKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177

Query: 197 WSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           +++G  L++++ G++PF    +    + L+       + +P      S + KDLC+ LL+
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK---FSPEAKDLCEALLQ 234

Query: 254 RNPVERLTF-----EEFFNHPF 270
           ++P +RL       +E   HP 
Sbjct: 235 KDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 7e-37
 Identities = 87/271 (32%), Positives = 139/271 (51%), Gaps = 26/271 (9%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           ++G ++G G+F  V+ A+H+  G   A K I +    +   E  M EI IL    HP+I+
Sbjct: 9   IIG-ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSECKHPNIV 65

Query: 75  RLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
            L++      KL +++E+C GG L S+ ++    + E   ++  +Q+   L  L  + +I
Sbjct: 66  GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGF----ARSLQPRGLAETLCGSPLYMAPEIMQL-- 187
           HRDLK  N+LL  D D   +K+ADFG       +LQ R   +T  G+P +MAPE++    
Sbjct: 126 HRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACET 179

Query: 188 ---QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILS 241
                YD KAD+WS+G  L +L   + P    N +++L  I+K+     PP        S
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE----PPTLDQPSKWS 235

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +   D  +  L ++P +R T  E   HPF+S
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  139 bits (351), Expect = 1e-36
 Identities = 80/249 (32%), Positives = 138/249 (55%), Gaps = 11/249 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINH 70
           D+   R +G+GSF  V  A ++      VA+K     ++ K+ Q + + SE  IL  INH
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P  + L+   +    L+L+LE+  GG+   +++R+   P +    +  Q+    + L+  
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           N+++RDLKP+NLLL   D +  +K+ DFGFA+ +  R    TLCG+P Y+APEI+    +
Sbjct: 151 NIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGH 205

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
              AD W++G  +++++ G  PF  +  + + Q I++   ++FP   K L  +CK L +K
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFP---KFLDNNCKHLMKK 261

Query: 251 LLRRNPVER 259
           LL  +  +R
Sbjct: 262 LLSHDLTKR 270

Length = 340

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  136 bits (344), Expect = 4e-36
 Identities = 81/277 (29%), Positives = 141/277 (50%), Gaps = 24/277 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRL--NKKLQESLMSEIFILKR 67
           ++ + R +G+G++  V+  R       G   AMK +    +    K  E   +E  +L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 68  INH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +   P ++ LH   +   KLHLIL+Y  GG+L  ++ +     E   + ++ ++   L  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEI 184
           L    +I+RD+K +N+LL   D    + + DFG ++         A + CG+  YMAPE+
Sbjct: 121 LHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 185 MQLQK--YDAKADLWSVGAILFQLVTGKTPFTGS----NQIQLLQNIVKATELHFPPDAK 238
           ++     +D   D WS+G + F+L+TG +PFT      +Q ++ + I+K+     PP  K
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK----PPFPK 233

Query: 239 ILSADCKDLCQKLLRRNPVERLTF---EEFFNHPFLS 272
            +SA+ +D  QKLL ++P +RL     +E  NHPF  
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 4e-36
 Identities = 81/275 (29%), Positives = 139/275 (50%), Gaps = 16/275 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI---NHPHIIR 75
           IG G+F  V+  R +      AMK ++   +  KK     + E  IL R      P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           L    +    L+L+ +Y  GG+L  ++Q+ G   E+ AK ++ +L   L+ L   ++++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQK-YDAK 193
           DLKP+N+LL   D    + + DFG +++ L       T CG+  Y+APE++  +K Y   
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D WS+G ++F++  G +PF   +  Q+ +NI    ++ FP +  +LS + +   + LL 
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPKN--VLSDEGRQFVKGLLN 234

Query: 254 RNPVERL----TFEEFFNHPFLSQTQPDQVFRSRM 284
           RNP  RL       E   HPF +    D + + ++
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQI 269

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  136 bits (345), Expect = 6e-36
 Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 16/272 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF-ILKRINHP 71
           D+ V   +G G F  V   R +  G   AMK +    L  +   S   E   IL   N P
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
            I +L    +    L+L++EY  GGDL   + R+     E+ A+ ++ +L   +  +   
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--LAETLCGSPLYMAPEIMQLQ 188
             +HRD+KP+N+L+   D    +K+ADFG A  L       ++   G+P Y+APE++   
Sbjct: 122 GYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 189 K------YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILS 241
                  Y  + D WS+G I ++++ G++PF      +   NI+     L FP D K+ S
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV-S 237

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           +D  DL Q LL     ERL +E    HPF S+
Sbjct: 238 SDFLDLIQSLL-CGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  133 bits (337), Expect = 1e-35
 Identities = 75/262 (28%), Positives = 141/262 (53%), Gaps = 10/262 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   R +G GS+  V   RHR  G +  +K++ +   +++ +++   E  +L ++ HP+I
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 74  IRLHDIIE-VPGKLHLILEYCKGGDL--SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           +   +  E   G L++++ +C+GGDL   +  Q+   +PE     +  Q+A  LQ L + 
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQK 189
           +++HRDLK QN+ L   +    +K+ D G AR L+ +  +A TL G+P YM+PE+   + 
Sbjct: 122 HILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           Y+ K+D+W++G  ++++ T K  F   +   L+  I+   E   PP  K  S +  +L  
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII---EGKLPPMPKDYSPELGELIA 235

Query: 250 KLLRRNPVERLTFEEFFNHPFL 271
            +L + P +R + +     P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 1e-35
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 40/289 (13%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEI---AMGRLNKKLQESLMSEIFILKRINHPHII 74
           + +G G    V+  R +  G   A+K +    M + NK   + +++E  IL  ++HP + 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLDHPFLP 64

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNL 132
            L+   +    L L+++YC GG+L   +QR    C+ EE A+ +  ++   L+ L    +
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI 124

Query: 133 IHRDLKPQNLLL----------------CTDDDNAALKIADFGFARSLQPRGLAETLCGS 176
           ++RDLKP+N+LL                   +     K    G  RS      +ET    
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 177 PL-----------YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI 225
           P            Y+APE++    + +  D W++G +L++++ G TPF GSN+ +   NI
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF----EEFFNHPF 270
           +K  E+ FP    + S+  +DL +KLL ++P +RL       E   HPF
Sbjct: 245 LK-KEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  134 bits (340), Expect = 2e-35
 Identities = 82/307 (26%), Positives = 132/307 (42%), Gaps = 52/307 (16%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
            DY +  ++G G+F  V+ AR    G  VA+K+I M         + + EI ILK++ HP
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67

Query: 72  HIIRLHDII--------EVPGKLHLILEYCKGGDLSMYIQRHGCVPEET-AKHFMKQLAA 122
           +++ L D+            G ++++  Y    DLS  ++       E+  K +M QL  
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLE 126

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---- 178
           G+  L +N+++HRD+K  N+L+   D+   LKIADFG AR            G       
Sbjct: 127 GINYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 179 --------YMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA- 228
                   Y  PE ++  ++Y    D+W +G +  ++ T +    G + I  L  I K  
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243

Query: 229 ---TELHFP-----PDAKI-----------------LSADCKDLCQKLLRRNPVERLTFE 263
              TE  +P     P  +                  L  +  DL  KLL  +P +RLT  
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303

Query: 264 EFFNHPF 270
           +   HP+
Sbjct: 304 DALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  133 bits (335), Expect = 4e-35
 Identities = 77/261 (29%), Positives = 137/261 (52%), Gaps = 20/261 (7%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEI-----AMGRLNKKLQES---LMSEIFI 64
           Y V   +GSG+F  V+  R + +G   +A+KEI     A G+  ++  +S   ++SE+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 65  LK-RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQ 119
           +K ++ HP+I+R +       +L+++++  +G  L  +     ++     EE   +   Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 120 LAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           +   L+ L ++  ++HRDL P N++L  DD    + I DFG A+  QP     ++ G+ L
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           Y  PEI++ + Y  KAD+W+ G IL+Q+ T + PF  +N + L   IV+A  ++ P    
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLPEG 236

Query: 239 ILSADCKDLCQKLLRRNPVER 259
           + S D  D+    L  +   R
Sbjct: 237 MYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  134 bits (338), Expect = 5e-35
 Identities = 84/276 (30%), Positives = 141/276 (51%), Gaps = 27/276 (9%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQ----ESLMSEIFILKRINHPH 72
           +G GSF  V  A  +  GT+    E+   ++ KK   +Q    E  M E  +L     P 
Sbjct: 8   LGKGSFGKVMLAERK--GTD----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 73  -IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            + +LH   +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  ++A GL  L    
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLK  N++L   D    +KIADFG  + ++       T CG+P Y+APEI+  Q Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W+ G +L++++ G+ PF G ++ +L Q+I++   + +P   K LS +   +C+ 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP---KSLSKEAVSICKG 234

Query: 251 LLRRNPVERLTF-----EEFFNHPFLSQTQPDQVFR 281
           LL ++P +RL        +   H F  +   +++ R
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER 270

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  133 bits (337), Expect = 7e-35
 Identities = 93/294 (31%), Positives = 143/294 (48%), Gaps = 38/294 (12%)

Query: 18  RQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI----- 68
           R +G GSF  V  AR     R++  +V  K++    L     E  M+E    KRI     
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI---LQDDDVECTMTE----KRILSLAR 53

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           NHP + +L+   + P +L  ++E+  GGDL  +IQ+     E  A+ +  ++ + L  L 
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQL 187
           D  +I+RDLK  N+LL   D     K+ADFG  +     G    T CG+P Y+APEI+Q 
Sbjct: 114 DKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             Y    D W++G +L++++ G  PF   N+  L + I+   E+ +P     LS D  D+
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVYP---TWLSQDAVDI 226

Query: 248 CQKLLRRNPVERLTF------EEFFNHPF--------LSQTQPDQVFRSRMFSR 287
            +  + +NP  RL        E    HPF        L++ Q +  FR R+ SR
Sbjct: 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSR 280

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  131 bits (332), Expect = 2e-34
 Identities = 76/269 (28%), Positives = 139/269 (51%), Gaps = 12/269 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  +  G +VA+K+  M    ++ +E L +E+ I++   HP+I+ ++ 
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKK--MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L  L    +IHRD+K
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL +D     +K++DFGF   +    PR   ++L G+P +MAPE++    Y  + D
Sbjct: 143 SDSILLTSD---GRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
           +WS+G ++ ++V G+ P+     +Q ++ I +        +   +S   +    ++L R+
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256

Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
           P +R T  E  NHPFL++  P       M
Sbjct: 257 PAQRATAAELLNHPFLAKAGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  131 bits (331), Expect = 2e-34
 Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 21/274 (7%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+F  V+ A+++  G   A K I     +++  E  M EI IL   NHP+I++L  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 79  IIEVPGKLHLILEYCKGG--DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                GKL +++E+C GG  D  M     G + E   +   +Q+   LQ L    +IHRD
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 137 LKPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEI-----MQL 187
           LK  N+LL  D D   +K+ADFG +    ++LQ R   ++  G+P +MAPE+     M+ 
Sbjct: 136 LKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRR---DSFIGTPYWMAPEVVMCETMKD 189

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             YD KAD+WS+G  L ++   + P    N +++L  I K+        +K  S + +D 
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-WSMEFRDF 248

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
            +  L ++P  R +  +   HPF+S    ++  R
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  133 bits (336), Expect = 2e-34
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 15/273 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           D+ V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N  
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            I++LH   +    L++++EY  GGDL   +  +  +PE+ A+ +  ++   L  +    
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMG 162

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEIMQLQK 189
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 190 YDA----KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
            D     + D WSVG  L++++ G TPF   + +     I+     L FP D +I S   
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI-SKQA 278

Query: 245 KDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQ 275
           KDL    L    V   R   +E  +HPF    Q
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  130 bits (329), Expect = 6e-34
 Identities = 93/304 (30%), Positives = 137/304 (45%), Gaps = 40/304 (13%)

Query: 6   GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           GR R V ++    +IG G++ +V+ AR    G  VA+K++ M      +  S + EI +L
Sbjct: 1   GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLL 60

Query: 66  KRINHPHIIRLHDIIEVPGK----LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQL 120
             + HP+I+ L ++  V GK    + L++EYC+  DL+  +        E   K  M QL
Sbjct: 61  LNLRHPNIVELKEV--VVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQL 117

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-Y 179
             GLQ L +N +IHRDLK  NLLL    D   LKIADFG AR+        T     L Y
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174

Query: 180 MAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----------- 227
            APE++     Y    D+W+VG IL +L+  K    G ++I+ L  I++           
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234

Query: 228 -------ATELHFP--------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                    +   P             LS     L   LL  +P +R T EE     +  
Sbjct: 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF- 293

Query: 273 QTQP 276
           + +P
Sbjct: 294 KEKP 297

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  129 bits (327), Expect = 6e-34
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 21/266 (7%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G++  V+   HR  G  +AMKEI +     K  + +M E+ IL +   P+I+  + 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDFYG 66

Query: 79  IIEVPGKLHLILEYCKGGDL-SMY--IQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIH 134
              + G +++ +EY   G L  +Y        +PE+  +     +  GL+ L++  N+IH
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE------IMQLQ 188
           RD+KP N+L+     N  +K+ DFG + +L    LA+T  G   YMAPE        Q  
Sbjct: 127 RDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGCQSYMAPERIKSGGPNQNP 182

Query: 189 KYDAKADLWSVGAILFQLVTGKTPF---TGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            Y  ++D+WS+G  + ++  G+ P+   T +N    L  IV       P      S D +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG---YSDDAQ 239

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D   K L + P  R T+ +   HP+L
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  129 bits (325), Expect = 1e-33
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 12/261 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+   V+ A     G EVA+K+I + +  KK  E +++EI ++K + +P+I+   D
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKNPNIVNFLD 83

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++EY  GG L+  +    C+ E       ++    L+ L  N +IHRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL  D    ++K+ DFGF   + P +    T+ G+P +MAPE++  + Y  K D+W
Sbjct: 143 SDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSADCKDLCQKLLRRN 255
           S+G +  ++V G+ P+   N ++ L  I      EL  P     LS   +D   + L  +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSPIFRDFLNRCLEMD 256

Query: 256 PVERLTFEEFFNHPFLSQTQP 276
             +R + +E   HPFL   +P
Sbjct: 257 VEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  129 bits (325), Expect = 2e-33
 Identities = 82/271 (30%), Positives = 138/271 (50%), Gaps = 12/271 (4%)

Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA+K++ + +  KK  E +++EI +++
Sbjct: 14  VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMR 71

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              HP+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEF 130

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P +    T+ G+P +MAPE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             + Y  K D+WS+G +  ++V G+ P+   N ++ L  I            K LSA  +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK-LSAIFR 246

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           D   + L  +  +R + +E   HPFL   +P
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  129 bits (326), Expect = 2e-33
 Identities = 87/306 (28%), Positives = 152/306 (49%), Gaps = 27/306 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHII 74
           +G GSF  V  A  +  G   A+K +   + +  L +  +    + KR+      +P + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL---KKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            L+   +    L  ++E+  GGDL  +IQ  G      A  +  ++  GLQ L    +I+
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N++L   D +  +KIADFG  + ++     A T CG+P Y+APEI+Q  KY   
Sbjct: 120 RDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D WS G +L++++ G++PF G ++ +L ++I   T  H+P   + ++ + KD+ +KL  
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-HYP---RWITKESKDILEKLFE 232

Query: 254 RNPVERL-TFEEFFNHPF--------LSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVA 304
           R+P  RL        HPF        L + + D  F+ ++  +S  D+  ++ + + +  
Sbjct: 233 RDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKV--KSPSDYSNFDREFLSEKP 290

Query: 305 ESSQDD 310
             S  D
Sbjct: 291 RLSYSD 296

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  130 bits (328), Expect = 2e-33
 Identities = 82/301 (27%), Positives = 152/301 (50%), Gaps = 53/301 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           R +G GS  +V+ A        VA+K+I +   + +  +  + EI I++R++H +I++++
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVY 68

Query: 78  DIIEVPGK--------------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           +++   G               ++++ EY +  DL+  ++  G + EE A+ FM QL  G
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRG 126

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RG-LAETLCGSPL 178
           L+ +   N++HRDLKP N+ + T+D    LKI DFG AR + P    +G L+E L  +  
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTED--LVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKW 183

Query: 179 YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA--------- 228
           Y +P + +    Y    D+W+ G I  +++TGK  F G+++++ +Q I+++         
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 229 ---------------TELHFPPDAKILSADCK--DLCQKLLRRNPVERLTFEEFFNHPFL 271
                           E   P    +   + +  D  +++L  NP++RLT EE   HP++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Query: 272 S 272
           S
Sbjct: 304 S 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 2e-33
 Identities = 79/281 (28%), Positives = 138/281 (49%), Gaps = 26/281 (9%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+  E++ ++E  IL+++N   ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G     EE A  +  ++  GL+ L    +++
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD   ++I+D G A  +          G+  YMAPE+++ ++Y    
Sbjct: 126 RDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSP 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           D W +G ++++++ GK+PF    +    + ++  VK  +  +   ++  S   + +C++L
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY---SEKFSEAARSICRQL 239

Query: 252 LRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSR 287
           L ++P  RL       EE   HPF         FR+  F R
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHPF---------FRTANFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  127 bits (321), Expect = 2e-33
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 15/266 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHR--VHGTEV-AMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           Y++ +++G GSF  V+  + +  V    +  +KEI +G LN         E  +L +++H
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           P I++ H          +I EYC+G DL   ++        + E     +  QL  G+  
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIM 185
           +    ++HRDLK +N+ L     N  LKI DFG +R L     LA T  G+P YM+PE +
Sbjct: 122 MHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + Q YD+K+D+WS+G IL+++      F G N + ++  IV+      P   +  S    
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP---ETYSRQLN 234

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            + Q +L ++P  R +  E   +PF+
Sbjct: 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  130 bits (327), Expect = 3e-33
 Identities = 87/273 (31%), Positives = 134/273 (49%), Gaps = 15/273 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ AK +  ++   L  +    
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMG 162

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQK 189
           LIHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  LF+++ G TPF   + +     I+     L+FP D +I S   
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI-SKHA 278

Query: 245 KDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQ 275
           K+L    L    V   R   EE   HPF    Q
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  128 bits (324), Expect = 4e-33
 Identities = 82/298 (27%), Positives = 139/298 (46%), Gaps = 38/298 (12%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRI-----NHP 71
           +G GSF  V  A  +  GT+    E+   ++ KK   LQ+  +      KRI      HP
Sbjct: 3   LGKGSFGKVMLAELK--GTD----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP 56

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  LH   +   +L  ++EY  GGDL   IQR     E  ++ +  ++   L  L  + 
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLK  N+LL   D     K+ADFG  +  +       T CG+P Y+APEI+Q  +Y
Sbjct: 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W++G ++++++ G+ PF   N+  L ++I+    L+       LS +   + + 
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY----PVWLSKEAVSILKA 229

Query: 251 LLRRNPVERL-------TFEEFFNHPF--------LSQTQPDQVFRSRMFS-RSADDF 292
            + +NP +RL         +    HPF        L Q +    F+ ++ + R  ++F
Sbjct: 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNF 287

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  128 bits (323), Expect = 6e-33
 Identities = 75/247 (30%), Positives = 131/247 (53%), Gaps = 16/247 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHII 74
           +G GSF  V  A  +      A+K +   + +  +Q+  +    + KR+       P + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKIL---KKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  +++ GL  L    +I+
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N++L   D    +KIADFG  +     G+   T CG+P Y+APEI+  Q Y   
Sbjct: 125 RDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D W+ G +L++++ G+ PF G ++ +L Q+I++   + +P   K LS +   +C+ L+ 
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP---KSLSKEAVSICKGLMT 237

Query: 254 RNPVERL 260
           ++P +RL
Sbjct: 238 KHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  126 bits (318), Expect = 7e-33
 Identities = 67/231 (29%), Positives = 128/231 (55%), Gaps = 10/231 (4%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN 69
           + ++ + ++IG G FS V+ A   + G  VA+K++ +  L + K +   + EI +LK++N
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQ 125
           HP++I+ +       +L+++LE    GDLS  I    ++   +PE+T   +  QL + L+
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEI 184
            +    ++HRD+KP N+ +        +K+ D G  R    +  A  +L G+P YM+PE 
Sbjct: 121 HMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           +    Y+ K+D+WS+G +L+++   ++PF G +++ L     K  +  +PP
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 8e-33
 Identities = 102/299 (34%), Positives = 148/299 (49%), Gaps = 45/299 (15%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y     IG G++ +V  A H+  G +VA+K+I+        Q +L  EI IL+R  H +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKHEN 64

Query: 73  IIRLHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           II + DII  P       ++++ E  +  DL   I +   +  +  ++F+ Q+  GL+ +
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYI 122

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-----RGLAETLCGSPLYMAP 182
              N++HRDLKP NLLL T+ D   LKI DFG AR   P       L E +  +  Y AP
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEYV-ATRWYRAP 178

Query: 183 EIMQLQKYDAKA-DLWSVGAILFQLVTGKTPFTGS---NQIQL------------LQNIV 226
           EIM   K   KA D+WSVG IL ++++ +  F G    +Q+ L            L  I+
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 227 --KATE----LHFPPD---AKILS-ADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             +A      L F P     K+   AD K  DL  K+L  NP +R+T EE   HP+L Q
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  127 bits (321), Expect = 1e-32
 Identities = 80/282 (28%), Positives = 142/282 (50%), Gaps = 29/282 (10%)

Query: 18  RQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPH 72
           R IG GS++ V   R     R++  +V  KE+     + +  + + +E  + ++  NHP 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN---DDEDIDWVQTEKHVFEQASNHPF 57

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++ LH   +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L +  +
Sbjct: 58  LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           I+RDLK  N+LL   D    +K+ D+G  +  L+P     T CG+P Y+APEI++ + Y 
Sbjct: 118 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 192 AKADLWSVGAILFQLVTGKTPF--TGS------NQIQLLQNIVKATELHFPPDAKILSAD 243
              D W++G ++F+++ G++PF   GS      N    L  ++   ++  P   + LS  
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---RSLSVK 231

Query: 244 CKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
              + +  L ++P ERL       F +   HPF      D +
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  127 bits (320), Expect = 1e-32
 Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 26/280 (9%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINH 70
            D+   + I +G++  V+  RH+      AMK+I    L  + Q + +  E  IL    +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P ++ +    E    L +++EY +GGD +  ++  G +P + A+ +  +    L+ L + 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR----SLQPRGLAE-------------TL 173
            ++HRDLKP NLL+ +      +K+ DFG ++    SL    L E              +
Sbjct: 121 GIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTTN-LYEGHIEKDTREFLDKQV 176

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           CG+P Y+APE++  Q Y    D W++G IL++ + G  PF G    +L   ++ + ++ +
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-SDDIEW 235

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNHPF 270
           P   + L AD +DL  +LLR+NP+ERL      E   H F
Sbjct: 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  127 bits (321), Expect = 1e-32
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 25/280 (8%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRI-NHPHIIR 75
           R IG GS++ V     +      AMK I    +N     + + +E  + +   NHP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           LH   +   +L  ++E+  GGDL  ++QR   +PEE A+ +  +++  L  L +  +I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           DLK  N+LL   D    +K+ D+G  +  ++P     T CG+P Y+APEI++ + Y    
Sbjct: 121 DLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 195 DLWSVGAILFQLVTGKTPF--TGSNQIQ-------LLQNIVKATELHFPPDAKILSADCK 245
           D W++G ++F+++ G++PF   G +          L Q I++   +  P   + LS    
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIP---RSLSVKAS 233

Query: 246 DLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            + +  L ++P ERL       F +  +HPF      D +
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  126 bits (318), Expect = 1e-32
 Identities = 83/273 (30%), Positives = 139/273 (50%), Gaps = 16/273 (5%)

Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA+K++ + +  KK  E +++EI +++
Sbjct: 14  VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILVMR 71

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L  
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDF 130

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P +    T+ G+P +MAPE++
Sbjct: 131 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  ++V G+ P+   N ++ L  I      EL  P   + LSA 
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP---ERLSAV 244

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +   R + +E   HPFL   +P
Sbjct: 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  126 bits (317), Expect = 2e-32
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 25/269 (9%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL---MSEIFILKRINHPHIIR 75
           ++G G+F  V+ A+++  G   A K I     + K +E L   M EI IL   +HP+I++
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVI-----DTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 76  LHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L D       L +++E+C GG + ++ ++    + E   +   KQ    L  L +N +IH
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEIMQLQK- 189
           RDLK  N+L   D D   +K+ADFG +    R++Q R   ++  G+P +MAPE++  +  
Sbjct: 127 RDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVVMCETS 180

Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
               YD KAD+WS+G  L ++   + P    N +++L  I K+        ++  S++ K
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR-WSSEFK 239

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           D  +K L +N   R T  +   HPF++  
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  126 bits (317), Expect = 2e-32
 Identities = 84/280 (30%), Positives = 135/280 (48%), Gaps = 33/280 (11%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G++ VV   RH+     VA+K+      N++++E+ + E+ +L+ +   +I+ L + 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
               GKL+L+ EY +   L +  +    VP E  + ++ QL   +     N+++HRD+KP
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128

Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAE--TLCGSPLYMAPEIMQLQKYDAKADLW 197
           +NLL+  +D    LK+ DFGFAR+L     A       +  Y +PE++    Y    D+W
Sbjct: 129 ENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------------TELHFP----P 235
           SVG IL +L  G+  F G ++I  L  I K                     L FP    P
Sbjct: 186 SVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHP 245

Query: 236 DA------KILSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
            +       ILS    DL + LL+ NP +R   E+  NHP
Sbjct: 246 QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 18/269 (6%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQ---ESLMSEIFILKRI 68
           G  IG G++  V+ A +   G  +A+K++       GR + + +   ++L SEI  LK +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           +H +I++          L + LEY  GG +   ++ +G   E+  + F +Q+  GL  L 
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR---SLQPRGLAETLCGSPLYMAPEIM 185
              ++HRDLK  NLL+   D +   KI+DFG ++    +       ++ GS  +MAPE++
Sbjct: 126 SKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 186 QLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPD-AKILS 241
                 Y AK D+WS+G ++ ++  G+ P++    I  +  +         PPD +  LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
               D        NP  R T  E   HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 84/281 (29%), Positives = 136/281 (48%), Gaps = 30/281 (10%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-N 69
            G + +   IG G++  V+ ARH+  G  VA+K +    + +  +E +  E  IL++  N
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSN 61

Query: 70  HPHIIRLH------DIIEVPGKLHLILEYCKGG---DL-SMYIQRHGCVPEETAKHFMKQ 119
           HP+I   +      +      +L L++E C GG   DL     ++   + EE   + +++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL 178
              GL  L +N +IHRD+K QN+LL     NA +K+ DFG +  L    G   T  G+P 
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 179 YMAPE-IMQLQK----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           +MAPE I   ++    YDA++D+WS+G    +L  GK P    + ++ L  I +      
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---- 234

Query: 234 PP---DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           PP     +  S    D   + L +N  +R   EE   HPF+
Sbjct: 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  125 bits (316), Expect = 3e-32
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 23/295 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES---LMSEIFILKRINHPHII 74
           R+IG GSF  V+ AR       VA+K+  M    K+  E    ++ E+  L+++ HP+ I
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKK--MSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMY-IQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
                        L++EYC G    +  + +      E A         GL  L  +  I
Sbjct: 79  EYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA-ICHGALQGLAYLHSHERI 137

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKY 190
           HRD+K  N+LL    +   +K+ADFG A  + P   A +  G+P +MAPE+   M   +Y
Sbjct: 138 HRDIKAGNILL---TEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQY 191

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           D K D+WS+G    +L   K P    N +  L +I +        +    S   ++    
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND--WSDYFRNFVDS 249

Query: 251 LLRRNPVERLTFEEFFNHPFLSQTQPDQVF-----RSRMFSRSADDFPFYESKSV 300
            L++ P +R + EE   H F+ + +P  V      R++   R  D+  + + K +
Sbjct: 250 CLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQYRKMKKI 304

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  125 bits (315), Expect = 6e-32
 Identities = 84/289 (29%), Positives = 144/289 (49%), Gaps = 27/289 (9%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPH 72
           + +G GSF  V+ A  +      A+K +   + +  L +  +    + KR+      HP 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPF 57

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           +  L+   +    L  ++EY  GGDL  +IQ         A  +  ++  GLQ L    +
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++RDLK  N+LL   D +  +KIADFG  + ++       T CG+P Y+APEI+  QKY+
Sbjct: 118 VYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D WS G +L++++ G++PF G ++ +L Q+I     +  P   + L+ + KD+  KL
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI----RMDNPCYPRWLTREAKDILVKL 230

Query: 252 LRRNPVERLTFE-EFFNHPF--------LSQTQPDQVFRSRMFSRSADD 291
             R P  RL  + +   HPF        L + + +  F+ ++  +SA+D
Sbjct: 231 FVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKV--KSAND 277

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  125 bits (315), Expect = 6e-32
 Identities = 72/272 (26%), Positives = 137/272 (50%), Gaps = 14/272 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   ++++RD+K
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 139 PQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
            +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y    D W
Sbjct: 123 LENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
            +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   LL+++P 
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAGLLKKDPK 235

Query: 258 ERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           +RL       +E   H F        V + ++
Sbjct: 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 267

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  123 bits (310), Expect = 8e-32
 Identities = 65/231 (28%), Positives = 127/231 (54%), Gaps = 10/231 (4%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN 69
           + ++ + ++IG G FS V+ A   +    VA+K++ +  + + K ++  + EI +LK++N
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQ 125
           HP++I+  D      +L+++LE    GDLS  I    ++   +PE T   +  QL + ++
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEI 184
            +    ++HRD+KP N+ +        +K+ D G  R    +  A  +L G+P YM+PE 
Sbjct: 121 HMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           +    Y+ K+D+WS+G +L+++   ++PF G +++ L     K  +  +PP
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPP 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  124 bits (313), Expect = 8e-32
 Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 58/294 (19%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR RV    +A+K+I + + ++ +  + + EI +LK + H +I+RL D
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE-----ETAKHFMKQLAAGLQVLRDNNLI 133
           ++    +L+L+ EY    DL +        P+        K ++ Q+  G+     + ++
Sbjct: 69  VVHSEKRLYLVFEYL---DLDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YMAP 182
           HRDLKPQNLL+  D    ALK+ADFG AR+           G P+           Y AP
Sbjct: 125 HRDLKPQNLLI--DRRTNALKLADFGLARAF----------GIPVRTFTHEVVTLWYRAP 172

Query: 183 EIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----ATELHFP--- 234
           EI+   + Y    D+WSVG I  ++V  K  F G ++I  L  I +      E  +P   
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 235 --PDAK----------------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
             PD K                 L     DL  K+LR +P +R+T      H +
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  124 bits (314), Expect = 1e-31
 Identities = 86/286 (30%), Positives = 138/286 (48%), Gaps = 40/286 (13%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + +G G+F +V  AR ++ G  VA+K+I        L +    E+ +LK + H +II L 
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75

Query: 78  DIIEVPGK-LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           DI   P + ++ + E   G DL   +     + ++  ++F+ Q+  GL+ +    ++HRD
Sbjct: 76  DIFISPLEDIYFVTEL-LGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPR--GLAETLCGSPLYMAPEIM-QLQKYDAK 193
           LKP N+L+   ++N  LKI DFG AR   P+  G   T      Y APEIM   QKYD +
Sbjct: 134 LKPSNILI---NENCDLKICDFGLARIQDPQMTGYVST----RYYRAPEIMLTWQKYDVE 186

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQI---------------QLLQNIVKATELHF----- 233
            D+WS G I  +++ GK  F G + +                ++  I     L F     
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246

Query: 234 -----PPDAKILSAD--CKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                P   K  +AD    DL +K+L  +P +R++  E   HP+L+
Sbjct: 247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  125 bits (316), Expect = 1e-31
 Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 30/276 (10%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
             +IGSG+   V+   HR  G   A+K I  G     ++  +  EI IL+ +NHP++++ 
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKC 137

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           HD+ +  G++ ++LE+  GG L    +      E+      +Q+ +G+  L   +++HRD
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRD 193

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL--CGSPL----YMAPEIMQLQ-- 188
           +KP NLL+   +    +KIADFG +R      LA+T+  C S +    YM+PE +     
Sbjct: 194 IKPSNLLI---NSAKNVKIADFGVSRI-----LAQTMDPCNSSVGTIAYMSPERINTDLN 245

Query: 189 --KYDAKA-DLWSVGAILFQLVTGKTPFTGSNQ---IQLLQNIVKATELHFPPDAKILSA 242
              YD  A D+WS+G  + +   G+ PF    Q     L+  I  +     P  A   S 
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA---SR 302

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           + +      L+R P +R +  +   HPF+ + QP Q
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338

Length = 353

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 1e-31
 Identities = 66/259 (25%), Positives = 126/259 (48%), Gaps = 12/259 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH---PHIIRL 76
           IG G++  V+  +H   G  VA+K I +   +  + + +  E+ +L ++     P+I + 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD-IQREVALLSQLRQSQPPNITKY 67

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +       +L +I+EY +GG +   + + G + E+     ++++   L+ +    +IHRD
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPE-IMQLQKYDAKA 194
           +K  N+L+        +K+ DFG A  L Q      T  G+P +MAPE I + + YD KA
Sbjct: 127 IKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D+WS+G  ++++ TG  P++  +  + +  I K+       +    S   ++     L  
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG--YSKLLREFVAACLDE 241

Query: 255 NPVERLTFEEFFNHPFLSQ 273
            P ERL+ EE     ++  
Sbjct: 242 EPKERLSAEELLKSKWIKA 260

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  123 bits (311), Expect = 2e-31
 Identities = 90/301 (29%), Positives = 141/301 (46%), Gaps = 71/301 (23%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           I  G++ VV+ AR +  G  VA+K++ M +  +    + + EI IL ++ HP+I+ + ++
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETA----KHFMKQLAAGLQVLRDNN 131
             V G    K+++++EY +  DL   ++      +       K  M QL +G+  L DN 
Sbjct: 73  --VVGSNLDKIYMVMEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW 126

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YM 180
           ++HRDLK  NLLL   ++   LKI DFG AR            GSPL           Y 
Sbjct: 127 ILHRDLKTSNLLL---NNRGILKICDFGLAR----------EYGSPLKPYTQLVVTLWYR 173

Query: 181 APEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE++   ++Y    D+WSVG I  +L+T K  F G ++I  L  I K            
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233

Query: 229 -TEL------------------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
            +EL                   FP  A  LS +  DL  +LL  +P +R++ E+   HP
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFP--ALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Query: 270 F 270
           +
Sbjct: 292 Y 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  123 bits (311), Expect = 2e-31
 Identities = 78/250 (31%), Positives = 132/250 (52%), Gaps = 22/250 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRI-----NHP 71
           +G GSF  V  A  +  GT+    E+   ++ KK   +Q+  +    + KR+       P
Sbjct: 8   LGKGSFGKVMLAERK--GTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            + +LH   +   +L+ ++EY  GGDL   IQ+ G   E  A  +  ++A GL  L    
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKY 190
           +I+RDLK  N++L   D    +KIADFG  +     G+  +T CG+P Y+APEI+  Q Y
Sbjct: 122 IIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY 178

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W+ G +L++++ G+ PF G ++ +L Q+I++    H     K +S +   +C+ 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAYPKSMSKEAVAICKG 234

Query: 251 LLRRNPVERL 260
           L+ ++P +RL
Sbjct: 235 LMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  122 bits (308), Expect = 2e-31
 Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 11/262 (4%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K +   R+ K+  ES+ ++E  IL+++N   ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G     EE A  +  ++  GL+ L   N ++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD   ++I+D G A  +          G+  YMAPE++  Q+Y    
Sbjct: 126 RDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSP 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D W +G ++++++ G++PF G  +    + + +         +   S + K +C+ LL +
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242

Query: 255 NPVERLTFE-----EFFNHPFL 271
           +P +RL  +     E   HPF 
Sbjct: 243 DPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  122 bits (309), Expect = 2e-31
 Identities = 87/289 (30%), Positives = 141/289 (48%), Gaps = 40/289 (13%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHIIRLH 77
           +IG G++  V+ AR +  G  VA+K+  +    + +  + + EI +L+ ++   +I+RL 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 78  DIIEV---PGK--LHLILEYCKGGDLSMYIQRHG-----CVPEETAKHFMKQLAAGLQVL 127
           D+  V    GK  L+L+ EY    DL  ++  +G      +P +T K FM QL  G+   
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-M 185
             + ++HRDLKPQNLL+  D     LKIAD G  R+   P         +  Y APE+ +
Sbjct: 127 HKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----ATELHFPPDAKI-- 239
               Y    D+WSVG I  ++   +  F G +++Q L +I K     TE  +P  +K+  
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244

Query: 240 ------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                             LS +  DL QK+LR +P +R++ +    HP+
Sbjct: 245 WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  124 bits (311), Expect = 3e-31
 Identities = 72/272 (26%), Positives = 135/272 (49%), Gaps = 14/272 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   R +  G   AMK +    +  K + +  ++E  +LK   HP +  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +   +L  ++EY  GG+L  ++ R     E+  + +  ++ + L  L    +++RDLK
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 139 PQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
            +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y    D W
Sbjct: 123 LENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
            +G ++++++ G+ PF   +  +L + ++   ++ FP   + LSAD K L   LL ++P 
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFE-LILMEDIKFP---RTLSADAKSLLSGLLIKDPN 235

Query: 258 ERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           +RL       +E   H F +      V+  ++
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKL 267

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  124 bits (312), Expect = 3e-31
 Identities = 80/287 (27%), Positives = 141/287 (49%), Gaps = 38/287 (13%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A++     +VA+K+IA    N+   +  + EI +L+ ++H ++I + DI
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 80  IEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +  P +     ++++ E     DL   I+    + ++  ++F+ QL  GL+ +   N++H
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPE-IMQLQKYDA 192
           RDLKP NLLL  + D   LKI DFG AR + +          +  Y APE ++   +Y  
Sbjct: 132 RDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188

Query: 193 KADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIV---KATELHF------------- 233
             D+WSVG I  +L+  K  F G    +Q++L+  ++      +L F             
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248

Query: 234 PPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           P   +          +    DL +K+L  +P +R+T EE   HP+L+
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  123 bits (310), Expect = 4e-31
 Identities = 80/313 (25%), Positives = 128/313 (40%), Gaps = 57/313 (18%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES------------LMSEIF 63
            G  +G G++  V  A   + G  VA+K++ +  ++  + +              + E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           I+  I H +I+ L D+      ++L+++     DL   + R   + E   K  + Q+  G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS---------------LQPRG 168
           L VL     +HRDL P N+ +   +     KIADFG AR                +Q R 
Sbjct: 132 LNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 169 LAETLCGSPLYMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI-- 225
              +   +  Y APE+ M  +KY    D+WSVG I  +L+TGK  F G N+I  L  I  
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248

Query: 226 ----------------------VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFE 263
                                                S D  DL Q LL+ NP+ER++ +
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 264 EFFNHPFLSQTQP 276
           E   H +  ++ P
Sbjct: 309 EALKHEYF-KSDP 320

Length = 335

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  120 bits (303), Expect = 8e-31
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 16/266 (6%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPH 72
           G  +G G++  V+       G  +A+K++ +   N     K  E L  E+ +LK + H +
Sbjct: 5   GEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I++          + + +E+  GG +S  + R G +PE     + KQ+  G+  L +N +
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-------LCGSPLYMAPEIM 185
           +HRD+K  N++L     N  +K+ DFG AR L   GL  T       + G+P +MAPE++
Sbjct: 124 VHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
               Y  K+D+WS+G  +F++ TGK P    +++  +  I     L  P      SA   
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLPDSFSAAAI 239

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D     L R+  ER +  +   H FL
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  122 bits (306), Expect = 1e-30
 Identities = 75/280 (26%), Positives = 140/280 (50%), Gaps = 27/280 (9%)

Query: 18  RQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           R IG GS++ V   R     +++  +V  KE+     + +  + + +E  + ++ + +P 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH---DDEDIDWVQTEKHVFEQASSNPF 57

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++ LH   +   +L L++EY  GGDL  ++QR   +PEE A+ +  ++   L  L +  +
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           I+RDLK  N+LL   D +  +K+ D+G  +  L P     T CG+P Y+APEI++ ++Y 
Sbjct: 118 IYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 192 AKADLWSVGAILFQLVTGKTPFT------GSNQIQLLQNIVKATELHFPPDAKILSADCK 245
              D W++G ++F+++ G++PF         N    L  ++    +  P   + LS    
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP---RFLSVKAS 231

Query: 246 DLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            + +  L ++P ERL       F +  +H F      D +
Sbjct: 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  120 bits (303), Expect = 1e-30
 Identities = 79/273 (28%), Positives = 138/273 (50%), Gaps = 16/273 (5%)

Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 72

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEF 131

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P     + + G+P +MAPE++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 245

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  120 bits (302), Expect = 1e-30
 Identities = 79/272 (29%), Positives = 132/272 (48%), Gaps = 28/272 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHD 78
           +G G F  V   + R  G   A K++   RL K K  E  M E  IL +++   I+ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
             +    L L++    GGDL  +I    + +   PE  A  +  Q+ +GL+ L    +I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSL-----QPRGLAETLCGSPLYMAPEIMQLQK 189
           RDLKP+N+LL   D++  ++I+D G A  L     + +G A    G+P +MAPE++Q ++
Sbjct: 121 RDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYA----GTPGFMAPELLQGEE 173

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP---PDAKILSADCKD 246
           YD   D +++G  L++++  + PF    + ++    +K   L+     PD    S   K 
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRILNDSVTYPDK--FSPASKS 230

Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPFLSQ 273
            C+ LL ++P +RL F     +    HP    
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  120 bits (303), Expect = 2e-30
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 34/282 (12%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS+ VV+  R+R  G  VA+K+      +  +++  + EI +LK++ HP+++ L +
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +     KLHL+ EYC    L+   +    VPE   K  + Q    +     +N IHRD+K
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC-GSPLYMAPEIM--QLQKYDAKAD 195
           P+N+L+        +K+ DFGFAR L   G   T    +  Y APE++    Q Y    D
Sbjct: 128 PENILITKQG---QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ-YGPPVD 183

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK---------- 245
           +W++G +  +L+TG+  + G + +  L  I K      P   +I S +            
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE 243

Query: 246 -----------------DLCQKLLRRNPVERLTFEEFFNHPF 270
                               +  L+ +P ERL+ EE   HP+
Sbjct: 244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  122 bits (306), Expect = 2e-30
 Identities = 83/273 (30%), Positives = 131/273 (47%), Gaps = 15/273 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ A+ +  ++   L  +    
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 162

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQK 189
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  L++++ G TPF   + +     I+     L FP D  I S + 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEA 278

Query: 245 KDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQ 275
           K+L    L    V   R   EE   H F    Q
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  119 bits (300), Expect = 3e-30
 Identities = 77/267 (28%), Positives = 136/267 (50%), Gaps = 17/267 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+  ES+ ++E  IL+++N   ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G     E  A  +  ++  GL+ L    +++
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD+  ++I+D G A  +      +   G+  YMAPE+++ ++Y    
Sbjct: 126 RDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           D W++G +L++++ G++PF    +    + ++ +VK  +  +   ++  S D + LC+ L
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY---SEKFSPDARSLCKML 239

Query: 252 LRRNPVERL-----TFEEFFNHPFLSQ 273
           L ++P ERL        E   HP   Q
Sbjct: 240 LCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  119 bits (300), Expect = 3e-30
 Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 18/262 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
            +G G+   V+ A H +    +A+K I +  +  +LQ+ +MSE+ IL + + P+II  + 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  ++ +  E+  GG L +Y      +PE         +  GL  L    ++HRD+K
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWS 198
           P N+L+ T      +K+ DFG +  L    +A+T  G+  YMAPE +  ++Y   +D+WS
Sbjct: 123 PSNMLVNT---RGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178

Query: 199 VGAILFQLVTGKTPFTG--SNQ-----IQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           +G    +L  G+ P+     NQ     +QLLQ IV       P      S        + 
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--VGQFSEKFVHFITQC 236

Query: 252 LRRNPVERLTFEEFFNHPFLSQ 273
           +R+ P ER   E   +HPF+ Q
Sbjct: 237 MRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  119 bits (300), Expect = 4e-30
 Identities = 76/262 (29%), Positives = 142/262 (54%), Gaps = 18/262 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  AR +  G +VA+K + + +  ++  E L +E+ I++   H +++ ++ 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHQNVVEMYK 85

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  + +     E+ A      L A L  L    +IHRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA-LCYLHSQGVIHRDIK 144

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    P+   ++L G+P +MAPE++    Y  + D
Sbjct: 145 SDSILLTLD---GRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK---ILSADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+   + +Q ++ +  +     PP  K    +S   +D  +++L
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----PPKLKNAHKISPVLRDFLERML 255

Query: 253 RRNPVERLTFEEFFNHPFLSQT 274
            R P ER T +E  +HPFL QT
Sbjct: 256 TREPQERATAQELLDHPFLLQT 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  119 bits (300), Expect = 7e-30
 Identities = 75/277 (27%), Positives = 135/277 (48%), Gaps = 24/277 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKE------IAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +G G+F  V   R +  G   AMK       IA   +   L ES      +L+   HP +
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-----VLQNTRHPFL 57

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
             L    +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L   +++
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +RDLK +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y  
Sbjct: 118 YRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
             D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLSPEAKSLLAGLL 230

Query: 253 RRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           +++P +RL       +E   H F +      V + ++
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  118 bits (297), Expect = 8e-30
 Identities = 76/249 (30%), Positives = 131/249 (52%), Gaps = 12/249 (4%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+  E++ ++E  IL+++N   ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G     E+ A  +  +L  GL+ L+   +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL---CGSPLYMAPEIMQLQKYD 191
           RDLKP+N+LL   DD   ++I+D G A  + P G  ET+    G+  YMAPE++  +KY 
Sbjct: 126 RDLKPENILL---DDRGHIRISDLGLAVQI-PEG--ETVRGRVGTVGYMAPEVINNEKYT 179

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D W +G ++++++ G++PF    +    + + +  +      ++  S D K +C+ L
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239

Query: 252 LRRNPVERL 260
           L +NP ERL
Sbjct: 240 LTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (295), Expect = 1e-29
 Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 29/262 (11%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           ++ + R++GSG F  VW    +     VA+K +     +   Q+    E+  LKR+ H H
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNR-VRVAIKILK--SDDLLKQQDFQKEVQALKRLRHKH 63

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK------HFMKQLAAGLQV 126
           +I L  +  V   +++I E  + G L  +++     PE              Q+A G+  
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVASLIDMACQVAEGMAY 119

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIM 185
           L + N IHRDL  +N+L+    ++   K+ADFG AR ++    L+        + APE  
Sbjct: 120 LEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
               +  K+D+WS G +L+++ T G+ P+ G N  ++   I     +  P         C
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA-------KC 229

Query: 245 KDLCQKLL----RRNPVERLTF 262
                K++       P +R +F
Sbjct: 230 PQEIYKIMLECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  118 bits (298), Expect = 1e-29
 Identities = 72/273 (26%), Positives = 139/273 (50%), Gaps = 15/273 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +T CG+P Y+APE+++   Y    D 
Sbjct: 123 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   LL+++P
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLSPEAKSLLSGLLKKDP 235

Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKL 268

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  117 bits (296), Expect = 1e-29
 Identities = 81/268 (30%), Positives = 130/268 (48%), Gaps = 19/268 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            ++G G+   V   R +  G   A+K I     N  LQ+ ++ E+ I K    P+I++ +
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 78  D--IIEVPGKLHLILEYCKGGDL-SMY---IQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
              + E    + + +EYC+GG L S+Y    +R G + E+      + +  GL  L    
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRD+KP N+LL        +K+ DFG +  L    LA T  G+  YMAPE +Q + Y 
Sbjct: 126 IIHRDIKPSNILLTR---KGQVKLCDFGVSGELV-NSLAGTFTGTSFYMAPERIQGKPYS 181

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQ-----IQLLQNIVKAT--ELHFPPDAKIL-SAD 243
             +D+WS+G  L ++   + PF    +     I+LL  IV     EL   P   I  S +
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEE 241

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFL 271
            KD  ++ L ++P  R T  +   HP++
Sbjct: 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  117 bits (294), Expect = 2e-29
 Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 19/269 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
             +G+G+   V   +H   GT +A K + +G     +++ ++ E+ I+     P+I+  +
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFY 69

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRD 136
                   + + +E+   G L    ++ G +P E        +  GL  L + + ++HRD
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           +KP N+L+   +    +K+ DFG +  L    +A+T  G+  YM+PE +Q  KY  K+D+
Sbjct: 130 IKPSNILV---NSRGQIKLCDFGVSGELI-NSIADTFVGTSTYMSPERIQGGKYTVKSDV 185

Query: 197 WSVGAILFQLVTGKTPFTGSNQ-----------IQLLQNIVKATELHFPPDAKILSADCK 245
           WS+G  + +L  GK PF  SN            + LLQ IV+      P        D +
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD--FPEDLR 243

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           D     L ++P ER T ++    P   Q 
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQA 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  116 bits (292), Expect = 3e-29
 Identities = 78/262 (29%), Positives = 135/262 (51%), Gaps = 19/262 (7%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G++ +V+ AR       +A+KEI     + +  + L  EI +   + H +I++    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQ-RHGCVP--EETAKHFMKQLAAGLQVLRDNNLIHRD 136
               G   + +E   GG LS  ++ + G +   E+T   + KQ+  GL+ L DN ++HRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQ--LQKYD 191
           +K  N+L+ T   +  +KI+DFG ++ L   G+    ET  G+  YMAPE++    + Y 
Sbjct: 134 IKGDNVLVNT--YSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 192 AKADLWSVGAILFQLVTGKTPFT--GSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           A AD+WS+G  + ++ TGK PF   G  Q  + +  V   ++H P   + LSA+ K+   
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGMFKIH-PEIPESLSAEAKNFIL 246

Query: 250 KLLRRNPVERLTFEEFFNHPFL 271
           +    +P +R +  +    PFL
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  116 bits (292), Expect = 4e-29
 Identities = 77/264 (29%), Positives = 139/264 (52%), Gaps = 18/264 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  +  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 84

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   ++L G+P +MAPE++    Y  + D
Sbjct: 144 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPKLKNLHKVSPSLKGFLDRLL 254

Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  115 bits (290), Expect = 6e-29
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 13/272 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GSF  V+          VA+K I +     ++ E +  EI +L + + P++ + + 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYG 69

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                 KL +I+EY  GG  ++ + R G   E      +K++  GL  L     IHRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL    D   +K+ADFG A  L    +   T  G+P +MAPE++Q   YD+KAD+W
Sbjct: 129 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI--LSADCKDLCQKLLRRN 255
           S+G    +L  G+ P +  + +++L  I K       P       S   K+     L ++
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPK-----NNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
           P  R T +E   H F+ +      + + +  R
Sbjct: 241 PSFRPTAKELLKHKFIVKNAKKTSYLTELIDR 272

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  117 bits (295), Expect = 1e-28
 Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 54/302 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRL 76
           + IG G+F  V   R        AMK +    +  + Q + + +E  IL   ++  +++L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +   +    L+ +++Y  GGD+   + R G   E+ A+ ++ +L   ++ +     IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSL-------------------------------- 164
           +KP N+L+   D +  +K+ DFG                                     
Sbjct: 127 IKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183

Query: 165 ------------QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP 212
                         R LA +L G+P Y+APE++    Y    D WSVG IL++++ G+ P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243

Query: 213 FTGSNQIQLLQNIVK-ATELHFPPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNH 268
           F      +    ++   T LH P  AK LS +  DL  +L      +RL     +E   H
Sbjct: 244 FLADTPAETQLKVINWETTLHIPSQAK-LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301

Query: 269 PF 270
           PF
Sbjct: 302 PF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  114 bits (287), Expect = 1e-28
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 19/257 (7%)

Query: 19  QIGSGSFSVVWHAR-HRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           ++G GSF VV         G    VA+K +   +L+  + +  + E  I+  ++H ++IR
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIR 60

Query: 76  LHDIIEVPGKLHLILEYCKGGDL--SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           L+ ++     L ++ E    G L   +     G     T   +  Q+A G++ L     I
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----LAETLCGSPLYMAPEIMQLQK 189
           HRDL  +N+LL +DD    +KI DFG  R+L        + E L     + APE ++ + 
Sbjct: 120 HRDLAARNILLASDD---KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDL 247
           +   +D+W  G  L+++ T G+ P+ G +  Q+L+ I K  E L  P        D  ++
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC---PQDIYNV 233

Query: 248 CQKLLRRNPVERLTFEE 264
             +    NP +R TF  
Sbjct: 234 MLQCWAHNPADRPTFAA 250

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 83/293 (28%), Positives = 132/293 (45%), Gaps = 55/293 (18%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-----SLMSEIFILKRINHPHII 74
           +G GS++ V+  R ++ G  VA+KEI   RL     E     + + E  +LK + H +I+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI---RLE---HEEGAPFTAIREASLLKDLKHANIV 66

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLI 133
            LHDII     L L+ EY    DL  Y+   G  +     + F+ QL  GL       ++
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFAR--SLQPRGLAE---TLCGSPLYMAPEI-MQL 187
           HRDLKPQNLL+    +   LK+ADFG AR  S+  +  +    TL     Y  P++ +  
Sbjct: 126 HRDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTL----WYRPPDVLLGS 178

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGS----NQIQLLQNI-----------------V 226
            +Y    D+W VG I +++ TG+  F GS    +Q+  +  +                  
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 227 KATELHFPPDAKILS--------ADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           K     F P   +++           ++L  K L+  P +R++  E   HP+ 
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  115 bits (290), Expect = 2e-28
 Identities = 79/271 (29%), Positives = 139/271 (51%), Gaps = 29/271 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-------KLQESLMSEIFILKRINH-P 71
           +G+G++  V+  R +V G +   K  AM  L K       K  E   +E  +L+ +   P
Sbjct: 8   LGTGAYGKVFLVR-KVTGHD-TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            ++ LH   +   KLHLIL+Y  GG++  ++ +     E+  + +  ++   L+ L    
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAETLCGSPLYMAPEIMQLQK 189
           +++RD+K +N+LL   D    + + DFG ++    + +    + CG+  YMAPEI++ + 
Sbjct: 126 IVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182

Query: 190 YDAKA-DLWSVGAILFQLVTGKTPFT----GSNQIQLLQNIVKATELHFPPDAKILSADC 244
              KA D WS+G ++F+L+TG +PFT     + Q ++ + I+K      PP    +  + 
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----PPFPSFIGPEA 238

Query: 245 KDLCQKLLRRNPVERL-----TFEEFFNHPF 270
           +DL  KLLR++P +RL        E   HPF
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  114 bits (286), Expect = 2e-28
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 15/275 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINH---PHIIR 75
           IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  ++    P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+ + +  +++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKA 194
           DLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSA 177

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D +S+G +LF+L+ G +PF         + I + T           S + + L + LL+R
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQR 236

Query: 255 NPVERLTF-----EEFFNHPFLSQTQPDQVFRSRM 284
           +   RL       +E   HPF        VF  + 
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 3e-28
 Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 49/304 (16%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHP 71
           D+   + IG G+F  V   + +  G   AMK++    + +K Q   + +E  IL   ++P
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L+   +    L+LI+EY  GGD+   + +     EE  + ++ +    +  +    
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFG------------FARSL--------------- 164
            IHRD+KP NLLL   D    +K++DFG            F R L               
Sbjct: 122 YIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 165 ------------QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP 212
                         R LA +  G+P Y+APE+     Y+ + D WS+G I+++++ G  P
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Query: 213 FTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLTF---EEFFNH 268
           F   N  +  + I+   E L FP +  + S + KDL ++L       RL      E  +H
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEVPL-SPEAKDLIKRLC-CEAERRLGNNGVNEIKSH 296

Query: 269 PFLS 272
           PF  
Sbjct: 297 PFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  113 bits (284), Expect = 4e-28
 Identities = 83/281 (29%), Positives = 148/281 (52%), Gaps = 30/281 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-------KLQESLMSEIFILKRINH-P 71
           +G+G++  V+  R +V G + + K  AM  L K       K  E   +E  +L+ I   P
Sbjct: 8   LGTGAYGKVFLVR-KVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            ++ LH   +   KLHLIL+Y  GG+L  ++ +     E+  + +  ++   L+ L    
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG 125

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEIMQLQK 189
           +I+RD+K +N+LL   D N  + + DFG ++      +  A + CG+  YMAP+I++   
Sbjct: 126 IIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182

Query: 190 --YDAKADLWSVGAILFQLVTGKTPFT----GSNQIQLLQNIVKATELHFPPDAKILSAD 243
             +D   D WS+G ++++L+TG +PFT     ++Q ++ + I+K+     PP  + +SA 
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYPQEMSAL 238

Query: 244 CKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQV 279
            KD+ Q+LL ++P +RL       +E   HPF  +   D +
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 5e-28
 Identities = 74/260 (28%), Positives = 131/260 (50%), Gaps = 33/260 (12%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           R++G+G F  VW        T VA+K +  G ++    +  ++E  I+K++ HP +I+L+
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLY 67

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ----RHGCVPE--ETAKHFMKQLAAGLQVLRDNN 131
            +  +   ++++ E  K G L  Y+Q    R   +P+  + A     Q+A+G+  L   N
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA----QVASGMAYLEAQN 123

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQ 188
            IHRDL  +N+L+    +N   K+ADFG AR ++   + E   G+     + APE     
Sbjct: 124 YIHRDLAARNVLV---GENNICKVADFGLARVIK-EDIYEAREGAKFPIKWTAPEAALYN 179

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK-- 245
           ++  K+D+WS G +L ++VT G+ P+ G    ++LQ + +   +  PP        C   
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP-------GCPKE 232

Query: 246 --DLCQKLLRRNPVERLTFE 263
             D+     + +P +R TFE
Sbjct: 233 LYDIMLDCWKEDPDDRPTFE 252

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  112 bits (282), Expect = 6e-28
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 11/271 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GSF  V+          VA+K I +     ++ E +  EI +L + + P+I R + 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYITRYYG 69

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                 KL +I+EY  GG  ++ + + G + E      ++++  GL  L     IHRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL    D   +K+ADFG A  L    +   T  G+P +MAPE+++   YD KAD+W
Sbjct: 129 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRNP 256
           S+G    +L  G+ P +  + +++L  I K +    PP  +   S   K+  +  L ++P
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----PPTLEGQYSKPFKEFVEACLNKDP 241

Query: 257 VERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
             R T +E   H F+++      F + +  R
Sbjct: 242 RFRPTAKELLKHKFITRYTKKTSFLTELIDR 272

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  112 bits (282), Expect = 1e-27
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 34/287 (11%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+   ++G G+++ V+  R ++    VA+KEI +    +    + + E+ +LK + H +I
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 66

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNL 132
           + LHDII     L L+ EY    DL  Y+   G  +     K F+ QL  GL       +
Sbjct: 67  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKY 190
           +HRDLKPQNLL+   ++   LK+ADFG AR+   P         +  Y  P+I +    Y
Sbjct: 126 LHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----ATELHFP------------ 234
             + D+W VG I +++ TG+  F GS   + L  I +     TE  +P            
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242

Query: 235 -----PD-----AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                 D     A  L +D  +L  KLL+    +R++ EE   HP+ 
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 95/328 (28%)

Query: 19  QIGSGSFSVVWHAR--HRVHGTEVAMKEIAMGRLNKKLQESL-MS---EIFILKRINHPH 72
            IG G++  V+ A+  +   G E A+K+    + +K+    +  S   EI +L+ + H +
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKF---KGDKEQYTGISQSACREIALLRELKHEN 63

Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAAGLQ 125
           ++ L ++        ++L+ +Y +  DL   I+ H       +P    K  + Q+  G+ 
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 126 VLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFARSLQPRGLAETLCGSPL------ 178
            L  N ++HRDLKP N+L+  +  +   +KI D G AR          L  +PL      
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR----------LFNAPLKPLADL 172

Query: 179 --------YMAPEIMQLQKYDAKA-DLWSVGAILFQLVTGKTPFTG-------SNQIQLL 222
                   Y APE++   ++  KA D+W++G I  +L+T +  F G       SN  Q  
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232

Query: 223 Q----------------------------------------NIVKATELHFPPDAKILSA 242
           Q                                        ++ K  E H  PD++    
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF-- 290

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPF 270
              DL +KLL  +P +R+T EE   HP+
Sbjct: 291 ---DLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  112 bits (281), Expect = 2e-27
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 49/296 (16%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE------SLMSEIFILKRINHPH 72
           ++G GS++ V+  + +V+G  VA+K I       +LQE      + + E  +LK + H +
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+ LHDII     L L+ EY    DL  Y+ +H G +  E  K F+ QL  GL  +    
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQK 189
           ++HRDLKPQNLL+    D   LK+ADFG AR+   P         +  Y  P++ +   +
Sbjct: 124 ILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKA-------------TELHFPP 235
           Y    D+W VG I  +++ G   F G   IQ  L+ I                +  HF P
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240

Query: 236 DAKILSAD---------------CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           +   L +                 +DL  KLL+  P  RL+ +   +H + S   P
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  115 bits (289), Expect = 2e-27
 Identities = 81/265 (30%), Positives = 130/265 (49%), Gaps = 20/265 (7%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHPHI 73
           LVGR   + +F      R      +V  K +    LN + Q +   SE+  L   +H  I
Sbjct: 74  LVGRNPTTAAFVAT---RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGI 127

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRD 129
           ++  D  +   KL LI+EY  GGDL+  I++    H    E        Q+   L  +  
Sbjct: 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR---GLAETLCGSPLYMAPEIMQ 186
             ++HRDLK  N+ L        +K+ DFGF++         +A + CG+P Y+APE+ +
Sbjct: 188 RKMMHRDLKSANIFLMP---TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++Y  KAD+WS+G IL++L+T   PF G +Q +++Q ++      FP     +S+  K 
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP---VSSGMKA 301

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFL 271
           L   LL +NP  R T ++  +  FL
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  111 bits (279), Expect = 2e-27
 Identities = 72/264 (27%), Positives = 141/264 (53%), Gaps = 18/264 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  +  G +VA+K++ + +  ++  E L +E+ I++  +H +++ +++
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHENVVDMYN 86

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  +       E+ A   +  L A L  L +  +IHRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRA-LSYLHNQGVIHRDIK 145

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL +D     +K++DFGF   +    P+   ++L G+P +MAPE++    Y  + D
Sbjct: 146 SDSILLTSD---GRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLCQKLL 252
           +WS+G ++ +++ G+ P+     +Q ++ I        PP   D+  +S+  +     +L
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN----LPPRVKDSHKVSSVLRGFLDLML 256

Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R P +R T +E   HPFL    P
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  110 bits (277), Expect = 4e-27
 Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 37/286 (12%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIR 75
           +IG G++  V+ AR    G  VA+K + +      L  S + E+ +LKR+   +HP+I+R
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 76  LHDI-----IEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLR 128
           L D+      +   K+ L+ E+    DL  Y+ +     +P ET K  M+Q   GL  L 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            N ++HRDLKP+N+L+ +      +K+ADFG AR    +     +  +  Y APE++   
Sbjct: 126 ANCIVHRDLKPENILVTS---GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---------------VKATELHF 233
            Y    D+WSVG I  ++   K  F G+++   L  I               V      F
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242

Query: 234 PPDAKILSADC--------KDLCQKLLRRNPVERLTFEEFFNHPFL 271
            P                   L  ++L  NP +R++      HPF 
Sbjct: 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  110 bits (278), Expect = 4e-27
 Identities = 74/280 (26%), Positives = 137/280 (48%), Gaps = 32/280 (11%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G GS+ +V   +H+  G  VA+K+      +K +++  M EI +LK++ H +++ L ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
                +L+L+ E+     L    +    + E   + ++ Q+  G++    +N+IHRD+KP
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP 128

Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIM-QLQKYDAKADLW 197
           +N+L+     +  +K+ DFGFAR+L   G   T    +  Y APE++    KY    D+W
Sbjct: 129 ENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-----------------PDAK-- 238
           +VG ++ +++TG+  F G + I  L +I+K      P                 P+ K  
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245

Query: 239 --------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                    LS    DL ++ LR +P +R +  +  +H F
Sbjct: 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  110 bits (277), Expect = 5e-27
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 37/290 (12%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           YL   ++G GS++ V+    R++G  VA+K I+M +  + +  + + E  +LK + H +I
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIREASLLKGLKHANI 65

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           + LHDII     L  + EY    DL+ Y+ +H G +     + FM QL  GL  +   ++
Sbjct: 66  VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKY 190
           +HRDLKPQNLL+    +   LK+ADFG AR+   P     +   +  Y  P++ +    Y
Sbjct: 125 LHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181

Query: 191 DAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT-------------------E 230
            +  D+W  G I  +++ G+  F G S+  + L+ I                       E
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241

Query: 231 LHFPPDAKILSADCK---------DLCQKLLRRNPVERLTFEEFFNHPFL 271
              P   + L    K         DL  ++L   P +R++ ++   HP+ 
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  112 bits (280), Expect = 5e-27
 Identities = 81/323 (25%), Positives = 147/323 (45%), Gaps = 60/323 (18%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V G  VA+K+++    N+   +    E+ +LK +NH +II L 
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       ++L++E     D ++    H  +  E   + + Q+  G++ L   
Sbjct: 87  NVF-TPQKSLEEFQDVYLVMELM---DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA 142

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 143 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 199

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA---------------------- 228
               D+WSVG I+ +LV G   F G++ I     +++                       
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 229 ---------TELH----FPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL- 271
                     EL     FP ++   K+ ++  +DL  K+L  +P +R++ +E   HP++ 
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Query: 272 -------SQTQPDQVFRSRMFSR 287
                  ++  P Q++ +++  R
Sbjct: 320 VWYDPAEAEAPPPQIYDAQLEER 342

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  110 bits (276), Expect = 5e-27
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 11/256 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRLHD 78
           +G G F  V   + +  G   A K++   RL KK  E + + E  IL+++N P I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
             E    L L++    GGDL  +I   G    E  +  H+  Q+  G+  L   ++++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           +KP+N+LL   DD    +++D G A  L+         G+  YMAPEI++ + Y    D 
Sbjct: 121 MKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDW 177

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---ELHFPPDAKILSADCKDLCQKLLR 253
           +++G  ++++V G+TPF    +    + + + T   E+ F       + + KD+C+  L 
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN--FTEESKDICRLFLA 235

Query: 254 RNPVERLTFEEFFNHP 269
           + P +RL   E  + P
Sbjct: 236 KKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  109 bits (274), Expect = 6e-27
 Identities = 75/272 (27%), Positives = 139/272 (51%), Gaps = 23/272 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLNKKLQESLMSEIFILKRIN 69
           ++ +G+ +G G+F  V+       G E+A+K++          K   +L  EI +LK + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 70  HPHIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           H  I++ +  +  P +  L + +E+  GG +   ++ +G + E   + + +Q+  G+  L
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGSPLYMAPE 183
             N ++HRD+K  N+L    D    +K+ DFG ++ LQ   L+ T    + G+P +M+PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSA 242
           ++  + Y  KAD+WSVG  + +++T K P+    + + +  I K AT+    P   +L  
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQ----PTNPVLPP 232

Query: 243 DCKDLCQKLLRRNPVE---RLTFEEFFNHPFL 271
              D C+  L+R  VE   R + +E   H F+
Sbjct: 233 HVSDHCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  110 bits (278), Expect = 6e-27
 Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 55/298 (18%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G+F  V+ ARH+     VA+K++ M    +    + + EI IL+ + H +++ L +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 80  IEVP--------GKLHLILEYCK---GGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVL 127
                       G  +L+ E+C+    G LS   ++          K  MK L  GL  +
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK----FTLSEIKKVMKMLLNGLYYI 135

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
             N ++HRD+K  N+L+     +  LK+ADFG AR+      ++    +       Y  P
Sbjct: 136 HRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 183 EIMQLQK-YDAKADLWSVGAILFQLVTGKTPF----TGSNQIQLLQNI-----------V 226
           E++  ++ Y    D+W  G I+ ++ T ++P     T  +Q+ L+  +           V
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 227 KATELH----FPPD----------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
              EL      P              +      DL  KLL  +P +R+  +   NH F
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  111 bits (278), Expect = 6e-27
 Identities = 89/333 (26%), Positives = 158/333 (47%), Gaps = 35/333 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQES-LMSEIFILKRIN 69
           D+ + + IG G+F  V  A  ++  TE   AMK +    + K+ + +    E  +L   +
Sbjct: 2   DFEIIKVIGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD 59

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLR 128
              I  LH   +    L+L+++Y  GGDL   + +    +PE+ A+ ++ ++   +  + 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             + +HRD+KP N+LL   D N  +++ADFG    +   G  ++    G+P Y++PEI+Q
Sbjct: 120 QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 187 -----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
                + KY  + D WS+G  +++++ G+TPF   + ++    I+   E   FP     +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236

Query: 241 SADCKDLCQKLL--RRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESK 298
           S + KDL Q+L+  R   + +   E+F  H F      + +                E+ 
Sbjct: 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRN-------------LEAP 283

Query: 299 SVRDVAESSQDDCLPFFLDDDS-SGPEGSPSFS 330
            + DV  SS  D   F +DDD    PE +P  S
Sbjct: 284 YIPDV--SSPSDTSNFDVDDDVLRNPEIAPPSS 314

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 8e-27
 Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 39/264 (14%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
            R++G+G F  VW        T+VA+K +  G ++    E+ + E  I+K++ H  +++L
Sbjct: 11  ERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQL 66

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH------FMKQLAAGLQVLRDN 130
           + +      ++++ EY   G L  +++      E              Q+A G+  L   
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKS----GEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-----PRGLAETLCGSPL-YMAPEI 184
           N IHRDL  +N+L+    +N   KIADFG AR ++      R  A+     P+ + APE 
Sbjct: 123 NYIHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKF----PIKWTAPEA 175

Query: 185 MQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
               ++  K+D+WS G +L ++VT G+ P+ G    ++L+ + +   +  PP       +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP-------N 228

Query: 244 CKDLCQKLLRR----NPVERLTFE 263
           C +    L+ +    +P ER TFE
Sbjct: 229 CPEELYDLMLQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  111 bits (279), Expect = 8e-27
 Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 77/308 (25%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF---------ILKRI 68
             +GSG++  V  A     G +VA+K         KL     S I          +LK +
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIK---------KLSRPFQSAIHAKRTYRELRLLKHM 71

Query: 69  NHPHIIRLHDIIEVPGKL----------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMK 118
           +H ++I L D+      L          HL+     G DL+  + +   + ++  +  + 
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIV-KCQKLSDDHIQFLVY 125

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG--- 175
           Q+  GL+ +    +IHRDLKP N+ +   +++  LKI DFG AR        + + G   
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHT-----DDEMTGYVA 177

Query: 176 SPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP 234
           +  Y APEIM     Y+   D+WSVG I+ +L+TGKT F GS+ I  L+ I+       P
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT--P 235

Query: 235 PD---AKILSADCK--------------------------DLCQKLLRRNPVERLTFEEF 265
            +    KI S   +                          DL +K+L  +P +R+T  E 
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295

Query: 266 FNHPFLSQ 273
             HP+L++
Sbjct: 296 LAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  110 bits (277), Expect = 9e-27
 Identities = 85/331 (25%), Positives = 158/331 (47%), Gaps = 26/331 (7%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           D+ + + IG G+F  V   + +      AMK +    + K+ + +    E  +L   ++ 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDN 130
            I  LH   +    L+L+++Y  GGDL   + +    +PE+ A+ ++ ++   +  +   
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQ 188
           + +HRD+KP N+L+   D N  +++ADFG    L   G  ++    G+P Y++PEI+Q  
Sbjct: 122 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 189 -----KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSA 242
                KY  + D WS+G  +++++ G+TPF   + ++    I+   E   FP     +S 
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238

Query: 243 DCKDLCQKLL--RRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSV 300
           D KDL ++L+  R + + +   E+F  HPF +    D +       R+ +     E  S 
Sbjct: 239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI-------RNCEAPYIPEVSSP 291

Query: 301 RDVAE-SSQDDCLPFFLDDDSSGPEGSPSFS 330
            D +     DDCL    + ++  P    +FS
Sbjct: 292 TDTSNFDVDDDCLK---NSETMPPPSHTAFS 319

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  115 bits (288), Expect = 1e-26
 Identities = 77/276 (27%), Positives = 141/276 (51%), Gaps = 30/276 (10%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           + +Y V ++IG+G F  V+  +H+        K I+   L ++ +  L+ E+ +++ + H
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 71  PHIIRLHD--IIEVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGL 124
            +I+R  D  + +   KL++++E+C  GDLS  IQ+     G + E       +QL   L
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 125 QV---LRD----NNLIHRDLKPQNLLLCTD--------------DDNAALKIADFGFARS 163
                L+D      ++HRDLKPQN+ L T               +     KI DFG +++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 164 LQPRGLAETLCGSPLYMAPEIM--QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-Q 220
           +    +A +  G+P Y +PE++  + + YD K+D+W++G I+++L +GKTPF  +N   Q
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251

Query: 221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           L+  + +  +L     +K L+   K+L     +  P
Sbjct: 252 LISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP 287

Length = 1021

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  110 bits (277), Expect = 1e-26
 Identities = 88/300 (29%), Positives = 132/300 (44%), Gaps = 46/300 (15%)

Query: 14  YLVGRQIGSGSFSVVWHARH--RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NH 70
           Y + +++G G++ +V  AR+        VA+K+I      K L +  + E+ +L+    H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 71  PHIIRLHDI-IEVPGKLHLILEYCK--GGDLSMYIQRHGCVPEETA--KHFMKQLAAGLQ 125
            +I  L+D+ I  PG  + +  Y +    DL   I      P   A  + F+ Q+  GL+
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILCGLK 119

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-----RGLAETLCGSPLYM 180
            +   N++HRDLKP NLL+  D     LKI DFG AR          G       +  Y 
Sbjct: 120 YIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 181 APEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV------------- 226
           APEIM   Q Y    D+WSVG IL +L+  K  F G + +  L  I+             
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236

Query: 227 ----KATE----LHFPPDAKI------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
               KA      L   P           +    DL +KLL  +P +R++ EE   HP+L+
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 75/271 (27%), Positives = 138/271 (50%), Gaps = 23/271 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLNKKLQESLMSEIFILKRIN 69
           ++ +G+ +G G+F  V+       G E+A+K++      +   K   +L  EI +LK + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 70  HPHIIRLHDIIEVP--GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           H  I++ +  +  P   KL + +EY  GG +   ++ +G + E   + + +Q+  G+  L
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGSPLYMAPE 183
             N ++HRD+K  N+L    D    +K+ DFG ++ +Q   ++ T    + G+P +M+PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSA 242
           ++  + Y  KAD+WSV   + +++T K P+    + + +  I K AT+    P   +L  
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQ----PTKPMLPD 232

Query: 243 DCKDLCQKLLRRNPVE---RLTFEEFFNHPF 270
              D C+  L++  VE   R T E    HPF
Sbjct: 233 GVSDACRDFLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  109 bits (273), Expect = 1e-26
 Identities = 73/229 (31%), Positives = 117/229 (51%), Gaps = 15/229 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHII 74
           +IG G++  V+ AR   +G   VA+K + +    + +  S + E+ +L+ +    HP+++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 75  RLHDIIEVP-----GKLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVL 127
           RL D+  V       KL L+ E+    DL+ Y+ +     VP ET K  M QL  GL  L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             + ++HRDLKPQN+L+ +   +  +K+ADFG AR    +    ++  +  Y APE++  
Sbjct: 127 HSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y    DLWSVG I  ++   K  F GS+ +  L  I+    L    D
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-26
 Identities = 74/272 (27%), Positives = 137/272 (50%), Gaps = 15/272 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           D+ + + IG G+F  V   + +  G   AMK +    + K+ + +    E  +L   +  
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDN 130
            I  LH   +    L+L+++Y  GGDL   + +    +PE+ A+ ++ ++   +  +   
Sbjct: 62  WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL--CGSPLYMAPEIMQLQ 188
             +HRD+KP N+LL   D N  +++ADFG    L   G  ++    G+P Y++PEI+Q  
Sbjct: 122 GYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 189 -----KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSA 242
                +Y  + D WS+G  +++++ G+TPF   + ++    I+   E   FPPD   +S 
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238

Query: 243 DCKDLCQKLL--RRNPVERLTFEEFFNHPFLS 272
           + KDL ++L+      + R   ++F +HPF  
Sbjct: 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+++ V+  R ++    VA+KEI +    +    + + E+ +LK + H +I+ LHD
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
           II     L L+ EY    DL  Y+   G  +     K FM QL  GL       ++HRDL
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKYDAKAD 195
           KPQNLL+   ++   LK+ADFG AR+   P         +  Y  P++ +   +Y    D
Sbjct: 130 KPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 196 LWSVGAILFQLVTGKTPFTGS 216
           +W VG IL+++ TG+  F GS
Sbjct: 187 MWGVGCILYEMATGRPMFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  109 bits (273), Expect = 2e-26
 Identities = 89/308 (28%), Positives = 138/308 (44%), Gaps = 54/308 (17%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R V  + +  QIG G++  V+ AR +  G  VA+K++ +    +    + + EI IL+++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 69  NHPHIIRLHDII----------EVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHF 116
           NH +I+ L +I+          +  G  +L+ EY    DL M +   G V   E+  K F
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DL-MGLLESGLVHFSEDHIKSF 121

Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR---SLQPRGLAE-- 171
           MKQL  GL      N +HRD+K  N+LL   ++   +K+ADFG AR   S + R      
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 172 -TLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT 229
            TL     Y  PE++   ++Y    D+WS G IL +L T K  F  + ++  L+ I +  
Sbjct: 179 ITL----WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234

Query: 230 ELHFP---PDA-----------------------KILSADCKDLCQKLLRRNPVERLTFE 263
               P   PD                          +     DL   +L  +P +R T E
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 264 EFFNHPFL 271
           E  N P+L
Sbjct: 295 EALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  108 bits (273), Expect = 2e-26
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IGSG+   V+  R +  G  +A+K++      ++ +  LM    +LK  + P+I++ + 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 79  IIEVPGKLHLILE-----YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NL 132
                  + + +E       K   L   IQ  G +PE+        +   L  L++   +
Sbjct: 82  YFITDSDVFICMELMSTCLDK---LLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGV 136

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ---- 188
           IHRD+KP N+LL   D +  +K+ DFG +  L          G   YMAPE +       
Sbjct: 137 IHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSN-QIQLLQNIVKATELHFPPDAKILSADCKDL 247
           KYD +AD+WS+G  L +L TG+ P+     + ++L  I++  E    P  +  S D    
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPPNEGFSPDFCSF 252

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
               L ++  +R  + E   HPF+ + +  +V
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  110 bits (277), Expect = 2e-26
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 58/307 (18%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRL 76
           + +G G+F  V  AR        AMK +    +  + Q + + +E  IL   ++  ++RL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +   +    L+ +++Y  GGD+   + R G  PE+ A+ ++ +L   ++ +     IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARS--------------------------------- 163
           +KP N+L+   D +  +K+ DFG                                     
Sbjct: 127 IKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 164 -----LQP----------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT 208
                L+P          R LA +L G+P Y+APE++    Y    D WSVG IL++++ 
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243

Query: 209 GKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADCKDLCQKLLRRNPVERL---TFEE 264
           G+ PF     ++    ++   T LH PP AK LS +  DL  KL  R P +RL     +E
Sbjct: 244 GQPPFLAQTPLETQMKVINWQTSLHIPPQAK-LSPEASDLIIKLC-RGPEDRLGKNGADE 301

Query: 265 FFNHPFL 271
              HPF 
Sbjct: 302 IKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  107 bits (270), Expect = 4e-26
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 24/275 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-P 71
           D  V  ++G G++ VV   RH   GT +A+K I    +N + Q+ L+ ++ I  R    P
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCP 60

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMY------IQRHGCVPEETAKHFMKQLAAGLQ 125
           + +  +  +   G + + +E     D S+         +   +PE+        +   L+
Sbjct: 61  YTVTFYGALFREGDVWICMEVM---DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 126 VLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-CGSPLYMAPE 183
            L    ++IHRD+KP N+L+   + N  +K+ DFG +  L    +A+T+  G   YMAPE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPE 173

Query: 184 ----IMQLQKYDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELHFPPDAK 238
                +  + YD K+D+WS+G  + +L TG+ P+ +     Q L+ +V+      P +  
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK- 232

Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             S + +D   K L++N  ER  + E   HPF   
Sbjct: 233 -FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  107 bits (267), Expect = 2e-25
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 17/292 (5%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHPHIIRL 76
           R+IG GSF  V+ AR       VA+K+++  G+ + +  + ++ E+  L+RI HP+ I  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                      L++EYC G    +       + E            GL  L  +N+IHRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKYDAK 193
           +K  N+LL    +   +K+ADFG A    P   A +  G+P +MAPE+   M   +YD K
Sbjct: 151 IKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D+WS+G    +L   K P    N +  L +I +        +    S   ++     L+
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE--WSDYFRNFVDSCLQ 262

Query: 254 RNPVERLTFEEFFNHPFLSQTQPDQVF-----RSRMFSRSADDFPFYESKSV 300
           + P +R T EE   H F+ + +P+ V      R++   R  D+  + + K +
Sbjct: 263 KIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNLQYRKMKKL 314

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  106 bits (266), Expect = 2e-25
 Identities = 72/297 (24%), Positives = 136/297 (45%), Gaps = 42/297 (14%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV    HR  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSPYIVGFYG 66

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDL 137
                G++ + +E+  GG L   +++ G +PE         +  GL  LR+   ++HRD+
Sbjct: 67  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDV 126

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+ +  +   +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 127 KPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYTVQSDIW 182

Query: 198 SVGAILFQLVTGKTPFTGSNQIQL------------LQNIVKATELHFPPDA-------- 237
           S+G  L ++  G+ P    +  +L             +   +    H PPD+        
Sbjct: 183 SLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH-PPDSPRPMAIFE 241

Query: 238 ---------------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
                             S + +D   K L++NP ER   +E   HPF+ + + ++V
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  104 bits (261), Expect = 3e-25
 Identities = 75/254 (29%), Positives = 131/254 (51%), Gaps = 22/254 (8%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW        T+VA+K +  G ++    ES + E  I+K++ H  +++L+
Sbjct: 12  KKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLY 67

Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
            ++ E P  ++++ EY   G L  +++    R   +P         Q+AAG+  +   N 
Sbjct: 68  AVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNY 123

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKY 190
           IHRDL+  N+L+    D    KIADFG AR ++     A      P+ + APE     ++
Sbjct: 124 IHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             K+D+WS G +L +LVT G+ P+ G N  ++L+ + +   +  P D  I      +L  
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI---SLHELML 237

Query: 250 KLLRRNPVERLTFE 263
           +  +++P ER TFE
Sbjct: 238 QCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  105 bits (264), Expect = 4e-25
 Identities = 77/297 (25%), Positives = 136/297 (45%), Gaps = 27/297 (9%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHPHIIRL 76
           R+IG GSF  V+ AR   +   VA+K+++  G+ + +  + ++ E+  L+++ HP+ I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                      L++EYC G    +       + E            GL  L  +N+IHRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKYDAK 193
           +K  N+LL    +   +K+ DFG A  + P   A    G+P +MAPE+   M   +YD K
Sbjct: 141 VKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD-----CKDLC 248
            D+WS+G    +L   K P    N +  L +I +        ++  L +       ++  
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------ESPALQSGHWSEYFRNFV 247

Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQP-----DQVFRSRMFSRSADDFPFYESKSV 300
              L++ P +R T E    H F+ + +P     D + R++   R  D+  + + K +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  105 bits (262), Expect = 4e-25
 Identities = 74/271 (27%), Positives = 130/271 (47%), Gaps = 11/271 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GSF  V+          VA+K I +     ++ E +  EI +L + + P++ + + 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYYG 69

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                 KL +I+EY  GG  ++ +   G + E      ++++  GL  L     IHRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL    ++  +K+ADFG A  L    +      G+P +MAPE+++   YD+KAD+W
Sbjct: 129 AANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRNP 256
           S+G    +L  G+ P +  + +++L  I K      PP  +   S   K+  +  L + P
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKEP 241

Query: 257 VERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
             R T +E   H F+ +      + + +  R
Sbjct: 242 SFRPTAKELLKHKFIVRFAKKTSYLTELIDR 272

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 5e-25
 Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 13/208 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG G+F  V+    +   TEVA+K      L   L+   + E  ILK+ +HP+I++L 
Sbjct: 1   EKIGKGNFGDVYKGVLKG-NTEVAVKTCRS-TLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      +++++E   GG L  ++++    +  +         AAG++ L   N IHRD
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS---PL-YMAPEIMQLQKYDA 192
           L  +N   C   +N  LKI+DFG +R  +  G+     G    P+ + APE +   +Y +
Sbjct: 119 LAARN---CLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 193 KADLWSVGAILFQLVT-GKTPFTG-SNQ 218
           ++D+WS G +L++  + G TP+ G SNQ
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQ 202

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  104 bits (260), Expect = 5e-25
 Identities = 73/267 (27%), Positives = 131/267 (49%), Gaps = 23/267 (8%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLNKKLQESLMSEIFILKRINHPHI 73
           G+ +G G+F  V+       G E+A K++          K   +L  EI +LK + H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++ +  +    +  L + +EY  GG +   ++ +G + E   + + +Q+  G+  L  N 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGSPLYMAPEIMQL 187
           ++HRD+K  N+L    D    +K+ DFG ++ LQ   ++ T    + G+P +M+PE++  
Sbjct: 127 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADCKD 246
           + Y  KAD+WS+G  + +++T K P+    + + +  I K AT+   P     +S   +D
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLPSHISEHARD 240

Query: 247 LCQKLLRRNPVE---RLTFEEFFNHPF 270
                L    VE   R + EE   HPF
Sbjct: 241 ----FLGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 6e-25
 Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 16/255 (6%)

Query: 18  RQIGSGSF-SVV--WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           +++G G+F SVV   +        EVA+K +         ++  + E  ++ +++HP I+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIV 59

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           RL  + +    L L++E    G L  Y+++   +P    K    Q+A G+  L   + +H
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIMQLQKY 190
           RDL  +N+LL  +   A  KI+DFG +R+L        A T    PL + APE +   K+
Sbjct: 119 RDLAARNVLL-VNRHQA--KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            +K+D+WS G  L++  + G  P+      +++  +     L  P +      +   +  
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC---PQEIYSIML 232

Query: 250 KLLRRNPVERLTFEE 264
              +  P +R TF E
Sbjct: 233 SCWKYRPEDRPTFSE 247

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  104 bits (260), Expect = 6e-25
 Identities = 83/291 (28%), Positives = 141/291 (48%), Gaps = 31/291 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINH---PHIIR 75
           IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  ++    P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +      P KL  IL+   GGDL  ++ +HG   E+  + +  ++  GL+ + +  +++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKA 194
           DLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++Q    YD+ A
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSA 177

Query: 195 DLWSVGAILFQLVTGKTPFTGS--------NQIQLLQNIVKATELHFPPDAKILSADCKD 246
           D +S+G +LF+L+ G +PF           +++ L  N+    EL   PD+   S + K 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV----EL---PDS--FSPELKS 228

Query: 247 LCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
           L + LL+R+  +RL       +E   H F       QV+  +         
Sbjct: 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPPR 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 6e-25
 Identities = 84/316 (26%), Positives = 141/316 (44%), Gaps = 56/316 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRINHPH 72
           +Q+GSG++  V  A  R  G +VA+K     +L +  Q  L +     E+ +LK + H +
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHMKHEN 75

Query: 73  IIRLHDIIEVPGKL------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +I L D+      L      +L++ +  G DL   + +H  + E+  +  + Q+  GL+ 
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPF-MGTDLGK-LMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IM 185
           +    +IHRDLKP NL +   +++  LKI DFG AR          +  +  Y APE I+
Sbjct: 134 IHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSEMTGYVV--TRWYRAPEVIL 188

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD---AKILSA 242
               Y    D+WSVG I+ +++TGK  F G + +  L  I+K T    P      K+ S 
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT--PSKEFVQKLQSE 246

Query: 243 DCKD--------------------------LCQKLLRRNPVERLTFEEFFNHPFLSQ-TQ 275
           D K+                          + +K+L  +   R+T  E   HP+  +   
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306

Query: 276 PDQVFRSRMFSRSADD 291
           P+    +  +  S D+
Sbjct: 307 PEDETEAPPYDDSFDE 322

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  103 bits (259), Expect = 1e-24
 Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 23/266 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G+F  V    H+  GT +A+K I      K+ +  LM    +++  + P+I++ +  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 80  IEVPGKLHLILEYCKGGDLSM-------YIQRHGCVPEETAKHFMKQLAAGLQVLRDN-N 131
           +   G   + +E     D+S+       Y      +PEE            L  L++   
Sbjct: 72  LFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-CGSPLYMAPEIM---QL 187
           +IHRD+KP N+LL   D N  +K+ DFG +  L    +A+T   G   YMAPE +     
Sbjct: 129 IIHRDVKPSNILL---DRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVK--ATELHFPPDAKILSADC 244
             YD ++D+WS+G  L+++ TGK P+   N +   L  +VK     L    + +  S   
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS-NSEEREFSPSF 243

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPF 270
            +     L ++  +R  ++E   HPF
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 64/237 (27%), Positives = 126/237 (53%), Gaps = 11/237 (4%)

Query: 19  QIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           ++GSG+F  V    +++  +E  VA+K +     +  L++ L+ E  +++++++P+I+R+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
             I E      L++E  + G L+ ++Q++  V E+     + Q++ G++ L + N +HRD
Sbjct: 62  IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIMQLQKYDA 192
           L  +N+LL T       KI+DFG +++L        A+T    P+ + APE M   K+ +
Sbjct: 121 LAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           K+D+WS G ++++  + G+ P+ G    ++ Q I     +  P        D   LC
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  105 bits (263), Expect = 4e-24
 Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 41/293 (13%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + R +GSG+   V  A+    G   A+K + M  +++  +    +E+  L   +   I
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 74  IRLHDII--------EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL- 124
           ++ H+          E    + L+L+Y   GDL   I+       +T + F +   AGL 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA----KTNRTFREH-EAGLL 148

Query: 125 --QVL------RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR---SLQPRGLAETL 173
             QVL         ++IHRD+K  N+LLC+   N  +K+ DFGF++   +     +  T 
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTF 205

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           CG+P Y+APEI + + Y  KAD++S+G +L++L+T K PF G N  +++    K     +
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH---KTLAGRY 262

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP----FLS------QTQP 276
            P    +S + +++   LL  +P  R +  +  N P    F+S      QTQP
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQP 315

Length = 496

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  103 bits (257), Expect = 5e-24
 Identities = 86/323 (26%), Positives = 135/323 (41%), Gaps = 72/323 (22%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF---------I 64
           Y   +Q+GSG++  V  A  +  G +VA+K         KL     SEIF         +
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK---------KLSRPFQSEIFAKRAYRELTL 67

Query: 65  LKRINHPHIIRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMK 118
           LK + H ++I L D+              L++ Y +  DL   +     + E+  ++ + 
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVY 124

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           Q+  GL+ +    +IHRDLKP NL +   +++  LKI DFG AR          +  +  
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGYVV--TRW 179

Query: 179 YMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           Y APE I+    Y+   D+WSVG I+ +++TGKT F G + +  L  I+K T +  P   
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 238 KIL---------------------------SADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
           + L                           S    DL +K+L  +  +RLT  E   HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 271 LSQTQPDQVFRSRMFSRSADDFP 293
                           R AD+  
Sbjct: 300 FDSF------------RDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  100 bits (250), Expect = 7e-24
 Identities = 72/255 (28%), Positives = 126/255 (49%), Gaps = 24/255 (9%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+F  V+  R R   T VA+K      L   L+   + E  ILK+ +HP+I+RL  
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL---AAGLQVLRDNNLIHR 135
           +      +++++E  +GGD   +++  G  P    K  ++ +   AAG++ L   + IHR
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHR 118

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPL-YMAPEIMQLQKYDA 192
           DL  +N   C   +   LKI+DFG +R  +    A T  +   P+ + APE +   +Y +
Sbjct: 119 DLAARN---CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           ++D+WS G +L++  + G  P+   +  Q  + I +   L   P+       C D   +L
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP-CPE------LCPDAVYRL 228

Query: 252 LRR----NPVERLTF 262
           + R    +P +R +F
Sbjct: 229 MERCWEYDPGQRPSF 243

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 8e-24
 Identities = 63/263 (23%), Positives = 129/263 (49%), Gaps = 32/263 (12%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +  +G  IG G F  V    +R  G +VA+K +   + +    ++ ++E  ++  + HP+
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPN 61

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDN 130
           +++L  ++     L+++ EY   G L  Y++  G   +       F   +  G++ L + 
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQL 187
           N +HRDL  +N+L+   +D  A K++DFG A+        +      L   + APE ++ 
Sbjct: 122 NFVHRDLAARNVLV--SEDLVA-KVSDFGLAKEAS-----QGQDSGKLPVKWTAPEALRE 173

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP---PDA--KILS 241
           +K+  K+D+WS G +L+++ + G+ P+       ++ ++ K   +  P   P    K++ 
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233

Query: 242 ADCKDLCQKLLRRNPVERLTFEE 264
            DC +L       +P +R TF++
Sbjct: 234 -DCWEL-------DPAKRPTFKQ 248

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  101 bits (252), Expect = 1e-23
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 8/206 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+   ++G G+++ V+  R ++    VA+KEI +    +    + + E+ +LK + H +I
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 66

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE-ETAKHFMKQLAAGLQVLRDNNL 132
           + LHDI+     L L+ EY    DL  Y+   G +      K F+ Q+  GL       +
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKY 190
           +HRDLKPQNLL+   ++   LK+ADFG AR+   P         +  Y  P++ +   +Y
Sbjct: 126 LHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGS 216
             + D+W VG I F++ +G+  F GS
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  100 bits (252), Expect = 1e-23
 Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 44/261 (16%)

Query: 40  VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLS 99
           VA+K +     +   +E  + E+ IL R++ P+I RL  +  V   L +I+EY + GDL+
Sbjct: 49  VAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 100 MYIQRH-----------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD 148
            ++Q+H             +   T  +   Q+A+G++ L   N +HRDL  +N L+    
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---G 164

Query: 149 DNAALKIADFGFARSL------QPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSV 199
            N  +KIADFG +R+L      + +G A      PL   +MA E + L K+  K+D+W+ 
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRA------PLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 200 GAILFQLVT--GKTPFTGSNQIQLLQNIVKATELHFP-------PDAKILSADCKDLCQK 250
           G  L++++T   + P+      Q+++N   A             P       D  +L  +
Sbjct: 219 GVTLWEILTLCREQPYEHLTDQQVIEN---AGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275

Query: 251 LLRRNPVERLTFEEFFNHPFL 271
             RR+  +R TF E   H FL
Sbjct: 276 CWRRDEEDRPTFREI--HLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 43/278 (15%)

Query: 18  RQIGSGSFSVVWHARHRVH----GTEVAMKEIAMGRLNKKLQESLMS----EIFILKRIN 69
           +Q+G G F  V   R+       G +VA+K      LN   +E   S    EI IL+ ++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-----LNHSGEEQHRSDFEREIEILRTLD 64

Query: 70  HPHIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGL 124
           H +I++   + E PG   L LI+EY   G L  Y+QRH    +   K    F  Q+  G+
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGM 122

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGL--AETLCGSPL-YM 180
             L     IHRDL  +N+L+   +    +KI+DFG A+ L + +     +    SP+ + 
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPF--------------TGSNQIQLLQNIV 226
           APE ++  K+ + +D+WS G  L++L T   P                G   +  L  ++
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Query: 227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           K  E    P +     +  DL +      P +R +F +
Sbjct: 240 KEGERLPRPPS--CPDEVYDLMKLCWEAEPQDRPSFAD 275

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =   99 bits (249), Expect = 1e-23
 Identities = 65/252 (25%), Positives = 126/252 (50%), Gaps = 16/252 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++GSG F VV   + R    +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLY 65

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      L+++ E+ + G L  Y+ QR G + ++      + +  G++ L  N+ IHRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDAK 193
           L  +N   C       +K++DFG  R +       +  G+     +  PE+    KY +K
Sbjct: 126 LAARN---CLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYSSK 181

Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +++++ T GK PF   +  ++++ I +   L+ P   K+ S    ++     
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMYSCW 238

Query: 253 RRNPVERLTFEE 264
              P  R TF E
Sbjct: 239 HEKPEGRPTFAE 250

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  102 bits (255), Expect = 2e-23
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 56/298 (18%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS------EIFILKRINHP 71
           R IG G+F VVW       G  VA+K++        + ++L+S      E+ +L    H 
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMP------NVFQNLVSCKRVFRELKMLCFFKHD 59

Query: 72  HIIRLHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +++   DI++ P      +++++ E  +  DL   I     +  +  K F+ Q+  GL+ 
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----LAETLCGSPLYMAP 182
           L    ++HRD+KP NLL+   + N  LKI DFG AR  +P        E +  +  Y AP
Sbjct: 119 LHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAP 173

Query: 183 EI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV------------KAT 229
           EI M  + Y +  D+WSVG I  +L+  +  F   + IQ L  I              A 
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233

Query: 230 E---------LHFPPDAKIL-------SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           E          H PP   +L       + +   L  ++L  +P +R++  +   HP+L
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (250), Expect = 2e-23
 Identities = 75/281 (26%), Positives = 129/281 (45%), Gaps = 45/281 (16%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTE-------VAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A     G +       VA+K +      K L + L+SE+ ++K I
Sbjct: 16  LGKPLGEGAFGQVVKAEAV--GLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 72

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE-------------TAK 114
             H +II L  +    G L++++EY   G+L  +++      E              T K
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    Q+A G++ L     IHRDL  +N+L+ T+D    +KIADFG AR +       
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDH--VMKIADFGLARDIHHIDYYR 189

Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + + +
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249

Query: 228 ATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
              +  P        +C      L+R      P +R TF++
Sbjct: 250 GYRMEKPQ-------NCTQELYHLMRDCWHEVPSQRPTFKQ 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  100 bits (249), Expect = 2e-23
 Identities = 73/270 (27%), Positives = 136/270 (50%), Gaps = 27/270 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHD 78
           IG G++  V+   ++ +G++ A+K +        + E + +E  ILK + +HP++++ + 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 79  I-----IEVPGKLHLILEYCKGGDLS----MYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +     ++   +L L+LE C GG ++     +++R   + E    + + +   GLQ L  
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQ 188
           N  IHRD+K  N+LL T+     +K+ DFG +  L   R    T  G+P +MAPE++  +
Sbjct: 143 NKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199

Query: 189 K-----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILS 241
           +     YDA+ D+WS+G    +L  G  P    + ++ L  I +     LH P   ++ S
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP---ELWS 256

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
            +  D  +K L ++  +R T  +   H F+
Sbjct: 257 NEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  100 bits (250), Expect = 3e-23
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 19/292 (6%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMG--RLNKKLQESLMSEIFILKRINHPHIIRL 76
           +IG GSF  V+ A +      VA+K+++    + N+K Q+ ++ E+  L+++ HP+ I  
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTIEY 86

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                      L++EYC G    +       + E            GL  L  +N+IHRD
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKYDAK 193
           +K  N+LL    +   +K+ADFG A    P   A +  G+P +MAPE+   M   +YD K
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D+WS+G    +L   K P    N +  L +I +        +    +   +      L+
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE--WTDSFRGFVDYCLQ 258

Query: 254 RNPVERLTFEEFFNHPFLSQTQPDQVF-----RSRMFSRSADDFPFYESKSV 300
           + P ER    E   H F+ + +P +V      R++   R  D+  + + K +
Sbjct: 259 KIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.2 bits (247), Expect = 3e-23
 Identities = 69/251 (27%), Positives = 129/251 (51%), Gaps = 16/251 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW   +  H T+VA+K +  G ++    E+ ++E  ++K++ HP ++RL+
Sbjct: 12  KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLY 67

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I EY + G L  +++    +     K      Q+A G+  +   N IHR
Sbjct: 68  AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+    +    KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 127 DLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +L ++VT G+ P+ G    +++QN+ +   +   P       +  +L +   
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPEELYELMRLCW 240

Query: 253 RRNPVERLTFE 263
           +  P ER TFE
Sbjct: 241 KEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 67/248 (27%), Positives = 132/248 (53%), Gaps = 14/248 (5%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IGSG F +VW   + +   +VA+K I  G ++   +E  + E  ++ +++HP +++L+ 
Sbjct: 11  EIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
           +      + L+ E+ + G LS Y++ + G   +ET       +  G+  L  +N+IHRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKAD 195
             +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    KY +K+D
Sbjct: 127 AARN---CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 196 LWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           +WS G +++++ + GKTP+   +  ++++ I     L+ P   ++ S    +L Q   + 
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYELMQHCWKE 240

Query: 255 NPVERLTF 262
            P +R +F
Sbjct: 241 RPEDRPSF 248

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           ++P+ I+L+  +       LI++Y K GDL   +++ G + E   K  ++QL   L  L 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            +N+IH D+K +N+L   D     + + D+G  +     G      G+  Y +PE ++  
Sbjct: 127 KHNIIHNDIKLENVLY--DRAKDRIYLCDYGLCKI---IGTPSCYDGTLDYFSPEKIKGH 181

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL-LQNIVKATELHFPPDAKILSADCKDL 247
            YD   D W+VG + ++L+TGK PF      +L L++++K  +   P   K +S +  D 
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI-KNVSKNANDF 240

Query: 248 CQKLLRRNPVERL-TFEEFFNHPFLS 272
            Q +L+ N   RL  + E   HPFL 
Sbjct: 241 VQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 98.0 bits (244), Expect = 4e-23
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 26/209 (12%)

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+++ LH  I     + L+L++ +GG L  +I +   +PEE  K +  ++   L  L   
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++ RDL P N+LL   DD   +++  F     ++     E +    +Y APE+  + + 
Sbjct: 105 GIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEE 159

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ----NIVKATELHFPPDAKILSADCKD 246
               D WS+GAILF+L+TGKT         L++     I   T L+ P   + +S + + 
Sbjct: 160 TEACDWWSLGAILFELLTGKT---------LVECHPSGINTHTTLNIP---EWVSEEARS 207

Query: 247 LCQKLLRRNPVERL-----TFEEFFNHPF 270
           L Q+LL+ NP ERL       E+  +HPF
Sbjct: 208 LLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 65/251 (25%), Positives = 125/251 (49%), Gaps = 15/251 (5%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW   +  + T+VA+K +  G ++    ++ + E  ++K + H  ++RL+
Sbjct: 12  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLY 67

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I EY   G L  ++     G V       F  Q+A G+  +   N IHR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+    ++   KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 128 DLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +L+++VT GK P+ G +   ++  + +   +   P  +    +  D+ +   
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPDELYDIMKTCW 241

Query: 253 RRNPVERLTFE 263
           +    ER TF+
Sbjct: 242 KEKAEERPTFD 252

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 82/319 (25%), Positives = 132/319 (41%), Gaps = 64/319 (20%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRL 76
           + +G G+F  V  A         AMK +     LN+     + +E  IL   ++  +++L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +   +    L+ +++Y  GGD+   + R    PE  A+ ++ +L   ++ +     IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 137 LKPQNLLLCTDDDNAALKIADFGF------------------------------------ 160
           +KP N+L+   D +  +K+ DFG                                     
Sbjct: 127 IKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 161 ------------ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT 208
                       A     R LA +L G+P Y+APE++  + Y    D WSVG ILF+++ 
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243

Query: 209 GKTPFTGSNQIQL-LQNIVKATELHFPPDAKILSADCKDLCQKL-------LRRNPVERL 260
           G+ PF      +  L+ I     LH PP  K LS +  DL  KL       L RN  + +
Sbjct: 244 GQPPFLAPTPTETQLKVINWENTLHIPPQVK-LSPEAVDLITKLCCSAEERLGRNGADDI 302

Query: 261 TFEEFFNHPFLS---QTQP 276
               FF+    S   +TQP
Sbjct: 303 KAHPFFSEVDFSSDIRTQP 321

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  102 bits (256), Expect = 1e-22
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 11/208 (5%)

Query: 61  EIFILKRINHPHIIRLHDIIEV-PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           E  +  R+ HP+I+ L D  E  PG L  + EY  G  L   +   G +P       M Q
Sbjct: 28  ETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQ 87

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG-------FARSLQPRGLAET 172
           +   L    +  ++HRDLKPQN+++         K+ DFG          +        T
Sbjct: 88  VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147

Query: 173 -LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL 231
            + G+P Y APE ++ +     +DL++ G I  + +TG+    G++  ++L   +   ++
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDV 207

Query: 232 HFPPDAKILSADCKDLCQKLLRRNPVER 259
             PP   I       + +K L ++P +R
Sbjct: 208 SLPP--WIAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 97.5 bits (242), Expect = 1e-22
 Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 23/267 (8%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G++  V+  RH   G   A+K +    +    +E +  EI +LK+ +H   I  +  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 80  IEV----PG---KLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDN 130
             +    PG   +L L++E+C  G ++  I+  +   + EE   +  +++  GL  L  +
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK 189
            +IHRD+K QN+LL    +NA +K+ DFG +  L +  G   T  G+P +MAPE++   +
Sbjct: 131 KVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 190 -----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
                YD K+DLWS+G    ++  G  P    + ++ L  I +         +K  S   
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--KSKKWSKKF 245

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFL 271
           +   +  L +N  +R T E+   HPF+
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 73/268 (27%), Positives = 125/268 (46%), Gaps = 20/268 (7%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM--GRLNKKLQESLMSEIFILKRINH 70
           D+ + ++IGSG++  V+ AR+   G   A+K I +  G     +Q+    EI ++K   H
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ----EIIMMKDCKH 65

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            +I+          KL + +E+C GG L       G + E    +  ++   GL  L   
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQK 189
             +HRD+K  N+LL    DN  +K+ADFG +  +       ++  G+P +MAPE+  +++
Sbjct: 126 GKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 190 ---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSA 242
              Y+   D+W+VG    +L   + P    + ++ L  + K+    F P    D    S 
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN---FQPPKLKDKMKWSN 239

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                 +  L +NP +R T E+   HPF
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 77/283 (27%), Positives = 133/283 (46%), Gaps = 40/283 (14%)

Query: 17  GRQIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRI-NH 70
           G+ +G+G+F  V  A  + +  ++  MK +A+  L        +E+LMSE+ I+  + NH
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMK-VAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLR 128
            +I+ L     + G + +I EYC  GDL  +++R     +  E    F  Q+A G+  L 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ------PRGLAETLCGSPL-YMA 181
             N IHRDL  +N+LL        +KI DFG AR +        +G A      P+ +MA
Sbjct: 159 SKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDSNYVVKGNARL----PVKWMA 211

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNIVKATELHFPPD 236
           PE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L++   +  +    P 
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA 271

Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
                 +  D+ +     +P++R TF        + Q    Q+
Sbjct: 272 ------EIYDIMKTCWDADPLKRPTF------KQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 48/278 (17%)

Query: 17  GRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI----AMGRLNKKLQE-SLMSEIFILK 66
            R++G GSF +V+   A+  V G   T VA+K +    +M    + L E S+M      K
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM------K 64

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE---------TAKHFM 117
             N  H++RL  ++       +++E    GDL  Y++     PE          T + F+
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPPTLQKFI 122

Query: 118 K---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
           +   ++A G+  L     +HRDL  +N ++  D     +KI DFG  R +          
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---TVKIGDFGMTRDIYETDYYRKGG 179

Query: 175 GSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE 230
              L   +MAPE ++   +  K+D+WS G +L+++ T  + P+ G +  ++L+ ++    
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239

Query: 231 LHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           L  P        +C D   +L+R     NP  R TF E
Sbjct: 240 LDLP-------ENCPDKLLELMRMCWQYNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 98.6 bits (245), Expect = 2e-22
 Identities = 68/304 (22%), Positives = 140/304 (46%), Gaps = 48/304 (15%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN-LIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 131 KPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 198 SVGAILFQLVTGKTPFTGSNQIQL-------LQNIVKATEL------------HFPPDAK 238
           S+G  L ++  G+ P    +  +L       ++     +E              + PD++
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR 246

Query: 239 -----------------------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                                  +  A+ +D   K L +NP ER   ++   H F+ +++
Sbjct: 247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306

Query: 276 PDQV 279
            ++V
Sbjct: 307 AEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 68/253 (26%), Positives = 131/253 (51%), Gaps = 20/253 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW A +  H T+VA+K +  G ++    E+ ++E  ++K + H  +++LH
Sbjct: 12  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 67

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I E+   G L  +++       P      F  Q+A G+  +   N IHR
Sbjct: 68  AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 136 DLKPQNLLLCTDDDNAAL--KIADFGFARSLQPRG-LAETLCGSPL-YMAPEIMQLQKYD 191
           DL+  N+L+     +A+L  KIADFG AR ++     A      P+ + APE +    + 
Sbjct: 127 DLRAANILV-----SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L ++VT G+ P+ G +  ++++ + +   +   P  +    +  ++  +
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPEELYNIMMR 238

Query: 251 LLRRNPVERLTFE 263
             +  P ER TFE
Sbjct: 239 CWKNRPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 98.2 bits (244), Expect = 3e-22
 Identities = 83/322 (25%), Positives = 147/322 (45%), Gaps = 58/322 (18%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 139

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 140 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------QL------------------LQNI 225
              D+WSVG I+ ++V  K  F G + I        QL                  ++N 
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ +E   HP+++ 
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316

Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 317 WYDPAEVEAPPPQIYDKQLDER 338

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 56/252 (22%), Positives = 124/252 (49%), Gaps = 14/252 (5%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
            +++GSG F VV   + R    +VA+K I  G ++   ++  + E  ++ +++HP++++L
Sbjct: 9   LKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQL 64

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           + +      + ++ EY   G L  Y++   G +  E        +   ++ L  N  IHR
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAK 193
           DL  +N   C   ++  +K++DFG AR  L  +  +      P+ +  PE+    ++ +K
Sbjct: 125 DLAARN---CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +++++ + GK P+   +  ++++++     L+ P   K+   +   +     
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP---KLAPTEVYTIMYSCW 238

Query: 253 RRNPVERLTFEE 264
              P +R  F++
Sbjct: 239 HEKPEDRPAFKK 250

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 70/258 (27%), Positives = 127/258 (49%), Gaps = 32/258 (12%)

Query: 19  QIGSGSFSVVWHARHRVHGT-EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++G G F  VW      +GT  VA+K +  G ++    E+ + E  ++K++ H  +++L+
Sbjct: 13  KLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 67

Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH--------FMKQLAAGLQVLR 128
            ++ E P  ++++ EY   G L  +++       E  K+           Q+A+G+  + 
Sbjct: 68  AVVSEEP--IYIVTEYMSKGSLLDFLK------GEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE   
Sbjct: 120 RMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLH 233

Query: 246 DLCQKLLRRNPVERLTFE 263
           DL  +  R+ P ER TFE
Sbjct: 234 DLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 72/269 (26%), Positives = 134/269 (49%), Gaps = 27/269 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G++  V+  RH   G   A+K +    + +  +E +  EI +LK+ +H   I  +  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 80  IEV----PG---KLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDN 130
             +    PG   +L L++E+C  G ++  ++  +   + E+   +  +++  GL  L  +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK 189
            +IHRD+K QN+LL    +NA +K+ DFG +  L +  G   T  G+P +MAPE++   +
Sbjct: 141 KVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 190 -----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP--DAKILSA 242
                YD ++D+WS+G    ++  G  P    + ++ L  I +      PP   +K  S 
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP----PPKLKSKKWSK 253

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              D  +  L +N + R + E+   HPF+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.8 bits (238), Expect = 7e-22
 Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 29/271 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHD 78
           IG G++  V+   ++  G+  A+K +        + E + +E  IL+ + NHP++++ + 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 79  IIE-----VPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRD 129
           +       V G+L L+LE C GG ++  ++        + E    + +     GLQ L +
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQ 188
           N +IHRD+K  N+LL T+     +K+ DFG +  L    L   T  G+P +MAPE++  +
Sbjct: 147 NRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 189 K-----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
           +     YDA+ D+WS+G    +L  G  P    + ++ L  I +      PP        
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP----PPTLLHPEKW 259

Query: 244 CKDLCQ---KLLRRNPVERLTFEEFFNHPFL 271
           C+       + L ++   R +      HPF+
Sbjct: 260 CRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.0 bits (236), Expect = 8e-22
 Identities = 63/223 (28%), Positives = 121/223 (54%), Gaps = 19/223 (8%)

Query: 18  RQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           + IG+G F  V   R ++ G     VA+K +  G   K+ +   +SE  I+ + +HP+II
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNII 68

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLI 133
            L  ++     + ++ EY + G L  ++++H G          ++ +A+G++ L D   +
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQLQK 189
           HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE +  +K
Sbjct: 129 HRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 190 YDAKADLWSVGAILFQLVT-GKTPF-TGSNQIQLLQNIVKATE 230
           + + +D+WS G +++++++ G+ P+   SN     Q+++KA E
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIE 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 96.4 bits (240), Expect = 9e-22
 Identities = 83/327 (25%), Positives = 138/327 (42%), Gaps = 43/327 (13%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +   IG GS+ VV  A     G +VA+K+I     +      ++ EI +L+ + HP I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 74  IRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           + +  I+  P +     ++++ E     DL   I+ +  +  E  + F+ QL   L+ + 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL----CGSPLYMAPEI 184
             N+ HRDLKP+N+L    + +  LKI DFG AR                 +  Y APE+
Sbjct: 121 TANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 185 MQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNI-------------- 225
                 KY    D+WS+G I  +++TGK  F G N   Q+ L+ ++              
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237

Query: 226 VKA--------TELHFPPDAKILSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
            KA         +   P   K  +AD     L ++LL  +P +R T EE    P+  +  
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF-KGL 296

Query: 276 PDQVFRSRMFSRSADDFPFYESKSVRD 302
                       +  +F F   +  ++
Sbjct: 297 AKVEREPSAQPITKLEFEFERRRLTKE 323

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 53/302 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V G  VA+K+++    N    +    E+ ++K +NH +II L 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       ++L++E     +L   IQ    +  E   + + Q+  G++ L   
Sbjct: 82  NVF-TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA 137

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 138 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 194

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQI--------QL----------LQNIVKA---- 228
               D+WSVG I+ +++ G   F G++ I        QL          LQ  V+     
Sbjct: 195 KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVEN 254

Query: 229 ---------TELH----FPPDA----KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                     EL     FPPD+    K+ ++  +DL  K+L  +P +R++ ++   HP++
Sbjct: 255 RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314

Query: 272 SQ 273
           + 
Sbjct: 315 NV 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 64/266 (24%), Positives = 125/266 (46%), Gaps = 17/266 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K   +     +++E L  E  ++K I HP+
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFL-KEAAVMKEIKHPN 63

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDN 130
           +++L  +       ++I E+   G+L  Y++      V      +   Q+++ ++ L   
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQ 188
           N IHRDL  +N L+    +N  +K+ADFG +R +      A      P+ + APE +   
Sbjct: 124 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P           +L
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC---PPKVYEL 237

Query: 248 CQKLLRRNPVERLTFEEF---FNHPF 270
            +   + NP +R +F E    F   F
Sbjct: 238 MRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 96.3 bits (239), Expect = 1e-21
 Identities = 76/300 (25%), Positives = 139/300 (46%), Gaps = 52/300 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       +++++E     +L   IQ    +  E   + + Q+  G++ L   
Sbjct: 90  NVF-TPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSA 145

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQI--------QL----------LQNIVKA---- 228
               D+WSVG I+ +++ G   F G++ I        QL          LQ  V+     
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 229 -------------TELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                         ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 82/352 (23%), Positives = 147/352 (41%), Gaps = 50/352 (14%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           D+   + IG G+F  V   + +  G   AMK +    + +K Q + + +E  IL   +  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            ++++    +    L+LI+E+  GGD+   + +   + EE  + ++ +    +  +    
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP------------------------- 166
            IHRD+KP NLLL   D    +K++DFG    L+                          
Sbjct: 122 FIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 167 -----------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG 215
                      R LA +  G+P Y+APE+     Y+   D WS+G I+++++ G  PF  
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 216 SNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLL--RRNPVERLTFEEFFNHPFLS 272
               +  + ++   E L FPP+  I S   KDL  +      N +     EE  +HPF  
Sbjct: 239 ETPQETYRKVMNWKETLVFPPEVPI-SEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297

Query: 273 QTQPDQVFRSRMFS-----RSADDFPFYESKSVRDVAESSQDDCLPFFLDDD 319
                 + R R  +     +S DD   ++     D+ + +++   P +   D
Sbjct: 298 GVDWGHI-RERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYKSKD 348

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 89/351 (25%), Positives = 153/351 (43%), Gaps = 62/351 (17%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           D+   + IG G+F  V   + +  G   AMK +    + KK Q + + +E  +L   + P
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            ++ L+   +    L+LI+E+  GGDL   + ++    E+  + +M +    ++ +    
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFG-------------FARSLQP------------ 166
            IHRD+KP N+L+   D    +K++DFG             + + LQ             
Sbjct: 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 167 -----------------------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAIL 203
                                  R +A +  G+P Y+APEI   Q Y  + D WS+GAI+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 204 FQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERL-- 260
           F+ + G  PF   N  +  + I+   E L+FP D   LS + +DL ++L+  N   RL  
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIH-LSVEAEDLIRRLI-TNAENRLGR 296

Query: 261 -TFEEFFNHPFLSQTQPDQVFRSRM-FS---RSADDFPFYESKSVRDVAES 306
               E  +HPF      D + + R  F    +S  D  ++ +  +  V E+
Sbjct: 297 GGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEA 347

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 18/267 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           DY + +++GSG++  V+ AR+   G   A+K I   +L      SL+  EIF++K   H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHC 66

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +I+          KL + +EYC GG L       G + E    +  ++   GL  L    
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQK- 189
            +HRD+K  N+LL    DN  +K+ADFG A  +       ++  G+P +MAPE+  ++K 
Sbjct: 127 KMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 190 --YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSAD 243
             Y+   D+W+VG    +L   + P    + ++ L  + K+    F P    D    S+ 
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN---FQPPKLKDKTKWSST 240

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPF 270
             +  +  L +NP +R T E    H F
Sbjct: 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 25/225 (11%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV   +H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   ++    +PEE        +  GL  LR+ + ++HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 131 KPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           S+G  L +L  G+ P                     PPDAK L A
Sbjct: 187 SMGLSLVELAIGRYPIP-------------------PPDAKELEA 212

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 66/226 (29%), Positives = 121/226 (53%), Gaps = 13/226 (5%)

Query: 20  IGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V+    ++ G     VA+K +  G   K+ Q+  +SE  I+ + +H +IIRL
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++       +I EY + G L  Y++ H G          ++ +AAG++ L D N +HR
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQLQKYD 191
           DL  +N+L+   + N   K++DFG +R L+  P G   T  G  P+ + APE +  +K+ 
Sbjct: 132 DLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
           + +D+WS G +++++++ G+ P+   +  ++++ I     L  P D
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 66/268 (24%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +G+ +G G F  V   +         +VA+K + +        E  +SE   +K  +HP+
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 73  IIRLHDI------IEVPGKLHLILEYCKGGDLSMYI--QRHGCVPE----ETAKHFMKQL 120
           +++L  +      ++   K  +IL + K GDL  ++   R G +PE    +T   FM  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-- 178
           A G++ L + N IHRDL  +N +L    ++  + +ADFG ++ +           + +  
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 179 -YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
            ++A E +  + Y +K+D+W+ G  ++++ T G+TP+ G    ++   +     L  P D
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239

Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEE 264
                 +  DL     R +P +R TF +
Sbjct: 240 C---LDELYDLMYSCWRADPKDRPTFTK 264

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 93.1 bits (231), Expect = 6e-21
 Identities = 68/233 (29%), Positives = 119/233 (51%), Gaps = 37/233 (15%)

Query: 16  VGRQIGSGSFSVV-----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+ +G G F  V     +  + R   T VA+K +     + +L++ L+SE  +LK++NH
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNH 62

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ---RHGCV---------------PEET 112
           PH+I+L+      G L LI+EY K G L  +++   + G                 P+E 
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 113 AKH------FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-- 164
           A        F  Q++ G+Q L +  L+HRDL  +N+L+    +   +KI+DFG +R +  
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRDVYE 179

Query: 165 QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG 215
           +   +  +    P+ +MA E +    Y  ++D+WS G +L+++VT G  P+ G
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 92.5 bits (230), Expect = 6e-21
 Identities = 65/259 (25%), Positives = 122/259 (47%), Gaps = 23/259 (8%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           GR IG G F  V+   +     E   VA+K       +  ++E  + E +I+++ +HPHI
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++L  +I     + +++E    G+L  Y+Q +   +   +   +  QL+  L  L     
Sbjct: 70  VKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQKY 190
           +HRD+  +N+L+ + D    +K+ DFG +R L+     +   G  P+ +MAPE +  +++
Sbjct: 129 VHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 191 DAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            + +D+W  G  +++ L+ G  PF G     ++  I     L  PP       +C     
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP-------NCPPTLY 238

Query: 250 KLLRR----NPVERLTFEE 264
            L+ +    +P +R  F E
Sbjct: 239 SLMTKCWAYDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 66/242 (27%), Positives = 119/242 (49%), Gaps = 22/242 (9%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           + +GR +G G F  V  A+ +       +VA+K +     +    E  + E   +K  +H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 71  PHIIRLHDII---EVPGKL---HLILEYCKGGDLSMYI--QRHG----CVPEETAKHFMK 118
           P++I+L  +       G+L    +IL + K GDL  ++   R G     +P +T   FM 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
            +A+G++ L   N IHRDL  +N +L   ++N  + +ADFG ++ +         C S L
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 179 ---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
              ++A E +    Y   +D+W+ G  +++++T G+TP+ G    ++   ++K   L  P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237

Query: 235 PD 236
           PD
Sbjct: 238 PD 239

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 31/268 (11%)

Query: 18  RQIGSGSFSVVWHARHR---VHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
             +GSG+F  V+          G+    VA+K +  G  +++ +E  + E  ++   NHP
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL-------AAGL 124
           +I++L  +  +    ++I+E  +GGDL  Y++             +K+L       A G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNA--ALKIADFGFARSL------QPRGLAETLCGS 176
             L   + IHRDL  +N L+     +A   +KI DFG AR +      +  G  E L   
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EGLL-- 175

Query: 177 PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           P+ +MAPE +   K+  ++D+WS G ++++++T G+ P+   N  ++LQ++     L  P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235

Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTF 262
            +          L      ++P ER TF
Sbjct: 236 ENC---PDKIYQLMTNCWAQDPSERPTF 260

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 65/233 (27%), Positives = 121/233 (51%), Gaps = 25/233 (10%)

Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V   R ++ G     VA+K +  G   K+ ++ L SE  I+ + +HP+II L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQFDHPNIIHL 70

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + +I E+ + G L  ++ Q  G          ++ +AAG++ L + N +HR
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-----PL-YMAPEIMQLQK 189
           DL  +N+L+   + N   K++DFG +R L+      T   S     P+ + APE +  +K
Sbjct: 131 DLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 190 YDAKADLWSVGAILFQLVT-GKTPF-TGSNQIQLLQNIVKATELHF----PPD 236
           + + +D+WS G +++++++ G+ P+   SN     Q+++ A E  +    P D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIEQDYRLPPPMD 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 16/229 (6%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +GSG+F  V+       G      VA+K +     + K  + ++ E +++  ++HPH
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPH 70

Query: 73  IIRLHDIIEVPGKLH-LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
           ++RL  I         LI +    G L  Y++ H   +  +   ++  Q+A G+  L + 
Sbjct: 71  VVRLLGI--CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS--PL-YMAPEIMQL 187
            L+HRDL  +N+L+ T      +KI DFG A+ L          G   P+ +MA E +  
Sbjct: 129 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + Y  K+D+WS G  +++L+T G  P+ G   +++   + K   L  PP
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 91.6 bits (227), Expect = 4e-20
 Identities = 79/310 (25%), Positives = 139/310 (44%), Gaps = 55/310 (17%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 143

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPLYMAPEIM-QLQKY 190
           RDLKP NL +   +++  LKI DFG AR        + + G   +  Y APEIM     Y
Sbjct: 144 RDLKPSNLAV---NEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHY 195

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK----- 245
           +   D+WSVG I+ +L+TG+T F G++ I  L+ I++          K +S++       
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255

Query: 246 ----------------------DLCQKLLRRNPVERLTFEEFFNHPFLSQ---------T 274
                                 DL +K+L  +  +R+T  +   H + +Q          
Sbjct: 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 315

Query: 275 QP-DQVFRSR 283
            P DQ F SR
Sbjct: 316 DPYDQSFESR 325

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 54/284 (19%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +G+ +G G F  V   +     +  +VA+K + +    +   E  +SE   +K  +HP++
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 74  IRL--------------HDIIEVP----GKLHLILEYCKGGDLSMYIQRHGCVPEETAKH 115
           +RL                ++ +P    G LH  L Y + GD   Y+      P +    
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL------PTQMLVK 116

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-------QPRG 168
           FM  +A+G++ L   + IHRDL  +N +L   ++N  + +ADFG ++ +       Q R 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGR- 172

Query: 169 LAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIV 226
               +   P+ ++A E +  + Y  K+D+WS G  ++++ T G+TP+ G    ++   + 
Sbjct: 173 ----IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228

Query: 227 KATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEEFF 266
           +   L  PP       DC D    L+      NP +R +FE   
Sbjct: 229 QGNRLKQPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLR 265

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 71/253 (28%), Positives = 127/253 (50%), Gaps = 22/253 (8%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T+VA+K +  G +   + E+ + E  I+K++ H  ++ L+ 
Sbjct: 13  KLGQGCFGEVWMGTWN-GTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ E+   G L  +++    ++  +P+        Q+A G+  +   N I
Sbjct: 69  VVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIERMNYI 124

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    DN   KIADFG AR ++     A      P+ + APE     ++ 
Sbjct: 125 HRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +LVT G+ P+ G    ++L+ + +   +  P        +   LC K
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK 241

Query: 251 LLRRNPVERLTFE 263
              ++P ER TFE
Sbjct: 242 ---KDPDERPTFE 251

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 35/271 (12%)

Query: 20  IGSGSFSVVWHARHRVHGTEV-----AMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHI 73
           IG G+F  V  AR +  G  +      MKE A    +K        E+ +L ++  HP+I
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNI 70

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA----------------KHFM 117
           I L    E  G L+L +EY   G+L  ++++   +  + A                 HF 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  Q   + +T+   P
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLP 186

Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L  P 
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246

Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           +      +  DL ++  R  P ER +F +  
Sbjct: 247 NC---DDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 32/259 (12%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G+F  V+    +   T VA+K      L ++L+   +SE  ILK+ +HP+I++L  +
Sbjct: 3   LGKGNFGEVFKGTLK-DKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK---QLAAGLQVLRDNNLIHRD 136
                 +++++E   GGD   ++++     E   K  +K     AAG+  L   N IHRD
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARS-----LQPRGLAETLCGSPL-YMAPEIMQLQKY 190
           L  +N   C   +N  LKI+DFG +R          GL +     P+ + APE +   +Y
Sbjct: 119 LAARN---CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI----PIKWTAPEALNYGRY 171

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            +++D+WS G +L++  + G  P+ G    Q  + + K   +  P         C D   
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP-------QKCPDDVY 224

Query: 250 KLLRR----NPVERLTFEE 264
           K+++R     P  R  F E
Sbjct: 225 KVMQRCWDYKPENRPKFSE 243

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 43/273 (15%)

Query: 20  IGSGSFSVVWHARHRVHGTEVA-----MKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           IG G+F  V  A  +  G ++      +KE A    ++        E+ +L ++ +HP+I
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNI 65

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-------------HGCVPEETAKH---FM 117
           I L    E  G L++ +EY   G+L  ++++             HG     T++    F 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+Q L +   IHRDL  +N+L+    +N A KIADFG +R  +   + +T+   P
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRG-EEVYVKKTMGRLP 181

Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y  K+D+WS G +L+++V+ G TP+ G    +L + + +   +  P 
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP- 240

Query: 236 DAKILSADCKDLCQKLLRR----NPVERLTFEE 264
                  +C D   +L+R+     P ER  F +
Sbjct: 241 ------RNCDDEVYELMRQCWRDRPYERPPFAQ 267

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 64/254 (25%), Positives = 127/254 (50%), Gaps = 23/254 (9%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +G  IG G F  V    +   G +VA+K I          ++ + E  ++ +++H +++R
Sbjct: 10  LGEIIGEGEFGAVLQGEYT--GQKVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVR 63

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLI 133
           L  +I   G L++++E    G+L  +++  G   V       F   +A G++ L    L+
Sbjct: 64  LLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-YMAPEIMQLQKYDA 192
           HRDL  +N+L+   +D  A K++DFG AR +   G+  +    P+ + APE ++ +K+ +
Sbjct: 123 HRDLAARNILV--SEDGVA-KVSDFGLAR-VGSMGVDNSKL--PVKWTAPEALKHKKFSS 176

Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH----FPPDAKILSADCKDL 247
           K+D+WS G +L+++ + G+ P+   +  ++ + + K   +      P D  +L   C + 
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET 236

Query: 248 CQKLLRRNPVERLT 261
             K  +R    +L 
Sbjct: 237 EPK--KRPSFHKLR 248

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 89.0 bits (220), Expect = 4e-19
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 42/273 (15%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           D+   + IG G+F  V   + +  G   AMK +    + +K Q   + +E  IL   +  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            ++++    +    L+LI+E+  GGD+   + +   + EE  + ++ +    +  +    
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP------------------------- 166
            IHRD+KP NLLL   D    +K++DFG    L+                          
Sbjct: 122 FIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 167 -----------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG 215
                      R LA +  G+P Y+APE+     Y+   D WS+G I+++++ G  PF  
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 216 SNQIQLLQNIVKATE-LHFPPDAKILSADCKDL 247
               +  + ++   E L FPP+  I S   KDL
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVPI-SEKAKDL 270

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 37/281 (13%)

Query: 13  DYLVGRQIGSGSFSVVWHAR-HRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++ R++G G+F  V+ A  + +  T+    VA+K  A+       ++    E  +L  
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLTN 63

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--------CVPEETAK----- 114
           + H HI++ + +      L ++ EY K GDL+ +++ HG          P +        
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 115 ---HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----R 167
              H   Q+A+G+  L   + +HRDL  +N   C    N  +KI DFG +R +      R
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRN---CLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 168 GLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI 225
               T+   P+ +M PE +  +K+  ++D+WS G IL+++ T GK P+   +  ++++ I
Sbjct: 181 VGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
            +   L  P   ++   +  D+     +R P +RL  +E +
Sbjct: 239 TQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIY 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.5 bits (214), Expect = 6e-19
 Identities = 60/257 (23%), Positives = 125/257 (48%), Gaps = 24/257 (9%)

Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +++G+G F VV    W  ++     +VA+K I  G ++   ++  + E  ++ +++H  +
Sbjct: 10  KELGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKL 61

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM-KQLAAGLQVLRDNNL 132
           ++L+ +      ++++ EY   G L  Y++ HG   + +    M K +  G+  L     
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           IHRDL  +N   C  DD   +K++DFG +R +       ++ GS     +  PE++   K
Sbjct: 122 IHRDLAARN---CLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYSK 177

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + +K+D+W+ G +++++ + GK P+   N  + ++ + +   L+ P  A   S     + 
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA---SEKVYAIM 234

Query: 249 QKLLRRNPVERLTFEEF 265
                    ER TF++ 
Sbjct: 235 YSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 71/261 (27%), Positives = 137/261 (52%), Gaps = 31/261 (11%)

Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG G F  V   R ++ G +   VA+K +  G  +K+ +   ++E  I+ + +HP+IIRL
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDHPNIIRL 70

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + +I EY + G L  +++ + G          ++ +A+G++ L + N +HR
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR 130

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCG-SPL-YMAPEIMQLQKYDA 192
           DL  +N+L+   + N   K++DFG +R L+       T  G  P+ + APE +  +K+ +
Sbjct: 131 DLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187

Query: 193 KADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHF---PPDAKILSADCKDL 247
            +D+WS G +++++++ G+ P+   SN     Q+++KA E  +   PP       DC   
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVEDGYRLPPP------MDCPSA 236

Query: 248 CQKLL----RRNPVERLTFEE 264
             +L+    +++  ER TF +
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQ 257

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 59/271 (21%), Positives = 120/271 (44%), Gaps = 32/271 (11%)

Query: 18  RQIGSGSFSVVWHA--RHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           R++G G+F  V+     H     +   VA+K +     N   ++    E  +L    H +
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-ARKDFEREAELLTNFQHEN 69

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG------------CVP--EETAKHFMK 118
           I++ + +        ++ EY + GDL+ +++ HG                          
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           Q+A+G+  L   + +HRDL  +N   C    +  +KI DFG +R +        + G  +
Sbjct: 130 QIASGMVYLASQHFVHRDLATRN---CLVGYDLVVKIGDFGMSRDVYTTDYYR-VGGHTM 185

Query: 179 ----YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF 233
               +M PE +  +K+  ++D+WS G +L+++ T GK P+ G +  ++++ I +   L  
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           P       ++  D+     +R+P +R+  ++
Sbjct: 246 PRTC---PSEVYDIMLGCWKRDPQQRINIKD 273

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 38/268 (14%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHI 73
           R IG G F  V+H    +  ++      A+  LN+    +  E  + E  I+K  +HP++
Sbjct: 1   RVIGKGHFGCVYHGT--LIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 74  IRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLRD 129
           + L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L  
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQVAKGMEYLAS 116

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR--------SLQPRGLAETLCGSPL-YM 180
              +HRDL  +N +L   D++  +K+ADFG AR        S+     A+     P+ +M
Sbjct: 117 KKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL----PVKWM 169

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP---PD 236
           A E +Q QK+  K+D+WS G +L++L+T G  P+   +   +   +++   L  P   PD
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229

Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEE 264
                    ++        P  R TF E
Sbjct: 230 P------LYEVMLSCWHPKPEMRPTFSE 251

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 57/226 (25%), Positives = 116/226 (51%), Gaps = 13/226 (5%)

Query: 19  QIGSGSFSVVWHA--RHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           ++GSG+F  V     + R    +VA+K +      K +++ +M E  I+ ++++P+I+R+
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             + E    L L++E   GG L+ ++  +   +        M Q++ G++ L   N +HR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIMQLQKYD 191
           DL  +N+LL    +    KI+DFG +++L        A +    PL + APE +  +K+ 
Sbjct: 120 DLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
           +++D+WS G  +++  + G+ P+      +++  I +   L  P +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE 222

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 43/273 (15%)

Query: 20  IGSGSFSVVWHARHRVHGTEV-----AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           IG G+F  V  AR +  G  +      MKE A    +K        E+ +L ++ +HP+I
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNI 58

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-------------HGCVPEETAKH---FM 117
           I L    E  G L+L +EY   G+L  ++++             +      +++    F 
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  Q   + +T+   P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLP 174

Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L  P 
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP- 233

Query: 236 DAKILSADCKDLCQKLLRR----NPVERLTFEE 264
                  +C D    L+R+     P ER +F +
Sbjct: 234 ------LNCDDEVYDLMRQCWREKPYERPSFAQ 260

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 35/240 (14%)

Query: 51  NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----- 105
           NK  +   + EI I+ R+  P+IIRL  +      L +I EY + GDL+ ++ RH     
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118

Query: 106 ------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG 159
                   +   T      Q+A+G++ L   N +HRDL  +N   C    N  +KIADFG
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN---CLVGKNYTIKIADFG 175

Query: 160 FARSLQPRGLAETLCGSPL----YMAPEIMQLQKYDAKADLWSVGAILFQLVT--GKTPF 213
            +R+L   G    + G  +    +M+ E + L K+   +D+W+ G  L++++T   + P+
Sbjct: 176 MSRNLY-SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234

Query: 214 TGSNQIQLLQNIV-----KATELHFPPDAKILSADCKDLCQKLL----RRNPVERLTFEE 264
           +  +  Q+++N       +  +++ P  A      C D   KL+    RRN  ER +F+E
Sbjct: 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPAL-----CPDSLYKLMLSCWRRNAKERPSFQE 289

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 87.8 bits (217), Expect = 2e-18
 Identities = 82/308 (26%), Positives = 132/308 (42%), Gaps = 47/308 (15%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +G  IG+GSF VV+ A       +VA+K++      K        E+ I+K +NH +I
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINI 121

Query: 74  IRLHD------------------IIE-VPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK 114
           I L D                  ++E +P  +H  +++        Y + +  +P    K
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH--------YARNNHALPLFLVK 173

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
            +  QL   L  +    + HRDLKPQNLL+  D +   LK+ DFG A++L     + +  
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 175 GSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----T 229
            S  Y APE+M     Y    DLWS+G I+ +++ G   F+G + +  L  I++     T
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Query: 230 ELHFP------PDAKILSADCKDLCQKLLRRNPVERLTF-EEFFNHPFLSQTQPDQVFRS 282
           E           D K      KDL +   +  P + + F  +F  +  L +  P +    
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351

Query: 283 RMFSRSAD 290
             F    D
Sbjct: 352 PFFDDLRD 359

Length = 440

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 63/242 (26%), Positives = 116/242 (47%), Gaps = 27/242 (11%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHGTE-----VAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           ++ R++G G+F  V+ A       E     VA+K +     N +  +    E  +L  + 
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQ 65

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------GCVPEETAK----HF 116
           H HI++ + +      L ++ EY K GDL+ +++ H         G  P E  +    H 
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS 176
            +Q+AAG+  L   + +HRDL  +N   C   +N  +KI DFG +R +           +
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRN---CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 177 PL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH 232
            L   +M PE +  +K+  ++D+WS+G +L+++ T GK P+   +  ++++ I +   L 
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242

Query: 233 FP 234
            P
Sbjct: 243 RP 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 62/250 (24%), Positives = 121/250 (48%), Gaps = 18/250 (7%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H ++++L  +
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 80  I-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  NN +HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           L  +N+L+   +DN A K++DFG  +  +     +T      + APE ++ +K+  K+D+
Sbjct: 128 LAARNVLV--SEDNVA-KVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 197 WSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
           WS G +L+++ + G+ P+       ++  + K  ++  P     +  D    C  L   +
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL---D 239

Query: 256 PVERLTFEEF 265
              R +F + 
Sbjct: 240 AATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 61/312 (19%)

Query: 9   RVVGD--YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
            VV    Y V + +  GS   V+ A        V +K   +G+    L E+++     L+
Sbjct: 61  EVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLK---IGQKGTTLIEAML-----LQ 112

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQ 125
            +NHP +IR+ D +       ++L +    DL  Y+ +R   +P + A    KQ+  GL+
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR--SLQPRGLAETLCGSPLYMAPE 183
            L    +IHRD+K +N+ +   +D   + I D G A+   + P  L   L G+    APE
Sbjct: 172 YLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNAPE 226

Query: 184 IMQLQKYDAKADLWSVGAILFQLV-----------TGKTPFTGSNQIQLLQNIVKATELH 232
           ++   KY++KAD+WS G +LF+++           +    +  S    LL+ I+   ++H
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK-IISTLKVH 285

Query: 233 ---FP--PDAKI-------------------------LSADCKDLCQKLLRRNPVERLTF 262
              FP  P +++                         L  D + L  K+L  +   R + 
Sbjct: 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345

Query: 263 EEFFNHPFLSQT 274
           EE  N+P  +Q 
Sbjct: 346 EEILNYPMFAQL 357

Length = 357

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 76/240 (31%), Positives = 118/240 (49%), Gaps = 37/240 (15%)

Query: 7   RGRVVGDYLV-GRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQE 56
           R  V  D LV G+ +G G F  V  A          +RV  T+VA+K +      K L +
Sbjct: 12  RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRV--TKVAVKMLKSDATEKDLSD 69

Query: 57  SLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------- 105
            L+SE+ ++K I  H +II L       G L++I+EY   G+L  Y++            
Sbjct: 70  -LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 106 -GCVPEE--TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG 159
              VPEE  + K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFG 185

Query: 160 FARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG 215
            AR +      +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 32/197 (16%)

Query: 51  NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRH---- 105
            K  +   + EI I+ R+ +P+IIRL  +      L +I EY + GDL+ ++ QR     
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 106 -------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF 158
                    V      +   Q+A+G++ L   N +HRDL  +N L+    ++  +KIADF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADF 173

Query: 159 GFARSL--------QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT- 208
           G +R+L        Q R +       P+ +MA E + L K+   +D+W+ G  L+++ T 
Sbjct: 174 GMSRNLYSGDYYRIQGRAVL------PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227

Query: 209 -GKTPFTGSNQIQLLQN 224
             + P++  +  Q+++N
Sbjct: 228 CKEQPYSLLSDEQVIEN 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 84.7 bits (209), Expect = 8e-18
 Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 51/295 (17%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRINHPH 72
             +GSG++  V  A       +VA+K     +L++  Q  + +     E+ +LK + H +
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVK-----KLSRPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 73  IIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +I L D+      IE   +++L+     G DL+  ++    + +E  +  + QL  GL+ 
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNL-MGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKY 133

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           +    +IHRDLKP N+ +   +++  L+I DFG AR  Q          +  Y APEIM 
Sbjct: 134 IHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIML 188

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD-- 243
               Y+   D+WSVG I+ +L+ GK  F G++ I  L+ I++      P   K +S++  
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248

Query: 244 -------------------------CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                                      DL +K+L  +  +R++  E   HP+ SQ
Sbjct: 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 14/225 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHIIR 75
           +GSG+F  V+       G  V +  +A+  LN+    K     M E  I+  ++HPH++R
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  +   P  + L+ +    G L  Y+  H   +  +   ++  Q+A G+  L +  L+H
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N+L+ + +    +KI DFG AR L+         G  +   +MA E +  +K+ 
Sbjct: 133 RDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
            ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 30/226 (13%)

Query: 19  QIGSGSFSVVWHAR-----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           ++G G+F  V+         R+  T VA+K +       K+Q+    E  ++  + HP+I
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH--------GCVPEETAK--------HFM 117
           + L  +        ++ EY   GDL  ++ R+            E            H  
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
            Q+AAG++ L  ++ +HRDL  +N L+    +   +KI+DFG +R +           S 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 178 L---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQ 218
           L   +M PE +   K+  ++D+WS G +L+++ + G  P+ G SNQ
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 63/278 (22%), Positives = 125/278 (44%), Gaps = 36/278 (12%)

Query: 13  DYLVGRQIGSGSFSVVW-----HARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++  ++G G+F  V+     +         VA+K  A+   ++  ++    E  +L  
Sbjct: 6   DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTV 63

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-------------CVPEETAK 114
           + H HI+R + +      L ++ EY + GDL+ +++ HG                    +
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RG 168
                 Q+A+G+  L   + +HRDL  +N   C       +KI DFG +R +      R 
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRN---CLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 169 LAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIV 226
              T+   P+ +M PE +  +K+  ++D+WS G +L+++ T GK P+   +  + ++ I 
Sbjct: 181 GGRTML--PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238

Query: 227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +  EL  P   +    +   + Q   +R P +R+  ++
Sbjct: 239 QGRELERP---RTCPPEVYAIMQGCWQREPQQRMVIKD 273

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 58/288 (20%)

Query: 18  RQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGR--LNKKLQESLMSEIFILKRINHPHI 73
           R IG G+F  V+ AR    +      M  + M +   +  +Q     E  ++   +HP+I
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH------------------ 115
           ++L  +  V   + L+ EY   GDL+ +++      + +  H                  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 116 ----FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
                 KQ+AAG+  L +   +HRDL  +N   C   +N  +KIADFG +R++     A+
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRN---CLVGENMVVKIADFGLSRNIY---SAD 184

Query: 172 TLCGS-----PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
               S     P+ +M PE +   +Y  ++D+W+ G +L+++ + G  P+ G    +++  
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244

Query: 225 IVKATELHFPPDAKILSADCKDLCQ----KLLR----RNPVERLTFEE 264
           +          D  +LS  C D C      L+R    + P +R +F  
Sbjct: 245 V---------RDGNVLS--CPDNCPLELYNLMRLCWSKLPSDRPSFAS 281

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 22/215 (10%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHPHIIR 75
           G ++G G++  V+ A+ +    E   KE A+ ++    +  S   EI +L+ + HP++I 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 76  LHDII--EVPGKLHLILEYCKGGDLSMYIQRHGC---------VPEETAKHFMKQLAAGL 124
           L  +       K+ L+ +Y +  DL   I+ H           +P    K  + Q+  G+
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFAR----SLQPRGLAETLCGSPLY 179
             L  N ++HRDLKP N+L+  +  +   +KIAD GFAR     L+P    + +  +  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 180 MAPEIMQLQKYDAKA-DLWSVGAILFQLVTGKTPF 213
            APE++   ++  KA D+W++G I  +L+T +  F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 18  RQIGSGSFSVVWHARHRVH----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +       G  VA+K +      ++       EI ILK + H +I
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENI 68

Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++        G   L LI+EY   G L  Y+ +H  +       F +Q+  G+  L   +
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQH 127

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHRDL  +N+LL   D++  +KI DFG A+++ P G     + E       + A E ++
Sbjct: 128 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 187 LQKYDAKADLWSVGAILFQLVT 208
             K+   +D+WS G  L++L+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 75/283 (26%), Positives = 131/283 (46%), Gaps = 43/283 (15%)

Query: 15  LVGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           ++G+ +G G F  V  A               VA+K +     +K L + L+SE+ ++K 
Sbjct: 15  VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEMELMKL 73

Query: 68  IN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TA 113
           I  H +II L  +    G L++I+EY   G+L  +++               VPEE  + 
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 114 KHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA 170
           K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +      
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN---VMKIADFGLARGVHDIDYY 190

Query: 171 ETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIV 226
           +      L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + 
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Query: 227 KATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEEF 265
           +   +  P        +C      L+R      P +R TF++ 
Sbjct: 251 EGHRMDKPS-------NCTHELYMLMRECWHAVPTQRPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 61/269 (22%), Positives = 129/269 (47%), Gaps = 28/269 (10%)

Query: 18  RQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           R +G+G F  +     ++       VA+  +  G  +K+ +   ++E   L + +H +I+
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIV 69

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           RL  +I     + ++ EY   G L  ++++H G +        +  LA+G++ L +   +
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG-SP-LYMAPEIMQLQKYD 191
           H+ L    +L+   + +   KI+ F   +  +   +  T+ G SP L+ APE +Q   + 
Sbjct: 130 HKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF--PPDAKILSADCKDLC 248
           + +D+WS G +++++++ G+ P+   +     Q+++KA E  F  P        +C +L 
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKAVEDGFRLPA-----PRNCPNLL 237

Query: 249 QKLL----RRNPVERLTFEEFFNHPFLSQ 273
            +L+    ++   ER  F +   H  LS+
Sbjct: 238 HQLMLDCWQKERGERPRFSQI--HSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 47/303 (15%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
             L+G+        +V  A+H+   T VA+K+I +   +K+  + L  EI   +++ HP+
Sbjct: 3   LTLIGK--CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHFMKQLAAGLQVLRDN 130
           I+       V  +L+++      G     ++ H     PE      +K +   L  +   
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLY-------MAP 182
             IHR +K  ++LL    D     ++   ++ S+   G     +   P         ++P
Sbjct: 121 GFIHRSVKASHILL--SGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 183 EIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFT-------------GSNQIQLLQNIVK 227
           E++Q  LQ Y+ K+D++SVG    +L  G  PF              G+    L ++   
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237

Query: 228 ATELHFPPDA-----------------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
             E                        +  S       +  L+R+P  R +  +  NH F
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297

Query: 271 LSQ 273
             Q
Sbjct: 298 FKQ 300

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 32/228 (14%)

Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 77

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VP+E  T K
Sbjct: 78  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    Q+A G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYK 194

Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG 215
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 23/238 (9%)

Query: 17  GRQIGSGSFSVVWHARHR-VHGTEVAMKEIAMGRL----NKKLQESLMSEIFILKRINHP 71
            R +G G+F  V+   +R   G  V + ++A+  L    +++ +   + E  I+ + NH 
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL-------AAGL 124
           +I+RL  +        ++LE   GGDL  +++ +   PE  +   MK L       A G 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-----SLQPRGLAETLCGSPL- 178
           + L +N+ IHRD+  +N LL         KIADFG AR     S   +G    L   P+ 
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML---PIK 186

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           +M PE      + +K D+WS G +L+++ + G  P+ G    ++++ +     L  P 
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 44/278 (15%)

Query: 18  RQIGSGSFSVVWH--ARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           R++G GSF +V+   A+  V     T VA+K +      ++  E  ++E  ++K  N  H
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 70

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQLAA 122
           ++RL  ++       +I+E    GDL  Y++             P    K      ++A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--------RGLAETLC 174
           G+  L  N  +HRDL  +N ++  D     +KI DFG  R +          +GL     
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186

Query: 175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF 233
               +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  
Sbjct: 187 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242

Query: 234 PPDAKILSADCKDLCQKLLRR----NPVERLTFEEFFN 267
           P        +C D+  +L+R     NP  R +F E  +
Sbjct: 243 PD-------NCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 20  IGSGSFSVVWHARHR-------VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +G G+F+ ++    R       +H TEV +K   + + ++   ES      ++ +++H H
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++  + +     +  ++ EY K G L  Y+++    +         KQLA  L  L D  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 132 LIHRDLKPQNLLLCTDDDNAA-----LKIADFGFARSLQPRGLAETLCGSPLYMAPE-IM 185
           L H ++  +N+LL  ++D        +K++D G + ++ P+   E L     ++ PE I 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIE 177

Query: 186 QLQKYDAKADLWSVGAILFQLVTG 209
             Q     AD WS G  L+++ +G
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 39/204 (19%)

Query: 51  NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----- 105
           NK  +   + E+ IL R+  P+IIRL  +      L +I EY + GDL+ ++  H     
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 106 -----------GCVPEETAK---HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA 151
                       C+P  +     H   Q+A+G++ L   N +HRDL  +N   C   +N 
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN---CLVGENL 175

Query: 152 ALKIADFGFARSL--------QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAI 202
            +KIADFG +R+L        Q R +       P+ +MA E + + K+   +D+W+ G  
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWECILMGKFTTASDVWAFGVT 229

Query: 203 LFQL--VTGKTPFTGSNQIQLLQN 224
           L+++  +  + P+      Q+++N
Sbjct: 230 LWEILMLCKEQPYGELTDEQVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 56/269 (20%), Positives = 111/269 (41%), Gaps = 34/269 (12%)

Query: 18  RQIGSGSFSVVWHARHRVHGTE-----VAMKEIAMGRLNKKLQ--ESLMSEIFILKRINH 70
             +G G+F+ ++    RV              + +  L    +   +      ++ +++H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRD 129
            H+++L+ +      + ++ EY K G L +++ R    V         KQLA+ L  L D
Sbjct: 61  KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 130 NNLIHRDLKPQNLLLCTDDDNAA----LKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
             L+H ++  +N+L+     N      +K++D G   ++  R   E +   P ++APE +
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR--EERVERIP-WIAPECI 176

Query: 186 Q--LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           +         AD WS G  L ++ + G+ P         L  +  + +  F  D   L  
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEP---------LSTLSSSEKERFYQDQHRLPM 227

Query: 243 -DCKDLCQKLLRR----NPVERLTFEEFF 266
            DC +L   L+ +    +P +R +F    
Sbjct: 228 PDCAELA-NLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 73/304 (24%), Positives = 130/304 (42%), Gaps = 21/304 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +    VA+KE+      K  +E ++ E +++  +++PH+
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 71

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK---QLAAGLQVLRDN 130
            RL  I  +   + LI +    G L  Y++ H       +++ +    Q+A G+  L + 
Sbjct: 72  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQL 187
            L+HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  
Sbjct: 129 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           + Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYM 242

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAES 306
           +  K    +   R  F E           P +    +   R     P   +     + E 
Sbjct: 243 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 302

Query: 307 SQDD 310
             DD
Sbjct: 303 DMDD 306

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 80/322 (24%), Positives = 138/322 (42%), Gaps = 77/322 (23%)

Query: 17  GRQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           G ++G G++  V+ A+ +      + A+K+I        +  S   EI +L+ + HP++I
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVI 61

Query: 75  RLHDII--EVPGKLHLILEYCKGGDLSMYIQRHGC---------VPEETAKHFMKQLAAG 123
            L  +       K+ L+ +Y +  DL   I+ H           +P    K  + Q+  G
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFAR----SLQPRGLAETLCGSPL 178
           +  L  N ++HRDLKP N+L+  +  +   +KIAD GFAR     L+P    + +  +  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 179 YMAPEIMQLQKYDAKA-DLWSVGAILFQLVTGKTPF-------TGSN-----QIQLLQNI 225
           Y APE++   ++  KA D+W++G I  +L+T +  F         SN     Q+  + N+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 226 -----------------------------------VKATELH-FPPDAKILSADCKDLCQ 249
                                              +K  E H   PD+K        L Q
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH-----LLQ 295

Query: 250 KLLRRNPVERLTFEEFFNHPFL 271
           KLL  +P++R+T E+    P+ 
Sbjct: 296 KLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 32/228 (14%)

Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +     +K L + L+SE+ ++K I
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMI 74

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----------GC-VPEE--TAK 114
             H +II L       G L++++EY   G+L  Y++             C +PEE  T K
Sbjct: 75  GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    Q+A G++ L     IHRDL  +N+L+ T+D+   +KIADFG AR +      +
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLV-TEDN--VMKIADFGLARDVHNIDYYK 191

Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG 215
                 L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)

Query: 18  RQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V   R+   G     +VA+K +        + + L  EI IL+ + H +I
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENI 68

Query: 74  IRLHDIIEVPG--KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   I    G   + LI+E+   G L  Y+ R+   +  +    +  Q+  G+  L   
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL---CGSPLY-MAPEIMQ 186
             +HRDL  +N+L+   +    +KI DFG  ++++      T+     SP++  APE + 
Sbjct: 129 QYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 187 LQKYDAKADLWSVGAILFQLVT----GKTPFT------GSNQIQL-LQNIVKATE----L 231
             K+   +D+WS G  L++L+T      +P T      G    Q+ +  +V+  E    L
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 232 HFPPDAKILSADCKDLCQKLLRR----NPVERLTFEEF 265
             PP       +C +   +L+R+     P +R TF+  
Sbjct: 246 PRPP-------NCPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 26/194 (13%)

Query: 54  LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI---QRHGCV-- 108
           L+E    E  +  R+ HP+I+ L  ++     L +I  YC   DL  ++     H  V  
Sbjct: 51  LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110

Query: 109 --PEETAK---------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD 157
              ++T K         H + Q+AAG++ L  ++++H+DL  +N+L+    D   +KI+D
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISD 167

Query: 158 FGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
            G  R +      + +  S L   +M+PE +   K+   +D+WS G +L+++ + G  P+
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Query: 214 TG-SNQ--IQLLQN 224
            G SNQ  I++++N
Sbjct: 228 CGYSNQDVIEMIRN 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 66/268 (24%), Positives = 125/268 (46%), Gaps = 33/268 (12%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS----EIFILKRINHPHII 74
            +G G F  V+ A+ +    E     + +  L K   E+L S    E+ + ++++H +++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQ------RHGCVPEETAKHFMK---QLAAGLQ 125
           RL  +       ++ILEY   GDL  +++           P  + K  +    Q+A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMA 181
            L +   +HRDL  +N L+ +  +   +K++    ++ +       L   L   PL ++A
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALI--PLRWLA 186

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           PE +Q   +  K+D+WS G +++++ T G+ PF G +  ++L  + +A +L  P      
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL-QAGKLELPVPEG-- 243

Query: 241 SADCKDLCQKLLRR----NPVERLTFEE 264
              C     KL+ R    NP +R +F E
Sbjct: 244 ---CPSRLYKLMTRCWAVNPKDRPSFSE 268

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 27/193 (13%)

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
            EI ILK I+H  II L         + +++   K  DL  Y+ R G +P E A    ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-------QPRGLAET 172
           L   L  L    +IHRD+K +N+ L  + +NA L   DFG A  L       Q  G + T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFL-DEPENAVL--GDFGAACKLDAHPDTPQCYGWSGT 250

Query: 173 LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG------SNQIQLLQNIV 226
           L  +    +PE++ L  Y AK D+WS G +LF++        G      S+Q   L++I+
Sbjct: 251 LETN----SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ---LRSII 303

Query: 227 KATELH---FPPD 236
           +  ++H   FP +
Sbjct: 304 RCMQVHPLEFPQN 316

Length = 392

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 27/176 (15%)

Query: 54  LQESLMSEIFILKRINHPHIIR-LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEET 112
           LQES +     L  ++H +I+  LH  IE      ++  Y   G+L +++Q+        
Sbjct: 56  LQESCL-----LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN 110

Query: 113 AK--------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
            +        H   Q+A G+  L    +IH+D+  +N   C  D+   +KI D   +R L
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARN---CVIDEELQVKITDNALSRDL 167

Query: 165 QPRGLAETLC-----GSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
            P    +  C       P+ +MA E +  ++Y + +D+WS G +L++L+T G+TP+
Sbjct: 168 FP---MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 24/236 (10%)

Query: 18  RQIGSGSFSVVW--HARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
            +IG+G F  V    A   +    V +KE+         Q   + E+   + +NHP++++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELR-ASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 76  -LHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLA----AGLQVLRD 129
            L   IE    L L+LE+C  GDL  Y++   G V +   K  ++++A    +GL  L  
Sbjct: 60  CLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPL-YMAPEIMQ 186
            + IH DL  +N  L  D    ++KI D+G A    P     T      PL ++APE+++
Sbjct: 119 ADFIHSDLALRNCQLTAD---LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 187 LQKYD-------AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           ++  D        K+++WS+G  +++L T    P+   +  Q+L+ +V+  ++  P
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 68/276 (24%), Positives = 127/276 (46%), Gaps = 40/276 (14%)

Query: 18  RQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+   AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 69

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--------RGLAETL 173
            G+  L     +HRDL  +N   C    +  +KI DFG  R +          +GL    
Sbjct: 130 DGMAYLNAKKFVHRDLAARN---CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL--- 183

Query: 174 CGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL 231
              P+ +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L
Sbjct: 184 ---PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240

Query: 232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN 267
             P +         DL +   + NP  R TF E  N
Sbjct: 241 DQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 54/209 (25%), Positives = 107/209 (51%), Gaps = 16/209 (7%)

Query: 17  GRQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +GSG F  V    W          VA+K I   R  ++  + +   +  +  ++H +
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 73  IIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
           I+RL  I   PG  L L+ +    G L  ++++H   +  +   ++  Q+A G+  L ++
Sbjct: 71  IVRLLGI--CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--RGLAETLCGSPL-YMAPEIMQL 187
            ++HR+L  +N+LL +D   + ++IADFG A  L P  +    +   +P+ +MA E +  
Sbjct: 129 RMVHRNLAARNILLKSD---SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTG 215
            +Y  ++D+WS G  ++++++ G  P+ G
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 30/208 (14%)

Query: 19  QIGSGSFSVVWHARHRV----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           Q+G G+F  V   R+       G  VA+K++       +       EI ILK + H +I+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIV 68

Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +   +    G+  L L++EY   G L  Y+Q+H   +       +  Q+  G++ L    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLY-M 180
            +HRDL  +N+L+   +    +KI DFG  + L          +P    E    SP++  
Sbjct: 129 YVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREP---GE----SPIFWY 178

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT 208
           APE +   K+   +D+WS G +L++L T
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 36/203 (17%)

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMY-IQRH-----GCVPEE--T 112
           E  ++  ++HP+I+ L  ++     + ++ EY   GDL  + I R      GC  +E  T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 113 AK---------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS 163
            K         H   Q+AAG++ L  +  +H+DL  +N+L+    +   +KI+D G +R 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSRE 173

Query: 164 L--------QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
           +        QP+ L       P+ +M PE +   K+ + +D+WS G +L+++ + G  P+
Sbjct: 174 IYSADYYRVQPKSLL------PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 214 TGSNQIQLLQNIVKATELHFPPD 236
            G +  ++++ + K   L    D
Sbjct: 228 YGFSNQEVIEMVRKRQLLPCSED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 57/230 (24%), Positives = 110/230 (47%), Gaps = 12/230 (5%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMK-EIAMGRLNK--KLQESLMSEIFILKRINHPHII 74
           + +GSG+F  V+       G  V +   I + R N   K  + ++ E +++  +  P++ 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           RL  I  +   + L+ +    G L  Y++ +   +  +   ++  Q+A G+  L +  L+
Sbjct: 73  RLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKY 190
           HRDL  +N+L+ + +    +KI DFG AR L          G  +   +MA E +  +++
Sbjct: 132 HRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
             ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 41/153 (26%), Positives = 80/153 (52%), Gaps = 8/153 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRIN 69
           ++++ + I  G+F  V+  R + +    A   +K+  M  +NK +   + +E   L    
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSK 62

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
            P I+ L+  ++    ++L++EY  GGD+   +  +G   EE A  ++ ++A  L  L  
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR 162
           + +IHRDLKP N+L+    +   +K+ DFG ++
Sbjct: 123 HGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 13/153 (8%)

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAETLCGS 176
           Q+A G++ L     IHRDL  +N+LL    +N  +KI DFG AR +   P  + +     
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 177 PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI--QLLQNIVKATELH 232
           PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G  QI  +  Q +   T + 
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV-QINEEFCQRLKDGTRMR 297

Query: 233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEF 265
            P +A   + +   +     + +P ER TF   
Sbjct: 298 APENA---TPEIYRIMLACWQGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 19/159 (11%)

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAETLCGS 176
           Q+A G++ L     IHRDL  +N+LL    +N  +KI DFG AR +   P  + +     
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 177 PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKATELHF 233
           PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + T +  
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297

Query: 234 PPDA--KILSA--DCKDLCQKLLRRNPVERLTFEEFFNH 268
           P  A  +I S   DC          NP +R TF E    
Sbjct: 298 PEYATPEIYSIMLDC-------WHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 32/230 (13%)

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           +E  IL+ INHP II+L           LIL   K  DL  Y+     +         + 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS 190

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLL------CTDDDNAALKIADFGFARSLQPRGLAETL 173
           +   +Q L +N +IHRD+K +N+ +      C  D  AA    D    +     G A T+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY---GWAGTI 247

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF----------TGSNQIQLLQ 223
             +    APE++    Y    D+WS G +LF++ T                   QI+L  
Sbjct: 248 ATN----APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-- 301

Query: 224 NIVKATELH---FPPDAK-ILSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
            I++ +  H   FP DA+  L      L +K  R+ P  R  +   +  P
Sbjct: 302 -IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRK-PGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 19/159 (11%)

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAETLCGS 176
           Q+A G++ L     IHRDL  +N+LL    +N  +KI DFG AR +   P  + +     
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 177 PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKATELHF 233
           PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + T +  
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 234 P----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           P    P+      DC           P +R TF E   H
Sbjct: 304 PDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 9/103 (8%)

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
           F  Q+A G++ L   N +HRDL  +N+L+C   +   +KI DFG AR +  R       G
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIM-RDSNYISKG 299

Query: 176 S---PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
           S   PL +MAPE +    Y   +D+WS G +L+++ T G TP+
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 27/163 (16%)

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP------RG 168
            F  Q+A G+  L   N IHRD+  +N+LL    D    KI DFG AR +        +G
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 169 LAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIV 226
            A      P+ +MAPE +    Y  ++D+WS G +L+++ + GK+P+ G         +V
Sbjct: 273 NARL----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 227 K-----ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           K     +     PP+   +   C +L        P ER TF +
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNL-------EPTERPTFSQ 364

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 11/167 (6%)

Query: 49  RLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV 108
           +   +    L +EI  L R+NH +I+++ +I+      ++I +     DL  ++      
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFD 259

Query: 109 PEET-----AKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS 163
            ++       +  MKQL   ++ + D  LIHRD+K +N+ L  D     + + DFG A  
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD---GKIVLGDFGTAMP 316

Query: 164 LQ-PRGLAE-TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            +  R   +    G+    +PEI+    Y    D+WS G IL  +++
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 32/202 (15%)

Query: 57  SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG---CVPEETA 113
           S + E  +L+R++HP ++ L D+  V G   L+L   +  DL  Y+        + + TA
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTA 264

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG---FAR----SLQP 166
               +QL + +  +    +IHRD+K +N+L+   +D   + + DFG   FAR    +   
Sbjct: 265 --VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTPFH 319

Query: 167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQ--------LVTGKTPFTGSNQ 218
            G+A T+  +    APE++    Y    D+WS G ++F+            +        
Sbjct: 320 YGIAGTVDTN----APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375

Query: 219 IQLLQNIVKATELH---FPPDA 237
            Q+L+ I++  ++H   FP  A
Sbjct: 376 AQILR-IIRQAQVHVDEFPQHA 396

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 1/102 (0%)

Query: 171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE 230
           E + G+P Y+APE++  + +    D W++G  LF+ +TG  PF      Q+ QNI+   +
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN-RD 596

Query: 231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           + +P   + LS + ++  + LL  +P +R   +E   HP   
Sbjct: 597 IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFH 638

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 9/151 (5%)

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
           F  Q+A G++ L   N +HRDL  +N+LL        +KI DFG AR +       +   
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSKGS 298

Query: 176 SPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL 231
           + L   +MAPE +    Y   +D+WS G +L+++ + G TP+ G        N +K+   
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 232 HFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
              PD    + +  D+  K     P +R +F
Sbjct: 359 MAKPDHA--TQEVYDIMVKCWNSEPEKRPSF 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 55/248 (22%), Positives = 107/248 (43%), Gaps = 40/248 (16%)

Query: 19  QIGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           +IG G  + + V+ ARH   GT V ++   +    ++  ++L +E+ +     HP+I+  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL----AAGLQVLRDNNL 132
             +      L +I  +   G  +  ++ +   PE  ++  +  +      GL  L  N  
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNGY 122

Query: 133 IHRDLKPQNLLLCTD----------------DDNAALKIADF-GFARSLQPRGLAETLCG 175
           IHR++K  ++L+  D                +   A  + DF  F+ S+ P         
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP--------- 173

Query: 176 SPLYMAPEIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
              +++PE+++  L  Y+ K+D++SVG    +L TG+ PF    + Q+L   +K    + 
Sbjct: 174 ---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPP-YS 229

Query: 234 PPDAKILS 241
           P D     
Sbjct: 230 PLDITTFP 237

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 29/248 (11%)

Query: 18  RQIGSGSFSVVW--HARHRVHGTEVAMKEIAMGRLNKKLQESL--MSEIFILKRINHPHI 73
           ++IG+G F  V            +V +KE+   R++  +QE +  + E    + + H ++
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKEL---RVSASVQEQMKFLEEAQPYRSLQHSNL 57

Query: 74  IR-LHDIIEVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMK-QLAAGLQVL 127
           ++ L    EV   L L++E+C  GDL  Y++         P+ T    M  ++A GL  L
Sbjct: 58  LQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEI 184
             NN IH DL  +N LL  D     +KI D+G + +          + L     ++APE+
Sbjct: 117 HKNNFIHSDLALRNCLLTAD---LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 185 MQ-------LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP-P 235
           +        +     ++++WS+G  +++L   G  P+   +  Q+L   V+  +L  P P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233

Query: 236 DAKILSAD 243
             K+  +D
Sbjct: 234 RLKLPLSD 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 15/108 (13%)

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP------RGL 169
           F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++       +G 
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 170 AETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG 215
           A      P+ +MAPE +    Y  ++D+WS G +L+++ + G +P+ G
Sbjct: 276 ARL----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 48/210 (22%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--MKQLA 121
           ++++++H HI+ L+ +     +  ++ E+ + G L +++ R       T   F   KQLA
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLA 115

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTD----DDNAALKIADFGFARSLQPRGLAETLCGSP 177
           + L  L D +L+H ++  +N+LL  +    +    +K++D G   ++  R   E +   P
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERIP 173

Query: 178 LYMAPEIMQLQK-YDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKATELHFPP 235
            ++APE ++  K     AD WS G  L+++   G+ P       +         E  +  
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFYEG 224

Query: 236 DAKILSADCK---DLCQKLLRRNPVERLTF 262
              +++  CK   DL    +  +P +R  F
Sbjct: 225 QCMLVTPSCKELADLMTHCMNYDPNQRPFF 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 52/238 (21%), Positives = 107/238 (44%), Gaps = 29/238 (12%)

Query: 18  RQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           ++IG+G F  V  +          V +KE+     + K Q   + +    + + HP+I++
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 76  -LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK----QLAAGLQVLRDN 130
            L   +E    L L+ EYC+ GDL  Y+ +       +    ++    ++AAG+  +  +
Sbjct: 60  CLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET---LCGSPLYMAPEIM-- 185
           N +H DL  +N  L +D     +K+ D+G   S       ET    C    ++APE++  
Sbjct: 119 NFLHSDLALRNCFLTSD---LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 186 --------QLQKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKATELHFP 234
                   +  K    +++W++G  L++L      P++  +  ++L +++K  ++   
Sbjct: 176 FHGGLITAEQTKP---SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 27/201 (13%)

Query: 52  KKLQESLMSEIFILKRINHPHIIRLH----DIIEVPGKLHLILEYCKGGDLSMYIQRHGC 107
           K L +   +EI  L+RI+  +I++++    DI++   +L LILEYC  G L   + +   
Sbjct: 59  KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD 118

Query: 108 VPEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP 166
           +  +T          GL  L +  N  +++L   + L+    +N  LKI           
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKII---------C 166

Query: 167 RGLAETLCGSP-------LYMAPEIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSN 217
            GL + L   P       +Y + +++     +Y  K D++S+G +L+++ TGK PF    
Sbjct: 167 HGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226

Query: 218 QIQLLQNIVKAT-ELHFPPDA 237
             ++   I+     L  P D 
Sbjct: 227 TKEIYDLIINKNNSLKLPLDC 247

Length = 283

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.0 bits (114), Expect = 7e-06
 Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 63/314 (20%)

Query: 20  IGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           IG G      V  AR++  G  V ++ I +     ++   L  E+ + K  NHP+I+   
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
                  +L ++  +   G     I  H    + E    + ++ +   L  +     +HR
Sbjct: 66  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125

Query: 136 DLKPQNLLLCTDDDN--AALKIADFGFARSLQ--------PRGLAETLCGSPLYMAPEIM 185
            +K  ++L+  D     + L+ ++       Q        P+   + L   P +++PE++
Sbjct: 126 SVKASHILISVDGKVYLSGLR-SNLSMINHGQRLRVVHDFPKYSVKVL---P-WLSPEVL 180

Query: 186 Q--LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL-------------QNIVKATE 230
           Q  LQ YDAK+D++SVG    +L  G  PF      Q+L                + A E
Sbjct: 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240

Query: 231 LHFPPDA-----------------------------KILSADCKDLCQKLLRRNPVERLT 261
           L   P                               +  S       ++ L+RNP  R +
Sbjct: 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300

Query: 262 FEEFFNHPFLSQTQ 275
                NH F  Q +
Sbjct: 301 ASTLLNHSFFKQIK 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 57  SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKH 115
           SLMS++      +H H+  +H +     +  ++ E+ + G L + +++  G VP      
Sbjct: 68  SLMSQV------SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLC----TDDDNAALKIADFGFARSLQPRGLAE 171
             +QLA+ L  L D NL+H ++  +N+LL      +  +  +K++D G + +   R   E
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EE 179

Query: 172 TLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKAT 229
            +   P ++APE +         AD WS G  L ++   G+ P         L+    + 
Sbjct: 180 RVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---------LKERTPSE 229

Query: 230 ELHF-PPDAKILSADCKDLC---QKLLRRNPVERLTF 262
           +  F     ++    CK+L     + L   P +R +F
Sbjct: 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSF 266

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 10/101 (9%)

Query: 13  DYLV-GRQIGSGSFSVVWHA-----RHRVHGTEVAMKEI-AMGRLNKKLQESLMSEIFIL 65
           D LV GR +GSG+F  V  A      H     +VA+K + +  R ++K  ++LMSE+ I+
Sbjct: 37  DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK--QALMSELKIM 94

Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH 105
             +  H +I+ L       G +++I EYC+ GDL  Y+ R+
Sbjct: 95  SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRN 135

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 36/164 (21%), Positives = 62/164 (37%), Gaps = 21/164 (12%)

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           Q    L+ L      HR  K  N+LL  D       +   G   + +     E     P 
Sbjct: 25  QCLGALREL------HRQAKSGNILLTWD-----GLLKLDGSV-AFKTP---EQSRPDPY 69

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELHFPPDA 237
           +MAPE++Q Q Y  KAD++S+G  L++ +  + P+    ++  +L+ ++       P D 
Sbjct: 70  FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129

Query: 238 KILSADC-----KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             L         +D  +    R P  R     +  H      + 
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAET 173

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 52/235 (22%), Positives = 100/235 (42%), Gaps = 36/235 (15%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN 69
           +  Y + R IG G    V+ A   V    VA+K+I      N  L++  + E  I   + 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ---RHGCVPEETA-----KHFMK--- 118
           HP I+ ++ I      ++  + Y +G  L   ++   +   + +E A       F+    
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLL------------------CTDDDNAALKIADFG- 159
           ++ A ++ +    ++HRDLKP N+LL                    ++D   + + +   
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 160 -FARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF 213
            ++    P      + G+P YMAPE +         D++++G IL+Q++T   P+
Sbjct: 181 CYSSMTIP----GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 31/165 (18%)

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           SEI  + ++ HP+I++L  +       +LI EY +G +LS  ++    +  E  +     
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIG 788

Query: 120 LAAGLQVLRDN---NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR---GLAETL 173
           +A  L+ L       ++  +L P+ +++   D                +P     L   L
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD----------------EPHLRLSLPGLL 832

Query: 174 C------GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP 212
           C       S  Y+APE  + +    K+D++  G IL +L+TGK+P
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 34/119 (28%)

Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLA 170
           M+Q+   L  L    ++HRD+KPQN++    + + + KI D G A  L       P+   
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGSFKIIDLGAAADLRVGINYIPK--- 315

Query: 171 ETLCGSPLYMAPE--IMQLQKYDAKA--------------------DLWSVGAILFQLV 207
           E L   P Y APE  IM  Q   A +                    D++S G I  Q+ 
Sbjct: 316 EFLL-DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 7/101 (6%)

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
           K  M+Q+  GL+ L    ++HRD+KP+NLL+  D     +KI DFG A  +        L
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGINFNPL 368

Query: 174 CG--SPLYMAPEIMQLQKYDAKADLWSVGAIL--FQLVTGK 210
            G   P Y  PE + + +   +A   ++ A+L  F  + G+
Sbjct: 369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGR 409

Length = 507

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 16/124 (12%)

Query: 101 YIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDD----------- 148
           +I +HG          + Q    L       +L+H DLKP+N+L+ T D           
Sbjct: 221 WIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280

Query: 149 --DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQL 206
             D   ++I D G       R     +  +  Y +PE++    +    D+WS+G I+++L
Sbjct: 281 PPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338

Query: 207 VTGK 210
            TGK
Sbjct: 339 YTGK 342

Length = 467

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 16  VGRQIGSGSFSVVWHAR----HRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFILKRI-N 69
           +G+ +G G+F  V  A      +      VA+K +  G    +  ++LMSE+ IL  I N
Sbjct: 11  LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-HKALMSELKILIHIGN 69

Query: 70  HPHIIRLHDIIEVP-GKLHLILEYCKGGDLSMYI--QRHGCVP 109
           H +++ L      P G L +I+E+CK G+LS ++  +R    P
Sbjct: 70  HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 7/88 (7%)

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           ++    E  G  +L++E+ +G  L    +      E+ A+   + LA  L  L    L H
Sbjct: 57  KVLASGESDGWSYLLMEWIEGETLD---EVSEEEKEDIAEQLAELLAK-LHQLPLLVLCH 112

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR 162
            DL P N+L+   DD   L I D+ +A 
Sbjct: 113 GDLHPGNILV---DDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	575
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
smart00090	237	RIO RIO-like kinase.	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.28
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.61
PRK09902	216	hypothetical protein; Provisional	98.37
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.29
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.15
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.93
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.89
PLN02876	822	acyl-CoA dehydrogenase	97.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.73
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.52
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.26
PRK05231	319	homoserine kinase; Provisional	97.25
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.22
KOG2270	520	consensus Serine/threonine protein kinase involved	97.15
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.1
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.07
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.96
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.85
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.84
PRK10593	297	hypothetical protein; Provisional	96.24
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.91
PLN02236	344	choline kinase	95.76
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.74
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.48
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.35
PLN02756	418	S-methyl-5-thioribose kinase	95.22
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.11
PRK12396	409	5-methylribose kinase; Reviewed	95.0
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.82
PRK11768	325	serine/threonine protein kinase; Provisional	93.64
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.28
PRK06148	1013	hypothetical protein; Provisional	92.94
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.71
PTZ00384	383	choline kinase; Provisional	92.03
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.27
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	91.22
PTZ00296	442	choline kinase; Provisional	89.78

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-59  Score=485.53  Aligned_cols=268  Identities=59%  Similarity=0.944  Sum_probs=250.3

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..++.+++|.+.++||+|+||+||+|+++.++..||||.|.+..++.+.++.+..|+.||+.++|||||+++++++.++.
T Consensus         4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            34789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC---CcEEEccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN---AALKIADFGFAR  162 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~---g~vKL~DFGla~  162 (575)
                      +|+|||||.||||.+||++++.++|..++.+++||+.||++||+++||||||||+|||++.....   ..+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999765333   689999999999


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      .+++..+..+.||+|.|||||++..+.|+.|+|+||+|+|||+|++|++||...+..+++..+.++.. ..+.....++.
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-~~~~~~~~~s~  242 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-IVPVLPAELSN  242 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-ccCchhhhccC
Confidence            99999999999999999999999999999999999999999999999999999999999987766643 33434456788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+.+|+..+|..+|..|.++.+.+.|+++...
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            88999999999999999999999999998654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-58  Score=477.95  Aligned_cols=267  Identities=33%  Similarity=0.588  Sum_probs=244.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-----KLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ..-+.|.+.+.||+|+||.|.+|..+.||+.||||++.+.....     .....+.+|++||++|+|||||+++++|+.+
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            35566899999999999999999999999999999998765432     1223467999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +..||||||++||+|++.+-.++.+.|...+.+++||+.||.|||+.||+||||||+|||+..+.....+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999999999999999999999999999999999999999999999999998887889999999999999


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccC---CcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCChhc
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKY---DAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y---~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~~~  239 (575)
                      .+......++||||.|.|||++...++   ..++|||||||+||.+++|.+||.+..... +.++|.++.....|+.+..
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            998899999999999999999986653   347899999999999999999999887666 7888988887777888899


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ++.++++||.+||..||++|||++|+|+||||+...
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-57  Score=463.68  Aligned_cols=271  Identities=34%  Similarity=0.608  Sum_probs=251.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...+|+++++||+|+||.||.++.+.|++.||+|++++..+.. +..+++..|..||..++||+||.++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4678999999999999999999999999999999999876644 456789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~  167 (575)
                      |+||+.||+|+..|++.+.|+|..++.++.+|+.||.|||++|||||||||+|||+   |..|+++|+|||+++.. ...
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   89999999999999854 445


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....++|||+.|||||++.+.+|+..+||||||+++|+|++|.+||.+.+..++.++|.+......|   ..++.++++|
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence            5677899999999999999999999999999999999999999999999999999999887533333   3589999999


Q ss_pred             HHHhhccCCCCCC----CHHHHHcCCCCCCCCchhhhhhcccC
Q 043425          248 CQKLLRRNPVERL----TFEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       248 I~k~L~~DP~~Rp----Ta~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      ++++|.+||.+|.    ++.+|.+||||..++|+.++.....+
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P  299 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP  299 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence            9999999999996    68999999999999999999877655

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-55  Score=471.28  Aligned_cols=260  Identities=35%  Similarity=0.646  Sum_probs=242.6

Q ss_pred             CCeeecC-----EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 043425            7 RGRVVGD-----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDII   80 (575)
Q Consensus         7 ~g~~v~~-----Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~   80 (575)
                      .++++-+     |..++.||+|+|+.||.+++..+|+.||+|++.+..+ +...++.+.+||+|.+.|+|||||+++++|
T Consensus         8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen    8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            4566666     9999999999999999999999999999999998665 456678899999999999999999999999


Q ss_pred             EeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           81 EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        81 ~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ++.+.+|||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|+   +++..|||+||||
T Consensus        88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGL  164 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGL  164 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccce
Confidence            9999999999999999999999999999999999999999999999999999999999999999   7888999999999


Q ss_pred             ccccCCC-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          161 ARSLQPR-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       161 a~~~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      |..+... ....+.||||.|+||||+...+++..+||||+||+||.||+|++||...+-.+.+.+|... .+.+|.   .
T Consensus       165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-~Y~~P~---~  240 (592)
T KOG0575|consen  165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-EYSMPS---H  240 (592)
T ss_pred             eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-Cccccc---c
Confidence            9998754 6778999999999999999999999999999999999999999999999999999888766 556665   6


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ++.++++||.+||++||.+|||++++|.|+||..
T Consensus       241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  241 LSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            8999999999999999999999999999999943

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.5e-55  Score=464.88  Aligned_cols=268  Identities=32%  Similarity=0.554  Sum_probs=244.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+++|+++.+||+||||.||+|+.+.||..||+|++.+..+-. ...++++.|..||....+|+||+||..|++...+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            46889999999999999999999999999999999999877643 44578999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-  166 (575)
                      |||||++|||+.++|.+.+.|+|..++.++.+++.|++.||+.|+|||||||+|+||   |..|++||+||||+..+.. 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999   9999999999999853211 


Q ss_pred             -----------------------------------------------CCCcccccCCCCCCChHHHhhccCCcccccchh
Q 043425          167 -----------------------------------------------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV  199 (575)
Q Consensus       167 -----------------------------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSL  199 (575)
                                                                     ..+....+|||.||||||+.+.+|+..+|||||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                                           012234689999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-CCCCCChhcccHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCC
Q 043425          200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQ  275 (575)
Q Consensus       200 GviLyeLltG~~PF~~~~~~~~l~~i~~~~~-~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~  275 (575)
                      ||||||||.|.+||.+.++.+...+|+.... ..+|.. ..++.+++|||.+||+ ||++|+.   ++||.+||||..++
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            9999999999999999999999999988764 445544 4688999999999999 9999994   99999999999999


Q ss_pred             chhhhh
Q 043425          276 PDQVFR  281 (575)
Q Consensus       276 ~~~~~~  281 (575)
                      |+.+..
T Consensus       453 W~~l~~  458 (550)
T KOG0605|consen  453 WDHLRE  458 (550)
T ss_pred             cchhhc
Confidence            998775

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-54  Score=433.21  Aligned_cols=269  Identities=33%  Similarity=0.634  Sum_probs=252.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      -.+++|++++.||.|+||.|.+++++.+|..||+|++++... ..+..++..+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            578899999999999999999999999999999999998765 3355678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||||++||.|+.++++.++|++..++.++.||+.||+|||.++|++|||||||||+   |.+|++||+|||+|+.+...
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc
Confidence            999999999999999999999999999999999999999999999999999999999   99999999999999987655


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                        ..+.||||.|+|||+++..+|+.++|||+|||++|||+.|.+||...+...+.++|+++ ...+|+   .++.++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-~v~fP~---~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-KVKFPS---YFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-cccCCc---ccCHHHHHH
Confidence              67899999999999999999999999999999999999999999999999999999988 677776   689999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcccC
Q 043425          248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       248 I~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      |+++|++|-.+|.     ...+|.+||||..+.|+.+..++..+
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~  315 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEP  315 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccC
Confidence            9999999999994     67899999999999999988765543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=438.25  Aligned_cols=260  Identities=30%  Similarity=0.559  Sum_probs=240.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-KLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l~L   88 (575)
                      ...+.+.++.||+|+.|+||+++|+.|++.+|+|+|. ...+...+.++.+|++|++.++|||||.+|+.|..++ .++|
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            4457788899999999999999999999999999994 4457788899999999999999999999999999998 5999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||.||+|.+++..-++++|.....++.+|++||.|||+ .+||||||||+|||+   +..|.|||||||.+..+...
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            99999999999999988999999999999999999999996 899999999999999   77899999999999988766


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS-----NQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~-----~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                       .+++++||..|||||.+.++.|+.++||||||++++||++|+.||...     +..+++..|+....+.+|..  .+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cCCH
Confidence             889999999999999999999999999999999999999999999875     67788888888777666665  5899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ++++||..||++||.+|||+.|+++|||+.+...
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            9999999999999999999999999999987544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-53  Score=450.39  Aligned_cols=267  Identities=33%  Similarity=0.604  Sum_probs=246.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      .+...||.+++.||+|+|++|++|+.+.+++.||||++++..+.. +....+..|..+|.+| .||.|++||..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            467889999999999999999999999999999999998876543 3345578899999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+|+||+++|+|.++|++.|.|++..++.++.||+.||+|||++|||||||||+|||+   |.++++||+|||.|+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999   899999999999998765


Q ss_pred             CCC--------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          166 PRG--------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       166 ~~~--------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +..              ...+++||..|++||++.....+..+|||+||||||+|+.|.+||.+.++.-++++|++. .+
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y  304 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DY  304 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cc
Confidence            322              125699999999999999999999999999999999999999999999999999999987 66


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      .||+.   +++.++|||+++|..||.+|+|++||.+||||..++|+.+..
T Consensus       305 ~fp~~---fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~  351 (604)
T KOG0592|consen  305 EFPEG---FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQ  351 (604)
T ss_pred             cCCCC---CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhh
Confidence            77764   779999999999999999999999999999999999998554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=445.02  Aligned_cols=261  Identities=40%  Similarity=0.751  Sum_probs=238.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---KKLQESLMSEIFILKRIN-HPHIIRLHDIIEVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~   83 (575)
                      ....+.|++++.||+|+||.|++|.+..+|+.||+|++++....   ....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            46788999999999999999999999999999999988775332   234567789999999999 99999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC-CcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN-AALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~-g~vKL~DFGla~  162 (575)
                      ..+|+|||||.||+|++++.+.+++.|..++.+|+||+.||+|||++||+||||||+|||+   +.+ +.+||+|||++.
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA  169 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999   666 899999999999


Q ss_pred             cc-CCCCCcccccCCCCCCChHHHhhcc-CC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          163 SL-QPRGLAETLCGSPLYMAPEIMQLQK-YD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       163 ~~-~~~~~~~~~~GT~~Y~APEvl~~~~-y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      .. .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++..|.++ ...+|.... 
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~~~~-  247 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPSYLL-  247 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-CccCCCCcC-
Confidence            88 5777889999999999999999988 86 6799999999999999999999999988888886655 566665422 


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                       +.++++|+.+||..||.+|+|+.+|++||||+..
T Consensus       248 -S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  248 -SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             -CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence             9999999999999999999999999999999863

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-52  Score=450.18  Aligned_cols=260  Identities=41%  Similarity=0.693  Sum_probs=243.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecC-ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-RLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ...+|-|++++.||.|+-|.|.+|+|..||+.+|||+|.+. .+.......+.+|+.||+.+.||||+++|+++++..++
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence            45789999999999999999999999999999999999877 45555567789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+|+||++||.|++++.++|+++|.++.++++||+.|+.|||..+|+||||||+|+|+   |..+.+||+|||+|..-.+
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccC
Confidence            9999999999999999999999999999999999999999999999999999999999   7777799999999998888


Q ss_pred             CCCcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      +.+..+-||+|+|.|||++.+.+|+ .++||||+|||||.|++|++||.+.+...++.++.++ .+..|.   .++++++
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-~f~MPs---~Is~eaQ  240 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-VFEMPS---NISSEAQ  240 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-cccCCC---cCCHHHH
Confidence            9999999999999999999999996 6799999999999999999999999998888887776 566664   6999999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||..||.+|+|.+||++|||++..
T Consensus       241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  241 DLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHHHHHhccCccccccHHHHhhCchhhcC
Confidence            99999999999999999999999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-54  Score=417.60  Aligned_cols=266  Identities=32%  Similarity=0.556  Sum_probs=249.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+-+.|.+.++||+|+|+.|+++.++.||+.+|+|+|+...+....-+.+.+|++|.+.|+||||+++.+.+...+..|
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            46677899999999999999999999999999999999988777667788999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||+|++.|++|..-|-.+..++|..+..+++||+.+|.|+|.+||||||+||+|+|+.+.+....+||+|||+|..++.+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999999999887766678999999999999999999999999999999999999998888899999999999999977


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .....++|||.|||||+++..+|+..+|||+.|||||.|+.|++||.+.+...+++.|+++.....++.+..+++++++|
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            77888999999999999999999999999999999999999999999999999999999885444444778899999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      |++||..||.+|+|+.|+|+|||+.+
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcc
Confidence            99999999999999999999999976

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=446.55  Aligned_cols=270  Identities=32%  Similarity=0.601  Sum_probs=246.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      ..+.+|.++++||+|+||.|+++..+.+++.||||++++..+ .++..+..+.|.+|+...+ ||.++.++..|++.+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            467889999999999999999999999999999999998765 4566788999999998876 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-  165 (575)
                      |+||||+.||++..+ +..+.|+|..++.|+.+|+.||+|||++||||||||.+|||+   |..|++||+|||+++... 
T Consensus       445 ~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence            999999999995444 445789999999999999999999999999999999999999   999999999999998754 


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......++||||.|||||++.++.|+.++|||+|||+|||||.|..||.|.+.++++..|+.. ...+|.   .++.++.
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~yP~---~ls~ea~  596 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRYPR---FLSKEAI  596 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCC---cccHHHH
Confidence            566788999999999999999999999999999999999999999999999999999998876 445554   6899999


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcccC
Q 043425          246 DLCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       246 dLI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      ++++++|.+||++|+.     +++|..||||+.++|+.+..+++-|
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P  642 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP  642 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence            9999999999999995     6899999999999999998877655

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.8e-51  Score=405.90  Aligned_cols=259  Identities=31%  Similarity=0.549  Sum_probs=229.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ..|+.+.++|+|+||+||+|+++.||+.||||.+..+.-++....-.++|+++|++|.|+|+|.++++|....++++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            57899999999999999999999999999999998776666667778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~  170 (575)
                      ||+..-|.++-.....+++..++.++.|++.|+.|+|++++|||||||+|||+   ..++.+||||||+|+.+. ++..+
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchh
Confidence            99886666555444579999999999999999999999999999999999999   778899999999999987 66677


Q ss_pred             ccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC----------------
Q 043425          171 ETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF----------------  233 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~----------------  233 (575)
                      ..++.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+.|.|..+.+++..|.+......                
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            78999999999999987 6899999999999999999999999999999998888775321111                


Q ss_pred             --CC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          234 --PP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       234 --p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                        |.         ..+.++.-+.||+++||..||++|++.+|+|.|+||..
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence              11         12345667899999999999999999999999999943

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-48  Score=403.16  Aligned_cols=265  Identities=30%  Similarity=0.610  Sum_probs=236.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      +..+++|.+.+.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.++++++||||+++++++...+.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            4567899999999999999999999999999999999976533 223346688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence            9999999999999999988899999999999999999999999999999999999999   7778999999999987643


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+ ...+|.   .++.++++
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~~  244 (329)
T PTZ00263        171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKFPN---WFDGRARD  244 (329)
T ss_pred             C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CcCCCC---CCCHHHHH
Confidence            3  23578999999999999999999999999999999999999999998888877777654 333343   47889999


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhh
Q 043425          247 LCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       247 LI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||++||++||.+||+     ++++++||||....++.+..
T Consensus       245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~  284 (329)
T PTZ00263        245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA  284 (329)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            999999999999996     79999999999988776654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=415.04  Aligned_cols=266  Identities=33%  Similarity=0.625  Sum_probs=243.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~   85 (575)
                      ......|.+.+.||+|.||.||+|+++.||+.+|+|++.+..... ...+.+.+|+.||+++. ||||+.++++|++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345567999999999999999999999999999999998876543 24567899999999998 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-CCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFGla~~~  164 (575)
                      +++|||+|.||+|++.|... .++|..+..+++|++.+++|||+.||+||||||+|+|+...+. .+.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999876 4999999999999999999999999999999999999976544 568999999999998


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .........||||.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+.......+.++......+.+..++..+
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a  269 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA  269 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence            88778889999999999999999999999999999999999999999999999999888888886544455567889999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++||++||..||.+|+|+.++|+|||++..
T Consensus       270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999999998764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-50  Score=400.77  Aligned_cols=249  Identities=31%  Similarity=0.615  Sum_probs=225.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCE-E
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD-IIEVPGK-L   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-~~~~~~~-l   86 (575)
                      ....+|+|+++||+|+||+||++.+..+|..+|.|.+.-..++.+.++.+..|+.+|++|+|||||++++ .|...+. +
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            4566799999999999999999999999999999999988889999999999999999999999999998 4544444 9


Q ss_pred             EEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh--CC--cccccccCCceeeecCCCCCcEEEccc
Q 043425           87 HLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRD--NN--LIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~--~g--IvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      +||||||.+|+|..+|+.    ++.++|..++.++.||+.||.++|.  .+  |+||||||.||++   +.+|.|||+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf  172 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF  172 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence            999999999999999864    3579999999999999999999999  45  9999999999999   78899999999


Q ss_pred             ccccccCCCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          159 GFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       159 Gla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      |+++.+.... .+.+++|||.||+||++...+|++++|||||||++|||+.-.+||.|.+-.++-++|.++...+.|.  
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence            9999886554 4678999999999999999999999999999999999999999999999888888888774322332  


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCH
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      ..+|.++..||..|+.+||..||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            5789999999999999999999986

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-47  Score=407.63  Aligned_cols=264  Identities=27%  Similarity=0.491  Sum_probs=225.9

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|.++++||+|+||.||+|++..+++.||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999976543 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC----
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR----  167 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~----  167 (575)
                      |++||+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||+   +..+.+||+|||++..+...    
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccc
Confidence            99999999999988899999999999999999999999999999999999999   67789999999997533100    


Q ss_pred             --------------------------------------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHH
Q 043425          168 --------------------------------------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAIL  203 (575)
Q Consensus       168 --------------------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviL  203 (575)
                                                                  ....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        012346899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhcc--CCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          204 FQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRR--NPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       204 yeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~--DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      |+|++|..||...+..+....+.... ...++. ...+++++++||.+||+.  +|..|++++++++||||....+....
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~  317 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDI  317 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHh
Confidence            99999999999888776666555432 223332 235789999999997654  44559999999999999988776543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-49  Score=407.79  Aligned_cols=266  Identities=28%  Similarity=0.499  Sum_probs=238.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..-...|++++.||+|.-|+||+|+.+.++..+|+|+++++.+. .+...++..|..||+.++||.++.||..|++++..
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            34556789999999999999999999999999999999988764 34456678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      |+|||||+||+|..++++.  +.|++..++.|+.+|+.||+|||-.|||+||||||||||   .++|+|.|+||.|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccC
Confidence            9999999999999999865  579999999999999999999999999999999999999   78899999999997432


Q ss_pred             C-------C----------------------------C----------------------CCcccccCCCCCCChHHHhh
Q 043425          165 Q-------P----------------------------R----------------------GLAETLCGSPLYMAPEIMQL  187 (575)
Q Consensus       165 ~-------~----------------------------~----------------------~~~~~~~GT~~Y~APEvl~~  187 (575)
                      .       .                            .                      .....++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            1       0                            0                      01234789999999999999


Q ss_pred             ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCC----HH
Q 043425          188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLT----FE  263 (575)
Q Consensus       188 ~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT----a~  263 (575)
                      .+.+.++|||+|||++|||+.|..||.|.+..+.+.+|+.. ++.||... ..+..++|||+++|.+||.+|+.    +.
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchH
Confidence            99999999999999999999999999999999999998865 66677654 67899999999999999999997    99


Q ss_pred             HHHcCCCCCCCCchh
Q 043425          264 EFFNHPFLSQTQPDQ  278 (575)
Q Consensus       264 eiL~Hpff~~~~~~~  278 (575)
                      ||.+||||..++|.-
T Consensus       388 eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  388 EIKRHPFFEGVNWAL  402 (459)
T ss_pred             HhhcCccccCCChhh
Confidence            999999999999983

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=421.14  Aligned_cols=255  Identities=36%  Similarity=0.655  Sum_probs=237.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +.+|.+.+.||+|+||+||+|+.+.+++.||+|.+++...+++....+.+|++|++.++||||+.++++|++..++|+|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            35799999999999999999999999999999999998888888889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      |||.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||+   +.++.+|+||||+|+....+. .
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCcee
Confidence            99977 999999999999999999999999999999999999999999999999   889999999999999775544 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|||.|||||++.+++|+..+|+||||||+|||++|++||......++.+.|.+. +..+|.   ..+..+++|++
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-~v~~p~---~~S~~f~nfl~  232 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-PVKPPS---TASSSFVNFLQ  232 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-CCCCcc---cccHHHHHHHH
Confidence            55678999999999999999999999999999999999999999999888888888765 334443   68999999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .+|.+||.+|+|..+++.|||...
T Consensus       233 gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  233 GLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHhhcChhhcccHHHHhcChHHhh
Confidence            999999999999999999999865

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=403.22  Aligned_cols=263  Identities=29%  Similarity=0.545  Sum_probs=229.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+|+++++||+|+||.||+|++..+|+.||||++..... .......+.+|+.++..++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999999999999999986533 2233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccc
Confidence            999999999999988899999999999999999999999999999999999999   778899999999987543211  


Q ss_pred             -------------------------------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCC
Q 043425          169 -------------------------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKT  211 (575)
Q Consensus       169 -------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~  211 (575)
                                                           .....+||+.|+|||++....|+.++|||||||++|+|++|.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 1123579999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHhcc-CCCCCChhcccHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCCchhh
Q 043425          212 PFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       212 PF~~~~~~~~l~~i~~~~~-~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~~~~~  279 (575)
                      ||.+.+..+....+..... ..++.. ..+++++++||++||. +|.+|++   ++|+++||||....++..
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~  307 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDE-VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHI  307 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCC-CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999988887777765432 223332 3578999999999997 9999998   999999999999877654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-47  Score=398.00  Aligned_cols=258  Identities=28%  Similarity=0.572  Sum_probs=227.9

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      +.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999999999999999986533 2233456789999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCcccccC
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCG  175 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~G  175 (575)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ........+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  157 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceec
Confidence            999999988899999999999999999999999999999999999999   777889999999987542 2333456789


Q ss_pred             CCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccC
Q 043425          176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       176 T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      |+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+... ...++.   .++.++.+||++||++|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~---~~~~~~~~li~~~L~~d  233 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPR---TLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCHHHHHHHHHHccCC
Confidence            99999999999999999999999999999999999999998887777666544 333443   57899999999999999


Q ss_pred             CCCCC-----CHHHHHcCCCCCCCCchhhhhh
Q 043425          256 PVERL-----TFEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       256 P~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~  282 (575)
                      |.+||     ++.++++||||....++.....
T Consensus       234 P~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~  265 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEHRFFASINWQDVVQK  265 (323)
T ss_pred             HHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            99999     8999999999999888776653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-47  Score=397.93  Aligned_cols=264  Identities=29%  Similarity=0.520  Sum_probs=231.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|+++++||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.++..++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998654322 33456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence            999999999999988899999999999999999999999999999999999999   6778999999999976543  34


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-CCCCCh---hcccHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPDA---KILSADCKD  246 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-~~p~~~---~~ls~el~d  246 (575)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ..+...   ..++.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            5678999999999999999999999999999999999999999998888777766543221 112111   256899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      ||.+||..+|.+||+++++++||||....+....
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~  269 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVDWNELR  269 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHh
Confidence            9999999999999999999999999988776544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-48  Score=394.48  Aligned_cols=260  Identities=32%  Similarity=0.575  Sum_probs=231.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4799999999999999999999999999999999764332 234456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--c
Confidence            999999999999988899999999999999999999999999999999999999   67788999999999866432  2


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ...++.   .++..+++||++
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~---~~~~~~~~li~~  231 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEFPR---HLDLYAKDLIKK  231 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CcCCCc---cCCHHHHHHHHH
Confidence            3568999999999999999999999999999999999999999999888877777665 333443   468899999999


Q ss_pred             hhccCCCCCCC-----HHHHHcCCCCCCCCchhhh
Q 043425          251 LLRRNPVERLT-----FEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       251 ~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~  280 (575)
                      ||+.||.+||+     ++++++||||....+....
T Consensus       232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  266 (291)
T cd05612         232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP  266 (291)
T ss_pred             HcCCCHHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence            99999999995     9999999999987766544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-47  Score=405.12  Aligned_cols=265  Identities=26%  Similarity=0.462  Sum_probs=229.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+.... ......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4799999999999999999999999999999999764332 233456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+....  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccccc
Confidence            999999999999988899999999999999999999999999999999999999   677899999999987543210  


Q ss_pred             ----------------------------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC
Q 043425          169 ----------------------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       169 ----------------------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~  214 (575)
                                                        .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              1234689999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCC---CCCCHHHHHcCCCCCCCCchhhhh
Q 043425          215 GSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPV---ERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       215 ~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~---~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      +.+..+....+.... ...+|+. ..++.++++||.+|++ +|.   .||+++|+++||||....|+.+..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~  306 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPE-VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRE  306 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCc-CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence            998888888777542 3344443 2478999999999876 444   468999999999999998877643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-49  Score=406.19  Aligned_cols=255  Identities=34%  Similarity=0.636  Sum_probs=238.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .--+|++.+.||+|.||.|-+|..+..|+.||||.|.++.+.+ +....+++|++||..|+||||+++|++|++.+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            4457999999999999999999999999999999999887754 455789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||..+|+|++|+.+.+.++|.+++.||+||+.|+.|||+++++|||||.+|||+   |+++.+||+|||++-.+....
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999   899999999999999999999


Q ss_pred             CcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      +..++||+|.|.+||++.+.+|. +.+|.|||||+||.|+.|..||.|.+...++.+|..+.. .-|    .-+.++.-|
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-rEP----~~PSdA~gL  282 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-REP----ETPSDASGL  282 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-cCC----CCCchHHHH
Confidence            99999999999999999999994 679999999999999999999999999999999887743 223    357789999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      |+.||..||++|.|+++|-.|=|.+
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhheee
Confidence            9999999999999999999998876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=415.51  Aligned_cols=263  Identities=28%  Similarity=0.508  Sum_probs=228.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-EE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPG-KL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~-~l   86 (575)
                      .+.++|.++++||.|+||.||+|+.+.+|..||||.+++.-.. ...-.-.+|+..|++|+ ||||+++++++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            4567899999999999999999999999999999998765333 22223468999999999 999999999997776 99


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |+||||| ..+|+++++.+ ..|+|..++.|+.||+.||+|+|++|+.||||||||||+   .....|||+|||+|+.+.
T Consensus        86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccc
Confidence            9999999 46999999755 579999999999999999999999999999999999999   446789999999999999


Q ss_pred             CCCCcccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--------------
Q 043425          166 PRGLAETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--------------  230 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~--------------  230 (575)
                      ....++.++-|.+|+|||++. ..-|+.++|||++|||++|+.+-++.|.|.+..+.+.+|..-..              
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            988889999999999999975 56789999999999999999999999999999998888775211              


Q ss_pred             ----CCCCCC--------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          231 ----LHFPPD--------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       231 ----~~~p~~--------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                          ..+|..        .+..+.++.+||.+||.+||.+||||.|+|+||||+....
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                112211        1346789999999999999999999999999999987543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-47  Score=403.72  Aligned_cols=263  Identities=29%  Similarity=0.513  Sum_probs=226.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.++++||+|+||.||+|.+..+|+.||||++.+... ..+....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999876432 2334466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+....  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999   677899999999986332100  


Q ss_pred             ----------------------------------------------CcccccCCCCCCChHHHhhccCCcccccchhhHH
Q 043425          169 ----------------------------------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAI  202 (575)
Q Consensus       169 ----------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGvi  202 (575)
                                                                    .....+||+.|+|||++.+..|+.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0113579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCC---CCHHHHHcCCCCCCCCchh
Q 043425          203 LFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVER---LTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       203 LyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~R---pTa~eiL~Hpff~~~~~~~  278 (575)
                      +|+|++|.+||.+.+..+.+..+.... ...+|. ...++.++++||.+||. +|.+|   +++.|++.||||....++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~  315 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDT  315 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            999999999999988877777766532 223332 23578999999999998 67665   5999999999999877765


Q ss_pred             h
Q 043425          279 V  279 (575)
Q Consensus       279 ~  279 (575)
                      +
T Consensus       316 ~  316 (377)
T cd05629         316 I  316 (377)
T ss_pred             H
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-48  Score=410.14  Aligned_cols=262  Identities=33%  Similarity=0.546  Sum_probs=232.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~   85 (575)
                      .+..+.|+.+++||+|+||.||+|++..+|+.||+|.+..+...+.......+||.||++|+||||++|.+++...  +.
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            3567779999999999999999999999999999999998887777777788999999999999999999998766  78


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      +|||+|||++ ||.-++...+ .|++.+++.|++||+.||+|||.+||+|||||.+||||   |++|.+||+|||||+.+
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence            9999999976 8888887644 79999999999999999999999999999999999999   89999999999999987


Q ss_pred             CCCC--CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC---------C
Q 043425          165 QPRG--LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL---------H  232 (575)
Q Consensus       165 ~~~~--~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~---------~  232 (575)
                      ....  .+...+-|.+|+|||++.+. .|+.++|+||+||||.||++|++.|.|.+..+.+..|.+....         .
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            6544  46677889999999998764 7999999999999999999999999999999999988864211         1


Q ss_pred             CC----------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          233 FP----------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       233 ~p----------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +|                +....++..+.+|+..||+.||.+|.|+.++|+|+||..
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            11                012346788999999999999999999999999999943

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.2e-47  Score=402.33  Aligned_cols=263  Identities=29%  Similarity=0.549  Sum_probs=226.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|.++++||+|+||.||+|++..+++.||||++.+... .......+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            69999999999999999999999999999999976432 23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-----
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-----  166 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-----  166 (575)
                      ||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+..     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccccc
Confidence            99999999999888889999999999999999999999999999999999999   7788999999999753210     


Q ss_pred             -------------------------------------------CCCcccccCCCCCCChHHHhhccCCcccccchhhHHH
Q 043425          167 -------------------------------------------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAIL  203 (575)
Q Consensus       167 -------------------------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviL  203 (575)
                                                                 .....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0012346899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCCchhh
Q 043425          204 FQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       204 yeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~~~~~  279 (575)
                      |+|++|++||.+.+..+....+.... ...+|. ...+++++.+||.+|+ .||.+|++   ++++++||||....+...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~  316 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSD  316 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHH
Confidence            99999999999988777666665432 222332 2457899999999976 59999997   999999999998876653


Q ss_pred             h
Q 043425          280 F  280 (575)
Q Consensus       280 ~  280 (575)
                      .
T Consensus       317 ~  317 (382)
T cd05625         317 L  317 (382)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-47  Score=399.79  Aligned_cols=264  Identities=33%  Similarity=0.596  Sum_probs=232.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.++..++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998654322 34456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      ||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcc
Confidence            999999999999988889999999999999999999999999999999999999   777899999999998664433  


Q ss_pred             ----------------------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH
Q 043425          169 ----------------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ  220 (575)
Q Consensus       169 ----------------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~  220 (575)
                                                  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                        2345679999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCCC-HHHHHcCCCCCCCCchhhh
Q 043425          221 LLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERLT-FEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       221 ~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT-a~eiL~Hpff~~~~~~~~~  280 (575)
                      ....+.... ...+|.. ..+++++.+||.+||. ||.+|++ ++++++||||....++...
T Consensus       238 ~~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~  297 (350)
T cd05573         238 TYNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR  297 (350)
T ss_pred             HHHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHh
Confidence            777776532 2223332 3479999999999997 9999999 9999999999998776544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=401.46  Aligned_cols=259  Identities=34%  Similarity=0.619  Sum_probs=220.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--KLHL   88 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--~l~L   88 (575)
                      ..+|..++.||+|+||.||++.+..+|+.+|||.+.......  .+.+.+|+.+|++++|||||++++......  .++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            456999999999999999999999999999999998763222  566899999999999999999999754443  7999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-CCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFGla~~~~~  166 (575)
                      +|||++||+|.+++.+.+ .++|..++.+.+||+.||.|||++|||||||||+|||+   +. ++.+||+|||++.....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccc
Confidence            999999999999999887 79999999999999999999999999999999999999   66 68999999999987663


Q ss_pred             ----CCCcccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCCChhcc
Q 043425          167 ----RGLAETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       167 ----~~~~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                          ........||+.|||||++..+. .+.++|||||||++.||+||..||.. ......+..+....  ..|.-...+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~l  248 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDSL  248 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCccc
Confidence                12244678999999999998632 33489999999999999999999998 44445444444433  233444569


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +.++++||.+||.+||++|||++++|+|||......
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999999976433

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-47  Score=388.08  Aligned_cols=267  Identities=27%  Similarity=0.479  Sum_probs=225.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3889999999999999999999999999999997654432 223457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |+++|+|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999999887643  368999999999999999999999999999999999999   6778899999999987655444


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..............++.++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            55678999999999999999999999999999999999999999876543322222221111111112357899999999


Q ss_pred             HhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhh
Q 043425          250 KLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       250 k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~  282 (575)
                      +||+.||.+||+     ++++++||||....++.+-..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~  275 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN  275 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence            999999999997     899999999999887765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-49  Score=390.04  Aligned_cols=263  Identities=35%  Similarity=0.605  Sum_probs=242.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc------CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL------NKKLQESLMSEIFILKRI-NHPHIIRLHDIIE   81 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~------~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~   81 (575)
                      .....|.-.+.||.|..++|.++.++.+|..+|+|+|+....      .....+..++|+.||+++ .||||+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            345567778899999999999999999999999999975322      234567788999999997 5999999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ++..+++|+|.|+.|.|++++...-.++|...+.|++||+.|++|||.++||||||||+|||+   +++..+||+|||++
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa  170 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA  170 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence            999999999999999999999998889999999999999999999999999999999999999   88999999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHh------hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQ------LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~------~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~  235 (575)
                      ..+.++......||||+|+|||.+.      ..+|+..+|+|++|||||.|+.|.+||....+.-++..|+.+......+
T Consensus       171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence            9999999999999999999999984      4578889999999999999999999999999999999999998777777


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+..++.+.+|||.+||+.||.+|+|++|+|+||||.++
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            888999999999999999999999999999999999764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=407.63  Aligned_cols=262  Identities=37%  Similarity=0.658  Sum_probs=245.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |++.|-|.+.+.||+|-|++|.+|+|..||+.||||+|++..++.-...++.+|++.|+.++|||||++|+++.+...+|
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            78889999999999999999999999999999999999998888777788999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +|+|+-.||+|++||.++ ..+.|..+++||.||+.|+.|+|+..+|||||||+|+.+.  ..-|.|||.|||++-.+.+
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCC
Confidence            999999999999999766 4699999999999999999999999999999999999875  5678999999999999999


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCc-ccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~-kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      +....+.||+..|.|||++.+..|+. ++||||||||||.|++|.+||...++.+.+-.|+... +..|.   .++.+|+
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPs---hvS~eCr  247 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPS---HVSKECR  247 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCch---hhhHHHH
Confidence            99999999999999999999999985 5899999999999999999999999999999998774 34443   6899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +||..||..||.+|.+.+||..|+|++..+
T Consensus       248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            999999999999999999999999999754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-47  Score=398.01  Aligned_cols=266  Identities=30%  Similarity=0.559  Sum_probs=234.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCC-cEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ....++|.+.+.||+|+||.||+|.++.++ ..||+|++.+... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            456788999999999999999999977654 7899999976433 23344668899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecC
Confidence            99999999999999999988899999999999999999999999999999999999999   777899999999998654


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ..  ..+.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.....+.+.... ..+|.   .++.+++
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~---~~~~~~~  256 (340)
T PTZ00426        183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPK---FLDNNCK  256 (340)
T ss_pred             CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCC---CCCHHHH
Confidence            32  346789999999999999999999999999999999999999999988887777776653 33343   4788999


Q ss_pred             HHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhh
Q 043425          246 DLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       246 dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ++|++||+.||.+|+     +++++++||||....|......
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~  298 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHK  298 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            999999999999995     8999999999999887765543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-48  Score=390.01  Aligned_cols=264  Identities=32%  Similarity=0.507  Sum_probs=230.3

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--   83 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--   83 (575)
                      ++.+.|.+|+.+.+|++|+||.||+|+++.|++.||+|.++.+.-.....-.-++||.+|.+++|||||.+.+++...  
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            346889999999999999999999999999999999999988765544455678999999999999999999998543  


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +.+|||||||+. ||..++.+-+ +|...+++.++.|++.||+|||.++|+||||||+|+|+   .+.|.+||+|||+|+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhh
Confidence            579999999966 9999998765 89999999999999999999999999999999999999   788999999999999


Q ss_pred             ccCCC-CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------
Q 043425          163 SLQPR-GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------  232 (575)
Q Consensus       163 ~~~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------  232 (575)
                      .+... ......+.|.+|+|||++.+ ..|+.++|+||+|||+.||+++++.|.|....+.+.+|.+....+        
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            88654 34566788999999999875 569999999999999999999999999999999999888632211        


Q ss_pred             ----------CCCC--------hhc--ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          233 ----------FPPD--------AKI--LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       233 ----------~p~~--------~~~--ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                ++..        ...  ++....+|+..+|.+||.+|.|++|.|+|.||.+
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence                      1110        011  4577899999999999999999999999999976

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-46  Score=399.22  Aligned_cols=265  Identities=26%  Similarity=0.486  Sum_probs=226.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|+++++||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999875432 2223456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC----
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----  166 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~----  166 (575)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|..+..    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence            999999999999988889999999999999999999999999999999999999   7778999999999753210    


Q ss_pred             ----------------------------------------CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHH
Q 043425          167 ----------------------------------------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQL  206 (575)
Q Consensus       167 ----------------------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeL  206 (575)
                                                              .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0011246899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCC---CHHHHHcCCCCCCCCchhhh
Q 043425          207 VTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       207 ltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~Rp---Ta~eiL~Hpff~~~~~~~~~  280 (575)
                      ++|+.||.+.+..+....+.........+....++.++.+||.+|+ .+|.+|+   +++++++||||....+....
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~  313 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLI  313 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHh
Confidence            9999999998877766665543222112222357899999999976 5999999   99999999999987665543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=411.74  Aligned_cols=263  Identities=29%  Similarity=0.566  Sum_probs=236.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.-...|....+||+|+-|.||.|....+++.||||.+++.....  .+-+.+|+.+|+.++|+|||.+++.|...+.+|
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            445567999999999999999999999999999999999875433  456899999999999999999999998889999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+.+... .++|..+..++++++.||+|||.+||+|||||.+|||+   ..+|.+||+|||+|..+...
T Consensus       347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccc
Confidence            999999999999998754 69999999999999999999999999999999999999   66677999999999887665


Q ss_pred             C-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 G-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 ~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      . ...+.+|||.|||||++....|++++||||||++++||+-|++||...++...+..|.....+.+.. ...+++++++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~klS~~~kd  501 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEKLSPELKD  501 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccccCHHHHH
Confidence            5 6778999999999999999999999999999999999999999999999888888877765544332 3569999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      |+.+||+.|+.+|+++.|+|+||||....+.
T Consensus       502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p~  532 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEHPFLKMAKPE  532 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence            9999999999999999999999999765544

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.4e-47  Score=383.93  Aligned_cols=257  Identities=32%  Similarity=0.557  Sum_probs=219.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|.+.+.||+|+||.||+|+++.+++.||||++..........+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999998765445556678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--C
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--L  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--~  169 (575)
                      |++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.......  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccccc
Confidence            99998777666555679999999999999999999999999999999999999   677889999999998764322  2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc------------------C
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE------------------L  231 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~------------------~  231 (575)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.....                  .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            3346799999999999988999999999999999999999999998776555444332110                  0


Q ss_pred             CCCCC----------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 HFPPD----------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 ~~p~~----------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++..          ...++.++.+||++||++||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            01100          01367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-47  Score=376.01  Aligned_cols=258  Identities=31%  Similarity=0.538  Sum_probs=228.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|...++||+|+||+||+|++..||+.||||.|......+.......+|+..|+.++|+||+.++++|-..+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            57888999999999999999999999999999999887777777788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |++ .+|+..|+.+ ..++...++.++.+++.||+|||.++|+||||||+|+|+   +.+|.+||+|||+|+.+..... 
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcc
Confidence            995 6999999765 479999999999999999999999999999999999999   7778999999999998865543 


Q ss_pred             cccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChh----------
Q 043425          170 AETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK----------  238 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~----------  238 (575)
                      ....+-|.+|+|||.+- ...|+..+||||+|||+.||+.|.+-|.|.++.+.+..|.+....+.+..++          
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            33347899999999875 4679999999999999999999999999999999999888754333222221          


Q ss_pred             --------------cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          239 --------------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       239 --------------~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                    ..+.++.||+.+||..||.+|+++.|+|+|+||..
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                          23457899999999999999999999999999975

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=386.03  Aligned_cols=254  Identities=33%  Similarity=0.590  Sum_probs=223.6

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999999999999999976432 233445678999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CCCcccccCCC
Q 043425           99 SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSP  177 (575)
Q Consensus        99 ~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~~~~~~~GT~  177 (575)
                      .+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.... .......+||+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCc
Confidence            9999988899999999999999999999999999999999999999   7778999999999975432 23345678999


Q ss_pred             CCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCC
Q 043425          178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV  257 (575)
Q Consensus       178 ~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~  257 (575)
                      .|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ...++   ..++.++++||.+||.+||.
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFP---DGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCC---CcCCHHHHHHHHHHcCCCHH
Confidence            999999999999999999999999999999999999998888877776654 33333   35789999999999999999


Q ss_pred             CCC---CHHHHHcCCCCCCCCchhhh
Q 043425          258 ERL---TFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       258 ~Rp---Ta~eiL~Hpff~~~~~~~~~  280 (575)
                      +||   ++.|+++||||.+..+....
T Consensus       234 ~R~~~~~~~e~l~hp~~~~~~~~~~~  259 (312)
T cd05585         234 RRLGYNGAQEIKNHPFFSQLSWKKLL  259 (312)
T ss_pred             HcCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            997   58999999999987655443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-48  Score=375.36  Aligned_cols=257  Identities=34%  Similarity=0.605  Sum_probs=237.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      -.+++|++++.||+|-||.||+|+.+.++-.||+|++.++.+. .....++.+|++|-..|+||||+++|++|.+...+|
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            4688999999999999999999999999999999999887653 345678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~--~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +++||..+|+|+..++  +.++|++..+..++.|++.||.|+|.++||||||||+|+|+   +..+.+||+|||.+..-.
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC
Confidence            9999999999999998  66789999999999999999999999999999999999999   667789999999986543


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                       .....+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||...+..+.+++|.+. ...+|.   .++.++.
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p~---~is~~a~  250 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFPS---TISGGAA  250 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCCc---ccChhHH
Confidence             66778999999999999999999999999999999999999999999999988888888776 566664   6899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      |||.+||.++|.+|.+..|+++|||+..
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999999864

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-46  Score=396.50  Aligned_cols=265  Identities=26%  Similarity=0.508  Sum_probs=230.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.++..++||||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999975432 2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC---
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR---  167 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~---  167 (575)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+...   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccccc
Confidence            999999999999988899999999999999999999999999999999999999   77789999999998754221   


Q ss_pred             ---------------------------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC
Q 043425          168 ---------------------------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       168 ---------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~  214 (575)
                                                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             01224689999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCC---CHHHHHcCCCCCCCCchhhhh
Q 043425          215 GSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       215 ~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~Rp---Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      +.+.......+.... ...+|+. ..++.++++||.+|+ .||.+|+   +++++++||||....|..+..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~  306 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPE-VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGHIRE  306 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCC-CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence            998888877776532 2333432 247899999999977 5999998   589999999999998877643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-46  Score=390.03  Aligned_cols=257  Identities=28%  Similarity=0.582  Sum_probs=225.7

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      +.||+|+||.||++.+..+|..||||++.+... .......+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999986533 2334456789999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCcccccC
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCG  175 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~G  175 (575)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ........+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccC
Confidence            999999888889999999999999999999999999999999999999   777899999999987532 2233456789


Q ss_pred             CCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccC
Q 043425          176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       176 T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      |+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ...+|.   .++.++.+||++||.+|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~---~~~~~~~~li~~~L~~d  233 (328)
T cd05593         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPR---TLSADAKSLLSGLLIKD  233 (328)
T ss_pred             CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCC---CCCHHHHHHHHHHcCCC
Confidence            99999999999999999999999999999999999999988877776665443 333443   57899999999999999


Q ss_pred             CCCCC-----CHHHHHcCCCCCCCCchhhhh
Q 043425          256 PVERL-----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       256 P~~Rp-----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      |.+|+     ++.|+++||||....+..+..
T Consensus       234 P~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  264 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD  264 (328)
T ss_pred             HHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99997     899999999999887776554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-46  Score=389.05  Aligned_cols=257  Identities=35%  Similarity=0.629  Sum_probs=226.0

Q ss_pred             EEecccCCeEEEEEEEc---CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      +.||+|+||.||++++.   .+|+.||+|++............+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            68999999999999863   578999999998765444445567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCcccc
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETL  173 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~~~  173 (575)
                      ||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... ......
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecc
Confidence            99999999888889999999999999999999999999999999999999   67788999999998765433 334467


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      +||+.|+|||++....++.++|||||||++|+|++|+.||.+.+..+....+.+.. ..+|   ..++.++.+||++||+
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p---~~~~~~~~~li~~~l~  234 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMP---QFLSPEAQSLLRALFK  234 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCC---CCCCHHHHHHHHHHhh
Confidence            89999999999998899999999999999999999999999988888777766542 2333   3578999999999999


Q ss_pred             cCCCCCCC-----HHHHHcCCCCCCCCchhhhh
Q 043425          254 RNPVERLT-----FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       254 ~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||.+||+     +++++.||||....+.....
T Consensus       235 ~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T cd05582         235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYR  267 (318)
T ss_pred             cCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHh
Confidence            99999999     78899999999987766554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-46  Score=388.18  Aligned_cols=259  Identities=28%  Similarity=0.574  Sum_probs=227.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      +.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++||||++++++|...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            479999999999999999999999999976532 2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CCCcccccC
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCG  175 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~~~~~~~G  175 (575)
                      +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+|
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  157 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCG  157 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccC
Confidence            999999888889999999999999999999999999999999999999   6778899999999875422 233445789


Q ss_pred             CCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccC
Q 043425          176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       176 T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+|.   .+++++.+||.+||++|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~p~---~~~~~~~~li~~~L~~d  233 (323)
T cd05595         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPR---TLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCC---CCCHHHHHHHHHHccCC
Confidence            99999999999999999999999999999999999999988887777666543 233343   57899999999999999


Q ss_pred             CCCCC-----CHHHHHcCCCCCCCCchhhhhhc
Q 043425          256 PVERL-----TFEEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       256 P~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~  283 (575)
                      |.+|+     ++.++++|+||....+.......
T Consensus       234 P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~  266 (323)
T cd05595         234 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK  266 (323)
T ss_pred             HHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence            99998     89999999999998887766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=390.65  Aligned_cols=274  Identities=28%  Similarity=0.501  Sum_probs=238.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++.++||.|.-++||+|+...+++.||||+++.+..+.. .+.+.+|+..|+.++||||+.++..|..+..+|+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            456789999999999999999999999999999999999877666 5779999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||.||.+|++.++++..  ..++|..+..|+++++.||.|||.+|.||||||+.|||+   +.+|.|||+|||.+-.+..
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence            99999999999999864  349999999999999999999999999999999999999   8889999999998765543


Q ss_pred             CC----C-cccccCCCCCCChHHHh--hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-----CC
Q 043425          167 RG----L-AETLCGSPLYMAPEIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-----FP  234 (575)
Q Consensus       167 ~~----~-~~~~~GT~~Y~APEvl~--~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-----~p  234 (575)
                      .+    . ..+++|||.|||||++.  ..+|+.|+||||||++..||.+|..||....+.+++-.-+++.++.     ++
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            22    1 26789999999999953  4689999999999999999999999999999998886666554331     11


Q ss_pred             CC-hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhhhcccC
Q 043425          235 PD-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       235 ~~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      .+ ...++..++.+|..||.+||.+|||+.++|+|+||+............+.
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~  311 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQ  311 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhc
Confidence            11 24577889999999999999999999999999999988665544444433

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=399.20  Aligned_cols=261  Identities=31%  Similarity=0.631  Sum_probs=225.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH------------HHHHHHHHHHHHHhCCCCCcce
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK------------LQESLMSEIFILKRINHPHIIR   75 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~------------~~~~i~~Ei~iL~~L~HpnIv~   75 (575)
                      ...++.|++++.||+|.||.|.+|++..+++.||||++.+..+..+            ..+.+.+||.||++|.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            4578899999999999999999999999999999999987654322            1257899999999999999999


Q ss_pred             EEEEEEeC--CEEEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc
Q 043425           76 LHDIIEVP--GKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA  152 (575)
Q Consensus        76 l~~~~~~~--~~l~LVmEy~~GgsL~~~l~~~~~-lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~  152 (575)
                      |+++..++  +.+|||+|||..|.+...-. .++ +++.+++.|+++++.||+|||.+|||||||||.|+|+   +..|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCc
Confidence            99999765  57999999999998765433 344 9999999999999999999999999999999999999   66699


Q ss_pred             EEEcccccccccCCC------CCcccccCCCCCCChHHHhhc---cC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHH
Q 043425          153 LKIADFGFARSLQPR------GLAETLCGSPLYMAPEIMQLQ---KY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLL  222 (575)
Q Consensus       153 vKL~DFGla~~~~~~------~~~~~~~GT~~Y~APEvl~~~---~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l  222 (575)
                      |||+|||.+......      ......+|||.|+|||....+   .| +.+.|||||||+||.|+.|..||.+....+++
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999998765221      122346899999999998652   33 56799999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          223 QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       223 ~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+|++. .+.+|.. +.+..+++|||++||++||++|++..+|..|||....
T Consensus       329 ~KIvn~-pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  329 DKIVND-PLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHhcC-cccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            998876 5666654 3678999999999999999999999999999998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.7e-46  Score=387.96  Aligned_cols=258  Identities=32%  Similarity=0.584  Sum_probs=225.4

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|+++.+++.||||++.+... .....+.+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999976432 223345567888888776 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999988899999999999999999999999999999999999999   777889999999987542 233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.... ..++   ..++.++.+||++||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~---~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYP---TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCC---CCCCHHHHHHHHHHccc
Confidence            9999999999999999999999999999999999999999999888887776543 2233   24789999999999999


Q ss_pred             CCCCCCCH------HHHHcCCCCCCCCchhhhhh
Q 043425          255 NPVERLTF------EEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       255 DP~~RpTa------~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ||.+||++      +++++||||....++.+...
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~  267 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR  267 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence            99999998      99999999999888766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-46  Score=390.19  Aligned_cols=264  Identities=30%  Similarity=0.524  Sum_probs=229.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999986543 2334456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876 689999999999999999999999999999999999999   7778999999999987654332


Q ss_pred             --cccccCCCCCCChHHHh------hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-CCCCChhcc
Q 043425          170 --AETLCGSPLYMAPEIMQ------LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPDAKIL  240 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~------~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-~~p~~~~~l  240 (575)
                        ....+||+.|+|||++.      ...++.++|||||||++|+|++|..||...+....+..+...... .++. ...+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~  236 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE-DPKV  236 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC-CCCC
Confidence              23457999999999986      456789999999999999999999999998888877777654332 2332 3357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      +.++.+||++||+ ||.+|||++++++||||....++.+.
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~  275 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIR  275 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHh
Confidence            8999999999998 99999999999999999988776543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.1e-46  Score=387.14  Aligned_cols=258  Identities=28%  Similarity=0.573  Sum_probs=225.6

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      +.||+|+||.||++.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999865432 233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      +|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFC  157 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCccccccc
Confidence            999999888889999999999999999999997 799999999999999   777899999999987543 233344578


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ...+|.   .+++++.+||++||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~~li~~~L~~  233 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPR---TLSPEAKSLLSGLLKK  233 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCC---CCCHHHHHHHHHHhhc
Confidence            999999999999999999999999999999999999999998887776665543 333443   4789999999999999


Q ss_pred             CCCCCC-----CHHHHHcCCCCCCCCchhhhhh
Q 043425          255 NPVERL-----TFEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       255 DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ||.+|+     ++.++++||||....+......
T Consensus       234 dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~  266 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK  266 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence            999997     8999999999999887766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.3e-46  Score=393.79  Aligned_cols=264  Identities=30%  Similarity=0.508  Sum_probs=228.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|++.++||+|+||.||+|++..+|..||+|++.+.... ......+.+|+.+++.++||||+++++++..++.+|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4567899999999999999999999999999999999764332 223345778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence            99999999999999865 468999999999999999999999999999999999999   77889999999999876443


Q ss_pred             C--CcccccCCCCCCChHHHhhc----cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-CCCCCChhcc
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQ----KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL  240 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~----~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-~~~p~~~~~l  240 (575)
                      .  .....+||+.|+|||++...    .++.++|||||||++|+|++|++||.+.+....+..+..... ..++. ...+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~  274 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD-DIEI  274 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC-cCCC
Confidence            3  23457899999999998654    478899999999999999999999999988888877776432 23333 2357


Q ss_pred             cHHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCch
Q 043425          241 SADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~  277 (575)
                      +.++++||++||+.+|.+  |++++++++||||....+.
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            999999999999999988  9999999999999986654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-45  Score=384.57  Aligned_cols=258  Identities=33%  Similarity=0.604  Sum_probs=222.6

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIF-ILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|++..+|+.||||++.+.... ......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765332 222344555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFC  157 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCcccccc
Confidence            9999999988899999999999999999999999999999999999999   777899999999987542 233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.... ...+   ..++.++.+||++||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~---~~~~~~~~~li~~~l~~  233 (323)
T cd05575         158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLK---PNISVSARHLLEGLLQK  233 (323)
T ss_pred             CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCC---CCCCHHHHHHHHHHhhc
Confidence            9999999999999999999999999999999999999999988888877776543 2233   24689999999999999


Q ss_pred             CCCCCCCH----HHHHcCCCCCCCCchhhhhh
Q 043425          255 NPVERLTF----EEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       255 DP~~RpTa----~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ||.+||++    .++++||||....+..+...
T Consensus       234 ~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~  265 (323)
T cd05575         234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNK  265 (323)
T ss_pred             CHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhc
Confidence            99999987    69999999998877765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.4e-46  Score=385.76  Aligned_cols=262  Identities=31%  Similarity=0.561  Sum_probs=229.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHP-HIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~l~LVm   90 (575)
                      +|++++.||+|+||.||+|.+..+++.||||++.+... .....+.+..|+.++..+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999986533 223445678899999999765 5888999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~  169 (575)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   677889999999987532 2333


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..++.   .++.++.+||+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~---~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPK---SLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCC---CCCHHHHHHHH
Confidence            446789999999999999999999999999999999999999999998888887776542 33333   57899999999


Q ss_pred             HhhccCCCCCCCH-----HHHHcCCCCCCCCchhhhh
Q 043425          250 KLLRRNPVERLTF-----EEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       250 k~L~~DP~~RpTa-----~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||.+||.+|++.     +++++||||....+.....
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~  270 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER  270 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            9999999999976     8999999999988876654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-45  Score=385.19  Aligned_cols=258  Identities=29%  Similarity=0.589  Sum_probs=219.4

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|++..++..||||++.+..... .....+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999998654322 3345678899999988 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.. .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888899999999999999999999999999999999999999   67788999999998753 3333445678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS--------NQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~--------~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      ||+.|+|||++.+..++.++|+|||||++|+|++|+.||...        ...+.+..........+|.   .++.++.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~  234 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKASS  234 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC---CCCHHHHH
Confidence            999999999999999999999999999999999999999632        1222222333333333443   57899999


Q ss_pred             HHHHhhccCCCCCCC------HHHHHcCCCCCCCCchhhhh
Q 043425          247 LCQKLLRRNPVERLT------FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       247 LI~k~L~~DP~~RpT------a~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||++||++||.+|++      ++++++||||....+.....
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~  275 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ  275 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence            999999999999997      79999999999887766543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-45  Score=383.91  Aligned_cols=259  Identities=33%  Similarity=0.608  Sum_probs=222.6

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIF-ILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|++..+|+.||+|++.+.... ......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765432 223344555654 67889999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~~~~~~~~  174 (575)
                      |+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFC  157 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   77789999999998753 2233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++....++.++|||||||++|+|++|..||.+.+...+...+... ...++.   ..+.++.++|.+||.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~---~~~~~~~~li~~~l~~  233 (321)
T cd05603         158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPG---GKTVAACDLLVGLLHK  233 (321)
T ss_pred             CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCC---CCCHHHHHHHHHHccC
Confidence            999999999999899999999999999999999999999998887777776654 333333   4678999999999999


Q ss_pred             CCCCCCCH----HHHHcCCCCCCCCchhhhhhc
Q 043425          255 NPVERLTF----EEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       255 DP~~RpTa----~eiL~Hpff~~~~~~~~~~~~  283 (575)
                      ||.+||++    .++++|+||....++......
T Consensus       234 ~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T cd05603         234 DQRRRLGAKADFLEIKNHVFFSPINWDDLYHKR  266 (321)
T ss_pred             CHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCC
Confidence            99999865    599999999998887765433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-45  Score=383.22  Aligned_cols=265  Identities=29%  Similarity=0.537  Sum_probs=231.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +|.+.+.||+|+||.||+|++..++..||||++.+.... ....+.+..|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999865332 22334567788888777 4789999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~  169 (575)
                      ||++||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888899999999999999999999999999999999999999   777899999999997543 2333


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+.... ..+|.   .++.++.+|+.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~---~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPK---SMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC---cCCHHHHHHHH
Confidence            456789999999999999999999999999999999999999999999888887777653 33343   47899999999


Q ss_pred             HhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcc
Q 043425          250 KLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       250 k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      +||++||.+|++     ..++++||||....|+...+...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~  273 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV  273 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence            999999999997     48999999999998887765443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-45  Score=390.81  Aligned_cols=264  Identities=32%  Similarity=0.536  Sum_probs=226.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|++.++||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++..++.+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            345789999999999999999999999999999999975432 2233455789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence            999999999999999754 68999999999999999999999999999999999999   77789999999999876443


Q ss_pred             CC--cccccCCCCCCChHHHhhcc----CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcc
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQK----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKIL  240 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~----y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~l  240 (575)
                      ..  ..+.+||+.|+|||++....    ++.++|||||||++|+|++|.+||.+.+....+..+.... ...+|.. ..+
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~  274 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED-VEI  274 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc-ccC
Confidence            32  34678999999999997643    7889999999999999999999999998888877777643 2333432 357


Q ss_pred             cHHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCch
Q 043425          241 SADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~  277 (575)
                      +..+++++.+||..++.+  |++++|+++||||....+.
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~  313 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN  313 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence            899999999999865544  8999999999999876543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.5e-46  Score=379.28  Aligned_cols=256  Identities=32%  Similarity=0.546  Sum_probs=216.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|.+.++||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            5679999999999999999999999999999999875432 222345779999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           91 EYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||+.| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..... .
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc
Confidence            99975 8999887654 57999999999999999999999999999999999999   67788999999999765332 2


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------------  232 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------------  232 (575)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.....               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2345678999999999865 568999999999999999999999999988777666554322110               


Q ss_pred             ---CCCC--------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 ---FPPD--------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 ---~p~~--------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                         ++..        ...++.++++||++||++||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence               1110        12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=385.40  Aligned_cols=273  Identities=27%  Similarity=0.563  Sum_probs=250.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+++|..+++||+|.||.|-+++.+.+|+.||+|+++++.+ ..+...+...|-++|+..+||.+..+...|++.+++|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            57789999999999999999999999999999999988765 34445677899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc-cCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~-~~~~  167 (575)
                      ||||..||.|+-.+.+...|+|..++.+-..|+.||.|||+++||+||||.+|+|+   |.+|++||+|||+++. +...
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999   9999999999999975 3445


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....++||||.|+|||++....|+.++|||.+||+||||++|++||+..+...++..|.-. .+.||.   .++++++.|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kFPr---~ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKFPR---TLSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccCCc---cCCHHHHHH
Confidence            5678999999999999999999999999999999999999999999999999888877655 677886   589999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcccCCCC
Q 043425          248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSRSA  289 (575)
Q Consensus       248 I~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~~~~~~  289 (575)
                      +..+|.+||.+|+     .+.||.+|+||..++|+.+++....|...
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfK  445 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFK  445 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCC
Confidence            9999999999998     58999999999999999999877665443

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-45  Score=383.78  Aligned_cols=259  Identities=34%  Similarity=0.626  Sum_probs=225.8

Q ss_pred             EEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           18 RQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      ++||+|+||.||++++.   .+|+.||||++......  ......+.+|+.+|+.++||||+++++++...+.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999874   47899999999764331  23335578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCcc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~  171 (575)
                      ++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++... ......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCccc
Confidence            9999999999988899999999999999999999999999999999999999   777899999999987543 233345


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.... ..++   ..++.++.+||++|
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~  234 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLP---PYLTPEARDLLKKL  234 (323)
T ss_pred             ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC---CCCCHHHHHHHHHH
Confidence            5789999999999998899999999999999999999999999988888777776553 3333   35789999999999


Q ss_pred             hccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhc
Q 043425          252 LRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       252 L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~  283 (575)
                      |.+||.+||     +++++++||||....+..+....
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~  271 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARK  271 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCC
Confidence            999999999     89999999999988777665433

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.1e-46  Score=384.93  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=214.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----GKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~l~   87 (575)
                      +|++.++||+|+||.||+|++..+|..||||.+............+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            59999999999999999999999999999999875433333445688999999999999999999987543     3589


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||| +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence            999999 56999999888889999999999999999999999999999999999999   77889999999999754322


Q ss_pred             C----CcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc------------
Q 043425          168 G----LAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------------  229 (575)
Q Consensus       168 ~----~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~------------  229 (575)
                      .    .....+||+.|+|||++..  ..++.++|||||||++|+|++|++||.+.+....+..+....            
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    2245689999999999876  678999999999999999999999998876544333222110            


Q ss_pred             ---------------cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          230 ---------------ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       230 ---------------~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                     ...+....+..++++.+||.+||+.||.+|||++|+++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                           0111111234678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-45  Score=382.42  Aligned_cols=257  Identities=28%  Similarity=0.524  Sum_probs=225.8

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|++..+|+.||||++.+... .....+.+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999976533 223345577889998866 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888899999999999999999999999999999999999999   777899999999987543 233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..+|   ..++.++.+||++||.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p---~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYP---VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC---CCCCHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999999999999999888888777653 2233   24789999999999999


Q ss_pred             CCCCCC-------CHHHHHcCCCCCCCCchhhhh
Q 043425          255 NPVERL-------TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~Rp-------Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||       +++++++||||....|+....
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~  267 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ  267 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence            999999       899999999999888776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=430.41  Aligned_cols=267  Identities=29%  Similarity=0.524  Sum_probs=240.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|+|+++||+|+||.|.+++++.|++.||+|++.+-.. +...-.-|..|..||..-+.+.|++++..|+++.++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            45789999999999999999999999999999999986432 23334568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||++||||-.++.+.++++|..++.|+..|+.||+-||+.|+|||||||+|||+   |..|+|||+|||.+-.+...+
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence            99999999999999999999999999999999999999999999999999999999   999999999999998887655


Q ss_pred             C--cccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcc
Q 043425          169 L--AETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKIL  240 (575)
Q Consensus       169 ~--~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~l  240 (575)
                      .  ....+|||.|++||+++.     +.|+..+|||||||++|||+.|..||+..+-.+.+.+|+... .+.|| +...+
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~V  308 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDV  308 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-ccccc
Confidence            4  456789999999999963     468899999999999999999999999999999999998764 45566 44569


Q ss_pred             cHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCCchhhhh
Q 043425          241 SADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~~~~~~~  281 (575)
                      |.++++||+++++ +|..|++   ++++.+||||..++|+.+..
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~  351 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE  351 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence            9999999999997 7788998   99999999999999966543

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-45  Score=379.79  Aligned_cols=266  Identities=27%  Similarity=0.542  Sum_probs=226.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|++++.||+|+||.||++++..+++.||||++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            479999999999999999999999999999999975332 2233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCC
Confidence            99999999999976 4579999999999999999999999999999999999999   6778899999999876544332


Q ss_pred             --cccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhccc
Q 043425          170 --AETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILS  241 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls  241 (575)
                        ....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+..+....+.... ...++.....++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence              223579999999999973     457889999999999999999999999988877777666532 234444445689


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCchhhh
Q 043425          242 ADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++++||++||+.++.+  |++++++++||||....+....
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~  278 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIR  278 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHh
Confidence            99999999999765544  7899999999999988776544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-45  Score=383.69  Aligned_cols=261  Identities=29%  Similarity=0.548  Sum_probs=219.2

Q ss_pred             CEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      +|+++++||+|+||.||++++.   .+|..||+|++.+....  ....+.+..|+.+++.+. ||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   47899999999764322  233456788999999995 89999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6778899999999976533


Q ss_pred             CC--CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCC----HHHHHHHHHHhccCCCCCChhc
Q 043425          167 RG--LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       167 ~~--~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~----~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      ..  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||....    .......+... ...++   ..
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~---~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DPPFP---SF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-CCCCC---CC
Confidence            22  23457899999999999865 47889999999999999999999997532    22333333322 22222   35


Q ss_pred             ccHHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhh
Q 043425          240 LSADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~  280 (575)
                      ++.++++||.+||..||.+||     +++++++||||....+....
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  279 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA  279 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            789999999999999999999     88999999999987665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.4e-45  Score=373.33  Aligned_cols=256  Identities=32%  Similarity=0.534  Sum_probs=214.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC-CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----e
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIRLHDIIE-----V   82 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~-----~   82 (575)
                      .+|++.+.||+|+||.||+|++.. +|..||+|.+............+.+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            379999999999999999999864 578899999876544333334566777777765   6999999999885     2


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence            456899999996 6899998754  358999999999999999999999999999999999999   6678899999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC----
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD----  236 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~----  236 (575)
                      +.............||+.|+|||++....++.++|||||||++|+|++|.+||.+.+..+.+..+........+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            9876655555667899999999999988999999999999999999999999999988887777765432211111    


Q ss_pred             -------------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          237 -------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       237 -------------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                         .+.++..+++|+.+||+.||++|||+.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               02367788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=373.73  Aligned_cols=266  Identities=27%  Similarity=0.482  Sum_probs=226.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|++.++||+|+||.||++.+..+++.||||++....... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4899999999999999999999999999999997654332 223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCc
Confidence            99999999888653  468999999999999999999999999999999999999   7778999999999987654444


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+|++.|+|||++....++.++||||+||++|+|++|..||.+.........+..............++..+.+||.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR  237 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence            45668999999999999889999999999999999999999999987654443333222111111222357889999999


Q ss_pred             HhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhh
Q 043425          250 KLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       250 k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||..||.+||     +++++++||||....++....
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  274 (285)
T cd05605         238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA  274 (285)
T ss_pred             HHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence            99999999999     899999999999988876654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-45  Score=381.22  Aligned_cols=260  Identities=31%  Similarity=0.600  Sum_probs=225.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFIL---KRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL---~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+.++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            7899999999999999999999999999999976532 223345577777665   456799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~  168 (575)
                      |||++|++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCC
Confidence            999999999988864 579999999999999999999999999999999999999   7778999999999875332 23


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..+|   ..++.++.+||
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p---~~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYP---RFLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC---CCCCHHHHHHH
Confidence            3456789999999999999999999999999999999999999999998888877776653 2333   25789999999


Q ss_pred             HHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhh
Q 043425          249 QKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       249 ~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      ++||..||.+||     +++++++||||....+.....
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~  270 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLA  270 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHh
Confidence            999999999999     799999999999887766543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-45  Score=377.75  Aligned_cols=261  Identities=31%  Similarity=0.556  Sum_probs=213.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.++||+|+||.||+|.++.+|+.||||++...... .....+.+|+.+++.++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999998754322 22345678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CC
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~  168 (575)
                      ||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..... ..
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc
Confidence            9995 6787777654 578999999999999999999999999999999999999   6778899999999875432 22


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhccCC----C---------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELH----F---------  233 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i~~~~~~~----~---------  233 (575)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+.......    +         
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            3345678999999999865 45888999999999999999999999875432 3333332211000    0         


Q ss_pred             ---------CCCh------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          234 ---------PPDA------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       234 ---------p~~~------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                               +...      ..++.++.+|+.+||++||.+|||++|+++||||....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                     0000      124568899999999999999999999999999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.3e-45  Score=379.37  Aligned_cols=256  Identities=31%  Similarity=0.555  Sum_probs=221.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKR-INHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|+++.+|..||+|++...... ......+..|..++.. ++||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999864321 2233456778888875 4899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+++.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ........+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   677889999999987532 223345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..+.+... ...++   ..++.++++||++||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYP---RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCC---CCCCHHHHHHHHHHccC
Confidence            999999999999999999999999999999999999999998887777766543 22233   35789999999999999


Q ss_pred             CCCCCCCH-HHHHcCCCCCCCCchhhh
Q 043425          255 NPVERLTF-EEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       255 DP~~RpTa-~eiL~Hpff~~~~~~~~~  280 (575)
                      ||.+||++ +++++||||....+....
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~~~~~~~  260 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTINWTALE  260 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCCCHHHHH
Confidence            99999997 689999999988766544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.5e-45  Score=379.44  Aligned_cols=259  Identities=30%  Similarity=0.595  Sum_probs=218.5

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|++..+++.||+|++.+.... ......+..|+.++.++ +||||+++++++...+.+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999875432 23345677899988776 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888899999999999999999999999999999999999999   777899999999987532 233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS--------NQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~--------~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...        .....+..........+|.   .++.++.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~  234 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAAS  234 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC---CCCHHHHH
Confidence            999999999999999999999999999999999999999521        1122222222233334443   57889999


Q ss_pred             HHHHhhccCCCCCCC------HHHHHcCCCCCCCCchhhhhh
Q 043425          247 LCQKLLRRNPVERLT------FEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       247 LI~k~L~~DP~~RpT------a~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ||++||++||.+||+      ++++++||||....|+.....
T Consensus       235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~  276 (329)
T cd05618         235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQK  276 (329)
T ss_pred             HHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcC
Confidence            999999999999998      589999999998877655443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-48  Score=401.49  Aligned_cols=257  Identities=29%  Similarity=0.489  Sum_probs=232.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ..|...+.||+|+||.||+|.+..+++.||+|+++.+...+. .+.+.+|+.+|.+++++||.++|+.|..+..+|++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            348888999999999999999999999999999998765443 5678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      ||.||++.++++....+.|..+..++++++.||.|||..+.+|||||+.|||+   ...|.+||+|||.+..+.... ..
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechhhcc
Confidence            99999999999988888999999999999999999999999999999999999   444889999999998775543 34


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      .+++|||.||||||++..+|+.++||||||++.|||++|.+||....++..+..|-+..++.+.   ..+++.+++||..
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVEA  245 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHHH
Confidence            7899999999999999899999999999999999999999999999987776666655433333   3689999999999


Q ss_pred             hhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          251 LLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ||++||+.||+|.++|+|+|++...
T Consensus       246 CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HhhcCcccCcCHHHHhhhHHHHhcC
Confidence            9999999999999999999998854

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.6e-45  Score=385.97  Aligned_cols=264  Identities=30%  Similarity=0.508  Sum_probs=225.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++..++.+|
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            345789999999999999999999999999999999975432 2233455788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+...
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence            999999999999998754 58999999999999999999999999999999999999   67789999999999876543


Q ss_pred             C--CcccccCCCCCCChHHHhhcc----CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-CCCCCChhcc
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQK----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL  240 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~----y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-~~~p~~~~~l  240 (575)
                      .  .....+||+.|+|||++....    ++.++|||||||++|+|++|.+||.+.+.......+..... ..++. ...+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~  274 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDI  274 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC-cCCC
Confidence            3  234678999999999997543    78899999999999999999999999988888887776532 23332 3468


Q ss_pred             cHHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCch
Q 043425          241 SADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~  277 (575)
                      +.++++||.+||..++.+  |++++++++|+||....+.
T Consensus       275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~  313 (371)
T cd05622         275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  313 (371)
T ss_pred             CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence            999999999999844443  7899999999999886543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.7e-45  Score=379.24  Aligned_cols=257  Identities=33%  Similarity=0.613  Sum_probs=221.5

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIF-ILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|++..+++.||+|++.+..... .....+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997643221 22234445544 56889999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCccccc
Confidence            9999999988889999999999999999999999999999999999999   677889999999987542 233445678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+... ...++   ..++.++.++|++||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~---~~~~~~~~~li~~~l~~  233 (325)
T cd05602         158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLK---PNITNSARHLLEGLLQK  233 (325)
T ss_pred             CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCC---CCCCHHHHHHHHHHccc
Confidence            999999999999999999999999999999999999999998888887777654 22223   35789999999999999


Q ss_pred             CCCCCCCHH----HHHcCCCCCCCCchhhhh
Q 043425          255 NPVERLTFE----EFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~RpTa~----eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+|+++.    ++++|+||....|+.+..
T Consensus       234 ~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~  264 (325)
T cd05602         234 DRTKRLGAKDDFMEIKNHIFFSPINWDDLIN  264 (325)
T ss_pred             CHHHCCCCCCCHHHHhcCcccCCCCHHHHHh
Confidence            999999765    899999999988877654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=382.84  Aligned_cols=256  Identities=30%  Similarity=0.576  Sum_probs=219.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRI---NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ||+|+||.||+|++..+|+.||||++.+..... ........|..++..+   +||||+++++++...+.+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997643322 2233455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999988899999999999999999999999999999999999999   677889999999987542 233445678


Q ss_pred             CCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          175 GSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       175 GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... ...++.  ..++.++++||++||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFPK--NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcC
Confidence            99999999998754 5899999999999999999999999998888877776544 233333  2478999999999999


Q ss_pred             cCCCCCC----CHHHHHcCCCCCCCCchhhhh
Q 043425          254 RNPVERL----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       254 ~DP~~Rp----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||.+||    +++++++||||....++....
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~  266 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADIDWDLLSK  266 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCCCHHHHHh
Confidence            9999998    799999999999887766544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.7e-45  Score=379.52  Aligned_cols=258  Identities=26%  Similarity=0.505  Sum_probs=221.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|+++++||+|+||.||++++..+|..+|+|++.... .......+.+|+.+|+.++||||+++++++...+.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            468999999999999999999999999999999987642 4455677999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+   +.++.+||+|||++...... .
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc-c
Confidence            9999999999999888899999999999999999999986 69999999999999   66788999999998765432 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHH----------------------
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----------------------  227 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~----------------------  227 (575)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+..                      
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            3456799999999999988999999999999999999999999987665443322110                      


Q ss_pred             ------------------------hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          228 ------------------------ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       228 ------------------------~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                              ......+  ...++.++++||.+||.+||++|||++|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                    0000111  124678999999999999999999999999999997653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=381.67  Aligned_cols=261  Identities=33%  Similarity=0.529  Sum_probs=224.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-----PG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-----~~   84 (575)
                      +-..|..++.||+|+||.|+.+.++.+|+.||||.+...-.+.-...+..+|+.+|+.++|+||+.+++++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445666899999999999999999999999999987443344556778999999999999999999999854     35


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+|+|+|++ +.+|...++.+..+++..++.++.||+.||+|+|+.||+||||||.|+|+   +.+..+||+|||+|+..
T Consensus       100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence            699999999 78999999988789999999999999999999999999999999999999   56667999999999987


Q ss_pred             CC---CCCcccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------
Q 043425          165 QP---RGLAETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------  232 (575)
Q Consensus       165 ~~---~~~~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------  232 (575)
                      ..   ....+.++.|.+|+|||++. ...|+..+||||+||||.||++|++.|.|.+....++.|+......        
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            53   45556788999999999874 5789999999999999999999999999998887777766422111        


Q ss_pred             -------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 -------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 -------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                         |....+..++++.+|+.+||..||.+|+|++|+|+|||+...
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                               111124567899999999999999999999999999999765

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.2e-45  Score=379.39  Aligned_cols=257  Identities=33%  Similarity=0.612  Sum_probs=221.4

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKR-INHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|.+..+++.||||++..... .....+.+..|..++.. .+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999986532 22233445667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~~~~~~~  174 (575)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888899999999999999999999999999999999999999   6778899999999976432 33445678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+... ...++   ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~---~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFP---RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCC---CCCCHHHHHHHHHHccC
Confidence            999999999999999999999999999999999999999999888877766543 22233   35789999999999999


Q ss_pred             CCCCCCCH-HHHHcCCCCCCCCchhhhh
Q 043425          255 NPVERLTF-EEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~RpTa-~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||++ +++++||||....++....
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGIDWERLEK  261 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCCCHHHHHh
Confidence            99999986 5899999999887766544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-44  Score=376.72  Aligned_cols=266  Identities=27%  Similarity=0.514  Sum_probs=227.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.++||+|+||.||+++++.+++.||+|++.+... .......+.+|+.++..++|+||+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            479999999999999999999999999999999975332 2233345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCc
Confidence            99999999999987 4679999999999999999999999999999999999999   6778899999999876543322


Q ss_pred             --cccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhccc
Q 043425          170 --AETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILS  241 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls  241 (575)
                        ....+||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+.+..+.... ...+|.....++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence              23468999999999986     3468889999999999999999999999998888887776543 233455445689


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCchhhh
Q 043425          242 ADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++++||++||+.++.+  |++++|+++||||..+.++.+.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~  278 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR  278 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence            99999999999765554  6899999999999998877654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.5e-45  Score=377.13  Aligned_cols=257  Identities=33%  Similarity=0.621  Sum_probs=224.2

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|.++.++..||||++.+.... ......+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999865432 23345577899999887 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999988899999999999999999999999999999999999999   677889999999987532 223344578


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+... ...++   ..++.++.+||++||.+
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~---~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYP---RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCC---CcCCHHHHHHHHHHccC
Confidence            999999999999999999999999999999999999999998887777766554 23333   25789999999999999


Q ss_pred             CCCCCCCH-----HHHHcCCCCCCCCchhhhh
Q 043425          255 NPVERLTF-----EEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~RpTa-----~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||++     .++++||||....++....
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~  265 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREIDWDKLER  265 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999     9999999999987765443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-44  Score=377.77  Aligned_cols=259  Identities=29%  Similarity=0.583  Sum_probs=220.6

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999875432 23445678999999888 599999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888899999999999999999999999999999999999999   67788999999998753 2333445678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC------CHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS------NQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~------~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||...      ...+.+..........+|.   .++..+.++|
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~li  234 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR---FLSVKASHVL  234 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC---CCCHHHHHHH
Confidence            999999999999999999999999999999999999999642      2223333333333333443   4789999999


Q ss_pred             HHhhccCCCCCCC------HHHHHcCCCCCCCCchhhhhh
Q 043425          249 QKLLRRNPVERLT------FEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       249 ~k~L~~DP~~RpT------a~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ++||++||.+|++      ++++++||||..+.++.....
T Consensus       235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~  274 (327)
T cd05617         235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK  274 (327)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence            9999999999997      579999999999988765543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.3e-45  Score=379.19  Aligned_cols=265  Identities=26%  Similarity=0.501  Sum_probs=227.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.++||+|+||.||+++++.+++.||+|++.+... .......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            479999999999999999999999999999999975322 2233455788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCCc
Confidence            99999999999987 4679999999999999999999999999999999999999   6778899999999976654332


Q ss_pred             --cccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhccc
Q 043425          170 --AETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILS  241 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls  241 (575)
                        ....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||...+..+.+..+.... ...++.....++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~  237 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS  237 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence              234679999999999875     568889999999999999999999999988877777766542 234455445678


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCchhh
Q 043425          242 ADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      .++++||.+||+.++.+  |++++++++||||....|+..
T Consensus       238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            99999999999976654  569999999999998877765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=386.67  Aligned_cols=247  Identities=29%  Similarity=0.535  Sum_probs=218.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcE-EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-KLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~-vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l~LVm   90 (575)
                      +..+.+.||+|+||+||+|..+  |+. ||||++............+.+|+.+|.+++|||||++++++..+. .++|||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            3456677999999999999988  777 999999887766666788999999999999999999999998776 799999


Q ss_pred             eecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCC-cccccccCCceeeecCCCCC-cEEEcccccccccCC
Q 043425           91 EYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNN-LIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSLQP  166 (575)
Q Consensus        91 Ey~~GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~g-IvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~~~~  166 (575)
                      ||+++|+|..++..  +..++...+..++.||+.||+|||+++ ||||||||+|||+   +... ++||+|||+++....
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeecc
Confidence            99999999999987  578999999999999999999999999 9999999999999   7776 999999999987765


Q ss_pred             C-CCcccccCCCCCCChHHHh--hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHH-hccCCCCCChhcccH
Q 043425          167 R-GLAETLCGSPLYMAPEIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSA  242 (575)
Q Consensus       167 ~-~~~~~~~GT~~Y~APEvl~--~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~-~~~~~~p~~~~~ls~  242 (575)
                      . .......||+.|||||++.  ...|+.++||||||++||||+||+.||.+....+....+.. ...+.+|.   ..++
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~---~~~~  273 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK---ECPP  273 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc---cCCH
Confidence            4 3334478999999999999  66999999999999999999999999999998776666653 33333343   3889


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+..|+.+||..||.+||++.+++.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999976

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=375.30  Aligned_cols=270  Identities=28%  Similarity=0.480  Sum_probs=235.8

Q ss_pred             eecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 043425           10 VVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        10 ~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~   87 (575)
                      +.+-|++. +.||+|+|+.|--+.+..+|.+||||+|++.  ....+.++.+|++++.++. |+||++++++|+++.+.|
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            33446554 6799999999999999999999999999886  4456678999999999985 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +|||.+.||.|...|+++..|+|.++..++++|+.||++||++||.||||||+|||....+.-..||||||.++......
T Consensus       153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999987777788999999998654322


Q ss_pred             C--------CcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCC---------------HH
Q 043425          168 G--------LAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSN---------------QI  219 (575)
Q Consensus       168 ~--------~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---------------~~  219 (575)
                      .        ...+.||+..|||||+..     ...|+.++|+||||||||.|+.|++||.|..               +.
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence            2        234679999999999863     4579999999999999999999999997652               56


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      .+++.|..+.......++..++.+++|||..+|..|+..|.++.++++|||++....+..+.
T Consensus       313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence            67777777754444456688999999999999999999999999999999999887775554

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-46  Score=393.82  Aligned_cols=257  Identities=33%  Similarity=0.633  Sum_probs=239.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK-LHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~-l~LV   89 (575)
                      ++.|.+++++|+|+||.+++++++..+..|++|.|.........++...+|+.+++++.|||||.+++.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            578999999999999999999999999999999999998888888899999999999999999999999988877 9999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |+||+||+|.+.|.+.  ..|+|+.+..++.|++.||+|||+++|+|||||+.||++   ...+.|||+|||+|+.+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCc
Confidence            9999999999999755  369999999999999999999999999999999999999   56667899999999999877


Q ss_pred             C-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 G-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 ~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      . ...+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|.+.+...++.+|.+......|   ..++.+++.
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~~  236 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELRS  236 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHHH
Confidence            6 888999999999999999999999999999999999999999999999999999999988644444   458999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +|+.||.++|..||++.++|.+|.+..
T Consensus       237 lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  237 LVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            999999999999999999999988754

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-44  Score=377.03  Aligned_cols=257  Identities=31%  Similarity=0.580  Sum_probs=221.2

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIF-ILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|++..+|+.||+|++.+... .......+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999976432 2233345556655 46789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CCCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~~~~~~~~  174 (575)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFC  157 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCccccc
Confidence            9999999888899999999999999999999999999999999999999   777899999999987532 233345678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.... ..+++   ..+.++.++|++||.+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~ll~~ll~~  233 (325)
T cd05604         158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRP---GASLTAWSILEELLEK  233 (325)
T ss_pred             CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCC---CCCHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999999999999988888877776543 22232   4788999999999999


Q ss_pred             CCCCCCCH----HHHHcCCCCCCCCchhhhh
Q 043425          255 NPVERLTF----EEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~RpTa----~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||++    .++++||||....+.....
T Consensus       234 ~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~  264 (325)
T cd05604         234 DRQRRLGAKEDFLEIQEHPFFESLSWTDLEQ  264 (325)
T ss_pred             CHHhcCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999976    6999999999887765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-44  Score=375.59  Aligned_cols=262  Identities=30%  Similarity=0.545  Sum_probs=228.1

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +|.+.+.||+|+||.||+|.++.+|+.||||++.+.... ....+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478899999999999999999999999999999865332 233455778899998886 477888999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      ||++||+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence            999999999999988899999999999999999999999999999999999999   67788999999998754322 23


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.... ..+|.   .++.++.+|+.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~---~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPK---SLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCc---cCCHHHHHHHH
Confidence            445789999999999999999999999999999999999999999998888887776643 33333   47889999999


Q ss_pred             HhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhh
Q 043425          250 KLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       250 k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||.+||.+|++     .+++++||||....+..+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  270 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN  270 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence            999999999997     57999999999988776554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-44  Score=367.26  Aligned_cols=255  Identities=31%  Similarity=0.545  Sum_probs=212.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CC
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIRLHDIIEV-----PG   84 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~~-----~~   84 (575)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+............+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58999999999999999999999999999999876433332233456777777655   79999999998854     34


Q ss_pred             EEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+++||||+.+ +|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCccc
Confidence            68999999974 898888764  348999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----CC----
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----FP----  234 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----~p----  234 (575)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|.+||.+......+..+.......    ++    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            7655544556778999999999998899999999999999999999999999887776666655421110    00    


Q ss_pred             ---------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          235 ---------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       235 ---------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                     ...+.++.++.+||.+||++||.+|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           0012467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-44  Score=375.11  Aligned_cols=257  Identities=31%  Similarity=0.543  Sum_probs=221.5

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKR-INHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|.+..+++.||||++...... .........|..++.. ++||||+++++++...+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999865321 2233456678888876 5899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CCCccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~~~~~~~  174 (575)
                      |+|..++.....+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999888889999999999999999999999999999999999999   6778899999999875322 22344678


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.... ..++   ..++.++++||.+||++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~---~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYP---RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCC---ccCCHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999999999999988887777665432 2333   25789999999999999


Q ss_pred             CCCCCCCHH-HHHcCCCCCCCCchhhhh
Q 043425          255 NPVERLTFE-EFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       255 DP~~RpTa~-eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||++. ++++||||....+.....
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~~~~~~~  261 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREIDWSALEE  261 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCCHHHHHh
Confidence            999999996 999999999987765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-44  Score=368.34  Aligned_cols=257  Identities=28%  Similarity=0.485  Sum_probs=213.4

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||+|+||+||++.++.+|+.||+|.+....... ...+.+..|+.+++.++||||+++++++...+.+++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999999999999999997654332 2235677899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccccc
Q 043425           99 SMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETL  173 (575)
Q Consensus        99 ~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~~~  173 (575)
                      ..++..    +..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+.... .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcccccc
Confidence            988743    3468999999999999999999999999999999999999   677889999999997654432 23456


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||...........+..............++.++.+|+.+||+
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            89999999999999999999999999999999999999998754322221222111111111123578999999999999


Q ss_pred             cCCCCCC-----CHHHHHcCCCCCCCCchhh
Q 043425          254 RNPVERL-----TFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       254 ~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~  279 (575)
                      .||.+||     +++++++||||+...+..+
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            9999999     8899999999998776654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.8e-45  Score=361.05  Aligned_cols=255  Identities=35%  Similarity=0.667  Sum_probs=219.1

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |++++.||+|+||.||++++..+++.||+|++..............+|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999987655555555667999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCCCCccc
Q 043425           94 KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAET  172 (575)
Q Consensus        94 ~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~~~~~~  172 (575)
                      .+++|.+++.+.+.+++..+..++.||+.||.+||++||+|+||||+|||+   +.++.++|+|||++... ........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            999999999988899999999999999999999999999999999999999   77889999999999763 33344556


Q ss_pred             ccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC---CCChhcccHHHHHHH
Q 043425          173 LCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF---PPDAKILSADCKDLC  248 (575)
Q Consensus       173 ~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~---p~~~~~ls~el~dLI  248 (575)
                      .++++.|+|||++. ...++.++||||||+++|+|++|..||...........+.+......   .......+.++.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            78999999999998 88899999999999999999999999998843333332222211111   111112248999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .+||+.||++||++.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-44  Score=381.82  Aligned_cols=259  Identities=29%  Similarity=0.507  Sum_probs=216.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----   84 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----   84 (575)
                      .++++|++.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4678999999999999999999999999999999999765444455567889999999999999999999986443    


Q ss_pred             --EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 --KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 --~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                        .+|+||||+.+ +|...+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~  171 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  171 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence              57999999965 6766664  358899999999999999999999999999999999999   677899999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc------------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE------------  230 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~------------  230 (575)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.+...            
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            76555555567899999999999999999999999999999999999999998776554433322110            


Q ss_pred             ---------CCCC--------------C---ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          231 ---------LHFP--------------P---DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       231 ---------~~~p--------------~---~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                               ..++              .   .....+.++++||.+||..||.+|||++|+++||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                     0000              0   01124678999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=371.96  Aligned_cols=258  Identities=35%  Similarity=0.590  Sum_probs=227.4

Q ss_pred             eeecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----
Q 043425            9 RVVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV----   82 (575)
Q Consensus         9 ~~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~----   82 (575)
                      .+.++|.+. .+||-|-.|.|..+.++.||+.+|+|++..       ....++|+++.-.. .|||||.++++|++    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            377888876 569999999999999999999999998753       23467888876544 69999999999854    


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ...+.||||.++||+|+..|+.++.  |+|.++..|++||..|+.|||+.+|.||||||+|+|..+...+..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            4578999999999999999998764  99999999999999999999999999999999999999888899999999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCCCC-
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPP-  235 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~p~-  235 (575)
                      |+.........+.|-||.|+|||++..+.|+..+|+||+||++|.|++|.+||+...-    ..+..+|..+ .+.||. 
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g-qy~FP~p  289 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG-QYEFPEP  289 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc-CccCCCh
Confidence            9988888888999999999999999999999999999999999999999999986532    2344455555 555554 


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+...|..++|+|+++|..+|.+|+|++++++|||+++.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            557899999999999999999999999999999999874

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.7e-45  Score=396.30  Aligned_cols=258  Identities=31%  Similarity=0.468  Sum_probs=221.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-H-----PHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-H-----pnIv~l~~~~~~~   83 (575)
                      +..+|.|.+.||+|+||.|.+|.+..|++.||||+++..   .....+...|+.||..|+ |     -|||+++++|...
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            444799999999999999999999999999999999763   455567789999999997 4     4899999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      +++|||+|.+ +.+|.++|+.++  .|+...++.+++||+.||.+||+.||||+|||||||||..- ....|||+|||.+
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSS  338 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccc
Confidence            9999999999 679999998774  58899999999999999999999999999999999999653 3458999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      ......  ..+++.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.|.+..+++..|++....+         
T Consensus       339 c~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  339 CFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            765433  338899999999999999999999999999999999999999999999999998887421110         


Q ss_pred             -----CCC-------------------------------------Chh--------cccHHHHHHHHHhhccCCCCCCCH
Q 043425          233 -----FPP-------------------------------------DAK--------ILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       233 -----~p~-------------------------------------~~~--------~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                           +..                                     ...        .-...+.|||++||.+||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                 000                                     000        112357899999999999999999


Q ss_pred             HHHHcCCCCCCC
Q 043425          263 EEFFNHPFLSQT  274 (575)
Q Consensus       263 ~eiL~Hpff~~~  274 (575)
                      .|+|+||||...
T Consensus       497 ~qal~Hpfl~~~  508 (586)
T KOG0667|consen  497 AQALNHPFLTGT  508 (586)
T ss_pred             HHHhcCcccccc
Confidence            999999999864

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-44  Score=379.69  Aligned_cols=259  Identities=26%  Similarity=0.481  Sum_probs=219.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            467899999999999999999999999999999999976544445556788999999999999999999987543     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+++ +|..++..  .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~  174 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  174 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCcc
Confidence             358999999965 77777754  48899999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-------  235 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-------  235 (575)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+........+.       
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            7665555566789999999999999999999999999999999999999999988777666655422111100       


Q ss_pred             -------------------------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          236 -------------------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       236 -------------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                                     .....+.++++||.+||+.||.+|||++|+|+||||..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                                           00113467899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-45  Score=392.76  Aligned_cols=265  Identities=37%  Similarity=0.675  Sum_probs=245.7

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ...+.++.|.+.+.||+|.|+.|.+|++..+|..||||+|++..++....+.+.+|+.+|+.|+|||||+++.+.++...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            34678999999999999999999999999999999999999999988888889999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||+.||++++++.+++...+..++.++.|++.|++|||+++|||||||++|||+   +.+..+||+|||++..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999   777889999999999999


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ......++||++.|.|||++.+..|+ +.+|+||+|++||-|+.|.+||.|.+...+-...+.+. +..|   ..++.+|
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp---~~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIP---FYMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-eccc---ceeechh
Confidence            99999999999999999999998885 67999999999999999999999998777766665542 2223   3588999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      .+||+++|..+|.+|++.++++.|.|++....+
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999999876544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.6e-44  Score=364.79  Aligned_cols=262  Identities=29%  Similarity=0.530  Sum_probs=221.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|++.+.||+|+||.||++.+..+++.||||.+....... .....+.+|+.++++++|+||+.+++.+...+.+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4788999999999999999999999999999987654332 233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   +..+.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCcc
Confidence            99999999988644  358999999999999999999999999999999999999   6778899999999976654444


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      ....+|++.|+|||++.+..++.++||||||+++|+|++|..||......   .....+.......++   ..++.++++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS---EKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC---ccCCHHHHH
Confidence            45568999999999999999999999999999999999999999875432   222222222121222   357889999


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhh
Q 043425          247 LCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       247 LI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~  280 (575)
                      |+++||+.||.+|||     ++|+++||||.+..+..+.
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~  273 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLE  273 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHh
Confidence            999999999999999     9999999999887766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.1e-44  Score=377.79  Aligned_cols=260  Identities=28%  Similarity=0.479  Sum_probs=218.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            468899999999999999999999999999999999976554555556788999999999999999999988543     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+++ +|...+..  .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~  167 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  167 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccc
Confidence             357999999965 67777654  48899999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC---------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF---------  233 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~---------  233 (575)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+......         
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            76655555667899999999999999999999999999999999999999998876555444332211000         


Q ss_pred             -----------------C---------C---ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 -----------------P---------P---DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 -----------------p---------~---~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                       +         .   .....+.++++||.+||..||.+|||++|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                             0         0   011235678999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=370.02  Aligned_cols=261  Identities=34%  Similarity=0.585  Sum_probs=224.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC-----
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPG-----   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~-----   84 (575)
                      ...|..+++||+|+||+||+|+++.+|+.||+|++......+.......+|+.+|+.|+|+| |+++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45577788899999999999999999999999999876543334456789999999999999 999999998777     


Q ss_pred             -EEEEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           85 -KLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        85 -~l~LVmEy~~GgsL~~~l~~~~----~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                       .+++|+||+ ..+|..++....    .++...++.+++||+.||+|||++||+||||||+|||+   +..|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccc
Confidence             899999999 569999998755    47788999999999999999999999999999999999   678999999999


Q ss_pred             cccccC-CCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC----
Q 043425          160 FARSLQ-PRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF----  233 (575)
Q Consensus       160 la~~~~-~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~----  233 (575)
                      +|+.+. +......-++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.|....+.+..|.+....+-    
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999776 44446677899999999998876 799999999999999999999999999999999988886432211    


Q ss_pred             -------------CCCh---------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          234 -------------PPDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       234 -------------p~~~---------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                   +...         +....+..+++.+||+.+|.+|.|++.+|.||||....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                         1110         11234789999999999999999999999999998763

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.6e-44  Score=373.32  Aligned_cols=258  Identities=26%  Similarity=0.527  Sum_probs=219.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.++||+|+||.||++.+..+|..+|+|.+.... .......+.+|+.+++.++||||++++++|...+.+++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            468999999999999999999999999999999987642 3445567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||++||+|.+++.+.+.+++..+..++.||+.||.|||+. +|+||||||+|||+   +..+.+||+|||++..+... .
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh-c
Confidence            9999999999999888899999999999999999999985 79999999999999   66788999999998765332 2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI------------------------  225 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i------------------------  225 (575)
                      ....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||......+....+                        
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            34567999999999999888999999999999999999999999876544332211                        


Q ss_pred             --------------------HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          226 --------------------VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       226 --------------------~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                          .......++.  ..++.++++||.+||++||.+|||++|++.||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                1110001111  13578899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.1e-44  Score=389.88  Aligned_cols=256  Identities=30%  Similarity=0.492  Sum_probs=211.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-------
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-------   83 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-------   83 (575)
                      .++|.++++||+|+||.||+|.+..+++.||||.+....      ....+|+.+|+.++||||+++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            356999999999999999999999999999999886432      1234799999999999999999887432       


Q ss_pred             -CEEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~----~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                       ..+++||||+++ +|.+++.    ....+++..++.++.||+.||+|||++||+||||||+|||+.  ...+.+||+||
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DF  215 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDF  215 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeecc
Confidence             257899999975 6766654    346799999999999999999999999999999999999992  23457999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-------  230 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-------  230 (575)
                      |+++.+.........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+...       
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99987765555556789999999999865 4689999999999999999999999999887776666554211       


Q ss_pred             ---------CCCCCC---------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          231 ---------LHFPPD---------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       231 ---------~~~p~~---------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                               ..++..         ....+.++++||.+||.+||.+|||+.|+++||||....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                     111110         013578999999999999999999999999999997653

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-44  Score=383.26  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=211.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |...++|.++++||+|+||.||+|.+..+++.||+|....        ..+.+|+.+|++++||||++++++|......+
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            3445689999999999999999999999999999996532        34678999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +|||++. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++......
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccc
Confidence            9999994 7899999888889999999999999999999999999999999999999   67788999999999754321


Q ss_pred             --CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhccC---CC--
Q 043425          168 --GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN-------QIQLLQNIVKATEL---HF--  233 (575)
Q Consensus       168 --~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~-------~~~~l~~i~~~~~~---~~--  233 (575)
                        ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....       ....+..+.+....   .+  
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence              23345689999999999999999999999999999999999998875432       11222222211100   00  


Q ss_pred             --------------------C---CC---hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 --------------------P---PD---AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 --------------------p---~~---~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                          +   +.   ...++.++.+||.+||++||.+|||++|+|+||||+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                                0   00   01346789999999999999999999999999999764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.9e-44  Score=378.44  Aligned_cols=259  Identities=26%  Similarity=0.480  Sum_probs=213.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ....++|+++++||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            345678999999999999999999999999999999986543 3445567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||+.+|+|...    ...++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+...
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccc
Confidence            99999999998653    346788889999999999999999999999999999999   67789999999999876433


Q ss_pred             C-CcccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          168 G-LAETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       168 ~-~~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      . .....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||......+....+........+.....++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 2345689999999998743     223568999999999999999999998543332222111111111222234578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .++++||.+||..||.+|||+.|+++||||...
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            999999999999999999999999999999875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.7e-43  Score=359.47  Aligned_cols=265  Identities=28%  Similarity=0.484  Sum_probs=224.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||+.+++.+..++.+++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4788899999999999999999999999999997654432 233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   +..+.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCCc
Confidence            99999999888653  369999999999999999999999999999999999999   6678899999999976554444


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..............++.++.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            45568999999999999889999999999999999999999999987665544443332211111122357889999999


Q ss_pred             HhhccCCCCCCC-----HHHHHcCCCCCCCCchhhh
Q 043425          250 KLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       250 k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~  280 (575)
                      +||..||.+||+     ++++++|+||....++...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  273 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLE  273 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHh
Confidence            999999999999     8999999999988766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-43  Score=360.53  Aligned_cols=255  Identities=27%  Similarity=0.495  Sum_probs=213.7

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||+|+||.||++.++.+|+.||+|.+........ ....+..|+.++++++||||++++++++....+++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999976544322 233456799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCC
Q 043425           99 SMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS  176 (575)
Q Consensus        99 ~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT  176 (575)
                      .+++...+  .+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.++|+|||++.............|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCC
Confidence            98886543  58899999999999999999999999999999999999   67788999999999876554444556799


Q ss_pred             CCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH----HHHHHHHHhccCCCCCChhcccHHHHHHHHHhh
Q 043425          177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI----QLLQNIVKATELHFPPDAKILSADCKDLCQKLL  252 (575)
Q Consensus       177 ~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~----~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L  252 (575)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||......    +........   ..+.....++.++++||.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---EVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc---ccccccccCCHHHHHHHHHHh
Confidence            9999999999888999999999999999999999999865332    222222221   112222357899999999999


Q ss_pred             ccCCCCCCCH----HHHHcCCCCCCCCchhhh
Q 043425          253 RRNPVERLTF----EEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       253 ~~DP~~RpTa----~eiL~Hpff~~~~~~~~~  280 (575)
                      ++||.+||++    ++++.|+||....+...-
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~  266 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTINFPRLE  266 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCCCHHHHh
Confidence            9999999999    778899999887665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=385.46  Aligned_cols=260  Identities=31%  Similarity=0.589  Sum_probs=235.2

Q ss_pred             EEEE--EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           14 YLVG--RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        14 Y~i~--~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      |+|.  ++||+|.||+||-|+++.+|+.||||+|++.++..+...++++|+.||+++.||.||.+--.|++.+++++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            5543  78999999999999999999999999999999988888899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l--~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      .+.| ++.+.|  .+.+++++...+.++.||+.||.|||.+||+|+||||+|||+.+.+...++||||||+|+.+.+...
T Consensus       644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            9955 655554  3568999999999999999999999999999999999999998888889999999999999999999


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ..+.+|||.|+|||++++.+|+...|+||+|||+|.-+.|..||....  ++-.+|.+..-...|..+.+++.+++|||.
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHH
Confidence            999999999999999999999999999999999999999999998643  333455555444445566889999999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      .+|+..-.+|.+++..+.|||++..+.
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhcchH
Confidence            999999999999999999999988643

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-43  Score=387.13  Aligned_cols=259  Identities=22%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC-
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH------PHIIRLHDIIEVP-   83 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H------pnIv~l~~~~~~~-   83 (575)
                      .++|+++++||+|+||.||+|.+..+++.||||++...   .........|+.+++.+.|      ++++.++++|... 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            36799999999999999999999999999999999642   1223345567777776644      4588899988654 


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCC-------------C
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDD-------------D  149 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd-------------~  149 (575)
                      +.+|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||+..++             +
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            5799999998 78999999888899999999999999999999998 5999999999999995332             1


Q ss_pred             CCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Q 043425          150 NAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~  229 (575)
                      ...+||+|||++....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.+..
T Consensus       284 ~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        284 PCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             CceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence            2359999999875432  23346789999999999999999999999999999999999999999888766555443321


Q ss_pred             cCCCCCC---------------------------------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          230 ELHFPPD---------------------------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       230 ~~~~p~~---------------------------------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      .. +|..                                       .......+.+||.+||++||.+|||++|+|+|||
T Consensus       362 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        362 GR-LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             CC-CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            10 0000                                       0011355789999999999999999999999999


Q ss_pred             CCCCCc
Q 043425          271 LSQTQP  276 (575)
Q Consensus       271 f~~~~~  276 (575)
                      |.....
T Consensus       441 ~~~~~~  446 (467)
T PTZ00284        441 VLKYYP  446 (467)
T ss_pred             ccccCC
Confidence            986543

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-43  Score=376.52  Aligned_cols=258  Identities=29%  Similarity=0.470  Sum_probs=217.4

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-----KLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~l~   87 (575)
                      +|+++++||+|+||.||+|.+..+|+.||||.+............+.+|+.+++.++||||+++++++...+     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            578999999999999999999999999999998654333344567889999999999999999999998776     799


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||+. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccC
Confidence            9999996 6898888877889999999999999999999999999999999999999   77789999999999765332


Q ss_pred             --CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--------------
Q 043425          168 --GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--------------  230 (575)
Q Consensus       168 --~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~--------------  230 (575)
                        .......+|+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.+...              
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence              223345789999999998764 578999999999999999999999999887766665543211              


Q ss_pred             --------CCCCC------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          231 --------LHFPP------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       231 --------~~~p~------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                              ...+.      .....+.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                    00010      012357889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-43  Score=365.09  Aligned_cols=259  Identities=29%  Similarity=0.539  Sum_probs=216.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..+|.+.++||+|+||.||+|+++.++..||+|.+...... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            47799999999999999999999999999999998754322 22345678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++...... .
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc
Confidence            99975 888887654 458999999999999999999999999999999999999   67788999999998764332 2


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC----------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----------------  231 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~----------------  231 (575)
                      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+....                
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2334578999999999865 46889999999999999999999999988776665554432110                


Q ss_pred             --CCCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 --HFPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 --~~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                        .++.        ....++.++++||++||+.||.+|||++|+++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence              0111        112467899999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7e-43  Score=347.12  Aligned_cols=253  Identities=30%  Similarity=0.568  Sum_probs=225.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||+|.+..+|..|++|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            58999999999999999999999999999999987666666777899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           93 CKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      ++|++|.+++...  ..+++..+..++.||+.||.|||++|++||||||+||++   +..+.++|+|||++..+.... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccch
Confidence            9999999999764  578999999999999999999999999999999999999   666889999999988765433 2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+|++.|+|||++....++.++|+||||+++|+|++|..||...+.......+........+   ..++.++.+++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~  234 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQLID  234 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHHH
Confidence            34567999999999999999999999999999999999999999998877777666654322222   257889999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +||+.+|++||++.+++.|||+
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-45  Score=378.54  Aligned_cols=275  Identities=28%  Similarity=0.498  Sum_probs=241.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHH-HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~-~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+.|++-++||+|+||.||-++.+.||+.||+|.+++.+++.+.- .-.++|..||.+++.+.||.+-..|++.+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456888899999999999999999999999999998877755433 3467999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |..|.||+|.-.|-+.+  .|+|..++.++.+|+.||++||+.+||+|||||+|||+   |+.|+|.|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence            99999999988886665  79999999999999999999999999999999999999   99999999999999999888


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ---LLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~---~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ......+||.+|||||+++++.|+...|||||||+||+|+.|+-||.......   -+.+.+......++   ..+++++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~kFS~ea  417 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DKFSEEA  417 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---cccCHHH
Confidence            88888899999999999999999999999999999999999999997653322   22233333344444   3589999


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcccCCCCCC
Q 043425          245 KDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSRSADD  291 (575)
Q Consensus       245 ~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~~~~~~~~  291 (575)
                      ++|++.+|.+||.+|+     +++++.+||||..++|..+....+.|....+
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd  469 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD  469 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence            9999999999999998     5789999999999999988877766654444

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=390.27  Aligned_cols=260  Identities=27%  Similarity=0.500  Sum_probs=227.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----   84 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----   84 (575)
                      ...++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4557899999999999999999999999999999999887666666677889999999999999999988774332    


Q ss_pred             ----EEEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           85 ----KLHLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        85 ----~l~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                          .+++||||+++|+|.+++...    ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence                478999999999999998643    468999999999999999999999999999999999999   667889999


Q ss_pred             ccccccccCCC---CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          157 DFGFARSLQPR---GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       157 DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      |||+++.+...   ......+||+.|+|||++....|+.++|||||||++|+|++|+.||.+.+..+.+..+.......+
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            99999765432   234567899999999999999999999999999999999999999999988887777765543333


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +   ..+++++.+|+.+||+.||.+||++.++++|||+...
T Consensus       266 ~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        266 P---PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             C---CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            3   3578999999999999999999999999999998653

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-43  Score=386.25  Aligned_cols=256  Identities=29%  Similarity=0.515  Sum_probs=224.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCC-CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVH-GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~t-g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+...  .......+.+|+.+|+.++||||+++++++...+.+|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34499999999999999999998887 788999987544  233445678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||++||+|.+++..    ..++++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+.
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecC
Confidence            999999999988753    3468999999999999999999999999999999999999   677899999999998764


Q ss_pred             CCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          166 PRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       166 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..+....++   ..++.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~s~  297 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP---CPVSS  297 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---ccCCH
Confidence            332   245678999999999999999999999999999999999999999999888888777765433333   35789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++++||.+||.+||.+||++++++.|+|+...
T Consensus       298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999998653

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-42  Score=346.35  Aligned_cols=253  Identities=29%  Similarity=0.597  Sum_probs=221.2

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~LVmE   91 (575)
                      +|++.+.||+|+||.||++.++.+++.||+|.+..........+.+.+|+.++++++|+|++++++.+.. .+.+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999998766555666678899999999999999999998764 457899999


Q ss_pred             ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           92 YCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        92 y~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      |+++++|.+++...  ..+++..++.++.||+.||.+||++|++||||||+||++   +..+.++|+|||++...... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence            99999999998763  458999999999999999999999999999999999999   67788999999999766432 2


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+.......+..+..   +.....++.++.+|+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  234 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---PPMPKDYSPELGELI  234 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCccccCHHHHHHH
Confidence            33456789999999999998999999999999999999999999998887776666555432   222245789999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .+||+.||.+||++.++++||||
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         235 ATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=349.93  Aligned_cols=255  Identities=26%  Similarity=0.508  Sum_probs=220.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK---KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +.|.+.+.||+|+||.||.|.+..++..||+|.+.......   .....+.+|+.++++++||||+++++++...+.+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46999999999999999999999999999999987654322   223567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |+||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||+|+||++   +.++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccccc
Confidence            99999999999999888889999999999999999999999999999999999999   667889999999987654322


Q ss_pred             C----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          169 L----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       169 ~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .    .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....  .+.....++.++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  236 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPQLPSHVSPDA  236 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--CCCCCccCCHHH
Confidence            1    1346788999999999988899999999999999999999999988766655544433211  122223578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++|++||.+||.+|||+.++++|+||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-42  Score=354.83  Aligned_cols=261  Identities=33%  Similarity=0.644  Sum_probs=230.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++..... ..+....+.+|+.++++++||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            479999999999999999999999999999999876433 2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|.|||+   +.++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--C
Confidence            999999999999988899999999999999999999999999999999999999   67788999999999876544  3


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ...+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....+.+... ...++.   .++..++++|++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~---~~~~~l~~li~~  231 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPS---FFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCc---cCCHHHHHHHHH
Confidence            4568999999999998888899999999999999999999999988876666666543 333333   468999999999


Q ss_pred             hhccCCCCCC-----CHHHHHcCCCCCCCCchhhhh
Q 043425          251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       251 ~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||..||.+|+     +++|+++||||....|.....
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  267 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ  267 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence            9999999999     999999999999888766553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-43  Score=370.40  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=215.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|.+++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            466789999999999999999999999999999999876433333445677999999999999999999987543     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+++|++ |++|..++. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence             4579999998 789988875 4579999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      ....  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......         
T Consensus       167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            6543  2345689999999999876 568999999999999999999999999877666655544321110         


Q ss_pred             -------------CCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 -------------FPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 -------------~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                   .+.     .....++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                         000     001245678999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-43  Score=361.97  Aligned_cols=250  Identities=28%  Similarity=0.507  Sum_probs=197.3

Q ss_pred             EEEecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEee
Q 043425           17 GRQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLHLILEY   92 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~LVmEy   92 (575)
                      +++||+|+||.||+|+++  .++..||+|.+......    ..+.+|+.+|+.++||||+++++++..  ...+|+||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            568999999999999976  36789999998754332    346789999999999999999999854  4678999999


Q ss_pred             cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC-CCCCcEEEccccccc
Q 043425           93 CKGGDLSMYIQRH---------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFAR  162 (575)
Q Consensus        93 ~~GgsL~~~l~~~---------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~vKL~DFGla~  162 (575)
                      +. ++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +..+.+||+|||+++
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            95 5888887532         258999999999999999999999999999999999999543 456789999999998


Q ss_pred             ccCCCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCH---------HHHHHHHHHh
Q 043425          163 SLQPRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ---------IQLLQNIVKA  228 (575)
Q Consensus       163 ~~~~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~---------~~~l~~i~~~  228 (575)
                      .+....    .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+...         ...+..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654321    2345689999999999976 4589999999999999999999999975432         1222222221


Q ss_pred             ccCCC----------CC------------------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          229 TELHF----------PP------------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       229 ~~~~~----------p~------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .....          +.                        .....+.++.+||++||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            10000          00                        001124578999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-42  Score=351.79  Aligned_cols=257  Identities=30%  Similarity=0.543  Sum_probs=217.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999999999999999987654333344567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      |++++.|..++.....+++..++.++.||+.||.|||+.|++||||||+||++   +.++.+||+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcccc
Confidence            99999998888777789999999999999999999999999999999999999   667889999999998765433 23


Q ss_pred             ccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC------------------
Q 043425          171 ETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL------------------  231 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~------------------  231 (575)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+......                  
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            34568899999999876 45788999999999999999999999987766555444321100                  


Q ss_pred             CCCC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 HFPP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 ~~p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ..+.         ....++..+.+||.+||++||++||++.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0010         012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-42  Score=346.16  Aligned_cols=256  Identities=31%  Similarity=0.544  Sum_probs=222.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++++.||.|+||.||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            47999999999999999999999899999999997655444 45678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           92 YCKGGDLSMYIQRH---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        92 y~~GgsL~~~l~~~---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |++|++|.+++...   +.+++..+..++.||+.||.+||+.|++||||||+||++   ++++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence            99999999999764   458999999999999999999999999999999999999   667889999999987664432


Q ss_pred             -----CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh--hcc
Q 043425          169 -----LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA--KIL  240 (575)
Q Consensus       169 -----~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~--~~l  240 (575)
                           .....+|++.|+|||++... .++.++|+||||+++|+|++|+.||...+....+..+.......++...  ..+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence                 22446799999999999877 7889999999999999999999999988777666665554333333322  357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +.++.+|+.+||.+||.+||++++++.||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-42  Score=343.36  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=225.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            58999999999999999999999999999999987766666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           93 CKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        93 ~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      ++|++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||++.  ++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccc
Confidence            9999999999764  3589999999999999999999999999999999999993  34457899999999877655555


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ....|++.|+|||++....++.++|+||||+++|+|++|+.||.+.+.......+.......++   ..++.++.+++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~  235 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DRYSPDLRQLILS  235 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---CCcCHHHHHHHHH
Confidence            5577999999999999888999999999999999999999999988877766666554333222   3478899999999


Q ss_pred             hhccCCCCCCCHHHHHcCCCC
Q 043425          251 LLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ||.+||.+|||+.|+++||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=401.54  Aligned_cols=272  Identities=29%  Similarity=0.518  Sum_probs=228.0

Q ss_pred             CCCCCCC-CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Q 043425            1 MSQATGR-GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI   79 (575)
Q Consensus         1 m~q~~~~-g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~   79 (575)
                      |+..... ...+++|.++++||+|+||.||+|++..++..||+|++............+..|+.+|+.|+||||++++++
T Consensus         1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266          1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            5555544 567899999999999999999999999999999999998776666667789999999999999999999998


Q ss_pred             EEe--CCEEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhC-------CcccccccCCceeeec
Q 043425           80 IEV--PGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDN-------NLIHRDLKPQNLLLCT  146 (575)
Q Consensus        80 ~~~--~~~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~-------gIvHrDLKPeNILl~~  146 (575)
                      |..  ...+||||||+++|+|.++|..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||..
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            854  4679999999999999999875    25799999999999999999999985       4999999999999953


Q ss_pred             C--------------CCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCC
Q 043425          147 D--------------DDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGK  210 (575)
Q Consensus       147 d--------------d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~  210 (575)
                      +              +....+||+|||++..+.........+||+.|+|||++..  ..++.++||||||||||+|++|.
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence            2              2245699999999987765555566789999999999864  45889999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          211 TPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       211 ~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .||...+....+...+.... .++  ....+.++.+||.+||..+|.+||++.|+|.|+||....
T Consensus       241 ~PF~~~~~~~qli~~lk~~p-~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        241 TPFHKANNFSQLISELKRGP-DLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCCCcCCcHHHHHHHHhcCC-CCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            99987665444433333221 112  124688999999999999999999999999999997653

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-42  Score=346.80  Aligned_cols=253  Identities=31%  Similarity=0.599  Sum_probs=219.4

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-------KLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-------~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      +|.++..||+|+||.||+|.+..++..||+|.+.......       +..+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4888999999999999999999899999999887643321       233567899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||++   ++++.++|+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcccc
Confidence            99999999999999999988889999999999999999999999999999999999999   677889999999987664


Q ss_pred             CCC-------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          166 PRG-------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       166 ~~~-------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      ...       ......|++.|+|||++....++.++|+||||+++|+|++|..||...+....+..+.....   +....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  234 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIPS  234 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCCc
Confidence            221       12235689999999999988899999999999999999999999998776655554444322   22223


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++.++.++|++||++||.+||++.|+++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.5e-42  Score=356.45  Aligned_cols=256  Identities=27%  Similarity=0.532  Sum_probs=218.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.++||+|+||.||++.+..+|..+|+|.+... ........+.+|+.++++++||||+++++++..++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            4799999999999999999999999999999998754 234556678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |++|++|.+++.+.+.+++..+..++.||+.||.|||+ .+++||||||+|||+   +.++.+||+|||++...... ..
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-cc
Confidence            99999999999988889999999999999999999998 599999999999999   66788999999998765332 23


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh----------------------
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------------------  228 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~----------------------  228 (575)
                      ...+|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...                      
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            4578999999999998888999999999999999999999999766544332222110                      


Q ss_pred             --------------ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          229 --------------TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       229 --------------~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                    .....+.  ..++.++.+|+.+||..||.+|||+.++++||||...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                          0000111  1367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-42  Score=350.45  Aligned_cols=255  Identities=32%  Similarity=0.570  Sum_probs=212.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..++.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            68999999999999999999999999999999876544444445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           93 CKGGDLSMYIQRH---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        93 ~~GgsL~~~l~~~---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      ++ ++|.+++...   +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence            97 5888887643   468999999999999999999999999999999999999   677889999999987653322 


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC----------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----------------  231 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~----------------  231 (575)
                      ......+++.|+|||++.+ ..++.++|+||||+++|+|++|++||.+.........+......                
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2234467899999999865 45788999999999999999999999987665444332221100                


Q ss_pred             ---------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 ---------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 ---------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                               ........++.++.+||++||+.||.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                     0000112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-42  Score=341.96  Aligned_cols=253  Identities=31%  Similarity=0.558  Sum_probs=225.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.+.||.|+||.||.+++..+|..+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            59999999999999999999999999999999987766666667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           93 CKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      ++|++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.+||+|||++....... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccccc
Confidence            9999999999765  468999999999999999999999999999999999999   667789999999997664433 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..+..   ++....++.++.++|.
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~  234 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY---TPVVSVYSSELISLVH  234 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---CCCccccCHHHHHHHH
Confidence            4456799999999999888889999999999999999999999999888777777665432   2222457899999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +||.+||.+||++.++++|+|+
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=355.89  Aligned_cols=262  Identities=28%  Similarity=0.539  Sum_probs=226.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998765443 34466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+.|++|.+++.+.  ..+++..++.++.||+.||+|||+.|++||||||+||++   +.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcccccc
Confidence            999999999998754  579999999999999999999999999999999999999   667889999999986543211


Q ss_pred             ------------------------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH
Q 043425          169 ------------------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ  218 (575)
Q Consensus       169 ------------------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~  218 (575)
                                                    ....+.||..|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          11235789999999999988899999999999999999999999998887


Q ss_pred             HHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCC----HHHHHcCCCCCCCCchh
Q 043425          219 IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLT----FEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       219 ~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT----a~eiL~Hpff~~~~~~~  278 (575)
                      ...+..+... ...++.. ..++.++.++|++||.+||.+||+    ++|+++||||+...+..
T Consensus       238 ~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         238 DETFSNILKK-EVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             HHHHHHHhcC-CccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            7777666543 2233332 237899999999999999999999    99999999998866543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-42  Score=355.43  Aligned_cols=260  Identities=31%  Similarity=0.545  Sum_probs=216.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|.+.++||+|+||.||+|.++.++..||+|.+...... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            467899999999999999999999999999999998754322 2234567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      |||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            99996 5888888654 568999999999999999999999999999999999999   67788999999998764322 


Q ss_pred             CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------------
Q 043425          168 GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------------  232 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------------  232 (575)
                      .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.......              
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            22334567899999999865 457889999999999999999999999888766655444321110              


Q ss_pred             ----CCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 ----FPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 ----~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                          ++.        ....++.++++||.+||+.||.+|||++|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                010        012467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9e-43  Score=363.64  Aligned_cols=249  Identities=29%  Similarity=0.493  Sum_probs=204.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-C
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP-G   84 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~-~   84 (575)
                      ++|+++++||+|+||.||+|.+.     .++..||||++.... .......+.+|+.++..+ +||||+++++++... +
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            57999999999999999999752     356789999987532 334456788999999999 899999999988654 4


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----------------------------------------------------------
Q 043425           85 KLHLILEYCKGGDLSMYIQRH-----------------------------------------------------------  105 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~-----------------------------------------------------------  105 (575)
                      .+++||||++||+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            689999999999999998753                                                           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---CcccccCCCCC
Q 043425          106 ---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLY  179 (575)
Q Consensus       106 ---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y  179 (575)
                         ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......   ......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               247788899999999999999999999999999999999   667889999999997653321   12234567889


Q ss_pred             CChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHH-HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCC
Q 043425          180 MAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLL-QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV  257 (575)
Q Consensus       180 ~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l-~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~  257 (575)
                      +|||++....|+.++|||||||++|+|++ |..||.+....+.+ ..+..+.....+   ...++++.+|+.+||+.||.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP---ENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHccCChh
Confidence            99999999999999999999999999997 99999886544333 333333222222   35788999999999999999


Q ss_pred             CCCCHHHHHc
Q 043425          258 ERLTFEEFFN  267 (575)
Q Consensus       258 ~RpTa~eiL~  267 (575)
                      +|||+.|+++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-43  Score=362.44  Aligned_cols=259  Identities=35%  Similarity=0.543  Sum_probs=220.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C---
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--G---   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~---   84 (575)
                      ..=.|.-.+++|.|+||.||.|....+++.||||.+-.+..      ---+|+.+|+.+.|||||++..+|...  +   
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            33458999999999999999999999999999998754321      123799999999999999999988443  2   


Q ss_pred             EEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      .+.+||||++. +|..+++.    +..++.-.++-+..||++||.|||..||+||||||+|||+  |.+.|.+||||||.
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv--D~~tg~LKicDFGS  172 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV--DPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE--cCCCCeEEeccCCc
Confidence            35689999965 89888874    5679999999999999999999999999999999999999  45679999999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-------
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-------  232 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-------  232 (575)
                      |+.+..+....++..|..|+|||.+.+ ..|+.+.||||.||++.||+.|++.|.|.+..+++..|++....+       
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            999988887788888999999998764 579999999999999999999999999999888888877532111       


Q ss_pred             ---------CCC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          233 ---------FPP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       233 ---------~p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                               +|.         .....++++.+|+.++|.++|.+|.++.|++.||||.+....
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                     111         113467899999999999999999999999999999876544

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-42  Score=352.92  Aligned_cols=265  Identities=27%  Similarity=0.522  Sum_probs=226.7

Q ss_pred             CCCCCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 043425            3 QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV   82 (575)
Q Consensus         3 q~~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~   82 (575)
                      +....|....+|.+.+.||+|+||.||+|.+..++..||+|.+.......  .+.+.+|+.+++.++||||+++++.+..
T Consensus        11 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~   88 (296)
T cd06654          11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV   88 (296)
T ss_pred             hccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence            34566888899999999999999999999999999999999998654432  3568899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      ....|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~  164 (296)
T cd06654          89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCA  164 (296)
T ss_pred             CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccch
Confidence            9999999999999999999865 468999999999999999999999999999999999999   667889999999987


Q ss_pred             ccCCCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          163 SLQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       163 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ...... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+....... ......++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  243 (296)
T cd06654         165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLS  243 (296)
T ss_pred             hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC-CCCccccC
Confidence            654332 2234578999999999998889999999999999999999999998877655444333322111 12224578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ..+.+||.+||.+||.+||++.++++||||...
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            899999999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-42  Score=341.41  Aligned_cols=253  Identities=36%  Similarity=0.639  Sum_probs=223.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~LVm   90 (575)
                      +|++.+.||.|+||.||+|.+..+|..||+|++..........+.+.+|+.+++.++||||+++++++..  ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999998776666667788999999999999999999998753  45789999


Q ss_pred             eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-----hCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           91 EYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLR-----DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        91 Ey~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH-----~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ||+++++|.+++.+    ...+++..++.++.||+.||.|||     +.+++|+||||+||++   +..+.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence            99999999999875    357899999999999999999999     8999999999999999   66789999999999


Q ss_pred             cccCCCCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          162 RSLQPRGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       162 ~~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ........ .....|++.|+|||++....++.++|+||||+++|+|++|..||...+...+.+.+.......++   ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  234 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP---YRY  234 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc---ccc
Confidence            87755443 44567999999999999888999999999999999999999999998877766666554332222   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +.++.+++.+||..+|.+||+++++++|||+
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            8999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.9e-42  Score=344.87  Aligned_cols=254  Identities=28%  Similarity=0.536  Sum_probs=217.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN----KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +|.+++.||+|+||.||+|.+. +|+.+|+|.+......    ......+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999874 7999999998754321    2334568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC--
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~--  166 (575)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||+|+||++   +..+.++|+|||++.....  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhcc
Confidence            99999999999999888889999999999999999999999999999999999999   6778999999999876422  


Q ss_pred             -----CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          167 -----RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       167 -----~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                           ........|++.|+|||++....++.++|+||||+++|+|++|..||...+.......+.... ...+.....++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  235 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-GLMPRLPDSFS  235 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc-CCCCCCCCCCC
Confidence                 112234678999999999998899999999999999999999999998876655444443321 12233334578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++.++|++||.++|.+||++.++++||||
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.8e-42  Score=352.59  Aligned_cols=266  Identities=29%  Similarity=0.569  Sum_probs=228.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998765432 233456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC---
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR---  167 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~---  167 (575)
                      ||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||++   +..+.+||+|||+++.....   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999999999999999999999   67788999999998632100   


Q ss_pred             -------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          168 -------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       168 -------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                                   .......|++.|+|||.+....++.++|+||||+++|+|++|..||.+....+....+.... ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~  236 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWP  236 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCC
Confidence                         01123568889999999988899999999999999999999999999988887777665542 2333


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCCchhhhh
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~~~~~~~  281 (575)
                      .....++.++.++|++||.+||.+||+   +.++++||||....+....+
T Consensus       237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~  286 (305)
T cd05609         237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR  286 (305)
T ss_pred             CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhh
Confidence            333367899999999999999999997   79999999998877665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-42  Score=352.13  Aligned_cols=255  Identities=34%  Similarity=0.587  Sum_probs=210.8

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.++||+|+||.||+|.+..+|..||+|.+............+.+|+.+++.++||||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58999999999999999999999999999999976544434445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           93 CKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        93 ~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      +. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +..+.+||+|||++..+.... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCc
Confidence            96 578777764 4679999999999999999999999999999999999999   667889999999997654322 22


Q ss_pred             ccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhccC-----------------
Q 043425          171 ETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATEL-----------------  231 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF-~~~~~~~~l~~i~~~~~~-----------------  231 (575)
                      ....+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+.+....                 
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            345678999999998764 4789999999999999999988885 555555554444322100                 


Q ss_pred             --CCC------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 --HFP------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 --~~p------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                        .++      ...+.++.++++||++||..||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              000      0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-42  Score=348.06  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=215.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|.+.++||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++.+...+.+++|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            3457999999999999999999999999999999987653  22334578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      |||+++++|.+++...+.+++..+..++.||+.||+|||+.|++|+||||+||++   +..+.+||+|||++....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence            9999999999999888899999999999999999999999999999999999999   677889999999987654321 


Q ss_pred             CcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-CCCCChhcccHHH
Q 043425          169 LAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPDAKILSADC  244 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-~~p~~~~~ls~el  244 (575)
                      ......|++.|+|||++.   ...++.++|+|||||++|+|++|..||.................. ........++..+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence            234567999999999984   456888999999999999999999999776654443333222111 1111112467889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      .+||.+||..||++||+++++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=347.30  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=225.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|.+.+.||.|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++..+..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            478999999999999999999999999999999876532 2334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~  170 (575)
                      |+++++|.+++... ++++..+..++.||+.||.|||+.|++||||+|+||++   +.++.++|+|||+++..... ...
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccccc
Confidence            99999999999765 79999999999999999999999999999999999999   67788999999999876543 233


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ....|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+........+..  .++.++.+++.+
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~  233 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGN--KFSKPFKDFVSL  233 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCccc--ccCHHHHHHHHH
Confidence            456789999999999988899999999999999999999999988777666655555433222221  278899999999


Q ss_pred             hhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          251 LLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      ||..||.+|||++++++||||......
T Consensus       234 ~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         234 CLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            999999999999999999999876444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7e-42  Score=340.88  Aligned_cols=253  Identities=30%  Similarity=0.618  Sum_probs=223.8

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.++||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            59999999999999999999999999999999987655555667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           93 CKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      +.+++|.+++....  .+++..+..++.||+.||.|||++|++|+||+|+|||+   +.++.++|+|||++..+.... .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhh
Confidence            99999999987643  57899999999999999999999999999999999999   667789999999997654432 2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+..+....   ....++.++.++|.
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~  234 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNLVS  234 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHHHH
Confidence            234568999999999998889999999999999999999999999888877777766554322   23457899999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +||+.+|.+||++.++++||||
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.2e-42  Score=350.73  Aligned_cols=261  Identities=29%  Similarity=0.509  Sum_probs=221.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      +.|+++++||+|+||.||+|++..++..+|+|.+...  .....+.+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            5599999999999999999999999999999998754  34456678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      |++|++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+||++   +.++.+||+|||++...... ..
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccccc
Confidence            9999999888754 4578999999999999999999999999999999999999   66788999999998754322 22


Q ss_pred             cccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          170 AETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .....|++.|+|||++.     ...++.++|+|||||++|+|++|.+||...+.......+........ .....++.++
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  245 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKWSMEF  245 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCcccCHHH
Confidence            34567899999999984     34578899999999999999999999988776665555544322211 1223577899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      .+||++||..||.+||+++++++||||....+..
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            9999999999999999999999999998876655

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-42  Score=347.86  Aligned_cols=256  Identities=34%  Similarity=0.590  Sum_probs=219.2

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.++++++||||+++++++..++.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            59999999999999999999999999999999987665555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--C
Q 043425           93 CKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--~  169 (575)
                      + |++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||++   +..+.++|+|||++.......  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCc
Confidence            9 99999998653 568999999999999999999999999999999999999   667889999999998765433  2


Q ss_pred             cccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----------------
Q 043425          170 AETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----------------  232 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----------------  232 (575)
                      .....|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+......+..+.......                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3456789999999998654 46889999999999999999999998887776666555422111                


Q ss_pred             --CCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          233 --FPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       233 --~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                        ++.        .....+.++.+||++||.+||.+|||++++++||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              000        0123568899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.3e-42  Score=348.76  Aligned_cols=255  Identities=29%  Similarity=0.520  Sum_probs=214.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++.++||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            36889999999999999999999999999999987653 34445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      |+++++|..+    ..+++..+..++.|++.||+|||+.||+|+||||+|||+   +.++.++|+|||++...... ...
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~~  151 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IAK  151 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-ccc
Confidence            9999999655    357899999999999999999999999999999999999   67789999999999765432 334


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhccCCCCCChhcccHHH
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-------IQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-------~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..+||+.|+|||++.+..++.++|+||||+++|+|++|..||.....       ......+........+  ...++.++
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  229 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--VGQFSEKF  229 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC--CCcCCHHH
Confidence            56899999999999988999999999999999999999999975322       1222222222111111  13477899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      .+||.+||+.||.+||+++|+++||||......
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence            999999999999999999999999999876433

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-42  Score=346.26  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=214.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.....  .....+.+|+.++++++||||+++++++...+.+++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            4579999999999999999999999999999999875432  22345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++..+.... .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccccc
Confidence            999999999999888889999999999999999999999999999999999999   677889999999998654322 2


Q ss_pred             cccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHH
Q 043425          170 AETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCK  245 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~  245 (575)
                      .....|++.|+|||.+.   ...++.++|+|||||++|+|++|..||...........+.... ..........++.++.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            34567899999999984   4457889999999999999999999997665444332222211 1111111234688999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      +||++||+.||.+|||++++++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-42  Score=348.26  Aligned_cols=259  Identities=30%  Similarity=0.516  Sum_probs=217.2

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999997654332 2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCC
Q 043425           99 SMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS  176 (575)
Q Consensus        99 ~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT  176 (575)
                      .+++.+.+  .+++..+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++.............|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCC
Confidence            99998765  79999999999999999999999999999999999999   67788999999999876544444556788


Q ss_pred             CCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCC
Q 043425          177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP  256 (575)
Q Consensus       177 ~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP  256 (575)
                      ..|+|||++.+..++.++|+||||+++|+|++|+.||...........+..............++.++.++|++||..||
T Consensus       158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (277)
T cd05577         158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP  237 (277)
T ss_pred             CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence            99999999988889999999999999999999999998765422222222221111111223478999999999999999


Q ss_pred             CCCC-----CHHHHHcCCCCCCCCchhhhh
Q 043425          257 VERL-----TFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       257 ~~Rp-----Ta~eiL~Hpff~~~~~~~~~~  281 (575)
                      .+||     ++.++++||||...+++....
T Consensus       238 ~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~  267 (277)
T cd05577         238 EKRLGCRGGSADEVREHPLFKDLNWRRLEA  267 (277)
T ss_pred             hHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence            9999     889999999999888766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=348.56  Aligned_cols=259  Identities=30%  Similarity=0.521  Sum_probs=222.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.++||.|+||.||+|.+..++..+|+|.+...  .....+.+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5699999999999999999999989999999998754  33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      |+++++|..++.+. ..+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++...... ..
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhcccccc
Confidence            99999999998764 579999999999999999999999999999999999999   67788999999998655332 22


Q ss_pred             cccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          170 AETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .....|++.|+|||++.     ...++.++|+||||+++|+|++|++||...+....+..+.......+. ....++.++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  238 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWSSSF  238 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCCHHH
Confidence            34567999999999985     345677899999999999999999999988877766666544322221 123578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      .++|.+||..||.+||+++++++||||.....
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            99999999999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.2e-42  Score=352.64  Aligned_cols=264  Identities=33%  Similarity=0.518  Sum_probs=220.0

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--G   84 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~   84 (575)
                      .++.+++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++|+||+++++++...  +
T Consensus         2 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             CcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            46788999999999999999999999999999999999976543333334567899999999999999999998654  5


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .+++||||+.+ +|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||++   +..+.+||+|||++..
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeee
Confidence            68999999964 888888753 678999999999999999999999999999999999999   6778899999999987


Q ss_pred             cCCC-CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          164 LQPR-GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       164 ~~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      .... .......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+.+..+.......         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            6543 22233456888999999865 568899999999999999999999999988887777665432110         


Q ss_pred             ---------CCCC--------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 ---------FPPD--------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 ---------~p~~--------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                               .+..        ....++++.+||.+||++||.+|||+++++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                     0000        12357889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-42  Score=358.36  Aligned_cols=256  Identities=23%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             EEEEeccc--CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           16 VGRQIGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        16 i~~~LG~G--aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      ++++||+|  +|++||++.++.+|+.||+|.++...........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7889999999999999999999876555556667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---
Q 043425           94 KGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---  168 (575)
Q Consensus        94 ~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---  168 (575)
                      ++|+|.+++..+  +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.++++||+.+.......   
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccccc
Confidence            999999999753  458999999999999999999999999999999999999   667789999998754432111   


Q ss_pred             -----CcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC--------
Q 043425          169 -----LAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF--------  233 (575)
Q Consensus       169 -----~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~--------  233 (575)
                           ......++..|+|||++.+  ..|+.++|||||||++|+|++|..||....................        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1123457788999999976  4689999999999999999999999987655444333222110000        


Q ss_pred             ----------------------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 ----------------------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 ----------------------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                                        .+....+++++.+||++||+.||.+|||++|+++||||.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                              00112356789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=339.36  Aligned_cols=254  Identities=31%  Similarity=0.499  Sum_probs=219.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.+.||.|+||.||+|.+..++..+|+|++.....  .....+.+|+.++++++||||+++++.+...+.+|++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999976532  245678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||++   +.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhhc
Confidence            99999999999776 789999999999999999999999999999999999999   677889999999987654332 3


Q ss_pred             cccccCCCCCCChHHHhhc---cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCK  245 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~---~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~  245 (575)
                      .....|+..|+|||++...   .++.++|+||||+++|+|++|.+||...+.......+.... ..........++.++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            3456789999999999776   88999999999999999999999999887666555444331 1111112234678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      +|+++||..||..|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=348.18  Aligned_cols=257  Identities=30%  Similarity=0.577  Sum_probs=219.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.++||+|+||.||+|.+..+++.||||++............+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999999999999999987655445556778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--C
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--L  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--~  169 (575)
                      |++++.+..+..+...+++..+..++.||+.||.|||++|++||||+|+||++   ++++.+||+|||++.......  .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcccc
Confidence            99988887777666779999999999999999999999999999999999999   678899999999998765443  3


Q ss_pred             cccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-----------------
Q 043425          170 AETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-----------------  231 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-----------------  231 (575)
                      .....++..|+|||++... .++.++|+||||+++|+|++|.+||.+....+.+..+......                 
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            4456789999999999887 8899999999999999999999999887665544433221100                 


Q ss_pred             -CCCC----------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 -HFPP----------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 -~~p~----------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                       .++.          ....++.++.+||++||..||.+||+++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             0000          001247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-42  Score=344.53  Aligned_cols=253  Identities=29%  Similarity=0.540  Sum_probs=221.1

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|++.+.||.|+||.||+|.+..++..||+|++.+..... .....+.+|+.++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999998654322 455678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      |+.|++|..++.....+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++..........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcccc
Confidence            99999999999887789999999999999999999999999999999999999   677889999999998766554455


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ--IQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~--~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ...|+..|+|||++....++.++|+||||+++|+|++|..||...+.  ...+...........+   ..++.++.++|.
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~  234 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP---ATWSTEAIDAIN  234 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc---ccCcHHHHHHHH
Confidence            67789999999999988899999999999999999999999998764  2222222221222222   357899999999


Q ss_pred             HhhccCCCCCCCH--HHHHcCCCC
Q 043425          250 KLLRRNPVERLTF--EEFFNHPFL  271 (575)
Q Consensus       250 k~L~~DP~~RpTa--~eiL~Hpff  271 (575)
                      +||..||.+||++  +|+++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-42  Score=343.74  Aligned_cols=257  Identities=33%  Similarity=0.600  Sum_probs=216.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN----KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +|+.++.||+|+||.||++.+..+|..||+|++......    .+....+.+|+.++++++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            488899999999999999999999999999998754322    2245678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC-CcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~-g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||++   +.. ..+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEcccccccccccc
Confidence            99999999999999888889999999999999999999999999999999999999   433 46999999998766432


Q ss_pred             C-----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-CCCCCChhccc
Q 043425          168 G-----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILS  241 (575)
Q Consensus       168 ~-----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-~~~p~~~~~ls  241 (575)
                      .     .....+|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+.+... ...+.....++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     12345789999999999888899999999999999999999999976543332222222111 11122224578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      .++.+++.+||..||.+||++.++++||||.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-42  Score=366.85  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=211.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...+|.++++||+|+||.||+|...  .++..||+|.+....       ...+|+.+|+.++||||+++++++...+.+|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            4557999999999999999999764  356889999876431       2458999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..+...
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcc
Confidence            9999995 6899999777889999999999999999999999999999999999999   77789999999999765433


Q ss_pred             C---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhc---cCCCCC---
Q 043425          168 G---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ---IQLLQNIVKAT---ELHFPP---  235 (575)
Q Consensus       168 ~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~---~~~l~~i~~~~---~~~~p~---  235 (575)
                      .   .....+||+.|+|||++....|+.++|||||||++|+|++|+.||.+...   ...+..+.+..   ...++.   
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2   22356799999999999999999999999999999999999999977542   22222222211   111111   


Q ss_pred             ----------------------Ch--hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          236 ----------------------DA--KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       236 ----------------------~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                                            ..  ..++.++.+||++||..||.+|||+.|+|+||||....++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence                                  00  1246688999999999999999999999999999875443

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=382.34  Aligned_cols=261  Identities=28%  Similarity=0.495  Sum_probs=230.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      -|.|+..||.|+||.||+|.++.++-..|.|+|...  .....+.++-||.||..+.||+||++++.|...+.+||+.||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            488999999999999999999999999999999765  345567899999999999999999999999889999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-CCCCCc
Q 043425           93 CKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLA  170 (575)
Q Consensus        93 ~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~~~~~~  170 (575)
                      |.||-....+..- ..+++..+.-+++|++.||.|||+++|||||||..|||+   ...|.|+|+|||.+... ......
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhHHhhh
Confidence            9999988876544 579999999999999999999999999999999999999   55677999999987543 234456


Q ss_pred             ccccCCCCCCChHHH-----hhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          171 ETLCGSPLYMAPEIM-----QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl-----~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .++.|||+|||||++     ...+|+.++||||||++|.+|..+.+|....+++..+-+|.+..++.+.. +..++..+.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~Ws~~F~  266 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSHWSRSFS  266 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cchhhhHHH
Confidence            789999999999985     56789999999999999999999999999999999999988876554332 245788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      ||+++||.+||..||++.++|+|||++.+.....
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~  300 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKM  300 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccCCcchH
Confidence            9999999999999999999999999997655443

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-42  Score=349.51  Aligned_cols=259  Identities=27%  Similarity=0.528  Sum_probs=217.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+... ........+.+|+.++++++||||+++++.+...+.+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            4789999999999999999999999999999998754 344445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           92 YCKGGDLSMYIQRH---GCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        92 y~~GgsL~~~l~~~---~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||++   +.++.+||+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence            99999999998763   378999999999999999999997 599999999999999   66788999999998765322


Q ss_pred             CCcccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          168 GLAETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                       ......|++.|+|||++...      .++.++|+|||||++|+|++|+.||...........+........+.....++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence             33456789999999998543      35788999999999999999999998765554443332221212222233588


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .++.+||.+||..+|.+||+++++++||||....
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=369.25  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=230.2

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      |.-++.||.|+||.||.|++..+.+.||||.+.-..- ....++.++.|+..|+++.|||++.+.++|......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5567889999999999999999999999999876532 335568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           93 CKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      | -|+..+++.-+ +++-|.++..|+.+.+.||.|||+.+.||||||..|||+   .+.|.|||+|||.|....+   .+
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---An  180 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---AN  180 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc---hh
Confidence            9 45888887643 579999999999999999999999999999999999999   7889999999999976543   46


Q ss_pred             cccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      +++|||+||||||+.   .+.|+-++||||||++..+|...++|+...+.+..+..|.....+.++.  +.++..++.|+
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs--~eWS~~F~~Fv  258 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--NEWSDYFRNFV  258 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--chhHHHHHHHH
Confidence            899999999999974   6789999999999999999999999999999999999998876666554  46899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      ..||.+-|..|||.+++|.|+|.....+..+
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R~Rp~tv  289 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLRERPPTV  289 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence            9999999999999999999999998776544

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=377.67  Aligned_cols=271  Identities=28%  Similarity=0.510  Sum_probs=249.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.+.+++..||-|+||.|-++........+|+|++++..+ +.+.++++..|.+||..++.|.||++|..|.+.+++|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            45567788899999999999999886666699999987665 45667889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      +||-|-||+|++.+..++.|++..++.++..++.|++|||.+|||+|||||+|+|+   +.+|.+||.|||+|+.+..+.
T Consensus       498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence            99999999999999999999999999999999999999999999999999999999   899999999999999999999


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-CCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-~~p~~~~~ls~el~dL  247 (575)
                      ...++||||.|+|||++.+.+.+.++|.||||+++|||++|.+||.+.+++..+..|+++... .+|   ..++..+.+|
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P---r~I~k~a~~L  651 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP---RRITKTATDL  651 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---cccchhHHHH
Confidence            999999999999999999999999999999999999999999999999999999999998743 455   3588999999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcccC
Q 043425          248 CQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       248 I~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      |++++..+|.+|+.     +.+|.+|.||...+|+.+......+
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~p  695 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPP  695 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCC
Confidence            99999999999995     7899999999999999876655444

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-41  Score=338.41  Aligned_cols=255  Identities=30%  Similarity=0.587  Sum_probs=219.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+............+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58999999999999999999999999999999987765555677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC---
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~---  169 (575)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||++   +..+.+||+|||++........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCccc
Confidence            9999999999887789999999999999999999999999999999999999   6678899999999877643322   


Q ss_pred             --cccccCCCCCCChHHHhhcc---CCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhccCCCCCChhcccHH
Q 043425          170 --AETLCGSPLYMAPEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~~~---y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                        .....+++.|+|||++....   ++.++||||||+++|+|++|..||..... ......+.......+|. ....+..
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD-SLQLSPE  236 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc-ccccCHH
Confidence              22457889999999998766   88899999999999999999999976643 33333333222223332 2345889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +.+||++||+.||.+||++.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-42  Score=364.38  Aligned_cols=250  Identities=28%  Similarity=0.416  Sum_probs=203.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++++.||+|+||.||+|.+..++..||+|+....        ....|+.++++++||||+++++++...+..++|||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4699999999999999999999999999999975432        23468999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.........
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCccc
Confidence            995 588888765 4579999999999999999999999999999999999999   77788999999999765444444


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCC-CCCCH---------HHHHHHHHHhc---cCCCCC--
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF-TGSNQ---------IQLLQNIVKAT---ELHFPP--  235 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF-~~~~~---------~~~l~~i~~~~---~~~~p~--  235 (575)
                      ....||+.|+|||++.+..|+.++|||||||++|+|+++..|+ .....         ...+..+....   ...++.  
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            5678999999999999999999999999999999999865444 33211         11111121111   111110  


Q ss_pred             -------------------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          236 -------------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       236 -------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                               ....++.++.+||.+||+.||.+|||++|+|+||||++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     00134667788999999999999999999999999975

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.9e-42  Score=344.42  Aligned_cols=253  Identities=29%  Similarity=0.519  Sum_probs=211.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC------
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP------   83 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~------   83 (575)
                      -+.|.+.+.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++++ +||||+++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356899999999999999999999999999999987543   2234678999999998 699999999998652      


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ..+|+||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||++   +.++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCc
Confidence            4689999999999999998863  468999999999999999999999999999999999999   67788999999998


Q ss_pred             cccCCC-CCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 043425          162 RSLQPR-GLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       162 ~~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~  235 (575)
                      ...... .......|++.|+|||++.     ...|+.++|+|||||++|+|++|..||...........+......  ..
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~  236 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--RL  236 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC--CC
Confidence            765332 2334567999999999986     346888999999999999999999999876655544433332111  11


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ....++.++.+|+.+||..||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            123578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-41  Score=345.72  Aligned_cols=255  Identities=29%  Similarity=0.518  Sum_probs=218.7

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |++.++||+|+||.||+|.+..++..+|+|.+...  .....+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            68889999999999999999999999999998654  2344566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCcc
Q 043425           94 KGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAE  171 (575)
Q Consensus        94 ~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~  171 (575)
                      ++++|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... ....
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccccccc
Confidence            99999988765 4579999999999999999999999999999999999999   67788999999998754322 2234


Q ss_pred             cccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          172 TLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      ...|++.|+|||++.     ...++.++|+|||||++|+|++|.+||...+.......+........+ ....++.++++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  240 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSSEFKD  240 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCHHHHH
Confidence            567899999999984     455778999999999999999999999988877766666554332221 22357889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ||++||.+||.+||+++++++||||...
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            9999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.6e-42  Score=351.54  Aligned_cols=263  Identities=28%  Similarity=0.530  Sum_probs=223.9

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..|...++|.+.++||+|+||.||+|.+..+|..||+|.+......  ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            4567778999999999999999999999999999999999765432  23567899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .++||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||+   +.++.++|+|||++....
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEcc
Confidence            9999999999999999865 468999999999999999999999999999999999999   677889999999987654


Q ss_pred             CCCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PRGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+....... ......++..+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPERLSAVF  245 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC-CCCccccCHHH
Confidence            4322 334678999999999998889999999999999999999999998876544433332221111 11224578889


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .+|+.+||..||.+||+++++++||||....
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            9999999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-41  Score=341.01  Aligned_cols=252  Identities=34%  Similarity=0.636  Sum_probs=220.8

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||.|+||.||+|.+..++..||+|++.+.... ......+.+|+.+++.++||||+++++.+..++.+++||||++|++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999865433 34456789999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCC
Q 043425           99 SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL  178 (575)
Q Consensus        99 ~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~  178 (575)
                      .+++.+...+++..+..++.||+.||+|||++|++|+||+|+||++   +..+.++|+|||++............+|++.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcC
Confidence            9999888889999999999999999999999999999999999999   6678899999999987765544455689999


Q ss_pred             CCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccC
Q 043425          179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--QIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       179 Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~--~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      |+|||.+....++.++|+||||+++|+|++|..||....  .......+.... ...+|.   ..+.++.++|.+||.+|
T Consensus       158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN---YIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc---ccCHHHHHHHHHHccCC
Confidence            999999988889999999999999999999999998877  556666555322 222332   34889999999999999


Q ss_pred             CCCCCC-----HHHHHcCCCCCCCCch
Q 043425          256 PVERLT-----FEEFFNHPFLSQTQPD  277 (575)
Q Consensus       256 P~~RpT-----a~eiL~Hpff~~~~~~  277 (575)
                      |.+||+     ++|+++||||....|+
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            999999     9999999999876554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=361.86  Aligned_cols=259  Identities=27%  Similarity=0.500  Sum_probs=228.4

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |.++++||+|+||.||+|.|+.+|..+|||.+..+    ...+.+..|+.|++++..|++|++|+.+.....+|||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            67889999999999999999999999999998754    34567899999999999999999999988888999999999


Q ss_pred             CCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCcc
Q 043425           94 KGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAE  171 (575)
Q Consensus        94 ~GgsL~~~l~-~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~  171 (575)
                      ..|++.+.++ ++++++|.++..+++.-+.||+|||...-||||||..|||+   +..|+.||+|||.|..+... ...+
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhC
Confidence            9999999986 55789999999999999999999999999999999999999   66789999999999766432 2356


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      +..|||.|||||+++..+|+.++||||||++..||..|++||....++..+..|-...++.|. ....++.++.|||++|
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~-KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK-KPEEWSSEFNDFIRSC  266 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC-ChHhhhhHHHHHHHHH
Confidence            789999999999999999999999999999999999999999998887766665444333332 2356899999999999


Q ss_pred             hccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          252 LRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      |.++|++|-|+-++++|||+.....-.+.
T Consensus       267 LiK~PE~R~TA~~L~~H~FiknA~g~~I~  295 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTFIKNAPGCDIM  295 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence            99999999999999999999876554443

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-41  Score=338.75  Aligned_cols=252  Identities=29%  Similarity=0.533  Sum_probs=218.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|.+.++||+|+||.||+|.+..++..||+|.+....    ..+.+.+|+.+++.++||||+++++++.....+|+++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            57999999999999999999999889999999986532    25678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      |+++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||+|+||++   +..+.++|+|||++....... .
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCccc
Confidence            9999999999975 4578999999999999999999999999999999999999   667889999999998765433 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+.......+. ....++.++.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS-DPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCC-chhhcCHHHHHHHH
Confidence            34456899999999999889999999999999999999999999887665544433322111111 12357789999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +||..||.+|||+.|++.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-41  Score=340.85  Aligned_cols=254  Identities=26%  Similarity=0.498  Sum_probs=214.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---KKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~   87 (575)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+......   .+....+.+|+.+++.++||||+++++++..  .+.++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            689999999999999999999999999999998754322   2334568899999999999999999998865  46789


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +++||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccccc
Confidence            999999999999999888889999999999999999999999999999999999999   67788999999998765321


Q ss_pred             ----CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          168 ----GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       168 ----~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                          .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+....  ..+.....++..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--TNPQLPSHISEH  237 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--CCCCCchhcCHH
Confidence                11233568999999999998889999999999999999999999998876655554433221  112222457888


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      +++++ +||..+|.+||+++|+++||||+
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.8e-42  Score=344.07  Aligned_cols=255  Identities=31%  Similarity=0.566  Sum_probs=219.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|.+..... ......+.+|+.++++++||||+++++.+...+.+++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            478899999999999999999999999999999876543 3455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |+++++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||++   +..+.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence            99999999999876 789999999999999999999999 999999999999999   6678899999999876543222


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS-----NQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~-----~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                       ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...     ...+.++.+........+..  .++.++
T Consensus       157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  233 (265)
T cd06605         157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG--KFSPDF  233 (265)
T ss_pred             -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh--hcCHHH
Confidence             2277899999999999889999999999999999999999999764     23334444443332222222  278899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .++|.+||..||.+|||+.+++.||||+.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            99999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=364.16  Aligned_cols=271  Identities=30%  Similarity=0.544  Sum_probs=243.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      ....+|.++.+||+|+||.|.++..+.+.+.||||+++++.+- ++..+-.+.|.++|.... -|.+++++.+|++-+++
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            3567899999999999999999999999999999999887653 334455678888887775 57899999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc-cC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~-~~  165 (575)
                      |+||||+.||+|--.|+.-++|.|..+..++.+|+-||-+||++|||+||||.+|||+   +..|++||+|||+++. +-
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccccc
Confidence            9999999999999999999999999999999999999999999999999999999999   8899999999999975 34


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......++||||.|+|||++..++|+..+||||+||+||||+.|.+||.|.+..++++.|.... ..+|.   .++.|+.
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPK---slSkEAv  578 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPK---SLSKEAV  578 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcc---cccHHHH
Confidence            4566789999999999999999999999999999999999999999999999999999998773 44454   5899999


Q ss_pred             HHHHHhhccCCCCCCCH-----HHHHcCCCCCCCCchhhhhhcccC
Q 043425          246 DLCQKLLRRNPVERLTF-----EEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa-----~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      ++++.+|.+.|.+|+..     .+|..||||+.++|+.+-+..+.+
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqP  624 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQP  624 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCC
Confidence            99999999999999854     799999999999999887755543

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-41  Score=336.07  Aligned_cols=254  Identities=33%  Similarity=0.606  Sum_probs=220.8

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +|+..+.||+|+||.||+|.+..++..|++|.+.....   ..+....+.+|+.+++.++||||+++++++.....+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58888999999999999999998999999999876432   234456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      +||++|++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||++   +..+.+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   6778899999999987655444


Q ss_pred             cccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      .....|++.|+|||.+.... ++.++|+||||+++|+|++|..||...........+....  ..+.....++.++.+++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  235 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHHH
Confidence            45677999999999987766 8999999999999999999999998776555554444321  12222245789999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ++||..+|.+||++.+++.|||+
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHhhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-41  Score=346.92  Aligned_cols=263  Identities=27%  Similarity=0.446  Sum_probs=213.2

Q ss_pred             CCCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425            5 TGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus         5 ~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      .+.+..+++|.+.++||+|+||.||+|.+..+|..||||.+............+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            34678899999999999999999999999999999999998765433333345678999999999999999999886543


Q ss_pred             --------EEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           85 --------KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        85 --------~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                              ..++||||+. ++|.+++... ..+++..++.++.||+.||+|||++|++|+||||+||++   +.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEE
Confidence                    4699999996 5888877654 368999999999999999999999999999999999999   67789999


Q ss_pred             cccccccccCCCC-----CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Q 043425          156 ADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       156 ~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~  229 (575)
                      +|||++..+....     ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+.......+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999997653322     12345678899999998654 47889999999999999999999999887665544333311


Q ss_pred             cC------------------CCCCC----------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          230 EL------------------HFPPD----------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       230 ~~------------------~~p~~----------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ..                  .++..          ....+..+.+||.+||..||.+|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            00                  00100          00124677899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-41  Score=342.63  Aligned_cols=258  Identities=27%  Similarity=0.501  Sum_probs=212.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI-LKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ++|.+.+.||+|+||.||+|.+..+|..||+|.+........ ...+..|+.+ ++.++||||+++++++...+.+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            479999999999999999999999999999999876543332 3445566665 66778999999999999999999999


Q ss_pred             eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           91 EYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        91 Ey~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ||++ |+|.+++..    ...+++..++.++.||+.||+|||++ +++||||||+|||+   +.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence            9996 688877754    24689999999999999999999998 99999999999999   777899999999998765


Q ss_pred             CCCCcccccCCCCCCChHHHhh----ccCCcccccchhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGLAETLCGSPLYMAPEIMQL----QKYDAKADLWSVGAILFQLVTGKTPFTGS-NQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~----~~y~~kaDIWSLGviLyeLltG~~PF~~~-~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .........|+..|+|||++..    ..++.++|+||||+++|+|++|..||... ...+.+..+.......++.  ..+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA--EKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc--ccc
Confidence            4433444678999999999864    45788999999999999999999999753 2333344444433333332  247


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +.++.+||.+||..+|.+||+++++++||||.....
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            899999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-41  Score=333.26  Aligned_cols=253  Identities=37%  Similarity=0.699  Sum_probs=226.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            58999999999999999999999999999999987766656667789999999999999999999999989999999999


Q ss_pred             cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           93 CKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        93 ~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      +++++|.+++.+.    ..+++..+..++.||+.||.+||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccCc
Confidence            9999999999764    679999999999999999999999999999999999999   667889999999998765443


Q ss_pred             -CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       .....+|++.|+|||.+....++.++|+||+|+++|+|++|..||...+.......+........+   ..++.++.++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELRNL  234 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHHHH
Confidence             344568999999999998888999999999999999999999999988877777766554332222   3578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +++||..+|.+|||+.++++||||
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=340.43  Aligned_cols=253  Identities=30%  Similarity=0.550  Sum_probs=214.2

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL-KRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL-~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|.+..+|+.||||++.+..... .....+..|..++ ...+||||+++++++...+.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999987644322 2223344555544 456899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccC
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG  175 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~G  175 (575)
                      ++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||++   +..+.+||+|||++.....   .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999988889999999999999999999999999999999999999   6678899999999875433   334578


Q ss_pred             CCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-ChhcccHHHHHHHHHhhcc
Q 043425          176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       176 T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-~~~~ls~el~dLI~k~L~~  254 (575)
                      ++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... .++. ....++.++.++|.+||..
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-NWPEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-CCCCcccccCCHHHHHHHHHHccC
Confidence            9999999999888899999999999999999999999999888777766654432 2222 2235789999999999999


Q ss_pred             CCCCCC---CHHHHHcCCCCCCCCch
Q 043425          255 NPVERL---TFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       255 DP~~Rp---Ta~eiL~Hpff~~~~~~  277 (575)
                      ||.+||   +++|++.||||....|+
T Consensus       235 ~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         235 DPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CHHHccCCCcHHHHHcChHhhcCCCC
Confidence            999999   55899999999887664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.6e-41  Score=343.31  Aligned_cols=260  Identities=25%  Similarity=0.494  Sum_probs=217.1

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP-   83 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~-   83 (575)
                      ..+...++|.+.+.||+|+||.||+|.+..+|+.+|+|++....   .....+.+|+.+++++ +||||+++++++... 
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            45677889999999999999999999999999999999986532   2234577899999998 799999999998653 


Q ss_pred             ----CEEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           84 ----GKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        84 ----~~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                          +.+++||||++|++|.++++.    ...+++..++.++.|++.||+|||+.|++||||||+||++   +..+.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEE
Confidence                468999999999999998853    3578999999999999999999999999999999999999   66778999


Q ss_pred             cccccccccCCCC-CcccccCCCCCCChHHHhhc-----cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Q 043425          156 ADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQ-----KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       156 ~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~-----~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~  229 (575)
                      +|||++....... ......|++.|+|||++...     .++.++|||||||++|+|++|++||........+..+.+..
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            9999987654332 22346789999999998643     36789999999999999999999999887766555554432


Q ss_pred             cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       230 ~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      ..... .....+.++.+||.+||.+||.+||++.|+++||||+
T Consensus       250 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 PPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22221 1224677899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-41  Score=337.44  Aligned_cols=255  Identities=26%  Similarity=0.511  Sum_probs=215.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---NKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l   86 (575)
                      .+|.+.+.||+|+||.||+|.+..+|..||||.+.....   ..+....+.+|+.+++++.||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999999864322   223446788999999999999999999988653  568


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++|++|.+++.+.+.+++..+..++.||+.||+|||+.||+|+||||+|||+   +.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccccc
Confidence            8999999999999999887889999999999999999999999999999999999999   6778899999999876532


Q ss_pred             C----CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          167 R----GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       167 ~----~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      .    .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||........+..+...  ...+.....++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  236 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCCchhhCH
Confidence            1    1223457899999999998888999999999999999999999999877655554443322  112222345788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      .+.++|++|+. +|.+||+++++++|||+.
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            89999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-41  Score=347.01  Aligned_cols=258  Identities=32%  Similarity=0.544  Sum_probs=218.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +|.+.+.||+|+||.||+|.+..+|+.||||.+......   ......+..|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999876543   33445677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence            9999 899999998766 79999999999999999999999999999999999999   667889999999998765432


Q ss_pred             -CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC------------
Q 043425          169 -LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP------------  234 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p------------  234 (575)
                       ......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+....+.++.........            
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence             2333457889999999854 46788999999999999999999999888776666555432111000            


Q ss_pred             ------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 ------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 ------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                  ......+.++.+||.+||.+||.+|||+.|++.|+||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                        0012356789999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-41  Score=347.47  Aligned_cols=261  Identities=29%  Similarity=0.549  Sum_probs=224.5

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|....+|.+.+.||.|+||.||+|.+..+|+.||+|.+......  ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            355567799999999999999999999999999999999765432  245678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++|+||++|++|..++... .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccc
Confidence            9999999999999998754 68999999999999999999999999999999999999   6678899999999876544


Q ss_pred             CCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ... ....+|++.|+|||.+....++.++|+|||||++|+|++|..||.+.+.......+....... ......++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFR  246 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHH
Confidence            322 334578999999999998889999999999999999999999999887766555544332211 122245788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||..||.+||++.+++.||||+..
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            99999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.3e-41  Score=334.80  Aligned_cols=249  Identities=32%  Similarity=0.600  Sum_probs=217.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.++||+|+||.||++.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            58999999999999999999999999999999875432 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           93 CKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      +++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||++   +..+.++|+|||++....... .
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccc
Confidence            9999999988653  458999999999999999999999999999999999999   677889999999997664332 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+........+   ..++.++.+||+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~  233 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSLIK  233 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHHHH
Confidence            34567999999999999888999999999999999999999999988877776666554332222   357889999999


Q ss_pred             HhhccCCCCCCCHHHHHcC
Q 043425          250 KLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~H  268 (575)
                      +||++||.+||++.+++.-
T Consensus       234 ~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         234 QMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhCCcccCCCHHHHhhc
Confidence            9999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-41  Score=348.93  Aligned_cols=251  Identities=28%  Similarity=0.486  Sum_probs=195.6

Q ss_pred             EEEEecccCCeEEEEEEEcC--CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 043425           16 VGRQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE--VPGKLHLILE   91 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~--~~~~l~LVmE   91 (575)
                      .+.+||+|+||.||+|.++.  ++..||+|.+.....    ...+.+|+.+++.++||||+++++++.  ....+++|||
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            34689999999999999764  668999999875432    234678999999999999999999884  3567899999


Q ss_pred             ecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC-CCCCcEEEcccccc
Q 043425           92 YCKGGDLSMYIQRH---------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFA  161 (575)
Q Consensus        92 y~~GgsL~~~l~~~---------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~vKL~DFGla  161 (575)
                      |+. ++|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ +..+.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            996 5788777422         248899999999999999999999999999999999999543 45678999999999


Q ss_pred             cccCCCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHH---------HHHHHHHH
Q 043425          162 RSLQPRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---------QLLQNIVK  227 (575)
Q Consensus       162 ~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---------~~l~~i~~  227 (575)
                      +......    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....         ..+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            8654322    2345678999999999876 45889999999999999999999999754321         11111111


Q ss_pred             hccCC-------------C---------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          228 ATELH-------------F---------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       228 ~~~~~-------------~---------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .....             +                     .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000             0                     00001234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-41  Score=339.73  Aligned_cols=256  Identities=29%  Similarity=0.541  Sum_probs=215.9

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN--------KKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~--------~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+......        ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            589999999999999999999999999999988643211        112356788999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccccc
Confidence            999999999999999999888889999999999999999999999999999999999999   67789999999998764


Q ss_pred             CCCC---CcccccCCCCCCChHHHhhcc--CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh-ccCCCCCC-h
Q 043425          165 QPRG---LAETLCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA-TELHFPPD-A  237 (575)
Q Consensus       165 ~~~~---~~~~~~GT~~Y~APEvl~~~~--y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~-~~~~~p~~-~  237 (575)
                      ....   ......|+..|+|||++....  ++.++|+||||+++|+|++|..||...........+... ....++.. .
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            3221   223457899999999987654  888999999999999999999999876655444333322 12222222 2


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ..++.++.++|.+||.+||.+||+++++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            4578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=337.49  Aligned_cols=254  Identities=31%  Similarity=0.552  Sum_probs=214.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC-----
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG-----   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~-----   84 (575)
                      .++|++.+.||+|+||.||+|.++.+++.+++|++.....   ..+.+.+|+.+++++ .|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4789999999999999999999998999999999876432   345688999999998 6999999999996544     


Q ss_pred             -EEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           85 -KLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        85 -~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                       .+++||||+++++|.+++..    +..+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCc
Confidence             58999999999999999865    3579999999999999999999999999999999999999   667889999999


Q ss_pred             cccccCCC-CCcccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          160 FARSLQPR-GLAETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       160 la~~~~~~-~~~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      ++...... .......|++.|+|||++..     ..++.++||||||++||+|++|..||........+..+.+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            98765332 22345678999999999853     3467889999999999999999999987766666655554432222


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .. ...++.++++||.+||..||.+|||++++++|||+
T Consensus       239 ~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KS-PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             Cc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            21 12367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-41  Score=356.70  Aligned_cols=260  Identities=29%  Similarity=0.524  Sum_probs=217.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||.+.+..........+.+|+.++++++||||++++++|...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            357889999999999999999999999999999999876444444456678999999999999999999988543     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+. ++|.+.+...  +++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence             35799999995 5888887654  8999999999999999999999999999999999999   777889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----------  232 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----------  232 (575)
                      ............|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.+.....          
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            7655544455678999999999999999999999999999999999999998877655554443211100          


Q ss_pred             -------------------------CCCC----hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 -------------------------FPPD----AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 -------------------------~p~~----~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                               ++..    ....+.++++||.+||+.||.+|||+.|+|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                                     0000    11246678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-41  Score=342.92  Aligned_cols=255  Identities=27%  Similarity=0.511  Sum_probs=213.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV-----   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~-----   82 (575)
                      .-.+.|++.+.||.|+||.||+|.+..+++.+|+|++...   ......+..|+.+++++ +||||+++++++..     
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3457899999999999999999999999999999998653   23345678899999988 69999999999842     


Q ss_pred             -CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           83 -PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        83 -~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                       ...+|++|||+++|+|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+||++   +..+.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence             46789999999999999998753  458899999999999999999999999999999999999   667789999999


Q ss_pred             cccccCCC-CCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          160 FARSLQPR-GLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       160 la~~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      ++...... .......|++.|+|||++.     ...++.++|+|||||++|+|++|..||...........+.+......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  246 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence            98755322 2234567999999999985     35688899999999999999999999987765554444333322111


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                        ....++.++.+||.+||..||.+|||+.|+++||||
T Consensus       247 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 --KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence              123578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-41  Score=345.02  Aligned_cols=257  Identities=28%  Similarity=0.522  Sum_probs=217.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|.+.++||+|+||.||+|.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47999999999999999999999899999999987654444445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      |++++.|..+......+++..+..++.||+.||.|||+.|++||||+|+||++   +.++.++|+|||++..+.... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcccc
Confidence            99999999888766679999999999999999999999999999999999999   677889999999988654332 23


Q ss_pred             ccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-----------------
Q 043425          171 ETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-----------------  232 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-----------------  232 (575)
                      ....|+..|+|||++.+ ..++.++||||||+++|+|++|++||.+....+....+.......                 
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34568999999999875 457788999999999999999999998877655544444211110                 


Q ss_pred             -CCC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 -FPP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 -~p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                       .+.         ..+.++..+.+|+++||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             000         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-41  Score=335.69  Aligned_cols=256  Identities=30%  Similarity=0.566  Sum_probs=224.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++.+.||+|+||.||+|.+..+|..||||++...... .....+.+|+.++..++|+||+++++++...+.+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            3689999999999999999999999999999998765432 445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |+++++|.+++.....+++..+..++.||+.||+|||+ .|++||||+|+||++   +.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCCc
Confidence            99999999999888889999999999999999999999 999999999999999   77789999999999876544332


Q ss_pred             -ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC---CHHHHHHHHHHhccCCCCCChhc-ccHHHH
Q 043425          171 -ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATELHFPPDAKI-LSADCK  245 (575)
Q Consensus       171 -~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~---~~~~~l~~i~~~~~~~~p~~~~~-ls~el~  245 (575)
                       ....++..|+|||.+....++.++|+||||+++|+|++|..||...   ...+....+........+   .. ++..+.
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~  233 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP---AEEFSPEFR  233 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCC---cccCCHHHH
Confidence             3567899999999999889999999999999999999999999877   444555555433222222   23 788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++|++||..+|++||++.++++||||+..
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-42  Score=370.21  Aligned_cols=262  Identities=28%  Similarity=0.495  Sum_probs=228.1

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc-cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      |..++.||-|+||+|.++...+|...||+|.+.+.. +.......++.|..||.....+.||+||..|++.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            778899999999999999999999999999987654 3444456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc--------
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--------  164 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~--------  164 (575)
                      ++||++-.+|-+.+.|.|..++.++.+|.+|+++.|+.|+|||||||+||||   |.+|+|||.||||+..+        
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecccccc
Confidence            9999999999999999999999999999999999999999999999999999   99999999999998642        


Q ss_pred             -CCC----------------------------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC
Q 043425          165 -QPR----------------------------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG  209 (575)
Q Consensus       165 -~~~----------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG  209 (575)
                       +.+                                  .....++||+.|+|||++...+|+..+||||.|||||+|+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence             110                                  022346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCC---CHHHHHcCCCCCCCCchhhh
Q 043425          210 KTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       210 ~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~Rp---Ta~eiL~Hpff~~~~~~~~~  280 (575)
                      .+||...+..+...++++.. .+.++.. ..++.++.++|.++++ +++.|+   .++|+..||||+.+++..+.
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~-~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslR  940 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIPYQ-GNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLR  940 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccccc-cccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhh
Confidence            99998877766555554433 3344443 4699999999999775 678888   47889999999999887744

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.6e-41  Score=339.74  Aligned_cols=249  Identities=19%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            46999999999999999999875   356789999987643 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||+   +.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccccc
Confidence            99999999999999764 578999999999999999999999999999999999999   67789999999987654332


Q ss_pred             CCcc--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GLAE--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~~~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ....  ...+++.|+|||++....++.++|||||||++|+|++ |..||.+.+..+.+..+........   ...++..+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  237 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA---PRNCPNLL  237 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHH
Confidence            2222  2345678999999999999999999999999999775 9999999888887777655433222   34578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+++.+||.++|.+||++++|++
T Consensus       238 ~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         238 HQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-41  Score=342.57  Aligned_cols=251  Identities=23%  Similarity=0.432  Sum_probs=216.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCC-----cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHG-----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-----~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..+|++.+.||+|+||.||+|.+...+     ..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            568999999999999999999987555     789999886543 34455678999999999999999999999998899


Q ss_pred             EEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      .+++|||+++++|.+++...                ..+++..+..++.||+.||.|||++|++||||||+|||+   ++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence            99999999999999999765                457889999999999999999999999999999999999   66


Q ss_pred             CCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      ++.+||+|||++.......   ......+++.|+|||++....++.++|||||||++|+|++ |..||.+....+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            7889999999997653322   2234567889999999988899999999999999999998 99999998888877766


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+......   ...++.++.+|+.+||+.||.+||++.|++++
T Consensus       240 ~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            65433222   24578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.4e-41  Score=344.84  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=207.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC----------------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcc
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV----------------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII   74 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~----------------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv   74 (575)
                      -++|++.++||+|+||.||+|.+..                ++..||+|++.... .......+.+|+.++.+++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            3689999999999999999998542                34579999987543 344456789999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeecCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccc
Q 043425           75 RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHR  135 (575)
Q Consensus        75 ~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~-------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHr  135 (575)
                      ++++++...+..++||||+++|+|.+++....                   .+++..+..++.||+.||.|||+.||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999999999999986532                   35677889999999999999999999999


Q ss_pred             cccCCceeeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh--CC
Q 043425          136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT--GK  210 (575)
Q Consensus       136 DLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt--G~  210 (575)
                      ||||+|||+   +..+.+||+|||+++.+....   ......+++.|+|||++....++.++||||||+++|+|++  +.
T Consensus       163 dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         163 DLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             CcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999   677889999999997654332   1233456888999999998899999999999999999986  67


Q ss_pred             CCCCCCCHHHHHHHHHHhc----cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          211 TPFTGSNQIQLLQNIVKAT----ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       211 ~PF~~~~~~~~l~~i~~~~----~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .||.+.+..+.+..+....    ...........+..+.+|+.+||..||.+|||++++.+
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            8898877766665443211    11111222356889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-41  Score=346.24  Aligned_cols=259  Identities=32%  Similarity=0.535  Sum_probs=217.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l   86 (575)
                      +.+++|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++++...  +.+
T Consensus         2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            456789999999999999999999999999999999986654444444577899999999999999999998777  889


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++|++|+||||+|||+   +.++.+||+|||++....
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYG  157 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeecc
Confidence            999999974 9999887643 58999999999999999999999999999999999999   677899999999998765


Q ss_pred             CC-CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC---------
Q 043425          166 PR-GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP---------  234 (575)
Q Consensus       166 ~~-~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p---------  234 (575)
                      .. .......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||......+.+.++........+         
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 233445688999999998754 4688999999999999999999999988877766655432111000         


Q ss_pred             -----------------CChhc--ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          235 -----------------PDAKI--LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       235 -----------------~~~~~--ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                       .....  ++..+.+||++||+.||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                             00111  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.1e-41  Score=342.70  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=211.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE-----
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGK-----   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~-----   85 (575)
                      ++|++.+.||+|+||.||+|.+..+|+.||||.+............+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999998765433333456788999999995 6999999999877655     


Q ss_pred             EEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-CCcEEEcccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFG  159 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFG  159 (575)
                      +|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||++   +. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~---~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---ecCCCeEEEeecc
Confidence            8999999985 888887643     357999999999999999999999999999999999999   44 7889999999


Q ss_pred             cccccCCC-CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-----
Q 043425          160 FARSLQPR-GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-----  232 (575)
Q Consensus       160 la~~~~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-----  232 (575)
                      ++..+... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+.......+.......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98765332 22233467889999999865 457899999999999999999999999887766655554321100     


Q ss_pred             -----------CC--------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          233 -----------FP--------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       233 -----------~p--------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                                 ++        ...+.++.++.+||.+||.+||.+||+++|++.||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                       00        00124788899999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.1e-41  Score=334.59  Aligned_cols=253  Identities=34%  Similarity=0.662  Sum_probs=220.1

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||+|.++.+|..+|+|.+..........+.+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58999999999999999999999999999999987655445556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC-CcEEEcccccccccCCCC-
Q 043425           93 CKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPRG-  168 (575)
Q Consensus        93 ~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~-g~vKL~DFGla~~~~~~~-  168 (575)
                      +++++|.+++.+..  .+++..+..++.||+.||.|||+.+++|+||||+||++   +++ ..+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL---SKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---cCCCCeEEecccccchhccCCcc
Confidence            99999999987643  47899999999999999999999999999999999999   444 457999999997765432 


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ......|++.|+|||++....++.++|+||||+++|+|++|..||...+..+....+....   +++....++.++.++|
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i  234 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---FAPISPNFSRDLRSLI  234 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---CCCCCCCCCHHHHHHH
Confidence            2234568999999999988889999999999999999999999999887777666555432   2222345788999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .+||..+|.+|||++++++||||
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-41  Score=343.65  Aligned_cols=257  Identities=28%  Similarity=0.489  Sum_probs=219.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..+|++.+.||+|+||.||++.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            357999999999999999999999999999999987543 3445667899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||+++++|..++.+.+.+++..+..++.|++.||.|||+ .|++||||||+||++   +..+.++|+|||++...... .
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-c
Confidence            999999999999888889999999999999999999997 599999999999999   67788999999998654322 2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHhccCCCCCChh
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-----------QLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-----------~~l~~i~~~~~~~~p~~~~  238 (575)
                      ....+|+..|+|||++....++.++|+|||||++|+|++|..||......           ..+..+.......++.  .
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  236 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS--S  236 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc--h
Confidence            34568999999999998888999999999999999999999999865542           2222333222222221  2


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .++.++.+|+.+||++||.+|||++|+++|+||.+.
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            367899999999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-41  Score=369.93  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=205.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||....        ..+.+|+.+|++++|+||+++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            4579999999999999999999999999999996432        23568999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      |++. ++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.+.... 
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccc
Confidence            9995 6888887654 569999999999999999999999999999999999999   667889999999997654322 


Q ss_pred             --CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhccC---CCCC
Q 043425          169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--------QIQLLQNIVKATEL---HFPP  235 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~--------~~~~l~~i~~~~~~---~~p~  235 (575)
                        .....+||+.|+|||++.+..++.++|||||||+||+|++|..|+....        ..++. ++++....   .++.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~-~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL-RIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH-HHHHhhccccccCCC
Confidence              2234679999999999999999999999999999999999886654321        22222 22222111   1110


Q ss_pred             ----------------------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          236 ----------------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       236 ----------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                                  ....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                        00134568999999999999999999999999999964

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.4e-41  Score=339.78  Aligned_cols=257  Identities=26%  Similarity=0.496  Sum_probs=212.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIE-----   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~-----   81 (575)
                      +...++|++.+.||+|+||.||+|.+..+|+.+|+|++....   .....+.+|+.+++.+ +||||+++++++.     
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            456778999999999999999999999999999999876432   2234577899999999 6999999999873     


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      .++.+++||||++|++|.+++..    ...+++..++.++.|++.||.|||+.+|+||||||+||++   +..+.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEcc
Confidence            34679999999999999998753    3568899999999999999999999999999999999999   6667899999


Q ss_pred             cccccccCCCC-CcccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          158 FGFARSLQPRG-LAETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       158 FGla~~~~~~~-~~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      ||++....... ......|++.|+|||++..     ..++.++|||||||++|+|++|..||........+..+......
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            99998664332 2334579999999999853     45788999999999999999999999887665544443332211


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .. .....++.++.+||.+||+.||.+|||+.|+++|+||
T Consensus       248 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            11 1122457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=328.28  Aligned_cols=253  Identities=32%  Similarity=0.611  Sum_probs=223.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||++.+..++..||+|.+............+.+|+.++++++|||++++++++...+.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58999999999999999999999999999999988766556667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-cc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-~~  171 (575)
                      +++++|.+++...+.+++..+..++.|++.||.+||++||+||||||+||++   +..+.++|+|||++........ ..
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccccc
Confidence            9999999999888889999999999999999999999999999999999999   5678899999999987654332 23


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ...|+..|+|||.+....++.++|+|+||+++|+|++|..||...........+......   .....++.++.+++.+|
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLMQC  234 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHH
Confidence            467899999999998888899999999999999999999999877765555444433222   22235789999999999


Q ss_pred             hccCCCCCCCHHHHHcCCCC
Q 043425          252 LRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpff  271 (575)
                      |..+|++|||+.+++.||||
T Consensus       235 l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         235 FQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.4e-41  Score=342.59  Aligned_cols=255  Identities=33%  Similarity=0.594  Sum_probs=213.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.+.||.|+||.||+|.+..+|..||||.+............+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999999876554444445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           93 CKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        93 ~~GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      +. ++|..++..  ...+++..+..++.||+.||+|||+.|++||||+|+||++   +.++.+||+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccc
Confidence            95 689888865  3568999999999999999999999999999999999999   677889999999987654322 2


Q ss_pred             cccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----------------
Q 043425          170 AETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----------------  232 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----------------  232 (575)
                      .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.+.....                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            33456789999999876543 6888999999999999999999999887666555544321111                


Q ss_pred             -CCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 -FPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 -~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                       ++.        ....++.+++++|.+||+.||.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence             000        012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.3e-41  Score=338.77  Aligned_cols=252  Identities=32%  Similarity=0.537  Sum_probs=209.4

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVP--GKLHLIL   90 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~l~LVm   90 (575)
                      |++.++||+|+||.||+|.+..++..||+|++....... ......+|+.++.++. |+||+++++++.+.  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            788999999999999999999999999999987543222 2233457888998885 99999999999887  8899999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||+.+ +|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+||++   +. +.+||+|||++........
T Consensus        80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCCC
Confidence            99974 78777765 3578999999999999999999999999999999999999   55 8999999999987755554


Q ss_pred             cccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-----------------C
Q 043425          170 AETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-----------------L  231 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-----------------~  231 (575)
                      .....+++.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....                 .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            455678999999998754 4568899999999999999999999998877665555443211                 0


Q ss_pred             CCCCC--------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 HFPPD--------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 ~~p~~--------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++..        ...++.++.+||.+||.+||.+||+++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11110        12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-41  Score=340.13  Aligned_cols=257  Identities=31%  Similarity=0.563  Sum_probs=209.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|.+.+.||+|+||.||+|.++.+|+.||||.+...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            357899999999999999999999999999999998754322 1223467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence            999975 999988764 468999999999999999999999999999999999999   777889999999987543221


Q ss_pred             -CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhccCC-------------
Q 043425          169 -LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSN-QIQLLQNIVKATELH-------------  232 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~-~~~~l~~i~~~~~~~-------------  232 (575)
                       ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.. ..+.+..+.+.....             
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             2223457889999999865 568899999999999999999999997765 333333332211000             


Q ss_pred             --------C-CC----Chhccc--HHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 --------F-PP----DAKILS--ADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 --------~-p~----~~~~ls--~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                              . +.    ....++  .++.+++.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    0 00    001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.6e-41  Score=341.38  Aligned_cols=261  Identities=31%  Similarity=0.531  Sum_probs=215.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|++.++||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++||||+++++++...+.+++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            46899999999999999999999999999999998765444444466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           91 EYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      ||++ ++|.+++....  .+++..++.++.||+.||+|||++|++||||+|+||++.  ..++.+||+|||++...... 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCc
Confidence            9995 58888876543  357889999999999999999999999999999999993  23467999999999765332 


Q ss_pred             CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------------
Q 043425          168 GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------------  232 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------------  232 (575)
                      .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||......+.+.++.......              
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            22234567899999999876 457889999999999999999999999887766665544321110              


Q ss_pred             ------CCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 ------FPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 ------~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                            ++.     ..+.++.++.+++.+||+.||.+||+++++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                  000     012467889999999999999999999999999999764

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-41  Score=334.19  Aligned_cols=252  Identities=33%  Similarity=0.592  Sum_probs=219.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||.|+||.||++++..+|+.+|+|++...... ....+.+.+|+.++++++||||+++++.+...+..|+||||++|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999765432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---------C
Q 043425           99 SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---------L  169 (575)
Q Consensus        99 ~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---------~  169 (575)
                      .+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++.......         .
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccccc
Confidence            9999887889999999999999999999999999999999999999   677889999999987543321         2


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .....+++.|+|||++....++.++|+||||+++|+|++|..||......+....+... ...++... .++.++.+|++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~i~  235 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-KIEWPEDV-EVSDEAIDLIS  235 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CcCCCccc-cCCHHHHHHHH
Confidence            23457889999999998888999999999999999999999999998888877776653 33333322 25899999999


Q ss_pred             HhhccCCCCCCCH---HHHHcCCCCCCCCc
Q 043425          250 KLLRRNPVERLTF---EEFFNHPFLSQTQP  276 (575)
Q Consensus       250 k~L~~DP~~RpTa---~eiL~Hpff~~~~~  276 (575)
                      +||+.+|.+|||+   .++++||||..+.|
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            9999999999999   99999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-40  Score=326.83  Aligned_cols=254  Identities=33%  Similarity=0.611  Sum_probs=221.4

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~LVm   90 (575)
                      +|.+.+.||+|+||.||+|.+..++..|++|++..........+.+.+|+.++++++||||+++++.+...  +.+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58899999999999999999999999999999987655555667889999999999999999999999888  8999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccccc
Confidence            999999999999888889999999999999999999999999999999999999   6678899999999987765543 


Q ss_pred             --cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          170 --AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN-QIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~-~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                        .....++..|+|||.+....++.++|+||||+++|+|++|..||.... .......+...  ...+.....++.++.+
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~  235 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHHHH
Confidence              455678999999999988889999999999999999999999998876 22222222211  1222223456899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ||.+||..||.+||++.++++||||
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-40  Score=330.85  Aligned_cols=252  Identities=32%  Similarity=0.589  Sum_probs=223.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.++||+|+||.||++.+..+|..+|+|.+............+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58999999999999999999999999999999987665666667788999999999999999999999989999999999


Q ss_pred             cCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           93 CKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        93 ~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      +++++|.+++.+    ...+++..+..++.||+.||.|||+.|++|+||+|.||++   ++.+.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC-
Confidence            999999999876    3568999999999999999999999999999999999999   55778999999999876554 


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....   ++.....++.++++++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li  233 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK---YPPIPPIYSQDLQNFI  233 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCchhhCHHHHHHH
Confidence            4445678999999999998899999999999999999999999999988777666655433   2333346789999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .+||..+|.+||++.++++||++
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         234 RSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-40  Score=333.61  Aligned_cols=252  Identities=28%  Similarity=0.568  Sum_probs=213.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc-cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|++.++||+|+||.||+|++..+|..||||.+.... ...+....+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            478999999999999999999999999999999886533 3445556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+|||+   +..+.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999988853    3458999999999999999999999999999999999999   667789999999988764


Q ss_pred             CCCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhccCCCCCC-hhccc
Q 043425          166 PRGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ--IQLLQNIVKATELHFPPD-AKILS  241 (575)
Q Consensus       166 ~~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~--~~~l~~i~~~~~~~~p~~-~~~ls  241 (575)
                      .... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....  ......+....   +++. ...++
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD---YPPLPTEHYS  234 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC---CCCCChhhcC
Confidence            4322 3346789999999999988899999999999999999999999976532  33333333222   2222 23567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+.++|.+||..+|.+||++.++++.
T Consensus       235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         235 EKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            889999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.7e-41  Score=340.24  Aligned_cols=254  Identities=30%  Similarity=0.537  Sum_probs=206.7

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH-HHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFIL---KRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~-~~~i~~Ei~iL---~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      .||+|+||.||++.+..+|+.+|+|.+......... .....+|..++   ...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999999765433221 22234444443   34579999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccccc
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC  174 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~  174 (575)
                      |++|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888899999999999999999999999999999999999999   777899999999987554332 23457


Q ss_pred             CCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          175 GSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI--QLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       175 GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~--~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      |++.|+|||++. +..++.++|+|||||++|+|++|..||......  ..+..........++   ..++.++.++|++|
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~  233 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP---DSFSPELKSLLEGL  233 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCc---cccCHHHHHHHHHH
Confidence            999999999986 456899999999999999999999999764322  122222211122222   35789999999999


Q ss_pred             hccCCCCCC-----CHHHHHcCCCCCCCCchhh
Q 043425          252 LRRNPVERL-----TFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       252 L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~  279 (575)
                      |+.||.+|+     +++++++||||....+.+.
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            999999999     6999999999998776554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=360.54  Aligned_cols=243  Identities=29%  Similarity=0.540  Sum_probs=214.3

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      .++++||+|-||+||+|... ....||+|.+....+..   +.+.+|+.+|++|+|+|||++++++..++.+||||||++
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            35688999999999999988 34599999998654432   457899999999999999999999998889999999999


Q ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccc
Q 043425           95 GGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET  172 (575)
Q Consensus        95 GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~  172 (575)
                      .|+|.++|+.  .+.+.......++.||+.|++||+++++|||||-..||||   +++..+||+|||+|+...+..+...
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCceeec
Confidence            9999999987  4579999999999999999999999999999999999999   7788999999999995544433221


Q ss_pred             c--cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          173 L--CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       173 ~--~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      .  --...|.|||.+....++.++|||||||+||||+| |+.||.+.++.+.++.+.++..+..|..   .|.++-++++
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~---CP~~vY~lM~  438 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG---CPDEVYELMK  438 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC---CCHHHHHHHH
Confidence            1  12335999999999999999999999999999998 9999999999999999999988877764   7899999999


Q ss_pred             HhhccCCCCCCCHHHHHc
Q 043425          250 KLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~  267 (575)
                      .||..+|++|||++.+..
T Consensus       439 ~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHhhCCcccCCCHHHHHH
Confidence            999999999999996643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-40  Score=340.23  Aligned_cols=240  Identities=21%  Similarity=0.325  Sum_probs=207.2

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEee
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKLHLILEY   92 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~LVmEy   92 (575)
                      ..||+|++|.||+|..  +|+.||||.+....... ...+.+.+|+.+|++++||||+++++++..    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999987  59999999997654322 334678899999999999999999999866    4578999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      ++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||+   +.++.+||+|||+++.+....  .
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--~  178 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--F  178 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--c
Confidence            99999999999888899999999999999999999985 99999999999999   677899999999997654322  2


Q ss_pred             cccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI  248 (575)
                      ...|++.|+|||++.+  ..|+.++|||||||++|+|++|..||.+.+..++...+.... ...++   ...+.++++|+
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~l~~li  255 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP---LDCPLEIKCIV  255 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC---CcCcHHHHHHH
Confidence            4578999999999976  689999999999999999999999999988888777765442 22222   24688999999


Q ss_pred             HHhhccCCCCCCCHHHHHc
Q 043425          249 QKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||+.||.+|||++|+++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999986

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-40  Score=324.47  Aligned_cols=252  Identities=33%  Similarity=0.602  Sum_probs=219.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|.+.+.||+|+||.||++.+..+|..+++|++.....  +....+.+|+.+++.++||||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            58999999999999999999998999999999976543  3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           93 CKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      ++|++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||++   ++++.++|+|||.+..........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccccc
Confidence            9999999999876 579999999999999999999999999999999999999   667889999999998765544345


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ...|+..|+|||++....++.++|+||||+++|+|++|..||...+................+. ...++.++.++|.+|
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~  234 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-PEKWSDEFKDFLKKC  234 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCc-ccccCHHHHHHHHHH
Confidence            6778999999999988889999999999999999999999999876555554444322222222 123488999999999


Q ss_pred             hccCCCCCCCHHHHHcCCC
Q 043425          252 LRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpf  270 (575)
                      |+.||.+|||+.+++.|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-40  Score=338.42  Aligned_cols=256  Identities=29%  Similarity=0.533  Sum_probs=210.5

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH-HHHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEI---FILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~-~~~i~~Ei---~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      .||+|+||.||+|.+..+|+.||+|.+......... ......|.   .+++...||||+.+++.+...+.+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999865443211 11233333   34555689999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccccc
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC  174 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~  174 (575)
                      |++|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++...... .....+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CCcCcC
Confidence            99999999888889999999999999999999999999999999999999   66788999999998765432 234568


Q ss_pred             CCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          175 GSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       175 GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~---~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      |++.|+|||++... .++.++||||+|+++|+|++|..||....   ..... .........++   ..++.++.+++.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~---~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELP---DSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhccCCCCC---CcCCHHHHHHHHH
Confidence            99999999999754 68999999999999999999999998763   22222 22222222233   2468999999999


Q ss_pred             hhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhh
Q 043425          251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       251 ~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~  282 (575)
                      ||..||.+||     +++++++||||....+......
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~  269 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ  269 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence            9999999999     9999999999999887776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.9e-41  Score=350.29  Aligned_cols=261  Identities=31%  Similarity=0.518  Sum_probs=215.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----G   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----~   84 (575)
                      +..+|.+.+.||+|+||.||+|.+..+|..||||.+............+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            34679999999999999999999999999999999876433333345677899999999999999999987544     3


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+|+|+||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||++   +..+.+||+|||++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTT  158 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccccc
Confidence            5899999995 6899999888889999999999999999999999999999999999999   66788999999999866


Q ss_pred             CCC-CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-----------
Q 043425          165 QPR-GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-----------  231 (575)
Q Consensus       165 ~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-----------  231 (575)
                      ... .......|+..|+|||++.. ..++.++|||||||++|+|++|++||.+.+.......+......           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            443 33445678999999999865 46889999999999999999999999887654433333221100           


Q ss_pred             ----------------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 ----------------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 ----------------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                      .+....+.++.++.+||++||+.||.+|||++++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                            0001113478899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.6e-41  Score=338.18  Aligned_cols=257  Identities=29%  Similarity=0.475  Sum_probs=221.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ..|...++||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.||||+++++.+...+..++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            468889999999999999999999999999999876533 3344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      |++|++|.+++.. +++++..+..++.|++.||+|||+++++|+||+|+||++   +..+.++|+|||++....... ..
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcccc
Confidence            9999999999864 578999999999999999999999999999999999999   667789999999997654333 22


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ....++..|+|||++.+..++.++|+||||+++|+|++|..||...........+.....   +.....++.++.+++.+
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  235 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHHHHH
Confidence            345688999999999888899999999999999999999999998877665554433222   22223577899999999


Q ss_pred             hhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          251 LLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ||..+|.+||++++++.|+||.....
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         236 CLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HcccCcccCcCHHHHHhChHhhhcch
Confidence            99999999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.5e-40  Score=337.36  Aligned_cols=259  Identities=24%  Similarity=0.412  Sum_probs=216.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      -++|.+.++||+|+||.||+|..+.     .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4679999999999999999997652     355899998865432 2334567899999999999999999999998999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           86 LHLILEYCKGGDLSMYIQRHG----------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~----------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .++||||+++|+|.+++...+          .++...+..++.||+.||.|||++||+||||||+|||+   +.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcEEE
Confidence            999999999999999997532          24567889999999999999999999999999999999   66788999


Q ss_pred             cccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccC
Q 043425          156 ADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       156 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +|||+++.......   .....++..|+|||.+....++.++|+|||||++|+|++ |..||.+....+....+......
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999876533221   122345778999999998899999999999999999998 89999998888877766654333


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc------CCCCCCCCc
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN------HPFLSQTQP  276 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~------Hpff~~~~~  276 (575)
                      ..+   ...+.++.+++.+||+.||.+|||+.++++      ||||..+.|
T Consensus       241 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         241 DQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            333   346789999999999999999999999987      899987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9e-41  Score=337.24  Aligned_cols=250  Identities=22%  Similarity=0.457  Sum_probs=214.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .++|.+.+.||+|+||.||+|.+..     ++..||||.+.... ..+..+.+.+|+.+++.+.||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            3568999999999999999998753     46889999987543 33345778999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRHG--------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~--------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      .++||||++|++|.+++...+              .+++..+..++.||+.||.+||++|++||||||+|||+   +..+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence            999999999999999997643              37889999999999999999999999999999999999   6778


Q ss_pred             cEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 043425          152 ALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK  227 (575)
Q Consensus       152 ~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~  227 (575)
                      .+||+|||++.......   ......+++.|+|||++....++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            99999999987653322   1233456788999999999999999999999999999998 9999999888887777665


Q ss_pred             hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       228 ~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.....+   ...+.++.+++++||.+||.+||+++|+++
T Consensus       240 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4332222   357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-40  Score=335.76  Aligned_cols=260  Identities=27%  Similarity=0.484  Sum_probs=215.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLHLI   89 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~LV   89 (575)
                      ++|+..++||.|+||.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++..  .+.+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            579999999999999999999999999999999875432 3445678999999999999999999998854  4579999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||++   +..+.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence            999999999988753    3468999999999999999999999999999999999999   666789999999987553


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhccCCCCCC---h
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS-----NQIQLLQNIVKATELHFPPD---A  237 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~-----~~~~~l~~i~~~~~~~~p~~---~  237 (575)
                      ... .....++..|+|||.+....++.++|+||||+++|+|++|..||...     ...+....+.......++..   .
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             ccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            322 23456889999999999899999999999999999999999999865     22333333333222111111   1


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ..+++++.+||.+||.+||.+|||+.|++.||||.....
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            235678999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-41  Score=357.48  Aligned_cols=251  Identities=28%  Similarity=0.441  Sum_probs=207.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCC-----CcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVH-----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|+++++||+|+||.||+|.+..+     +..||||.+.... .....+.+.+|+.+++.+ +|+||+++++++...
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            355799999999999999999986543     3579999997643 233456788999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc----------------------------------------------------------
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH----------------------------------------------------------  105 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~----------------------------------------------------------  105 (575)
                      +.+++|||||++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999998642                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC---c
Q 043425          106 ------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---A  170 (575)
Q Consensus       106 ------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~---~  170 (575)
                                  .++++..++.++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+++.+.....   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence                        247788899999999999999999999999999999999   6678899999999976543221   1


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI  248 (575)
                      ....+++.|+|||++....|+.++|||||||++|+|++ |+.||........+....... ....+   ..++.++.+++
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li  348 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP---DFAPPEIYSIM  348 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC---CCCCHHHHHHH
Confidence            22345678999999998899999999999999999997 999998876554444444332 22222   34689999999


Q ss_pred             HHhhccCCCCCCCHHHHHc
Q 043425          249 QKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||+.||.+|||++++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.1e-41  Score=344.48  Aligned_cols=262  Identities=26%  Similarity=0.508  Sum_probs=221.7

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.....|.....||+|+||.||++.+..++..||||.+....  ....+.+.+|+.+++.++||||+++++.+..++..+
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            334445666788999999999999999999999999986542  334566889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccc
Confidence            99999999999998854 568999999999999999999999999999999999999   66788999999998754322


Q ss_pred             -CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+....+..+........+ ....++..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-DSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-cccccCHHHHH
Confidence             2234467899999999998888999999999999999999999999988776666554443222222 22347889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ++.+||..||.+|||++++++||||.....
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            999999999999999999999999986533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=366.60  Aligned_cols=251  Identities=29%  Similarity=0.530  Sum_probs=217.0

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      +||+|.||+||.|++..|...+|||.|...  +....+-+..||.+.++|+|.|||+++|.+..++.+-|+||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            699999999999999999999999998754  334456688999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CCCccccc
Q 043425           99 SMYIQRH-GCV--PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLC  174 (575)
Q Consensus        99 ~~~l~~~-~~l--se~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~~~~~~~  174 (575)
                      .+++... |++  .|..+-.+.+||+.||.|||++.|||||||-+|+|+.  .-.|.+||+|||-++.+.. .....++.
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccc
Confidence            9999765 777  8999999999999999999999999999999999994  5678999999999987754 44567899


Q ss_pred             CCCCCCChHHHhhc--cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhh
Q 043425          175 GSPLYMAPEIMQLQ--KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL  252 (575)
Q Consensus       175 GT~~Y~APEvl~~~--~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L  252 (575)
                      ||..|||||++..+  +|+.++|||||||++.||.||++||......+...--+ +..-.-|+-+..++.+++.||.+|+
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcHHHHHHHHHHHHHHc
Confidence            99999999999765  68999999999999999999999997654333221111 1112224445679999999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCC
Q 043425          253 RRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       253 ~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+||..||++.++|..||++..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCcccCccHHHhccCcccccC
Confidence            9999999999999999999865

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-40  Score=335.26  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=214.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            569999999999999999999987     78899999886432 334456688999999999999999999999888899


Q ss_pred             EEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           87 HLILEYCKGGDLSMYIQRHG-------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      ++||||++|++|.+++...+       .+++..+..++.||+.||+|||++|++||||||+|||+..++....+||+|||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999999997653       48899999999999999999999999999999999999654445579999999


Q ss_pred             cccccCCCCCc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCC
Q 043425          160 FARSLQPRGLA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       160 la~~~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~  235 (575)
                      +++........   ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......++ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  243 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP-  243 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC-
Confidence            99866332221   12233567999999998899999999999999999996 99999988877776665544333333 


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                        ..++..+.+++.+||+.||.+||++.++++|
T Consensus       244 --~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         244 --KGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              3578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=333.42  Aligned_cols=254  Identities=32%  Similarity=0.557  Sum_probs=214.1

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE-----
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIRLHDIIEVPGK-----   85 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~~~~~-----   85 (575)
                      |++.+.||+|+||.||+|+++.+|..||+|.+............+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999998999999999976544333345566788877665   59999999999987776     


Q ss_pred             EEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ++++|||+.+ +|.+++.+..  .+++..++.++.||+.||.|||+.|++|+||+|+||++   +.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCccee
Confidence            9999999964 8999887643  58999999999999999999999999999999999999   6668999999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----C------
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----F------  233 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----~------  233 (575)
                      +..........+++.|+|||++.+..++.++|+||||+++|+|++|.+||.+....+.+.++.......    +      
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            655544455668999999999998899999999999999999999999999988877777665422110    0      


Q ss_pred             -------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          234 -------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       234 -------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                   ......++..+.++|++||+.||.+||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         00012356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-40  Score=336.62  Aligned_cols=250  Identities=28%  Similarity=0.487  Sum_probs=205.4

Q ss_pred             eeecCEEEEEEe--cccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            9 RVVGDYLVGRQI--GSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~L--G~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ...++|.+.+.+  |+|+||.||++.++.+|..+|+|++........       |+.+...+ +||||+++++.+...+.
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            345678887776  999999999999999999999999876433211       22222222 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC-cEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~~  164 (575)
                      +|+||||++|++|.+++..+..+++..++.++.||+.||.|||+.|++||||||+||++   +..+ .++|+|||++...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY---DRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---eCCCCeEEEecCccceec
Confidence            99999999999999999888889999999999999999999999999999999999999   4445 8999999998765


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhccCCCCCChhcccHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL-LQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~-l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...   ....|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ...+.... .........++..
T Consensus       161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (267)
T PHA03390        161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKN  236 (267)
T ss_pred             CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHH
Confidence            432   235689999999999999999999999999999999999999986544332 11121111 1112223468899


Q ss_pred             HHHHHHHhhccCCCCCCC-HHHHHcCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLT-FEEFFNHPFLS  272 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpT-a~eiL~Hpff~  272 (575)
                      +.+||.+||+.||.+||+ ++|+++||||.
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            999999999999999996 69999999995

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.8e-40  Score=335.50  Aligned_cols=256  Identities=27%  Similarity=0.522  Sum_probs=220.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      .|...++||+|+||.||++.+..+++.+|+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            4556689999999999999999899999999986532  23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~  171 (575)
                      ++|++|.+++.. +.+++..+..++.||+.||+|||++|++||||+|+||++   +.++.++|+|||++....... ...
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccc
Confidence            999999999877 678999999999999999999999999999999999999   677899999999887543322 223


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ...|++.|+|||++....++.++|+||||+++|+|++|..||...+.......+....... ......++..+.+||++|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-LKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-CcccccCCHHHHHHHHHH
Confidence            4579999999999988889999999999999999999999999888777766655442222 222234788999999999


Q ss_pred             hccCCCCCCCHHHHHcCCCCCCCC
Q 043425          252 LRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      |..||.+||++.++++||||....
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCC
Confidence            999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-40  Score=331.32  Aligned_cols=242  Identities=25%  Similarity=0.440  Sum_probs=208.2

Q ss_pred             EecccCCeEEEEEEE--cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           19 QIGSGSFSVVWHARH--RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      +||+|+||.||+|..  ..++..+|+|++..........+.+.+|+.+++.+.||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999965  457899999998766555566678999999999999999999999885 45679999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC----ccc
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL----AET  172 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~----~~~  172 (575)
                      +|.+++...+.+++..+..++.||+.||+|||++||+||||||.|||+   +.++.+||+|||++..+.....    ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCC
Confidence            999999888889999999999999999999999999999999999999   6678899999999987643322    122


Q ss_pred             ccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          173 LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       173 ~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ..+++.|+|||++....++.++|+||||+++|+|++ |..||...+..+....+.++.....|   ..++.++.+||.+|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~  234 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP---QRCPPEMYDLMKLC  234 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHH
Confidence            344678999999988889999999999999999998 99999988887777776655433333   35789999999999


Q ss_pred             hccCCCCCCCHHHHHc
Q 043425          252 LRRNPVERLTFEEFFN  267 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~  267 (575)
                      |++||.+||++++|..
T Consensus       235 ~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         235 WTYGVDERPGFAVVEL  250 (257)
T ss_pred             hccCchhCcCHHHHHH
Confidence            9999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.8e-40  Score=330.20  Aligned_cols=246  Identities=25%  Similarity=0.510  Sum_probs=211.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++.+.||+|+||.||++..+ .+..+|+|.+......   ...+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            57999999999999999999876 4568999988654332   3468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee
Confidence            99999999998753 568999999999999999999999999999999999999   67788999999998765433222


Q ss_pred             c--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          171 E--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       171 ~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .  ...++..|+|||++....++.++|+||||+++|+|++ |+.||...+..+.+..+........+   ...+.++.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~l  233 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEV  233 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHH
Confidence            1  2235668999999998899999999999999999999 99999998888887777665433333   3467889999


Q ss_pred             HHHhhccCCCCCCCHHHHHc
Q 043425          248 CQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.+||..||.+||+++++++
T Consensus       234 i~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.3e-40  Score=331.41  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=214.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ...+|.+.++||+|+||.||+|.+..++..||+|.+....   .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            4567999999999999999999999999999999987542   2345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+|||+   ++++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccc
Confidence            9999999999999754  358899999999999999999999999999999999999   67788999999999876543


Q ss_pred             CCcc--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GLAE--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~~~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ....  ...+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+........+   ...+.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP---EGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHH
Confidence            2211  2234668999999998999999999999999999998 99999998887777666554333333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+++.+||+.||.+||++.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-40  Score=334.79  Aligned_cols=254  Identities=33%  Similarity=0.592  Sum_probs=212.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      +|++.++||.|+||.||+|++..+|..||||++...... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            589999999999999999999999999999999765432 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           93 CKGGDLSMYIQRH---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        93 ~~GgsL~~~l~~~---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      +++ +|.+++...   ..+++..+..++.||+.||+|||+.|++||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc
Confidence            975 888888654   358999999999999999999999999999999999999   677889999999997653322 


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------------  232 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------------  232 (575)
                      ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.+.....               
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            2234567899999999865 457889999999999999999999999887766655544321100               


Q ss_pred             --CCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 --FPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 --~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                        ++.        ..+..+.++++++.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              000        012357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.7e-41  Score=355.54  Aligned_cols=251  Identities=28%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEE-----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARH-----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~   84 (575)
                      .++|+++++||+|+||.||+|..     ..++..||||++..... ....+.+.+|+.+|..+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            45799999999999999999974     34677899999865432 23446788999999999 8999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC----------------------------------------------------------
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG----------------------------------------------------------  106 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~----------------------------------------------------------  106 (575)
                      ..++|||||+||+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986432                                                          


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425          107 -----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus       107 -----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                                       .+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCccc
Confidence                             46788899999999999999999999999999999999   5677899999999986543321


Q ss_pred             ---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHH
Q 043425          170 ---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADC  244 (575)
Q Consensus       170 ---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el  244 (575)
                         .....++..|+|||++....++.++|||||||++|+|++ |..||.+......+....... ....+   ...+.++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  346 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP---ECAPSEM  346 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC---CCCCHHH
Confidence               122345677999999999999999999999999999997 899998876544443333322 22212   3467899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+|+.+||+.||.+||++.|+++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.9e-41  Score=339.13  Aligned_cols=261  Identities=27%  Similarity=0.456  Sum_probs=212.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+|...++||+|+||.||++.+..+|..||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4677788999999999999999999999999998765433 44566889999999996 999999999998899999999


Q ss_pred             eecCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           91 EYCKGGDLSMYIQ-----RHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        91 Ey~~GgsL~~~l~-----~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      ||+. +++.++..     ..+.+++..+..++.|++.||+|||+. ||+||||||+|||+   +..+.+||+|||++..+
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHh
Confidence            9985 46555432     236799999999999999999999975 99999999999999   66788999999999876


Q ss_pred             CCCCCcccccCCCCCCChHHHhhc---cCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhccCCCCCC-hhc
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKATELHFPPD-AKI  239 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~---~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~~~~~p~~-~~~  239 (575)
                      ..........|++.|+|||++...   .++.++||||||+++|+|++|++||..... .+.+..+........+.. ...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            554444456789999999999766   689999999999999999999999976542 122222222222222211 134


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      ++.++.+||.+||.+||.+|||++++++||||....+.
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            78899999999999999999999999999999875433

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=326.85  Aligned_cols=244  Identities=27%  Similarity=0.519  Sum_probs=214.7

Q ss_pred             EEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      +.||+|+||.||+|.+...   +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++...+.+++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4799999999999999866   9999999997654333 45678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           95 GGDLSMYIQRH---------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        95 GgsL~~~l~~~---------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +++|.+++...         ..+++..++.++.||+.||+|||++|++||||||+||++   +.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence            99999999875         789999999999999999999999999999999999999   677899999999998765


Q ss_pred             CCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ...   ......+++.|+|||++....++.++||||||+++|+|++ |..||......+....+........+   ..++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  233 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP---EYCP  233 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCC
Confidence            432   2344568889999999988899999999999999999999 69999999888887777664433333   3568


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++.+++.+||+.||.+|||++|++++
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         234 DELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-41  Score=343.16  Aligned_cols=259  Identities=27%  Similarity=0.508  Sum_probs=220.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .....|....+||+|+||.||+|.+..++..||+|++.....  ...+.+.+|+.+++.++||||+++++.+..++..++
T Consensus        18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            344456667789999999999999999999999999875432  234568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||+++++|..++.. ..+++..+..++.||+.||.|||++|++||||||+|||+   +.++.+||+|||++.......
T Consensus        96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccc
Confidence            9999999999998764 568999999999999999999999999999999999999   777899999999987554322


Q ss_pred             -CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       .....+|++.|+|||++....++.++|+||||+++|+|++|+.||......+.+..+.... .........++.++.++
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~  250 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDF  250 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHH
Confidence             2345679999999999998889999999999999999999999999887776665544332 22222234578899999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |++||+.+|.+||+++++++||||.+.
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccC
Confidence            999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.5e-40  Score=337.10  Aligned_cols=256  Identities=29%  Similarity=0.542  Sum_probs=206.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+||+++++++..++..|+||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3679999999999999999999999999999999865432 222335678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||+. ++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+   +..+.+||+|||+++..... .
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC
Confidence            9995 677776654 3568889999999999999999999999999999999999   66788999999998754322 2


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhccCC--------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELH--------------  232 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i~~~~~~~--------------  232 (575)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... +.+..+.......              
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            2344568999999999865 45788999999999999999999999865532 2222222110000              


Q ss_pred             ----C----CCC------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 ----F----PPD------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 ----~----p~~------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                          +    +..      ....+.++.+++.+||..||.+|||++|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                0    000      00125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.7e-41  Score=348.79  Aligned_cols=260  Identities=32%  Similarity=0.520  Sum_probs=215.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l   86 (575)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++..    ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999999999999999987654333445667889999999999999999998753    3578


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceeecc
Confidence            99999995 6899999877889999999999999999999999999999999999999   6778999999999976543


Q ss_pred             CC-----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC---------
Q 043425          167 RG-----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL---------  231 (575)
Q Consensus       167 ~~-----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~---------  231 (575)
                      ..     .....+|+..|+|||++.. ..++.++||||||+++|+|++|++||.+.+....+..+......         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            22     2234578999999999865 56889999999999999999999999887655444333221100         


Q ss_pred             --------------CCCC----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 --------------HFPP----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 --------------~~p~----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                    ..+.    ..+..+.++.++|++||+.||.+||++++++.||||.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                          0000    013468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=331.24  Aligned_cols=249  Identities=24%  Similarity=0.442  Sum_probs=211.2

Q ss_pred             EEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-----
Q 043425           14 YLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK-----   85 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~-----   85 (575)
                      |.+++.||+|+||.||+|....   ++..||+|.+............+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998765   34889999998765555556778999999999999999999998755443     


Q ss_pred             -EEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           86 -LHLILEYCKGGDLSMYIQRH------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        86 -l~LVmEy~~GgsL~~~l~~~------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                       .++||||+++|+|..++...      ..+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence             79999999999999988532      358999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCCc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          159 GFARSLQPRGLA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       159 Gla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      |+++........   ....++..|+|||++....++.++|||||||++|+|++ |.+||.+....+.++.+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            999865433221   12345678999999988899999999999999999999 99999998888877776655443333


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                         ...+.++.+++.+||..||.+|||+.|++++
T Consensus       238 ---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         238 ---EDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               3578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-40  Score=333.88  Aligned_cols=253  Identities=37%  Similarity=0.668  Sum_probs=222.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+|.+.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.+++++. ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4799999999999999999999999999999999764432 333466889999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.+||++|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999   667889999999987654322 


Q ss_pred             --------------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 043425          169 --------------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA  228 (575)
Q Consensus       169 --------------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~  228 (575)
                                          ......|+..|+|||++....++.++|+||||+++++|++|..||...+....+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                123456889999999998888999999999999999999999999988876666665533


Q ss_pred             ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCH----HHHHcCCCC
Q 043425          229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTF----EEFFNHPFL  271 (575)
Q Consensus       229 ~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa----~eiL~Hpff  271 (575)
                       ...++.   .++..+.+||++||+.||.+||++    +++++||||
T Consensus       238 -~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 -EYSFPP---NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -CCCCCC---ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             223332   468899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-40  Score=340.90  Aligned_cols=262  Identities=29%  Similarity=0.547  Sum_probs=222.4

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|...++|.+.+.||+|+||.||++.+..++..||+|.+.....  ...+.+.+|+.+++.++||||+++++.+...+..
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            45667899999999999999999999998999999999865432  2345688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+|+||+++++|.+++.+. .+++..+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccc
Confidence            9999999999999998754 58899999999999999999999999999999999999   6678899999999876543


Q ss_pred             CC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .. ......|++.|+|||++....++.++|+||||+++|+|++|..||...+....+..+.......++ ....++..+.
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHHH
Confidence            32 233457899999999998888999999999999999999999999887665544333332222222 1234678899


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ++|++||..+|.+||++++++.|+||....
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=337.17  Aligned_cols=254  Identities=32%  Similarity=0.568  Sum_probs=213.2

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |++.+.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999999999999999999866544444456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           94 KGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        94 ~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      + ++|.+++....  .+++..+..++.||+.||+|||++|++||||+|+||++   +.++.++|+|||++....... ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcccc
Confidence            5 68999987765  68999999999999999999999999999999999999   667889999999997653322 22


Q ss_pred             ccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC------------------
Q 043425          171 ETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL------------------  231 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~------------------  231 (575)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+....+..+.+....                  
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            334678899999987654 5788999999999999999999999988766555444332100                  


Q ss_pred             -------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          232 -------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       232 -------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                             ........++.++.++|.+||+.||.+|||++|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                   0011123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=345.87  Aligned_cols=259  Identities=34%  Similarity=0.542  Sum_probs=210.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----G   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----~   84 (575)
                      +.++|.+.++||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            4578999999999999999999999999999999986432 223445678899999999999999999887543     3


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+++|+||+. ++|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||+   +..+.+||+|||++...
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIA  156 (336)
T ss_pred             eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeec
Confidence            5899999996 588888754 579999999999999999999999999999999999999   77788999999998765


Q ss_pred             CCCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-------
Q 043425          165 QPRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-------  232 (575)
Q Consensus       165 ~~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-------  232 (575)
                      ....    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.......       
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            3322    2234678999999998754 568899999999999999999999998776544433322111000       


Q ss_pred             --------------CC------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 --------------FP------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 --------------~p------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                    ..      ...+..+.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                          00      0012357789999999999999999999999999999764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.1e-40  Score=334.21  Aligned_cols=251  Identities=20%  Similarity=0.408  Sum_probs=212.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEc----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHR----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+|++.++||+|+||.||+|.+.    .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            467999999999999999999853    456889999987533 334446788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           87 HLILEYCKGGDLSMYIQRH-----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      |+||||+++++|.+++...                 ..+++..+..++.||+.||.|||++||+||||||+|||+   +.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cC
Confidence            9999999999999998533                 237888899999999999999999999999999999999   66


Q ss_pred             CCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      .+.+||+|||+++......   ......++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.........+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            7789999999998654332   2234456778999999988889999999999999999998 99999988776666655


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ........   ...++.++.+++.+||+.||.+||++.+++++
T Consensus       240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPC---SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            54432222   23578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.6e-40  Score=338.00  Aligned_cols=250  Identities=27%  Similarity=0.452  Sum_probs=209.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCc--EEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~--~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ++|++.+.||+|+||.||+|....+|.  .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            579999999999999999999887765  46888776322 334456788999999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc
Q 043425           89 ILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA  152 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~  152 (575)
                      ||||+++++|.+++.+..                .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCe
Confidence            999999999999997542                47889999999999999999999999999999999999   66788


Q ss_pred             EEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccC
Q 043425          153 LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       153 vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +||+|||++..............+..|+|||++....++.++|||||||++|+|++ |..||.+....+....+......
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            99999999864322111122233557999999998899999999999999999997 99999998888877776554322


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+   ..++.++.+|+.+||..||.+||+++++++.
T Consensus       238 ~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 EKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222   3578899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-40  Score=339.10  Aligned_cols=259  Identities=31%  Similarity=0.526  Sum_probs=211.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      ..+++|.+.++||+|+||.||+|.++.+|+.+|||++............+.+|+.+++.++||||+++++++...     
T Consensus         5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            457999999999999999999999999999999999876543333334567899999999999999999987433     


Q ss_pred             ---CEEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           84 ---GKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        84 ---~~l~LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                         ..+++||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence               357999999965 67776654 3579999999999999999999999999999999999999   777899999999


Q ss_pred             cccccCCCCC------------cccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 043425          160 FARSLQPRGL------------AETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV  226 (575)
Q Consensus       160 la~~~~~~~~------------~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~  226 (575)
                      ++........            .....|++.|+|||++.+ ..++.++||||||+++|+|++|++||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9976533211            123467889999998865 458899999999999999999999999888777666555


Q ss_pred             HhccCCC----------------------CCC----hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          227 KATELHF----------------------PPD----AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       227 ~~~~~~~----------------------p~~----~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .......                      +..    ...+..++.+||++||..||.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            4211100                      000    12345688999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-41  Score=346.43  Aligned_cols=259  Identities=33%  Similarity=0.522  Sum_probs=221.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-----KLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~l~   87 (575)
                      +|++.+.||.|+||.||+|.+..+|..||||.+............+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999999999999998765433445567889999999999999999999987664     799


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++ ++|.+++.+...+++..++.++.||+.||++||++||+||||||+|||+   +.++.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeeccc
Confidence            9999997 5899999887789999999999999999999999999999999999999   66789999999999876544


Q ss_pred             C----CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-------
Q 043425          168 G----LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-------  235 (575)
Q Consensus       168 ~----~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-------  235 (575)
                      .    ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+........+.       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            2    24456789999999999877 88999999999999999999999999988877766655432111100       


Q ss_pred             --------------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          236 --------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       236 --------------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                          ....++.++.+||++||++||.+||++++++.||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                                0123678899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-40  Score=333.94  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=220.4

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      -|++.++||.|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            37889999999999999999998999999999875433 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~  171 (575)
                      +++++|..++.. +.+++..+..++.|++.||.+||++|++|+||||+||++   +.++.++|+|||++..+.... ...
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchhhhc
Confidence            999999999864 568999999999999999999999999999999999999   667889999999987654332 223


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ...|+..|+|||.+....++.++|+|||||++|+|++|..||...........+.....   +.....++.++.+++.+|
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHHHH
Confidence            45789999999999888889999999999999999999999988777666655543322   222235788999999999


Q ss_pred             hccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          252 LRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      |..+|.+||++.++++||||.+...
T Consensus       237 l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         237 LNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             ccCChhhCcCHHHHHhCHHHhhhhh
Confidence            9999999999999999999987533

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=334.07  Aligned_cols=256  Identities=25%  Similarity=0.498  Sum_probs=216.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .|.+.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.+.   ||||+++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4788999999999999999999999999999987543 2333456789999999986   99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      |||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||++   +..+.++|+|||++..+.... 
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCcc
Confidence            999999999999865 478999999999999999999999999999999999999   667889999999998765433 


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......|++.|+|||++.. ..++.++|+||||+++|+|++|..||.+.........+.......++.  ..++.++.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  234 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED--NGYSKLLREF  234 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCc--ccCCHHHHHH
Confidence            2334579999999999865 456889999999999999999999998877655544333222112221  1378899999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +.+||+.||.+||++.+++.|+||....
T Consensus       235 i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         235 VAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            9999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-40  Score=332.94  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=211.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ..++|++.++||+|+||.||+|.++     .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3467999999999999999999865     245789999886432 2334556889999999999999999999999889


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEE
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG----------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~----------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                      ..++||||+++++|.+++....          .++...+..++.|++.||.|||+.|++||||||+|||+   +..+.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCEE
Confidence            9999999999999999987532          25677889999999999999999999999999999999   6678899


Q ss_pred             EcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcc
Q 043425          155 IADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       155 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      |+|||+++.......   .....+++.|+|||++....++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999876543222   112356788999999998899999999999999999998 7999999888777776665433


Q ss_pred             CCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       231 ~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...+   ...+..+.+++.+||+.||.+|||+.|++++
T Consensus       240 ~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222   3578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=327.52  Aligned_cols=254  Identities=27%  Similarity=0.526  Sum_probs=215.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR---LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l   86 (575)
                      .+|++.+.||+|+||.||+|.+..+|..||+|.+....   ........+.+|+.++++++||||+++++++...  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36999999999999999999999999999999886432   1233445788999999999999999999998654  568


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++|+||++|++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccccc
Confidence            9999999999999999887889999999999999999999999999999999999999   6677899999999976532


Q ss_pred             C----CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          167 R----GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       167 ~----~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      .    .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||........+..+.....  .+.....++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~  236 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVSD  236 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccCH
Confidence            1    122346789999999999888899999999999999999999999988766665554443221  1222345789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ++.++|.+||. +|.+||++.+++.|||.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.3e-40  Score=339.01  Aligned_cols=251  Identities=28%  Similarity=0.462  Sum_probs=208.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEE--EEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEV--AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~v--AVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~   87 (575)
                      .++|.+.+.||+|+||.||+|.++.+|..+  |+|.+... ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            468999999999999999999998887654  66665432 2344556788999999999 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           88 LILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      +||||+++++|.+++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||+   +..+
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999997543                47899999999999999999999999999999999999   6778


Q ss_pred             cEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcc
Q 043425          152 ALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       152 ~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      .+||+|||++.............++..|+|||++....++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            899999999864322111122234667999999988889999999999999999998 9999998887776665543322


Q ss_pred             CCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       231 ~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...   ....+.++.+|+.+||+.||.+||++++++.+
T Consensus       242 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         242 LEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            112   22467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-41  Score=341.42  Aligned_cols=258  Identities=29%  Similarity=0.468  Sum_probs=219.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ..|.+.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            346677889999999999999999999999999875533 2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~  170 (575)
                      |+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++..+.... ..
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcchhh
Confidence            9999999998864 578999999999999999999999999999999999999   567789999999997654332 22


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+........   ....+.++.++|.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~  235 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL---EGQYSKPFKEFVEA  235 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC---CcccCHHHHHHHHH
Confidence            345689999999999988899999999999999999999999987766655544433322222   23467899999999


Q ss_pred             hhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          251 LLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      ||..+|.+||++.++++||||......
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             HccCCcccCcCHHHHHHhHHHHHHhhh
Confidence            999999999999999999999765433

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-40  Score=328.31  Aligned_cols=243  Identities=27%  Similarity=0.492  Sum_probs=206.2

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGD   97 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Ggs   97 (575)
                      ++||+|+||.||+|.++.+|+.||+|.+... ...+....+.+|+.++++++||||+++++++...+.+++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4699999999999999999999999987643 344556678999999999999999999999999999999999999999


Q ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc---cc
Q 043425           98 LSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---TL  173 (575)
Q Consensus        98 L~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~---~~  173 (575)
                      |.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..........   ..
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCCCC
Confidence            999997654 68999999999999999999999999999999999999   667789999999987654322111   11


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhh
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL  252 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L  252 (575)
                      .++..|+|||.+....++.++||||||+++|+|++ |.+||...........+........+   ...+..+.+|+++||
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l  233 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP---ELCPDAVYRLMERCW  233 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc---ccCCHHHHHHHHHHc
Confidence            23456999999998889999999999999999997 99999887776666555544333332   356889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 043425          253 RRNPVERLTFEEFFN  267 (575)
Q Consensus       253 ~~DP~~RpTa~eiL~  267 (575)
                      ++||++|||+.++++
T Consensus       234 ~~~p~~Rps~~~~~~  248 (252)
T cd05084         234 EYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=338.57  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=205.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcC--CCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~   87 (575)
                      +|.+.++||+|+||.||+|.+..  +|..||+|.+..... .....+.+.+|+.+++.++||||+++++++...  +.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  899999999976431 122335678899999999999999999999887  8899


Q ss_pred             EEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec-CCCCCcEEEcccccc
Q 043425           88 LILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT-DDDNAALKIADFGFA  161 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~-dd~~g~vKL~DFGla  161 (575)
                      +||||+++ +|.+++...     ..+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 777776432     36899999999999999999999999999999999999943 122789999999999


Q ss_pred             cccCCCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHH---------HHHHHHH
Q 043425          162 RSLQPRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ---------LLQNIVK  227 (575)
Q Consensus       162 ~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~---------~l~~i~~  227 (575)
                      .......    .....++++.|+|||++.+ ..++.++||||||+++|+|++|++||.+.....         .+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            8654322    2234578999999999876 457899999999999999999999998654322         1111111


Q ss_pred             hc-------------------------cCCCCCC--------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          228 AT-------------------------ELHFPPD--------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       228 ~~-------------------------~~~~p~~--------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ..                         ...++..        ....+.++.+++.+||..||.+|||+.|+++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            10                         0001100        01456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.3e-40  Score=331.68  Aligned_cols=249  Identities=24%  Similarity=0.456  Sum_probs=208.9

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCc--EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------PGK   85 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~--~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------~~~   85 (575)
                      |.++++||+|+||.||+|.+..++.  .+|+|.+..........+.+.+|+.+++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3578899999999999999887775  69999987765555666788999999999999999999997632      235


Q ss_pred             EEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      .++||||+++|+|..++...      ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence            78999999999999887421      347899999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCC
Q 043425          160 FARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       160 la~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~  235 (575)
                      ++........   .....+++.|+|||++....++.++||||||+++|+|++ |..||.+....+....+.+......+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  236 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP-  236 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence            9987643322   123356778999999999999999999999999999999 89999988887777766655433333 


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                        ..++..+.++|.+||+.||.+|||+++++++
T Consensus       237 --~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         237 --PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              3577899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.4e-40  Score=329.31  Aligned_cols=248  Identities=29%  Similarity=0.525  Sum_probs=205.3

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      ...||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            358999999999999999999999999887543  334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Cccc
Q 043425           97 DLSMYIQRH-GCV--PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAET  172 (575)
Q Consensus        97 sL~~~l~~~-~~l--se~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~~  172 (575)
                      +|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||++.  ...+.++|+|||++....... ....
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCcccc
Confidence            999999764 455  8889999999999999999999999999999999993  235689999999987654322 2334


Q ss_pred             ccCCCCCCChHHHhhcc--CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH-HH-HHhccCCCCCChhcccHHHHHHH
Q 043425          173 LCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ-NI-VKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       173 ~~GT~~Y~APEvl~~~~--y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~-~i-~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ..|++.|+|||++....  ++.++|+||||+++|+|++|..||.......... .. .....   +.....++.++++|+
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  245 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH---PEIPESLSAEAKNFI  245 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC---CCCCcccCHHHHHHH
Confidence            56899999999986543  7889999999999999999999997654322111 11 11111   222235788999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      ++||..+|.+|||+.|++.||||
T Consensus       246 ~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         246 LRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.4e-40  Score=334.44  Aligned_cols=260  Identities=30%  Similarity=0.560  Sum_probs=217.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++......  ....+.+.+|+.+++++ +|+||+.+++.++.++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   47899999998754321  23345678899999999 589999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6678999999999976544


Q ss_pred             CC--CcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCCCCChh
Q 043425          167 RG--LAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       167 ~~--~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~p~~~~  238 (575)
                      ..  .....+|+..|+|||++..  ..++.++||||||+++|+|++|..||.....    ..+...+... ...++   .
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~---~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP---Q  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCC---c
Confidence            32  2234679999999999865  3577899999999999999999999975432    2232333222 22222   3


Q ss_pred             cccHHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhh
Q 043425          239 ILSADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~  279 (575)
                      .++..+.+++++||..||.+||     +++++++||||+...|+..
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence            4788999999999999999997     8999999999999877554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-40  Score=329.82  Aligned_cols=250  Identities=23%  Similarity=0.428  Sum_probs=213.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCC-----CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVH-----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .++|.+.+.||+|+||.||+|..+..     +..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            46799999999999999999988744     4889999986543 33445678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           86 LHLILEYCKGGDLSMYIQRHG----------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~----------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .++||||+++|+|.+++....          .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCEEE
Confidence            999999999999999986432          36778899999999999999999999999999999999   67788999


Q ss_pred             cccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccC
Q 043425          156 ADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       156 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +|||+++.+.....   .....++..|+|||.+....++.++|||||||++|+|++ |..||.+.+..+..+.+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            99999976543322   234457889999999988889999999999999999998 99999998888877766644333


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..+.   ..+.++.+++.+||+.+|.+|||+.++++
T Consensus       241 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         241 DLPE---NCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3333   46899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7e-40  Score=334.08  Aligned_cols=248  Identities=26%  Similarity=0.501  Sum_probs=212.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+...  .......+.+|+.++++++||||+++++++...+.+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            46999999999999999999853     35667999988653  334456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           87 HLILEYCKGGDLSMYIQRHG-------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      ++||||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+|||+   ++.+.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcE
Confidence            99999999999999997543             38999999999999999999999999999999999999   677889


Q ss_pred             EEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Q 043425          154 KIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       154 KL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~  229 (575)
                      ||+|||++.......   ......+++.|+|||++....++.++|+|||||++|+|++ |.+||...........+..+.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999997653322   1223446788999999998899999999999999999998 999999988887777776654


Q ss_pred             cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       230 ~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....+   ..++.++.+|+.+||+.||.+|||++++++
T Consensus       240 ~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            32222   357889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.5e-40  Score=330.64  Aligned_cols=252  Identities=28%  Similarity=0.573  Sum_probs=212.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|.+.+.||+|+||.||+|.+..+|..+|||.+..... .......+.+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            4689999999999999999999999999999998875433 334456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||++|++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998863    3468999999999999999999999999999999999999   667889999999987654


Q ss_pred             CCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhccCCCCCChhcccH
Q 043425          166 PRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ--IQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       166 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~--~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ... .....+|++.|+|||++....++.++|+||||+++|+|++|..||.+...  ......+........+  ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP--SDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC--cccccH
Confidence            332 23356799999999999988999999999999999999999999976543  2333333322211111  235788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.+++.+||..||.+|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.6e-40  Score=327.55  Aligned_cols=247  Identities=26%  Similarity=0.493  Sum_probs=211.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.++||+|+||.||+|.+. ++..||+|.+.....   ..+.+.+|+.++++++|+||+++++.+...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            467999999999999999999875 567899998765322   3457889999999999999999999999899999999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++++|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+||++   +..+.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence            999999999999753  468899999999999999999999999999999999999   677899999999998764332


Q ss_pred             C--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 L--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .  .....++..|+|||++....++.++|||||||++|+|++ |..||.+.........+......  + ....++.++.
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~  234 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--P-RMENCPDELY  234 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--C-CCCCCCHHHH
Confidence            2  122345678999999988889999999999999999998 99999988887777766554322  2 2235788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||..||.+||+++++++
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.6e-40  Score=333.47  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=214.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCC-----CcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVH-----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~   81 (575)
                      ..-.++|++.+.||+|+||.||++.+...     ...+|+|.+..... .+....+.+|+.+++++ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34456899999999999999999988643     37899999875433 33445688999999999 7999999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeee
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC  145 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~  145 (575)
                      ..+.+++||||+++|+|..++...                +.+++..+..++.||+.||+|||++||+||||||+|||+ 
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~-  165 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-  165 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE-
Confidence            999999999999999999999642                458899999999999999999999999999999999999 


Q ss_pred             cCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHH
Q 043425          146 TDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQL  221 (575)
Q Consensus       146 ~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~  221 (575)
                        ++.+.+||+|||+++.+.....   .....++..|+|||++....++.++|||||||++|+|++ |..||.+....+.
T Consensus       166 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         166 --TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             --cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence              6678999999999987654322   122335678999999998899999999999999999997 9999999888777


Q ss_pred             HHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       222 l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...+........+   ...+.++.+|+.+||..||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGYRMEKP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            7766554333323   3467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.9e-40  Score=333.83  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=212.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCC----------------cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcc
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHG----------------TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII   74 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg----------------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv   74 (575)
                      .++|+++++||+|+||.||+|.+..++                ..||+|.+.... .....+.+.+|+.++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999999877544                558999887543 334566789999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           75 RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-----------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        75 ~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~-----------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      ++++++...+..++||||+++++|..++.+..           .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999998899999999999999999998765           6899999999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh--CCCCCCCCCH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT--GKTPFTGSNQ  218 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt--G~~PF~~~~~  218 (575)
                      +   +..+.++|+|||++.......   ......+++.|+|||++....++.++|||||||++|+|++  |..||...+.
T Consensus       163 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         163 V---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             e---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9   666889999999987654332   2234557788999999988889999999999999999998  7889988777


Q ss_pred             HHHHHHHHHh----ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          219 IQLLQNIVKA----TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       219 ~~~l~~i~~~----~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+.+..+...    ......+.....+.++.+|+.+||..||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7766655433    111111122346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.4e-40  Score=339.95  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=209.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcE----EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~----vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+|++.+.||+|+||.||+|.+..+|..    ||+|++... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            45799999999999999999998766664    899988643 2344556788999999999999999999998754 57


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++|+||+.+|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccccc
Confidence            8999999999999999865 468899999999999999999999999999999999999   667789999999998765


Q ss_pred             CCCCc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRGLA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      .....   ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+........   ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT  237 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence            43322   22334678999999999999999999999999999997 9999998877665544433322222   23567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++.+++.+||..||.+||++.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=327.64  Aligned_cols=250  Identities=24%  Similarity=0.473  Sum_probs=213.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ++|.+.+.||+|+||.||+|.++.+   ...||||.+.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            5799999999999999999998754   4579999886543 34445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-  166 (575)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||+   +..+.++|+|||++..... 
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccccc
Confidence            99999999999999764 478999999999999999999999999999999999999   6778899999999987642 


Q ss_pred             CCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          167 RGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       167 ~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...  .....+++.|+|||.+....++.++||||||+++|+|++ |..||......+....+........+   ...+..
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  236 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP---MDCPSA  236 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHH
Confidence            111  112345678999999998899999999999999999997 99999888877777666554332222   357889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+|+.+||..||++||++++++++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=331.72  Aligned_cols=254  Identities=32%  Similarity=0.557  Sum_probs=214.2

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEe
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKLHLILE   91 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~LVmE   91 (575)
                      |.+.++||+|+||.||+|.+..+|..+|+|.+............+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7889999999999999999999999999999987643344456688999999999999999999999887  89999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      |+++ +|..++... ..+++..++.++.||+.||+|||+.|++|+||||+|||+   ++++.+||+|||++.......  
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence            9975 898888765 579999999999999999999999999999999999999   678899999999998765443  


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP------------  235 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~------------  235 (575)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+.+......+.            
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2334567889999998754 467889999999999999999999999888776666555421110000            


Q ss_pred             --------------Chhc-ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          236 --------------DAKI-LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       236 --------------~~~~-ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                    .... ++.++.+++++||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          0011 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.7e-40  Score=336.74  Aligned_cols=260  Identities=30%  Similarity=0.504  Sum_probs=214.7

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      .+.+++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.++++++||||+++++++....   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            45678999999999999999999999999999999999765433334456778999999999999999999986544   


Q ss_pred             -------EEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           85 -------KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        85 -------~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                             .+++|+||+++ ++..++... ..+++..++.++.||+.||.|||+.||+||||||+||++   ++++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence                   79999999976 677777654 468999999999999999999999999999999999999   777899999


Q ss_pred             ccccccccCCCC--CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          157 DFGFARSLQPRG--LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       157 DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      |||++.......  ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.+......
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999997664332  2223456888999998864 4578899999999999999999999998777666655544211110


Q ss_pred             C--------------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          234 P--------------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       234 p--------------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +                          .....++..+.++|.+||..||.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                          0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-39  Score=324.87  Aligned_cols=252  Identities=29%  Similarity=0.590  Sum_probs=212.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.++++++|+||+++++.+...+..++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            3689999999999999999999999999999999875433 334466789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||+++++|..++..    ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999999864    2458999999999999999999999999999999999999   667889999999987654


Q ss_pred             CCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhccCCCCCChhcccH
Q 043425          166 PRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--QIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       166 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~--~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....  .......+........+  ...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP--ADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC--hhhcCH
Confidence            332 2344678999999999998899999999999999999999999996543  22333333333222222  125788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.++|.+||..+|.+|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.3e-40  Score=337.26  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=218.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      .....|.+.+.||+|+||.||+|.+..+|+.||+|++..... ..+....+.+|+.+++.++||||+++++++...+..+
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            445669999999999999999999999999999999865432 3344567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||++.....
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence            9999996 577776654 4578999999999999999999999999999999999999   6778899999999876533


Q ss_pred             CCCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      .   ....|++.|+|||++.   ...++.++||||||+++|+|++|..||.+.+.......+........+.  ..++.+
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  242 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS--NDWSDY  242 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCc--hhhCHH
Confidence            2   3457889999999874   4568889999999999999999999999887766655554432222221  246789


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +.++|.+||..||.+||++.+++.||||.....
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence            999999999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-40  Score=367.02  Aligned_cols=267  Identities=22%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCC-cEEEEEEe--------------ec-CccCHHHHHHHHHHHHHHHhCCCCC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEI--------------AM-GRLNKKLQESLMSEIFILKRINHPH   72 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-~~vAVK~i--------------~~-~~~~~~~~~~i~~Ei~iL~~L~Hpn   72 (575)
                      ...++|+++++||+|+||.||+|..+... ...++|.+              .+ ..........+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999999875432 22222211              11 0112233456789999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD  147 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~-----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d  147 (575)
                      |+++++++...+..|+|+|++. ++|..++...     .......++.++.||+.||+|||++|||||||||+|||+   
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence            9999999999999999999994 5777776432     223467788999999999999999999999999999999   


Q ss_pred             CCCCcEEEcccccccccCCCC--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC-CC--CHHHHH
Q 043425          148 DDNAALKIADFGFARSLQPRG--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT-GS--NQIQLL  222 (575)
Q Consensus       148 d~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~-~~--~~~~~l  222 (575)
                      +..+.+||+|||++..+....  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..++. ..  .....+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            677889999999998765432  2335689999999999999999999999999999999999886543 22  222233


Q ss_pred             HHHHHhcc---CCCCC-----------------------C--hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          223 QNIVKATE---LHFPP-----------------------D--AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       223 ~~i~~~~~---~~~p~-----------------------~--~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ..++....   ..++.                       .  ...++.++.++|.+||.+||.+|||+.|+|.||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            23222111   00110                       0  01245678889999999999999999999999999886


Q ss_pred             Cchhh
Q 043425          275 QPDQV  279 (575)
Q Consensus       275 ~~~~~  279 (575)
                      ..+..
T Consensus       461 ~~~~~  465 (501)
T PHA03210        461 EEEEI  465 (501)
T ss_pred             CchHH
Confidence            55443

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-39  Score=327.20  Aligned_cols=247  Identities=23%  Similarity=0.459  Sum_probs=211.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ++|.+.+.||+|+||.||+|... .+..+|+|.+......   .+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            57999999999999999999876 3556999988754332   3468899999999999999999999988888999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |+.+|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||+   +.++.+||+|||+++........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee
Confidence            99999999999764 468999999999999999999999999999999999999   66788999999998765443322


Q ss_pred             c--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          171 E--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       171 ~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .  ...++..|+|||++....++.++||||||+++|+|++ |..||...+..+....+........+   ...+..+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  233 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVYAI  233 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHHHH
Confidence            1  2235567999999998889999999999999999998 99999988887777777655433222   3468899999


Q ss_pred             HHHhhccCCCCCCCHHHHHcC
Q 043425          248 CQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+||+.||.+||++.+++.+
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=332.41  Aligned_cols=254  Identities=33%  Similarity=0.569  Sum_probs=216.5

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |.+.+.||+|++|.||+|.+..+|+.+|+|.+............+.+|+.+++.++||||+++++++..++.+++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999999999999998876555455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccc
Q 043425           94 KGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAE  171 (575)
Q Consensus        94 ~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~  171 (575)
                      ++ +|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccccc
Confidence            75 888877663 589999999999999999999999999999999999999   667889999999998765543 233


Q ss_pred             cccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC----------------
Q 043425          172 TLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP----------------  234 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p----------------  234 (575)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..+........+                
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            45688899999998876 7889999999999999999999999988877766555432111100                


Q ss_pred             ----------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          235 ----------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       235 ----------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                                .....++.++.+||.+||.+||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      0112367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8e-40  Score=332.90  Aligned_cols=263  Identities=31%  Similarity=0.560  Sum_probs=216.9

Q ss_pred             CEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      +|.+.+.||+|+||.||++.+.   .++..||||++.+....  ......+.+|+.++.++ +||||+++++.+...+.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   46789999998754322  22345678999999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++||+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence            9999999999999999887889999999999999999999999999999999999999   6678899999999876543


Q ss_pred             CCC--cccccCCCCCCChHHHhhcc--CCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCCCCChh
Q 043425          167 RGL--AETLCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       167 ~~~--~~~~~GT~~Y~APEvl~~~~--y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~p~~~~  238 (575)
                      ...  ....+|++.|+|||++.+..  ++.++|+||||+++|+|++|..||.....    ....+.+... .   ++...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~---~~~~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-K---PPFPK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-C---CCCCc
Confidence            322  23457899999999987654  78899999999999999999999964332    2222222222 1   22223


Q ss_pred             cccHHHHHHHHHhhccCCCCCCC---HHHHHcCCCCCCCCchhhhhh
Q 043425          239 ILSADCKDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpT---a~eiL~Hpff~~~~~~~~~~~  282 (575)
                      .++.++.+++.+||..||.+|||   +.++|+||||+...|+.+...
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~  280 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK  280 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence            57889999999999999999998   578899999999888765443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=331.16  Aligned_cols=263  Identities=31%  Similarity=0.560  Sum_probs=226.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.....|.+.+.||+|+||.||+|.+..++..||+|++.....   ....+.+|+.+++.++|+||+++++.+...+..+
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            4455669999999999999999999998999999999976432   4566889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhcc
Confidence            9999999999999998876 89999999999999999999999999999999999999   6678899999999865533


Q ss_pred             CC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......... ....++.++.
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~  247 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-NPEKWSPEFK  247 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-chhhCCHHHH
Confidence            21 223456889999999998888999999999999999999999999988776655555443322222 2234788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      +||.+||+.+|.+||++.++++|+||....+.
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence            99999999999999999999999999885443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4e-40  Score=333.83  Aligned_cols=251  Identities=23%  Similarity=0.422  Sum_probs=213.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..+|++.++||+|+||.||+|.+..     .+..||||++.... .....+.+.+|+.++..++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            3568889999999999999998754     35789999987543 34455678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      .++++||+.+++|.+++...                ..+++..+..++.|++.||+|||++||+||||||+|||+   ++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence            99999999999999998532                347888999999999999999999999999999999999   66


Q ss_pred             CCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      .+.+||+|||+++.......   .....+++.|+|||++....++.++|||||||++|+|++ |..||.+....+....+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            67899999999876543221   233456789999999988889999999999999999998 89999998888877777


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ........+   ...+.++.+|+.+||+++|.+||++++|+..
T Consensus       240 ~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            665433333   3578899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-39  Score=339.53  Aligned_cols=258  Identities=31%  Similarity=0.489  Sum_probs=212.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCC--CcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVH--GTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV----PGK   85 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~t--g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~----~~~   85 (575)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+............+.+|+.+++++ +||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999988  99999999875433333455678999999999 59999999987532    246


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +++++||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence            889999985 6899999888889999999999999999999999999999999999999   677889999999997654


Q ss_pred             CCC-----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---------
Q 043425          166 PRG-----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE---------  230 (575)
Q Consensus       166 ~~~-----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~---------  230 (575)
                      ...     ......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+....+..+.....         
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            322     1234579999999998765 5689999999999999999999999988776555544333211         


Q ss_pred             ------------------CCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          231 ------------------LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       231 ------------------~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                        ..++......+.++.+|+.+||+.||.+|||+.+++.||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                              01111112357889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=363.45  Aligned_cols=257  Identities=28%  Similarity=0.526  Sum_probs=223.2

Q ss_pred             ecCE-EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--E
Q 043425           11 VGDY-LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--K   85 (575)
Q Consensus        11 v~~Y-~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--~   85 (575)
                      -|+| +...+||+|+|-+||+|.+..+|-.||.-.++...+.  ....+.+..|+.+|+.|+||||+++|++..+..  .
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            3445 4567899999999999999999999998776655543  344588999999999999999999999886654  4


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +-+|.|++..|+|..|+++.+.++...++.|++||+.||.|||.+  -|||||||.+||+|+  +..|.|||+|+|||..
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence            889999999999999999999999999999999999999999998  699999999999994  6778999999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC-CCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT-GSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~-~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ..... +....|||.|||||+.. ..|+..+||||||++|+||+|+..||. +.++.++++++..+..+.-..  ..-.+
T Consensus       196 ~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dP  271 (632)
T KOG0584|consen  196 LRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDP  271 (632)
T ss_pred             hhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCH
Confidence            66544 44589999999999998 899999999999999999999999996 467777888888775432111  23478


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++++||.+||.. ...|||+.|+|+||||...
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999999 8999999999999999874

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.6e-40  Score=328.08  Aligned_cols=250  Identities=26%  Similarity=0.464  Sum_probs=215.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +-..+|.+.++||.|+||.||+|.+.. +..+|+|++....  ......+..|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            344679999999999999999999987 8999999987643  2234568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCC
Confidence            99999999999999753  468999999999999999999999999999999999999   6778899999999976643


Q ss_pred             CCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          167 RGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       167 ~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ... .....++..|+|||++....++.++||||||+++|+|++ |..||.+.+..+.+..+........+   ..++.++
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  233 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP---AKCPQEI  233 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC---CCCCHHH
Confidence            322 223345678999999998899999999999999999998 89999998888777776654332222   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+++.+||+.||.+|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-39  Score=341.68  Aligned_cols=258  Identities=29%  Similarity=0.517  Sum_probs=211.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-------
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-------   83 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-------   83 (575)
                      .++|.+.+.||.|+||.||+|.+..+|..||+|++.....  .....+.+|+.+++.++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            4789999999999999999999999999999999876543  3345688999999999999999999876543       


Q ss_pred             -------CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           84 -------GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        84 -------~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                             ..+|+||||++ ++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+||++.  ..++.+||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~  157 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIG  157 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEEC
Confidence                   35899999996 589888764 4799999999999999999999999999999999999993  245679999


Q ss_pred             ccccccccCCCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          157 DFGFARSLQPRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       157 DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      |||++..+....    ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999997654321    1223468899999998754 56888999999999999999999999988766655554432211


Q ss_pred             CCC--------------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 HFP--------------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 ~~p--------------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ..+                          .....++.++.+||++||+.||.+|||+++++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            100                          0012467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-39  Score=370.10  Aligned_cols=149  Identities=27%  Similarity=0.527  Sum_probs=138.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|.++++||+|+||.||+|.+..+++.||||++..... .......+..|+.+++.++||||+++++++...+.+|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            6889999999999999999999999999999999976443 344556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      |||+.|++|.+++...+.+++..++.++.||+.||+|||.+|||||||||+|||+   +..+.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999   667889999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=324.66  Aligned_cols=247  Identities=27%  Similarity=0.478  Sum_probs=210.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+......   .+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            356999999999999999999976 4678999998764332   355889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||++|++|.+++....  .+++..+..++.|++.||.+||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCc
Confidence            9999999999997654  68999999999999999999999999999999999999   677889999999998765332


Q ss_pred             Ccc--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 LAE--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~~~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ...  ...++..|+|||++....++.++|+||||+++|+|++ |+.||.+.+....+..+........+   ...+..+.
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP---PGCPKELY  234 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CcCCHHHH
Confidence            211  1223457999999998899999999999999999999 99999998887777766544322222   35788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||+.||.+||++++++.
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.9e-40  Score=341.67  Aligned_cols=254  Identities=22%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             EEeccc--CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~G--aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ..||+|  +||+||++++..+|+.||+|++.......+..+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  999999999999999999999987655555567889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC----
Q 043425           96 GDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL----  169 (575)
Q Consensus        96 gsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~----  169 (575)
                      ++|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.++++||+.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccc
Confidence            9999998864  358999999999999999999999999999999999999   5667899999986543321110    


Q ss_pred             ----cccccCCCCCCChHHHhhc--cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-----------
Q 043425          170 ----AETLCGSPLYMAPEIMQLQ--KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-----------  232 (575)
Q Consensus       170 ----~~~~~GT~~Y~APEvl~~~--~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-----------  232 (575)
                          .....++..|+|||++.+.  .++.++|||||||++|+|++|.+||...................           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                1112356679999999763  57889999999999999999999998876655443333221100           


Q ss_pred             --------------------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 --------------------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 --------------------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                                      ..+....++.++.+|+++||+.||.+|||++|+++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                            000112356789999999999999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=329.85  Aligned_cols=254  Identities=35%  Similarity=0.617  Sum_probs=216.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |++.+.||+|.||.||+|++..+++.||+|++..........+.+.+|+.+++.++|+||+++++++...+.+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999999876534444567789999999999999999999999889999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccc
Q 043425           94 KGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAE  171 (575)
Q Consensus        94 ~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~  171 (575)
                      + ++|.+++.+. ..+++..+..++.|++.||++||++||+||||+|+||++   ++++.++|+|||++....... ...
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccccC
Confidence            7 5899999876 579999999999999999999999999999999999999   677899999999997664432 233


Q ss_pred             cccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-----------------CC
Q 043425          172 TLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-----------------HF  233 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-----------------~~  233 (575)
                      ...++..|+|||++... .++.++|+||||+++|+|++|.+||.+.+....+..+......                 .+
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            45668889999998766 7889999999999999999999999988877666555432110                 00


Q ss_pred             C--------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          234 P--------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       234 p--------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      +        ...+.++.++.++|++||..||.+||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0        0112347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-39  Score=333.57  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=212.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDI   79 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~   79 (575)
                      ....++|.+++.||+|+||.||+|++..       ++..+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3445789999999999999999998643       33579999987543 233446688999999999 79999999999


Q ss_pred             EEeCCEEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           80 IEVPGKLHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        80 ~~~~~~l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      +...+.+|+||||+++|+|.+++...+                .++...+..++.||+.||+|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                4788899999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCCCc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI  219 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~  219 (575)
                      +   +.++.+||+|||++.........   ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+....
T Consensus       173 l---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         173 V---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             E---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9   66788999999998765432211   12234578999999998899999999999999999998 89999988877


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +....+........+   ...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            766665544332322   3578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-39  Score=330.91  Aligned_cols=249  Identities=26%  Similarity=0.485  Sum_probs=211.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .++|.+.+.||+|+||.||+|.+.     .++..+++|.+....  ......+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            467999999999999999999864     345678999876432  3334568899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      .++||||+++++|.+++..++                .+++..+..++.||+.||+|||++||+||||||+|||+   +.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence            999999999999999997543                37899999999999999999999999999999999999   67


Q ss_pred             CCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      ++.++|+|||++.......   ......|++.|+|||++....++.++||||||+++|+|++ |..||...+..+....+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7899999999997654322   2234557888999999998999999999999999999998 99999988887777666


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .......   .....+.++.+++.+||.+||.+||++.++++
T Consensus       239 ~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            5443222   22357889999999999999999999999977

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-39  Score=341.49  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=217.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      ..+.++|.+.+.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            45678899999999999999999999999999999998765444445567889999999999999999999986543   


Q ss_pred             ---EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           85 ---KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        85 ---~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                         .+++||||+ |++|..++.. ..+++..++.++.||+.||+|||+.||+||||||+||++   +..+.+||+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~  165 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA  165 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccc
Confidence               469999999 7899988864 579999999999999999999999999999999999999   66788999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------  232 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------  232 (575)
                      ......  .....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+.......+.+.....        
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            765432  234578999999999875 457889999999999999999999999887665555444321100        


Q ss_pred             -------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 -------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 -------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                         +......++.++.++|.+||+.||.+|||+.+++.||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                               000112467789999999999999999999999999999765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-40  Score=343.23  Aligned_cols=260  Identities=29%  Similarity=0.468  Sum_probs=218.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK--   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~--   85 (575)
                      ....++|.+.+.||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++...+.  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            356778999999999999999999999999999999987643334445667889999999999999999988765544  


Q ss_pred             ----EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           86 ----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        86 ----l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                          +++|+||+ |++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||++   +.++.+||+|||++
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~  165 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA  165 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccc
Confidence                89999999 6799999875 579999999999999999999999999999999999999   66788999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC-------
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF-------  233 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~-------  233 (575)
                      ......  .....+++.|+|||++.. ..++.++||||||+++|+|++|+.||.+.+....+..+........       
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            765432  345678999999999865 3678899999999999999999999998887766665544321100       


Q ss_pred             --------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 --------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 --------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                          ......++.++.+||++||+.||.+|||+.++++||||.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                                00112358899999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-39  Score=324.92  Aligned_cols=250  Identities=25%  Similarity=0.471  Sum_probs=211.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +++|++.+.||+|+||.||+|.++.++.   .||||.+... ........+..|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            4679999999999999999999887665   5999998654 24455677999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999999999999998764 568999999999999999999999999999999999999   6778899999999876543


Q ss_pred             CCCccc----cc--CCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          167 RGLAET----LC--GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       167 ~~~~~~----~~--GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      ......    ..  ++..|+|||++....++.++||||||+++|+|++ |..||...+..+....+........+   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~  235 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP---MD  235 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc---cc
Confidence            221111    11  2457999999998999999999999999999886 99999988877776666443222222   34


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+..+.+++.+||.++|.+||++++++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=324.73  Aligned_cols=247  Identities=22%  Similarity=0.483  Sum_probs=210.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++......   ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            46899999999999999999886 5778999998654332   2357789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |++|++|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc
Confidence            99999999999764 468999999999999999999999999999999999999   67788999999998765433221


Q ss_pred             c--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          171 E--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       171 ~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .  ...++..|+|||++....++.++|+||||+++|+|++ |.+||...+..+....+........+   ...+.++.++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  233 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP---KLAPTEVYTI  233 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC---CCCCHHHHHH
Confidence            1  1123457999999998999999999999999999998 89999988877777666554333333   3478999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcC
Q 043425          248 CQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+||..+|.+|||+.|+++.
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=339.75  Aligned_cols=261  Identities=30%  Similarity=0.477  Sum_probs=215.7

Q ss_pred             eecCEEE-EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH------------HHHHHHHHHHHHhCCCCCcceE
Q 043425           10 VVGDYLV-GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL------------QESLMSEIFILKRINHPHIIRL   76 (575)
Q Consensus        10 ~v~~Y~i-~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~------------~~~i~~Ei~iL~~L~HpnIv~l   76 (575)
                      +.++|.. .+.||.|+||.||+|.+..+|+.||||++.........            ...+.+|+.+++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            4567864 57799999999999999999999999998654332200            1246789999999999999999


Q ss_pred             EEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           77 HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        77 ~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                      ++++...+..++||||+. |+|.+++.....+++..+..++.||+.||+|||+.||+||||+|+||++   +..+.++|+
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl~  161 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIA  161 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEEC
Confidence            999999999999999996 6999999888889999999999999999999999999999999999999   677899999


Q ss_pred             ccccccccCCC---------------CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHH
Q 043425          157 DFGFARSLQPR---------------GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ  220 (575)
Q Consensus       157 DFGla~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~  220 (575)
                      |||++......               .......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999765411               112234578899999998754 46889999999999999999999999988877


Q ss_pred             HHHHHHHhccCCCC--------------------C----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          221 LLQNIVKATELHFP--------------------P----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       221 ~l~~i~~~~~~~~p--------------------~----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+..+........+                    .    .....+.++.++|++||++||.+||+++|++.||||+..
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            76665542211100                    0    012347789999999999999999999999999999754

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-39  Score=326.68  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+|++.++||+|+||+||+|.+..+|.    .||+|++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            4679999999999999999999877776    48999886543 34445678899999999999999999999865 457


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++++||+++|+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||+   ++.+.+||+|||+++.+.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeecc
Confidence            8999999999999999764 579999999999999999999999999999999999999   666789999999998764


Q ss_pred             CCCCc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRGLA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      .....   ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........   ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPICT  237 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccCC
Confidence            33221   12335678999999998899999999999999999998 9999988777666554444322222   23578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++.+++.+||..||++||++.+++.
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=336.40  Aligned_cols=274  Identities=28%  Similarity=0.575  Sum_probs=241.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH-HHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      +..+.+|+++++||+|+|+.|.+++++.|.+.||+|+++++-.+++ ...=+..|..+..+. +||.+|-++.+|++..+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            4567899999999999999999999999999999999988766543 234456788888765 68999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc-c
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS-L  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~-~  164 (575)
                      +++|.||++||+|--..++..+++|+.++.+..+|+.||.|||++|||+||||.+|+|+   |..|++||.|+|+++. +
T Consensus       326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l  402 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCC
Confidence            99999999999999889888999999999999999999999999999999999999999   8899999999999975 5


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC-------CCCHHHHHHHHHHhccCCCCCCh
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT-------GSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~-------~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      .+.....++||||.|+|||++++..|+..+|||+|||+|+||+.|+.||.       ..+.++.+.+++-..+...|.  
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--  480 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--  480 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--
Confidence            66777889999999999999999999999999999999999999999994       234556666665555666665  


Q ss_pred             hcccHHHHHHHHHhhccCCCCCC------CHHHHHcCCCCCCCCchhhhhhcccCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQVFRSRMFSR  287 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~Rp------Ta~eiL~Hpff~~~~~~~~~~~~~~~~  287 (575)
                       .++-.+-.+++..|++||.+|+      .+.++..|+||+.++|+.+-+....+.
T Consensus       481 -slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp  535 (593)
T KOG0695|consen  481 -SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP  535 (593)
T ss_pred             -eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence             4777888999999999999997      578999999999999988776655443

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-39  Score=332.05  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=216.6

Q ss_pred             CCCCCCeeecCEEEEEEecccCCeEEEEEEEc-------CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcc
Q 043425            3 QATGRGRVVGDYLVGRQIGSGSFSVVWHARHR-------VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHII   74 (575)
Q Consensus         3 q~~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~-------~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv   74 (575)
                      |........++|.+.+.||+|+||.||+|++.       ..+..||+|.+.... .......+.+|+.+++.+ +||||+
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~   84 (304)
T cd05101           6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNII   84 (304)
T ss_pred             cCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCch
Confidence            33444566788999999999999999999753       234579999886542 334456788999999999 799999


Q ss_pred             eEEEEEEeCCEEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCccccccc
Q 043425           75 RLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK  138 (575)
Q Consensus        75 ~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLK  138 (575)
                      ++++++...+.+++||||+.+|+|.+++.+.                ..++...+..++.||+.||.|||++||+|||||
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk  164 (304)
T cd05101          85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA  164 (304)
T ss_pred             heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999999999999999999999999764                246778899999999999999999999999999


Q ss_pred             CCceeeecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCC
Q 043425          139 PQNLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFT  214 (575)
Q Consensus       139 PeNILl~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~  214 (575)
                      |+|||+   +.++.+||+|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       165 p~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         165 ARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             cceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999999   6678899999999987643221   223446778999999998899999999999999999998 899999


Q ss_pred             CCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          215 GSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       215 ~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +....++...+........+   ...+.++.+|+.+||..+|.+||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         242 GIPVEELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            98888877776554333222   3578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-39  Score=324.55  Aligned_cols=250  Identities=24%  Similarity=0.469  Sum_probs=211.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      .++|++.+.||+|+||.||+|.++.++.   .+|+|.+.... .......+.+|+.++++++||||+++++++...+.++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3579999999999999999999875543   79999886543 3444567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||++|++|.+++.+. +.+++..+..++.|++.||.+||++|++||||||+|||+   +.++.++|+|||++..+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence            999999999999999765 468999999999999999999999999999999999999   6678899999999986643


Q ss_pred             CCC--c--ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          167 RGL--A--ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       167 ~~~--~--~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ...  .  ....++..|+|||++.+..++.++|+||||+++|+|++ |..||......+....+.+......   ....+
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  235 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDCP  235 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCCC
Confidence            321  1  11223567999999998899999999999999999886 9999998877776666655432222   23468


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..+.+++.+||+++|.+||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            89999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=321.29  Aligned_cols=245  Identities=38%  Similarity=0.702  Sum_probs=215.9

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      ||.|+||.||++.+..+++.+|+|++....... .....+..|+.+++.++||||+++++.++.++.+++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999999899999999998764432 3456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCcccccCCC
Q 043425           99 SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSP  177 (575)
Q Consensus        99 ~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~~~~GT~  177 (575)
                      .+++.....+++..+..++.||+.||.|||+.|++|+||+|+||++   +..+.++|+|||++...... .......|+.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTP  157 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence            9999988889999999999999999999999999999999999999   66778999999999776443 2344567899


Q ss_pred             CCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCC
Q 043425          178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV  257 (575)
Q Consensus       178 ~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~  257 (575)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ...++.   .++.++.+++++||..||.
T Consensus       158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~---~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-PLRFPE---FLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCCCC---CCCHHHHHHHHHHhcCCHh
Confidence            999999998888899999999999999999999999888876666665542 233333   4689999999999999999


Q ss_pred             CCCCH---HHHHcCCCC
Q 043425          258 ERLTF---EEFFNHPFL  271 (575)
Q Consensus       258 ~RpTa---~eiL~Hpff  271 (575)
                      +||++   +++++||||
T Consensus       234 ~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         234 KRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hCCCcccHHHHHhCCCC
Confidence            99999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.6e-39  Score=324.38  Aligned_cols=246  Identities=25%  Similarity=0.462  Sum_probs=207.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.+......   .+.+.+|+.+++.++||||+++++.+. .+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence            46799999999999999999988755 46999998754332   245789999999999999999999874 45689999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||++   ++++.+||+|||++..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccccc
Confidence            999999999999763  358899999999999999999999999999999999999   667889999999997664433


Q ss_pred             C--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 L--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .  .....++..|+|||++....++.++||||||+++|+|++ |..||.+....+....+........   ...++..+.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~  233 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLH  233 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHHHH
Confidence            2  123446678999999988899999999999999999999 8999998887777666654432222   235788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +|+.+||.+||.+||++.++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-39  Score=339.91  Aligned_cols=259  Identities=28%  Similarity=0.461  Sum_probs=213.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|.+.+.||+|+||.||+|.+..+|..||+|++..........+.+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            355789999999999999999999999999999999876433333445678999999999999999999988543     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ...|++++++ |++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||++   +.++.+||+|||++.
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~  168 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  168 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence             3478899887 7899888764 469999999999999999999999999999999999999   677889999999987


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC----------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----------  231 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~----------  231 (575)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......          
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            6432  2344678999999999866 56888999999999999999999999887766655544332110          


Q ss_pred             ------------CCCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 ------------HFPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 ------------~~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                  ..+.     .....+.++.+||.+||+.||.+||++.++++||||.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                        0000     011347789999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-39  Score=327.63  Aligned_cols=246  Identities=30%  Similarity=0.565  Sum_probs=207.3

Q ss_pred             EEEEEecccCCeEEEEEEEc----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHR----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+.+.||.|+||.||+|...    ..+..|+||.+.. .......+.+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            46889999999999999988    4678899999954 334455778999999999999999999999999888899999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++|||+   +.++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            999999999999886  679999999999999999999999999999999999999   667899999999998763222


Q ss_pred             ---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          169 ---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       169 ---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                         ......+...|+|||++....++.++||||||+++|||++ |..||...+..+....+.+......+   ..++..+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---DNCPKDI  234 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---TTSBHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec---cchhHHH
Confidence               1233456778999999999999999999999999999999 78999999988888888666554433   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++|.+||..||.+|||+.++++
T Consensus       235 ~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  235 YSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHh
Confidence            99999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.7e-39  Score=327.47  Aligned_cols=248  Identities=24%  Similarity=0.476  Sum_probs=211.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .+|.+.++||+|+||.||++...     .++..+|+|.+...  .......+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            46888999999999999999743     35678999987643  345566789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           87 HLILEYCKGGDLSMYIQRHG---------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~---------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      +++|||+++++|.+++...+               .+++..+..++.||+.||+|||++|++||||||+|||+   ++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cCCC
Confidence            99999999999999997653               47889999999999999999999999999999999999   6678


Q ss_pred             cEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 043425          152 ALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK  227 (575)
Q Consensus       152 ~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~  227 (575)
                      .+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            899999999875533221   223345788999999998999999999999999999998 9999988887777776665


Q ss_pred             hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       228 ~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ......+   ..++..+.+||.+||+.||.+||+++++++
T Consensus       240 ~~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5433322   357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-40  Score=352.43  Aligned_cols=253  Identities=31%  Similarity=0.548  Sum_probs=210.1

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|+++++||+||-+.||++... ..+.||+|.+.....+.+....+.+|+..|.+|. |.+|++++++-..++.+|||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4999999999999999999876 4567888877777778888889999999999996 8999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           92 YCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~l-se~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      |- ..+|..+|+++... +.-.++.|..|++.|++++|+.||||.||||.|+|+    -.|.+||+|||+|..+....  
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccc
Confidence            76 67999999877543 336899999999999999999999999999999998    35789999999998776544  


Q ss_pred             -CcccccCCCCCCChHHHhhcc-----------CCcccccchhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHh-ccCCCC
Q 043425          169 -LAETLCGSPLYMAPEIMQLQK-----------YDAKADLWSVGAILFQLVTGKTPFTGSN-QIQLLQNIVKA-TELHFP  234 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~-----------y~~kaDIWSLGviLyeLltG~~PF~~~~-~~~~l~~i~~~-~~~~~p  234 (575)
                       ...+.+||+.||+||.+....           .+.++||||||||||+|+-|++||.... ...-+..|..- ..+.||
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP  595 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence             355789999999999985332           4568999999999999999999998654 22223333322 123444


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ....  ..++.++++.||.+||.+||++.++|+|||++.
T Consensus       596 ~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  596 DIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            3322  234999999999999999999999999999976

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-39  Score=321.97  Aligned_cols=242  Identities=24%  Similarity=0.439  Sum_probs=205.6

Q ss_pred             EEecccCCeEEEEEEEcCCC---cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg---~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      ++||+|+||.||+|....++   ..+|+|.+...... .....+.+|+.+++.+.||||+++++++. .+..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            47999999999999876654   78999998766543 44567889999999999999999999876 456899999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc---
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---  171 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~---  171 (575)
                      +++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||||+|||+   +.++.+||+|||+++.........   
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccccc
Confidence            99999999888889999999999999999999999999999999999999   677889999999998664332211   


Q ss_pred             -cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          172 -TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       172 -~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                       ...++..|+|||.+....++.++||||||+++|+|++ |.+||...+..+....+........+   ...+..+.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~  232 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP---EECPQEIYSIML  232 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC---CCCCHHHHHHHH
Confidence             1123467999999998899999999999999999997 99999988877776666554332222   357889999999


Q ss_pred             HhhccCCCCCCCHHHHHc
Q 043425          250 KLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~  267 (575)
                      +||..||.+||++.++++
T Consensus       233 ~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         233 SCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-39  Score=341.08  Aligned_cols=259  Identities=29%  Similarity=0.509  Sum_probs=213.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      ++.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            345789999999999999999999999999999999876443344445678999999999999999999998654     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+++|+||+. .+|..++  ...+++..+..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||+++
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~  165 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR  165 (342)
T ss_pred             CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence             35699999995 4777665  3468999999999999999999999999999999999999   677899999999987


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      ....  ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+....+..+.......         
T Consensus       166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            6432  2234578899999999875 468899999999999999999999999887666555444321100         


Q ss_pred             -------------CCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          233 -------------FPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       233 -------------~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                   .+.     ..+..+.++.+||++||+.||.+||++++++.||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                         010     0123567899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.3e-39  Score=331.64  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=217.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|...++||+|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++|||++++++++......|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            37778899999999999999999999999999976533 23344568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      |+. |+|.+++.. ...+++..+..++.||+.||.|||++|++||||+|+||++   +.++.+||+|||++....   ..
T Consensus       102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~---~~  174 (313)
T cd06633         102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSS---PA  174 (313)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccC---CC
Confidence            996 577777754 4578999999999999999999999999999999999999   667889999999986432   23


Q ss_pred             ccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....|+..|+|||++.   ...++.++|+||||+++|+|++|..||...+.......+.........  ...++..+++|
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  252 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ--SNEWTDSFRGF  252 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--ccccCHHHHHH
Confidence            4567899999999984   456888999999999999999999999988776666655543222211  13467889999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      +.+||+++|.+||++.+++.||||.......+
T Consensus       253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         253 VDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             HHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            99999999999999999999999987654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=321.32  Aligned_cols=244  Identities=23%  Similarity=0.460  Sum_probs=211.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..+|++.+.||.|+||.||+|...  |+.||+|.+.....   ...++.+|+.+++.++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            457999999999999999999876  89999999975432   4567889999999999999999999998889999999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc
Confidence            9999999999998765  68999999999999999999999999999999999999   677889999999998763322


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .  ...++..|+|||++....++.++|+||||+++|+|++ |..||......+....+........+   ..++.++.++
T Consensus       157 ~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (256)
T cd05039         157 D--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP---EGCPPEVYKV  231 (256)
T ss_pred             c--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCc---cCCCHHHHHH
Confidence            2  3345667999999988889999999999999999997 99999988877776665544322222   3578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHc
Q 043425          248 CQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~  267 (575)
                      |.+||..+|.+||++.++++
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhccChhhCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-39  Score=342.08  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=204.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CC
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV-PG   84 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~-~~   84 (575)
                      ++|++.++||+|+||.||+|...     .+++.||+|++.... .......+..|+.++.++ +||||+++++++.. ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            47999999999999999999753     346889999987543 333445678999999999 79999999998754 46


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----------------------------------------------------------
Q 043425           85 KLHLILEYCKGGDLSMYIQRH-----------------------------------------------------------  105 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~-----------------------------------------------------------  105 (575)
                      .++++|||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            789999999999999998642                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCC
Q 043425          106 --GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYM  180 (575)
Q Consensus       106 --~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~  180 (575)
                        ..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+....   ......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              257889999999999999999999999999999999999   667789999999998753322   122345677899


Q ss_pred             ChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHh-ccCCCCCChhcccHHHHHHHHHhhccCCCC
Q 043425          181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA-TELHFPPDAKILSADCKDLCQKLLRRNPVE  258 (575)
Q Consensus       181 APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~-~~~~~p~~~~~ls~el~dLI~k~L~~DP~~  258 (575)
                      |||++.+..++.++|||||||++|+|++ |..||.+....+.+...... .....   ....+.++.+++.+||+.+|.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---PEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---CccCCHHHHHHHHHHccCChhh
Confidence            9999999999999999999999999997 99999876544443333322 22222   2356789999999999999999


Q ss_pred             CCCHHHHHcC
Q 043425          259 RLTFEEFFNH  268 (575)
Q Consensus       259 RpTa~eiL~H  268 (575)
                      ||+++|+++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.6e-39  Score=321.54  Aligned_cols=246  Identities=26%  Similarity=0.492  Sum_probs=209.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -++|+++++||+|+||.||+|... +++.||+|.+......   ...+.+|+.++++++||||+++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            357999999999999999999866 6788999998765433   346889999999999999999999874 56789999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCCC
Confidence            999999999998653  368899999999999999999999999999999999999   677889999999997665322


Q ss_pred             C--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 L--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .  .....++..|+|||++....++.++||||||+++|+|++ |++||.+.+..+....+........   ....+.++.
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  233 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR---PDNCPEELY  233 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence            2  123446778999999998899999999999999999998 9999998887777666654432222   234688999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||+.||.+||++++++.
T Consensus       234 ~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         234 ELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-39  Score=324.67  Aligned_cols=252  Identities=30%  Similarity=0.570  Sum_probs=213.3

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR---LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +|.+.++||+|+||.||++.+..++..+++|++....   ........+..|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5899999999999999999999888777777765422   2333344577899999999999999999999888899999


Q ss_pred             EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           90 LEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||++.   + +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~---~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK---N-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee---c-CCEeecccCceeecC
Confidence            999999999998864    35689999999999999999999999999999999999993   2 469999999987664


Q ss_pred             CC-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PR-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .. .......|++.|+|||.+....++.++|+||||+++|+|++|..||...........+.....   +.....++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPETYSRQL  233 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC---CCCcchhcHHH
Confidence            33 233456789999999999888899999999999999999999999988776666655554332   22223578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .++|.+||..||.+||++.++++||||
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.5e-39  Score=329.38  Aligned_cols=260  Identities=25%  Similarity=0.485  Sum_probs=213.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|.+.+.||+|+||.||+|.+..+|..||||.+....... ....+..|+.++..+ .||||+++++++......|
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            35678999999999999999999999999999999997654332 334566677766666 4999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||||+. ++|.+++.. .+.+++..+..++.||+.||+|||+ .||+||||+|+||++   +.++.+||+|||++..+.
T Consensus        91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhcc
Confidence            9999985 577777765 4578999999999999999999997 599999999999999   677899999999997765


Q ss_pred             CCCCcccccCCCCCCChHHHhhc----cCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQ----KYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~----~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .........+++.|+|||++...    .++.++||||||+++|+|++|+.||..... .+.+..+........+. ...+
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  245 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP-NEGF  245 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC-CCCC
Confidence            44444445688999999998754    388899999999999999999999976433 34444444433222222 2246


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +.++.+|+.+||..||.+||++++++.||||...
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            8899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-39  Score=322.02  Aligned_cols=247  Identities=27%  Similarity=0.493  Sum_probs=208.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|++.++||+|+||.||+|.+. .+..+|+|.+......   .+.+.+|+.++++++||||+++++++. .+..+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            3467999999999999999999876 5677999998765443   245889999999999999999999875 4568999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++   ++++.++|+|||++..+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccCc
Confidence            9999999999999753  358999999999999999999999999999999999999   66788999999999765433


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....++..|+|||++....++.++|+||||+++|+|++ |.+||.+.+..+....+........+   ...+..+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP---QDCPISL  232 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CcCCHHH
Confidence            22  122345667999999988889999999999999999999 99999988887777766554333222   3578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+|+.+||.+||.+|||++++.+
T Consensus       233 ~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         233 HELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.6e-39  Score=318.45  Aligned_cols=246  Identities=28%  Similarity=0.529  Sum_probs=213.3

Q ss_pred             EEEEEecccCCeEEEEEEEcCCC----cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg----~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+.+.||.|+||.||++.+...+    ..+|+|.+..... ......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            57789999999999999998766    9999999865432 224567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++++|.+++.....  +++..+..++.||+.||.+||+.|++||||||+||++   +..+.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccccc
Confidence            99999999999976544  9999999999999999999999999999999999999   677799999999998765442


Q ss_pred             Ccc--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 LAE--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~~~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ...  ...+++.|+|||.+....++.++|+||||+++|+|++ |.+||...+.....+.+........+   ...+.++.
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPEIY  234 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHHH
Confidence            222  1336789999999988889999999999999999998 89999988888887777665443333   34789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||+.||.+|||+.|+++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.4e-39  Score=321.57  Aligned_cols=244  Identities=23%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDII-EVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~-~~~~~l~L   88 (575)
                      ...+|.+.+.||+|+||.||++...  |..+|+|.+....    ..+.+.+|+.++++++|+||+++++++ ...+.+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            3468999999999999999999765  8899999886432    245688999999999999999999975 45567999


Q ss_pred             EEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||+++++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+||++   ++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999997654  48899999999999999999999999999999999999   6778899999999876433


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ..  ....++..|+|||++....++.++|||||||++|+|++ |++||...+..+....+.+......+   ..++..+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            22  33455678999999998899999999999999999997 99999988877776666554322222   35789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||+.||.+|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.6e-39  Score=331.05  Aligned_cols=251  Identities=26%  Similarity=0.436  Sum_probs=210.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIE   81 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~   81 (575)
                      -.++|.++++||+|+||.||+|.+..       .+..+|+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34679999999999999999998642       35579999887543 334456688999999999 5999999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeee
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC  145 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~  145 (575)
                      ..+.+++||||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||+ 
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-  167 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV-  167 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence            889999999999999999999753                347888999999999999999999999999999999999 


Q ss_pred             cCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHH
Q 043425          146 TDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQL  221 (575)
Q Consensus       146 ~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~  221 (575)
                        +.++.+||+|||+++.......   .....+++.|+|||++....++.++||||||+++|+|++ |..||.+....+.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence              6677899999999976543221   112234567999999998899999999999999999999 8999999888777


Q ss_pred             HHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       222 l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +..+........+   ...+.++++|+.+||..||.+||++.++++
T Consensus       246 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7766554333333   346789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=330.03  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=208.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCC--------------cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHG--------------TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH   77 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg--------------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~   77 (575)
                      ++|++.++||+|+||.||+|++..++              ..||+|.+... ......+.+.+|++++++++||||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            57999999999999999999876432              35899998754 3345566789999999999999999999


Q ss_pred             EEEEeCCEEEEEEeecCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeee
Q 043425           78 DIIEVPGKLHLILEYCKGGDLSMYIQRHG------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC  145 (575)
Q Consensus        78 ~~~~~~~~l~LVmEy~~GgsL~~~l~~~~------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~  145 (575)
                      +++...+..++||||+++++|.+++....            .+++..+..++.||+.||+|||++|++||||||+|||+ 
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill-  162 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-  162 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE-
Confidence            99999999999999999999999986532            36788899999999999999999999999999999999 


Q ss_pred             cCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh--CCCCCCCCCHHH
Q 043425          146 TDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT--GKTPFTGSNQIQ  220 (575)
Q Consensus       146 ~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt--G~~PF~~~~~~~  220 (575)
                        ++++.+||+|||++........   .....+++.|+|||++....++.++|+||||+++|+|++  |..||...+..+
T Consensus       163 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         163 --GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             --cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence              5667899999999976543321   122345778999999998899999999999999999988  778998887777


Q ss_pred             HHHHHHHhc----cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          221 LLQNIVKAT----ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       221 ~l~~i~~~~----~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+..+.+..    ...+.......+..+.+|+.+||..||.+||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            665543311    11112223357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.5e-39  Score=329.67  Aligned_cols=255  Identities=27%  Similarity=0.522  Sum_probs=217.3

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      ....+||+|+||.||++.+..+|..||||++...  .......+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3346799999999999999999999999998643  23345668899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccccc
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETL  173 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~~~  173 (575)
                      +++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||++   +.++.++|+|||++....... .....
T Consensus       101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccccccccc
Confidence            999999875 4568999999999999999999999999999999999999   667889999999987653322 23346


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      .|++.|+|||.+....++.++|+||+|+++|+|++|..||.+.........+.......+.. ...++..+.+++.+||.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN-LHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCC-cccCCHHHHHHHHHHHh
Confidence            78999999999988888999999999999999999999999887776665554433222222 23578899999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCc
Q 043425          254 RNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       254 ~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      .||.+||++.+++.||||.....
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.1e-40  Score=341.59  Aligned_cols=261  Identities=33%  Similarity=0.563  Sum_probs=216.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP--GK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~--~~   85 (575)
                      .+.++|.+.+.||+|+||.||+|.+..+|..+|||.+............+.+|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            567889999999999999999999999999999998865433334445677899999999 999999999998543  46


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhccc
Confidence            899999996 5999998765 78999999999999999999999999999999999999   778899999999998654


Q ss_pred             CCC------CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-------
Q 043425          166 PRG------LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-------  231 (575)
Q Consensus       166 ~~~------~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-------  231 (575)
                      ...      ....+.|++.|+|||++.. ..++.++|+||||+++|+|++|++||.+....+....+......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322      2234678999999998754 55788999999999999999999999887766555444332111       


Q ss_pred             --------------------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 --------------------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 --------------------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                          .+....+.++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                                0111113368899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.4e-39  Score=331.88  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=218.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..|...+.||+|+||.||++++..+|..+|+|++..... ..+....+.+|+.+++.++|||++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            348889999999999999999999999999999875432 3344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||+.| +|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||++   +..+.+||+|||++.....   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC---
Confidence            99975 77777654 4678999999999999999999999999999999999999   6678899999999865432   


Q ss_pred             cccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .....|++.|+|||++.   ...++.++|+|||||++|+|++|..||...+.......+.........  ...++..+++
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  255 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYFRN  255 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--CccccHHHHH
Confidence            23457899999999974   456888999999999999999999999988777777666654332222  2357789999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      |+.+||+.+|.+||++.++++|+|+.......
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            99999999999999999999999997654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.6e-39  Score=328.03  Aligned_cols=248  Identities=28%  Similarity=0.470  Sum_probs=208.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            58899999999999999998753     33578888886543 2333467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           88 LILEYCKGGDLSMYIQRH------------------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~------------------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      +||||+.+++|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999999999998642                        24778899999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI  219 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~  219 (575)
                      +   ++++.+||+|||+++.......   ....+++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       160 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         160 V---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             E---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9   6678899999999976533221   223456778999999988889999999999999999998 99999988877


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+...+........+   ..++.++.+++.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 RLFNLLKTGYRMERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHhCCCCCCCC---CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            776655443322222   357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=329.02  Aligned_cols=260  Identities=25%  Similarity=0.508  Sum_probs=223.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++.+++..||.|+.|+||+++.+.+|...|||.+.+.. +.+...+++..+.++...+ .|+||+.+++|-.+..++|.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            344567788999999999999999999999999998754 4444566788888776655 89999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||.+ +.-+..++++ .++++|..+-++...++.||.||.++ ||+|||+||+|||+   |+.|.+||||||++..+...
T Consensus       170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecc
Confidence            9999 4566666654 46899999999999999999999876 99999999999999   99999999999999888777


Q ss_pred             CCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          168 GLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGS-NQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~-~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      .....-.|.+.|||||.+.   ...|+.++||||||++|+||+||..||.+. .+.+.+.++.+..++.++... .+++.
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~-gFSp~  324 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHM-GFSPD  324 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCccc-CcCHH
Confidence            6666678999999999985   457999999999999999999999999884 556777788876655555443 48999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +++|+..||.+|+.+||.+.++|+|||+.....
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            999999999999999999999999999976543

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-39  Score=324.73  Aligned_cols=243  Identities=29%  Similarity=0.487  Sum_probs=202.3

Q ss_pred             EEecccCCeEEEEEEEcCCCcE--EEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~--vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      +.||+|+||.||+|.+..+|..  +|+|.+... ......+.+.+|+.++.++ +||||+++++++...+.+++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            3689999999999999887764  578877632 2344556788999999999 79999999999999999999999999


Q ss_pred             CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           95 GGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        95 GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      +|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||+   +.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCC
Confidence            999999997543                47889999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      |++..............++.|+|||++....++.++|+||||+++|+|++ |..||.+.+..+....+........+   
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  233 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP---  233 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC---
Confidence            99864322111122334667999999988899999999999999999997 99999988877776665443222222   


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ...+.++.+|+.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-42  Score=389.12  Aligned_cols=257  Identities=29%  Similarity=0.555  Sum_probs=226.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +--+|.-+.+||.|.||.||-|.+..+|+..|||.|.......+....+.+|+.+|..++|||+|++|++=...+.++|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            44568888999999999999999999999999999987665555556788999999999999999999998888999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      ||||+||+|.++++..+..+|...+-+..|++.||.|||+.|||||||||+|||+   +.+|.+|++|||.|..+.... 
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCchh
Confidence            9999999999999988889999999999999999999999999999999999999   888999999999998875542 


Q ss_pred             ----CcccccCCCCCCChHHHhh---ccCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhccCCCCCChhcc
Q 043425          169 ----LAETLCGSPLYMAPEIMQL---QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       169 ----~~~~~~GT~~Y~APEvl~~---~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                          ..+...|||.|||||++.+   .+...++|||||||++.||+||+.||...+. ..++.++..+..+.+|.   .+
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~---~l 1466 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE---RL 1466 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch---hh
Confidence                2446789999999999964   4566789999999999999999999987654 45555666665555555   49


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      +++.++||..||..||.+|.++.|+++|-|=.
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            99999999999999999999999999998853

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.7e-39  Score=326.61  Aligned_cols=250  Identities=25%  Similarity=0.454  Sum_probs=211.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|++.... .......+.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4679999999999999999998753     67899999987543 34445678899999999999999999999998899


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           86 LHLILEYCKGGDLSMYIQRHG----------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~----------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      .++||||+++|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            999999999999999997532                      3678889999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI  219 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~  219 (575)
                      +   +..+.++|+|||++..+.....   .....+++.|+|||++....++.++|||||||++|+|++ |..||.+.+..
T Consensus       163 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         163 V---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             e---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9   6678899999999876533221   122345677999999998999999999999999999997 88999988888


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +....+........+   ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777766554332222   357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.5e-39  Score=369.64  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=208.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|+++++||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            5799999999999999999999999999999999975432 234556789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           90 LEYCKGGDLSMYIQRH-----------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-----------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||+   +..+.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999998642           234566788999999999999999999999999999999   77788999999


Q ss_pred             ccccccCCC-------------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH
Q 043425          159 GFARSLQPR-------------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI  219 (575)
Q Consensus       159 Gla~~~~~~-------------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~  219 (575)
                      |++......                   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999765211                   0112357999999999999999999999999999999999999999876554


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ............... ....+++.+.+++.+||..||.+|++..+.+.
T Consensus       238 ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        238 KISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            433221111111111 12357889999999999999999987655443

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.9e-39  Score=321.39  Aligned_cols=241  Identities=23%  Similarity=0.441  Sum_probs=203.3

Q ss_pred             EecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           19 QIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      .||+|+||.||+|.+.  .++..||+|++... ......+.+.+|+.++++++||||++++++++ ....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            4899999999999775  35667999988654 23455567899999999999999999999986 45789999999999


Q ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC----cc
Q 043425           97 DLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL----AE  171 (575)
Q Consensus        97 sL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~----~~  171 (575)
                      +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||+   +.++.+||+|||++..+.....    ..
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceeccC
Confidence            99999875 4578999999999999999999999999999999999999   6678899999999976543221    11


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ...+++.|+|||++....++.++||||||+++|+|++ |..||......+....+..+.....+.   ..+.++.++|.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~  233 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA---ECPPEMYALMKD  233 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC---CCCHHHHHHHHH
Confidence            1223578999999998889999999999999999996 999999988887777666654444333   468899999999


Q ss_pred             hhccCCCCCCCHHHHHc
Q 043425          251 LLRRNPVERLTFEEFFN  267 (575)
Q Consensus       251 ~L~~DP~~RpTa~eiL~  267 (575)
                      ||..||++||++.++.+
T Consensus       234 c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         234 CWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999966

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-38  Score=320.46  Aligned_cols=249  Identities=25%  Similarity=0.457  Sum_probs=211.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+|...+.||+|+||.||+|.+..++.   .+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            478999999999999999999886654   79999886543 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+++++|.+++..+ +.+++..+..++.|++.||+|||+.|++||||||+||++   +.++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecccc
Confidence            99999999999999764 578999999999999999999999999999999999999   66788999999998765432


Q ss_pred             CCc--c--cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GLA--E--TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~~--~--~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ...  .  ....++.|+|||++....++.++|||||||++|+|++ |..||...+..+....+.......   .....+.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~  237 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---APMDCPS  237 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---CCCCCCH
Confidence            211  1  1223457999999998889999999999999999997 999999888877777665543222   2234788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.+++.+||..||++||++.++++
T Consensus       238 ~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         238 AVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.5e-39  Score=346.40  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=207.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEV   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~   82 (575)
                      .-.++|.++++||+|+||.||+|.+..     ++..||||++.... .....+.+.+|+.+|+++. ||||+++++++..
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            345678999999999999999998753     34579999986542 3344567899999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHc---------------------------------------------------------
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRH---------------------------------------------------------  105 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~---------------------------------------------------------  105 (575)
                      .+.+|||||||++|+|.+++...                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999988642                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec
Q 043425          106 ---------------------------------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT  146 (575)
Q Consensus       106 ---------------------------------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~  146 (575)
                                                             ..+++..+..++.||+.||+|||++||+||||||+|||+  
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--  270 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--  270 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE--
Confidence                                                   136778889999999999999999999999999999999  


Q ss_pred             CCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHH
Q 043425          147 DDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLL  222 (575)
Q Consensus       147 dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l  222 (575)
                       +.++.+||+|||+++.+.....   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||........+
T Consensus       271 -~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         271 -AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             -eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence             6677899999999986543221   223457788999999998899999999999999999997 99999876554443


Q ss_pred             HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          223 QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       223 ~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ........ . +.....++.++.+++.+||..||++||++.++.+
T Consensus       350 ~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSGY-R-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcCC-C-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33333221 1 1222357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.4e-39  Score=325.00  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=206.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcE----EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~----vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .++|++.+.||+|+||.||+|.+..+|..    +++|.+... ........+..|+.+++.++||||+++++++. ....
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            46899999999999999999999877764    667766432 22333456778888999999999999999875 4567


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||+   +.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence            8999999999999999764 578999999999999999999999999999999999999   677889999999997654


Q ss_pred             CCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ...   ......++..|+|||++....++.++||||||+++|+|++ |..||.+.........+.++.....   ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICT  237 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCC
Confidence            322   2234557788999999998899999999999999999998 9999998877665554443332222   23457


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++.+++.+||..||.+|||+.|+++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            78999999999999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.1e-39  Score=331.65  Aligned_cols=249  Identities=24%  Similarity=0.446  Sum_probs=202.1

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHH
Q 043425           24 SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ  103 (575)
Q Consensus        24 aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~  103 (575)
                      ++|.||.+++..+|..||||++............+.+|+.+++.++||||+++++++...+..+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            45667777777789999999998765555566789999999999999999999999999999999999999999999997


Q ss_pred             Hc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--------Ccccc
Q 043425          104 RH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--------LAETL  173 (575)
Q Consensus       104 ~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--------~~~~~  173 (575)
                      ..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||.+..+....        .....
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccc
Confidence            64  468999999999999999999999999999999999999   667889999999886553221        12334


Q ss_pred             cCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC------CCC-----------
Q 043425          174 CGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL------HFP-----------  234 (575)
Q Consensus       174 ~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~------~~p-----------  234 (575)
                      .++..|+|||++..  ..|+.++|+|||||++|+|++|..||..............+...      ..+           
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            67888999999975  46889999999999999999999999876654433222211000      000           


Q ss_pred             -------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          235 -------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       235 -------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                   .....++.++.+|+++||+.||.+|||++++++||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                         00112456789999999999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-38  Score=328.73  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=209.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEE-----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARH-----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|.+.+.||+|+||.||++.+     ..++..+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            445799999999999999999975     3356689999887543 234456788999999999 799999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      +.+++||||+.+|+|.+++....  .+++..+..++.||+.||+|||++||+|+||||+|||+   +.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence            99999999999999999997643  38999999999999999999999999999999999999   66788999999999


Q ss_pred             cccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          162 RSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       162 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      ..+.....   .....+++.|+|||++....++.++|||||||++|+|++ |..||........+.........  +...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  266 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--MAQP  266 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--CCCC
Confidence            76543221   223446788999999998899999999999999999998 99999887765555444433211  1122


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ...+.++.+|+.+||.++|++|||+.|+++
T Consensus       267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=322.37  Aligned_cols=249  Identities=27%  Similarity=0.430  Sum_probs=212.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .++|++.+.||+|+||.||+|.++.+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4679999999999999999999877665    589998876543 4445678899999999999999999999876 789


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+++|+|.+++.++ ..+++..+..++.||+.||+|||++|++||||||+|||+   +..+.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccccc
Confidence            9999999999999999874 468999999999999999999999999999999999999   667789999999998765


Q ss_pred             CCCCcc---cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRGLAE---TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~~~~---~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ......   ...++..|+|||.+....++.++|+||||+++|+|++ |..||.+....++...+.+......+   ...+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  237 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---PICT  237 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---CCCC
Confidence            332211   1223567999999988899999999999999999998 99999998887777766654333333   2467


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++.+++.+||..||.+||++.++++
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            88999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.1e-39  Score=318.63  Aligned_cols=243  Identities=27%  Similarity=0.482  Sum_probs=207.1

Q ss_pred             EEecccCCeEEEEEEEcC-CCc--EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSVVWHARHRV-HGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~-tg~--~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      ++||+|+||.||+|.+.. ++.  .||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999865 333  6999999876544 556778999999999999999999999887 88999999999


Q ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC----
Q 043425           95 GGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----  168 (575)
Q Consensus        95 GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~----  168 (575)
                      +++|.+++....  .+++..++.++.|++.||+|||++|++||||||+||++   +.++.+||+|||++..+....    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEecccccccccccccccee
Confidence            999999997754  68999999999999999999999999999999999999   666899999999998764422    


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......++..|+|||++....++.++|||||||++|+|++ |..||...+..+....+..... . .......+..+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~l  233 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-R-LERPEACPQDIYNV  233 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-c-CCCCccCCHHHHHH
Confidence            1223457888999999999999999999999999999998 9999998888877776654221 1 11223578899999


Q ss_pred             HHHhhccCCCCCCCHHHHHc
Q 043425          248 CQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.+||+.+|.+||++.++++
T Consensus       234 i~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         234 MLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.2e-39  Score=333.93  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=213.3

Q ss_pred             CCCCeeecCEEEEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceE
Q 043425            5 TGRGRVVGDYLVGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRL   76 (575)
Q Consensus         5 ~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l   76 (575)
                      +.......+|.+++.||+|+||.||+|.+..       .+..||+|.+... ........+.+|+.+++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            3334455679999999999999999998643       2347899988643 2344456788999999999 79999999


Q ss_pred             EEEEEeCCEEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCC
Q 043425           77 HDIIEVPGKLHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQ  140 (575)
Q Consensus        77 ~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPe  140 (575)
                      ++++...+.++++|||+++|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999998899999999999999999997532                3677888999999999999999999999999999


Q ss_pred             ceeeecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCC
Q 043425          141 NLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGS  216 (575)
Q Consensus       141 NILl~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~  216 (575)
                      |||+   +.++.+||+|||+++.......   .....++..|+|||++....++.++||||||+++|+|++ |..||.+.
T Consensus       164 Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         164 NVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             eEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            9999   6667899999999976543221   122334567999999999999999999999999999998 89999998


Q ss_pred             CHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          217 NQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       217 ~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +..+....+........+   ...+.++.+|+.+||..+|.+||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         241 PVEELFKLLKEGHRMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            888877766554333322   3467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=354.43  Aligned_cols=251  Identities=26%  Similarity=0.468  Sum_probs=215.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      -.++..+++.||+|.||+||+|++.  | .||||++......++..+.|++|+.+|++-+|.||+-+.|++..+.. .||
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             CHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            3455678899999999999999986  3 79999999999888888999999999999999999999999988876 999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc---cC
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS---LQ  165 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~---~~  165 (575)
                      ..||+|-+|+.+|+-. .+|.....+.|++||++|+.|||.++|||||||..||++   .+++.|||+|||++..   +.
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence            9999999999998633 468899999999999999999999999999999999999   7779999999999864   23


Q ss_pred             CCCCcccccCCCCCCChHHHhhc---cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-CCCCChhccc
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-HFPPDAKILS  241 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~---~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-~~p~~~~~ls  241 (575)
                      .........|...|||||+++.+   +|++.+||||||+++|||++|.+||...+..+++..+-++.-. .........+
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p  622 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP  622 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence            33445667789999999999754   6889999999999999999999999977777766655554211 1111223456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++++|+..||.+++++||.+.+||.
T Consensus       623 k~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  623 KAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHhcCcccCccHHHHHH
Confidence            79999999999999999999999987

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=317.87  Aligned_cols=248  Identities=27%  Similarity=0.480  Sum_probs=211.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|.+.++||+|+||.||+|.+. .+..+|||.+......   ...+.+|+.+++.++||||+++++++......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            3467999999999999999999976 5678999998765433   34588999999999999999999999988999999


Q ss_pred             EeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++++|.+++....  .+++..+..++.||+.||.|||++|++|+||||+||++   +.++.+||+|||++..+...
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccch
Confidence            99999999999997643  68999999999999999999999999999999999999   66789999999998766432


Q ss_pred             CCc--ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GLA--ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~~--~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ...  ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+....+..+........+   ...+.++
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  233 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP---PNCPEEL  233 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHH
Confidence            211  12234568999999998889999999999999999998 99999998887777776654332222   2458899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+++.+||+.||.+||++++++.
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         234 YDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=325.62  Aligned_cols=253  Identities=30%  Similarity=0.540  Sum_probs=211.9

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEee
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      |.+.+.||+|+||.||+|....+++.||||.+...... .......+|+..++++. ||||+++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            78899999999999999999989999999998654322 22233457999999999 99999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           93 CKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        93 ~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      + +|+|.+++....  .+++..+..++.||+.+|.|||++|++|+||+|.||++   ++++.++|+|||++.........
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCCc
Confidence            9 889999887764  78999999999999999999999999999999999999   77889999999999877655555


Q ss_pred             ccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC-----------------
Q 043425          171 ETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH-----------------  232 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~-----------------  232 (575)
                      ....|+..|+|||++. ...++.++|+||||+++++|++|++||......+.+..+.......                 
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            5667899999999874 4557889999999999999999999998887666555443211110                 


Q ss_pred             -CCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          233 -FPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       233 -~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                       ++.        .....+.++.+||++||..||.+|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence             000        011235789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-38  Score=319.81  Aligned_cols=246  Identities=26%  Similarity=0.466  Sum_probs=207.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.++||+|+||.||+|.+..+ ..+|+|.+.....   ..+.+.+|+.++++++||||+++++++. .+..++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            36799999999999999999988754 4699998765432   2356788999999999999999999875 45689999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+.+++|.+++...  ..+++..+..++.||+.||.|||+.|++||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence            999999999999764  347899999999999999999999999999999999999   777889999999997654332


Q ss_pred             C--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 L--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .  .....++..|+|||++....++.++||||||+++|+|++ |.+||.+....+....+........   ...++..+.
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  233 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC---PQGCPESLH  233 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHH
Confidence            2  122346678999999988889999999999999999999 9999999888777766654432222   235788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++++||.+||.+||+++++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         234 ELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=350.03  Aligned_cols=237  Identities=25%  Similarity=0.474  Sum_probs=206.7

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      ++-||.|+-|.||+|+.+  ++.||||++..         .-..+|.-|++|+||||+.|.++|.....+|||||||..|
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            355999999999999987  99999997642         2235778899999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCC
Q 043425           97 DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS  176 (575)
Q Consensus        97 sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT  176 (575)
                      -|...|+....++......+..+|+.|++|||.+.|||||||.-||||+.+   ..|||+|||-++.+......-.++||
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~---d~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD---DVVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc---ceEEeccccchHhhhhhhhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999554   46999999999888776666789999


Q ss_pred             CCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh-ccCCCCCChhcccHHHHHHHHHhhccC
Q 043425          177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA-TELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       177 ~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~-~~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      ..|||||++++++.+.|+|||||||+||||+||..||...+...++-.+-.. ..+..|   ...+..++-||++||+..
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP---stcP~GfklL~Kqcw~sK  351 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP---STCPDGFKLLLKQCWNSK  351 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc---ccCchHHHHHHHHHHhcC
Confidence            9999999999999999999999999999999999999887765544322211 122333   357889999999999999


Q ss_pred             CCCCCCHHHHHcCCC
Q 043425          256 PVERLTFEEFFNHPF  270 (575)
Q Consensus       256 P~~RpTa~eiL~Hpf  270 (575)
                      |..||+|.+||.|-=
T Consensus       352 pRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  352 PRNRPSFRQILLHLD  366 (904)
T ss_pred             CCCCccHHHHHHHHh
Confidence            999999999999843

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-38  Score=328.85  Aligned_cols=256  Identities=27%  Similarity=0.465  Sum_probs=215.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ...|...+.||+|+||.||+|++..++..+|+|.+..... .......+.+|+.+++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            3448888999999999999999999999999999875422 334445688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+   +..+.++|+|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc-
Confidence            99996 577777654 4568999999999999999999999999999999999999   66788999999998765432 


Q ss_pred             CcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                        ....|++.|+|||++.   ...++.++|||||||++|+|++|..||...+.......+.........  ...++..+.
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  244 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFR  244 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC--cccccHHHH
Confidence              3457899999999985   356788999999999999999999999887766665555544322222  235788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +||++||.++|.+||+++++++|||+....
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            999999999999999999999999997753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=323.09  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=200.2

Q ss_pred             cCE-EEEEEecccCCeEEEEEE----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 043425           12 GDY-LVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PG   84 (575)
Q Consensus        12 ~~Y-~i~~~LG~GaFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~   84 (575)
                      ++| .+.+.||+|+||.||++.    ...++..||+|.+.... .......+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            456 899999999999998865    34578899999987543 23345678899999999999999999998755  34


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+++||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+   +..+.+||+|||++...
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccccc
Confidence            689999999999999999764 59999999999999999999999999999999999999   66688999999999866


Q ss_pred             CCCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH--HHH-------------HHH
Q 043425          165 QPRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI--QLL-------------QNI  225 (575)
Q Consensus       165 ~~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~--~~l-------------~~i  225 (575)
                      .....    .....++..|+|||++....++.++||||||+++|+|++|..||......  +..             ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            43221    22334567799999998888999999999999999999999998654321  000             011


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....   .++.....+.++.+++.+||..||.+|||++++++
T Consensus       238 ~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGM---RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCC---CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111   11112356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-38  Score=315.06  Aligned_cols=243  Identities=26%  Similarity=0.465  Sum_probs=206.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGD   97 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Ggs   97 (575)
                      ++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46999999999999865 68899999886543 34455678899999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc--cccc
Q 043425           98 LSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLC  174 (575)
Q Consensus        98 L~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~--~~~~  174 (575)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.........  ....
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCC
Confidence            99998754 468899999999999999999999999999999999999   67788999999998754332221  1224


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      +++.|+|||++....++.++||||||+++|+|++ |..||.+.........+........+   ..++.++.+++.+||.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~  232 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCP---QKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcc
Confidence            4677999999998889999999999999999998 99999988877766666544332222   3578999999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q 043425          254 RNPVERLTFEEFFNH  268 (575)
Q Consensus       254 ~DP~~RpTa~eiL~H  268 (575)
                      .+|.+||++.++++.
T Consensus       233 ~~p~~Rp~~~~l~~~  247 (250)
T cd05085         233 YKPENRPKFSELQKE  247 (250)
T ss_pred             cCcccCCCHHHHHHH
Confidence            999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-38  Score=315.91  Aligned_cols=247  Identities=26%  Similarity=0.530  Sum_probs=211.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+.......   ..+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            57999999999999999999876 57789999887554432   357889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |+.+++|.+++... +.+++..++.++.|++.||++||+.|++||||||+||++   +.++.+||+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCccc
Confidence            99999999998764 568999999999999999999999999999999999999   6678899999999876543322 


Q ss_pred             -cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          170 -AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       170 -~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       .....++..|+|||++....++.++|+||||+++|+|++ |..||...........+.+......+   ...+.++.+|
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  233 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYEL  233 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHHH
Confidence             112335678999999988889999999999999999998 99999988887777776554333222   2468899999


Q ss_pred             HHHhhccCCCCCCCHHHHHcC
Q 043425          248 CQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+||..+|.+|||+++++++
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.5e-39  Score=333.70  Aligned_cols=258  Identities=31%  Similarity=0.541  Sum_probs=212.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~L   88 (575)
                      ..++|.+.+.||.|+||.||+|.+..+|..||||.+.+..........+.+|+.+++.++||||++++++|.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4678999999999999999999999999999999987654444445678899999999999999999999865 567899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||+ +++|..++.. ..+++..+..++.||+.||+|||++||+||||+|.|||+   +.++.+||+|||++...... 
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC-
Confidence            99999 6689888764 468899999999999999999999999999999999999   67789999999998754332 


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc------------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------------------  229 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~------------------  229 (575)
                       .....+++.|+|||++.. ..++.++|+||||+++|+|++|++||.+.........+.+..                  
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence             234568899999998765 568999999999999999999999998776543332222110                  


Q ss_pred             ---------cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          230 ---------ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       230 ---------~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                               ........+.++.++.++|++||+.+|.+||++++++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                     000001112467899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-38  Score=324.71  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=206.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC----------------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcce
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV----------------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR   75 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~----------------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~   75 (575)
                      ++|++.++||+|+||.||++.+..                ++..+|+|++.... .......+.+|+.+++.++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            569999999999999999986542                34579999986542 3445567899999999999999999


Q ss_pred             EEEEEEeCCEEEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceee
Q 043425           76 LHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-----------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL  144 (575)
Q Consensus        76 l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~-----------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl  144 (575)
                      +++++...+..++||||+++++|.+++....           .+++..+..++.||+.||+|||+.|++||||||+|||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999999999999987643           36677899999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh--CCCCCCCCCHH
Q 043425          145 CTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT--GKTPFTGSNQI  219 (575)
Q Consensus       145 ~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt--G~~PF~~~~~~  219 (575)
                         +.++.++|+|||++..+.....   .....+++.|+|||+.....++.++|+|||||++|+|++  |..||...+..
T Consensus       164 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         164 ---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             ---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence               6678899999999976543321   223345678999999988899999999999999999998  78999887766


Q ss_pred             HHHHHHHHh----ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          220 QLLQNIVKA----TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       220 ~~l~~i~~~----~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.+......    ......+.....+..+.+|+.+||+.||.+||++.++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            655443221    011111222346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=315.44  Aligned_cols=242  Identities=27%  Similarity=0.469  Sum_probs=206.1

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGD   97 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Ggs   97 (575)
                      ++||+|+||.||+|.+.. ++.||+|.+...... +....+.+|+.++++++||||+++++++...+..++||||+.|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            479999999999999987 999999998765433 455678999999999999999999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc---ccc
Q 043425           98 LSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETL  173 (575)
Q Consensus        98 L~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~---~~~  173 (575)
                      |.+++... ..+++..+..++.|++.||+|||++|++||||||+|||+   +..+.+||+|||++.........   ...
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccC
Confidence            99999654 568899999999999999999999999999999999999   67788999999998765422211   122


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhh
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL  252 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L  252 (575)
                      .++..|+|||++....++.++|+||||+++|+|++ |..||...........+........+   ...+.++.+++.+||
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l  232 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP---QLCPEEIYRLMLQCW  232 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHh
Confidence            34567999999988899999999999999999998 89999888876666655443222222   357889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 043425          253 RRNPVERLTFEEFFN  267 (575)
Q Consensus       253 ~~DP~~RpTa~eiL~  267 (575)
                      +.+|.+|||++|+++
T Consensus       233 ~~~p~~Rp~~~ell~  247 (251)
T cd05041         233 AYDPENRPSFSEIYN  247 (251)
T ss_pred             ccChhhCcCHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-38  Score=315.49  Aligned_cols=247  Identities=26%  Similarity=0.487  Sum_probs=208.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|++.++||+|+||.||++.+. .+..+|+|.+...   ....+.+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            4578999999999999999999865 5667999988653   2234568899999999999999999999876 778999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++++|.+++.+.  ..++...+..++.||+.||.|||+.|++||||||+||++   +..+.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence            9999999999999763  357888999999999999999999999999999999999   67789999999999765432


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....++..|+|||++....++.++|+||||+++|+|++ |..||.+.+.......+........   ....+.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PENCPEEL  232 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC---cccCCHHH
Confidence            21  122345677999999988889999999999999999998 9999998887777666554432222   23578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+++.+||++||.+||++.++++
T Consensus       233 ~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         233 YNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=307.73  Aligned_cols=259  Identities=34%  Similarity=0.597  Sum_probs=222.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|.-+++||+|.||+||+|+++.+++.||+|.+..+.-++.......+|+.+|+.+.|.|||+++++...++.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            45777899999999999999999999999999998876666666788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      || ..+|..+... ++.++.+.++.++.|++.||.++|++++.||||||+|+|+   +.+|.+||+|||+++-+.-.-.+
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceEe
Confidence            99 5688888764 5789999999999999999999999999999999999999   78899999999999876544322


Q ss_pred             -ccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCC----CCC--------
Q 043425          171 -ETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH----FPP--------  235 (575)
Q Consensus       171 -~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~----~p~--------  235 (575)
                       ..-+.|.+|++|.++-+. -|+...|+||-|||+.|+.. |++.|.|.+-.+.+++|.+.....    +|.        
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence             234679999999998654 58999999999999999986 888899999999998887642211    111        


Q ss_pred             -------C------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 -------D------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 -------~------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                             .      .+.+...-+||++++|.-+|.+|++++++++||||.+.
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                   0      01234456899999999999999999999999999764

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-38  Score=319.70  Aligned_cols=250  Identities=20%  Similarity=0.353  Sum_probs=210.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~   85 (575)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+... ........+.+|+.+++.++||||+++++++.. +..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4679999999999999999999886    3688999987643 344556778899999999999999999998655 577


Q ss_pred             EEEEEeecCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           86 LHLILEYCKGGDLSMYIQRH--------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~--------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      .++++||+++++|.+++...        ..+++..+..++.||+.||+|||++|++||||||+|||+   +..+.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEECC
Confidence            89999999999999998753        358899999999999999999999999999999999999   6668899999


Q ss_pred             cccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          158 FGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       158 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      ||+++.+.....   .....++..|+|||++....++.++||||||+++|+|++ |++||...+..+....+....... 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA-  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC-
Confidence            999986543321   123346778999999998899999999999999999998 999999888777665554432222 


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                        ....++.++.+++.+||..||++|||+.++++
T Consensus       240 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 --QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              22346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-38  Score=318.29  Aligned_cols=249  Identities=24%  Similarity=0.465  Sum_probs=209.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+|.+.++||+|+||.||+|.+...   ...||||.+.... ..+..+.+.+|+.++++++||||+++++++.. +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4689999999999999999987654   3468999886542 34556678999999999999999999999865 55789


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.|++||||||+|||+   +..+.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeecccc
Confidence            999999999999998654 58999999999999999999999999999999999999   66778999999999765443


Q ss_pred             CCc--ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GLA--ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~~--~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ...  ....+++.|+|||.+....++.++||||||+++|+|++ |..||.+....+....+.+......+   ..++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  237 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP---PNCPPTL  237 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---CCCCHHH
Confidence            321  12334568999999988889999999999999999986 99999998887777666655443333   3578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++|.+||..+|.+|||+.+++..
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.6e-38  Score=318.25  Aligned_cols=245  Identities=24%  Similarity=0.419  Sum_probs=198.6

Q ss_pred             EEecccCCeEEEEEEEcC--CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|....  ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            369999999999996543  45678888775432 344456688999999999999999999999989999999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           96 GDLSMYIQRHG-----CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        96 gsL~~~l~~~~-----~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |+|.+++....     .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence            99999997643     24678889999999999999999999999999999999   6778899999999875433221 


Q ss_pred             --cccccCCCCCCChHHHhh-------ccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCC--Ch
Q 043425          170 --AETLCGSPLYMAPEIMQL-------QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP--DA  237 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~-------~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~--~~  237 (575)
                        .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||......+.+..+.......++.  ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence              123456778999999853       356778999999999999998 889998888777666665554433332  22


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..++..+.+++..|+ .||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            457888999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.7e-38  Score=318.71  Aligned_cols=251  Identities=22%  Similarity=0.418  Sum_probs=211.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .+|++.+.||+|+||.||+|+.+.     +...+|+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            579999999999999999999764     34679999886532 233456789999999999999999999999888899


Q ss_pred             EEEEeecCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           87 HLILEYCKGGDLSMYIQRHG---------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~---------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      ++||||+++|+|.+++....         .+++..+..++.||+.||+|||++||+||||||+|||+   +..+.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEcc
Confidence            99999999999999998665         68999999999999999999999999999999999999   6678899999


Q ss_pred             cccccccCCCC--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          158 FGFARSLQPRG--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       158 FGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      ||++.......  ......+++.|+|||.+....++.++||||||+++|+|++ |..||...........+... ...++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~  239 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-KLELP  239 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC-CcCCC
Confidence            99986543221  2234456788999999988888999999999999999998 88999887776666655433 22222


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      . ...++..+.+++.+||+.||.+|||+.|++++
T Consensus       240 ~-~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 V-PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            1 23578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=358.61  Aligned_cols=250  Identities=28%  Similarity=0.480  Sum_probs=207.5

Q ss_pred             eecC--EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---
Q 043425           10 VVGD--YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDI-IEV---   82 (575)
Q Consensus        10 ~v~~--Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~-~~~---   82 (575)
                      .||.  ++|.+.|.+|||+.||+|.+...|..||+|.+-..  ++...+.+++|+++|+.|. |+|||.+++. ...   
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            4555  57889999999999999999988899999988654  5566678999999999997 9999999993 211   


Q ss_pred             C---CEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEE
Q 043425           83 P---GKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        83 ~---~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .   -.++|.||||.||.|-+++..+  ..|+|.++.+|+.|+++||.+||...  |||||||-|||||   ..++.+||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KL  187 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKL  187 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEe
Confidence            1   2588999999999999999743  46999999999999999999999997  9999999999999   77789999


Q ss_pred             cccccccccCCCC-Ccc---------cccCCCCCCChHHH---hhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH
Q 043425          156 ADFGFARSLQPRG-LAE---------TLCGSPLYMAPEIM---QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL  222 (575)
Q Consensus       156 ~DFGla~~~~~~~-~~~---------~~~GT~~Y~APEvl---~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l  222 (575)
                      ||||.|.-..... ...         ...-|+-|+|||++   .+.+.+.|+|||+|||+||.|+....||.......  
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--  265 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--  265 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence            9999986432211 100         12358999999987   47789999999999999999999999999875433  


Q ss_pred             HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          223 QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       223 ~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                        |+++ .+.+|+. +.++..+++||+.||..||.+||++.|++.+-+
T Consensus       266 --Ilng-~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  266 --ILNG-NYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             --EEec-cccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence              4444 4455554 458999999999999999999999999987533

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4e-38  Score=317.29  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             EEecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      +.||+|+||.||+|...  .++..+|+|.+..... ......+.+|+.++++++||||+++++++.....+++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            46899999999999764  3567899998865432 33345688999999999999999999999888899999999999


Q ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           96 GDLSMYIQRHG-----CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        96 gsL~~~l~~~~-----~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |+|.+++....     ..++..+..++.|++.||+|||++|++||||||+||++   +..+.+||+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCccee
Confidence            99999986532     35677888999999999999999999999999999999   6678899999999875433221 


Q ss_pred             --cccccCCCCCCChHHHhhc-------cCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCC--h
Q 043425          170 --AETLCGSPLYMAPEIMQLQ-------KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD--A  237 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~~-------~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~--~  237 (575)
                        ....+|++.|+|||++...       .++.++||||||+++|+|++ |..||......+............++..  .
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              2235678899999998642       35789999999999999996 9999988777665554444333333222  1


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ...+..+.+++++|+ .+|++|||++|++.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            246788999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.6e-40  Score=328.26  Aligned_cols=264  Identities=28%  Similarity=0.475  Sum_probs=213.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~   84 (575)
                      ....|+++..||+|.||.||+|..+.++.    .||+|.++-+.-.........+|+.+++.++||||+.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            45569999999999999999997666543    68999987653333445667899999999999999999999866 78


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC-CCCCcEEEccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADF  158 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~-----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~vKL~DF  158 (575)
                      .+++++||.+. +|...|+-+     ..++...++.|+.||+.|+.|||++.|+||||||.|||+..+ ...|.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999976 899888633     468999999999999999999999999999999999999654 45799999999


Q ss_pred             ccccccCCC----CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCC---------HHHHHHH
Q 043425          159 GFARSLQPR----GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSN---------QIQLLQN  224 (575)
Q Consensus       159 Gla~~~~~~----~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~---------~~~~l~~  224 (575)
                      |+++.+...    ......+.|.+|+|||.+.+ ..|+.+.|||++|||+.||++-.+.|.|..         ..+.+.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999987542    23445678999999999875 569999999999999999999999997642         2344555


Q ss_pred             HHHhccCCCCCChh---------------------------------cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          225 IVKATELHFPPDAK---------------------------------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       225 i~~~~~~~~p~~~~---------------------------------~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      |.+-...+-..+++                                 .-++...+|+.+||.+||.+|+|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            55432211111110                                 112347799999999999999999999999999


Q ss_pred             CCC
Q 043425          272 SQT  274 (575)
Q Consensus       272 ~~~  274 (575)
                      ...
T Consensus       341 ~~d  343 (438)
T KOG0666|consen  341 TED  343 (438)
T ss_pred             ccC
Confidence            764

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.4e-38  Score=314.79  Aligned_cols=242  Identities=24%  Similarity=0.461  Sum_probs=205.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|.+.+.||+|+||.||++..  ++..||+|.+....    ..+.+.+|+.+++.++||||+++++++... ..++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            46899999999999999999864  68899999986432    235688999999999999999999998654 479999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++...... 
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc-
Confidence            9999999999997653  57899999999999999999999999999999999999   66788999999998754322 


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       ......+..|+|||++.+..++.++|+||||+++|+|++ |++||...+..+....+.+......   ...++.++.++
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  229 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP---PEGCPADVYVL  229 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC---CCcCCHHHHHH
Confidence             122344667999999988899999999999999999997 9999998888777666655432222   23578899999


Q ss_pred             HHHhhccCCCCCCCHHHHHc
Q 043425          248 CQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++||+.+|.+||++++++.
T Consensus       230 i~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         230 MTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-38  Score=333.42  Aligned_cols=251  Identities=28%  Similarity=0.483  Sum_probs=203.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEE-----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARH-----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV-P   83 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~-~   83 (575)
                      .++|+++++||+|+||.||+|.+     ..+++.||||.+..... ......+.+|+.++.++ +||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            35799999999999999999984     34678999999975432 33345688999999999 68999999998754 4


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc----------------------------------------------------------
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH----------------------------------------------------------  105 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~----------------------------------------------------------  105 (575)
                      ..+++|||||++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5689999999999999998643                                                          


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---Ccccc
Q 043425          106 ---------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETL  173 (575)
Q Consensus       106 ---------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~  173 (575)
                               ..++...+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......   .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCCC
Confidence                     236777888999999999999999999999999999999   667889999999997653221   11223


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHH-HHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLL-QNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l-~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      .+++.|+|||++....++.++||||||+++|+|++ |..||.+......+ ..+........+   ...++++.+++.+|
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~c  318 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC---CCCCHHHHHHHHHH
Confidence            45678999999988899999999999999999996 99999876543333 333333222222   24678999999999


Q ss_pred             hccCCCCCCCHHHHHcC
Q 043425          252 LRRNPVERLTFEEFFNH  268 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~H  268 (575)
                      |..||.+|||+.|+++|
T Consensus       319 l~~~p~~Rps~~eil~~  335 (343)
T cd05103         319 WHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=337.57  Aligned_cols=258  Identities=28%  Similarity=0.508  Sum_probs=214.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CC----cceEEEEEEeCC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PH----IIRLHDIIEVPG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pn----Iv~l~~~~~~~~   84 (575)
                      .++|.+...+|+|.||.|-.+.+..++..||||+++.   -.+.++..+-|+++|.++.+  |+    ++++.+||+-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            5679999999999999999999999999999999864   35667778899999999942  43    788999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC--------------
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD--------------  148 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd--------------  148 (575)
                      ++|||+|.+ |-++++++.+++  +|+...++.+..||+.++++||+++++|.||||+|||+.+.+              
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999999999 779999998765  688999999999999999999999999999999999995431              


Q ss_pred             ---CCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH---HH
Q 043425          149 ---DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ---LL  222 (575)
Q Consensus       149 ---~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~---~l  222 (575)
                         ....|+|+|||.|+.-...  ..+.+.|..|+|||++.+-+++.++||||+||||+||.+|...|+..++.+   ++
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM  321 (415)
T ss_pred             ccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence               1346899999999865433  367889999999999999999999999999999999999999999887655   44


Q ss_pred             HHHHHhc-----------------cCCCCCCh----------------------hcccHHHHHHHHHhhccCCCCCCCHH
Q 043425          223 QNIVKAT-----------------ELHFPPDA----------------------KILSADCKDLCQKLLRRNPVERLTFE  263 (575)
Q Consensus       223 ~~i~~~~-----------------~~~~p~~~----------------------~~ls~el~dLI~k~L~~DP~~RpTa~  263 (575)
                      +.|....                 .+.++...                      .....++.|||++||..||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            4443110                 11111110                      01123578999999999999999999


Q ss_pred             HHHcCCCCCCC
Q 043425          264 EFFNHPFLSQT  274 (575)
Q Consensus       264 eiL~Hpff~~~  274 (575)
                      |+|.||||...
T Consensus       402 EAL~HpFF~~~  412 (415)
T KOG0671|consen  402 EALSHPFFARL  412 (415)
T ss_pred             HHhcCHHhhcC
Confidence            99999999764

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.8e-38  Score=313.68  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=200.0

Q ss_pred             EEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEeec
Q 043425           18 RQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE-VPGKLHLILEYC   93 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~-~~~~l~LVmEy~   93 (575)
                      +.||+|+||.||+|.+..   .+..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998754   34679999875422 3344567889999999999999999999764 456689999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC----
Q 043425           94 KGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----  168 (575)
Q Consensus        94 ~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~----  168 (575)
                      .+|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+|||+   ++.+.+||+|||+++......    
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcceee
Confidence            999999999764 356778889999999999999999999999999999999   667889999999997653321    


Q ss_pred             -CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ......+++.|+|||++....++.++||||||+++|+|++ |.+||...+..+....+........+   ...+..+.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  233 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPLYE  233 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHHHH
Confidence             1123456778999999988899999999999999999999 57788887777766665554332222   346889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++.+||..+|++||++.++++.
T Consensus       234 li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         234 VMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999873

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-38  Score=319.54  Aligned_cols=248  Identities=24%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             EEEEEEecccCCeEEEEEEE----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARH----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--GKLH   87 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~~l~   87 (575)
                      |+++++||+|+||.||+|+.    ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            68999999999999999974    4578999999986543 334456789999999999999999999998765  5689


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||++|++|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+|||+   +.++.++|+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccccccc
Confidence            999999999999999765 358999999999999999999999999999999999999   6677899999999987643


Q ss_pred             CC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC---------------HHHHHHHHHH
Q 043425          167 RG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN---------------QIQLLQNIVK  227 (575)
Q Consensus       167 ~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---------------~~~~l~~i~~  227 (575)
                      ..    ......|+..|+|||++.+..++.++||||||+++|+|+++..|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            32    1234567788999999988889999999999999999999877653211               0111111111


Q ss_pred             hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       228 ~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...   .+....++.++.+|+.+||+.||.+|||+++++++
T Consensus       242 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             Ccc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111   11223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-38  Score=314.53  Aligned_cols=238  Identities=21%  Similarity=0.362  Sum_probs=194.4

Q ss_pred             EEecccCCeEEEEEEEcCCC----------cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           18 RQIGSGSFSVVWHARHRVHG----------TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg----------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.||+|+||.||+|.+..++          ..+++|++.....   ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            47999999999999998776          4578887654321   15678899999999999999999999877 7789


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC----CCCcEEEccccccc
Q 043425           88 LILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----DNAALKIADFGFAR  162 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd----~~g~vKL~DFGla~  162 (575)
                      +||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+..+.    ....+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999999998766 789999999999999999999999999999999999994332    22379999999997


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhc--cCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQ--KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~--~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      ....   .....++..|+|||++...  .++.++||||||+++|+|++ |..||...+.............  .+.   .
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~---~  228 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPM---P  228 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCC---C
Confidence            6543   2345677889999999876  78899999999999999999 6888877754443333222111  111   1


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....+.++|.+||..||.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.3e-38  Score=315.63  Aligned_cols=251  Identities=29%  Similarity=0.508  Sum_probs=212.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcC-CCcEEEEEEeecCcc--------CHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRL--------NKKLQESLMSEIFILKR-INHPHIIRLHDIIEV   82 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~--------~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~~~~   82 (575)
                      +|.+.+.||+|+||.||+|.+.. ++..+|+|.+.....        .......+.+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 789999998864321        22334567788888865 799999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      .+..++||||++|++|.+++..    ...+++..++.++.||+.||.|||+ .|++|+||+|+|||+   +..+.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            9999999999999999988743    3468999999999999999999996 689999999999999   6778899999


Q ss_pred             cccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      ||++.............|+..|+|||++....++.++|+||||+++|+|++|.+||...+.......+......  +...
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLPE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCCc
Confidence            99998765554445677999999999999888999999999999999999999999888777666665544322  2222


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..++.++.++|++||..||.+||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3578899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.7e-38  Score=316.24  Aligned_cols=249  Identities=25%  Similarity=0.455  Sum_probs=208.2

Q ss_pred             EEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 043425           14 YLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG------   84 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~------   84 (575)
                      |.+.+.||+|+||.||+|..+.   ++..||||++..........+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998653   6789999999776555556677899999999999999999999875432      


Q ss_pred             EEEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      ..++++||+.+|+|..++...      ..+++..+..++.||+.||+|||++||+||||||+||++   +.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcc
Confidence            357899999999999887432      247889999999999999999999999999999999999   66788999999


Q ss_pred             ccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          159 GFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       159 Gla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      |+++.......   .....+++.|++||.+....++.++||||||+++|+|++ |.+||.+.+..+....+........+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99986543221   223345678999999998899999999999999999999 99999988887776666655433333


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                         ...+..+.+++.+||..+|.+||++.+++.+
T Consensus       238 ---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         238 ---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               2467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.3e-38  Score=338.95  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEV   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~   82 (575)
                      .-.++|.++++||+|+||.||+|+++     .++..||||++.... .....+.+.+|+.+|.++. ||||+++++++..
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            34466889999999999999999864     356789999997643 2333456889999999997 9999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcC--------------------------------------------------------
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHG--------------------------------------------------------  106 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~--------------------------------------------------------  106 (575)
                      .+.+++||||+++|+|.+++.+.+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996532                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceee
Q 043425          107 ------------------------------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL  144 (575)
Q Consensus       107 ------------------------------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl  144 (575)
                                                                .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      25667788899999999999999999999999999999


Q ss_pred             ecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHH
Q 043425          145 CTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQ  220 (575)
Q Consensus       145 ~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~  220 (575)
                         ++.+.+||+|||+++.+....   .....++++.|+|||++....++.++||||||+++|+|++ |..||......+
T Consensus       273 ---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         273 ---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             ---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence               667889999999998653322   1223567889999999998889999999999999999998 899998766555


Q ss_pred             HHHHHHHh-ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          221 LLQNIVKA-TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       221 ~l~~i~~~-~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ........ .....+   ...+.++.+|+.+||.++|.+||++++|++.
T Consensus       350 ~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMAKP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            54443332 222222   3468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=351.44  Aligned_cols=245  Identities=30%  Similarity=0.502  Sum_probs=212.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ....|.+...+|.|+|+.|..+.+..+++.+++|++.+...      +..+|+.++... +||||+.+++.+.++...|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence            45679999999999999999999999999999999987621      234677666554 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++.|+.|.+.+.....+. ..+..|+++|+.|+.|||++|||||||||+|||+.  +..++++|+|||.++..... 
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh-
Confidence            999999999999887766555 88889999999999999999999999999999993  46788999999999887655 


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       ..+.|-|..|.|||++...+|++++||||||++||+|++|+.||...... ++..++..      ++-...+|.++++|
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~------~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM------PKFSECVSDEAKDL  542 (612)
T ss_pred             -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC------CccccccCHHHHHH
Confidence             56778899999999999999999999999999999999999999876555 33333322      21125799999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      |++||+.||.+||++.+++.||||
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-38  Score=318.65  Aligned_cols=241  Identities=22%  Similarity=0.407  Sum_probs=196.1

Q ss_pred             EEecccCCeEEEEEEEcCCCcE-------EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           18 RQIGSGSFSVVWHARHRVHGTE-------VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~-------vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +.||+|+||.||+|.++..+..       +|+|.+...  .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            4699999999999998765543       888887543  2334467889999999999999999999999989999999


Q ss_pred             eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-----CCcEEEccccccccc
Q 043425           91 EYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-----NAALKIADFGFARSL  164 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-----~g~vKL~DFGla~~~  164 (575)
                      ||+++|+|..++..++ .+++..+..++.||+.||+|||++||+||||||+|||+..++.     .+.++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997654 5899999999999999999999999999999999999954321     234899999998655


Q ss_pred             CCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ...   ....+++.|+|||++.. ..++.++||||||+++|+|++| .+||........... ... ...+|.   ..+.
T Consensus       159 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~-~~~~~~---~~~~  230 (258)
T cd05078         159 LPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED-RHQLPA---PKWT  230 (258)
T ss_pred             CCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc-cccCCC---CCcH
Confidence            432   34678899999999976 4578999999999999999998 577766655544332 222 222332   3567


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++.+||.+||+.||.+|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-37  Score=315.58  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=199.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEE----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARH----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGK   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~   85 (575)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+...  .......+.+|+.+++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4699999999999999999974    457899999998654  33445678899999999999999999998743  346


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      +++||||+++++|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence            89999999999999999764 468999999999999999999999999999999999999   66788999999999866


Q ss_pred             CCCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHH---------------HHHH
Q 043425          165 QPRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---------------LQNI  225 (575)
Q Consensus       165 ~~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~---------------l~~i  225 (575)
                      .....    .....++..|+|||++.+..++.++||||||+++|+|++|..|+........               +..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            43221    1122344569999999888899999999999999999998877643321100               0111


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+.. .. .+....++.++.+|+.+||..+|++|||++|+++
T Consensus       239 ~~~~-~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNN-GR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcC-Cc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1111 11 1222357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-38  Score=315.43  Aligned_cols=246  Identities=25%  Similarity=0.451  Sum_probs=203.0

Q ss_pred             EEecccCCeEEEEEEEcCCC------cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           18 RQIGSGSFSVVWHARHRVHG------TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      +.||+|+||.||+|++...+      ..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999986544      789999886532 22335568899999999999999999999998899999999


Q ss_pred             ecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC--CCCcEEEccccccc
Q 043425           92 YCKGGDLSMYIQRH-------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD--DNAALKIADFGFAR  162 (575)
Q Consensus        92 y~~GgsL~~~l~~~-------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd--~~g~vKL~DFGla~  162 (575)
                      |++|++|.+++...       ..+++..+..++.||+.||+|||+++++|+||||+|||+..++  ....++|+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999998642       3478899999999999999999999999999999999994332  22379999999987


Q ss_pred             ccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          163 SLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       163 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      .......   .....++..|+|||++....++.++||||||+++|+|++ |..||...+..+....+........+   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  236 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP---E  236 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc---c
Confidence            6533221   123345788999999998999999999999999999998 99999988877766665443322222   3


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++..+.+||.+||.++|.+||+++++++
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         237 NCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            57889999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-37  Score=320.99  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=207.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .++|++.+.||+|+||.||+|.+..+|.    .+|+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            4678999999999999999999987776    46888876443 334445688999999999999999999998654 47


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++++||+++|+|.+++..+. .+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccccc
Confidence            79999999999999987654 68999999999999999999999999999999999999   666789999999998654


Q ss_pred             CCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ....   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+........   ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PPICT  237 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCC
Confidence            3221   223445778999999998999999999999999999997 9999988776665544443322222   23467


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+.+++.+||..||++||+++++++.
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=319.82  Aligned_cols=253  Identities=17%  Similarity=0.234  Sum_probs=192.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHH---------HHHHHHHHHHHhCCCCCcceEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQ---------ESLMSEIFILKRINHPHIIRLH   77 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~---------~~i~~Ei~iL~~L~HpnIv~l~   77 (575)
                      .-++|++.++||+|+||.||+|.+..+   +..+|+|+...........         .....+...+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346799999999999999999998877   6778888654332211110         1122334455667899999999


Q ss_pred             EEEEeCC----EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           78 DIIEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        78 ~~~~~~~----~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      +++....    ..++++|++ ..++.+.+.....+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~~~  165 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNNRG  165 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCcE
Confidence            8765443    457888887 45777777766667899999999999999999999999999999999999   667889


Q ss_pred             EEcccccccccCCCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHH
Q 043425          154 KIADFGFARSLQPRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQN  224 (575)
Q Consensus       154 KL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~  224 (575)
                      +|+|||+++.+....        ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+... ......
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            999999998653221        12335799999999999999999999999999999999999999987732 222211


Q ss_pred             H----HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          225 I----VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       225 i----~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .    .+.... ........+.++.++++.|+..+|.+||+++++++
T Consensus       246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        246 AKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1    111000 00012345789999999999999999999999975

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-38  Score=315.43  Aligned_cols=241  Identities=18%  Similarity=0.353  Sum_probs=193.2

Q ss_pred             EEecccCCeEEEEEEEcC------------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           18 RQIGSGSFSVVWHARHRV------------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~------------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      +.||+|+||.||+|+...            ....+|+|++...  .......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999998542            2345888887653  23344567889999999999999999999998889


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC----CCCcEEEccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----DNAALKIADFGF  160 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd----~~g~vKL~DFGl  160 (575)
                      .++||||+++|+|..++.+. ..+++..+..++.||+.||+|||++||+||||||+|||+..+.    ....++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999988754 5799999999999999999999999999999999999994321    122489999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHH-hCCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLl-tG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      +......   ....|+..|+|||++. ...++.++|||||||++|+|+ .|..||......+... ...... ...   .
T Consensus       159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~-~~~---~  230 (262)
T cd05077         159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC-MLV---T  230 (262)
T ss_pred             CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc-cCC---C
Confidence            8654322   3456888999999986 467899999999999999997 5899998766544322 222211 111   1


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+.++.+||.+||+.||.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=341.07  Aligned_cols=249  Identities=26%  Similarity=0.524  Sum_probs=214.9

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCc---E-EEEEEeec-CccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGT---E-VAMKEIAM-GRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~-vAVK~i~~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +-.+.++||+|+||.||+|+.+..+.   . ||+|.... ..........+.+|.++|++++|||||++||+......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34466899999999999999876432   3 89998875 3356677788999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||+|.||+|.+++++++ .++..+...++.+.+.||+|||++++|||||-.+|+|+   ..+..+||+|||+++.-..
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCCcc
Confidence            9999999999999999887 49999999999999999999999999999999999999   6666799999999876442


Q ss_pred             CCCccccc-CCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHH-hccCCCCCChhcccHH
Q 043425          167 RGLAETLC-GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSAD  243 (575)
Q Consensus       167 ~~~~~~~~-GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~-~~~~~~p~~~~~ls~e  243 (575)
                      .......+ -...|+|||.+....|+.++|||||||++||+++ |..||.+....+....|.. +.....|.   ..+.+
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---~~p~~  391 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---KTPKE  391 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---CCHHH
Confidence            23333233 3457999999999999999999999999999998 8889999999999998854 44444443   46788


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHc
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +..++.+|+..||+.||++.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999876

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.8e-38  Score=317.74  Aligned_cols=240  Identities=21%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             EecccCCeEEEEEEEcCC------------------------CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcc
Q 043425           19 QIGSGSFSVVWHARHRVH------------------------GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII   74 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~t------------------------g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv   74 (575)
                      .||+|+||.||+|....+                        ...||+|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            599999999999985432                        245888888643  223445688899999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC----CC
Q 043425           75 RLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD----DD  149 (575)
Q Consensus        75 ~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d----d~  149 (575)
                      ++++++...+..++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||+...    ..
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999875 4678999999999999999999999999999999999999532    12


Q ss_pred             CCcEEEcccccccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHH-hCCCCCCCCCHHHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVK  227 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLl-tG~~PF~~~~~~~~l~~i~~  227 (575)
                      ...+||+|||++......   ....+++.|+|||++.+ ..++.++||||||+++|+|+ +|..||.+....+....+..
T Consensus       160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence            345899999987644222   23457888999999865 56899999999999999985 79999988766554333222


Q ss_pred             hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       228 ~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .  ...+.   ..+.++.++|.+||+.+|.+|||+++++++
T Consensus       237 ~--~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 K--HRLPE---PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             c--cCCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1  12222   246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.2e-38  Score=313.62  Aligned_cols=229  Identities=28%  Similarity=0.459  Sum_probs=193.2

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHH
Q 043425           23 GSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI  102 (575)
Q Consensus        23 GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l  102 (575)
                      |.||.||+++++.+|+.||+|.+....       ...+|...+....||||+++++++...+.+++||||++||+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999999999999999987542       1234455555667999999999999999999999999999999999


Q ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCCh
Q 043425          103 QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP  182 (575)
Q Consensus       103 ~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~AP  182 (575)
                      .+...+++..+..++.||+.||+|||++||+||||||+||++   +..+.++|+|||.+......  .....++..|+||
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aP  151 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAP  151 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCccccCC
Confidence            888789999999999999999999999999999999999999   66788999999987655432  2345677889999


Q ss_pred             HHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       183 Evl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      |.+....++.++|+||+|+++|+|++|+.||......     +.......+|   ..++..+++||.+||+.||.+||++
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIP---EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCc---ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            9998888999999999999999999999987643221     1111111223   3478899999999999999999985


Q ss_pred             -----HHHHcCCCC
Q 043425          263 -----EEFFNHPFL  271 (575)
Q Consensus       263 -----~eiL~Hpff  271 (575)
                           +++++||||
T Consensus       224 ~~~~~~~~~~h~~~  237 (237)
T cd05576         224 GVAGVEDIKSHPFF  237 (237)
T ss_pred             CccchHHHHcCCCC
Confidence                 999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-37  Score=311.49  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=203.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGK   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~   85 (575)
                      .+|.+.+.||+|+||.||+|...    .++..+|||++...... .....+.+|+.+++.+.||||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            46888999999999999999864    35889999999765433 345678999999999999999999999877  557


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||+   +.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccccc
Confidence            999999999999999997654 68999999999999999999999999999999999999   66789999999999876


Q ss_pred             CCCCCc----ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH--------------HHHHHH
Q 043425          165 QPRGLA----ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ--------------LLQNIV  226 (575)
Q Consensus       165 ~~~~~~----~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~--------------~l~~i~  226 (575)
                      ......    ....++..|+|||.+....++.++||||||+++|+|++|..||.......              .+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            532211    12234567999999988899999999999999999999999987543221              111122


Q ss_pred             HhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       227 ~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .. ...++ .....+.++.+|+.+||++||.+|||+.|+++
T Consensus       240 ~~-~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KE-GERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             Hc-CCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            21 11112 12346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-38  Score=349.98  Aligned_cols=248  Identities=25%  Similarity=0.479  Sum_probs=217.2

Q ss_pred             CEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +-.+.+.||+|+||.||+|+-..     ....||||.++... ..+.+++|++|+++|..++|||||+|+|++..++.+|
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34577899999999999997642     34679999987643 4557889999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           88 LILEYCKGGDLSMYIQRH--------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~--------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      +|+|||..|||.++|...              .+++..+...|+.||+.|++||-++.+|||||-..|+||   .++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceEE
Confidence            999999999999999633              227888999999999999999999999999999999999   788899


Q ss_pred             EEcccccccccCCCCCccc---ccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Q 043425          154 KIADFGFARSLQPRGLAET---LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       154 KL~DFGla~~~~~~~~~~~---~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~  229 (575)
                      ||+|||+++..-...++..   ..-..+|||||.|..++|+.++||||+||+|||+++ |+.||.+..+.+.++.|.++.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~  722 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ  722 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence            9999999987654444332   223567999999999999999999999999999998 999999999999999998887


Q ss_pred             cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       230 ~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      -+..|.   ..|.++.+|+..||+.+|.+||++.||-.
T Consensus       723 lL~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  723 LLSCPE---NCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cccCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            655554   57899999999999999999999999843

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.8e-37  Score=309.37  Aligned_cols=244  Identities=22%  Similarity=0.379  Sum_probs=196.0

Q ss_pred             EecccCCeEEEEEEEcCC--CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           19 QIGSGSFSVVWHARHRVH--GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~t--g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      .||+|+||.||++.....  ...+++|.+.... ..+....+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            699999999999975432  3456677665433 2344567899999999999999999999999889999999999999


Q ss_pred             CHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---C
Q 043425           97 DLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---L  169 (575)
Q Consensus        97 sL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~  169 (575)
                      +|.+++.+.    ..+++..++.++.||+.||+|||+.+++||||||+|||+   +.++.+||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhc
Confidence            999999754    245677888999999999999999999999999999999   677889999999986432211   2


Q ss_pred             cccccCCCCCCChHHHhh-------ccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCC--CCChhc
Q 043425          170 AETLCGSPLYMAPEIMQL-------QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF--PPDAKI  239 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~-------~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~--p~~~~~  239 (575)
                      ....+|++.|+|||++..       ..++.++||||||+++|+|++ |..||......+.+..+.+......  +.....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            235678999999999753       245778999999999999996 6789988887777776655433322  222235


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++..+.++++.|| .+|.+||+++++++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7888999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=311.15  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE-----VPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~-----~~~~l   86 (575)
                      .+|++.++||+|+|+-||++++..++..||+|.+....  .+..+..++|++..++++||||++++++..     .....
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45999999999999999999999999999999997664  456778999999999999999999988752     23459


Q ss_pred             EEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ||++.|...|+|.+.+++.    ..++|..+..|+.+|++||++||+..  ++||||||.|||+   .+.+.++|.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEeccC
Confidence            9999999999999998753    36999999999999999999999998  9999999999999   5578899999999


Q ss_pred             ccccCC----CC-------CcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 043425          161 ARSLQP----RG-------LAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNI  225 (575)
Q Consensus       161 a~~~~~----~~-------~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i  225 (575)
                      +....-    +.       ... -..|..|+|||.+.   +...+.++|||||||+||.|+.|.-||...-.. ..+.--
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~-e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAE-ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             ccccceEeechHHHHHHHHHHH-HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            875321    11       111 23488899999985   445688999999999999999999999642210 001111


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +....+.+|.... ++..+.+||+.||++||.+||++.+++.+
T Consensus       255 v~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1222445565544 89999999999999999999999999874

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=344.33  Aligned_cols=249  Identities=32%  Similarity=0.546  Sum_probs=203.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-----   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-----   84 (575)
                      .-+-|...+.||+||||.||+++++.+|+.||||.+.... ....++...+|+++|++|+|||||+++++=++..     
T Consensus        11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            3466889999999999999999999999999999997644 3455677889999999999999999999864433     


Q ss_pred             -EEEEEEeecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC-CCCCcEEEcccc
Q 043425           85 -KLHLILEYCKGGDLSMYIQRH---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFG  159 (575)
Q Consensus        85 -~l~LVmEy~~GgsL~~~l~~~---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~vKL~DFG  159 (575)
                       ...+|||||.||+|...+++.   ..++|.++..++.+++.||.|||++|||||||||.||++... +.....||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             468999999999999999753   459999999999999999999999999999999999998543 355678999999


Q ss_pred             cccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcc----
Q 043425          160 FARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATE----  230 (575)
Q Consensus       160 la~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~----  230 (575)
                      .|+.+..+....+++||+.|.+||++.. ..|+..+|.|||||++|+.+||..||-....    .+..-.+....+    
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9999999999999999999999999985 7899999999999999999999999954322    223333322110    


Q ss_pred             --------------CCCCCChhcccH----HHHHHHHHhhccCCCCCC
Q 043425          231 --------------LHFPPDAKILSA----DCKDLCQKLLRRNPVERL  260 (575)
Q Consensus       231 --------------~~~p~~~~~ls~----el~dLI~k~L~~DP~~Rp  260 (575)
                                    ..+|. ...+++    .+...+..+|..||.+|-
T Consensus       250 i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                          01122 112333    345777888999999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=352.42  Aligned_cols=247  Identities=25%  Similarity=0.500  Sum_probs=215.6

Q ss_pred             EEEEEEecccCCeEEEEEEEcCC-Cc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVH-GT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~t-g~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      -.+.+.||+|+||.||.|..... |.    .||||.+.+.. +.+....|.+|..+|+.++|||||+++|++-+.+..+|
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            56789999999999999987753 33    38888887543 45667789999999999999999999999988999999


Q ss_pred             EEeecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           89 ILEYCKGGDLSMYIQRH-------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ++|||+||||..+|++.       ..++..+...++.||+.|++||+++++|||||..+|+|+   +....|||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcccchh
Confidence            99999999999999875       348899999999999999999999999999999999999   67799999999999


Q ss_pred             cccCCCCC-cccccC--CCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          162 RSLQPRGL-AETLCG--SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       162 ~~~~~~~~-~~~~~G--T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      +.+....+ .....+  ...|||||.+..+.++.++|||||||+|||+++ |..||.+.++.+++....++..+..|+  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~--  927 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS--  927 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC--
Confidence            95433332 222222  246999999999999999999999999999998 999999999999999888887666554  


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                       +.+..+.++|.+||+.+|++||++..|++
T Consensus       928 -~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 -YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             57888999999999999999999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.1e-38  Score=357.20  Aligned_cols=256  Identities=30%  Similarity=0.533  Sum_probs=206.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-Ee-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDII-EV-----   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~-~~-----   82 (575)
                      |...+|+.++.||+||||.||+++++-+|+.||||.|.... ..+....+.+|+.+|.+|+|||||++|... +.     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            46778889999999999999999999999999999998765 566677899999999999999999998420 00     


Q ss_pred             ------------------------------------------------------------------------C-------
Q 043425           83 ------------------------------------------------------------------------P-------   83 (575)
Q Consensus        83 ------------------------------------------------------------------------~-------   83 (575)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CEEEEEEeecCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHh
Q 043425           84 ----------------------------------GKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLR  128 (575)
Q Consensus        84 ----------------------------------~~l~LVmEy~~GgsL~~~l~~~~~l-se~~i~~i~~QLl~aL~~LH  128 (575)
                                                        -.+||=||||+...|.+++.++... ....++.+++||+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1368889999988888888877654 47789999999999999999


Q ss_pred             hCCcccccccCCceeeecCCCCCcEEEcccccccccC-------------------CCCCcccccCCCCCCChHHHhhcc
Q 043425          129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-------------------PRGLAETLCGSPLYMAPEIMQLQK  189 (575)
Q Consensus       129 ~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-------------------~~~~~~~~~GT~~Y~APEvl~~~~  189 (575)
                      +.|||||||||.||++   +....|||+|||+|....                   +....++.+||..|+|||++.+..
T Consensus       715 ~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999   788889999999998621                   111345678999999999997654


Q ss_pred             ---CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC---hhcccHHHHHHHHHhhccCCCCCCCHH
Q 043425          190 ---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD---AKILSADCKDLCQKLLRRNPVERLTFE  263 (575)
Q Consensus       190 ---y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~---~~~ls~el~dLI~k~L~~DP~~RpTa~  263 (575)
                         |+.|+|+||||+||+||+   .||.-  .++-...+.+.....+|..   ...--+.-..+|+.||++||++||||.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence               999999999999999998   45542  3333333333223333333   222345668999999999999999999


Q ss_pred             HHHcCCCCCC
Q 043425          264 EFFNHPFLSQ  273 (575)
Q Consensus       264 eiL~Hpff~~  273 (575)
                      |+|++.||-.
T Consensus       867 eLL~s~llpp  876 (1351)
T KOG1035|consen  867 ELLNSELLPP  876 (1351)
T ss_pred             HHhhccCCCc
Confidence            9999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=328.34  Aligned_cols=269  Identities=30%  Similarity=0.563  Sum_probs=229.4

Q ss_pred             CCCCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-----CHHHHHHHHHHHHHHHhCCCCCcceEEE
Q 043425            4 ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-----NKKLQESLMSEIFILKRINHPHIIRLHD   78 (575)
Q Consensus         4 ~~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~   78 (575)
                      ..+....-++|.++..||+|+|+.||+|.+....+.||||+-....-     +........+|.+|.+.|.||-||++|+
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            33444566789999999999999999999999999999998654322     1223456789999999999999999999


Q ss_pred             EEEe-CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccccccCCceeeecCCCCCcEEE
Q 043425           79 IIEV-PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--NLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        79 ~~~~-~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      +|.- .+..|-|+|||+|.+|.-|++.++.++|.+++.|+.||+.||.||.+.  .|||.||||.|||+......|.+||
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence            9954 456899999999999999999999999999999999999999999987  6999999999999987778899999


Q ss_pred             cccccccccCCCC--------CcccccCCCCCCChHHHhhc----cCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHH
Q 043425          156 ADFGFARSLQPRG--------LAETLCGSPLYMAPEIMQLQ----KYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLL  222 (575)
Q Consensus       156 ~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~----~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l  222 (575)
                      .|||+++.+....        +...+.||.+|++||++.-+    ..+.++||||+|||+|..+.|+-||..... .+++
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            9999998775432        34567899999999987533    467789999999999999999999987543 3333


Q ss_pred             H--HHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          223 Q--NIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       223 ~--~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +  .|++.....||+.+ ..+.++++||++||.+--+.|..+.++-.||||..
T Consensus       695 qeNTIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  695 QENTILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhhchhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            3  47777788888764 68999999999999999999999999999999965

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-37  Score=324.45  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=199.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-KLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l~LVm   90 (575)
                      ++|.-...||+|+||.||+|.... |..||||.+.......  ..+|.+|+.++.+++|||+|+|+|+|.+.+ ..+||+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            456667899999999999999874 5999999877654332  334999999999999999999999998888 599999


Q ss_pred             eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           91 EYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNN---LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~g---IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ||+++|+|.+++....  .+++....+|+.+++.||+|||...   |||||||++|||+   |.+...||+|||+|+...
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCC
Confidence            9999999999997654  8899999999999999999999964   9999999999999   889999999999996654


Q ss_pred             C-CCCcccc-cCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC---H---HHHHHHHHHh------ccC
Q 043425          166 P-RGLAETL-CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN---Q---IQLLQNIVKA------TEL  231 (575)
Q Consensus       166 ~-~~~~~~~-~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---~---~~~l~~i~~~------~~~  231 (575)
                      . .....+. .||.+|+|||++..+..+.++||||||++|.||++|+.+.....   .   .++....+..      ...
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~  308 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP  308 (361)
T ss_pred             ccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence            4 3333333 89999999999999999999999999999999999998876432   1   1221122221      111


Q ss_pred             CCC-CChh--cccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          232 HFP-PDAK--ILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       232 ~~p-~~~~--~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+. ....  ..-..+..+..+|++.+|..||++.|+.+
T Consensus       309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111 1111  11123567888999999999999999755

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3e-36  Score=293.39  Aligned_cols=243  Identities=44%  Similarity=0.816  Sum_probs=209.5

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHH
Q 043425           24 SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ  103 (575)
Q Consensus        24 aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~  103 (575)
                      +||.||+|.+..+|+.+|+|++........ ...+.+|+.++++++|+||+++++++......++++||+++++|..++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            689999999998999999999976544322 5678999999999999999999999998899999999999999999998


Q ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChH
Q 043425          104 RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE  183 (575)
Q Consensus       104 ~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APE  183 (575)
                      ....++...+..++.+++.+|.+||+.|++|+||+|.||++   +.++.++|+|||.+.............++..|+|||
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            77668999999999999999999999999999999999999   666899999999998776655556678899999999


Q ss_pred             HHhhccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       184 vl~~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      .+....++.++|+|+||+++|+|++|..||.. .........+... ..........++.++.+++.+||..||++||++
T Consensus       157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP-KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence            99888899999999999999999999999988 4444444433332 222222212278899999999999999999999


Q ss_pred             HHHHcCCCC
Q 043425          263 EEFFNHPFL  271 (575)
Q Consensus       263 ~eiL~Hpff  271 (575)
                      .++++||||
T Consensus       236 ~~~~~~~~~  244 (244)
T smart00220      236 EEALQHPFF  244 (244)
T ss_pred             HHHhhCCCC
Confidence            999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=338.98  Aligned_cols=257  Identities=28%  Similarity=0.523  Sum_probs=223.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----CC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV-----PG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~-----~~   84 (575)
                      -+.|++.++||.|.+|.||+++++.+|+..|+|+.+...   +..+++..|++||+.+ .|||++.+|++|..     ++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            456999999999999999999999999999999987643   3345677899999887 58999999999843     46


Q ss_pred             EEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+|||||||.||+..++++.-  .++.|..+.-|++.++.||.+||.+.++|||||-.|||+   ...+.|||+|||.+.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSA  171 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeee
Confidence            899999999999999998753  578899999999999999999999999999999999999   677889999999988


Q ss_pred             ccCC-CCCcccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          163 SLQP-RGLAETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       163 ~~~~-~~~~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      .+.. .....+.+|||.|||||++..     ..|+.++|+||||++..||.-|.+|+....+...+..|....++.+- .
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk-r  250 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK-R  250 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc-c
Confidence            7654 445678999999999999853     34788999999999999999999999999988888777665433322 2


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +..++.++.+||..||.+|..+||+..++|+|||+...
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            35678999999999999999999999999999999853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=311.72  Aligned_cols=264  Identities=27%  Similarity=0.473  Sum_probs=217.1

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----   82 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----   82 (575)
                      ....++.|+-..+||+|.||.||+|+.+.+|+.||+|++-.+..+........+|+.+|..|.|+|++.+++++..    
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            3567888999999999999999999999999999999876554444455667899999999999999998887632    


Q ss_pred             ----CCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           83 ----PGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        83 ----~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                          ...+|+||.+|+. +|+-++... .+|+..+++.++.+|..||.|+|.+.|+|||+|++|+|+   +..+.+||+|
T Consensus        92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklAD  167 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLAD  167 (376)
T ss_pred             cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeec
Confidence                2348999999965 888888655 579999999999999999999999999999999999999   7889999999


Q ss_pred             cccccccCCC-----CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          158 FGFARSLQPR-----GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       158 FGla~~~~~~-----~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      ||+++.+...     ..+...+.|.+|++||.+.+ ..|+++.|||.-|||+.+|+++.+.|.+.+..+.+..|......
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            9999765321     22344567999999999875 57999999999999999999999999999888777665432111


Q ss_pred             ----CCCC-----------------Ch-h---------cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 ----HFPP-----------------DA-K---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 ----~~p~-----------------~~-~---------~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                          .+|.                 .. .         .-.+++.+|+.+||..||.+|++++++++|.||-..
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence                1111                 00 0         012378899999999999999999999999999653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6e-37  Score=323.27  Aligned_cols=255  Identities=31%  Similarity=0.515  Sum_probs=216.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEEeCCE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH------PHIIRLHDIIEVPGK   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H------pnIv~l~~~~~~~~~   85 (575)
                      ++|.|....|+|-|++|..|.+..-|..||||+|....   -....=+.|++||++|+.      -|+++|+-.|...++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            45999999999999999999999999999999997643   333445789999999953      489999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +|||+|-+ ..+|.++|++.|   .+....++.|+.||+.||..|-..||+|.||||.||||.  .....+||||||.|.
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSAS  585 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcccc
Confidence            99999998 679999998765   378899999999999999999999999999999999994  556789999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc------------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE------------  230 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~------------  230 (575)
                      ....+... .+..+.+|.|||++.+.+|+...|+||+||+||||.||+..|.|.++.+++...+....            
T Consensus       586 ~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF  664 (752)
T KOG0670|consen  586 FASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF  664 (752)
T ss_pred             cccccccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence            77666554 44568889999999999999999999999999999999999999999988876553210            


Q ss_pred             --CCC------------------------------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHH
Q 043425          231 --LHF------------------------------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFF  266 (575)
Q Consensus       231 --~~~------------------------------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL  266 (575)
                        ..|                                          |.+...+-.++++|+.+||..||++|.|..++|
T Consensus       665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL  744 (752)
T KOG0670|consen  665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL  744 (752)
T ss_pred             hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence              011                                          111112234688999999999999999999999


Q ss_pred             cCCCCCC
Q 043425          267 NHPFLSQ  273 (575)
Q Consensus       267 ~Hpff~~  273 (575)
                      .||||+.
T Consensus       745 ~HpFi~~  751 (752)
T KOG0670|consen  745 KHPFITE  751 (752)
T ss_pred             cCCcccC
Confidence            9999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-35  Score=332.50  Aligned_cols=258  Identities=20%  Similarity=0.333  Sum_probs=180.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCC----CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVH----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI-----   79 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~t----g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~-----   79 (575)
                      ...++|.+.++||+|+||.||+|.+..+    +..||||.+......    +....+  .++...+.++..+...     
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4667899999999999999999999988    999999987643211    111111  1122222222222111     


Q ss_pred             -EEeCCEEEEEEeecCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCccccccc
Q 043425           80 -IEVPGKLHLILEYCKGGDLSMYIQRHGC--------------------VPEETAKHFMKQLAAGLQVLRDNNLIHRDLK  138 (575)
Q Consensus        80 -~~~~~~l~LVmEy~~GgsL~~~l~~~~~--------------------lse~~i~~i~~QLl~aL~~LH~~gIvHrDLK  138 (575)
                       ......+++||||+.+++|.+++.....                    ..+..+..++.||+.||+|||++||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             2456679999999999999999875421                    1234567899999999999999999999999


Q ss_pred             CCceeeecCCCCCcEEEcccccccccCCC--CCcccccCCCCCCChHHHhhc----------------------cCCccc
Q 043425          139 PQNLLLCTDDDNAALKIADFGFARSLQPR--GLAETLCGSPLYMAPEIMQLQ----------------------KYDAKA  194 (575)
Q Consensus       139 PeNILl~~dd~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~~----------------------~y~~ka  194 (575)
                      |+|||+.  ++.+.+||+|||+++.+...  .....++||+.|+|||.+...                      .++.++
T Consensus       283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999993  24578999999999865332  234567899999999976432                      244567


Q ss_pred             ccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC-----------CCCCC-------hhcccHHHHHHHHHhhccCC
Q 043425          195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL-----------HFPPD-------AKILSADCKDLCQKLLRRNP  256 (575)
Q Consensus       195 DIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~-----------~~p~~-------~~~ls~el~dLI~k~L~~DP  256 (575)
                      |||||||+||+|+++..++..  ....+..++.....           .....       ........++||.+||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766432  22222222211110           00000       00112345699999999999


Q ss_pred             CCCCCHHHHHcCCCCCCCCc
Q 043425          257 VERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       257 ~~RpTa~eiL~Hpff~~~~~  276 (575)
                      .+|||++|+|+||||+....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987644

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=304.79  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=212.4

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL-KRINHPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      -+..||.|+||+|++-.++.+|+..|||.|..... .+.+.+++.|.+.. +.-+.||||++|+..-.++..||.||++ 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            34679999999999999999999999999986544 45567788888765 4456899999999988889999999999 


Q ss_pred             CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           95 GGDLSMYIQ-----RHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        95 GgsL~~~l~-----~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ..+|..+.+     .+..++|..+-.|....+.||+||-+. +|||||+||+|||+   +..|.|||||||++..+...-
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHH
Confidence            567766653     346799999999999999999999876 89999999999999   899999999999998776655


Q ss_pred             CcccccCCCCCCChHHHh--hccCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhccCC--CCCChhcccHH
Q 043425          169 LAETLCGSPLYMAPEIMQ--LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKATELH--FPPDAKILSAD  243 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~--~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~~~~--~p~~~~~ls~e  243 (575)
                      ......|...|||||.+.  ..+|+.++|+||||++|||+.||..||.+.+. .+.+..++.+..+.  ++.....++..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~  302 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS  302 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence            555567899999999985  34799999999999999999999999988653 34555555554332  23333468899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +..||.-||.+|-..||.+.+++++||+..
T Consensus       303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             HHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            999999999999999999999999999864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-36  Score=293.65  Aligned_cols=255  Identities=28%  Similarity=0.525  Sum_probs=216.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVP--GKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~l   86 (575)
                      ..++|++.+++|+|.|++||.|.+..+++.++||+++.     -....+.+|+.||..|. ||||+.++++..++  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            67889999999999999999999999999999998853     33456899999999997 99999999999765  457


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      .+|+||+.+.+...+..   .++.-.++.++.+|+.||.|||+.||+|||+||.|+++  |.....++|+|+|+|.++.+
T Consensus       111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI--dh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee--chhhceeeeeecchHhhcCC
Confidence            89999999988877754   47888999999999999999999999999999999999  34566899999999999999


Q ss_pred             CCCcccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHh------------ccCC
Q 043425          167 RGLAETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKA------------TELH  232 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF-~~~~~~~~l~~i~~~------------~~~~  232 (575)
                      +...+-.+.+..|--||.+. .+.|+...|+|||||+|..|+..+-|| .|.++.+.+-+|.+-            -...
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            88888888999999999874 567999999999999999999988886 455666655555431            0111


Q ss_pred             CCC--------------------C-hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 FPP--------------------D-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 ~p~--------------------~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +++                    . ....++++.||+.++|.+|..+|+|+.|++.||||...
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            111                    1 12346899999999999999999999999999999764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=323.09  Aligned_cols=254  Identities=27%  Similarity=0.451  Sum_probs=220.8

Q ss_pred             EEEEEEecccCCeEEEEEEEcC-CC--cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRV-HG--TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~-tg--~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -.+.++||+|.||+||.|.+.. +|  -.||||.+....+.. ....|++|+.+|.+|+|||+++||+++.+ ..+.|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4567899999999999998876 33  458999998776655 56789999999999999999999999876 6789999


Q ss_pred             eecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |+++.|+|.+.|.+  ...|.......|+.||+.|+.||..+++|||||-..|+|+   -....|||+||||.+.+....
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceeccCCCC
Confidence            99999999999976  3568899999999999999999999999999999999999   446689999999999887665


Q ss_pred             Cccccc----CCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          169 LAETLC----GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       169 ~~~~~~----GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ..+...    -...|+|||.++...++.++|+|++||++|||++ |+.||.|....+++++|-++..+..|+   ..+.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk---~csed  343 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPK---YCSED  343 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCC---CChHH
Confidence            444332    2345999999999999999999999999999998 899999999999999998777666665   57889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +.++++.||..+|..||||..|.+.-++....
T Consensus       344 IY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence            99999999999999999999998765555443

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=316.53  Aligned_cols=244  Identities=26%  Similarity=0.495  Sum_probs=211.9

Q ss_pred             EEEEecccCCeEEEEEEEcC--CCc--EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           16 VGRQIGSGSFSVVWHARHRV--HGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~--tg~--~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      +.+.||.|-||.||.|....  .|+  -||||..+.+... +..+.|+.|..+|++++||||++++|++. ....|||||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmE  470 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVME  470 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEe
Confidence            45789999999999998653  233  4888988876644 44788999999999999999999999996 456999999


Q ss_pred             ecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           92 YCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        92 y~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      +++-|.|..|++.++ .++......++.||+.||.|||++++|||||-..|||++   ....|||+|||+++.+....++
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccchh
Confidence            999999999998764 689999999999999999999999999999999999994   4456999999999988776655


Q ss_pred             ccccC--CCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          171 ETLCG--SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       171 ~~~~G--T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ..-.|  ..-|||||-+....++.++|||-|||++||++. |.-||.|-.+.+.+-.+.++..++.|+   ..++.+..|
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~---nCPp~LYsl  624 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP---NCPPALYSL  624 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC---CCChHHHHH
Confidence            44444  334999999999999999999999999999875 999999999999988888888777776   478899999


Q ss_pred             HHHhhccCCCCCCCHHHHHc
Q 043425          248 CQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.+||.+||.+||++.+|..
T Consensus       625 mskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHhccCcccCCcHHHHHH
Confidence            99999999999999987754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-34  Score=314.53  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=188.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc----------------CCCcEEEEEEeecCccCH--H----------HHHHHHHH
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR----------------VHGTEVAMKEIAMGRLNK--K----------LQESLMSE   61 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~----------------~tg~~vAVK~i~~~~~~~--~----------~~~~i~~E   61 (575)
                      ..++|.+.++||+|+||.||+|...                ..++.||||.+.......  +          ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                345689999986532110  0          11223346


Q ss_pred             HHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeecCCCCHHHHHHHc-----------------------
Q 043425           62 IFILKRINHPHI-----IRLHDIIEV--------PGKLHLILEYCKGGDLSMYIQRH-----------------------  105 (575)
Q Consensus        62 i~iL~~L~HpnI-----v~l~~~~~~--------~~~l~LVmEy~~GgsL~~~l~~~-----------------------  105 (575)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.+++...                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766543     566666542        35689999999999999988642                       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccc--ccCCCCCCCh
Q 043425          106 -GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP  182 (575)
Q Consensus       106 -~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~--~~GT~~Y~AP  182 (575)
                       ..+++..++.++.||+.||.|||+.+|+||||||+|||+   +..+.+||+|||++...........  ..+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             123566788999999999999999999999999999999   6667899999999976544332233  2348999999


Q ss_pred             HHHhhcc--------------------CC--cccccchhhHHHHHHHhCCC-CCCCCCHHHH--------HH--HHHHhc
Q 043425          183 EIMQLQK--------------------YD--AKADLWSVGAILFQLVTGKT-PFTGSNQIQL--------LQ--NIVKAT  229 (575)
Q Consensus       183 Evl~~~~--------------------y~--~kaDIWSLGviLyeLltG~~-PF~~~~~~~~--------l~--~i~~~~  229 (575)
                      |++....                    |+  .+.|+||+||++|+|++|.+ ||........        ..  ...+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875322                    22  24799999999999999986 7754221110        00  011122


Q ss_pred             cCCCCCChhcccHHHHHHHHHhhccCC---CCCCCHHHHHcCCCCCC
Q 043425          230 ELHFPPDAKILSADCKDLCQKLLRRNP---VERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       230 ~~~~p~~~~~ls~el~dLI~k~L~~DP---~~RpTa~eiL~Hpff~~  273 (575)
                      ...++. ....+..++||+.+||.++|   .+|+|++|+|+||||..
T Consensus       460 ~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            233332 34578899999999999876   68999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=301.69  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=200.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-----C---CCcceEEEEEEe-
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-----H---PHIIRLHDIIEV-   82 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----H---pnIv~l~~~~~~-   82 (575)
                      ++|.+.++||+|-|++||+|++.++.+.||+|+.+..   +...+..+.||.+|++++     |   .+||+|++.|.. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            7899999999999999999999999999999998753   445677889999999873     3   369999999964 


Q ss_pred             ---CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCC-------
Q 043425           83 ---PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDD-------  149 (575)
Q Consensus        83 ---~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~-------  149 (575)
                         +.++|||+|++ |.+|..+|...  +.++...++.|++||+.||.|||.. ||||.||||+|||+..++-       
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence               45899999999 78999999865  4599999999999999999999986 9999999999999932200       


Q ss_pred             --------------------------------------------------------------------------------
Q 043425          150 --------------------------------------------------------------------------------  149 (575)
Q Consensus       150 --------------------------------------------------------------------------------  149 (575)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CCcE
Q 043425          150 ----------------------------------------------------------------------------NAAL  153 (575)
Q Consensus       150 ----------------------------------------------------------------------------~g~v  153 (575)
                                                                                                  .-.|
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                        0024


Q ss_pred             EEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC------CHHHHHHHHHH
Q 043425          154 KIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS------NQIQLLQNIVK  227 (575)
Q Consensus       154 KL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~------~~~~~l~~i~~  227 (575)
                      ||+|||-|......  ...-..|..|+||||+.+.+|+..+||||++|++|||+||...|.-.      .+++-+..|++
T Consensus       394 KIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  394 KIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             EEeeccchhhhhhh--hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence            55555555443211  22334688899999999999999999999999999999999998432      23333444432


Q ss_pred             hc----------------------------cCCCCCCh----------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCC
Q 043425          228 AT----------------------------ELHFPPDA----------KILSADCKDLCQKLLRRNPVERLTFEEFFNHP  269 (575)
Q Consensus       228 ~~----------------------------~~~~p~~~----------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hp  269 (575)
                      ..                            .+++.+..          .....++-+|+.-||+.+|++||||.++|+||
T Consensus       472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            10                            01111110          11234678999999999999999999999999


Q ss_pred             CCCCCC
Q 043425          270 FLSQTQ  275 (575)
Q Consensus       270 ff~~~~  275 (575)
                      |++...
T Consensus       552 wLn~~~  557 (590)
T KOG1290|consen  552 WLNPVA  557 (590)
T ss_pred             cccCCC
Confidence            998754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=316.15  Aligned_cols=248  Identities=27%  Similarity=0.520  Sum_probs=221.1

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCC---cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg---~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -.|.++||.|.||+|+.|+.+..|   ..||||.++.. ..++.+..|+.|..||-+++||||++|-+++.....++||.
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            468899999999999999998766   45999998754 45677788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      |||++|+|..+|+++ +.|+..++.-+++-|+.|++||-+.|+|||||-..|||+   +.+-.+|++|||+++.+.++. 
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccCCC
Confidence            999999999999765 689999999999999999999999999999999999999   788899999999999875544 


Q ss_pred             -CcccccC--CCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          169 -LAETLCG--SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       169 -~~~~~~G--T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                       ...+..|  ..+|.|||.+...+++.++||||+|++|||.++ |+-||-...+.+.++.|.++-.++.|.+   .+..+
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD---CP~aL  863 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD---CPAAL  863 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC---CcHHH
Confidence             2222323  457999999999999999999999999998765 9999999999999999998877666654   78899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+|+..||++|-++||.+.||+++
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999884

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=293.87  Aligned_cols=258  Identities=29%  Similarity=0.480  Sum_probs=218.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      ..+-.+|.-++.+|.|+- .|-.+.+...++.||+|.+.....+........+|..++..++|+||++++.+|.-..   
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            456778999999999998 7888999999999999988766444444566789999999999999999999985433   


Q ss_pred             ---EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           85 ---KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        85 ---~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                         .+|+||||+ ..+|...+..  .++-..+..++.|+++|++|||+.||+||||||+||++   .....+||.|||+|
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence               489999999 5689888874  47888999999999999999999999999999999999   77788999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC----------
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----------  231 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~----------  231 (575)
                      +.-+.......++.|..|.|||++.+-+|.+.+||||+||++.||++|+..|.|.+..+...++......          
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            8877666677889999999999999988999999999999999999999999998877766666532111          


Q ss_pred             -------------------------CCCCCh---hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          232 -------------------------HFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       232 -------------------------~~p~~~---~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                                               .|+...   +.-+..+++|+.+||..||++|.+++++|+|||++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                     011110   12234689999999999999999999999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=304.47  Aligned_cols=249  Identities=26%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      -.+.++||+|-||+|.+|.-. .+.+||||.+.... ....+..|.+|+.+|.+|+||||++++++|..++.+++|+||+
T Consensus       540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             eehhhhhcCcccceeEEEEec-CceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            467899999999999999865 47999999987654 3445678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           94 KGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        94 ~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      +.|+|.+++.++..  ..-.....++.||+.|++||.+.++|||||.+.|+|+   +.++++||+|||+++.+-....+.
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCCcee
Confidence            99999999988732  2344556799999999999999999999999999999   889999999999999765444322


Q ss_pred             ---cccCCCCCCChHHHhhccCCcccccchhhHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcc----CCCCCChhcccH
Q 043425          172 ---TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV--TGKTPFTGSNQIQLLQNIVKATE----LHFPPDAKILSA  242 (575)
Q Consensus       172 ---~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLl--tG~~PF~~~~~~~~l~~i~~~~~----~~~p~~~~~ls~  242 (575)
                         ..+-...|||||.+..++++.++|+|+||++|||++  +..-||....+++..++......    ..++..+...+.
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence               244567899999999999999999999999999986  47899999998888876554221    122333456788


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.+|+.+||++|-.+||+++++-.
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHHH
Confidence            9999999999999999999999854

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-33  Score=333.24  Aligned_cols=242  Identities=19%  Similarity=0.293  Sum_probs=188.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ...|...++||+|+||.||+|++..+|..||||.+.....      ....|+.++++++||||+++++++...+..|+||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3456677899999999999999999999999998864321      1134688999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR---DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH---~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||++||+|.++++.   +++..+..++.||+.||+|||   +.+|+||||||+||++   +..+..++. ||........
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC
Confidence            99999999999963   789999999999999999999   6799999999999999   555556654 6654432211


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHh------ccCCCCC-
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN-----QIQLLQNIVKA------TELHFPP-  235 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~-----~~~~l~~i~~~------~~~~~p~-  235 (575)
                         ....||+.|+|||++....|+.++|||||||++|||++|+.||....     ..+........      ....... 
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence               23468999999999999999999999999999999999999985421     11111111000      0000100 


Q ss_pred             --ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          236 --DAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       236 --~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                        .......++.+++.+||+.||.+|||+.|+++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              011223467899999999999999999999874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-33  Score=297.90  Aligned_cols=242  Identities=24%  Similarity=0.463  Sum_probs=212.7

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      -..-.+||-|.||.||.|.++...-.||||.++.+.+   ..++|+.|..+|+.+.|||+|+|+++|...-..|||.|||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            3455789999999999999999999999999876432   3567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           94 KGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        94 ~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      ..|+|.+||.+..  -++.-....++.||..|++||..+++|||||-..|+|+   ..+..||++|||+++.+..+.+..
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceec
Confidence            9999999998764  36667778889999999999999999999999999999   677889999999999876554322


Q ss_pred             cccC---CCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          172 TLCG---SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       172 ~~~G---T~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       ..|   ..-|.|||-+....++.++|||+|||+|||+.| |--||.|.+..+.+..+.++....-|..   .++.+.+|
T Consensus       423 -HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG---CPpkVYeL  498 (1157)
T KOG4278|consen  423 -HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG---CPPKVYEL  498 (1157)
T ss_pred             -ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC---CCHHHHHH
Confidence             223   345999999999999999999999999999998 8999999999998888877776666654   68899999


Q ss_pred             HHHhhccCCCCCCCHHHH
Q 043425          248 CQKLLRRNPVERLTFEEF  265 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~ei  265 (575)
                      ++.||+++|..||++.|+
T Consensus       499 MraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  499 MRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHhcCCcccCccHHHH
Confidence            999999999999999887

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=311.13  Aligned_cols=261  Identities=28%  Similarity=0.450  Sum_probs=227.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .--++|+++.++|.|+||.||+++++.+++..|+|+++...-  +...-+.+|+-+++.++||||+.+++.+.....+||
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            345689999999999999999999999999999999987643  334557789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-C
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-R  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~  167 (575)
                      +||||.||+|.+..+-.++++|..+..++++.+.||+|||..|-+|||||-.|||+   .+.|.+|++|||.+..+.. -
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhhhh
Confidence            99999999999998888999999999999999999999999999999999999999   6778899999999866543 2


Q ss_pred             CCcccccCCCCCCChHHH---hhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-CCCCCChhcccHH
Q 043425          168 GLAETLCGSPLYMAPEIM---QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSAD  243 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl---~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~-~~~p~~~~~ls~e  243 (575)
                      .....+.|||.|||||+-   +.++|+..+|||++|++..|+..-.+|.....++..+....+... ..-..+....++.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            345678999999999985   567899999999999999999999999888777777665555432 1222233567889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +.+|++.+|.++|.+||+++.+|.|||..+.
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            9999999999999999999999999999876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=311.41  Aligned_cols=246  Identities=27%  Similarity=0.434  Sum_probs=196.5

Q ss_pred             EEEecccCCeE-EEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecC
Q 043425           17 GRQIGSGSFSV-VWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        17 ~~~LG~GaFG~-Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      .+.+|.|+-|+ ||+|...  |+.||||.+-.     ....-+.+|+..|+..+ |||||++|+.-.+....||..|.| 
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            35689999986 8999876  99999997753     23345679999999884 999999999988899999999999 


Q ss_pred             CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC--CCCcEEEcccccccccCCCC
Q 043425           95 GGDLSMYIQRHGC----VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD--DNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        95 GgsL~~~l~~~~~----lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd--~~g~vKL~DFGla~~~~~~~  168 (575)
                      ..+|.+++...+.    ......+.++.|++.||++||+.+||||||||+||||...+  ....++|+|||+++.+..+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            5699999986411    11145688999999999999999999999999999997643  34579999999999886543


Q ss_pred             ----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          169 ----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       169 ----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                          ...+..||-+|+|||++....-..++||+||||++|+.++| ..||...-..+  .+|+++..... ........+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~-~L~~~~d~e  742 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLV-HLEPLPDCE  742 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcccee-eeccCchHH
Confidence                34567899999999999988888899999999999888875 89998654322  34555432211 111111228


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +.+||.+||++||..||++.++|+||||=.
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            999999999999999999999999999944

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=299.61  Aligned_cols=202  Identities=32%  Similarity=0.496  Sum_probs=181.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHH------HHHHHHHHHHHhCC---CCCcceEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ------ESLMSEIFILKRIN---HPHIIRLHDII   80 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~------~~i~~Ei~iL~~L~---HpnIv~l~~~~   80 (575)
                      ...+|..++.+|.|+||.||+|.++.+...|+||.|.++++-.+.+      -.+..|++||.+|+   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456999999999999999999999999999999998877533222      23568999999997   99999999999


Q ss_pred             EeCCEEEEEEeec-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           81 EVPGKLHLILEYC-KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        81 ~~~~~l~LVmEy~-~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      ++++.+||+||-- +|.+|+++|..+..++|.+++-|++|++.|+++||+.||||||||-+|+.+   +.+|.+||+|||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfg  715 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFG  715 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeecc
Confidence            9999999999965 467999999999999999999999999999999999999999999999999   889999999999


Q ss_pred             cccccCCCCCcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCC
Q 043425          160 FARSLQPRGLAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTG  215 (575)
Q Consensus       160 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~  215 (575)
                      .+.... .+....++||..|.|||++.+.+|- ..-|||+||++||.++..+.||+.
T Consensus       716 saa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            987554 4556789999999999999999984 569999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=283.06  Aligned_cols=256  Identities=32%  Similarity=0.511  Sum_probs=208.9

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-----KLHLI   89 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~l~LV   89 (575)
                      +-.+.||.|+||+||.+.+..+|+.||+|++..-.-+-.....+.+|+.+|..++|.|++..+++.+-..     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3347899999999999999999999999987542212223456889999999999999999998875443     47889


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      .|++. .+|...|-....++...++-++.||++||+|||+.||.||||||.|+|+   +.+..+||||||+++....+..
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhhh
Confidence            99984 5899888888889999999999999999999999999999999999999   7778999999999987654432


Q ss_pred             --cccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC---------------
Q 043425          170 --AETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL---------------  231 (575)
Q Consensus       170 --~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~---------------  231 (575)
                        ...-+.|-.|+|||++.+ ..|+.++||||+|||+.||+..+..|...++.+.++.|......               
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence              334466889999999865 57999999999999999999999999999888877776542111               


Q ss_pred             -------CCCC---Chh-----cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 -------HFPP---DAK-----ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 -------~~p~---~~~-----~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                             .-|.   .+.     .-..+..+++.++|..||.+|.+.++.+.|+++.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                   1111   011     123467899999999999999999999999998543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=263.32  Aligned_cols=217  Identities=26%  Similarity=0.489  Sum_probs=185.8

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEee
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      ..-+..||+|+||.|-+.++..+|...|+|.+.. .++.+.+.+..+|+.+..+. .+|.+|.+|+.....+.+||.||.
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~-tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA-TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehh-hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3456789999999999999999999999999975 45667778888999986654 689999999998889999999999


Q ss_pred             cCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           93 CKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        93 ~~GgsL~~~l----~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      + ..+|..+.    ++.+.++|..+-+|+..++.||.|||++ .|||||+||.|||+   +..|+||+||||++..+.+.
T Consensus       127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhh
Confidence            9 56887664    4567899999999999999999999987 89999999999999   88899999999999877655


Q ss_pred             CCcccccCCCCCCChHHHh----hccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCC
Q 043425          168 GLAETLCGSPLYMAPEIMQ----LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~----~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~  235 (575)
                      -......|.-.|||||.+.    ..+|+-++||||||++++||.+++.||.. .++.++++++++...+.+|.
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~  275 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA  275 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence            4444467888999999874    34899999999999999999999999964 67888888888776555554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-31  Score=300.90  Aligned_cols=246  Identities=30%  Similarity=0.504  Sum_probs=209.3

Q ss_pred             EEEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      .+.+.||+|+||.||+|.-..       ....||||.+...... ...+.+..|+.+|+.+. ||||+.+++++...+.+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            466799999999999996431       1567999988766544 56678999999999985 99999999999889999


Q ss_pred             EEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC
Q 043425           87 HLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN  150 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~  150 (575)
                      ++|+||+..|+|..++..++                .++......++.||+.|++||++.++|||||-..|||+   ..+
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~  454 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKN  454 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCC
Confidence            99999999999999998765                38889999999999999999999999999999999999   666


Q ss_pred             CcEEEcccccccccCCCCCcc--cccCCC--CCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCC-HHHHHHH
Q 043425          151 AALKIADFGFARSLQPRGLAE--TLCGSP--LYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQN  224 (575)
Q Consensus       151 g~vKL~DFGla~~~~~~~~~~--~~~GT~--~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~-~~~~l~~  224 (575)
                      ..+||+|||+|+.........  .-.|+.  .|||||.+....|+.++||||+|++|||+++ |..||.+.. ..++++.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            889999999999765544432  222323  3999999999999999999999999999998 899999865 6667776


Q ss_pred             HHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       225 i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +..+.....|.   ..+.++.++++.||+.+|.+||++.++.+
T Consensus       535 l~~G~r~~~P~---~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  535 LKEGNRMEQPE---HCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhcCCCCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66666555554   46899999999999999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=9.4e-31  Score=247.33  Aligned_cols=211  Identities=40%  Similarity=0.754  Sum_probs=188.0

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLS   99 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~   99 (575)
                      ||+|++|.||++....+|+.+++|++....... ....+.+|+.+++.+.|++|+++++++......++++||+.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999999889999999998654332 3467889999999999999999999999889999999999999999


Q ss_pred             HHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-CCcEEEcccccccccCCCC-CcccccCC
Q 043425          100 MYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGFARSLQPRG-LAETLCGS  176 (575)
Q Consensus       100 ~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFGla~~~~~~~-~~~~~~GT  176 (575)
                      +++... ..++...+..++.+++.+|++||+.|++|+||+|.||++   +. .+.++|+|||.+....... ......+.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999876 478999999999999999999999999999999999999   55 6789999999997664432 23345688


Q ss_pred             CCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccC
Q 043425          177 PLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN  255 (575)
Q Consensus       177 ~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~D  255 (575)
                      ..|++||.+... .++.+.|+|+||+++++|                                   ..+.+++.+|++.|
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCC
Confidence            899999999877 888999999999999999                                   68899999999999


Q ss_pred             CCCCCCHHHHHcCC
Q 043425          256 PVERLTFEEFFNHP  269 (575)
Q Consensus       256 P~~RpTa~eiL~Hp  269 (575)
                      |.+||+++++++|+
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-30  Score=251.35  Aligned_cols=212  Identities=37%  Similarity=0.719  Sum_probs=185.5

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      |.+.+.||.|+||.||++.+..++..+|+|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            67889999999999999999988999999999865433 24567889999999999999999999998889999999999


Q ss_pred             CCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--Cc
Q 043425           94 KGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--LA  170 (575)
Q Consensus        94 ~GgsL~~~l~~~~~-lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--~~  170 (575)
                      ++++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||++   +..+.++|+|||++.......  ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccc
Confidence            99999999987766 8999999999999999999999999999999999999   666899999999998765543  34


Q ss_pred             ccccCCCCCCChHHH-hhccCCcccccchhhHHHHHHHhCCCCCCC-CCHH-HHHHHHHHhc
Q 043425          171 ETLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQI-QLLQNIVKAT  229 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl-~~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~-~~l~~i~~~~  229 (575)
                      ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++. .+.+.+..+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            456788999999998 667788899999999999999999999988 4444 5556666554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=8.2e-32  Score=280.16  Aligned_cols=256  Identities=26%  Similarity=0.459  Sum_probs=202.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~   85 (575)
                      +...|.++++||.|.|++||++.+..   ..+.||+|.+..-..    ...+.+|+++|..+. +.||+.+.+++..++.
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            45668999999999999999999887   789999999875432    245889999999985 7999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +++||||+++.+..+++..   ++...++.+++.++.||.++|.+|||||||||.|+|.+  ...+.-.|+|||+|....
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHH
Confidence            9999999999999888754   67899999999999999999999999999999999994  556678899999997221


Q ss_pred             CC----------------------------------CC-----------cccccCCCCCCChHHHhh-ccCCcccccchh
Q 043425          166 PR----------------------------------GL-----------AETLCGSPLYMAPEIMQL-QKYDAKADLWSV  199 (575)
Q Consensus       166 ~~----------------------------------~~-----------~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSL  199 (575)
                      ..                                  +.           .....||++|+|||++.. ...+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            00                                  00           012359999999999754 557889999999


Q ss_pred             hHHHHHHHhCCCCCCCCC-HHHHHHHHHH--------------hc-------------------------------c--C
Q 043425          200 GAILFQLVTGKTPFTGSN-QIQLLQNIVK--------------AT-------------------------------E--L  231 (575)
Q Consensus       200 GviLyeLltG~~PF~~~~-~~~~l~~i~~--------------~~-------------------------------~--~  231 (575)
                      |||+.-++++..||.... +...+..+..              +.                               .  .
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999985432 1111111110              00                               0  0


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .........+..+.+|+.+||..||.+|+|++++|+||||...
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            0000012345578999999999999999999999999999854

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-31  Score=275.22  Aligned_cols=245  Identities=23%  Similarity=0.371  Sum_probs=193.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR--INHPHIIRLHDIIEVPG----   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~~~~~~~----   84 (575)
                      +..-.+.+.||+|.||.||+|...  ++.||||++.     ....+.+.+|.+|.+.  +.|+||+++++.-+...    
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            445677889999999999999876  7999999985     4556778899998875  57999999998865554    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC---------CcccccccCCceeeecCCCCCcEEE
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN---------NLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~---------gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .++||+||.+.|+|.+||+.+ .++.....+++.-+++||+|||+.         .|+|||||..||||   ..+.+..|
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence            799999999999999999875 589999999999999999999963         59999999999999   67789999


Q ss_pred             cccccccccCCCC---CcccccCCCCCCChHHHhhcc-CC-----cccccchhhHHHHHHHhCCC------------CCC
Q 043425          156 ADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQK-YD-----AKADLWSVGAILFQLVTGKT------------PFT  214 (575)
Q Consensus       156 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~-y~-----~kaDIWSLGviLyeLltG~~------------PF~  214 (575)
                      +|||+|..+.+..   ..-.-+||.+|||||++.+.- ..     .+.||||+|.+||||++...            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999998876433   333478999999999996532 11     25899999999999998533            232


Q ss_pred             -----CCCHHHHHHHHHH-hccCCCCCChhc--ccHHHHHHHHHhhccCCCCCCCHHHHH
Q 043425          215 -----GSNQIQLLQNIVK-ATELHFPPDAKI--LSADCKDLCQKLLRRNPVERLTFEEFF  266 (575)
Q Consensus       215 -----~~~~~~~l~~i~~-~~~~~~p~~~~~--ls~el~dLI~k~L~~DP~~RpTa~eiL  266 (575)
                           ...-+++...++. ..++.+|..+..  --.-+++.+..||+.||+.|+|+.=+.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence                 1223344433333 334555554422  234578999999999999999986443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=271.19  Aligned_cols=246  Identities=26%  Similarity=0.411  Sum_probs=190.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeC----
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR--INHPHIIRLHDIIEVP----   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~~~~~~----   83 (575)
                      +...-.+.+.||+|-||+||+|.++  |+.||||++...     ......+|.+|.+.  |+|+||+.+++.-..+    
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            4455789999999999999999998  999999999753     23456778888765  6999999998864322    


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccccccCCceeeecCCCCCcEEE
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--------NLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--------gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .++|||.+|.+.|+|+|||.+ ..++.....+++.-++.||+|||-.        .|.|||||..||||   ..++.+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEE
Confidence            369999999999999999998 5689999999999999999999953        59999999999999   78899999


Q ss_pred             cccccccccCCCC-----CcccccCCCCCCChHHHhhcc----CC--cccccchhhHHHHHHHhC----------CCCCC
Q 043425          156 ADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQLQK----YD--AKADLWSVGAILFQLVTG----------KTPFT  214 (575)
Q Consensus       156 ~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~----y~--~kaDIWSLGviLyeLltG----------~~PF~  214 (575)
                      +|+|||.......     ..+..+||-+|||||++...-    +.  ..+||||||.++||++..          .+||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999997765432     235679999999999985321    11  259999999999999852          67886


Q ss_pred             CC-----CHHHHHHHHHH--hccCCCCCChhcc--cHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          215 GS-----NQIQLLQNIVK--ATELHFPPDAKIL--SADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       215 ~~-----~~~~~l~~i~~--~~~~~~p~~~~~l--s~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..     ..+++. +++.  ...+..|..+...  =..+-.+++.||..||..|.|+--|.+
T Consensus       438 d~Vp~DPs~eeMr-kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  438 DVVPSDPSFEEMR-KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cCCCCCCCHHHHh-cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            53     223333 3322  2233334333211  124678999999999999999876654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=286.44  Aligned_cols=246  Identities=27%  Similarity=0.452  Sum_probs=209.9

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+..++||+|+||+||+|...-.|+    +||+|++..... .+....+..|..+|..++|||++++++++.... +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            4456899999999999998765554    578888765543 344567899999999999999999999997655 8999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ++|+++|.|.++++.+ +.+-......|..||+.|+.|||++++|||||-..|+||   ....++||.|||+++.+....
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence            9999999999999865 578899999999999999999999999999999999999   666789999999999887655


Q ss_pred             Ccccc---cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          169 LAETL---CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       169 ~~~~~---~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .....   .-.+-|||-|.+....|+.++||||+||++||++| |.-|+.+....++-..+.++..+.-|+   ..+.++
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPp---iCtiDV  929 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPP---ICTIDV  929 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCC---CccHHH
Confidence            43322   23456999999999999999999999999999998 999999999888877777766654444   578899


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .-++.+||..|+..||+|+++-.
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999998865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=258.50  Aligned_cols=246  Identities=24%  Similarity=0.415  Sum_probs=200.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEE-EEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDI-IEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~-~~~~~~l   86 (575)
                      ..++.|.|.+.||+|-||.+.+|+|+.+++.+++|.+....   .....+.+|..---.|. |.||+.-|++ |++.+.+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            45678999999999999999999999999999999987643   34456888887655554 7899988774 7888999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++++||++-|+|..-+... .+.|...+.++.||+.||.|+|++++||||||.+|||+...|. ..|||||||+.+....
T Consensus        98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df-~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF-YRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc-cEEEeeecccccccCc
Confidence            9999999999999988764 4889999999999999999999999999999999999976544 4899999999865432


Q ss_pred             CCCcccccCCCCCCChHHHhh---c--cCCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCCCCCh
Q 043425          167 RGLAETLCGSPLYMAPEIMQL---Q--KYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~---~--~y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~p~~~  237 (575)
                        .....-.+..|.|||+...   +  ..++..|+|.||+++|.+++|++||+....    .--...+.++.....|...
T Consensus       176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence              2222334567999998642   2  346789999999999999999999985432    2223345555566777777


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLT  261 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpT  261 (575)
                      ..+++.+..+.++-|.+++++|--
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drck  277 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCK  277 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccch
Confidence            889999999999999999999943

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=6.7e-30  Score=297.21  Aligned_cols=202  Identities=15%  Similarity=0.261  Sum_probs=153.3

Q ss_pred             hCCC-CCcceEEEEE-------EeCCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccc
Q 043425           67 RINH-PHIIRLHDII-------EVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL  137 (575)
Q Consensus        67 ~L~H-pnIv~l~~~~-------~~~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDL  137 (575)
                      .++| +||++++++|       .....++.+|||+ +++|.+++... ..+++..++.+++||+.||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4455 5788888877       2234578889987 67999999753 46999999999999999999999999999999


Q ss_pred             cCCceeeec----------------CCCCCcEEEcccccccccCCCC-----------------CcccccCCCCCCChHH
Q 043425          138 KPQNLLLCT----------------DDDNAALKIADFGFARSLQPRG-----------------LAETLCGSPLYMAPEI  184 (575)
Q Consensus       138 KPeNILl~~----------------dd~~g~vKL~DFGla~~~~~~~-----------------~~~~~~GT~~Y~APEv  184 (575)
                      ||+||||..                .+..+.+||+|||+++......                 .....+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999942                1334668888888876432100                 0112468999999999


Q ss_pred             HhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHH
Q 043425          185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE  264 (575)
Q Consensus       185 l~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~e  264 (575)
                      +.+..|+.++|||||||+||||++|.+||....  ..+..+...   .+++.......+..+++.+||.+||.+||++.|
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR---VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh---hcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence            999999999999999999999999998876432  122222211   112221122456789999999999999999999


Q ss_pred             HHcCCCCCCC
Q 043425          265 FFNHPFLSQT  274 (575)
Q Consensus       265 iL~Hpff~~~  274 (575)
                      +++||||...
T Consensus       262 il~h~~~~~~  271 (793)
T PLN00181        262 LLQSEFINEP  271 (793)
T ss_pred             Hhhchhhhhh
Confidence            9999999764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=277.72  Aligned_cols=248  Identities=32%  Similarity=0.548  Sum_probs=216.8

Q ss_pred             EecccCCeEEEEEEE---cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecC
Q 043425           19 QIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~---~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      ++|+|+||.|++++.   ...|..||+|+..+.............|..++..++ ||.+++++..|+.++.+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998643   346888999999887765555556778889999887 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccccc
Q 043425           95 GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC  174 (575)
Q Consensus        95 GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~  174 (575)
                      ||+|+..+.....+++...+.+...++.+++++|+.||+|||+|++||++   +..|++++.|||+.+..-.....   |
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---c
Confidence            99999999988899999999999999999999999999999999999999   89999999999999876544333   9


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||..|||||+++  +....+|+||+|+++|+|++|..||.+    +....|.+. ...+|   ..++.++++++.+++..
T Consensus       155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-~~~~p---~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-ELEMP---RELSAEARSLFRQLFKR  224 (612)
T ss_pred             cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-ccCCc---hhhhHHHHHHHHHHHhh
Confidence            999999999998  788899999999999999999999998    555566654 23333   46899999999999999


Q ss_pred             CCCCCCC-----HHHHHcCCCCCCCCchhhhhh
Q 043425          255 NPVERLT-----FEEFFNHPFLSQTQPDQVFRS  282 (575)
Q Consensus       255 DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~  282 (575)
                      +|..|..     +.|+++|+||+.+.|..+..+
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r  257 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSIDWNELEAR  257 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeeeHhhHhhc
Confidence            9999984     589999999999999876553

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.2e-26  Score=229.69  Aligned_cols=254  Identities=36%  Similarity=0.611  Sum_probs=210.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH-HHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHP-HIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~l~LVmE   91 (575)
                      |.+.+.||.|+||.||++.+.   ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+...+..+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999988   8899999887654443 567789999999999988 79999999988888999999


Q ss_pred             ecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC-cEEEcccccccccCCC
Q 043425           92 YCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSLQPR  167 (575)
Q Consensus        92 y~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~~~~~  167 (575)
                      |+.++++.+++....   .+++..+..++.|++.++.++|+.|++|||+||+||++   +..+ .++++|||++..+...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence            999999998877664   79999999999999999999999999999999999999   5555 7999999999865443


Q ss_pred             C-------CcccccCCCCCCChHHHhh---ccCCcccccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCC
Q 043425          168 G-------LAETLCGSPLYMAPEIMQL---QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHF  233 (575)
Q Consensus       168 ~-------~~~~~~GT~~Y~APEvl~~---~~y~~kaDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~  233 (575)
                      .       .....+||+.|+|||.+..   ..+....|+|++|++++++++|..||.....    ......+........
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            3       3467889999999999987   5788899999999999999999999887763    344444433322101


Q ss_pred             CCCh-hcc----cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          234 PPDA-KIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       234 p~~~-~~l----s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .... ...    ...+.+++.+++..+|..|.+..+...++|...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            1111 111    257899999999999999999999998866543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-26  Score=241.89  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=198.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCC-cEEEEEEeecCccCHHHHHHHHHHHHHHHhCC----CCCcceEEEEE-EeCCEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEIAMGRLNKKLQESLMSEIFILKRIN----HPHIIRLHDII-EVPGKL   86 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg-~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~----HpnIv~l~~~~-~~~~~l   86 (575)
                      +|.+.++||+|+||.||+|.+..++ ..+|+|+.........  ..+..|..++..+.    .+++..+++.+ ..+..-
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999998764 6899998765422111  14677888888876    26899999999 577889


Q ss_pred             EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC--CCCcEEEccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD--DNAALKIADFGFAR  162 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd--~~g~vKL~DFGla~  162 (575)
                      ||||+.+ |.+|.++....  +.|+..++..++.|++.+|++||+.|++||||||+|++++...  ....+.|.|||+++
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999999 88999988654  5799999999999999999999999999999999999996543  22579999999998


Q ss_pred             --ccC-CCC-----C---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          163 --SLQ-PRG-----L---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       163 --~~~-~~~-----~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                        .+. ...     .   ...+.||..|+++.+..+...+.+.|+||+++++.+|+.|.+||.+...........+....
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              321 111     1   22356999999999999999999999999999999999999999876543222222221111


Q ss_pred             -CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 -HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 -~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                       .........+.++..+...+-..+...+|.+..+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence             1111122345678888888888899999999888764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.4e-27  Score=224.09  Aligned_cols=162  Identities=23%  Similarity=0.318  Sum_probs=131.5

Q ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCccccc
Q 043425           96 GDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC  174 (575)
Q Consensus        96 gsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~  174 (575)
                      |+|.+++..+ +.+++..++.++.||+.||+|||+.+      ||+|||+   +.++.+|+  ||++......    ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~----~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE----QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc----cCC
Confidence            6899999864 46999999999999999999999999      9999999   77788999  9998765432    236


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhccCCCCC---ChhcccH--HHHHHH
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELHFPP---DAKILSA--DCKDLC  248 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i~~~~~~~~p~---~~~~ls~--el~dLI  248 (575)
                      ||+.|||||++.+..|+.++|||||||++|+|++|+.||...... ..+..+........+.   ....++.  +++++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            899999999999999999999999999999999999999765432 3333443332222111   1123333  699999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      .+||..||.+||++.|+++|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.9e-29  Score=278.70  Aligned_cols=263  Identities=28%  Similarity=0.450  Sum_probs=209.2

Q ss_pred             ecCE-EEEEEecccCCeEEEEEEEcCCCcEEEEEEeec----CccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDY-LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM----GRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y-~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~----~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ...| ...+.+|.|++|.|+.+........++.|.+..    .....+....+..|+.+-..+.|||++.....+.....
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            3446 467889999999999988887777777776542    11122333337788888889999999887777666655


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ..-+||||++ +|+.++...+.++..++..+++||+.||+|||+.||.||||||+|+++   ..++.+||+|||.+..+.
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence            6666999999 999999988889999999999999999999999999999999999999   777899999999987653


Q ss_pred             CC-----CCcccccCCCCCCChHHHhhccCCcc-cccchhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhccC----CCC
Q 043425          166 PR-----GLAETLCGSPLYMAPEIMQLQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLL-QNIVKATEL----HFP  234 (575)
Q Consensus       166 ~~-----~~~~~~~GT~~Y~APEvl~~~~y~~k-aDIWSLGviLyeLltG~~PF~~~~~~~~l-~~i~~~~~~----~~p  234 (575)
                      ..     ......+|+..|+|||++....|++. +||||.|++++.|.+|+.||......+.. .........    ...
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            32     23456899999999999999999875 89999999999999999999765544332 111111011    111


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      .....++.+.+.+|.+||+.||.+|.|+++|++.+||+.+..-
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            1224688899999999999999999999999999999887543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=2e-27  Score=268.57  Aligned_cols=231  Identities=29%  Similarity=0.584  Sum_probs=191.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .-.+|..++.|..|+||.||+++|+.+-+.+|+| +++..+       +.+.  |+.....|.+|               
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee---------------
Confidence            4567999999999999999999999999999994 544321       1111  33333444444               


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC---
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---  166 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~---  166 (575)
                            ||-.++++.-+.++...        +.+++|||..||+|||+||+|.|+   ..-|++|+.|||+.+..-.   
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence                  67788887767776554        889999999999999999999999   7789999999999864211   


Q ss_pred             -------------CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          167 -------------RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       167 -------------~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                                   ....+..||||.|+||||+..++|+..+|||+||+|+|+++.|+.||.+.++++++..++.. ...+
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd-~i~w  277 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-DIEW  277 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-hccc
Confidence                         11234679999999999999999999999999999999999999999999999999887765 5566


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCC---CHHHHHcCCCCCCCCchhhhhhc
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERL---TFEEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~Rp---Ta~eiL~Hpff~~~~~~~~~~~~  283 (575)
                      |+....+++|++++|.++|+.+|..|.   .+-++.+|+||+..+|..+++..
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqk  330 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQK  330 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhh
Confidence            766777999999999999999999997   57899999999999999777644

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=241.41  Aligned_cols=250  Identities=20%  Similarity=0.275  Sum_probs=194.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      ..+.-.|+|+++||+|+||+.+.|++..+++.||||.-......+    +++.|.+..+.|. .++|...|.+...+.+-
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            345556999999999999999999999999999999765543333    4678888888886 59999999998888888


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec--CCCCCcEEEcccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT--DDDNAALKIADFGFARS  163 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~--dd~~g~vKL~DFGla~~  163 (575)
                      .||+|++ |-+|+++..-.+ .|+..++..++.|++.-++++|++.+|+|||||+|+||+.  ..+...|.|+|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 889988877554 6999999999999999999999999999999999999963  23456799999999988


Q ss_pred             cCCCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhccCC
Q 043425          164 LQPRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELH  232 (575)
Q Consensus       164 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---~~l~~i~~~~~~~  232 (575)
                      +....        ..+.+.||..||+=....+.+.+.+.|+-|||-++++++-|.+||.|....   +-.++|-......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            75432        345678999999999888999999999999999999999999999986544   4444444332221


Q ss_pred             CC-CChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          233 FP-PDAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       233 ~p-~~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      .. ..+..++.++-.-++-.-+.+=.+-|++
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            11 1113345555544444333333344443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3e-26  Score=224.04  Aligned_cols=250  Identities=21%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l   86 (575)
                      -.++|.|+++++||+|+||.+|+|.+..+|+.||||+-....-.    .++..|..+.+.|++ ..|..+..++.....-
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            45788999999999999999999999999999999987654332    346788899999875 7788888888888889


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .+||+++ |-+|+++.+-. ..|+..++.-++.|++.-++|+|.+++|||||||+|+|++-+.....+.|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999999 88999988644 469999999999999999999999999999999999999888888899999999998764


Q ss_pred             CCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhccC-CC
Q 043425          166 PRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL---QNIVKATEL-HF  233 (575)
Q Consensus       166 ~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l---~~i~~~~~~-~~  233 (575)
                      ...        ......||..|.+-....+...+.+.|+-|+|++|.++..|.+||++.......   ++|.+..-. ..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            322        234578999999988888888889999999999999999999999997655443   344433211 11


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      ...+.-+|.|+.-.+..|-..-=++-|++
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            11224567788777777766555555654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-25  Score=231.51  Aligned_cols=249  Identities=20%  Similarity=0.331  Sum_probs=203.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCC-----cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHG-----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDII-EVPGK   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg-----~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~-~~~~~   85 (575)
                      .++++...+-+|.||.||.|..+...     +.|-+|.++... .+-....+..|--.|..+.|||+..+.++. ++...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            34677778889999999999776422     334455554322 222234567888888999999999999976 55677


Q ss_pred             EEEEEeecCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           86 LHLILEYCKGGDLSMYIQRH--------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~--------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      .++++.+..-|+|..++...        ..++..+...++.||+.|++|||+.||||.||-..|+++   ++.-+|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence            89999999999999999722        236667788899999999999999999999999999999   8889999999


Q ss_pred             cccccccCCCCCcc---cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          158 FGFARSLQPRGLAE---TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       158 FGla~~~~~~~~~~---~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      =.+++.+-+..+..   .-.....||+||.+.+..|+.++|+|||||+||||++ |+.||...++.++...+.++..+.-
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ  519 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ  519 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence            99998775544321   1223456999999999999999999999999999998 9999999999999988888765544


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      |   .+.+.++..++..||..+|++||+++|+..
T Consensus       520 P---~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  520 P---FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             C---CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            4   357899999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.4e-25  Score=236.24  Aligned_cols=167  Identities=20%  Similarity=0.249  Sum_probs=133.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcC-CCcEEEEEEeecCcc---CHHHHHHHHHHHHHHHhCCCCCcce-EEEEEEe
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRL---NKKLQESLMSEIFILKRINHPHIIR-LHDIIEV   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~-l~~~~~~   82 (575)
                      .-..++|.+.++||+|+||+||+|.++. +|+.+|||++.....   .......+.+|+.+|+.++|+||+. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3467789999999999999999999886 788889998753311   2334567899999999999999985 4432   


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccc-cCCceeeecCCCCCcEEEcccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL-KPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDL-KPeNILl~~dd~~g~vKL~DFGla  161 (575)
                       +..|+||||++|++|... ..   ..   ...++.|++.||.|||++||+|||| ||+|||+   +..+.+||+|||+|
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQLA  159 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECccc
Confidence             458999999999999732 11   11   2568899999999999999999999 9999999   56678999999999


Q ss_pred             cccCCCC---------CcccccCCCCCCChHHHhhc
Q 043425          162 RSLQPRG---------LAETLCGSPLYMAPEIMQLQ  188 (575)
Q Consensus       162 ~~~~~~~---------~~~~~~GT~~Y~APEvl~~~  188 (575)
                      +.+....         ...+.+|++.|+|||++...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            8664432         12456789999999998543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=9.7e-23  Score=198.14  Aligned_cols=141  Identities=24%  Similarity=0.262  Sum_probs=111.8

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL------------------------QESLMSEIFILKRINHPH   72 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~------------------------~~~i~~Ei~iL~~L~Hpn   72 (575)
                      ...||+|+||.||+|.+. +|+.||||++.........                        .....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 8999999999765321111                        122345999999998877


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hhCCcccccccCCceeeecCCCCC
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~L-H~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      +.....+. ... .+|||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+|||+   + .+
T Consensus        81 v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli---~-~~  154 (190)
T cd05147          81 IPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY---H-DG  154 (190)
T ss_pred             CCCCcEEE-ecC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---E-CC
Confidence            64433332 222 389999999988776655567899999999999999999999 79999999999999999   3 36


Q ss_pred             cEEEccccccccc
Q 043425          152 ALKIADFGFARSL  164 (575)
Q Consensus       152 ~vKL~DFGla~~~  164 (575)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            7999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=3.2e-22  Score=199.46  Aligned_cols=173  Identities=16%  Similarity=0.204  Sum_probs=134.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHH------HHHHHHHHHhCCCCCcceEEEEEEe
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQES------LMSEIFILKRINHPHIIRLHDIIEV   82 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~------i~~Ei~iL~~L~HpnIv~l~~~~~~   82 (575)
                      +-++|++.++||.|+||.||++..  ++..+|||++....... ...+.      +.+|+..+.++.||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999655  47789999997543322 22222      5789999999999999999988653


Q ss_pred             C--------CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEE
Q 043425           83 P--------GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        83 ~--------~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                      .        +..+|||||++|.+|.++..    +++    ....+++.+|..||+.|++|||+||.||++   +..+ ++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g-i~  174 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG-LR  174 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC-EE
Confidence            3        35899999999999988732    333    346699999999999999999999999999   4455 99


Q ss_pred             EcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHH
Q 043425          155 IADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV  207 (575)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLl  207 (575)
                      |+|||............           .++....|+.++|+|+||+++..+.
T Consensus       175 liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            99999886543222111           1445667888999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=1.5e-21  Score=189.23  Aligned_cols=143  Identities=23%  Similarity=0.238  Sum_probs=113.7

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH------------------------HHHHHHHHHHHHHHhCCCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK------------------------KLQESLMSEIFILKRINHPH   72 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~------------------------~~~~~i~~Ei~iL~~L~Hpn   72 (575)
                      .+.||+|+||.||+|.+. +|+.||||++.......                        .....+..|...+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999988 89999999988653110                        01123457899999999998


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCC
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      |.....+....  .+|||||++|+++.........+++..+..++.|++.+|.++|. .||+||||||+|||+   + .+
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~-~~  154 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H-DG  154 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E-CC
Confidence            75544443322  48999999988654443345678899999999999999999999 999999999999999   3 57


Q ss_pred             cEEEcccccccccCC
Q 043425          152 ALKIADFGFARSLQP  166 (575)
Q Consensus       152 ~vKL~DFGla~~~~~  166 (575)
                      .++|+|||++.....
T Consensus       155 ~~~liDFG~a~~~~~  169 (190)
T cd05145         155 KPYIIDVSQAVELDH  169 (190)
T ss_pred             CEEEEEcccceecCC
Confidence            899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=1.3e-21  Score=200.71  Aligned_cols=233  Identities=24%  Similarity=0.343  Sum_probs=151.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINH----------PHIIRLHDIIE   81 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~H----------pnIv~l~~~~~   81 (575)
                      ....++.||.|+|+.||.+.+..||+.+|||++....... ...+++++|......+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            5678899999999999999999999999999987654322 234556555544433221          12332333321


Q ss_pred             ---------eC---C-----EEEEEEeecCCCCHHHHHH---HcCCC--C-HHHH-HHHHHHHHHHHHHHhhCCcccccc
Q 043425           82 ---------VP---G-----KLHLILEYCKGGDLSMYIQ---RHGCV--P-EETA-KHFMKQLAAGLQVLRDNNLIHRDL  137 (575)
Q Consensus        82 ---------~~---~-----~l~LVmEy~~GgsL~~~l~---~~~~l--s-e~~i-~~i~~QLl~aL~~LH~~gIvHrDL  137 (575)
                               ..   +     ..+++|+-+ -++|.+++.   .....  . ...+ ..+..|++..+++||..|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     136677777 468887754   22222  1 1223 445589999999999999999999


Q ss_pred             cCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc--------cCCcccccchhhHHHHHHHhC
Q 043425          138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ--------KYDAKADLWSVGAILFQLVTG  209 (575)
Q Consensus       138 KPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~--------~y~~kaDIWSLGviLyeLltG  209 (575)
                      ||+|+|+   +.+|.++|+||+.....+.....  ...+..|.|||.....        .++.+.|.|+||+++|.|.+|
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   78899999999987665443222  3345779999987542        578889999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCC
Q 043425          210 KTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER  259 (575)
Q Consensus       210 ~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~R  259 (575)
                      ..||...........       .|... ..++..++.||+.+|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~-------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW-------DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG-------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc-------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            999987643221111       22333 3789999999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=6.7e-21  Score=187.12  Aligned_cols=187  Identities=19%  Similarity=0.235  Sum_probs=143.5

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH--HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK--KLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+...|++|+||+||++..  .+..++.+.+.....-.  -....+.+|+++|++|. +++|++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678999999999998765  58888877776543311  11235789999999996 4889999886    34799999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccc-cCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL-KPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDL-KPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |+.|.+|...+..      . ...++.|++.+|+++|++||+|||| ||+|||+   +..+.++|+|||++........ 
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence            9999998765422      1 2457889999999999999999999 7999999   5667899999999986554331 


Q ss_pred             ----c---------ccccCCCCCCChHHHhhc-cCC-cccccchhhHHHHHHHhCCCCCCCCC
Q 043425          170 ----A---------ETLCGSPLYMAPEIMQLQ-KYD-AKADLWSVGAILFQLVTGKTPFTGSN  217 (575)
Q Consensus       170 ----~---------~~~~GT~~Y~APEvl~~~-~y~-~kaDIWSLGviLyeLltG~~PF~~~~  217 (575)
                          .         .-...++.|+.|+...-. ..+ .+.++++.|+-+|.++|+..++.+.+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                1         012368899999975432 223 56899999999999999999876544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.5e-21  Score=202.11  Aligned_cols=195  Identities=28%  Similarity=0.453  Sum_probs=147.4

Q ss_pred             CCCCcceEEEEEEe---------------------------CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 043425           69 NHPHIIRLHDIIEV---------------------------PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA  121 (575)
Q Consensus        69 ~HpnIv~l~~~~~~---------------------------~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl  121 (575)
                      .|||||+++..|-+                           +..+|+||.-++ .+|..++-.+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999887632                           125899999885 4899998754 357788889999999


Q ss_pred             HHHHHHhhCCcccccccCCceeeecC-CCCCcEEEcccccccccCCCC-------CcccccCCCCCCChHHHhhccC---
Q 043425          122 AGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFARSLQPRG-------LAETLCGSPLYMAPEIMQLQKY---  190 (575)
Q Consensus       122 ~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~vKL~DFGla~~~~~~~-------~~~~~~GT~~Y~APEvl~~~~y---  190 (575)
                      +|+.|||++||.|||||.+|||+.-+ |.-..+.|+|||++---..-+       ..-...|....||||+...-+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999754 445678999999874322111       1123457888999999864331   


Q ss_pred             --C-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCH---HH
Q 043425          191 --D-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF---EE  264 (575)
Q Consensus       191 --~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa---~e  264 (575)
                        + .++|.|+.|.+.||++....||++...+.+-..-.  .+..+|......++.+++|+..+|+.||.+|++.   ..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y--qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY--QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhh--hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence              1 36999999999999999999999855433222222  2233455555688999999999999999999985   34


Q ss_pred             HHc
Q 043425          265 FFN  267 (575)
Q Consensus       265 iL~  267 (575)
                      +++
T Consensus       510 vl~  512 (598)
T KOG4158|consen  510 VLN  512 (598)
T ss_pred             HHH
Confidence            554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=6.2e-22  Score=224.55  Aligned_cols=244  Identities=21%  Similarity=0.303  Sum_probs=180.8

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR--LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +|...+.||++-|=.|.+|+++ .|. |+||++-+..  +.-....+...|+. ...+++||++.+..+.++.+..|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            7889999999999999999988 354 9999987653  22222233345555 56678999999998888888889999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc--CCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~--~~~~  168 (575)
                      +|..+ +|+|.+..+..+.+.+.+-|+.||+.||..+|+.||+|||||.||||+   ..-..+.|+||..-+..  ..++
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCCC
Confidence            99954 999999888888888999999999999999999999999999999999   56677999999876432  1111


Q ss_pred             --Ccccc----cCCCCCCChHHHhhc----------c-CCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcc
Q 043425          169 --LAETL----CGSPLYMAPEIMQLQ----------K-YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       169 --~~~~~----~GT~~Y~APEvl~~~----------~-y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~  230 (575)
                        ....+    ..-..|.|||.+...          + ..++.||||+||++.||++ |.+||.-.   +++. ...+. 
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~a-Yr~~~-  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLA-YRSGN-  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHh-HhccC-
Confidence              11111    122249999987432          2 5567999999999999988 78888521   1111 11110 


Q ss_pred             CCCCCC--hhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          231 LHFPPD--AKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       231 ~~~p~~--~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...+..  ...-+..++++|..|++.||.+|.++++.|+-
T Consensus       252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            000000  01224478999999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.2e-20  Score=183.35  Aligned_cols=137  Identities=18%  Similarity=0.204  Sum_probs=109.2

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE-
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHIIRLHDIIEVPG---KLH-   87 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-----~HpnIv~l~~~~~~~~---~l~-   87 (575)
                      .+.||+|+||.||.  ++.++.. +||++.....  ...+.+.+|+.+++.+     .||||++++++++++.   .++ 
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            46899999999995  7777666 6999876432  2345689999999999     5799999999998873   434 


Q ss_pred             EEEee--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHhhCCcccccccCCceeeecCC-CCCcEEEcccccc
Q 043425           88 LILEY--CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL-QVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFA  161 (575)
Q Consensus        88 LVmEy--~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL-~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla  161 (575)
                      +|+||  +.+++|.+++++. .+++.  ..++.|++.++ +|||+++|+||||||+|||+...+ ....++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  5579999999764 56666  36688888777 999999999999999999996433 3458999995433

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=7.4e-21  Score=188.86  Aligned_cols=245  Identities=22%  Similarity=0.397  Sum_probs=198.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |..++...+.-+|.+...|+.|+|+..  |..+++|++............|..|.-.|+.+.||||+.+++.+..+..+.
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            445566667888999999999999987  777888999887777777778899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcE--EEcccccc
Q 043425           88 LILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAAL--KIADFGFA  161 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~v--KL~DFGla  161 (575)
                      ++..|++-|+|+..+....  ..+..++.+++.++++|+.|||+..  |.-.-|....+++   |+.-+.  -.+|--++
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceee
Confidence            9999999999999998654  3677889999999999999999873  3444788888998   554444  44553332


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhhccCC---cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHH-HHhccCCCCCCh
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQLQKYD---AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI-VKATELHFPPDA  237 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~---~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i-~~~~~~~~p~~~  237 (575)
                      .  +..    ...-+|.||+||.++..+-+   .++|+|||++++|||.|.+.||....+++.-.+| .++.....|+  
T Consensus       341 f--qe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp--  412 (448)
T KOG0195|consen  341 F--QEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--  412 (448)
T ss_pred             e--ecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC--
Confidence            1  111    22346889999999877655   3599999999999999999999998888765544 3555666666  


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHH
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFF  266 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL  266 (575)
                       -++.....|+.-|++.||.+||.++.+.
T Consensus       413 -gis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  413 -GISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence             4789999999999999999999998764

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.6e-19  Score=180.12  Aligned_cols=145  Identities=21%  Similarity=0.239  Sum_probs=115.4

Q ss_pred             CEEEEEEecccCCeEEEEEE-EcCCCcEEEEEEeecCccCH----------------------HHHHHHHHHHHHHHhCC
Q 043425           13 DYLVGRQIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNK----------------------KLQESLMSEIFILKRIN   69 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~-~~~tg~~vAVK~i~~~~~~~----------------------~~~~~i~~Ei~iL~~L~   69 (575)
                      .|.+.+.||+|+||.||+|. +..+|+.||||++.......                      .....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            37899999999999999999 66799999999987543210                      01234568999999997


Q ss_pred             CCC--cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccccccCCceeeec
Q 043425           70 HPH--IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN-LIHRDLKPQNLLLCT  146 (575)
Q Consensus        70 Hpn--Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g-IvHrDLKPeNILl~~  146 (575)
                      +.+  +.++++.   . ..++||||++|++|.........+.+..+..++.||+.+|.+||+.| |+||||||+||++  
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli--  182 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV--  182 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE--
Confidence            533  4444443   2 35899999999888776544556777778899999999999999999 9999999999999  


Q ss_pred             CCCCCcEEEcccccccccC
Q 043425          147 DDDNAALKIADFGFARSLQ  165 (575)
Q Consensus       147 dd~~g~vKL~DFGla~~~~  165 (575)
                       + .+.++|+|||.+....
T Consensus       183 -~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 -H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -E-CCCEEEEEChhhhccC
Confidence             4 5689999999986543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=2.3e-19  Score=206.91  Aligned_cols=237  Identities=20%  Similarity=0.293  Sum_probs=175.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..|.|-+.||+|+||.||.|.+.. |+.||+|+-.....-+     +.=-.+++.+|+   -+.|..+...+...+.-++
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            459999999999999999999986 9999999865433211     111112233333   1455555555566777899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec----CCCCCcEEEccccccccc
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT----DDDNAALKIADFGFARSL  164 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~----dd~~g~vKL~DFGla~~~  164 (575)
                      |+||.+-|+|.++++..+.+++..+..+..|++..|++||..+|||+||||+|+||..    +.+..-++|+|||.+-.+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999999999998889999999999999999999999999999999999999953    334557999999998543


Q ss_pred             ---CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC-hhcc
Q 043425          165 ---QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKIL  240 (575)
Q Consensus       165 ---~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~-~~~l  240 (575)
                         .++......++|-.+-.+|+..+.+++..+|.|.|+.+++.||.|+.-          + ...+..-..... ..++
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~~~Ry~  920 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTNFPRYW  920 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceeccccchhhh
Confidence               344466778999999999999999999999999999999999999742          1 111111111111 1122


Q ss_pred             cH-HHHHHHHHhhccCCCCCCCHHHH
Q 043425          241 SA-DCKDLCQKLLRRNPVERLTFEEF  265 (575)
Q Consensus       241 s~-el~dLI~k~L~~DP~~RpTa~ei  265 (575)
                      .. -.-+|+..+|+.|-..=|...++
T Consensus       921 ~~~~W~~~F~~lLN~~~~~~p~l~~l  946 (974)
T KOG1166|consen  921 KRDMWNKFFDLLLNPDCDTLPNLQEL  946 (974)
T ss_pred             hHHHHHHHHHHHhCcCcccchhHHHH
Confidence            22 34578888888555444555444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2.3e-18  Score=168.09  Aligned_cols=136  Identities=20%  Similarity=0.314  Sum_probs=113.9

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-----H-HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-----K-LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-----~-~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      +.||+|++|.||+|.+  .|..+++|+........     . ....+.+|+.++..+.|++|.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  58889999865433211     1 12457789999999999998877777767778899999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      |++|++|.+++.....    ....++.+++.+|.+||+.|++|||++|.|||+   + .+.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence            9999999999875432    788999999999999999999999999999999   3 57799999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=7e-21  Score=214.22  Aligned_cols=260  Identities=31%  Similarity=0.484  Sum_probs=211.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...|.+.+.||+|+|+.|-++.+.. +...+|+|.+...........++..|..+-+.+. |+|++.+++........++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4569999999999999999987743 5566777777655433344456677888888887 9999999999999999999


Q ss_pred             EEeecCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHh-hCCcccccccCCceeeecCCCCC-cEEEccccccccc
Q 043425           89 ILEYCKGGDLSMYI-QRHG-CVPEETAKHFMKQLAAGLQVLR-DNNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSL  164 (575)
Q Consensus        89 VmEy~~GgsL~~~l-~~~~-~lse~~i~~i~~QLl~aL~~LH-~~gIvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~~  164 (575)
                      +++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.++   +..+ .++++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence            99999999999999 5554 6788899999999999999999 9999999999999999   6666 8999999999876


Q ss_pred             CC-CC---CcccccC-CCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHH-HHHHhccCCCCCCh
Q 043425          165 QP-RG---LAETLCG-SPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ-NIVKATELHFPPDA  237 (575)
Q Consensus       165 ~~-~~---~~~~~~G-T~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~-~i~~~~~~~~p~~~  237 (575)
                      .. .+   .....|| ++.|+|||...+..| ....|+||+|+++.-+++|..||.......... .........-...+
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            55 22   3445788 999999999887544 577999999999999999999998765544221 11211111112223


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ..++....+++.+++..+|..|.+.+++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            568889999999999999999999999999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=1.5e-19  Score=193.82  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=164.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEE-------EEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD-------IIE   81 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-------~~~   81 (575)
                      +.+.+.+..+.++++.++...-..+   .+.++-+..+.+..  .......+++-.+.-..|.+..-+.+       .+.
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~--~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~  321 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL--CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK  321 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccch--hhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence            3355556666666666655443322   22333333322211  11122344444444444444333333       111


Q ss_pred             e-----CCEEEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           82 V-----PGKLHLILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        82 ~-----~~~l~LVmEy~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      .     ...+||.|++|...+|.++|.++.   ..+......++.|++.|++|   +|.+|||+||.||++   ..+..+
T Consensus       322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~  395 (516)
T KOG1033|consen  322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQL  395 (516)
T ss_pred             ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhh
Confidence            1     235899999999999999997543   35677889999999999999   999999999999999   445589


Q ss_pred             EEcccccccccCCCC-------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          154 KIADFGFARSLQPRG-------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       154 KL~DFGla~~~~~~~-------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      ||+|||+........       ......||..||+||.+.++.|+.++|||+||+||+||+. -...|....   .+..+
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~  472 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDI  472 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhh
Confidence            999999987765444       3456789999999999999999999999999999999996 223332211   11122


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      -   ...+|+....--++-.+|+.+||.+.|.+||++.+.--|+|.
T Consensus       473 r---~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 R---DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             h---cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2   223343332223455799999999999999988887777765

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=8.8e-18  Score=162.63  Aligned_cols=132  Identities=18%  Similarity=0.312  Sum_probs=106.1

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KK-----LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~-----~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      .||+|+||.||+|..  +|..+++|+....... ..     ....+.+|+.++..+.|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999984  5889999986543221 11     125577899999999988765544444556667999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ++|++|.+++.....       .++.+++.+|.+||+.|++|||++|.||++   + .+.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence            999999998765321       889999999999999999999999999999   4 57899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=8e-18  Score=163.72  Aligned_cols=139  Identities=24%  Similarity=0.292  Sum_probs=109.8

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH--------------------HHHHHHHHHHHHHHhCCCCC-
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK--------------------KLQESLMSEIFILKRINHPH-   72 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--------------------~~~~~i~~Ei~iL~~L~Hpn-   72 (575)
                      |.+.+.||+|+||.||++.+. +|+.||||++.......                    ........|+.++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999876 79999999876543100                    01123567888999888774 


Q ss_pred             -cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           73 -IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        73 -Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                       ++.+++    .+..++||||++|++|..+...      .....++.+++.++.++|+.||+||||||+||++   +.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~~  162 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDDE  162 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCCC
Confidence             444443    2456899999999998766431      3457789999999999999999999999999999   6678


Q ss_pred             cEEEcccccccccCC
Q 043425          152 ALKIADFGFARSLQP  166 (575)
Q Consensus       152 ~vKL~DFGla~~~~~  166 (575)
                      .++|+|||++.....
T Consensus       163 ~~~liDfg~~~~~~~  177 (198)
T cd05144         163 KIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEEECCccccCCC
Confidence            999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.71  E-value=4.7e-17  Score=176.97  Aligned_cols=200  Identities=21%  Similarity=0.355  Sum_probs=159.1

Q ss_pred             HHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCc-ccccccCCce
Q 043425           65 LKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL-IHRDLKPQNL  142 (575)
Q Consensus        65 L~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gI-vHrDLKPeNI  142 (575)
                      |+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+... -.++......++++|+.||.|||...| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45688999999999999999999999999999999999863 467888889999999999999999866 9999999999


Q ss_pred             eeecCCCCCcEEEcccccccccCC---CCCcccccCCCCCCChHHHhhcc-------CCcccccchhhHHHHHHHhCCCC
Q 043425          143 LLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQK-------YDAKADLWSVGAILFQLVTGKTP  212 (575)
Q Consensus       143 Ll~~dd~~g~vKL~DFGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~-------y~~kaDIWSLGviLyeLltG~~P  212 (575)
                      ++   +....+||+|||+......   ........-...|.|||.+....       .+.+.|+||+|++++|+++..-|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   8899999999999876532   11112223455699999997642       35569999999999999999999


Q ss_pred             CCCC----CHHHHHHHHHH-hccCCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          213 FTGS----NQIQLLQNIVK-ATELHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       213 F~~~----~~~~~l~~i~~-~~~~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      |...    ...+++..+.+ +.....|...  ....+++..++++||..+|.+||+++++..
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9763    23345555555 2222333322  145668999999999999999999998854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=6.7e-17  Score=180.69  Aligned_cols=136  Identities=18%  Similarity=0.276  Sum_probs=109.8

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-C----H-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-N----K-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~----~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |...+.||+|+||.||++...  +..+++|+...... .    . ...+.+.+|+.+++.++|++|+....+.......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            456789999999999999876  44455554322211 1    1 12356789999999999999988877777777789


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +||||++|++|.+++.        ....++.|++.+|.+||+.|++||||||+|||+   + .+.++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---~-~~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---R-DDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE---E-CCcEEEEeCccccc
Confidence            9999999999999885        357799999999999999999999999999999   2 35799999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=9.4e-17  Score=153.72  Aligned_cols=138  Identities=25%  Similarity=0.347  Sum_probs=100.1

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----------------------LMSEIFILKRINHPH--   72 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~----------------------i~~Ei~iL~~L~Hpn--   72 (575)
                      ++.||+|+||.||+|.+. +|+.||||++............                      ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999987 8999999998764322111111                      135666666665433  


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCC
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSM-YIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDN  150 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~-~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~  150 (575)
                      +.++++.    ...++||||++|+.+.. .+.... . ...++.++.+++.++.++|. .||+||||||+||++   + .
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-C
Confidence            4555543    23589999999954321 121111 1 16788999999999999999 999999999999999   4 6


Q ss_pred             CcEEEcccccccccC
Q 043425          151 AALKIADFGFARSLQ  165 (575)
Q Consensus       151 g~vKL~DFGla~~~~  165 (575)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            789999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=6.1e-18  Score=192.37  Aligned_cols=268  Identities=27%  Similarity=0.422  Sum_probs=221.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..+++.+++-+-+|+|+.++.+.-..+|...+.|+..+...- ....+.+..+-.++....+|-+++....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            567788889999999999999998888988888866543211 1112334444445544556777766666666778999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC--
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~--  166 (575)
                      +++|+.|++|...++.-++.+++.++.++..++.++++||...+.|||++|.|+|.   ...++.++.|||......-  
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999   6778899999984432110  


Q ss_pred             ---------C---------------------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC
Q 043425          167 ---------R---------------------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS  216 (575)
Q Consensus       167 ---------~---------------------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~  216 (575)
                               +                     .......||+.|.+||...+......+|+|++|+++++.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                     0                     0112357999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHH---HHHcCCCCCCCCchhhhh
Q 043425          217 NQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFE---EFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       217 ~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~---eiL~Hpff~~~~~~~~~~  281 (575)
                      ...+.+++|.++ ...+|......+.++++++.++|..+|.+|..+.   ++..|+||+..+|+.+..
T Consensus      1039 tpq~~f~ni~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1039 TPQQIFENILNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             chhhhhhccccC-CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence            999999888876 5667777778999999999999999999999887   999999999999987654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=1.7e-15  Score=152.57  Aligned_cols=136  Identities=21%  Similarity=0.349  Sum_probs=104.1

Q ss_pred             EEec-ccCCeEEEEEEEcCCCcEEEEEEeecCcc-----------CHHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 043425           18 RQIG-SGSFSVVWHARHRVHGTEVAMKEIAMGRL-----------NKKLQESLMSEIFILKRINHPHI--IRLHDIIEVP   83 (575)
Q Consensus        18 ~~LG-~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-----------~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~~~~~~   83 (575)
                      ..|| .|+.|+||.+...  +..++||.+.....           .......+.+|+.++..|.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888888888765  88999998864321           11223457889999999998775  6777664332


Q ss_pred             -C---EEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           84 -G---KLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        84 -~---~l~LVmEy~~G-gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                       +   ..++||||++| .+|.+++.. ..+++.    .+.||+.+|.+||++||+||||||+|||+   +.++.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEEC
Confidence             2   23599999997 699988865 455554    36789999999999999999999999999   55568999999


Q ss_pred             ccccc
Q 043425          159 GFARS  163 (575)
Q Consensus       159 Gla~~  163 (575)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.3e-15  Score=137.50  Aligned_cols=132  Identities=24%  Similarity=0.284  Sum_probs=111.7

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEeec
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      +++.||+|.++.||++...  +..+++|.+.....    ...+.+|+.+++.+.+  .++++++.++...+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            4678999999999999986  47899998865432    4568899999999976  58999999888888899999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           94 KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN---NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        94 ~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~---gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .|+.+..+       +......++.+++.+|..||..   +++|+||+|+|||+   +..+.++++|||.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence            99877654       4566778899999999999985   79999999999999   4567899999998854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=7.5e-15  Score=160.22  Aligned_cols=253  Identities=20%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             cCEEEEEEecc--cCCeEEEEEEE--cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGS--GSFSVVWHARH--RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~--GaFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      ..+.+...+|.  |.+|.||.+..  ..++..+|+|.-+...........-.+|..-.+.++ |+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34567788999  99999999998  889999999974332222222223346666666665 89999989999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHhhCCcccccccCCceeeecCCCC-CcEEEccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAA----GLQVLRDNNLIHRDLKPQNLLLCTDDDN-AALKIADFGF  160 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~-lse~~i~~i~~QLl~----aL~~LH~~gIvHrDLKPeNILl~~dd~~-g~vKL~DFGl  160 (575)
                      ++=+|+| |.+|..+...... +++..++.++.+...    ||.++|..+++|-|+||.||++.   .+ ...+++|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcce
Confidence            9999999 5788888776544 889999999999999    99999999999999999999994   44 7799999999


Q ss_pred             ccccCCCCCccc------ccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          161 ARSLQPRGLAET------LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       161 a~~~~~~~~~~~------~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      ...+........      .-|...|++||..+ .-++...|+++||.++.+-.+|..++.......+.+    ......+
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----~r~~~ip  344 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----LRQGYIP  344 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----cccccCc
Confidence            988766553322      25777899999985 567888999999999998888776654431111111    0000111


Q ss_pred             CC-hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          235 PD-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       235 ~~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .. ....+.++...+..|++.+|..|++++.+++|+++..
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            11 1235666777999999999999999999999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=9.2e-14  Score=154.38  Aligned_cols=148  Identities=21%  Similarity=0.390  Sum_probs=97.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---------------------------C-----HHHHH
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---------------------------N-----KKLQE   56 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---------------------------~-----~~~~~   56 (575)
                      .+..+|+. +.||.|++|.||+|+.+.+|+.||||++.....                           .     .+...
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34456776 789999999999999998899999999964321                           0     01122


Q ss_pred             HHHHHHHHH------HhC----CCCCcceEEEEE-EeCCEEEEEEeecCCCCHHHH--HHHcC----CCCHHHHHHHHHH
Q 043425           57 SLMSEIFIL------KRI----NHPHIIRLHDII-EVPGKLHLILEYCKGGDLSMY--IQRHG----CVPEETAKHFMKQ  119 (575)
Q Consensus        57 ~i~~Ei~iL------~~L----~HpnIv~l~~~~-~~~~~l~LVmEy~~GgsL~~~--l~~~~----~lse~~i~~i~~Q  119 (575)
                      .+.+|++..      .++    .+.+.+.+-.++ +..+..+|||||+.|+.+.++  +...+    .+.+..+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            333444433      332    233333332333 224456799999999999774  33333    2444555556666


Q ss_pred             HHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEccccccccc
Q 043425          120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSL  164 (575)
Q Consensus       120 Ll~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~~~  164 (575)
                      ++       ..|++|+|+||.||++..++ ..+.++++|||++..+
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            54       58999999999999994321 2348999999998654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.2e-13  Score=151.00  Aligned_cols=254  Identities=20%  Similarity=0.226  Sum_probs=189.9

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEc-CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHR-VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~-~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~   85 (575)
                      -...++|.++..||.|.|+.|+.+..+ .++..|++|..............-..|+.+...+. |.++++.+..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            356788999999999999999998765 68999999988765544443344457777777664 7888887776666667


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .||=.|||+|+++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++  +..++.|||++..+.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence            789999999999988876666789999999999999999999999999999999999995433  788999999987532


Q ss_pred             CCCCcccccCCCCCC--ChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          166 PRGLAETLCGSPLYM--APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~--APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      -..  ....+.-++.  +++......+..++|+++||..+++.++|...-.....   ...|..+. .  +. .+....+
T Consensus       419 ~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~-~--p~-~~~~~~~  489 (524)
T KOG0601|consen  419 FSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD-T--PN-LPGLKLQ  489 (524)
T ss_pred             eec--ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc-c--cC-CCchHHh
Confidence            111  1122333344  55555667788999999999999999998754322221   11122221 1  11 1233478


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      +..+.+.++.+++..|+.+.++..|.-|.
T Consensus       490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  490 LQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhhcCCccccchhhhhhcccchhh
Confidence            89999999999999999999998876553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=7.1e-13  Score=144.81  Aligned_cols=139  Identities=22%  Similarity=0.307  Sum_probs=95.8

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH--------------------------------HHHH------HHH
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK--------------------------------KLQE------SLM   59 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--------------------------------~~~~------~i~   59 (575)
                      +.||.|++|.||+|+.+ +|+.||||+........                                ....      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999976 79999999985432100                                0001      133


Q ss_pred             HHHHHHHhC----C-CCCc--ceEEEEEEeCCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHhhC
Q 043425           60 SEIFILKRI----N-HPHI--IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAA-GLQVLRDN  130 (575)
Q Consensus        60 ~Ei~iL~~L----~-HpnI--v~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~-aL~~LH~~  130 (575)
                      +|...+.++    . +++|  .+++.  ...+..+|||||++|++|.++.... ...   ....++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence            444444444    2 3433  23332  2234579999999999998876532 112   23445666655 47889999


Q ss_pred             CcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425          131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus       131 gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |++|+|+||.||++   +.++.++|+|||++..+.
T Consensus       277 g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence            99999999999999   666889999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=4e-12  Score=124.37  Aligned_cols=141  Identities=21%  Similarity=0.220  Sum_probs=103.3

Q ss_pred             EEEecccCCeEEEEEEEcC------CCcEEEEEEeecCcc--CH------------------HHHHHH----HHHHHHHH
Q 043425           17 GRQIGSGSFSVVWHARHRV------HGTEVAMKEIAMGRL--NK------------------KLQESL----MSEIFILK   66 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~------tg~~vAVK~i~~~~~--~~------------------~~~~~i----~~Ei~iL~   66 (575)
                      ...||.|--+.||.|....      .+..+|||+......  +.                  ..+..+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998653      357999998754221  00                  001122    38999999


Q ss_pred             hCCC--CCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hhCCcccccccCCcee
Q 043425           67 RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLL  143 (575)
Q Consensus        67 ~L~H--pnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~L-H~~gIvHrDLKPeNIL  143 (575)
                      ++..  -++..++++    ..-+|||||+.++.+.....+...+++..+..++.+++.+|..| |+.|+||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  466677764    45689999997765533222334566677888899999999988 8999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccC
Q 043425          144 LCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +.    .+.++|+|||.+....
T Consensus       158 ~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE----CCcEEEEECCCceeCC
Confidence            93    3569999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=3.1e-12  Score=120.04  Aligned_cols=127  Identities=21%  Similarity=0.210  Sum_probs=95.8

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeecCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++.|+.|.++.||++...  |..|++|+......   ....+..|+.+++.+.+.++ .+++....  ...++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            467899999999999875  88999998754321   12235688889888865444 45555543  335799999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCc-----ccccccCCceeeecCCCCCcEEEccccccc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL-----IHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gI-----vHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .++...        ......++.+++.+|..||..++     +|+|++|.||++   + .+.++++|||.+.
T Consensus        76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~  135 (170)
T cd05151          76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D-DGRLWLIDWEYAG  135 (170)
T ss_pred             Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E-CCeEEEEeccccc
Confidence            887643        11124567899999999999985     999999999999   3 4569999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.28  E-value=4.9e-11  Score=132.02  Aligned_cols=183  Identities=21%  Similarity=0.324  Sum_probs=139.4

Q ss_pred             CEEEEEEecccCCeEEE-EEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVW-HARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy-~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      -|.+ ...+-++.+ +| .|..+.++..|.|.+.+.+.-  ...+.+.+.+.-|+.++||||+++++.++..+.+|||+|
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence            3666 444444444 45 577788999999999887643  334557788899999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH-~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      -+  .-|..++++.+   ...+.-.+.||+.||.+|| +.+++|++|.-.-|+|   +..|..||++|-++....... .
T Consensus        90 rV--~Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~  161 (690)
T KOG1243|consen   90 RV--RPLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP  161 (690)
T ss_pred             cc--ccHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc
Confidence            98  46888887654   7778888999999999998 5689999999999999   788899999999885533221 1


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG  209 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG  209 (575)
                      .....---.|..|+.+....  -..|.|-||+++++++.|
T Consensus       162 ~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            11111122355666543222  347999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=5.1e-13  Score=136.65  Aligned_cols=242  Identities=19%  Similarity=0.279  Sum_probs=161.4

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCcc-CHHHHH-HHHHHHHHHHhCCCCCcceEEEEEEe-----CCEEEEEEeecCCCCHH
Q 043425           27 VVWHARHRVHGTEVAMKEIAMGRL-NKKLQE-SLMSEIFILKRINHPHIIRLHDIIEV-----PGKLHLILEYCKGGDLS   99 (575)
Q Consensus        27 ~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~-~i~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~l~LVmEy~~GgsL~   99 (575)
                      .||++.++..|..|+...+..... +.+.++ ....-..-|-++-|.||++++.+..+     ..++.++.||+..|+|.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            356666666666655443322111 111111 12222334556678999999988743     34588999999999999


Q ss_pred             HHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhC--CcccccccCCceeeecCCCCCcEEEcccccccccCCC-C----
Q 043425          100 MYIQRH----GCVPEETAKHFMKQLAAGLQVLRDN--NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G----  168 (575)
Q Consensus       100 ~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~--gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~----  168 (575)
                      .+|++-    ..+.....++|+.||+.||.|||+.  -|+|+.+..+-|++   ..++.+|++--.... .... .    
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s-~h~s~~~~~~  236 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDS-THPSVNSTRE  236 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccc-cchhhhhhhH
Confidence            999754    3577888899999999999999987  59999999999999   678888874322111 1110 0    


Q ss_pred             -CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCC-CCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFT-GSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~-~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ......|-++|.|||.=....-+.++|||++|....+|..+..--. +......-..+.+... .      .-..--++
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-~------len~lqr~  309 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-G------LENGLQRG  309 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-e------ccCccccC
Confidence             0111346788999998766677788999999999999998775422 2211111112211110 0      01122367


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      ++.+||+..|+.||++.+++.||.+-.+.....
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeeecchHHH
Confidence            899999999999999999999999887765543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=1.3e-10  Score=111.46  Aligned_cols=133  Identities=18%  Similarity=0.263  Sum_probs=98.8

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEe-ecCccCHH----H-HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEI-AMGRLNKK----L-QESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i-~~~~~~~~----~-~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      ..+++|+-+.+|.+...  |..+++|.- .+.-..+.    . .....+|..++..+.--.|.-..=++.+++...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999998664  666777753 33222332    2 2446789999988865444433333445777889999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      |++|..|.+++...       ...+++.+-.-+.-||.+||||+||.++||+++.    +.+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~----~~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC----CcEEEEECCcccc
Confidence            99999999998765       2567788888888999999999999999999942    2399999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=2.3e-10  Score=111.49  Aligned_cols=142  Identities=20%  Similarity=0.320  Sum_probs=104.9

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEee
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVP---GKLHLILEY   92 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~---~~l~LVmEy   92 (575)
                      +.||.|.++.||++... +|..+++|........ .....+.+|..+++.+.+  .++.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            67899999999999875 3689999987654321 123457899999999875  3467777776543   367899999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-------------------------------------------  129 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-------------------------------------------  129 (575)
                      ++|.++...+.. ..+++.....++.+++.+|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888775532 346677777777777777777773                                           


Q ss_pred             -------------CCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425          130 -------------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       130 -------------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                                   ..++|+|++|.|||+..+ ..+.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                         236999999999999321 145689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=8.6e-10  Score=105.75  Aligned_cols=146  Identities=21%  Similarity=0.234  Sum_probs=109.8

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEee-cCccCH----HH-HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIA-MGRLNK----KL-QESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~-~~~~~~----~~-~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+..|-+|+-+.|+++...  |+.+.||.-. +.-..+    +. +....+|.++|.++.--.|.-..=+|-+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678889999999999876  9998888532 222222    22 34567899999988655554444455556667899


Q ss_pred             EeecCC-CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           90 LEYCKG-GDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        90 mEy~~G-gsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      |||++| .++.+++...-  .........++++|-..|.-||.++|||+||..+||++..++....+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999977 47788886542  222333378999999999999999999999999999998777777789999999853

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=1.3e-08  Score=104.49  Aligned_cols=134  Identities=14%  Similarity=0.086  Sum_probs=94.4

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCccCHHHH---------HHHHHHHHHHHhCCCCC--cceEEEEEEe-----CCEEEEEE
Q 043425           27 VVWHARHRVHGTEVAMKEIAMGRLNKKLQ---------ESLMSEIFILKRINHPH--IIRLHDIIEV-----PGKLHLIL   90 (575)
Q Consensus        27 ~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~---------~~i~~Ei~iL~~L~Hpn--Iv~l~~~~~~-----~~~l~LVm   90 (575)
                      .|..+..  .|+.|.||.........-..         ..+.+|...+..|..-+  .+.+..+++.     ...-+||+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  47789999764322111011         13678888887774333  3344444432     23578999


Q ss_pred             eecCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC----CCCCcEEEccccccc
Q 043425           91 EYCKGG-DLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD----DDNAALKIADFGFAR  162 (575)
Q Consensus        91 Ey~~Gg-sL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d----d~~g~vKL~DFGla~  162 (575)
                      |+++|. +|.+++..  ....++.....++.+++..+.-||+.||+|+||++.|||+..+    ++...+.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999886 89998864  3456677888999999999999999999999999999999531    235789999999875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=3e-10  Score=126.25  Aligned_cols=153  Identities=19%  Similarity=0.335  Sum_probs=113.9

Q ss_pred             HHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCCCC----------cccccCCCCCCChHHHhh
Q 043425          119 QLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL----------AETLCGSPLYMAPEIMQL  187 (575)
Q Consensus       119 QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~----------~~~~~GT~~Y~APEvl~~  187 (575)
                      +++.|+.|+|.. ++||+.|.|++|.+   +.++.+||+.|+++........          .-...-...|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344999999976 89999999999999   8889999999999865443111          011224567999999998


Q ss_pred             ccCCcccccchhhHHHHHHH-hCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHH
Q 043425          188 QKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFF  266 (575)
Q Consensus       188 ~~y~~kaDIWSLGviLyeLl-tG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL  266 (575)
                      ...+.++|++|||+++|.+. .|+..+.+.+.......-..............++.++++=+.++|..++..||++.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            88889999999999999998 56666655433222221111111111111256899999999999999999999999999


Q ss_pred             cCCCCCCC
Q 043425          267 NHPFLSQT  274 (575)
Q Consensus       267 ~Hpff~~~  274 (575)
                      .-|||++.
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.98  E-value=7.3e-09  Score=112.06  Aligned_cols=210  Identities=20%  Similarity=0.281  Sum_probs=154.6

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeecCC-CCHHH
Q 043425           26 SVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKLHLILEYCKG-GDLSM  100 (575)
Q Consensus        26 G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~LVmEy~~G-gsL~~  100 (575)
                      .+.|++....+|..|++|.++-.+..  .......-+++++++.|+|||++.++|.+    +..+++|++|+++ ++|.+
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            56899999999999999999433221  11123456788999999999999999863    3468999999987 56766


Q ss_pred             HHH---------------HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425          101 YIQ---------------RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus       101 ~l~---------------~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +.-               .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||+   ..+.+++|...|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeec
Confidence            541               22347899999999999999999999999999999999999   555578888888776655


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCC-CCCCCHHHH-HHHHHHhccCCCCCChhcccHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP-FTGSNQIQL-LQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~P-F~~~~~~~~-l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...      +       |-+..+   .+-|.=.||.+++.|.+|..- +......+. +..|.           ..++.+
T Consensus       445 ~d~------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D  497 (655)
T KOG3741|consen  445 EDP------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTD  497 (655)
T ss_pred             CCC------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHH
Confidence            443      1       111111   247888999999999999643 222222222 22221           247889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++++|.-+...++++ -++.+++.|
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999998886 778888775

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.88  E-value=3.1e-08  Score=104.97  Aligned_cols=237  Identities=18%  Similarity=0.238  Sum_probs=154.3

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh-CCCCCcceEEEE------E-EeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHPHIIRLHDI------I-EVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~------~-~~~~~l~   87 (575)
                      .++.||+|+-+.+|-.-.-  +..|| |++.....  ..+.+.   +..|.. -.||-+-.-+.|      . .....+-
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Ppp--a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPP--AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh--hchhh-eeecCCCc--hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            4578999999999976433  33444 87765432  222222   222222 245533221111      1 1122367


Q ss_pred             EEEeecCCCC-HHHHH---HHc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           88 LILEYCKGGD-LSMYI---QRH---GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        88 LVmEy~~Ggs-L~~~l---~~~---~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ++|..++|.. +..++   .+.   ..+....+..+.+.|+.+...||+.|.+-+|+.++|+|+   .+.+.|.|.|=..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcccc
Confidence            8888888753 22222   122   236677889999999999999999999999999999999   6667899988654


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhC-CCCCCCCCHH----HHHH-HHHHh-
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQI----QLLQ-NIVKA-  228 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~----~~l~-~i~~~-  228 (575)
                      -.....+......+|.+.|.+||.-.     +.+-+...|.|.||+++|+|+.| +.||.|....    .-.+ .|..+ 
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            44444455566778999999999743     45667789999999999999986 9999775211    0111 12111 


Q ss_pred             --------ccCCCC---CChhcccHHHHHHHHHhhcc--CCCCCCCHH
Q 043425          229 --------TELHFP---PDAKILSADCKDLCQKLLRR--NPVERLTFE  263 (575)
Q Consensus       229 --------~~~~~p---~~~~~ls~el~dLI~k~L~~--DP~~RpTa~  263 (575)
                              .....+   ..+..+++.+..|..+|+..  ++.-|||++
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                    111111   12356889999999999974  466899875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=7.1e-09  Score=100.94  Aligned_cols=128  Identities=27%  Similarity=0.346  Sum_probs=83.6

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCccC------------------------HHHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 043425           27 VVWHARHRVHGTEVAMKEIAMGRLN------------------------KKLQESLMSEIFILKRINHP--HIIRLHDII   80 (575)
Q Consensus        27 ~Vy~a~~~~tg~~vAVK~i~~~~~~------------------------~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~~~   80 (575)
                      .||.|... .|..+|||+.......                        ........+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38898875 6889999987542110                        01224567899999999765  567776553


Q ss_pred             EeCCEEEEEEeecC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           81 EVPGKLHLILEYCK--GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV-LRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        81 ~~~~~l~LVmEy~~--GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~-LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                        .  -+|||||++  |..+..+....  ++......++.+++..+.. +|..||+|+||.+.|||+.   ++ .+.|+|
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~~iID  149 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KVYIID  149 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CEEE--
T ss_pred             --C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eEEEEe
Confidence              2  379999998  65665544321  2245667788888885554 6899999999999999993   33 799999


Q ss_pred             cccccccC
Q 043425          158 FGFARSLQ  165 (575)
Q Consensus       158 FGla~~~~  165 (575)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=9.3e-08  Score=94.18  Aligned_cols=108  Identities=23%  Similarity=0.249  Sum_probs=84.9

Q ss_pred             HHHHHHHHHHHhCCCC--CcceEEEEEEeC----CEEEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh
Q 043425           56 ESLMSEIFILKRINHP--HIIRLHDIIEVP----GKLHLILEYCKGG-DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR  128 (575)
Q Consensus        56 ~~i~~Ei~iL~~L~Hp--nIv~l~~~~~~~----~~l~LVmEy~~Gg-sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH  128 (575)
                      ....+|...+..|..-  .++..+.+.+..    ...++|+|+++|. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            3567888877776432  244555555442    2458999999984 89999987555778888999999999999999


Q ss_pred             hCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425          129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       129 ~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ++||+|+|+++.|||+..++....+.|+||+-++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999996555456899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.63  E-value=3.4e-09  Score=116.94  Aligned_cols=243  Identities=16%  Similarity=0.161  Sum_probs=172.3

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEee
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~LVmEy   92 (575)
                      |....-+++|+++.+++.+...+.... .+++...       ....-++++|.+++||| .++.++-++.+...++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            556677889999999998877655544 6666432       34567889999999999 77777777778889999999


Q ss_pred             cCCC-CHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCc
Q 043425           93 CKGG-DLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA  170 (575)
Q Consensus        93 ~~Gg-sL~~~l-~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~  170 (575)
                      +.++ +-.... ...-.+.+-....+.+.=+.+++++|+.--+|||    ||+.+    .+..+..||+....+......
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCccccc
Confidence            9887 222111 0111233445566677778999999998778999    88873    366899999999888777667


Q ss_pred             ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHH
Q 043425          171 ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       171 ~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~  249 (575)
                      .++.+++.++|||+.....++...|.|++|+--.+|.-|.+|-...-  .....+-.+. ...+......-+.+-.++..
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~  465 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPA  465 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCcc
Confidence            78999999999999999999999999999998888888887754411  0000000000 00000000000111225778


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .|+..-|..|+..-.++.|.+|...
T Consensus       466 ~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  466 PCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccCCCCCCCcchhhHHHHHHhccC
Confidence            8999999999999999999888763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.61  E-value=1.8e-07  Score=94.90  Aligned_cols=137  Identities=21%  Similarity=0.309  Sum_probs=102.7

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-------C-------------HHHHHHHHHHHHHHHhCCCC--
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-------N-------------KKLQESLMSEIFILKRINHP--   71 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-------~-------------~~~~~~i~~Ei~iL~~L~Hp--   71 (575)
                      +.++.+||-|--+.||.|.+. .|.++|||.=.....       .             .-.+....+|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457899999999999999987 799999995322110       0             01234467899999999754  


Q ss_pred             CcceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           72 HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        72 nIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      .|.+.+++    ++-++||||++|..|...-     ++...+..++..|+.-+..+-..||||+|+.+=|||+   +++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            67776654    5678999999997776542     2345566667777777776668999999999999999   6677


Q ss_pred             cEEEcccccccc
Q 043425          152 ALKIADFGFARS  163 (575)
Q Consensus       152 ~vKL~DFGla~~  163 (575)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            899999976643

>PRK09902 hypothetical protein; Provisional

Probab=98.37  E-value=4.6e-06  Score=82.59  Aligned_cols=140  Identities=14%  Similarity=0.188  Sum_probs=98.2

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCc---cC-HHHHHHHHHHHHHHHhCCCCC--cceEEEE--EEeC--CEEEEE
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGR---LN-KKLQESLMSEIFILKRINHPH--IIRLHDI--IEVP--GKLHLI   89 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~---~~-~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~~--~~~~--~~l~LV   89 (575)
                      -|+|+-+-|+.....  |..|-+|.-....   +. +--...+.+|+..|.+|..-+  +.++...  ...+  -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            466888888887654  5578888654111   00 112356889999998885322  4444411  1122  236899


Q ss_pred             EeecCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           90 LEYCKG-GDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        90 mEy~~G-gsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +|-+.| .+|.+++...  .+.++.....++.+|+..+.-||+.|+.|+|+-+.|||+..+ +...++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence            998865 6898888653  345778888999999999999999999999999999999322 12349999997664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.35  E-value=7.6e-06  Score=81.43  Aligned_cols=139  Identities=16%  Similarity=0.181  Sum_probs=87.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH-HHH------HHHHHHHHHHhC---CCCCcceEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQE------SLMSEIFILKRI---NHPHIIRLHDII   80 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~------~i~~Ei~iL~~L---~HpnIv~l~~~~   80 (575)
                      -++|.+.+++-......|.+..-  .|..+.+|.........+ ...      ...+++..+..+   .--.+..++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45688888888777777776654  489999998754321111 001      112233333332   222222322222


Q ss_pred             -----EeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           81 -----EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        81 -----~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                           ......++||||++|..|.++..    +++    .+...|+.++.-||+.|++|+|..|.|+++.   + +.+++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---~-~~i~i  175 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---N-NGIRI  175 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE---C-CcEEE
Confidence                 22245678999999988877642    232    3556677889999999999999999999994   2 34999


Q ss_pred             cccccccc
Q 043425          156 ADFGFARS  163 (575)
Q Consensus       156 ~DFGla~~  163 (575)
                      +||+..+.
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99986643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=6.2e-06  Score=80.39  Aligned_cols=78  Identities=21%  Similarity=0.213  Sum_probs=57.5

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEEe
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLHDII---EVPGKLHLILE   91 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~~~---~~~~~l~LVmE   91 (575)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+...  .+.+++...   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            4789999999999999874  59999987542    3456678899988887533  355666643   33456899999


Q ss_pred             ecCCCCHHH
Q 043425           92 YCKGGDLSM  100 (575)
Q Consensus        92 y~~GgsL~~  100 (575)
                      +++|..+..
T Consensus        76 ~i~g~~~~~   84 (239)
T PF01636_consen   76 YIPGRPLDD   84 (239)
T ss_dssp             EESSEEHHH
T ss_pred             Eeccccccc
Confidence            999988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=5.5e-06  Score=82.96  Aligned_cols=72  Identities=21%  Similarity=0.213  Sum_probs=54.6

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH--IIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ..||+|..+.||+.    .|..+++|......    ....+.+|.++++.+..-+  +.+.+++.+..+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999983    25578889876432    1234688999998886433  56778888778888999999999


Q ss_pred             CC
Q 043425           96 GD   97 (575)
Q Consensus        96 gs   97 (575)
                      ..
T Consensus        79 ~~   80 (226)
T TIGR02172        79 KR   80 (226)
T ss_pred             cc
Confidence            63

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=2.4e-06  Score=95.13  Aligned_cols=142  Identities=22%  Similarity=0.317  Sum_probs=89.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC--------------------------------HHHHHH------HH
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN--------------------------------KKLQES------LM   59 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~--------------------------------~~~~~~------i~   59 (575)
                      ..|+.++-|.||+|+.+ +|+.||||+....-..                                ++..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999988 5999999987532100                                001111      22


Q ss_pred             HHHHHHHhC-----CCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Q 043425           60 SEIFILKRI-----NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNNL  132 (575)
Q Consensus        60 ~Ei~iL~~L-----~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l--~~~~~lse~~i~~i~~QLl~aL~~LH~~gI  132 (575)
                      +|..-+.++     +.|+|.-..=+.+-.+.-.|+|||+.|..+.+..  +. ..++...+...+.++  -+..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            343333333     2344322211223345568999999999888874  43 334433322222211  1233344899


Q ss_pred             ccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425          133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus       133 vHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +|+|.+|.||++   +..+.+.+.|||+...+.+
T Consensus       287 fHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            999999999999   6668999999999877654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.28  E-value=2.7e-06  Score=99.77  Aligned_cols=206  Identities=23%  Similarity=0.264  Sum_probs=150.6

Q ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 043425           55 QESLMSEIFILKRINHPHIIRLHDIIEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN  130 (575)
Q Consensus        55 ~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~  130 (575)
                      ......|+..+..+.|+|++.++.+.....    .+.+..++|.+-++...++.-+..+...++.+..+++.||.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344456777788899999999998864332    2334568999999999999989999999999999999999999999


Q ss_pred             CcccccccCCceeeecCCCCCcEEEc--ccccccccCCCCCcccccCCCCCCChHHHhhccCCcc--cccchhhHHHHHH
Q 043425          131 NLIHRDLKPQNLLLCTDDDNAALKIA--DFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK--ADLWSVGAILFQL  206 (575)
Q Consensus       131 gIvHrDLKPeNILl~~dd~~g~vKL~--DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~k--aDIWSLGviLyeL  206 (575)
                      ...|.-|...-..-...+..+.+.+.  ||+....+..........-+..+.|||......+..+  .|+|.+|..+..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            66666555552222222555667766  9998877766555445555667888998877766655  7999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          207 VTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       207 ltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ..|..+-.....   ...+       .+..   ...+..+++.+|+.-++.+|+++.+++.|+|.+.
T Consensus       386 ~~~~~i~~~~~~---~~~~-------l~~~---~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  386 SQGEDISEKSAV---PVSL-------LDVL---STSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhcCcccccccc---hhhh-------hccc---cchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            987654321110   0011       1111   1127788999999999999999999999999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=1.4e-05  Score=78.53  Aligned_cols=136  Identities=22%  Similarity=0.316  Sum_probs=97.5

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCc--------------cCHHHHHHHHHHHHHHHhCC------CCCcceEE
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR--------------LNKKLQESLMSEIFILKRIN------HPHIIRLH   77 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~--------------~~~~~~~~i~~Ei~iL~~L~------HpnIv~l~   77 (575)
                      ..||+|+.-.||.  |. .....+||++....              .......+..+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4689999999985  33 45667789887665              00111244566666655554      78899999


Q ss_pred             EEEEeCCEEEEEEeecCC------CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           78 DIIEVPGKLHLILEYCKG------GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        78 ~~~~~~~~l~LVmEy~~G------gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      |+.++...+-+|+|.+..      -+|.+++.+. .+++ .+   ...|-.-.++|-+.+|+.+||+|.||++...+++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998753      3578888544 4655 33   34444556778899999999999999998766555


Q ss_pred             -cEEEcc-cccc
Q 043425          152 -ALKIAD-FGFA  161 (575)
Q Consensus       152 -~vKL~D-FGla  161 (575)
                       .+.|+| ||..
T Consensus       159 ~~lvlIDG~G~~  170 (199)
T PF10707_consen  159 FRLVLIDGLGEK  170 (199)
T ss_pred             eEEEEEeCCCCc
Confidence             788888 6644

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.19  E-value=1.4e-05  Score=80.49  Aligned_cols=137  Identities=20%  Similarity=0.169  Sum_probs=95.0

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHH----------------------HHHHHHHHHHHhCC--CCCcc
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----------------------ESLMSEIFILKRIN--HPHII   74 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~----------------------~~i~~Ei~iL~~L~--HpnIv   74 (575)
                      .|+.|--+.||+|... .+..+|+|++......-+..                      .=...|+.-|+++.  +-.+.
T Consensus        55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            6778888899999864 68999999987543221110                      01246777787774  33455


Q ss_pred             eEEEEEEeCCEEEEEEeecCCCC-HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCc
Q 043425           75 RLHDIIEVPGKLHLILEYCKGGD-LSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAA  152 (575)
Q Consensus        75 ~l~~~~~~~~~l~LVmEy~~Ggs-L~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~  152 (575)
                      +.+.+.    .-.|||||+...- -.-.|+. -.+...++..+..+++..+.-|-. .|+||+||+.=|||+   . .+.
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~---~-~~~  204 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV---H-DGE  204 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE---E-CCe
Confidence            555554    2469999995531 1112221 223344788899999999988776 899999999999999   3 567


Q ss_pred             EEEcccccccccC
Q 043425          153 LKIADFGFARSLQ  165 (575)
Q Consensus       153 vKL~DFGla~~~~  165 (575)
                      +.|+|||-|....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999886544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.15  E-value=1.8e-07  Score=111.12  Aligned_cols=222  Identities=18%  Similarity=0.068  Sum_probs=151.5

Q ss_pred             ecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHH
Q 043425           46 AMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE--VPGKLHLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQ  119 (575)
Q Consensus        46 ~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~--~~~~l~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~Q  119 (575)
                      +...+.+-..+-...|..-++...|+++...+.-..  .....+++++|+.+|.+++.|.+.    ..+.+..+.....+
T Consensus      1264 d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kv 1343 (2724)
T KOG1826|consen 1264 DFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKV 1343 (2724)
T ss_pred             hHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHH
Confidence            333344444555667777777788998876655442  234578999999999999998654    33445555555555


Q ss_pred             HHHHHHHHhhC-----CcccccccCCceeeecCCCCCcEEEcccccccc-cCCCCCcccccCCCCCCChHHHhhccCCcc
Q 043425          120 LAAGLQVLRDN-----NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAK  193 (575)
Q Consensus       120 Ll~aL~~LH~~-----gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~-~~~~~~~~~~~GT~~Y~APEvl~~~~y~~k  193 (575)
                      .+.+..-+|..     -.+|++||+-|.++   ..+..+|++++|+.+. -..........+++.|++|++.+.-.++.+
T Consensus      1344 svl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r 1420 (2724)
T KOG1826|consen 1344 SVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR 1420 (2724)
T ss_pred             HHhccchhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH
Confidence            58888887765     26899999999999   6677899999999983 333445667788999999999999999999


Q ss_pred             cccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       194 aDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .|+|..|+.+|.+..|..+|....+..+...+.++.   +-.-....+.++-.+...+|-.....||.-..++.-+.|..
T Consensus      1421 sdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~t---f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1421 SDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHT---FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccc---cccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            999999999999999988875433222211111111   11111122333444444445555577888888877766643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.09  E-value=2.4e-05  Score=78.34  Aligned_cols=75  Identities=15%  Similarity=0.146  Sum_probs=53.5

Q ss_pred             EecccCC-eEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           19 QIGSGSF-SVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        19 ~LG~GaF-G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      .|-.|.. ..||++...  +..+.||+.....     ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            4555666 789998754  4688889875432     234667888888774 344667888877667789999999998


Q ss_pred             CHHH
Q 043425           97 DLSM  100 (575)
Q Consensus        97 sL~~  100 (575)
                      .|..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=8.3e-05  Score=73.23  Aligned_cols=127  Identities=18%  Similarity=0.282  Sum_probs=91.9

Q ss_pred             cCEEEEEEecccCC-eEEEEEEEcCCCcEEEEEEeec---C-------ccCH---------HHHHHHHHHHHHHHhCC--
Q 043425           12 GDYLVGRQIGSGSF-SVVWHARHRVHGTEVAMKEIAM---G-------RLNK---------KLQESLMSEIFILKRIN--   69 (575)
Q Consensus        12 ~~Y~i~~~LG~GaF-G~Vy~a~~~~tg~~vAVK~i~~---~-------~~~~---------~~~~~i~~Ei~iL~~L~--   69 (575)
                      .+++.++.||.|.- |.||+++..  |..||+|++..   .       ....         ....-+..|.+...+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999876  88999999322   1       0110         11234677888776664  


Q ss_pred             -CCCc--ceEEEEEEeC------------------CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh
Q 043425           70 -HPHI--IRLHDIIEVP------------------GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR  128 (575)
Q Consensus        70 -HpnI--v~l~~~~~~~------------------~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH  128 (575)
                       +.++  +++++|+.-.                  ....||.||.+...         .+.    ..-+.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             4456  8999987322                  12478888887644         122    334566777788999


Q ss_pred             hCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425          129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus       129 ~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ..||+-+|+++.|..=        -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999984        489999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.93  E-value=3.4e-05  Score=74.22  Aligned_cols=128  Identities=23%  Similarity=0.275  Sum_probs=91.3

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeec
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII-RLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~~~~~~~~l~LVmEy~   93 (575)
                      ++.+.||+|.+|.||+|..+  |..+|+|+-..+    .-+..+..|.++|..+..-++. ++|.+.    ..++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhh
Confidence            35678999999999999987  779999986543    3345688999999999877764 555543    234559999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCccccccc-C-CceeeecCCCCCcEEEcccccccc
Q 043425           94 KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK-P-QNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        94 ~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLK-P-eNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .|-.|.++-...   +    ++-+..++..---|-..||-|..|. | .||++    ..+.+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            998888775421   1    3334445555445667799999886 3 45565    223699999999874

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.89  E-value=5.6e-05  Score=84.28  Aligned_cols=142  Identities=20%  Similarity=0.342  Sum_probs=90.9

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-----------------------------HHHHHHHHHHHHHH---
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-----------------------------KKLQESLMSEIFIL---   65 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-----------------------------~~~~~~i~~Ei~iL---   65 (575)
                      +.||.-+.|.|++|+.+. |+.||||+-+..-..                             ++....+..|++.+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999985 999999976432110                             11122233333322   


Q ss_pred             -------HhCCCCC------cceEEEEEEeCCEEEEEEeecCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHH-HHHHhh
Q 043425           66 -------KRINHPH------IIRLHDIIEVPGKLHLILEYCKGGDLSMY--IQRHGCVPEETAKHFMKQLAAG-LQVLRD  129 (575)
Q Consensus        66 -------~~L~Hpn------Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~--l~~~~~lse~~i~~i~~QLl~a-L~~LH~  129 (575)
                             +.+.|-+      |.++|..+  ...-.|+||||+|..+.+.  +.+.+ ++...   ++..+..+ ++.|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence                   2234444      45554443  3456899999999877554  55554 44443   33333333 233456


Q ss_pred             CCcccccccCCceeeecC-CCCCcEEEcccccccccCC
Q 043425          130 NNLIHRDLKPQNLLLCTD-DDNAALKIADFGFARSLQP  166 (575)
Q Consensus       130 ~gIvHrDLKPeNILl~~d-d~~g~vKL~DFGla~~~~~  166 (575)
                      .|++|+|-+|.||++..+ ..++.+.+-|||+...+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            789999999999999643 3567899999999876543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.87  E-value=0.00012  Score=86.52  Aligned_cols=81  Identities=17%  Similarity=0.267  Sum_probs=57.9

Q ss_pred             EEEEecccCCeEEEEEEEcCCC--cEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHG--TEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHI--IRLHDIIEVP---GKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg--~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnI--v~l~~~~~~~---~~l~   87 (575)
                      -++.|+.|.+..+|+......+  ..+++|+........ ....+.+|+.+|+.+. |++|  .+++.++.+.   +..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            3578899999999998765432  468888765432211 1245789999999995 6664  7778777654   4689


Q ss_pred             EEEeecCCCC
Q 043425           88 LILEYCKGGD   97 (575)
Q Consensus        88 LVmEy~~Ggs   97 (575)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.73  E-value=0.00011  Score=73.57  Aligned_cols=72  Identities=11%  Similarity=0.095  Sum_probs=46.1

Q ss_pred             EEecccCCe-EEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEEE
Q 043425           18 RQIGSGSFS-VVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP---HIIRLHDIIEVP---GKLHLIL   90 (575)
Q Consensus        18 ~~LG~GaFG-~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~~~~~~---~~l~LVm   90 (575)
                      +.|+.|+.. .||+.     +..+++|+....    .....+.+|..+|..+...   -+.++++.....   +..+++|
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            567767776 58976     345778875432    1234688899999887532   345555544332   2358899


Q ss_pred             eecCCCCH
Q 043425           91 EYCKGGDL   98 (575)
Q Consensus        91 Ey~~GgsL   98 (575)
                      ++++|.++
T Consensus        74 ~~i~G~~l   81 (235)
T cd05155          74 RWLEGETA   81 (235)
T ss_pred             EeecCCCC
Confidence            99999665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.52  E-value=0.00076  Score=66.98  Aligned_cols=75  Identities=16%  Similarity=0.141  Sum_probs=48.8

Q ss_pred             EEEecccCCeEEEEEEEcC-CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeecC
Q 043425           17 GRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      ++.|..|-...+|++.... .+..|++|+......   ......+|+.+++.+...+ .++++..+.  +  .+||||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence            4677778888999987553 357899997754311   1122347888888885433 445554432  2  37999999


Q ss_pred             CCCH
Q 043425           95 GGDL   98 (575)
Q Consensus        95 GgsL   98 (575)
                      |..+
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.26  E-value=0.00081  Score=68.04  Aligned_cols=132  Identities=16%  Similarity=0.231  Sum_probs=74.9

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeecCCCCH
Q 043425           20 IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHLILEYCKGGDL   98 (575)
Q Consensus        20 LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~~GgsL   98 (575)
                      +..|-...+|+..  .+|..+++|.......  .......+|..+++.+....+ .+++...  .  -++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            4557778899887  3577899997543211  110124678888888864333 3444443  2  2689999998665


Q ss_pred             HH--------------HHHH---c----CCCCH-HHHHHHHHHH---------HHHHHHHhh--------CCcccccccC
Q 043425           99 SM--------------YIQR---H----GCVPE-ETAKHFMKQL---------AAGLQVLRD--------NNLIHRDLKP  139 (575)
Q Consensus        99 ~~--------------~l~~---~----~~lse-~~i~~i~~QL---------l~aL~~LH~--------~gIvHrDLKP  139 (575)
                      ..              .+.+   -    .+++. ..+..+..++         ...+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            31              1111   0    11121 1222222222         111222211        2589999999


Q ss_pred             CceeeecCCCCCcEEEcccccccc
Q 043425          140 QNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       140 eNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .||++.   +++ +.|+||..+..
T Consensus       156 ~Nil~~---~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVT---PQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEe---CCC-CEEEeccccCc
Confidence            999993   334 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.25  E-value=0.0075  Score=62.89  Aligned_cols=74  Identities=16%  Similarity=0.147  Sum_probs=44.5

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLHD------IIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~------~~~~~~~l~L   88 (575)
                      .+.|+.|....+|++...  +..+++|++.  ....   ..+..|+.++..|...  .+.+++.      +....+..++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~   99 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA   99 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence            355777777889998754  3378999875  2222   2233455555554311  1333332      2234667899


Q ss_pred             EEeecCCCC
Q 043425           89 ILEYCKGGD   97 (575)
Q Consensus        89 VmEy~~Ggs   97 (575)
                      +++|++|..
T Consensus       100 l~~~l~G~~  108 (319)
T PRK05231        100 IVTFLEGKW  108 (319)
T ss_pred             EEEecCCCC
Confidence            999999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.22  E-value=0.0036  Score=64.43  Aligned_cols=136  Identities=20%  Similarity=0.216  Sum_probs=81.1

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLHD------IIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~------~~~~~~~l~L   88 (575)
                      .+.|..|....+|++...  +..+++|+....  .   ...+..|+.++..|...  .+.+++.      +....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            567777888899998653  457899987641  1   23466777777777432  2444443      2234567899


Q ss_pred             EEeecCCCCHHH----H-------H---HHc-CCCC--------HHHHH------------HHHHHHHHHHHHHhh----
Q 043425           89 ILEYCKGGDLSM----Y-------I---QRH-GCVP--------EETAK------------HFMKQLAAGLQVLRD----  129 (575)
Q Consensus        89 VmEy~~GgsL~~----~-------l---~~~-~~ls--------e~~i~------------~i~~QLl~aL~~LH~----  129 (575)
                      |++|++|..+..    .       +   +.. ..+.        .....            .....+..++.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999999876421    1       1   100 0000        00000            011122334444443    


Q ss_pred             ---CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          130 ---NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       130 ---~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                         .+++|+|+.|.|||+   ++++.+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLF---DGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence               379999999999999   555556899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.15  E-value=0.0016  Score=69.15  Aligned_cols=141  Identities=23%  Similarity=0.267  Sum_probs=96.9

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-----------------------HHHH-HHHHHHHHHHhCCCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-----------------------KLQE-SLMSEIFILKRINHPH   72 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-----------------------~~~~-~i~~Ei~iL~~L~Hpn   72 (575)
                      -.-|.-|--+.||.|... .|..+|||+++.+.+.-                       +... =...|++-|++|+...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345667888899999876 78889999886543211                       1111 1236777788876555


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-hhCCcccccccCCceeeecCCCCC
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~L-H~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      |.-.--+.. . .-.|||+++.+.....-..+.-.++...+..+-+|++.-+.-| |..++||.||.-=|+|+    ..|
T Consensus       228 IP~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----hdG  301 (520)
T KOG2270|consen  228 IPCPEPILL-K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----HDG  301 (520)
T ss_pred             CCCCCceee-e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----ECC
Confidence            432221211 1 2469999996544333333455688889999999999888876 45699999999999998    567


Q ss_pred             cEEEccccccccc
Q 043425          152 ALKIADFGFARSL  164 (575)
Q Consensus       152 ~vKL~DFGla~~~  164 (575)
                      .+.|+|-+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999999876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.10  E-value=0.0013  Score=64.11  Aligned_cols=98  Identities=21%  Similarity=0.251  Sum_probs=76.9

Q ss_pred             HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeecCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHhh---CC
Q 043425           59 MSEIFILKRINH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMY---IQRHGCVPEETAKHFMKQLAAGLQVLRD---NN  131 (575)
Q Consensus        59 ~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~---l~~~~~lse~~i~~i~~QLl~aL~~LH~---~g  131 (575)
                      ..|.-+|+.+.+ +++++++|.+   + -++|.||...+++...   +..-...+.....+|+.+++..+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C---G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC---G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC---C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999876 6999999998   2 3578899987766421   1111235788899999999999999998   35


Q ss_pred             cccccccCCceeeecCCCCCcEEEcccccccc
Q 043425          132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       132 IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.-+|++|+|+-+   ++++.+|++|.+.+..
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcch
Confidence            7788999999999   5667899999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.07  E-value=0.0099  Score=64.62  Aligned_cols=78  Identities=17%  Similarity=0.146  Sum_probs=53.1

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecC-cc--C--HHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-RL--N--KKLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~-~~--~--~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.||.|.+..||++.....++.++||.-... ..  .  +-..+....|...|+.+.   ..++++++.+-  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            36899999999999998744468999974311 00  0  112345667778777753   34677777773  455789


Q ss_pred             EEeecCCC
Q 043425           89 ILEYCKGG   96 (575)
Q Consensus        89 VmEy~~Gg   96 (575)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.96  E-value=0.0036  Score=64.76  Aligned_cols=76  Identities=16%  Similarity=0.156  Sum_probs=48.8

Q ss_pred             EEEecccCCeEEEEEEEcC------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRV------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~LV   89 (575)
                      ++.|..|---.||++....      .+..|++|+......   ......+|..+++.+...+ ..++++.+. +   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            3456667777899887543      368899998765321   1234568888888875433 345565553 2   358


Q ss_pred             EeecCCCCHH
Q 043425           90 LEYCKGGDLS   99 (575)
Q Consensus        90 mEy~~GgsL~   99 (575)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.88  E-value=0.013  Score=60.91  Aligned_cols=138  Identities=19%  Similarity=0.217  Sum_probs=79.0

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLHDI------IEVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~~------~~~~~~l~   87 (575)
                      -++.++.|.-..+|++...  +..+++|+..... .   .+.+..|..++..|...  .+.+++..      ....+..+
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eccccCCccccceEEEEeC--CCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            3566777877899998643  4468889875422 1   12345666777666321  23444432      12356789


Q ss_pred             EEEeecCCCCHH-----------HHH---HHc-CCC--------CHHH-----HH----------HHHHHHHHHHHHHhh
Q 043425           88 LILEYCKGGDLS-----------MYI---QRH-GCV--------PEET-----AK----------HFMKQLAAGLQVLRD  129 (575)
Q Consensus        88 LVmEy~~GgsL~-----------~~l---~~~-~~l--------se~~-----i~----------~i~~QLl~aL~~LH~  129 (575)
                      ++++|++|..+.           ..+   +.. ..+        ....     ..          .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999985431           111   110 001        0000     00          011123334555532


Q ss_pred             -------CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          130 -------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       130 -------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                             .+++|+|+.+.||++   +.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEE---ECCceEEEeeccccc
Confidence                   589999999999999   444556899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.85  E-value=0.00065  Score=71.12  Aligned_cols=136  Identities=21%  Similarity=0.303  Sum_probs=97.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-------H----------H---HHHHHHHHHHHHHhCCC-C-
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-------K----------K---LQESLMSEIFILKRINH-P-   71 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-------~----------~---~~~~i~~Ei~iL~~L~H-p-   71 (575)
                      |.++++||-|--+.||.+.+. .|..+++|.=...+..       .          +   .+-...+|+..|+.|.. . 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            568899999999999999887 6889999853222110       0          0   11234578888888853 2 


Q ss_pred             CcceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           72 HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        72 nIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      -+.+.++    .++-++|||++.|-.|...-+      ...+..+...+..-+--|-.+|+||+|+.-=||++   .+.+
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd~  239 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDDD  239 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecCC
Confidence            2344433    356789999999977765532      12345666677777788899999999999999999   5667


Q ss_pred             cEEEcccccccc
Q 043425          152 ALKIADFGFARS  163 (575)
Q Consensus       152 ~vKL~DFGla~~  163 (575)
                      .++++||--...
T Consensus       240 ~i~vIDFPQmvS  251 (465)
T KOG2268|consen  240 KIVVIDFPQMVS  251 (465)
T ss_pred             CEEEeechHhhc
Confidence            899999976543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.84  E-value=0.0037  Score=68.97  Aligned_cols=164  Identities=18%  Similarity=0.231  Sum_probs=108.6

Q ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccc
Q 043425           57 SLMSEIFILKRINHPHIIRLHDIIEV-PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR  135 (575)
Q Consensus        57 ~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHr  135 (575)
                      ++.-...+++.+.|+|..+++++... ..+..+|||++ +.+|++++..+. +-.   ..+.               +||
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~---~s~~---------------~~~   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKD---ESLL---------------AHG   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cch---hhhc---------------ccc
Confidence            46677889999999999999988743 35689999999 789999987653 111   1111               222


Q ss_pred             cccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCC
Q 043425          136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG  215 (575)
Q Consensus       136 DLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~  215 (575)
                      =+ +-||          ++++| -++..    .  .+..|                +++|||++|.++.++..|...|..
T Consensus        88 ~~-~~~~----------~~~td-~~~t~----~--~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   88 VL-HLNI----------IYITD-HFLTK----Y--PSPIG----------------PKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             cc-eehh----------hhccc-ccccc----C--CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence            11 1222          23333 11100    0  11111                389999999999999999988887


Q ss_pred             CCHHHHHHHHHHhccCCCCC--------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          216 SNQIQLLQNIVKATELHFPP--------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       216 ~~~~~~l~~i~~~~~~~~p~--------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ....+....+.+-.......        -....+....++..+|+-..|..||...++.+++-|...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            77777666665432111000        001244556789999999999999999999999988765

>PRK10593 hypothetical protein; Provisional

Probab=96.24  E-value=0.036  Score=57.79  Aligned_cols=103  Identities=14%  Similarity=0.137  Sum_probs=74.5

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH---PHIIRLHDIIEV---PGKLHLIL   90 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~~~~~---~~~l~LVm   90 (575)
                      .+.||.|..+.||.....  +..+++|..+. ..   ....+..|...|+.|..   -.+.++++++..   .+..+|||
T Consensus        19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         19 VECISEQPYAALWALYDS--QGNPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eeecCCccceeEEEEEcC--CCCEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            467999999999998654  33577787432 11   12357789999988853   367888887754   36789999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN  130 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~  130 (575)
                      |+++|+.+.+.     ..+......+..+++.+|.-||+.
T Consensus        93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999887752     133455667788889999999985

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.00  E-value=0.05  Score=56.21  Aligned_cols=30  Identities=30%  Similarity=0.558  Sum_probs=23.7

Q ss_pred             CcccccccCCceeeecCCC-CCcEEEcccccccc
Q 043425          131 NLIHRDLKPQNLLLCTDDD-NAALKIADFGFARS  163 (575)
Q Consensus       131 gIvHrDLKPeNILl~~dd~-~g~vKL~DFGla~~  163 (575)
                      .++|+|++|.|||+   ++ ....-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv---~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILI---DEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEE---eCCCCEEEEECcHhccc
Confidence            48999999999999   33 33456999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.91  E-value=0.062  Score=56.74  Aligned_cols=79  Identities=10%  Similarity=0.103  Sum_probs=45.2

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVPG--KLHLIL   90 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~~--~l~LVm   90 (575)
                      .+++.+-.|.--.+|.....  ++.++++ ...............+|+.+++.+.-  --+.+.++++..+.  ..|.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34444433333345555444  8888888 33211122333456788888888754  22344555554443  679999


Q ss_pred             eecCCC
Q 043425           91 EYCKGG   96 (575)
Q Consensus        91 Ey~~Gg   96 (575)
                      +|++|.
T Consensus       105 ~~veGe  110 (321)
T COG3173         105 EWVEGE  110 (321)
T ss_pred             EEecce
Confidence            999984

>PLN02236 choline kinase

Probab=95.76  E-value=0.059  Score=57.43  Aligned_cols=138  Identities=17%  Similarity=0.239  Sum_probs=79.2

Q ss_pred             EEEEecccCCeEEEEEEEcC----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRV----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVm   90 (575)
                      -+..|-.|-.-.+|++....    .+..|++|+.....  ... -...+|..+++.+..-++ .++++.+.. +   .|.
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~  112 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE  112 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence            33455558888899986432    34789999876532  111 123578888888865444 355666533 2   579


Q ss_pred             eecCCCCHHHH--------------HH---HcC----C-CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 043425           91 EYCKGGDLSMY--------------IQ---RHG----C-VP-EETAKHFMKQL-----------------AAGLQVL---  127 (575)
Q Consensus        91 Ey~~GgsL~~~--------------l~---~~~----~-ls-e~~i~~i~~QL-----------------l~aL~~L---  127 (575)
                      +|++|..|...              +.   .-.    . .. ...+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987665311              11   000    0 11 12233332221                 1111111   


Q ss_pred             -----hhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          128 -----RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       128 -----H~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                           +...++|+|+++.|||+.  +..+.+.|+||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence                 123589999999999993  224679999998874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.74  E-value=0.22  Score=51.39  Aligned_cols=29  Identities=28%  Similarity=0.578  Sum_probs=24.1

Q ss_pred             CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       130 ~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+++|+|+.+.||++   +. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~---~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILL---KD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEE---eC-CcEEEEECcccc
Confidence            478999999999999   33 458899999663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.66  E-value=0.084  Score=56.67  Aligned_cols=74  Identities=15%  Similarity=0.166  Sum_probs=47.6

Q ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEeec------CccCHHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 043425           19 QIGSGSFSVVWHARHRVHGTEVAMKEIAM------GRLNKKLQESLMSEIFILKRIN--HP-HIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        19 ~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~------~~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~l~LV   89 (575)
                      .||.|....||++.+...+..++||.-..      ... +-...+..-|...|+...  -| .++++|.+  ++....+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            57999999999999864446899996421      111 112234556777777654  24 45565544  35566799


Q ss_pred             EeecCC
Q 043425           90 LEYCKG   95 (575)
Q Consensus        90 mEy~~G   95 (575)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999954

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.48  E-value=0.072  Score=56.37  Aligned_cols=79  Identities=14%  Similarity=0.221  Sum_probs=48.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~   87 (575)
                      ++..+. .|..|=.-.+|++.....   +..|++|+......   ..-...+|..+++.+..-++ .++++++. .+   
T Consensus        15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---   86 (330)
T PLN02421         15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---   86 (330)
T ss_pred             CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence            344444 444477778998875432   34899998754321   11123578888888865555 45666653 32   


Q ss_pred             EEEeecCCCCH
Q 043425           88 LILEYCKGGDL   98 (575)
Q Consensus        88 LVmEy~~GgsL   98 (575)
                      +|.+|++|..|
T Consensus        87 ~i~~fi~g~~l   97 (330)
T PLN02421         87 MIQSFINARTL   97 (330)
T ss_pred             EeehhhcCCCC
Confidence            58999987654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.35  E-value=0.15  Score=53.19  Aligned_cols=29  Identities=24%  Similarity=0.328  Sum_probs=25.5

Q ss_pred             CcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       131 gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +++|+|+.+.|||+   ++++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence            79999999999999   666678999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.22  E-value=0.16  Score=55.47  Aligned_cols=76  Identities=12%  Similarity=0.113  Sum_probs=50.3

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc--CH---HHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NK---KLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~--~~---~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+.||.|.--.||++.+.  +..++||.-.....  ..   -...+...|...|+.+.   ..++.+++.+.+  +.-+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3678899999999999874  45688997541111  00   01233445566666653   247888888875  4467


Q ss_pred             EEEeecCC
Q 043425           88 LILEYCKG   95 (575)
Q Consensus        88 LVmEy~~G   95 (575)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.11  E-value=0.096  Score=56.80  Aligned_cols=61  Identities=28%  Similarity=0.416  Sum_probs=45.3

Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHhhCCcccccccCCceeeec
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ-VLRDNNLIHRDLKPQNLLLCT  146 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~-~LH~~gIvHrDLKPeNILl~~  146 (575)
                      ...|+-+|..|-.+..+++.. ..+|+..+.++.--+.||- .|---+++|.|+.|.||++.-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            356777899999999988754 3566666667666666644 344568999999999999953

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.00  E-value=0.13  Score=55.96  Aligned_cols=77  Identities=16%  Similarity=0.175  Sum_probs=50.4

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecC-ccC---HHHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-RLN---KKLQESLMSEIFILKRIN--HP-HIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~-~~~---~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~l~LV   89 (575)
                      .+.||.|.-..||++.+...+..++||.-..- +..   +-..++..-|..+|+.+.  .| +++++|.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            67899999999999998544567888864211 010   112345567778887764  24 45666544  45567899


Q ss_pred             EeecCC
Q 043425           90 LEYCKG   95 (575)
Q Consensus        90 mEy~~G   95 (575)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999954

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.82  E-value=0.58  Score=48.78  Aligned_cols=73  Identities=15%  Similarity=0.160  Sum_probs=46.8

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeec
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      .+.+|.|....+|...  .++..+.||+-....     ...+..|..-|+.|.   --.+++++.+....+.-++||||+
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            4668889999999987  578899999876321     233667887777773   345788999988777789999999


Q ss_pred             CCC
Q 043425           94 KGG   96 (575)
Q Consensus        94 ~Gg   96 (575)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.64  E-value=1.4  Score=46.41  Aligned_cols=70  Identities=13%  Similarity=0.112  Sum_probs=42.1

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEE---E--EEEeCCEEEEEEeecCCC
Q 043425           24 SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLH---D--IIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        24 aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~---~--~~~~~~~l~LVmEy~~Gg   96 (575)
                      .--.||.+... +|..+++|+.......   ...+..|...+..|...  .++...   +  +...++..+.++++++|.
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            34468888653 5678999987543322   34466777777666321  122211   1  233457788999999886


Q ss_pred             C
Q 043425           97 D   97 (575)
Q Consensus        97 s   97 (575)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.28  E-value=0.12  Score=50.54  Aligned_cols=31  Identities=32%  Similarity=0.695  Sum_probs=20.2

Q ss_pred             CcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425          131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       131 gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .++|.||.|.|||+  ++..+.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~--~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILI--NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEE--TSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEe--ccCCCeEEEecHHHHhh
Confidence            47899999999999  34567899999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=92.94  E-value=0.99  Score=55.03  Aligned_cols=77  Identities=14%  Similarity=0.207  Sum_probs=44.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-------CCCcceEE-----EEEEe-CC
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-------HPHIIRLH-----DIIEV-PG   84 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-------HpnIv~l~-----~~~~~-~~   84 (575)
                      +.|+ |..-.+|++... +|..|++|+..... .   ...+..|..+|..|.       -|.+++-.     ..+.. .+
T Consensus        31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G  104 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE-P---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG  104 (1013)
T ss_pred             eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-c---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence            5675 456778888644 67789999987542 1   122334555554442       23333211     11222 22


Q ss_pred             --EEEEEEeecCCCCHHH
Q 043425           85 --KLHLILEYCKGGDLSM  100 (575)
Q Consensus        85 --~l~LVmEy~~GgsL~~  100 (575)
                        +.+.+++|++|..+.+
T Consensus       105 ~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        105 EPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             ceEEEEEEeccCCCcHHh
Confidence              5778999999977754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.71  E-value=0.25  Score=52.98  Aligned_cols=71  Identities=24%  Similarity=0.337  Sum_probs=55.8

Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      ...|++|++- |+.+.-.    .....+++..|+.+.+..+.-+..+ .+-|||+...|||+   + .|.|.|+||-+++
T Consensus       299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeeee
Confidence            4567888876 5555422    2234678888999998888888766 78999999999999   6 7899999999998


Q ss_pred             c
Q 043425          163 S  163 (575)
Q Consensus       163 ~  163 (575)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            4

>PTZ00384 choline kinase; Provisional

Probab=92.03  E-value=0.92  Score=49.21  Aligned_cols=76  Identities=14%  Similarity=0.128  Sum_probs=45.6

Q ss_pred             EEEEecccCCeEEEEEEEcCC-CcE-----EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVH-GTE-----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHL   88 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~t-g~~-----vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~L   88 (575)
                      .++.|..|-...+|++..... +..     |.+++...   .....-.-.+|+.+++.+...++ .++++.+..    ++
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            344565588889999975432 222     44443211   11111123578999999876555 566666632    59


Q ss_pred             EEeecCCCCH
Q 043425           89 ILEYCKGGDL   98 (575)
Q Consensus        89 VmEy~~GgsL   98 (575)
                      |.||++|..|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            9999998765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.27  E-value=0.76  Score=46.40  Aligned_cols=85  Identities=22%  Similarity=0.305  Sum_probs=59.5

Q ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--Cccc
Q 043425           57 SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--NLIH  134 (575)
Q Consensus        57 ~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--gIvH  134 (575)
                      .+.++.+++.++  ..|+++.-  ...-.+-+++|+|-...             .....++..=+.+|...|+.  +.+|
T Consensus       104 ~y~nky~v~Arm--hGilrL~N--Dn~~~yGvIlE~Cy~~~-------------i~~~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  104 LYFNKYRVFARM--HGILRLKN--DNNYKYGVILERCYKIK-------------INFSNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhhHHHHh--hheeEeec--CCCceeEEEEeeccCcc-------------cchhHHHHHhHHHHHHhhccCCCeec
Confidence            457888998887  56777762  13345779999994311             01122223334667788843  7999


Q ss_pred             ccccCCceeeecCCCCCcEEEcccccc
Q 043425          135 RDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus       135 rDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      +|-.|+||+.   |..|.+||.|-+..
T Consensus       167 GD~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  167 GDCNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             CCCChhheee---cCCCCEEecChhhh
Confidence            9999999999   89999999998754

The function of this family is unknown.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=91.22  E-value=0.044  Score=60.42  Aligned_cols=73  Identities=25%  Similarity=0.453  Sum_probs=61.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~   81 (575)
                      -+...++..+..+|.|+||+|+.+.++..+..+|||.|.... ....+..+.+|..-+..+.|++|+++...+.
T Consensus        45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn-~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~  117 (516)
T KOG1033|consen   45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN-REESRSRVLREVSSLAEFEHPGIKRYFHAWY  117 (516)
T ss_pred             hhhhccccccccccccCccccCCccccccchhhHHHHhcccc-hhhhhhhhhccccchhhhcccchhhheecee
Confidence            356778999999999999999999999888899999987643 2344566788999999999999999877664

>PTZ00296 choline kinase; Provisional

Probab=89.78  E-value=2.3  Score=47.06  Aligned_cols=76  Identities=20%  Similarity=0.170  Sum_probs=46.7

Q ss_pred             EEEEecccCCeEEEEEEEcC--------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEE
Q 043425           16 VGRQIGSGSFSVVWHARHRV--------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII-RLHDIIEVPGKL   86 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~--------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~~~~~~~~l   86 (575)
                      -++.|..|=.-.+|++....        .++.|.+|+.....  .... ...+|..+++.+...+|. ++++.+. +   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence            44566667777888887542        25689999875432  1111 235678887777655553 5566553 2   


Q ss_pred             EEEEeecCCCCH
Q 043425           87 HLILEYCKGGDL   98 (575)
Q Consensus        87 ~LVmEy~~GgsL   98 (575)
                      +.|.||++|..|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            357899988643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	575
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-48
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-47
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-47
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-47
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-47
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-47
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-46
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-46
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-45
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-45
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-41
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-41
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-40
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-40
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-40
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-40
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-40
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-39
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-39
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-39
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-39
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-39
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-39
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-39
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-39
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-39
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-39
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-39
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-39
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-39
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-39
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-39
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-38
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-38
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-38
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-38
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-38
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-38
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-38
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-37
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-37
3soa_A	444	Full-Length Human Camkii Length = 444		2e-37
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-37
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-37
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-37
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-37
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-37
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-37
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-37
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-37
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-37
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-37
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-37
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-37
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-37
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-37
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-37
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-37
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-37
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-37
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-36
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-36
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-36
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-36
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-36
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-36
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-36
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-36
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-36
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-35
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-35
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-35
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-35
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-35
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-35
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-35
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-35
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-35
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-35
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-35
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-35
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-35
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-35
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-35
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-35
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-35
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-35
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-35
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-35
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-35
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-35
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-35
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-35
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-35
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-35
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-35
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-35
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-35
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-35
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-34
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-34
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-34
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-34
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-34
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-34
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-34
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-34
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-34
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-34
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-34
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-34
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-34
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-34
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-34
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-34
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-34
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-34
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-34
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-34
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-34
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-34
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-34
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-34
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-34
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-34
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-34
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-34
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-34
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-34
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-34
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-34
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-34
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-34
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-34
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-34
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-34
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-34
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-34
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-34
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-34
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-34
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-34
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-34
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-34
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-34
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-34
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-34
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-34
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-34
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-34
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-34
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-34
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-34
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-34
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-33
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-33
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-33
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-33
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-33
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-33
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-33
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-33
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-33
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-33
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-33
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-33
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-33
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-33
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-33
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-33
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-33
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-33
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-33
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-33
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-33
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-33
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-33
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-33
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-33
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-33
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-32
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-32
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-32
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-32
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-32
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-32
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-32
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-32
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-32
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-32
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-32
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-32
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-32
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-32
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-32
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-32
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-32
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-32
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-32
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-32
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-32
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-32
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-32
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-32
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-32
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		9e-32
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-31
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-31
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-31
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-31
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-31
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-31
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-31
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-31
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-31
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-31
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-31
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-31
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-30
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-30
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-30
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-30
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-30
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-30
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-30
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-30
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-30
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-30
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-30
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-30
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-30
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-30
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-30
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-30
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-30
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-30
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-30
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-30
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-30
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-30
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-30
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-30
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-30
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-30
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-30
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-30
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-30
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-30
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-30
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-30
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-30
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-30
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-30
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-30
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-30
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-30
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-30
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-30
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-29
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-29
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-29
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-29
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-29
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-29
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-29
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-29
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-29
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-29
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-28
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-28
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-28
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-28
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-28
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-28
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-28
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-28
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-28
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-28
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-28
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-28
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-28
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-28
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-28
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-28
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-28
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-28
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-28
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-28
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-28
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-27
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-27
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-27
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-27
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-27
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-27
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-27
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-27
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-27
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-27
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-27
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-27
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-27
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-27
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-27
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-27
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-27
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-27
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-27
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-27
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-27
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-27
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-27
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-27
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-27
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-27
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-27
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-26
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-26
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-26
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-26
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-26
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-26
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-26
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-26
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-26
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-26
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-26
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-26
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-26
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-26
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-26
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-25
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-25
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-25
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-25
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-25
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-25
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-25
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-25
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-25
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-25
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-25
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-25
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-25
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-25
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-25
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-24
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-24
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-24
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-24
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-24
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-24
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-24
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-24
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-24
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-24
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-24
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-24
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-24
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-24
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-24
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-24
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-23
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-23
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-23
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-23
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-23
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-23
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-23
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-23
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-23
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-23
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-23
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-23
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-23
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-23
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-23
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-23
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-23
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-23
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-23
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-23
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-23
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-23
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-23
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-23
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-23
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-23
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-23
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-23
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-23
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-23
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-23
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-23
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-23
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-23
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-23
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-23
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-23
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-23
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-23
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-23
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-23
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-23
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-23
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-23
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-23
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-22
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-22
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-22
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-22
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-22
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-22
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-22
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-22
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-22
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-22
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-22
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-22
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-22
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-22
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-22
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-22
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-22
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-22
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-22
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-22
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-21
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-21
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-21
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-21
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-21
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-21
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-21
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-21
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-21
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-21
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-20
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-20
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-20
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-20
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-20
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-20
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-20
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-20
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-20
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-20
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-20
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-20
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-20
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-20
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-20
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-19
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-19
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-19
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-19
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-19
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-19
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-19
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-19
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-19
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-19
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-19
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-19
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-19
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-19
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-19
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-19
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-19
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-19
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-19
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-18
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-18
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-18
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-18
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-18
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-18
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-18
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-18
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-18
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-18
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-18
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-18
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-18
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-18
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-18
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-18
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-18
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-18
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-18
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-18
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-18
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-18
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-18
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-18
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-18
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-18
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-17
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-17
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-17
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-17
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-17
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-16
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-15
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-14
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-13

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  190 bits (483), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 160/263 (60%), Gaps = 8/263 (3%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 70
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+LI+EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+      G  +T CGSP Y APE+ Q +KY
Sbjct: 131 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF---YMSTDCENLLK 243
Query: 250 KLLRRNPVERLTFEEFFNHPFLS 272
           + L  NP++R T E+     +++
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWIN 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  187 bits (476), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 159/263 (60%), Gaps = 8/263 (3%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+LI+EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+      G  +  CG+P Y APE+ Q +KY
Sbjct: 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPF---YMSTDCENLLK 246
Query: 250 KLLRRNPVERLTFEEFFNHPFLS 272
           + L  NP++R T E+     +++
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWIN 269

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  187 bits (474), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 159/268 (59%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +T CGSP Y APE+ Q +KY
Sbjct: 126 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 238
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 239 KFLILNPSKRGTLEQIMKDRWMNVGHED 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 159/268 (59%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +T CGSP Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHED 273

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 99/268 (36%), Positives = 159/268 (59%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +T CGSP Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHED 273

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  186 bits (471), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 159/268 (59%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA++ I   +LN    + L  E+ I+K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +T CGSP Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHED 273

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 158/268 (58%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I+K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +  CG+P Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHED 273

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 158/268 (58%), Gaps = 8/268 (2%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA++ I   +LN    + L  E+ I+K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL   D +  +KIADFGF+         +  CGSP Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     +S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYMSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           K L  NP +R T E+     +++    D
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHED 273

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  179 bits (453), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 96/255 (37%), Positives = 150/255 (58%), Gaps = 8/255 (3%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  E+ I K +NH
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I++L ++IE    L+L+ EY  GG++  Y+  HG   E+ A+   +Q+ + +Q     
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            ++HRDLK +NLLL  D +   +KIADFGF+         +  CG+P Y APE+ Q +KY
Sbjct: 133 FIVHRDLKAENLLLDADXN---IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 191 DA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           D  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P      S DC++L +
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FYXSTDCENLLK 245
Query: 250 KLLRRNPVERLTFEE 264
           K L  NP +R T E+
Sbjct: 246 KFLILNPSKRGTLEQ 260

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  178 bits (451), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 164/273 (60%), Gaps = 8/273 (2%)
Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           ++ AT     +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           E+ I+K +NHP+I++L ++IE    L+L++EY  GG++  Y+  HG + E+ A+   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            + +Q      ++HRDLK +NLLL   D +  +KIADFGF+         +T CGSP Y 
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 181 APEIMQLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           APE+ Q +KYD  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIP---FY 236
Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +S DC++L +KLL  NP++R + E+     +++
Sbjct: 237 MSTDCENLLKKLLVLNPIKRGSLEQIMKDRWMN 269

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 152/275 (55%), Gaps = 10/275 (3%)
Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMS 60
           S AT  G  + D+ VG  +G GSF+ V+ A     G EVA+K I    + K  + + + +
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQ 119
           E+ I  ++ HP I+ L++  E    ++L+LE C  G+++ Y++ R     E  A+HFM Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL 178
           +  G+  L  + ++HRDL   NLLL     N  +KIADFG A  L+ P     TLCG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           Y++PEI     +  ++D+WS+G + + L+ G+ PF        L  +V A +   P    
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMP---S 233
Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            LS + KDL  +LLRRNP +RL+     +HPF+S+
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  166 bits (421), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 144/268 (53%), Gaps = 9/268 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRINH 70
           Y +   IG G+FSVV    +R  G + A+K + + +         E L  E  I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           PHI+ L +     G L+++ E+  G DL   I +         E  A H+M+Q+   L+ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIM 185
             DNN+IHRD+KP+N+LL + +++A +K+ DFG A  L   GL A    G+P +MAPE++
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + Y    D+W  G ILF L++G  PF G+ + +L + I+K      P     +S   K
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           DL +++L  +P ER+T  E  NHP+L +
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 141/253 (55%), Gaps = 1/253 (0%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G+FS V  A  +     VA+K IA   L  K + S+ +EI +L +I HP+I+ L DI
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            E  G L+LI++   GG+L   I   G   E  A   + Q+   ++ L D  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV 199
           +NLL  + D+++ + I+DFG ++   P  +  T CG+P Y+APE++  + Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+ ++P +R
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264
Query: 260 LTFEEFFNHPFLS 272
            T E+   HP+++
Sbjct: 265 FTCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 141/253 (55%), Gaps = 1/253 (0%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G+FS V  A  +     VA+K IA   L  K + S+ +EI +L +I HP+I+ L DI
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            E  G L+LI++   GG+L   I   G   E  A   + Q+   ++ L D  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV 199
           +NLL  + D+++ + I+DFG ++   P  +  T CG+P Y+APE++  + Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+ ++P +R
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264
Query: 260 LTFEEFFNHPFLS 272
            T E+   HP+++
Sbjct: 265 FTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 141/253 (55%), Gaps = 1/253 (0%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G+FS V  A  +     VA+K IA   L  K + S+ +EI +L +I HP+I+ L DI
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            E  G L+LI++   GG+L   I   G   E  A   + Q+   ++ L D  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV 199
           +NLL  + D+++ + I+DFG ++   P  +  T CG+P Y+APE++  + Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+ ++P +R
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264
Query: 260 LTFEEFFNHPFLS 272
            T E+   HP+++
Sbjct: 265 FTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/253 (34%), Positives = 141/253 (55%), Gaps = 1/253 (0%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G+FS V  A  +     VA+K IA   L  K + S+ +EI +L +I HP+I+ L DI
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            E  G L+LI++   GG+L   I   G   E  A   + Q+   ++ L D  ++HRDLKP
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 144
Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV 199
           +NLL  + D+++ + I+DFG ++   P  +  T CG+P Y+APE++  + Y    D WS+
Sbjct: 145 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+ ++P +R
Sbjct: 205 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264
Query: 260 LTFEEFFNHPFLS 272
            T E+   HP+++
Sbjct: 265 FTCEQALQHPWIA 277

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/287 (34%), Positives = 158/287 (55%), Gaps = 21/287 (7%)
Query: 2   SQATGRGRVVGDYL--------------VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM 47
           S A G   +V DY               V  ++G G+ S+V+  + +  GT+   K  A+
Sbjct: 29  SAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQK--GTQ---KPYAL 83
Query: 48  GRLNKKLQESLM-SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG 106
             L K + + ++ +EI +L R++HP+II+L +I E P ++ L+LE   GG+L   I   G
Sbjct: 84  KVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG 143
Query: 107 CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP 166
              E  A   +KQ+   +  L +N ++HRDLKP+NLL  T   +A LKIADFG ++ ++ 
Sbjct: 144 YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV 226
           + L +T+CG+P Y APEI++   Y  + D+WSVG I + L+ G  PF      Q +   +
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263
Query: 227 KATELHF-PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              E +F  P    +S + KDL +KL+  +P +RLT  +   HP+++
Sbjct: 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 145/267 (54%), Gaps = 16/267 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMK--EIAMGRLN----KKLQESLMSEIFILKRI-NHPH 72
           IG G  SVV    HR  G E A+K  E+   RL+    ++++E+   E  IL+++  HPH
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           II L D  E    + L+ +  + G+L  Y+     + E+  +  M+ L   +  L  NN+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK--- 189
           +HRDLKP+N+LL   DDN  ++++DFGF+  L+P      LCG+P Y+APEI++      
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 190 ---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
              Y  + DLW+ G ILF L+ G  PF    QI +L+ I++       P+    S+  KD
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L  +LL+ +P  RLT E+   HPF  +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 154/273 (56%), Gaps = 1/273 (0%)
Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           M   + +G +   Y   +++GSG++  V   R +V   E A+K I    ++      L+ 
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           E+ +LK ++HP+I++L+D  E     +L++E  KGG+L   I       E  A   +KQ+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            +G+  L  +N++HRDLKP+NLLL + + +A +KI DFG +   + +   +   G+  Y+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APE+++ +KYD K D+WS+G ILF L+ G  PF G    ++L+ + K       P+ K +
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           S   KDL +++L+ +   R++ ++   HP++ +
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 146/255 (57%), Gaps = 2/255 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-SLMSEIFILKRINHPHIIRL 76
           +++GSG++  V   + ++ G E A+K I    +       +L+ E+ +LK+++HP+I++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E     +L++E  +GG+L   I       E  A   MKQ+ +G   L  +N++HRD
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A +KI DFG +   +  G  +   G+  Y+APE+++ +KYD K D+
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR-KKYDEKCDV 205
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L+ G  PF G    ++L+ + K      PPD   +S + K L + +L   P
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 257 VERLTFEEFFNHPFL 271
            +R++ EE  NHP++
Sbjct: 266 SKRISAEEALNHPWI 280

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 148/263 (56%), Gaps = 2/263 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPHIIRL 76
           R +G GSF  V   + ++ G E A+K I+  ++ +K  +ESL+ E+ +LK+++HP+I++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+  +  N ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD K D+
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDV 234
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L++G  PF G+N+  +L+ + K       P  K +S   KDL +K+L   P
Sbjct: 235 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 294
Query: 257 VERLTFEEFFNHPFLSQTQPDQV 279
             R++  +  +H ++     +Q+
Sbjct: 295 SMRISARDALDHEWIQTYTKEQI 317

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 148/263 (56%), Gaps = 2/263 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPHIIRL 76
           R +G GSF  V   + ++ G E A+K I+  ++ +K  +ESL+ E+ +LK+++HP+I++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+  +  N ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD K D+
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDV 233
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L++G  PF G+N+  +L+ + K       P  K +S   KDL +K+L   P
Sbjct: 234 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 293
Query: 257 VERLTFEEFFNHPFLSQTQPDQV 279
             R++  +  +H ++     +Q+
Sbjct: 294 SMRISARDALDHEWIQTYTKEQI 316

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 146/255 (57%), Gaps = 2/255 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-SLMSEIFILKRINHPHIIRL 76
           +++GSG++  V   + ++ G E A+K I    +       +L+ E+ +LK+++HP+I++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E     +L++E  +GG+L   I       E  A   MKQ+ +G   L  +N++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A +KI DFG +   +  G  +   G+  Y+APE+++ +KYD K D+
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR-KKYDEKCDV 188
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L+ G  PF G    ++L+ + K      PPD   +S + K L + +L   P
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 248
Query: 257 VERLTFEEFFNHPFL 271
            +R++ EE  NHP++
Sbjct: 249 SKRISAEEALNHPWI 263

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 148/263 (56%), Gaps = 2/263 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPHIIRL 76
           R +G GSF  V   + ++ G E A+K I+  ++ +K  +ESL+ E+ +LK+++HP+I++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+  +  N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD K D+
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDV 210
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L++G  PF G+N+  +L+ + K       P  K +S   KDL +K+L   P
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 270
Query: 257 VERLTFEEFFNHPFLSQTQPDQV 279
             R++  +  +H ++     +Q+
Sbjct: 271 SMRISARDALDHEWIQTYTKEQI 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 141/263 (53%), Gaps = 3/263 (1%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y +  ++G G+FSVV        G E A K I   +L+ +  + L  E  I + + HP+
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I   G  +L+ +   GG+L   I       E  A H ++Q+   +     N +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQKYD 191
           +HRDLKP+NLLL +    AA+K+ADFG A  +Q    A     G+P Y++PE+++   Y 
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQK 250
              D+W+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + KDL  K
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
           +L  NP +R+T  E   HP++ Q
Sbjct: 244 MLTINPAKRITASEALKHPWICQ 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 9/268 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRINH 70
           Y +   IG G FSVV    +R  G + A+K + + +         E L  E  I   + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           PHI+ L +     G L+++ E+  G DL   I +         E  A H+M+Q+   L+ 
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIM 185
             DNN+IHRD+KP  +LL + +++A +K+  FG A  L   GL A    G+P +MAPE++
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + Y    D+W  G ILF L++G  PF G+ + +L + I+K      P     +S   K
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAK 266
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           DL +++L  +P ER+T  E  NHP+L +
Sbjct: 267 DLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 141/263 (53%), Gaps = 3/263 (1%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y +  ++G G+FSVV        G E A K I   +L+ +  + L  E  I + + HP+
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I   G  +L+ +   GG+L   I       E  A H ++Q+   +     N +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQKYD 191
           +HRDLKP+NLLL +    AA+K+ADFG A  +Q    A     G+P Y++PE+++   Y 
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQK 250
              D+W+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + KDL  K
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
           +L  NP +R+T  E   HP++ Q
Sbjct: 244 MLTINPAKRITASEALKHPWICQ 266

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 147/272 (54%), Gaps = 1/272 (0%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G     Y +   +G GSF  V   + R+   E A+K I       K   +++ E+ +LK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +++HP+I++L +I+E     +++ E   GG+L   I +     E  A   +KQ+ +G+  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           +  +N++HRDLKP+N+LL + + +  +KI DFG +   Q     +   G+  Y+APE+++
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
              YD K D+WS G IL+ L++G  PF G N+  +L+ +         P  + +S D KD
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           L +K+L  +P  R+T  +   HP++ +   ++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  159 bits (401), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 145/267 (54%), Gaps = 1/267 (0%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G     Y +   +G GSF  V   + R+   E A+K I       K   +++ E+ +LK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +++HP+I++L +I+E     +++ E   GG+L   I +     E  A   +KQ+ +G+  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           +  +N++HRDLKP+N+LL + + +  +KI DFG +   Q     +   G+  Y+APE+++
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
              YD K D+WS G IL+ L++G  PF G N+  +L+ +         P  + +S D KD
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L +K+L  +P  R+T  +   HP++ +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 142/258 (55%), Gaps = 3/258 (1%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           ++    +GSG+FS V+  + R+ G   A+K I      +    SL +EI +LK+I H +I
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENI 68
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           + L DI E     +L+++   GG+L   I   G   E+ A   ++Q+ + ++ L +N ++
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           HRDLKP+NLL  T ++N+ + I DFG ++ ++  G+  T CG+P Y+APE++  + Y   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D WS+G I + L+ G  PF    + +L + I +       P    +S   KD    LL 
Sbjct: 188 VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247
Query: 254 RNPVERLTFEEFFNHPFL 271
           ++P ER T E+  +HP++
Sbjct: 248 KDPNERYTCEKALSHPWI 265

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  158 bits (400), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 147/262 (56%), Gaps = 2/262 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPHIIRL 76
           R +G GSF  V   + ++ G E A+K I+  ++ +K  +ESL+ E+ +LK+++HP+I++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+  +  N ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD K D+
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDV 216
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L++G  PF G+N+  +L+ + K       P  K +S   KDL +K+L   P
Sbjct: 217 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 276
Query: 257 VERLTFEEFFNHPFLSQTQPDQ 278
             R++  +  +H ++     +Q
Sbjct: 277 SMRISARDALDHEWIQTYTKEQ 298

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  158 bits (400), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 9/268 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRINH 70
           Y +   IG G FSVV    +R  G + A+K + + +         E L  E  I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           PHI+ L +     G L+++ E+  G DL   I +         E  A H+M+Q+   L+ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIM 185
             DNN+IHRD+KP  +LL + +++A +K+  FG A  L   GL A    G+P +MAPE++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + Y    D+W  G ILF L++G  PF G+ + +L + I+K      P     +S   K
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           DL +++L  +P ER+T  E  NHP+L +
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  158 bits (400), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 145/267 (54%), Gaps = 1/267 (0%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G     Y +   +G GSF  V   + R+   E A+K I       K   +++ E+ +LK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +++HP+I++L +I+E     +++ E   GG+L   I +     E  A   +KQ+ +G+  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           +  +N++HRDLKP+N+LL + + +  +KI DFG +   Q     +   G+  Y+APE+++
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
              YD K D+WS G IL+ L++G  PF G N+  +L+ +         P  + +S D KD
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L +K+L  +P  R+T  +   HP++ +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 138/253 (54%), Gaps = 1/253 (0%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G+FS V  A  +  G   A+K I    L  K + S+ +EI +L++I H +I+ L DI
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGK-ESSIENEIAVLRKIKHENIVALEDI 88
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            E P  L+L+++   GG+L   I   G   E+ A   ++Q+   +  L    ++HRDLKP
Sbjct: 89  YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKP 148
Query: 140 QNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSV 199
           +NLL  + D+ + + I+DFG ++      +  T CG+P Y+APE++  + Y    D WS+
Sbjct: 149 ENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 208
Query: 200 GAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+ ++P +R
Sbjct: 209 GVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKR 268
Query: 260 LTFEEFFNHPFLS 272
            T E+   HP+++
Sbjct: 269 YTCEQAARHPWIA 281

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 145/263 (55%), Gaps = 2/263 (0%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPHIIRL 76
           R +G GSF  V   + ++ G E A+K I+  ++ +K  +ESL+ E+ +LK+++HP+I +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           ++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+     N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD K D+
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLH-GTYDEKCDV 210
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G IL+ L++G  PF G+N+  +L+ + K       P  K +S   KDL +K L   P
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVP 270
Query: 257 VERLTFEEFFNHPFLSQTQPDQV 279
             R++  +  +H ++     +Q+
Sbjct: 271 SXRISARDALDHEWIQTYTKEQI 293

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 144/267 (53%), Gaps = 3/267 (1%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R   DY +  ++G G+FSVV     +    E A K I   +L+ +  + L  E  I + +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP+I+RLHD I   G  +L+ +   GG+L   I       E  A H + Q+   +  + 
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQL 187
            ++++HRDLKP+NLLL +    AA+K+ADFG A  +Q    A     G+P Y++PE+++ 
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKD 246
             Y    D+W+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + K+
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-KAGAYDFPSPEWDTVTPEAKN 266
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L  ++L  NP +R+T ++   HP++ Q
Sbjct: 267 LINQMLTINPAKRITADQALKHPWVCQ 293

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 166/310 (53%), Gaps = 28/310 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMK----EIAMGRLNKKLQESLMSEIFILKRI 68
           D+ + R +G+GSF  V   R R +G   AMK    EI + RL  K  E    E  +L  +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RL--KQVEHTNDERLMLSIV 63
Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP IIR+    +   ++ +I++Y +GG+L   +++    P   AK +  ++   L+ L 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             ++I+RDLKP+N+LL   D N  +KI DFGFA+ +    +   LCG+P Y+APE++  +
Sbjct: 124 SKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVSTK 178
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
            Y+   D WS G ++++++ G TPF  SN ++  + I+ A EL FPP     + D KDL 
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPP---FFNEDVKDLL 234
Query: 249 QKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDV 303
            +L+ R+  +RL       E+  NHP+       +V   ++ SR+ +  P YE    +  
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFK-----EVVWEKLLSRNIET-P-YEPPIQQGQ 287
Query: 304 AESSQDDCLP 313
            ++SQ D  P
Sbjct: 288 GDTSQFDKYP 297

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 90/273 (32%), Positives = 150/273 (54%), Gaps = 14/273 (5%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKR 67
           R +G Y++   +G GSF  V  A H     +VA+K I+   L K  +   +  EI  LK 
Sbjct: 6   RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           + HPHII+L+D+I  P  + +++EY  GG+L  YI     + E+  + F +Q+   ++  
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             + ++HRDLKP+NLLL   DDN  +KIADFG +  +      +T CGSP Y APE++  
Sbjct: 125 HRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING 181
Query: 188 QKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--LHFPPDAKILSADC 244
           + Y   + D+WS G +L+ ++ G+ PF      + + N+ K     ++  PD   LS   
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDD----EFIPNLFKKVNSCVYVMPD--FLSPGA 235
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           + L ++++  +P++R+T +E    P+ +   PD
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  155 bits (393), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 162/311 (52%), Gaps = 26/311 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEI--AMGRLNKKLQESLMSEIFILKRINHP 71
           R +G G +  V+  R +V G       AMK +  AM   N K      +E  IL+ + HP
Sbjct: 23  RVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            I+ L    +  GKL+LILEY  GG+L M ++R G   E+TA  ++ +++  L  L    
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLKP+N++L   +    +K+ DFG  + S+    +  T CG+  YMAPEI+    +
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +   D WS+GA+++ ++TG  PFTG N+ + +  I+K  +L+ PP    L+ + +DL +K
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNLPP---YLTQEARDLLKK 254
Query: 251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM------FSRSADDFPFYESKS 299
           LL+RN   RL        E   HPF      +++   ++        +S +D   ++SK 
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKF 314
Query: 300 VRDVAESSQDD 310
            R     S DD
Sbjct: 315 TRQTPVDSPDD 325

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 153/276 (55%), Gaps = 15/276 (5%)
Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLM 59
           +++   R   + D+ +GR +G G F  V+ AR + +   +A+K +   +L K+ ++  L 
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 63
Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
            EI I   + HP+I+R+++      +++L+LE+   G+L   +Q+HG   E+ +  FM++
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGS 176
           LA  L    +  +IHRD+KP+NLL+        LKIADFG+   A SL+ R     +CG+
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGY---KGELKIADFGWSVHAPSLRRR----XMCGT 176
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y+ PE+++ + +D K DLW  G + ++ + G  PF   +  +  + IV   +L FPP 
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPP- 234
Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              LS   KDL  KLLR +P +RL  +    HP++ 
Sbjct: 235 --FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 140/262 (53%), Gaps = 3/262 (1%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +  ++G G+FSVV      + G E A K I   +L+ +  + L  E  I + + HP+I
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +RLHD I   G  +LI +   GG+L   I       E  A H ++Q+   +       ++
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQKYDA 192
           HRDLKP+NLLL +    AA+K+ADFG A  ++    A     G+P Y++PE+++   Y  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKL 251
             DLW+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + KDL  K+
Sbjct: 204 PVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 252 LRRNPVERLTFEEFFNHPFLSQ 273
           L  NP +R+T  E   HP++S 
Sbjct: 263 LTINPSKRITAAEALKHPWISH 284

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  155 bits (391), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 145/266 (54%), Gaps = 11/266 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I   RL+   +    E +  E+ IL+ I 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP+II LHDI E    + LILE   GG+L  ++     + E+ A  F+KQ+  G+  L  
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 130 NNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +  N  +K+ DFG A  ++     + + G+P ++APEI+  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD---CK 245
               +AD+WS+G I + L++G +PF G  + + L NI   + +++  D +  S      K
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---SAVNYDFDEEYFSNTSELAK 243
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D  ++LL ++P  R+T  +   H ++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 151/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP+II LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TAVSYDFDEEFFSQTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/311 (32%), Positives = 161/311 (51%), Gaps = 26/311 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEI--AMGRLNKKLQESLMSEIFILKRINHP 71
           R +G G +  V+  R +V G       AMK +  AM   N K      +E  IL+ + HP
Sbjct: 23  RVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            I+ L    +  GKL+LILEY  GG+L M ++R G   E+TA  ++ +++  L  L    
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +I+RDLKP+N++L   +    +K+ DFG  + S+    +    CG+  YMAPEI+    +
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +   D WS+GA+++ ++TG  PFTG N+ + +  I+K  +L+ PP    L+ + +DL +K
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNLPP---YLTQEARDLLKK 254
Query: 251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM------FSRSADDFPFYESKS 299
           LL+RN   RL        E   HPF      +++   ++        +S +D   ++SK 
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKF 314
Query: 300 VRDVAESSQDD 310
            R     S DD
Sbjct: 315 TRQTPVDSPDD 325

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 141/267 (52%), Gaps = 3/267 (1%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R   +Y +  ++G G+FSVV      + G E A   I   +L+ +  + L  E  I + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP+I+RLHD I   G  +LI +   GG+L   I       E  A H ++Q+   +    
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQL 187
              ++HR+LKP+NLLL +    AA+K+ADFG A  ++    A     G+P Y++PE+++ 
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKD 246
             Y    DLW+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + KD
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKD 246
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L  K+L  NP +R+T  E   HP++S 
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISH 273

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 143/279 (51%), Gaps = 11/279 (3%)
Query: 3   QATGRG---------RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK 53
           Q  GRG         +   +Y V  ++G G+FSVV    H+  G E A K I   +L+ +
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 54  LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA 113
             + L  E  I +++ HP+I+RLHD I+     +L+ +   GG+L   I       E  A
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
            H ++Q+   +     N ++HR+LKP+NLLL +    AA+K+ADFG A  +         
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
            G+P Y++PE+++   Y    D+W+ G IL+ L+ G  PF   +Q +L   I KA    +
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDY 249
Query: 234 P-PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           P P+   ++ + K L   +L  NP +R+T ++    P++
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPA 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 286

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 240
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 240
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 139/264 (52%), Gaps = 2/264 (0%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y V  ++G G+FSVV    H+  G E A K I   +L+ +  + L  E  I +++ HP+
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I+     +L+ +   GG+L   I       E  A H ++Q+   +     N +
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +HR+LKP+NLLL +    AA+K+ADFG A  +          G+P Y++PE+++   Y  
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKL 251
             D+W+ G IL+ L+ G  PF   +Q +L   I KA    +P P+   ++ + K L   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 252 LRRNPVERLTFEEFFNHPFLSQTQ 275
           L  NP +R+T ++    P++   +
Sbjct: 246 LTVNPKKRITADQALKVPWICNRE 269

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 286

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 151/295 (51%), Gaps = 12/295 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
              SA  KD  ++LL ++P +R+T ++   HP++      Q    +  + + + F
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKF 296

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 144/266 (54%), Gaps = 11/266 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I   RL+   +    E +  E+ IL+ I 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP+II LHDI E    + LILE   GG+L  ++     + E+ A  F+KQ+  G+  L  
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 130 NNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +  N  +K+ DFG A  ++     + + G+P ++APEI+  +
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD---CK 245
               +AD+WS+G I + L++G +PF G  + + L NI   + +++  D +  S      K
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---SAVNYDFDEEYFSNTSELAK 250
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D  ++LL ++P  R+   +   H ++
Sbjct: 251 DFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 138/260 (53%), Gaps = 2/260 (0%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y V  ++G G+FSVV    H+  G E A K I   +L+ +  + L  E  I +++ HP+
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I+     +L+ +   GG+L   I       E  A H ++Q+   +     N +
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +HR+LKP+NLLL +    AA+K+ADFG A  +          G+P Y++PE+++   Y  
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKL 251
             D+W+ G IL+ L+ G  PF   +Q +L   I KA    +P P+   ++ + K L   +
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 252 LRRNPVERLTFEEFFNHPFL 271
           L  NP +R+T ++    P++
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  152 bits (384), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 139/264 (52%), Gaps = 2/264 (0%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y V  ++G G+FSVV    H+  G E A K I   +L+ +  + L  E  I +++ HP+
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I+     +L+ +   GG+L   I       E  A H ++Q+   +     N +
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 125
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +HR+LKP+NLLL +    AA+K+ADFG A  +          G+P Y++PE+++   Y  
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKL 251
             D+W+ G IL+ L+ G  PF   +Q +L   I KA    +P P+   ++ + K L   +
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLIDSM 244
Query: 252 LRRNPVERLTFEEFFNHPFLSQTQ 275
           L  NP +R+T ++    P++   +
Sbjct: 245 LTVNPKKRITADQALKVPWICNRE 268

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  152 bits (384), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 286

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 147/274 (53%), Gaps = 16/274 (5%)
Query: 20  IGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           +G GSF  V+  R       G   AMK +    L  + +     E  IL  +NHP +++L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           H   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA GL  L    +I+RD
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRD 155
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
           LKP+N+LL   D+   +K+ DFG ++ ++     A + CG+  YMAPE++  Q +   AD
Sbjct: 156 LKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSAD 212
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
            WS G ++F+++TG  PF G ++ + +  I+KA +L  P   + LS + + L + L +RN
Sbjct: 213 WWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA-KLGMP---QFLSTEAQSLLRALFKRN 268
Query: 256 PVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           P  RL       EE   H F S    ++++R  +
Sbjct: 269 PANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREI 302

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 143/266 (53%), Gaps = 11/266 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I   RL    +    E +  E+ IL+ I 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP+II LHDI E    + LILE   GG+L  ++     + E+ A  F+KQ+  G+  L  
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 130 NNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +  N  +K+ DFG A  ++     + + G+P ++APEI+  +
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD---CK 245
               +AD+WS+G I + L++G +PF G  + + L NI   + +++  D +  S      K
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---SAVNYDFDEEYFSNTSELAK 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           D  ++LL ++P  R+   +   H ++
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 152/276 (55%), Gaps = 15/276 (5%)
Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLM 59
           +++   R   + D+ + R +G G F  V+ AR + +   +A+K +   +L K+ ++  L 
Sbjct: 3   LAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
            EI I   + HP+I+R+++      +++L+LE+   G+L   +Q+HG   E+ +  FM++
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGS 176
           LA  L    +  +IHRD+KP+NLL+        LKIADFG+   A SL+ R     +CG+
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGY---KGELKIADFGWSVHAPSLRRR----XMCGT 175
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y+ PE+++ + +D K DLW  G + ++ + G  PF   +  +  + IV   +L FPP 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPP- 233
Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              LS   KDL  KLLR +P +RL  +    HP++ 
Sbjct: 234 --FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 12/274 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              SA  KD  ++LL ++P +R+T ++   HP++
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 150/275 (54%), Gaps = 18/275 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +G GSF  V+  + ++ G++     AMK +    L  + +     E  IL  +NHP I++
Sbjct: 32  LGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           LH   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA  L  L    +I+R
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           DLKP+N+LL   D+   +K+ DFG ++ S+     A + CG+  YMAPE++  + +   A
Sbjct: 151 DLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D WS G ++F+++TG  PF G ++ + +  I+KA +L  P   + LS + + L + L +R
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMP---QFLSPEAQSLLRMLFKR 263
Query: 255 NPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           NP  RL       EE   H F S    ++++R  +
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 298

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 150/275 (54%), Gaps = 18/275 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +G GSF  V+  + ++ G++     AMK +    L  + +     E  IL  +NHP I++
Sbjct: 33  LGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           LH   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA  L  L    +I+R
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 151
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           DLKP+N+LL   D+   +K+ DFG ++ S+     A + CG+  YMAPE++  + +   A
Sbjct: 152 DLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 208
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D WS G ++F+++TG  PF G ++ + +  I+KA +L  P   + LS + + L + L +R
Sbjct: 209 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMP---QFLSPEAQSLLRMLFKR 264
Query: 255 NPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           NP  RL       EE   H F S    ++++R  +
Sbjct: 265 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 299

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 150/275 (54%), Gaps = 18/275 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +G GSF  V+  + ++ G++     AMK +    L  + +     E  IL  +NHP I++
Sbjct: 32  LGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           LH   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA  L  L    +I+R
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           DLKP+N+LL   D+   +K+ DFG ++ S+     A + CG+  YMAPE++  + +   A
Sbjct: 151 DLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR 254
           D WS G ++F+++TG  PF G ++ + +  I+KA +L  P   + LS + + L + L +R
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMP---QFLSPEAQSLLRMLFKR 263
Query: 255 NPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           NP  RL       EE   H F S    ++++R  +
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 148/279 (53%), Gaps = 14/279 (5%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-AMGRLNKKLQESLMSE-IFILKRINH 70
           D+   + IG GSF  V  ARH+      A+K +     L KK ++ +MSE   +LK + H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P ++ LH   +   KL+ +L+Y  GG+L  ++QR  C  E  A+ +  ++A+ L  L   
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQK 189
           N+++RDLKP+N+LL   D    + + DFG  + +++      T CG+P Y+APE++  Q 
Sbjct: 159 NIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           YD   D W +GA+L++++ G  PF   N  ++  NI+    L   P+   ++   + L +
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPN---ITNSARHLLE 271
Query: 250 KLLRRNPVERL----TFEEFFNHPFLSQTQPDQVFRSRM 284
            LL+++  +RL     F E  +H F S    D +   ++
Sbjct: 272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  150 bits (378), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 139/263 (52%), Gaps = 3/263 (1%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +Y +   IG G+FSVV        G E A K I   +L+ +  + L  E  I + + H +
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN 64
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD I   G  +L+ +   GG+L   I       E  A H ++Q+   +       +
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 124
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPLYMAPEIMQLQKYD 191
           +HRDLKP+NLLL +    AA+K+ADFG A  +Q    A     G+P Y++PE+++ + Y 
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYG 184
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQK 250
              D+W+ G IL+ L+ G  PF   +Q +L Q I KA    FP P+   ++ + K+L  +
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI-KAGAYDFPSPEWDTVTPEAKNLINQ 243
Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
           +L  NP +R+T  E   HP++ Q
Sbjct: 244 MLTINPAKRITAHEALKHPWVCQ 266

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 146/276 (52%), Gaps = 10/276 (3%)
Query: 8   GRV-VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
           GRV +G Y++G  +G G+F  V    H++ G +VA+K +   ++    +   +  EI  L
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           K   HPHII+L+ +I  P    +++EY  GG+L  YI +HG V E  A+   +Q+ + + 
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
               + ++HRDLKP+N+LL   D +   KIADFG +  +       T CGSP Y APE++
Sbjct: 126 YCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 186 QLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
             + Y   + D+WS G IL+ L+ G  PF   +   L + I +    + P   + L+   
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIP---EYLNRSV 238
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
             L   +L+ +P++R T ++   H +  Q  P  +F
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 146/285 (51%), Gaps = 12/285 (4%)
Query: 7   RGRVVGDYL-VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSE 61
           R   V DY   G ++GSG F+VV   R +  G + A K I   R     +    E +  E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + ILK I HP++I LH++ E    + LI E   GG+L  ++     + EE A  F+KQ+ 
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPL 178
            G+  L    + H DLKP+N++L   D N     +KI DFG A  +      + + G+P 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA- 237
           ++APEI+  +    +AD+WS+G I + L++G +PF G  + + L N V A    F  +  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYF 241
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
              SA  KD  ++LL ++P +R+T ++   HP++      Q   S
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 286

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  148 bits (373), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 149/276 (53%), Gaps = 10/276 (3%)
Query: 8   GRV-VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
           GRV +G Y++G  +G G+F  V   +H + G +VA+K +   ++    +   +  EI  L
Sbjct: 11  GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           K   HPHII+L+ +I  P  + +++EY  GG+L  YI ++G + E+ ++   +Q+ +G+ 
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
               + ++HRDLKP+N+LL   D +   KIADFG +  +         CGSP Y APE++
Sbjct: 131 YCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187
Query: 186 QLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
             + Y   + D+WS G IL+ L+ G  PF   +   L + I     + + P  + L+   
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTP--QYLNPSV 243
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
             L + +L+ +P++R T ++   H +  Q  P  +F
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLF 279

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 144/271 (53%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G++   +Q+     E+    ++ +LA
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 179
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 235
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TAVSYDFDEEFFSQTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TSVSYDFDEEFFSHTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TSVSYDFDEEFFSHTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TAVSYDFDEEFFSQTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/276 (31%), Positives = 145/276 (52%), Gaps = 10/276 (3%)
Query: 8   GRV-VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
           GRV +G Y++G  +G G+F  V    H++ G +VA+K +   ++    +   +  EI  L
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           K   HPHII+L+ +I  P    +++EY  GG+L  YI +HG V E  A+   +Q+ + + 
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
               + ++HRDLKP+N+LL   D +   KIADFG +  +         CGSP Y APE++
Sbjct: 126 YCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVI 182
Query: 186 QLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
             + Y   + D+WS G IL+ L+ G  PF   +   L + I +    + P   + L+   
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIP---EYLNRSV 238
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
             L   +L+ +P++R T ++   H +  Q  P  +F
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 15/280 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKK--LQESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I     R +++   +E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 130 NNLIHRDLKPQNLLLCTDDDNAA---LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             + H DLKP+N++L   D N     +K+ DFG A  ++     + + G+P ++APEI+ 
Sbjct: 134 KKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD--- 243
            +    +AD+WS+G I + L++G +PF G  + + L NI   T + +  D +  S     
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TSVSYDFDEEFFSHTSEL 248
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
            KD  +KLL +   +RLT +E   HP+++     Q    R
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I     A+G   +     ++ +EI ILK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I     A+G   +     ++ +EI ILK
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 70  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 248
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 249 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 287

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I     A+G   +     ++ +EI ILK
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 77  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 255
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 256 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 294

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I     A+G   +     ++ +EI ILK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I     A+G   +     ++ +EI ILK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 200
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 256
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 257 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 16  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 136 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 191
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 247
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 248 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 278

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + IG+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GGD+  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +K+ADFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + IG+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GGD+  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +K+ADFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 142/267 (53%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P    +TLCG+  Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRDTLCGTLDYLPPEMI 179
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 235
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 151/275 (54%), Gaps = 10/275 (3%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILK 66
           G  +G+Y + + +G GSF  V  A H   G +VA+K I    L K  +Q  +  EI  L+
Sbjct: 10  GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR 69
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            + HPHII+L+D+I+   ++ +++EY  G +L  YI +   + E+ A+ F +Q+ + ++ 
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEY 128
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
              + ++HRDLKP+NLLL   D++  +KIADFG +  +      +T CGSP Y APE++ 
Sbjct: 129 CHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 185
Query: 187 LQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            + Y   + D+WS G IL+ ++  + PF   +   L +NI  +  ++  P  K LS    
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--SNGVYTLP--KFLSPGAA 241
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
            L +++L  NP+ R++  E     +     P+ + 
Sbjct: 242 GLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 276

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 151/275 (54%), Gaps = 10/275 (3%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILK 66
           G  +G+Y + + +G GSF  V  A H   G +VA+K I    L K  +Q  +  EI  L+
Sbjct: 9   GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR 68
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            + HPHII+L+D+I+   ++ +++EY  G +L  YI +   + E+ A+ F +Q+ + ++ 
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEY 127
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
              + ++HRDLKP+NLLL   D++  +KIADFG +  +      +T CGSP Y APE++ 
Sbjct: 128 CHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 184
Query: 187 LQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            + Y   + D+WS G IL+ ++  + PF   +   L +NI  +  ++  P  K LS    
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--SNGVYTLP--KFLSPGAA 240
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
            L +++L  NP+ R++  E     +     P+ + 
Sbjct: 241 GLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 177
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 233
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 9/269 (3%)
Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEI 62
            + R   + D+ +GR +G G F  V+ AR R     +A+K +   +L K  ++  L  E+
Sbjct: 4   GSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREV 63
Query: 63  FILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
            I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L       +IHRD+KP+NLLL +   N  LKIADFG++    P    +TLCG+  Y+ P
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLLGS---NGELKIADFGWSVH-APSSRRDTLCGTLDYLPP 179
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           E+++ + +D K DLWS+G + ++ + G  PF      +  + I +  E  FP     ++ 
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISR-VEFTFP---DFVTE 235
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
             +DL  +LL+ N  +RLT  E   HP++
Sbjct: 236 GARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 179
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 235
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 159/299 (53%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G   TLCG+P Y+APEI+  + Y+   D 
Sbjct: 188 LKPENLLI---DQQGYIQVTDFGFAKRV--KGATWTLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 243 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 298
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 299 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 357

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 141/263 (53%), Gaps = 9/263 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+  ++IG GSF      +    G +  +KEI + R++ K +E    E+ +L  + HP+I
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++  +  E  G L+++++YC+GGDL   I  Q+     E+    +  Q+   L+ + D  
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           ++HRD+K QN+ L  D     +++ DFG AR L     LA    G+P Y++PEI + + Y
Sbjct: 146 ILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           + K+D+W++G +L++L T K  F   +   L+  I+  +   FPP +   S D + L  +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSLHYSYDLRSLVSQ 259
Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
           L +RNP +R +        F+++
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAK 282

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  145 bits (366), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 151/275 (54%), Gaps = 10/275 (3%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILK 66
           G  +G+Y + + +G GSF  V  A H   G +VA+K I    L K  +Q  +  EI  L+
Sbjct: 4   GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR 63
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            + HPHII+L+D+I+   ++ +++EY  G +L  YI +   + E+ A+ F +Q+ + ++ 
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEY 122
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
              + ++HRDLKP+NLLL   D++  +KIADFG +  +      +T CGSP Y APE++ 
Sbjct: 123 CHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 179
Query: 187 LQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            + Y   + D+WS G IL+ ++  + PF   +   L +NI  +  ++  P  K LS    
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--SNGVYTLP--KFLSPGAA 235
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
            L +++L  NP+ R++  E     +     P+ + 
Sbjct: 236 GLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 142/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 179
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE ++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 235
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 236 EGARDLISRLLKHNPSQRPXLREVLEHPWIT 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 141/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 140/265 (52%), Gaps = 6/265 (2%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y +  ++G+G+F VV     R  G   A K +     + K  E++  EI  +  + 
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLR 106
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLR 128
           HP ++ LHD  E   ++ +I E+  GG+L   +   H  + E+ A  +M+Q+  GL  + 
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
           +NN +H DLKP+N++  T   N  LK+ DFG    L P+   +   G+  + APE+ + +
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 225
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDL 247
                 D+WSVG + + L++G +PF G N  + L+N VK+ + +    A   +S D KD 
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-VKSCDWNMDDSAFSGISEDGKDF 284
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLS 272
            +KLL  +P  R+T  +   HP+L+
Sbjct: 285 IRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 143/272 (52%), Gaps = 9/272 (3%)
Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMS 60
           +  + R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  
Sbjct: 2   AMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           E+ I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
           A  L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYL 177
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
            PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFV 233
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +   +DL  +LL+ NP +R    E   HP+++
Sbjct: 234 TEGARDLISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA++ I     A+G   +     ++ +EI ILK
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 210 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 388
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 389 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 427

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 150/272 (55%), Gaps = 10/272 (3%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRIN 69
           +G+Y + + +G GSF  V  A H   G +VA+K I    L K  +Q  +  EI  L+ + 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HPHII+L+D+I+   ++ +++EY  G +L  YI +   + E+ A+ F +Q+ + ++    
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
           + ++HRDLKP+NLLL   D++  +KIADFG +  +      +T CGSP Y APE++  + 
Sbjct: 122 HKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 190 YDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y   + D+WS G IL+ ++  + PF   +   L +NI  +  ++  P  K LS     L 
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--SNGVYTLP--KFLSPGAAGLI 234
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
           +++L  NP+ R++  E     +     P+ + 
Sbjct: 235 KRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 153/279 (54%), Gaps = 11/279 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQE-SLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA++ I     A+G   +     ++ +EI ILK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 186 --QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSA 242
                 Y+   D WS+G ILF  ++G  PF+       L++ + + + +F P+    +S 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              DL +KLL  +P  R T EE   HP+L      + F+
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 148/278 (53%), Gaps = 14/278 (5%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-----------KLQE 56
           G++   Y   R++GSG++  V   + +   +E A+K I   + +K           K  E
Sbjct: 32  GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 57  SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKH 115
            + +EI +LK ++HP+II+L D+ E     +L+ E+ +GG+L    I RH    E  A +
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAAN 150
Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
            MKQ+ +G+  L  +N++HRD+KP+N+LL   +    +KI DFG +             G
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           +  Y+APE+++ +KY+ K D+WS G I++ L+ G  PF G N   +++ + K        
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           D K +S + K+L + +L  +  +R T EE  N  ++ +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  145 bits (365), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 140/265 (52%), Gaps = 6/265 (2%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y +  ++G+G+F VV     R  G   A K +     + K  E++  EI  +  + 
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLR 212
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLR 128
           HP ++ LHD  E   ++ +I E+  GG+L   +   H  + E+ A  +M+Q+  GL  + 
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
           +NN +H DLKP+N++  T   N  LK+ DFG    L P+   +   G+  + APE+ + +
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDL 247
                 D+WSVG + + L++G +PF G N  + L+N VK+ + +    A   +S D KD 
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-VKSCDWNMDDSAFSGISEDGKDF 390
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLS 272
            +KLL  +P  R+T  +   HP+L+
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLT 415

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLP 177
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 233
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P    + LCG+  Y+ 
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRDDLCGTLDYLP 200
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 256
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 257 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  145 bits (365), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 141/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 2   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ PE++
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMI 177
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 178 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 233
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 234 DLISRLLKHNPSQRPMLREVLEHPWIT 260

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 9/269 (3%)
Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEI 62
            + R   + D+ +GR +G G F  V+ AR R     +A+K +   +L K  ++  L  E+
Sbjct: 4   GSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREV 63
Query: 63  FILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
            I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA 
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L       +IHRD+KP+NLLL +   N  LKIADFG++    P     TLCG+  Y+ P
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLLGS---NGELKIADFGWSVH-APSSRRTTLCGTLDYLPP 179
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           E+++ + +D K DLWS+G + ++ + G  PF      +  + I +  E  FP     ++ 
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-EFTFP---DFVTE 235
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
             +DL  +LL+ N  +RLT  E   HP++
Sbjct: 236 GARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + IG+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +K+ADFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           R +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  I + +N P +++L
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L+++LEY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +K+ADFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIA+FG++    P     TLCG+  Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVH-APSSRRTTLCGTLDYLP 176
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 232
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 233 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 139/261 (53%), Gaps = 9/261 (3%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHP 71
           D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I   + HP
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L       
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRD+KP+NLLL +  +   LKIADFG++    P     TLCG+  Y+ PE+++ + +D
Sbjct: 126 VIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +DL  +L
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGARDLISRL 237
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ NP +R    E   HP+++
Sbjct: 238 LKHNPSQRPMLREVLEHPWIT 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 142/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRXXLCGTLDYLP 176
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 232
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 233 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++Q+  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYQMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 147/281 (52%), Gaps = 28/281 (9%)
Query: 10  VVGDYLVGRQI-GSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQESLMSEIF 63
           V  DY + +Q+ G G    V    HR  G + A+K +     A   ++   Q S      
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS------ 60
Query: 64  ILKRINHPHIIRLHDIIEV--PGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFM 117
                  PHI+ + D+ E    GK  L +I+E  +GG+L   IQ  G     E  A   M
Sbjct: 61  -----GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 115
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
           + +   +Q L  +N+ HRD+KP+NLL  + + +A LK+ DFGFA+      L +T C +P
Sbjct: 116 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTP 174
Query: 178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF---TGSNQIQLLQNIVKATELHFP 234
            Y+APE++  +KYD   D+WS+G I++ L+ G  PF   TG      ++  ++  +  FP
Sbjct: 175 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 234
Query: 235 -PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
            P+   +S D K L + LL+ +P ERLT  +F NHP+++Q+
Sbjct: 235 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 147/281 (52%), Gaps = 28/281 (9%)
Query: 10  VVGDYLVGRQI-GSGSFSVVWHARHRVHGTEVAMKEI-----AMGRLNKKLQESLMSEIF 63
           V  DY + +Q+ G G    V    HR  G + A+K +     A   ++   Q S      
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS------ 79
Query: 64  ILKRINHPHIIRLHDIIEV--PGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFM 117
                  PHI+ + D+ E    GK  L +I+E  +GG+L   IQ  G     E  A   M
Sbjct: 80  -----GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
           + +   +Q L  +N+ HRD+KP+NLL  + + +A LK+ DFGFA+      L +T C +P
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTP 193
Query: 178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF---TGSNQIQLLQNIVKATELHFP 234
            Y+APE++  +KYD   D+WS+G I++ L+ G  PF   TG      ++  ++  +  FP
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253
Query: 235 -PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
            P+   +S D K L + LL+ +P ERLT  +F NHP+++Q+
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRAALCGTLDYLPPEMI 181
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 237
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 142/274 (51%), Gaps = 17/274 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLN----KKLQESLMSEIFILKRIN-HP 71
           +G G  SVV    H+    E A+K I +   G  +    ++L+E+ + E+ IL++++ HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +II+L D  E      L+ +  K G+L  Y+     + E+  +  M+ L   +  L   N
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK-- 189
           ++HRDLKP+N+LL   DD+  +K+ DFGF+  L P     ++CG+P Y+APEI++     
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
               Y  + D+WS G I++ L+ G  PF    Q+ +L+ I+        P+    S   K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           DL  + L   P +R T EE   HPF  Q   ++V
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 143/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIA+FG++    P     TLCG+  Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVH-APSSRRTTLCGTLDYLP 177
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 233
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTELCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 240
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 241 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 139/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 153
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D+   +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 154 LKPENLLI---DEQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 208
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 209 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 264
Query: 257 VERL 260
            +R 
Sbjct: 265 TKRF 268

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 141/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P    + LCG+  Y+ PE++
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRDDLCGTLDYLPPEMI 181
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 237
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 188
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 8   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTDLCGTLDYLPPEMI 183
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 239
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 204
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 205 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 264
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 265 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 129
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 130 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 189
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 190 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 190
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 191 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTDLCGTLDYLPPEMI 179
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 235
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRAALCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 142/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRXXLCGTLDYLP 177
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 233
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIXNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 136
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 137 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 196
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 197 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTDLCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 17/274 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLN----KKLQESLMSEIFILKRIN-HP 71
           +G G  SVV    H+    E A+K I +   G  +    ++L+E+ + E+ IL++++ HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +II+L D  E      L+ +  K G+L  Y+     + E+  +  M+ L   +  L   N
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK-- 189
           ++HRDLKP+N+LL   DD+  +K+ DFGF+  L P      +CG+P Y+APEI++     
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
               Y  + D+WS G I++ L+ G  PF    Q+ +L+ I+        P+    S   K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           DL  + L   P +R T EE   HPF  Q   ++V
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G   TLCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTDLCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 134
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 135 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 194
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 195 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 75/214 (35%), Positives = 120/214 (56%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 136 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 195
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 196 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL 260
            +R 
Sbjct: 278 TKRF 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 188 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 243 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 298
Query: 257 VERL 260
            +R 
Sbjct: 299 TKRF 302

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRXXLCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADEPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRAALCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQDTYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  142 bits (359), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 152
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G   TLCG+P Y+APEI+  + Y+   D 
Sbjct: 153 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEIILSKGYNKAVDW 207
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 208 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 263
Query: 257 VERL 260
            +R 
Sbjct: 264 TKRF 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P      LCG+  Y+ PE++
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTXLCGTLDYLPPEMI 178
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 234
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 160 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 215 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 270
Query: 257 VERL 260
            +R 
Sbjct: 271 TKRF 274

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 161
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 162 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 216
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 217 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 272
Query: 257 VERL 260
            +R 
Sbjct: 273 TKRF 276

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 188 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 243 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 298
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 299 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 357

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 9/267 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NLLL +  +   LKIADFG++    P     TL G+  Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMI 179
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++   +
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVTEGAR 235
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DL  +LL+ NP +R    E   HP+++
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 158/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLII---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIIISKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 138/268 (51%), Gaps = 17/268 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAM---GRLN----KKLQESLMSEIFILKRIN-HP 71
           +G G  SVV    H+    E A+K I +   G  +    ++L+E+ + E+ IL++++ HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +II+L D  E      L+ +  K G+L  Y+     + E+  +  M+ L   +  L   N
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK-- 189
           ++HRDLKP+N+LL   DD+  +K+ DFGF+  L P      +CG+P Y+APEI++     
Sbjct: 132 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
               Y  + D+WS G I++ L+ G  PF    Q+ +L+ I+        P+    S   K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           DL  + L   P +R T EE   HPF  Q
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 138/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 160 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 215 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 270
Query: 257 VERL 260
            +R 
Sbjct: 271 TKRF 274

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 135/237 (56%), Gaps = 10/237 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQ 274

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 142/271 (52%), Gaps = 9/271 (3%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSE 61
           ++  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           + I   + HP+I+RL+       +++LILEY   G++   +Q+     E+    ++ +LA
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
             L       +IHRD+KP+NLLL +  +   LKIADFG++    P      L G+  Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRXXLXGTLDYLP 179
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           PE+++ + +D K DLWS+G + ++ + GK PF  +N  Q     +   E  FP     ++
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFP---DFVT 235
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              +DL  +LL+ NP +R    E   HP+++
Sbjct: 236 EGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 119/214 (55%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 128
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+           C +P Y+APE+
Sbjct: 129 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV 188
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 189 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+AP I+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPAIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +++ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLMI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 156/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P + +L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 144/267 (53%), Gaps = 6/267 (2%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G V   Y +  ++GSG+F VV     +  G     K I       K   ++ +EI I+ 
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMN 103
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQ 125
           +++HP +I LHD  E   ++ LILE+  GG+L   I      + E    ++M+Q   GL+
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +++++H D+KP+N++ C     +++KI DFG A  L P  + +    +  + APEI+
Sbjct: 164 HMHEHSIVHLDIKPENIM-CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADC 244
             +      D+W++G + + L++G +PF G + ++ LQN VK  +  F  DA   +S + 
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-VKRCDWEFDEDAFSSVSPEA 281
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFL 271
           KD  + LL++ P +RLT  +   HP+L
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 156/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P + +L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 156/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K  Q E  ++E  IL+ +N P + +L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFGFA+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 168 LKPENLMI---DQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 278
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 279 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 337

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 143/268 (53%), Gaps = 11/268 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + + IGSG+F V    R +     VA+K I  G   +K+ E++  EI   + + HP+I
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNI 76
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +++EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 136
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKI DFG+++S       ++  G+P Y+APE++  ++YD
Sbjct: 137 HRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 193
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFP-PDAKILSADCKDLC 248
            K AD+WS G  L+ ++ G  PF    + +   + I +   + +  PD   +S +C+ L 
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 253
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            ++   +P +R++  E  NH +  +  P
Sbjct: 254 SRIFVADPAKRISIPEIRNHEWFLKNLP 281

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 144/266 (54%), Gaps = 9/266 (3%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFIL 65
           R   + D+ +GR +G G F  V+ AR +     VA+K +   ++ K+ ++  L  EI I 
Sbjct: 18  RHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
             ++HP+I+RL++      +++LILEY   G+L   +Q+     E+     M++LA  L 
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALM 137
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +IHRD+KP+NL          LKIADFG++    P    +T+CG+  Y+ PE++
Sbjct: 138 YCHGKKVIHRDIKPENL---LLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMI 193
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + + ++ K DLW +G + ++L+ G  PF  ++  +  + IVK  +L FP     +    +
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK-VDLKFPAS---VPTGAQ 249
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
           DL  KLLR NP ERL   +   HP++
Sbjct: 250 DLISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 137/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    L G+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLAGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL 260
            +R 
Sbjct: 278 TKRF 281

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 157/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    LCG+P  +APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLCGTPEALAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 140/256 (54%), Gaps = 16/256 (6%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHI 73
           L  + +G GSFS+     H+      A+K I+     K+++ +   EI  LK    HP+I
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----KRMEANTQKEITALKLCEGHPNI 68
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++LH++        L++E   GG+L   I++     E  A + M++L + +  + D  ++
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDA 192
           HRDLKP+NLL   ++DN  +KI DFGFAR   P     +T C +  Y APE++    YD 
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 193 KADLWSVGAILFQLVTGKTPF-------TGSNQIQLLQNIVKATELHFPPDA-KILSADC 244
             DLWS+G IL+ +++G+ PF       T ++ +++++ I K  +  F  +A K +S + 
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DFSFEGEAWKNVSQEA 247
Query: 245 KDLCQKLLRRNPVERL 260
           KDL Q LL  +P +RL
Sbjct: 248 KDLIQGLLTVDPNKRL 263

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 148/283 (52%), Gaps = 11/283 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + + IG+G+F V    R +     VA+K I  G   +K+ E++  EI   + + HP+I
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERG---EKIDENVKREIINHRSLRHPNI 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +++EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVA 137
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKIADFG++++       ++  G+P Y+APE++  ++YD
Sbjct: 138 HRDLKLENTLL---DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFP-PDAKILSADCKDLC 248
            K AD+WS G  L+ ++ G  PF    + +   + I +   + +  PD   +S +C+ L 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADD 291
            ++   +P +R++  E  NH +  +  P  +      +   D+
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDE 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 156/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K K  E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +K+ DFG A+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLMI---DQQGYIKVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 137/244 (56%), Gaps = 10/244 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H+  G   AMK +   ++ K  Q E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NLL+   D    +++ DFGFA+ +  +G    L G+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWXLXGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL 260
            +R 
Sbjct: 278 TKRF 281

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A +  G+  Y++PE++  +
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP   +      +DL 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---EKFFPKARDLV 266
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 267 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 6/269 (2%)
Query: 7   RGRVVGDYLVGRQ--IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           +G V   Y V +   +G G F  V        G ++A K I    +  K  E + +EI +
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISV 139
Query: 65  LKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAG 123
           + +++H ++I+L+D  E    + L++EY  GG+L    I     + E     FMKQ+  G
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ +    ++H DLKP+N+L C + D   +KI DFG AR  +PR   +   G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENIL-CVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
           ++         D+WSVG I + L++G +PF G N  + L NI+         + + +S +
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
            K+   KLL +    R++  E   HP+LS
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 263
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A +  G+  Y++PE++  +
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 262
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 263 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A +  G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP   +      +DL 
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---EKFFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP   +      +DL 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---EKFFPKARDLV 266
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 267 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 263
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 146/283 (51%), Gaps = 11/283 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + + IGSG+F V    R +     VA+K I  G   +K+  ++  EI   + + HP+I
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIAANVKREIINHRSLRHPNI 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +++EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 137
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKI DFG+++S       ++  G+P Y+APE++  ++YD
Sbjct: 138 HRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFP-PDAKILSADCKDLC 248
            K AD+WS G  L+ ++ G  PF    + +   + I +   + +  PD   +S +C+ L 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADD 291
            ++   +P +R++  E  NH +  +  P  +      +   D+
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDE 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---AAFFPKARDLV 268
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 269 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP   +      +DL 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---EKFFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 263
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 156/299 (52%), Gaps = 24/299 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRL 76
           + +G+GSF  V   +H   G   AMK +   ++ K K  E  ++E  IL+ +N P +++L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +LI+RD
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           LKP+NL++   D    +++ DFG A+ +  +G    LCG+P Y+APEI+  + Y+   D 
Sbjct: 167 LKPENLMI---DQQGYIQVTDFGLAKRV--KGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++++  G  PF     IQ+ + IV + ++ FP      S+D KDL + LL+ + 
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSH---FSSDLKDLLRNLLQVDL 277
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM-------FSRSAD--DFPFYESKSVR 301
            +R         +  NH + + T    +++ ++       F    D  +F  YE + +R
Sbjct: 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 240
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 241 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP   +      +DL 
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFP---EKFFPKARDLV 270
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 271 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 247
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 248 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 242
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 243 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 146/283 (51%), Gaps = 11/283 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + + IGSG+F V    R +     VA+K I  G   +K+ E++  EI   + + HP+I
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNI 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +++EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 137
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKI  FG+++S       ++  G+P Y+APE++  ++YD
Sbjct: 138 HRDLKLENTLL---DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFP-PDAKILSADCKDLC 248
            K AD+WS G  L+ ++ G  PF    + +   + I +   + +  PD   +S +C+ L 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADD 291
            ++   +P +R++  E  NH +  +  P  +      +   D+
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDE 297

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 241
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 243
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 244 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 140/270 (51%), Gaps = 17/270 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 262
Query: 249 QKLLRRNPVERLTFEEFFN------HPFLS 272
           +KLL  +  +RL  EE         HPF  
Sbjct: 263 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 139/269 (51%), Gaps = 13/269 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IGSG+F V    R ++    VA+K I  G     + E++  EI   + + HP+I
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRHPNI 78
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +I+EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKI DFG+++S       ++  G+P Y+APE++  Q+YD
Sbjct: 139 HRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK---ATELHFPPDAKILSADCKDL 247
            K AD+WS G  L+ ++ G  PF    + +  +  ++   + +   P D +I S +C  L
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI-SPECCHL 254
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             ++   +P  R++  E   H +  +  P
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLP 283

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 144/271 (53%), Gaps = 7/271 (2%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G +   ++  R++GSG+F  V     R  G E  +K I   R    + E + +EI +LK
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEAEIEVLK 75
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAA 122
            ++HP+II++ ++ E    +++++E C+GG+L   I     R   + E      MKQ+  
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L      +++H+DLKP+N+L      ++ +KI DFG A   +    +    G+ LYMAP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           E+ + +    K D+WS G +++ L+TG  PFTG++ ++ +Q      E ++  + + L+ 
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPNYAVECRPLTP 253
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              DL +++L ++P  R +  +  +H +  Q
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 145/283 (51%), Gaps = 11/283 (3%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y + + IGSG+F V    R +     VA+K I  G   +K+ E++  EI   + + HP+I
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNI 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +R  ++I  P  L +++EY  GG+L   I   G   E+ A+ F +QL +G+       + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 137
Query: 134 HRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           HRDLK +N LL   D + A  LKI  FG+++S       +   G+P Y+APE++  ++YD
Sbjct: 138 HRDLKLENTLL---DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 192 AK-ADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFP-PDAKILSADCKDLC 248
            K AD+WS G  L+ ++ G  PF    + +   + I +   + +  PD   +S +C+ L 
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADD 291
            ++   +P +R++  E  NH +  +  P  +      +   D+
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDE 297

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS    AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDFPEK---FFPKARDLV 263
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 3/278 (1%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHI 73
           L  +++G G F+VV     +  G E A K +   R  +  +  ++ EI +L+     P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDL-SMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I LH++ E   ++ LILEY  GG++ S+ + +    V E      +KQ+  G+  L  NN
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++H DLKPQN+LL +      +KI DFG +R +        + G+P Y+APEI+      
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT 211
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D+W++G I + L+T  +PF G +  +   NI +    +       +S    D  Q L
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 252 LRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSA 289
           L +NP +R T E   +H +L Q   + +F     S S+
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++  V+ A++R     VA+K + +   ++ +  S + EI +LK + H +I+RLHD
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
           ++    KL L+ E+C   DL  Y    +G +  E  K F+ QL  GL      N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQK-YDAKAD 195
           KPQNLL+   + N  LK+ADFG AR+   P         +  Y  P+++   K Y    D
Sbjct: 128 KPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 196 LWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVK----ATELHFP-----PDAKI------ 239
           +WS G I  +L     P F G++    L+ I +     TE  +P     PD K       
Sbjct: 185 MWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 240 ----------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                     L+A  +DL Q LL+ NPV+R++ EE   HP+ S   P
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 74/214 (34%), Positives = 114/214 (53%), Gaps = 10/214 (4%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L ++ E   GG+L   IQ  G     E  A    K +   +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAI 174
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE+
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
           +  +KYD   D WS+G I + L+ G  PF  ++ + +    +  ++  +  FP P+   +
Sbjct: 235 LGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R T  EF NHP++ Q+
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  +   I+K  E  FP          +DL 
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-LEYDFPEK---FFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 140/277 (50%), Gaps = 14/277 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           Y+V   IG GS+S      H+    E A+K I       K +     EI IL R   HP+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI------DKSKRDPSEEIEILLRYGQHPN 82
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           II L D+ +    ++L+ E  +GG+L   I R     E  A   +  +   ++ L    +
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 133 IHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           +HRDLKP N+L   +  N   L+I DFGFA+ L+   GL  T C +  ++APE+++ Q Y
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           D   D+WS+G +L+ ++ G TPF         ++L  I          +   +S   KDL
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDL 262
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
             K+L  +P +RLT ++   HP++  TQ D++ +S++
Sbjct: 263 VSKMLHVDPHQRLTAKQVLQHPWV--TQKDKLPQSQL 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 140/277 (50%), Gaps = 14/277 (5%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           Y+V   IG GS+S      H+    E A+K I       K +     EI IL R   HP+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI------DKSKRDPSEEIEILLRYGQHPN 82
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           II L D+ +    ++L+ E  +GG+L   I R     E  A   +  +   ++ L    +
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 133 IHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           +HRDLKP N+L   +  N   L+I DFGFA+ L+   GL  T C +  ++APE+++ Q Y
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           D   D+WS+G +L+ ++ G TPF         ++L  I          +   +S   KDL
Sbjct: 203 DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDL 262
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
             K+L  +P +RLT ++   HP++  TQ D++ +S++
Sbjct: 263 VSKMLHVDPHQRLTAKQVLQHPWV--TQKDKLPQSQL 297

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 136/271 (50%), Gaps = 18/271 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG+GS+      R +  G  +  KE+  G + +  ++ L+SE+ +L+ + HP+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQV 126
           I+R +D I       L++++EYC+GGDL+  I +       + EE     M QL   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 127 LR-----DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYM 180
                   + ++HRDLKP N+ L   D    +K+ DFG AR L      A+T  G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE M    Y+ K+D+WS+G +L++L     PFT  +Q +L   I +      P      
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---Y 240
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           S +  ++  ++L      R + EE   +P +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 17/269 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+ +   ++ E  ++ R++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P   +  A    G+  Y++PE++  +
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  +   I+K  E  FP          +DL 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-LEYDFPEK---FFPKARDLV 265
Query: 249 QKLLRRNPVERLTFEEFFN------HPFL 271
           +KLL  +  +RL  EE         HPF 
Sbjct: 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 141/272 (51%), Gaps = 21/272 (7%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSE 61
           R +  Y+ GR +G G F+  +        T++  KE+  G++  K        +E + +E
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI------TDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           I I K +++PH++  H   E    ++++LE C+   L    +R   V E  A++FM+Q  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
            G+Q L +N +IHRDLK  NL L   +D+  +KI DFG A  ++  G   +TLCG+P Y+
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYI 209
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APE++  + +  + D+WS+G IL+ L+ GK PF  S   +    I K  E   P   + +
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP---RHI 265
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +     L +++L  +P  R +  E     F +
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++  V+ A++R     VA+K + +   ++ +  S + EI +LK + H +I+RLHD
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
           ++    KL L+ E+C   DL  Y    +G +  E  K F+ QL  GL      N++HRDL
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQK-YDAKAD 195
           KPQNLL+   + N  LK+A+FG AR+   P         +  Y  P+++   K Y    D
Sbjct: 128 KPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 196 LWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVK----ATELHFP-----PDAKI------ 239
           +WS G I  +L     P F G++    L+ I +     TE  +P     PD K       
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 240 ----------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                     L+A  +DL Q LL+ NPV+R++ EE   HP+ S   P
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           D+ + R IG GS++ V   R     R++   V  KE+     + +  + + +E  + ++ 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN---DDEDIDWVQTEKHVFEQA 109
Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
            NHP ++ LH   +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQ 186
            +  +I+RDLK  N+LL   D    +K+ D+G  +  L+P     T CG+P Y+APEI++
Sbjct: 170 HERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPF--TGS------NQIQLLQNIVKATELHFPPDAK 238
            + Y    D W++G ++F+++ G++PF   GS      N    L  ++   ++  P   +
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---R 283
Query: 239 ILSADCKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            LS     + +  L ++P ERL       F +   HPF      D +
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG+GS+      R +  G  +  KE+  G + +  ++ L+SE+ +L+ + HP+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQV 126
           I+R +D I       L++++EYC+GGDL+  I +       + EE     M QL   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 127 LR-----DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYM 180
                   + ++HRDLKP N+ L   D    +K+ DFG AR L      A+   G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE M    Y+ K+D+WS+G +L++L     PFT  +Q +L   I +      P      
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---Y 240
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           S +  ++  ++L      R + EE   +P +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 138/272 (50%), Gaps = 5/272 (1%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEI 62
           Q + +G +   Y +   IG GS+  V  A  +  GT +      + +   +  +    EI
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQK--GTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 63  FILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
            I+K ++HP+IIRL++  E    ++L++E C GG+L   +       E  A   MK + +
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            +      N+ HRDLKP+N L  TD  ++ LK+ DFG A   +P  +  T  G+P Y++P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILS 241
           ++++   Y  + D WS G +++ L+ G  PF+     +++  I + T   FP  D   +S
Sbjct: 195 QVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT-FTFPEKDWLNVS 252
Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              + L ++LL ++P +R+T  +   H +  +
Sbjct: 253 PQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG+GS+      R +  G  +  KE+  G + +  ++ L+SE+ +L+ + HP+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQV 126
           I+R +D I       L++++EYC+GGDL+  I +       + EE     M QL   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 127 LR-----DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYM 180
                   + ++HRDLKP N+ L   D    +K+ DFG AR L      A+   G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE M    Y+ K+D+WS+G +L++L     PFT  +Q +L   I +      P      
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---Y 240
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           S +  ++  ++L      R + EE   +P +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 140/272 (51%), Gaps = 21/272 (7%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSE 61
           R +  Y+ GR +G G F+  +        T++  KE+  G++  K        +E + +E
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI------TDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           I I K +++PH++  H   E    ++++LE C+   L    +R   V E  A++FM+Q  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
            G+Q L +N +IHRDLK  NL L   +D+  +KI DFG A  ++  G   + LCG+P Y+
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYI 209
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APE++  + +  + D+WS+G IL+ L+ GK PF  S   +    I K  E   P   + +
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP---RHI 265
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +     L +++L  +P  R +  E     F +
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 140/272 (51%), Gaps = 21/272 (7%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSE 61
           R +  Y+ GR +G G F+  +        T++  KE+  G++  K        +E + +E
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEI------TDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           I I K +++PH++  H   E    ++++LE C+   L    +R   V E  A++FM+Q  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
            G+Q L +N +IHRDLK  NL L   +D+  +KI DFG A  ++  G   + LCG+P Y+
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 209
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APE++  + +  + D+WS+G IL+ L+ GK PF  S   +    I K  E   P   + +
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP---RHI 265
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +     L +++L  +P  R +  E     F +
Sbjct: 266 NPVASALIRRMLHADPTLRPSVAELLTDEFFT 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 140/272 (51%), Gaps = 21/272 (7%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSE 61
           R +  Y+ GR +G G F+  +        T++  KE+  G++  K        +E + +E
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEI------TDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 76
Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           I I K +++PH++  H   E    ++++LE C+   L    +R   V E  A++FM+Q  
Sbjct: 77  IAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 136
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
            G+Q L +N +IHRDLK  NL L   +D+  +KI DFG A  ++  G   + LCG+P Y+
Sbjct: 137 QGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 193
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APE++  + +  + D+WS+G IL+ L+ GK PF  S   +    I K  E   P   + +
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-KKNEYSVP---RHI 249
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
           +     L +++L  +P  R +  E     F +
Sbjct: 250 NPVASALIRRMLHADPTLRPSVAELLTDEFFT 281

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 136 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAV 192
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           D+ + R IG GS++ V   R     R++  +V  KE+     + +  + + +E  + ++ 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN---DDEDIDWVQTEKHVFEQA 77
Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
            NHP ++ LH   +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQ 186
            +  +I+RDLK  N+LL   D    +K+ D+G  +  L+P       CG+P Y+APEI++
Sbjct: 138 HERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPF--TGS------NQIQLLQNIVKATELHFPPDAK 238
            + Y    D W++G ++F+++ G++PF   GS      N    L  ++   ++  P   +
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---R 251
Query: 239 ILSADCKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            +S     + +  L ++P ERL       F +   HPF      D +
Sbjct: 252 SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMM 298

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           D+ + R IG GS++ V   R     R++  +V  KE+     + +  + + +E  + ++ 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN---DDEDIDWVQTEKHVFEQA 62
Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
            NHP ++ LH   +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQ 186
            +  +I+RDLK  N+LL   D    +K+ D+G  +  L+P       CG+P Y+APEI++
Sbjct: 123 HERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPF--TGS------NQIQLLQNIVKATELHFPPDAK 238
            + Y    D W++G ++F+++ G++PF   GS      N    L  ++   ++  P   +
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---R 236
Query: 239 ILSADCKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            LS     + +  L ++P ERL       F +   HPF      D +
Sbjct: 237 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 283

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           D+ + R IG GS++ V   R     R++  +V  KE+     + +  + + +E  + ++ 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN---DDEDIDWVQTEKHVFEQA 66
Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
            NHP ++ LH   +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQ 186
            +  +I+RDLK  N+LL   D    +K+ D+G  +  L+P       CG+P Y+APEI++
Sbjct: 127 HERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPF--TGS------NQIQLLQNIVKATELHFPPDAK 238
            + Y    D W++G ++F+++ G++PF   GS      N    L  ++   ++  P   +
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---R 240
Query: 239 ILSADCKDLCQKLLRRNPVERL------TFEEFFNHPFLSQTQPDQV 279
            LS     + +  L ++P ERL       F +   HPF      D +
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 137/271 (50%), Gaps = 5/271 (1%)
Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF 63
            + +G +   Y +   IG GS+  V  A  +  GT +      + +   +  +    EI 
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQK--GTRIRRAAKKIPKYFVEDVDRFKQEIE 58
Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           I+K ++HP+IIRL++  E    ++L++E C GG+L   +       E  A   MK + + 
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           +      N+ HRDLKP+N L  TD  ++ LK+ DFG A   +P  +  T  G+P Y++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSA 242
           +++   Y  + D WS G +++ L+ G  PF+     +++  I + T   FP  D   +S 
Sbjct: 179 VLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGT-FTFPEKDWLNVSP 236
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             + L ++LL ++P +R+T  +   H +  +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 131/264 (49%), Gaps = 12/264 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           Y V   IG GS+SV     H+    E A+K I       K +     EI IL R   HP+
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPN 77
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           II L D+ +    ++++ E  KGG+L   I R     E  A   +  +   ++ L    +
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 133 IHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           +HRDLKP N+L   +  N  +++I DFGFA+ L+   GL  T C +  ++APE+++ Q Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI---LSADCKDL 247
           DA  D+WS+G +L+ ++TG TPF         + + +     F         +S   KDL
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257
Query: 248 CQKLLRRNPVERLTFEEFFNHPFL 271
             K+L  +P +RLT      HP++
Sbjct: 258 VSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ AK +  ++   L  +    
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMG 194
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQK 189
           LIHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 190 ----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  LF+++ G TPF   + +     I+     L FP DA+I S   
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI-SKHA 310
Query: 245 KDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQ 275
           K+L    L    V   R   EE   HPF    Q
Sbjct: 311 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 343

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 146/282 (51%), Gaps = 33/282 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                     L  D + L  ++L  +P +R++ +    HPF 
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 72  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 74  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 133 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEHVH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 77  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 136 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 192
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 193 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 252
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 253 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 74  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 133 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 189
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 190 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 249
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 250 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 71  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKP+NLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKP+NLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 132 LKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 188
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 189 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 248
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 249 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 72  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKP+NLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 131 LKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 187
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 188 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 247
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 248 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 71  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKP+NLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 130 LKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 186
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 187 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 246
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 247 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 129/264 (48%), Gaps = 12/264 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           Y V   IG GS+SV     H+    E A+K I       K +     EI IL R   HP+
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKII------DKSKRDPTEEIEILLRYGQHPN 77
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           II L D+ +    ++++ E  KGG+L   I R     E  A   +  +   ++ L    +
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 133 IHRDLKPQNLLLCTDDDN-AALKIADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQKY 190
           +HRDLKP N+L   +  N  +++I DFGFA+ L+   GL  T C +  ++APE+++ Q Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGY 197
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI---LSADCKDL 247
           DA  D+WS+G +L+  +TG TPF         + + +     F         +S   KDL
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257
Query: 248 CQKLLRRNPVERLTFEEFFNHPFL 271
             K L  +P +RLT      HP++
Sbjct: 258 VSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 149/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKP+NLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 148/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+ +I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 129 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 186 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 245
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 246 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 148/288 (51%), Gaps = 34/288 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ AR+++ G  VA+ +I +    + +  + + EI +LK +NHP+I++L D
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           +I    KL+L+ E+    DL  ++       +P    K ++ QL  GL     + ++HRD
Sbjct: 69  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQKYDAKA- 194
           LKPQNLL+ T+    A+K+ADFG AR+   P         +  Y APEI+   KY + A 
Sbjct: 128 LKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFP-----PDAK------- 238
           D+WS+G I  ++VT +  F G ++I  L  I +      E+ +P     PD K       
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 239 ---------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-TQP 276
                     L  D + L  ++L  +P +R++ +    HPF    T+P
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 11  DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y
Sbjct: 129 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 241
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 242 LLKKDPKQRL 251

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 132/247 (53%), Gaps = 16/247 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHII 74
           +G GSF  V  A  +  GTE  +  I + + +  +Q+  +    + KR+       P + 
Sbjct: 27  LGKGSFGKVMLADRK--GTE-ELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  +++ GL  L    +I+
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N++L   D    +KIADFG  +     G+     CG+P Y+APEI+  Q Y   
Sbjct: 144 RDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D W+ G +L++++ G+ PF G ++ +L Q+I++   + +P   K LS +   +C+ L+ 
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYP---KSLSKEAVSICKGLMT 256
Query: 254 RNPVERL 260
           ++P +RL
Sbjct: 257 KHPAKRL 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 238
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 239 LLKKDPKQRL 248

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPH 72
           R +G GSF  V  AR +  G   A+K +   + +  LQ+  +      KRI     NHP 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           + +L    + P +L  ++E+  GGDL  +IQ+     E  A+ +  ++ + L  L D  +
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQLQKYD 191
           I+RDLK  N+LL   D     K+ADFG  +     G+   T CG+P Y+APEI+Q   Y 
Sbjct: 146 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D W++G +L++++ G  PF   N+  L + I+   E+ +P     L  D   + +  
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVYP---TWLHEDATGILKSF 258
Query: 252 LRRNPVERLTF------EEFFNHPF--------LSQTQPDQVFRSRMFSRS 288
           + +NP  RL             HPF        L+  Q +  FR R+ SR 
Sbjct: 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSRE 309

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 238
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 239 LLKKDPKQRL 248

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 139/273 (50%), Gaps = 16/273 (5%)
Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 72
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 131
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P +    T+ G+P +MAPE++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 245
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 154/304 (50%), Gaps = 30/304 (9%)
Query: 8   GRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-RLNKKLQESLMSEIFIL 65
           G+++ + Y +  ++G G  S V+ A   +   +VA+K I +  R  ++  +    E+   
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
            +++H +I+ + D+ E     +L++EY +G  LS YI+ HG +  +TA +F  Q+  G++
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPE 183
              D  ++HRD+KPQN+L+   D N  LKI DFG A++L    L +T  + G+  Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
             + +  D   D++S+G +L++++ G+ PF G   + +    ++ +  +   D +     
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR----- 237
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFP--FYESKSVR 301
            KD+ Q L               ++  L  T+ D+  R +      DD     +E+++  
Sbjct: 238 -KDIPQSL---------------SNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281
Query: 302 DVAE 305
           DV E
Sbjct: 282 DVYE 285

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  125 bits (313), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 132/250 (52%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +  CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 238
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 239 LLKKDPKQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 132/250 (52%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +  CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 238
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 239 LLKKDPKQRL 248

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 132/250 (52%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +  CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 238
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 239 LLKKDPKQRL 248

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 134/247 (54%), Gaps = 16/247 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHII 74
           +G GSF  V  +  +  GT+  +  + + + +  +Q+  +    + KR+       P + 
Sbjct: 349 LGKGSFGKVMLSERK--GTD-ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  ++A GL  L+   +I+
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N++L   D    +KIADFG  +     G+  +  CG+P Y+APEI+  Q Y   
Sbjct: 466 RDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D W+ G +L++++ G+ PF G ++ +L Q+I++   + +P   K +S +   +C+ L+ 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP---KSMSKEAVAICKGLMT 578
Query: 254 RNPVERL 260
           ++P +RL
Sbjct: 579 KHPGKRL 585

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 132/250 (52%), Gaps = 11/250 (4%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHP 71
           DYL  + +G G+F  V   R +  G   AMK +    +  K + +  ++E  +L+   HP
Sbjct: 13  DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +  +      +  CG+P Y+APE+++   Y
Sbjct: 131 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP   + LS + K L   
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRFP---RTLSPEAKSLLAG 243
Query: 251 LLRRNPVERL 260
           LL+++P +RL
Sbjct: 244 LLKKDPKQRL 253

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 138/273 (50%), Gaps = 16/273 (5%)
Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 72
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 131
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P +     + G+P +MAPE++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 245
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 139/273 (50%), Gaps = 16/273 (5%)
Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 16  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 73
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 132
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHR++K  N+LL  D    ++K+ DFGF   + P +    T+ G+P +MAPE++
Sbjct: 133 LHSNQVIHRNIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 246
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 247 FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 138/273 (50%), Gaps = 16/273 (5%)
Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 16  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 73
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 132
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P +     + G+P +MAPE++
Sbjct: 133 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 246
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 247 FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 10/216 (4%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G + +  ++G+G F  V    H+  G +VA+K+     L+ K +E    EI I+K++NHP
Sbjct: 15  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHP 73
Query: 72  HIIRLHDIIE-----VPGKLHLI-LEYCKGGDLSMYI-QRHGC--VPEETAKHFMKQLAA 122
           +++   ++ +      P  L L+ +EYC+GGDL  Y+ Q   C  + E   +  +  +++
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L+ L +N +IHRDLKP+N++L         KI D G+A+ L    L     G+  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ 218
           E+++ +KY    D WS G + F+ +TG  PF  + Q
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 229

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 152/302 (50%), Gaps = 36/302 (11%)
Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ------ 55
           S ++G    +  Y +  +IG GS+ VV  A +    T  AMK ++  +L ++        
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 56  ------------------ESLMSEIFILKRINHPHIIRLHDIIEVPGK--LHLILEYCKG 95
                             E +  EI ILK+++HP++++L ++++ P +  L+++ E    
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 96  GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI 155
           G + M +     + E+ A+ + + L  G++ L    +IHRD+KP NLL+  D     +KI
Sbjct: 123 GPV-MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKI 178
Query: 156 ADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQK--YDAKA-DLWSVGAILFQLVTGKT 211
           ADFG +   +    L     G+P +MAPE +   +  +  KA D+W++G  L+  V G+ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 212 PFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           PF    +I  L + +K+  L F PD   ++ D KDL  ++L +NP  R+   E   HP++
Sbjct: 239 PFM-DERIMCLHSKIKSQALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
Query: 272 SQ 273
           ++
Sbjct: 297 TR 298

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 10/216 (4%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G + +  ++G+G F  V    H+  G +VA+K+     L+ K +E    EI I+K++NHP
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHP 72
Query: 72  HIIRLHDIIE-----VPGKLHLI-LEYCKGGDLSMYI-QRHGC--VPEETAKHFMKQLAA 122
           +++   ++ +      P  L L+ +EYC+GGDL  Y+ Q   C  + E   +  +  +++
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L+ L +N +IHRDLKP+N++L         KI D G+A+ L    L     G+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ 218
           E+++ +KY    D WS G + F+ +TG  PF  + Q
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 134/247 (54%), Gaps = 16/247 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-----NHPHII 74
           +G GSF  V  +  +  GT+  +  + + + +  +Q+  +    + KR+       P + 
Sbjct: 28  LGKGSFGKVMLSERK--GTD-ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +LH   +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  ++A GL  L+   +I+
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAK 193
           RDLK  N++L   D    +KIADFG  +     G+  +  CG+P Y+APEI+  Q Y   
Sbjct: 145 RDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D W+ G +L++++ G+ PF G ++ +L Q+I++   + +P   K +S +   +C+ L+ 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYP---KSMSKEAVAICKGLMT 257
Query: 254 RNPVERL 260
           ++P +RL
Sbjct: 258 KHPGKRL 264

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 127/231 (54%), Gaps = 10/231 (4%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRIN 69
           + ++ + ++IG G FS V+ A   + G  VA+K++ +  L + K +   + EI +LK++N
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQ 125
           HP++I+ +       +L+++LE    GDLS  I+    +   +PE T   +  QL + L+
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEI 184
            +    ++HRD+KP N+ +        +K+ D G  R    +  A  +L G+P YM+PE 
Sbjct: 151 HMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           +    Y+ K+D+WS+G +L+++   ++PF G +++ L     K  +  +PP
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP 257

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 138/273 (50%), Gaps = 16/273 (5%)
Query: 11  VGD----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           VGD    Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMR 72
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
              +P+I+   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEF 131
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIM 185
           L  N +IHRD+K  N+LL  D    ++K+ DFGF   + P     + + G+P +MAPE++
Sbjct: 132 LHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK--ATELHFPPDAKILSAD 243
             + Y  K D+WS+G +  +++ G+ P+   N ++ L  I      EL  P     LSA 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK---LSAI 245
Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            +D   + L  +  +R + +E   H FL   +P
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 21/283 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ A+ +  ++   L  +    
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 193
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQ- 188
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 189 ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  L++++ G TPF   + +     I+     L FP D  I S + 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEA 309
Query: 245 KDL-CQKL------LRRNPVERLTFEEFF-NHPFLSQTQPDQV 279
           K+L C  L      L RN VE +    FF N  +  +T  D V
Sbjct: 310 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 352

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 21/283 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ A+ +  ++   L  +    
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 188
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQ- 188
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 189 ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  L++++ G TPF   + +     I+     L FP D  I S + 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEA 304
Query: 245 KDL-CQKL------LRRNPVERLTFEEFF-NHPFLSQTQPDQV 279
           K+L C  L      L RN VE +    FF N  +  +T  D V
Sbjct: 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 347

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 21/283 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+   +    E  I+   N P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL   +  +  VPE+ A+ +  ++   L  +    
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 193
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA--ETLCGSPLYMAPEIMQLQ- 188
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 189 ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK-ATELHFPPDAKILSADC 244
               Y  + D WSVG  L++++ G TPF   + +     I+     L FP D  I S + 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEA 309
Query: 245 KDL-CQKL------LRRNPVERLTFEEFF-NHPFLSQTQPDQV 279
           K+L C  L      L RN VE +    FF N  +  +T  D V
Sbjct: 310 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 352

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 25/267 (9%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+F  V+ A+++      A K I     +++  E  M EI IL   +HP+I++L D
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 79  IIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  L +++E+C GG + ++ ++    + E   +   KQ    L  L DN +IHRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 138 KPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEIMQLQK---- 189
           K  N+L   D D   +K+ADFG +    R++Q R   ++  G+P +MAPE++  +     
Sbjct: 162 KAGNILFTLDGD---IKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVVMCETSKDR 215
Query: 190 -YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCK 245
            YD KAD+WS+G  L ++   + P    N +++L  I K+     PP        S++ K
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNFK 271
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           D  +K L +N   R T  +   HPF++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 140/279 (50%), Gaps = 13/279 (4%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRI 68
           + D+++ + +G GSF  V+ A  +      A+K +   +  ++  ++ +++ +  +    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP +  +    +    L  ++EY  GGDL  +IQ         A  +  ++  GLQ L 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
              +++RDLK  N+LL   D +  +KIADFG  +     G A+T   CG+P Y+APEI+ 
Sbjct: 136 SKGIVYRDLKLDNILL---DKDGHIKIADFGMCKE-NMLGDAKTNXFCGTPDYIAPEILL 191
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            QKY+   D WS G +L++++ G++PF G ++ +L  +I     +  P   + L  + KD
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----RMDNPFYPRWLEKEAKD 247
Query: 247 LCQKLLRRNPVERLTFE-EFFNHPFLSQTQPDQVFRSRM 284
           L  KL  R P +RL    +   HP   +   +++ R  +
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 286

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 136/267 (50%), Gaps = 25/267 (9%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+F  V+ A+++      A K I     +++  E  M EI IL   +HP+I++L D
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 79  IIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  L +++E+C GG + ++ ++    + E   +   KQ    L  L DN +IHRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 138 KPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEIMQLQK---- 189
           K  N+L   D D   +K+ADFG +    R +Q R   ++  G+P +MAPE++  +     
Sbjct: 162 KAGNILFTLDGD---IKLADFGVSAKNTRXIQRR---DSFIGTPYWMAPEVVMCETSKDR 215
Query: 190 -YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCK 245
            YD KAD+WS+G  L ++   + P    N +++L  I K+     PP        S++ K
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNFK 271
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           D  +K L +N   R T  +   HPF++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-------NKKLQE 56
           A   G     Y     +GSG+F  VW A  +    EV +K I   ++       + KL +
Sbjct: 16  AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 57  SLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE-YCKGGDLSMYIQRHGCVPEETAKH 115
             + EI IL R+ H +II++ DI E  G   L++E +  G DL  +I RH  + E  A +
Sbjct: 76  VTL-EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
             +QL + +  LR  ++IHRD+K +N+++  D     +K+ DFG A  L+   L  T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAED---FTIKLIDFGSAAYLERGKLFYTFCG 191
Query: 176 SPLYMAPEIMQLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP 234
           +  Y APE++    Y   + ++WS+G  L+ LV  + PF        L+  V+A  +H P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAA-IH-P 243
Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           P   ++S +   L   LL+  P  R T E+    P+++Q
Sbjct: 244 P--YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 25  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 78
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   +TLCG+P Y+APE++  + + 
Sbjct: 139 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 251
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 252 LQTDPTARPTINELLNDEFFT 272

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 29  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 82
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 142
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   +TLCG+P Y+APE++  + + 
Sbjct: 143 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 255
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 256 LQTDPTARPTINELLNDEFFT 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 25  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 78
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   +TLCG+P Y+APE++  + + 
Sbjct: 139 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 251
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 252 LQTDPTARPTINELLNDEFFT 272

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 135/267 (50%), Gaps = 25/267 (9%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G+F  V+ A+++      A K I     +++  E  M EI IL   +HP+I++L D
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 79  IIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  L +++E+C GG + ++ ++    + E   +   KQ    L  L DN +IHRDL
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 138 KPQNLLLCTDDDNAALKIADFGFA----RSLQPRGLAETLCGSPLYMAPEIMQLQK---- 189
           K  N+L   D D   +K+ADFG +    R +Q R   +   G+P +MAPE++  +     
Sbjct: 162 KAGNILFTLDGD---IKLADFGVSAKNTRXIQRR---DXFIGTPYWMAPEVVMCETSKDR 215
Query: 190 -YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCK 245
            YD KAD+WS+G  L ++   + P    N +++L  I K+     PP        S++ K
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPTLAQPSRWSSNFK 271
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           D  +K L +N   R T  +   HPF++
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 142/262 (54%), Gaps = 18/262 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  AR +  G +VA+K + + +  ++  E L +E+ I++   H +++ ++ 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  + +     E+ A      L A L  L    +IHRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA-LAYLHAQGVIHRDIK 168
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    P+   + L G+P +MAPE++    Y  + D
Sbjct: 169 SDSILLTLD---GRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK---ILSADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+   + +Q ++ +  +     PP  K    +S   +D  +++L
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----PPKLKNSHKVSPVLRDFLERML 279
Query: 253 RRNPVERLTFEEFFNHPFLSQT 274
            R+P ER T +E  +HPFL QT
Sbjct: 280 VRDPQERATAQELLDHPFLLQT 301

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 143/293 (48%), Gaps = 43/293 (14%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+++ V+   ++  G  VA+KE+ +    +    + + EI ++K + H +I+RL+D
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRH--GCVPE----ETAKHFMKQLAAGLQVLRDNNL 132
           +I    KL L+ E+    DL  Y+     G  P        K+F  QL  GL    +N +
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKY 190
           +HRDLKPQNLL+   +    LK+ DFG AR+   P     +   +  Y AP++ M  + Y
Sbjct: 130 LHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKA-TELHFPPDAKI------- 239
               D+WS G IL +++TGK  F G+N   Q++L+ +I+    E  +P   K+       
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 240 -------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                              L  +  D    LL+ NP  RL+ ++  +HP+ ++
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 138/273 (50%), Gaps = 15/273 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +T CG+P Y+APE+++   Y    D 
Sbjct: 276 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + L  + K L   LL+++P
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLGPEAKSLLSGLLKKDP 388
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 421

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 62
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 123 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 238
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPL 267

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 138/273 (50%), Gaps = 15/273 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 278
Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +T CG+P Y+APE+++   Y    D 
Sbjct: 279 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 335
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + L  + K L   LL+++P
Sbjct: 336 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLGPEAKSLLSGLLKKDP 391
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 392 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 424

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 139/279 (49%), Gaps = 13/279 (4%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRI 68
           + D+ + + +G GSF  V+ A  +      A+K +   +  ++  ++ +++ +  +    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP +  +    +    L  ++EY  GGDL  +IQ         A  +  ++  GLQ L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
              +++RDLK  N+LL   D +  +KIADFG  +     G A+T   CG+P Y+APEI+ 
Sbjct: 137 SKGIVYRDLKLDNILL---DKDGHIKIADFGMCKE-NMLGDAKTNEFCGTPDYIAPEILL 192
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            QKY+   D WS G +L++++ G++PF G ++ +L  +I     +  P   + L  + KD
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----RMDNPFYPRWLEKEAKD 248
Query: 247 LCQKLLRRNPVERLTFE-EFFNHPFLSQTQPDQVFRSRM 284
           L  KL  R P +RL    +   HP   +   +++ R  +
Sbjct: 249 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 287

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 47  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 100
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 160
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   + LCG+P Y+APE++  + + 
Sbjct: 161 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 273
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 274 LQTDPTARPTINELLNDEFFT 294

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 49  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   + LCG+P Y+APE++  + + 
Sbjct: 163 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 275
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 276 LQTDPTARPTINELLNDEFFT 296

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 215
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  +  H  + EE        +   L VL    +IHRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 275 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 385
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 386 VRDPAQRATAAELLKHPFLAKAGP 409

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 84
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 144 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 254
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGP 278

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 21/261 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------LQESLMSEIFILKRINHPH 72
           +G G F+  +        ++   KE+  G++  K        +E +  EI I + + H H
Sbjct: 23  LGKGGFAKCFEI------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q L  N +
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           IHRDLK  NL L   +++  +KI DFG A  ++  G   + LCG+P Y+APE++  + + 
Sbjct: 137 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++A    L QK+
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAA---SLIQKM 249
Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ +P  R T  E  N  F +
Sbjct: 250 LQTDPTARPTINELLNDEFFT 270

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 93
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 153 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 263
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 264 VRDPAQRATAAELLKHPFLAKAGP 287

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 139/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 95
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 155 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 265
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 266 VRDPAQRATAAELLKHPFLAKAGP 289

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 88
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 148 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 258
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 259 VRDPAQRATAAELLKHPFLAKAGP 282

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  R  G  VA+K++ + +  ++  E L +E+ I++   H +++ +++
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRDYQHENVVEMYN 138
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L VL    +IHRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL  D     +K++DFGF   +    PR   + L G+P +MAPE++    Y  + D
Sbjct: 198 SDSILLTHD---GRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ ++V G+ P+     ++ ++ I      + PP  K L   S   K    +LL
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPRLKNLHKVSPSLKGFLDRLL 308
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R+P +R T  E   HPFL++  P
Sbjct: 309 VRDPAQRATAAELLKHPFLAKAGP 332

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 138/266 (51%), Gaps = 12/266 (4%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 150
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 151 KPSNILV---NSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 206
Query: 198 SVGAILFQLVTGKTPF---TGSNQI-QLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           S+G  L ++  G+ P    +GS  I +LL  IV       P  + + S + +D   K L 
Sbjct: 207 SMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLI 264
Query: 254 RNPVERLTFEEFFNHPFLSQTQPDQV 279
           +NP ER   ++   H F+ ++  ++V
Sbjct: 265 KNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 133/262 (50%), Gaps = 8/262 (3%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A    G+  YM+PE +Q   Y  ++D+W
Sbjct: 135 KPSNILV---NSRGEIKLCDFGVSGQLIDE-MANEFVGTRSYMSPERLQGTHYSVQSDIW 190
Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
           S+G  L ++  G+ P       +LL  IV       P  + + S + +D   K L +NP 
Sbjct: 191 SMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLP--SAVFSLEFQDFVNKCLIKNPA 248
Query: 258 ERLTFEEFFNHPFLSQTQPDQV 279
           ER   ++   H F+ ++  ++V
Sbjct: 249 ERADLKQLMVHAFIKRSDAEEV 270

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 137/273 (50%), Gaps = 15/273 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 137
Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +  CG+P Y+APE+++   Y    D 
Sbjct: 138 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 194
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + L  + K L   LL+++P
Sbjct: 195 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLGPEAKSLLSGLLKKDP 250
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 251 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 283

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 137/273 (50%), Gaps = 15/273 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 136
Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +  CG+P Y+APE+++   Y    D 
Sbjct: 137 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 193
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + L  + K L   LL+++P
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLGPEAKSLLSGLLKKDP 249
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 250 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 282

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 137/273 (50%), Gaps = 15/273 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES-LMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +    +  K + +  ++E  +L+   HP +  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 135
Query: 138 KPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +  CG+P Y+APE+++   Y    D 
Sbjct: 136 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 192
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP   + L  + K L   LL+++P
Sbjct: 193 WGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFP---RTLGPEAKSLLSGLLKKDP 248
Query: 257 VERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
            +RL       +E   H F +      V+  ++
Sbjct: 249 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL 281

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G+   V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 146/283 (51%), Gaps = 14/283 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           +VG ++G G+F  V+ A+++  G   A K I     +++  E  + EI IL   +HP+I+
Sbjct: 23  IVG-ELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIV 79
Query: 75  RLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +L       GKL +++E+C GG + ++ ++    + E   +   +Q+   L  L    +I
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGF-ARSLQPRGLAETLCGSPLYMAPEI-----MQL 187
           HRDLK  N+L+  + D   +++ADFG  A++L+     ++  G+P +MAPE+     M+ 
Sbjct: 140 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             YD KAD+WS+G  L ++   + P    N +++L  I K+        +K  S + +D 
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-WSVEFRDF 255
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSAD 290
            +  L +NP  R +  +   HPF+S    ++  R  +    A+
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 298

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 141/285 (49%), Gaps = 33/285 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ A++  +G   A+K+I + + ++ +  + + EI ILK + H +I++L+D
Sbjct: 9   KIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I    +L L+ E+       +     G +   TAK F+ QL  G+    D  ++HRDLK
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 139 PQNLLLCTDDDNAALKIADFGFARS--LQPRGLAETLCGSPLYMAPEI-MQLQKYDAKAD 195
           PQNLL+   +    LKIADFG AR+  +  R     +  +  Y AP++ M  +KY    D
Sbjct: 128 PQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK------------ATEL-HFPPDAKI--- 239
           +WSVG I  ++V G   F G ++   L  I +             TEL  + P+  +   
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 240 ---------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                    L     DL  K+L+ +P +R+T ++   H +  +  
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 31/284 (10%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ A++  +G   A+K+I + + ++ +  + + EI ILK + H +I++L+D
Sbjct: 9   KIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I    +L L+ E+       +     G +   TAK F+ QL  G+    D  ++HRDLK
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKYDAKADL 196
           PQNLL+   +    LKIADFG AR+   P         +  Y AP++ M  +KY    D+
Sbjct: 128 PQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVK------------ATEL-HFPPDAKI---- 239
           WSVG I  ++V G   F G ++   L  I +             TEL  + P+  +    
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 240 --------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                   L     DL  K+L+ +P +R+T ++   H +  +  
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I   +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINAMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 146/283 (51%), Gaps = 14/283 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           +VG ++G G+F  V+ A+++  G   A K I     +++  E  + EI IL   +HP+I+
Sbjct: 15  IVG-ELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIV 71
Query: 75  RLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +L       GKL +++E+C GG + ++ ++    + E   +   +Q+   L  L    +I
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGF-ARSLQPRGLAETLCGSPLYMAPEI-----MQL 187
           HRDLK  N+L+  + D   +++ADFG  A++L+     ++  G+P +MAPE+     M+ 
Sbjct: 132 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             YD KAD+WS+G  L ++   + P    N +++L  I K+        +K  S + +D 
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-WSVEFRDF 247
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSAD 290
            +  L +NP  R +  +   HPF+S    ++  R  +    A+
Sbjct: 248 LKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 290

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 131/265 (49%), Gaps = 13/265 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL---QESLMSEIFILKRINH 70
           Y++   +G G F +V    HR    E + K+  M +  K     Q  +  EI IL    H
Sbjct: 7   YMIAEDLGRGEFGIV----HRC--VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRD 129
            +I+ LH+  E   +L +I E+  G D+   I      + E     ++ Q+   LQ L  
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
           +N+ H D++P+N++  T   ++ +KI +FG AR L+P      L  +P Y APE+ Q   
Sbjct: 121 HNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLC 248
                D+WS+G +++ L++G  PF      Q+++NI+ A E  F  +A K +S +  D  
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-EYTFDEEAFKEISIEAMDFV 238
Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQ 273
            +LL +    R+T  E   HP+L Q
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 31/284 (10%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++ VV+ A++  +G   A+K+I + + ++ +  + + EI ILK + H +I++L+D
Sbjct: 9   KIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I    +L L+ E+       +     G +   TAK F+ QL  G+    D  ++HRDLK
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKYDAKADL 196
           PQNLL+   +    LKIADFG AR+   P         +  Y AP++ M  +KY    D+
Sbjct: 128 PQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVK------------ATEL-HFPPDAKI---- 239
           WSVG I  ++V G   F G ++   L  I +             TEL  + P+  +    
Sbjct: 185 WSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 240 --------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                   L     DL  K+L+ +P +R+T ++   H +  +  
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   + G+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 31/214 (14%)
Query: 71  PHIIRLHDIIE--VPGK--LHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGL 124
           PHI+R+ D+ E    G+  L +++E   GG+L   IQ  G     E  A   MK +   +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+                      
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------------ 172
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFP-PDAKIL 240
              +KYD   D+WS+G I++ L+ G  PF  ++ + +   ++  ++  +  FP P+   +
Sbjct: 173 ---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
           S + K L + LL+  P +R+T  EF NHP++ Q+
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   + G+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEIXINKMLNH 64
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   + G+  Y+APE+++ 
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 240
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   + G+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 138/271 (50%), Gaps = 16/271 (5%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           V  ++G GS+  V+ A H+  G  VA+K++    +   LQE ++ EI I+++ + PH+++
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE-IIKEISIMQQCDSPHVVK 88
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            +        L +++EYC  G +S  I+ R+  + E+     ++    GL+ L     IH
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           RD+K  N+LL T+      K+ADFG A  L         + G+P +MAPE++Q   Y+  
Sbjct: 149 RDIKAGNILLNTE---GHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLCQK 250
           AD+WS+G    ++  GK P+   + ++ +  I      + PP     ++ S +  D  ++
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI----PTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 251 LLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
            L ++P +R T  +   HPF+   +   + R
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVSILR 292

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 14/269 (5%)
Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNH 63
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   R      L   + G+  Y+APE+++ 
Sbjct: 124 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 188 QKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A+  D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI SA    
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA- 239
Query: 247 LCQKLLRRNPVERLTF-----EEFFNHPF 270
           L  K+L  NP  R+T      + ++N P 
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 138/264 (52%), Gaps = 18/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  A  +  G +VA+K++ + +  ++  E L +E+ I++  +H +++ ++ 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR--ELLFNEVVIMRDYHHDNVVDMYS 109
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I  H  + EE        +   L  L +  +IHRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
             ++LL +D     +K++DFGF   +    P+   + L G+P +MAPE++    Y  + D
Sbjct: 169 SDSILLTSD---GRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL---SADCKDLCQKLL 252
           +WS+G ++ +++ G+ P+     +Q ++ I  +     PP  K L   S+  +     +L
Sbjct: 224 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDS----LPPRVKDLHKVSSVLRGFLDLML 279
Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
            R P +R T +E   HPFL    P
Sbjct: 280 VREPSQRATAQELLGHPFLKLAGP 303

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 140/315 (44%), Gaps = 58/315 (18%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ------ESLMSEIFILKRINHPHI 73
           IG GS+ VV   R  +     A++ I +   NK  Q      E + +E+ ++K+++HP+I
Sbjct: 34  IGQGSYGVV---RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDL---------------SMYIQRHGCVP--------- 109
            RL+++ E    + L++E C GG L               +M + +    P         
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 110 ----------------EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL 153
                           E+   + M+Q+ + L  L +  + HRD+KP+N L  T+  +  +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-SFEI 209
Query: 154 KIADFGFARSLQPRGLAE-----TLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQL 206
           K+ DFG ++        E     T  G+P ++APE++    + Y  K D WS G +L  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 207 VTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           + G  PF G N    +  ++        P+  +LS   +DL   LL RN  ER       
Sbjct: 270 LMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 267 NHPFLSQTQPDQVFR 281
            HP++SQ   D++++
Sbjct: 330 QHPWISQFS-DKIYK 343

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 139/279 (49%), Gaps = 15/279 (5%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           D+ + + IG G+F  V   + +      AMK +    + K+ + +    E  +L   +  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDN 130
            I  LH   +    L+L+++Y  GGDL   + +    +PEE A+ ++ ++   +  +   
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQ 188
           + +HRD+KP N+L+   D N  +++ADFG    L   G  ++    G+P Y++PEI+Q  
Sbjct: 195 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 189 -----KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSA 242
                +Y  + D WS+G  +++++ G+TPF   + ++    I+   E   FP     +S 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 243 DCKDLCQKLL--RRNPVERLTFEEFFNHPFLSQTQPDQV 279
           + KDL ++L+  R + + +   E+F  HPF S    D +
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 132 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 198 SVGAILFQLVTGKTPFTGSNQ----------IQLLQNIVKATELHFPPDAKILSADCKDL 247
           S+G  L ++  G+ P    +            +LL  IV       P  + + S + +D 
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDF 245
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
             K L +NP ER   ++   H F+ ++  ++V
Sbjct: 246 VNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 277

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 146/297 (49%), Gaps = 35/297 (11%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY +   IGSG+ +VV  A       +VA+K I + +    + E L+ EI  + + +HP+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPN 74
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAKHFMKQLAAGL 124
           I+  +    V  +L L+++   GG +   I+        + G + E T    ++++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG------LAETLCGSPL 178
           + L  N  IHRD+K  N+LL  D    +++IADFG +  L   G      + +T  G+P 
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE+M Q++ YD KAD+WS G    +L TG  P+     +++L   ++    + PP  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ----NDPPSL 247
Query: 238 KILSADCKDLCQKL-----------LRRNPVERLTFEEFFNHPFLSQTQPDQVFRSR 283
           +    D K++ +K            L+++P +R T  E   H F  + +  +  + +
Sbjct: 248 ETGVQD-KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 139/300 (46%), Gaps = 38/300 (12%)
Query: 6   GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFI 64
           G  R    Y    +IG G++  V+ AR   +G   VA+K + +    + +  S + E+ +
Sbjct: 5   GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64
Query: 65  LKRIN---HPHIIRLHDIIEV-----PGKLHLILEYCKGGDLSMYIQR--HGCVPEETAK 114
           L+ +    HP+++RL D+  V       KL L+ E+    DL+ Y+ +     VP ET K
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
             M QL  GL  L  + ++HRDLKPQN+L+ +   +  +K+ADFG AR    +    ++ 
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVV 180
Query: 175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----E 230
            +  Y APE++    Y    DLWSVG I  ++   K  F GS+ +  L  I+       E
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 231 LHFPPDAKI-------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
             +P D  +                   +    KDL  K L  NP +R++     +HP+ 
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 19  QIGSGSFSVVWHARHRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHII 74
           +IG G++  V+ AR   +G   VA+K + +    + +  S + E+ +L+ +    HP+++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 75  RLHDIIEV-----PGKLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVL 127
           RL D+  V       KL L+ E+    DL+ Y+ +     VP ET K  M QL  GL  L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             + ++HRDLKPQN+L+ +   +  +K+ADFG AR    +    ++  +  Y APE++  
Sbjct: 137 HSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFPPDAKI---- 239
             Y    DLWSVG I  ++   K  F GS+ +  L  I+       E  +P D  +    
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 240 ---------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                          +    KDL  K L  NP +R++     +HP+ 
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 19  QIGSGSFSVVWHARHRVHGTE-VAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHII 74
           +IG G++  V+ AR   +G   VA+K + +    + +  S + E+ +L+ +    HP+++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 75  RLHDIIEV-----PGKLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVL 127
           RL D+  V       KL L+ E+    DL+ Y+ +     VP ET K  M QL  GL  L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             + ++HRDLKPQN+L+ +   +  +K+ADFG AR    +    ++  +  Y APE++  
Sbjct: 137 HSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFPPDAKI---- 239
             Y    DLWSVG I  ++   K  F GS+ +  L  I+       E  +P D  +    
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 240 ---------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                          +    KDL  K L  NP +R++     +HP+ 
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 24/257 (9%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G GSF  V     +  G + A+K++       +L+     E+     +  P I+ L+ 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            +     +++ +E  +GG L   ++  GC+PE+ A +++ Q   GL+ L    ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC------GSPLYMAPEIMQLQKYDA 192
             N+LL +D  +AAL   DFG A  LQP GL ++L       G+  +MAPE++  +  DA
Sbjct: 213 ADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDA 270
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC---- 248
           K D+WS   ++  ++ G  P+T   +  L   I  A+E   PP  + +   C  L     
Sbjct: 271 KVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKI--ASE---PPPVREIPPSCAPLTAQAI 325
Query: 249 QKLLRRNPVERLTFEEF 265
           Q+ LR+ P+ R++  E 
Sbjct: 326 QEGLRKEPIHRVSAAEL 342

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 143/289 (49%), Gaps = 35/289 (12%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY +   IGSG+ +VV  A       +VA+K I + +    + E L+ EI  + + +HP+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPN 69
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAKHFMKQLAAGL 124
           I+  +    V  +L L+++   GG +   I+        + G + E T    ++++  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG------LAETLCGSPL 178
           + L  N  IHRD+K  N+LL  D    +++IADFG +  L   G      + +T  G+P 
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE+M Q++ YD KAD+WS G    +L TG  P+     +++L   ++    + PP  
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ----NDPPSL 242
Query: 238 KILSADCKDLCQKL-----------LRRNPVERLTFEEFFNHPFLSQTQ 275
           +    D K++ +K            L+++P +R T  E   H F  + +
Sbjct: 243 ETGVQD-KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 145/274 (52%), Gaps = 27/274 (9%)
Query: 5   TGRGRVVG--DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-------KLQ 55
           TG    VG  ++ + + +G+G++  V+  R ++ G +   K  AM  L K       K  
Sbjct: 45  TGHAEKVGIENFELLKVLGTGAYGKVFLVR-KISGHDTG-KLYAMKVLKKATIVQKAKTT 102
Query: 56  ESLMSEIFILKRINH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK 114
           E   +E  +L+ I   P ++ LH   +   KLHLIL+Y  GG+L  ++ +     E   +
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAET 172
            ++ ++   L+ L    +I+RD+K +N+LL   D N  + + DFG ++         A  
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 173 LCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFT----GSNQIQLLQNIV 226
            CG+  YMAP+I++     +D   D WS+G ++++L+TG +PFT     ++Q ++ + I+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERL 260
           K+     PP  + +SA  KDL Q+LL ++P +RL
Sbjct: 280 KSE----PPYPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 95/308 (30%), Positives = 144/308 (46%), Gaps = 45/308 (14%)
Query: 11  VGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           VGD Y +   IG+G++ VV  AR R+ G +VA+K+I          +  + E+ ILK   
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 111
Query: 70  HPHIIRLHDIIE--VP----GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II + DI+   VP      ++++L+  +  DL   I     +  E  ++F+ QL  G
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-----QPRGLAETLCGSPL 178
           L+ +    +IHRDLKP NLL+   ++N  LKI DFG AR L     + +        +  
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI------------ 225
           Y APE+M  L +Y    DLWSVG I  +++  +  F G N +  LQ I            
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287
Query: 226 -------VKATELHFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPF 270
                  V+A     PP   +        AD +   L  ++LR  P  R++      HPF
Sbjct: 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347
Query: 271 LSQTQ-PD 277
           L++   PD
Sbjct: 348 LAKYHDPD 355

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 93/303 (30%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 11  VGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           VGD Y +   IG+G++ VV  AR R+ G +VA+K+I          +  + E+ ILK   
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 112
Query: 70  HPHIIRLHDIIE--VP----GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II + DI+   VP      ++++L+  +  DL   I     +  E  ++F+ QL  G
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-----QPRGLAETLCGSPL 178
           L+ +    +IHRDLKP NLL+   ++N  LKI DFG AR L     + +        +  
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI------------ 225
           Y APE+M  L +Y    DLWSVG I  +++  +  F G N +  LQ I            
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 288
Query: 226 -------VKATELHFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPF 270
                  V+A     PP   +        AD +   L  ++LR  P  R++      HPF
Sbjct: 289 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 348
Query: 271 LSQ 273
           L++
Sbjct: 349 LAK 351

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHA--RHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +++G YL+G  +G GS+  V        +    V + +    R     + ++  EI +L+
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67  RINHPHIIRLHDII--EVPGKLHLILEYCKGGDLSMYIQRHGCVPEE-----TAKHFMKQ 119
           R+ H ++I+L D++  E   K+++++EYC  G   M       VPE+      A  +  Q
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML----DSVPEKRFPVCQAHGYFCQ 117
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC----G 175
           L  GL+ L    ++H+D+KP NLLL T      LKI+  G A +L P   A+  C    G
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFA-ADDTCRTSQG 173
Query: 176 SPLYMAPEIMQ-LQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           SP +  PEI   L  +   K D+WS G  L+ + TG  PF G N  +L +NI K +    
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---- 229
Query: 234 PPDAKILSADC----KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                 +  DC     DL + +L   P +R +  +   H +  +  P
Sbjct: 230 ----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 131/256 (51%), Gaps = 27/256 (10%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G+F VV  A+ R    +VA+K+I     ++  +++ + E+  L R+NHP+I++L+  
Sbjct: 17  VGRGAFGVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMK------QLAAGLQVLRDNN 131
              P  + L++EY +GG  S+Y   HG   +P  TA H M       Q  A L  ++   
Sbjct: 71  CLNP--VCLVMEYAEGG--SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           LIHRDLKP NLLL        LKI DFG A  +Q         GS  +MAPE+ +   Y 
Sbjct: 127 LIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYS 182
Query: 192 AKADLWSVGAILFQLVTGKTPF--TGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            K D++S G IL++++T + PF   G    +++  +   T    PP  K L    + L  
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLPKPIESLMT 239
Query: 250 KLLRRNPVERLTFEEF 265
           +   ++P +R + EE 
Sbjct: 240 RCWSKDPSQRPSMEEI 255

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 128/257 (49%), Gaps = 24/257 (9%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G GSF  V     +  G + A+K++       +L+     E+     +  P I+ L+ 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            +     +++ +E  +GG L   ++  GC+PE+ A +++ Q   GL+ L    ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC------GSPLYMAPEIMQLQKYDA 192
             N+LL +D  +AAL   DFG A  LQP GL + L       G+  +MAPE++  +  DA
Sbjct: 194 ADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDA 251
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC---- 248
           K D+WS   ++  ++ G  P+T   +  L   I  A+E   PP  + +   C  L     
Sbjct: 252 KVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKI--ASE---PPPVREIPPSCAPLTAQAI 306
Query: 249 QKLLRRNPVERLTFEEF 265
           Q+ LR+ P+ R++  E 
Sbjct: 307 QEGLRKEPIHRVSAAEL 323

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 131/256 (51%), Gaps = 27/256 (10%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G+F VV  A+ R    +VA+K+I     ++  +++ + E+  L R+NHP+I++L+  
Sbjct: 16  VGRGAFGVVCKAKWR--AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMK------QLAAGLQVLRDNN 131
              P  + L++EY +GG  S+Y   HG   +P  TA H M       Q  A L  ++   
Sbjct: 70  CLNP--VCLVMEYAEGG--SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           LIHRDLKP NLLL        LKI DFG A  +Q         GS  +MAPE+ +   Y 
Sbjct: 126 LIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFEGSNYS 181
Query: 192 AKADLWSVGAILFQLVTGKTPF--TGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            K D++S G IL++++T + PF   G    +++  +   T    PP  K L    + L  
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLPKPIESLMT 238
Query: 250 KLLRRNPVERLTFEEF 265
           +   ++P +R + EE 
Sbjct: 239 RCWSKDPSQRPSMEEI 254

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 137/278 (49%), Gaps = 13/278 (4%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPH 72
           + + R IG GSF  V   +        AMK +   + + +    ++  E+ I++ + HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++ L    +    + ++++   GGDL  ++Q++    EET K F+ +L   L  L++  +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK--- 189
           IHRD+KP N+LL   D++  + I DF  A  L       T+ G+  YMAPE+   +K   
Sbjct: 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 190 YDAKADLWSVGAILFQLVTGKTPF--TGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           Y    D WS+G   ++L+ G+ P+    S   + + +  + T + +P      S +   L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP---SAWSQEMVSL 250
Query: 248 CQKLLRRNPVERLT-FEEFFNHPFLSQTQPDQVFRSRM 284
            +KLL  NP +R +   +  N P+++    D VF+ R+
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRL 288

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 133/286 (46%), Gaps = 32/286 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS+ VV+  R+R  G  VA+K+      +  +++  + EI +LK++ HP+++ L +
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +     +LHL+ EYC    L    +    VPE   K    Q    +     +N IHRD+K
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQ-KYDAKADL 196
           P+N+L+     ++ +K+ DFGFAR L  P    +    +  Y +PE++    +Y    D+
Sbjct: 130 PENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA----------DCKD 246
           W++G +  +L++G   + G + +  L  I K      P   ++ S           D +D
Sbjct: 187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246
Query: 247 -----------------LCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                            L +  L  +P ERLT E+  +HP+    +
Sbjct: 247 MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 109
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   ++ +  G DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 168
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 169 DLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 226 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 285
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 286 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 158/305 (51%), Gaps = 53/305 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+  + +G G   +V+ A        VA+K+I +   + +  +  + EI I++R++H +I
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNI 70
Query: 74  IRLHDIIEVPGK--------------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           +++ +I+   G               ++++ EY +  DL+  +++ G + EE A+ FM Q
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQ 128
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RG-LAETLC 174
           L  GL+ +   N++HRDLKP NL + T+D    LKI DFG AR + P    +G L+E L 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTED--LVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 175 GSPLYMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----- 228
            +  Y +P  ++    Y    D+W+ G I  +++TGKT F G+++++ +Q I+++     
Sbjct: 187 -TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 229 -------------------TELHFPPDAKI--LSADCKDLCQKLLRRNPVERLTFEEFFN 267
                              TE H P    +  +S +  D  +++L  +P++RLT EE  +
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
Query: 268 HPFLS 272
           HP++S
Sbjct: 306 HPYMS 310

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 140/293 (47%), Gaps = 31/293 (10%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           L    +G G+++ V  A    +G E A+K I   +     +  +  E+  L +   + +I
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE--KQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           + L +  E   + +L+ E  +GG +  +IQ+     E  A   ++ +AA L  L    + 
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQ------PRGLAE--TLCGSPLYMAPEIM 185
           HRDLKP+N+L  + +  + +KI DF     ++      P    E  T CGS  YMAPE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 186 -----QLQKYDAKADLWSVGAILFQLVTGKTPFTG----------SNQIQLLQN----IV 226
                Q   YD + DLWS+G +L+ +++G  PF G              ++ QN     +
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 253
Query: 227 KATELHFP-PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           +  +  FP  D   +S++ KDL  KLL R+  +RL+  +   HP++    P++
Sbjct: 254 QEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEK 306

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 54  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 285 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 20/277 (7%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           GD +V   +G G++ +V+  R   +   +A+KEI     + +  + L  EI + K + H 
Sbjct: 25  GDRVV---LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHK 79
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVP--EETAKHFMKQLAAGLQVLR 128
           +I++        G + + +E   GG LS  ++ + G +   E+T   + KQ+  GL+ L 
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQL 187
           DN ++HRD+K  N+L+ T   +  LKI+DFG ++ L       ET  G+  YMAPEI+  
Sbjct: 140 DNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 188 --QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             + Y   AD+WS+G  + ++ TGK PF    + Q     V   ++H P   + +SA+ K
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAK 256
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL------SQTQP 276
               K    +P +R    +     FL       +TQP
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 54  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 285 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 54  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 285 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 34/287 (11%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+   ++G G+++ V+  + ++    VA+KEI +    +    + + E+ +LK + H +I
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANI 62
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNL 132
           + LHDII     L L+ EY    DL  Y+   G  +     K F+ QL  GL       +
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEI-MQLQKY 190
           +HRDLKPQNLL+   ++   LK+ADFG AR+   P    +    +  Y  P+I +    Y
Sbjct: 122 LHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHFP------------ 234
             + D+W VG I +++ TG+  F GS   + L  I +     TE  +P            
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 235 ----------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                       A  L +D  DL  KLL+     R++ E+   HPF 
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 7   KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 238 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 26  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 141 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 257 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++  G+  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP 182
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 133/266 (50%), Gaps = 14/266 (5%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           GD +V   +G G++ +V+  R   +   +A+KEI     + +  + L  EI + K + H 
Sbjct: 11  GDRVV---LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHK 65
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVP--EETAKHFMKQLAAGLQVLR 128
           +I++        G + + +E   GG LS  ++ + G +   E+T   + KQ+  GL+ L 
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQL 187
           DN ++HRD+K  N+L+ T   +  LKI+DFG ++ L       ET  G+  YMAPEI+  
Sbjct: 126 DNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183
Query: 188 --QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             + Y   AD+WS+G  + ++ TGK PF    + Q     V   ++H P   + +SA+ K
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAK 242
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
               K    +P +R    +     FL
Sbjct: 243 AFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 131/249 (52%), Gaps = 12/249 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+  E++ ++E  IL+++N   ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G    PE  A  +  ++  GL+ L    +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD+  ++I+D G A  +      +   G+  YMAPE+++ ++Y    
Sbjct: 310 RDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           D W++G +L++++ G++PF    +    + ++ +VK     +   ++  S   + LC +L
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSPQARSLCSQL 423
Query: 252 LRRNPVERL 260
           L ++P ERL
Sbjct: 424 LCKDPAERL 432

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 131/249 (52%), Gaps = 12/249 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+  E++ ++E  IL+++N   ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G    PE  A  +  ++  GL+ L    +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD+  ++I+D G A  +      +   G+  YMAPE+++ ++Y    
Sbjct: 310 RDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 195 DLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           D W++G +L++++ G++PF    +    + ++ +VK     +   ++  S   + LC +L
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSPQARSLCSQL 423
Query: 252 LRRNPVERL 260
           L ++P ERL
Sbjct: 424 LCKDPAERL 432

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 26  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 141 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMP 196
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 257 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G++ VV+ A+    G  VA+K I +   ++ +  + + EI +LK ++HP+I+ L D
Sbjct: 28  KVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I     L L+ E+ +     +  +    + +   K ++ QL  G+     + ++HRDLK
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 139 PQNLLLCTDDDNAALKIADFGFARS--LQPRGLAETLCGSPLYMAPEI-MQLQKYDAKAD 195
           PQNLL+ +D    ALK+ADFG AR+  +  R     +  +  Y AP++ M  +KY    D
Sbjct: 147 PQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 196 LWSVGAILFQLVTGKTPFTGSN---------------------QIQLLQNIVKATELHF- 233
           +WS+G I  +++TGK  F G                       Q+Q L    + T   F 
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 234 -PPDAKILSADCK---DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             P + I+   C+   DL   +L  +P +R++  +  NHP+     P
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 20/261 (7%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRI 68
            + D+ V R IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 69  NH---PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +    P I+ +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+
Sbjct: 246 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +  +++RDLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++
Sbjct: 306 HMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 361
Query: 186 QLQ-KYDAKADLWSVGAILFQLVTGKTPF-----TGSNQIQLLQNIVKATELHFPPDAKI 239
           Q    YD+ AD +S+G +LF+L+ G +PF        ++I  +  +  A EL   PD+  
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVEL---PDS-- 415
Query: 240 LSADCKDLCQKLLRRNPVERL 260
            S + + L + LL+R+   RL
Sbjct: 416 FSPELRSLLEGLLQRDVNRRL 436

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++  G+  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH       +P    K +M QL  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L       +   S  Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G++ VV+ A+    G  VA+K I +   ++ +  + + EI +LK ++HP+I+ L D
Sbjct: 28  KVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I     L L+ E+ +     +  +    + +   K ++ QL  G+     + ++HRDLK
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 139 PQNLLLCTDDDNAALKIADFGFARS--LQPRGLAETLCGSPLYMAPEI-MQLQKYDAKAD 195
           PQNLL+ +D    ALK+ADFG AR+  +  R     +  +  Y AP++ M  +KY    D
Sbjct: 147 PQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 196 LWSVGAILFQLVTGKTPFTGSN---------------------QIQLLQNIVKATELHF- 233
           +WS+G I  +++TGK  F G                       Q+Q L    + T   F 
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 234 -PPDAKILSADCK---DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             P + I+   C+   DL   +L  +P +R++  +  NHP+     P
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 20/261 (7%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRI 68
            + D+ V R IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 69  NH---PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +    P I+ +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +  +++RDLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++
Sbjct: 307 HMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 362
Query: 186 QLQ-KYDAKADLWSVGAILFQLVTGKTPF-----TGSNQIQLLQNIVKATELHFPPDAKI 239
           Q    YD+ AD +S+G +LF+L+ G +PF        ++I  +  +  A EL   PD+  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVEL---PDS-- 416
Query: 240 LSADCKDLCQKLLRRNPVERL 260
            S + + L + LL+R+   RL
Sbjct: 417 FSPELRSLLEGLLQRDVNRRL 437

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 20/261 (7%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRI 68
            + D+ V R IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 69  NH---PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +    P I+ +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +  +++RDLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++
Sbjct: 307 HMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 362
Query: 186 QLQ-KYDAKADLWSVGAILFQLVTGKTPF-----TGSNQIQLLQNIVKATELHFPPDAKI 239
           Q    YD+ AD +S+G +LF+L+ G +PF        ++I  +  +  A EL   PD+  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVEL---PDS-- 416
Query: 240 LSADCKDLCQKLLRRNPVERL 260
            S + + L + LL+R+   RL
Sbjct: 417 FSPELRSLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 20/261 (7%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL-MSEIFILKRI 68
            + D+ V R IG G F  V+  R    G   AMK +   R+  K  E+L ++E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 69  NH---PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +    P I+ +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +  +++RDLKP N+LL   D++  ++I+D G A     +    ++ G+  YMAPE++
Sbjct: 307 HMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 362
Query: 186 QLQ-KYDAKADLWSVGAILFQLVTGKTPF-----TGSNQIQLLQNIVKATELHFPPDAKI 239
           Q    YD+ AD +S+G +LF+L+ G +PF        ++I  +  +  A EL   PD+  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVEL---PDS-- 416
Query: 240 LSADCKDLCQKLLRRNPVERL 260
            S + + L + LL+R+   RL
Sbjct: 417 FSPELRSLLEGLLQRDVNRRL 437

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 10  KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 65
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 66  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 124
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 125 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 240
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 241 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++  G+  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH       +P    K +M QL  
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L       +   S  Y AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 89
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 148
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 149 DLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 206 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLL 265
Query: 232 HFPPDAKIL------SADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 142/289 (49%), Gaps = 31/289 (10%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +GR+   Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L 
Sbjct: 6   KGRI---YSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 61
Query: 67  RINH--PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++      IIRL+D       +++++E C   DL+ ++++   +     K + K +   +
Sbjct: 62  KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 120
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMA 181
             +  + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM 
Sbjct: 121 HTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 182 PEIMQ-----------LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT 229
           PE ++             K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+   
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 236
Query: 230 -ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS-QTQP 276
            E+ FP    I   D +D+ +  L+R+P +R++  E   HP++  QT P
Sbjct: 237 HEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 89
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 148
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 149 DLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 206 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLL 265
Query: 232 HFPPDAKIL------SADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 89
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 148
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 149 DLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 206 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 138/273 (50%), Gaps = 19/273 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLM-SEIFILKRIN 69
           D+ + + IG G+F  V  A  ++  TE   AMK +    + K+ + +    E  +L   +
Sbjct: 91  DFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGD 148
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLR 128
              I  LH   +    L+L+++Y  GGDL   + +    +PE+ A+ ++ ++   +  + 
Sbjct: 149 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             + +HRD+KP N+LL   D N  +++ADFG    +   G  ++    G+P Y++PEI+Q
Sbjct: 209 QLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 187 -----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
                + KY  + D WS+G  +++++ G+TPF   + ++    I+   E   FP     +
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDV 325
Query: 241 SADCKDLCQKLL--RRNPVERLTFEEFFNHPFL 271
           S + KDL Q+L+  R   + +   E+F  H F 
Sbjct: 326 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 358

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G GSF  V   + +  G + A+K++       +L+   + E+     ++ P I+ L+ 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            +     +++ +E  +GG L   I++ GC+PE+ A +++ Q   GL+ L    ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC------GSPLYMAPEIMQLQKYDA 192
             N+LL +D   AAL   DFG A  LQP GL ++L       G+  +MAPE++  +  DA
Sbjct: 178 ADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 193 KADLWSVGAILFQLVTGKTPFT 214
           K D+WS   ++  ++ G  P+T
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWT 257

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 17/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GSF  V+         EVA  E+   +L K  ++    E   LK + HP+I+R +D
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 79  IIE--VPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL--RDNNL 132
             E  V GK  + L+ E    G L  Y++R      +  + + +Q+  GLQ L  R   +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           IHRDLK  N+ +       ++KI D G A +L+    A+ + G+P + APE  + +KYD 
Sbjct: 153 IHRDLKCDNIFIT--GPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYE-EKYDE 208
Query: 193 KADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDA--KILSADCKDLCQ 249
             D+++ G    +  T + P++   N  Q+ + +    +    P +  K+   + K++ +
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEVKEIIE 264
Query: 250 KLLRRNPVERLTFEEFFNHPFLSQ 273
             +R+N  ER + ++  NH F  +
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 138/273 (50%), Gaps = 19/273 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLM-SEIFILKRIN 69
           D+ + + IG G+F  V  A  ++  TE   AMK +    + K+ + +    E  +L   +
Sbjct: 75  DFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLR 128
              I  LH   +    L+L+++Y  GGDL   + +    +PE+ A+ ++ ++   +  + 
Sbjct: 133 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             + +HRD+KP N+LL   D N  +++ADFG    +   G  ++    G+P Y++PEI+Q
Sbjct: 193 QLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 187 -----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
                + KY  + D WS+G  +++++ G+TPF   + ++    I+   E   FP     +
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDV 309
Query: 241 SADCKDLCQKLL--RRNPVERLTFEEFFNHPFL 271
           S + KDL Q+L+  R   + +   E+F  H F 
Sbjct: 310 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 342

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G GSF  V   + +  G + A+K++       +L+   + E+     ++ P I+ L+ 
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYG 133
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            +     +++ +E  +GG L   I++ GC+PE+ A +++ Q   GL+ L    ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC------GSPLYMAPEIMQLQKYDA 192
             N+LL +D   AAL   DFG A  LQP GL ++L       G+  +MAPE++  +  DA
Sbjct: 194 ADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 251
Query: 193 KADLWSVGAILFQLVTGKTPFT 214
           K D+WS   ++  ++ G  P+T
Sbjct: 252 KVDIWSSCCMMLHMLNGCHPWT 273

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 109
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 168
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 169 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 226 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 285
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 286 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 91
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 150
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 151 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 208 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 267
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 113
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 172 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 227
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 287
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 288 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 346

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G GSF  V   + +  G + A+K++       +L+   + E+     ++ P I+ L+ 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
            +     +++ +E  +GG L   I++ GC+PE+ A +++ Q   GL+ L    ++H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC------GSPLYMAPEIMQLQKYDA 192
             N+LL +D   AAL   DFG A  LQP GL ++L       G+  +MAPE++  +  DA
Sbjct: 192 ADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 249
Query: 193 KADLWSVGAILFQLVTGKTPFT 214
           K D+WS   ++  ++ G  P+T
Sbjct: 250 KVDIWSSCCMMLHMLNGCHPWT 271

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D + G  +G G F       HR  G  + MKE+   R +++ Q + + E+ +++ + HP+
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPN 68
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +++   ++    +L+ I EY KGG L   I+      P      F K +A+G+  L   N
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-----QPRGLAE----------TLCGS 176
           +IHRDL   N   C   +N  + +ADFG AR +     QP GL            T+ G+
Sbjct: 129 IIHRDLNSHN---CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLV 207
           P +MAPE++  + YD K D++S G +L +++
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 223
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 154
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 268
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 328
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 329 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 387

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 103
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 162 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 217
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 277
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 278 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 336

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 97
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 156
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 157 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 213
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 214 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 273
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 274 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 89
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 148
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 149 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 206 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 89
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 148
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 149 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 206 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 153 DLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 223
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 111
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 225
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 285
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 286 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 344

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 153 DLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL    H +II ++DI
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENIIGINDI 91
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 150
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 151 DLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 208 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLL 267
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L+Q
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 80
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSYIC-SRYYR 194
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 254
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 255 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 313

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 201
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 261
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 262 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 94
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 153
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 154 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 210
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 211 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 270
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 271 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 115/228 (50%), Gaps = 16/228 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIR 75
           +IG G++  V+ AR    G  VA+K + +    + L  S + E+ +L+R+    HP+++R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 76  LHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLR 128
           L D+          K+ L+ E+    DL  Y+ +     +P ET K  M+Q   GL  L 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            N ++HRDLKP+N+L+ +      +K+ADFG AR    +   + +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS 186
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
            Y    D+WSVG I  ++   K  F G+++   L  I     L  PP+
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL--PPE 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 95
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 154
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 155 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 211
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 212 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 271
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 272 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 86
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 145
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 146 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 203 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 262
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 263 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 153 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 94
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 208
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 268
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 269 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 327

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 88
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L       +   S  Y AP
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 264
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 265 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 321

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 201
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 261
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 262 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 87
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 146
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 147 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 204 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 263
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 264 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 153 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 209
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 83
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRHGCVPEET-----AKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH    ++T      K +M QL  
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 197
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 257
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 258 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 316

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 94
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 153
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 154 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 210
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 211 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 270
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 271 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 87
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 146
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 147 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 204 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLL 263
Query: 232 HFPPDAKIL------SADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 264 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 146/266 (54%), Gaps = 28/266 (10%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 12  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 68
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM---KQLAAGLQVLR 128
           +I+        P +L ++ ++C+G   S+Y   H    +   K  +   +Q A G+  L 
Sbjct: 69  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH 125
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMAPEI 184
             ++IHRDLK  N+ L  D+    +KI DFG A +++ R       E L GS L+MAPE+
Sbjct: 126 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 185 MQLQK---YDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKIL 240
           +++Q    Y  ++D+++ G +L++L+TG+ P++  +N+ Q+++ + + +     PD   +
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---LSPDLSKV 238
Query: 241 SADC----KDLCQKLLRRNPVERLTF 262
            ++C    K L  + L++   ER +F
Sbjct: 239 RSNCPKRMKRLMAECLKKKRDERPSF 264

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V+   VA+K+I+        Q +L  EI IL    H +II ++DI
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLAFRHENIIGINDI 91
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 150
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 151 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 208 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 267
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L+Q
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 131/295 (44%), Gaps = 43/295 (14%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE- 183
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L       +   S  Y APE 
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA--------------- 228
           I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K                
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 229 -TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP 182
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 135/299 (45%), Gaps = 51/299 (17%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 79
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSMYIQRH-----GCVPEETAKHFMKQLAA 122
           +RL       G+      L+L+L+Y    +    + RH       +P    K +M QL  
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYM 180
            L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y 
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYR 193
Query: 181 APE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------- 228
           APE I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K            
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 253
Query: 229 -----TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 254 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 312

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP 182
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 143/265 (53%), Gaps = 26/265 (9%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 24  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM---KQLAAGLQVLR 128
           +I+        P +L ++ ++C+G   S+Y   H    +   K  +   +Q A G+  L 
Sbjct: 81  NILLFMGYSTAP-QLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAPEIM 185
             ++IHRDLK  N+ L  D+    +KI DFG A        +   E L GS L+MAPE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 186 QLQK---YDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILS 241
           ++Q    Y  ++D+++ G +L++L+TG+ P++  +N+ Q+++ + + +     PD   + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---LSPDLSKVR 251
Query: 242 ADC----KDLCQKLLRRNPVERLTF 262
           ++C    K L  + L++   ER +F
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSF 276

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 76
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP 182
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y AP
Sbjct: 137 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYRAP 192
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 252
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 253 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 309

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IG+GSF VV+ A+    G  VA+K++   +  K        E+ I+++++H +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAGL 124
           +RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAP 182
             +    + HRD+KPQNLLL  D D A LK+ DFG A+ L  RG      +C S  Y AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV-RGEPNVSXIC-SRYYRAP 191
Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------- 228
           E I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 229 ---TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              TE  FP     P  K+       +   LC +LL   P  RLT  E   H F  +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 134/290 (46%), Gaps = 41/290 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+++I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           I  P     K   I++     DL   ++      +    +F+ Q+  GL+ +   N++HR
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSANVLHR 152
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK-Y 190
           DLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K Y
Sbjct: 153 DLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATEL 231
               D+WSVG IL ++++ +  F G + +  L +I+                   +   L
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 232 HFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 137/291 (47%), Gaps = 43/291 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   ++   VA+K+I+        Q +L  EI IL R  H +II ++DI
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 80  IEVPG----KLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           I  P     K   I++     DL   ++ +H  +  +   +F+ Q+  GL+ +   N++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMAPEIMQLQK- 189
           RDLKP NLLL T  D   LKI DFG AR   P     G       +  Y APEIM   K 
Sbjct: 152 RDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-------------------KATE 230
           Y    D+WSVG IL ++++ +  F G + +  L +I+                   +   
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 231 LHFPPDAKI------LSADCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L  P   K+       +AD K  DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 16/228 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIR 75
           +IG G++  V+ AR    G  VA+K + +    + L  S + E+ +L+R+    HP+++R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 76  LHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLR 128
           L D+          K+ L+ E+    DL  Y+ +     +P ET K  M+Q   GL  L 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            N ++HRDLKP+N+L+ +      +K+ADFG AR    +     +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS 186
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
            Y    D+WSVG I  ++   K  F G+++   L  I     L  PP+
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL--PPE 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 129/271 (47%), Gaps = 11/271 (4%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GSF  V+      H  EV   +I      +   E +  EI +L + + P+I R   
Sbjct: 26  RIGKGSFGEVYKGIDN-HTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
                 KL +I+EY  GG  ++ + + G + E      ++++  GL  L     IHRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIMQLQKYDAKADLW 197
             N+LL    D   +K+ADFG A  L    +      G+P +MAPE+++   YD KAD+W
Sbjct: 144 AANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIW 200
Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL-SADCKDLCQKLLRRNP 256
           S+G    +L  G+ P +  + +++L  I K +    PP  +   S   K+  +  L ++P
Sbjct: 201 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----PPTLEGQHSKPFKEFVEACLNKDP 256
Query: 257 VERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
             R T +E   H F+++      F + +  R
Sbjct: 257 RFRPTAKELLKHKFITRYTKKTSFLTELIDR 287

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----- 68
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++D    E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 69  ---LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGS 176
              L     N +IHRD+KP N+++   +   A+K+ DFG AR++   G + T    + G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +    V+  E   PP 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPS 240
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 66
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++D    E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 67  -AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGS 176
              L     N +IHRD+KP N+++   +   A+K+ DFG AR++   G + T    + G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +    V+  E   PP 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPS 240
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----- 68
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++D    E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 69  ---LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGS 176
              L     N +IHRD+KP N+L+   +   A+K+ DFG AR++   G +      + G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +    V+  E   PP 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPS 240
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 143/265 (53%), Gaps = 26/265 (9%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 24  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM---KQLAAGLQVLR 128
           +I+        P +L ++ ++C+G   S+Y   H    +   K  +   +Q A G+  L 
Sbjct: 81  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAPEIM 185
             ++IHRDLK  N+ L  D+    +KI DFG A        +   E L GS L+MAPE++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 186 QLQK---YDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILS 241
           ++Q    Y  ++D+++ G +L++L+TG+ P++  +N+ Q+++ + + +     PD   + 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---LSPDLSKVR 251
Query: 242 ADC----KDLCQKLLRRNPVERLTF 262
           ++C    K L  + L++   ER +F
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSF 276

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 134/292 (45%), Gaps = 17/292 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHPHIIRL 76
           R+IG GSF  V+ AR   +   VA+K+++  G+ + +  + ++ E+  L+++ HP+ I+ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                      L++EYC G    +       + E            GL  L  +N+IHRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKYDAK 193
           +K  N+LL    +   +K+ DFG A  + P   A    G+P +MAPE+   M   +YD K
Sbjct: 180 VKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D+WS+G    +L   K P    N +  L +I +         +   S   ++     L+
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQ 291
Query: 254 RNPVERLTFEEFFNHPFLSQTQP-----DQVFRSRMFSRSADDFPFYESKSV 300
           + P +R T E    H F+ + +P     D + R++   R  D+  + + K +
Sbjct: 292 KIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 11/272 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG GSF  V+          VA+K I +    +   E +  EI +L + +  ++ + +
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  KL +I+EY  GG  ++ + R G   E      +K++  GL  L     IHRD+
Sbjct: 88  GSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 146
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL    D   +K+ADFG A  L    +   T  G+P +MAPE++Q   YD+KAD+
Sbjct: 147 KAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKILSADCKDLCQKLLRRN 255
           WS+G    +L  G+ P +  + +++L  I K      PP      +   K+     L ++
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN----PPTLVGDFTKSFKEFIDACLNKD 259
Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
           P  R T +E   H F+ +      + + +  R
Sbjct: 260 PSFRPTAKELLKHKFIVKNSKKTSYLTELIDR 291

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  +IG+GSF  V   R   HG++VA+K +     + +     + E+ I+KR+ HP+
Sbjct: 38  DLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC---VPEETAKHFMKQLAAGLQVLRD 129
           I+     +  P  L ++ EY   G L   + + G    + E         +A G+  L +
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 130 NN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQ 186
            N  ++HRDLK  NLL+   D    +K+ DFG +R      L ++   G+P +MAPE+++
Sbjct: 156 RNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI-VKATELHFPPDAKILSADCK 245
            +  + K+D++S G IL++L T + P+   N  Q++  +  K   L  P   + L+    
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---RNLNPQVA 269
Query: 246 DLCQKLLRRNPVERLTFEEFFN--HPFLSQTQP 276
            + +      P +R +F    +   P +    P
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 33/290 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G++  V+ A   V    VA+K I +    + +  + + E+ +LK + H +II L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
           +I    +LHLI EY +  DL  Y+ ++  V     K F+ QL  G+        +HRDLK
Sbjct: 101 VIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 139 PQNLLLCTDD--DNAALKIADFGFARS--LQPRGLAETLCGSPLYMAPEIMQLQK-YDAK 193
           PQNLLL   D  +   LKI DFG AR+  +  R     +  +  Y  PEI+   + Y   
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS 218
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----HFP-----PDAK------ 238
            D+WS+  I  +++     F G ++I  L  I +   L     +P     PD K      
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF 278
Query: 239 -------ILSADCKDLCQK----LLRRNPVERLTFEEFFNHPFLSQTQPD 277
                  +L A   D        +L  +PV+R++ +    HP+ S    D
Sbjct: 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 16/228 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIR 75
           +IG G++  V+ AR    G  VA+K + +    + L  S + E+ +L+R+    HP+++R
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 76  LHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLR 128
           L D+          K+ L+ E+    DL  Y+ +     +P ET K  M+Q   GL  L 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            N ++HRDLKP+N+L+ +      +K+ADFG AR    +     +  +  Y APE++   
Sbjct: 130 ANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS 186
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
            Y    D+WSVG I  ++   K  F G+++   L  I     L  PP+
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL--PPE 232

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 95/315 (30%), Positives = 141/315 (44%), Gaps = 47/315 (14%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IG G++ +V  A   V  T VA+K+I+        Q +L  EI IL R  H ++I + DI
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTL-REIQILLRFRHENVIGIRDI 109
Query: 80  I-----EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           +     E    ++++ +  +  DL   ++      +    +F+ Q+  GL+ +   N++H
Sbjct: 110 LRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHIC-YFLYQILRGLKYIHSANVLH 167
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPR----GLAETLCGSPLYMAPEIMQLQK- 189
           RDLKP NLL+ T  D   LKI DFG AR   P     G       +  Y APEIM   K 
Sbjct: 168 RDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV-----------------KATEL- 231
           Y    D+WSVG IL ++++ +  F G + +  L +I+                 KA    
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYL 284
Query: 232 -HFPPDAKILSA------DCK--DLCQKLLRRNPVERLTFEEFFNHPFLSQ----TQPDQ 278
              P   K+  A      D K  DL  ++L  NP +R+T EE   HP+L Q    T    
Sbjct: 285 QSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPV 344
Query: 279 VFRSRMFSRSADDFP 293
                 F+   DD P
Sbjct: 345 AEEPFTFAMELDDLP 359

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 131/273 (47%), Gaps = 17/273 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  +IG+GSF  V   R   HG++VA+K +     + +     + E+ I+KR+ HP+
Sbjct: 38  DLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC---VPEETAKHFMKQLAAGLQVLRD 129
           I+     +  P  L ++ EY   G L   + + G    + E         +A G+  L +
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 130 NN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQ 186
            N  ++HR+LK  NLL+   D    +K+ DFG +R      L +++  G+P +MAPE+++
Sbjct: 156 RNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI-VKATELHFPPDAKILSADCK 245
            +  + K+D++S G IL++L T + P+   N  Q++  +  K   L  P   + L+    
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---RNLNPQVA 269
Query: 246 DLCQKLLRRNPVERLTFEEFFN--HPFLSQTQP 276
            + +      P +R +F    +   P +    P
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/330 (26%), Positives = 151/330 (45%), Gaps = 58/330 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   V G  VA+K+++    N+   +    E+ +LK +N
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 81
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    ++L++E     +L   I  H  +  E   + + Q+  G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--HMELDHERMSYLLYQMLCG 138
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 195
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI------------------ 225
           ++    Y A  D+WSVG I+ +LV G   F G++ I     +                  
Sbjct: 196 VILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 255
Query: 226 -------------VKATELH----FPPDA---KILSADCKDLCQKLLRRNPVERLTFEEF 265
                        +K  EL     FP ++   KI ++  +DL  K+L  +P +R++ +E 
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 266 FNHPFLS--------QTQPDQVFRSRMFSR 287
             HP+++        +  P Q++ +++  R
Sbjct: 316 LRHPYITVWYDPAEAEAPPPQIYDAQLEER 345

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 134/292 (45%), Gaps = 17/292 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHPHIIRL 76
           R+IG GSF  V+ AR   +   VA+K+++  G+ + +  + ++ E+  L+++ HP+ I+ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
                      L++EYC G    +       + E            GL  L  +N+IHRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQKYDAK 193
           +K  N+LL    +   +K+ DFG A  + P   A    G+P +MAPE+   M   +YD K
Sbjct: 141 VKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D+WS+G    +L   K P    N +  L +I +         +   S   ++     L+
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQ 252
Query: 254 RNPVERLTFEEFFNHPFLSQTQP-----DQVFRSRMFSRSADDFPFYESKSV 300
           + P +R T E    H F+ + +P     D + R++   R  D+  + + K +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 83
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++D    E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 84  -AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGS 176
              L     N +IHRD+KP N+++   +   A+K+ DFG AR++   G + T    + G+
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +    V+  E   PP 
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPS 257
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 258 ARHEGLSADLDAVVLKALAKNPENR 282

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 193
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 194 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 249
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 250 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 309
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 310 MAIFELLDYIVNEPPPKLP--SAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 367
Query: 276 PDQV 279
            ++V
Sbjct: 368 AEEV 371

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 149/330 (45%), Gaps = 58/330 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   V G  VA+K+++    N+   +    E+ +LK +N
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 79
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    ++L++E     +L   I  H  +  E   + + Q+  G
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--HMELDHERMSYLLYQMLCG 136
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTASTNFMMTPYVVTRYYRAPE 193
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-------------- 229
           ++    Y    D+WSVG I+ +LV G   F G++ I     +++                
Sbjct: 194 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPT 253
Query: 230 ---------------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEF 265
                                +  FP ++   KI ++  +DL  K+L  +P +R++ +E 
Sbjct: 254 VRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 266 FNHPFLS--------QTQPDQVFRSRMFSR 287
             HP+++        +  P Q++ +++  R
Sbjct: 314 LRHPYITVWYDPAEAEAPPPQIYDAQLEER 343

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 130/272 (47%), Gaps = 11/272 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG GSF  V+          VA+K I +    +   E +  EI +L + + P++ + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  KL +I+EY  GG  ++ +   G + E      ++++  GL  L     IHRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL    ++  +K+ADFG A  L    +   T  G+P +MAPE+++   YD+KAD+
Sbjct: 131 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRN 255
           WS+G    +L  G+ P +  + +++L  I K      PP  +   S   K+  +  L + 
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 243
Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
           P  R T +E   H F+ +      + + +  R
Sbjct: 244 PSFRPTAKELLKHKFILRNAKKTSYLTELIDR 275

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 136/262 (51%), Gaps = 19/262 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPH 72
           +L  R +G G F  V+  + +  G   A K++   RL K+   +  M E  IL +++   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLR 128
           I+ L    E    L L++    GGD+  +I    + +    E  A  +  Q+ +GL+ L 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             N+I+RDLKP+N+LL   DD+  ++I+D G A  L+  G  +T    G+P +MAPE++ 
Sbjct: 307 QRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKA-GQTKTKGYAGTPGFMAPELLL 362
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAKILSA 242
            ++YD   D +++G  L++++  + PF    +     +L Q +++    +  PD    S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDK--FSP 418
Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
             KD C+ LL+++P +RL F +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRD 440

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 132 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 248 MAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
Query: 276 PDQV 279
            ++V
Sbjct: 306 AEEV 309

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 129/251 (51%), Gaps = 16/251 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW A +  H T+VA+K +  G ++    E+ ++E  ++K + H  +++LH
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 249
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I E+   G L  +++      +   K   F  Q+A G+  +   N IHR
Sbjct: 250 AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+     +   KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 309 DLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +L ++VT G+ P+ G +  ++++ + +   +  P +      +  ++  +  
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC---PEELYNIMMRCW 422
Query: 253 RRNPVERLTFE 263
           +  P ER TFE
Sbjct: 423 KNRPEERPTFE 433

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 132 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 248 MAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
Query: 276 PDQV 279
            ++V
Sbjct: 306 AEEV 309

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 136/262 (51%), Gaps = 19/262 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPH 72
           +L  R +G G F  V+  + +  G   A K++   RL K+   +  M E  IL +++   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLR 128
           I+ L    E    L L++    GGD+  +I    + +    E  A  +  Q+ +GL+ L 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             N+I+RDLKP+N+LL   DD+  ++I+D G A  L+  G  +T    G+P +MAPE++ 
Sbjct: 307 QRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKA-GQTKTKGYAGTPGFMAPELLL 362
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAKILSA 242
            ++YD   D +++G  L++++  + PF    +     +L Q +++    +  PD    S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDK--FSP 418
Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
             KD C+ LL+++P +RL F +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRD 440

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 136/262 (51%), Gaps = 19/262 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPH 72
           +L  R +G G F  V+  + +  G   A K++   RL K+   +  M E  IL +++   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLR 128
           I+ L    E    L L++    GGD+  +I    + +    E  A  +  Q+ +GL+ L 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             N+I+RDLKP+N+LL   DD+  ++I+D G A  L+  G  +T    G+P +MAPE++ 
Sbjct: 307 QRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKA-GQTKTKGYAGTPGFMAPELLL 362
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAKILSA 242
            ++YD   D +++G  L++++  + PF    +     +L Q +++    +  PD    S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDK--FSP 418
Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
             KD C+ LL+++P +RL F +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRD 440

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----- 68
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++D    E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 69  ---LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGS 176
              L     N +IHRD+KP N+++   +   A+K+ DFG AR++   G + T    + G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG +   +    V+  E   PP 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR--EDPIPPS 240
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 132 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 248 MAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
Query: 276 PDQV 279
            ++V
Sbjct: 306 AEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 132 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 248 MAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
Query: 276 PDQV 279
            ++V
Sbjct: 306 AEEV 309

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 136/262 (51%), Gaps = 19/262 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILKRINHPH 72
           +L  R +G G F  V+  + +  G   A K++   RL K+   +  M E  IL +++   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLR 128
           I+ L    E    L L++    GGD+  +I    + +    E  A  +  Q+ +GL+ L 
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
             N+I+RDLKP+N+LL   DD+  ++I+D G A  L+  G  +T    G+P +MAPE++ 
Sbjct: 307 QRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKA-GQTKTKGYAGTPGFMAPELLL 362
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAKILSA 242
            ++YD   D +++G  L++++  + PF    +     +L Q +++    +  PD    S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDK--FSP 418
Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
             KD C+ LL+++P +RL F +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRD 440

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 125/256 (48%), Gaps = 11/256 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG GSF  V+          VA+K I +    +   E +  EI +L + + P++ + +
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  KL +I+EY  GG  ++ +   G + E      ++++  GL  L     IHRD+
Sbjct: 92  GSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 150
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL    ++  +K+ADFG A  L    +   T  G+P +MAPE+++   YD+KAD+
Sbjct: 151 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRN 255
           WS+G    +L  G+ P +  + +++L  I K      PP  +   S   K+  +  L + 
Sbjct: 208 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 263
Query: 256 PVERLTFEEFFNHPFL 271
           P  R T +E   H F+
Sbjct: 264 PSFRPTAKELLKHKFI 279

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 28  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 83
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 84  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 143 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 256
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 257 ERPEDRPTFDYLRSVLEDFFT 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 26  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 81
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 141 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 254
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 255 ERPEDRPTFDYLRSVLEDFFT 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 30  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 85
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 86  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 145 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 258
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 259 ERPEDRPTFDYLRSVLEDFFT 279

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 135/304 (44%), Gaps = 50/304 (16%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + ++HRD+
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y  ++D+W
Sbjct: 159 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L ++  G+ P    +                                        
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274
Query: 219 ---IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
               +LL  IV       P  + + S + +D   K L +NP ER   ++   H F+ ++ 
Sbjct: 275 MAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332
Query: 276 PDQV 279
            ++V
Sbjct: 333 AEEV 336

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 25  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 80
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 81  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 140 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 253
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 254 ERPEDRPTFDYLRSVLEDFFT 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 20  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 75
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 135 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 248
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFT 269

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 26  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 81
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 141 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 254
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 255 ERPEDRPTFDYLRSVLEDFFT 275

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 21  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 76
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 77  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 136 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 249
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 250 ERPEDRPTFDYLRSVLEDFFT 270

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 130 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 236
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 20  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 75
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 135 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 248
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFT 269

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 85  KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL 144
           + +L+ E  +GG +  +I +     E  A   ++ +A+ L  L +  + HRDLKP+N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 145 CTDDDNAALKIADFGFARSLQPRGLAE--------TLCGSPLYMAPEIM-----QLQKYD 191
              +  + +KI DFG    ++  G           T CGS  YMAPE++     +   YD
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 192 AKADLWSVGAILFQLVTGKTPFTG---------------SNQIQLLQNIVKATELHFP-P 235
            + DLWS+G IL+ L++G  PF G               + Q  L ++I +  +  FP  
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI-QEGKYEFPDK 263
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
           D   +S   KDL  KLL R+  +RL+  +   HP++    P+    + M
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPM 312

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 22/296 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG GSF  V+          VA+K I +    +   E +  EI +L + + P++ + +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  KL +I+EY  GG  ++ +   G + E      ++++  GL  L     IHRD+
Sbjct: 87  GSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL    ++  +K+ADFG A  L    +      G+P +MAPE+++   YD+KAD+
Sbjct: 146 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRN 255
           WS+G    +L  G+ P +  + +++L  I K      PP  +   S   K+  +  L + 
Sbjct: 203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 258
Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAESSQDDC 311
           P  R T +E   H F+ +      + + +  R             R  AE S DD 
Sbjct: 259 PSFRPTAKELLKHKFILRNAKKTSYLTELIDRYK-----------RWKAEQSHDDS 303

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 15  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 70
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 71  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 130 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 243
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 244 ERPEDRPTFDYLRSVLEDFFT 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 22  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 77
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 78  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 137 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 250
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 251 ERPEDRPTFDYLRSVLEDFFT 271

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 131 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 237
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 20  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 75
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 135 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 248
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFT 269

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 29  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 84
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 85  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 144 LRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 257
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 258 ERPEDRPTFDYLRSVLEDFFT 278

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 146 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 252
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 253 HLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 32/265 (12%)
Query: 14  YLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMG-----RLNKKLQESLMSEIFI 64
           Y +G  +G G  S V  AR    HR    +V   ++A       R  ++ Q +       
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA------- 66
Query: 65  LKRINHPHIIRLHDI--IEVP-GKL-HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
              +NHP I+ ++     E P G L ++++EY  G  L   +   G +  + A   +   
Sbjct: 67  -AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGS 176
              L     N +IHRD+KP N+++   +   A+K+ DFG AR++   G + T    + G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +    V+  E   PP 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPS 240
Query: 237 AK--ILSADCKDLCQKLLRRNPVER 259
           A+   LSAD   +  K L +NP  R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 145 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 251
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 130 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 236
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 131 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 237
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 173 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 279
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 131 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 237
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 165 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 271
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 137/269 (50%), Gaps = 24/269 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW      + T+VA+K +  G ++    ES + E  I+K++ H  +++L+
Sbjct: 15  KRLGNGQFGEVWMGTWNGN-TKVAIKTLKPGTMSP---ESFLEEAQIMKKLKHDKLVQLY 70
Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
            ++ E P  ++++ EY   G L  +++    R   +P         Q+AAG+  +   N 
Sbjct: 71  AVVSEEP--IYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYIERMNY 126
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKY 190
           IHRDL+  N+L+    +    KIADFG AR ++     A      P+ + APE     ++
Sbjct: 127 IHRDLRSANILV---GNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             K+D+WS G +L +LVT G+ P+ G N  ++L+ + +   +  P D  I   +    C 
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCW 243
Query: 250 KLLRRNPVERLTFEEF--FNHPFLSQTQP 276
           K   ++P ER TFE    F   + + T+P
Sbjct: 244 K---KDPEERPTFEYLQSFLEDYFTATEP 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 129/251 (51%), Gaps = 16/251 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW A +  H T+VA+K +  G ++    E+ ++E  ++K + H  +++LH
Sbjct: 21  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 76
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I E+   G L  +++      +   K   F  Q+A G+  +   N IHR
Sbjct: 77  AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+     +   KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 136 DLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +L ++VT G+ P+ G +  ++++ + +   +  P +      +  ++  +  
Sbjct: 193 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC---PEELYNIMMRCW 249
Query: 253 RRNPVERLTFE 263
           +  P ER TFE
Sbjct: 250 KNRPEERPTFE 260

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 146 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 252
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 253 HLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G+G++  V+  RH   G   A+K +    +    +E +  EI +LK+ +H   I  +  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 80  IEV----PG---KLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDN 130
             +    PG   +L L++E+C  G ++  I+  +   + EE   +  +++  GL  L  +
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQK 189
            +IHRD+K QN+LL    +NA +K+ DFG +  L +  G   T  G+P +MAPE++   +
Sbjct: 149 KVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 190 -----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
                YD K+DLWS+G    ++  G  P    + ++ L  I +         +K  S   
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--KSKKWSKKF 263
Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           +   +  L +N  +R   E+   HPF+ + QP++
Sbjct: 264 QSFIESCLVKNHSQRPATEQLMKHPFI-RDQPNE 296

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 158 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 274 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 330 VVSEEP--IYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 382 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 495
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 145 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 251
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 252 HLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 159 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSSECQ 265
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 159 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSSECQ 265
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 146 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 252
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 253 HLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 158 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSSECQ 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 129 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 235
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 129/272 (47%), Gaps = 11/272 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
            +IG GSF  V+          VA+K I +    +   E +  EI +L + + P++ + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
                  KL +I+EY  GG  ++ +   G + E      ++++  GL  L     IHRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL    ++  +K+ADFG A  L    +      G+P +MAPE+++   YD+KAD+
Sbjct: 131 KAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK-ILSADCKDLCQKLLRRN 255
           WS+G    +L  G+ P +  + +++L  I K      PP  +   S   K+  +  L + 
Sbjct: 188 WSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEACLNKE 243
Query: 256 PVERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
           P  R T +E   H F+ +      + + +  R
Sbjct: 244 PSFRPTAKELLKHKFILRNAKKTSYLTELIDR 275

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/304 (29%), Positives = 131/304 (43%), Gaps = 45/304 (14%)
Query: 5   TGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           TG  R +  Y   + IG+GSF VV+ A+  V   EVA+K++   +  K        E+ I
Sbjct: 34  TGEQREIA-YTNCKVIGNGSFGVVFQAK-LVESDEVAIKKVLQDKRFKN------RELQI 85
Query: 65  LKRINHPHIIRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKH 115
           ++ + HP+++ L       G       L+L+LEY           Y +    +P    K 
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
           +M QL   L  +    + HRD+KPQNLLL  D  +  LK+ DFG A+ L       +   
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 176 SPLYMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------ 228
           S  Y APE I     Y    D+WS G ++ +L+ G+  F G + I  L  I+K       
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 229 ----------TELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFNHP 269
                      E  FP     P +K+       D  DL  +LL   P  RLT  E   HP
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 270 FLSQ 273
           F  +
Sbjct: 324 FFDE 327

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 158 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSSECQ 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 126 CHNXGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 232
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT 274
            L +  L   P +R TFEE  NHP++   
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 126 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSSECQ 232
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 178 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 234
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 284
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 285 HLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 130/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 126 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S++C+
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSSECQ 232
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 158 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSXECQ 264
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 173 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 279
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 159 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSXECQ 265
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 247 VVSEEP--IYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 299 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 412
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 247 VVSEEP--IYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 299 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 412
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 159 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR----------VSXECQ 265
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 119/234 (50%), Gaps = 14/234 (5%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D ++G QIG G+F  V+  R R   T VA+K      L   L+   + E  ILK+ +HP+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           I+RL  +      +++++E  +GGD   +++  G  +  +T    +   AAG++ L    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPL-YMAPEIMQL 187
            IHRDL  +N   C   +   LKI+DFG +R  +  G+     G    P+ + APE +  
Sbjct: 234 CIHRDLAARN---CLVTEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP---PDA 237
            +Y +++D+WS G +L++  + G +P+   +  Q  + + K   L  P   PDA
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 21/266 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+++
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 70  --HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
                +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   ++ 
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
             +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ +Y  PE ++
Sbjct: 153 CHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 187 LQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +Y  + A +WS+G +L+ +V G  PF    +I   Q   +            +S +C+
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------VSXECQ 259
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            L +  L   P +R TFEE  NHP++
Sbjct: 260 HLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G+  VV   +HR  G  +A K I +  +   ++  ++ E+ +L   N P+I+  + 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                G++ + +E+  GG L   ++    +PEE        +  GL  LR+ + ++HRD+
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 141
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
           KP N+L+   +    +K+ DFG +  L    +A +  G+  YMAPE +Q   Y  ++D+W
Sbjct: 142 KPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERLQGTHYSVQSDIW 197
Query: 198 SVGAILFQLVTGKTPFTGSNQ--------------------------------------- 218
           S+G  L +L  G+ P    +                                        
Sbjct: 198 SMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 257
Query: 219 -------IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                   +LL  IV       P    + + D ++   K L +NP ER   +   NH F+
Sbjct: 258 SRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFI 315
Query: 272 SQTQPDQV 279
            +++ ++V
Sbjct: 316 KRSEVEEV 323

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 131/260 (50%), Gaps = 23/260 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 16  RLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 71
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHR+
Sbjct: 72  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 131 LRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 244
Query: 254 RNPVERLTF-------EEFF 266
             P +R TF       E+FF
Sbjct: 245 ERPEDRPTFDYLRSVLEDFF 264

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESL 58
           S AT R   V       +IG G++  V+ AR    G  VA+K + +         L  S 
Sbjct: 5   SMATSRYEPVA------EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58
Query: 59  MSEIFILKRIN---HPHIIRLHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHG--CV 108
           + E+ +L+R+    HP+++RL D+          K+ L+ E+    DL  Y+ +     +
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGL 117
Query: 109 PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           P ET K  M+Q   GL  L  N ++HRDLKP+N+L+ +      +K+ADFG AR    + 
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQM 174
Query: 169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA 228
               +  +  Y APE++    Y    D+WSVG I  ++   K  F G+++   L  I   
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 229 TELHFPPD 236
             L  PP+
Sbjct: 235 IGL--PPE 240

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 16  QEIGSGQFGLV-HLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 71
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L +  +IHRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 132 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     R
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWR 245
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 246 ERPEDRPAF 254

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 126/252 (50%), Gaps = 28/252 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW A +  H T+VA+K +  G ++    E+ ++E  ++K + H  +++LH
Sbjct: 188 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLH 243
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I E+   G L  +++      +   K   F  Q+A G+  +   N IHR
Sbjct: 244 AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL+  N+L+     +   KIADFG AR            G+     + APE +    +  
Sbjct: 303 DLRAANILVSA---SLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTI 348
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           K+D+WS G +L ++VT G+ P+ G +  ++++ + +   +  P +      +  ++  + 
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC---PEELYNIMMRC 405
Query: 252 LRRNPVERLTFE 263
            +  P ER TFE
Sbjct: 406 WKNRPEERPTFE 417

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 119/234 (50%), Gaps = 14/234 (5%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D ++G QIG G+F  V+  R R   T VA+K      L   L+   + E  ILK+ +HP+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           I+RL  +      +++++E  +GGD   +++  G  +  +T    +   AAG++ L    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPL-YMAPEIMQL 187
            IHRDL  +N   C   +   LKI+DFG +R  +  G+     G    P+ + APE +  
Sbjct: 234 CIHRDLAARN---CLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP---PDA 237
            +Y +++D+WS G +L++  + G +P+   +  Q  + + K   L  P   PDA
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 130/249 (52%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 13  QEIGSGQFGLV-HLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 68
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L + ++IHRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 129 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWK 242
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 243 ERPEDRPAF 251

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 36/284 (12%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRINHPHIIRL 76
           +G G F+ V+ AR +     VA+K+I +G  ++    +  + + EI +L+ ++HP+II L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEET-AKHFMKQLAAGLQVLRDNNLIHR 135
            D       + L+ ++ +  DL + I+ +  V   +  K +M     GL+ L  + ++HR
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           DLKP NLLL   D+N  LK+ADFG A+S   P         +  Y APE++   + Y   
Sbjct: 137 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVG 193
Query: 194 ADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKA----TELHFP-------------- 234
            D+W+VG IL +L+  + PF  G + +  L  I +     TE  +P              
Sbjct: 194 VDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 252
Query: 235 ---PDAKILSA---DCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
              P   I SA   D  DL Q L   NP  R+T  +     + S
Sbjct: 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 191 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 247 VVSEEP--IYIVGEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 299 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 412
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM-SEIFILKRINHP 71
           D+ + + IG G+FS V   + +  G   AMK +    + K+ + S    E  +L   +  
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDN 130
            I +LH   +    L+L++EY  GGDL   + + G  +P E A+ ++ ++   +  +   
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL--CGSPLYMAPEIMQ-- 186
             +HRD+KP N+LL   D    +++ADFG    L+  G   +L   G+P Y++PEI+Q  
Sbjct: 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 187 -----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
                   Y  + D W++G   +++  G+TPF   +  +    IV   E L  P   + +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 241 SADCKDLCQKLL--RRNPVERLTFEEFFNHPFL 271
             + +D  Q+LL      + R    +F  HPF 
Sbjct: 299 PEEARDFIQRLLCPPETRLGRGGAGDFRTHPFF 331

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 138/272 (50%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 65  NILLFMGYSTAP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 118
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 174
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 232
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 41/282 (14%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESLMSEIFILK 66
           GR + D+   + +G G F VV+ A+++V     A+K I +   N++L +E +M E+  L 
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALA 58
Query: 67  RINHPHIIRLHDIIEVPGK------------LHLILEYCKGGDLSMYIQRHGCVPEETAK 114
           ++ HP I+R  +                   L++ ++ C+  +L  ++    C  EE  +
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERER 117
Query: 115 ----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA 170
               H   Q+A  ++ L    L+HRDLKP N+    DD    +K+ DFG   ++      
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEE 174
Query: 171 ETL-------------CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN 217
           +T+              G+ LYM+PE +    Y  K D++S+G ILF+L+    PF  S 
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPF--ST 229
Query: 218 QIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
           Q++ ++ +     L FPP           + Q +L  +P+ER
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 138/272 (50%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 91
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 92  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 145
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 146 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 201
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 259
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 260 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 291

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 22  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM--------KQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 78  VVSEEP--IYIVTEYMNKGSLLDFLKG------ETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 130 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALY 186
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 243
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 244 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 138/272 (50%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 93  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 146
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 202
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 260
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 261 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 18  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 73
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 74  VVSEEP--IYIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 126 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 182
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 183 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 239
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 240 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 271

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 14  QEIGSGQFGLV-HLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 69
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L +  +IHRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 130 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     R
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWR 243
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 244 ERPEDRPAF 252

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 130/261 (49%), Gaps = 23/261 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G+G    VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL+ 
Sbjct: 20  RLGAGQAGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 75
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--HFMKQLAAGLQVLRDNNLIHRD 136
           ++     +++I EY + G L  +++    +     K      Q+A G+  + + N IHRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L+  N+L+    D  + KIADFG AR ++     A      P+ + APE +    +  K+
Sbjct: 135 LRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +          LC K   
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK--- 248
Query: 254 RNPVERLTF-------EEFFN 267
             P +R TF       E+FF 
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFT 269

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 22  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 77
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM--------KQLAAGLQVLRD 129
           ++ E P  ++++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 78  VVSEEP--IYIVTEYMNKGSLLDFLKG------ETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 130 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 186
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 243
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 244 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 139/272 (51%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 13  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 70  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 123
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 179
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 237
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 142/310 (45%), Gaps = 55/310 (17%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  +     G ++A+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 177
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 178 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNMT 232
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS------------ 241
            D+WSVG I+ +L+TG+T F G++ I  LQ I++ T     P A ++S            
Sbjct: 233 VDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGT---PPASVISRMPSHEARNYIN 289
Query: 242 ----------AD--------CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ---------T 274
                     AD          DL +K+L  +  +R+T  E   HP+ SQ         +
Sbjct: 290 SLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDEPES 349
Query: 275 QP-DQVFRSR 283
           +P DQ F SR
Sbjct: 350 EPYDQSFESR 359

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 30/229 (13%)
Query: 85  KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL 144
           + +L+ E  +GG +  +I +     E  A   ++ +A+ L  L +  + HRDLKP+N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 145 CTDDDNAALKIADFGFARSLQPRGLAE--------TLCGSPLYMAPEIM-----QLQKYD 191
              +  + +KI DF     ++  G           T CGS  YMAPE++     +   YD
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 192 AKADLWSVGAILFQLVTGKTPFTG---------------SNQIQLLQNIVKATELHFP-P 235
            + DLWS+G IL+ L++G  PF G               + Q  L ++I +  +  FP  
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI-QEGKYEFPDK 263
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
           D   +S   KDL  KLL R+  +RL+  +   HP++    P+    + M
Sbjct: 264 DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPM 312

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 139/272 (51%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 13  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 70  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 123
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 179
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 237
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 145/322 (45%), Gaps = 58/322 (18%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 128 NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 184
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 185 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361
Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 362 WYDPAEVEAPPPQIYDKQLDER 383

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 139/272 (51%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 10  GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 66
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 67  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 120
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 121 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 176
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 234
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 235 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 134/258 (51%), Gaps = 16/258 (6%)
Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + R IG+G F  V   R ++ G     VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPN 105
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++ L  ++     + +++E+ + G L  ++++H G          ++ +AAG++ L D  
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG +R ++  P  +  T  G  P+ + APE +Q 
Sbjct: 166 YVHRDLAARNILV---NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +K+ + +D+WS G +++++++ G+ P+   +   +++ I +   L  P D     A    
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDC---PAGLHQ 279
Query: 247 LCQKLLRRNPVERLTFEE 264
           L     ++   ER  FE+
Sbjct: 280 LMLDCWQKERAERPKFEQ 297

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 136/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  +++++EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K+I H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKIRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 136/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  +++++EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 14/217 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G +VA+K++     ++   +    E+ +LK + H ++I L D+
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 80  IEVPGKL------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
                 L      +L++ +  G DL   + +H  + E+  +  + Q+  GL+ +    +I
Sbjct: 93  FTPDETLDDFTDFYLVMPFM-GTDLGK-LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQLQKYDA 192
           HRDLKP NL +   +++  LKI DFG AR          +  +  Y APE I+   +Y  
Sbjct: 151 HRDLKPGNLAV---NEDCELKILDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQ 205
Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT 229
             D+WSVG I+ +++TGKT F GS+ +  L+ I+K T
Sbjct: 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 13  QEIGSGQFGLV-HLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 68
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L +  +IHRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 129 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWK 242
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 243 ERPEDRPAF 251

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   +E  + E  ++ +++HP +++L+
Sbjct: 11  QEIGSGQFGLV-HLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 66
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L +  +IHRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 127 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWK 240
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 241 ERPEDRPAF 249

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +L+   +G G+ + V+  RH+  G   A+K        + + +  M E  +LK++NH +I
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNI 69
Query: 74  IRLHDIIEVPGKLH--LILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVL 127
           ++L  I E     H  LI+E+C  G L   ++     +G +PE      ++ +  G+  L
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHL 128
Query: 128 RDNNLIHRDLKPQNLL-LCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           R+N ++HR++KP N++ +  +D  +  K+ DFG AR L+      +L G+  Y+ P++ +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 187 --------LQKYDAKADLWSVGAILFQLVTGKTPF 213
                    +KY A  DLWS+G   +   TG  PF
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 138/272 (50%), Gaps = 32/272 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 65  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 118
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA----ETLCGSPLYMA 181
            L   ++IHRDLK  N+ L  D     +KI DFG A +++ R       E L GS L+MA
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 174
Query: 182 PEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           PE++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD  
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLS 232
Query: 239 ILSADC----KDLCQKLLRRNPVERLTFEEFF 266
            + ++C    K L  + L++   ER  F +  
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 324 WYDPAEVEAPPPQIYDKQLDERE 346

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 138/300 (46%), Gaps = 52/300 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       +++++E     +LS  IQ    +  E   + + Q+  G++ L   
Sbjct: 90  NVF-TPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA 145
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D   A LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT--------------------- 229
               D+WSVG I+ +++ G   F G++ I     +++                       
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 230 --------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                         ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 138/300 (46%), Gaps = 52/300 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       +++++E     +LS  IQ    +  E   + + Q+  G++ L   
Sbjct: 90  NVF-TPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA 145
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D   A LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT--------------------- 229
               D+WSVG I+ +++ G   F G++ I     +++                       
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 230 --------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                         ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 134/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 192 KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGNMSP---EAFLQEAQVMKKLRHEKLVQLYA 247
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 248 VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 303
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG  R ++     A      P+ + APE     ++ 
Sbjct: 304 HRDLRAANILV---GENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 417
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 418 CWRKDPEERPTFEYLQAFLEDYFTSTEP 445

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 30/271 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 93  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 146
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAP 182
            L   ++IHRDLK  N+ L  D     +KI DFG A        +   E L GS L+MAP
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203
Query: 183 EIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           E++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD   
Sbjct: 204 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSK 261
Query: 240 LSADC----KDLCQKLLRRNPVERLTFEEFF 266
           + ++C    K L  + L++   ER  F +  
Sbjct: 262 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 132/272 (48%), Gaps = 32/272 (11%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 15  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 70
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF--------MKQLAAGLQVLRD 129
           ++ E P  + ++ EY   G L  +++       ET K+           Q+A+G+  +  
Sbjct: 71  VVSEEP--IXIVTEYMSKGSLLDFLKG------ETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL-YMAPEIMQL 187
            N +HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE    
Sbjct: 123 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALY 179
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         D
Sbjct: 180 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHD 236
Query: 247 LCQKLLRRNPVERLTFE--EFFNHPFLSQTQP 276
           L  +  R+ P ER TFE  + F   + + T+P
Sbjct: 237 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 268

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 30/271 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKW--HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 84
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 85  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 138
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAP 182
            L   ++IHRDLK  N+ L  D     +KI DFG A        +   E L GS L+MAP
Sbjct: 139 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195
Query: 183 EIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           E++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD   
Sbjct: 196 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSK 253
Query: 240 LSADC----KDLCQKLLRRNPVERLTFEEFF 266
           + ++C    K L  + L++   ER  F +  
Sbjct: 254 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 126/275 (45%), Gaps = 23/275 (8%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMS--EIFILKRI 68
           +Y +G  +G G F  V+         +VA+K I   R+     L +S+    E+ +L ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 69  N----HPHIIRLHDIIEVPGKLHLILEY-CKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
                HP +IRL D  E      L+LE      DL  YI   G + E  ++ F  Q+ A 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           +Q      ++HRD+K +N+L+  D      K+ DFG    L      +   G+ +Y  PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPE 208
Query: 184 IMQLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
            +   +Y A  A +WS+G +L+ +V G  PF         Q I++A ELHFP     +S 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEA-ELHFPAH---VSP 258
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           DC  L ++ L   P  R + EE    P++     D
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 16  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 71
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 72  VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 127
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 128 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 241
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 242 CWRKDPEERPTFEYLQAFLEDYFTSTEP 269

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +L+   +G G+ + V+  RH+  G   A+K        + + +  M E  +LK++NH +I
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNI 69
Query: 74  IRLHDIIEVPGKLH--LILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVL 127
           ++L  I E     H  LI+E+C  G L   ++     +G +PE      ++ +  G+  L
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHL 128
Query: 128 RDNNLIHRDLKPQNLL-LCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           R+N ++HR++KP N++ +  +D  +  K+ DFG AR L+       L G+  Y+ P++ +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 187 --------LQKYDAKADLWSVGAILFQLVTGKTPF 213
                    +KY A  DLWS+G   +   TG  PF
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 14  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 69
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 70  VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 125
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 126 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 239
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 240 CWRKDPEERPTFEYLQAFLEDYFTSTEP 267

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 138/300 (46%), Gaps = 52/300 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 78  DIIEVPGK-------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           ++   P K       +++++E     +LS  IQ    +  E   + + Q+  G++ L   
Sbjct: 90  NVF-TPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLVGIKHLHSA 145
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLKP N+++ +D   A LKI DFG AR+     +      +  Y APE++    Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT--------------------- 229
               D+WSVG I+ +++ G   F G++ I     +++                       
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 230 --------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                         ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 136/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  +++++EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 145/322 (45%), Gaps = 58/322 (18%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 128 NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 184
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 185 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361
Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 362 WYDPAEVEAPPPQIYDKQLDER 383

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 145/322 (45%), Gaps = 58/322 (18%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323
Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 324 WYDPAEVEAPPPQIYDKQLDER 345

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 145/322 (45%), Gaps = 58/322 (18%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 89  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 145
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 146 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 202
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 203 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 262
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 263 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 322
Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 323 WYDPAEVEAPPPQIYDKQLDER 344

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 145/322 (45%), Gaps = 58/322 (18%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 91  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 148 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 205 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 265 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 324
Query: 273 -------QTQPDQVFRSRMFSR 287
                  +  P Q++  ++  R
Sbjct: 325 WYDPAEVEAPPPQIYDKQLDER 346

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 138/299 (46%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +LS  IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D   A LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 148/330 (44%), Gaps = 58/330 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +N
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCG 139
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI------------------------ 219
           ++    Y    D+WSVG I+ ++V  K  F G + I                        
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 220 --QLLQNIVKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEF 265
               ++N  K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++ 
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 266 FNHPFLS--------QTQPDQVFRSRMFSR 287
             HP+++        +  P Q++  ++  R
Sbjct: 317 LQHPYINVWYDPAEVEAPPPQIYDKQLDER 346

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 129/249 (51%), Gaps = 14/249 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           ++IGSG F +V H  + ++  +VA+K I  G ++   ++  + E  ++ +++HP +++L+
Sbjct: 33  QEIGSGQFGLV-HLGYWLNKDKVAIKTIKEGSMS---EDDFIEEAEVMMKLSHPKLVQLY 88
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            +      + L+ E+ + G LS Y++ + G    ET       +  G+  L +  +IHRD
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPL-YMAPEIMQLQKYDAKA 194
           L  +N   C   +N  +K++DFG  R  L  +  + T    P+ + +PE+    +Y +K+
Sbjct: 149 LAARN---CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 195 DLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
           D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     +     +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWK 262
Query: 254 RNPVERLTF 262
             P +R  F
Sbjct: 263 ERPEDRPAF 271

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 148/330 (44%), Gaps = 58/330 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +N
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCG 138
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI------------------------ 219
           ++    Y    D+WSVG I+ ++V  K  F G + I                        
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 220 --QLLQNIVKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEF 265
               ++N  K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++ 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 266 FNHPFLS--------QTQPDQVFRSRMFSR 287
             HP+++        +  P Q++  ++  R
Sbjct: 316 LQHPYINVWYDPAEVEAPPPQIYDKQLDER 345

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 136/271 (50%), Gaps = 30/271 (11%)
Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  + + HG +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 8   GQITVGQRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMK------QLAAGLQ 125
           +I+        P +L ++ ++C+G   S+Y   H     ET    +K      Q A G+ 
Sbjct: 65  NILLFMGYSTKP-QLAIVTQWCEGS--SLYHHLHII---ETKFEMIKLIDIARQTAQGMD 118
Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA---ETLCGSPLYMAP 182
            L   ++IHRDLK  N+ L  D     +KI DFG A        +   E L GS L+MAP
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175
Query: 183 EIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           E++++Q    Y  ++D+++ G +L++L+TG+ P++  N     Q I      +  PD   
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSK 233
Query: 240 LSADC----KDLCQKLLRRNPVERLTFEEFF 266
           + ++C    K L  + L++   ER  F +  
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 324 WYDPAEVEAPPPQIYDKQLDERE 346

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 84  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 141 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 317
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 318 WYDPAEVEAPPPQIYDKQLDERE 340

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 84  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 141 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 317
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 318 WYDPAEVEAPPPQIYDKQLDERE 340

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 120/224 (53%), Gaps = 17/224 (7%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + R IG+G F  V   R ++ G     VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 84
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           II L  ++     + ++ EY + G L  +++++ G          ++ ++AG++ L D  
Sbjct: 85  IIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMG 144
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE +  
Sbjct: 145 YVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE 230
           +K+ + +D+WS G +++++V+ G+ P+         Q+++KA E
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTN----QDVIKAVE 241

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 83  NVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 139
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 140 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 317 WYDPAEVEAPPPQIYDKQLDERE 339

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 138/299 (46%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +LS  IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D   A LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 145/323 (44%), Gaps = 58/323 (17%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    ++L++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 83  NVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME--LDHERMSYLLYQMLXGIKHLHSAG 139
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 140 IIHRDLKPSNIVVKSD---XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI--------------------------QLLQNI 225
              D+WSVG I+ ++V  K  F G + I                            ++N 
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 226 VKATELHFP---PDA---------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS- 272
            K   L FP   PD+         K+ ++  +DL  K+L  +P +R++ ++   HP+++ 
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316
Query: 273 -------QTQPDQVFRSRMFSRS 288
                  +  P Q++  ++  R 
Sbjct: 317 WYDPAEVEAPPPQIYDKQLDERE 339

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL   N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLAAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 114/209 (54%), Gaps = 18/209 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMG------RLNKKLQESLMSEIFILKRINHP 71
           +QIG G F +V   R     + VA+K + +G       + +K QE    E+FI+  +NHP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE-FQREVFIMSNLNHP 83
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           +I++L+ ++  P ++  ++E+   GDL    + +   +        M  +A G++ +++ 
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 131 N--LIHRDLKPQNLLLCTDDDNAAL--KIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           N  ++HRDL+  N+ L + D+NA +  K+ADFG ++  Q       L G+  +MAPE + 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIG 199
Query: 186 -QLQKYDAKADLWSVGAILFQLVTGKTPF 213
            + + Y  KAD +S   IL+ ++TG+ PF
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 21/247 (8%)
Query: 20  IGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IGSG    V + R RV G     VA+K +  G   ++ +   +SE  I+ + +HP+IIRL
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIRL 115
Query: 77  HDIIEVPGKLHLIL-EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
             ++   G+L +I+ EY + G L  +++ H G          ++ + AG++ L D   +H
Sbjct: 116 EGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQLQKY 190
           RDL  +N+L+   D N   K++DFG +R L+  P     T  G  P+ + APE +  + +
Sbjct: 175 RDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 191 DAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFP---PDA-KILSADC- 244
            + +D+WS G ++++ L  G+ P+       ++ ++ +   L  P   P A   L  DC 
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCW 291
Query: 245 -KDLCQK 250
            KD  Q+
Sbjct: 292 HKDRAQR 298

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++L+ 
Sbjct: 25  KLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 79  II-EVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           ++ E P  ++++ EY   G L  +++    ++  +P+        Q+A+G+  +   N +
Sbjct: 81  VVSEEP--IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVERMNYV 136
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYD 191
           HRDL+  N+L+    +N   K+ADFG AR ++     A      P+ + APE     ++ 
Sbjct: 137 HRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL  +
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQ 250
Query: 251 LLRRNPVERLTFE--EFFNHPFLSQTQP 276
             R++P ER TFE  + F   + + T+P
Sbjct: 251 CWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 21/247 (8%)
Query: 20  IGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IGSG    V + R RV G     VA+K +  G   ++ +   +SE  I+ + +HP+IIRL
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIRL 115
Query: 77  HDIIEVPGKLHLIL-EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
             ++   G+L +I+ EY + G L  +++ H G          ++ + AG++ L D   +H
Sbjct: 116 EGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQLQKY 190
           RDL  +N+L+   D N   K++DFG +R L+  P     T  G  P+ + APE +  + +
Sbjct: 175 RDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 191 DAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFP---PDA-KILSADC- 244
            + +D+WS G ++++ L  G+ P+       ++ ++ +   L  P   P A   L  DC 
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCW 291
Query: 245 -KDLCQK 250
            KD  Q+
Sbjct: 292 HKDRAQR 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 125/251 (49%), Gaps = 15/251 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW   +  + T+VA+K +  G ++    ++ + E  ++K + H  ++RL+
Sbjct: 19  KRLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLY 74
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I EY   G L  +++    G V       F  Q+A G+  +   N IHR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+    ++   KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 135 DLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +D+WS G +L+++VT GK P+ G     ++  + +   +   P  +    +  D+ +   
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM---PRVENCPDELYDIMKMCW 248
Query: 253 RRNPVERLTFE 263
           +    ER TF+
Sbjct: 249 KEKAEERPTFD 259

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMG------RLNKKLQESLMSEIFILKRINHP 71
           +QIG G F +V   R     + VA+K + +G       + +K QE    E+FI+  +NHP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE-FQREVFIMSNLNHP 83
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           +I++L+ ++  P ++  ++E+   GDL    + +   +        M  +A G++ +++ 
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 131 N--LIHRDLKPQNLLLCTDDDNAAL--KIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           N  ++HRDL+  N+ L + D+NA +  K+ADFG   S Q       L G+  +MAPE + 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--TSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 186 -QLQKYDAKADLWSVGAILFQLVTGKTPF 213
            + + Y  KAD +S   IL+ ++TG+ PF
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 145/334 (43%), Gaps = 78/334 (23%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y + +++G G++ +VW +  R  G  VA+K+I     N    +    EI IL  ++
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 70  -HPHIIRLHDIIEVPG--KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
            H +I+ L +++       ++L+ +Y +  DL   I+ +   P    ++ + QL   ++ 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVH-KQYVVYQLIKVIKY 124
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ---------PRGLAET----- 172
           L    L+HRD+KP N+LL  +     +K+ADFG +RS           P  + E      
Sbjct: 125 LHSGGLLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 173 --------LCGSPLYMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ 223
                      +  Y APEI +   KY    D+WS+G IL +++ GK  F GS+ +  L+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 224 NIVKATELHFP----------PDAKIL-------------------------------SA 242
            I+   +  FP          P AK +                                A
Sbjct: 242 RIIGVID--FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 243 DCK----DLCQKLLRRNPVERLTFEEFFNHPFLS 272
           DC     DL  KLL+ NP +R++  +   HPF+S
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+    +GSG++  V  A  +  G +VA+K+++    ++   +    E+ +LK + H ++
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 74  IRLHDIIEVPGKL------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L D+      L      +L++ + +  DL   +       EE  ++ + Q+  GL+ +
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGME--FSEEKIQYLVYQMLKGLKYI 160
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQ 186
               ++HRDLKP NL +   +++  LKI DFG AR          +  +  Y APE I+ 
Sbjct: 161 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 215
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL------ 240
              Y+   D+WSVG I+ +++TGKT F G + +  L  I+K T +   P  + +      
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV---PGTEFVQKLNDK 272
Query: 241 ------------------------SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                   S    DL +K+L  +  +RLT  +   HPF 
Sbjct: 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +LS  IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG AR L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 126/242 (52%), Gaps = 17/242 (7%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IG G F  V   R +V G     VA+K +  G  +K+ +   +SE  I+ + +HP+
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           II L  ++     + +I EY + G L  +++++ G          ++ + +G++ L D +
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 130
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE +  
Sbjct: 131 YVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI----LSA 242
           +K+ + +D+WS G +++++++ G+ P+   +   +++ I +   L  P D  I    L  
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 247
Query: 243 DC 244
           DC
Sbjct: 248 DC 249

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 126/242 (52%), Gaps = 17/242 (7%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IG G F  V   R +V G     VA+K +  G  +K+ +   +SE  I+ + +HP+
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 76
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           II L  ++     + +I EY + G L  +++++ G          ++ + +G++ L D +
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 136
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE +  
Sbjct: 137 YVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI----LSA 242
           +K+ + +D+WS G +++++++ G+ P+   +   +++ I +   L  P D  I    L  
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 253
Query: 243 DC 244
           DC
Sbjct: 254 DC 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 126/242 (52%), Gaps = 17/242 (7%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IG G F  V   R +V G     VA+K +  G  +K+ +   +SE  I+ + +HP+
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 91
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           II L  ++     + +I EY + G L  +++++ G          ++ + +G++ L D +
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE +  
Sbjct: 152 AVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI----LSA 242
           +K+ + +D+WS G +++++++ G+ P+   +   +++ I +   L  P D  I    L  
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 268
Query: 243 DC 244
           DC
Sbjct: 269 DC 270

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 140/285 (49%), Gaps = 40/285 (14%)
Query: 13  DYLVGRQIGSGSFSVV-----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           + ++G+ +G G F  V     +H + R   T VA+K +       +L++ L+SE  +LK+
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQ 82
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV------------------P 109
           +NHPH+I+L+      G L LI+EY K G L  +++    V                  P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 110 EETAK------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS 163
           +E A        F  Q++ G+Q L + +L+HRDL  +N+L+    +   +KI+DFG +R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKISDFGLSRD 199
Query: 164 L--QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI 219
           +  +   +  +    P+ +MA E +    Y  ++D+WS G +L+++VT G  P+ G    
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +L  N++K       PD    S +   L  +  ++ P +R  F +
Sbjct: 260 RLF-NLLKTGHRMERPDN--CSEEMYRLMLQCWKQEPDKRPVFAD 301

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI----AMGRLNKKLQES-----LMSEIFI 64
           Y V R I SGS+  V  A     G  VA+K +    + GR    L +S     ++ EI +
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 65  LKRINHPHIIRLHDII---EVPG--KLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFM 117
           L   +HP+I+ L DI    E P   KL+L+ E  +  DL+  I  QR    P+   ++FM
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHI-QYFM 140
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +  GL VL +  ++HRDL P N+LL    DN  + I DF  AR               
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 178 LYMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------- 229
            Y APE +MQ + +    D+WS G ++ ++   K  F GS     L  IV+         
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 230 -ELHFPPDAK------------------ILSAD--CKDLCQKLLRRNPVERLTFEEFFNH 268
             +   P A+                  + +AD    DL  K+L  NP  R++ E+   H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 269 PFL 271
           P+ 
Sbjct: 318 PYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 132/303 (43%), Gaps = 51/303 (16%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI----AMGRLNKKLQES-----LMSEIFI 64
           Y V R I SGS+  V  A     G  VA+K +    + GR    L +S     ++ EI +
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 65  LKRINHPHIIRLHDII---EVPG--KLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFM 117
           L   +HP+I+ L DI    E P   KL+L+ E  +  DL+  I  QR    P+   ++FM
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHI-QYFM 140
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +  GL VL +  ++HRDL P N+LL    DN  + I DF  AR               
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 178 LYMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------- 229
            Y APE +MQ + +    D+WS G ++ ++   K  F GS     L  IV+         
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 230 -ELHFPPDAK------------------ILSAD--CKDLCQKLLRRNPVERLTFEEFFNH 268
             +   P A+                  + +AD    DL  K+L  NP  R++ E+   H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 269 PFL 271
           P+ 
Sbjct: 318 PYF 320

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 118/244 (48%), Gaps = 23/244 (9%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ--ESLMSEIFILKRINHPHIIRLH 77
           IG G F  V+ A     G EVA+K           Q  E++  E  +   + HP+II L 
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL---IH 134
            +      L L++E+ +GG L+  +     +P +   ++  Q+A G+  L D  +   IH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 135 RDLKPQNLLLCT-----DDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
           RDLK  N+L+       D  N  LKI DFG AR    R    +  G+  +MAPE+++   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAAGAYAWMAPEVIRASM 190
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-------PDAKILSA 242
           +   +D+WS G +L++L+TG+ PF G + + +    V   +L  P       P AK++  
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-VAMNKLALPIPSTCPEPFAKLME- 248
Query: 243 DCKD 246
           DC +
Sbjct: 249 DCWN 252

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 48/295 (16%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+    +GSG++  V  A  +  G +VA+K+++    ++   +    E+ +LK + H ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 74  IRLHDIIEVPGKL------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L D+      L      +L++ + +  DL   +       EE  ++ + Q+  GL+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYI 142
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQ 186
               ++HRDLKP NL +   +++  LKI DFG AR          +  +  Y APE I+ 
Sbjct: 143 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 197
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL------ 240
              Y+   D+WSVG I+ +++TGKT F G + +  L  I+K T +   P  + +      
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV---PGTEFVQKLNDK 254
Query: 241 ------------------------SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                   S    DL +K+L  +  +RLT  +   HPF 
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 20  IGSGSFSVVWHARHRVHGTEV-----AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           IG G+F  V  AR +  G  +      MKE A    +K        E+ +L ++ +HP+I
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNI 88
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA----------------KHFM 117
           I L    E  G L+L +EY   G+L  ++++   +  + A                 HF 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  Q   + +T+   P
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLP 204
Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L  P 
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 264
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           +      +  DL ++  R  P ER +F +  
Sbjct: 265 NC---DDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 78
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 136
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 137 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 242

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 112/209 (53%), Gaps = 5/209 (2%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G GS+ +V   R++  G  VA+K+      +K +++  M EI +LK++ H +++ L ++
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP 139
            +   + +L+ E+     L         +  +  + ++ Q+  G+     +N+IHRD+KP
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152
Query: 140 QNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLW 197
           +N+L+     +  +K+ DFGFAR+L  P  + +    +  Y APE++    KY    D+W
Sbjct: 153 ENILVSQ---SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVW 209
Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIV 226
           ++G ++ ++  G+  F G + I  L +I+
Sbjct: 210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 95
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 153
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 154 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 259

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMG------RLNKKLQESLMSEIFILKRINHP 71
           +QIG G F +V   R     + VA+K + +G       + +K QE    E+FI+  +NHP
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE-FQREVFIMSNLNHP 83
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           +I++L+ ++  P ++  ++E+   GDL    + +   +        M  +A G++ +++ 
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 131 N--LIHRDLKPQNLLLCTDDDNAAL--KIADFGFARSLQPRGLAETLCGSPLYMAPEIM- 185
           N  ++HRDL+  N+ L + D+NA +  K+ADF  ++  Q       L G+  +MAPE + 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPETIG 199
Query: 186 -QLQKYDAKADLWSVGAILFQLVTGKTPF 213
            + + Y  KAD +S   IL+ ++TG+ PF
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 138/283 (48%), Gaps = 40/283 (14%)
Query: 13  DYLVGRQIGSGSFSVV-----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           + ++G+ +G G F  V     +H + R   T VA+K +       +L++ L+SE  +LK+
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQ 82
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV------------------P 109
           +NHPH+I+L+      G L LI+EY K G L  +++    V                  P
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 110 EETAK------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS 163
           +E A        F  Q++ G+Q L +  L+HRDL  +N+L+    +   +KI+DFG +R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRD 199
Query: 164 L--QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI 219
           +  +   +  +    P+ +MA E +    Y  ++D+WS G +L+++VT G  P+ G    
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
           +L  N++K       PD    S +   L  +  ++ P +R  F
Sbjct: 260 RLF-NLLKTGHRMERPDN--CSEEMYRLMLQCWKQEPDKRPVF 299

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 373 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 432
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 433 IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 491
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 492 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 608
Query: 248 C 248
           C
Sbjct: 609 C 609

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 25/268 (9%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           + +GR +G G F  V  A+ +       +VA+K +    +     E  + E   +K  +H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 71  PHIIRLHDII---EVPGKL---HLILEYCKGGDLSMYI--QRHG----CVPEETAKHFMK 118
           PH+ +L  +       G+L    +IL + K GDL  ++   R G     +P +T   FM 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
            +A G++ L   N IHRDL  +N +L  D     + +ADFG +R +         C S L
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 179 ---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
              ++A E +    Y   +D+W+ G  +++++T G+TP+ G    ++   ++    L  P
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP 261
Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTF 262
           P+      +  DL  +    +P +R +F
Sbjct: 262 PECM---EEVYDLMYQCWSADPKQRPSF 286

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 105
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 163
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 164 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 269

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 372 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 431
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 432 IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 491 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 607
Query: 248 C 248
           C
Sbjct: 608 C 608

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 20  IGSGSFSVVWHARHRVHGTEV-----AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           IG G+F  V  AR +  G  +      MKE A    +K        E+ +L ++ +HP+I
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNI 78
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA----------------KHFM 117
           I L    E  G L+L +EY   G+L  ++++   +  + A                 HF 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  Q   + +T+   P
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLP 194
Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L  P 
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 254
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           +      +  DL ++  R  P ER +F +  
Sbjct: 255 NC---DDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 125/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 124/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ EY + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG  R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 15  LVGRQIGSGSFSVV-----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           ++G+ +G G F  V     +H + R   T VA+K +       +L++ L+SE  +LK++N
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVN 84
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV------------------PEE 111
           HPH+I+L+      G L LI+EY K G L  +++    V                  P+E
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 112 TAK------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL- 164
            A        F  Q++ G+Q L +  L+HRDL  +N+L+    +   +KI+DFG +R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVY 201
Query: 165 -QPRGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQL 221
            +   +  +    P+ +MA E +    Y  ++D+WS G +L+++VT G  P+ G    +L
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
             N++K       PD    S +   L  +  ++ P +R  F
Sbjct: 262 F-NLLKTGHRMERPDN--CSEEMYRLMLQCWKQEPDKRPVF 299

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 145/309 (46%), Gaps = 55/309 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-SLMSEIFILKRI 68
           +  D+ +   +G G++ VV  A H+  G  VA+K+I     +K L     + EI ILK  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHF 66
Query: 69  NHPHIIRLHDI-----IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
            H +II + +I      E   ++++I E  +  DL   I     + ++  ++F+ Q    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRA 124
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------------QPRGLAE 171
           ++VL  +N+IHRDLKP NLL+   + N  LK+ DFG AR +            Q  G+ E
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 172 TLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIV- 226
            +  +  Y APE+M    KY    D+WS G IL +L   +  F G +   Q+ L+  I+ 
Sbjct: 182 XV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 227 --------------KATE----LHFPPDAKI------LSADCKDLCQKLLRRNPVERLTF 262
                         +A E    L   P A +      ++    DL Q++L  +P +R+T 
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 263 EEFFNHPFL 271
           +E   HP+L
Sbjct: 301 KEALEHPYL 309

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 148
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 149 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYK 205
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----------------------- 228
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 206 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 265
Query: 229 ------------TELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 266 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 324

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 139/307 (45%), Gaps = 50/307 (16%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +N
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    +++++E     +L   IQ    +  E   + + Q+  G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCG 138
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     + E    +  Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-------------- 229
           ++    Y    DLWSVG I+ ++V  K  F G + I     +++                
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 230 ---------------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEF 265
                                ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 266 FNHPFLS 272
             HP+++
Sbjct: 316 LQHPYIN 322

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 30  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 89
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 90  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 148
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 149 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 265
Query: 248 C 248
           C
Sbjct: 266 C 266

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 30  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 89
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 90  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 148
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 149 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 265
Query: 248 C 248
           C
Sbjct: 266 C 266

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 144/309 (46%), Gaps = 55/309 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-SLMSEIFILKRI 68
           +  D+ +   +G G++ VV  A H+  G  VA+K+I     +K L     + EI ILK  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHF 66
Query: 69  NHPHIIRLHDI-----IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
            H +II + +I      E   ++++I E  +  DL   I     + ++  ++F+ Q    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRA 124
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------------QPRGLAE 171
           ++VL  +N+IHRDLKP NLL+   + N  LK+ DFG AR +            Q  G+ E
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 172 TLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIV- 226
               +  Y APE+M    KY    D+WS G IL +L   +  F G +   Q+ L+  I+ 
Sbjct: 182 -FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 227 --------------KATE----LHFPPDAKI------LSADCKDLCQKLLRRNPVERLTF 262
                         +A E    L   P A +      ++    DL Q++L  +P +R+T 
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 263 EEFFNHPFL 271
           +E   HP+L
Sbjct: 301 KEALEHPYL 309

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/309 (29%), Positives = 145/309 (46%), Gaps = 55/309 (17%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-SLMSEIFILKRI 68
           +  D+ +   +G G++ VV  A H+  G  VA+K+I     +K L     + EI ILK  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHF 66
Query: 69  NHPHIIRLHDI-----IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
            H +II + +I      E   ++++I E  +  DL   I     + ++  ++F+ Q    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRA 124
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------------QPRGLAE 171
           ++VL  +N+IHRDLKP NLL+   + N  LK+ DFG AR +            Q  G+ E
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 172 TLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIV- 226
            +  +  Y APE+M    KY    D+WS G IL +L   +  F G +   Q+ L+  I+ 
Sbjct: 182 YV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 227 --------------KATE----LHFPPDAKI------LSADCKDLCQKLLRRNPVERLTF 262
                         +A E    L   P A +      ++    DL Q++L  +P +R+T 
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 263 EEFFNHPFL 271
           +E   HP+L
Sbjct: 301 KEALEHPYL 309

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 91  NVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 148 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 28  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 87
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 88  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 146
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 147 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 263
Query: 248 C 248
           C
Sbjct: 264 C 264

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 90  NVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 146
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 147 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              D+WSVG I+ +++ G   F G++ I     +++                        
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 125/251 (49%), Gaps = 15/251 (5%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F  VW   +  + T+VA+K +  G ++    ++ + E  ++K + H  ++RL+
Sbjct: 18  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLY 73
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            ++     +++I E+   G L  +++    G V       F  Q+A G+  +   N IHR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQLQKYDAK 193
           DL+  N+L+    ++   KIADFG AR ++     A      P+ + APE +    +  K
Sbjct: 134 DLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 194 ADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
           +++WS G +L+++VT GK P+ G     ++  + +   +   P  +    +  D+ +   
Sbjct: 191 SNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM---PRMENCPDELYDIMKMCW 247
Query: 253 RRNPVERLTFE 263
           +    ER TF+
Sbjct: 248 KEKAEERPTFD 258

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 14  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 73
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 74  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 133 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 249
Query: 248 C 248
           C
Sbjct: 250 C 250

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 14  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 73
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 74  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 133 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 249
Query: 248 C 248
           C
Sbjct: 250 C 250

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 80  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 139 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 255
Query: 248 C 248
           C
Sbjct: 256 C 256

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 127/238 (53%), Gaps = 11/238 (4%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPHIIR 75
           +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N +HR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQKYD 191
           DL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   K+ 
Sbjct: 130 DLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +LC
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 244

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      +    +     +  L++ L++E  +++++++P+
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E    + L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 70  IVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQ 188
           +HRDL  +N+LL T       KI+DFG +++L   +    A+T    P+ + APE +   
Sbjct: 129 VHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        D  +L
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245
Query: 248 C 248
           C
Sbjct: 246 C 246

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 139/307 (45%), Gaps = 50/307 (16%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +N
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    +++++E     +L   IQ    +  E   + + Q+  G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCG 138
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     + E    +  Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-------------- 229
           ++    Y    D+WSVG I+ ++V  K  F G + I     +++                
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPT 255
Query: 230 ---------------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEF 265
                                ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E 
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 266 FNHPFLS 272
             HP+++
Sbjct: 316 LQHPYIN 322

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 61  EIFILKRIN--HPHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFM 117
           E+ +LK+++     +IRL D  E P    LILE  +   DL  +I   G + EE A+ F 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
            Q+   ++   +  ++HRD+K +N+L+  D +   LK+ DFG + +L    +     G+ 
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFG-SGALLKDTVYTDFDGTR 220
Query: 178 LYMAPEIMQLQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
           +Y  PE ++  +Y  + A +WS+G +L+ +V G  PF    +I   Q   +         
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------- 273
Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              +S++C+ L +  L   P +R TFEE  NHP++
Sbjct: 274 ---VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G F  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 68
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 127 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP-------EGCP 236
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 277

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 135/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 95  NVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 151
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 152 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 208
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              DLWSVG I+ ++V  K  F G + I     +++                        
Sbjct: 209 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 268
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 269 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 327

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 20  IGSGSFSVVWHARHRVHGTEV-----AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHI 73
           IG G+F  V  AR +  G  +      MKE A    +K        E+ +L ++ +HP+I
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNI 85
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA----------------KHFM 117
           I L    E  G L+L +EY   G+L  ++++   +  + A                 HF 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +A G+  L     IHR+L  +N+L+    +N   KIADFG +R  Q   + +T+   P
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLP 201
Query: 178 L-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
           + +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L  P 
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 261
Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           +      +  DL ++  R  P ER +F +  
Sbjct: 262 NC---DDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 135/299 (45%), Gaps = 50/299 (16%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +II L 
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 78  DI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++      +E    +++++E     +L   IQ    +  E   + + Q+  G++ L    
Sbjct: 84  NVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG 140
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE++    Y 
Sbjct: 141 IIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 197
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---------------------- 229
              DLWSVG I+ ++V  K  F G + I     +++                        
Sbjct: 198 ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 257
Query: 230 -------------ELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        ++ FP D+   K+ ++  +DL  K+L  +  +R++ +E   HP+++
Sbjct: 258 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 316

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I+E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I+E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 131/262 (50%), Gaps = 30/262 (11%)
Query: 18  RQIGSGSFSVVWH------ARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINH 70
           R IG G F VV+H      A++R+   + A+K  ++ R+ +  Q E+ + E  +++ +NH
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRI---QCAIK--SLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 71  PHIIRLHDIIEVP-GKLHLILEYCKGGDLSMYI---QRHGCVPEETAKHFMKQLAAGLQV 126
           P+++ L  I+  P G  H++L Y   GDL  +I   QR+  V +  +  F  Q+A G++ 
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS--FGLQVARGMEY 139
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL----CGSPL-YMA 181
           L +   +HRDL  +N   C  D++  +K+ADFG AR +  R             P+ + A
Sbjct: 140 LAEQKFVHRDLAARN---CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
            E +Q  ++  K+D+WS G +L++L+T G  P+   +   L   + +   L   P  +  
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---PQPEYC 253
Query: 241 SADCKDLCQKLLRRNPVERLTF 262
                 + Q+    +P  R TF
Sbjct: 254 PDSLYQVMQQCWEADPAVRPTF 275

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 68
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 127 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLA 183
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP-------EGCP 236
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 277

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 121/238 (50%), Gaps = 17/238 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           ++G G+F  V    +R+   +  VA+K +  G   K   E +M E  I+ ++++P+I+RL
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMY-IQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             + +    L L++E   GG L  + + +   +P       + Q++ G++ L + N +HR
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQKYD 191
           DL  +N+LL    +    KI+DFG +++L        A +    PL + APE +  +K+ 
Sbjct: 135 DLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 192 AKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK----ILSADC 244
           +++D+WS G  +++ L  G+ P+      +++  I +   +  PP+       L +DC
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 249

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 126/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 68
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I+E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 127 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP-------EGCP 236
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAE 259

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 37/278 (13%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IGSG F  V+ A+HR+ G    +K +          E    E+  L +++H +I+  +  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 80  I-------EVPGK---------LHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLA 121
                   E   K         L + +E+C  G L  +I+  R   + +  A    +Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
            G+  +    LI+RDLKP N+ L    D   +KI DFG   SL+  G      G+  YM+
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 182 PEIMQLQKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           PE +  Q Y  + DL+++G IL +L+    T F  S            T+L     + I 
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF---------TDLRDGIISDIF 240
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
               K L QKLL + P +R    E      + +  P++
Sbjct: 241 DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 123/246 (50%), Gaps = 26/246 (10%)
Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V     ++ G     VA+K +  G   K+ +   +SE  I+ + +HP++I L
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNVIHL 99
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + +I E+ + G L  ++ Q  G          ++ +AAG++ L D N +HR
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-----PL-YMAPEIMQLQK 189
           DL  +N+L+   + N   K++DFG +R L+      T   +     P+ + APE +Q +K
Sbjct: 160 DLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF--PPDAKILSADCKD 246
           + + +D+WS G +++++++ G+ P+         Q+++ A E  +  PP       DC  
Sbjct: 217 FTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQDYRLPP-----PMDCPS 267
Query: 247 LCQKLL 252
              +L+
Sbjct: 268 ALHQLM 273

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+F  V+ ARHR  G +VA+K++ M    +    + + EI IL+ + H +++ L +
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 79  IIEVP--------GKLHLILEYCK---GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I            G ++L+ ++C+    G LS  + +         K  M+ L  GL  +
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQMLLNGLYYI 141
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLAETLCGSPLYMA 181
             N ++HRD+K  N+L+  D     LK+ADFG AR+       QP      +  +  Y  
Sbjct: 142 HRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 182 PEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPD 236
           PE++  ++ Y    DLW  G I+ ++ T ++P    N    Q+ L+  +  +      P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 237 -------------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                    A +      DL  KLL  +P +R+  ++  NH F 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 124/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 78
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ E  + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 136
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 137 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 242

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 134 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 243
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 284

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 71
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I+E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 130 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 186
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 239
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 280

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 123/250 (49%), Gaps = 31/250 (12%)
Query: 18  RQIGSGSFSVV---WHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRIN 69
           R +GSG++  V   + AR R        +++A+ +L++  Q  + +     E+ +LK + 
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--------QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H ++I L D+      IE   +++L+     G DL+  ++    + +E  +  + QL  G
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKSQ-ALSDEHVQFLVYQLLRG 143
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           L+ +    +IHRDLKP N+ +  D +   L+I DFG AR  Q          +  Y APE
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDSE---LRILDFGLAR--QADEEMTGYVATRWYRAPE 198
Query: 184 IM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKILS 241
           IM     Y+   D+WSVG I+ +L+ GK  F GS+ I  L+ I++      P   AKI S
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 258
Query: 242 ADCKDLCQKL 251
              +   Q L
Sbjct: 259 EHARTYIQSL 268

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 124/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ E  + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 128/252 (50%), Gaps = 26/252 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + ++  +IGSGSF  V+  +   HG +VA+K + +     +  ++  +E+ +L++  H +
Sbjct: 37  EVMLSTRIGSGSFGTVYKGKW--HG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM-----KQLAAGLQVL 127
           I+     +     L ++ ++C+G  L     +H  V E   + F      +Q A G+  L
Sbjct: 94  ILLFMGYM-TKDNLAIVTQWCEGSSLY----KHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----LAETLCGSPLYMAPE 183
              N+IHRD+K  N+ L    +   +KI DFG A +++ R       E   GS L+MAPE
Sbjct: 149 HAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLA-TVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 184 IMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           ++++Q    +  ++D++S G +L++L+TG+ P++  N     Q I      +  PD   L
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGYASPDLSKL 262
Query: 241 SADCKDLCQKLL 252
             +C    ++L+
Sbjct: 263 YKNCPKAMKRLV 274

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 139/307 (45%), Gaps = 50/307 (16%)
Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V+  Y   + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +N
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H +II L ++      +E    +++++E     +L   IQ    +  E   + + Q+  G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME--LDHERMSYLLYQMLCG 138
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ L    +IHRDLKP N+++ +D     LKI DFG AR+     +      +  Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPEVVTRYYRAPE 195
Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA--------------- 228
           ++    Y    D+WSVG I+ +++ G   F G++ I     +++                
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 229 --------------------TELHFPPDAK---ILSADCKDLCQKLLRRNPVERLTFEEF 265
                                ++ FP D++   + ++  +DL  K+L  +  +R++ +E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 266 FNHPFLS 272
             HP+++
Sbjct: 316 LQHPYIN 322

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 127/265 (47%), Gaps = 18/265 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI-LKRINHPHIIRLH 77
           ++G G++ VV   RH   G  +A+K I    +N + Q+ L+ ++ I ++ ++ P  +  +
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 78  DIIEVPGKLHLILEYCKGGDLSMY---IQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLI 133
             +   G + + +E         Y   I +   +PE+        +   L+ L    ++I
Sbjct: 117 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-CGSPLYMAPE----IMQLQ 188
           HRD+KP N+L+   +    +K+ DFG +  L    +A+T+  G   YMAPE     +  +
Sbjct: 177 HRDVKPSNVLI---NALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 189 KYDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
            Y  K+D+WS+G  + +L   + P+ +     Q L+ +V+      P D    SA+  D 
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK--FSAEFVDF 290
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLS 272
             + L++N  ER T+ E   HPF +
Sbjct: 291 TSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 24/269 (8%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G++  V    H+  G  +A+K I      K+ ++ LM    +++  + P+I++ + 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGC----VPEETAKHFMKQLAAGLQVLRDN-NLI 133
            +   G   + +E         Y   +      +PEE            L  L++N  +I
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ----LQK 189
           HRD+KP N+LL   D +  +K+ DFG +  L          G   YMAPE +      Q 
Sbjct: 149 HRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQI--QLLQNIVKATELHFPP-----DAKILSA 242
           YD ++D+WS+G  L++L TG+ P+   N +  QL Q +VK      PP     + +  S 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-VVKGD----PPQLSNSEEREFSP 260
Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
              +     L ++  +R  ++E   HPF+
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 131/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 277
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E +     +   Q+++ ++ L 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHR+L  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 336 KKNFIHRNLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 445
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+F  V+ ARHR  G +VA+K++ M    +    + + EI IL+ + H +++ L +
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 79  IIEVP--------GKLHLILEYCK---GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I            G ++L+ ++C+    G LS  + +         K  M+ L  GL  +
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQMLLNGLYYI 141
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLAETLCGSPLYMA 181
             N ++HRD+K  N+L+  D     LK+ADFG AR+       QP      +  +  Y  
Sbjct: 142 HRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 182 PEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPD 236
           PE++  ++ Y    DLW  G I+ ++ T ++P    N    Q+ L+  +  +      P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 237 -------------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                    A +      DL  KLL  +P +R+  ++  NH F 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 95/383 (24%), Positives = 164/383 (42%), Gaps = 104/383 (27%)
Query: 3   QATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE-----S 57
           Q      V  +Y++   IG GS+  V+ A  +   TE   K +A+ ++N+  ++      
Sbjct: 17  QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDK--NTE---KNVAIKKVNRMFEDLIDCKR 71
Query: 58  LMSEIFILKRINHPHIIRLHDIIEVPG------KLHLILEYCKGGDLSMYIQRHGCVPEE 111
           ++ EI IL R+   +IIRL+D+I +P       +L+++LE     DL    +    + EE
Sbjct: 72  ILREITILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEE 129
Query: 112 TAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----- 166
             K  +  L  G   + ++ +IHRDLKP N LL  D    ++K+ DFG AR++       
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD---CSVKVCDFGLARTINSEKDTN 186
Query: 167 ---------------RGLAETLCG---SPLYMAPEIMQLQK-YDAKADLWSVGAILFQLV 207
                          + L + L     +  Y APE++ LQ+ Y    D+WS G I  +L+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 208 ----------TGKTP-FTGS--------------------NQIQLLQNI----------- 225
                     T + P F GS                    +Q+ ++ NI           
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN 306
Query: 226 ------VKATELHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                 +K  +L FP    I        +S D  +L + +L+ NP +R+T ++  +HP+L
Sbjct: 307 INKPEVIKYIKL-FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
Query: 272 SQTQPDQV--FRSRMFSRSADDF 292
              +  ++  F ++      DD+
Sbjct: 366 KDVRKKKLENFSTKKIILPFDDW 388

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 124/233 (53%), Gaps = 23/233 (9%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++   +   VA+K + +G   K+ +   + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPN 107
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF---MKQLAAGLQVLRD 129
           IIRL  ++     + ++ E  + G L  ++++H    + T       ++ +A+G++ L D
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEIM 185
              +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + +PE +
Sbjct: 166 MGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE--LHFPP 235
             +K+ + +D+WS G +L+++++ G+ P+   +     Q+++KA +     PP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGYRLPP 271

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 130/325 (40%), Gaps = 75/325 (23%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +G+ +G+GSF +V        G   A+K++      K        E+ I+K ++H +I
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------RELDIMKVLDHVNI 62
Query: 74  IRLHDIIEVPGK--------------------------------------LHLILEYCKG 95
           I+L D     G                                       L++I+EY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 96  G---DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA 152
                L  +I+    +P      ++ QL   +  +    + HRD+KPQNLL+ + D+   
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--T 180
Query: 153 LKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKT 211
           LK+ DFG A+ L P   +     S  Y APE+M    +Y    DLWS+G +  +L+ GK 
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 212 PFTGSNQIQLLQNIVKA----------------TELHFPPDA-----KILSADCK----D 246
            F+G   I  L  I++                 TE+ FP        KIL         D
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 247 LCQKLLRRNPVERLTFEEFFNHPFL 271
           L +++LR  P  R+   E   HPF 
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 11/274 (4%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           ++GSG+   VW  R R  G  +A+K++      ++ +  LM    +LK  + P+I++   
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDL 137
                  + + +E        +  +  G +PE         +   L  L++ + +IHRD+
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ-----LQKYDA 192
           KP N+LL   D+   +K+ DFG +  L      +   G   YMAPE +         YD 
Sbjct: 152 KPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 193 KADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           +AD+WS+G  L +L TG+ P+       ++L  +++  E    P     S D +   +  
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDC 267
Query: 252 LRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMF 285
           L ++  +R  + +   H F+ + +  +V  +  F
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWF 301

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 125/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I+E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 134 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 243
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAE 266

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+F  V+ ARHR  G +VA+K++ M    +    + + EI IL+ + H +++ L +
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 79  IIEVP--------GKLHLILEYCK---GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I            G ++L+ ++C+    G LS  + +         K  M+ L  GL  +
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQMLLNGLYYI 140
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLAETLCGSPLYMA 181
             N ++HRD+K  N+L+  D     LK+ADFG AR+       QP      +  +  Y  
Sbjct: 141 HRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 196
Query: 182 PEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPD 236
           PE++  ++ Y    DLW  G I+ ++ T ++P    N    Q+ L+  +  +      P+
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 237 -------------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                    A +      DL  KLL  +P +R+  ++  NH F 
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 121/238 (50%), Gaps = 17/238 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           ++G G+F  V    +R+   +  VA+K +  G   K   E +M E  I+ ++++P+I+RL
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMY-IQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             + +    L L++E   GG L  + + +   +P       + Q++ G++ L + N +HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPL-YMAPEIMQLQKYD 191
           +L  +N+LL    +    KI+DFG +++L        A +    PL + APE +  +K+ 
Sbjct: 461 NLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 192 AKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK----ILSADC 244
           +++D+WS G  +++ L  G+ P+      +++  I +   +  PP+       L +DC
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 575

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +  D +   LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAVNEDXE---LKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + V R  G G+F  V   + +  G  VA+K++      +  +  +M ++ +L   +HP+I
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHPNI 81
Query: 74  IRLHDIIEVPGK-------LHLILEY--------CKGGDLSMYIQRHGCVPEETAKHFMK 118
           ++L       G+       L++++EY        C+      Y +R    P    K F+ 
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN-----YYRRQVAPPPILIKVFLF 136
Query: 119 QL--AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS 176
           QL  + G   L   N+ HRD+KP N+L+  ++ +  LK+ DFG A+ L P         S
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 177 PLYMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA 228
             Y APE I   Q Y    D+WSVG I  +++ G+  F G N    L  IV+ 
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 123/264 (46%), Gaps = 16/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI-LKRINHPHIIRLH 77
           ++G G++ VV   RH   G  +A+K I    +N + Q+ L+ ++ I ++ ++ P  +  +
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 78  DIIEVPGKLHLILEYCKGGDLSMY---IQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLI 133
             +   G + + +E         Y   I +   +PE+        +   L+ L    ++I
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE----IMQLQK 189
           HRD+KP N+L+   +    +K+ DFG +  L      +   G   YMAPE     +  + 
Sbjct: 133 HRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 190 YDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y  K+D+WS+G  + +L   + P+ +     Q L+ +V+      P D    SA+  D  
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK--FSAEFVDFT 247
Query: 249 QKLLRRNPVERLTFEEFFNHPFLS 272
            + L++N  ER T+ E   HPF +
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFT 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 134 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 243
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 284

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V   R +  G +   VA+K +  G   ++ +E  +SE  I+ +  HP+IIRL
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE-FLSEASIMGQFEHPNIIRL 80
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + ++ E+ + G L  +++ + G          ++ +A+G++ L + + +HR
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-----PL-YMAPEIMQLQK 189
           DL  +N+L+   + N   K++DFG +R L+      T   S     P+ + APE +  +K
Sbjct: 141 DLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
           + + +D WS G +++++++ G+ P+   +   ++  I +   L  PPD
Sbjct: 198 FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPD 245

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 155
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPLYMAPEIM-QLQKY 190
           RDLKP NL +   +++  LKI DFG AR       A+ + G   +  Y APEIM     Y
Sbjct: 156 RDLKPSNLAV---NEDCELKILDFGLARHT-----ADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
           +   D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 304

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 99/366 (27%), Positives = 151/366 (41%), Gaps = 94/366 (25%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP-- 71
           Y++ R++G G FS VW A+  V+ T VAMK +   R +K   E+   EI +L+R+N    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 72  ---------HIIRLHDII--EVPGKLHLILEY-CKGGDLSMYIQR--HGCVPEETAKHFM 117
                    HI++L D    + P  +H+++ +   G +L   I++  H  +P    K   
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 118 KQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAAL---KIADFG--------FARSLQ 165
           KQL  GL  + R   +IH D+KP+N+L+   D    L   KIAD G        +  S+Q
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF------------ 213
            R           Y +PE++    +   AD+WS   ++F+L+TG   F            
Sbjct: 198 TRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 214 -------------------------TGSNQIQLLQNIVKATELHFPPDAKILSADCK--- 245
                                    T  N   LL+NI K   L F P   +L+   K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK---LKFWPLEDVLTEKYKFSK 304
Query: 246 -------DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR--SRMFSRSADDFPFYE 296
                  D    +L+ +P +R       NHP+L  T   +  R   R    S  D P + 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGW- 363
Query: 297 SKSVRD 302
            + VRD
Sbjct: 364 FEEVRD 369

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 304

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 99/366 (27%), Positives = 151/366 (41%), Gaps = 94/366 (25%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP-- 71
           Y++ R++G G FS VW A+  V+ T VAMK +   R +K   E+   EI +L+R+N    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 72  ---------HIIRLHDII--EVPGKLHLILEY-CKGGDLSMYIQR--HGCVPEETAKHFM 117
                    HI++L D    + P  +H+++ +   G +L   I++  H  +P    K   
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 118 KQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAAL---KIADFG--------FARSLQ 165
           KQL  GL  + R   +IH D+KP+N+L+   D    L   KIAD G        +  S+Q
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF------------ 213
            R           Y +PE++    +   AD+WS   ++F+L+TG   F            
Sbjct: 198 TRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 214 -------------------------TGSNQIQLLQNIVKATELHFPPDAKILSADCK--- 245
                                    T  N   LL+NI K   L F P   +L+   K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK---LKFWPLEDVLTEKYKFSK 304
Query: 246 -------DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR--SRMFSRSADDFPFYE 296
                  D    +L+ +P +R       NHP+L  T   +  R   R    S  D P + 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGW- 363
Query: 297 SKSVRD 302
            + VRD
Sbjct: 364 FEEVRD 369

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 131 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 187
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 240
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 281

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 40/283 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMK--------- 118
            +++ L      PG  L +I+E+CK G+LS Y+  +R+  VP +T +   K         
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 119 ----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAET 172
               Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + + 
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 173 LCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKAT 229
               PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + T
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 230 ELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
            +  P    P+      DC           P +R TF E   H
Sbjct: 269 RMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 304

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 150
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   ++++ LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 151 RDLKPSNLAV---NEDSELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 205
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 239

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 131 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 187
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 240
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 281

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           IGSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 153
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +  D +   LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 154 RDLKPSNLAVNEDXE---LKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 208
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 242

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 123/250 (49%), Gaps = 31/250 (12%)
Query: 18  RQIGSGSFSVV---WHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRIN 69
           R +GSG++  V   + AR R        +++A+ +L++  Q  + +     E+ +LK + 
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--------QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H ++I L D+      IE   +++L+     G DL+  I +   + +E  +  + QL  G
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTT-LMGADLNN-IVKCQALSDEHVQFLVYQLLRG 143
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           L+ +    +IHRDLKP N+ +  D +   L+I DFG AR  Q          +  Y APE
Sbjct: 144 LKYIHSAGIIHRDLKPSNVAVNEDSE---LRILDFGLAR--QADEEMTGYVATRWYRAPE 198
Query: 184 IM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKILS 241
           IM     Y+   D+WSVG I+ +L+ GK  F GS+ I  L+ I++      P   AKI S
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 258
Query: 242 ADCKDLCQKL 251
              +   Q L
Sbjct: 259 EHARTYIQSL 268

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 13  DYLVGRQIGSGSFSVVWHAR-HRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++ R++G G+F  V+ A  + +  T+    VA+K +    L  +  +    E  +L  
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 73
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--------CVPEETAK----- 114
           + H HI++ + +      L ++ EY K GDL+ +++ HG          P +        
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 115 ---HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
              H   Q+A+G+  L   + +HRDL  +N   C    N  +KI DFG +R +       
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRN---CLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
               + L   +M PE +  +K+  ++D+WS G IL+++ T GK P+   +  ++++ I +
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN 267
              L  P   ++   +  D+     +R P +RL  +E + 
Sbjct: 251 GRVLERP---RVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 155
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPLYMAPEIM-QLQKY 190
           RDLKP NL +   +++  LKI DFG AR       A+ + G   +  Y APEIM     Y
Sbjct: 156 RDLKPSNLAV---NEDCELKILDFGLARHT-----ADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
           +   D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 155
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG---SPLYMAPEIM-QLQKY 190
           RDLKP NL +   +++  LKI DFG AR       A+ + G   +  Y APEIM     Y
Sbjct: 156 RDLKPSNLAV---NEDCELKILDFGLARHT-----ADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
           +   D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 121/259 (46%), Gaps = 18/259 (6%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 89
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +  +    +++ EY   G+L  Y++   C  EE       +   Q+++ ++ L 
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE--CNREEVTAVVLLYMATQISSAMEYLE 147
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 148 KKNFIHRDLAARN---CLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 204
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
              +  K+D+W+ G +L+++ T G +P+ G +  Q+   + K   +  P           
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC---PPKVY 261
Query: 246 DLCQKLLRRNPVERLTFEE 264
           +L +   + +P +R +F E
Sbjct: 262 ELMRACWKWSPADRPSFAE 280

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 295

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 121/233 (51%), Gaps = 16/233 (6%)
Query: 16  VGRQ--IGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V RQ  IG+G F  V+    +    +    VA+K +  G   K+ +   + E  I+ + +
Sbjct: 46  VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFS 104
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLR 128
           H +IIRL  +I     + +I EY + G L  ++ ++ G          ++ +AAG++ L 
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGS-PL-YMAPEI 184
           + N +HRDL  +N+L+   + N   K++DFG +R L+  P     T  G  P+ + APE 
Sbjct: 165 NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 185 MQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
           +  +K+ + +D+WS G ++++++T G+ P+   +  ++++ I     L  P D
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRINHPHII 74
           +GSG++  V  A     G  VA+K     +L+K  Q  + +     E+ +LK + H ++I
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK-----KLSKPFQSIIHAKRTYRELRLLKHMKHENVI 96
Query: 75  RLHDIIEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
            L D+      L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +  
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHS 155
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQ 188
            ++IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM    
Sbjct: 156 ADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWM 210
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            Y+   D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 142/310 (45%), Gaps = 42/310 (13%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R   D+     +G G+F  V  AR+ +     A+K+I   R  ++   +++SE+ +L  +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASL 59
Query: 69  NHPHIIRLH-------------DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE-ETAK 114
           NH +++R +               ++    L + +EYC+ G L   I       + +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR------- 167
              +Q+   L  +    +IHRDLKP N+ +   D++  +KI DFG A+++          
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 168 -----GLAETL---CGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPF-TGSN 217
                G ++ L    G+ +Y+A E++     Y+ K D++S+G I F+++    PF TG  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGME 233
Query: 218 QIQLLQNIVKATELHFPPDAKILSADC-KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++ +L+ + ++  + FPPD         K + + L+  +P +R       N  +L     
Sbjct: 234 RVNILKKL-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
Query: 277 DQVFRSRMFS 286
           D+V +  + S
Sbjct: 293 DEVIKEALKS 302

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 71
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 130 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 239
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 280

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 131 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 187
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 240
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 281

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 83
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 142 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 198
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 251
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 292

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 111/216 (51%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   ++++ LKI DFG AR             +  Y APEIM     Y+
Sbjct: 153 IHRDLKPSNLAV---NEDSELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYN 207
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 243

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 171
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 172 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMXG--YVATRWYRAPEIMLNWMHYNQT 226
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 260

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 304

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 134 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 190
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 243
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAE 266

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  I +   + ++  +  + Q+  GL+ +   ++IH
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNN-IVKCAKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 145 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 199
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 134/272 (49%), Gaps = 36/272 (13%)
Query: 15  LVGRQIGSGSFSVVWHARHRVH-GT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           ++G+ +G G F  V     +   GT  +VA+K + +   +++  E  +SE   +K  +HP
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 72  HIIRLHDI-IEVPG----KLHLILEYCKGGDLSMYI--------QRHGCVPEETAKHFMK 118
           ++IRL  + IE+      K  +IL + K GDL  Y+         +H  +P +T   FM 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH--IPLQTLLKFMV 154
Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGS 176
            +A G++ L + N +HRDL  +N   C   D+  + +ADFG ++ +          +   
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARN---CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 177 PL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           P+ ++A E +  + Y +K+D+W+ G  ++++ T G TP+ G    ++   ++    L  P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 235 PDAKILSADCKDLCQKLL----RRNPVERLTF 262
                   DC D   +++    R +P++R TF
Sbjct: 272 -------EDCLDELYEIMYSCWRTDPLDRPTF 296

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 134 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 243
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAE 266

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 119/228 (52%), Gaps = 15/228 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V   R +  G +   VA+K +  G   ++ +E  +SE  I+ +  HP+IIRL
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE-FLSEASIMGQFEHPNIIRL 82
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + ++ E+ + G L  +++ + G          ++ +A+G++ L + + +HR
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-----PL-YMAPEIMQLQK 189
           DL  +N+L+   + N   K++DFG +R L+      T   S     P+ + APE +  +K
Sbjct: 143 DLAARNILV---NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
           + + +D WS G +++++++ G+ P+   +   ++  I +   L  PPD
Sbjct: 200 FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPD 247

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 153
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +  D +   LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 154 RDLKPSNLAVNEDXE---LKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 208
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 242

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 153
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 154 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 208
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 242

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 150
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 151 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 205
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 239

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 147
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 148 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 202
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 236

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 138/286 (48%), Gaps = 40/286 (13%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           G+ +G    G+ I + +F +   A  R     VA+K +  G  + +   +LMSE+ IL  
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRT----VAVKMLKEGATHSE-HRALMSELKILIH 88
Query: 68  I-NHPHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYI--QRHGCVP---EETAKHFMK-- 118
           I +H +++ L      PG  L +I+E+CK G+LS Y+  +R+  VP   E+  K F+   
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 119 -------QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGL 169
                  Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  +
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILL---SEKNVVKICDFGLARDIXKDPDXV 205
Query: 170 AETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIV 226
            +     PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + 
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 227 KATELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           + T +  P    P+      DC           P +R TF E   H
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 304

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 160
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 161 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 215
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 249

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 74
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 133 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 242
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAE 265

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 160
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 161 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 215
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 249

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 145
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 146 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 200
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 234

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 159
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +  D +   LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 160 RDLKPSNLAVNEDXE---LKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 214
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 248

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 150
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 151 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 205
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMAG--FVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 145
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 146 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 200
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 234

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 159
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 160 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 214
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 248

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 150
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 151 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 205
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 239

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAE 261

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 305 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 341

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 151
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 209
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 210 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 144
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 145 RDLKPSNLAV---NEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQT 199
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDE--MAGFVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGX--VATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+
Sbjct: 153 IHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYN 207
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 155
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 156 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 210
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 153
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 154 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 208
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 242

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 146
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 147 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 201
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 235

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 167
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 168 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 222
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 256

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 154
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 155 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 209
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 243

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 145 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 199
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 130/281 (46%), Gaps = 29/281 (10%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 316
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHR+L  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 375 KKNFIHRNLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 431
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 484
Query: 246 DLCQKLLR----RNPVERLTFEEF---FNHPFLSQTQPDQV 279
           +   +L+R     NP +R +F E    F   F   +  D+V
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 525

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 168
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 169 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 223
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 257

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 31/250 (12%)
Query: 18  RQIGSGSFSVV---WHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-----EIFILKRIN 69
           R +GSG++  V   + AR R        +++A+ +L++  Q  + +     E+ +LK + 
Sbjct: 26  RPVGSGAYGSVCSAYDARLR--------QKVAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 70  HPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H ++I L D+      IE   +++L+     G DL+  I +   + +E  +  + QL  G
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTT-LMGADLNN-IVKCQALSDEHVQFLVYQLLRG 135
Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           L+ +    +IHRDLKP N+ +   +++  L+I DFG AR  Q          +  Y APE
Sbjct: 136 LKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADEEMTGYVATRWYRAPE 190
Query: 184 IM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKILS 241
           IM     Y+   D+WSVG I+ +L+ GK  F GS+ I  L+ I++      P   AKI S
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 250
Query: 242 ADCKDLCQKL 251
              +   Q L
Sbjct: 251 EHARTYIQSL 260

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   ++++ LKI DFG  R             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDSELKILDFGLCRHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 124/263 (47%), Gaps = 26/263 (9%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPN 70
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----HFMKQLAAGLQVLR 128
           +++L  +       ++I E+   G+L  Y++   C  +E       +   Q+++ ++ L 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPL-YMAPEIMQ 186
             N IHRDL  +N   C   +N  +K+ADFG +R +      A      P+ + APE + 
Sbjct: 129 KKNFIHRDLAARN---CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-------EGCP 238
Query: 246 DLCQKLLR----RNPVERLTFEE 264
           +   +L+R     NP +R +F E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAE 261

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNAMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 93
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 151
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 152 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 260

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 171
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 172 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 226
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 260

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+
Sbjct: 166 IHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYN 220
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 221 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 256

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 92
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 151 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 90
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 148
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 149 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 257

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+
Sbjct: 167 IHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYN 221
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 222 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 257

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 97
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 155
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 156 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL 231
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+
Sbjct: 167 IHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMXGX--VATRWYRAPEIMLNWMHYN 221
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 222 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 257

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 158
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 159 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 213
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 214 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 92
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 151 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 144
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 145 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 199
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNL 132
                 L       ++ +  G DL+  ++   C  + ++  +  + Q+  GL+ +   ++
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYD 191
           IHRDLKP NL +   +++  LKI DFG AR             +  Y APEIM     Y+
Sbjct: 153 IHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYN 207
Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
              D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 208 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMK---- 118
            +++ L      PG  L +I E+CK G+LS Y++        +   PE+  K F+     
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 258
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 295

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 50/272 (18%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH-- 77
           IGSG F  V+ A+HR+ G    ++ +          E    E+  L +++H +I+  +  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYN------NEKAEREVKALAKLDHVNIVHYNGC 73
Query: 78  ------------DIIEVPGK---------------LHLILEYCKGGDLSMYIQ--RHGCV 108
                       D +E                   L + +E+C  G L  +I+  R   +
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 109 PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
            +  A    +Q+  G+  +    LIHRDLKP N+ L    D   +KI DFG   SL+  G
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG 190
Query: 169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV-TGKTPFTGSNQIQLLQNIVK 227
                 G+  YM+PE +  Q Y  + DL+++G IL +L+    T F  S           
Sbjct: 191 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF-------- 242
Query: 228 ATELHFPPDAKILSADCKDLCQKLLRRNPVER 259
            T+L     + I     K L QKLL + P +R
Sbjct: 243 -TDLRDGIISDIFDKKEKTLLQKLLSKKPEDR 273

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 93
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFLA 151
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 152 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 122/246 (49%), Gaps = 26/246 (10%)
Query: 20  IGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           IG+G F  V     ++ G     VA+K +  G   K+ +   +SE  I+ + +HP++I L
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNVIHL 73
Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             ++     + +I E+ + G L  ++ Q  G          ++ +AAG++ L D N +HR
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-----PL-YMAPEIMQLQK 189
            L  +N+L+   + N   K++DFG +R L+      T   +     P+ + APE +Q +K
Sbjct: 134 ALAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF--PPDAKILSADCKD 246
           + + +D+WS G +++++++ G+ P+         Q+++ A E  +  PP       DC  
Sbjct: 191 FTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQDYRLPP-----PMDCPS 241
Query: 247 LCQKLL 252
              +L+
Sbjct: 242 ALHQLM 247

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG G+F  V+ ARHR  G +VA+K++ M    +    + + EI IL+ + H +++ L +
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 79  IIEVPGK--------LHLILEYCK---GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I              ++L+ ++C+    G LS  + +         K  M+ L  GL  +
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQMLLNGLYYI 141
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLAETLCGSPLYMA 181
             N ++HRD+K  N+L+  D     LK+ADFG AR+       QP      +  +  Y  
Sbjct: 142 HRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 182 PEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPD 236
           PE++  ++ Y    DLW  G I+ ++ T ++P    N    Q+ L+  +  +      P+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 237 -------------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                    A +      DL  KLL  +P +R+  ++  NH F 
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 41/284 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +    S    LMSE+ IL  I +H
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 71  PHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYI--QRHGCVP-----EETAKHFMK---- 118
            +++ L      PG  L +I+E+CK G+LS Y+  +R+  VP     E+  K F+     
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 269
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 270 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 306

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 91
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 149
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 150 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 258

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 92
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 151 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 111
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 169
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 170 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 278

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 110
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 168
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 169 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 277

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 90
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 148
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 149 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 87
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 145
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 146 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 91
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 149
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 150 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 89
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 147
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 148 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 84
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 142
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 143 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 251

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI D+G AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDYGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 138/284 (48%), Gaps = 38/284 (13%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           G+ +G    G+ I + +F +   A  R     VA+K +  G  + +   +LMSE+ IL  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRT----VAVKMLKEGATHSE-HRALMSELKILIH 86
Query: 68  I-NHPHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYI--QRHGCVP-EETAKHFMK---- 118
           I +H +++ L      PG  L +I+E+CK G+LS Y+  +R+  VP ++  K F+     
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 119 -----QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
                Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 263
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 264 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 300

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 138/284 (48%), Gaps = 38/284 (13%)
Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           G+ +G    G+ I + +F +   A  R     VA+K +  G  + +   +LMSE+ IL  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRT----VAVKMLKEGATHSE-HRALMSELKILIH 86
Query: 68  I-NHPHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYI--QRHGCVPEE-------TAKHF 116
           I +H +++ L      PG  L +I+E+CK G+LS Y+  +R+  VP +       T +H 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 117 MK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGLAE 171
           +    Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +   P  + +
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSN-QIQLLQNIVKA 228
                PL +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + 
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEG 263
Query: 229 TELHFP----PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           T +  P    P+      DC           P +R TF E   H
Sbjct: 264 TRMRAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 300

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 20  IGSGSFSVVWHAR------HRVHGTEVAMKEIA-MGRLNKKLQESLMSEIFILKRINHPH 72
           IG G F  V+H         ++H    ++  I  +G +++ L E +     I+K  +HP+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-----IMKDFSHPN 92
Query: 73  IIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVLR 128
           ++ L  I +   G   ++L Y K GDL  +I+     P  T K    F  Q+A G++ L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYLA 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPL---YMAPE 183
               +HRDL  +N   C  D+   +K+ADFG AR +  +         G+ L   +MA E
Sbjct: 151 SKKFVHRDLAARN---CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 259

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 12/228 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 512 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 95/377 (25%), Positives = 160/377 (42%), Gaps = 102/377 (27%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES--LMSEIFILK 66
           +V  +Y +   IG GS+  V+ A  +     VA+K++   R+ + L +   ++ EI IL 
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILN 82
Query: 67  RINHPHIIRLHDIIEVP------GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           R+   +IIRLHD+I +P       +L+++LE     DL    +    + E+  K  +  L
Sbjct: 83  RLKSDYIIRLHDLI-IPEDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-------------- 166
             G + + ++ +IHRDLKP N LL  D    ++KI DFG AR++                
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLLNQD---CSVKICDFGLARTINSDKDIHIVNDLEEKE 197
Query: 167 ---------RGLAETLCG---SPLYMAPEIMQLQK-YDAKADLWSVGAILFQLV------ 207
                    + L + L     +  Y APE++ LQ+ Y    D+WS G I  +L+      
Sbjct: 198 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSH 257
Query: 208 ----TGKTP-FTGS--------------------NQIQLL-----------------QNI 225
               T + P F GS                    +Q+ ++                 Q +
Sbjct: 258 INNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEV 317
Query: 226 VKATELHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           +K  +L FP    I        +S +  DL + +LR N  +R+T ++  +HP+L   + +
Sbjct: 318 IKYIKL-FPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKE 376
Query: 278 QVFRSRMFSRSADDFPF 294
            +     FS      PF
Sbjct: 377 NL---ENFSTEKIILPF 390

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 15/257 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 42  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 101 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 159
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 160 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+          L 
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC---PPTLYSLM 273
Query: 249 QKLLRRNPVERLTFEEF 265
            K    +P  R  F E 
Sbjct: 274 TKCWAYDPSRRPRFTEL 290

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 16  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 75  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 134 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 239

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 15/257 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 78  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 137 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+          L 
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC---PPTLYSLM 250
Query: 249 QKLLRRNPVERLTFEEF 265
            K    +P  R  F E 
Sbjct: 251 TKCWAYDPSRRPRFTEL 267

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 76  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 135 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 240

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 132 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 70  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+ ++D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 129 FVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+   D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 512 FVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 141/310 (45%), Gaps = 42/310 (13%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R   D+     +G G+F  V  AR+ +     A+K+I   R  ++   +++SE+ +L  +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASL 59
Query: 69  NHPHIIRLH-------------DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE-ETAK 114
           NH +++R +               ++    L + +EYC+   L   I       + +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR------- 167
              +Q+   L  +    +IHRDLKP N+ +   D++  +KI DFG A+++          
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 168 -----GLAETL---CGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPF-TGSN 217
                G ++ L    G+ +Y+A E++     Y+ K D++S+G I F+++    PF TG  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGME 233
Query: 218 QIQLLQNIVKATELHFPPDAKILSADC-KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++ +L+ + ++  + FPPD         K + + L+  +P +R       N  +L     
Sbjct: 234 RVNILKKL-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
Query: 277 DQVFRSRMFS 286
           D+V +  + S
Sbjct: 293 DEVIKEALKS 302

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 128/275 (46%), Gaps = 36/275 (13%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE---------ETAK-----HFM 117
           +I+ L       G + +I EYC  GDL  +++R   V E          TA      HF 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCG 175
            Q+A G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +    
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 176 SPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNIVKAT 229
            P+ +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L+++  +  
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +  F P       +   + Q      P  R TF++
Sbjct: 288 QPAFAPK------NIYSIMQACWALEPTHRPTFQQ 316

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++    + ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI  FG AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILGFGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 109/229 (47%), Gaps = 12/229 (5%)
Query: 16  VGRQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPH
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L  +I     + +I+E C  G+L  ++Q R   +   +   +  QL+  L  L    
Sbjct: 73  IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQK 189
            +HRD+  +N+L+   D    +K+ DFG +R ++     +   G  P+ +MAPE +  ++
Sbjct: 132 FVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 190 YDAKADLWSVGAILFQ-LVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           + + +D+W  G  +++ L+ G  PF G     ++  I     L  PP+ 
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI D G AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDAGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 113/225 (50%), Gaps = 19/225 (8%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           +++GSG F VV    W  ++     +VA+K I  G ++   ++    E   + +++HP +
Sbjct: 14  KELGSGQFGVVKLGKWKGQY-----DVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKL 65
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFM-KQLAAGLQVLRDNNL 132
           ++ + +      ++++ EY   G L  Y++ HG   E +    M   +  G+  L  +  
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQPRGLAETLCGSPL-YMAPEIMQLQKY 190
           IHRDL  +N   C  D +  +K++DFG  R  L  + ++      P+ + APE+    KY
Sbjct: 126 IHRDLAARN---CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            +K+D+W+ G +++++ + GK P+      +++  + +   L+ P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP 227

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 36/275 (13%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK--------------HFM 117
           +I+ L       G + +I EYC  GDL  +++R   V E                  HF 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCG 175
            Q+A G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +    
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 176 SPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNIVKAT 229
            P+ +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L+++  +  
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +  F P       +   + Q      P  R TF++
Sbjct: 288 QPAFAPK------NIYSIMQACWALEPTHRPTFQQ 316

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI DF  AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDFYLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI D G AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDRGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 116/242 (47%), Gaps = 27/242 (11%)
Query: 15  LVGRQIGSGSFSVVWHARHRVHGTE-----VAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           ++ R++G G+F  V+ A       E     VA+K +     N +  +    E  +L  + 
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQ 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------GCVPEETAK----HF 116
           H HI++ + +      L ++ EY K GDL+ +++ H         G  P E  +    H 
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS 176
            +Q+AAG+  L   + +HRDL  +N   C   +N  +KI DFG +R +           +
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRN---CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 177 PL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH 232
            L   +M PE +  +K+  ++D+WS+G +L+++ T GK P+   +  ++++ I +   L 
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250
Query: 233 FP 234
            P
Sbjct: 251 RP 252

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++I L D+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 80  IEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
                 L       ++ +  G DL+  ++      ++  +  + Q+  GL+ +   ++IH
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-DDHVQFLIYQILRGLKYIHSADIIH 148
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQKYDAK 193
           RDLKP NL +   +++  LKI D G AR             +  Y APEIM     Y+  
Sbjct: 149 RDLKPSNLAV---NEDCELKILDGGLARHTDDEMTG--YVATRWYRAPEIMLNWMHYNQT 203
Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK 227
            D+WSVG I+ +L+TG+T F G++ I  L+ I++
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 237

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +   +   G  VA+K +  G    +L+     EI IL+ + H HI
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG-CGPQLRSGWQREIEILRTLYHEHI 73
Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++     E  G+  + L++EY   G L  Y+ RH CV       F +Q+  G+  L   +
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH 132
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHR L  +N+LL   D++  +KI DFG A+++ P G     + E       + APE ++
Sbjct: 133 YIHRALAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ 218
             K+   +D+WS G  L++L+T    +  SNQ
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT----YCDSNQ 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +   +   G  VA+K +  G    +L+     EI IL+ + H HI
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG-CGPQLRSGWQREIEILRTLYHEHI 72
Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           ++     E  G+  + L++EY   G L  Y+ RH CV       F +Q+  G+  L   +
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHR L  +N+LL   D++  +KI DFG A+++ P G     + E       + APE ++
Sbjct: 132 YIHRALAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ 218
             K+   +D+WS G  L++L+T    +  SNQ
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT----YCDSNQ 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 54/304 (17%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEFF-----------NHPFLS 272
              +  P       A+C +    ++R      P +R TF++             N  +L 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 273 QTQP 276
            +QP
Sbjct: 328 LSQP 331

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 16/259 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLH 77
           ++G GS+  V+  R +  G   A+K         K +   ++E+   +++  HP  +RL 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
              E  G L+L  E C G  L  + +  G  +PE     +++     L  L    L+H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           +KP N+ L         K+ DFG    L   G  E   G P YMAPE++Q   Y   AD+
Sbjct: 183 VKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADV 238
Query: 197 WSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFPPDAKI-LSADCKDLCQKLLRR 254
           +S+G  + ++    + P  G    QL Q        + PP+    LS++ + +   +L  
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQG-------YLPPEFTAGLSSELRSVLVMMLEP 291
Query: 255 NPVERLTFEEFFNHPFLSQ 273
           +P  R T E     P L Q
Sbjct: 292 DPKLRATAEALLALPVLRQ 310

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 137/304 (45%), Gaps = 54/304 (17%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEFF-----------NHPFLS 272
              +  P       A+C +    ++R      P +R TF++             N  +L 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 273 QTQP 276
            +QP
Sbjct: 328 LSQP 331

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 49/252 (19%)
Query: 17  GRQIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRI-NH 70
           G+ +GSG+F  V +A  + +  T V++ ++A+  L +K     +E+LMSE+ ++ ++ +H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSI-QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKH------------- 115
            +I+ L     + G ++LI EYC  GDL  Y+  +R     +E                 
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 116 --------FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP- 166
                   F  Q+A G++ L   + +HRDL  +N+L+        +KI DFG AR +   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSD 225
Query: 167 -----RGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG---- 215
                RG A      P+ +MAPE +    Y  K+D+WS G +L+++ + G  P+ G    
Sbjct: 226 SNYVVRGNARL----PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 216 SNQIQLLQNIVK 227
           +N  +L+QN  K
Sbjct: 282 ANFYKLIQNGFK 293

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 87
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR------HGCV-----PEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q         C      PEE  
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 204
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 265 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 72
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR------HGCV-----PEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q         C      PEE  
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 189
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 250 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 137/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 23  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 79
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q                PEE  
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 196
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 256
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 257 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 294

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR--HGCVPEETAK--------HFMKQLA 121
           +I+ L       G + +I EYC  GDL  +++R     + +E  +        HF  Q+A
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGSPL- 178
            G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +     P+ 
Sbjct: 171 QGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNIVKATELHF 233
           +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L+++  +  +  F
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 287
Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
            P       +   + Q      P  R TF++
Sbjct: 288 APK------NIYSIMQACWALEPTHRPTFQQ 312

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR--HGCVPEETAK--------HFMKQLA 121
           +I+ L       G + +I EYC  GDL  +++R     + +E  +        HF  Q+A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAETLCGSPL- 178
            G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +     P+ 
Sbjct: 163 QGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNIVKATELHF 233
           +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L+++  +  +  F
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 279
Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
            P       +   + Q      P  R TF++
Sbjct: 280 APK------NIYSIMQACWALEPTHRPTFQQ 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 137/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 20  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 76
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q                PEE  
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 193
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 253
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 254 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 291

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 14/231 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G  V +  +A+  LN+    K     M E  I+  ++HPH+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           +RL  +   P  + L+ +    G L  Y+  H   +  +   ++  Q+A G+  L +  L
Sbjct: 80  VRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ + +    +KI DFG AR L+         G  +   +MA E +  +K
Sbjct: 139 VHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           +  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 246

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 42/279 (15%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQR-------------HGCVPEETAK---- 114
           +I+ L       G + +I EYC  GDL  +++R             H   PEE       
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN--PEEQLSSRDL 168
Query: 115 -HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--PRGLAE 171
            HF  Q+A G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQLLQNI 225
                P+ +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +L+++ 
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 285
Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
            +  +  F P       +   + Q      P  R TF++
Sbjct: 286 YQMAQPAFAPK------NIYSIMQACWALEPTHRPTFQQ 318

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 137/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 24  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 80
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q                PEE  
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 197
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 257
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 258 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 295

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 87
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-------------RHGCVPEE 111
           K I  H +II L       G L++I+EY   G+L  Y+Q              H    + 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 204
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 265 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 87
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-------------RHGCVPEE 111
           K I  H +II L       G L++I+EY   G+L  Y+Q              H    + 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 204
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 265 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 128
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-------------RHGCVPEE 111
           K I  H +II L       G L++I+EY   G+L  Y+Q              H    + 
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 245
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 306 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 343

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 137/285 (48%), Gaps = 47/285 (16%)
Query: 15  LVGRQIGSGSFSVVWHAR---------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           ++G+ +G G+F  V  A          +RV  T+VA+K +      K L + L+SE+ ++
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRV--TKVAVKMLKSDATEKDLSD-LISEMEMM 87
Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE-- 111
           K I  H +II L       G L++I+EY   G+L  Y+Q                PEE  
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 112 TAKHFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
           ++K  +    Q+A G++ L     IHRDL  +N+L+  D+    +KIADFG AR +    
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHHID 204
Query: 169 LAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN 224
             +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
           + +   +  P       ++C +    ++R      P +R TF++ 
Sbjct: 265 LKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 14/231 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G  V +  +A+  LN+    K     M E  I+  ++HPH+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           +RL  +   P  + L+ +    G L  Y+  H   +  +   ++  Q+A G+  L +  L
Sbjct: 103 VRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ + +    +KI DFG AR L+         G  +   +MA E +  +K
Sbjct: 162 VHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           +  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I
Sbjct: 219 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 269

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/321 (22%), Positives = 142/321 (44%), Gaps = 47/321 (14%)
Query: 7   RGRVVGDYLVGRQIGSGSFSVV--------WHARHRVHGTEVAMKEIAMGRLNKKLQ--- 55
           + + + DY + R +  G F+ +        ++A  +   + +  K       N K+    
Sbjct: 26  KDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 56  --ESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG-----DLSMYI--QRHG 106
             +   +E+ I+  I + + +    II    ++++I EY +       D   ++  + + 
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 107 C-VPEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
           C +P +  K  +K +      +  + N+ HRD+KP N+L+   D N  +K++DFG +  +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYM 202
Query: 165 QPRGLAETLCGSPLYMAPEIMQLQK-YD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLL 222
             + +  +  G+  +M PE    +  Y+ AK D+WS+G  L+ +     PF+    +  L
Sbjct: 203 VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 223 QNIVKATELHFPPD----------------AKILSADCKDLCQKLLRRNPVERLTFEEFF 266
            N ++   + +P D                   LS +  D  +  LR+NP ER+T E+  
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321
Query: 267 NHPFLSQTQPDQVFRSRMFSR 287
            H +L+ T  + +   R FS+
Sbjct: 322 KHEWLADTNIEDL---REFSK 339

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 16/264 (6%)
Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHPHIIRLH 77
           ++G G++ VV   RH   G   A+K I    +N + Q+ L+ ++ I  R ++ P  +  +
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 78  DIIEVPGKLHLILEYCKGGDLSMY---IQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLI 133
             +   G + +  E         Y   I +   +PE+        +   L+ L    ++I
Sbjct: 100 GALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 159
Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE----IMQLQK 189
           HRD+KP N+L+   +    +K  DFG +  L      +   G   Y APE     +  + 
Sbjct: 160 HRDVKPSNVLI---NALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKG 216
Query: 190 YDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y  K+D+WS+G    +L   + P+ +     Q L+ +V+      P D    SA+  D  
Sbjct: 217 YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK--FSAEFVDFT 274
Query: 249 QKLLRRNPVERLTFEEFFNHPFLS 272
            + L++N  ER T+ E   HPF +
Sbjct: 275 SQCLKKNSKERPTYPELXQHPFFT 298

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 143
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 260
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 321 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 355

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 86
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 87  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 203
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 263
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 264 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 298

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 23/204 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H ++++L 
Sbjct: 27  QTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  NN +H
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGSPL-YMAPEIMQLQKY 190
           RDL  +N+L+   +DN A K++DFG    A S Q  G        P+ + APE ++ +K+
Sbjct: 141 RDLAARNVLV--SEDNVA-KVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKF 191
Query: 191 DAKADLWSVGAILFQLVT-GKTPF 213
             K+D+WS G +L+++ + G+ P+
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPY 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 23/204 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H ++++L 
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  NN +H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGSPL-YMAPEIMQLQKY 190
           RDL  +N+L+   +DN A K++DFG    A S Q  G        P+ + APE ++ +K+
Sbjct: 313 RDLAARNVLV--SEDNVA-KVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKF 363
Query: 191 DAKADLWSVGAILFQLVT-GKTPF 213
             K+D+WS G +L+++ + G+ P+
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 89
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 90  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 206
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 266
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 267 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 301

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 84
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 85  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNIDYYK 201
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 261
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 262 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 296

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 23/204 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H ++++L 
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  NN +H
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGSPL-YMAPEIMQLQKY 190
           RDL  +N+L+   +DN A K++DFG    A S Q  G        P+ + APE ++ +K+
Sbjct: 126 RDLAARNVLV--SEDNVA-KVSDFGLTKEASSTQDTG------KLPVKWTAPEALREKKF 176
Query: 191 DAKADLWSVGAILFQLVT-GKTPF 213
             K+D+WS G +L+++ + G+ P+
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY 200

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL--QESLMSEIFILKRINH 70
           D ++ R +G G F  V+   +  H  E     +   + +  L  +E  MSE  I+K ++H
Sbjct: 25  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           PHI++L  IIE      +I+E    G+L  Y++R+   +   T   +  Q+   +  L  
Sbjct: 85  PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPL-YMAPEIMQL 187
            N +HRD+  +N+L+ + +    +K+ DFG +R ++     + ++   P+ +M+PE +  
Sbjct: 144 INCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH----FPPDAKILSA 242
           +++   +D+W     ++++++ GK PF       ++  + K   L      PP    L  
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMT 260
Query: 243 DCKDLCQKLLRRNPVERLTFEEF 265
            C D        +P +R  F E 
Sbjct: 261 RCWDY-------DPSDRPRFTEL 276

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  ++IADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHP 71
           DY + R++G G +S V+ A +  +  +V +K +   + NK     +  EI IL+ +   P
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNK-----IKREIKILENLRGGP 92
Query: 72  HIIRLHDIIEVPGKL--HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +II L DI++ P      L+ E+    D     Q +  + +   + +M ++   L     
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYMYEILKALDYCHS 149
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQ 188
             ++HRD+KP N+++  D ++  L++ D+G A    P         S  +  PE++   Q
Sbjct: 150 MGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 189 KYDAKADLWSVGAILFQLVTGKTPFT--GSNQIQL-----------LQNIVKATELHFPP 235
            YD   D+WS+G +L  ++  K PF     N  QL           L + +    +   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 236 ---------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                +  ++S +  D   KLLR +   RLT  E   HP+ 
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 113/226 (50%), Gaps = 21/226 (9%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 15  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 70
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 129
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSL------QPRGLAETLCGSPLYMAPEIMQLQK 189
           DL  +N   C  +D   +K++DFG +R +        RG    +  SP    PE++   K
Sbjct: 130 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP----PEVLMYSK 182
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           + +K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 45/284 (15%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRIN-HP 71
           G+ +G+G+F  V  A     G E A+ ++A+  L        +E+LMSE+ I+  +  H 
Sbjct: 36  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 95
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEETAK------ 114
           +I+ L       G + +I EYC  GDL  +++R            G  PE   K      
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPL 155
Query: 115 ------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--P 166
                 HF  Q+A G+  L   N IHRD+  +N+LL    +    KI DFG AR +    
Sbjct: 156 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDS 212
Query: 167 RGLAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG----SNQIQ 220
             + +     P+ +MAPE +    Y  ++D+WS G +L+++ + G  P+ G    S   +
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 272
Query: 221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           L+++  +  +  F P       +   + Q      P  R TF++
Sbjct: 273 LVKDGYQMAQPAFAPK------NIYSIMQACWALEPTHRPTFQQ 310

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL--QESLMSEIFILKRINH 70
           D ++ R +G G F  V+   +  H  E     +   + +  L  +E  MSE  I+K ++H
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           PHI++L  IIE      +I+E    G+L  Y++R+   +   T   +  Q+   +  L  
Sbjct: 69  PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPL-YMAPEIMQL 187
            N +HRD+  +N+L+ + +    +K+ DFG +R ++     + ++   P+ +M+PE +  
Sbjct: 128 INCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH----FPPDAKILSA 242
           +++   +D+W     ++++++ GK PF       ++  + K   L      PP    L  
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMT 244
Query: 243 DCKDLCQKLLRRNPVERLTFEEF 265
            C D        +P +R  F E 
Sbjct: 245 RCWDY-------DPSDRPRFTEL 260

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 123/263 (46%), Gaps = 21/263 (7%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL--QESLMSEIFILKRINH 70
           D ++ R +G G F  V+   +  H  E     +   + +  L  +E  MSE  I+K ++H
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           PHI++L  IIE      +I+E    G+L  Y++R+   +   T   +  Q+   +  L  
Sbjct: 73  PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPL-YMAPEIMQL 187
            N +HRD+  +N+L+ + +    +K+ DFG +R ++     + ++   P+ +M+PE +  
Sbjct: 132 INCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH----FPPDAKILSA 242
           +++   +D+W     ++++++ GK PF       ++  + K   L      PP    L  
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMT 248
Query: 243 DCKDLCQKLLRRNPVERLTFEEF 265
            C D        +P +R  F E 
Sbjct: 249 RCWDY-------DPSDRPRFTEL 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 85
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 144
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 145 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSS 200
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 21  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 76
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 135
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 136 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSS 191
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 234

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      + L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+EY   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 14  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 69
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 128
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 129 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSS 184
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 10  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 65
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 124
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 125 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSS 180
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 15/232 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPE 183
           L +N+ IHRD+  +N LL         KI DFG AR +   G       + L   +M PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
                 + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 234 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 285

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 77
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 254
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 255 PERVTDLMRMCWQF---NPKMRPTFLEIVN 281

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 15  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 70
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 129
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 130 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSS 185
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 228

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 15/232 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPE 183
           L +N+ IHRD+  +N LL         KI DFG AR +   G       + L   +M PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
                 + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 78  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQL 187
           IHRDL  +NLLL T D    +KI DFG  R+L P+      + E       + APE ++ 
Sbjct: 137 IHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCK 245
           + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D      D  
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC---PQDIY 249
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++  +     P +R TF    +  FL + QP
Sbjct: 250 NVMVQCWAHKPEDRPTFVALRD--FLLEAQP 278

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 258 PERVTDLMRMCWQF---NPKMRPTFLEIVN 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 258 PERVTDLMRMCWQF---NPNMRPTFLEIVN 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 258 PERVTDLMRMCWQF---NPKMRPTFLEIVN 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 79
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 256
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 257 PERVTDLMRMCWQF---NPKMRPTFLEIVN 283

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 84  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLYMAP 182
           IHRDL  +NLLL T D    +KI DFG  R+L          + R +    C      AP
Sbjct: 143 IHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------AP 193
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
           E ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 250
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             D  ++  +     P +R TF    +  FL + QP
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP 284

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 84  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLYMAP 182
           IHRDL  +NLLL T D    +KI DFG  R+L          + R +    C      AP
Sbjct: 143 IHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC------AP 193
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
           E ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 250
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             D  ++  +     P +R TF    +  FL + QP
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP 284

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+ Y   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           +++G+G F VV + + R    +VA+K I  G ++   ++  + E  ++  ++H  +++L+
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLY 85
Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQ--RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
            +      + +I EY   G L  Y++  RH    ++  +   K +   ++ L     +HR
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQFLHR 144
Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N   C  +D   +K++DFG +R +       ++ GS     +  PE++   K+ +
Sbjct: 145 DLAARN---CLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLMYSKFSS 200
Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           K+D+W+ G +++++ + GK P+      +  ++I +   L+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HRDL  +N ++  D     +KI DFG  R +             L   
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 258 PERVTDLMRMCWQF---NPKMRPTFLEIVN 284

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQL 187
           IHRDL  +NLLL T D    +KI DFG  R+L P+      + E       + APE ++ 
Sbjct: 133 IHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCK 245
           + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D      D  
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC---PQDIY 245
Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++  +     P +R TF    +  FL + QP
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRD--FLLEAQP 274

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLYMAP 182
           IHRDL  +NLLL T D    +KI DFG  R+L          + R +    C      AP
Sbjct: 133 IHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------AP 183
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
           E ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 240
Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             D  ++  +     P +R TF    +  FL + QP
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQP 274

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 122/277 (44%), Gaps = 38/277 (13%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRINHPHI 73
           R IG G+F  V+ AR            +A+  L ++    +Q     E  ++   ++P+I
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----------------------GCVPEE 111
           ++L  +  V   + L+ EY   GDL+ +++                        G  P  
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 112 TAKHF--MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL 169
            A+     +Q+AAG+  L +   +HRDL  +N   C   +N  +KIADFG +R++     
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRN---CLVGENMVVKIADFGLSRNIYSADY 229
Query: 170 --AETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI 225
             A+     P+ +M PE +   +Y  ++D+W+ G +L+++ + G  P+ G    +++  +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289
Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTF 262
                L  P +  +   +   LC   L   P +R +F
Sbjct: 290 RDGNILACPENCPLELYNLMRLCWSKL---PADRPSF 323

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 16  VGRQIGSGSFSVVWHAR-------HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           +G+ +G G+F  V  A               VA+K +      K L + L+SE+ ++K I
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMI 97
Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-----------GCVPEE--TAK 114
             H +II L       G L++I+ Y   G+L  Y++               VPEE  T K
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 115 HFMK---QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE 171
             +    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +      +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214
Query: 172 TLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                 L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + + +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEEF 265
              +  P       A+C +    ++R      P +R TF++ 
Sbjct: 275 GHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQL 309

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 26/194 (13%)
Query: 54  LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI---QRHGCV-- 108
           L+E    E  +  R+ HP+++ L  ++     L +I  YC  GDL  ++     H  V  
Sbjct: 55  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 109 --PEETAK---------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD 157
              + T K         H + Q+AAG++ L  ++++H+DL  +N+L+    D   +KI+D
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISD 171
Query: 158 FGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
            G  R +      + L  S L   +MAPE +   K+   +D+WS G +L+++ + G  P+
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 214 TG-SNQ--IQLLQN 224
            G SNQ  +++++N
Sbjct: 232 CGYSNQDVVEMIRN 245

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 26/194 (13%)
Query: 54  LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI---QRHGCV-- 108
           L+E    E  +  R+ HP+++ L  ++     L +I  YC  GDL  ++     H  V  
Sbjct: 72  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 109 --PEETAK---------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD 157
              + T K         H + Q+AAG++ L  ++++H+DL  +N+L+    D   +KI+D
Sbjct: 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISD 188
Query: 158 FGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPF 213
            G  R +      + L  S L   +MAPE +   K+   +D+WS G +L+++ + G  P+
Sbjct: 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248
Query: 214 TG-SNQ--IQLLQN 224
            G SNQ  +++++N
Sbjct: 249 CGYSNQDVVEMIRN 262

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           RQ+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+E+   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH----KERIDHIKLLQYTSQICKGM 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 131 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 186
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 17  GRQIGSGSFS-VVWHARHRVHGTEVAMK-EIAMGRLNKKL--QESLMSEIFILKRI-NHP 71
           G+ +G+G+F  VV    + +  ++ AM   + M + +  L  +E+LMSE+ +L  + NH 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETA-------------- 113
           +I+ L     + G   +I EYC  GDL  +++R      C     A              
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
             F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++        
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVK 204
Query: 174 CGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT 229
             + L   +MAPE +    Y  ++D+WS G  L++L + G +P+ G         ++K  
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
                P+     A+  D+ +     +P++R TF++
Sbjct: 265 FRMLSPEHA--PAEMYDIMKTCWDADPLKRPTFKQ 297

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ ++NH +I
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 215
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 268

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 21/235 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ ++NH +I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-----SLQPRGLAETLCGSPL-YM 180
           L +N+ IHRD+  +N LL         KI DFG AR     S   +G    L   P+ +M
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML---PVKWM 227
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 282

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 5/151 (3%)
Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           R+  PH++ +HD  E+ G+L++      G DL+  ++R G +    A   ++Q+ + L  
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE--TLCGSPLYMAPEI 184
                  HRD+KP+N+L+  DD      + DFG A +     L +     G+  Y APE 
Sbjct: 150 AHAAGATHRDVKPENILVSADD---FAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER 206
Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTG 215
                   +AD++++  +L++ +TG  P+ G
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 17  GRQIGSGSFS-VVWHARHRVHGTEVAMK-EIAMGRLNKKL--QESLMSEIFILKRI-NHP 71
           G+ +G+G+F  VV    + +  ++ AM   + M + +  L  +E+LMSE+ +L  + NH 
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 103
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETA-------------- 113
           +I+ L     + G   +I EYC  GDL  +++R      C     A              
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
             F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++        
Sbjct: 164 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVK 220
Query: 174 CGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT 229
             + L   +MAPE +    Y  ++D+WS G  L++L + G +P+ G         ++K  
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 280
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
                P+     A+  D+ +     +P++R TF++
Sbjct: 281 FRMLSPEHA--PAEMYDIMKTCWDADPLKRPTFKQ 313

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 78
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 134
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 135 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 190
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLH 77
           + IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H ++++L 
Sbjct: 18  QTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLL 71
Query: 78  DII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  NN +H
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGF---ARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           RDL  +N+L+   +DN A K++DFG    A S Q  G          + APE ++   + 
Sbjct: 132 RDLAARNVLV--SEDNVA-KVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREAAFS 183
Query: 192 AKADLWSVGAILFQLVT-GKTPF 213
            K+D+WS G +L+++ + G+ P+
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 17  GRQIGSGSFS-VVWHARHRVHGTEVAMK-EIAMGRLNKKL--QESLMSEIFILKRI-NHP 71
           G+ +G+G+F  VV    + +  ++ AM   + M + +  L  +E+LMSE+ +L  + NH 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETA-------------- 113
           +I+ L     + G   +I EYC  GDL  +++R      C     A              
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
             F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++        
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVK 227
Query: 174 CGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT 229
             + L   +MAPE +    Y  ++D+WS G  L++L + G +P+ G         ++K  
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 287
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
                P+     A+  D+ +     +P++R TF++
Sbjct: 288 FRMLSPEHA--PAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 76
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 132
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 133 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 188
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 215
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 268

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 131 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 186
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 21/233 (9%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINH-- 70
           Y +   IG GSF  V  A  RV    VA+K I     NKK        E+ +L+ +N   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHD 111
Query: 71  ----PHIIRLHDIIEVPGKLHLILEYCKGG--DLSMYIQRHGCVPEETAKHFMKQLAAGL 124
                +I+ L         L L+ E       DL       G V     + F +Q+   L
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTAL 170
Query: 125 QVLR--DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
             L   + ++IH DLKP+N+LLC +   +A+KI DFG +  L  R        S  Y +P
Sbjct: 171 LFLATPELSIIHCDLKPENILLC-NPKRSAIKIVDFGSSCQLGQR--IYQXIQSRFYRSP 227
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           E++    YD   D+WS+G IL ++ TG+  F+G+N++  +  IV+   L  PP
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPP 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 17  GRQIGSGSFS-VVWHARHRVHGTEVAMK-EIAMGRLNKKL--QESLMSEIFILKRI-NHP 71
           G+ +G+G+F  VV    + +  ++ AM   + M + +  L  +E+LMSE+ +L  + NH 
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 105
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETA-------------- 113
           +I+ L     + G   +I EYC  GDL  +++R      C     A              
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
             F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++        
Sbjct: 166 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVK 222
Query: 174 CGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT 229
             + L   +MAPE +    Y  ++D+WS G  L++L + G +P+ G         ++K  
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 282
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
                P+     A+  D+ +     +P++R TF++
Sbjct: 283 FRMLSPEHA--PAEMYDIMKTCWDADPLKRPTFKQ 315

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 221
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 274

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 106/233 (45%), Gaps = 21/233 (9%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINH-- 70
           Y +   IG GSF  V  A  RV    VA+K I     NKK        E+ +L+ +N   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHD 92
Query: 71  ----PHIIRLHDIIEVPGKLHLILEYCKGG--DLSMYIQRHGCVPEETAKHFMKQLAAGL 124
                +I+ L         L L+ E       DL       G V     + F +Q+   L
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTAL 151
Query: 125 QVLRDNNL--IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
             L    L  IH DLKP+N+LLC +   +A+KI DFG +  L  R        S  Y +P
Sbjct: 152 LFLATPELSIIHCDLKPENILLC-NPKRSAIKIVDFGSSCQLGQR--IYQXIQSRFYRSP 208
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           E++    YD   D+WS+G IL ++ TG+  F+G+N++  +  IV+   L  PP
Sbjct: 209 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPP 259

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 158
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 159 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 214
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHPHII 74
           +Q+G G+F  V   R+         + +A+ +L    +E L     EI ILK + H +I+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGLQVL 127
           +   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G++ L
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL 130
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
                IHRDL  +N+L+   ++   +KI DFG  + L P+         P      + AP
Sbjct: 131 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAP 186
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT 208
           E +   K+   +D+WS G +L++L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRINHPHII 74
           G ++G G F VV+  +  V+ T VA+K++A  +    ++L++    EI ++ +  H +++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE--TAKHFMKQLAAG----LQVLR 128
            L         L L+  Y   G L   + R  C+      + H   ++A G    +  L 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIM 185
           +N+ IHRD+K  N+LL   D+    KI+DFG AR+ +      +   + G+  YMAPE +
Sbjct: 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL 222
           +  +   K+D++S G +L +++TG        + QLL
Sbjct: 208 R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 229
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 282

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 21/235 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-----SLQPRGLAETLCGSPL-YM 180
           L +N+ IHRD+  +N LL         KI DFG AR     S   +G    L   P+ +M
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML---PVKWM 204
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 259

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 70
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 126
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 127 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 182
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 137/310 (44%), Gaps = 42/310 (13%)
Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R   D+     +G G+F  V  AR+ +     A+K+I   R  ++   +++SE+ +L  +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASL 59
Query: 69  NHPHIIRLH-------------DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE-ETAK 114
           NH +++R +               ++    L +  EYC+   L   I       + +   
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR------- 167
              +Q+   L  +    +IHR+LKP N+ +   D++  +KI DFG A+++          
Sbjct: 120 RLFRQILEALSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 168 -----GLAETL---CGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPF-TGSN 217
                G ++ L    G+  Y+A E++     Y+ K D +S+G I F+ +    PF TG  
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXE 233
Query: 218 QIQLLQNIVKATELHFPPDAKILSADC-KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++ +L+ + ++  + FPPD         K + + L+  +P +R       N  +L     
Sbjct: 234 RVNILKKL-RSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
Query: 277 DQVFRSRMFS 286
           D+V +  + S
Sbjct: 293 DEVIKEALKS 302

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 77
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 133
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 134 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 189
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 21/235 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-----SLQPRGLAETLCGSPL-YM 180
           L +N+ IHRD+  +N LL         KI DFG AR     S   +G    L   P+ +M
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML---PVKWM 212
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 69
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 125
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 126 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 181
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRINHPHII 74
           G ++G G F VV+  +  V+ T VA+K++A  +    ++L++    EI ++ +  H +++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE--TAKHFMKQLAAG----LQVLR 128
            L         L L+  Y   G L   + R  C+      + H   ++A G    +  L 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIM 185
           +N+ IHRD+K  N+LL   D+    KI+DFG AR+ +      +   + G+  YMAPE +
Sbjct: 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL 222
           +  +   K+D++S G +L +++TG        + QLL
Sbjct: 208 R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 231
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 284

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 32/275 (11%)
Query: 17  GRQIGSGSFS-VVWHARHRVHGTEVAMK-EIAMGRLNKKL--QESLMSEIFILKRI-NHP 71
           G+ +G+G+F  VV    + +  ++ AM   + M + +  L  +E+LMSE+ +L  + NH 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETA-------------- 113
           +I+ L     + G   +I EYC  GDL  +++R      C     A              
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
             F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++        
Sbjct: 171 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARHIKNDSNYVVK 227
Query: 174 CGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT 229
             + L   +MAPE +    Y  ++D+WS G  L++L + G +P+ G         ++K  
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 287
Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
                P+     A+  D+ +     +P++R TF++
Sbjct: 288 FRMLSPEHA--PAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 127
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 128 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 183
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRINHPHII 74
           G ++G G F VV+  +  V+ T VA+K++A  +    ++L++    EI ++ +  H +++
Sbjct: 30  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHFMKQLAAG----LQVLR 128
            L         L L+  Y   G L   + R  C+      + H   ++A G    +  L 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIM 185
           +N+ IHRD+K  N+LL   D+    KI+DFG AR+ +      +   + G+  YMAPE +
Sbjct: 145 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL 222
           +  +   K+D++S G +L +++TG        + QLL
Sbjct: 202 R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHPHII 74
           +Q+G G+F  V   R+         + +A+ +L    +E L     EI ILK + H +I+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 78
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGLQVL 127
           +   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G++ L
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL 134
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
                IHRDL  +N+L+   ++   +KI DFG  + L P+         P      + AP
Sbjct: 135 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAP 190
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT 208
           E +   K+   +D+WS G +L++L T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHPHII 74
           +Q+G G+F  V   R+         + +A+ +L    +E L     EI ILK + H +I+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGLQVL 127
           +   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G++ L
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL 148
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
                IHRDL  +N+L+   ++   +KI DFG  + L P+         P      + AP
Sbjct: 149 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAP 204
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT 208
           E +   K+   +D+WS G +L++L T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 81
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HR+L  +N ++  D     +KI DFG  R +             L   
Sbjct: 142 DGMAYLNAKKFVHRNLAARNCMVAHD---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 258
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 259 PERVTDLMRMCWQF---NPNMRPTFLEIVN 285

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 241
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 294

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHPHII 74
           +Q+G G+F  V   R+         + +A+ +L    +E L     EI ILK + H +I+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGLQVL 127
           +   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G++ L
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL 148
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
                IHRDL  +N+L+   ++   +KI DFG  + L P+         P      + AP
Sbjct: 149 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAP 204
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT 208
           E +   K+   +D+WS G +L++L T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 28/270 (10%)
Query: 18  RQIGSGSFSVVW--HARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHP 71
           R++G GSF +V+  +AR  + G   T VA+K +     L ++++   ++E  ++K     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCH 80
Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-------QRHGCVPEETAKHFMK---QLA 121
           H++RL  ++       +++E    GDL  Y+       + +   P  T +  ++   ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G+  L     +HR+L  +N ++  D     +KI DFG  R +             L   
Sbjct: 141 DGMAYLNAKKFVHRNLAARNCMVAHD---FTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +MAPE ++   +   +D+WS G +L+++ +  + P+ G +  Q+L+ ++    L  P + 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFN 267
                D   +C +    NP  R TF E  N
Sbjct: 258 PERVTDLMRMCWQF---NPNMRPTFLEIVN 284

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 107/233 (45%), Gaps = 21/233 (9%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINH-- 70
           Y +   IG GSF  V  A  RV    VA+K I     NKK        E+ +L+ +N   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHD 111
Query: 71  ----PHIIRLHDIIEVPGKLHLILEYCKGG--DLSMYIQRHGCVPEETAKHFMKQLAAGL 124
                +I+ L         L L+ E       DL       G V     + F +Q+   L
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTAL 170
Query: 125 QVLR--DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
             L   + ++IH DLKP+N+LLC +    A+KI DFG +  L  R        S  Y +P
Sbjct: 171 LFLATPELSIIHCDLKPENILLC-NPKRXAIKIVDFGSSCQLGQR--IYQXIQSRFYRSP 227
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           E++    YD   D+WS+G IL ++ TG+  F+G+N++  +  IV+   L  PP
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV--LGIPP 278

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        +++E   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG AR +  R       G  +    +M P
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRKGGCAMLPVKWMPP 229
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 282

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 32/262 (12%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 78  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLYMAP 182
           IHRDL  +NLLL T D    +KI DFG  R+L          + R +    C      AP
Sbjct: 137 IHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------AP 187
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
           E ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 244
Query: 241 SADCKDLCQKLLRRNPVERLTF 262
             D  ++  +     P +R TF
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTF 266

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 80
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 81  CRLLGIC-LTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 139
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 140 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 256

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 21/235 (8%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        +++E   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR-----SLQPRGLAETLCGSPL-YM 180
           L +N+ IHRD+  +N LL         KI DFG AR     S   +G    L   P+ +M
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML---PVKWM 212
Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
            PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +   +   G  VA+K +       + +     EI IL+ + H HI
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 74  IRLHDIIEVPG--KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+     E  G   L L++EY   G L  Y+ RH  +       F +Q+  G+  L   +
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHRDL  +N+LL   D++  +KI DFG A+++ P G     + E       + APE ++
Sbjct: 155 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 187 LQKYDAKADLWSVGAILFQLVT 208
             K+   +D+WS G  L++L+T
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 32/262 (12%)
Query: 19  QIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHI 73
           ++G GSF VV    W A        VA+K +    L++ +  +  + E+  +  ++H ++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSG-KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L     
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL----------QPRGLAETLCGSPLYMAP 182
           IHRDL  +NLLL T D    +KI DFG  R+L          + R +    C      AP
Sbjct: 133 IHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------AP 183
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKIL 240
           E ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P D    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 240
Query: 241 SADCKDLCQKLLRRNPVERLTF 262
             D  ++  +     P +R TF
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHPHII 74
           +Q+G G+F  V   R+         + +A+ +L    +E L     EI ILK + H +I+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGLQVL 127
           +   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G++ L
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYL 130
Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LYMAP 182
                IHRDL  +N+L+   ++   +KI DFG  + L P+         P      + AP
Sbjct: 131 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAP 186
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT 208
           E +   K+   +D+WS G +L++L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +   +   G  VA+K +       + +     EI IL+ + H HI
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+     E  G+  L L++EY   G L  Y+ RH  +       F +Q+  G+  L   +
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQH 137
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHR+L  +N+LL   D++  +KI DFG A+++ P G     + E       + APE ++
Sbjct: 138 YIHRNLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 187 LQKYDAKADLWSVGAILFQLVT 208
             K+   +D+WS G  L++L+T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 83
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 84  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 142
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 143 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 259

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 80
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 81  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N ++  D     +KI DFG  R +             L 
Sbjct: 141 IADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 256
Query: 236 DAKILSADCKDLCQKLLRR----NPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 257 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 81
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 82  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 140
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 141 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 42/231 (18%)
Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE--SLMSEIFILKRINHP 71
           Y +   IG+GS+  V  A  ++    VA+K+I   R+ + L +   ++ EI IL R+NH 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRILREIAILNRLNHD 112
Query: 72  HIIRLHDII-----EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           H++++ DI+     E   +L+++LE     D     +    + E   K  +  L  G++ 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS------------LQPR------- 167
           +    ++HRDLKP N L+  D    ++K+ DFG AR+            + PR       
Sbjct: 172 VHSAGILHRDLKPANCLVNQD---CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 168 ------GLAETLCG---SPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVT 208
                  L   L G   +  Y APE++ LQ+ Y    D+WS+G I  +L+ 
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q H     E   H     +  Q+  G+
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA----ERIDHIKLLQYTSQICKGM 130
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHRDL  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 131 EYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFW 186
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 71
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 72  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 131
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 132 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 247
Query: 236 DAKILSADCKDLCQKLLRR----NPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 248 ------DNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 80
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 81  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 139
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 140 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 256

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 82
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 83  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 141
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 142 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 17/233 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQES----LMSEIFILKRINHPHI 73
           R +G G+F  V+  +      + +  ++A+  L +   E      + E  I+ + NH +I
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLAAGLQV 126
           +R   +        ++LE   GGDL  +++     P + +        H  + +A G Q 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----YMAP 182
           L +N+ IHRD+  +N LL         KI DFG A+ +  R       G  +    +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY-RASYYRKGGCAMLPVKWMPP 215
Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP 234
           E      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 268

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 80  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 80
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 81  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 140
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 141 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 256
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 257 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 86
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 146
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N ++  D     +KI DFG  R +             L 
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 262
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 263 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 74  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 134 IADGMAYLNANKFVHRDLAARN---CXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 249
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 250 ------DNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           R +G G F  V    +   +   G  VA+K +       + +     EI IL+ + H HI
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 74  IRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+     E  G+  L L++EY   G L  Y+ RH  +       F +Q+  G+  L   +
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH 137
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQ 186
            IHR+L  +N+LL   D++  +KI DFG A+++ P G     + E       + APE ++
Sbjct: 138 YIHRNLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 187 LQKYDAKADLWSVGAILFQLVT 208
             K+   +D+WS G  L++L+T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 77
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 78  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 137
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 138 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 195 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 253
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 254 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 86
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 87  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 147 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 262
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 263 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 76
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 77  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 136
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 137 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 252
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 253 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 73
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 74  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 133
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 134 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 249
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 250 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 79
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 80  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 140 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 255
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 256 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 126/273 (46%), Gaps = 36/273 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 51  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 108
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 109 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 168
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 169 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 284
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEE 264
                  +C D+  +L+R     NP  R +F E
Sbjct: 285 ------DNCPDMLFELMRMCWQYNPKMRPSFLE 311

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 135/288 (46%), Gaps = 35/288 (12%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG F  V    W          V +K I   +  ++  +++   +  +  ++H HI
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 74  IRLHDIIEVPGK-LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           +RL  +   PG  L L+ +Y   G L  ++++H G +  +   ++  Q+A G+  L ++ 
Sbjct: 96  VRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--RGLAETLCGSPL-YMAPEIMQLQ 188
           ++HR+L  +N+LL +    + +++ADFG A  L P  + L  +   +P+ +MA E +   
Sbjct: 154 MVHRNLAARNVLLKSP---SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           KY  ++D+WS G  +++L+T G  P+ G    ++   + K   L  P   +I + D   +
Sbjct: 211 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QICTIDVYMV 267
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFY 295
             K    +   R TF+E  N                 F+R A D P Y
Sbjct: 268 MVKCWMIDENIRPTFKELANE----------------FTRMARDPPRY 299

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 16  VGRQIGSGSFSVVWH--ARHRVHG---TEVAMKEI-AMGRLNKKLQESLMSEIFILKRIN 69
           + R++G GSF +V+   A+  V     T VA+K +     + ++++   ++E  ++K  N
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFN 79
Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ--------RHGCVPEETAK--HFMKQ 119
             H++RL  ++       +I+E    GDL  Y++             P   +K      +
Sbjct: 80  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGE 139
Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           +A G+  L  N  +HRDL  +N   C   ++  +KI DFG  R +             L 
Sbjct: 140 IADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 179 --YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP 235
             +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P 
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP- 255
Query: 236 DAKILSADCKDLCQKLLR----RNPVERLTFEEFFN 267
                  +C D+  +L+R     NP  R +F E  +
Sbjct: 256 ------DNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 18  RQIGSGSFSVVWHARH---RVHGTEVAMKEIAMGRLNKKLQESLMS---EIFILKRINHP 71
           +Q+G G+F  V   R+   + +  EV    +A+ +L    +E L     EI ILK + H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEV----VAVKKLQHSTEEHLRDFEREIEILKSLQHD 72
Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKH-----FMKQLAAGL 124
           +I++   +    G+  L LI+EY   G L  Y+Q+H    +E   H     +  Q+  G+
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGM 128
Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP-----LY 179
           + L     IHR+L  +N+L+   ++   +KI DFG  + L P+         P      +
Sbjct: 129 EYLGTKRYIHRNLATRNILV---ENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFW 184
Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT 208
            APE +   K+   +D+WS G +L++L T
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 40/275 (14%)
Query: 13  DYLVGRQIGSGSFSVVWHAR-HRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++  ++G G+F  V+ A  H +   +    VA+K  A+   ++  ++    E  +L  
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTM 99
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG------CVPEETAKH------ 115
           + H HI+R   +      L ++ EY + GDL+ +++ HG         E+ A        
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 116 ---FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
                 Q+AAG+  L   + +HRDL  +N   C       +KI DFG +R +        
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRN---CLVGQGLVVKIGDFGMSRDIYSTDYYRV 216
Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA 228
              + L   +M PE +  +K+  ++D+WS G +L+++ T GK P+   +  + +  I + 
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 229 TELH----FPPDAKILSADCKDLCQKLLRRNPVER 259
            EL      PP+   +   C        +R P +R
Sbjct: 277 RELERPRACPPEVYAIMRGC-------WQREPQQR 304

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 104
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 105 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 163
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 164 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 221 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 280

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 33/260 (12%)
Query: 13  DYLVGRQIGSGSFSVVWHAR-HRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++  ++G G+F  V+ A  H +   +    VA+K  A+   ++  ++    E  +L  
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTM 70
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG------CVPEETAK------- 114
           + H HI+R   +      L ++ EY + GDL+ +++ HG         E+ A        
Sbjct: 71  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 130
Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
                 Q+AAG+  L   + +HRDL  +N   C       +KI DFG +R +        
Sbjct: 131 LLAVASQVAAGMVYLAGLHFVHRDLATRN---CLVGQGLVVKIGDFGMSRDIYSTDYYRV 187
Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA 228
              + L   +M PE +  +K+  ++D+WS G +L+++ T GK P+   +  + +  I + 
Sbjct: 188 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 247
Query: 229 TELH----FPPDAKILSADC 244
            EL      PP+   +   C
Sbjct: 248 RELERPRACPPEVYAIMRGC 267

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 33/260 (12%)
Query: 13  DYLVGRQIGSGSFSVVWHAR-HRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKR 67
           D ++  ++G G+F  V+ A  H +   +    VA+K  A+   ++  ++    E  +L  
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQREAELLTM 76
Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG------CVPEETAK------- 114
           + H HI+R   +      L ++ EY + GDL+ +++ HG         E+ A        
Sbjct: 77  LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 136
Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
                 Q+AAG+  L   + +HRDL  +N   C       +KI DFG +R +        
Sbjct: 137 LLAVASQVAAGMVYLAGLHFVHRDLATRN---CLVGQGLVVKIGDFGMSRDIYSTDYYRV 193
Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA 228
              + L   +M PE +  +K+  ++D+WS G +L+++ T GK P+   +  + +  I + 
Sbjct: 194 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 253
Query: 229 TELH----FPPDAKILSADC 244
            EL      PP+   +   C
Sbjct: 254 RELERPRACPPEVYAIMRGC 273

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 121/256 (47%), Gaps = 17/256 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCR 83
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L+H
Sbjct: 84  LLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + Y 
Sbjct: 143 RDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   + +K
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYMIMRK 256
Query: 251 LLRRNPVERLTFEEFF 266
               +   R  F E  
Sbjct: 257 CWMIDADSRPKFRELI 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 17/258 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 82
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 83  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 141
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 142 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   + 
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYMIM 255
Query: 249 QKLLRRNPVERLTFEEFF 266
           +K    +   R  F E  
Sbjct: 256 RKCWMIDADSRPKFRELI 273

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 35/288 (12%)
Query: 18  RQIGSGSFSVV----WHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG F  V    W          V +K I   +  ++  +++   +  +  ++H HI
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 74  IRLHDIIEVPGK-LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           +RL  +   PG  L L+ +Y   G L  ++++H G +  +   ++  Q+A G+  L ++ 
Sbjct: 78  VRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--RGLAETLCGSPL-YMAPEIMQLQ 188
           ++HR+L  +N+LL      + +++ADFG A  L P  + L  +   +P+ +MA E +   
Sbjct: 136 MVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           KY  ++D+WS G  +++L+T G  P+ G    ++   + K   L  P   +I + D   +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QICTIDVYMV 249
Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFY 295
             K    +   R TF+E  N                 F+R A D P Y
Sbjct: 250 MVKCWMIDENIRPTFKELANE----------------FTRMARDPPRY 281

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 85
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 86  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 144
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 145 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 202 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 261

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 81
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 82  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 140
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 141 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 81
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 82  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 140
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 141 VHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 82
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 83  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 141
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 142 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 17/256 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+ R
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCR 91
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L+H
Sbjct: 92  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + Y 
Sbjct: 151 RDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   + +K
Sbjct: 208 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYMIMRK 264
Query: 251 LLRRNPVERLTFEEFF 266
               +   R  F E  
Sbjct: 265 CWMIDADSRPKFRELI 280

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 82
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 83  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 141
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 142 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           Q+G G+F  V   R+   G      VA+K++     ++  Q     EI ILK ++   I+
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIV 71
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +   +   PG+  L L++EY   G L  ++QRH   +       +  Q+  G++ L    
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPLYM-APEIMQL 187
            +HRDL  +N+L+   +  A +KIADFG A+ L   +   +      SP++  APE +  
Sbjct: 132 CVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 188 QKYDAKADLWSVGAILFQLVT 208
             +  ++D+WS G +L++L T
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 73
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 74  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 133 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 86
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 87  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 145
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 146 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 83
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 84  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 142
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 143 VHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 259

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 76
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 77  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRL 135
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 136 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 193 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 252

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHII 74
           V R +  G F+ V+ A+    G E A+K +      K    +++ E+  +K+++ HP+I+
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIV 89
Query: 75  RLHDIIEV--------PGKLHLILEYCKGGDLSMY--IQRHGCVPEETAKHFMKQLAAGL 124
           +      +          +  L+ E CKG  +     ++  G +  +T      Q    +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 125 QVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFG----------FARSLQPRGLAE- 171
           Q +      +IHRDLK +NLLL    +   +K+ DFG          ++ S Q R L E 
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 172 --TLCGSPLYMAPEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV 226
             T   +P+Y  PEI+ L        K D+W++G IL+ L   + PF    +++++    
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG-- 264
Query: 227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
              +   PP     +     L + +L+ NP ERL+  E
Sbjct: 265 ---KYSIPPHDTQYTV-FHSLIRAMLQVNPEERLSIAE 298

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 17/258 (6%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   + 
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYMIM 252
Query: 249 QKLLRRNPVERLTFEEFF 266
           +K    +   R  F E  
Sbjct: 253 RKCWMIDADSRPKFRELI 270

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           Q+G G+F  V   R+   G      VA+K++     ++  Q     EI ILK ++   I+
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIV 74
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +   +   PG+  L L++EY   G L  ++QRH   +       +  Q+  G++ L    
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPLYM-APEIMQL 187
            +HRDL  +N+L+   +  A +KIADFG A+ L   +   +      SP++  APE +  
Sbjct: 135 CVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 188 QKYDAKADLWSVGAILFQLVT 208
             +  ++D+WS G +L++L T
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           Q+G G+F  V   R+   G      VA+K++     ++  Q     EI ILK ++   I+
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIV 75
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +   +   PG+  L L++EY   G L  ++QRH   +       +  Q+  G++ L    
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPLYM-APEIMQL 187
            +HRDL  +N+L+   +  A +KIADFG A+ L   +   +      SP++  APE +  
Sbjct: 136 CVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 188 QKYDAKADLWSVGAILFQLVT 208
             +  ++D+WS G +L++L T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 19  QIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHII 74
           Q+G G+F  V   R+   G      VA+K++     ++  Q     EI ILK ++   I+
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIV 87
Query: 75  RLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           +   +   PG+  L L++EY   G L  ++QRH   +       +  Q+  G++ L    
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPLYM-APEIMQL 187
            +HRDL  +N+L+   +  A +KIADFG A+ L   +   +      SP++  APE +  
Sbjct: 148 CVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 188 QKYDAKADLWSVGAILFQLVT 208
             +  ++D+WS G +L++L T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 114/238 (47%), Gaps = 18/238 (7%)
Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHIIR 75
           +GSG+F  V+       G +V +  +A+  L +    K  + ++ E +++  +++PH+ R
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIP-VAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L+H
Sbjct: 116 LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 174
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + Y 
Sbjct: 175 RDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
            ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 232 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 289

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 17/256 (6%)
Query: 20  IGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+ R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCR 83
Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L+H
Sbjct: 84  LLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + Y 
Sbjct: 143 RDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP   I + D   + +K
Sbjct: 200 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP---ICTIDVYMIMRK 256
Query: 251 LLRRNPVERLTFEEFF 266
               +   R  F E  
Sbjct: 257 CWMIDADSRPKFRELI 272

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 83/345 (24%), Positives = 139/345 (40%), Gaps = 79/345 (22%)
Query: 11  VGDYLVGRQ-----IGSGSFS-VVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           VGD+L  R      +G G+F  VV    HR  G  VA+K I   +  +K +E+   EI +
Sbjct: 27  VGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII---KNVEKYKEAARLEINV 83
Query: 65  LKRINHPH------IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPE--ETAKHF 116
           L++IN          +++ D  +  G + +  E   G     +++ +  +P      +H 
Sbjct: 84  LEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHM 142
Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----------------DNAALKIADFGF 160
             QL   ++ L DN L H DLKP+N+L    D                 + A+++ DFG 
Sbjct: 143 AFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGS 202
Query: 161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF-TGSNQI 219
           A          T+  +  Y APE++    +    D+WS+G I+F+   G T F T  N+ 
Sbjct: 203 ATFDHEH--HSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNRE 260
Query: 220 QLL-------------------QNIVKATELHFPPD---AKILSADCK------------ 245
            L                    Q       L +  +    + +  +CK            
Sbjct: 261 HLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEE 320
Query: 246 -----DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ---PDQVFRS 282
                DL + +L   P +RLT  E   HPF ++ +   P++++ S
Sbjct: 321 HHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDS 365

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY + R++G G +S V+ A +  +  +VA+K +   +  K  +E  + E         P+
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILE----NLRGGPN 93
Query: 73  IIRLHDIIEVPGKL--HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           II L DI++ P      L+ E+    D     Q +  + +   + +M ++   L      
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM-QLQK 189
            ++HRD+KP N+L+  D ++  L++ D+G A    P         S  +  PE++   Q 
Sbjct: 151 GIMHRDVKPHNVLI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 190 YDAKADLWSVGAILFQLVTGKTPFT--GSNQIQL-----------LQNIVKATELHFPP- 235
           YD   D+WS+G +L  ++  K PF     N  QL           L + +    +   P 
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 236 --------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
                               +  ++S +  D   KLLR +   RLT  E   HP+     
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 328
Query: 276 PDQ 278
            DQ
Sbjct: 329 KDQ 331

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + + SG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 86
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI++    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 87  CRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 145
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 146 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 86
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 87  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 145
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 146 VHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 17  GRQIGSGSFSVVW------------HARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           G ++G G++  V+            +A  ++ GT ++M              S   EI +
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM--------------SACREIAL 71
Query: 65  LKRINHPHIIRLHDII--EVPGKLHLILEYCKGGDLSMYIQRHGC---------VPEETA 113
           L+ + HP++I L  +       K+ L+ +Y +  DL   I+ H           +P    
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFAR----SLQPRG 168
           K  + Q+  G+  L  N ++HRDLKP N+L+  +  +   +KIAD GFAR     L+P  
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 169 LAETLCGSPLYMAPEIMQLQKYDAKA-DLWSVGAILFQLVTGKTPF 213
             + +  +  Y APE++   ++  KA D+W++G I  +L+T +  F
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 115/240 (47%), Gaps = 18/240 (7%)
Query: 18  RQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +GSG+F  V+       G +V    A+KE+     + K  + ++ E +++  +++PH+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHV 79
Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
            RL  I  +   + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  L
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N+L+ T      +KI DFG A+ L          G  +   +MA E +  + 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPP----DAKILSADC 244
           Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP    D  ++   C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/341 (23%), Positives = 138/341 (40%), Gaps = 82/341 (24%)
Query: 11  VGDYLVGR-----QIGSGSFSVVW----HARHRVHGTEVAMKEIAMGRLNKKLQESLMSE 61
           +GD+L  R      +G G+F  V     HAR +   ++VA+K I   R   K +E+   E
Sbjct: 45  IGDWLQERYEIVGNLGEGTFGKVVECLDHARGK---SQVALKII---RNVGKYREAARLE 98
Query: 62  IFILKRI------NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEET--A 113
           I +LK+I      N    + + D     G + +  E   G +   +++ +   P      
Sbjct: 99  INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV 157
Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----------------DNAALKIAD 157
           +H   QL   L+ L +N L H DLKP+N+L    +                 N ++++AD
Sbjct: 158 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 217
Query: 158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF-TGS 216
           FG A          T+  +  Y  PE++    +    D+WS+G ILF+   G T F T  
Sbjct: 218 FGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 275
Query: 217 NQ--IQLLQNIVKATELHF--------------------PPDAKILSADCK--------- 245
           N+  + +++ I+     H                       D + +  +CK         
Sbjct: 276 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 335
Query: 246 --------DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
                   DL +++L  +P +R+T  E   HPF +   P++
Sbjct: 336 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 376
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	575
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-106
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-105
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-105
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-103
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-103
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-98
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-93
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-92
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-91
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-91
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-90
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-90
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-90
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-90
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-89
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-89
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-89
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-89
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-89
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-89
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-89
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-88
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-87
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-87
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-87
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-87
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-87
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-87
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-87
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-86
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-86
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-86
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-85
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-85
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-85
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-85
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-85
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-84
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-84
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-84
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-84
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-83
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-83
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-82
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-82
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-82
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-82
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-81
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-81
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-81
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-79
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-79
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-76
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-75
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-75
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-74
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-74
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-72
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-69
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-69
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-69
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-68
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-68
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-67
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-67
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-66
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-66
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-65
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-65
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-64
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-64
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-63
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-63
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-63
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-63
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-62
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-62
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-62
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-62
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-61
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-60
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-60
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-60
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-60
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-60
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-59
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-58
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-58
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-58
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-58
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-57
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-57
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-57
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-56
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-56
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-55
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-55
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-54
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-54
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-53
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-53
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-51
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-51
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-51
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-51
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-50
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-50
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-50
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-50
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-49
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-49
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-49
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-49
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-49
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-48
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-48
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-48
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-48
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-48
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-48
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-47
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-45
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-45
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-44
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-44
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-43
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-43
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-42
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-42
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-41
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-41
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-41
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-39
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-39
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-38
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-38
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-38
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-37
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-32
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-30
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-28
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  322 bits (827), Expect = e-106
 Identities = 82/343 (23%), Positives = 148/343 (43%), Gaps = 32/343 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP- 71
            Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L ++    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 72  -HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
             IIRL+D       +++++E     DL+ ++++   +     K + K +   +  +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQL 187
            ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM PE ++ 
Sbjct: 128 GIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 188 Q-----------KYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT-ELHFP 234
                       K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+    E+ FP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL-----SQTQPDQVFRSRMFSRSA 289
               I   D +D+ +  L+R+P +R++  E   HP++        Q  +     M     
Sbjct: 244 D---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

Query: 290 DDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKR 332
                    S+   A++  +        + SS         K+
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  318 bits (817), Expect = e-105
 Identities = 78/285 (27%), Positives = 137/285 (48%), Gaps = 28/285 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP- 71
            Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L ++    
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 72  -HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
             IIRL+D       +++++E     DL+ ++++   +     K + K +   +  +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQL 187
            ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM PE ++ 
Sbjct: 147 GIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 188 Q-----------KYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT-ELHFP 234
                       K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+    E+ FP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262

Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL-SQTQPDQ 278
               I   D +D+ +  L+R+P +R++  E   HP++  QT P  
Sbjct: 263 D---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  318 bits (817), Expect = e-105
 Identities = 68/314 (21%), Positives = 125/314 (39%), Gaps = 41/314 (13%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +      +L+   +G G+ + V+  RH+  G   A+K        +   +  M E  +LK
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLK 62

Query: 67  RINHPHIIRLHDIIEVPGKLH--LILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLA 121
           ++NH +I++L  I E     H  LI+E+C  G L   ++       +PE      ++ + 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            G+  LR+N ++HR++KP N++     D  +  K+ DFG AR L+      +L G+  Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 181 APEIMQL--------QKYDAKADLWSVGAILFQLVTGKTPF----TGSNQIQLLQNIVKA 228
            P++ +         +KY A  DLWS+G   +   TG  PF          +++  I+  
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 229 T------------------ELHFPPDAKI---LSADCKDLCQKLLRRNPVERLTFEEFFN 267
                                  P    +   L      +   +L  +  +   F++FF 
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 268 HP-FLSQTQPDQVF 280
               +         
Sbjct: 303 ETSDILHRGNSHHH 316

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  315 bits (809), Expect = e-103
 Identities = 82/344 (23%), Positives = 148/344 (43%), Gaps = 32/344 (9%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
             Y + +QIGSG  S V+   +       A+K + +   + +  +S  +EI  L ++   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 72  --HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
              IIRL+D       +++++E     DL+ ++++   +     K + K +   +  +  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQ 186
           + ++H DLKP N L+     +  LK+ DFG A  +QP     + ++  G+  YM PE ++
Sbjct: 174 HGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 187 LQ-----------KYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT-ELHF 233
                        K   K+D+WS+G IL+ +  GKTPF    NQI  L  I+    E+ F
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ-----TQPDQVFRSRMFSRS 288
           P    I   D +D+ +  L+R+P +R++  E   HP++        Q  +     M    
Sbjct: 290 PD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 346

Query: 289 ADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKR 332
                     S+   A++  +        + SS         K+
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  324 bits (832), Expect = e-103
 Identities = 76/304 (25%), Positives = 134/304 (44%), Gaps = 30/304 (9%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
             +  G + +  ++G+G F  V    H+  G +VA+K+     L+ K +E    EI I+K
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMK 67

Query: 67  RINHPHIIRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHG---CVPEETAKHFM 117
           ++NHP+++   ++ +   KL       L +EYC+GGDL  Y+ +      + E   +  +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 118 KQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSP 177
             +++ L+ L +N +IHRDLKP+N++L         KI D G+A+ L    L     G+ 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD- 236
            Y+APE+++ +KY    D WS G + F+ +TG  PF  + Q       V+          
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247

Query: 237 -------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
                              + IL+   +   Q +L  +  +R T  +  N          
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307

Query: 278 QVFR 281
              +
Sbjct: 308 LSLK 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  304 bits (780), Expect = 1e-98
 Identities = 70/316 (22%), Positives = 127/316 (40%), Gaps = 41/316 (12%)

Query: 5   TGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
             +      +L+   +G G+ + V+  RH+  G   A+K        +   +  M E  +
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEV 60

Query: 65  LKRINHPHIIRLHDIIEVPGKLH--LILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQ 119
           LK++NH +I++L  I E     H  LI+E+C  G L   ++       +PE      ++ 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           +  G+  LR+N ++HR++KP N++     D  +  K+ DFG AR L+      +L G+  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 179 YMAPEIMQL--------QKYDAKADLWSVGAILFQLVTGKTPF----TGSNQIQLLQNIV 226
           Y+ P++ +         +KY A  DLWS+G   +   TG  PF          +++  I+
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 227 KAT------------------ELHFPPDAKI---LSADCKDLCQKLLRRNPVERLTFEEF 265
                                    P    +   L      +   +L  +  +   F++F
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 266 FNHP-FLSQTQPDQVF 280
           F     +       VF
Sbjct: 301 FAETSDILHRMVIHVF 316

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  295 bits (757), Expect = 9e-96
 Identities = 86/344 (25%), Positives = 158/344 (45%), Gaps = 13/344 (3%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           +       + +  Y+  ++IG GSF      +    G +  +KEI + R++ K +E    
Sbjct: 13  LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMK 118
           E+ +L  + HP+I++  +  E  G L+++++YC+GGDL   I         E+    +  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSP 177
           Q+   L+ + D  ++HRD+K QN+ L  D     +++ DFG AR L     LA    G+P
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNSTVELARACIGTP 189

Query: 178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
            Y++PEI + + Y+ K+D+W++G +L++L T K  F   +   L+  I+  +   FPP +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVS 246

Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL----SQTQPDQVFRSRMFSRSADDFP 293
              S D + L  +L +RNP +R +        F+     +    Q+       ++   F 
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306

Query: 294 FYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMK 337
                + R  +  +    +P       +   G P   K+    K
Sbjct: 307 SQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDKK 350

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  286 bits (735), Expect = 2e-93
 Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 18/273 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG+GS+      R +  G  +  KE+  G + +  ++ L+SE+ +L+ + HP+
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 73  IIRLHD--IIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           I+R +D  I      L++++EYC+GGDL+  I +       + EE     M QL   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 127 L-----RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
                   + ++HRDLKP N+ L    +   +K+ DFG AR L      A+T  G+P YM
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE M    Y+ K+D+WS+G +L++L     PFT  +Q +L   I +     F       
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIPYRY 240

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           S +  ++  ++L      R + EE   +P + +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  288 bits (739), Expect = 2e-93
 Identities = 97/283 (34%), Positives = 163/283 (57%), Gaps = 8/283 (2%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           ++        +G+Y + + IG G+F+ V  ARH + G EVA+K I   +LN    + L  
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR 63

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           E+ I+K +NHP+I++L ++IE    L+LI+EY  GG++  Y+  HG + E+ A+   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            + +Q      ++HRDLK +NLLL   D +  +KIADFGF+      G  +  CG+P Y 
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180

Query: 181 APEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           APE+ Q +KYD  + D+WS+G IL+ LV+G  PF G N  +L + +++  +   P     
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRIPFY--- 236

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRS 282
           +S DC++L ++ L  NP++R T E+     +++    +   + 
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  285 bits (731), Expect = 1e-92
 Identities = 81/264 (30%), Positives = 136/264 (51%), Gaps = 2/264 (0%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y V  ++G G+FSVV    H+  G E A K I   +L+ +  + L  E  I +++ HP+I
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +RLHD I+     +L+ +   GG+L   I       E  A H ++Q+   +     N ++
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           HR+LKP+NLLL +    AA+K+ADFG A  +          G+P Y++PE+++   Y   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKLL 252
            D+W+ G IL+ L+ G  PF   +Q +L   I       +P P+   ++ + K L   +L
Sbjct: 188 VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSML 246

Query: 253 RRNPVERLTFEEFFNHPFLSQTQP 276
             NP +R+T ++    P++   + 
Sbjct: 247 TVNPKKRITADQALKVPWICNRER 270

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  284 bits (730), Expect = 1e-92
 Identities = 82/271 (30%), Positives = 140/271 (51%), Gaps = 9/271 (3%)

Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEI 62
           +  R   + D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 63  FILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
            I   + HP+I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA 
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
            L       +IHRD+KP+NLLL        LKIADFG++    P      LCG+  Y+ P
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPP 176

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
           E+++ + +D K DLWS+G + ++ + GK PF  +   +  + I +  E  FP     ++ 
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF---VTE 232

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             +DL  +LL+ NP +R    E   HP+++ 
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  284 bits (729), Expect = 2e-92
 Identities = 88/278 (31%), Positives = 150/278 (53%), Gaps = 9/278 (3%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLM 59
           +++   R   + D+ +GR +G G F  V+ AR + +   +A+K +   +L K  ++  L 
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
            EI I   + HP+I+R+++      +++L+LE+   G+L   +Q+HG   E+ +  FM++
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           LA  L    +  +IHRD+KP+NLL+        LKIADFG++    P     T+CG+  Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWS-VHAPSLRRRTMCGTLDY 178

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           + PE+++ + +D K DLW  G + ++ + G  PF   +  +  + IV   +L FPP    
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPF--- 234

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           LS   KDL  KLLR +P +RL  +    HP++      
Sbjct: 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  281 bits (722), Expect = 2e-91
 Identities = 97/282 (34%), Positives = 152/282 (53%), Gaps = 10/282 (3%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMS 60
           S AT  G  + D+ VG  +G GSF+ V+ A     G EVA+K I    + K  + + + +
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQ 119
           E+ I  ++ HP I+ L++  E    ++L+LE C  G+++ Y++ R     E  A+HFM Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA-RSLQPRGLAETLCGSPL 178
           +  G+  L  + ++HRDL   NLLL     N  +KIADFG A +   P     TLCG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           Y++PEI     +  ++D+WS+G + + L+ G+ PF        L  +V A +   P    
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSF-- 234

Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
            LS + KDL  +LLRRNP +RL+     +HPF+S+    +  
Sbjct: 235 -LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  282 bits (723), Expect = 4e-91
 Identities = 90/291 (30%), Positives = 151/291 (51%), Gaps = 13/291 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA------MGRLNKKLQESLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA+K I+                ++ +EI ILK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 187 ---LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDA-KILS 241
                 Y+   D WS+G ILF  ++G  PF+    Q+ L   I    + +F P+    +S
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNFIPEVWAEVS 248

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
               DL +KLL  +P  R T EE   HP+L      + F+  +   +    
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTA 299

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  281 bits (720), Expect = 5e-91
 Identities = 82/279 (29%), Positives = 148/279 (53%), Gaps = 3/279 (1%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
                 +G     Y +   +G GSF  V   + R+   E A+K I       K   +++ 
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           E+ +LK+++HP+I++L +I+E     +++ E   GG+L   I +     E  A   +KQ+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            +G+  +  +N++HRDLKP+N+LL + + +  +KI DFG +   Q     +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KI 239
           APE+++   YD K D+WS G IL+ L++G  PF G N+  +L+ +    +  F     + 
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRT 248

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           +S D KDL +K+L  +P  R+T  +   HP++ +   ++
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  278 bits (714), Expect = 2e-90
 Identities = 86/272 (31%), Positives = 141/272 (51%), Gaps = 9/272 (3%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRIN 69
           +G Y++G  +G G+F  V    H++ G +VA+K +   ++    +   +  EI  LK   
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HPHII+L+ +I  P    +++EY  GG+L  YI +HG V E  A+   +Q+ + +     
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
           + ++HRDLKP+N+LL   D +   KIADFG +  +       T CGSP Y APE++  + 
Sbjct: 130 HMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186

Query: 190 YD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y   + D+WS G IL+ L+ G  PF   +   L + I      + P     L+     L 
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VFYIPEY---LNRSVATLL 242

Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
             +L+ +P++R T ++   H +  Q  P  +F
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  281 bits (721), Expect = 3e-90
 Identities = 81/270 (30%), Positives = 138/270 (51%), Gaps = 2/270 (0%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
            +   +Y V  ++G G+FSVV    H+  G E A K I   +L+ +  + L  E  I ++
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           + HP+I+RLHD I+     +L+ +   GG+L   I       E  A H ++Q+   +   
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             N ++HR+LKP+NLLL +    AA+K+ADFG A  +          G+P Y++PE+++ 
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKD 246
             Y    D+W+ G IL+ L+ G  PF   +Q +L   I       +P P+   ++ + K 
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKS 263

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           L   +L  NP +R+T ++    P++   + 
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRER 293

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  278 bits (713), Expect = 3e-90
 Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 5/265 (1%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +   IG GS+  V  A  +      A K+I    +     +    EI I+K ++HP+I
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNI 68

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           IRL++  E    ++L++E C GG+L   +       E  A   MK + + +      N+ 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           HRDLKP+N L  TD  ++ LK+ DFG A   +P  +  T  G+P Y++P++++   Y  +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPE 187

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKLL 252
            D WS G +++ L+ G  PF+     +++  I +     FP  D   +S   + L ++LL
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-TFTFPEKDWLNVSPQAESLIRRLL 246

Query: 253 RRNPVERLTFEEFFNHPFLSQTQPD 277
            ++P +R+T  +   H +  +    
Sbjct: 247 TKSPKQRITSLQALEHEWFEKQLSS 271

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  277 bits (712), Expect = 8e-90
 Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 9/269 (3%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
             R    Y+ GR +G G F+  +           A K +    L K   +E +  EI I 
Sbjct: 10  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           + + H H++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEI 184
            L  N +IHRDLK  NL L   +++  +KI DFG A  +       + LCG+P Y+APE+
Sbjct: 130 YLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
           +  + +  + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++   
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKH---INPVA 242

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             L QK+L+ +P  R T  E  N  F + 
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTS 271

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  277 bits (710), Expect = 1e-89
 Identities = 76/264 (28%), Positives = 139/264 (52%), Gaps = 7/264 (2%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           ++  R++GSG+F  V     R  G E  +K I   R      E + +EI +LK ++HP+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNI 82

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLRD 129
           I++ ++ E    +++++E C+GG+L   I     R   + E      MKQ+   L     
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
            +++H+DLKP+N+L      ++ +KI DFG A   +    +    G+ LYMAPE+ + + 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RD 201

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
              K D+WS G +++ L+TG  PFTG++  ++ Q      E ++  + + L+    DL +
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAVECRPLTPQAVDLLK 260

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQ 273
           ++L ++P  R +  +  +H +  Q
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  280 bits (719), Expect = 3e-89
 Identities = 88/277 (31%), Positives = 147/277 (53%), Gaps = 13/277 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA------MGRLNKKLQESLMSEIFILK 66
           +Y++ + +GSG+   V  A  R    +VA++ I+                ++ +EI ILK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           ++NHP II++ +  +     +++LE  +GG+L   +  +  + E T K +  Q+   +Q 
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           L +N +IHRDLKP+N+LL + +++  +KI DFG ++ L    L  TLCG+P Y+APE++ 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314

Query: 187 ---LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDA-KILS 241
                 Y+   D WS+G ILF  ++G  PF+    Q+ L   I    + +F P+    +S
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNFIPEVWAEVS 373

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
               DL +KLL  +P  R T EE   HP+L      +
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  278 bits (712), Expect = 3e-89
 Identities = 90/287 (31%), Positives = 148/287 (51%), Gaps = 10/287 (3%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
             R +G Y++   +G GSF  V  A H     +VA+K I+   L K  +   +  EI  L
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           K + HPHII+L+D+I  P  + +++EY  GG+L  YI     + E+  + F +Q+   ++
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
               + ++HRDLKP+NLLL   DDN  +KIADFG +  +      +T CGSP Y APE++
Sbjct: 123 YCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179

Query: 186 QLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
             + Y   + D+WS G +L+ ++ G+ PF       L + +        P     LS   
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDF---LSPGA 235

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADD 291
           + L ++++  +P++R+T +E    P+ +   PD +        S  D
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYAD 282

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  276 bits (709), Expect = 5e-89
 Identities = 89/307 (28%), Positives = 150/307 (48%), Gaps = 11/307 (3%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
             V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML 62

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           NH ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIM 185
              + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE++
Sbjct: 123 GIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 186 QLQKYD-AKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELHFPPDAKILSAD 243
           + +++     D+WS G +L  ++ G+ P+   S+  Q   +  +  + +  P  KI  + 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKI-DSA 237

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDV 303
              L  K+L  NP  R+T  +     + ++       R R+ S    + P   SK ++  
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297

Query: 304 AESSQDD 310
            + S  +
Sbjct: 298 LDFSPVN 304

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  281 bits (722), Expect = 8e-89
 Identities = 82/272 (30%), Positives = 146/272 (53%), Gaps = 3/272 (1%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           G     Y +   +G GSF  V   + R+   E A+K I       K   +++ E+ +LK+
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           ++HP+I++L +I+E     +++ E   GG+L   I +     E  A   +KQ+ +G+  +
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
             +N++HRDLKP+N+LL + + +  +KI DFG +   Q     +   G+  Y+APE+++ 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR- 196

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKD 246
             YD K D+WS G IL+ L++G  PF G N+  +L+ +    +  F     + +S D KD
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDDAKD 255

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
           L +K+L  +P  R+T  +   HP++ +   + 
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  276 bits (709), Expect = 8e-89
 Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 9/269 (3%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFIL 65
             R    Y+ GR +G G F+  +           A K +    L K   +E +  EI I 
Sbjct: 36  DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           + + H H++  H   E    + ++LE C+   L    +R   + E  A+++++Q+  G Q
Sbjct: 96  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEI 184
            L  N +IHRDLK  NL L   +++  +KI DFG A  +       + LCG+P Y+APE+
Sbjct: 156 YLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
           +  + +  + D+WS+G I++ L+ GK PF  S   +    I K  E   P     ++   
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKH---INPVA 268

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             L QK+L+ +P  R T  E  N  F + 
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFTS 297

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  273 bits (701), Expect = 2e-88
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 11/278 (3%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
             V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML 62

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           NH ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA---RSLQPRGLAETLCGSPLYMAPEIM 185
              + HRD+KP+NLLL   D+   LKI+DFG A   R      L   +CG+  Y+APE++
Sbjct: 123 GIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 186 QLQKYD-AKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSAD 243
           + +++     D+WS G +L  ++ G+ P+   S+  Q   +  +  + +  P  KI  + 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKI-DSA 237

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
              L  K+L  NP  R+T  +     + ++       R
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  278 bits (713), Expect = 2e-87
 Identities = 84/262 (32%), Positives = 149/262 (56%), Gaps = 3/262 (1%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y   +++GSG++  V   R +V   E A+K I    ++      L+ E+ +LK ++HP+
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I++L+D  E     +L++E  KGG+L   I       E  A   +KQ+ +G+  L  +N+
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +HRDLKP+NLLL + + +A +KI DFG +   + +   +   G+  Y+APE+++ +KYD 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDE 216

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLCQKL 251
           K D+WS+G ILF L+ G  PF G    ++L+ + K  +  F     K +S   KDL +++
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-KYTFDSPEWKNVSEGAKDLIKQM 275

Query: 252 LRRNPVERLTFEEFFNHPFLSQ 273
           L+ +   R++ ++   HP++ +
Sbjct: 276 LQFDSQRRISAQQALEHPWIKE 297

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  271 bits (696), Expect = 2e-87
 Identities = 86/271 (31%), Positives = 142/271 (52%), Gaps = 7/271 (2%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
             +   ++    +GSG+FS V+  + R+ G   A+K I      +    SL +EI +LK+
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKK 62

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I H +I+ L DI E     +L+++   GG+L   I   G   E+ A   ++Q+ + ++ L
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
            +N ++HRDLKP+NLL  T ++N+ + I DFG ++  Q  G+  T CG+P Y+APE++  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQ 181

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD--AKILSADCK 245
           + Y    D WS+G I + L+ G  PF    + +L + I +     F       I S   K
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-YYEFESPFWDDI-SESAK 239

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           D    LL ++P ER T E+  +HP++     
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA 270

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  270 bits (694), Expect = 2e-87
 Identities = 86/266 (32%), Positives = 141/266 (53%), Gaps = 7/266 (2%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I   RL+   +    E +  E+ IL+ I 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP+II LHDI E    + LILE   GG+L  ++     + E+ A  F+KQ+  G+  L  
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 130 NNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +  N  +K+ DFG A  ++     + + G+P ++APEI+  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDL 247
               +AD+WS+G I + L++G +PF G  + + L NI       F  +     S   KD 
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-NYDFDEEYFSNTSELAKDF 245

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQ 273
            ++LL ++P  R+T  +   H ++  
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEHSWIKA 271

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  273 bits (699), Expect = 3e-87
 Identities = 81/318 (25%), Positives = 136/318 (42%), Gaps = 53/318 (16%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA---MGRLNKKLQESLMSEIF 63
              +   Y +   IG GS+ VV  A         A+K +    + ++N K  E + +E+ 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVP-------------- 109
           ++K+++HP+I RL+++ E    + L++E C GG L   +                     
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 110 --------------------------EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL 143
                                     E+   + M+Q+ + L  L +  + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 144 LCTDDDNAALKIADFGFARSLQPRGLAE-----TLCGSPLYMAPEIMQL--QKYDAKADL 196
             T+     +K+ DFG ++        E     T  G+P ++APE++    + Y  K D 
Sbjct: 201 FSTNKS-FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCKDLCQKLLRRN 255
           WS G +L  L+ G  PF G N    +  ++   +L F  P+  +LS   +DL   LL RN
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSPLARDLLSNLLNRN 318

Query: 256 PVERLTFEEFFNHPFLSQ 273
             ER        HP++SQ
Sbjct: 319 VDERFDAMRALQHPWISQ 336

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  277 bits (711), Expect = 4e-87
 Identities = 85/269 (31%), Positives = 149/269 (55%), Gaps = 4/269 (1%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHP 71
            Y   R +G GSF  V   + ++ G E A+K I+  ++  K  +ESL+ E+ +LK+++HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +I++L++  E  G  +L+ E   GG+L   I       E  A   ++Q+ +G+  +  N 
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++HRDLKP+NLLL +   +A ++I DFG +   +     +   G+  Y+APE++    YD
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYD 205

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLCQK 250
            K D+WS G IL+ L++G  PF G+N+  +L+ + K  +  F     K +S   KDL +K
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVSESAKDLIRK 264

Query: 251 LLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           +L   P  R++  +  +H ++     +Q+
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQI 293

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  272 bits (697), Expect = 4e-87
 Identities = 89/282 (31%), Positives = 144/282 (51%), Gaps = 8/282 (2%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRIN 69
           Y  G ++GSG F+VV   R +  G + A K I   R         +E +  E+ ILK I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+  G+  L  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 130 NNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +     +KI DFG A  +      + + G+P ++APEI+  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDL 247
               +AD+WS+G I + L++G +PF G  + + L N+       F  +     SA  KD 
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYFSNTSALAKDF 251

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSA 289
            ++LL ++P +R+T ++   HP++      Q   SR  S   
Sbjct: 252 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA-LSRKASAVN 292

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  271 bits (695), Expect = 9e-87
 Identities = 88/317 (27%), Positives = 143/317 (45%), Gaps = 21/317 (6%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI------AMGRLNKKLQ 55
             A   G     Y     +GSG+F  VW A  +    EV +K I          +     
Sbjct: 14  GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73

Query: 56  ESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE-YCKGGDLSMYIQRHGCVPEETAK 114
             +  EI IL R+ H +II++ DI E  G   L++E +  G DL  +I RH  + E  A 
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
           +  +QL + +  LR  ++IHRD+K +N+++    ++  +K+ DFG A  L+   L  T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 175 GSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           G+  Y APE++    Y   + ++WS+G  L+ LV  + PF        L+  V+A  +H 
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEA-AIHP 243

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFP 293
           P    ++S +   L   LL+  P  R T E+    P+++Q      +      R      
Sbjct: 244 PY---LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300

Query: 294 FYESKSVRDVAESSQDD 310
              S +  ++   S  D
Sbjct: 301 GVLSAASLEMGNRSLSD 317

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  270 bits (692), Expect = 2e-86
 Identities = 86/285 (30%), Positives = 147/285 (51%), Gaps = 7/285 (2%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKRIN 69
           Y +G ++GSG F++V   R +  G E A K I   +     +    E +  E+ IL+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           H ++I LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G+  L  
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 130 NNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
             + H DLKP+N++L   +     +K+ DFG A  ++     + + G+P ++APEI+  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDL 247
               +AD+WS+G I + L++G +PF G  + + L NI       F  +     S   KD 
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SYDFDEEFFSHTSELAKDF 252

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
            +KLL +   +RLT +E   HP+++     Q    R    + ++F
Sbjct: 253 IRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  275 bits (704), Expect = 3e-86
 Identities = 85/281 (30%), Positives = 146/281 (51%), Gaps = 9/281 (3%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMS 60
            Q       +G Y++G  +G G+F  V   +H + G +VA+K +   ++    +   +  
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EI  LK   HPHII+L+ +I  P  + +++EY  GG+L  YI ++G + E+ ++   +Q+
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
            +G+     + ++HRDLKP+N+LL   D +   KIADFG +  +       T CGSP Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 181 APEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           APE++  + Y   + D+WS G IL+ L+ G  PF   +   L + I      + P     
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-IFYTPQY--- 238

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
           L+     L + +L+ +P++R T ++   H +  Q  P  +F
Sbjct: 239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLF 279

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  270 bits (692), Expect = 4e-86
 Identities = 89/285 (31%), Positives = 143/285 (50%), Gaps = 13/285 (4%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL---QESLMSEIFILKRINH 70
           Y +   IG G FSVV    +R  G + A+K + + +         E L  E  I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVP----EETAKHFMKQLAAGLQV 126
           PHI+ L +     G L+++ E+  G DL   I +         E  A H+M+Q+   L+ 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIM 185
             DNN+IHRD+KP  +LL + +++A +K+  FG A  L   GL      G+P +MAPE++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADC 244
           + + Y    D+W  G ILF L++G  PF G+ + +L + I+K  +    P     +S   
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG-KYKMNPRQWSHISESA 263

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ--TQPDQVFRSRMFSR 287
           KDL +++L  +P ER+T  E  NHP+L +      ++       +
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQ 308

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  273 bits (699), Expect = 6e-86
 Identities = 91/284 (32%), Positives = 142/284 (50%), Gaps = 5/284 (1%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
            R   +Y +  ++G G+FSVV      + G E A   I   +L+ +  + L  E  I + 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           + HP+I+RLHD I   G  +LI +   GG+L   I       E  A H ++Q+   +   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPLYMAPEIMQ 186
               ++HR+LKP+NLLL +    AA+K+ADFG A  ++    A     G+P Y++PE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADCK 245
              Y    DLW+ G IL+ L+ G  PF   +Q +L Q I       FP P+   ++ + K
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-AYDFPSPEWDTVTPEAK 245

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ--TQPDQVFRSRMFSR 287
           DL  K+L  NP +R+T  E   HP++S   T    + R      
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 289

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  269 bits (689), Expect = 2e-85
 Identities = 85/309 (27%), Positives = 147/309 (47%), Gaps = 14/309 (4%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
              Y   + IGSG+F V    R ++    VA+K I  G     + E++  EI   + + H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRH 75

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P+I+R  ++I  P  L +I+EY  GG+L   I   G   E+ A+ F +QL +G+      
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135

Query: 131 NLIHRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
            + HRDLK +N LL   D + A  LKI DFG+++S       ++  G+P Y+APE++  Q
Sbjct: 136 QICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 189 KYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---VKATELHFPPDAKILSADC 244
           +YD   AD+WS G  L+ ++ G  PF    + +  +     + + +   P D +I S +C
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI-SPEC 251

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVA 304
             L  ++   +P  R++  E   H +  +  P  +           +      +S+  + 
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQ-PMQSLDTIM 310

Query: 305 ESSQDDCLP 313
           +   +  +P
Sbjct: 311 QIISEATIP 319

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  266 bits (683), Expect = 3e-85
 Identities = 77/300 (25%), Positives = 122/300 (40%), Gaps = 23/300 (7%)

Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLM 59
              R     +Y +G  +G G F  V+         +VA+K I   R+          +  
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 60  SEIFILKRIN----HPHIIRLHDIIEVPGKLHLILEY-CKGGDLSMYIQRHGCVPEETAK 114
            E+ +L ++     HP +IRL D  E      L+LE      DL  YI   G + E  ++
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
            F  Q+ A +Q      ++HRD+K +N+L+  D      K+ DFG   +L          
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSG-ALLHDEPYTDFD 199

Query: 175 GSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           G+ +Y  PE +   +Y    A +WS+G +L+ +V G  PF    +I          ELHF
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEAELHF 252

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFP 293
           P     +S DC  L ++ L   P  R + EE    P++     D          +   + 
Sbjct: 253 PAH---VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  267 bits (685), Expect = 3e-85
 Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 5/271 (1%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHI 73
           L  +++G G F+VV     +  G E A K +   R  +  +  ++ EI +L+     P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I LH++ E   ++ LILEY  GG++      +    V E      +KQ+  G+  L  NN
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++H DLKPQN+LL +      +KI DFG +R +        + G+P Y+APEI+      
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT 211

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLCQK 250
              D+W++G I + L+T  +PF G +  +   NI +   + +  +    +S    D  Q 
Sbjct: 212 TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-NVDYSEETFSSVSQLATDFIQS 270

Query: 251 LLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
           LL +NP +R T E   +H +L Q   + +F 
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQQWDFENLFH 301

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  268 bits (686), Expect = 4e-85
 Identities = 89/291 (30%), Positives = 150/291 (51%), Gaps = 7/291 (2%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIF 63
            +V   Y +G ++GSG F++V   R +  G E A K I   +         +E +  E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           IL+++ HP+II LHD+ E    + LILE   GG+L  ++ +   + EE A  F+KQ+  G
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 124 LQVLRDNNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
           +  L    + H DLKP+N++L   +     +K+ DFG A  ++     + + G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILS 241
           EI+  +    +AD+WS+G I + L++G +PF G  + + L NI       F  +     S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-SYDFDEEFFSQTS 246

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
              KD  +KLL +   +RLT +E   HP+++     Q    R    + ++F
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  266 bits (681), Expect = 5e-85
 Identities = 80/280 (28%), Positives = 129/280 (46%), Gaps = 19/280 (6%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK--LQESLMSEIFILK 66
           +++G YL+G  +G GS+  V            A+K +   +L +    + ++  EI +L+
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 67  RINHPHIIRLHDII--EVPGKLHLILEYCKGGDLSM--YIQRHGCVPEETAKHFMKQLAA 122
           R+ H ++I+L D++  E   K+++++EYC  G   M   +      P   A  +  QL  
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLID 120

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR---GLAETLCGSPLY 179
           GL+ L    ++H+D+KP NLLL        LKI+  G A +L P        T  GSP +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 180 MAPEIMQLQK-YD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
             PEI      +   K D+WS G  L+ + TG  PF G N  +L +NI K      P D 
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAIPGD- 235

Query: 238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
                   DL + +L   P +R +  +   H +  +  P 
Sbjct: 236 --CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  265 bits (679), Expect = 8e-85
 Identities = 89/281 (31%), Positives = 139/281 (49%), Gaps = 19/281 (6%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-------KKLQESLMSEIFILK 66
           Y     +G G  SVV    H+    E A+K I +           ++L+E+ + E+ IL+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 67  RIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +++ HP+II+L D  E      L+ +  K G+L  Y+     + E+  +  M+ L   + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI- 184
            L   N++HRDLKP+N+LL   DD+  +K+ DFGF+  L P      +CG+P Y+APEI 
Sbjct: 139 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195

Query: 185 -----MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAK 238
                     Y  + D+WS G I++ L+ G  PF    Q+ +L+ I+      F  P+  
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGSPEWD 254

Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
             S   KDL  + L   P +R T EE   HPF  Q   ++V
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  271 bits (695), Expect = 1e-84
 Identities = 81/279 (29%), Positives = 146/279 (52%), Gaps = 14/279 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIA-----------MGRLNKKLQESLMSE 61
            Y   R++GSG++  V   + +   +E A+K I              +  +K  E + +E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLA 121
           I +LK ++HP+II+L D+ E     +L+ E+ +GG+L   I       E  A + MKQ+ 
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMA 181
           +G+  L  +N++HRD+KP+N+LL   +    +KI DFG +             G+  Y+A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KIL 240
           PE+++ +KY+ K D+WS G I++ L+ G  PF G N   +++ + K  + +F  +  K +
Sbjct: 217 PEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-KYYFDFNDWKNI 274

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           S + K+L + +L  +  +R T EE  N  ++ +   +  
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  266 bits (682), Expect = 1e-84
 Identities = 88/275 (32%), Positives = 149/275 (54%), Gaps = 5/275 (1%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + V  ++G G+ S+V+  + +      A+K +         ++ + +EI +L R++HP+I
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNI 110

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           I+L +I E P ++ L+LE   GG+L   I   G   E  A   +KQ+   +  L +N ++
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           HRDLKP+NLL  T   +A LKIADFG ++ ++ + L +T+CG+P Y APEI++   Y  +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLCQKLL 252
            D+WSVG I + L+ G  PF      Q +   +   E +F       +S + KDL +KL+
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLI 290

Query: 253 RRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSR 287
             +P +RLT  +   HP+++    + V       +
Sbjct: 291 VLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKK 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  264 bits (676), Expect = 2e-84
 Identities = 68/305 (22%), Positives = 132/305 (43%), Gaps = 40/305 (13%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
            R   D+     +G G+F  V  AR+ +     A+K+I   R  ++   +++SE+ +L  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLAS 58

Query: 68  INHPHIIRLHD-------------IIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETA 113
           +NH +++R +               ++    L + +EYC+ G L   I         +  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-------- 165
               +Q+   L  +    +IHRDLKP N+ +   D++  +KI DFG A+++         
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 166 -------PRGLAETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSN 217
                        +  G+ +Y+A E++     Y+ K D++S+G I F+++      TG  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGME 233

Query: 218 QIQLLQNIVKATELHFPPD-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           ++ +L+ +     + FPPD         K + + L+  +P +R       N  +L     
Sbjct: 234 RVNILKKLRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292

Query: 277 DQVFR 281
           D+V +
Sbjct: 293 DEVIK 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  264 bits (677), Expect = 3e-84
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 21/279 (7%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QE 56
           ++    +  +   Y VG  +GSG F  V+          VA+K +   R++         
Sbjct: 32  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91

Query: 57  SLMSEIFILKRINH--PHIIRLHDIIEVPGKLHLILEYCKG-GDLSMYIQRHGCVPEETA 113
            +  E+ +LK+++     +IRL D  E P    LILE  +   DL  +I   G + EE A
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
           + F  Q+   ++   +  ++HRD+K +N+L+  D +   LK+ DFG   +L    +    
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSG-ALLKDTVYTDF 208

Query: 174 CGSPLYMAPEIMQLQKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH 232
            G+ +Y  PE ++  +Y    A +WS+G +L+ +V G  PF    +I          ++ 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQVF 261

Query: 233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           F      +S++C+ L +  L   P +R TFEE  NHP++
Sbjct: 262 FRQR---VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  265 bits (678), Expect = 4e-84
 Identities = 67/321 (20%), Positives = 128/321 (39%), Gaps = 50/321 (15%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-------- 53
                + + + DY + R +  G F+ +            A+K+     L KK        
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNN 78

Query: 54  -------LQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG 106
                    +   +E+ I+  I + + +    II    ++++I EY +   +  + +   
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138

Query: 107 CV--------PEETAKHFMKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNAALKIAD 157
            +        P +  K  +K +      +  + N+ HRD+KP N+L+   D N  +K++D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSD 195

Query: 158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTG 215
           FG +         +   G+  +M PE    +     AK D+WS+G  L+ +     PF+ 
Sbjct: 196 FGES-EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 216 -SNQIQLLQNIVKATELHFPPDAKI----------------LSADCKDLCQKLLRRNPVE 258
             + ++L  NI     + +P D                   LS +  D  +  LR+NP E
Sbjct: 255 KISLVELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 259 RLTFEEFFNHPFLSQTQPDQV 279
           R+T E+   H +L+ T  + +
Sbjct: 314 RITSEDALKHEWLADTNIEDL 334

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  262 bits (672), Expect = 1e-83
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 15/284 (5%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINH 70
            ++ + ++IG G FS V+ A   + G  VA+K++ +  L + K +   + EI +LK++NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQV 126
           P++I+ +       +L+++LE    GDLS  I+        +PE T   +  QL + L+ 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIM 185
           +    ++HRD+KP N+ +        +K+ D G  R        A +L G+P YM+PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGS--NQIQLLQNIVKATELHFPP-DAKILSA 242
               Y+ K+D+WS+G +L+++   ++PF G   N   L + I +     +PP  +   S 
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPPLPSDHYSE 265

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFS 286
           + + L    +  +P +R      ++                   
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  261 bits (670), Expect = 2e-83
 Identities = 80/302 (26%), Positives = 144/302 (47%), Gaps = 36/302 (11%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS- 60
           S ++G    +  Y +  +IG GS+ VV  A +    T  AMK ++  +L ++        
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 61  -----------------------EIFILKRINHPHIIRLHDIIEVP--GKLHLILEYCKG 95
                                  EI ILK+++HP++++L ++++ P    L+++ E    
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 96  GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI 155
           G + M +     + E+ A+ + + L  G++ L    +IHRD+KP NLL+    ++  +KI
Sbjct: 123 GPV-MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKI 178

Query: 156 ADFGFARSLQPR-GLAETLCGSPLYMAPEIMQLQK--YD-AKADLWSVGAILFQLVTGKT 211
           ADFG +   +    L     G+P +MAPE +   +  +     D+W++G  L+  V G+ 
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 212 PFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           PF     + L   I     L F PD   ++ D KDL  ++L +NP  R+   E   HP++
Sbjct: 239 PFMDERIMCLHSKIKSQ-ALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

Query: 272 SQ 273
           ++
Sbjct: 297 TR 298

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  260 bits (667), Expect = 1e-82
 Identities = 85/270 (31%), Positives = 142/270 (52%), Gaps = 16/270 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPH 72
            L  + +G GSFS+     H+      A+K I     +K+++ +   EI  LK    HP+
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGHPN 67

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I++LH++        L++E   GG+L   I++     E  A + M++L + +  + D  +
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYD 191
           +HRDLKP+NLL   ++DN  +KI DFGFAR   P     +T C +  Y APE++    YD
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD 187

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQ-------IQLLQNIVKATELHFPPDA-KILSAD 243
              DLWS+G IL+ +++G+ PF   ++       +++++ I K  +  F  +A K +S +
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DFSFEGEAWKNVSQE 246

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            KDL Q LL  +P +RL       + +L  
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  260 bits (667), Expect = 3e-82
 Identities = 94/274 (34%), Positives = 141/274 (51%), Gaps = 18/274 (6%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK------LQESLMSEIFILKR 67
           Y     IG G  SVV    HR  G E A+K + +            ++E+   E  IL++
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 68  I-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           +  HPHII L D  E    + L+ +  + G+L  Y+     + E+  +  M+ L   +  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI-- 184
           L  NN++HRDLKP+N+LL   DDN  ++++DFGF+  L+P      LCG+P Y+APEI  
Sbjct: 216 LHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272

Query: 185 ----MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKI 239
                    Y  + DLW+ G ILF L+ G  PF    QI +L+ I++  +  F  P+   
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG-QYQFSSPEWDD 331

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            S+  KDL  +LL+ +P  RLT E+   HPF  +
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  257 bits (660), Expect = 3e-82
 Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 37/288 (12%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D+     IGSG F  V+ A+HR+ G    +K +          E    E+  L +++H +
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVN 65

Query: 73  IIRLHDIIE----------------VPGKLHLILEYCKGGDLSMYI--QRHGCVPEETAK 114
           I+  +   +                    L + +E+C  G L  +I  +R   + +  A 
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
              +Q+  G+  +    LI+RDLKP N+ L    D   +KI DFG   SL+  G      
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF 233
           G+  YM+PE +  Q Y  + DL+++G IL +L+    T F  S     L++ +       
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI------I 236

Query: 234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
                I     K L QKLL + P +R    E      + +  P++  R
Sbjct: 237 SD---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  260 bits (666), Expect = 8e-82
 Identities = 80/269 (29%), Positives = 143/269 (53%), Gaps = 6/269 (2%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G V   Y +  ++GSG+F VV     +  G     K I       K   ++ +EI I+ 
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMN 103

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQ 125
           +++HP +I LHD  E   ++ LILE+  GG+L   I        E    ++M+Q   GL+
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +++++H D+KP+N++  T   ++ +KI DFG A  L P  + +    +  + APEI+
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADC 244
             +      D+W++G + + L++G +PF G + ++ LQN+ +  +  F  DA   +S + 
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-DWEFDEDAFSSVSPEA 281

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           KD  + LL++ P +RLT  +   HP+L  
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 310

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  256 bits (657), Expect = 2e-81
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 14/264 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHP 71
            +    ++G GS+  V+  R +  G   A+K         K +   ++E+   +++  HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDN 130
             +RL    E  G L+L  E C G  L  + +  G  +PE     +++     L  L   
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            L+H D+KP N+ L         K+ DFG    L   G  E   G P YMAPE++Q   Y
Sbjct: 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSY 232

Query: 191 DAKADLWSVGAILFQLVTGKT-PFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
              AD++S+G  + ++      P  G    QL Q  +       P     LS++ + +  
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP------PEFTAGLSSELRSVLV 286

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQ 273
            +L  +P  R T E     P L Q
Sbjct: 287 MMLEPDPKLRATAEALLALPVLRQ 310

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  257 bits (658), Expect = 2e-81
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 9/280 (3%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y++   +G G F +V              K +   ++    Q  +  EI IL    H +I
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNI 63

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNNL 132
           + LH+  E   +L +I E+  G D+   I        E     ++ Q+   LQ L  +N+
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
            H D++P+N++      ++ +KI +FG AR L+P      L  +P Y APE+ Q      
Sbjct: 124 GHFDIRPENII-YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADCKDLCQKL 251
             D+WS+G +++ L++G  PF      Q+++NI+ A E  F  +A K +S +  D   +L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-EYTFDEEAFKEISIEAMDFVDRL 241

Query: 252 LRRNPVERLTFEEFFNHPFLSQ--TQPDQVFRSRMFSRSA 289
           L +    R+T  E   HP+L Q   +        +  R  
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRY 281

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  256 bits (657), Expect = 5e-81
 Identities = 92/312 (29%), Positives = 145/312 (46%), Gaps = 26/312 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHP 71
            Y V   IG GS+SV     H+    E A+K I       K +     EI IL R   HP
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHP 76

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +II L D+ +    ++++ E  KGG+L   I R     E  A   +  +   ++ L    
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 132 LIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQK 189
           ++HRDLKP N+L   +  N  +++I DFGFA+ L+   GL  T C +  ++APE+++ Q 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATELHFPPDA-KILSADCK 245
           YDA  D+WS+G +L+ ++TG TPF         ++L  I    +          +S   K
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KFSLSGGYWNSVSDTAK 255

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL------SQTQPDQVFRSRMFSRSADDFPF----- 294
           DL  K+L  +P +RLT      HP++       Q Q ++     +  + A    +     
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV-KGAMAATYSALNR 314

Query: 295 YESKSVRDVAES 306
            +S  +  V  S
Sbjct: 315 NQSPVLEPVGRS 326

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  254 bits (650), Expect = 1e-79
 Identities = 84/290 (28%), Positives = 141/290 (48%), Gaps = 8/290 (2%)

Query: 7   RGRVVGDYLVGRQ--IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           +G V   Y V +   +G G F  V        G ++A K I    +  K  E + +EI +
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISV 139

Query: 65  LKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAG 123
           + +++H ++I+L+D  E    + L++EY  GG+L   I        E     FMKQ+  G
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE 183
           ++ +    ++H DLKP+N+L C + D   +KI DFG AR  +PR   +   G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENIL-CVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSA 242
           ++         D+WSVG I + L++G +PF G N  + L NI+         +  + +S 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWDLEDEEFQDISE 317

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRMFSRSADDF 292
           + K+   KLL +    R++  E   HP+LS  +      ++       D 
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDA 367

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  260 bits (666), Expect = 1e-79
 Identities = 81/269 (30%), Positives = 137/269 (50%), Gaps = 6/269 (2%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
              V+  Y +  ++G+G+F VV     R  G   A K +     + K  E++  EI  + 
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMS 209

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQ 125
            + HP ++ LHD  E   ++ +I E+  GG+L       H  + E+ A  +M+Q+  GL 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +NN +H DLKP+N++  T   N  LK+ DFG    L P+   +   G+  + APE+ 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-KILSADC 244
           + +      D+WSVG + + L++G +PF G N  + L+N+    + +    A   +S D 
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISEDG 387

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           KD  +KLL  +P  R+T  +   HP+L+ 
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTP 416

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  242 bits (621), Expect = 5e-76
 Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 36/302 (11%)

Query: 8   GRVVGDYLVGRQ-IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           GR    Y +    +G G+ + V    + +   E A+K I     + +    +  E+ +L 
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLY 65

Query: 67  RI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           +   H +++ L +  E   + +L+ E  +GG +  +I +     E  A   ++ +A+ L 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE--------TLCGSP 177
            L +  + HRDLKP+N+L    +  + +KI DF     ++  G           T CGS 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 178 LYMAPEI-----MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--------------- 217
            YMAPE+      +   YD + DLWS+G IL+ L++G  PF G                 
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 218 QIQLLQNIVKATELHFPPD--AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
           Q  L ++I +  +  FP    A I S   KDL  KLL R+  +RL+  +   HP++    
Sbjct: 246 QNMLFESIQEG-KYEFPDKDWAHI-SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

Query: 276 PD 277
           P+
Sbjct: 304 PE 305

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  241 bits (618), Expect = 3e-75
 Identities = 86/279 (30%), Positives = 139/279 (49%), Gaps = 20/279 (7%)

Query: 7   RGRVVGDYLVGRQ-IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           +  V  DY + +Q +G G    V    HR  G + A+K +               E+   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDS--PKARQEVDHH 75

Query: 66  KRI-NHPHIIRLHDIIE----VPGKLHLILEYCKGGDLSMYIQRHGCVP--EETAKHFMK 118
            +    PHI+ + D+ E        L +I+E  +GG+L   IQ  G     E  A   M+
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
            +   +Q L  +N+ HRD+KP+NLL  + + +A LK+ DFGFA+        +T C +P 
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPY 194

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---VKATELHFPP 235
           Y+APE++  +KYD   D+WS+G I++ L+ G  PF  +    +   +   ++  +  FP 
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254

Query: 236 DA-KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                +S D K L + LL+ +P ERLT  +F NHP+++Q
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  242 bits (620), Expect = 8e-75
 Identities = 89/343 (25%), Positives = 149/343 (43%), Gaps = 30/343 (8%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPH 72
            +  + +G G    V    ++    + A+K +               E+ +  R    PH
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDC--PKARREVELHWRASQCPH 116

Query: 73  IIRLHDIIE----VPGKLHLILEYCKGGDLSMYIQRHGCVP--EETAKHFMKQLAAGLQV 126
           I+R+ D+ E        L +++E   GG+L   IQ  G     E  A   MK +   +Q 
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P Y+APE++ 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---VKATELHFPPDA-KILSA 242
            +KYD   D+WS+G I++ L+ G  PF  ++ + +   +   ++  +  FP      +S 
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFL------SQTQPDQVFRSRMFSRSADDFPFYE 296
           + K L + LL+  P +R+T  EF NHP++       QT        +      +D    E
Sbjct: 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED--VKE 354

Query: 297 SKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKST 339
             +          + +     +D+S P       KRR   ++ 
Sbjct: 355 EMTSALATMRVDYEQIKIKKIEDASNPL----LLKRRKKARAL 393

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  237 bits (608), Expect = 3e-74
 Identities = 80/272 (29%), Positives = 135/272 (49%), Gaps = 25/272 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMK-----EIAMGRLNKKLQESLMSEIFILKR 67
           D+  G+ +G GSFS V  AR      E A+K      I    + +     +  E  ++ R
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI----IKENKVPYVTRERDVMSR 86

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           ++HP  ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR---SLQPRGLAETLCGSPLYMAPEI 184
               +IHRDLKP+N+LL   +++  ++I DFG A+       +  A +  G+  Y++PE+
Sbjct: 147 HGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 185 MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
           +  +     +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEK---FFPKA 259

Query: 245 KDLCQKLLRRNPVERLT------FEEFFNHPF 270
           +DL +KLL  +  +RL       +     HPF
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  237 bits (606), Expect = 5e-74
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 37/292 (12%)

Query: 8   GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           GR + D+   + +G G F VV+ A+++V     A+K I +       +E +M E+  L +
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAK 59

Query: 68  INHPHIIRLHDIIE------------VPGKLHLILEYCKGGDLSMYIQRHGCV---PEET 112
           + HP I+R  +                   L++ ++ C+  +L  ++     +       
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 113 AKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ------- 165
             H   Q+A  ++ L    L+HRDLKP N+   T DD   +K+ DFG   ++        
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF-TMDDV--VKVGDFGLVTAMDQDEEEQT 176

Query: 166 ------PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI 219
                          G+ LYM+PE +    Y  K D++S+G ILF+L+      T   ++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERV 234

Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           + L ++       FPP           + Q +L  +P+ER        +   
Sbjct: 235 RTLTDVRNL---KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  233 bits (596), Expect = 2e-72
 Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 28/289 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            YL  +++G G FS V        G   A+K I      ++ +E    E  + +  NHP+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPN 87

Query: 73  IIRLHDIIEVPG----KLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGL 124
           I+RL            +  L+L + K G L   I     +   + E+     +  +  GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR--SLQPRGLAE--------TLC 174
           + +      HRDLKP N+LL    D     + D G      +   G  +           
Sbjct: 148 EAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 175 GSPLYMAPEIMQLQKY---DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL 231
            +  Y APE+  +Q +   D + D+WS+G +L+ ++ G+ P+    Q      +    +L
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP-FLSQTQPDQV 279
             P   +  S+    L   ++  +P +R       +    L    P Q 
Sbjct: 265 SIPQSPR-HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  226 bits (579), Expect = 6e-69
 Identities = 70/263 (26%), Positives = 127/263 (48%), Gaps = 15/263 (5%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRL 76
           R IG GSF  V   +        AMK +   + + +    ++  E+ I++ + HP ++ L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
               +    + ++++   GGDL  ++Q++    EET K F+ +L   L  L++  +IHRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK---YDAK 193
           +KP N+LL   D++  + I DF  A  L       T+ G+  YMAPE+   +K   Y   
Sbjct: 141 MKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197

Query: 194 ADLWSVGAILFQLVTGKTPFTG---SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            D WS+G   ++L+ G+ P+     ++  +++        + +P      S +   L +K
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSA---WSQEMVSLLKK 253

Query: 251 LLRRNPVERL-TFEEFFNHPFLS 272
           LL  NP +R     +  N P+++
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMN 276

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  227 bits (581), Expect = 9e-69
 Identities = 67/300 (22%), Positives = 126/300 (42%), Gaps = 41/300 (13%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPH 72
            +  + +G GS   V   +    G  VA+K     R+     +  + EI +L    +HP+
Sbjct: 17  VVSEKILGYGSSGTV-VFQGSFQGRPVAVK-----RMLIDFCDIALMEIKLLTESDDHPN 70

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-------VPEETAKHFMKQLAAGLQ 125
           +IR +        L++ LE C   +L   ++             E      ++Q+A+G+ 
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 126 VLRDNNLIHRDLKPQNLLLCTDD----------DNAALKIADFGFARSLQP-----RGLA 170
            L    +IHRDLKPQN+L+ T            +N  + I+DFG  + L       R   
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 171 ETLCGSPLYMAPEIMQ-------LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQ-- 220
               G+  + APE+++        ++     D++S+G + + +++ GK PF      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

Query: 221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
           +++ I    E+    D  +  A+  DL  +++  +P++R T  +   HP          F
Sbjct: 250 IIRGIFSLDEMKCLHDRSL-IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEF 308

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  222 bits (569), Expect = 9e-69
 Identities = 52/285 (18%), Positives = 104/285 (36%), Gaps = 31/285 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHP 71
           ++    +IGSG F  V+    R+ G   A+K           +++ + E++    +  H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVL 127
           H++R          + +  EYC GG L+  I  +        E   K  + Q+  GL+ +
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 128 RDNNLIHRDLKPQNLLLCTD----------------DDNAALKIADFGFARSLQPRGLAE 171
              +L+H D+KP N+ +                    +    KI D G    +      +
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQ 188

Query: 172 TLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE 230
              G   ++A E++Q    +  KAD++++   +      +              I +   
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQG-- 243

Query: 231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ 275
              P   ++LS +  +L + ++  +P  R +      H  L    
Sbjct: 244 -RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  223 bits (571), Expect = 2e-68
 Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 16/270 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
                 ++G GSF  V   + +  G + A+K++       +L+   + E+     ++ P 
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPR 111

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+ L+  +     +++ +E  +GG L   I++ GC+PE+ A +++ Q   GL+ L    +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA------ETLCGSPLYMAPEIMQ 186
           +H D+K  N+LL    D +   + DFG A  LQP GL       + + G+  +MAPE++ 
Sbjct: 172 LHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
            +  DAK D+WS   ++  ++ G  P+T   +  L   I               +     
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPLTAQ 288

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
             Q+ LR+ PV R +  E       +  + 
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEV 318

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  222 bits (568), Expect = 8e-68
 Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 15/264 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHP 71
            +   + +G+GSF  V   +H+  G   AMK +   + +  K  E  ++E  IL+ +N P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           LI+RDLKP+NLL+   D    +++ DFGFA+ ++ R    TLCG+P  +APEI+  + Y+
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYN 216

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D W++G +++++  G  PF     IQ+ + IV   ++ FP      S+D KDL + L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSH---FSSDLKDLLRNL 272

Query: 252 LRRNPVERL-----TFEEFFNHPF 270
           L+ +  +R         +  NH +
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKW 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  224 bits (572), Expect = 2e-67
 Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 20/280 (7%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HP 71
            +     +G G+   +   R      +VA+K     R+  +       E+ +L+  + HP
Sbjct: 25  SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVK-----RILPECFSFADREVQLLRESDEHP 78

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDN 130
           ++IR     +     ++ +E C    L  Y+++             ++Q  +GL  L   
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 131 NLIHRDLKPQNLLLCTDDDNAALK--IADFGFARSLQP----RGLAETLCGSPLYMAPEI 184
           N++HRDLKP N+L+   + +  +K  I+DFG  + L            + G+  ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 185 MQ---LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +     +      D++S G + + +++ G  PF  S Q Q    +  A  L      K  
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLHPEKHE 256

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF 280
               ++L +K++  +P +R + +    HPF    +    F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  219 bits (561), Expect = 4e-67
 Identities = 89/264 (33%), Positives = 145/264 (54%), Gaps = 15/264 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHP 71
           D+ + R +G+GSF  V   R R +G   AMK +     +  K  E    E  +L  + HP
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            IIR+    +   ++ +I++Y +GG+L   +++    P   AK +  ++   L+ L   +
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +I+RDLKP+N+LL   D N  +KI DFGFA+ +       TLCG+P Y+APE++  + Y+
Sbjct: 127 IIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYN 181

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D WS G ++++++ G TPF  SN ++  + I+ A EL FPP     + D KDL  +L
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPF---FNEDVKDLLSRL 237

Query: 252 LRRNPVERL-----TFEEFFNHPF 270
           + R+  +RL       E+  NHP+
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPW 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  217 bits (555), Expect = 1e-66
 Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 11/263 (4%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
             +IG GSF  V+         EVA  E+   +L K  ++    E  +LK + HP+I+R 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 77  H----DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL--RDN 130
           +      ++    + L+ E    G L  Y++R   +  +  + + +Q+  GLQ L  R  
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
            +IHRDLK  N+ +       ++KI D G A   +    A+ + G+P +MAPE+ + +KY
Sbjct: 151 PIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYE-EKY 206

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           D   D+++ G  + ++ T + P++       +   V +       D K+   + K++ + 
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKEIIEG 265

Query: 251 LLRRNPVERLTFEEFFNHPFLSQ 273
            +R+N  ER + ++  NH F  +
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  218 bits (557), Expect = 2e-66
 Identities = 89/262 (33%), Positives = 141/262 (53%), Gaps = 18/262 (6%)

Query: 20  IGSGSFSVVWHARHRVH---GTEVAMKEIAMGRL--NKKLQESLMSEIFILKRINHPHII 74
           +G G +  V+  R       G   AMK +    +  N K      +E  IL+ + HP I+
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 75  RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            L    +  GKL+LILEY  GG+L M ++R G   E+TA  ++ +++  L  L    +I+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAK 193
           RDLKP+N++L   +    +K+ DFG  + S+    +  T CG+  YMAPEI+    ++  
Sbjct: 145 RDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201

Query: 194 ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR 253
            D WS+GA+++ ++TG  PFTG N+ + +  I+K  +L+ PP    L+ + +DL +KLL+
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNLPPY---LTQEARDLLKKLLK 257

Query: 254 RNPVERL-----TFEEFFNHPF 270
           RN   RL        E   HPF
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPF 279

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  215 bits (551), Expect = 1e-65
 Identities = 87/260 (33%), Positives = 137/260 (52%), Gaps = 16/260 (6%)

Query: 20  IGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           +G GSF  V+  +           AMK +    L  + +     E  IL  +NHP I++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
           H   +  GKL+LIL++ +GGDL   + +     EE  K ++ +LA  L  L    +I+RD
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151

Query: 137 LKPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKAD 195
           LKP+N+LL   D+   +K+ DFG ++ S+     A + CG+  YMAPE++  + +   AD
Sbjct: 152 LKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 208

Query: 196 LWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
            WS G ++F+++TG  PF G ++ + +  I+KA +L  P     LS + + L + L +RN
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KLGMPQF---LSPEAQSLLRMLFKRN 264

Query: 256 PVERL-----TFEEFFNHPF 270
           P  RL       EE   H F
Sbjct: 265 PANRLGAGPDGVEEIKRHSF 284

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  214 bits (548), Expect = 6e-65
 Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 14/258 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   R +  G   AMK +     + K      ++E  +L+   HP +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
             +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   ++++RD+K
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132

Query: 139 PQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
            +NL+L   D +  +KI DFG  +  +      +T CG+P Y+APE+++   Y    D W
Sbjct: 133 LENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPV 257
            +G ++++++ G+ PF   +  +L + I+   E+ FP     LS + K L   LL+++P 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRT---LSPEAKSLLAGLLKKDPK 245

Query: 258 ERL-----TFEEFFNHPF 270
           +RL       +E   H F
Sbjct: 246 QRLGGGPSDAKEVMEHRF 263

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  214 bits (546), Expect = 3e-64
 Identities = 84/258 (32%), Positives = 139/258 (53%), Gaps = 14/258 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFIL-KRINHPHIIRLH 77
           IG GSF  V  ARH+      A+K +     L KK ++ +MSE  +L K + HP ++ LH
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   KL+ +L+Y  GG+L  ++QR  C  E  A+ +  ++A+ L  L   N+++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 138 KPQNLLLCTDDDNAALKIADFGFA-RSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           KP+N+LL   D    + + DFG    +++      T CG+P Y+APE++  Q YD   D 
Sbjct: 166 KPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +GA+L++++ G  PF   N  ++  NI+    L   P+   ++   + L + LL+++ 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPN---ITNSARHLLEGLLQKDR 278

Query: 257 VERL----TFEEFFNHPF 270
            +RL     F E  +H F
Sbjct: 279 TKRLGAKDDFMEIKSHVF 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  210 bits (536), Expect = 9e-64
 Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 39/271 (14%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPH 72
            +  + +G G    V    ++    + A+K +               E+ +  R    PH
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDC--PKARREVELHWRASQCPH 72

Query: 73  IIRLHDIIE----VPGKLHLILEYCKGGDLSMYIQRHGCVP--EETAKHFMKQLAAGLQV 126
           I+R+ D+ E        L +++E   GG+L   IQ  G     E  A   MK +   +Q 
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           L   N+ HRD+KP+NLL  +   NA LK+ DFGF                    A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG 172

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---VKATELHFPPDA-KILSA 242
            +KYD   D+WS+G I++ L+ G  PF  ++ + +   +   ++  +  FP      +S 
Sbjct: 173 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           + K L + LL+  P +R+T  EF NHP++ Q
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  209 bits (535), Expect = 1e-63
 Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 13/275 (4%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
              +G G++ +V+  R   +   +A+KEI     + +  + L  EI + K + H +I++ 
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 77  HDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVP--EETAKHFMKQLAAGLQVLRDNNLI 133
                  G + + +E   GG L ++   + G +   E+T   + KQ+  GL+ L DN ++
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PRGLAETLCGSPLYMAPEIMQLQK--Y 190
           HRD+K  N+L+  +  +  LKI+DFG ++ L       ET  G+  YMAPEI+      Y
Sbjct: 145 HRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 191 DAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
              AD+WS+G  + ++ TGK PF         +  +        P   + +SA+ K    
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--PEIPESMSAEAKAFIL 260

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
           K    +P +R    +     FL  +   +  + ++
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  210 bits (537), Expect = 2e-63
 Identities = 79/255 (30%), Positives = 122/255 (47%), Gaps = 11/255 (4%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKR-INHPHIIRLH 77
           +G GSF  V+ A  +      A+K +     L     E  M E  +L     HP +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +    L  ++EY  GGDL  +IQ         A  +  ++  GLQ L    +++RDL
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL   D +  +KIADFG  + ++       T CG+P Y+APEI+  QKY+   D 
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           WS G +L++++ G++PF G ++ +L  +I       +P     L  + KDL  KL  R P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRW---LEKEAKDLLVKLFVREP 257

Query: 257 VERL-TFEEFFNHPF 270
            +RL    +   HP 
Sbjct: 258 EKRLGVRGDIRQHPL 272

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  210 bits (536), Expect = 6e-63
 Identities = 44/320 (13%), Positives = 89/320 (27%), Gaps = 62/320 (19%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMS 60
           S+   R R     + G  +G         A  +  G    +              + +  
Sbjct: 66  SELGERPR---TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122

Query: 61  EIFILKR---INHPHIIRLH-------DIIEVPGK-----------------LHLILEYC 93
           E+  L+    I +    ++H       D+++ P K                    +    
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 94  K------GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD 147
           +      G  L  +   H  +          Q+   L  L    L+H  L+P +++L   
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--- 239

Query: 148 DDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-----------KYDAKADL 196
           D    + +  F         G       S  +  PE+   +                 D 
Sbjct: 240 DQRGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +++ +     P T    +   + I          +   +    + L +  LR   
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWI-----FRSCKN---IPQPVRALLEGFLRYPK 348

Query: 257 VERLTFEEFFNHPFLSQTQP 276
            +RL   +    P   Q + 
Sbjct: 349 EDRLLPLQAMETPEYEQLRT 368

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  212 bits (541), Expect = 9e-63
 Identities = 70/259 (27%), Positives = 130/259 (50%), Gaps = 15/259 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +G G+F  V   + +  G   AMK +     + K      ++E  +L+   HP +  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL-RDNNLIHRDL 137
             +   +L  ++EY  GG+L  ++ R     E+ A+ +  ++ + L  L  + N+++RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K +NL+L   D +  +KI DFG  +  ++     +T CG+P Y+APE+++   Y    D 
Sbjct: 276 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W +G ++++++ G+ PF   +  +L + I+   E+ FP     L  + K L   LL+++P
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRT---LGPEAKSLLSGLLKKDP 388

Query: 257 VERL-----TFEEFFNHPF 270
            +RL       +E   H F
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  209 bits (534), Expect = 1e-62
 Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 15/259 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRI-NHPHIIRLH 77
           +G GSF  V  +  +      A+K +     +     E  M E  +L      P + +LH
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  ++A GL  L+   +I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N++L   D    +KIADFG  + ++      +T CG+P Y+APEI+  Q Y    D 
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W+ G +L++++ G+ PF G ++ +L Q+I++   + +P     +S +   +C+ L+ ++P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKS---MSKEAVAICKGLMTKHP 260

Query: 257 VERL-----TFEEFFNHPF 270
            +RL        +   H F
Sbjct: 261 GKRLGCGPEGERDIKEHAF 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  208 bits (531), Expect = 1e-62
 Identities = 73/307 (23%), Positives = 129/307 (42%), Gaps = 42/307 (13%)

Query: 2   SQATGRGRVVGD--YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM 59
           S   G+   +G+    V R +  G F+ V+ A+    G E A+K +      ++   +++
Sbjct: 16  SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAII 73

Query: 60  SEIFILKRI-NHPHIIRLHD-------IIEVPGKLHLILEYCKGGDLSMYIQR---HGCV 108
            E+  +K++  HP+I++            +      L+L     G L  ++++    G +
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133

Query: 109 PEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-- 164
             +T      Q    +Q +      +IHRDLK +NLLL    +   +K+ DFG A ++  
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISH 190

Query: 165 --------QPRGLAE---TLCGSPLYMAPEIMQLQK---YDAKADLWSVGAILFQLVTGK 210
                   Q R L E   T   +P+Y  PEI+ L        K D+W++G IL+ L   +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

Query: 211 TPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
            PF    +++    IV   +   PP           L + +L+ NP ERL+  E  +   
Sbjct: 251 HPFEDGAKLR----IVNG-KYSIPPHDTQ-YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

Query: 271 LSQTQPD 277
                 +
Sbjct: 305 EIAAARN 311

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  208 bits (532), Expect = 2e-62
 Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 16/260 (6%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRI-NHPHIIRLH 77
           +G GSF  V  AR +  G   A+K +     L     E  M+E  IL    NHP + +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              + P +L  ++E+  GGDL  +IQ+     E  A+ +  ++ + L  L D  +I+RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL   D     K+ADFG  +  +       T CG+P Y+APEI+Q   Y    D 
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W++G +L++++ G  PF   N+  L + I+   E+ +P     L  D   + +  + +NP
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPTW---LHEDATGILKSFMTKNP 263

Query: 257 VERL------TFEEFFNHPF 270
             RL             HPF
Sbjct: 264 TMRLGSLTQGGEHAILRHPF 283

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  208 bits (530), Expect = 4e-62
 Identities = 50/316 (15%), Positives = 84/316 (26%), Gaps = 50/316 (15%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMS 60
           S  +   R      +   +  G  SVV+  R      + A+K   MG  N + + E L  
Sbjct: 55  SLLSQGER---KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHE 111

Query: 61  EIFILKRINHP---------HIIRLHDIIEVPGK-----------------LHLILEYCK 94
             F   R+             ++   D + V  +                   L++    
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171

Query: 95  G------GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD 148
                    L       G            QL      L+   L+H    P NL +    
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---M 228

Query: 149 DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQL 206
            +  L + D      +  RG          Y   E +      +    + W +G  ++++
Sbjct: 229 PDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286

Query: 207 VTGKTPFTGSNQ------IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERL 260
                PF            +    +     L F     +     K L  + L  +   RL
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL-PDFVKTLIGRFLNFDRRRRL 345

Query: 261 TFEEFFNHPFLSQTQP 276
              E    P   Q Q 
Sbjct: 346 LPLEAMETPEFLQLQN 361

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  205 bits (524), Expect = 2e-61
 Identities = 76/269 (28%), Positives = 136/269 (50%), Gaps = 25/269 (9%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRI-NHPHIIRLH 77
           IG GS++ V   R +      AMK +      + +  + + +E  + ++  NHP ++ LH
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L +  +I+RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL   D    +K+ D+G  +  L+P     T CG+P Y+APEI++ + Y    D 
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 197 WSVGAILFQLVTGKTPFT---------GSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           W++G ++F+++ G++PF           + +  L Q I++  ++  P     LS     +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRS---LSVKAASV 249

Query: 248 CQKLLRRNPVERL------TFEEFFNHPF 270
            +  L ++P ERL       F +   HPF
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  210 bits (535), Expect = 1e-60
 Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 17/264 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRL 76
           R +G G F  V   + R  G   A K++   R+ K+      ++E  IL+++N   ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKHFMKQLAAGLQVLRDNNLIH 134
               E    L L+L    GGDL  +I   G    PE  A  +  ++  GL+ L    +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKA 194
           RDLKP+N+LL   DD+  ++I+D G A  +      +   G+  YMAPE+++ ++Y    
Sbjct: 310 RDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---ELHFPPDAKILSADCKDLCQKL 251
           D W++G +L++++ G++PF    +    + + +        +       S   + LC +L
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER---FSPQARSLCSQL 423

Query: 252 LRRNPVERL-----TFEEFFNHPF 270
           L ++P ERL     +  E   HP 
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPL 447

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  206 bits (525), Expect = 2e-60
 Identities = 73/275 (26%), Positives = 130/275 (47%), Gaps = 25/275 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMK-----EIAMGRLNKKLQESLMSEIFILKR 67
           D+ + + IG G+F  V   + +      AMK     E+    L +        E  +L  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM----LKRAETACFREERDVLVN 130

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQV 126
            +   I  LH   +    L+L+++Y  GGDL   + +    +PEE A+ ++ ++   +  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEI 184
           +   + +HRD+KP N+L+   D N  +++ADFG    L   G   +    G+P Y++PEI
Sbjct: 191 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247

Query: 185 MQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA-TELHFPPDAK 238
           +Q       +Y  + D WS+G  +++++ G+TPF   + ++    I+       FP    
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307

Query: 239 ILSADCKDLCQKLLRRNPVERLT---FEEFFNHPF 270
            +S + KDL ++L+      RL     E+F  HPF
Sbjct: 308 DVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPF 341

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  203 bits (519), Expect = 6e-60
 Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 19/266 (7%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPHIIRLHD 78
           IG G+FS V   + +  G   AMK +    + K+ +      E  +L   +   I +LH 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
             +    L+L++EY  GGDL   + + G  +P E A+ ++ ++   +  +     +HRD+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188

Query: 138 KPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEIMQLQ------- 188
           KP N+LL   D    +++ADFG    L+  G   +    G+P Y++PEI+Q         
Sbjct: 189 KPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDL 247
            Y  + D W++G   +++  G+TPF   +  +    IV   E L  P   + +  + +D 
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDF 305

Query: 248 CQKLLRRNPVERLT---FEEFFNHPF 270
            Q+LL   P  RL      +F  HPF
Sbjct: 306 IQRLL-CPPETRLGRGGAGDFRTHPF 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  203 bits (519), Expect = 6e-60
 Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 17/274 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHP 71
           DY V + IG G+F  V   RH+      AMK ++   + K+        E  I+   N P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GGDL + +  +  VPE+ A+ +  ++   L  +    
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEIMQLQ- 188
            IHRD+KP N+LL   D +  LK+ADFG    +   G+   +T  G+P Y++PE+++ Q 
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245

Query: 189 ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADC 244
               Y  + D WSVG  L++++ G TPF   + +     I+     L FP D  I S + 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEA 304

Query: 245 KDLCQKLLRRNPVERLT---FEEFFNHPFLSQTQ 275
           K+L    L  +   RL     EE   H F    Q
Sbjct: 305 KNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  203 bits (518), Expect = 7e-60
 Identities = 75/269 (27%), Positives = 136/269 (50%), Gaps = 25/269 (9%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRI-NHPHIIRLH 77
           IG GS++ V   R +      AM+ +      + +  + + +E  + ++  NHP ++ LH
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   +L  ++EY  GGDL  ++QR   +PEE A+ +  +++  L  L +  +I+RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N+LL   D    +K+ D+G  +  L+P     T CG+P Y+APEI++ + Y    D 
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 197 WSVGAILFQLVTGKTPFT---------GSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           W++G ++F+++ G++PF           + +  L Q I++  ++  P     LS     +
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRS---LSVKAASV 292

Query: 248 CQKLLRRNPVERL------TFEEFFNHPF 270
            +  L ++P ERL       F +   HPF
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  206 bits (525), Expect = 2e-59
 Identities = 72/268 (26%), Positives = 132/268 (49%), Gaps = 22/268 (8%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRL 76
           R +G G F  V+  + +  G   A K++   R   +K  +  M E  IL +++   I+ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
               E    L L++    GGD+  +I    + +    E  A  +  Q+ +GL+ L   N+
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFA-RSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           I+RDLKP+N+LL   DD+  ++I+D G A      +   +   G+P +MAPE++  ++YD
Sbjct: 311 IYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQI----QLLQNIVKATELHFPPDAKILSADCKDL 247
              D +++G  L++++  + PF    +     +L Q +++   + +P      S   KD 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDK---FSPASKDF 423

Query: 248 CQKLLRRNPVERL-----TFEEFFNHPF 270
           C+ LL+++P +RL     + +    HP 
Sbjct: 424 CEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  207 bits (527), Expect = 1e-58
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 21/266 (7%)

Query: 18  RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRIN---HPHI 73
           R IG G F  V+  R    G   AMK +   R+  K      ++E  +L  ++    P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           + +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+ + +  ++
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK-YDA 192
           +RDLKP N+LL   D++  ++I+D G A     +       G+  YMAPE++Q    YD+
Sbjct: 315 YRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDS 370

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            AD +S+G +LF+L+ G +PF         ++ +  +    +  P      S + + L +
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDS---FSPELRSLLE 426

Query: 250 KLLRRNPVERL-----TFEEFFNHPF 270
            LL+R+   RL       +E    PF
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPF 452

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  198 bits (505), Expect = 2e-58
 Identities = 80/270 (29%), Positives = 139/270 (51%), Gaps = 26/270 (9%)

Query: 20  IGSGSFSVVWHARHRVH---GTEVAMKEI--AMGRLNKKLQESLMSEIFILKRINH-PHI 73
           +G+G++  V+  R       G   AMK +  A      K  E   +E  +L+ I   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           + LH   +   KLHLIL+Y  GG+L  ++ +     E   + ++ ++   L+ L    +I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARS--LQPRGLAETLCGSPLYMAPEIMQLQK-- 189
           +RD+K +N+LL   D N  + + DFG ++         A   CG+  YMAP+I++     
Sbjct: 182 YRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTG----SNQIQLLQNIVKATELHFPPDAKILSADCK 245
           +D   D WS+G ++++L+TG +PFT     ++Q ++ + I+K+ E  +P +   +SA  K
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE---MSALAK 294

Query: 246 DLCQKLLRRNPVERL-----TFEEFFNHPF 270
           DL Q+LL ++P +RL       +E   H F
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  205 bits (523), Expect = 2e-58
 Identities = 75/259 (28%), Positives = 131/259 (50%), Gaps = 15/259 (5%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRIN-HPHIIRLH 77
           +G GSF  V  +  +      A+K +     +     E  M E  +L      P + +LH
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 78  DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDL 137
              +   +L+ ++EY  GGDL  +IQ+ G   E  A  +  ++A GL  L+   +I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468

Query: 138 KPQNLLLCTDDDNAALKIADFGFAR-SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADL 196
           K  N++L   D    +KIADFG  + ++      +T CG+P Y+APEI+  Q Y    D 
Sbjct: 469 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525

Query: 197 WSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNP 256
           W+ G +L++++ G+ PF G ++ +L Q+I++   + +P     +S +   +C+ L+ ++P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKS---MSKEAVAICKGLMTKHP 581

Query: 257 VERL-----TFEEFFNHPF 270
            +RL        +   H F
Sbjct: 582 GKRLGCGPEGERDIKEHAF 600

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  197 bits (503), Expect = 3e-58
 Identities = 41/278 (14%), Positives = 88/278 (31%), Gaps = 29/278 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL---QESLMSEIFILKRIN 69
              V   +G G+F+ V+ A           ++  +                 +  LK   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-----CVPEETAKHFMKQLAAGL 124
               ++ +          L+ E    G L   I  +       +P+     F  ++   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 125 QVLRDNNLIHRDLKPQNLLLCT--------DDDNAALKIADFGFAR--SLQPRG-LAETL 173
           + + D  +IH D+KP N +L          DD +A L + D G +    L P+G +    
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELH 232
           C +  +   E++  + ++ + D + V A ++ ++ G              + + +     
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR---L 302

Query: 233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
              D         +    +L       L   +      
Sbjct: 303 PHLDM------WNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  195 bits (497), Expect = 1e-57
 Identities = 84/314 (26%), Positives = 133/314 (42%), Gaps = 51/314 (16%)

Query: 4   ATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF 63
           A      +  Y    ++G G++  V+ A   V    VA+K I +    + +  + + E+ 
Sbjct: 26  AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS 85

Query: 64  ILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           +LK + H +II L  +I    +LHLI EY +  DL  Y+ ++  V     K F+ QL  G
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 124 LQVLRDNNLIHRDLKPQNLLL--CTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
           +        +HRDLKPQNLLL      +   LKI DFG AR+           G P+   
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGIPIRQF 194

Query: 179 --------YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA- 228
                   Y  PEI +  + Y    D+WS+  I  +++     F G ++I  L  I +  
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254

Query: 229 ---TELHFP-----PDAK-----------------ILSADCKDLCQKLLRRNPVERLTFE 263
               +  +P     PD K                 +L  +  DL   +L  +PV+R++ +
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314

Query: 264 EFFNHPFLSQTQPD 277
               HP+ S    D
Sbjct: 315 NALEHPYFSHNDFD 328

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  197 bits (503), Expect = 1e-57
 Identities = 44/330 (13%), Positives = 94/330 (28%), Gaps = 55/330 (16%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMS 60
           S+   R R     + G  +G         A  +  G    +              + +  
Sbjct: 71  SELGERPRT---LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127

Query: 61  EIFILKRI----------NHPHIIRLHDIIEVPGKLHL-----------ILEYC------ 93
           E+  L+ +           H   I   D+++ P K  +           +L         
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187

Query: 94  ------KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD 147
                  G  L  +   H  +          Q+   L  L    L+H  L+P +++L   
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--- 244

Query: 148 DDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQK-----YDAKADLWSVG 200
           D    + +  F          ++        P   A  ++   +          D W++G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 201 AILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERL 260
             ++ +     P T    +   + I ++ + + P          + L +  LR    +RL
Sbjct: 305 LAIYWIWCADLPNTDDAALGGSEWIFRSCK-NIPQPV-------RALLEGFLRYPKEDRL 356

Query: 261 TFEEFFNHPFLSQTQPDQVFRSRMFSRSAD 290
              +    P   Q + +      ++    +
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGE 386

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  193 bits (494), Expect = 2e-57
 Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 54/303 (17%)

Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           ++  Y    +IG GS+ VV+  R+R  G  VA+K+      +  +++  + EI +LK++ 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLR 128
           HP+++ L ++     +LHL+ EYC    +   + R+   VPE   K    Q    +    
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---------- 178
            +N IHRD+KP+N+L+     ++ +K+ DFGFAR L            P           
Sbjct: 120 KHNCIHRDVKPENILI---TKHSVIKLCDFGFARLL----------TGPSDYYDDEVATR 166

Query: 179 -YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELH 232
            Y +PE+ +   +Y    D+W++G +  +L++G   + G + +  L  I K        H
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226

Query: 233 FP-----PDAKI------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
                                         +S     L +  L  +P ERLT E+  +HP
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286

Query: 270 FLS 272
           +  
Sbjct: 287 YFE 289

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  191 bits (488), Expect = 3e-56
 Identities = 69/312 (22%), Positives = 134/312 (42%), Gaps = 54/312 (17%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           + +  Y     +G GS+ +V   R++  G  VA+K+      +K +++  M EI +LK++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVL 127
            H +++ L ++ +   + +L+ E+     +   ++     +  +  + ++ Q+  G+   
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------- 178
             +N+IHRD+KP+N+L+     +  +K+ DFGFAR+L           +P          
Sbjct: 141 HSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTL----------AAPGEVYDDEVAT 187

Query: 179 --YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TEL 231
             Y APE+ +   KY    D+W++G ++ ++  G+  F G + I  L +I+         
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247

Query: 232 HFP-----PDAKI------------------LSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           H       P                      LS    DL +K L  +P +R    E  +H
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307

Query: 269 PFLSQTQPDQVF 280
            F       + F
Sbjct: 308 DFFQMDGFAERF 319

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  191 bits (487), Expect = 5e-56
 Identities = 86/335 (25%), Positives = 132/335 (39%), Gaps = 65/335 (19%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS----EIFI 64
                Y     +G G F+ V+ AR +     VA+K+I +G    + ++ +      EI +
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH-RSEAKDGINRTALREIKL 65

Query: 65  LKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAG 123
           L+ ++HP+II L D       + L+ ++ +  DL + I+ +  V      K +M     G
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----- 178
           L+ L  + ++HRDLKP NLLL   D+N  LK+ADFG A+S           GSP      
Sbjct: 125 LEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF----------GSPNRAYTH 171

Query: 179 ------YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA--- 228
                 Y APE+    + Y    D+W+VG IL +L+       G + +  L  I +    
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231

Query: 229 -TELHFP-----PDAKI---------------LSADCKDLCQKLLRRNPVERLTFEEFFN 267
            TE  +P     PD                     D  DL Q L   NP  R+T  +   
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

Query: 268 HPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRD 302
             +         F +R         P         
Sbjct: 292 MKY---------FSNRPGPTPGCQLPRPNCPVETL 317

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  189 bits (482), Expect = 7e-56
 Identities = 94/303 (31%), Positives = 141/303 (46%), Gaps = 53/303 (17%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y    +IG G++  V+ A++R     VA+K + +   ++ +  S + EI +LK + H +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNN 131
           I+RLHD++    KL L+ E+C   DL  Y          E  K F+ QL  GL      N
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YM 180
           ++HRDLKPQNLL+   + N  LK+A+FG AR+           G P+           Y 
Sbjct: 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAF----------GIPVRCYSAEVVTLWYR 168

Query: 181 APEI-MQLQKYDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVKA----TELHFP 234
            P++    + Y    D+WS G I  +L     P F G++    L+ I +     TE  +P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 235 -----PDAKI----------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                PD K                 L+A  +DL Q LL+ NPV+R++ EE   HP+ S 
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 274 TQP 276
             P
Sbjct: 289 FCP 291

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 1e-55
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
            G  +G G F       HR  G  + MKE+   R +++ Q + + E+ +++ + HP++++
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIH 134
              ++    +L+ I EY KGG L   I+      P      F K +A+G+  L   N+IH
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQ---------------PRGLAETLCGSPLY 179
           RDL   N L+    +N  + +ADFG AR +                 R    T+ G+P +
Sbjct: 132 RDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG--SNQIQLLQNIVKATELHFPPDA 237
           MAPE++  + YD K D++S G +L +++             +    N+    + + PP+ 
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 238 KILSADCKDLCQKLLRRNPVERLTFEE 264
                    +  +    +P +R +F +
Sbjct: 249 ---PPSFFPITVRCCDLDPEKRPSFVK 272

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  188 bits (479), Expect = 2e-55
 Identities = 67/256 (26%), Positives = 123/256 (48%), Gaps = 15/256 (5%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +  +IG+GSF  V  A     G++VA+K +     + +     + E+ I+KR+ HP+I+ 
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC---VPEETAKHFMKQLAAGLQVL--RDN 130
               +  P  L ++ EY   G L   + + G    + E         +A G+  L  R+ 
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-LCGSPLYMAPEIMQLQK 189
            ++HR+LK  NLL+   D    +K+ DFG +R      L+     G+P +MAPE+++ + 
Sbjct: 159 PIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCKDLC 248
            + K+D++S G IL++L T + P+   N  Q++  +    + L  P +   L+     + 
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN---LNPQVAAII 272

Query: 249 QKLLRRNPVERLTFEE 264
           +      P +R +F  
Sbjct: 273 EGCWTNEPWKRPSFAT 288

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  187 bits (478), Expect = 3e-55
 Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 53/299 (17%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y    +IG G++ VV+ A++  +G   A+K+I + + ++ +  + + EI ILK + H +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNN 131
           I++L+D+I    +L L+ E+    DL   +          TAK F+ QL  G+    D  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-----------YM 180
           ++HRDLKPQNLL+   +    LKIADFG AR+           G P+           Y 
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYR 167

Query: 181 APEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHFP- 234
           AP++ M  +KY    D+WSVG I  ++V G   F G ++   L  I +        ++P 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 235 ----PDAKI----------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
               P                    L     DL  K+L+ +P +R+T ++   H +  +
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  188 bits (479), Expect = 3e-55
 Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 54/314 (17%)

Query: 2   SQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSE 61
            +      ++  Y    ++G G++ VV+ A+    G  VA+K I +   ++ +  + + E
Sbjct: 11  RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIRE 69

Query: 62  IFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQL 120
           I +LK ++HP+I+ L D+I     L L+ E+ +  DL   +  +     +   K ++ QL
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL 128

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-- 178
             G+     + ++HRDLKPQNLL+   + + ALK+ADFG AR+           G P+  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF----------GIPVRS 175

Query: 179 ---------YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA 228
                    Y AP++ M  +KY    D+WS+G I  +++TGK  F G      L  I   
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235

Query: 229 ----TELHFP-----PDAKI-----------------LSADCKDLCQKLLRRNPVERLTF 262
                   +P     P  K                     +  DL   +L  +P +R++ 
Sbjct: 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295

Query: 263 EEFFNHPFLSQTQP 276
            +  NHP+     P
Sbjct: 296 RDAMNHPYFKDLDP 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 1e-54
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 23/260 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +  V   +G G+F VV  A+ R    +VA+K+I     ++  +++ + E+  L R+NHP+
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI----ESESERKAFIVELRQLSRVNHPN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH---FMKQLAAGLQVL-- 127
           I++L+     P  + L++EY +GG L   +     +P  TA H   +  Q + G+  L  
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 128 -RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
            +   LIHRDLKP NLLL        LKI DFG A  +Q         GS  +MAPE+ +
Sbjct: 121 MQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVFE 176

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTG--SNQIQLLQNIVKATELHFPPDAKILSADC 244
              Y  K D++S G IL++++T + PF        +++  +   T      +   L    
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN---LPKPI 233

Query: 245 KDLCQKLLRRNPVERLTFEE 264
           + L  +   ++P +R + EE
Sbjct: 234 ESLMTRCWSKDPSQRPSMEE 253

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  185 bits (473), Expect = 2e-54
 Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 60/315 (19%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE---SLMSEIFIL 65
                Y    +IG G++  V+ AR    G  VA+K + +            S + E+ +L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 66  KRIN---HPHIIRLHDII-----EVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAKH 115
           +R+    HP+++RL D+      +   K+ L+ E+    DL  Y+ +      P ET K 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
            M+Q   GL  L  N ++HRDLKP+N+L+        +K+ADFG AR             
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARI----------YS 171

Query: 176 SPL----------YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI 225
             +          Y APE++    Y    D+WSVG I  ++   K  F G+++   L  I
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

Query: 226 VKA------------TEL---HFPPDAKI--------LSADCKDLCQKLLRRNPVERLTF 262
                            L    FPP            +      L  ++L  NP +R++ 
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291

Query: 263 EEFFNHPFLSQTQPD 277
                H +L + + +
Sbjct: 292 FRALQHSYLHKDEGN 306

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (470), Expect = 3e-54
 Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 22/264 (8%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-----ESLMSEIFILKRINH 70
             +QIG G F +V   R     + VA+K + +G    + +     +    E+FI+  +NH
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVL-- 127
           P+I++L+ ++  P    +++E+   GDL   +      +        M  +A G++ +  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAA--LKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
           ++  ++HRDL+  N+ L + D+NA    K+ADFG ++          L G+  +MAPE +
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETI 198

Query: 186 QLQ--KYDAKADLWSVGAILFQLVTGKTPFTG--SNQIQLLQNIVKATE-LHFPPDAKIL 240
             +   Y  KAD +S   IL+ ++TG+ PF      +I+ +  I +       P D    
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED---C 255

Query: 241 SADCKDLCQKLLRRNPVERLTFEE 264
               +++ +     +P +R  F  
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSY 279

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (468), Expect = 4e-54
 Identities = 48/259 (18%), Positives = 103/259 (39%), Gaps = 22/259 (8%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
              ++       +W  R +  G ++ +K + +   + +       E   L+  +HP+++ 
Sbjct: 14  FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 76  LHDIIEVP--GKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVL--RD 129
           +    + P      LI  +   G L   +       V +  A  F   +A G+  L   +
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
             +    L  +++++   D++   +I+      S Q  G       +P ++APE +Q + 
Sbjct: 132 PLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RMYAPAWVAPEALQKKP 184

Query: 190 YDA---KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADCK 245
            D     AD+WS   +L++LVT + PF   + +++   +         PP    +S    
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG---ISPHVS 241

Query: 246 DLCQKLLRRNPVERLTFEE 264
            L +  +  +P +R  F+ 
Sbjct: 242 KLMKICMNEDPAKRPKFDM 260

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  184 bits (469), Expect = 1e-53
 Identities = 86/301 (28%), Positives = 133/301 (44%), Gaps = 58/301 (19%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK--LQESLMSEIFILKRINH 70
            Y+   ++G G+++ V+  + ++    VA+KEI   RL  +     + + E+ +LK + H
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKH 59

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRD 129
            +I+ LHDII     L L+ EY    DL  Y+   G +      K F+ QL  GL     
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL----------- 178
             ++HRDLKPQNLL+   ++   LK+ADFG AR+             P            
Sbjct: 119 QKVLHRDLKPQNLLI---NERGELKLADFGLARAK----------SIPTKTYDNEVVTLW 165

Query: 179 YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHF 233
           Y  P+I +    Y  + D+W VG I +++ TG+  F GS   + L  I +     TE  +
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

Query: 234 P-----PDAKI-----------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           P      + K                  L +D  DL  KLL+     R++ E+   HPF 
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

Query: 272 S 272
            
Sbjct: 286 L 286

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  185 bits (470), Expect = 2e-53
 Identities = 70/310 (22%), Positives = 134/310 (43%), Gaps = 50/310 (16%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D+    ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPY 92

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-N 131
           I+  +      G++ + +E+  GG L   +++ G +PE+        +  GL  LR+   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++HRD+KP N+L+   +    +K+ DFG +  L    +A +  G+  YM+PE +Q   Y 
Sbjct: 153 IMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYS 208

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQ--------------------------------- 218
            ++D+WS+G  L ++  G+ P    +                                  
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268

Query: 219 ---------IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
                     +LL  IV       P      S + +D   K L +NP ER   ++   H 
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGV--FSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 270 FLSQTQPDQV 279
           F+ ++  ++V
Sbjct: 327 FIKRSDAEEV 336

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  183 bits (467), Expect = 2e-53
 Identities = 87/328 (26%), Positives = 141/328 (42%), Gaps = 72/328 (21%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQE----SLMSEIFILK 66
              +    ++G+G+++ V+   ++  G  VA+KE+   +L+ +  E    + + EI ++K
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSE--EGTPSTAIREISLMK 58

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV------PEETAKHFMKQL 120
            + H +I+RL+D+I    KL L+ E+    DL  Y+                 K+F  QL
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-- 178
             GL    +N ++HRDLKPQNLL+   +    LK+ DFG AR+           G P+  
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAF----------GIPVNT 164

Query: 179 ---------YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA 228
                    Y AP++ M  + Y    D+WS G IL +++TGK  F G+N  + L+ I   
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

Query: 229 ----TELHFP-----PDAKI---------------------LSADCKDLCQKLLRRNPVE 258
                E  +P     P                         L  +  D    LL+ NP  
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284

Query: 259 RLTFEEFFNHP-FLSQTQPDQVFRSRMF 285
           RL+ ++  +HP F        +  SR  
Sbjct: 285 RLSAKQALHHPWFAEYYHHASMGGSRSH 312

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (459), Expect = 8e-53
 Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 18/260 (6%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINHPHI 73
           +   IG G F  V+ A     G EVA+K           +  E++  E  +   + HP+I
Sbjct: 11  LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN-- 131
           I L  +      L L++E+ +GG L+  +     +P +   ++  Q+A G+  L D    
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 132 -LIHRDLKPQNLLL-----CTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            +IHRDLK  N+L+       D  N  LKI DFG AR    R    +  G+  +MAPE++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEVI 186

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADC 244
           +   +   +D+WS G +L++L+TG+ PF G + + +   +      L  P          
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST---CPEPF 243

Query: 245 KDLCQKLLRRNPVERLTFEE 264
             L +     +P  R +F  
Sbjct: 244 AKLMEDCWNPDPHSRPSFTN 263

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  181 bits (461), Expect = 1e-52
 Identities = 63/275 (22%), Positives = 124/275 (45%), Gaps = 13/275 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHP 71
           D     ++GSG+   VW  R R  G  +A+K++     NK+  + ++ ++ ++ +  + P
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCP 84

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-N 130
           +I++          + + +E        +  +  G +PE         +   L  L++ +
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL--- 187
            +IHRD+KP N+LL   D+   +K+ DFG +  L      +   G   YMAPE +     
Sbjct: 145 GVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 188 --QKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADC 244
               YD +AD+WS+G  L +L TG+ P+       ++L  +++      P      S D 
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG-FSGDF 260

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           +   +  L ++  +R  + +   H F+ + +  +V
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (452), Expect = 1e-51
 Identities = 66/261 (25%), Positives = 133/261 (50%), Gaps = 22/261 (8%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           VG++IGSGSF  V+  +      +VA+K + +     +  ++  +E+ +L++  H +I+ 
Sbjct: 28  VGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIH 134
                  P +L ++ ++C+G  L  ++         +      +Q A G+  L   ++IH
Sbjct: 85  FMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL---CGSPLYMAPEIMQLQ--- 188
           RDLK  N+ L    ++  +KI DFG A        +       GS L+MAPE++++Q   
Sbjct: 144 RDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADC--- 244
            Y  ++D+++ G +L++L+TG+ P++  +N+ Q+++ + +       PD   + ++C   
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG---SLSPDLSKVRSNCPKR 257

Query: 245 -KDLCQKLLRRNPVERLTFEE 264
            K L  + L++   ER +F  
Sbjct: 258 MKRLMAECLKKKRDERPSFPR 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  177 bits (450), Expect = 2e-51
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 16/277 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHP 71
           D     ++G G++ VV   RH   G  +A+K I    +N + Q+ L+ ++ I  R ++ P
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCP 66

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMY---IQRHGCVPEETAKHFMKQLAAGLQVLR 128
             +  +  +   G + + +E         Y   I +   +PE+        +   L+ L 
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 129 DN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE---- 183
              ++IHRD+KP N+L+   +    +K+ DFG +  L      +   G   YMAPE    
Sbjct: 127 SKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 184 IMQLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSA 242
            +  + Y  K+D+WS+G  + +L   + P+       Q L+ +V+      P D    SA
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK--FSA 241

Query: 243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
           +  D   + L++N  ER T+ E   HPF +  +    
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  178 bits (453), Expect = 2e-51
 Identities = 66/336 (19%), Positives = 116/336 (34%), Gaps = 82/336 (24%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           R + D+   + +G G F VV+ A+++V     A+K I +    +  +E +M E+  L ++
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL 61

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKG--------------------------------- 95
            HP I+R  +            E  +                                  
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 96  ----------GDLSMYIQ-----------------RHGCVPEETAKHFMKQLAAGLQVLR 128
                       + +YIQ                            H   Q+A  ++ L 
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-------------PRGLAETLCG 175
              L+HRDLKP N+    DD    +K+ DFG   ++                       G
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP 235
           + LYM+PE +    Y  K D++S+G ILF+L+      T   +++++ ++     L FP 
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS--FSTQMERVRIITDVRN---LKFPL 293

Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                      + Q +L  +P ER    +   +   
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  177 bits (452), Expect = 4e-51
 Identities = 84/315 (26%), Positives = 133/315 (42%), Gaps = 58/315 (18%)

Query: 6   GRGRVVGDYLVGRQIGSGSFSVVWHARH-RVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           G  R    Y    +IG G++  V+ AR  +  G  VA+K + +    + +  S + E+ +
Sbjct: 5   GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64

Query: 65  LKRIN---HPHIIRLHDII-----EVPGKLHLILEYCKGGDLSMYIQRHGCV--PEETAK 114
           L+ +    HP+++RL D+      +   KL L+ E+    DL+ Y+ +      P ET K
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
             M QL  GL  L  + ++HRDLKPQN+L+     +  +K+ADFG AR            
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARI----------Y 170

Query: 175 GSPL----------YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN 224
              +          Y APE++    Y    DLWSVG I  ++   K  F GS+ +  L  
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

Query: 225 IVKA------------TEL---HFPPDAKI--------LSADCKDLCQKLLRRNPVERLT 261
           I+                L    F   +          +    KDL  K L  NP +R++
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

Query: 262 FEEFFNHPFLSQTQP 276
                +HP+    + 
Sbjct: 291 AYSALSHPYFQDLER 305

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  175 bits (446), Expect = 1e-50
 Identities = 74/267 (27%), Positives = 136/267 (50%), Gaps = 14/267 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++EI +++   +P+I
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNI 79

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLI 133
           +   D   V  +L +++EY  GG L+  +    C+ E       ++    L+ L  N +I
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQKYDA 192
           HRD+K  N+LL     + ++K+ DFGF   + P +    T+ G+P +MAPE++  + Y  
Sbjct: 139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLCQ 249
           K D+WS+G +  +++ G+ P+   N ++ L  I         P   + + LSA  +D   
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----TPELQNPEKLSAIFRDFLN 251

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQP 276
           + L  +  +R + +E   H FL   +P
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFLKIAKP 278

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  174 bits (444), Expect = 2e-50
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 11/264 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            +    +IG GSF  V+          VA+K I +     ++++ +  EI +L + + P+
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPY 81

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           + + +       KL +I+EY  GG     +   G + E      ++++  GL  L     
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-AETLCGSPLYMAPEIMQLQKYD 191
           IHRD+K  N+LL    ++  +K+ADFG A  L    +   T  G+P +MAPE+++   YD
Sbjct: 141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AKILSADCKDLCQK 250
           +KAD+WS+G    +L  G+ P +  + +++L  I K      PP      S   K+  + 
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN----PPTLEGNYSKPLKEFVEA 253

Query: 251 LLRRNPVERLTFEEFFNHPFLSQT 274
            L + P  R T +E   H F+ + 
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRN 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  175 bits (445), Expect = 3e-50
 Identities = 55/289 (19%), Positives = 109/289 (37%), Gaps = 31/289 (10%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +G  IG G F  V+H R      EVA++ I + R N+   ++   E+   ++  H +++ 
Sbjct: 37  IGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNNLIH 134
                  P  L +I   CKG  L   ++    V      +   +++  G+  L    ++H
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE------TLCGSPLYMAPEIMQLQ 188
           +DLK +N+      DN  + I DFG                     G   ++APEI++  
Sbjct: 154 KDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 189 K---------YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
                     +   +D++++G I ++L   + PF       ++  +    + +       
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG-- 267

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNH------PFLSQTQPDQVFRS 282
           +  +  D+          ER TF +  +            + P   ++S
Sbjct: 268 MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  175 bits (447), Expect = 3e-50
 Identities = 79/340 (23%), Positives = 134/340 (39%), Gaps = 56/340 (16%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL----MSEIFI 64
             V  Y    +IG G+F  V+ ARHR  G +VA+K++ M       +E      + EI I
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME----NEKEGFPITALREIKI 69

Query: 65  LKRINHPHIIRLHDII--------EVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKH 115
           L+ + H +++ L +I            G ++L+ ++C+  DL+  +            K 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
            M+ L  GL  +  N ++HRD+K  N+L+     +  LK+ADFG AR+      ++    
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 176 SPL-----YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA- 228
           +       Y  PE+ +  + Y    DLW  G I+ ++ T      G+ +   L  I +  
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245

Query: 229 ---TELHFP-----PDAK-------------------ILSADCKDLCQKLLRRNPVERLT 261
              T   +P        +                   +      DL  KLL  +P +R+ 
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305

Query: 262 FEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVR 301
            ++  NH F   + P       M S        Y +   R
Sbjct: 306 SDDALNHDFFW-SDPMPSDLKGMLSTHLTSMFEYLAPPRR 344

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  174 bits (442), Expect = 7e-50
 Identities = 72/262 (27%), Positives = 141/262 (53%), Gaps = 14/262 (5%)

Query: 19  QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD 78
           +IG GS  +V  AR +  G +VA+K + + +  ++  E L +E+ I++   H +++ ++ 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYK 109

Query: 79  IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLK 138
              V  +L +++E+ +GG L+  I     + EE      + +   L  L    +IHRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168

Query: 139 PQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 197
             ++LL     +  +K++DFGF   +       ++L G+P +MAPE++    Y  + D+W
Sbjct: 169 SDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225

Query: 198 SVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLCQKLLRR 254
           S+G ++ ++V G+ P+   + +Q ++ +  +     PP   ++  +S   +D  +++L R
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----PPKLKNSHKVSPVLRDFLERMLVR 281

Query: 255 NPVERLTFEEFFNHPFLSQTQP 276
           +P ER T +E  +HPFL QT  
Sbjct: 282 DPQERATAQELLDHPFLLQTGL 303

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  176 bits (449), Expect = 8e-50
 Identities = 88/306 (28%), Positives = 132/306 (43%), Gaps = 65/306 (21%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS--EIFILKRINHP 71
           Y   + IG+GSF VV+ A+    G  VA+K++        LQ+      E+ I+++++H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHC 107

Query: 72  HIIRLHDIIEVPG------KLHLILEYCKGGDLSMYIQRHGC----VPEETAKHFMKQLA 121
           +I+RL       G       L+L+L+Y     +    + +      +P    K +M QL 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
             L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L          G P    
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVR--------GEPNVSY 216

Query: 179 -----YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK----- 227
                Y APE++     Y +  D+WS G +L +L+ G+  F G + +  L  I+K     
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276

Query: 228 -----------ATELHFP-----PDAKIL----SADCKDLCQKLLRRNPVERLTFEEFFN 267
                       TE  FP     P  K+       +   LC +LL   P  RLT  E   
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

Query: 268 HPFLSQ 273
           H F  +
Sbjct: 337 HSFFDE 342

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  172 bits (437), Expect = 3e-49
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 25/285 (8%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY +   IGSG+ +VV  A       +VA+K I + +    + E L+ EI  + + +HP+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPN 74

Query: 73  IIRLHDIIEVPGKLHLILEYCKGG---DL-----SMYIQRHGCVPEETAKHFMKQLAAGL 124
           I+  +    V  +L L+++   GG   D+     +    + G + E T    ++++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE------TLCGSPL 178
           + L  N  IHRD+K  N+LL    ++ +++IADFG +  L   G         T  G+P 
Sbjct: 135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 179 YMAPE-IMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK------ATEL 231
           +MAPE + Q++ YD KAD+WS G    +L TG  P+     +++L   ++       T +
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251

Query: 232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                 K      + +    L+++P +R T  E   H F  + + 
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  171 bits (436), Expect = 5e-49
 Identities = 75/273 (27%), Positives = 137/273 (50%), Gaps = 16/273 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + V  ++G GS+  V+ A H+  G  VA+K++    +   LQE ++ EI I+++ + PH+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE-IIKEISIMQQCDSPHV 86

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++ +        L +++EYC  G +S +   R+  + E+     ++    GL+ L     
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIMQLQKYD 191
           IHRD+K  N+LL   +     K+ADFG A  L        T+ G+P +MAPE++Q   Y+
Sbjct: 147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSADCKDLC 248
             AD+WS+G    ++  GK P+   + ++ +  I        PP     ++ S +  D  
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----PPTFRKPELWSDNFTDFV 259

Query: 249 QKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
           ++ L ++P +R T  +   HPF+   +   + R
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGVSILR 292

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  174 bits (442), Expect = 5e-49
 Identities = 87/299 (29%), Positives = 130/299 (43%), Gaps = 52/299 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS--EIFILKRINHP 71
           Y   + IG+GSF VV+ A+      EVA+K++        LQ+      E+ I++ + HP
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKV--------LQDKRFKNRELQIMRIVKHP 92

Query: 72  HIIRLHDIIEVPG------KLHLILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLA 121
           +++ L       G       L+L+LEY     +    + +      +P    K +M QL 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYM 180
             L  +    + HRD+KPQNLLL  D  +  LK+ DFG A+ L         +C S  Y 
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYR 208

Query: 181 APEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVK------------ 227
           APE++     Y    D+WS G ++ +L+ G+  F G + I  L  I+K            
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268

Query: 228 ----ATELHFP-----PDAKI----LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                 E  FP     P +K+       D  DL  +LL   P  RLT  E   HPF  +
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  172 bits (438), Expect = 6e-49
 Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 21/298 (7%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ-ESLMSEIFILKRINHPH 72
           +   R+IG GSF  V+ AR   +   VA+K+++        + + ++ E+  L+++ HP+
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
            I+            L++EYC G    +       + E            GL  L  +N+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK--- 189
           IHRD+K  N+LL    +   +K+ DFG A  + P     +  G+P +MAPE++       
Sbjct: 176 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQ 229

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP--DAKILSADCKDL 247
           YD K D+WS+G    +L   K P    N +  L +I +       P   +   S   ++ 
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNF 285

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF-----RSRMFSRSADDFPFYESKSV 300
               L++ P +R T E    H F+ + +P  V      R++   R  D+  + + K +
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  171 bits (435), Expect = 1e-48
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 56/302 (18%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHP 71
           DY + R++G G +S V+ A +  +  +V +K +   +  K  +E     I IL+ +   P
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-----IKILENLRGGP 91

Query: 72  HIIRLHDIIEVP--GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +II L DI++ P      L+ E+    D     Q    + +   + +M ++   L     
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 148

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAE---TLCGSPLYMAPEIM 185
             ++HRD+KP N+++  D ++  L++ D+G A    P +       +      +  PE++
Sbjct: 149 MGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FKGPELL 202

Query: 186 -QLQKYDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVK------------ATEL 231
              Q YD   D+WS+G +L  ++  K P F G +    L  I K               +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262

Query: 232 HFPPD---------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
              P                        ++S +  D   KLLR +   RLT  E   HP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

Query: 271 LS 272
             
Sbjct: 323 FY 324

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  171 bits (435), Expect = 2e-48
 Identities = 77/334 (23%), Positives = 138/334 (41%), Gaps = 52/334 (15%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + V R  G G+F  V   + +  G  VA+K++     + + +   +  +  L  ++HP+I
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 74  IRLHDIIEVPGK-------LHLILEYCKGGDLSMYIQRHGC----VPEETAKHFMKQLAA 122
           ++L       G+       L++++EY     L    + +       P    K F+ QL  
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 123 GLQVLRDN--NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLY 179
            +  L     N+ HRD+KP N+L+  ++ +  LK+ DFG A+ L P       +C S  Y
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYY 197

Query: 180 MAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA---------- 228
            APE++   Q Y    D+WSVG I  +++ G+  F G N    L  IV+           
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257

Query: 229 ------TELHFP-----PDAKIL-------SADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                 T++        P + +        + +  DL   LL+  P ER+   E   HP+
Sbjct: 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317

Query: 271 LSQ--TQPDQVFRSRMFSRSADDFPFYESKSVRD 302
             +      ++  ++        F   E + + +
Sbjct: 318 FDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSE 351

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  169 bits (430), Expect = 2e-48
 Identities = 68/269 (25%), Positives = 132/269 (49%), Gaps = 32/269 (11%)

Query: 8   GRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFIL 65
           G+++ + Y +  ++G G  S V+ A   +   +VA+K          +       E  + 
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK---------AIFIPPREKEETLK 56

Query: 66  K---------RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHF 116
           +         +++H +I+ + D+ E     +L++EY +G  LS YI+ HG +  +TA +F
Sbjct: 57  RFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF 116

Query: 117 MKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LC 174
             Q+  G++   D  ++HRD+KPQN+L+   D N  LKI DFG A++L    L +T  + 
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVL 173

Query: 175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL----LQNIVKATE 230
           G+  Y +PE  + +  D   D++S+G +L++++ G+ PF G   + +    +Q+ V    
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT 233

Query: 231 LHFPPDAKILSADCKDLCQKLLRRNPVER 259
                D   +     ++  +   ++   R
Sbjct: 234 TDVRKD---IPQSLSNVILRATEKDKANR 259

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  169 bits (430), Expect = 3e-48
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 19/278 (6%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           + +  ++G G+F  V+ A+++  G   A K I      +   E  + EI IL   +HP+I
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEILATCDHPYI 78

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLS-MYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++L       GKL +++E+C GG +  + ++    + E   +   +Q+   L  L    +
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPLYMAPEI-----MQ 186
           IHRDLK  N+L+        +++ADFG +          ++  G+P +MAPE+     M+
Sbjct: 139 IHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP---DAKILSAD 243
              YD KAD+WS+G  L ++   + P    N +++L  I K+     PP        S +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD----PPTLLTPSKWSVE 251

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR 281
            +D  +  L +NP  R +  +   HPF+S    ++  R
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  169 bits (430), Expect = 3e-48
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 31/275 (11%)

Query: 1   MSQATGR--GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL 58
           M        G   G Y + R +G G    V+ A   V    VA+K          + E+L
Sbjct: 21  MDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK---------LMSETL 71

Query: 59  MS-EIFILK---------RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV 108
            S  +F  +         R+  PH++ +HD  E+ G+L++ +    G DL+  ++R G +
Sbjct: 72  SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL 131

Query: 109 PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
               A   ++Q+ + L         HRD+KP+N+L+ + DD A   + DFG A +     
Sbjct: 132 APPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV-SADDFA--YLVDFGIASATTDEK 188

Query: 169 LAET--LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV 226
           L +     G+  YMAPE         +AD++++  +L++ +TG  P+ G     +  +I 
Sbjct: 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN 248

Query: 227 KATEL--HFPPDAKILSADCKDLCQKLLRRNPVER 259
           +A        P    +      +  + + +NP +R
Sbjct: 249 QAIPRPSTVRPG---IPVAFDAVIARGMAKNPEDR 280

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  169 bits (431), Expect = 4e-48
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 18/280 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHP 71
           D     +IG G++  V    H+  G  +A+K I    +++K Q+ L+ ++ ++ R  + P
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVL 127
           +I++ +  +   G   + +E         Y          +PEE            L  L
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 128 RDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ 186
           ++N  +IHRD+KP N+LL   D +  +K+ DFG +  L          G   YMAPE + 
Sbjct: 142 KENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198

Query: 187 ----LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKAT--ELHFPPDAKI 239
                Q YD ++D+WS+G  L++L TG+ P+   ++    L  +VK    +L    + + 
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE- 257

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV 279
            S    +     L ++  +R  ++E   HPF+   +   V
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  167 bits (426), Expect = 2e-47
 Identities = 73/290 (25%), Positives = 137/290 (47%), Gaps = 27/290 (9%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NH 70
           G + +   +G+G++  V+  RH   G   A+K +    +    +E +  EI +LK+  +H
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHH 80

Query: 71  PHIIRLHD------IIEVPGKLHLILEYCKGGDLS--MYIQRHGCVPEETAKHFMKQLAA 122
            +I   +          +  +L L++E+C  G ++  +   +   + EE   +  +++  
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMA 181
           GL  L  + +IHRD+K QN+LL    +NA +K+ DFG +  L +  G   T  G+P +MA
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 182 PEIMQLQK-----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP- 235
           PE++   +     YD K+DLWS+G    ++  G  P    + ++ L  I +       P 
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP----APR 253

Query: 236 -DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
             +K  S   +   +  L +N  +R   E+   HPF+     ++  R ++
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  163 bits (415), Expect = 3e-45
 Identities = 79/343 (23%), Positives = 134/343 (39%), Gaps = 88/343 (25%)

Query: 4   ATGRGRVVGDY-LVGRQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMS 60
           ++ R RV   +   G ++G G++  V+ A+ +      + A+K+I        +  S   
Sbjct: 12  SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACR 67

Query: 61  EIFILKRINHPHIIRLHDIIEVPG--KLHLILEYCKGGDLSMYIQRHGC---------VP 109
           EI +L+ + HP++I L  +       K+ L+ +Y +  DL   I+ H           +P
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 126

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSLQPRG 168
               K  + Q+  G+  L  N ++HRDLKP N+L+  +      +KIAD GFAR      
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR------ 180

Query: 169 LAETLCGSPL--------------YMAPEI-MQLQKYDAKADLWSVGAILFQLVTGKTPF 213
               L  SPL              Y APE+ +  + Y    D+W++G I  +L+T +  F
Sbjct: 181 ----LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

Query: 214 TGSNQIQLLQNIVKATELH-------FP-----------PDAK----------------- 238
               +     N     +L        FP           P+                   
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296

Query: 239 --------ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                      +    L QKLL  +P++R+T E+    P+  +
Sbjct: 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  160 bits (407), Expect = 7e-45
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 37/274 (13%)

Query: 8   GRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS-EIFIL 65
              + D Y +G  +G G  S V  AR      +VA+K          L+  L     F L
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK---------VLRADLARDPSFYL 57

Query: 66  K---------RINHPHIIRLHDIIEVPGKLH----LILEYCKGGDLSMYIQRHGCVPEET 112
           +          +NHP I+ ++D  E          +++EY  G  L   +   G +  + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117

Query: 113 AKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
           A   +      L     N +IHRD+KP N+++       A+K+ DFG AR++   G + T
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVT 174

Query: 173 ----LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL-LQNIVK 227
               + G+  Y++PE  +    DA++D++S+G +L++++TG+ PFTG + + +  Q++ +
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234

Query: 228 ATELHFPPDAKI--LSADCKDLCQKLLRRNPVER 259
                 PP A+   LSAD   +  K L +NP  R
Sbjct: 235 DPI---PPSARHEGLSADLDAVVLKALAKNPENR 265

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  160 bits (406), Expect = 1e-44
 Identities = 79/309 (25%), Positives = 144/309 (46%), Gaps = 59/309 (19%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+  + +G G   +V+ A        VA+K+I +   + +  +  + EI I++R++H +I
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNI 70

Query: 74  IRLHDIIEVPGK--------------LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           +++ +I+   G               ++++ EY    DL+  +   G + EE A+ FM Q
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLLEEHARLFMYQ 128

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL- 178
           L  GL+ +   N++HRDLKP NL +  + ++  LKI DFG AR + P           L 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDP----HYSHKGHLS 182

Query: 179 -------YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQL------ 221
                  Y +P ++     Y    D+W+ G I  +++TGKT F G+    Q+QL      
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 222 ---------LQNIVKATELHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEE 264
                    L +++     +   +           +S +  D  +++L  +P++RLT EE
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302

Query: 265 FFNHPFLSQ 273
             +HP++S 
Sbjct: 303 ALSHPYMSI 311

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  159 bits (404), Expect = 9e-44
 Identities = 82/329 (24%), Positives = 132/329 (40%), Gaps = 79/329 (24%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +G+ +G+GSF +V        G   A+K++     + + +     E+ I+K ++H +I
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYK---NRELDIMKVLDHVNI 62

Query: 74  IRLHDIIEVPGK--------------------------------------LHLILEYCKG 95
           I+L D     G                                       L++I+EY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-P 121

Query: 96  GDLSMYIQRHGC----VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA 151
             L   ++        +P      ++ QL   +  +    + HRD+KPQNLL+  +  + 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDN 179

Query: 152 ALKIADFGFARSLQP-RGLAETLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTG 209
            LK+ DFG A+ L P       +C S  Y APE+M    +Y    DLWS+G +  +L+ G
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 210 KTPFTGSNQIQLLQNIVK----------------ATELHFP-----PDAKILS----ADC 244
           K  F+G   I  L  I++                 TE+ FP        KIL     +  
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            DL +++LR  P  R+   E   HPF   
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  155 bits (395), Expect = 7e-43
 Identities = 81/306 (26%), Positives = 129/306 (42%), Gaps = 53/306 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-AMGRLNKKLQESLMSEIFILKRINHPH 72
           + +   +G G++ VV  A H+  G  VA+K+I              + EI ILK   H +
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHEN 70

Query: 73  IIRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           II + +I           +++I E     DL   I     + ++  ++F+ Q    ++VL
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVL 128

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------- 178
             +N+IHRDLKP NLL+   + N  LK+ DFG AR +       +               
Sbjct: 129 HGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 179 --YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIV------ 226
             Y APE+M    KY    D+WS G IL +L   +  F G    +Q+ L+  I+      
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 227 ---------KATE--LHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFN 267
                    +A E     P             ++    DL Q++L  +P +R+T +E   
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 268 HPFLSQ 273
           HP+L  
Sbjct: 306 HPYLQT 311

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  156 bits (397), Expect = 8e-43
 Identities = 57/321 (17%), Positives = 111/321 (34%), Gaps = 59/321 (18%)

Query: 12  GDYLVGRQIGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           G Y +   IG G      V  AR++  G  V ++ I +   + ++   L  E+ + K  N
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLS--MYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           HP+I+          +L ++  +   G     +       + E    + ++ +   L  +
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--------LAETLCGSPLY 179
                +HR +K  ++L+     +  + ++      S+   G          +       +
Sbjct: 145 HHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 180 MAPEIMQ--LQKYDAKADLWSVG--AI-----------------LFQLVTGKTP------ 212
           ++PE++Q  LQ YDAK+D++SVG  A                  L + + G  P      
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 213 -----------------FTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRN 255
                               S+ +          +    P  +  S       ++ L+RN
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 256 PVERLTFEEFFNHPFLSQTQP 276
           P  R +     NH F  Q + 
Sbjct: 322 PDARPSASTLLNHSFFKQIKR 342

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  155 bits (394), Expect = 2e-42
 Identities = 67/304 (22%), Positives = 126/304 (41%), Gaps = 50/304 (16%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IGSG+  +V  A   +    VA+K+++    N+   +    E+ ++K +NH +I
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 74  IRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L ++      L       +++E     +L   IQ    +  E   + + Q+  G++ L
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMSYLLYQMLCGIKHL 143

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
               +IHRDLKP N+++     +  LKI DFG AR+     +      +  Y APE++  
Sbjct: 144 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV--------------------- 226
             Y    D+WSVG I+ +++ G   F G++ I     ++                     
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 227 -----------------KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP 269
                                       K+ ++  +DL  K+L  +  +R++ +E   HP
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320

Query: 270 FLSQ 273
           +++ 
Sbjct: 321 YINV 324

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  160 bits (405), Expect = 4e-42
 Identities = 58/261 (22%), Positives = 105/261 (40%), Gaps = 32/261 (12%)

Query: 8   GRVVGD-YLVGRQIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           G +V   Y V   I  G    ++ A    V+G  V +K +     + + Q   M+E   L
Sbjct: 75  GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFL 133

Query: 66  KRINHPHIIRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
             + HP I+++ + +E   +      ++++EY  G  L     +   +P   A  ++ ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEI 191

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYM 180
              L  L    L++ DLKP+N++L  +     LK+ D G    +   G    L G+P + 
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRINSFG---YLYGTPGFQ 244

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           APEI++        D+++VG  L  L        G                  P D  +L
Sbjct: 245 APEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNG------------RYVDGLPEDDPVL 291

Query: 241 S--ADCKDLCQKLLRRNPVER 259
                   L ++ +  +P +R
Sbjct: 292 KTYDSYGRLLRRAIDPDPRQR 312

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  154 bits (391), Expect = 4e-42
 Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 55/307 (17%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ---ESLMS------EIFI 64
           Y V R I SGS+  V        G  VA+K +     + +                EI +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 65  LKRINHPHIIRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMK 118
           L   +HP+I+ L DI     +     L+L+ E     DL+  I  +   +  +  ++FM 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMY 141

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
            +  GL VL +  ++HRDL P N+LL    DN  + I DF  AR                
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRW 198

Query: 179 YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLL------------ 222
           Y APE++ Q + +    D+WS G ++ ++   K  F GS   NQ+  +            
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258

Query: 223 --------QNIVKATELHFP--------PDAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
                   ++ ++ +  + P        P A        DL  K+L  NP  R++ E+  
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTA---DPVALDLIAKMLEFNPQRRISTEQAL 315

Query: 267 NHPFLSQ 273
            HP+   
Sbjct: 316 RHPYFES 322

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  151 bits (384), Expect = 3e-41
 Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 48/297 (16%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y+    +GSG++  V  A  +  G +VA+K+++    ++   +    E+ +LK + H ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 74  IRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L D+      L       L++ +    DL   +       EE  ++ + Q+  GL+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYI 142

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---TLCGSPLYMAPEI 184
               ++HRDLKP NL +   +++  LKI DFG AR      +     T      Y APE+
Sbjct: 143 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE-MTGYVVTR----WYRAPEV 194

Query: 185 M-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------ELHF---- 233
           +     Y+   D+WSVG I+ +++TGKT F G + +  L  I+K T       +      
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254

Query: 234 ---------PPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                    P   +          S    DL +K+L  +  +RLT  +   HPF   
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  151 bits (383), Expect = 5e-41
 Identities = 79/306 (25%), Positives = 133/306 (43%), Gaps = 57/306 (18%)

Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           V   Y   + +GSG++  V  A     G +VA+K++     ++   +    E+ +LK + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 70  HPHIIRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAG 123
           H ++I L D+      L       L++ +  G DL   + +H  + E+  +  + Q+  G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKG 140

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--------RGLAETLCG 175
           L+ +    +IHRDLKP NL +   +++  LKI DFG AR            R        
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEMTGYVVTR-------- 189

Query: 176 SPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----- 229
              Y APE++    +Y    D+WSVG I+ +++TGKT F GS+ +  L+ I+K T     
Sbjct: 190 --WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247

Query: 230 -ELHF-------------PPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFN 267
             +               P   K          S    +L +K+L  +  +R+T  E   
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

Query: 268 HPFLSQ 273
           HP+   
Sbjct: 308 HPYFES 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  149 bits (377), Expect = 7e-41
 Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 32/228 (14%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
              +G G +  VW    +  G  VA+K  +        +E+   E++    + H +I+  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRET---ELYNTVMLRHENILGF 67

Query: 77  ----HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD--- 129
                       +L LI  Y + G L  Y+Q    +   +    +  +A+GL  L     
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 130 -----NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-----CGSPLY 179
                  + HRDLK +N+L+     N    IAD G A           +      G+  Y
Sbjct: 127 GTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 180 MAPEIM------QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL 221
           MAPE++             + D+W+ G +L+++             + 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  150 bits (381), Expect = 9e-41
 Identities = 75/302 (24%), Positives = 129/302 (42%), Gaps = 57/302 (18%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y     +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H ++
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90

Query: 74  IRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L D+      L       L+     G DL+  + +   + ++  +  + Q+  GL+ +
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYI 148

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--------RGLAETLCGSPLY 179
              ++IHRDLKP NL +   +++  LKI DFG AR            R           Y
Sbjct: 149 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEMTGYVATR----------WY 195

Query: 180 MAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------ELH 232
            APEIM     Y+   D+WSVG I+ +L+TG+T F G++ I  L+ I++         L 
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255

Query: 233 F-------------PPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                             K+         +    DL +K+L  +  +R+T  +   H + 
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 272 SQ 273
           +Q
Sbjct: 316 AQ 317

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  148 bits (377), Expect = 4e-40
 Identities = 82/301 (27%), Positives = 135/301 (44%), Gaps = 51/301 (16%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y     IG G++ +V  A   ++   VA+K+I+    ++   +  + EI IL R  H +I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENI 87

Query: 74  IRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           I ++DII  P       ++++ +     DL   + +   +  +   +F+ Q+  GL+ + 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 145

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--------YM 180
             N++HRDLKP NLLL   +    LKI DFG AR   P    +      L        Y 
Sbjct: 146 SANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP----DHDHTGFLTEYVATRWYR 198

Query: 181 APEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT------ELHF 233
           APEIM   + Y    D+WSVG IL ++++ +  F G + +  L +I+         +L+ 
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258

Query: 234 -------------PPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
                        P   K+          +   DL  K+L  NP +R+  E+   HP+L 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 273 Q 273
           Q
Sbjct: 319 Q 319

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  147 bits (373), Expect = 7e-40
 Identities = 61/289 (21%), Positives = 104/289 (35%), Gaps = 50/289 (17%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
            +QIG G +  VW  + R  G +VA+K           +E+   EI+    + H +I+  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRET---EIYQTVLMRHENILGF 96

Query: 77  ----HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL----- 127
                       +L+LI +Y + G L  Y++    +  ++         +GL  L     
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 128 ---RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-----CGSPLY 179
                  + HRDLK +N+L+     N    IAD G A           +      G+  Y
Sbjct: 156 STQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 180 MAPEI------MQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF 233
           M PE+          +    AD++S G IL+++           + QL  + +  ++  +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 234 -------------PP-DAKILSADC----KDLCQKLLRRNPVERLTFEE 264
                        P    +  S +C      L  +    NP  RLT   
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  146 bits (369), Expect = 3e-39
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 32/229 (13%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +   IG G F  VW  + R  G EVA+K  +        +E   +EI+    + H +I+ 
Sbjct: 46  LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILG 100

Query: 76  L----HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN- 130
                +       +L L+ +Y + G L  Y+ R+  V  E         A+GL  L    
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 159

Query: 131 -------NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL-----CGSPL 178
                   + HRDLK +N+L+     N    IAD G A           +      G+  
Sbjct: 160 VGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 179 YMAPEIM------QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL 221
           YMAPE++      +  +   +AD++++G + +++    +        QL
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  148 bits (374), Expect = 4e-39
 Identities = 76/352 (21%), Positives = 132/352 (37%), Gaps = 96/352 (27%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y +   IG+GS+  V  A  ++    VA+K+I     +    + ++ EI IL R+NH H+
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 74  IRLHDIIEVPG-----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           +++ DI+         +L+++LE     D     +    + E   K  +  L  G++ + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---------- 178
              ++HRDLKP N L+   + + ++K+ DFG AR++       +                
Sbjct: 174 SAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 179 ------------------YMAPEIM-QLQKYDAKADLWSVGAILFQLVT----------- 208
                             Y APE++   + Y    D+WS+G I  +L+            
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 209 GKTPFTGS-----------------------NQIQLLQNIV--------------KATE- 230
               F GS                       +Q+ ++ NI+               A   
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350

Query: 231 -LHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
              FP              SAD   L +++L  NP +R+T  E   HPF  +
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  144 bits (366), Expect = 1e-38
 Identities = 87/361 (24%), Positives = 142/361 (39%), Gaps = 89/361 (24%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---- 69
           Y++ R++G G FS VW A+  V+ T VAMK +   R +K   E+   EI +L+R+N    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77

Query: 70  -------HPHIIRLHD--IIEVPGKLHLIL--EYCKGGDLSMYIQRHGCV--PEETAKHF 116
                    HI++L D    + P  +H+++  E   G +L   I+++     P    K  
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136

Query: 117 MKQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDDDNA---ALKIADFGFARS--------L 164
            KQL  GL  + R   +IH D+KP+N+L+   D       +KIAD G A          +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN 224
           Q R           Y +PE++    +   AD+WS   ++F+L+TG   F         ++
Sbjct: 197 QTR----------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 225 ---IVKATELHFPPDAKIL----------------------------------------- 240
              I +  EL     + +L                                         
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR--SRMFSRSADDFPFYESK 298
           + +  D    +L+ +P +R       NHP+L  T   +  R   R    S  D P +  +
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 366

Query: 299 S 299
            
Sbjct: 367 V 367

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 3e-38
 Identities = 60/262 (22%), Positives = 121/262 (46%), Gaps = 22/262 (8%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +  ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP++++
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQ 280

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLI 133
           L  +       ++I E+   G+L  Y++      V      +   Q+++ ++ L   N I
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQKYD 191
           HR+L  +N L+    +N  +K+ADFG +R +             P+ + APE +   K+ 
Sbjct: 341 HRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C +   +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE-------GCPEKVYE 450

Query: 251 LLRR----NPVERLTFEEFFNH 268
           L+R     NP +R +F E    
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQA 472

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  144 bits (364), Expect = 7e-38
 Identities = 78/344 (22%), Positives = 136/344 (39%), Gaps = 88/344 (25%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y++   IG GS+  V+ A  +     VA+K++     +    + ++ EI IL R+   +I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87

Query: 74  IRLHDIIEVPGK-----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           IRL+D+I          L+++LE     DL    +    + EE  K  +  L  G   + 
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---------- 178
           ++ +IHRDLKP N LL   + + ++K+ DFG AR++        +               
Sbjct: 147 ESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 179 -------------YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTP-----------F 213
                        Y APE++   + Y    D+WS G I  +L+                F
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 214 TGS--------------------NQIQLLQNIV--------------KATE--LHFPPDA 237
            GS                    +Q+ ++ NI+              +  +    FP   
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323

Query: 238 KI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            I        +S D  +L + +L+ NP +R+T ++  +HP+L  
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  144 bits (365), Expect = 8e-38
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 15/259 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +NH +I
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 74  IRLHDIIEVPGKLH------LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L ++      L       L++E     +L   IQ    +  E   + + Q+  G++ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHL 180

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
               +IHRDLKP N+++     +  LKI DFG AR+     +      +  Y APE++  
Sbjct: 181 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             Y    D+WSVG I+ ++V  K  F G + I     +++      P   K L    ++ 
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 248 CQKLLRRNPVERLTFEEFF 266
            +   +   +   TF + F
Sbjct: 298 VENRPKYAGL---TFPKLF 313

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  142 bits (361), Expect = 9e-38
 Identities = 78/329 (23%), Positives = 134/329 (40%), Gaps = 74/329 (22%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH 72
           Y + +++G G++ +VW +  R  G  VA+K+I     N    +    EI IL  ++ H +
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           I+ L +++       ++L+ +Y    DL   I R   +     ++ + QL   ++ L   
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL------------ 178
            L+HRD+KP N+LL   +    +K+ADFG +RS              +            
Sbjct: 129 GLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

Query: 179 ----------YMAPEIM-QLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQN 224
                     Y APEI+    KY    D+WS+G IL +++ GK  F GS   NQ++ +  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

Query: 225 IV-------------------------------KATELHFPPDAKIL---------SADC 244
           ++                                     F     +L         + + 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
            DL  KLL+ NP +R++  +   HPF+S 
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSI 334

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  139 bits (353), Expect = 3e-37
 Identities = 63/272 (23%), Positives = 115/272 (42%), Gaps = 33/272 (12%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +GR +G G F  V  A+ +       +VA+K +    +     E  + E   +K  +HPH
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 73  IIRL------HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA------KHFMKQL 120
           + +L                 +IL + K GDL  ++                   FM  +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL-- 178
           A G++ L   N IHRDL  +N +L    ++  + +ADFG +R +         C S L  
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 179 -YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD 236
            ++A E +    Y   +D+W+ G  +++++T G+TP+ G    ++   ++    L  PP 
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP- 262

Query: 237 AKILSADCKDLCQKLLRR----NPVERLTFEE 264
                 +C +    L+ +    +P +R +F  
Sbjct: 263 ------ECMEEVYDLMYQCWSADPKQRPSFTC 288

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  138 bits (350), Expect = 3e-37
 Identities = 41/257 (15%), Positives = 79/257 (30%), Gaps = 36/257 (14%)

Query: 8   GRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEI-AMGRLNKKLQESLMSEIFIL 65
            R+    Y +    G       W A       +VA+  +   G L   + +  +S    L
Sbjct: 26  ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85

Query: 66  KRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
            RI+ P + R+ D++       ++ E+ +GG L          P       M+ LAA   
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVGAI-RAMQSLAAAAD 143

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
                 +      P  + +  D D   + +A                       M     
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGD---VVLAYPA-------------------TMPDA-- 179

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI---LSA 242
                + + D+  +GA L+ L+  + P   +     L    + T       A I   +  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 243 DCKDLCQKLLRRNPVER 259
               +  + ++ +   R
Sbjct: 235 QISAVAARSVQGDGGIR 251

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (353), Expect = 4e-37
 Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 25/261 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +GSG+F  V+       G      VA+KE+      K  +E ++ E +++  +++PH
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPH 78

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           + RL  I      + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  
Sbjct: 79  VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS--PL-YMAPEIMQLQ 188
           L+HRDL  +N+L+        +KI DFG A+ L          G   P+ +MA E +  +
Sbjct: 138 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC-KD 246
            Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP        C  D
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP-------ICTID 247

Query: 247 LCQKLLR---RNPVERLTFEE 264
           +   + +    +   R  F E
Sbjct: 248 VYMIMRKCWMIDADSRPKFRE 268

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (349), Expect = 5e-37
 Identities = 61/258 (23%), Positives = 120/258 (46%), Gaps = 24/258 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
             ++G G +  V+    + +   VA+K +    +     E  + E  ++K I HP++++L
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
             +       ++I E+   G+L  Y++      V      +   Q+++ ++ L   N IH
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N L+    +N  +K+ADFG +R +          G+     + APE +   K+ 
Sbjct: 135 RDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
            K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P         C +   +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE-------GCPEKVYE 243

Query: 251 LLRR----NPVERLTFEE 264
           L+R     NP +R +F E
Sbjct: 244 LMRACWQWNPSDRPSFAE 261

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  138 bits (349), Expect = 6e-37
 Identities = 60/269 (22%), Positives = 126/269 (46%), Gaps = 38/269 (14%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHG--TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           L  +++GSG+F  V    +++      VA+K +     +  L++ L++E  +++++++P+
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+R+  I E      L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N 
Sbjct: 80  IVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY------------M 180
           +HRDL  +N+LL         KI+DFG +++L+             Y             
Sbjct: 139 VHRDLAARNVLL---VTQHYAKISDFGLSKALRA--------DENYYKAQTHGKWPVKWY 187

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           APE +   K+ +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P     
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---- 243

Query: 240 LSADCKDLCQKLLRR----NPVERLTFEE 264
               C      L+      +   R  F  
Sbjct: 244 ---GCPREMYDLMNLCWTYDVENRPGFAA 269

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  139 bits (353), Expect = 1e-36
 Identities = 69/258 (26%), Positives = 119/258 (46%), Gaps = 22/258 (8%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
           G QIG G+F  V+  R R   T VA+K            +  + E  ILK+ +HP+I+RL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRL 177

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHR 135
             +      +++++E  +GGD   +++  G  +  +T    +   AAG++ L     IHR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY----MAPEIMQLQKYD 191
           DL  +N L+    +   LKI+DFG +R     G+     G         APE +   +Y 
Sbjct: 238 DLAARNCLV---TEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +++D+WS G +L++  + G +P+   +  Q  + + K   L  P         C D   +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE-------LCPDAVFR 346

Query: 251 LLRR----NPVERLTFEE 264
           L+ +     P +R +F  
Sbjct: 347 LMEQCWAYEPGQRPSFST 364

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  137 bits (346), Expect = 1e-36
 Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRINH 70
              IG G F  V+H     +       A   +  I     +       ++E  I+K  +H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSH 85

Query: 71  PHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK---HFMKQLAAGLQV 126
           P+++ L  I     G   ++L Y K GDL  +I+        T K    F  Q+A G++ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKY 143

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPL-YMA 181
           L     +HRDL  +N +L   D+   +K+ADFG AR +          +T    P+ +MA
Sbjct: 144 LASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
            E +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P      
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE----- 255

Query: 241 SADCKDLCQKLLRR----NPVERLTFEE 264
              C D   +++ +        R +F E
Sbjct: 256 --YCPDPLYEVMLKCWHPKAEMRPSFSE 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (346), Expect = 3e-36
 Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 42/275 (15%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
            R++G GSF +V+             T VA   + E A      + +   ++E  ++K  
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEF 85

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----------HFMK 118
           N  H++RL  ++       +I+E    GDL  Y++                         
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
           ++A G+  L  N  +HRDL  +N ++    ++  +KI DFG  R +             L
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202

Query: 179 ---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHF 233
              +M+PE ++   +   +D+WS G +L+++ T  + P+ G SN+ Q+L+ +++   L  
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDK 261

Query: 234 PPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           P        +C D+  +L+R     NP  R +F E
Sbjct: 262 PD-------NCPDMLFELMRMCWQYNPKMRPSFLE 289

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  136 bits (344), Expect = 3e-36
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 36/268 (13%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRINH 70
            R IG G F VV+H  +        + A   +  I       +  E+ + E  +++ +NH
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNH 81

Query: 71  PHIIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK---HFMKQLAAGLQV 126
           P+++ L  I +   G  H++L Y   GDL  +I+        T K    F  Q+A G++ 
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEY 139

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--LAETLCGSPL---YMA 181
           L +   +HRDL  +N +L   D++  +K+ADFG AR +  R     +    + L   + A
Sbjct: 140 LAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
            E +Q  ++  K+D+WS G +L++L+T G  P+   +   L   + +   L  P      
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE----- 251

Query: 241 SADCKDLCQKLLRR----NPVERLTFEE 264
              C D   +++++    +P  R TF  
Sbjct: 252 --YCPDSLYQVMQQCWEADPAVRPTFRV 277

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (345), Expect = 4e-36
 Identities = 63/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +G+ +G G F  V     +       +VA+K + +   +++  E  +SE   +K  +HP+
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 73  IIRL-----HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE---TAK---HFMKQLA 121
           +IRL         +   K  +IL + K GDL  Y+              +    FM  +A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G++ L + N +HRDL  +N +L    D+  + +ADFG ++ +           + +   
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           ++A E +  + Y +K+D+W+ G  ++++ T G TP+ G    ++   ++    L  P   
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE-- 272

Query: 238 KILSADCKDLCQKLLRR----NPVERLTFEE 264
                DC D   +++      +P++R TF  
Sbjct: 273 -----DCLDELYEIMYSCWRTDPLDRPTFSV 298

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  134 bits (339), Expect = 9e-36
 Identities = 57/263 (21%), Positives = 121/263 (46%), Gaps = 38/263 (14%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IG G F  V    +R  G +VA   +K  A         ++ ++E  ++ ++ H +
Sbjct: 25  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSN 75

Query: 73  IIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRD 129
           +++L  +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQ 186
           NN +HRDL  +N+L+    ++   K++DFG  +       + T     L   + APE ++
Sbjct: 136 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALR 187

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            +K+  K+D+WS G +L+++ + G+ P+       ++  + K  ++  P         C 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GCP 240

Query: 246 DLCQKLLRR----NPVERLTFEE 264
               ++++     +   R +F +
Sbjct: 241 PAVYEVMKNCWHLDAAMRPSFLQ 263

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  134 bits (340), Expect = 2e-35
 Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 34/271 (12%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
            R +G G+F  V+  +     +     +VA   + E+      ++ +   + E  I+ + 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS----EQDELDFLMEALIISKF 90

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLA 121
           NH +I+R   +        +++E   GGDL  +++     P + +        H  + +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G Q L +N+ IHRD+  +N LL         KI DFG AR +           + L   
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +M PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P   
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK-- 268

Query: 238 KILSADCKDLCQKLLRR----NPVERLTFEE 264
                +C     +++ +     P +R  F  
Sbjct: 269 -----NCPGPVYRIMTQCWQHQPEDRPNFAI 294

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  134 bits (339), Expect = 2e-35
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
                 G F  VW A+       VA+K   +        E    E++ L  + H +I++ 
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEY---EVYSLPGMKHENILQF 83

Query: 77  --HDII--EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
              +     V   L LI  + + G LS +++ +  V      H  + +A GL  L ++  
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIP 142

Query: 133 ----------IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---TLCGSPLY 179
                      HRD+K +N+LL    +N    IADFG A   +    A       G+  Y
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 180 MAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSN 217
           MAPE+++      +    + D++++G +L++L +  T   G  
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  134 bits (339), Expect = 3e-35
 Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 63/300 (21%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
              IG G +  V+          VA+K  +       + E     I+ +  + H +I R 
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEK---NIYRVPLMEHDNIARF 72

Query: 77  -----HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-- 129
                    +   +  L++EY   G L  Y+  H      ++      +  GL  L    
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTEL 131

Query: 130 -------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE---------TL 173
                    + HRDL  +N+L+    ++    I+DFG +  L    L           + 
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 174 CGSPLYMAPEIMQ-------LQKYDAKADLWSVGAILFQLVTGKT---PFTGSNQIQL-- 221
            G+  YMAPE+++        +    + D++++G I +++    T   P     + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 222 ------------LQNIV--KATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFE 263
                       +Q +V  +     FP   K  S   + L  + +      +   RLT +
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK-ETIEDCWDQDAEARLTAQ 307

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (344), Expect = 5e-35
 Identities = 58/263 (22%), Positives = 120/263 (45%), Gaps = 38/263 (14%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IG G F  V    +R  G +VA   +K  A         ++ ++E  ++ ++ H +
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSN 247

Query: 73  IIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRD 129
           +++L  +I E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQ 186
           NN +HRDL  +N+L+    ++   K++DFG  +       + T     L   + APE ++
Sbjct: 308 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALR 359

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            +K+  K+D+WS G +L+++ + G+ P+       ++  + K  ++  P         C 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GCP 412

Query: 246 DLCQKLLRR----NPVERLTFEE 264
                +++     +   R TF +
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQ 435

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (336), Expect = 6e-35
 Identities = 65/261 (24%), Positives = 116/261 (44%), Gaps = 25/261 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +GSG+F  V+       G      VA+KE+      K  +E ++ E +++  +++PH
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPH 78

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           + RL  I      + LI +    G L  Y++ H   +  +   ++  Q+A G+  L D  
Sbjct: 79  VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQ 188
           L+HRDL  +N+L+        +KI DFG A+ L          G  +   +MA E +  +
Sbjct: 138 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
            Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP        C   
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP-------ICTID 247

Query: 248 CQKLLRR----NPVERLTFEE 264
              ++ +    +   R  F E
Sbjct: 248 VYMIMVKCWMIDADSRPKFRE 268

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  134 bits (339), Expect = 7e-35
 Identities = 69/268 (25%), Positives = 116/268 (43%), Gaps = 36/268 (13%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRINH 70
              IG G F  V+H     +       A   +  I     +       ++E  I+K  +H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSH 149

Query: 71  PHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK---HFMKQLAAGLQV 126
           P+++ L  I     G   ++L Y K GDL  +I+        T K    F  Q+A G++ 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 207

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS----PL-YMA 181
           L     +HRDL  +N +L   D+   +K+ADFG AR +  +        +    P+ +MA
Sbjct: 208 LASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 182 PEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
            E +Q QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P      
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE----- 319

Query: 241 SADCKDLCQKLLRR----NPVERLTFEE 264
              C D   +++ +        R +F E
Sbjct: 320 --YCPDPLYEVMLKCWHPKAEMRPSFSE 345

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (338), Expect = 8e-35
 Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 34/271 (12%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
            R +G G+F  V+  +     +     +VA   + E+      ++ +   + E  I+ + 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS----EQDELDFLMEALIISKF 131

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------HFMKQLA 121
           NH +I+R   +        ++LE   GGDL  +++     P + +        H  + +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL--- 178
            G Q L +N+ IHRD+  +N LL         KI DFG AR +   G       + L   
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDA 237
           +M PE      + +K D WS G +L+++ + G  P+   +  ++L+ +     +  P   
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK-- 309

Query: 238 KILSADCKDLCQKLLRR----NPVERLTFEE 264
                +C     +++ +     P +R  F  
Sbjct: 310 -----NCPGPVYRIMTQCWQHQPEDRPNFAI 335

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 8e-35
 Identities = 67/274 (24%), Positives = 128/274 (46%), Gaps = 28/274 (10%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +  ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQ 243

Query: 76  LHDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNL 132
           L+ ++ E P  ++++ EY   G L  +++      +          Q+A+G+  +   N 
Sbjct: 244 LYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQKY 190
           +HRDL+  N+L+    +N   K+ADFG AR ++            P+ + APE     ++
Sbjct: 302 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP       +C +   
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-------ECPESLH 411

Query: 250 KLLRR----NPVERLTFEEFFNH--PFLSQTQPD 277
            L+ +     P ER TFE        + + T+P 
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (333), Expect = 9e-35
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 28/278 (10%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPH 72
             ++G GSF VV              VA+K +    L+  +  +  + E+  +  ++H +
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           +IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L    
Sbjct: 83  LIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RGLAETLCGSPL---YMAPEIMQL 187
            IHRDL  +NLLL        +KI DFG  R+L              +   + APE ++ 
Sbjct: 142 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE-LHFPPDAKILSADC- 244
           + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E L  P        DC 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE-------DCP 251

Query: 245 KDLCQKLLR---RNPVERLTFEEFFNHPFLSQTQPDQV 279
           +D+   +++     P +R TF       FL + QP  +
Sbjct: 252 QDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDM 287

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (334), Expect = 1e-34
 Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 25/261 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +GSG F  V        G      V +K I      +  Q  +   +  +  ++H H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGSLDHAH 76

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+RL  +      L L+ +Y   G L  ++++H G +  +   ++  Q+A G+  L ++ 
Sbjct: 77  IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQ 188
           ++HR+L  +N+LL      + +++ADFG A  L P         +     +MA E +   
Sbjct: 136 MVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           KY  ++D+WS G  +++L+T G  P+ G    ++   + K   L  P         C   
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ-------ICTID 245

Query: 248 CQKLLRR----NPVERLTFEE 264
              ++ +    +   R TF+E
Sbjct: 246 VYMVMVKCWMIDENIRPTFKE 266

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (330), Expect = 1e-34
 Identities = 56/258 (21%), Positives = 121/258 (46%), Gaps = 24/258 (9%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           + +++GSG F VV   + +    +VA+K I  G +++   +    E   + +++HP +++
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVK 67

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIH 134
            + +      ++++ EY   G L  Y++ HG  +           +  G+  L  +  IH
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYD 191
           RDL  +N L+   D +  +K++DFG  R +       +  G+     + APE+    KY 
Sbjct: 128 RDLAARNCLV---DRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +K+D+W+ G +++++ + GK P+      +++  + +   L+ P           D   +
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH-------LASDTIYQ 236

Query: 251 LLRR----NPVERLTFEE 264
           ++       P +R TF++
Sbjct: 237 IMYSCWHELPEKRPTFQQ 254

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  134 bits (338), Expect = 3e-34
 Identities = 73/347 (21%), Positives = 121/347 (34%), Gaps = 99/347 (28%)

Query: 10  VVGDYLVGR-----QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           V  D++  R      IG GSF  V  A        VA+K +   R  K+       EI I
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRI 146

Query: 65  LKRINH------PHIIRLHDIIEVPGKLHLILEYCKGGDLSM----YIQRHGCVP--EET 112
           L+ +         ++I + +       + +  E      LSM     I+++         
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL-----LSMNLYELIKKNKFQGFSLPL 201

Query: 113 AKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA--------RSL 164
            + F   +   L  L  N +IH DLKP+N+LL      + +K+ DFG +          +
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSCYEHQRVYTYI 260

Query: 165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN 224
           Q R           Y APE++   +Y    D+WS+G IL +L+TG     G ++   L  
Sbjct: 261 QSR----------FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310

Query: 225 IV--------------KATELHF---------------------------------PPDA 237
           ++              K  +                                    PP++
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370

Query: 238 KILSADCK--------DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
           +      K        D  ++ L  +P  R+T  +   HP+L +  P
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (327), Expect = 4e-34
 Identities = 58/257 (22%), Positives = 121/257 (47%), Gaps = 24/257 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
            ++IGSG F +V          +VA+K I  G +++   E  + E  ++ +++HP +++L
Sbjct: 13  VQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQL 68

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           + +      + L+ E+ + G LS Y++   G    ET       +  G+  L +  +IHR
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKYDA 192
           DL  +N L+    +N  +K++DFG  R +       +  G+     + +PE+    +Y +
Sbjct: 129 DLAARNCLV---GENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 193 KADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
           K+D+WS G +++++ + GK P+   +  +++++I     L+ P               ++
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-------LASTHVYQI 237

Query: 252 LRR----NPVERLTFEE 264
           +       P +R  F  
Sbjct: 238 MNHCWRERPEDRPAFSR 254

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (328), Expect = 5e-34
 Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 43/279 (15%)

Query: 17  GRQIGSGSFSVVWHARHRVH----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            +Q+G G+F  V   R+       G  VA+K++               EI ILK + H +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDN 72

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           I++   +    G+  L LI+EY   G L  Y+Q+H   +       +  Q+  G++ L  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPL-YMAPEIM 185
              IHRDL  +N+L+   ++   +KI DFG  + L         +    SP+ + APE +
Sbjct: 133 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 186 QLQKYDAKADLWSVGAILFQLVT----------------GKTPFTGSNQIQLLQNIVKAT 229
              K+   +D+WS G +L++L T                G           L++ +    
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249

Query: 230 ELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            L  P         C D    ++      N  +R +F +
Sbjct: 250 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRD 281

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (327), Expect = 1e-33
 Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 43/279 (15%)

Query: 17  GRQIGSGSFSVVWHARHRVH----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            +Q+G G+F  V   R+       G  VA+K++      ++       EI ILK + H +
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           I++   +    G+  L LI+EY   G L  Y+Q+H   +       +  Q+  G++ L  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIM 185
              IHRDL  +N+L+   ++   +KI DFG  + L         +    SP+ + APE +
Sbjct: 164 KRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 186 QLQKYDAKADLWSVGAILFQLVT----------------GKTPFTGSNQIQLLQNIVKAT 229
              K+   +D+WS G +L++L T                G           L++ +    
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280

Query: 230 ELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            L  P         C D    ++      N  +R +F +
Sbjct: 281 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRD 312

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (327), Expect = 1e-33
 Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 56/289 (19%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
           G+ +G G F  V  A       R   T VA   +KE A           L+SE  +LK++
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS----PSELRDLLSEFNVLKQV 83

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------------- 114
           NHPH+I+L+      G L LI+EY K G L  +++    V                    
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 115 ----------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
                      F  Q++ G+Q L +  L+HRDL  +N+L+    +   +KI+DFG +R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDV 200

Query: 165 QPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQI 219
                        +   +MA E +    Y  ++D+WS G +L+++VT G  P+ G   + 
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE- 259

Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           +L   +     +  P        +C +   +L+ +     P +R  F +
Sbjct: 260 RLFNLLKTGHRMERPD-------NCSEEMYRLMLQCWKQEPDKRPVFAD 301

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (324), Expect = 1e-33
 Identities = 53/260 (20%), Positives = 115/260 (44%), Gaps = 30/260 (11%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
            +++G+G F VV + + R    +VA   +KE +M        +  + E  ++  ++H  +
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKL 81

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++L+ +      + +I EY   G L  Y++        +      K +   ++ L     
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           +HRDL  +N L+   +D   +K++DFG +R +       +  GS     +  PE++   K
Sbjct: 142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 197

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + +K+D+W+ G +++++ + GK P+      +  ++I +   L+ P           +  
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH-------LASEKV 250

Query: 249 QKLLRR----NPVERLTFEE 264
             ++         ER TF+ 
Sbjct: 251 YTIMYSCWHEKADERPTFKI 270

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (323), Expect = 2e-33
 Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 17  GRQIGSGSFSVVW--HARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
             ++G   F  V+  H      G     VA   +K+ A       L+E    E  +  R+
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARL 69

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------------- 114
            HP+++ L  ++     L +I  YC  GDL  ++       +  +               
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
             H + Q+AAG++ L  ++++H+DL  +N+L+    D   +KI+D G  R +      + 
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKL 186

Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVK 227
           L  S L   +MAPE +   K+   +D+WS G +L+++ + G  P+ G SNQ  +++ I  
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVVEMIRN 245

Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEE 264
              L  P        DC      L+       P  R  F++
Sbjct: 246 RQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKD 279

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  127 bits (322), Expect = 2e-33
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 35/265 (13%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRINH 70
           GR IG G F  V    +         VA    K          ++E  + E   +++ +H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----DSVREKFLQEALTMRQFDH 75

Query: 71  PHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLR 128
           PHI++L  +I E P  + +I+E C  G+L  ++Q     +   +   +  QL+  L  L 
Sbjct: 76  PHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIM 185
               +HRD+  +N+L+     N  +K+ DFG +R ++            L   +MAPE +
Sbjct: 134 SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI 189

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSAD 243
             +++ + +D+W  G  +++++  G  PF G  N   ++  I     L  PP       +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPP-------N 241

Query: 244 CKDLCQKLLRR----NPVERLTFEE 264
           C      L+ +    +P  R  F E
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTE 266

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (328), Expect = 2e-33
 Identities = 65/304 (21%), Positives = 140/304 (46%), Gaps = 33/304 (10%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + +G+G F  V   R ++       VA+K + +G   K+ ++  + E  I+ + +HP+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPN 107

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           IIRL  ++     + ++ EY + G L  ++++H            ++ +A+G++ L D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPL---YMAPEIMQL 187
            +HRDL  +N+L+   + N   K++DFG  R L+     A T  G  +   + +PE +  
Sbjct: 168 YVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +K+ + +D+WS G +L+++++ G+ P+   +   +++ + +   L  P        DC  
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM-------DCPA 277

Query: 247 LCQKLLRR----NPVERLTFEE-------FFNHPFLSQTQPDQVFR--SRMFSRSADDFP 293
              +L+      +   R  FE+          +P   +       R  + +  +S  D  
Sbjct: 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDIT 337

Query: 294 FYES 297
            + +
Sbjct: 338 TFRT 341

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  127 bits (322), Expect = 2e-33
 Identities = 69/274 (25%), Positives = 136/274 (49%), Gaps = 30/274 (10%)

Query: 17  GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRL 76
             ++G+G F  VW   +  H T+VA+K +  G ++    ++ ++E  ++K++ H  ++RL
Sbjct: 18  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRL 73

Query: 77  HDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLI 133
           + ++ + P  +++I EY + G L  +++      +          Q+A G+  + + N I
Sbjct: 74  YAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131

Query: 134 HRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQKY 190
           HRDL+  N+L+    D  + KIADFG AR ++         G+     + APE +    +
Sbjct: 132 HRDLRAANILV---SDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             K+D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P        +C +   
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD-------NCPEELY 240

Query: 250 KLLRR----NPVERLTFEEFFNH--PFLSQTQPD 277
           +L+R      P +R TF+   +    F + T+  
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  132 bits (334), Expect = 3e-33
 Identities = 67/274 (24%), Positives = 128/274 (46%), Gaps = 28/274 (10%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +  ++G G F  VW        T VA+K +  G ++    E+ + E  ++K++ H  +++
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQ 326

Query: 76  LHDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNL 132
           L+ ++ E P  ++++ EY   G L  +++      +          Q+A+G+  +   N 
Sbjct: 327 LYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGS-PL-YMAPEIMQLQKY 190
           +HRDL+  N+L+    +N   K+ADFG AR ++            P+ + APE     ++
Sbjct: 385 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
             K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP       +C +   
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP-------ECPESLH 494

Query: 250 KLLRR----NPVERLTFEEFFNH--PFLSQTQPD 277
            L+ +     P ER TFE        + + T+P 
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (337), Expect = 3e-33
 Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 25/260 (9%)

Query: 17  GRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           GR IG G F  V    +         VA+K       +  ++E  + E   +++ +HPHI
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHI 453

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNL 132
           ++L  +I     + +I+E C  G+L  ++Q     +   +   +  QL+  L  L     
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG-SPL-YMAPEIMQLQKY 190
           +HRD+  +N+L+     N  +K+ DFG +R ++     +   G  P+ +MAPE +  +++
Sbjct: 513 VHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
            + +D+W  G  +++++  G  PF G  N   ++  I     L  PP       +C    
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPP-------NCPPTL 621

Query: 249 QKLLRR----NPVERLTFEE 264
             L+ +    +P  R  F E
Sbjct: 622 YSLMTKCWAYDPSRRPRFTE 641

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  128 bits (324), Expect = 3e-33
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 17/214 (7%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
             Q+G G+F  V   R+   G      VA+K++     ++  Q     EI ILK ++   
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDF 85

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           I++   +   PG+  L L++EY   G L  ++QRH   +       +  Q+  G++ L  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIM 185
              +HRDL  +N+L+   +  A +KIADFG A+ L       +      SP+ + APE +
Sbjct: 146 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQ 218
               +  ++D+WS G +L++L T      + S +
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  128 bits (325), Expect = 3e-33
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 49/283 (17%)

Query: 17  GRQIGSGSFSVVWHAR-------HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILK 66
           G+ +G G+F  V  A               VA   +K+ A     +K    L+SE+ ++K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT----EKDLSDLVSEMEMMK 95

Query: 67  RI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----------- 114
            I  H +II L       G L++I+EY   G+L  Y++       E +            
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 115 -----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL 169
                    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +     
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDY 212

Query: 170 AETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI 225
            +      L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            +   +  P        +C +    ++R      P +R TF++
Sbjct: 273 KEGHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 308

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (321), Expect = 4e-33
 Identities = 58/266 (21%), Positives = 117/266 (43%), Gaps = 31/266 (11%)

Query: 17  GRQIGSGSFSVVWHARHRVHG-------TEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
              +G G+F+ ++    R  G       TEV +K +     N    ES      ++ +++
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLS 70

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLR 128
           H H++  + +     +  L+ E+ K G L  Y++++  C+         KQLAA +  L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 129 DNNLIHRDLKPQNLLLCTDD-----DNAALKIADFGFARSLQPRGLAETLCGSPL-YMAP 182
           +N LIH ++  +N+LL  ++     +   +K++D G + ++ P    + +    + ++ P
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPP 186

Query: 183 E-IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI- 239
           E I   +  +   D WS G  L+++ + G  P +  +  + LQ      +L  P  A++ 
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELA 246

Query: 240 -LSADCKDLCQKLLRRNPVERLTFEE 264
            L  +C       +   P  R +F  
Sbjct: 247 NLINNC-------MDYEPDHRPSFRA 265

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (324), Expect = 4e-33
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 48/281 (17%)

Query: 17  GRQIGSGSFSVVWHARHRVHG-----TEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
           G+ +G+G+F  V  A     G      +VA   +K  A        +E+LMSE+ I+  +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH----ADEKEALMSELKIMSHL 106

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK------------- 114
             H +I+ L       G + +I EYC  GDL  +++R   V E                 
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 115 -HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--LAE 171
            HF  Q+A G+  L   N IHRD+  +N+LL    +    KI DFG AR +      + +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 172 TLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG--SNQIQLLQNIVK 227
                P+ +MAPE +    Y  ++D+WS G +L+++ + G  P+ G   N  +  + +  
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLVKD 282

Query: 228 ATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
             ++  P                +++      P  R TF++
Sbjct: 283 GYQMAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQ 316

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (320), Expect = 4e-33
 Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 33/265 (12%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKRIN 69
           + R +G G F  V+   +  H      VA    K+       +K     MSE  I+K ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNLD 71

Query: 70  HPHIIRLHDII-EVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVL 127
           HPHI++L  II E P    +I+E    G+L  Y++R+   +   T   +  Q+   +  L
Sbjct: 72  HPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEI 184
              N +HRD+  +N+L+        +K+ DFG +R ++          + L   +M+PE 
Sbjct: 130 ESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPES 185

Query: 185 MQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
           +  +++   +D+W     ++++++ GK PF       ++  + K   L  P         
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-------L 238

Query: 244 CKDLCQKLLRR----NPVERLTFEE 264
           C  +   L+ R    +P +R  F E
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTE 263

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (320), Expect = 7e-33
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 50/284 (17%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
           G+ +G+G+F  V  A             VA   +K  A        +E+LMSE+ +L  +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYL 83

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK------------- 114
            NH +I+ L     + G   +I EYC  GDL  +++R       +               
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 115 -----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG- 168
                 F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++    
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200

Query: 169 -LAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQN 224
            + +     P+ +MAPE +    Y  ++D+WS G  L++L + G +P+ G     +  + 
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 225 IVKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           I +   +  P                +++     +P++R TF++
Sbjct: 261 IKEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQ 297

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  126 bits (319), Expect = 8e-33
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 16/214 (7%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            R +G G F  V   R+   G     +VA+K +            L  EI IL+ + H +
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHEN 84

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRD 129
           I++   I    G   + LI+E+   G L  Y+ ++   +  +    +  Q+  G+  L  
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIM 185
              +HRDL  +N+L+   +    +KI DFG  ++++        +    SP+ + APE +
Sbjct: 145 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQ 218
              K+   +D+WS G  L +L+T   +  +    
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  128 bits (323), Expect = 9e-33
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 49/283 (17%)

Query: 17  GRQIGSGSFSVVWHAR-------HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILK 66
           G+ +G G F  V  A               VA   +K+ A     +K    L+SE+ ++K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT----EKDLSDLVSEMEMMK 141

Query: 67  RI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----------- 114
            I  H +II L       G L++I+EY   G+L  Y++       E +            
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 115 -----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL 169
                    QLA G++ L     IHRDL  +N+L+    +N  +KIADFG AR +     
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDY 258

Query: 170 AETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI 225
            +      L   +MAPE +  + Y  ++D+WS G +++++ T G +P+ G    +L + +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            +   +  P        +C +    ++R      P +R TF++
Sbjct: 319 KEGHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 354

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  127 bits (320), Expect = 1e-32
 Identities = 64/262 (24%), Positives = 125/262 (47%), Gaps = 24/262 (9%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           + + IGSG    V + R RV G     VA+K +  G   ++ ++  +SE  I+ + +HP+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPN 111

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           IIRL  ++       ++ EY + G L  +++ H G          ++ + AG++ L D  
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAETLCGSPL---YMAPEIMQL 187
            +HRDL  +N+L+   D N   K++DFG +R L+     A T  G  +   + APE +  
Sbjct: 172 YVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           + + + +D+WS G ++++++  G+ P+       ++ ++ +   L  P         C  
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM-------GCPH 281

Query: 247 LCQKLLRR----NPVERLTFEE 264
              +L+      +  +R  F +
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQ 303

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  125 bits (317), Expect = 1e-32
 Identities = 59/270 (21%), Positives = 121/270 (44%), Gaps = 40/270 (14%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHG--TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +   ++G G+F  V    +R+     +VA+K +  G      +E +M E  I+ ++++P+
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPY 71

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+RL  + +    L L++E   GG L  ++      +P       + Q++ G++ L + N
Sbjct: 72  IVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY------------ 179
            +HRDL  +N+LL    +    KI+DFG +++L              Y            
Sbjct: 131 FVHRDLAARNVLL---VNRHYAKISDFGLSKALGA--------DDSYYTARSAGKWPLKW 179

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
            APE +  +K+ +++D+WS G  +++ ++ G+ P+      +++  I +   +  PP   
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP--- 236

Query: 239 ILSADC-KDLCQKLLR---RNPVERLTFEE 264
               +C  +L   +         +R  F  
Sbjct: 237 ----ECPPELYALMSDCWIYKWEDRPDFLT 262

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  126 bits (319), Expect = 2e-32
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 49/279 (17%)

Query: 17  GRQIGSGSFSVVWHARHRVHG--TEVA---MKEIAMGRLNKKLQESLMSEIFILKRI-NH 70
              IG G+F  V  AR +  G   + A   MKE A     K        E+ +L ++ +H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----KDDHRDFAGELEVLCKLGHH 85

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK---------------- 114
           P+II L    E  G L+L +EY   G+L  ++++   +  + A                 
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 115 HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC 174
           HF   +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  +   +     
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQE---VYVKKT 199

Query: 175 GSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKAT 229
              L   +MA E +    Y   +D+WS G +L+++V+ G TP+ G +   +L + + +  
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGY 258

Query: 230 ELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            L  P        +C D    L+R+     P ER +F +
Sbjct: 259 RLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQ 290

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  125 bits (316), Expect = 2e-32
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 49/281 (17%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
            R++G G+F  V+ A             VA   +K+  +       ++    E  +L  +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-----AARKDFQREAELLTNL 74

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------------- 114
            H HI++ + +      L ++ EY K GDL+ +++ HG                      
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
             H   Q+A+G+  L   + +HRDL  +N L+     N  +KI DFG +R +        
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVK 227
              + L   +M PE +  +K+  ++D+WS G IL+++ T GK P+   SN  ++++ I +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECITQ 250

Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEE 264
              L  P         C      ++     R P +RL  +E
Sbjct: 251 GRVLERPR-------VCPKEVYDVMLGCWQREPQQRLNIKE 284

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  125 bits (317), Expect = 2e-32
 Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 41/277 (14%)

Query: 17  GRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            R +G G F  V    +          VA+K +       + +     EI IL+ + H H
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEH 94

Query: 73  IIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           II+     E  G   L L++EY   G L  Y+ RH  +       F +Q+  G+  L   
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ 153

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPL-YMAPEIMQ 186
           + IHRDL  +N+LL   D++  +KI DFG A+++              SP+ + APE ++
Sbjct: 154 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 187 LQKYDAKADLWSVGAILFQLVT---------------GKTPFTGSNQIQLLQNIVKATEL 231
             K+   +D+WS G  L++L+T                         ++L + + +   L
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270

Query: 232 HFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
             P         C      L++         R TFE 
Sbjct: 271 PRPD-------KCPAEVYHLMKNCWETEASFRPTFEN 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 3e-32
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 49/283 (17%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
           G+ +G G+F  V  A             VA   +KE A          +LMSE+ IL  I
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKILIHI 87

Query: 69  -NHPHIIRLHDIIEVPGK-LHLILEYCKGGDLSMYIQRHGCVPEETAK------------ 114
            +H +++ L      PG  L +I+E+CK G+LS Y++                       
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 115 ----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA 170
                +  Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +      
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY 204

Query: 171 ETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNI 225
                + L   +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            + T +  P               + +       P +R TF E
Sbjct: 265 KEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSE 300

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (316), Expect = 5e-32
 Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 55/289 (19%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
           G+ +GSG+F  V +A            +VA   +KE A        +E+LMSE+ ++ ++
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQL 105

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKH------------ 115
            +H +I+ L     + G ++LI EYC  GDL  Y++       E                
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 116 -----------FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
                      F  Q+A G++ L   + +HRDL  +N+L+        +KI DFG AR +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI 222

Query: 165 QPRG--LAETLCGSPL-YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQI 219
                 +       P+ +MAPE +    Y  K+D+WS G +L+++ + G  P+ G     
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
              + I    ++  P           +    +++     +  +R +F  
Sbjct: 283 NFYKLIQNGFKMDQPF-------YATEEIYIIMQSCWAFDSRKRPSFPN 324

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  125 bits (317), Expect = 5e-32
 Identities = 74/351 (21%), Positives = 125/351 (35%), Gaps = 100/351 (28%)

Query: 10  VVGDYLVGR-----QIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNKKLQESLMSEIF 63
            +GD+L  R      +G G+F  V     H    ++VA+K I   R   K +E+   EI 
Sbjct: 12  RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEIN 68

Query: 64  ILKRINHP------HIIRLHDIIEVPGKLHLILEYCKGGDLSM----YIQRHGCV--PEE 111
           +LK+I           + + D     G + +  E      L      +++ +     P  
Sbjct: 69  VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL-----LGKNTFEFLKENNFQPYPLP 123

Query: 112 TAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----------------DNAALKI 155
             +H   QL   L+ L +N L H DLKP+N+L    +                 N ++++
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 156 ADFG---FARS-----LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV 207
           ADFG   F        +  R           Y  PE++    +    D+WS+G ILF+  
Sbjct: 184 ADFGSATFDHEHHTTIVATR----------HYRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 208 TGKTPFTGSNQIQLLQNIV--------------KATELHF-------------------- 233
            G T F      + L  +               +  +  +                    
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 234 PPDAKILSAD------CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ 278
            P    +  D        DL +++L  +P +R+T  E   HPF +   P++
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (315), Expect = 6e-32
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 48/281 (17%)

Query: 16  VGRQIGSGSFSVVW--HARHRVHG---TEVA---MKEIAMGRLNKKLQESLMSEIFILKR 67
           +  ++G G+F  V+     + +       VA   +KE +        ++    E  +L  
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-----SARQDFQREAELLTM 99

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK------------- 114
           + H HI+R   +      L ++ EY + GDL+ +++ HG   +  A              
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 115 --HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET 172
                 Q+AAG+  L   + +HRDL  +N L+        +KI DFG +R +        
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 173 LCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVK 227
              + L   +M PE +  +K+  ++D+WS G +L+++ T GK P+   SN  + +  I +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAIDCITQ 275

Query: 228 ATELHFPPDAKILSADCKDLCQKLLR----RNPVERLTFEE 264
             EL  P         C      ++R    R P +R + ++
Sbjct: 276 GRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKD 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  127 bits (321), Expect = 6e-32
 Identities = 70/275 (25%), Positives = 135/275 (49%), Gaps = 30/275 (10%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           + +++G+G F  VW A +  H T+VA+K +  G ++    E+ ++E  ++K + H  +++
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVK 247

Query: 76  LHDII-EVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNL 132
           LH ++ + P  +++I E+   G L  +++       P      F  Q+A G+  +   N 
Sbjct: 248 LHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL---YMAPEIMQLQK 189
           IHRDL+  N+L+     +   KIADFG AR ++         G+     + APE +    
Sbjct: 306 IHRDLRAANILV---SASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           +  K+D+WS G +L ++VT G+ P+ G +  ++++ + +   +  P        +C +  
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE-------NCPEEL 414

Query: 249 QKLLRR----NPVERLTFEEFFNH--PFLSQTQPD 277
             ++ R     P ER TFE   +    F + T+  
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (316), Expect = 1e-31
 Identities = 73/283 (25%), Positives = 125/283 (44%), Gaps = 49/283 (17%)

Query: 17  GRQIGSGSFSVVWHAR-------HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILK 66
           G+ +G G+F  V  A             T+VA   +K  A     +K    L+SE+ ++K
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----EKDLSDLISEMEMMK 129

Query: 67  RI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK----------- 114
            I  H +II L       G L++I+EY   G+L  Y+Q       E +            
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 115 -----HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL 169
                    Q+A G++ L     IHRDL  +N+L+    ++  +KIADFG AR +     
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDY 246

Query: 170 AETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI 225
            +      L   +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
            +   +  P        +C +    ++R      P +R TF++
Sbjct: 307 KEGHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQ 342

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  123 bits (311), Expect = 2e-31
 Identities = 73/349 (20%), Positives = 124/349 (35%), Gaps = 100/349 (28%)

Query: 10  VVGDYLVGR-----QIGSGSFSVVWHAR-HRVHGTEVAMKEIAMGRLNKKLQESLMSEIF 63
             GD L  R      +G G+F  V     H+  G  VA+K +   +   +  E+  SEI 
Sbjct: 7   QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQ 63

Query: 64  ILKRINHP------HIIRLHDIIEVPGKLHLILEYCKGGDLSM----YIQRHGCV--PEE 111
           +L+ +N          +++ +  E  G + ++ E      L +    +I+ +G +    +
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL-----LGLSTYDFIKENGFLPFRLD 118

Query: 112 TAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----------------DNAALKI 155
             +    Q+   +  L  N L H DLKP+N+L    D                 N  +K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 156 ADFG---FARS-----LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV 207
            DFG   +        +  R           Y APE++    +    D+WS+G IL +  
Sbjct: 179 VDFGSATYDDEHHSTLVSTR----------HYRAPEVILALGWSQPCDVWSIGCILIEYY 228

Query: 208 TGKTPFTGSNQIQLLQNIVKA--------------------TELHFPPDAK--------- 238
            G T F   +  + L  + +                       L +   +          
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288

Query: 239 ------ILSAD-----CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                 +LS D       DL QK+L  +P +R+T  E   HPF    + 
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (311), Expect = 2e-31
 Identities = 72/295 (24%), Positives = 133/295 (45%), Gaps = 36/295 (12%)

Query: 16  VGRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
             + IG+G F  V+    +         VA+K +  G   K+  +  + E  I+ + +H 
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHH 106

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
           +IIRL  +I     + +I EY + G L  +++   G          ++ +AAG++ L + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-TLCGSPL---YMAPEIMQ 186
           N +HRDL  +N+L+   + N   K++DFG +R L+    A  T  G  +   + APE + 
Sbjct: 167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSADC 244
            +K+ + +D+WS G ++++++T G+ P+   SN  ++++ I     L  P        DC
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPM-------DC 275

Query: 245 KDLCQKLLRR----NPVERLTFEE-------FFNHPFLSQTQPDQVFRSRMFSRS 288
                +L+ +        R  F +           P   +T  D  F  R+  R 
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD--FDPRVSIRL 328

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (309), Expect = 5e-31
 Identities = 64/289 (22%), Positives = 121/289 (41%), Gaps = 56/289 (19%)

Query: 17  GRQIGSGSFSVVWHAR-----HRVHGTEVA---MKEIAMGRLNKKLQESLMSEIFILKRI 68
            R IG G+F  V+ AR          T VA   +KE A       +Q     E  ++   
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMAEF 107

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAK-------------- 114
           ++P+I++L  +  V   + L+ EY   GDL+ +++        +                
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 115 ----------HFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
                        +Q+AAG+  L +   +HRDL  +N L+    +N  +KIADFG +R++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNI 224

Query: 165 QPRGLAETLCGSPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQI 219
                 +      +   +M PE +   +Y  ++D+W+ G +L+++ + G  P+ G +++ 
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283

Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           +++  +     L  P        +C      L+R      P +R +F  
Sbjct: 284 EVIYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCS 325

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  122 bits (307), Expect = 1e-30
 Identities = 72/350 (20%), Positives = 115/350 (32%), Gaps = 106/350 (30%)

Query: 10  VVGDYLVGR-----QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI 64
             G  L        ++G G+F  V   +H  +    A+K +   R  KK   S   E  I
Sbjct: 28  KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADI 84

Query: 65  LKRINH-----PHIIRLHDIIEVPGKLHLILEYCKGGDLSM----YIQRHGCV--PEETA 113
           LK+I +      +I++ H        + LI E      L       I R+       E  
Sbjct: 85  LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNGFHIEDI 139

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD----------------------DNA 151
           K +  ++   L  LR  +L H DLKP+N+LL                           + 
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 152 ALKIADFG---FARS-----LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAIL 203
            +K+ DFG   F        +  R           Y APE++    +D  +D+WS G +L
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTR----------QYRAPEVILNLGWDVSSDMWSFGCVL 249

Query: 204 FQLVTGKTPFTGSNQIQLLQNIVK-------------------------ATELHFPPDAK 238
            +L TG   F     ++ L  +                             +L +P +A 
Sbjct: 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309

Query: 239 ILS-----------------ADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
            ++                     D    +L+ +P  R +  E   H FL
Sbjct: 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (315), Expect = 2e-30
 Identities = 57/262 (21%), Positives = 120/262 (45%), Gaps = 24/262 (9%)

Query: 15  LVGRQIGSGSFSVVWHARHRVHG--TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +   ++G G+F  V    +R+     +VA+K +  G      +E +M E  I+ ++++P+
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPY 397

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN 131
           I+RL  + +    L L++E   GG L  ++      +P       + Q++ G++ L + N
Sbjct: 398 IVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLA-ETLCGSPL---YMAPEIMQL 187
            +HR+L  +N+LL    +    KI+DFG +++L                  + APE +  
Sbjct: 457 FVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 188 QKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +K+ +++D+WS G  +++ ++ G+ P+      +++  I +   +  PP       +C  
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-------ECPP 566

Query: 247 LCQKLLRR----NPVERLTFEE 264
               L+         +R  F  
Sbjct: 567 ELYALMSDCWIYKWEDRPDFLT 588

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  120 bits (302), Expect = 7e-30
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 28/241 (11%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP-- 71
           Y +   IG GSF  V  A  RV    VA+K I   +  K        E+ +L+ +N    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 72  ----HIIRLHDIIEVPGKLHLILEYCKGGDLSM----YIQRHGCVP--EETAKHFMKQLA 121
               +I+ L         L L+ E      LS      ++            + F +Q+ 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 122 AGLQVLRDN--NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
             L  L     ++IH DLKP+N+LLC +   +A+KI DFG +     + + + +  S  Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLC-NPKRSAIKIVDFGSS-CQLGQRIYQYIQ-SRFY 224

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
            +PE++    YD   D+WS+G IL ++ TG+  F+G+N++  +  IV   E+   P A I
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV---EVLGIPPAHI 281

Query: 240 L 240
           L
Sbjct: 282 L 282

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  115 bits (289), Expect = 5e-28
 Identities = 77/366 (21%), Positives = 130/366 (35%), Gaps = 111/366 (30%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI--- 68
           G Y V R++G G FS VW +        VAMK   + +  +   E+ + EI +LK +   
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNS 93

Query: 69  --NHP---HIIRLHDIIEVPGK--LH--LILEYCKGGDLSMYIQR--HGCVPEETAKHFM 117
             N P    +++L D  ++ G    H  ++ E   G  L  +I +  +  +P    K  +
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 118 KQLAAGLQVL-RDNNLIHRDLKPQNLLLCTDD---------------------------- 148
           +Q+  GL  L     +IH D+KP+N+LL  ++                            
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 149 ------------------DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKY 190
                             +   +KIAD G A  +           +  Y + E++    Y
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGSGY 270

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSN-------------QIQLLQ-------------- 223
           +  AD+WS   + F+L TG   F   +              I+LL               
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330

Query: 224 -------NIVKATELHFPPDAKIL----------SADCKDLCQKLLRRNPVERLTFEEFF 266
                  ++   T+L      ++L          +A   D    +L   P +R T  E  
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

Query: 267 NHPFLS 272
            HP+L+
Sbjct: 391 RHPWLN 396

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 47/309 (15%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           RV   Y +GR+IGSGSF  ++       G EVA+K   +  +  K    L  E  I K +
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHP-QLHIESKIYKMM 61

Query: 69  NH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQV 126
                I  +           +++E   G  L             +T      Q+ + ++ 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ--------PRGLAETLCGSPL 178
           +   N IHRD+KP N L+        + I DFG A+  +        P    + L G+  
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG---SNQIQLLQNIVKATELHFPP 235
           Y +       +   + DL S+G +L     G  P+ G   + + Q  + I +        
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-------- 232

Query: 236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNH----PFLSQTQPD-----QVFRSRMFS 286
             K +S   + LC+      P E   F  + N      F    +PD     Q+FR+    
Sbjct: 233 --KKMSTPIEVLCKGY----PSE---FATYLNFCRSLRF--DDKPDYSYLRQLFRNLFHR 281

Query: 287 RS-ADDFPF 294
           +  + D+ F
Sbjct: 282 QGFSYDYVF 290

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 50/316 (15%)

Query: 5   TGRGRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF 63
           +G+  VVG  Y VGR+IG GSF V++   + ++  +VA+K              L  E  
Sbjct: 2   SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP-QLRDEYR 57

Query: 64  ILKRI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLA 121
             K +     I  ++   +      L+++   G  L   +   G     +T     KQ+ 
Sbjct: 58  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQML 116

Query: 122 AGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI--ADFGFA------RSLQPRGLAE-- 171
           A +Q + + +L++RD+KP N L+   +   A  I   DFG         + Q     E  
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176

Query: 172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG---SNQIQLLQNIVKA 228
            L G+  YM+      ++   + DL ++G +    + G  P+ G   +   Q  + I + 
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE- 235

Query: 229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH----PFLSQTQPD-----QV 279
                    K  S   ++LC       P E   F ++ ++     F     PD      +
Sbjct: 236 ---------KKQSTPLRELCAGF----PEE---FYKYMHYARNLAF--DATPDYDYLQGL 277

Query: 280 FRSRMFSRS-ADDFPF 294
           F   +   +  +D  F
Sbjct: 278 FSKVLERLNTTEDENF 293

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
           +  Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +           
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGD 254

Query: 176 SPL---YMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG-SNQIQLLQNIVKATE 230
           + L   +MAPE +  + Y  ++D+WS G +L+++ + G +P+ G     +  + + + T 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314

Query: 231 LHFPPDAKILSADCKDLCQKLLRR----NPVERLTFEE 264
           +  P               + +       P +R TF E
Sbjct: 315 MRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSE 345

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 16/145 (11%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRI-NH 70
           +G+ +G G+F  V  A           + +A+  L +        +LMSE+ IL  I +H
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 71  PHIIRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
            +++ L     +  G L +I+E+CK G+LS Y++            F+     G +  + 
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYKTKGARFRQG 138

Query: 130 N---NLIHRDLKPQNLLLCTDDDNA 151
                 I  DLK +   + +   +A
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSA 163

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 33/210 (15%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESL------MSEIFILKRINHPHI 73
           IG G F  V+    R  G +VA+K     R      ES        +EI  L    HPH+
Sbjct: 47  IGHGVFGKVYKGVLR-DGAKVALK-----RRT---PESSQGIEEFETEIETLSFCRHPHL 97

Query: 74  IRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL------AAGLQVL 127
           + L    +   ++ LI +Y + G+L  ++  +G      +  + ++L      A GL  L
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYL 155

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET-----LCGSPLYMAP 182
               +IHRD+K  N+LL  D++    KI DFG ++        +T     + G+  Y+ P
Sbjct: 156 HTRAIIHRDVKSINILL--DENFVP-KITDFGISK-KGTEL-DQTHLSTVVKGTLGYIDP 210

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTP 212
           E     +   K+D++S G +LF+++  ++ 
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.8 bits (188), Expect = 2e-15
 Identities = 53/255 (20%), Positives = 78/255 (30%), Gaps = 66/255 (25%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG---RLNKKLQ---ESLMSEIFILK 66
                 +IG G F  V+        T VA+K IA+     +N   Q   E ++ EI I K
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 67  RI---------NHPHIIRLHDIIEVPGK------------------------------LH 87
            +              I L+ +  V G                               L 
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 88  LILEYCKGG-DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLC 145
           ++LE+  GG DL     +       TAK  + QL A L V   +    HRDL   N+LL 
Sbjct: 139 IVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL- 195

Query: 146 TDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQ 205
                +  K+      +S          CG         + +  Y           +   
Sbjct: 196 --KKTSLKKLHYTLNGKSSTI-----PSCGL-------QVSIIDYTLSRLERDGIVVFCD 241

Query: 206 LVTGKTPFTGSNQIQ 220
           +   +  FTG    Q
Sbjct: 242 VSMDEDLFTGDGDYQ 256

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 55/308 (17%), Positives = 110/308 (35%), Gaps = 44/308 (14%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
            V  ++ VG++IG G+F  +   ++      VA+K   +  +  +    L  E    K++
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAP-QLHLEYRFYKQL 61

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQV 126
            +   I +++          ++LE   G  L             +T      QL + ++ 
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKI--ADFGFA------RSLQPRGLAET--LCGS 176
           +   NLI+RD+KP+N L+    +     I   DF  A       + +     E   L G+
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

Query: 177 PLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD 236
             YM+      ++   + DL ++G +    + G  P+ G     L +   K  +      
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD------ 234

Query: 237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNH----PFLSQTQPD-----QVFRSRMFSR 287
               +   + LC+      P        +  +     F    +PD     ++F      +
Sbjct: 235 -TKRATPIEVLCENF----P----EMATYLRYVRRLDF--FEKPDYDYLRKLFTDLFDRK 283

Query: 288 S-ADDFPF 294
               D+ +
Sbjct: 284 GYMFDYEY 291

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 87/491 (17%), Positives = 159/491 (32%), Gaps = 49/491 (9%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           RV   + +GR+IGSGSF  ++   +     EVA+K   +    K     L+ E  I + +
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKIYRIL 59

Query: 69  N-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQV 126
                I  +           L+++   G  L          +  +T      Q+   ++ 
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA------RSLQPRGLAET--LCGSPL 178
           +   + +HRD+KP N L+        + I DFG A       + Q     E   L G+  
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           Y +       +   + DL S+G +L   + G  P+ G       Q   K +E       K
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-------K 231

Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNH----PFLSQTQPDQVFRSRMFSRSA----- 289
            ++   + LC+      P E   F  +F++     F    +PD  +  R+F         
Sbjct: 232 KVATSIEALCRGY----PTE---FASYFHYCRSLRF--DDKPDYSYLKRLFRDLFIREGF 282

Query: 290 -DDFPFY-ESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSKRRSSMKSTYGFSVDAK 347
             D+ F       +    +S            S     +    ++    +          
Sbjct: 283 QFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMD 342

Query: 348 HGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKCLDQRLANTRSKVGDSL 407
             R     A      +    + N         +S  N         +R A + S+    +
Sbjct: 343 RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPI 402

Query: 408 DLVDQDYVLVSGPPMDTSSSSTSVSKPTHIPRTSERPLISVPKYTTSSAPVPIIGATNSK 467
           D  +             + +S    + T  P+ S     + PK+++S+     +    S 
Sbjct: 403 DTSEP-------SRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESA 455

Query: 468 ISHIGSLESQS 478
           +  I  L    
Sbjct: 456 LKGIEGLNFDG 466

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 38/242 (15%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ--ESL 58
           +   T         + G ++G G F VV+     V+ T VA+K++A        +  +  
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQF 77

Query: 59  MSEIFILKRINHPHIIRLHDI-IEVPGKLHLILEYCKGGDLSMYI-QRHGCVP------- 109
             EI ++ +  H +++ L     +      L+  Y   G L   +    G  P       
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136

Query: 110 ---EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGFARSLQ 165
              +  A         G+  L +N+ IHRD+K  N+LL  D+   A  KI+DFG AR   
Sbjct: 137 KIAQGAAN--------GINFLHENHHIHRDIKSANILL--DEAFTA--KISDFGLAR-AS 183

Query: 166 PRGLAET-----LCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ 220
            +  A+T     + G+  YMAPE ++  +   K+D++S G +L +++TG        + Q
Sbjct: 184 EKF-AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

Query: 221 LL 222
           LL
Sbjct: 242 LL 243

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 50/334 (14%), Positives = 107/334 (32%), Gaps = 53/334 (15%)

Query: 1   MSQATGRGRVVGD-----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ 55
           +++    G ++ D     + VG  IG G F  ++ A        V      + ++     
Sbjct: 19  LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLAD-MNSSESVGSDAPCVVKVEPSDN 77

Query: 56  ESLMSEIFILKRINHPHIIRLHDIIEVPGKL-------------------HLILEYCKGG 96
             L +E+   +R   P  I+          L                    +I++   G 
Sbjct: 78  GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GS 136

Query: 97  DLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI 155
           DL    + +      +T      ++   L+ + ++  +H D+K  NLLL   + +  + +
Sbjct: 137 DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYL 195

Query: 156 ADFGFARSLQPRGLAE--------TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLV 207
            D+G A    P G+ +           G+  + + +         + DL  +G  + Q +
Sbjct: 196 VDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255

Query: 208 TGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR-RNPVERLTFEEFF 266
           TG  P+  + +        K                  +   ++ +    V+ L + E  
Sbjct: 256 TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTE-- 313

Query: 267 NHPFLSQTQPD-----QVFRSRMFSR-SADDFPF 294
                   +P       +    + +  S DD   
Sbjct: 314 --------KPLYENLRDILLQGLKAIGSKDDGKL 339

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 50/302 (16%), Positives = 108/302 (35%), Gaps = 66/302 (21%)

Query: 8   GRVVGD-----YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEI 62
           G+V+ D     +++G++IGSG F +++ A       + A   +   ++  +    L SE+
Sbjct: 28  GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENGPLFSEL 84

Query: 63  FILKRINHPHII------RLHDIIEVPGKLH--------------LILEYCKGGDLSMYI 102
              +R+     I      +  D + +P   +              +++E   G DL    
Sbjct: 85  KFYQRVAKKDCIKKWIERKQLDYLGIP-LFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142

Query: 103 QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR 162
            ++G   + T      ++   L+ + +N  +H D+K  NLLL   + +  + +AD+G + 
Sbjct: 143 GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201

Query: 163 SLQPRGLAE--------TLCGSPLYMAPEIMQLQKYDA--------KADLWSVGAILFQL 206
              P G  +           G+  + +         DA        ++D+  +G  + + 
Sbjct: 202 RYCPNGNHKQYQENPRKGHNGTIEFTS--------LDAHKGVALSRRSDVEILGYCMLRW 253

Query: 207 VTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFF 266
           + GK P+            V+  + +   +    S                E     +F 
Sbjct: 254 LCGKLPWEQ---NLKDPVAVQTAKTNLLDELP-QSVLKWAPSGSS----CCE---IAQFL 302

Query: 267 NH 268
             
Sbjct: 303 VC 304

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 44/218 (20%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDI 79
           +G G F  V+  R    GT VA+K +   R      +   +E+ ++    H +++RL   
Sbjct: 38  LGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 95

Query: 80  IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE--------------TAKHFMKQLAAGLQ 125
              P +  L+  Y   G ++  +        +              +A+        GL 
Sbjct: 96  CMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSAR--------GLA 145

Query: 126 VLRDN---NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-------LAETLCG 175
            L D+    +IHRD+K  N+LL  D++  A  + DFG A+ L           +  T+  
Sbjct: 146 YLHDHCDPKIIHRDVKAANILL--DEEFEA-VVGDFGLAK-LMDYKDTHVTTAVRGTIG- 200

Query: 176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPF 213
              ++APE +   K   K D++  G +L +L+TG+  F
Sbjct: 201 ---HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 42/310 (13%), Positives = 91/310 (29%), Gaps = 79/310 (25%)

Query: 8   GRVVGD-----YLVGRQIGSGSFSVVWHARHRVHGT--------EVAMK-EIAMGRL--- 50
           G V+ D     + +       +  +++ A      T        + ++K +   GRL   
Sbjct: 33  GTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNE 92

Query: 51  ----NKKLQESLMSEIFILKRINHPHIIRLHD-----------IIEVPGK-LHLILEYCK 94
                +  +   +++   L       I                ++   G+ L   L+   
Sbjct: 93  QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP 152

Query: 95  GGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALK 154
              LS            +      +L   L+ L +N  +H ++  +N+ +  +D +  + 
Sbjct: 153 KHVLSE----------RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-QVT 201

Query: 155 IADFGFARSLQPRGL--------AETLCGSPLYMAPEIMQLQKYDA--------KADLWS 198
           +A +GFA    P G              G   +++         D         ++DL S
Sbjct: 202 LAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS--------MDLHKGCGPSRRSDLQS 253

Query: 199 VGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVE 258
           +G  + + + G  P+T            K   +  P             C     R    
Sbjct: 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF-------VGPC-GHWIRPSET 305

Query: 259 RLTFEEFFNH 268
               +++   
Sbjct: 306 ---LQKYLKV 312

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 2e-08
 Identities = 76/460 (16%), Positives = 137/460 (29%), Gaps = 153/460 (33%)

Query: 35  VHGTEVAM----KEI--AMGRLNKKLQESLMSEIF-I-LKRINHPHIIRLHDIIEVPGKL 86
           + G    +    K        L+ K+Q  +  +IF + LK  N P       ++E+  KL
Sbjct: 155 IDG----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE-----TVLEMLQKL 205

Query: 87  HLILE--YCKGGDLSMYIQRHGCVPEETAKHFM--KQLAAGLQVLRD------------- 129
              ++  +    D S  I+      +   +  +  K     L VL +             
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265

Query: 130 ------------------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL--QPRGL 169
                                 H  L   ++ L T D+  +L        + L  +P+ L
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL-TPDEVKSL------LLKYLDCRPQDL 318

Query: 170 AETLC-GSPLYMA--PEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV 226
              +   +P  ++   E   ++   A  D W        +   K     +  I+   N++
Sbjct: 319 PREVLTTNPRRLSIIAE--SIRDGLATWDNWK------HVNCDKL----TTIIESSLNVL 366

Query: 227 KATELH--------FPPDAKI----LS--------ADCKDLCQKLLRRNPVERLTFEEFF 266
           +  E          FPP A I    LS        +D   +  KL + + VE+   E   
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426

Query: 267 NHP---FLSQTQPDQVFR--SRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSS 321
           + P      + + +  +     +          Y      D      DD +P +LD    
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDH-------YNIPKTFD-----SDDLIPPYLDQ--- 471

Query: 322 GPEGSPSFSKRRSSMKSTYGFSVDAKHGREATSSALNN------LDLRY-GNKLDNTNLR 374
                             Y +S    H +               LD R+   K     +R
Sbjct: 472 ------------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK-----IR 508

Query: 375 HDSYKLSDENLNEPPKCLD--QRLANTRSKVGDSLDLVDQ 412
           HDS        N     L+  Q+L   +  + D+    ++
Sbjct: 509 HDST-----AWNASGSILNTLQQLKFYKPYICDNDPKYER 543

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 3e-08
 Identities = 64/429 (14%), Positives = 127/429 (29%), Gaps = 121/429 (28%)

Query: 55  QESLMSEIFI--LKRINHPHII-RLHDIIEVPGKLHLILEYCKG---GDLSMYIQRHGCV 108
           QE ++ + F+  + RIN+  ++  +      P  +  +    +     D  ++ + +  V
Sbjct: 75  QEEMV-QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN--V 131

Query: 109 PEETAKHFMKQLAAGLQVLRDNN--LIH---------------RDLKPQ----------N 141
                     +L   L  LR     LI                   K Q          N
Sbjct: 132 SRL---QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188

Query: 142 LLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE--------IMQLQKY--- 190
           L  C   +     +        + P   + +   S + +           +++ + Y   
Sbjct: 189 LKNCNSPETVLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 191 ----DAKADLWSVGAI-LFQ-----LVTGKTPFTGSNQIQLLQNIVKATELH-------- 232
                   ++ +  A   F      L+T       +   Q+   +  AT  H        
Sbjct: 247 LLVLL---NVQNAKAWNAFNLSCKILLT-------TRFKQVTDFLSAATTTHISLDHHSM 296

Query: 233 -FPPD------AKILSADCKDLCQKLLRRNPV------ERLTFEEFFNHP-FLSQTQPDQ 278
              PD       K L    +DL +++L  NP       E +   +             D+
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--RDGLATWDNWKHVNCDK 354

Query: 279 VFRSRMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPE-------GSPSFSK 331
           +  + +   S +     E + +        D    F     +  P             S 
Sbjct: 355 L--TTIIESSLNVLEPAEYRKM-------FDRLSVF--PPSAHIPTILLSLIWFDVIKSD 403

Query: 332 RRSSMKSTYGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRH----DSYKLSD--ENL 385
               +   + +S+  K  +E+T S + ++ L    KL+N    H    D Y +    ++ 
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTIS-IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 386 NEPPKCLDQ 394
           +  P  LDQ
Sbjct: 463 DLIPPYLDQ 471

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 55/375 (14%), Positives = 111/375 (29%), Gaps = 110/375 (29%)

Query: 214 TGSNQIQL-LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS 272
             + + Q   ++I+   E  F  +      DCKD+ Q + +   +  L+ EE  +H    
Sbjct: 9   FETGEHQYQYKDILSVFEDAFVDNF-----DCKDV-QDMPK--SI--LSKEEI-DHII-- 55

Query: 273 QTQPDQVFRS-RMFSRSADDFPFYESKSVRDVAESSQDDCLPFFLDDDSSGPEGSPSFSK 331
               D V  + R+F                    S Q++ +  F+++             
Sbjct: 56  -MSKDAVSGTLRLF----------------WTLLSKQEEMVQKFVEE------------- 85

Query: 332 RRSSMKSTYGFSVDAKHGREATSSALNNLDLRYGNKLDNTNLRHDSYKLSDENLNEPPKC 391
               ++  Y F +      +   S +  + +   ++L N N     Y +S     +P   
Sbjct: 86  ---VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL---QPYLK 139

Query: 392 LDQRLANTRSKVGDSLDLVDQDYVLVSGPPMDTSSSST---SVSKPTHIPRTSERPL--I 446
           L Q L          L+L     VL+ G  +  S  +     V     +    +  +  +
Sbjct: 140 LRQAL----------LELRPAKNVLIDG--VLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 447 SVPKYTTSSAPVPIIGATNSKISHIGSLESQSSAPGTSLGSTDMGDALEQPSTHCMTRIK 506
           ++    +            + +  +  L  Q     TS    D    ++         ++
Sbjct: 188 NLKNCNS----------PETVLEMLQKLLYQIDPNWTSRS--DHSSNIKLRIHSIQAELR 235

Query: 507 SL------KRCACAITEL-----VNEKIVAGKHLEGFSIQLVILAIWKQALHICHTQAAS 555
            L      + C      L     V       K    F++   IL           T+   
Sbjct: 236 RLLKSKPYENC------LLVLLNVQNA----KAWNAFNLSCKILLT---------TRFKQ 276

Query: 556 AMDGSPSGESTRLRS 570
             D   +  +T +  
Sbjct: 277 VTDFLSAATTTHISL 291

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	575
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.61
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.21
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.1
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.93
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.92
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.6
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.4
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.15
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.09
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.33
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.4
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.61

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.2e-63  Score=516.28  Aligned_cols=266  Identities=31%  Similarity=0.572  Sum_probs=242.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|+++++||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|+.|+|||||+++++|++.+.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45678999999999999999999999999999999998754322 23467899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||||+||+|.+++.+.+.++|..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence            999999999999999999999999999999999999999999999999999999999   77889999999999877432


Q ss_pred             ---CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 ---GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ---~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                         ....++|||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++.+|.+. ...+|.   .+++++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~p~---~~s~~~  261 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-EYDFPE---KFFPKA  261 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCT---TCCHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCc---ccCHHH
Confidence               3456789999999999999999999999999999999999999999999999999988876 345554   589999


Q ss_pred             HHHHHHhhccCCCCCCCHHH------HHcCCCCCCCCchhhhh
Q 043425          245 KDLCQKLLRRNPVERLTFEE------FFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~e------iL~Hpff~~~~~~~~~~  281 (575)
                      ++||++||.+||.+|||++|      |++||||+.++|+.+.+
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  304 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence            99999999999999999987      68999999999988764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-62  Score=499.23  Aligned_cols=261  Identities=33%  Similarity=0.631  Sum_probs=215.9

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      +.|..+|+|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|+.++||||+++++++++.+
T Consensus         7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A            7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            44788999999999999999999999999999999999998765543 33567899999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+||||||| +|+|.+++.+++.+++..++.+++||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+..
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC---
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeec
Confidence            999999999 78999999999999999999999999999999999999999999999999   77789999999999987


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      .......+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+...+++.+.+.. ..+|.   .++++
T Consensus       163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~---~~s~~  238 (275)
T 3hyh_A          163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPK---FLSPG  238 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCT---TSCHH
T ss_pred             CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCC---CCCHH
Confidence            77777778999999999999998887 578999999999999999999999999988888887663 34443   58999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +++||++||++||.+|||++|+++||||+..
T Consensus       239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999999999999999754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.6e-62  Score=513.46  Aligned_cols=258  Identities=29%  Similarity=0.597  Sum_probs=231.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++.+.....+..+.+.+|+.+|++|+|||||+++++|++++.+|||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            45789999999999999999999999999999999998888887788899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+||+|.++|...  ..++|..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            9999999999999754  357999999999999999999999999999999999999   77789999999999876543


Q ss_pred             -CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ....+.|||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++.++.+...   ++....++.++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF---PPVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---CCCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCCccCCHHHHH
Confidence             234568999999999999999999999999999999999999999999999999998887653   3333468999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||.+||.+||.+|||++|+|+||||++
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            999999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.5e-61  Score=505.82  Aligned_cols=259  Identities=27%  Similarity=0.509  Sum_probs=234.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ...|+++++||+|+||.||+|+++.+|+.||||++++.....  .+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            456999999999999999999999999999999998654332  345889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+... ..
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCc
Confidence            99999999999975 579999999999999999999999999999999999999   77789999999999877543 45


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ..+.|||+.|||||++.+.+|+.++|||||||+||+|++|++||.+.+..+.+..+....... ......+++++++||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-CCccccCCHHHHHHHH
Confidence            678999999999999999999999999999999999999999999999999888887654333 2334578999999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +||.+||.+|||++|+|+||||++..+
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.1e-62  Score=504.29  Aligned_cols=266  Identities=33%  Similarity=0.586  Sum_probs=233.5

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ++|+++++||+|+||+||+|++.   .+++.||||++.+..........+.+|+.+|++++|||||+++++|++++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999984   468899999998765443334467889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-C
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-R  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~  167 (575)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.... .
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccCCC
Confidence            99999999999999999999999999999999999999999999999999999999   7788999999999986543 4


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....+.|||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++..+.+.. ..+|.   .+++++++|
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~---~~s~~~~~l  256 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQ---FLSPEAQSL  256 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCT---TSCHHHHHH
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCC---cCCHHHHHH
Confidence            45667899999999999999999999999999999999999999999999999998888763 34443   589999999


Q ss_pred             HHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcc
Q 043425          248 CQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       248 I~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      |++||++||.+|||     ++|+++||||+.++|+.+..+..
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~  298 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI  298 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCC
Confidence            99999999999998     58999999999999988776543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-60  Score=486.14  Aligned_cols=256  Identities=27%  Similarity=0.512  Sum_probs=222.9

Q ss_pred             cCE-EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEE
Q 043425           12 GDY-LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKL   86 (575)
Q Consensus        12 ~~Y-~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l   86 (575)
                      ++| ++.++||+|+||+||+|.++.+|..||+|++..........+.+.+|+.+|++|+|||||+++++|++    .+.+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            455 78889999999999999999999999999999887777777889999999999999999999999865    3568


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  ||||||||+|||+.  +.++.+||+|||+|+..
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeC
Confidence            999999999999999999999999999999999999999999998  99999999999992  24678999999999754


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCChhcccHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      . .....+.||||.|||||++. ++|+.++|||||||+||+|++|++||.+..... +...+.....  .+......+++
T Consensus       183 ~-~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  258 (290)
T 3fpq_A          183 R-ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPE  258 (290)
T ss_dssp             C-TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHH
T ss_pred             C-CCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHH
Confidence            3 44566789999999999986 469999999999999999999999998765544 4444433321  11222457889


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +++||.+||.+||.+|||++|+|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-59  Score=506.71  Aligned_cols=260  Identities=27%  Similarity=0.510  Sum_probs=234.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      -...|+++++||+|+||.||+|+++.+|+.||||++.......  .+.+.+|+.+|+.++|||||+++++|++.+.+|||
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            3467999999999999999999999999999999998754332  35688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+... .
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc
Confidence            999999999999975 579999999999999999999999999999999999999   77789999999999877543 4


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ...+.|||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.......+ .....+++++++||
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~dli  381 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKVSPSLKGFL  381 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSSCHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-cccccCCHHHHHHH
Confidence            56788999999999999999999999999999999999999999999999998888876643332 23356899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      .+||.+||.+|||++|+|+||||++..+
T Consensus       382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            9999999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.7e-59  Score=489.56  Aligned_cols=254  Identities=26%  Similarity=0.450  Sum_probs=223.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .++.|++.++||+|+||.||+|+++.+|+.||||+++++...       .+|+.+|+.++|||||+++++|++++.+|||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356799999999999999999999999999999999875432       4699999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC-cEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~~~~~~  168 (575)
                      ||||+||+|.+++++.+.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++ .+||+|||+|+.+....
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999999999999999999999999999999999999999999999   5555 69999999998775433


Q ss_pred             C------cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          169 L------AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       169 ~------~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      .      ...+|||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++.++..... .+......+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-PIREIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-GGGGSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-CchhcCccCCH
Confidence            2      2347899999999999999999999999999999999999999999888777777776532 22222346899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHH-------------HcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEF-------------FNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~ei-------------L~Hpff~~~  274 (575)
                      ++++||.+||.+||.+|||+.|+             ++|||+.+.
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999999998             578998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.6e-58  Score=473.39  Aligned_cols=260  Identities=25%  Similarity=0.479  Sum_probs=212.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      |+.+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|...+   
T Consensus         1 GR~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             CHHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             CCcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            677889999999999999999999999999999999997654 3455677999999999999999999999986544   


Q ss_pred             ---------EEEEEEeecCCCCHHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc
Q 043425           85 ---------KLHLILEYCKGGDLSMYIQRHGCV---PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA  152 (575)
Q Consensus        85 ---------~l~LVmEy~~GgsL~~~l~~~~~l---se~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~  152 (575)
                               .+|||||||+||+|.+++...+.+   ++..++.++.||+.||+|||++|||||||||+|||+   +.++.
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~  156 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDV  156 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCc
Confidence                     479999999999999999876543   456789999999999999999999999999999999   67789


Q ss_pred             EEEcccccccccCCCC-------------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH
Q 043425          153 LKIADFGFARSLQPRG-------------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI  219 (575)
Q Consensus       153 vKL~DFGla~~~~~~~-------------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~  219 (575)
                      +||+|||+|+.+....             ...+.|||+.|||||++.+..|+.++|||||||+||||++   ||.+..  
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--  231 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--  231 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence            9999999998765432             2235689999999999999999999999999999999996   786532  


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +....+.......+|+.....++++.+||++||++||.+|||+.|+++||||+..++
T Consensus       232 ~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            223333333344566655667788999999999999999999999999999988754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-57  Score=484.23  Aligned_cols=261  Identities=32%  Similarity=0.506  Sum_probs=228.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------PG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------~~   84 (575)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.|+|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999998776666667788999999999999999999999754      36


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+|||||||+ |+|.+++.+++.+++..++.|++||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceeeec
Confidence            7999999995 6899999988999999999999999999999999999999999999999   77889999999999876


Q ss_pred             CC-----CCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC----
Q 043425          165 QP-----RGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP----  234 (575)
Q Consensus       165 ~~-----~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p----  234 (575)
                      ..     .....+.|||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.+.......    
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            43     2345678999999999998875 5699999999999999999999999999999998888764322110    


Q ss_pred             ---------------C----C----hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          235 ---------------P----D----AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       235 ---------------~----~----~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                     .    .    .+.+++++++||.+||.+||.+|||++|+|+||||++..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                           0    0    124688999999999999999999999999999998753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.6e-56  Score=500.84  Aligned_cols=271  Identities=28%  Similarity=0.492  Sum_probs=233.7

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH-HHHHH---HHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESL---MSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~-~~~~i---~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ...+++|+++++||+|+||.||+|+++.+|+.||||++.+..+... ....+   ..++.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            3467899999999999999999999999999999999986543221 11223   3445667778999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+   +.+|++||+|||+|+.
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD  341 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence            9999999999999999999999999999999999999999999999999999999999999   7889999999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHh-hccCCcccccchhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhccCCCCCChhc
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQ-LQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~-~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      +... ...+.||||.|||||++. +..|+.++|||||||+||+|++|.+||.+.+   ..++...+... ...+|.   .
T Consensus       342 ~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~---~  416 (689)
T 3v5w_A          342 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPD---S  416 (689)
T ss_dssp             CSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCT---T
T ss_pred             cCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCc---c
Confidence            6543 356789999999999996 4689999999999999999999999997643   33444444443 444443   5


Q ss_pred             ccHHHHHHHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcccC
Q 043425          240 LSADCKDLCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      +++++++||.+||++||.+|++     ++||++||||+.++|+.+....+.+
T Consensus       417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~p  468 (689)
T 3v5w_A          417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP  468 (689)
T ss_dssp             SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCC
T ss_pred             CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCc
Confidence            8999999999999999999998     7999999999999999988765544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.5e-56  Score=495.85  Aligned_cols=266  Identities=29%  Similarity=0.536  Sum_probs=240.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.++++|+++++||+|+||.||+|+++.+|+.||||++....  ....+.+.+|+.+|+.|+||||++++++|++.+.+|
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            456789999999999999999999999999999999997653  344567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||||+||+|.++|.+ .+.+++..++.+++||+.||+|||++||+||||||+|||+..+ ..+.+||+|||+|+.+..
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECCT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEccC
Confidence            99999999999999964 4689999999999999999999999999999999999999432 347899999999999888


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .....+.|||+.|||||++.+.+|+.++|||||||+||+|++|.+||.+.+..+.+..+.+......+..+..++.++++
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            77778899999999999999999999999999999999999999999999999999888776433223334678999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ||++||.+||.+|||++|+|+||||+...+
T Consensus       390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            999999999999999999999999987644

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.4e-55  Score=463.07  Aligned_cols=257  Identities=22%  Similarity=0.396  Sum_probs=212.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG   84 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~   84 (575)
                      .+.++|+++++||+|+||+||+|+++   .+++.||||++.....    ..++.+|+.+|+.+ +||||++++++|++.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            34578999999999999999999986   3688999999865432    34578999999998 6999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+|||||||+||+|.+++.   .+++..++.+++||+.||+|||++||+||||||+|||+.  .+.+.+||+|||+|+..
T Consensus        94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCccc
Confidence            9999999999999999983   599999999999999999999999999999999999993  23478999999999765


Q ss_pred             CCC-----------------------------CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCC
Q 043425          165 QPR-----------------------------GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       165 ~~~-----------------------------~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~  214 (575)
                      ...                             ....+.|||+.|||||++.+. .|+.++||||+||++|+|++|++||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            332                             123456899999999999875 58999999999999999999999995


Q ss_pred             C-CCHHHHHHHHHHhcc-------------------------------------CCC-------------CCChhcccHH
Q 043425          215 G-SNQIQLLQNIVKATE-------------------------------------LHF-------------PPDAKILSAD  243 (575)
Q Consensus       215 ~-~~~~~~l~~i~~~~~-------------------------------------~~~-------------p~~~~~ls~e  243 (575)
                      . .+..+.+..|.+...                                     ...             ...+..++++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            4 455555555443100                                     000             0112357899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++|||++||++||.+|||++|+|+||||+++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.7e-55  Score=451.06  Aligned_cols=249  Identities=24%  Similarity=0.462  Sum_probs=219.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..+|.+.++||+|+||.||+|++.     .+|..||||+++..  ..+..+.+.+|+.+|++++|||||++++++.+++.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            357999999999999999999875     36889999999754  45566789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA  152 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~  152 (575)
                      +|||||||+||+|.++|...             ..+++..+..++.||+.||+|||+++||||||||+|||+   +.++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCc
Confidence            99999999999999999764             369999999999999999999999999999999999999   77789


Q ss_pred             EEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 043425          153 LKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA  228 (575)
Q Consensus       153 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~  228 (575)
                      +||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+.++
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987644332   234579999999999999999999999999999999998 99999999999999988887


Q ss_pred             ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       229 ~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....|.   .+++++.+||.+||+.||.+|||++|+..
T Consensus       247 ~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~~i~~  282 (299)
T 4asz_A          247 RVLQRPR---TCPQEVYELMLGCWQREPHMRKNIKGIHT  282 (299)
T ss_dssp             CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6555443   57899999999999999999999999943

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=452.03  Aligned_cols=250  Identities=24%  Similarity=0.455  Sum_probs=216.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..+|.+.++||+|+||.||+|+++     .+++.||||+++..  .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            357999999999999999999865     36899999999754  45566789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRH---------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN  150 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~---------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~  150 (575)
                      +|||||||+||+|.+++.+.               +++++..+..|+.||+.||+|||+++||||||||+|||+   +.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CCC
Confidence            99999999999999999753               358999999999999999999999999999999999999   777


Q ss_pred             CcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 043425          151 AALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIV  226 (575)
Q Consensus       151 g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~  226 (575)
                      +.+||+|||+++......   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            899999999998764432   2345789999999999999999999999999999999998 999999999999998888


Q ss_pred             HhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       227 ~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++..+..|.   .+++++.+||.+||++||++|||++||+++
T Consensus       275 ~g~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          275 QGRELERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HTCCCCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cCCCCCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            876555554   578999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-54  Score=445.96  Aligned_cols=251  Identities=24%  Similarity=0.435  Sum_probs=210.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .+++.++++||+|+||+||+|+++   ..||||+++......+..+.+.+|+.+|++++|||||++++++. .+.+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence            356789999999999999999865   35999999877667777788999999999999999999999875 45689999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC---
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---  166 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~---  166 (575)
                      |||+||+|.+++... +.+++..+..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....   
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCc
Confidence            999999999999764 579999999999999999999999999999999999999   6778999999999986543   


Q ss_pred             CCCcccccCCCCCCChHHHhh---ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--CCCCCChhccc
Q 043425          167 RGLAETLCGSPLYMAPEIMQL---QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--LHFPPDAKILS  241 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~---~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~--~~~p~~~~~ls  241 (575)
                      .....+.+||+.|||||++..   ..|+.++|||||||+||||++|+.||.+.+....+..++....  +..+.....++
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence            223456799999999999974   3589999999999999999999999998776665555444321  12233345688


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++.+||.+||.+||.+|||+.|++++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999988653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.6e-54  Score=446.03  Aligned_cols=252  Identities=23%  Similarity=0.431  Sum_probs=221.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ...+++++++||+|+||+||+|...     .+++.||||++.... .....+.+.+|+.+|++++|||||++++++..++
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            4567999999999999999999863     467899999997543 3344567999999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC
Q 043425           85 KLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD  148 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd  148 (575)
                      .++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||+   +
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence            999999999999999999653                358999999999999999999999999999999999999   7


Q ss_pred             CCCcEEEcccccccccCCC---CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 043425          149 DNAALKIADFGFARSLQPR---GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQN  224 (575)
Q Consensus       149 ~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~  224 (575)
                      +++.+||+|||+++.+...   ......+||+.|||||++....|+.++|||||||+||||+| |..||.+.+..+++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            7789999999999876433   23456789999999999999999999999999999999998 8999999999999888


Q ss_pred             HHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       225 i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +..+.....|   ..++.++.+|+.+||+.||.+|||+.||+++
T Consensus       260 i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8776554444   3578999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-52  Score=434.59  Aligned_cols=262  Identities=37%  Similarity=0.702  Sum_probs=241.3

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ....+++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++...+.+
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            45689999999999999999999999999999999999988777777778899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence            9999999999999999988999999999999999999999999999999999999999   7788999999999988777


Q ss_pred             CCCcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..++...+..+. ..+|.   .++.++.
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~---~~s~~~~  242 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIPF---YMSTDCE  242 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCT---TSCHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC---CCCHHHH
Confidence            7777788999999999999988875 78999999999999999999999999988888877663 33333   5789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +||++||..||.+|||++|+++||||+...
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999997643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.8e-52  Score=438.34  Aligned_cols=272  Identities=32%  Similarity=0.567  Sum_probs=240.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~----~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      +.+.+.|++++.||+|+||.||+|.++.+|+.||||++.+......    ..+.+.+|+.+|+.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            5677889999999999999999999999999999999987654221    245688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~  162 (575)
                      +.+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..++ ....+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999999998888999999999999999999999999999999999999994221 12279999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-Chhccc
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILS  241 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-~~~~ls  241 (575)
                      ...........+||+.|+|||++....|+.++|||||||++|+|++|.+||.+.+..+.+..+.... ..++. .+..++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s  246 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS-YDFDEEFFSQTS  246 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-CCCCHHHHTTSC
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCchhccCCC
Confidence            8777666677899999999999999999999999999999999999999999999998888887653 33332 235689


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++++||++||.+||.+|||++|+++||||....+....
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~  285 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM  285 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhh
Confidence            999999999999999999999999999999987765543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.6e-52  Score=435.92  Aligned_cols=270  Identities=30%  Similarity=0.542  Sum_probs=235.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+++|+++++||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|..+++.+ +||||+++++++...+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            457889999999999999999999999999999999986532 222345678999999988 699999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-  165 (575)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++... 
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeeccc
Confidence            9999999999999999998999999999999999999999999999999999999999   778899999999998643 


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......+.|||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..+... ...+|.   .++.++.
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~  252 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPT---WLHEDAT  252 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHHH
T ss_pred             CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCHHHH
Confidence            334456789999999999999999999999999999999999999999999999999888876 344443   4889999


Q ss_pred             HHHHHhhccCCCCCCCH------HHHHcCCCCCCCCchhhhhhccc
Q 043425          246 DLCQKLLRRNPVERLTF------EEFFNHPFLSQTQPDQVFRSRMF  285 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa------~eiL~Hpff~~~~~~~~~~~~~~  285 (575)
                      +||++||.+||.+||++      +|+++||||..++|+.+......
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~  298 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIE  298 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCC
Confidence            99999999999999998      89999999999999887765443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-51  Score=431.71  Aligned_cols=270  Identities=27%  Similarity=0.559  Sum_probs=241.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            46799999999999999999999999999999999976432 11224568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC-CC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-PR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~~  167 (575)
                      ||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ..
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence            99999999999999988899999999999999999999999999999999999999   778899999999998643 33


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+...+...+... ...+|.   .++.++++|
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~~~~l  235 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPR---TLSPEAKSL  235 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCHHHHHH
Confidence            4556789999999999999999999999999999999999999999999988888877765 344443   589999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcccC
Q 043425          248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       248 I~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      |++||.+||.+||     +++|+++||||..+.|+.+......+
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~p  279 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP  279 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCC
Confidence            9999999999999     89999999999999998887655443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-51  Score=433.73  Aligned_cols=265  Identities=30%  Similarity=0.537  Sum_probs=241.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.++|++.+.||+|+||.||+|.++.+|..||+|++..........+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999999999999999999877777777789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++.......
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            99999999999999888889999999999999999999999999999999999999655556789999999998877666


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.......+..+......+.+..++.++++||
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  265 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI  265 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            66678999999999999999999999999999999999999999999998888888777643333334467899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .+||.+||.+|||++|+++||||..
T Consensus       266 ~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          266 DSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999964

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.1e-52  Score=439.22  Aligned_cols=250  Identities=28%  Similarity=0.477  Sum_probs=214.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC-----CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEe-CC
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH-----GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHIIRLHDIIEV-PG   84 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~~~~~-~~   84 (575)
                      ++|+++++||+|+||.||+|.+..+     ++.||||.+.... .....+.+.+|+.+|.++.| ||||+++++|.. ++
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            6799999999999999999997653     4689999997644 34445679999999999976 899999999865 45


Q ss_pred             EEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC
Q 043425           85 KLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD  148 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd  148 (575)
                      .+|||||||+||+|.++|+..                ..+++..+..++.||+.||+|||+++||||||||+|||+   +
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---C
Confidence            799999999999999999753                348999999999999999999999999999999999999   7


Q ss_pred             CCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH-HHHH
Q 043425          149 DNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI-QLLQ  223 (575)
Q Consensus       149 ~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~-~~l~  223 (575)
                      .++.+||+|||+|+.+....   ...+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+.. .+..
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~  299 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  299 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            77899999999998765433   2345789999999999999999999999999999999998 99999987644 4444


Q ss_pred             HHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          224 NIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       224 ~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+..+..+..|.   ..++++.+||.+||+.||.+|||+.||++|
T Consensus       300 ~i~~g~~~~~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          300 RLKEGTRMRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555554444443   578999999999999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5e-51  Score=442.93  Aligned_cols=267  Identities=32%  Similarity=0.530  Sum_probs=240.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++.++|+++++||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            45677889999999999999999999999999999999998777666677899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+...+.+||+|||++.....
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999999999999999999999999999999999999999999999999999996555678999999999987654


Q ss_pred             CC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .. .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+....+..+..+......+.+..++++++
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            33 34567899999999999999999999999999999999999999999999998888887754433444467899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +||.+||.+||.+|||+.|+|+||||+.
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            9999999999999999999999999964

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-51  Score=421.87  Aligned_cols=267  Identities=33%  Similarity=0.643  Sum_probs=240.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            35689999999999999999999999999999999997643211 22356789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.... 
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS-
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC-
Confidence            999999999999999998899999999999999999999999999999999999999   7788999999999987543 


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+... ...+|.   .++.++++|
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~~l  233 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPP---FFNEDVKDL  233 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCCCT---TSCHHHHHH
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCC---CCCHHHHHH
Confidence             345679999999999999999999999999999999999999999999998888888776 344443   578999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       248 I~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      |++||.+||.+||     +++|+++||||+.+.|+.+.....
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~  275 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI  275 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCC
Confidence            9999999999999     899999999999999988776443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.9e-51  Score=435.00  Aligned_cols=271  Identities=29%  Similarity=0.579  Sum_probs=235.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+++|+++++||+|+||.||+|+++.+|+.||||++.+..... ...+.+.+|..+|.++ +||||++++++|.+.+.+
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            45678999999999999999999999999999999998765433 3335678999999876 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc-cC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS-LQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~-~~  165 (575)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++. ..
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeeccc
Confidence            9999999999999999998999999999999999999999999999999999999999   7788999999999986 34


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC---------CHHHHHHHHHHhccCCCCCC
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS---------NQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~---------~~~~~l~~i~~~~~~~~p~~  236 (575)
                      ......+.|||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.         ....+...+... ...+|. 
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~-  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR-  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCT-
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCC-
Confidence            445567789999999999999999999999999999999999999999643         222334444433 445554 


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCH------HHHHcCCCCCCCCchhhhhhcccC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTF------EEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa------~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                        .++.++++||++||++||.+||++      +|+++||||+.++|+.+......+
T Consensus       284 --~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~p  337 (396)
T 4dc2_A          284 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP  337 (396)
T ss_dssp             --TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCC
T ss_pred             --cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCC
Confidence              489999999999999999999984      899999999999999887655443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.8e-51  Score=438.25  Aligned_cols=270  Identities=30%  Similarity=0.479  Sum_probs=236.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|+++++||+|+||.||+|+++.+|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            4678999999999999999999999999999999997532111 112347799999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||||+||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++......
T Consensus       147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTS
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccCC
Confidence            9999999999999975 469999999999999999999999999999999999999   788899999999998765544


Q ss_pred             --CcccccCCCCCCChHHHhhcc----CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhccc
Q 043425          169 --LAETLCGSPLYMAPEIMQLQK----YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILS  241 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~----y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls  241 (575)
                        ...+.+||+.|+|||++....    |+.++|||||||++|+|++|.+||.+.+....+..+.+.. ...+|. ...++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s  301 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDIS  301 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-TCCCC
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC-ccccc
Confidence              245789999999999998765    8889999999999999999999999999999998888754 334443 34689


Q ss_pred             HHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCchhhhhhcc
Q 043425          242 ADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      .++++||++||+.+|.+  |++++||++||||+.++|+.......
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~  346 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT  346 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhccc
Confidence            99999999999999988  99999999999999998876655443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-50  Score=421.66  Aligned_cols=270  Identities=29%  Similarity=0.569  Sum_probs=236.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            457899999999999999999999999999999999987654 344556788999999987 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-C
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-Q  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~  165 (575)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.. .
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccC
Confidence            9999999999999999988899999999999999999999999999999999999999   77889999999999864 3


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC---------CHHHHHHHHHHhccCCCCCC
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS---------NQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~---------~~~~~l~~i~~~~~~~~p~~  236 (575)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...         ....+...+... ...+|. 
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~-  240 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR-  240 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCT-
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCC-
Confidence            344556789999999999999999999999999999999999999999752         233344444443 444443 


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCH------HHHHcCCCCCCCCchhhhhhccc
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTF------EEFFNHPFLSQTQPDQVFRSRMF  285 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa------~eiL~Hpff~~~~~~~~~~~~~~  285 (575)
                        .++.++++||++||++||.+||++      +|+++||||..+.|+.+......
T Consensus       241 --~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~  293 (345)
T 3a8x_A          241 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV  293 (345)
T ss_dssp             --TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             --CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence              589999999999999999999985      89999999999999887665443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.1e-51  Score=427.92  Aligned_cols=272  Identities=28%  Similarity=0.514  Sum_probs=240.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ...+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+..|..++..+ +||||++++++++..+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            35678999999999999999999999999999999999864321 12245678999999887 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence            99999999999999999988899999999999999999999999999999999999999   778899999999998643


Q ss_pred             -CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 -PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 -~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                       ........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++..+... ...+|.   .++.++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~~  248 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPK---SMSKEA  248 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-CCCCCC---CCCHHH
Confidence             334456789999999999999999999999999999999999999999999999988888775 344443   589999


Q ss_pred             HHHHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcccC
Q 043425          245 KDLCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      ++||++||.+||.+||+     ++++++||||..++|+.+......+
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~  295 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP  295 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCC
Confidence            99999999999999994     7999999999999999887655443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.4e-51  Score=440.92  Aligned_cols=268  Identities=27%  Similarity=0.497  Sum_probs=237.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|+++++||+|+||.||+|+++.+|+.||||++.+..... .....+.+|+.++..++||||++++++|.+.+.+|+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            3578999999999999999999999999999999997532211 112337899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence            9999999999999987 4789999999999999999999999999999999999999   77889999999999876544


Q ss_pred             CC--cccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhc
Q 043425          168 GL--AETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKI  239 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~  239 (575)
                      ..  ....+||+.|+|||++.     ...|+.++|||||||++|+|++|++||.+.+..+.+..+.... ...+|.....
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            33  34478999999999997     4578999999999999999999999999999999888887643 4566666567


Q ss_pred             ccHHHHHHHHHhhccCCCC--CCCHHHHHcCCCCCCCCchhhh
Q 043425          240 LSADCKDLCQKLLRRNPVE--RLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~--RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      +++++++||++||+.+|.+  |++++|+++||||+.++|+.+.
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence            8999999999999998888  9999999999999999998873

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.2e-50  Score=405.00  Aligned_cols=266  Identities=30%  Similarity=0.535  Sum_probs=242.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.++|++.++||+|+||.||+|.++.+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            35678999999999999999999999999999999998877777777889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++.......
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            99999999999999988899999999999999999999999999999999999999665566679999999998877666


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.........+....+++++.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI  242 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence            66678899999999999999999999999999999999999999999998888887776644333333457899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+||..||.+|||++|+++||||...
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          243 DSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHcccChhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=419.82  Aligned_cols=272  Identities=32%  Similarity=0.565  Sum_probs=238.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ..+.+.|.+.+.||+|+||.||+|.++.+|..||||++.......    ...+.+.+|+.+|+.++||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            456678999999999999999999999999999999998754322    1246688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~  162 (575)
                      +.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999999998888899999999999999999999999999999999999994322 22379999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-Chhccc
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILS  241 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-~~~~ls  241 (575)
                      ...........+||+.|+|||++....|+.++|||||||++|+|++|..||.+.+..+.+..+..... .++. ....++
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFEDEYFSNTS  245 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-CCCHHHHTTSC
T ss_pred             ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-CcCccccccCC
Confidence            87666666678899999999999999999999999999999999999999999998888877766532 2222 224678


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++++||++||..||.+|||++|+++||||.........
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~  284 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL  284 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchhhh
Confidence            999999999999999999999999999999887655433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.5e-51  Score=427.76  Aligned_cols=270  Identities=30%  Similarity=0.541  Sum_probs=238.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ...+++|.+.+.||+|+||.||+|+++.+|+.||||++.+.... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45788999999999999999999999999999999999764321 12235578899999876 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence            99999999999999999988899999999999999999999999999999999999999   777899999999998643


Q ss_pred             -CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 -PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 -~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                       ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+++..+.... ..+|.   .++.++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~---~~s~~~  245 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPR---WLEKEA  245 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCT---TSCHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCc---ccCHHH
Confidence             2334567899999999999999999999999999999999999999999999988888877653 33443   589999


Q ss_pred             HHHHHHhhccCCCCCCCHH-HHHcCCCCCCCCchhhhhhcc
Q 043425          245 KDLCQKLLRRNPVERLTFE-EFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~-eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      ++||++||..||.+||++. ++++||||..++|+.+.....
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~  286 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI  286 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCC
Confidence            9999999999999999998 999999999999988766443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-50  Score=424.87  Aligned_cols=269  Identities=29%  Similarity=0.560  Sum_probs=242.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ...+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            45788999999999999999999999999999999999764321 12245688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence            9999999999999999988899999999999999999999999999999999999999   7788999999999987644


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .  ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+... ...+|.   .++.++.+
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~~  267 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPS---HFSSDLKD  267 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TCCHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCC---CCCHHHHH
Confidence            3  34678999999999999999999999999999999999999999999998888888776 344443   57999999


Q ss_pred             HHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhccc
Q 043425          247 LCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMF  285 (575)
Q Consensus       247 LI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~  285 (575)
                      ||++||+.||.+||+     ++|+++||||...+|+.+......
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~  311 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE  311 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCC
Confidence            999999999999998     999999999999999887765443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-51  Score=421.80  Aligned_cols=262  Identities=27%  Similarity=0.466  Sum_probs=234.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.++|.+++.||+|+||.||+|.+..+|..||+|++...   ......+.+|+.+++.++||||+++++++...+.+++
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            3567899999999999999999999999999999998753   3345668899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+..+ ..+.+||+|||++..+...
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCC
Confidence            999999999999997653 79999999999999999999999999999999999999421 2678999999999988766


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...........+..++.++++|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  237 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence            66677889999999999999889999999999999999999999999999998888887764332222235689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |++||..||.+|||+.|+++||||.+.
T Consensus       238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          238 VDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999999763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-50  Score=426.46  Aligned_cols=272  Identities=31%  Similarity=0.581  Sum_probs=235.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFI-LKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~i-L~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ....++|++++.||+|+||.||+|+++.++..||||++.+..... .....+..|..+ ++.++||||+++++++...+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            356789999999999999999999999999999999998765433 334556778777 577899999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-  164 (575)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.. 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999   77889999999999864 


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+... ...+++   .++.++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~---~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKP---NITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCS---SSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCC---CCCHHH
Confidence            3344566789999999999999999999999999999999999999999999999988888775 334443   588999


Q ss_pred             HHHHHHhhccCCCCCCCH----HHHHcCCCCCCCCchhhhhhcccC
Q 043425          245 KDLCQKLLRRNPVERLTF----EEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa----~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      ++||++||++||.+||++    +++++||||..++|+.+......+
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~p  312 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP  312 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCC
Confidence            999999999999999986    699999999999999887655443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.9e-50  Score=405.25  Aligned_cols=261  Identities=33%  Similarity=0.571  Sum_probs=223.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|+++++||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            46899999999999999999999999999999999877666666677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           91 EYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        91 Ey~~GgsL~~~l-~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||++| +|.+++ ...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... .
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc
Confidence            99976 555554 446789999999999999999999999999999999999999   77789999999999876533 3


Q ss_pred             CcccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCC-CCCCCHHHHHHHHHHhccCCCCC-----------
Q 043425          169 LAETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVKATELHFPP-----------  235 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~P-F~~~~~~~~l~~i~~~~~~~~p~-----------  235 (575)
                      .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+........           
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            345678999999999998766 89999999999999999987766 66777777777766532211111           


Q ss_pred             --------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          236 --------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       236 --------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                    ....++.++++||++||+.||.+|||++|+++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                          1124788999999999999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.8e-50  Score=408.09  Aligned_cols=263  Identities=28%  Similarity=0.545  Sum_probs=233.1

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|...++|++.++||+|+||.||+|.+..+|+.||||++.......  .+.+.+|+.+++.++||||+++++++...+.+
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            4567788999999999999999999999999999999997654333  35688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence            9999999999999999765 69999999999999999999999999999999999999   6778899999999987654


Q ss_pred             CC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .. .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+.......+ .....++..+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCHHHH
Confidence            33 34567899999999999999999999999999999999999999999988887776665543332 22356899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +||.+||..||.+|||++|+++||||+...+
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.1e-50  Score=440.69  Aligned_cols=268  Identities=31%  Similarity=0.578  Sum_probs=238.6

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|.+.++|+++++||+|+||.||+|.++.+|+.||||++.+..........+.+|+.+|++++||||+++++++...+.+
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            36788999999999999999999999999999999999976543333356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..+..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999998888999999999999999999999999999999999999996666677899999999988776


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........+.+..+++++++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            666677889999999999875 6999999999999999999999999999999988888776543333445678999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ||++||.+||.+|||+.|+|+||||+...
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999997653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=428.26  Aligned_cols=267  Identities=27%  Similarity=0.472  Sum_probs=233.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|+++++||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.++..++||||++++++|++.+.+|+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            457899999999999999999999999999999999764321 1122447899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.....
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccCC
Confidence            999999999999998764 79999999999999999999999999999999999999   77889999999999876554


Q ss_pred             CC--cccccCCCCCCChHHHhh-------ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCCh
Q 043425          168 GL--AETLCGSPLYMAPEIMQL-------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDA  237 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~-------~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~  237 (575)
                      ..  ....+||+.|+|||++..       ..|+.++|||||||++|+|++|++||.+.+..+.+.++.+.. ...+|...
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            33  345799999999999973       568999999999999999999999999999998888887643 34445434


Q ss_pred             hcccHHHHHHHHHhhccCCCCC---CCHHHHHcCCCCCCCCchhhh
Q 043425          238 KILSADCKDLCQKLLRRNPVER---LTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~R---pTa~eiL~Hpff~~~~~~~~~  280 (575)
                      ..++.++++||++||+ +|.+|   ++++|+++||||..++|+.+.
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            5689999999999999 99998   599999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-49  Score=411.47  Aligned_cols=269  Identities=33%  Similarity=0.589  Sum_probs=228.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINHPHIIRLHDIIEV   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~   82 (575)
                      ....++|++++.||+|+||.||+|++.   .+|+.||||++.+....  ......+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            345678999999999999999999985   68999999999875432  2334567899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK  169 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence            99999999999999999999988899999999999999999999999999999999999999   777899999999997


Q ss_pred             ccCC-CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          163 SLQP-RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       163 ~~~~-~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      .... .......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+....+..+.+.. ..+++   .++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~---~~~  245 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPP---YLT  245 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCT---TSC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCC---CCC
Confidence            6432 334556789999999999999999999999999999999999999999999888888877653 33443   578


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhc
Q 043425          242 ADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~  283 (575)
                      .++++||++||..||.+||     +++|+++||||....|+.+....
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~  292 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK  292 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhcc
Confidence            9999999999999999999     89999999999999988776544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-50  Score=421.65  Aligned_cols=263  Identities=34%  Similarity=0.597  Sum_probs=226.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      +.++|++.+.||+|+||.||+|.++.+|+.||||++......   ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            346799999999999999999999999999999999753211   11245688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      |+|||||+|++|.+++.+.    ..+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999999887643    358999999999999999999999999999999999999665556679999999998


Q ss_pred             ccCCCCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          163 SLQPRGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       163 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. ...+..+.+......+..+..++
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence            7765443 456789999999999999999999999999999999999999998854 45566666553322222335689


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .++++||++||.+||.+|||+.|+++||||+.
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            99999999999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.4e-50  Score=414.03  Aligned_cols=270  Identities=29%  Similarity=0.496  Sum_probs=221.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .+..+++|+++++||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+.+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            46788999999999999999999999999999999999987665555566788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC--CCCCcEEEccccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD--DDNAALKIADFGFARSL  164 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d--d~~g~vKL~DFGla~~~  164 (575)
                      ++||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..+  +..+.+||+|||++...
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999997 4999999998899999999999999999999999999999999999999643  34567999999999876


Q ss_pred             CCC-CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh-----
Q 043425          165 QPR-GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-----  237 (575)
Q Consensus       165 ~~~-~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~-----  237 (575)
                      ... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+...........+     
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            432 334556889999999999874 5899999999999999999999999999988888777664322211110     


Q ss_pred             ---------------------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          238 ---------------------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       238 ---------------------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                                           ..++.++.+||++||.+||.+|||++|+++||||+...++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence                                 1267899999999999999999999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.8e-50  Score=425.57  Aligned_cols=272  Identities=27%  Similarity=0.505  Sum_probs=238.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++.+.... ......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34578899999999999999999999999999999999764321 12235688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..+..
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccC
Confidence            9999999999999999988899999999999999999999999999999999999999   7788999999999998877


Q ss_pred             CCCcccccCCCCCCChHHHhh---ccCCcccccchhhHHHHHHHhCCCCCCCC---CHHHHHHHHHHhccCCCCCChhcc
Q 043425          167 RGLAETLCGSPLYMAPEIMQL---QKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~---~~y~~kaDIWSLGviLyeLltG~~PF~~~---~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .......+||+.|+|||++..   ..|+.++|||||||++|+|++|..||.+.   ........+.. ....+|.   .+
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~p~---~~  243 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TVVTYPS---AW  243 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CCCCCCT---TS
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cccCCCC---cC
Confidence            777778999999999999863   46899999999999999999999999754   33334444333 2334443   57


Q ss_pred             cHHHHHHHHHhhccCCCCCCC-HHHHHcCCCCCCCCchhhhhhcccC
Q 043425          241 SADCKDLCQKLLRRNPVERLT-FEEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpT-a~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      +.++.+||++||.+||.+||+ ++++++||||..+.|+.+......+
T Consensus       244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p  290 (384)
T 4fr4_A          244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP  290 (384)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCC
Confidence            899999999999999999998 9999999999999999988766544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-49  Score=430.60  Aligned_cols=268  Identities=26%  Similarity=0.561  Sum_probs=229.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|+++++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            45789999999999999999999999999999999986532 22334567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccC-C
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ-P  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~-~  166 (575)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||+++... .
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccCC
Confidence            99999999999999988899999999999999999999998 999999999999999   677899999999998643 3


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+...+... ...+|.   .+++++.+
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~~~~~~~  378 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPR---TLGPEAKS  378 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCCCc---cCCHHHHH
Confidence            34456789999999999999999999999999999999999999999999988888877665 344443   57899999


Q ss_pred             HHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          247 LCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       247 LI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      ||.+||.+||.+||     +++|+++||||....|+.+.....
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~  421 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKL  421 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcC
Confidence            99999999999999     999999999999999988776443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-49  Score=409.85  Aligned_cols=263  Identities=29%  Similarity=0.537  Sum_probs=221.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.++|+++++||+|+||.||+|++. +|+.||||++............+.+|+.+++.++||||+++++++...+.+++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            57788999999999999999999996 59999999997665444455678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSC
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCC
Confidence            9999975 788887655 459999999999999999999999999999999999999   67788999999999876533


Q ss_pred             -CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC---------
Q 043425          168 -GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD---------  236 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~---------  236 (575)
                       ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+........+..         
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence             33445689999999999976 5689999999999999999999999999887777766655332221111         


Q ss_pred             -----------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          237 -----------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       237 -----------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                                       ...+++++++||++||++||.+|||++|+++||||+...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                             1236789999999999999999999999999999988754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.3e-50  Score=437.55  Aligned_cols=266  Identities=32%  Similarity=0.572  Sum_probs=234.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      +.+.++|+++++||+|+||.||+|+++.+|..||||++.+..........+.+|+.+++.++||||+++++++...+.+|
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45667899999999999999999999999999999999876544444567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..+...
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999999999999988889999999999999999999999999999999999999965555678999999999887766


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+++..+.........+.+..++.++++|
T Consensus       193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL  271 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred             ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence            6667789999999999986 579999999999999999999999999999999988888775444444456789999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |++||.+||.+|||+.|+|+||||+..
T Consensus       272 i~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.9e-49  Score=398.41  Aligned_cols=264  Identities=28%  Similarity=0.507  Sum_probs=235.5

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|.+.++|++.++||+|+||.||+|.+..++..+|+|++.......  .+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            3667788999999999999999999999999999999997654332  45688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999999999999888999999999999999999999999999999999999997777788999999999988777


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..............+++++.+
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          162 GKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             TSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             ccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            777777899999999999875 4899999999999999999999999999988888877765332222222468999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||.+||..||.+|||+.|+++||||++
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            999999999999999999999999964

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-49  Score=401.14  Aligned_cols=263  Identities=29%  Similarity=0.555  Sum_probs=224.9

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |.+.++|.+.++||+|+||.||+|.++.+|..+|+|++...... ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            67889999999999999999999999999999999999875432 22456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +||||++||+|.+++..    ...+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|||++..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999998854    36799999999999999999999999999999999999996656678899999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ..........+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+.... ..++.....++++
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  254 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVECRPLTPQ  254 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCC--CCCCHH
T ss_pred             cCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC-cccccccCcCCHH
Confidence            76666666788999999999986 578999999999999999999999999998887776655442 3333333457899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +.+||++||..||.+|||+.|+++||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3e-49  Score=421.49  Aligned_cols=265  Identities=29%  Similarity=0.525  Sum_probs=236.2

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|.+.++|++++.||+|+||.||+|.++.+|+.||+|++....  ......+.+|+.+|+.++||||+++++++...+.+
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            3667889999999999999999999999999999999997643  33445788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++...
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecC
Confidence            99999999999999987554 7999999999999999999999999999999999999932 234679999999999887


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+........+.....++.+++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            66666677999999999999999999999999999999999999999999998888887776543333333456899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||..||.+|||++|+++||||...
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-49  Score=408.65  Aligned_cols=269  Identities=32%  Similarity=0.569  Sum_probs=237.9

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~----~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++........    ..+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4567789999999999999999999999999999999986543221    245688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC----cEEEcccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA----ALKIADFG  159 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g----~vKL~DFG  159 (575)
                      +.+++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+    .+||+|||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~---~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE---ecCCCCcCCEEEccCc
Confidence            9999999999999999999988889999999999999999999999999999999999999   3444    79999999


Q ss_pred             cccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC-hh
Q 043425          160 FARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-AK  238 (575)
Q Consensus       160 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~-~~  238 (575)
                      ++............+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+..... .++.. ..
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~  243 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-DFDEEFFS  243 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-CCCHHHHT
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-ccChhhhc
Confidence            99887766666677899999999999999999999999999999999999999999998888877765532 22221 24


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++.++.+||++||..||.+|||++|+++||||....+....
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~~  285 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM  285 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccccc
Confidence            678999999999999999999999999999999987765544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-49  Score=402.35  Aligned_cols=266  Identities=28%  Similarity=0.504  Sum_probs=223.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ++++|+++++||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            36789999999999999999999999999999999987766666677889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~  168 (575)
                      |||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence            9999999999999888889999999999999999999999999999999999999   7778999999999987653 33


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------------  232 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------------  232 (575)
                      .....+||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.+....+....+.+.....               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            3456789999999999976 678999999999999999999999999998887766655432111               


Q ss_pred             ---CC--C-------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          233 ---FP--P-------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       233 ---~p--~-------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                         .+  .       ....++.++.+||++||..||.+|||++|+++||||+......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence               00  0       0135788899999999999999999999999999998875443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-49  Score=435.63  Aligned_cols=267  Identities=31%  Similarity=0.541  Sum_probs=234.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-----------HHHHHHHHHHHHHHhCCCCCcceE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-----------KLQESLMSEIFILKRINHPHIIRL   76 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-----------~~~~~i~~Ei~iL~~L~HpnIv~l   76 (575)
                      +.+.++|+++++||+|+||.||+|.++.++..||||++.......           ...+.+.+|+.+|+.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            567788999999999999999999999999999999998754332           234678899999999999999999


Q ss_pred             EEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           77 HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        77 ~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                      ++++...+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++....+||+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            99999999999999999999999999988899999999999999999999999999999999999999554444579999


Q ss_pred             ccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          157 DFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       157 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      |||++............+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+++..+.++......+.
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            999999887766677789999999999987 5699999999999999999999999999999998888877643222233


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +..++.++++||++||.+||.+|||++|+|+||||+...
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            356899999999999999999999999999999997643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.6e-50  Score=435.39  Aligned_cols=267  Identities=31%  Similarity=0.562  Sum_probs=240.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      +.+.++|++.++||+|+||.||+|.++.+|+.||||++.+.... ....+.+.+|+.++++++||||+++++++...+.+
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34567899999999999999999999999999999999766443 23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..+..
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999999999999999888999999999999999999999999999999999999996656678999999999988777


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.++......+.+..+++++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            666677899999999999975 7999999999999999999999999999999988888776543333444678999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ||++||.+||.+|||++|+|+||||+...
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            99999999999999999999999997543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=414.79  Aligned_cols=263  Identities=33%  Similarity=0.566  Sum_probs=214.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....    ..+.+.+|+.++++++||||+++++++...+.+++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            45567999999999999999999999999999999997542    23557899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++......
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999999999888889999999999999999999999999999999999999654557899999999998776665


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.........+....++.++++|
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  285 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL  285 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence            6667889999999999999999999999999999999999999998766554 555565554333333345689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      |++||..||.+|||+.|+++||||....
T Consensus       286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          286 VRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-49  Score=401.81  Aligned_cols=262  Identities=29%  Similarity=0.503  Sum_probs=220.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---HHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---KKLQESLMSEIFILKRI---NHPHIIRLHDIIEV   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~~   82 (575)
                      ...++|+++++||+|+||.||+|++..+|+.||||++......   ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567899999999999999999999999999999998754321   11123456777776665   59999999999977


Q ss_pred             CC-----EEEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           83 PG-----KLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        83 ~~-----~l~LVmEy~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      ..     .+++||||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence            65     5899999996 599999987654  9999999999999999999999999999999999999   67789999


Q ss_pred             cccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 043425          156 ADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP  235 (575)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~  235 (575)
                      +|||+++...........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+........
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999988776666677899999999999999999999999999999999999999999999988888877643222111


Q ss_pred             C-----------------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 D-----------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 ~-----------------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .                       ...++.++.+||.+||.+||.+|||+.|+|+||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            1                       12477899999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.9e-49  Score=399.90  Aligned_cols=258  Identities=31%  Similarity=0.519  Sum_probs=218.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|+++++||+|+||.||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            46899999999999999999999 58999999999765544434466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-C
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-G  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~  168 (575)
                      ||+++ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc
Confidence            99975 999998764 679999999999999999999999999999999999999   77789999999999876432 2


Q ss_pred             CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC-------------
Q 043425          169 LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-------------  234 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p-------------  234 (575)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.......             
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            33456899999999999764 5899999999999999999999999999888877776653211100             


Q ss_pred             ------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          235 ------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       235 ------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                  .....++.++++||++||..||.+|||++|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        001247889999999999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-49  Score=411.43  Aligned_cols=262  Identities=30%  Similarity=0.481  Sum_probs=222.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..+++|+++++||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3578999999999999999999999999999999999765432 234568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      ||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++..+... 
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccCC
Confidence            99999999999999888889999999999999999999999999999999999999   77788999999999765322 


Q ss_pred             --CCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 --GLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 --~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                        ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+................. ......++.++
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAP  238 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-STTGGGSCHHH
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-CCccccCCHHH
Confidence              23456789999999999987776 678999999999999999999998766543322222222222 22345689999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .+||++||..||.+|||++|+++||||+...
T Consensus       239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-49  Score=418.28  Aligned_cols=262  Identities=29%  Similarity=0.520  Sum_probs=216.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--E
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPG--K   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~--~   85 (575)
                      .+.++|+++++||+|+||.||+|.++.+|+.||||++............+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4678899999999999999999999999999999999766556666778889999999997 999999999997554  7


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|+||||++ ++|..++.. +.+++..++.++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESS
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccccc
Confidence            999999997 589999876 579999999999999999999999999999999999999   777899999999998653


Q ss_pred             C----------------------CCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH
Q 043425          166 P----------------------RGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL  222 (575)
Q Consensus       166 ~----------------------~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l  222 (575)
                      .                      .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2                      122345789999999999986 67999999999999999999999999999998888


Q ss_pred             HHHHHhccCCCCC------------------------------C-------------hhcccHHHHHHHHHhhccCCCCC
Q 043425          223 QNIVKATELHFPP------------------------------D-------------AKILSADCKDLCQKLLRRNPVER  259 (575)
Q Consensus       223 ~~i~~~~~~~~p~------------------------------~-------------~~~ls~el~dLI~k~L~~DP~~R  259 (575)
                      ..+........+.                              .             ....++++.+||++||..||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            8776533211100                              0             01467899999999999999999


Q ss_pred             CCHHHHHcCCCCCCCC
Q 043425          260 LTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       260 pTa~eiL~Hpff~~~~  275 (575)
                      ||++|+|+||||+...
T Consensus       321 ~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          321 ISANDALKHPFVSIFH  336 (388)
T ss_dssp             CCHHHHTTSTTTTTTC
T ss_pred             CCHHHHhCCHHHHHhc
Confidence            9999999999997653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-49  Score=429.49  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=219.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|+++++||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++...     
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            457889999999999999999999999999999999987665666677899999999999999999999999554     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  212 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-
T ss_pred             CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeee
Confidence             468999999976 5666664  359999999999999999999999999999999999999   777899999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh-----
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA-----  237 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~-----  237 (575)
                      ...........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.+......+...     
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            877666677789999999999999999999999999999999999999999999988888877664322111000     


Q ss_pred             ---------------------------------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          238 ---------------------------------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       238 ---------------------------------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                                       ...++++++||++||.+||.+|||++|+|+||||+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                                             0115789999999999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-49  Score=409.99  Aligned_cols=272  Identities=30%  Similarity=0.501  Sum_probs=233.0

Q ss_pred             eecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 043425           10 VVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        10 ~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~   87 (575)
                      +-++|.+. +.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.+. ||||+++++++...+.++
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            45668887 8999999999999999999999999999876555444567889999999985 699999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||||+.||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||+......+.+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999998543  679999999999999999999999999999999999999543347889999999998876


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ........+||+.|+|||++....++.++||||||+++|+|++|..||.+.+..+....+..............++.++.
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence            66666678899999999999999999999999999999999999999999998888877776544333444457899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      +||.+||..||.+|||++|+++||||+...++..+.
T Consensus       266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC--
T ss_pred             HHHHHHcCCChhhCcCHHHHhCCHhhcccccccccC
Confidence            999999999999999999999999999887765543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-49  Score=412.70  Aligned_cols=259  Identities=32%  Similarity=0.541  Sum_probs=225.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~   87 (575)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++.+....      ..+|+.++.++ +||||+++++++.+.+.+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4667899999999999999999999999999999999865432      34688888887 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~~~~~  166 (575)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..++ ..+.+||+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            9999999999999999888999999999999999999999999999999999999985432 335699999999987644


Q ss_pred             C-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCC---CCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          167 R-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG---SNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       167 ~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~---~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      . ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+   .+..+++..+..+........+..++.
T Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence            3 345678999999999999998899999999999999999999999986   455666666666533222223356899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ++++||++||..||.+|||+.|+++||||..
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999999999954

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-50  Score=422.01  Aligned_cols=259  Identities=33%  Similarity=0.644  Sum_probs=227.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      +..+++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++...+.+
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            578999999999999999999999999999999999997543221 1234688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccC
Confidence            9999999 78999999888899999999999999999999999999999999999999   7778999999999988777


Q ss_pred             CCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+... ...+|   ..+++++.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p---~~~s~~~~  236 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMP---DFLSPGAQ  236 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCC---TTSCHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCc---ccCCHHHH
Confidence            777778899999999999988776 68999999999999999999999876544433222211 11222   35899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||..||.+|||++|+++||||+..
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            99999999999999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-49  Score=411.08  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----KL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----~l   86 (575)
                      ..+|.+.++||+|+||+||+|++  +|+.||||+++...   ........|+.++.+++|||||++++++..++    .+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            45799999999999999999987  49999999997542   11222335666677899999999999997653    68


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccccccCCceeeecCCCCCcEEEccc
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--------NLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--------gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      |||||||+||+|.+++++. .+++..+..++.|++.||+|||++        +||||||||+|||+   +.++.+||+||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF  152 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence            9999999999999999764 689999999999999999999987        99999999999999   77889999999


Q ss_pred             ccccccCCCC-----CcccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhCCCCCCCC-----------
Q 043425          159 GFARSLQPRG-----LAETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTGKTPFTGS-----------  216 (575)
Q Consensus       159 Gla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG~~PF~~~-----------  216 (575)
                      |+|+......     .....+||+.|||||++.+.      .|+.++|||||||+||||++|.+||...           
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            9998765432     22346899999999999754      4678999999999999999998765321           


Q ss_pred             ----CHHHHHHHHHHh-ccCCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          217 ----NQIQLLQNIVKA-TELHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       217 ----~~~~~l~~i~~~-~~~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                          ....+...+... ..+.+|...  ...+..+.+|+.+||..||.+|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                122333332222 122233222  1234578999999999999999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-48  Score=394.43  Aligned_cols=270  Identities=32%  Similarity=0.564  Sum_probs=235.5

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---C----HHHHHHHHHHHHHHHhCC-CCCcceEE
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---N----KKLQESLMSEIFILKRIN-HPHIIRLH   77 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---~----~~~~~~i~~Ei~iL~~L~-HpnIv~l~   77 (575)
                      ......++|++.+.||+|+||.||+|.++.+|+.||||++.....   .    ....+.+.+|+.+++++. ||||++++
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            345678999999999999999999999999999999999976531   1    233567889999999995 99999999


Q ss_pred             EEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           78 DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        78 ~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      +++...+..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d  167 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD  167 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEec
Confidence            9999999999999999999999999988899999999999999999999999999999999999999   6778899999


Q ss_pred             cccccccCCCCCcccccCCCCCCChHHHh------hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAPEIMQ------LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~APEvl~------~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      ||++............+||+.|+|||++.      ...++.++||||||+++|+|++|..||.+.+.......+......
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            99998877666667788999999999986      346788999999999999999999999999888888777766443


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      ...+....++.++.+||.+||..||.+|||++|+++||||++...+.
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            33344457899999999999999999999999999999998765543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.6e-49  Score=415.63  Aligned_cols=264  Identities=22%  Similarity=0.359  Sum_probs=224.8

Q ss_pred             eeecCEEEEEEeccc--CCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSG--SFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~G--aFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ...++|+++++||+|  +||.||+|+++.+|+.||||++..........+.+.+|+.+++.++||||+++++++...+.+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            467889999999999  999999999999999999999998777777778899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      |+||||++||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence            9999999999999999876  679999999999999999999999999999999999999   77789999999998654


Q ss_pred             CCC--------CCcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--
Q 043425          165 QPR--------GLAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--  232 (575)
Q Consensus       165 ~~~--------~~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--  232 (575)
                      ...        ......+||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.+....+..+.......  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            221        12234589999999999987  679999999999999999999999998876555444333221100  


Q ss_pred             ----------------------------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          233 ----------------------------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       233 ----------------------------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                                                              ..+....+++++++||++||..||.+|||++|+++||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    0011234788999999999999999999999999999998


Q ss_pred             CCC
Q 043425          273 QTQ  275 (575)
Q Consensus       273 ~~~  275 (575)
                      ...
T Consensus       339 ~~~  341 (389)
T 3gni_B          339 QIK  341 (389)
T ss_dssp             GC-
T ss_pred             HHh
Confidence            754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-49  Score=403.00  Aligned_cols=268  Identities=29%  Similarity=0.524  Sum_probs=219.2

Q ss_pred             CCeeecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 043425            7 RGRVVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG   84 (575)
Q Consensus         7 ~g~~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~   84 (575)
                      .|+..+.|++. +.||+|+||.||+|.+..+|+.||||++.....  ...+.+.+|+.++.++ +||||+++++++...+
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            36778889995 789999999999999999999999999976532  2345688999999885 7999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998889999999999999999999999999999999999999955444456999999998765


Q ss_pred             CCCC--------CcccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCCH-------------
Q 043425          165 QPRG--------LAETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-------------  218 (575)
Q Consensus       165 ~~~~--------~~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-------------  218 (575)
                      ....        .....+||+.|+|||++..     ..++.++|||||||++|+|++|..||.+...             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        2234679999999999975     6689999999999999999999999987642             


Q ss_pred             --HHHHHHHHHhccCCCCCC-hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          219 --IQLLQNIVKATELHFPPD-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       219 --~~~l~~i~~~~~~~~p~~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                        ..+...+... ...++.. ...++.++++||++||..||.+|||++|+++||||+...++
T Consensus       245 ~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          245 CQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             HHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence              3344444443 3333322 24578999999999999999999999999999999876554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-49  Score=431.90  Aligned_cols=263  Identities=31%  Similarity=0.624  Sum_probs=236.3

Q ss_pred             CCCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            5 TGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         5 ~~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ......+++|.+++.||+|+||.||+|++..+|+.||||++....... +....+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A            9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            344568999999999999999999999999999999999997643221 2245688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.+|+||||++||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence            9999999999999999999888899999999999999999999999999999999999999   7778899999999998


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ........+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+..+. ...|   ..+++
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p---~~~s~  241 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTP---QYLNP  241 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCC---TTCCH
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCC---ccCCH
Confidence            777666778899999999999988776 688999999999999999999999998888888777653 2223   35789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++.+||++||..||.+|||++|+++||||...
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.6e-49  Score=413.73  Aligned_cols=261  Identities=31%  Similarity=0.571  Sum_probs=211.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ....++|+++++||+|+||.||+|+++.+|+.||||++.......   +.+.+|+.+++.++||||+++++++...+.++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            345678999999999999999999999999999999998654322   45779999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.....
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCcccccccc
Confidence            99999999999999998889999999999999999999999999999999999999932 12235999999999865555


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcc-cccchhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQ----IQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~k-aDIWSLGviLyeLltG~~PF~~~~~----~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...    ...+..+... ...++.. ..+++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~s~  249 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDD-IRISP  249 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-CCCCCTT-SCCCH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-CCCCCCc-CCCCH
Confidence            55566789999999999998888766 8999999999999999999987544    3333333332 2233332 35789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++++||++||.+||.+|||++|+++||||...
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            99999999999999999999999999999654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-49  Score=425.70  Aligned_cols=267  Identities=27%  Similarity=0.452  Sum_probs=208.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----C
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-----P   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-----~   83 (575)
                      .+.++|+++++||+|+||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++..     .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            45578999999999999999999999999999999997765566666789999999999999999999999843     3


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART  205 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred             ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence            5799999998 57999999988889999999999999999999999999999999999999   7778999999999987


Q ss_pred             cCCC----------------------------CCcccccCCCCCCChHHH-hhccCCcccccchhhHHHHHHHh------
Q 043425          164 LQPR----------------------------GLAETLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVT------  208 (575)
Q Consensus       164 ~~~~----------------------------~~~~~~~GT~~Y~APEvl-~~~~y~~kaDIWSLGviLyeLlt------  208 (575)
                      ....                            ......+||+.|+|||++ ....|+.++|||||||+||+|++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            5422                            123456899999999987 45679999999999999999998      


Q ss_pred             -----CCCCCCCCCH--------------------HHHHHHHHHhccC---------------------------CCCCC
Q 043425          209 -----GKTPFTGSNQ--------------------IQLLQNIVKATEL---------------------------HFPPD  236 (575)
Q Consensus       209 -----G~~PF~~~~~--------------------~~~l~~i~~~~~~---------------------------~~p~~  236 (575)
                           |+++|.+.+.                    .+.+..+.+....                           .+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 7888877542                    2223333221100                           00111


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      .+..+.++.+||++||.+||.+|||++|+|+||||+...+...
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            2345899999999999999999999999999999998866543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.4e-49  Score=446.03  Aligned_cols=271  Identities=28%  Similarity=0.524  Sum_probs=241.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+++|+++++||+|+||.||+|+++.+|+.||||++.+... .....+.+..|..+|..+ +||||+++++++++.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            357889999999999999999999999999999999986432 112235678899999887 689999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc-C
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-Q  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~-~  165 (575)
                      ||||||++||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++.. .
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence            9999999999999999998999999999999999999999999999999999999999   77889999999999864 3


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......+.+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+..+++..|... ...+|.   .++.+++
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~~~  570 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPK---SMSKEAV  570 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-CCCCCT---TSCHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-CCCCCc---cCCHHHH
Confidence            344566789999999999999999999999999999999999999999999999999888875 344453   5899999


Q ss_pred             HHHHHhhccCCCCCCCH-----HHHHcCCCCCCCCchhhhhhcccC
Q 043425          246 DLCQKLLRRNPVERLTF-----EEFFNHPFLSQTQPDQVFRSRMFS  286 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa-----~eiL~Hpff~~~~~~~~~~~~~~~  286 (575)
                      +||++||.+||.+||++     +||++||||..++|+.+....+.+
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~p  616 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP  616 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCC
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCC
Confidence            99999999999999997     999999999999999887655443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=398.46  Aligned_cols=261  Identities=30%  Similarity=0.549  Sum_probs=219.4

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH------------------------HHHHHHHHH
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK------------------------KLQESLMSE   61 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~------------------------~~~~~i~~E   61 (575)
                      +....+++|++.+.||+|+||.||+|++..+|+.||||++.......                        ...+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            33467899999999999999999999999999999999997654321                        123568899


Q ss_pred             HHHHHhCCCCCcceEEEEEEe--CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccC
Q 043425           62 IFILKRINHPHIIRLHDIIEV--PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP  139 (575)
Q Consensus        62 i~iL~~L~HpnIv~l~~~~~~--~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKP  139 (575)
                      +.+++.++||||+++++++..  .+.+++||||+++++|.+++. .+.+++..++.++.||+.||+|||++||+||||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  578999999999999988654 45799999999999999999999999999999999


Q ss_pred             CceeeecCCCCCcEEEcccccccccCCCC-CcccccCCCCCCChHHHhhcc---CCcccccchhhHHHHHHHhCCCCCCC
Q 043425          140 QNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTG  215 (575)
Q Consensus       140 eNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~---y~~kaDIWSLGviLyeLltG~~PF~~  215 (575)
                      +|||+   +.++.+||+|||++....... .....+||+.|+|||++....   ++.++|||||||++|+|++|..||.+
T Consensus       166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          166 SNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999   677899999999998765433 345678999999999987655   37789999999999999999999999


Q ss_pred             CCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          216 SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       216 ~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      .........+... ...++. ...++.++.+||.+||..||.+|||++|+++||||+
T Consensus       243 ~~~~~~~~~~~~~-~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          243 ERIMCLHSKIKSQ-ALEFPD-QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SSHHHHHHHHHHC-CCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             ccHHHHHHHHhcc-cCCCCC-ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            8887776666554 233332 246889999999999999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.1e-49  Score=396.87  Aligned_cols=266  Identities=31%  Similarity=0.580  Sum_probs=236.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      |.+.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++++++||||+++++++...+.++
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            56778999999999999999999999999999999999876554445567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99999999999999988889999999999999999999999999999999999999965555668999999999877665


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.........+....++.++.+|
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence            55566779999999999875 58999999999999999999999999999888887777654322223335689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |++||..||.+|||++|+++||||++.
T Consensus       257 i~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-48  Score=402.00  Aligned_cols=261  Identities=29%  Similarity=0.518  Sum_probs=210.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|+++++||+|+||.||+|.++.+|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            5689999999999999999999999999999999976542 222345789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           91 EYCKGGDLSMYIQRH------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      ||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceec
Confidence            9997 5999998754      358999999999999999999999999999999999999   77789999999999876


Q ss_pred             CCC-CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC--------
Q 043425          165 QPR-GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP--------  234 (575)
Q Consensus       165 ~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p--------  234 (575)
                      ... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+.......        
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            432 33456789999999999976 46899999999999999999999999999988888777653211100        


Q ss_pred             ----------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          235 ----------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       235 ----------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                                            .....++.++.+||++||+.||.+|||++|+++||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                  001246789999999999999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-48  Score=398.83  Aligned_cols=257  Identities=25%  Similarity=0.454  Sum_probs=215.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      .+.+++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...+   
T Consensus         2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            356789999999999999999999999999999999997654 3334567899999999999999999999985543   


Q ss_pred             ------------------------------------------------------EEEEEEeecCCCCHHHHHHHcCC---
Q 043425           85 ------------------------------------------------------KLHLILEYCKGGDLSMYIQRHGC---  107 (575)
Q Consensus        85 ------------------------------------------------------~l~LVmEy~~GgsL~~~l~~~~~---  107 (575)
                                                                            .+++|||||+|++|.+++.+...   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987643   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-------------Cccccc
Q 043425          108 VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-------------LAETLC  174 (575)
Q Consensus       108 lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-------------~~~~~~  174 (575)
                      .++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......             .....+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            4566789999999999999999999999999999999   677899999999998765432             234568


Q ss_pred             CCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhcc
Q 043425          175 GSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRR  254 (575)
Q Consensus       175 GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~  254 (575)
                      ||+.|+|||++.+..++.++||||||+++|+|++|..|+..     ....+.......++......++++.+||.+||.+
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcccccCChhHHHHHHHHccC
Confidence            99999999999999999999999999999999998776532     1112222223344544456788999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCC
Q 043425          255 NPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       255 DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||.+|||++|+++||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=412.22  Aligned_cols=262  Identities=31%  Similarity=0.514  Sum_probs=227.4

Q ss_pred             ecCEEE--EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           11 VGDYLV--GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        11 v~~Y~i--~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.|.+  .+.||+|+||.||+|.+..+|+.||+|++....  ....+.+.+|+.+|++++||||+++++++...+.+++
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            344665  678999999999999999999999999998653  3445678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.+...
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence            99999999999988654 46999999999999999999999999999999999999943 34578999999999988776


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++....++.++|||||||++|+|++|..||.+.+..+.+..+........+.....++.++++|
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            66667789999999999999999999999999999999999999999999998888888764333333345689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      |.+||.+||.+|||++|+++||||....
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            9999999999999999999999998753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-48  Score=404.70  Aligned_cols=265  Identities=27%  Similarity=0.440  Sum_probs=224.5

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----   82 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----   82 (575)
                      .+..+++|+++++||+|+||.||+|+++.+|+.||||++............+.+|+.+++.++||||+++++++..    
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            4567899999999999999999999999999999999997665544444567899999999999999999999977    


Q ss_pred             ----CCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           83 ----PGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        83 ----~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                          .+.+++||||++| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~D  167 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLAD  167 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECC
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEcc
Confidence                4578999999975 777776544 579999999999999999999999999999999999999   7778999999


Q ss_pred             cccccccCC-----CCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC
Q 043425          158 FGFARSLQP-----RGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       158 FGla~~~~~-----~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      ||+++.+..     .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999986542     223345689999999999976 46899999999999999999999999999988887777654322


Q ss_pred             CCCCChhc----------------------------ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          232 HFPPDAKI----------------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       232 ~~p~~~~~----------------------------ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ..+...+.                            .++++.+||.+||..||.+|||++|+++||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            22211111                            267899999999999999999999999999997643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.7e-49  Score=406.07  Aligned_cols=260  Identities=32%  Similarity=0.553  Sum_probs=203.2

Q ss_pred             eecCEEEE---EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVG---RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~---~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~   85 (575)
                      ...+|.+.   ++||+|+||.||+|.++.+|+.||||++...     ....+.+|+.+++.+. ||||+++++++...+.
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            34678876   7899999999999999999999999999753     2345778999999997 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            99999999999999999998899999999999999999999999999999999999999655555689999999998654


Q ss_pred             CC-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhccCCCCCCh
Q 043425          166 PR-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-------IQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       166 ~~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-------~~~l~~i~~~~~~~~p~~~  237 (575)
                      .. ......+||+.|+|||++....|+.++||||||+++|+|++|..||.+.+.       .+.+..+..+........+
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW  240 (325)
T ss_dssp             C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred             CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence            43 334567899999999999999999999999999999999999999987543       3455555444222222223


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ..++.++++||++||..||.+|||++|+++||||+..
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            5689999999999999999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.4e-48  Score=394.66  Aligned_cols=264  Identities=32%  Similarity=0.563  Sum_probs=231.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+.++|.+.+.||+|+||.||+|++..+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            4566789999999999999999999999999999999986432  22356889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++..... 
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            9999999999999998888999999999999999999999999999999999999996666778999999999875443 


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.........+....++.++.+|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence            23445689999999999999999999999999999999999999999999888888777664322223335689999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |.+||..||.+|||++|+++||||...
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-48  Score=436.73  Aligned_cols=269  Identities=27%  Similarity=0.512  Sum_probs=235.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|++.++||+|+||.||+|+++.+|+.||||++.+..... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34577999999999999999999999999999999997643321 22356789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||||++||+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence            99999999999999987543  9999999999999999999999999999999999999   778899999999998877


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC----HHHHHHHHHHhccCCCCCChhccc
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~----~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+..    ...+...+.. ....++   ..++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p---~~~s  413 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYS---ERFS  413 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCC---TTSC
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCC---ccCC
Confidence            6666667899999999999999999999999999999999999999998764    3344444433 334444   3589


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          242 ADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      .++++||++||++||.+||     +++|+++||||+.++|+.+.....
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~  461 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGML  461 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCC
Confidence            9999999999999999999     899999999999999988765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-49  Score=406.91  Aligned_cols=266  Identities=29%  Similarity=0.524  Sum_probs=224.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .+.++|++++.||+|+||.||+|.+..++..||+|++.....   .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            355779999999999999999999999999999999976432   23445678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 043425           86 LHLILEYCKGGDLSMYIQR----------------------------------------HGCVPEETAKHFMKQLAAGLQ  125 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~----------------------------------------~~~lse~~i~~i~~QLl~aL~  125 (575)
                      +++||||++||+|.+++..                                        ...+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            9999999999999998842                                        112467889999999999999


Q ss_pred             HHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-----CcccccCCCCCCChHHHhh--ccCCcccccch
Q 043425          126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQL--QKYDAKADLWS  198 (575)
Q Consensus       126 ~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWS  198 (575)
                      |||++||+||||||+|||+..+ ....+||+|||++..+....     .....+||+.|+|||++..  ..++.++||||
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            9999999999999999999321 22389999999998653311     2345789999999999975  67899999999


Q ss_pred             hhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          199 VGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       199 LGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ||+++|+|++|..||.+.+..+....+.........+....+++++.+||.+||..||.+|||+.|+++||||++..
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999999888888877654333344456899999999999999999999999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-48  Score=391.11  Aligned_cols=264  Identities=32%  Similarity=0.578  Sum_probs=226.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~----~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++........    ..+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4679999999999999999999999999999999987644321    246788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999999888999999999999999999999999999999999999994322 23389999999998776


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ........+||+.|+|||++....++.++||||||+++|+|++|..||.+.+..+.+..+........+.....++.++.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK  243 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence            65555667899999999999999999999999999999999999999999988887777665432221122246788999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||..||.+|||+.|+++||||+..
T Consensus       244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-48  Score=417.71  Aligned_cols=260  Identities=32%  Similarity=0.587  Sum_probs=213.6

Q ss_pred             CCeeecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHH-HhCCCCCcceEEEEEEe--
Q 043425            7 RGRVVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL-KRINHPHIIRLHDIIEV--   82 (575)
Q Consensus         7 ~g~~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~~~~~--   82 (575)
                      .+.++++|.+. ++||+|+||.||+|.++.+|+.||||++...       ..+.+|+.++ +..+||||++++++|..  
T Consensus        56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            35678899987 7899999999999999999999999999642       2466788887 45689999999999876  


Q ss_pred             --CCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           83 --PGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        83 --~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                        .+.+|||||||+||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||+..++.++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567999999999999999998653  5999999999999999999999999999999999999954444789999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH----HHHHHHHhccCCCC
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ----LLQNIVKATELHFP  234 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~----~l~~i~~~~~~~~p  234 (575)
                      |+++...........+||+.|+|||++....|+.++|||||||++|+|++|..||.+.....    ....+..+ ...++
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-~~~~~  287 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-QYEFP  287 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-CCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-cccCC
Confidence            99987766666677899999999999999999999999999999999999999998765322    33344433 23333


Q ss_pred             -CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 -PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 -~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                       +.+..++.++++||++||..||.+|||++|+++||||...
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence             2335689999999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.2e-48  Score=405.26  Aligned_cols=261  Identities=36%  Similarity=0.629  Sum_probs=230.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc--C----HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--N----KKLQESLMSEIFILKRI-NHPHIIRLHDIIEV   82 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~--~----~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~   82 (575)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||||++.....  .    ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            34679999999999999999999999999999999976532  2    12345678999999999 79999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC  248 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence            99999999999999999999988889999999999999999999999999999999999999   777899999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      .+.........+||+.|+|||++.+.      .|+.++|||||||++|+|++|..||.+.+....+..+.........+.
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            87766666778999999999998643      588899999999999999999999999888888877776543222223


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +..++.++.+||++||..||.+|||++|+++||||++
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            3467899999999999999999999999999999963

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.7e-48  Score=415.45  Aligned_cols=267  Identities=28%  Similarity=0.471  Sum_probs=219.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP----   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~----   83 (575)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++...    
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            3567889999999999999999999999999999999987655566667899999999999999999999999765    


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       +.+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence             57999999995 5999999988889999999999999999999999999999999999999   777899999999998


Q ss_pred             ccCCCC-----------------------CcccccCCCCCCChHHH-hhccCCcccccchhhHHHHHHHh----------
Q 043425          163 SLQPRG-----------------------LAETLCGSPLYMAPEIM-QLQKYDAKADLWSVGAILFQLVT----------  208 (575)
Q Consensus       163 ~~~~~~-----------------------~~~~~~GT~~Y~APEvl-~~~~y~~kaDIWSLGviLyeLlt----------  208 (575)
                      ......                       .....+||+.|+|||++ ....|+.++|||||||++|+|++          
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            764332                       23668999999999997 45679999999999999999998          


Q ss_pred             -CCCCCCCCC-----------------HHHHHHHHHHhcc-----------------------CCCCC----ChhcccHH
Q 043425          209 -GKTPFTGSN-----------------QIQLLQNIVKATE-----------------------LHFPP----DAKILSAD  243 (575)
Q Consensus       209 -G~~PF~~~~-----------------~~~~l~~i~~~~~-----------------------~~~p~----~~~~ls~e  243 (575)
                       |.++|.+.+                 ..+.+..+.....                       ...+.    ..+.++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence             555555543                 1222322222111                       11111    01347899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      +.+||++||..||.+|||++|+|+||||....+..
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            99999999999999999999999999999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-48  Score=401.26  Aligned_cols=267  Identities=25%  Similarity=0.434  Sum_probs=228.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      -..+++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++...+.++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            35788999999999999999999999999999999999877666666777889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-  166 (575)
                      +||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... 
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence            999999999999998877889999999999999999999999999999999999999   7778999999999976543 


Q ss_pred             CCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC------------
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF------------  233 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~------------  233 (575)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+........            
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            3334567899999999999875 789999999999999999999999999988877766654321110            


Q ss_pred             ------CC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          234 ------PP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       234 ------p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                            +.         ....++.++.+||.+||..||.+|||++|+++||||+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  316 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA  316 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHH
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChh
Confidence                  00         012468899999999999999999999999999999865433

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-47  Score=404.88  Aligned_cols=260  Identities=27%  Similarity=0.479  Sum_probs=214.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----   84 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----   84 (575)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            4678999999999999999999999999999999999876656666778899999999999999999999997654    


Q ss_pred             --EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 --KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 --~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                        .+|+||||+.| +|.+++.  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  175 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC--
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeeccc
Confidence              78999999965 7888885  458999999999999999999999999999999999999   677899999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC--------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP--------  234 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p--------  234 (575)
                      ...........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+.+......+        
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            776555566788999999999999999999999999999999999999999999988877776653221110        


Q ss_pred             ---------------------------CC---hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 ---------------------------PD---AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 ---------------------------~~---~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                                 ..   ....+.++++||++||..||.+|||++|+++||||+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                                       00   01126789999999999999999999999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-47  Score=383.04  Aligned_cols=259  Identities=20%  Similarity=0.378  Sum_probs=219.8

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      .++..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...+.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            35677899999999999999999999999999999999987655555667788999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-------------
Q 043425           86 LHLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-------------  148 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-------------  148 (575)
                      +++||||++|++|.+++...    +.+++..++.++.||+.||+|||++||+||||||+|||+..++             
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999765    6799999999999999999999999999999999999995332             


Q ss_pred             ---CCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHH
Q 043425          149 ---DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN  224 (575)
Q Consensus       149 ---~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~  224 (575)
                         ....+||+|||++......   ...+||+.|+|||++.+. .++.++||||||+++|+|++|.+|+.....   ...
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred             ccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence               4568999999999876543   235699999999999765 566899999999999999999988765533   333


Q ss_pred             HHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       225 i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +.......+   ...++.++.+||.+||..||.+|||+.|+++||||...
T Consensus       240 ~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            443332222   34689999999999999999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7e-49  Score=421.76  Aligned_cols=271  Identities=32%  Similarity=0.561  Sum_probs=219.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN------KKLQESLMSEIFILKRINHPHIIRLHDIIEV   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~------~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~   82 (575)
                      ...++|.+.++||+|+||.||+|.++.+++.||||++.+....      ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3467899999999999999999999999999999999865432      122235789999999999999999999985 


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+.+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|||+++
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            55689999999999999999888899999999999999999999999999999999999999665556679999999999


Q ss_pred             ccCCCCCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhccCCCCCChh
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL-QNIVKATELHFPPDAK  238 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l-~~i~~~~~~~~p~~~~  238 (575)
                      ...........+||+.|+|||++.   ...|+.++|||||||++|+|++|.+||.+......+ ..+........+....
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  370 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  370 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence            877666677889999999999985   367888999999999999999999999876544333 3333332222233335


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++.++.+||++||..||.+|||++|+++||||+.......+
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~  412 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF  412 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHH
Confidence            689999999999999999999999999999999876554433

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-47  Score=398.76  Aligned_cols=257  Identities=28%  Similarity=0.398  Sum_probs=220.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-----HPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIv~l~~~~~~~   83 (575)
                      .+.++|+++++||+|+||.||+|++..+|+.||||++..   .......+..|+.+++.+.     ||||+++++++...
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            455779999999999999999999999999999999964   2344566788999999986     99999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC--------------
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD--------------  147 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d--------------  147 (575)
                      +.+++||||+ |++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+..+              
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999999 999999998764  59999999999999999999999999999999999999421              


Q ss_pred             --------CCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH
Q 043425          148 --------DDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI  219 (575)
Q Consensus       148 --------d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~  219 (575)
                              ...+.+||+|||++.....  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                    1267899999999976433  335678999999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHhccCCCCC--------------------------C-----------------hhcccHHHHHHHHHhhccCC
Q 043425          220 QLLQNIVKATELHFPP--------------------------D-----------------AKILSADCKDLCQKLLRRNP  256 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~--------------------------~-----------------~~~ls~el~dLI~k~L~~DP  256 (575)
                      +.+..+...... ++.                          .                 ....++++.+||++||+.||
T Consensus       266 ~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          266 EHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            777766543211 110                          0                 01123678899999999999


Q ss_pred             CCCCCHHHHHcCCCCC
Q 043425          257 VERLTFEEFFNHPFLS  272 (575)
Q Consensus       257 ~~RpTa~eiL~Hpff~  272 (575)
                      .+|||++|+|+||||+
T Consensus       345 ~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          345 TLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGSCCHHHHTTSGGGC
T ss_pred             hhCCCHHHHhcCcccC
Confidence            9999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.7e-48  Score=387.64  Aligned_cols=258  Identities=31%  Similarity=0.593  Sum_probs=226.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ...+++|++++.||+|+||.||+|.+..++..||||++....... .....+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            456789999999999999999999999999999999997643222 1245688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC--
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCc
Confidence            9999999999999999988899999999999999999999999999999999999999   7778999999999865433


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      . .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... ...++   ..++.++.+
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~  236 (279)
T 3fdn_A          162 S-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFP---DFVTEGARD  236 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCC---TTSCHHHHH
T ss_pred             c-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-CCCCC---CcCCHHHHH
Confidence            3 234568999999999999999999999999999999999999999999888887776654 33333   347899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||.+||..||.+|||++|+++||||+.
T Consensus       237 li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          237 LISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHhhCccccC
Confidence            999999999999999999999999965

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-47  Score=405.52  Aligned_cols=260  Identities=29%  Similarity=0.489  Sum_probs=220.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++...     
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            356789999999999999999999999999999999976655666677889999999999999999999999765     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR  176 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence             3469999999 8899999976 579999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      .....  ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.....         
T Consensus       177 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            75432  446789999999999987 689999999999999999999999999999888877766532111         


Q ss_pred             ------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          233 ------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       233 ------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                        +.......++++.+||.+||..||.+|||++|+++||||....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                              1111234688999999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.4e-48  Score=429.04  Aligned_cols=271  Identities=28%  Similarity=0.496  Sum_probs=235.7

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      +...++|++.++||+|+||.||+|+++.+|+.||||++.+..... ...+.+.+|+.+|+.++||||+++++++...+.+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            456688999999999999999999999999999999997653321 2235688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence            9999999999999999764    369999999999999999999999999999999999999   778899999999998


Q ss_pred             ccCCCCC-cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhccCCCCCCh
Q 043425          163 SLQPRGL-AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS----NQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       163 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~----~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      .+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.    ....+...+... ...+|   
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p---  413 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYP---  413 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCC---
T ss_pred             eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCC---
Confidence            7655433 44579999999999999999999999999999999999999999875    345555555544 33444   


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhccc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMF  285 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~~  285 (575)
                      ..++.++++||++||.+||.+||+     ++++++||||+.+.|+.+......
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~  466 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT  466 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCC
Confidence            358999999999999999999996     589999999999999887665443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=401.41  Aligned_cols=260  Identities=30%  Similarity=0.530  Sum_probs=215.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|+++++||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            4789999999999999999999999999999999975432 111223567999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CC
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~  168 (575)
                      ||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-----
T ss_pred             cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc
Confidence            9997 5898888765 459999999999999999999999999999999999999   6778899999999976543 23


Q ss_pred             CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC-----------
Q 043425          169 LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-----------  236 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~-----------  236 (575)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+......+..           
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            3445689999999999976 5689999999999999999999999999998888877766432221111           


Q ss_pred             ---------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          237 ---------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       237 ---------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                     ...++.++.+||++||+.||.+|||++|+++||||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                           123678999999999999999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.9e-47  Score=393.00  Aligned_cols=256  Identities=27%  Similarity=0.516  Sum_probs=227.0

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      .|...++||+|+||.||+|++..+|+.||||++......  ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            488899999999999999999999999999999765432  245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-Ccc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~~~  171 (575)
                      ++|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....... ...
T Consensus       124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccc
Confidence            999999999864 579999999999999999999999999999999999999   677889999999998765432 345


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      ..+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+. ....++.++.+||.+|
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-NSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT-TGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC-ccccCCHHHHHHHHHH
Confidence            678999999999999999999999999999999999999999999888887777665433222 2346889999999999


Q ss_pred             hccCCCCCCCHHHHHcCCCCCCCC
Q 043425          252 LRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      |..||.+|||++|+++||||.+..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.2e-48  Score=385.44  Aligned_cols=262  Identities=32%  Similarity=0.623  Sum_probs=221.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ....++|.+++.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            45779999999999999999999999999999999999754321 12235688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCC
Confidence            9999999999999999988899999999999999999999999999999999999999   6778899999999988766


Q ss_pred             CCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ..++   ..++.++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~  239 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIP---EYLNRSVA  239 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC---TTSCHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCc---hhcCHHHH
Confidence            655667789999999999987766 578999999999999999999999988888777766542 2233   35789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      +||.+||+.||.+|||++|+++||||++..+
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            9999999999999999999999999976543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-47  Score=387.06  Aligned_cols=260  Identities=33%  Similarity=0.624  Sum_probs=229.8

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      .....+++|++++.||+|+||.||+|.+..++..||||++....... .....+.+|+.+++.++||||+++++++...+
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            34567899999999999999999999999999999999997543211 12356889999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence            999999999999999999988899999999999999999999999999999999999999   67788999999998765


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...++   ..++.++
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  239 (284)
T 2vgo_A          165 PSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFP---PFLSDGS  239 (284)
T ss_dssp             SSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCC---TTSCHHH
T ss_pred             ccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccCCC---CcCCHHH
Confidence            432 334678999999999999999999999999999999999999999998888877776654 33333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ++||.+||..||.+|||++++++||||+.
T Consensus       240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          240 KDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence            99999999999999999999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3e-48  Score=399.55  Aligned_cols=269  Identities=32%  Similarity=0.556  Sum_probs=223.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN------KKLQESLMSEIFILKRINHPHIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~------~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~   81 (575)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++......      ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            34567899999999999999999999999999999999765321      122345789999999999999999999997


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      ..+ +++||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            665 8999999999999999988889999999999999999999999999999999999999965555567999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCCh
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDA  237 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~  237 (575)
                      ............+||+.|+|||++.   ...++.++|||||||++|+|++|..||....... ....+........+...
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8776555555678999999999985   4678899999999999999999999998765432 33334333222222223


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      ..++.++.+||.+||..||.+|||++++++||||+.....
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~  284 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK  284 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence            4678999999999999999999999999999999875443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-47  Score=383.83  Aligned_cols=256  Identities=27%  Similarity=0.480  Sum_probs=220.7

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKLHL   88 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~L   88 (575)
                      .|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+++.++||||+++++++..    ...+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3899999999999999999999999999999998877777777889999999999999999999999865    456899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||+.  +..+.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCT
T ss_pred             EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcccccc
Confidence            9999999999999998889999999999999999999999999  99999999999992  2667899999999975433


Q ss_pred             CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ......+||+.|+|||++. ..++.++||||||+++|+|++|..||.+............... .........++++.+
T Consensus       185 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  261 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPASFDKVAIPEVKE  261 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCGGGGGCCCHHHHH
T ss_pred             -cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-CccccCCCCCHHHHH
Confidence             3345678999999999886 4699999999999999999999999988555444433332211 111222456789999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||.+||..||.+|||++|+++||||++
T Consensus       262 li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=394.56  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=211.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .++|++.++||+|+||+||+|++..+|+.||||++...............|+..+..+ .||||+++++++...+.+++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            3679999999999999999999999999999999876655555555666677666555 899999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCC
Confidence            9999 67898888765 469999999999999999999999999999999999999   677889999999998876666


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-ChhcccHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILSADCKDL  247 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-~~~~ls~el~dL  247 (575)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.....   .+...   ..++ ....++.++.+|
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG---YLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT---CCCHHHHTTSCHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc---CCCcccccCCCHHHHHH
Confidence            6667789999999999875 79999999999999999999977776543322   22221   1121 124578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      |.+||..||.+|||++|+++||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=403.87  Aligned_cols=254  Identities=32%  Similarity=0.552  Sum_probs=223.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH------HHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK------LQESLMSEIFILKRINHPHIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~------~~~~i~~Ei~iL~~L~HpnIv~l~~~~~   81 (575)
                      |...++|++++.||+|+||.||+|.++.+|+.||||++........      ....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            5667889999999999999999999999999999999987643221      2335678999999999999999999999


Q ss_pred             eCCEEEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           82 VPGKLHLILEYCKGG-DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        82 ~~~~l~LVmEy~~Gg-sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ..+.+++||||+.+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~  176 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS  176 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence            999999999999776 999999988899999999999999999999999999999999999999   6778999999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      +............+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....      .... ....   ...
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~-~~~~---~~~  246 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA-AIHP---PYL  246 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT-CCCC---SSC
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh-ccCC---Ccc
Confidence            998877777778899999999999988877 7889999999999999999999986332      1111 1111   234


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++.++.+||.+||.+||.+|||++|+++||||++.
T Consensus       247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            78999999999999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-48  Score=398.50  Aligned_cols=264  Identities=25%  Similarity=0.426  Sum_probs=222.7

Q ss_pred             CCCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425            6 GRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus         6 ~~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ....+.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            346788899999999999999999999999999999999987543 3455567899999999999999999999986543


Q ss_pred             ----EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           85 ----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        85 ----~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                          ..|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~  162 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI  162 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence                459999999999999999988899999999999999999999999999999999999999   6667899999999


Q ss_pred             ccccCCCC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          161 ARSLQPRG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       161 a~~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      +..+....    .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+...........
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            98664332    23346799999999999999999999999999999999999999999998887776665533221111


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      ...++.++.+||.+||..||.+||++.+++.|+|+.
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            245889999999999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-47  Score=385.13  Aligned_cols=259  Identities=25%  Similarity=0.453  Sum_probs=206.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|+++++||+|+||.||+|.+..+|+.||||++..........+.+.++...++.++||||+++++++...+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            34678999999999999999999999999999999997654444444445556666888999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           89 ILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ||||++| +|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||+   +..+.+||+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence            9999975 88777653    46899999999999999999999998 99999999999999   6778999999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHH----hhccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCCChh
Q 043425          164 LQPRGLAETLCGSPLYMAPEIM----QLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl----~~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      ..........+||+.|+|||++    ....++.++||||||+++|+|++|..||.. ......+...........+.  .
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  237 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA--D  237 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT--T
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc--c
Confidence            7666556667899999999997    566789999999999999999999999986 34445555555443333332  3


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .++.++.+||.+||..||.+|||++|+++||||+.
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            57999999999999999999999999999999964

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7e-47  Score=383.49  Aligned_cols=259  Identities=31%  Similarity=0.543  Sum_probs=231.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ...++|.+++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            455789999999999999999999999999999999987643 3455677899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence            999999999999999988899999999999999999999999999999999999999   67788999999999876532


Q ss_pred             -CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+... ...++   ..++.++.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~  244 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIP---KHINPVAAS  244 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCC---TTSCHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCCc---cccCHHHHH
Confidence             3345578999999999999989999999999999999999999999998887777666554 22333   357899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ||++||+.||.+|||++|+++||||...
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHHcccChhhCcCHHHHhhChheecC
Confidence            9999999999999999999999999653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-48  Score=404.27  Aligned_cols=267  Identities=30%  Similarity=0.539  Sum_probs=224.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCcc--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRL--NKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      .+++|+++++||+|+||.||+|++.   .+|+.||||++.....  .....+.+.+|+.+|+.+ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3478999999999999999999984   5899999999875432  112234467899999999 699999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            9999999999999999999988899999999999999999999999999999999999999   7778999999999986


Q ss_pred             cCCC--CCcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCCCCC----HHHHHHHHHHhccCCCCC
Q 043425          164 LQPR--GLAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKATELHFPP  235 (575)
Q Consensus       164 ~~~~--~~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~~~~----~~~~l~~i~~~~~~~~p~  235 (575)
                      +...  ......+||+.|+|||++.+  ..++.++|||||||++|+|++|..||....    ...+...+... ...++ 
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYP-  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCC-
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCC-
Confidence            5432  23345789999999999985  457889999999999999999999997543    33344444333 22223 


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhc
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~  283 (575)
                        ..++..+++||.+||.+||.+||     +++|+++||||....++.+....
T Consensus       287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~  337 (355)
T 1vzo_A          287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK  337 (355)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred             --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhcc
Confidence              35789999999999999999999     99999999999998887766543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=387.36  Aligned_cols=260  Identities=36%  Similarity=0.668  Sum_probs=200.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      |..+++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            667889999999999999999999999999999999997543211 1235688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeecc
Confidence            9999999999999999865 579999999999999999999999999999999999999   677889999999998764


Q ss_pred             CC-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PR-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .. ......+||+.|+|||++.+..++.++||||||+++|+|++|..||........+..+... ....+   ..++.++
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~  239 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMP---SFLSIEA  239 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCC---TTSCHHH
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCc---cccCHHH
Confidence            32 2334578999999999999999999999999999999999999999887655544433221 11222   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .+||.+||..||.+|||++++++||||...
T Consensus       240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            999999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-47  Score=399.83  Aligned_cols=261  Identities=26%  Similarity=0.521  Sum_probs=224.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|+++++||+|+||.||+|.+..+|..||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            34578999999999999999999999999999999998653 45566789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||.|||+. ||+||||||+|||+   +.++.+||+|||++......
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcccccc
Confidence            999999999999999888999999999999999999999996 99999999999999   67788999999999765322


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH------------------------
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ------------------------  223 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~------------------------  223 (575)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+...                        
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             2345689999999999999999999999999999999999999998876554322                        


Q ss_pred             ------------------HHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          224 ------------------NIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       224 ------------------~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                                        .+........+  ...++.++.+||++||..||.+|||++|+++||||+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                              12222111111  1347889999999999999999999999999999986543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8e-47  Score=392.22  Aligned_cols=258  Identities=30%  Similarity=0.534  Sum_probs=231.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++|.+++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            44679999999999999999999999999999999986543 34556778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      ||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTT
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccCc
Confidence            99999999999999988899999999999999999999999999999999999999   67788999999999876532 


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ...++.   .++.++.+|
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~l  271 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPK---HINPVAASL  271 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCT---TSCHHHHHH
T ss_pred             ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-CCCCCc---cCCHHHHHH
Confidence            3345678999999999999999999999999999999999999999998887777666654 233332   578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          248 CQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      |++||..||.+|||++|+++||||...
T Consensus       272 i~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          272 IQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-47  Score=382.48  Aligned_cols=260  Identities=30%  Similarity=0.493  Sum_probs=224.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|++++.||+|+||.||+|.++.+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            568899999999999999999999999999999999765432 3346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC--
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR--  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~--  167 (575)
                      |||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCCcc
Confidence            9999999999999877789999999999999999999999999999999999999   67788999999999765322  


Q ss_pred             -CCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCChhcccHHH
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                       ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+..... ....+... ... ......++.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~  238 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTY-LNPWKKIDSAP  238 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CTT-STTGGGSCHHH
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-ccc-cCchhhcCHHH
Confidence             23456789999999999987765 678999999999999999999998765432 22333322 222 22335689999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .+||.+||..||.+|||++|+++||||++..
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999999998753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.3e-47  Score=388.62  Aligned_cols=259  Identities=26%  Similarity=0.463  Sum_probs=217.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEV--PGK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~--~~~   85 (575)
                      ...++|+++++||+|+||.||+|.+..+|+.||||++....     ...+.+|+.+++.+. ||||+++++++..  ...
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            45678999999999999999999999999999999987432     345889999999997 9999999999987  667


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .++||||+.+++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||+.  .+...+||+|||+++...
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcC
Confidence            999999999999999875   389999999999999999999999999999999999993  233489999999998877


Q ss_pred             CCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHh------------ccC
Q 043425          166 PRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKA------------TEL  231 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~------------~~~  231 (575)
                      ........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.. ....+.+..+.+.            ...
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            6666677889999999999977 6789999999999999999999999954 3443333332221            011


Q ss_pred             CCC---------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          232 HFP---------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       232 ~~p---------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      ..+                     .....++.++.+||++||.+||.+|||++|+|+||||+.+.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence            111                     1112378999999999999999999999999999999887554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-47  Score=396.58  Aligned_cols=264  Identities=28%  Similarity=0.460  Sum_probs=217.1

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK---KLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      .+...++|++++.||+|+||.||+|.+..+|+.||||++.......   .....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            4667899999999999999999999999999999999997543221   2234678999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +.+++||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccce
Confidence            999999999976 888888765 369999999999999999999999999999999999999   677899999999998


Q ss_pred             ccCCC-CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC----
Q 043425          163 SLQPR-GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD----  236 (575)
Q Consensus       163 ~~~~~-~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~----  236 (575)
                      .+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+...........    
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            76433 334567899999999999754 589999999999999999999999999998888887776432211110    


Q ss_pred             --------------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          237 --------------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       237 --------------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                          ...++.++++||++||..||.+|||++|+++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                                03457899999999999999999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.1e-47  Score=381.32  Aligned_cols=259  Identities=32%  Similarity=0.575  Sum_probs=228.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLH   87 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~   87 (575)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..  .+.++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4689999999999999999999999999999999998877777777889999999999999999999998743  67899


Q ss_pred             EEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccccccCCceeeecCCCCCcEEEccc
Q 043425           88 LILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQVLRDNN-----LIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~----~~lse~~i~~i~~QLl~aL~~LH~~g-----IvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      +||||++|++|.+++...    ..+++..++.++.||+.||+|||++|     |+||||||+|||+   +.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence            999999999999999754    34999999999999999999999999     9999999999999   67788999999


Q ss_pred             ccccccCCCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          159 GFARSLQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       159 Gla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      |++....... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......++   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---  237 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---  237 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC---
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC---
Confidence            9998765432 234568999999999999999999999999999999999999999999888887777766443333   


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ..++.++.+||.+||..||.+|||++|+++|+|+...
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            3578999999999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.5e-47  Score=388.26  Aligned_cols=266  Identities=32%  Similarity=0.521  Sum_probs=224.9

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEc-CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHR-VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIRLHDIIE-   81 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~-~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~-   81 (575)
                      .-+..++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+   .||||+++++++. 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            3456688999999999999999999995 6789999999976543322223456777777665   8999999999987 


Q ss_pred             ----eCCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           82 ----VPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        82 ----~~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                          ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl  161 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKL  161 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEE
Confidence                4567999999997 59999998753  49999999999999999999999999999999999999   67789999


Q ss_pred             cccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---
Q 043425          156 ADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---  232 (575)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---  232 (575)
                      +|||++............+||+.|+|||++....++.++||||||+++|+|++|.+||.+.+....+..+.......   
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99999987665555566789999999999999999999999999999999999999999999888887776532211   


Q ss_pred             -CC-------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          233 -FP-------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       233 -~p-------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                       ++                   .....++.++++||.+||..||.+|||+.|+++||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence             00                   011347889999999999999999999999999999987644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-46  Score=404.78  Aligned_cols=259  Identities=26%  Similarity=0.397  Sum_probs=219.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI------NHPHIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L------~HpnIv~l~~~~~   81 (575)
                      ..+.++|+++++||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+++.+      +|+||+++++++.
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            35667899999999999999999999999999999999753   34456678888888876      5779999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc--EEEcc
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA--LKIAD  157 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~--vKL~D  157 (575)
                      ..+.+++||||+. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+   +..+.  +||+|
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~D  245 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGIKVID  245 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCEEECC
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcceEEee
Confidence            9999999999995 69999998764  49999999999999999999999999999999999999   44454  99999


Q ss_pred             cccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC---
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP---  234 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p---  234 (575)
                      ||++.....  ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+......+   
T Consensus       246 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          246 FGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            999976433  344678999999999999999999999999999999999999999999988888776653211100   


Q ss_pred             --------------------------------------------CC--------hhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          235 --------------------------------------------PD--------AKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       235 --------------------------------------------~~--------~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                                                                  +.        ....++++.+||++||++||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                        00        01236789999999999999999999


Q ss_pred             HHHHcCCCCCCCC
Q 043425          263 EEFFNHPFLSQTQ  275 (575)
Q Consensus       263 ~eiL~Hpff~~~~  275 (575)
                      +|+|+||||++..
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999998643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-47  Score=393.19  Aligned_cols=254  Identities=29%  Similarity=0.546  Sum_probs=213.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~~~l~L   88 (575)
                      .++|++++.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+|+.+.|  |||+++++++...+.+++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            345999999999999999999985 69999999998877777777889999999999986  999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||| +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.    ++.+||+|||+++......
T Consensus        87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC----
T ss_pred             EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCccc
Confidence            999 55889999999989999999999999999999999999999999999999993    3679999999998764432


Q ss_pred             ---CcccccCCCCCCChHHHhh-----------ccCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhc-cCC
Q 043425          169 ---LAETLCGSPLYMAPEIMQL-----------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKAT-ELH  232 (575)
Q Consensus       169 ---~~~~~~GT~~Y~APEvl~~-----------~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~-~~~  232 (575)
                         .....+||+.|+|||++..           ..|+.++|||||||++|+|++|..||..... ...+..+.... ...
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence               2346789999999999975           6789999999999999999999999987543 33333333221 222


Q ss_pred             CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       233 ~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ++   ...+.++.+||.+||..||.+|||+.|+++||||+.
T Consensus       242 ~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          242 FP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             Cc---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            22   346789999999999999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.2e-47  Score=384.81  Aligned_cols=259  Identities=25%  Similarity=0.458  Sum_probs=217.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      .+.++|++++.||+|+||.||+|++..+|..||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            455679999999999999999999999999999999866433 3455677899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC---
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccccccc
Confidence            999999999999999988899999999999999999999999999999999999999   77789999999999876543


Q ss_pred             C--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC-CChhcccHHH
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-PDAKILSADC  244 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p-~~~~~ls~el  244 (575)
                      .  .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+................+ .....++..+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence            3  234568999999999999999999999999999999999999999998887766555543222111 1124578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      .++|.+||.+||.+||+..+.+.+.|
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHH
Confidence            99999999999999995555555444

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-47  Score=402.30  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=207.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----   83 (575)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            456789999999999999999999999999999999976555556667889999999999999999999998654     


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  180 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeeccccc
Confidence             5689999999 7899999875 579999999999999999999999999999999999999   677899999999998


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC---------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH---------  232 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~---------  232 (575)
                      .....  ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.....         
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            65432  345789999999999987 679999999999999999999999999999888777766532111         


Q ss_pred             -------------CCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          233 -------------FPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       233 -------------~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                   .+.     .....++++.+||.+||..||.+|||++|+|+||||....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                         000     0123578899999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-46  Score=394.49  Aligned_cols=258  Identities=27%  Similarity=0.483  Sum_probs=225.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..|.+++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4599999999999999999999999999999999865433 344567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~-~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||+. |+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC--
Confidence            9997 57877775 45679999999999999999999999999999999999999   66789999999999765432  


Q ss_pred             cccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ...+||+.|+|||++.   ...++.++|||||||++|+|++|..||.+.+....+..+.........  ...++.++.+
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~  284 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRN  284 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHH
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHH
Confidence             4578999999999985   567899999999999999999999999998888877777665433222  2357899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      ||.+||..||.+|||++++++||||....+..
T Consensus       285 li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999999998765443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-46  Score=382.02  Aligned_cols=266  Identities=27%  Similarity=0.478  Sum_probs=223.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++++.||+|+||.||+|.+..+|..||+|++.....  ...+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            355679999999999999999999999999999999875432  234568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-
Q 043425           89 ILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-  166 (575)
                      ||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... 
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccccc
Confidence            9999999999999876 4679999999999999999999999999999999999999   6778899999999754321 


Q ss_pred             CCCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          167 RGLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      .......+||+.|+|||++.     ...++.++||||||+++|+|++|..||...+.......+.+...... .....++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  249 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSKWS  249 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccccC
Confidence            12234567999999999984     56788899999999999999999999999988887777666543222 2234678


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhh
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVF  280 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~  280 (575)
                      .++.+||.+||..||.+|||++++++||||+...+....
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  288 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL  288 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHH
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhH
Confidence            999999999999999999999999999999987665443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-46  Score=400.06  Aligned_cols=253  Identities=30%  Similarity=0.548  Sum_probs=215.5

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEEE
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN--HPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +|.++++||+|+||.||+|.+.. |+.||||++..........+.+.+|+.+|+.+.  ||||+++++++...+.+||||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            49999999999999999999874 999999999887767777788999999999996  599999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      | +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   + .+.+||+|||+++.+....  
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE---S-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---E-CCeEEEEecCccccccCCCcc
Confidence            9 5688999999998899999999999999999999999999999999999999   3 3689999999998765432  


Q ss_pred             -CcccccCCCCCCChHHHhh-----------ccCCcccccchhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhc-cCCCC
Q 043425          169 -LAETLCGSPLYMAPEIMQL-----------QKYDAKADLWSVGAILFQLVTGKTPFTGSN-QIQLLQNIVKAT-ELHFP  234 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~-----------~~y~~kaDIWSLGviLyeLltG~~PF~~~~-~~~~l~~i~~~~-~~~~p  234 (575)
                       .....+||+.|+|||++..           ..|+.++|||||||+||+|++|..||.+.. ....+..+.... ...++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  290 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence             2356789999999999975           468999999999999999999999998754 334444444332 12222


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                         ...+.++.+||++||..||.+|||+.|+++||||+..
T Consensus       291 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          291 ---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             ---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ---ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence               2457899999999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=386.91  Aligned_cols=259  Identities=26%  Similarity=0.486  Sum_probs=218.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--KLH   87 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--~l~   87 (575)
                      ..++|++.++||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++...+  .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            4567999999999999999999999999999999997643322 2455789999999999999999999997665  789


Q ss_pred             EEEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec-CCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQRHGC---VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~---lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~-dd~~g~vKL~DFGla~~  163 (575)
                      +||||++|++|.+++.....   +++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999999986533   999999999999999999999999999999999999743 35567899999999998


Q ss_pred             cCCCCCcccccCCCCCCChHHHh--------hccCCcccccchhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhccC
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQ--------LQKYDAKADLWSVGAILFQLVTGKTPFTGS----NQIQLLQNIVKATEL  231 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~y~~kaDIWSLGviLyeLltG~~PF~~~----~~~~~l~~i~~~~~~  231 (575)
                      ..........+||+.|+|||++.        ...++.++|||||||++|+|++|..||...    ...+.+..+......
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            87766667788999999999987        467899999999999999999999999743    234555555554321


Q ss_pred             C------------------CCC---ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCC
Q 043425          232 H------------------FPP---DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP  269 (575)
Q Consensus       232 ~------------------~p~---~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hp  269 (575)
                      .                  ++.   ....++..+.+||++||..||.+|||++|+|+||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            1                  111   1134667899999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-46  Score=398.44  Aligned_cols=257  Identities=29%  Similarity=0.481  Sum_probs=216.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------   82 (575)
                      ...++|+++++||+|+||.||+|.+..+|+.||||++.....      ...+|+.+++.++||||+++++++..      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            456789999999999999999999999999999999875432      12379999999999999999999843      


Q ss_pred             --------------------------------CCEEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Q 043425           83 --------------------------------PGKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQV  126 (575)
Q Consensus        83 --------------------------------~~~l~LVmEy~~GgsL~~~l~----~~~~lse~~i~~i~~QLl~aL~~  126 (575)
                                                      ...+++||||++| +|.+.+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3448999999975 7766654    45789999999999999999999


Q ss_pred             HhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHH
Q 043425          127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQ  205 (575)
Q Consensus       127 LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLye  205 (575)
                      ||++||+||||||+|||+.  ..++.+||+|||+++.+.........+||+.|+|||++.+. .|+.++|||||||++|+
T Consensus       157 LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            9999999999999999993  25678999999999987766666778899999999998765 48999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHHhccC----------------CCCC---------ChhcccHHHHHHHHHhhccCCCCCC
Q 043425          206 LVTGKTPFTGSNQIQLLQNIVKATEL----------------HFPP---------DAKILSADCKDLCQKLLRRNPVERL  260 (575)
Q Consensus       206 LltG~~PF~~~~~~~~l~~i~~~~~~----------------~~p~---------~~~~ls~el~dLI~k~L~~DP~~Rp  260 (575)
                      |++|.+||.+.+..+.+..+++....                .++.         .....+.++.+||.+||.+||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999999988888777653211                1111         0123688899999999999999999


Q ss_pred             CHHHHHcCCCCCCC
Q 043425          261 TFEEFFNHPFLSQT  274 (575)
Q Consensus       261 Ta~eiL~Hpff~~~  274 (575)
                      |+.|+++||||...
T Consensus       315 t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          315 NPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHTSGGGHHH
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=378.56  Aligned_cols=265  Identities=27%  Similarity=0.512  Sum_probs=225.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.....    .+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            345679999999999999999999999999999999986532    2457899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~-~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhh
Confidence            999999999999997 45689999999999999999999999999999999999999   67788999999999776443


Q ss_pred             C-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 G-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 ~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      . ......||+.|+|||++....++.++||||||+++|+|++|..||...+.......+.......+. ....++.++.+
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~  257 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR-KPELWSDNFTD  257 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-SGGGSCHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC-CcccCCHHHHH
Confidence            2 344568999999999999999999999999999999999999999998877766655554332222 23457899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      ||.+||..||.+|||++++++||||+........+
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~  292 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILR  292 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGH
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHH
Confidence            99999999999999999999999998876554443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.2e-47  Score=384.66  Aligned_cols=267  Identities=28%  Similarity=0.490  Sum_probs=201.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4567889999999999999999999998999999999875432 233456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           88 LILEYCKGGDLSMYIQR--------HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~--------~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      +||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEecc
Confidence            99999999999999874        4569999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCC------CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC
Q 043425          160 FARSLQPR------GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH  232 (575)
Q Consensus       160 la~~~~~~------~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~  232 (575)
                      ++......      ......+||+.|+|||++.. ..++.++||||||+++|+|++|..||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            99765432      12345689999999999976 578999999999999999999999999887766655544432222


Q ss_pred             CC------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          233 FP------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       233 ~p------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      ..      .....++.++.+||.+||..||.+|||+.|+++||||+....+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            11      11235788999999999999999999999999999998765544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.1e-46  Score=380.87  Aligned_cols=259  Identities=26%  Similarity=0.441  Sum_probs=218.6

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEE-cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC------CcceEEEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARH-RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP------HIIRLHDIIE   81 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~-~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp------nIv~l~~~~~   81 (575)
                      .+.++|+++++||+|+||.||+|.+ ..+|+.||||++...   ....+.+.+|+.+++.++|+      +|+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            4557899999999999999999998 558999999999643   34456788999999988655      4999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC----------
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD----------  149 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~----------  149 (575)
                      ..+.+++||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||+..++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 889999998765  6899999999999999999999999999999999999943221          


Q ss_pred             ------CCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH
Q 043425          150 ------NAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ  223 (575)
Q Consensus       150 ------~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~  223 (575)
                            .+.+||+|||++.....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  56799999999976443  2346789999999999999999999999999999999999999999988777665


Q ss_pred             HHHHhccCCCCC-----------------------------------------ChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          224 NIVKATELHFPP-----------------------------------------DAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       224 ~i~~~~~~~~p~-----------------------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      .+.+.... +|.                                         .....+.++.+||.+||..||.+|||+
T Consensus       245 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          245 MMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            54432211 110                                         011235789999999999999999999


Q ss_pred             HHHHcCCCCCCC
Q 043425          263 EEFFNHPFLSQT  274 (575)
Q Consensus       263 ~eiL~Hpff~~~  274 (575)
                      +|+++||||+..
T Consensus       324 ~ell~hp~f~~~  335 (339)
T 1z57_A          324 REALKHPFFDLL  335 (339)
T ss_dssp             HHHTTSGGGGGG
T ss_pred             HHHhcCHHHHHH
Confidence            999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.9e-46  Score=382.53  Aligned_cols=251  Identities=27%  Similarity=0.504  Sum_probs=213.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++.++||+|+||.||+|++  +|..||||++..........+.+.+|+.++++++||||+++++++...+.+++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3457899999999999999999987  48999999998877777777789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           89 ILEYCKGGDLSMYIQRHGC---VPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~---lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ||||++||+|.+++.+.+.   +++..++.++.||+.||+|||++|  |+||||||+|||+   +.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCcc
Confidence            9999999999999986653   999999999999999999999999  9999999999999   7778999999999976


Q ss_pred             cCCCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-cCCCCCChhccc
Q 043425          164 LQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-ELHFPPDAKILS  241 (575)
Q Consensus       164 ~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-~~~~p~~~~~ls  241 (575)
                      ..... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.... ...++   ..++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~  265 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---RNLN  265 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC---TTSC
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---ccCC
Confidence            54332 2445789999999999999999999999999999999999999999998888776654332 22222   3588


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +++.+||++||..||.+|||++++++
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.8e-46  Score=391.41  Aligned_cols=257  Identities=30%  Similarity=0.495  Sum_probs=219.7

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----GKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~l   86 (575)
                      ++|+++++||+|+||.||+|.+..+|..||||++.... .....+.+.+|+.+++.++||||+++++++...     ..+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            58999999999999999999999999999999997533 344557789999999999999999999999655     468


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       106 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCC
Confidence            99999996 599999875 469999999999999999999999999999999999999   7778899999999987643


Q ss_pred             CC----CcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC-------
Q 043425          167 RG----LAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP-------  234 (575)
Q Consensus       167 ~~----~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p-------  234 (575)
                      ..    .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.........       
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            32    23456899999999987654 5899999999999999999999999998887777766542211100       


Q ss_pred             --------------------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 --------------------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 --------------------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                          .....++.++.+||.+||.+||.+|||++|+++||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                                0013468899999999999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.2e-46  Score=392.79  Aligned_cols=259  Identities=29%  Similarity=0.500  Sum_probs=220.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE--
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL--   86 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l--   86 (575)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+..  
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            355789999999999999999999999999999999987666666677899999999999999999999999776654  


Q ss_pred             ----EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           87 ----HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        87 ----~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                          ++||||+. ++|.+++.  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR  192 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred             ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence                99999996 68888773  459999999999999999999999999999999999999   777889999999997


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC--------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF--------  233 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~--------  233 (575)
                      .....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+......        
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            65432  345789999999999987 6889999999999999999999999999998887777665322110        


Q ss_pred             --------------C-C----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          234 --------------P-P----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       234 --------------p-~----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                    + .    ....+++++.+||++||+.||.+|||++|+++||||+...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                          0 0    0124688999999999999999999999999999998653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.8e-46  Score=399.78  Aligned_cols=256  Identities=31%  Similarity=0.475  Sum_probs=214.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP------   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~------   83 (575)
                      ...+|+++++||+|+||.||+|++..+|+.||||++.....      ...+|+.+|+.++||||++++++|...      
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            44579999999999999999999999999999999875421      234799999999999999999988432      


Q ss_pred             CEEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQ----RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~----~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      ..+++||||+++ +|..++.    ....+++..++.++.||+.||+|||++||+||||||+|||+.  .+.+.+||+|||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG  202 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCT
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccch
Confidence            247799999976 6665554    346799999999999999999999999999999999999993  244678999999


Q ss_pred             cccccCCCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--------
Q 043425          160 FARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE--------  230 (575)
Q Consensus       160 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~--------  230 (575)
                      +++.+.........+||+.|+|||++.+. .|+.++|||||||+||+|++|++||.+.+..+.+..+++...        
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99887666556678899999999999764 799999999999999999999999999988877777665311        


Q ss_pred             --------CCCCCC---------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          231 --------LHFPPD---------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       231 --------~~~p~~---------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                              ..++..         ...++.++++||.+||.+||.+|||+.|+++||||...
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                    111110         12457899999999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.3e-46  Score=392.28  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC--------CCCcceEEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN--------HPHIIRLHDIIE   81 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~--------HpnIv~l~~~~~   81 (575)
                      +.++|+++++||+|+||.||+|++..+|+.||||++...   ....+.+.+|+.+++.+.        |+||+++++++.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            457899999999999999999999999999999999753   445567889999999885        788999999987


Q ss_pred             ----eCCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCC------
Q 043425           82 ----VPGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDD------  148 (575)
Q Consensus        82 ----~~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd------  148 (575)
                          ....+++||||+ +++|.+++...  +.+++..++.++.||+.||+|||++ ||+||||||+|||+..++      
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence                456899999999 66776666544  4699999999999999999999999 999999999999994221      


Q ss_pred             ----------------------------------------CCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc
Q 043425          149 ----------------------------------------DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ  188 (575)
Q Consensus       149 ----------------------------------------~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~  188 (575)
                                                              ....+||+|||++......  ....+||+.|+|||++.+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence                                                    1137999999999876433  3456899999999999999


Q ss_pred             cCCcccccchhhHHHHHHHhCCCCCCCCC------HHHHHHHHHHhccCCC-----------------------------
Q 043425          189 KYDAKADLWSVGAILFQLVTGKTPFTGSN------QIQLLQNIVKATELHF-----------------------------  233 (575)
Q Consensus       189 ~y~~kaDIWSLGviLyeLltG~~PF~~~~------~~~~l~~i~~~~~~~~-----------------------------  233 (575)
                      .|+.++|||||||+||+|++|..||.+.+      ....+..+.+......                             
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            99999999999999999999999998654      2333333332111000                             


Q ss_pred             ---------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          234 ---------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       234 ---------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                               .......+.++.+||.+||++||.+|||++|+|+||||+
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                     001123467889999999999999999999999999996

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.1e-46  Score=377.23  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=227.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      ...|++++.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            35599999999999999999999999999999999865433 23466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      ||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... .
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCC
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccccc
Confidence            99999999999864 579999999999999999999999999999999999999   677889999999998765433 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++....++.++||||||+++|+|++|..||...........+.......++   ..++.++.+||.
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~  252 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---GNYSKPLKEFVE  252 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC---SSCCHHHHHHHH
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCc---cccCHHHHHHHH
Confidence            44578999999999999999999999999999999999999999998888877766655433333   357899999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||..||.+|||++|+++||||...
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999999999654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=380.61  Aligned_cols=263  Identities=27%  Similarity=0.502  Sum_probs=219.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV----   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~----   82 (575)
                      ....++|++++.||+|+||.||+|++..+|+.||||++......   .+.+.+|+.+++++ +||||+++++++..    
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            34567899999999999999999999999999999999765332   34678999999998 79999999999976    


Q ss_pred             --CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           83 --PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        83 --~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                        .+.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Df  173 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF  173 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeC
Confidence              56899999999999999999864  579999999999999999999999999999999999999   67788999999


Q ss_pred             ccccccCCC-CCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC
Q 043425          159 GFARSLQPR-GLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH  232 (575)
Q Consensus       159 Gla~~~~~~-~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~  232 (575)
                      |++...... ......+||+.|+|||++.     ...++.++||||||+++|+|++|..||.+.+.......+.......
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  253 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  253 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence            999765432 2344568999999999986     5678999999999999999999999999988877766665543222


Q ss_pred             CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       233 ~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                      ..  ...++.++.+||.+||..||.+|||++++++||||+....+.
T Consensus       254 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          254 LK--SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             CS--CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             CC--ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            22  245789999999999999999999999999999998765543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=400.31  Aligned_cols=262  Identities=27%  Similarity=0.483  Sum_probs=201.8

Q ss_pred             CeeecCEEE-EEEecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 043425            8 GRVVGDYLV-GRQIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--   82 (575)
Q Consensus         8 g~~v~~Y~i-~~~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--   82 (575)
                      .++.+.|.+ +++||+|+||.||+|+++  .++..||||++......    ..+.+|+.+|+.++||||+++++++..  
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            345566887 568999999999999976  47899999999765443    347789999999999999999999954  


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC-CCCCc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRH---------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD-DDNAA  152 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~---------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d-d~~g~  152 (575)
                      ...+|+||||+. ++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +..+.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            678999999996 5888887532         249999999999999999999999999999999999999654 46689


Q ss_pred             EEEcccccccccCCC----CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCH---------
Q 043425          153 LKIADFGFARSLQPR----GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQ---------  218 (575)
Q Consensus       153 vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~---------  218 (575)
                      +||+|||+++.+...    ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+...         
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876432    234567899999999999874 589999999999999999999999987654         


Q ss_pred             HHHHHHHHHhccCCCCCChhc----------------------------------ccHHHHHHHHHhhccCCCCCCCHHH
Q 043425          219 IQLLQNIVKATELHFPPDAKI----------------------------------LSADCKDLCQKLLRRNPVERLTFEE  264 (575)
Q Consensus       219 ~~~l~~i~~~~~~~~p~~~~~----------------------------------ls~el~dLI~k~L~~DP~~RpTa~e  264 (575)
                      .+.+..+...........+..                                  .+.++.+||++||.+||.+|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            244555544332222111111                                  1678899999999999999999999


Q ss_pred             HHcCCCCCCC
Q 043425          265 FFNHPFLSQT  274 (575)
Q Consensus       265 iL~Hpff~~~  274 (575)
                      +|+||||...
T Consensus       331 ~L~hp~f~~~  340 (405)
T 3rgf_A          331 AMQDPYFLED  340 (405)
T ss_dssp             HHTSGGGTSS
T ss_pred             HhcChhhccC
Confidence            9999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-46  Score=398.04  Aligned_cols=260  Identities=30%  Similarity=0.458  Sum_probs=215.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG---   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~---   84 (575)
                      ....++|.++++||+|+||.||+|++..++. +|+|++.....      ...+|+.+++.++||||+++++++...+   
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3456789999999999999999999987665 88887754321      1236999999999999999999985543   


Q ss_pred             ---EEEEEEeecCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           85 ---KLHLILEYCKGGDLSMYI---QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        85 ---~l~LVmEy~~GgsL~~~l---~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                         .+++||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||+.  ..++.+||+||
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DF  186 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDF  186 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeC
Confidence               389999999875443332   2356799999999999999999999999999999999999992  26789999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC------
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL------  231 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~------  231 (575)
                      |+++.+.........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.+....      
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999887666666678899999999999765 5899999999999999999999999999988877777653211      


Q ss_pred             ----------CCCCC---------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          232 ----------HFPPD---------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       232 ----------~~p~~---------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                                .++..         ...+++++++||.+||.+||.+|||+.|+++||||....+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                      11110         0237789999999999999999999999999999987654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-46  Score=391.48  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=207.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK---   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~---   85 (575)
                      ..+++|++.++||+|+||.||+|.+..+|+.||||++......   .....+++..+..++||||+++++++...+.   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            5678999999999999999999999999999999998654321   2345678888899999999999999865433   


Q ss_pred             ----EEEEEeecCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccccccCCceeeecCCCCCcEEE
Q 043425           86 ----LHLILEYCKGGDLSMYI----QRHGCVPEETAKHFMKQLAAGLQVLR--DNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        86 ----l~LVmEy~~GgsL~~~l----~~~~~lse~~i~~i~~QLl~aL~~LH--~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                          +++||||+++ +|...+    .....+++..++.++.||+.||.|||  ++||+||||||+|||+.  ..++.+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEE
Confidence                8999999976 444433    34567999999999999999999999  99999999999999993  23679999


Q ss_pred             cccccccccCCCCCcccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--
Q 043425          156 ADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--  232 (575)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--  232 (575)
                      +|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.+.....  
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            9999998877666666788999999999996654 8999999999999999999999999999888887776532111  


Q ss_pred             --------------------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          233 --------------------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       233 --------------------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                                ++......+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                                      0011112567899999999999999999999999999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-45  Score=382.77  Aligned_cols=262  Identities=30%  Similarity=0.475  Sum_probs=220.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP----   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~----   83 (575)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...    
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            456788999999999999999999999999999999996432 344556788999999999999999999987654    


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                       ...++||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccc
Confidence             67999999996 589999876 579999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCC-----------CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Q 043425          163 SLQPRG-----------LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       163 ~~~~~~-----------~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      ......           .....+||+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            764321           1234689999999999865 6789999999999999999999999999887776655543211


Q ss_pred             CCC-----------------------CC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          231 LHF-----------------------PP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       231 ~~~-----------------------p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ...                       +.     ....++.++.+||++||..||.+|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            110                       00     0135788999999999999999999999999999998654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-46  Score=384.07  Aligned_cols=262  Identities=24%  Similarity=0.450  Sum_probs=203.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|++++.||+|+||.||+|.+..++.   .||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45679999999999999999999887765   899999987655555667899999999999999999999999776654


Q ss_pred             ------EEEEeecCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEE
Q 043425           87 ------HLILEYCKGGDLSMYIQRHG------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        87 ------~LVmEy~~GgsL~~~l~~~~------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                            ++||||+.+|+|.+++....      .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCCEE
Confidence                  99999999999999996543      59999999999999999999999999999999999999   6778999


Q ss_pred             EcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcc
Q 043425          155 IADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       155 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      |+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            999999987644332   223456788999999999999999999999999999999 9999999988888887776654


Q ss_pred             CCCCCChhcccHHHHHHHHHhhccCCCCCCC-------HHHHHcCCCCCCCCch
Q 043425          231 LHFPPDAKILSADCKDLCQKLLRRNPVERLT-------FEEFFNHPFLSQTQPD  277 (575)
Q Consensus       231 ~~~p~~~~~ls~el~dLI~k~L~~DP~~RpT-------a~eiL~Hpff~~~~~~  277 (575)
                      ...+   ..++.++.+||.+||..||.+|||       +++++.|+|+.....+
T Consensus       258 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          258 LKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             CCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            4433   357899999999999999999999       7888999999775443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=380.24  Aligned_cols=262  Identities=29%  Similarity=0.538  Sum_probs=216.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE------
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE------   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~------   81 (575)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.      
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            35677899999999999999999999999999999998754  3455677899999999999999999999873      


Q ss_pred             --------eCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           82 --------VPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        82 --------~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                              ..+.+++||||++ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+.  ..++.+
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~  160 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVL  160 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEE
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeE
Confidence                    3468999999997 599999864 6799999999999999999999999999999999999993  245789


Q ss_pred             EEcccccccccCCC----CCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 043425          154 KIADFGFARSLQPR----GLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA  228 (575)
Q Consensus       154 KL~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~  228 (575)
                      ||+|||++......    .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||.+.+..+.+..+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999865432    23345678999999999875 67899999999999999999999999999888877776654


Q ss_pred             ccCCC---------------------CC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          229 TELHF---------------------PP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       229 ~~~~~---------------------p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .....                     +.     ....++.++++||++||..||.+|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            32110                     00     0124789999999999999999999999999999997653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.9e-46  Score=374.14  Aligned_cols=263  Identities=25%  Similarity=0.507  Sum_probs=213.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------   82 (575)
                      +..++|++++.||+|+||.||+|++..+|+.||||++...   ....+.+.+|+.+++.++||||+++++++..      
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            3567899999999999999999999999999999999652   3445678999999999999999999998754      


Q ss_pred             -------CCEEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEE
Q 043425           83 -------PGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        83 -------~~~l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                             .+.+++||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEE
Confidence                   457899999999999999998654 57899999999999999999999999999999999999   6778899


Q ss_pred             EcccccccccCCC---------------CCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCC-C
Q 043425          155 IADFGFARSLQPR---------------GLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGS-N  217 (575)
Q Consensus       155 L~DFGla~~~~~~---------------~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~-~  217 (575)
                      |+|||++......               ......+||+.|+|||++.+. .++.++||||||+++|+|++   ||... .
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999765421               223456799999999999864 68999999999999999998   56533 3


Q ss_pred             HHHHHHHHHHhccCCCCCCh-hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          218 QIQLLQNIVKATELHFPPDA-KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       218 ~~~~l~~i~~~~~~~~p~~~-~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      .......+.. ....+++.. ...+..+.+||++||..||.+|||++++++||||.....+...+
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  297 (303)
T 1zy4_A          234 RVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK  297 (303)
T ss_dssp             HHHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHHH
T ss_pred             HHHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHHH
Confidence            3334444333 233334332 45678899999999999999999999999999998776655443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-46  Score=391.27  Aligned_cols=261  Identities=30%  Similarity=0.464  Sum_probs=219.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CC-----CcceEEEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HP-----HIIRLHDIIE   81 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hp-----nIv~l~~~~~   81 (575)
                      ....++|++.++||+|+||.||+|.+..+|+.||||++...   ......+..|+.+++.+. |+     +|+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            35678899999999999999999999999999999999743   344566778999988875 44     4999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLR--DNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH--~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      ..+.+|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||+.. +..+.+||+|
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~D  204 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVD  204 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEe
Confidence            9999999999996 5999999865  46999999999999999999999  579999999999999943 2457899999


Q ss_pred             cccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC---
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP---  234 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p---  234 (575)
                      ||+++.....  ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.......   
T Consensus       205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL  282 (382)
T ss_dssp             CTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9999876432  34678999999999999999999999999999999999999999999988888777654221100   


Q ss_pred             --------------------------------CChh-------------------------cccHHHHHHHHHhhccCCC
Q 043425          235 --------------------------------PDAK-------------------------ILSADCKDLCQKLLRRNPV  257 (575)
Q Consensus       235 --------------------------------~~~~-------------------------~ls~el~dLI~k~L~~DP~  257 (575)
                                                      +...                         ....++++||++||++||.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence                                            0000                         0114789999999999999


Q ss_pred             CCCCHHHHHcCCCCCCCC
Q 043425          258 ERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       258 ~RpTa~eiL~Hpff~~~~  275 (575)
                      +|||++|+|+||||+...
T Consensus       363 ~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TSCCHHHHTTSGGGCC--
T ss_pred             hCCCHHHHhcCcccccCC
Confidence            999999999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.9e-46  Score=386.63  Aligned_cols=259  Identities=29%  Similarity=0.505  Sum_probs=220.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK---   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~---   85 (575)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++...+.   
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            35688999999999999999999999999999999998766566667788999999999999999999999976653   


Q ss_pred             ---EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           86 ---LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        86 ---l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                         +|+||||+. ++|.+++.  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR  174 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTT
T ss_pred             ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccccc
Confidence               599999997 58888774  359999999999999999999999999999999999999   677899999999997


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC----------
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL----------  231 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~----------  231 (575)
                      .....  ....+||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+.+..+.+....          
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            65432  345689999999999986 67899999999999999999999999999887777666543111          


Q ss_pred             -----------------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          232 -----------------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       232 -----------------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                       .++.....++.++.+||.+||+.||.+|||++|+++||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                             11222245789999999999999999999999999999997653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-45  Score=390.32  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=220.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEc-------CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHR-------VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDII   80 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~-------~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~   80 (575)
                      ...++|.+++.||+|+||.||+|++.       .++..||||++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34578999999999999999999975       356789999997653 445567799999999999 899999999999


Q ss_pred             EeCCEEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceee
Q 043425           81 EVPGKLHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL  144 (575)
Q Consensus        81 ~~~~~l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl  144 (575)
                      ...+.+|+||||++||+|.+++...+                .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999998653                47899999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHH
Q 043425          145 CTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQ  220 (575)
Q Consensus       145 ~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~  220 (575)
                         +.++.+||+|||+++......   ......||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+....+
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence               777899999999998665432   2234567889999999999999999999999999999999 999999988888


Q ss_pred             HHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       221 ~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +...+........+   ..++.++.+||.+||..||.+|||+.|++++
T Consensus       314 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77776665443333   3578999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=379.58  Aligned_cols=259  Identities=30%  Similarity=0.548  Sum_probs=219.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEE--EeCC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINHPHIIRLHDII--EVPG   84 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~--~~~~   84 (575)
                      +++++|++++.||+|+||.||+|.+..+|..||+|++......  ......+.+|+.+++.++||||+++++++  ...+
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            4678999999999999999999999999999999999764321  13346789999999999999999999998  4456


Q ss_pred             EEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      .+++||||+.++ |.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            799999999876 7777765  3579999999999999999999999999999999999999   677899999999998


Q ss_pred             ccCC---CCCcccccCCCCCCChHHHhhcc--CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          163 SLQP---RGLAETLCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       163 ~~~~---~~~~~~~~GT~~Y~APEvl~~~~--y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      ....   ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||.+.+..+....+.+.. ..++   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~---  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIP---  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCC---
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCC---
Confidence            7643   22334567999999999997644  3778999999999999999999999998888877776653 3333   


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ..++.++.+||++||..||.+|||++|+++||||+...
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            25789999999999999999999999999999997653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-45  Score=380.60  Aligned_cols=263  Identities=27%  Similarity=0.458  Sum_probs=220.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCC-cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC------cceEEEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHG-TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH------IIRLHDIIE   81 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~~~~   81 (575)
                      .+.++|++++.||+|+||.||+|.+..++ ..||||++...   ....+.+.+|+.+++.+.|++      ++.+++++.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            35578999999999999999999998877 78999999643   345567889999999987655      999999999


Q ss_pred             eCCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC------------
Q 043425           82 VPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD------------  147 (575)
Q Consensus        82 ~~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d------------  147 (575)
                      ..+.+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+..+            
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999999 667777776553  69999999999999999999999999999999999999432            


Q ss_pred             ----CCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH
Q 043425          148 ----DDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ  223 (575)
Q Consensus       148 ----d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~  223 (575)
                          +..+.+||+|||++.....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                3467899999999976433  2345789999999999999999999999999999999999999999988777665


Q ss_pred             HHHHhccCCCCC-----------------------------------------ChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          224 NIVKATELHFPP-----------------------------------------DAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       224 ~i~~~~~~~~p~-----------------------------------------~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      .+.+.... .|.                                         .....+.++.+||++||..||.+|||+
T Consensus       250 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          250 MMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            55443211 110                                         001235688999999999999999999


Q ss_pred             HHHHcCCCCCCCCchh
Q 043425          263 EEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       263 ~eiL~Hpff~~~~~~~  278 (575)
                      +|+++||||+...++.
T Consensus       329 ~e~l~hp~f~~~~~~~  344 (355)
T 2eu9_A          329 AEALLHPFFAGLTPEE  344 (355)
T ss_dssp             HHHTTSGGGGGCCHHH
T ss_pred             HHHhcChhhcCCChhh
Confidence            9999999999876653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=393.04  Aligned_cols=259  Identities=22%  Similarity=0.380  Sum_probs=223.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEE-----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHAR-----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~-----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ..++|+++++||+|+||.||+|.     +..++..||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34679999999999999999999     55678899999986533 4455567889999999999999999999999989


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG-------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~-------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      ..++||||++||+|.+++...+       .+++..++.++.||+.||+|||++||+||||||+|||+..++....+||+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999999998653       489999999999999999999999999999999999995544566799999


Q ss_pred             cccccccCC---CCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          158 FGFARSLQP---RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       158 FGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      ||+++....   .......+||+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+....+....+........
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~  307 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  307 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999975432   223345678999999999999999999999999999999998 9999999999888888777654443


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      +   ..++.++.+||.+||+.||.+|||++++++|.++.
T Consensus       308 ~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          308 P---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            3   35789999999999999999999999999987764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.5e-46  Score=387.23  Aligned_cols=265  Identities=29%  Similarity=0.453  Sum_probs=212.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc---------CHHHHHHHHHHHHHHHhCCCCCcceEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL---------NKKLQESLMSEIFILKRINHPHIIRLHDI   79 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~---------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~   79 (575)
                      ...++|.+++.||+|+||.||+|.+.. |..||||++.....         .....+.+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345789999999999999999999874 99999999865322         23345778999999999999999999999


Q ss_pred             EEe-----CCEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           80 IEV-----PGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        80 ~~~-----~~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      +..     ...+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~  173 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDI  173 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCE
Confidence            844     347899999997 5888887654 479999999999999999999999999999999999999   677889


Q ss_pred             EEcccccccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC
Q 043425          154 KIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH  232 (575)
Q Consensus       154 KL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~  232 (575)
                      ||+|||++............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999987666555667789999999999977 678999999999999999999999999998888777766432111


Q ss_pred             -----------------------CCC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchh
Q 043425          233 -----------------------FPP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQ  278 (575)
Q Consensus       233 -----------------------~p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~  278 (575)
                                             .+.     .....++.+.+||.+||..||.+|||++|+++||||+......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence                                   000     0124578899999999999999999999999999999875443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-47  Score=404.93  Aligned_cols=249  Identities=15%  Similarity=0.225  Sum_probs=205.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIF---ILKRINHPHIIRLH-------DI   79 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~---iL~~L~HpnIv~l~-------~~   79 (575)
                      .++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.   +|+.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4789999999999999999999999999999999986532 3344567889995   55556899999998       77


Q ss_pred             EEeCCE-----------------EEEEEeecCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHhhCCcccc
Q 043425           80 IEVPGK-----------------LHLILEYCKGGDLSMYIQRHGCVPE-------ETAKHFMKQLAAGLQVLRDNNLIHR  135 (575)
Q Consensus        80 ~~~~~~-----------------l~LVmEy~~GgsL~~~l~~~~~lse-------~~i~~i~~QLl~aL~~LH~~gIvHr  135 (575)
                      ++..+.                 .||||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776643                 89999999 6899999987666666       7888899999999999999999999


Q ss_pred             cccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc-----------cCCcccccchhhHHHH
Q 043425          136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-----------KYDAKADLWSVGAILF  204 (575)
Q Consensus       136 DLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-----------~y~~kaDIWSLGviLy  204 (575)
                      ||||+|||+   +.++.+||+|||+++....  .....+| +.|+|||++...           .|+.++|||||||++|
T Consensus       231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999   6778999999999986432  3456788 999999999988           8999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          205 QLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       205 eLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +|++|+.||.+.+.......+..        ....++.++.+||.+||..||.+|||+.|+++||||+..
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999987664443322221        123578999999999999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=375.44  Aligned_cols=260  Identities=25%  Similarity=0.480  Sum_probs=204.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|++++.||+|+||.||+|.++.+|+.||||++..........+.+.++..+++.++||||+++++++...+.+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            56789999999999999999999999999999999987654444444555666678889999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCC
Confidence            9999 6666666654 46899999999999999999999996 99999999999999   67789999999999877655


Q ss_pred             CCcccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCCChhccc
Q 043425          168 GLAETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ......+||+.|+|||++.     ...++.++||||||+++|+|++|..||.. ....+.+..+.......++. ...++
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  257 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG-HMGFS  257 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS-SSCCC
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc-cCCCC
Confidence            5556678999999999994     56788999999999999999999999987 45556666666654443332 23578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      .++.+||.+||..||.+|||++++++||||+..
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            999999999999999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=381.14  Aligned_cols=251  Identities=24%  Similarity=0.451  Sum_probs=218.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|++.+.||+|+||.||+|.+..+|.   .||||++.... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            45779999999999999999999986655   49999997543 455567799999999999999999999999988999


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccccc
Confidence            9999999999999999755 579999999999999999999999999999999999999   777899999999998765


Q ss_pred             CCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+........+   ..+
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  279 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP---MGC  279 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC---CCc
Confidence            4321    223456788999999999999999999999999999999 99999999998888887766444333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.++.+||.+||..||.+|||+.++++
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            899999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-45  Score=366.48  Aligned_cols=249  Identities=24%  Similarity=0.486  Sum_probs=219.8

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.......   +.+.+|+.++++++||||+++++++...+..++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            4468999999999999999999987 58889999998765443   4588999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccccc
Confidence            9999999999999754 469999999999999999999999999999999999999   667889999999998654332


Q ss_pred             --CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                        ......||+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+........+   ...+.++.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  237 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY  237 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHHH
Confidence              2334567888999999999999999999999999999999 99999999998888887766443333   35789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +|+.+||..||.+|||+.++++|
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-46  Score=388.72  Aligned_cols=265  Identities=25%  Similarity=0.492  Sum_probs=226.8

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHH---------------HHHHHHHHHHHHHhCCCCC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---------------LQESLMSEIFILKRINHPH   72 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~---------------~~~~i~~Ei~iL~~L~Hpn   72 (575)
                      ....++|++++.||+|+||.||+|.+  +|+.||||++........               ..+.+.+|+.+++.++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            45679999999999999999999999  899999999975432211               1166889999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEeecCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCcee
Q 043425           73 IIRLHDIIEVPGKLHLILEYCKGGDLSMY------IQR--HGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLL  143 (575)
Q Consensus        73 Iv~l~~~~~~~~~l~LVmEy~~GgsL~~~------l~~--~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNIL  143 (575)
                      |+++++++...+.+++||||++|++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      665  5679999999999999999999999 99999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhc-cCCc-ccccchhhHHHHHHHhCCCCCCCCCH-HH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ-KYDA-KADLWSVGAILFQLVTGKTPFTGSNQ-IQ  220 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~-kaDIWSLGviLyeLltG~~PF~~~~~-~~  220 (575)
                      +   +.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||.+... .+
T Consensus       185 ~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 M---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             E---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             E---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9   67789999999999876443 34567899999999999877 6666 89999999999999999999998876 66


Q ss_pred             HHHHHHHhccCCCCCC----------------hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhh
Q 043425          221 LLQNIVKATELHFPPD----------------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQV  279 (575)
Q Consensus       221 ~l~~i~~~~~~~~p~~----------------~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~  279 (575)
                      ....+... ...++..                ...++.++.+||.+||+.||.+|||++|+++||||....++.+
T Consensus       261 ~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~  334 (348)
T 2pml_X          261 LFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL  334 (348)
T ss_dssp             HHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHH
Confidence            66555443 3333321                1457899999999999999999999999999999998766543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.3e-46  Score=386.33  Aligned_cols=259  Identities=33%  Similarity=0.559  Sum_probs=190.0

Q ss_pred             CeeecCEEEEE-EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 043425            8 GRVVGDYLVGR-QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----   82 (575)
Q Consensus         8 g~~v~~Y~i~~-~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----   82 (575)
                      ..+.++|.+.+ .||+|+||.||+|.++.+|+.||||++...   ....   .+....++.+.||||+++++++..    
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            35778999965 699999999999999999999999999653   2221   222334667899999999999976    


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      ...+++||||++||+|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            456899999999999999998764  699999999999999999999999999999999999996655677899999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH----HHHHhccCCCCCC
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ----NIVKATELHFPPD  236 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~----~i~~~~~~~~p~~  236 (575)
                      +...... .....+||+.|+|||++....++.++||||||+++|+|++|..||.+........    .+.........+.
T Consensus       178 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          178 AKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             CEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             ceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            9865433 3446789999999999988899999999999999999999999998766544322    2222211112223


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ...++.++++||++||..||.+|||++|+++||||++
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            3568999999999999999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=379.39  Aligned_cols=252  Identities=24%  Similarity=0.425  Sum_probs=220.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ..++|++++.||+|+||.||+|++.     .+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            4578999999999999999999997     456899999997543 4555678999999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCC
Q 043425           85 KLHLILEYCKGGDLSMYIQRH------------------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQ  140 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~------------------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPe  140 (575)
                      .+++||||++||+|.+++...                        ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            999999999999999999864                        56999999999999999999999999999999999


Q ss_pred             ceeeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCC
Q 043425          141 NLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGS  216 (575)
Q Consensus       141 NILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~  216 (575)
                      |||+   +.++.+||+|||++.......   ......||+.|+|||++....++.++||||||+++|+|++ |..||.+.
T Consensus       204 NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          204 NCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             eEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999   677889999999998654332   2334678999999999999999999999999999999999 99999999


Q ss_pred             CHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          217 NQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       217 ~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +..+....+........+   ..++.++.+||++||..||.+|||+.+++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            988888777766443333   3578999999999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=376.08  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=212.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|.++++||+|+||.||+|.+..+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            457899999999999999999999999999999988543  456677899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccc
Confidence            999999999999987 4679999999999999999999999999999999999999   777889999999998654332


Q ss_pred             Cc---------------ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHHh
Q 043425          169 LA---------------ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-----LLQNIVKA  228 (575)
Q Consensus       169 ~~---------------~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~-----~l~~i~~~  228 (575)
                      ..               ...+||+.|+|||++.+..++.++||||||+++|+|++|..||.......     ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            21               25689999999999999999999999999999999999999987542211     01111111


Q ss_pred             ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       229 ~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                         ..+   ..+++++.+||.+||..||.+|||++++++
T Consensus       243 ---~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 ---YCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             ---TCC---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---cCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               112   246788999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5e-45  Score=364.51  Aligned_cols=250  Identities=22%  Similarity=0.438  Sum_probs=220.0

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++.......   +.+.+|+.+++.++||||+++++++...+..++
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            35578999999999999999999877 67789999998765443   458899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTT
T ss_pred             EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchh
Confidence            999999999999998754 59999999999999999999999999999999999999   77789999999999876544


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........+   ...++++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  234 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTI  234 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHH
Confidence            32  223456778999999999999999999999999999999 99999999988888777665443333   3478999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+||.+||..||.+|||+.|++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=370.10  Aligned_cols=252  Identities=29%  Similarity=0.498  Sum_probs=208.6

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      ...||+|+||.||+|.+..++..||||++....  ....+.+.+|+.+++.++||||+++++++...+.+++||||++|+
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  104 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG  104 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence            348999999999999999999999999997653  334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCccc
Q 043425           97 DLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAET  172 (575)
Q Consensus        97 sL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~~  172 (575)
                      +|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+.  ...+.+||+|||++...... .....
T Consensus       105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CC
T ss_pred             CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccc
Confidence            9999998652   467999999999999999999999999999999999993  22678999999999876442 23445


Q ss_pred             ccCCCCCCChHHHhhcc--CCcccccchhhHHHHHHHhCCCCCCCCCHHHH-HHHH-HHhccCCCCCChhcccHHHHHHH
Q 043425          173 LCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQL-LQNI-VKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       173 ~~GT~~Y~APEvl~~~~--y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~-l~~i-~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ..||+.|+|||++....  ++.++||||||+++|+|++|..||........ .... .....   +.....++.++.+||
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  259 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH---PEIPESMSAEAKAFI  259 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC---CCCCTTSCHHHHHHH
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc---ccccccCCHHHHHHH
Confidence            78999999999997654  88999999999999999999999976543322 2111 11212   222245889999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .+||..||.+|||++++++||||+...
T Consensus       260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHccCChhhCCCHHHHhcChhhhhcc
Confidence            999999999999999999999998653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-45  Score=383.51  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=213.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEE-----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHAR-----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~-----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|+++++||+|+||.||+|+     +..+++.||||++.... .....+.+.+|+.++.++ +||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            45789999999999999999999     55677999999997543 344456789999999999 789999999998775


Q ss_pred             C-EEEEEEeecCCCCHHHHHHHcCC-------------------------------------------------------
Q 043425           84 G-KLHLILEYCKGGDLSMYIQRHGC-------------------------------------------------------  107 (575)
Q Consensus        84 ~-~l~LVmEy~~GgsL~~~l~~~~~-------------------------------------------------------  107 (575)
                      + .+++||||++||+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            4 49999999999999999976543                                                       


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC---Ccccc
Q 043425          108 -----------VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETL  173 (575)
Q Consensus       108 -----------lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~  173 (575)
                                 +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......   .....
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhcccc
Confidence                       8999999999999999999999999999999999999   667889999999998654332   23346


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHH-HHHHhccCCCCCChhcccHHHHHHHHHh
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQ-NIVKATELHFPPDAKILSADCKDLCQKL  251 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~-~i~~~~~~~~p~~~~~ls~el~dLI~k~  251 (575)
                      .||+.|+|||++.+..|+.++||||||+++|+|++ |..||.+......+. .+........+   ..+++++.+||.+|
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~  332 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDC  332 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHH
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHH
Confidence            78999999999999999999999999999999998 999999876544443 33333333333   35789999999999


Q ss_pred             hccCCCCCCCHHHHHcC
Q 043425          252 LRRNPVERLTFEEFFNH  268 (575)
Q Consensus       252 L~~DP~~RpTa~eiL~H  268 (575)
                      |..||.+|||+.|+++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-44  Score=366.72  Aligned_cols=256  Identities=19%  Similarity=0.246  Sum_probs=214.7

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l   86 (575)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++......    ..+.+|+.+++.+ +|+||+++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            34556699999999999999999999999999999998754322    3477899999999 799999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC--CCCCcEEEcccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD--DDNAALKIADFGFARS  163 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d--d~~g~vKL~DFGla~~  163 (575)
                      ++||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+..+  .....+||+|||++..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 999999998754 69999999999999999999999999999999999999433  2234499999999987


Q ss_pred             cCCCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcc-C
Q 043425          164 LQPRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATE-L  231 (575)
Q Consensus       164 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~---~~~~~l~~i~~~~~-~  231 (575)
                      .....        .....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.   .....+..+..... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            65432        234578999999999999999999999999999999999999999884   34444444443322 1


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+.....++.++.+||.+||..||.+|||++++++.
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111123578999999999999999999999999773

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.1e-45  Score=377.09  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=210.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~   87 (575)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++......    +.+.+|+.+++.+ +||||+++++++...+..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            4456799999999999999999999999999999998765332    3477999999999 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCc-----EEEcccccc
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAA-----LKIADFGFA  161 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~-----vKL~DFGla  161 (575)
                      +||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.     +||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCCTTC
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEcccc
Confidence            999999 99999999864 689999999999999999999999999999999999999   44444     999999999


Q ss_pred             cccCCCCC--------cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcc
Q 043425          162 RSLQPRGL--------AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS---NQIQLLQNIVKATE  230 (575)
Q Consensus       162 ~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~---~~~~~l~~i~~~~~  230 (575)
                      +.+.....        ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   ...+.+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            87643322        24678999999999999999999999999999999999999999884   33444444443322


Q ss_pred             CCCCCC-hhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          231 LHFPPD-AKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       231 ~~~p~~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ...... ....+ ++.+||.+||..||.+||+++++++
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111111 12244 9999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.2e-45  Score=373.17  Aligned_cols=253  Identities=27%  Similarity=0.444  Sum_probs=220.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      -..++|.+++.||+|+||.||+|.+.     .++..||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            34578999999999999999999983     456899999997543 455567789999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHhhCCcccccccC
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGC------------------------VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP  139 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~------------------------lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKP  139 (575)
                      +.+++||||++|++|.+++.....                        +++..++.++.||+.||+|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            999999999999999999987543                        89999999999999999999999999999999


Q ss_pred             CceeeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCC
Q 043425          140 QNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTG  215 (575)
Q Consensus       140 eNILl~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~  215 (575)
                      +|||+   +.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus       179 ~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          179 RNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             heEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999   667889999999998664432   2234567889999999999999999999999999999999 9999999


Q ss_pred             CCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          216 SNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       216 ~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .........+........+   ..++.++.+||.+||..||.+|||+++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8887777766655433333   3588999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.3e-45  Score=366.16  Aligned_cols=250  Identities=21%  Similarity=0.415  Sum_probs=217.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++++.||+|+||.||+|.+. ++..||||++.......   +.+.+|+.+++.++||||+++++++...+.+++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            45568999999999999999999887 68889999998765443   458899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccc
Confidence            9999999999999976 4679999999999999999999999999999999999999   77789999999999865433


Q ss_pred             C--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .  ......||+.|+|||++....++.++||||||+++|+|++ |..||...+..+....+........+   ...+.++
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  250 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV  250 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHH
Confidence            2  1233457788999999999999999999999999999998 99999999988888887766444333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+||.+||..||.+|||++++++|
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.6e-45  Score=380.72  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=211.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-----------CCCcceEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-----------HPHIIRLHDI   79 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~~   79 (575)
                      .++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+++++.           ||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            46899999999999999999999999999999999753   334566789999998876           8999999999


Q ss_pred             EEeCC----EEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecC---CC
Q 043425           80 IEVPG----KLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTD---DD  149 (575)
Q Consensus        80 ~~~~~----~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~d---d~  149 (575)
                      +...+    .+++||||+ |++|.+++...  +.+++..++.++.||+.||+|||++ ||+||||||+|||+..+   +.
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            87654    799999999 89999999864  4599999999999999999999998 99999999999999543   34


Q ss_pred             CCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC------HHHHHH
Q 043425          150 NAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN------QIQLLQ  223 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~------~~~~l~  223 (575)
                      .+.+||+|||++......  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+      ....+.
T Consensus       174 ~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             cceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            458999999999876432  345689999999999999999999999999999999999999998754      223333


Q ss_pred             HHHHhccCCC--------------------------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHH
Q 043425          224 NIVKATELHF--------------------------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEF  265 (575)
Q Consensus       224 ~i~~~~~~~~--------------------------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~ei  265 (575)
                      .+........                                      ......++.++.+||.+||+.||.+|||++|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            3332111000                                      00112456789999999999999999999999


Q ss_pred             HcCCCCCCC
Q 043425          266 FNHPFLSQT  274 (575)
Q Consensus       266 L~Hpff~~~  274 (575)
                      ++||||++.
T Consensus       332 l~hp~f~~~  340 (373)
T 1q8y_A          332 VNHPWLKDT  340 (373)
T ss_dssp             HTCGGGTTC
T ss_pred             hhChhhhcc
Confidence            999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=382.51  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=222.9

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDI   79 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~   79 (575)
                      ....++|.++++||+|+||.||+|.+..       .+..||||++.... .......+.+|+.+++.+ +||||++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3445789999999999999999999753       34689999997653 455567789999999999 89999999999


Q ss_pred             EEeCCEEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           80 IEVPGKLHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        80 ~~~~~~l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      +...+.+++||||++||+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            999999999999999999999998754                4999999999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI  219 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~  219 (575)
                      +   +.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       224 l---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          224 V---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             E---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             E---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9   677899999999998765432   2334567899999999999999999999999999999999 99999999988


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +....+........+   ..++.++.+||++||..||.+|||++|++++
T Consensus       301 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888877766544444   3578999999999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-46  Score=391.93  Aligned_cols=261  Identities=20%  Similarity=0.215  Sum_probs=198.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhC--CCCCcceEE-------E
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRI--NHPHIIRLH-------D   78 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L--~HpnIv~l~-------~   78 (575)
                      .....|.++++||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+++.|  +||||++++       +
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            3445699999999999999999999999999999999886653 34456677885544444  699987755       5


Q ss_pred             EEEeC-----------------CEEEEEEeecCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHhhCCccc
Q 043425           79 IIEVP-----------------GKLHLILEYCKGGDLSMYIQRH-GCVPEETA------KHFMKQLAAGLQVLRDNNLIH  134 (575)
Q Consensus        79 ~~~~~-----------------~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i------~~i~~QLl~aL~~LH~~gIvH  134 (575)
                      ++...                 ..+||||||++ |+|.+++... ..+++...      ..++.||+.||+|||++||+|
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            65544                 33899999998 8999999864 33444444      567799999999999999999


Q ss_pred             ccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCC
Q 043425          135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTP  212 (575)
Q Consensus       135 rDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~P  212 (575)
                      |||||+|||+   +.++.+||+|||+++.....  .....||+.|+|||++.+  ..|+.++|||||||+||+|++|+.|
T Consensus       218 rDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999   77789999999999865432  224567799999999987  7899999999999999999999999


Q ss_pred             CCCCCHHHHH--HH---HHH-hccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          213 FTGSNQIQLL--QN---IVK-ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       213 F~~~~~~~~l--~~---i~~-~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      |.+.......  ..   ... .....++ ....++.++.+||.+||+.||.+|||++|+++||||+...+
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            9876432100  00   000 0011112 22468999999999999999999999999999999976533

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-44  Score=371.89  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=208.6

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .|..+++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            47889999999999999999999999999999999999976543 34455778999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence            99999999999999999988899999999999999999999999999999999999999   667899999999997664


Q ss_pred             CCC--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          166 PRG--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       166 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...  .....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...+...+. ............++.+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHH
Confidence            432  2345679999999999998999999999999999999999999999877664443333 2222111223468899


Q ss_pred             HHHHHHHhhccCCCCCC-CHHHHHc
Q 043425          244 CKDLCQKLLRRNPVERL-TFEEFFN  267 (575)
Q Consensus       244 l~dLI~k~L~~DP~~Rp-Ta~eiL~  267 (575)
                      +.+||.+||..||.+|| +++++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 8888876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-45  Score=386.32  Aligned_cols=251  Identities=27%  Similarity=0.478  Sum_probs=219.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|.++++||+|+||.||+|.++.+|+.||||++... ......+.+.+|+.+|+.++||||+++++++...+.+++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            346799999999999999999999999999999998753 3455566788999999999999999999999988899999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           90 LEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence            99999999999998654 69999999999999999999999999999999999999   677899999999998654332


Q ss_pred             Cc---ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          169 LA---ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       169 ~~---~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..   ....+++.|+|||++....++.++|||||||++|+|++ |..||.+....+....+.++.....|.   .++.++
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l  344 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE---LCPDAV  344 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT---TCCHHH
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCCHHH
Confidence            21   12235778999999999999999999999999999998 999999998888777776655444443   578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||.+||..||.+|||++++++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8e-45  Score=366.44  Aligned_cols=253  Identities=24%  Similarity=0.449  Sum_probs=208.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~   84 (575)
                      ....++|++++.||+|+||.||+|.+..+   +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            44567899999999999999999998753   5679999886532 4555677999999999999999999999984 56


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECccccccc
Confidence            7899999999999999998654 69999999999999999999999999999999999999   5567899999999987


Q ss_pred             cCCCCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          164 LQPRGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       164 ~~~~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ......  .....+|+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+........+   ..+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~  242 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---PNC  242 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TTC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC---CCC
Confidence            654332  233457889999999999999999999999999999996 99999998888877777665444333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+||.+||..||.+|||+.|++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-45  Score=374.35  Aligned_cols=253  Identities=28%  Similarity=0.462  Sum_probs=216.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEE--EEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEV--AMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~v--AVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ...++|++.+.||+|+||.||+|++..+|..+  |+|.+.... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            45578999999999999999999999899866  999887532 333456688999999999 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           86 LHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      +++||||++||+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||+   +.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~  177 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GE  177 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cC
Confidence            999999999999999997654                69999999999999999999999999999999999999   66


Q ss_pred             CCcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 043425          150 NAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKA  228 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~  228 (575)
                      ++.+||+|||+++............+++.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            78899999999975443333445567899999999999999999999999999999998 99999999988877776555


Q ss_pred             ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       229 ~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .....+   ..++.++.+||.+||..||.+|||++|++++
T Consensus       258 ~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 YRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            333333   3578999999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-44  Score=369.73  Aligned_cols=254  Identities=29%  Similarity=0.545  Sum_probs=212.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN--HPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ++|++++.||+|+||.||+|.+. +|+.||||++..........+.+.+|+.+++.+.  ||||+++++++...+.+++|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            45999999999999999999986 5999999999887767777788999999999997  59999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      || +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++....... 
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~-~~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---E-TTEEEECCCSSSCC------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---E-CCeEEEeeccccccccCccc
Confidence            99 5688999999988899999999999999999999999999999999999999   3 2789999999998764432 


Q ss_pred             --CcccccCCCCCCChHHHhh-----------ccCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhc-cCCC
Q 043425          169 --LAETLCGSPLYMAPEIMQL-----------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKAT-ELHF  233 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~-----------~~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~-~~~~  233 (575)
                        .....+||+.|+|||++..           ..++.++||||||+++|+|++|..||..... ...+..+.... ...+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  261 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  261 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence              2345679999999999875           4788899999999999999999999987643 33333333321 1122


Q ss_pred             CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +   ...+.++.+||.+||..||.+||+++|+++||||+..
T Consensus       262 ~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          262 P---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             C---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             c---ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            2   2457899999999999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-44  Score=359.61  Aligned_cols=250  Identities=19%  Similarity=0.337  Sum_probs=218.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--G   84 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~   84 (575)
                      .+...++|++.++||+|+||.||+|++.  |..||||++..........+.+.+|+.++++++||||+++++++...  +
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            3567789999999999999999999986  99999999988776777778899999999999999999999999876  7


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                      .+++||||++||+|.+++....  .+++..++.++.||+.||+|||++|  |+||||||+|||+   +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~  159 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADV  159 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGS
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccc
Confidence            8899999999999999998765  4899999999999999999999999  9999999999999   6778899999888


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhhccCCc---ccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA---KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~---kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      +....    ....+||+.|+|||++.+..++.   ++||||||+++|+|++|..||.+.+.......+......  +...
T Consensus       160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  233 (271)
T 3kmu_A          160 KFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--PTIP  233 (271)
T ss_dssp             CCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC--CCCC
T ss_pred             eeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC--CCCC
Confidence            75432    23467899999999998765554   799999999999999999999999888877666554321  2222


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..++.++.+||.+||..||.+|||++|+++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            458999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-44  Score=365.19  Aligned_cols=250  Identities=23%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             ecCEEEEE-EecccCCeEEEEEEE--cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           11 VGDYLVGR-QIGSGSFSVVWHARH--RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        11 v~~Y~i~~-~LG~GaFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      .++|.+.+ .||+|+||.||+|.+  ..++..||||++..........+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45799998 999999999999954  56789999999987655555567899999999999999999999999 566789


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      +||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeeccC
Confidence            999999999999999988889999999999999999999999999999999999999   55678999999999876543


Q ss_pred             CC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ..    .....|++.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+........+   ..++.
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  247 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPR  247 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred             CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCH
Confidence            32    223456789999999999899999999999999999999 99999999988887777665444333   35789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.++|.+||..||.+||++.++++
T Consensus       248 ~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-44  Score=367.90  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=216.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEE-----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARH-----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|.+++.||+|+||.||+|.+     ..++..||||++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            346899999999999999999985     4578899999997653 344557789999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeee
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLC  145 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~  145 (575)
                      +..++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|||+ 
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-  178 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE-
Confidence            99999999999999999998654                  48999999999999999999999999999999999999 


Q ss_pred             cCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHH
Q 043425          146 TDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQL  221 (575)
Q Consensus       146 ~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~  221 (575)
                        +.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+......
T Consensus       179 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             --cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence              6678899999999987654332   234567889999999999999999999999999999998 9999988765554


Q ss_pred             HHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       222 l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...........  .....++.++.+||.+||..||.+|||++|++++
T Consensus       257 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            44444432211  1123578999999999999999999999999884

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.6e-45  Score=377.92  Aligned_cols=261  Identities=26%  Similarity=0.459  Sum_probs=194.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIF-ILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      -..++|++++.||+|+||.||+|.++.+|+.||||++..... ......+..|+. +++.++||||+++++++...+..+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            345789999999999999999999999999999999976543 334445556665 677789999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           88 LILEYCKGGDLSMYIQR-----HGCVPEETAKHFMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-----~~~lse~~i~~i~~QLl~aL~~LH~~-gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      +||||+.| +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||+   +.++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCc
Confidence            99999975 88888763     56799999999999999999999999 99999999999999   66788999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHH----hhccCCcccccchhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhccCCCCC-
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIM----QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-QLLQNIVKATELHFPP-  235 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl----~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-~~l~~i~~~~~~~~p~-  235 (575)
                      ............+||+.|+|||++    ....++.++||||||+++|+|++|..||.+.... +.+..+.......++. 
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            877655555556899999999998    4667899999999999999999999999875432 2222222222222221 


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ....++.++.+||.+||..||.+|||+.++++||||...
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            123578999999999999999999999999999999653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-44  Score=366.98  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEE----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-   82 (575)
                      .-..++|+++++||+|+||.||+|+    +..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.. 
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3456789999999999999999998    5678999999998754  44555778999999999999999999999854 


Q ss_pred             -CCEEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccc
Q 043425           83 -PGKLHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGF  160 (575)
Q Consensus        83 -~~~l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGl  160 (575)
                       ...+++||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence             356899999999999999998754 59999999999999999999999999999999999999   5667899999999


Q ss_pred             ccccCCCC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH----------------H
Q 043425          161 ARSLQPRG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI----------------Q  220 (575)
Q Consensus       161 a~~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~----------------~  220 (575)
                      +.......    ......|++.|+|||++.+..++.++||||||+++|+|++|..||......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            98764432    223456788899999999999999999999999999999999998654321                1


Q ss_pred             HHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       221 ~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....+.......   ....++.++.+||++||..||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222222222222   23457899999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-45  Score=376.90  Aligned_cols=256  Identities=29%  Similarity=0.543  Sum_probs=219.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----HHHHHHHHHHHHHHhCC--CCCcceEEEEEEe
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRIN--HPHIIRLHDIIEV   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~~~~~   82 (575)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.......    .....+.+|+.+++.+.  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            46678999999999999999999999999999999997654322    12234668999999996  5999999999999


Q ss_pred             CCEEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           83 PGKLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        83 ~~~l~LVmEy~~G-gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                      .+..++||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.  ...+.+||+|||++
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG  197 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCccc
Confidence            9999999999986 89999999888999999999999999999999999999999999999993  25678999999999


Q ss_pred             cccCCCCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          162 RSLQPRGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       162 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ...... .....+||+.|+|||++....+ +.++||||||+++|+|++|..||....      .+... ...++   ..+
T Consensus       198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-~~~~~---~~~  266 (320)
T 3a99_A          198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFR---QRV  266 (320)
T ss_dssp             EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCS---SCC
T ss_pred             cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-ccccc---ccC
Confidence            876543 3445789999999999987776 678999999999999999999997642      12222 22223   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                      +.++.+||++||..||.+|||++|+++||||+.....
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            8999999999999999999999999999999886543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-44  Score=359.94  Aligned_cols=253  Identities=27%  Similarity=0.481  Sum_probs=204.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK--KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~--~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..++|++.++||+|+||.||+|.+.  |..||||++.......  ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            4578999999999999999999975  8999999987643222  23467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccccccCCceeeecCC-----CCCcEEEcccc
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN---LIHRDLKPQNLLLCTDD-----DNAALKIADFG  159 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g---IvHrDLKPeNILl~~dd-----~~g~vKL~DFG  159 (575)
                      +||||++|++|.+++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||+..+.     ..+.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999999985 457999999999999999999999999   89999999999995321     26789999999


Q ss_pred             cccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          160 FARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       160 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      ++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......  .+....
T Consensus       162 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  238 (271)
T 3dtc_A          162 LAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIPST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCCTT
T ss_pred             ccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCCcc
Confidence            998655433 23567999999999999999999999999999999999999999998887776665544221  112245


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++.++.+||.+||..||.+|||+.|++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            78999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-45  Score=374.38  Aligned_cols=260  Identities=22%  Similarity=0.378  Sum_probs=220.4

Q ss_pred             eeecCEEEEEEecccCCeEEEEEE-----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHAR-----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~-----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ...++|++++.||+|+||.||+|+     +..++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            345789999999999999999999     56688999999996433 445556789999999999999999999999988


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG-------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~-------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                      +..++||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||+..++....+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            89999999999999999998763       48999999999999999999999999999999999999655566789999


Q ss_pred             ccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCC
Q 043425          157 DFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH  232 (575)
Q Consensus       157 DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~  232 (575)
                      |||++.......   ......||+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+.......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            999997653322   2334678999999999999999999999999999999998 999999998888877776654433


Q ss_pred             CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       233 ~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      .+   ..++.++.+||.+||..||.+|||+.++++|.|+.
T Consensus       266 ~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          266 PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            33   35789999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.1e-44  Score=363.29  Aligned_cols=251  Identities=24%  Similarity=0.418  Sum_probs=221.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ....++|++.++||+|+||.||+|.+..++..||+|++....   ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            456678999999999999999999999999999999997543   23466889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||||++|++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceecc
Confidence            999999999999999874  459999999999999999999999999999999999999   667889999999998765


Q ss_pred             CCCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          166 PRGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       166 ~~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ....  .....||+.|+|||++....++.++||||||+++|+|++ |.+||.+.+.......+........+   ..++.
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  239 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGCPE  239 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---TTCCH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC---CCCCH
Confidence            4332  234567889999999999999999999999999999999 99999998887777766655433333   35789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.+||++||..||.+|||++++++
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.6e-44  Score=369.89  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=220.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEc-------CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHR-------VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDI   79 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~-------~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~   79 (575)
                      .-..++|++++.||+|+||.||+|.+.       .++..||||++.... .......+.+|+.+++.+ +||||++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            345578999999999999999999986       467889999997543 445567789999999999 89999999999


Q ss_pred             EEeCCEEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCcee
Q 043425           80 IEVPGKLHLILEYCKGGDLSMYIQRHG----------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLL  143 (575)
Q Consensus        80 ~~~~~~l~LVmEy~~GgsL~~~l~~~~----------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNIL  143 (575)
                      +...+.+++||||++||+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            999999999999999999999998654                3899999999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHH
Q 043425          144 LCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI  219 (575)
Q Consensus       144 l~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~  219 (575)
                      +   +.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       190 l---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          190 V---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             E---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             E---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            9   6778999999999987654332   234567889999999999999999999999999999999 99999999988


Q ss_pred             HHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       220 ~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +....+........+   ..++.++.+||++||..||.+|||+.|++++
T Consensus       267 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            888777666443333   3578999999999999999999999999885

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-44  Score=356.22  Aligned_cols=248  Identities=24%  Similarity=0.487  Sum_probs=218.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.......   +.+.+|+.+++.++||||+++++++...+.+++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            468999999999999999999987 68899999998765433   46889999999999999999999999899999999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-  168 (575)
                      ||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc
Confidence            999999999999865 568999999999999999999999999999999999999   667889999999998654322 


Q ss_pred             -CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHH
Q 043425          169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       169 -~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                       ......|++.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+........+   ...+.++.+
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~  236 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQ  236 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHHHH
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHHHHH
Confidence             2234567889999999999999999999999999999999 99999999988888777765433333   357899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      |+.+||..||.+|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=371.47  Aligned_cols=255  Identities=29%  Similarity=0.518  Sum_probs=208.4

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----HHHHHHHHHHHHHHhC----CCCCcceEEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRI----NHPHIIRLHDI   79 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----~~~~~i~~Ei~iL~~L----~HpnIv~l~~~   79 (575)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++.......    .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            456778999999999999999999999999999999997654432    1223456799999998    89999999999


Q ss_pred             EEeCCEEEEEEee-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           80 IEVPGKLHLILEY-CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        80 ~~~~~~l~LVmEy-~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      +...+..++|||| +.+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.  ..++.+||+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df  184 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF  184 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence            9989999999999 78999999999888999999999999999999999999999999999999993  25678999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhccCC-cccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCCh
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD-AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA  237 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~-~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~  237 (575)
                      |++...... ......||+.|+|||++....+. .++||||||+++|+|++|+.||....      .+... ...++   
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-~~~~~---  253 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-ELHFP---  253 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-CCCCC---
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-ccCCc---
Confidence            999876543 34467799999999999877764 58999999999999999999997642      12222 23333   


Q ss_pred             hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          238 KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       238 ~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ..++.++.+||.+||..||.+|||++|+++||||+...
T Consensus       254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            35789999999999999999999999999999998643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3e-44  Score=368.33  Aligned_cols=253  Identities=23%  Similarity=0.407  Sum_probs=220.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ...++|++.+.||+|+||.||+|.+.     .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            34567999999999999999999887     468899999997543 344556789999999999999999999999988


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcE
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH----------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAAL  153 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~----------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~v  153 (575)
                      +..++||||++||+|.+++...          ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCeE
Confidence            9999999999999999998753          357899999999999999999999999999999999999   677899


Q ss_pred             EEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhc
Q 043425          154 KIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKAT  229 (575)
Q Consensus       154 KL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~  229 (575)
                      ||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  257 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  257 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence            9999999976543322   234567899999999999999999999999999999999 899999999888887776654


Q ss_pred             cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          230 ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       230 ~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ....+   ..++.++.+||.+||..||.+|||+.|+++|
T Consensus       258 ~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 LLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33333   4588999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=373.71  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=212.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|.+++.||+|+||.||+|.+.     .++..||||++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3467999999999999999999973     367789999997543 233456789999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCC
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHG-----------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQ  140 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~-----------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPe  140 (575)
                      +.+++||||++||+|.+++....                       .+++..++.++.||+.||+|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            99999999999999999997653                       3789999999999999999999999999999999


Q ss_pred             ceeeecCCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCC
Q 043425          141 NLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGS  216 (575)
Q Consensus       141 NILl~~dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~  216 (575)
                      |||+   +.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       202 NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          202 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999   6678999999999986643322   334567889999999999999999999999999999998 99999987


Q ss_pred             CHHHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCC
Q 043425          217 NQIQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP  269 (575)
Q Consensus       217 ~~~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hp  269 (575)
                      .....+..+.... ....   ...++.++.+||.+||..||.+|||+.++++|.
T Consensus       279 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            7555554444432 2222   235789999999999999999999999999863

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-44  Score=362.39  Aligned_cols=253  Identities=25%  Similarity=0.437  Sum_probs=208.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH--H---HHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL--Q---ESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~--~---~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.........  .   +.+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            4557899999999999999999999999999999998765432211  1   5688999999999999999999998665


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCC--CCCcEEEccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDD--DNAALKIADF  158 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd--~~g~vKL~DF  158 (575)
                      .  ++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|  |+||||||+|||+..++  ....+||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  7999999999999988654 47999999999999999999999999  99999999999994322  1223999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHH--hhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhccCCCC
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIM--QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQL--LQNIVKATELHFP  234 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl--~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~--l~~i~~~~~~~~p  234 (575)
                      |+++....  .....+||+.|+|||++  ....++.++||||||+++|+|++|..||........  ...+....  ..+
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~  249 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG--LRP  249 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC--CCC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC--CCC
Confidence            99975433  34457899999999998  455678899999999999999999999987654333  33333221  112


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....+++++.+||.+||..||.+|||++|+++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            223468899999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-43  Score=362.60  Aligned_cols=255  Identities=27%  Similarity=0.559  Sum_probs=205.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc-cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+++|++.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+++.++||||+++++++...+.++
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            46788999999999999999999999999999999997643 34556678899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence            99999999999999864    4569999999999999999999999999999999999999   6778999999999976


Q ss_pred             cCCCC-CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhccCCCCCChhcc
Q 043425          164 LQPRG-LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--QIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       164 ~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~--~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ..... ......||+.|+|||++....++.++||||||+++|+|++|..||.+..  .......+........+  ...+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP--SDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC--TTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc--cccc
Confidence            54432 2345679999999999999999999999999999999999999997643  33444444433222111  2457


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+||.+||..||.+|||+++++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-44  Score=372.01  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=208.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEE----EEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~v----AVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..++|+++++||+|+||.||+|++..+|+.+    |+|.+.... .......+.+|+.++++++||||+++++++...+ 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            3467999999999999999999998888765    666664322 2334467889999999999999999999998655 


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++..
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeEc
Confidence            78999999999999999874 579999999999999999999999999999999999999   56678999999999876


Q ss_pred             CCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          165 QPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       165 ~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .....   .....||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.........+........+   ...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  244 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PIC  244 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TTB
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC---ccC
Confidence            54332   233457889999999999999999999999999999999 99999998887777666655433333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+|+.+||..||.+|||+.|++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-44  Score=367.27  Aligned_cols=253  Identities=25%  Similarity=0.453  Sum_probs=209.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--   84 (575)
                      ..++|.+++.||+|+||.||+|.+..   ++..||||++..........+.+.+|+.+++.++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34679999999999999999998875   5668999999877666666778999999999999999999999987654  


Q ss_pred             ---EEEEEEeecCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           85 ---KLHLILEYCKGGDLSMYIQR------HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        85 ---~l~LVmEy~~GgsL~~~l~~------~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                         ..++||||+++|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEE
Confidence               35999999999999999853      3569999999999999999999999999999999999999   67789999


Q ss_pred             cccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccC
Q 043425          156 ADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       156 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +|||++.......   ......+++.|+|||++....++.++||||||+++|+|++ |.+||.+.........+......
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  268 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL  268 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence            9999998664432   1234567889999999999999999999999999999999 99999998888887777765443


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..+   ..++.++.+||.+||..||.+|||+.+++++
T Consensus       269 ~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 KQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCB---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCC---ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333   3578999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.6e-44  Score=364.20  Aligned_cols=249  Identities=22%  Similarity=0.424  Sum_probs=208.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCC-------cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHG-------TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV   82 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~   82 (575)
                      ..++|.+.+.||+|+||.||+|.+..++       ..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4578999999999999999999999877       479999986543  2344678999999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-----CCcEEEc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-----NAALKIA  156 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~-lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-----~g~vKL~  156 (575)
                      .+..++||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||+..+..     .+.+||+
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999999987654 999999999999999999999999999999999999954322     1239999


Q ss_pred             ccccccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          157 DFGFARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       157 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      |||++......   ....||+.|+|||++.. ..++.++||||||+++|+|++| .+||............. . ...++
T Consensus       164 Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~-~~~~~  238 (289)
T 4fvq_A          164 DPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D-RHQLP  238 (289)
T ss_dssp             CCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-T-TCCCC
T ss_pred             cCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-c-cCCCC
Confidence            99998654332   34568999999999987 7799999999999999999995 55566555554443332 2 22222


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .   ..+.++.+||.+||..||.+|||++|+++|
T Consensus       239 ~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 A---PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             C---CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2   357789999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.2e-44  Score=360.20  Aligned_cols=254  Identities=21%  Similarity=0.249  Sum_probs=210.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD-IIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-~~~~~~~l~   87 (575)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++......    ..+.+|+.+++.+.|++++..+. ++...+..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            5667899999999999999999999999999999998765433    24789999999999887655554 447788899


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999999 9999999974 45799999999999999999999999999999999999996545678899999999987654


Q ss_pred             CCC--------cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhc-cCCCC
Q 043425          167 RGL--------AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKAT-ELHFP  234 (575)
Q Consensus       167 ~~~--------~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---~~~~l~~i~~~~-~~~~p  234 (575)
                      ...        ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..   ....+..+.... ....+
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            322        345689999999999999999999999999999999999999998743   222333333221 11111


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....++.++.+||++||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111357899999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.1e-45  Score=374.80  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcE----EEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~----vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..++|+++++||+|+||.||+|.+..+|..    ||+|.+..... ......+.+|+.+++.++||||+++++++. .+.
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            456799999999999999999999988876    66676643321 122234678999999999999999999986 456


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence            89999999999999999764 579999999999999999999999999999999999999   67788999999999876


Q ss_pred             CCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          165 QPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       165 ~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....   ......||+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+........+.   .+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  242 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---IC  242 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT---TB
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC---cC
Confidence            4432   2345678889999999999999999999999999999999 999999988877777776654444443   47


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+||.+||..||.+|||+.++++|
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-44  Score=379.10  Aligned_cols=262  Identities=15%  Similarity=0.205  Sum_probs=205.8

Q ss_pred             CCCCCeeec-----CEEEEEEecccCCeEEEEEEEcCC-----CcEEEEEEeecCccCHHH---------HHHHHHHHHH
Q 043425            4 ATGRGRVVG-----DYLVGRQIGSGSFSVVWHARHRVH-----GTEVAMKEIAMGRLNKKL---------QESLMSEIFI   64 (575)
Q Consensus         4 ~~~~g~~v~-----~Y~i~~~LG~GaFG~Vy~a~~~~t-----g~~vAVK~i~~~~~~~~~---------~~~i~~Ei~i   64 (575)
                      ....|..++     +|+++++||+|+||.||+|.+..+     ++.||||++.........         ...+..|+..
T Consensus        22 ~~~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~  101 (364)
T 3op5_A           22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR  101 (364)
T ss_dssp             CCCTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             hcCCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHH
Confidence            334566666     899999999999999999999764     588999998765321100         1223456667


Q ss_pred             HHhCCCCCcceEEEEEEeC----CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccC
Q 043425           65 LKRINHPHIIRLHDIIEVP----GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKP  139 (575)
Q Consensus        65 L~~L~HpnIv~l~~~~~~~----~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKP  139 (575)
                      ++.++||||+++++++...    ...+|||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||
T Consensus       102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp  180 (364)
T 3op5_A          102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA  180 (364)
T ss_dssp             HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCH
Confidence            7888999999999998664    5589999999 99999999876 6799999999999999999999999999999999


Q ss_pred             CceeeecCCCCCcEEEcccccccccCCCCC--------cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCC
Q 043425          140 QNLLLCTDDDNAALKIADFGFARSLQPRGL--------AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKT  211 (575)
Q Consensus       140 eNILl~~dd~~g~vKL~DFGla~~~~~~~~--------~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~  211 (575)
                      +|||+.. +..+.+||+|||+++.+.....        ....+||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       181 ~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~  259 (364)
T 3op5_A          181 SNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL  259 (364)
T ss_dssp             GGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999942 1568899999999987643321        234569999999999999999999999999999999999999


Q ss_pred             CCCCCCHHH-HHHHHHHhccCCCCC------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          212 PFTGSNQIQ-LLQNIVKATELHFPP------DAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       212 PF~~~~~~~-~l~~i~~~~~~~~p~------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ||.+..... .............+.      ....++.++.+|+..||..||.+||+++++++
T Consensus       260 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          260 PWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            998643222 221111110000000      00246899999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=384.07  Aligned_cols=258  Identities=26%  Similarity=0.485  Sum_probs=215.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--KLH   87 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--~l~   87 (575)
                      ..++|.+.++||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++...+  ..+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            4567999999999999999999999999999999997643322 2355789999999999999999999998755  789


Q ss_pred             EEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec-CCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT-DDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~-dd~~g~vKL~DFGla~~  163 (575)
                      +||||++||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++.
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999999997543   3999999999999999999999999999999999999843 35567899999999988


Q ss_pred             cCCCCCcccccCCCCCCChHHHhh--------ccCCcccccchhhHHHHHHHhCCCCCCC----CCHHHHHHHHHHhccC
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQL--------QKYDAKADLWSVGAILFQLVTGKTPFTG----SNQIQLLQNIVKATEL  231 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~--------~~y~~kaDIWSLGviLyeLltG~~PF~~----~~~~~~l~~i~~~~~~  231 (575)
                      ..........+||+.|+|||++..        ..++.++|||||||++|+|++|+.||..    ....+.+..+..+.+.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            776666667889999999999875        6788899999999999999999999964    3344555555554322


Q ss_pred             CC------------------CC---ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 HF------------------PP---DAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 ~~------------------p~---~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..                  +.   ....++..+.+||++||..||.+||+++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            11                  11   113466788999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.9e-44  Score=358.34  Aligned_cols=254  Identities=24%  Similarity=0.431  Sum_probs=215.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP   83 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~   83 (575)
                      .+...++|.+.+.||+|+||.||+|.+..   ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            46677899999999999999999998764   34569999987653 34556779999999999999999999999864 


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +..++||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSR  161 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGG
T ss_pred             CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCc
Confidence            4578999999999999999765 459999999999999999999999999999999999999   556789999999998


Q ss_pred             ccCCCCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          163 SLQPRGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       163 ~~~~~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      .......  .....||+.|+|||++....++.++||||||+++|+|++ |+.||...........+........+   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  238 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP---DL  238 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---TT
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---CC
Confidence            7654332  234567889999999999999999999999999999998 99999988777777666665443333   35


Q ss_pred             ccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          240 LSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +++.+.+||.+||..||.+|||+.|++++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            78999999999999999999999999885

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.4e-44  Score=365.13  Aligned_cols=252  Identities=28%  Similarity=0.489  Sum_probs=213.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEE-----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARH-----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~-----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|++++.||+|+||.||+|.+     ..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            346899999999999999999985     3578999999997653 344556789999999999 689999999998765


Q ss_pred             C-EEEEEEeecCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec
Q 043425           84 G-KLHLILEYCKGGDLSMYIQRHGC----------------VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT  146 (575)
Q Consensus        84 ~-~l~LVmEy~~GgsL~~~l~~~~~----------------lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~  146 (575)
                      + .+++||||++||+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||+  
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--  181 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  181 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence            4 59999999999999999987643                8999999999999999999999999999999999999  


Q ss_pred             CCCCCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHH-H
Q 043425          147 DDDNAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQ-L  221 (575)
Q Consensus       147 dd~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~-~  221 (575)
                       +..+.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... .
T Consensus       182 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          182 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence             6678899999999986643322   234568899999999999999999999999999999998 999998876443 3


Q ss_pred             HHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       222 l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...+........+   ..+++++.++|.+||..||.+|||+.|+++|
T Consensus       261 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3444444333333   3578999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.3e-44  Score=362.34  Aligned_cols=251  Identities=26%  Similarity=0.473  Sum_probs=202.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .-++|++.++||+|+||.||+|++.   ..||||++..........+.+.+|+.+++.++||||++++++. ..+..++|
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            4456999999999999999999864   3599999987776777778899999999999999999999965 56678999


Q ss_pred             EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC--
Q 043425           90 LEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP--  166 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~--  166 (575)
                      |||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC---------
T ss_pred             EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccccccc
Confidence            9999999999999643 579999999999999999999999999999999999999   6668899999999976542  


Q ss_pred             -CCCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--CCCChhcc
Q 043425          167 -RGLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--FPPDAKIL  240 (575)
Q Consensus       167 -~~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--~p~~~~~l  240 (575)
                       .......+||+.|+|||++.   ...++.++||||||+++|+|++|..||.+....+.+..........  +......+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence             22344568999999999986   5678889999999999999999999998876655554444332221  22223467


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.++.+||.+||..||.+|||++++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=359.39  Aligned_cols=253  Identities=23%  Similarity=0.423  Sum_probs=217.8

Q ss_pred             eecCEEEEE-EecccCCeEEEEEEEc--CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGR-QIGSGSFSVVWHARHR--VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~-~LG~GaFG~Vy~a~~~--~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            346688777 9999999999999864  468899999997653 445567799999999999999999999999 45669


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeec
Confidence            9999999999999999654 569999999999999999999999999999999999999   566789999999998764


Q ss_pred             CCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....    .....||+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+.......++   ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~  238 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---PEC  238 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC---TTC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCC---CCc
Confidence            4322    233457899999999999999999999999999999998 99999998888887777665444444   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                      +.++.+||.+||..||.+||++.++++|.+
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            899999999999999999999999998743

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.4e-44  Score=378.82  Aligned_cols=251  Identities=23%  Similarity=0.455  Sum_probs=208.4

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|.+.+.||+|+||.||+|+++   .++..||||++.... .....+.+.+|+.++++++||||+++++++...+.+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            4457999999999999999999987   467889999997643 455567899999999999999999999999988999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccccc
Confidence            99999999999999998754 69999999999999999999999999999999999999   777899999999998764


Q ss_pred             CCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....    .....+++.|+|||++....++.++||||||+++|+|++ |+.||.+....+....+........+   ..+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~  275 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDC  275 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC---TTC
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---ccc
Confidence            4321    122345788999999999999999999999999999998 99999999988888777665443333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.++.+||.+||..||.+||+++++++
T Consensus       276 ~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          276 PAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            899999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.8e-44  Score=356.96  Aligned_cols=248  Identities=27%  Similarity=0.469  Sum_probs=214.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------   82 (575)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++....      +.+.+|+.+++.++||||+++++++..      
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            45678999999999999999999999999999999997643      246789999999999999999998854      


Q ss_pred             ----------CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC
Q 043425           83 ----------PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN  150 (575)
Q Consensus        83 ----------~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~  150 (575)
                                ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCC
Confidence                      45589999999999999999754  579999999999999999999999999999999999999   566


Q ss_pred             CcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Q 043425          151 AALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       151 g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      +.+||+|||++.............||+.|+|||++....++.++||||||+++|+|++|..||...  ......+...  
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--  234 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--  234 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence            789999999998876665566678999999999999999999999999999999999999988532  2222222221  


Q ss_pred             CCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       231 ~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                       .++   ..++.++.+||.+||..||.+|||+.|+++|.+.-.
T Consensus       235 -~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 -IIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -ccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence             122   357889999999999999999999999999977543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.3e-44  Score=368.99  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----KL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----~l   86 (575)
                      .++|+++++||+|+||.||+|++.  |+.||||++...   .........|+.++++++||||+++++++....    .+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            456999999999999999999876  899999999654   233345567999999999999999999997643    47


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC----------CcccccccCCceeeecCCCCCcEEEc
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN----------NLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~----------gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                      ++||||+++|+|.+++... .+++..++.++.||+.||+|||+.          ||+||||||+|||+   +..+.+||+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~  173 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA  173 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence            9999999999999999764 599999999999999999999999          99999999999999   777899999


Q ss_pred             ccccccccCCCCC---cccccCCCCCCChHHHhh-----ccCCcccccchhhHHHHHHHhCCCCCCCCC-----------
Q 043425          157 DFGFARSLQPRGL---AETLCGSPLYMAPEIMQL-----QKYDAKADLWSVGAILFQLVTGKTPFTGSN-----------  217 (575)
Q Consensus       157 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~-----~~y~~kaDIWSLGviLyeLltG~~PF~~~~-----------  217 (575)
                      |||+++.+.....   ....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+..           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987654332   334689999999999986     456678999999999999999999997642           


Q ss_pred             -----HHHHHHHHHHhcc-CCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          218 -----QIQLLQNIVKATE-LHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       218 -----~~~~l~~i~~~~~-~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                           ...+...+..... ..++...  ...+.++.+||++||..||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 2222222222111 1111111  123456999999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=373.84  Aligned_cols=260  Identities=16%  Similarity=0.213  Sum_probs=204.3

Q ss_pred             CCCeeec-----CEEEEEEecccCCeEEEEEEEcC---CCcEEEEEEeecCccCHH---------HHHHHHHHHHHHHhC
Q 043425            6 GRGRVVG-----DYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNKK---------LQESLMSEIFILKRI   68 (575)
Q Consensus         6 ~~g~~v~-----~Y~i~~~LG~GaFG~Vy~a~~~~---tg~~vAVK~i~~~~~~~~---------~~~~i~~Ei~iL~~L   68 (575)
                      +.|..++     +|++++.||+|+||.||+|.+..   ++..+|||++........         ....+.+|+.+++.+
T Consensus        26 ~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l  105 (345)
T 2v62_A           26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL  105 (345)
T ss_dssp             CTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC
T ss_pred             CCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc
Confidence            3455554     69999999999999999999987   889999999976532111         112356788999999


Q ss_pred             CCCCcceEEEEEEe----CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceee
Q 043425           69 NHPHIIRLHDIIEV----PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLL  144 (575)
Q Consensus        69 ~HpnIv~l~~~~~~----~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl  144 (575)
                      +||||+++++++..    ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL  184 (345)
T ss_dssp             SCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             cccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence            99999999999987    78899999999 99999999887789999999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEcccccccccCCCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC
Q 043425          145 CTDDDNAALKIADFGFARSLQPRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS  216 (575)
Q Consensus       145 ~~dd~~g~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~  216 (575)
                      ..++ .+.+||+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       185 ~~~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          185 GYKN-PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             ESSS-TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             ccCC-CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            4322 2389999999998764322        124568999999999999999999999999999999999999999652


Q ss_pred             -CHHHHHHHHHHhccCCCCCCh------hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          217 -NQIQLLQNIVKATELHFPPDA------KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       217 -~~~~~l~~i~~~~~~~~p~~~------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                       ................++...      ..++.++.+||.+||..||.+|||++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             TTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             222222222222122222211      157889999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=365.59  Aligned_cols=251  Identities=24%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCC----cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg----~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..+|.+.+.||+|+||.||+|.+..++    ..||||++.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            456999999999999999999987653    459999987543 445566789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchhhc
Confidence            9999999999999999765 579999999999999999999999999999999999999   677899999999998764


Q ss_pred             CCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....    .....+|+.|+|||++....++.++||||||+++|+|++ |..||.+....+....+........+   ..+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~  275 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---MDC  275 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCc---ccC
Confidence            3321    223456888999999999999999999999999999998 99999999888888777665433333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+||.+||..||.+||++.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-43  Score=366.39  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=215.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCc-----EEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGT-----EVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~-----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~   83 (575)
                      ..++|.+++.||+|+||.||+|.+..+|.     .||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            34679999999999999999999987664     79999987543 344567789999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH--------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD  149 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~--------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~  149 (575)
                      +.+++||||+++|+|.+++...              ..+++..+..++.||+.||+|||++||+||||||+|||+   +.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CC
Confidence            9999999999999999999753              358999999999999999999999999999999999999   56


Q ss_pred             CCcEEEcccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNI  225 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i  225 (575)
                      ++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+......+..+
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            67899999999986543321   234567889999999999999999999999999999998 99999987665555554


Q ss_pred             HHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       226 ~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ......  +......+.++.+||.+||..||.+|||+.|++++
T Consensus       280 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          280 VKDGYQ--MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            443221  11223578999999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-43  Score=360.08  Aligned_cols=250  Identities=23%  Similarity=0.401  Sum_probs=206.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEE----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 043425           11 VGDYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP--G   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~--~   84 (575)
                      -..|+++++||+|+||.||+|+    +..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...  .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            3459999999999999999999    56789999999997543 222345688999999999999999999999766  6


Q ss_pred             EEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .+++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccccc
Confidence            68999999999999999954 4579999999999999999999999999999999999999   5667899999999987


Q ss_pred             cCCCC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCC--------------CH-HHHHHH
Q 043425          164 LQPRG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGS--------------NQ-IQLLQN  224 (575)
Q Consensus       164 ~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~--------------~~-~~~l~~  224 (575)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...              .. ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            65443    234567888999999999999999999999999999999999876422              11 122222


Q ss_pred             HHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       225 i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +........+   ..++.++.+||.+||..||.+|||++++++
T Consensus       256 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          256 LKEGKRLPCP---PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCC---CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            3333222222   358899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-43  Score=358.57  Aligned_cols=254  Identities=21%  Similarity=0.247  Sum_probs=204.9

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHD-IIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-~~~~~~~l~   87 (575)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++.....    ...+.+|+.+++.+.|++++..+. ++...+..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            456789999999999999999999999999999998765432    234778999999999877665555 457788999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999999 9999999985 45799999999999999999999999999999999999996556678899999999987654


Q ss_pred             CC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc-cCCCC
Q 043425          167 RG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---QLLQNIVKAT-ELHFP  234 (575)
Q Consensus       167 ~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---~~l~~i~~~~-~~~~p  234 (575)
                      ..        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..   ..+..+.... ....+
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            32        233568999999999999999999999999999999999999999874322   2222222221 11111


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....++.++.+||.+||..||.+|||++++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            111346899999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-43  Score=365.39  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=211.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEE----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE--VPG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~--~~~   84 (575)
                      .++|+++++||+|+||.||+|+    +..+|..||||++...  .....+.+.+|+.+++.++||||+++++++.  ..+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            3569999999999999999999    5678999999999764  3455667899999999999999999999886  456


Q ss_pred             EEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .+++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEccccccee
Confidence            799999999999999999864 569999999999999999999999999999999999999   5677899999999987


Q ss_pred             cCCCC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH---------------HHHHH
Q 043425          164 LQPRG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---------------QLLQN  224 (575)
Q Consensus       164 ~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---------------~~l~~  224 (575)
                      .....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......               .....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            65433    233456888999999999999999999999999999999999999754432               22222


Q ss_pred             HHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          225 IVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       225 i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +......   +....++.++.+||.+||..||.+|||++|++++
T Consensus       257 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222222   2234688999999999999999999999999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.4e-43  Score=382.14  Aligned_cols=245  Identities=22%  Similarity=0.429  Sum_probs=213.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-KLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-~l~   87 (575)
                      ...++|+++++||+|+||.||+|.+.  |+.||||++....    ..+.+.+|+.+|++++||||+++++++...+ .++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            34578999999999999999999886  8899999997653    2356889999999999999999999986654 799


Q ss_pred             EEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||||+++|+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccc
Confidence            99999999999999987654  7999999999999999999999999999999999999   677899999999998643


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....+++.|+|||++....++.++||||||+++|+|++ |..||.+....+....+.++.....|   ..+++++
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l  415 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DGCPPAV  415 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CcCCHHH
Confidence            32  233467899999999999999999999999999999998 99999998888877777766544444   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||++||..||.+|||+.++++
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-43  Score=353.27  Aligned_cols=248  Identities=25%  Similarity=0.484  Sum_probs=215.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++++.||+|+||.||+|.+. ++..||||++......   .+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            34578999999999999999999976 6778999999765433   346889999999999999999999986 456899


Q ss_pred             EEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           89 ILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ||||++|++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccC
Confidence            999999999999986543  69999999999999999999999999999999999999   6778999999999987654


Q ss_pred             CCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          167 RGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       167 ~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...  .....+++.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+........+   ..++.+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  238 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNCPEE  238 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHH
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc---ccccHH
Confidence            332  234567889999999999999999999999999999999 99999999988888777665433333   357899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHc
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.+|+.+||..||.+|||++++++
T Consensus       239 l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          239 LYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=368.93  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=208.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEE----EEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEV----AMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~v----AVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      ..++|+++++||+|+||.||+|.+..+|+.+    |+|.+.... .......+.+|+.+++.++||||+++++++.... 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            3467999999999999999999999888876    555554322 2233466889999999999999999999998665 


Q ss_pred             EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeEc
Confidence            88999999999999999864 579999999999999999999999999999999999999   56678999999999876


Q ss_pred             CCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          165 QPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       165 ~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .....   .....||+.|+|||++.+..|+.++|||||||++|+|++ |..||.+....+....+........+   ..+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  244 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PIC  244 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---TTB
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---ccC
Confidence            43322   233457888999999999999999999999999999999 99999998888777766655433333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.+||++||..||.+|||+.|+++.
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999883

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-43  Score=381.26  Aligned_cols=247  Identities=26%  Similarity=0.506  Sum_probs=216.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ...+|.+.++||+|+||.||+|.+. ++..||||++......   .+.+.+|+.+|+.++||||+++++++. .+.+++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            3467999999999999999999987 5788999999865432   456899999999999999999999986 6678999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCC
Confidence            9999999999999754  368999999999999999999999999999999999999   67789999999999876432


Q ss_pred             C--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .  ......+++.|+|||++....++.++|||||||+||+|++ |..||.+.+..+....+..+.....+   ..++.++
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  414 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP---ENCPEEL  414 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC---TTSCHHH
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHH
Confidence            2  1233456788999999999999999999999999999999 99999999998888887766444333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||.+||..||.+|||++++++
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=369.69  Aligned_cols=251  Identities=16%  Similarity=0.209  Sum_probs=206.9

Q ss_pred             CCCeee-----cCEEEEEEecccCCeEEEEEEEcCC--------CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC
Q 043425            6 GRGRVV-----GDYLVGRQIGSGSFSVVWHARHRVH--------GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH   72 (575)
Q Consensus         6 ~~g~~v-----~~Y~i~~~LG~GaFG~Vy~a~~~~t--------g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn   72 (575)
                      ..|.++     ++|++++.||+|+||.||+|++..+        ++.||||++...       +.+.+|+.+++.++|||
T Consensus        31 ~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~n  103 (352)
T 2jii_A           31 PTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPL  103 (352)
T ss_dssp             CTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHH
T ss_pred             CCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccc
Confidence            446666     7899999999999999999999874        899999999754       34778999999999999


Q ss_pred             cce---------------EEEEEEe-CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCccc
Q 043425           73 IIR---------------LHDIIEV-PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIH  134 (575)
Q Consensus        73 Iv~---------------l~~~~~~-~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvH  134 (575)
                      |++               +++++.. .+.+++||||+ |++|.+++...  +.+++..++.++.||+.||+|||++||+|
T Consensus       104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH  182 (352)
T 2jii_A          104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH  182 (352)
T ss_dssp             HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            887               6777766 78899999999 99999999876  78999999999999999999999999999


Q ss_pred             ccccCCceeeecCCCCC--cEEEcccccccccCCCC--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHH
Q 043425          135 RDLKPQNLLLCTDDDNA--ALKIADFGFARSLQPRG--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILF  204 (575)
Q Consensus       135 rDLKPeNILl~~dd~~g--~vKL~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLy  204 (575)
                      |||||+|||+   +.++  .+||+|||+++.+....        .....+||+.|+|||++.+..++.++||||||+++|
T Consensus       183 ~Dikp~NIl~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  259 (352)
T 2jii_A          183 GNVTAENIFV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML  259 (352)
T ss_dssp             SCCCGGGEEE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence            9999999999   4555  89999999997654322        223458999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC--HHHHHHHHHH--hccCCCCCC---hhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          205 QLVTGKTPFTGSN--QIQLLQNIVK--ATELHFPPD---AKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       205 eLltG~~PF~~~~--~~~~l~~i~~--~~~~~~p~~---~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +|++|..||.+..  ..........  .....+...   ...++.++.+||.+||..||.+|||++++++
T Consensus       260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            9999999998763  3333322221  111111111   1346899999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-43  Score=388.06  Aligned_cols=249  Identities=23%  Similarity=0.431  Sum_probs=219.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ...+|.+.++||+|+||.||+|.++.++..||||++......   .+.+.+|+.+|++++||||+++++++...+.++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            346799999999999999999999999999999999765433   45688999999999999999999999988999999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCC
Confidence            9999999999999864  458999999999999999999999999999999999999   67789999999999876443


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....+++.|+|||++....|+.++|||||||+||+|++ |..||.+.+..+....+........+   ..++.++
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  448 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGCPEKV  448 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHH
Confidence            22  233456788999999999999999999999999999999 99999998887777766655443333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||.+||..||.+|||+.++++
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-43  Score=357.04  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=213.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeC
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDII-EVP   83 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~-~~~   83 (575)
                      +.....|++.++||+|+||.||+|.+..+   +..+|+|.+.... .....+.+.+|+.++++++||||+++++++ ...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            45556799999999999999999997643   3468999887532 445567789999999999999999999985 556


Q ss_pred             CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +..++||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLAR  176 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccc
Confidence            7889999999999999999764 468999999999999999999999999999999999999   777899999999998


Q ss_pred             ccCCCC-----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          163 SLQPRG-----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       163 ~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      ......     ......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+........+  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  254 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--  254 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC--
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC--
Confidence            654332     2234567889999999999999999999999999999999 77888887777777666665443333  


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                       ..++.++.++|.+||..||.+|||+.|+++
T Consensus       255 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             357899999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=353.43  Aligned_cols=249  Identities=27%  Similarity=0.462  Sum_probs=211.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-E
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL-H   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l-~   87 (575)
                      -.|.+.++||+|+||.||+|.+..++.   .||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. +
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            357888999999999999999765554   79999987532 445567789999999999999999999999766554 9


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTT
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccC
Confidence            99999999999999986 3568999999999999999999999999999999999999   7778999999999976543


Q ss_pred             C-----CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          167 R-----GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       167 ~-----~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      .     .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+........+   ..+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  253 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP---EYC  253 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC---TTC
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC---ccc
Confidence            2     22344678899999999999999999999999999999999 56667777776666666655433333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +.++.+||.+||..||.+|||++++++
T Consensus       254 ~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          254 PDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            899999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3e-43  Score=353.93  Aligned_cols=245  Identities=22%  Similarity=0.433  Sum_probs=205.1

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~   87 (575)
                      ...++|++.+.||+|+||.||+|.+.  |+.||||++....    ..+.+.+|+.+++.++||||+++++++.. .+.++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            45678999999999999999999875  8999999987543    34568899999999999999999998744 45789


Q ss_pred             EEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           88 LILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~--lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +||||+++++|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccc
Confidence            99999999999999976543  8999999999999999999999999999999999999   677899999999987654


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....+++.|+|||++....++.++||||||+++|+|++ |..||......+....+........+   ..+++++
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  243 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DGCPPAV  243 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC---TTCCHHH
T ss_pred             cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc---ccCCHHH
Confidence            32  234568899999999999999999999999999999998 99999998877777666554333333   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++|++||..||.+|||+.|+++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.7e-44  Score=369.89  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=211.5

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            456788999999999999999999965 799999998876532  33466889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~----~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +||||++||+|.+++....    .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccccc
Confidence            9999999999999986543    58999999999999999999999999999999999999   7778999999999976


Q ss_pred             cCCC---CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH------HHHHHhccC---
Q 043425          164 LQPR---GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL------QNIVKATEL---  231 (575)
Q Consensus       164 ~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l------~~i~~~~~~---  231 (575)
                      ....   ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+..      .........   
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            4322   2234567999999999999999999999999999999999999999765432211      111111000   


Q ss_pred             ---CC-CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          232 ---HF-PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       232 ---~~-p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                         .. .......+.++.+++.+||..||.+|||+.|++++
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               00 11123456789999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-43  Score=357.85  Aligned_cols=241  Identities=31%  Similarity=0.556  Sum_probs=197.6

Q ss_pred             CCCeeecCEEEE-EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHH-HhCCCCCcceEEEEEEe-
Q 043425            6 GRGRVVGDYLVG-RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL-KRINHPHIIRLHDIIEV-   82 (575)
Q Consensus         6 ~~g~~v~~Y~i~-~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~~~~~-   82 (575)
                      ..|.++++|.+. +.||+|+||.||+|.+..+|+.||||++...       ..+.+|+.++ +.++||||+++++++.. 
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            347899999998 7799999999999999999999999999642       2466888887 66789999999999977 


Q ss_pred             ---CCEEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           83 ---PGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        83 ---~~~l~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                         .+.+++||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  699999999999999999999999999999999999995544478999999


Q ss_pred             cccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc---cCCCC
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT---ELHFP  234 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~---~~~~p  234 (575)
                      ||++....                     ...|+.++|||||||++|+|++|..||.+.........+....   ...++
T Consensus       164 fg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          164 FGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            99986532                     2456788999999999999999999998766544322111111   11111


Q ss_pred             C-ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 P-DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 ~-~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      . ....++.++.+||.+||..||.+|||++|+++||||.+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            1 113578999999999999999999999999999999763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=362.19  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~   87 (575)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            4699999999999999999999999999999998654  34556778999999999999999999999862    34789


Q ss_pred             EEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           88 LILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +||||+.+|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchh
Confidence            99999999999999976    4679999999999999999999999999999999999999   6778899999999875


Q ss_pred             cCCCC----------CcccccCCCCCCChHHHhhcc---CCcccccchhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Q 043425          164 LQPRG----------LAETLCGSPLYMAPEIMQLQK---YDAKADLWSVGAILFQLVTGKTPFTGSNQI--QLLQNIVKA  228 (575)
Q Consensus       164 ~~~~~----------~~~~~~GT~~Y~APEvl~~~~---y~~kaDIWSLGviLyeLltG~~PF~~~~~~--~~l~~i~~~  228 (575)
                      .....          ......||+.|+|||++....   ++.++||||||+++|+|++|..||......  .....+.. 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            43211          112346899999999987543   788999999999999999999999542110  11111221 


Q ss_pred             ccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          229 TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       229 ~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                       ...++ ....++.++.+||.+||..||.+|||+++++++
T Consensus       263 -~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 -QLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -C--CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cCCCC-ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             12222 224578999999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.8e-43  Score=354.07  Aligned_cols=252  Identities=27%  Similarity=0.444  Sum_probs=205.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-CCc--EEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-HGT--EVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-tg~--~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .++|++++.||+|+||.||+|.+.. ++.  .||||++...... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3579999999999999999998653 333  6899998765432 345577899999999999999999999997665 8


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEcccccccccc
Confidence            9999999999999999764 579999999999999999999999999999999999999   566789999999998765


Q ss_pred             CCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          166 PRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       166 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ....    .....||+.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+......  ++....+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  250 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--LPRPEDC  250 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--CCCCTTC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC--CCCCcCc
Confidence            4332    234567889999999999999999999999999999999 99999999988888777654321  2223468


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.++|.+||..||.+|||+.+++++
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            8999999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.7e-43  Score=354.46  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=199.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEe----
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR--INHPHIIRLHDIIEV----   82 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~~~~~----   82 (575)
                      .+.++|+++++||+|+||.||+|++  +|+.||||++....     ...+..|.+++..  ++||||+++++++..    
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            4667899999999999999999987  59999999986532     2345667777766  799999999998643    


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hCCcccccccCCceeeecCCCCCcEE
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR--------DNNLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH--------~~gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                      ...+++||||+++|+|.++++. ..+++..+..++.||+.||+|||        ++||+||||||+|||+   +.++.+|
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k  153 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC  153 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence            3568999999999999999954 57999999999999999999999        9999999999999999   6778999


Q ss_pred             EcccccccccCCCCC-----cccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhC----------CCCC
Q 043425          155 IADFGFARSLQPRGL-----AETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTG----------KTPF  213 (575)
Q Consensus       155 L~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG----------~~PF  213 (575)
                      |+|||+++.......     ....+||+.|+|||++...      .++.++|||||||++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            999999976543322     2345899999999999876      455789999999999999999          8898


Q ss_pred             CCCC----HHHHHHHHHHhc--cCCCCCC--hhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          214 TGSN----QIQLLQNIVKAT--ELHFPPD--AKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       214 ~~~~----~~~~l~~i~~~~--~~~~p~~--~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....    ....+.......  ....+..  ....+.++.+||++||..||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            6532    222233322221  1122211  1235678999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.6e-43  Score=359.82  Aligned_cols=251  Identities=27%  Similarity=0.404  Sum_probs=208.2

Q ss_pred             eeecCE-EEEEEecccCCeEEEEEEE----cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 043425            9 RVVGDY-LVGRQIGSGSFSVVWHARH----RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-   82 (575)
Q Consensus         9 ~~v~~Y-~i~~~LG~GaFG~Vy~a~~----~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-   82 (575)
                      .+-++| +++++||+|+||.||++..    ..+|+.||||++... ......+.+.+|+.+++.++||||+++++++.. 
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            345555 9999999999999988753    458999999999765 345556779999999999999999999999987 


Q ss_pred             -CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           83 -PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        83 -~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                       ...+++||||+++|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcccc
Confidence             46899999999999999999765 59999999999999999999999999999999999999   77789999999999


Q ss_pred             cccCCCC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH---------------HHH
Q 043425          162 RSLQPRG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI---------------QLL  222 (575)
Q Consensus       162 ~~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~---------------~~l  222 (575)
                      .......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||......               ...
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            8765443    234456888999999999999999999999999999999999999764321               111


Q ss_pred             HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          223 QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       223 ~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..+.....   .+....++.++.+||++||..||.+|||++|+++
T Consensus       262 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          262 ELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11222222   2223468899999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=360.73  Aligned_cols=245  Identities=27%  Similarity=0.511  Sum_probs=187.8

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEE--------eC
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIE--------VP   83 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~--------~~   83 (575)
                      +|++.++||+|+||.||+|++..+|+.||||++...  .....+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            699999999999999999999999999999998654  3445567889999999996 999999999984        34


Q ss_pred             CEEEEEEeecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQR---HGCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~---~~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      ..+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||+   +..+.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecC
Confidence            45899999995 699888865   467999999999999999999999999  9999999999999   67788999999


Q ss_pred             ccccccCCCCC-------------cccccCCCCCCChHHH---hhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHH
Q 043425          159 GFARSLQPRGL-------------AETLCGSPLYMAPEIM---QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLL  222 (575)
Q Consensus       159 Gla~~~~~~~~-------------~~~~~GT~~Y~APEvl---~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l  222 (575)
                      |++........             ....+||+.|+|||++   ....++.++||||||+++|+|++|..||.........
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            99987654322             1246799999999998   5667889999999999999999999999876554433


Q ss_pred             HHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCC
Q 043425          223 QNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHP  269 (575)
Q Consensus       223 ~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hp  269 (575)
                      ...     ...+. ....+..+.+||++||..||.+|||++|+++|-
T Consensus       263 ~~~-----~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          263 NGK-----YSIPP-HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------CCCCT-TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cCc-----ccCCc-ccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            221     11121 234667899999999999999999999999973

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-42  Score=376.55  Aligned_cols=247  Identities=25%  Similarity=0.465  Sum_probs=210.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|++.++||+|+||.||+|.+.. +..||||++......   .+.+.+|+.+|++++||||+++++++.. +.+++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            34679999999999999999999874 567999999865433   3468899999999999999999999865 678999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCC
Confidence            9999999999999643  569999999999999999999999999999999999999   66788999999999876433


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....+++.|+|||++....++.++||||||+++|+|++ |..||.+....+.+..+..+.....+   ..++.++
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  410 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---PECPESL  410 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHH
Confidence            22  233457888999999999999999999999999999999 99999999988888887766444433   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||.+||..||.+|||++++++
T Consensus       411 ~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-42  Score=374.78  Aligned_cols=258  Identities=25%  Similarity=0.452  Sum_probs=200.4

Q ss_pred             CCeeecC-EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 043425            7 RGRVVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG   84 (575)
Q Consensus         7 ~g~~v~~-Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~   84 (575)
                      .+..+++ |.+.+.||+|+||+||.+. ..+|+.||||++....     .+.+.+|+.+|+.+ +||||+++++++...+
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3444444 5667889999999998754 4589999999987532     24567899999876 8999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCC-------HHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC----------
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVP-------EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD----------  147 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~ls-------e~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d----------  147 (575)
                      .+|||||||. |+|.+++...+...       +..++.++.||+.||+|||++||+||||||+|||+..+          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999995 69999998664332       33457899999999999999999999999999999543          


Q ss_pred             CCCCcEEEcccccccccCCCC-----CcccccCCCCCCChHHHhh-------ccCCcccccchhhHHHHHHHh-CCCCCC
Q 043425          148 DDNAALKIADFGFARSLQPRG-----LAETLCGSPLYMAPEIMQL-------QKYDAKADLWSVGAILFQLVT-GKTPFT  214 (575)
Q Consensus       148 d~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~-------~~y~~kaDIWSLGviLyeLlt-G~~PF~  214 (575)
                      +....+||+|||++.......     .....+||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            245689999999998765432     2335689999999999975       678999999999999999999 999998


Q ss_pred             CCCHHHHHHHHHHhccCCCCC----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          215 GSNQIQLLQNIVKATELHFPP----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       215 ~~~~~~~l~~i~~~~~~~~p~----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ......  ..+.... ...+.    ....++.++.+||.+||+.||.+|||+.|+++||||...
T Consensus       242 ~~~~~~--~~i~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          242 DKYSRE--SNIIRGI-FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             STTTHH--HHHHHTC-CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CchhhH--HHHhcCC-CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            765433  2333332 11111    113467899999999999999999999999999999754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-42  Score=392.14  Aligned_cols=247  Identities=23%  Similarity=0.422  Sum_probs=213.1

Q ss_pred             EEEE-EEecccCCeEEEEEEE--cCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           14 YLVG-RQIGSGSFSVVWHARH--RVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        14 Y~i~-~~LG~GaFG~Vy~a~~--~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +.+. ++||+|+||.||+|.+  +.++..||||++..........+.+.+|+.+|++++||||++++++++. +.+++||
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~  448 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM  448 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence            4443 5899999999999955  4577899999998765555556789999999999999999999999964 4589999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC--
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~--  168 (575)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....  
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC----
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccc
Confidence            999999999999988899999999999999999999999999999999999999   566789999999998765432  


Q ss_pred             --CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                        ......||+.|+|||++....|+.++|||||||+||+|++ |..||.+.+..+....+.++.....+.   .++.++.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~~~l~  602 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---GCPREMY  602 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---TCCHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCCHHHH
Confidence              1233457889999999999999999999999999999998 999999999988888887765554443   5789999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      +||.+||..||.+|||++++++
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=379.06  Aligned_cols=260  Identities=23%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             eeecC--EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425            9 RVVGD--YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus         9 ~~v~~--Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ..++.  |.+.++||+|+||+||. ....+|+.||||++......     .+.+|+.+|+.+ +||||+++++++...+.
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~   92 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQF   92 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred             EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence            34554  99999999999999764 34458999999999754322     246899999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC--CCCcEEEccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD--DNAALKIADFGFAR  162 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd--~~g~vKL~DFGla~  162 (575)
                      +|||||||. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+..++  ....+||+|||+++
T Consensus        93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            999999996 59999997654 466667889999999999999999999999999999996433  33468899999998


Q ss_pred             ccCCC----CCcccccCCCCCCChHHHh---hccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCC
Q 043425          163 SLQPR----GLAETLCGSPLYMAPEIMQ---LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFP  234 (575)
Q Consensus       163 ~~~~~----~~~~~~~GT~~Y~APEvl~---~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p  234 (575)
                      .....    ......+||+.|+|||++.   ...++.++|||||||++|+|++ |..||.......... +.........
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~  250 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCL  250 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTS
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCcccc
Confidence            76533    2344578999999999997   4667889999999999999999 999997665444322 2222222222


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                      ......+..+++||.+||..||.+|||++|+++||||....+
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            222345677999999999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=355.35  Aligned_cols=242  Identities=31%  Similarity=0.521  Sum_probs=198.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++.+.||+|+||.||+|++.  ++.||||++...    ...+.+.+|+.++++++||||+++++++.  +..++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            568999999999999999999876  889999998643    23467889999999999999999999875  4489999


Q ss_pred             eecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh---CCcccccccCCceeeecCCCCC-cEEEcccccccc
Q 043425           91 EYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRD---NNLIHRDLKPQNLLLCTDDDNA-ALKIADFGFARS  163 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~---~gIvHrDLKPeNILl~~dd~~g-~vKL~DFGla~~  163 (575)
                      ||++||+|.+++....   .+++..+..++.||+.||+|||+   +||+||||||+|||+   +.++ .+||+|||++..
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTACD  155 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE---ETTTTEEEECCCCC---
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE---eCCCCEEEEcccccccc
Confidence            9999999999998654   37899999999999999999999   899999999999999   4444 489999999976


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhccCCCCCChhccc
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN--QIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~--~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....  .......+....   .++....++
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLP  230 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCC
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccC
Confidence            5432  234579999999999999999999999999999999999999998643  223333333332   233334688


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++.+||.+||..||.+|||+++++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999999884

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-42  Score=353.22  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=199.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeC---
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR--INHPHIIRLHDIIEVP---   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~~~~~~---   83 (575)
                      .+.++|+++++||+|+||.||+|++.  |+.||||++....     ......|..++..  ++||||+++++++...   
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            45678999999999999999999886  9999999986432     2234455666554  4899999999999877   


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC--------CcccccccCCceeeecCCCCCcEE
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN--------NLIHRDLKPQNLLLCTDDDNAALK  154 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~--------gIvHrDLKPeNILl~~dd~~g~vK  154 (575)
                       ..+++||||++||+|.++++.. .+++..++.++.||+.||.|||++        ||+||||||+|||+   +.++.+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~k  182 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCC  182 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEE
Confidence             7899999999999999999754 699999999999999999999999        99999999999999   6778999


Q ss_pred             EcccccccccCCCCC-----cccccCCCCCCChHHHhhccCCcc------cccchhhHHHHHHHhC----------CCCC
Q 043425          155 IADFGFARSLQPRGL-----AETLCGSPLYMAPEIMQLQKYDAK------ADLWSVGAILFQLVTG----------KTPF  213 (575)
Q Consensus       155 L~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~y~~k------aDIWSLGviLyeLltG----------~~PF  213 (575)
                      |+|||++..+.....     ....+||+.|+|||++....+...      +|||||||++|+|++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            999999976543322     235689999999999988777665      9999999999999999          7777


Q ss_pred             CCCC----HHHHHHHHHHhc--cCCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          214 TGSN----QIQLLQNIVKAT--ELHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       214 ~~~~----~~~~l~~i~~~~--~~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ....    ............  ...++...  ..++.++.+||.+||..||.+|||+.|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            6532    222222222221  12222211  2467789999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=363.81  Aligned_cols=244  Identities=16%  Similarity=0.224  Sum_probs=197.7

Q ss_pred             ecCEEEEEEecccCCeEEEEE-----EEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEe
Q 043425           11 VGDYLVGRQIGSGSFSVVWHA-----RHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDIIEV   82 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a-----~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~   82 (575)
                      .++|.+.++||+|+||.||+|     .+..+++.||||++....     ...+..|+.+++.+.   |+||+++++++..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            356999999999999999999     467789999999997542     335678888888886   8999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec--------CCC
Q 043425           83 PGKLHLILEYCKGGDLSMYIQR-----HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT--------DDD  149 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~-----~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~--------dd~  149 (575)
                      .+..|+|||||+||+|.+++..     .+.+++..++.++.||+.||+|||++|||||||||+|||+..        ++.
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            9999999999999999999974     457999999999999999999999999999999999999943        122


Q ss_pred             CCcEEEcccccccccC---CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 043425          150 NAALKIADFGFARSLQ---PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIV  226 (575)
Q Consensus       150 ~g~vKL~DFGla~~~~---~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~  226 (575)
                      .+.+||+|||+++.+.   ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........     
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence            7899999999996543   33345667899999999999999999999999999999999999999965432110     


Q ss_pred             HhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       227 ~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                       .....+...  ..+..+.+++..||+.+|.+|++..+.+.
T Consensus       294 -~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 -KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence             001111111  24678899999999999999965444433

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=369.02  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCC---cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDII-EVPGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg---~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~-~~~~~l~   87 (575)
                      ..|.+.++||+|+||.||+|.+..++   ..||+|.+.... .....+.+.+|+.++++++||||+++++++ ...+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            45899999999999999999986433   468999886533 334567789999999999999999999986 4456789


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccc
Confidence            999999999999999765 458899999999999999999999999999999999999   7778999999999986543


Q ss_pred             CCC-----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcc
Q 043425          167 RGL-----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKIL  240 (575)
Q Consensus       167 ~~~-----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~l  240 (575)
                      ...     .....||+.|+|||++....++.++||||||+++|+|++ |.+||.+.+..+....+..+.....+   ..+
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~~~  321 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYC  321 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---TTC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence            321     233567889999999999999999999999999999999 78899887776666666665443333   357


Q ss_pred             cHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          241 SADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       241 s~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.++.++|.+||..||.+|||+.|++++
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999884

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-43  Score=362.82  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  106 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY  106 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence            467999999999999999999855 7999999998764322 11235789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           91 EYCKGGDLSMYIQRHG----CVPEETAKHFMKQLAAGLQVLRDN---NLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~----~lse~~i~~i~~QLl~aL~~LH~~---gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ||+.||+|.+++....    .+++..+..++.||+.||+|||++   ||+||||||+|||+   +.++.+||+|||++..
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccccc
Confidence            9999999999998643    499999999999999999999999   99999999999999   7778999999999987


Q ss_pred             cCCCC--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC----HHHHHHHHHHh----ccC--
Q 043425          164 LQPRG--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN----QIQLLQNIVKA----TEL--  231 (575)
Q Consensus       164 ~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~----~~~~l~~i~~~----~~~--  231 (575)
                      .....  .....+||+.|+|||++.+..++.++||||||+++|+|++|..||....    ...........    ...  
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            64332  3445679999999999999999999999999999999999999995211    00111111111    000  


Q ss_pred             ----CC-CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCC
Q 043425          232 ----HF-PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF  270 (575)
Q Consensus       232 ----~~-p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpf  270 (575)
                          .. .......+.++.+|+.+||..||.+|||+.|+++|-.
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                00 0111234578999999999999999999999999744

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=355.65  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHH--HHhCCCCCcceEEEEEEe--
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFI--LKRINHPHIIRLHDIIEV--   82 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~i--L~~L~HpnIv~l~~~~~~--   82 (575)
                      .+..+++|+++++||+|+||.||+|++  +|+.||||++....     ...+..|..+  +..++||||+++++.+..  
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            366789999999999999999999976  59999999997542     1223344444  456899999999986532  


Q ss_pred             ---CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC---------CcccccccCCceeeecCCCC
Q 043425           83 ---PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN---------NLIHRDLKPQNLLLCTDDDN  150 (575)
Q Consensus        83 ---~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~---------gIvHrDLKPeNILl~~dd~~  150 (575)
                         ...+++||||++||+|.+++... .+++..+..++.||+.||.|||+.         ||+||||||+|||+   +..
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~  156 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KND  156 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTT
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCC
Confidence               23679999999999999999765 468999999999999999999999         99999999999999   677


Q ss_pred             CcEEEcccccccccCCCC---------CcccccCCCCCCChHHHhh-------ccCCcccccchhhHHHHHHHhCCCCCC
Q 043425          151 AALKIADFGFARSLQPRG---------LAETLCGSPLYMAPEIMQL-------QKYDAKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       151 g~vKL~DFGla~~~~~~~---------~~~~~~GT~~Y~APEvl~~-------~~y~~kaDIWSLGviLyeLltG~~PF~  214 (575)
                      +.+||+|||++..+....         .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            899999999998764322         2235679999999999976       567788999999999999999977764


Q ss_pred             CCCH-----------------HHHHHHHHHh--ccCCCCCCh---hcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          215 GSNQ-----------------IQLLQNIVKA--TELHFPPDA---KILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       215 ~~~~-----------------~~~l~~i~~~--~~~~~p~~~---~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ....                 ..........  ....++...   ...++++.+||.+||..||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            3211                 1111111111  122223222   235668999999999999999999999955

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.9e-42  Score=376.24  Aligned_cols=254  Identities=19%  Similarity=0.258  Sum_probs=212.2

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l~   87 (575)
                      .+.++|+++++||+|+||.||+|++..+|+.||||++......    ..+.+|+.+++.+.| ++|..+..++...+..+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            5668899999999999999999999999999999998765433    236789999999987 56667777778889999


Q ss_pred             EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+..++..+.+||+|||+++.+..
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 9999999985 46799999999999999999999999999999999999996555778999999999987654


Q ss_pred             CCC--------cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcc-CCCC
Q 043425          167 RGL--------AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQ---IQLLQNIVKATE-LHFP  234 (575)
Q Consensus       167 ~~~--------~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~---~~~l~~i~~~~~-~~~p  234 (575)
                      ...        ....+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+...   .+.+..+..... ....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            322        2367899999999999999999999999999999999999999987543   333443333221 1111


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....++.++.+||.+||..||.+||++++|++
T Consensus       239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            112357899999999999999999999988765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.7e-42  Score=380.27  Aligned_cols=247  Identities=25%  Similarity=0.463  Sum_probs=215.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..++|++.++||+|+||.||+|.+.. +..||||++......   .+.+.+|+.+|+.++||||+++++++.. +.+|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            34679999999999999999999874 567999999865443   3468899999999999999999999865 678999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCC
Confidence            9999999999999643  569999999999999999999999999999999999999   66788999999999866432


Q ss_pred             C--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .  ......+++.|+|||++....++.++|||||||+||+|++ |..||.+....+.+..+..+.....+   ..++.++
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  493 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---PECPESL  493 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHH
Confidence            2  1223457788999999999999999999999999999999 99999999988888887766444433   3578999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+||.+||..||.+|||++++++
T Consensus       494 ~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=354.27  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEE----EcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHAR----HRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-   83 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~----~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-   83 (575)
                      ...++|++++.||+|+||.||+|+    +..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++... 
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            345669999999999999999998    4568999999998764  334556789999999999999999999998554 


Q ss_pred             -CEEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccc
Q 043425           84 -GKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFA  161 (575)
Q Consensus        84 -~~l~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla  161 (575)
                       ..+++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcch
Confidence             3689999999999999999876 469999999999999999999999999999999999999   56678999999999


Q ss_pred             cccCCCCC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH----------------HH
Q 043425          162 RSLQPRGL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI----------------QL  221 (575)
Q Consensus       162 ~~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~----------------~~  221 (575)
                      ........    .....+++.|+|||++.+..++.++||||||+++|+|++|..||......                .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654332    23356788899999999999999999999999999999999998643111                11


Q ss_pred             HHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          222 LQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       222 l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ...+......   +....++.++.+||++||..||.+|||+.|+++
T Consensus       273 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1122222122   223457899999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-42  Score=353.31  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCc--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR--LNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      |..+++||+|+||.||+|.+  +++.||||++....  ......+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999986  58999999987542  223456778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           92 YCKGGDLSMYIQR---HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        92 y~~GgsL~~~l~~---~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |++|++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccccc
Confidence            9999999999974   3469999999999999999999999999999999999999   777899999999998654322


Q ss_pred             ---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-----------cCCCC
Q 043425          169 ---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-----------ELHFP  234 (575)
Q Consensus       169 ---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~-----------~~~~p  234 (575)
                         .....+||+.|+|||++.+ .++.++||||||+++|+|++|.+||.+......+..+....           ...++
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               2334679999999999875 58899999999999999999999998765433222222110           11122


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ......+..+.+++.+||..||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2234466789999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=385.49  Aligned_cols=248  Identities=23%  Similarity=0.459  Sum_probs=210.0

Q ss_pred             cCEEEEE-EecccCCeEEEEEEEcC--CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGR-QIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~-~LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +++.+.+ +||+|+||.||+|.++.  ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence            3466666 89999999999998763  56779999997653 23345678999999999999999999999976 56999


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCC
Confidence            99999999999999654 469999999999999999999999999999999999999   56678999999999876433


Q ss_pred             CC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ..    .....+++.|+|||++....|+.++|||||||+||+|++ |..||.+.+..+....+.++....++.   .++.
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~~  566 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---ECPP  566 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---TCCH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---cCCH
Confidence            21    122346789999999999999999999999999999998 999999999888888887765555444   5789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++.+||.+||..||.+||+++++++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=358.77  Aligned_cols=251  Identities=21%  Similarity=0.370  Sum_probs=211.3

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++|++++.||+|+||.||+|.+..   .+|+|++..........+.+.+|+.++++++||||+++++++...+.+++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            456789999999999999999999863   49999997654443334457789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-  166 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-  166 (575)
                      ||||++|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+   + ++.+||+|||++..... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccccccc
Confidence            999999999999997654 69999999999999999999999999999999999999   4 46899999999865431 


Q ss_pred             -----CCCcccccCCCCCCChHHHhh---------ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC
Q 043425          167 -----RGLAETLCGSPLYMAPEIMQL---------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH  232 (575)
Q Consensus       167 -----~~~~~~~~GT~~Y~APEvl~~---------~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~  232 (575)
                           ........||+.|+|||++..         ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 122344579999999999974         457889999999999999999999999998888877766654333


Q ss_pred             CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       233 ~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...  ..++.++.+||.+||..||.+|||++++++.
T Consensus       263 ~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          263 LSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            222  2478899999999999999999999999883

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-41  Score=350.39  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR--INHPHIIRLHDIIEVPG----   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~~~~~~~----   84 (575)
                      .++|.+.+.||+|+||.||+|++.  |+.||||++...     ....+.+|..++..  ++||||+++++++....    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            467999999999999999999984  999999998643     23457788999887  78999999999998775    


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh--------hCCcccccccCCceeeecCCCCCcEEEc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR--------DNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH--------~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                      .+++||||+++|+|.+++.+ ..+++..++.++.||+.||.|||        +.||+||||||+|||+   +.++.+||+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~  189 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  189 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEEC
T ss_pred             eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEE
Confidence            79999999999999999976 46999999999999999999999        8999999999999999   677899999


Q ss_pred             ccccccccCCCC-----CcccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhC----------CCCCCC
Q 043425          157 DFGFARSLQPRG-----LAETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTG----------KTPFTG  215 (575)
Q Consensus       157 DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG----------~~PF~~  215 (575)
                      |||++.......     .....+||+.|+|||++...      .++.++||||||+++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            999998765433     23456899999999999765      334689999999999999999          789876


Q ss_pred             CC-----HHHHHHHHHHhc-cCCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          216 SN-----QIQLLQNIVKAT-ELHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       216 ~~-----~~~~l~~i~~~~-~~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ..     ...+...+.... ...++...  ...+..+.+||.+||..||.+|||++|+++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            52     233333332221 12222211  2345689999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-43  Score=398.31  Aligned_cols=266  Identities=29%  Similarity=0.500  Sum_probs=216.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-----   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-----   82 (575)
                      +..+++|++.++||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.+++.++||||+++++++..     
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            67789999999999999999999999999999999998754 355666789999999999999999999998755     


Q ss_pred             -CCEEEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           83 -PGKLHLILEYCKGGDLSMYIQRHG---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        83 -~~~l~LVmEy~~GgsL~~~l~~~~---~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                       .+..++||||++||+|.+++....   .+++..++.++.||+.||+|||+.||+||||||+|||+..++....+||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             667899999999999999998654   5999999999999999999999999999999999999965555566999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHH---------HHH--
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQN---------IVK--  227 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~---------i~~--  227 (575)
                      |++............+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........         +..  
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            999988776666778999999999999999999999999999999999999999987543321100         000  


Q ss_pred             --hccCCC------CC-ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          228 --ATELHF------PP-DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       228 --~~~~~~------p~-~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                        .....+      +. ....++.++.+||++||.+||.+|||+.|+++||||...
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence              000011      11 113467899999999999999999999999999999763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.4e-41  Score=380.73  Aligned_cols=251  Identities=24%  Similarity=0.467  Sum_probs=215.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|++++.||+|+||.||+|.+..+   +..||||.+... ......+.+.+|+.+++.++||||+++++++. .+.+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            346799999999999999999998653   567999988653 24555678999999999999999999999984 5668


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeecC
Confidence            99999999999999998654 68999999999999999999999999999999999999   566789999999998765


Q ss_pred             CCCC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          166 PRGL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       166 ~~~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ....  .....||+.|+|||++....++.++||||||+++|+|++ |..||.+....+.+..+........+.   .++.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~  619 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---NCPP  619 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---TCCH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---cccH
Confidence            4332  223567889999999999999999999999999999997 999999999988888887765544443   5789


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++.+||.+||..||.+|||+.++++.
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.3e-44  Score=369.79  Aligned_cols=249  Identities=21%  Similarity=0.268  Sum_probs=196.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC------HHHHHHHHHHHHHHHhCC---------CCCcce
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN------KKLQESLMSEIFILKRIN---------HPHIIR   75 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~------~~~~~~i~~Ei~iL~~L~---------HpnIv~   75 (575)
                      .++|+++++||+|+||.||+|++  +|+.||||++......      ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999998  6899999999876421      222356788999988875         888888


Q ss_pred             EEEEEE------------------------------eCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 043425           76 LHDIIE------------------------------VPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ  125 (575)
Q Consensus        76 l~~~~~------------------------------~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~  125 (575)
                      +.+++.                              ..+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            877642                              26789999999999976666643 67899999999999999999


Q ss_pred             HHh-hCCcccccccCCceeeecCC-----------------CCCcEEEcccccccccCCCCCcccccCCCCCCChHHHhh
Q 043425          126 VLR-DNNLIHRDLKPQNLLLCTDD-----------------DNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL  187 (575)
Q Consensus       126 ~LH-~~gIvHrDLKPeNILl~~dd-----------------~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~  187 (575)
                      ||| ++||+||||||+|||+..++                 ....+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999995432                 1238999999999876532    4589999999999986


Q ss_pred             ccCCcccccchhhHH-HHHHHhCCCCCCCCCH-HHHHHHHHHhccCC---CCCChhcccHHHHHHHHHhhccCCCCCCCH
Q 043425          188 QKYDAKADLWSVGAI-LFQLVTGKTPFTGSNQ-IQLLQNIVKATELH---FPPDAKILSADCKDLCQKLLRRNPVERLTF  262 (575)
Q Consensus       188 ~~y~~kaDIWSLGvi-LyeLltG~~PF~~~~~-~~~l~~i~~~~~~~---~p~~~~~ls~el~dLI~k~L~~DP~~RpTa  262 (575)
                      .. +.++||||||++ .++++.|..||.+... ......+.......   .+.....+++++++||++||.+|     |+
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            66 889999998777 7888999999964322 12223333222111   11113468899999999999977     99


Q ss_pred             HHHH-cCCCCC
Q 043425          263 EEFF-NHPFLS  272 (575)
Q Consensus       263 ~eiL-~Hpff~  272 (575)
                      +|+| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-42  Score=367.03  Aligned_cols=248  Identities=15%  Similarity=0.189  Sum_probs=195.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCC-CCc---------c------
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINH-PHI---------I------   74 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~H-pnI---------v------   74 (575)
                      ..|.++++||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+.| .|+         +      
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            458899999999999999999999999999999874332 22334668899999999977 221         1      


Q ss_pred             ------eEEEEEEe-----CCEEEEEEeecCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHhhCCccccc
Q 043425           75 ------RLHDIIEV-----PGKLHLILEYCKGGDLSMYIQR-------HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD  136 (575)
Q Consensus        75 ------~l~~~~~~-----~~~l~LVmEy~~GgsL~~~l~~-------~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrD  136 (575)
                            .+..++..     ...++++|+++ +++|.++++.       .+.+++..+..++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                  11111111     22467788876 6899999852       23477888999999999999999999999999


Q ss_pred             ccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCCCChHHH----------hhccCCcccccchhhHHHHHH
Q 043425          137 LKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM----------QLQKYDAKADLWSVGAILFQL  206 (575)
Q Consensus       137 LKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl----------~~~~y~~kaDIWSLGviLyeL  206 (575)
                      |||+|||+   +.++.+||+|||+++.....  ....+| +.|+|||++          ....|+.++|||||||++|+|
T Consensus       237 iKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          237 LRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            99999999   77788999999998765433  456788 999999999          455688899999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          207 VTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       207 ltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      ++|+.||.+.+.......+..        ....++.++.+||.+||..||.+||++.++++||||+..
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999988765443322211        113578999999999999999999999999999999765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.7e-40  Score=334.79  Aligned_cols=226  Identities=15%  Similarity=0.194  Sum_probs=187.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.++..++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            37799999999999999999999999999999999876543 45567789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |||++|++|.+++++ + ..+..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+++|          
T Consensus       110 ~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA----------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC----------
T ss_pred             EEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc----------
Confidence            999999999999954 3 4666788999999999999999999999999999999   667789998554          


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhccCCCCCChhcccHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ---NIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~---~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                               |++       .++.++|||||||++|+|++|+.||.+.+....+.   ................++.++.+
T Consensus       175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                     333       37889999999999999999999999866433111   00111100000111357899999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ||.+||.+||.+| |+.|+++.
T Consensus       239 li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999 99999883

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-40  Score=375.75  Aligned_cols=242  Identities=24%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcC-CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE---
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRV-HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK---   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~-tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~---   85 (575)
                      +.++|++.++||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            44889999999999999999999986 79999999986532 34556678999999999999999999999977654   


Q ss_pred             --EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           86 --LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        86 --l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                        .||||||++|++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||+   +. +.+||+|||+++.
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll---~~-~~~kl~DFG~a~~  230 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML---TE-EQLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CS-SCEEECCCTTCEE
T ss_pred             ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE---eC-CcEEEEecccchh
Confidence              7999999999999998754  79999999999999999999999999999999999999   33 3799999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ....   ...+||+.|+|||++... ++.++|||||||++|+|++|.+||.+....          ...........+..
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~~~~~~~~  296 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDDPVLKTYDS  296 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTCHHHHHCHH
T ss_pred             cccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccccccccccCHH
Confidence            6543   457899999999999764 588999999999999999999998763210          00001111235678


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      +.+||.+||.+||.+||+..+.+.|+|+.
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999999988863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=5.1e-33  Score=310.55  Aligned_cols=188  Identities=18%  Similarity=0.133  Sum_probs=139.4

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCcc----C----HHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL----N----KKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~----~----~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ..++.|++|.+..++....|+.||||++.+...    .    +...+++.+|+.+|+++ .|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            346778888888888888999999999976532    1    23346789999999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      |||||+|++|.++|.+.+++++.   .|++||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+..... 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence            99999999999999999888875   488999999999999999999999999999   77789999999999876543 


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCC
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP  212 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~P  212 (575)
                      ....+.+||+.|||||++.+ .+...+|+|++|+++++|.++..+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            34567899999999999875 467789999999998888765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.5e-28  Score=272.79  Aligned_cols=185  Identities=17%  Similarity=0.186  Sum_probs=146.4

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-H-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-K-----KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ...++||+|+||.||+|.  ..+..+|+|........ .     ...+.+.+|+.+|++++||||+++..++...+..||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345789999999999994  45889999987554332 1     123557899999999999999955555556777899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||++|++|.+++.+        +..++.||+.||+|||++||+||||||+|||+   +.  .+||+|||+++......
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEECCCHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEECCCcc
Confidence            9999999999999865        67899999999999999999999999999999   44  89999999998875532


Q ss_pred             C--------cccccCCCCCCChHHHhh--ccCCcccccchhhHHHHHHHhCCCCCC
Q 043425          169 L--------AETLCGSPLYMAPEIMQL--QKYDAKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       169 ~--------~~~~~GT~~Y~APEvl~~--~~y~~kaDIWSLGviLyeLltG~~PF~  214 (575)
                      .        ...++||+.|||||++..  ..|+...|+|+..+-..+.+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1        246799999999999987  778888999999888888877776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.8e-25  Score=225.69  Aligned_cols=156  Identities=17%  Similarity=0.237  Sum_probs=122.8

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----------------HHHHHHHHHHHHHHhCCCCCcceEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----------------KLQESLMSEIFILKRINHPHIIRLHD   78 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----------------~~~~~i~~Ei~iL~~L~HpnIv~l~~   78 (575)
                      .+++.||+|+||.||+|.+ .+|+.||||++.......                .....+.+|+.+|+.++  | +++.+
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3449999999999999999 789999999996533211                13566889999999998  4 55555


Q ss_pred             EEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           79 IIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        79 ~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      ++.. +..|+||||++|++|.+ +.      ...+..++.||+.||.|||++||+||||||+|||+   + ++.+||+||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vkl~DF  236 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIWIIDF  236 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEEECCC
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEEEEEC
Confidence            5544 45699999999999988 42      13356799999999999999999999999999999   4 788999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhh----------ccCCcccccch
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQL----------QKYDAKADLWS  198 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~----------~~y~~kaDIWS  198 (575)
                      |+++.            +..|+|||++..          ..|+..+|+|.
T Consensus       237 G~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99863            456899999853          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=6.8e-21  Score=191.22  Aligned_cols=139  Identities=20%  Similarity=0.224  Sum_probs=109.3

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcE--EEEEEeecCccC----------------------HHHHHHHHHHHHHHHhCC
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLN----------------------KKLQESLMSEIFILKRIN   69 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~--vAVK~i~~~~~~----------------------~~~~~~i~~Ei~iL~~L~   69 (575)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||++......                      ......+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999778999  999997543211                      011235789999999998


Q ss_pred             CCCc--ceEEEEEEeCCEEEEEEeecCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccccccCCc
Q 043425           70 HPHI--IRLHDIIEVPGKLHLILEYCKG-G----DLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDLKPQN  141 (575)
Q Consensus        70 HpnI--v~l~~~~~~~~~l~LVmEy~~G-g----sL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH-~~gIvHrDLKPeN  141 (575)
                      |++|  +.+++.    +..+|||||+.+ |    .|.++...   .++..+..++.||+.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  444443    246899999942 3    67666432   245678899999999999999 9999999999999


Q ss_pred             eeeecCCCCCcEEEccccccccc
Q 043425          142 LLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus       142 ILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      ||+   +.  .++|+|||+|...
T Consensus       202 ILl---~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMY---ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEE---SS--SEEECCCTTCEET
T ss_pred             EEE---cC--cEEEEECcccccC
Confidence            999   44  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=2.5e-17  Score=175.39  Aligned_cols=139  Identities=19%  Similarity=0.232  Sum_probs=102.0

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC---------------HH-----HHHHHHHHHHHHHhCCCCCc
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN---------------KK-----LQESLMSEIFILKRINHPHI   73 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~---------------~~-----~~~~i~~Ei~iL~~L~HpnI   73 (575)
                      |.++++||.|+||.||+|.+. +|+.||||++......               ..     .+....+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999986 7999999987543211               00     01112467778888865554


Q ss_pred             c--eEEEEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCC-
Q 043425           74 I--RLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDN-  150 (575)
Q Consensus        74 v--~l~~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~-  150 (575)
                      .  ..++.  ..  .+|||||++|+.|..+.      ....+..++.||+.+|.+||+.|||||||||.|||+..+++. 
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            3  33332  22  37999999998886543      223457789999999999999999999999999999644321 


Q ss_pred             ------CcEEEcccccccc
Q 043425          151 ------AALKIADFGFARS  163 (575)
Q Consensus       151 ------g~vKL~DFGla~~  163 (575)
                            ..+.|+||+-+..
T Consensus       246 d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEE
T ss_pred             cccccccceEEEEeCCccc
Confidence                  1489999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=1.6e-12  Score=129.13  Aligned_cols=143  Identities=13%  Similarity=0.145  Sum_probs=114.0

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l   86 (575)
                      ...+++|.+...+|.|+++.||++...  |..+++|+........  ...+.+|+.+++.+. +..+.++++++...+..
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            346788999999999999999999754  7899999986522111  234788999999885 67788999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-------------------------------------  129 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-------------------------------------  129 (575)
                      |+||||++|.+|.+.+.     +......++.+++.+|..||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999999877531     223345788999999999998                                     


Q ss_pred             ----------------------CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          130 ----------------------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       130 ----------------------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                                            ..++|+|++|.|||+   +++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhcc
Confidence                                  448999999999999   444556799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=1.4e-11  Score=120.80  Aligned_cols=138  Identities=17%  Similarity=0.136  Sum_probs=101.9

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH--IIRLHDIIEVPGK   85 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~   85 (575)
                      ...+.+|.+....+.|..+.||++.. .+|..+++|+.....     ...+.+|+.+++.+.+.+  +.+++++...++.
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~   89 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR   89 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             HHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence            34556678765555677799999964 467889999876431     134678999998886544  5678898888888


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN----------------------------------  131 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g----------------------------------  131 (575)
                      .++||||++|.+|.  ..   ...   ...++.+++..|..||+..                                  
T Consensus        90 ~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             CEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99999999998884  21   112   2356777777788887643                                  


Q ss_pred             ------------------------cccccccCCceeeecCCCCCcEEEccccccc
Q 043425          132 ------------------------LIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       132 ------------------------IvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                                              ++|+|++|.|||+   ++++.+.|+|||.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhcc
Confidence                                    9999999999999   444556799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=3e-10  Score=118.25  Aligned_cols=142  Identities=13%  Similarity=0.220  Sum_probs=104.9

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEee--cCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIA--MGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVP---GKLHL   88 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~--~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~---~~l~L   88 (575)
                      -++.|+.|.++.||++...  +..+++|+..  ..... .....+.+|+.+++.|..  ..+++++.++...   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            4678999999999998765  5688889775  32211 123467889999999874  5578899888665   45899


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD---------------------------------------  129 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~---------------------------------------  129 (575)
                      ||||++|..+.+..  ...+++.....++.+++..|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999998875421  2346788889999999999999997                                       


Q ss_pred             -------------------CCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425          130 -------------------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus       130 -------------------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                                         .+++|+|++|.|||+..++ ...+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence                               3689999999999993221 13468999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=4.8e-10  Score=114.15  Aligned_cols=182  Identities=22%  Similarity=0.248  Sum_probs=123.0

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEEEe
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPH--IIRLHDIIEVPG---KLHLILE   91 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hpn--Iv~l~~~~~~~~---~l~LVmE   91 (575)
                      +.++.|.+..||++.     ..+++|+...    ......+.+|..+|+.+. +..  +.+++......+   ..|+||+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            458999999999863     5688998642    234567889999998873 333  445555543333   3589999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh------------------------------------------
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD------------------------------------------  129 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~------------------------------------------  129 (575)
                      +++|..|.....  ..++......++.|++..|..||+                                          
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988876433  246788888888999988888886                                          


Q ss_pred             ----------------CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccccCCCCC---CChHHHhh--c
Q 043425          130 ----------------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY---MAPEIMQL--Q  188 (575)
Q Consensus       130 ----------------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y---~APEvl~~--~  188 (575)
                                      ..++|+|++|.|||+..+ ....+.|+||+.+....+-..   +.....+   ..|+....  .
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHH
Confidence                            136999999999999422 156688999999865322111   1111111   23443211  1


Q ss_pred             cCC------------cccccchhhHHHHHHHhCCCCCC
Q 043425          189 KYD------------AKADLWSVGAILFQLVTGKTPFT  214 (575)
Q Consensus       189 ~y~------------~kaDIWSLGviLyeLltG~~PF~  214 (575)
                      .|.            ...+.|++|.++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            111            12589999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=1e-06  Score=90.09  Aligned_cols=137  Identities=20%  Similarity=0.191  Sum_probs=94.4

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEee
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP---HIIRLHDIIE-VPGKLHLILEY   92 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~~~~-~~~~l~LVmEy   92 (575)
                      ++.++.|....||+.     |..+++|+-.    .......+.+|..+|+.+.+.   .+.+++.+.. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            355788988999988     6778899753    234456788999999998752   3567777764 34567899999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN------------------------------------------  130 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~------------------------------------------  130 (575)
                      ++|..|....-  ..++......++.++...|..||+.                                          
T Consensus        95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            99988876321  1234555555555555555555532                                          


Q ss_pred             ------------------CcccccccCCceeeecCCCCCc-EEEccccccccc
Q 043425          131 ------------------NLIHRDLKPQNLLLCTDDDNAA-LKIADFGFARSL  164 (575)
Q Consensus       131 ------------------gIvHrDLKPeNILl~~dd~~g~-vKL~DFGla~~~  164 (575)
                                        .++|+|++|.|||+..++..+. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              3599999999999943212344 589999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=1.3e-06  Score=86.41  Aligned_cols=138  Identities=16%  Similarity=0.230  Sum_probs=98.9

Q ss_pred             cCEEEEEEecccCC-eEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 043425           12 GDYLVGRQIGSGSF-SVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        12 ~~Y~i~~~LG~GaF-G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~LV   89 (575)
                      ..|+... +..|.. +.||+......+..+++|+-..     .....+.+|..+|+.|. +--+.+++.++...+..++|
T Consensus        25 ~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           25 YGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             cCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            3455443 344544 4799988777788899998653     23445788999998875 23367889999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN---------------------------------------  130 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~---------------------------------------  130 (575)
                      ||+++|.++.+.....    ......+..++...|..||..                                       
T Consensus        99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999999887765432    223344556666666666631                                       


Q ss_pred             -------------------CcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          131 -------------------NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       131 -------------------gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                                         .++|+|+.+.|||+   ++.+.+-|+||+.+.
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccc
Confidence                               16899999999999   555666799999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.12  E-value=6.3e-06  Score=86.74  Aligned_cols=79  Identities=16%  Similarity=0.138  Sum_probs=50.0

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc--CH---HHHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL--NK---KLQESLMSEIFILKRINH--P-HIIRLHDIIEVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~--~~---~~~~~i~~Ei~iL~~L~H--p-nIv~l~~~~~~~~~l~   87 (575)
                      -.+.||.|.++.||++....++..++||.......  ..   ...+.+..|..+|+.+..  | .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35689999999999997665678999997643211  00   012345678888887742  3 34466644  344568


Q ss_pred             EEEeecCCC
Q 043425           88 LILEYCKGG   96 (575)
Q Consensus        88 LVmEy~~Gg   96 (575)
                      +||||++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.07  E-value=4.1e-05  Score=77.73  Aligned_cols=74  Identities=16%  Similarity=0.289  Sum_probs=42.6

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-----HPHIIRLH-D--IIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIv~l~-~--~~~~~~~l~L   88 (575)
                      ++.|+.|..+.||++...  +..+++|+....   .   ..+..|..+++.|.     .|.++... +  +....+..++
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            356777788999998764  445999988752   1   22334555554442     34444310 0  2235778999


Q ss_pred             EEeecCCCCH
Q 043425           89 ILEYCKGGDL   98 (575)
Q Consensus        89 VmEy~~GgsL   98 (575)
                      ||+|++|..+
T Consensus       109 l~~~i~G~~~  118 (346)
T 2q83_A          109 VYDWIEGRPF  118 (346)
T ss_dssp             EEECCCCBCC
T ss_pred             EEEeecCccC
Confidence            9999998653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=5.6e-06  Score=85.56  Aligned_cols=82  Identities=12%  Similarity=0.126  Sum_probs=55.1

Q ss_pred             EEEEEe-cccCCeEEEEEEEc--C----CCcEEEEEEeecCc---cCHHHHHHHHHHHHHHHhCCC---CCcceEEEEEE
Q 043425           15 LVGRQI-GSGSFSVVWHARHR--V----HGTEVAMKEIAMGR---LNKKLQESLMSEIFILKRINH---PHIIRLHDIIE   81 (575)
Q Consensus        15 ~i~~~L-G~GaFG~Vy~a~~~--~----tg~~vAVK~i~~~~---~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~~~~   81 (575)
                      ...+.| +.|....+|++...  .    ++..+++|+.....   ...  ...+.+|+.+++.|..   -.+.+++.+..
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            345778 88989999988653  1    26789999765432   100  1246678888887742   35677888775


Q ss_pred             eC---CEEEEEEeecCCCCH
Q 043425           82 VP---GKLHLILEYCKGGDL   98 (575)
Q Consensus        82 ~~---~~l~LVmEy~~GgsL   98 (575)
                      ..   +..++||||++|..+
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCC
T ss_pred             CCCccCCceEEEEecCCCCh
Confidence            54   356899999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.61  E-value=0.00018  Score=76.45  Aligned_cols=76  Identities=11%  Similarity=0.158  Sum_probs=45.1

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecC-c-cCHH-----HHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-R-LNKK-----LQESLMSEIFILK-RINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~-~-~~~~-----~~~~i~~Ei~iL~-~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      -.+.||.|....||++..  ++..++||..... . ....     ....+..|+..+. ......+.+++.+.  .+..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            357899999999999954  4778999942210 0 0000     1122233333222 22234567777665  56679


Q ss_pred             EEEeec-CC
Q 043425           88 LILEYC-KG   95 (575)
Q Consensus        88 LVmEy~-~G   95 (575)
                      +||||+ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.53  E-value=0.00064  Score=69.89  Aligned_cols=75  Identities=16%  Similarity=0.142  Sum_probs=59.7

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeec
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDIIEVPGKLHLILEYC   93 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~~~~~~~l~LVmEy~   93 (575)
                      .+.|+.|.+..+|+...  .+..+++|+....     ....+..|...|+.|.   ...+++++.+....+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            46789999999999874  4778999987643     1345778988888874   356888998888888999999999


Q ss_pred             CCCCH
Q 043425           94 KGGDL   98 (575)
Q Consensus        94 ~GgsL   98 (575)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            99764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.21  E-value=0.00044  Score=70.00  Aligned_cols=139  Identities=13%  Similarity=0.112  Sum_probs=76.4

Q ss_pred             EEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH--IIRLHD------IIEVPGKL   86 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~------~~~~~~~l   86 (575)
                      .-.+.|+.|....+|++...  +..+++|+.....    ..+.+..|+.+++.|...+  +.+++.      +....+..
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            34567888888999998754  3378899886521    1223556777776653211  233321      12345778


Q ss_pred             EEEEeecCCCCHH-----H------H---HHHc-CCC--------CHHHHHHH---------------HHHHHHHHHHHh
Q 043425           87 HLILEYCKGGDLS-----M------Y---IQRH-GCV--------PEETAKHF---------------MKQLAAGLQVLR  128 (575)
Q Consensus        87 ~LVmEy~~GgsL~-----~------~---l~~~-~~l--------se~~i~~i---------------~~QLl~aL~~LH  128 (575)
                      +++|+|++|..+.     .      .   ++.. ..+        ....-...               -..+...++.+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999986531     1      1   1111 011        11100000               011333445554


Q ss_pred             h-------CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          129 D-------NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       129 ~-------~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +       .+++|+|+.+.|||+   +++..+.|+||+.+.
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             hhCcccCCcccCCCCCCccCEEE---eCCceEEEecchhcc
Confidence            2       368999999999999   444455799999764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.10  E-value=0.00037  Score=70.37  Aligned_cols=71  Identities=10%  Similarity=0.146  Sum_probs=44.5

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeec-C
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHLILEYC-K   94 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~-~   94 (575)
                      ++.|+.|....+|++      ..+++|+.....  .. .....+|..+++.+...++ .+++...  .+.-++|+||+ +
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~--~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT--EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc--cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            678888999999998      568889876421  10 1112467777776643222 4565543  33357899999 6


Q ss_pred             CCCH
Q 043425           95 GGDL   98 (575)
Q Consensus        95 GgsL   98 (575)
                      |..|
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.95  E-value=0.0033  Score=61.49  Aligned_cols=135  Identities=14%  Similarity=0.141  Sum_probs=86.2

Q ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHh-hCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcccc
Q 043425           96 GDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLR-DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL  173 (575)
Q Consensus        96 gsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH-~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~~~  173 (575)
                      -+|.+.|+. +.+++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|++   ...|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            368888874 468999999999999999988762 1221233445688888   5556676643 1110           


Q ss_pred             cCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhc
Q 043425          174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLLR  253 (575)
Q Consensus       174 ~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~  253 (575)
                      .....+.|||... ...+.+.-|||||+++|.-+--..|                     +.....+++++..||..|..
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTT
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHh
Confidence            1223456777652 3445678999999999988742221                     12225689999999999975


Q ss_pred             c-------------------------CCCCCCCHHHHHc
Q 043425          254 R-------------------------NPVERLTFEEFFN  267 (575)
Q Consensus       254 ~-------------------------DP~~RpTa~eiL~  267 (575)
                      -                         .+..|+++++|++
T Consensus       156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             CCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            5                         2457788888876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.93  E-value=0.0015  Score=69.87  Aligned_cols=74  Identities=18%  Similarity=0.240  Sum_probs=50.2

Q ss_pred             EEEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 043425           16 VGRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLH   87 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~   87 (575)
                      -++.|+.|-...||++....       .+..+++|+..... .   ...+..|..+++.|...++ .++++.+.  +  .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence            35678888889999998653       25789999884321 1   1335578888888754333 56776653  3  2


Q ss_pred             EEEeecCCCC
Q 043425           88 LILEYCKGGD   97 (575)
Q Consensus        88 LVmEy~~Ggs   97 (575)
                      +|+||++|..
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998733

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.92  E-value=0.0047  Score=62.50  Aligned_cols=75  Identities=8%  Similarity=0.099  Sum_probs=47.3

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCC--CcceEEEE-----EEeCCEEEEEE
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP--HIIRLHDI-----IEVPGKLHLIL   90 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~~-----~~~~~~l~LVm   90 (575)
                      ..|+ |....||++... +|+.+++|+........   ..+..|..+++.|...  .+++++..     ....+..++||
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            4566 778899987643 46689999986432222   3456677777766321  13333332     23466788999


Q ss_pred             eecCCCC
Q 043425           91 EYCKGGD   97 (575)
Q Consensus        91 Ey~~Ggs   97 (575)
                      +|++|..
T Consensus       107 ~~i~G~~  113 (328)
T 1zyl_A          107 PSVGGRQ  113 (328)
T ss_dssp             ECCCCEE
T ss_pred             EecCCCC
Confidence            9998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.88  E-value=0.002  Score=65.73  Aligned_cols=138  Identities=16%  Similarity=0.178  Sum_probs=70.4

Q ss_pred             EEecccCCeE-EEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEeecC
Q 043425           18 RQIGSGSFSV-VWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVPGKLHLILEYCK   94 (575)
Q Consensus        18 ~~LG~GaFG~-Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~~~l~LVmEy~~   94 (575)
                      +.|+.|+... +|+... .+|..+++|.......     ..+..|+.+++.+..  -.+.+++.+....+  +++||++.
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            4455554444 666643 2366777776543210     224456777666642  23566666533333  78999998


Q ss_pred             CCCHHHHHHHc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH-
Q 043425           95 GGDLSMYIQRH--------------------------GCVPEETAK-------H-FM------------KQLAAGLQVL-  127 (575)
Q Consensus        95 GgsL~~~l~~~--------------------------~~lse~~i~-------~-i~------------~QLl~aL~~L-  127 (575)
                      |..+.+++...                          ..++.....       . +.            ..+...++.+ 
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            76665443211                          012221110       0 00            0111122222 


Q ss_pred             -----hhCCcccccccCCceeeecCCC-CCcEEEcccccccc
Q 043425          128 -----RDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGFARS  163 (575)
Q Consensus       128 -----H~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFGla~~  163 (575)
                           +...++|||+.+.|||+..+.. .+.+.|+||+.+..
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence                 2347999999999999942211 25789999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.60  E-value=0.011  Score=58.90  Aligned_cols=78  Identities=12%  Similarity=0.086  Sum_probs=54.3

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC---CCcceEEEEEEeCCEEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH---PHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~~~~~~~~l~LVm   90 (575)
                      ..-++.+|.|..+.||++... +|+.|++|+.......  ....+..|...|+.|..   --+++++.+.  .  -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence            456788999999999999865 7899999986543221  12246789999988742   2345555542  2  37899


Q ss_pred             eecCCCCH
Q 043425           91 EYCKGGDL   98 (575)
Q Consensus        91 Ey~~GgsL   98 (575)
                      ||+.++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.58  E-value=0.002  Score=66.86  Aligned_cols=74  Identities=19%  Similarity=0.156  Sum_probs=44.3

Q ss_pred             EEEecccCCeEEEEEEEcC--------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEE
Q 043425           17 GRQIGSGSFSVVWHARHRV--------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLH   87 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~--------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~   87 (575)
                      .+.|+.|..-.+|++....        .+..+++|+.....  .. ......|..+++.|...+ +.++++.+  .+  +
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence            4678888888999998653        13688999875421  11 112356788877775333 44666554  33  6


Q ss_pred             EEEeecCCCC
Q 043425           88 LILEYCKGGD   97 (575)
Q Consensus        88 LVmEy~~Ggs   97 (575)
                      +||||++|..
T Consensus       111 ~v~e~i~G~~  120 (369)
T 3c5i_A          111 RIEEWLYGDP  120 (369)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEecCCc
Confidence            8999998854

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.40  E-value=0.0038  Score=65.86  Aligned_cols=138  Identities=16%  Similarity=0.221  Sum_probs=78.7

Q ss_pred             EEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 043425           18 RQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~LV   89 (575)
                      +.|..|-...+|++....       .+..|++|+.....   .....+.+|..+++.|...+ ..++++.+.  +.  +|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~g--~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFP--EG--RL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--TE--EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--Cc--cE
Confidence            567668888899988642       35789999863311   11234568999888775322 356776653  32  99


Q ss_pred             EeecCCCCHH--------------HHHH---Hc----C-CCC--HHHHHHHHHHHHH-------------------HHHH
Q 043425           90 LEYCKGGDLS--------------MYIQ---RH----G-CVP--EETAKHFMKQLAA-------------------GLQV  126 (575)
Q Consensus        90 mEy~~GgsL~--------------~~l~---~~----~-~ls--e~~i~~i~~QLl~-------------------aL~~  126 (575)
                      |||++|..|.              ..+.   .-    + ...  ...+..++.++-.                   .++.
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999985442              1111   11    1 111  3455555554422                   2233


Q ss_pred             Hh----h----CCcccccccCCceeeecC-CCCCcEEEccccccc
Q 043425          127 LR----D----NNLIHRDLKPQNLLLCTD-DDNAALKIADFGFAR  162 (575)
Q Consensus       127 LH----~----~gIvHrDLKPeNILl~~d-d~~g~vKL~DFGla~  162 (575)
                      |.    .    ..++|+|+.+.|||+..+ +..+.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            32    2    258999999999999543 123679999999874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.28  E-value=0.017  Score=62.42  Aligned_cols=75  Identities=12%  Similarity=0.063  Sum_probs=48.8

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeecCC
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++.|+.|-...+|++.....+..+++|+...... . . ....+|..+++.|...++ .++++.+  .+.  +||||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~-~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E-I-INREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S-C-SCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h-h-cCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCC
Confidence            4678888889999998764458899998753210 0 0 012478899988875554 5777776  332  49999987


Q ss_pred             CCH
Q 043425           96 GDL   98 (575)
Q Consensus        96 gsL   98 (575)
                      ..|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.15  E-value=0.03  Score=57.53  Aligned_cols=68  Identities=9%  Similarity=-0.001  Sum_probs=42.4

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC---CCCcceEEEE------EEeCCEEEEEEe
Q 043425           21 GSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN---HPHIIRLHDI------IEVPGKLHLILE   91 (575)
Q Consensus        21 G~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~~------~~~~~~l~LVmE   91 (575)
                      |.|....||++... +| .+++|+......        ..|+.+++.|.   -|++++++..      ....+..++||+
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~  101 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP  101 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence            33336789998754 45 899998776442        24555554442   2334444432      234678899999


Q ss_pred             ecCCCCH
Q 043425           92 YCKGGDL   98 (575)
Q Consensus        92 y~~GgsL   98 (575)
                      |++|..+
T Consensus       102 ~i~G~~~  108 (339)
T 3i1a_A          102 FIHAPNG  108 (339)
T ss_dssp             CCCCCBT
T ss_pred             ccCCCcC
Confidence            9998755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.33  E-value=0.084  Score=56.39  Aligned_cols=74  Identities=12%  Similarity=0.050  Sum_probs=47.1

Q ss_pred             EEEecccCCeEEEEEEEcCC-------CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVH-------GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~t-------g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~L   88 (575)
                      ++.|..|-.-.+|++.....       +..|++|+.....   .......+|..+++.|...+ ..++++.+  .+  ++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence            35666688889999987521       6889999865421   11112346888877774322 45666543  33  68


Q ss_pred             EEeecCCCC
Q 043425           89 ILEYCKGGD   97 (575)
Q Consensus        89 VmEy~~Ggs   97 (575)
                      ||||++|..
T Consensus       148 I~efI~G~~  156 (424)
T 3mes_A          148 IEEFIDGEP  156 (424)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEeCCcc
Confidence            999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.40  E-value=1  Score=47.05  Aligned_cols=32  Identities=25%  Similarity=0.485  Sum_probs=25.9

Q ss_pred             cccccccCCceeeecC---CCCCcEEEcccccccc
Q 043425          132 LIHRDLKPQNLLLCTD---DDNAALKIADFGFARS  163 (575)
Q Consensus       132 IvHrDLKPeNILl~~d---d~~g~vKL~DFGla~~  163 (575)
                      ++|+|+.+.|||+..+   +....++++||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999542   4567799999998753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.61  E-value=0.12  Score=55.77  Aligned_cols=61  Identities=11%  Similarity=0.170  Sum_probs=16.3

Q ss_pred             EEecccCCeEEEEEEEcCCCcEEEE------EEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 043425           18 RQIGSGSFSVVWHARHRVHGTEVAM------KEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE   81 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~tg~~vAV------K~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~   81 (575)
                      ++||   ||+||++........||+      |.........+....+.+|..+++.++|||+++.+.+..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4555   999999988765678888      665544444444456788999999999999999887753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	575
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-86
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-83
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-81
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-81
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-81
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-80
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-80
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-80
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-80
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-79
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-79
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-79
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-78
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-76
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-75
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-74
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-70
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-68
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-64
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-64
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-64
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-63
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-63
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-61
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-61
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-61
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-59
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-58
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-57
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-55
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-47
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-24

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  268 bits (685), Expect = 3e-86
 Identities = 89/261 (34%), Positives = 142/261 (54%), Gaps = 1/261 (0%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y     +G+G+FS V  A  +     VA+K IA   L  K + S+ +EI +L +I HP+
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPN 68

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+ L DI E  G L+LI++   GG+L   I   G   E  A   + Q+   ++ L D  +
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDA 192
           +HRDLKP+NLL  + D+++ + I+DFG ++   P  +  T CG+P Y+APE++  + Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 193 KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKLL 252
             D WS+G I + L+ G  PF   N  +L + I+KA      P    +S   KD  + L+
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248

Query: 253 RRNPVERLTFEEFFNHPFLSQ 273
            ++P +R T E+   HP+++ 
Sbjct: 249 EKDPEKRFTCEQALQHPWIAG 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  265 bits (679), Expect = 9e-85
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 4/268 (1%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
              V+  Y +  ++G+G+F VV     R  G   A K +     + K  E++  EI  + 
Sbjct: 21  HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMS 78

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQ 125
            + HP ++ LHD  E   ++ +I E+  GG+L   +   H  + E+ A  +M+Q+  GL 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +NN +H DLKP+N++  T   N  LK+ DFG    L P+   +   G+  + APE+ 
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           + +      D+WSVG + + L++G +PF G N  + L+N+              +S D K
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           D  +KLL  +P  R+T  +   HP+L+ 
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (664), Expect = 1e-83
 Identities = 82/261 (31%), Positives = 138/261 (52%), Gaps = 9/261 (3%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHP 71
           D+ +GR +G G F  V+ AR +     +A+K +   +L K  ++  L  E+ I   + HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +I+RL+       +++LILEY   G +   +Q+     E+    ++ +LA  L       
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +IHRD+KP+NLLL        LKIADFG++    P     TLCG+  Y+ PE+++ + +D
Sbjct: 127 VIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 182

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
            K DLWS+G + ++ + GK PF  +   +  + I +  E  FP     ++   +DL  +L
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPDF---VTEGARDLISRL 238

Query: 252 LRRNPVERLTFEEFFNHPFLS 272
           L+ NP +R    E   HP+++
Sbjct: 239 LKHNPSQRPMLREVLEHPWIT 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  257 bits (657), Expect = 2e-81
 Identities = 77/272 (28%), Positives = 141/272 (51%), Gaps = 4/272 (1%)

Query: 7   RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILK 66
           +G V   Y +  ++GSG+F VV     +  G     K I       K   ++ +EI I+ 
Sbjct: 24  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMN 81

Query: 67  RINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQ 125
           +++HP +I LHD  E   ++ LILE+  GG+L   I      + E    ++M+Q   GL+
Sbjct: 82  QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIM 185
            + +++++H D+KP+N++  T   ++ +KI DFG A  L P  + +    +  + APEI+
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             +      D+W++G + + L++G +PF G + ++ LQN+ +            +S + K
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
           D  + LL++ P +RLT  +   HP+L     +
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (648), Expect = 5e-81
 Identities = 84/279 (30%), Positives = 141/279 (50%), Gaps = 17/279 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK-LQESLMSEIFILKRINHP 71
           D+  G+ +G GSFS V  AR      E A+K +    + K+     +  E  ++ R++HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
             ++L+   +   KL+  L Y K G+L  YI++ G   E   + +  ++ + L+ L    
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQ 188
           +IHRDLKP+N+LL   +++  ++I DFG A+ L P      A +  G+  Y++PE++  +
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 189 KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
                +DLW++G I++QLV G  PF   N+  + Q I+K  E  FP          +DL 
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPEK---FFPKARDLV 241

Query: 249 QKLLRRNPVERLTFEEFFN------HPFLSQTQPDQVFR 281
           +KLL  +  +RL  EE         HPF      + + +
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (647), Expect = 9e-81
 Identities = 75/268 (27%), Positives = 132/268 (49%), Gaps = 13/268 (4%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            + +  ++G G+F  V+ A+++      A K I     +++  E  M EI IL   +HP+
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPN 70

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L D       L +++E+C GG +   + +    + E   +   KQ    L  L DN 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQL--- 187
           +IHRDLK  N+L      +  +K+ADFG +    +     ++  G+P +MAPE++     
Sbjct: 131 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187

Query: 188 --QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
             + YD KAD+WS+G  L ++   + P    N +++L  I K+        ++  S++ K
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-SSNFK 246

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           D  +K L +N   R T  +   HPF++ 
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (642), Expect = 2e-80
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 11/264 (4%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
                +IG GSF  V+         EVA  E+   +L K  ++    E  +LK + HP+I
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 74  IRLHDIIEVPGK----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +R +D  E   K    + L+ E    G L  Y++R   +  +  + + +Q+  GLQ L  
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 130 NN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
               +IHRDLK  N+ +       ++KI D G A  L+    A+ + G+P +MAPE+ + 
Sbjct: 131 RTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE- 186

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           +KYD   D+++ G  + ++ T + P++       +   V +       D K+   + K++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKEI 245

Query: 248 CQKLLRRNPVERLTFEEFFNHPFL 271
            +  +R+N  ER + ++  NH F 
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFF 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (641), Expect = 4e-80
 Identities = 82/271 (30%), Positives = 135/271 (49%), Gaps = 18/271 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           DY V   IG+GS+      R +  G  +  KE+  G + +  ++ L+SE+ +L+ + HP+
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 73  IIRLHDII--EVPGKLHLILEYCKGGDLSMYIQRH----GCVPEETAKHFMKQLAAGLQV 126
           I+R +D I       L++++EYC+GGDL+  I +       + EE     M QL   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 127 L-----RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYM 180
                   + ++HRDLKP N+ L   D    +K+ DFG AR L      A+   G+P YM
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 181 APEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKIL 240
           +PE M    Y+ K+D+WS+G +L++L     PFT  +Q +L   I +      P      
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---Y 238

Query: 241 SADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
           S +  ++  ++L      R + EE   +P +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (644), Expect = 4e-80
 Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 17/296 (5%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAM-GRLNKKLQESLMSEIFILKRINHPH 72
           +   R+IG GSF  V+ AR   +   VA+K+++  G+ + +  + ++ E+  L+++ HP+
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
            I+            L++EYC G    +       + E            GL  L  +N+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI---MQLQK 189
           IHRD+K  N+LL    +   +K+ DFG A  + P   A +  G+P +MAPE+   M   +
Sbjct: 137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQ 190

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           YD K D+WS+G    +L   K P    N +  L +I +             S   ++   
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG--HWSEYFRNFVD 248

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQP-----DQVFRSRMFSRSADDFPFYESKSV 300
             L++ P +R T E    H F+ + +P     D + R++   R  D+  + + K +
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (640), Expect = 6e-80
 Identities = 81/267 (30%), Positives = 136/267 (50%), Gaps = 9/267 (3%)

Query: 11  VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH 70
           V D+ + + +G G++  V  A +RV    VA+K + M R      E++  EI I K +NH
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNH 62

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
            ++++ +         +L LEYC GG+L   I+    +PE  A+ F  QL AG+  L   
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP---RGLAETLCGSPLYMAPEIMQL 187
            + HRD+KP+NLLL   D+   LKI+DFG A   +      L   +CG+  Y+APE+++ 
Sbjct: 123 GITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 188 QKYDA-KADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKD 246
           +++ A   D+WS G +L  ++ G+ P+   +      +  K  + +  P  KI  +    
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLA 238

Query: 247 LCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           L  K+L  NP  R+T  +     + ++
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNK 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 2e-79
 Identities = 72/277 (25%), Positives = 133/277 (48%), Gaps = 8/277 (2%)

Query: 1   MSQATGRGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMS 60
           +      G     Y    +IG G+   V+ A     G EVA++++ + +  KK  E +++
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIIN 66

Query: 61  EIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
           EI +++   +P+I+   D   V  +L +++EY  GG L+  +       E       ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCREC 125

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLY 179
              L+ L  N +IHRD+K  N+LL     + ++K+ DFGF   +   +    T+ G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
           MAPE++  + Y  K D+WS+G +  +++ G+ P+   N ++ L  I            K+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242

Query: 240 LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
            SA  +D   + L  +  +R + +E   H FL   +P
Sbjct: 243 -SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  248 bits (633), Expect = 6e-79
 Identities = 87/275 (31%), Positives = 138/275 (50%), Gaps = 17/275 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-------KKLQESLMSEIFIL 65
           +Y     +G G  SVV    H+    E A+K I +           ++L+E+ + E+ IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 66  KRIN-HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++++ HP+II+L D  E      L+ +  K G+L  Y+     + E+  +  M+ L   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
             L   N++HRDLKP+N+LL   DD+  +K+ DFGF+  L P      +CG+P Y+APEI
Sbjct: 124 CALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 185 MQL------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK 238
           ++         Y  + D+WS G I++ L+ G  PF    Q+ +L+ I+        P+  
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
             S   KDL  + L   P +R T EE   HPF  Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 7e-79
 Identities = 74/303 (24%), Positives = 131/303 (43%), Gaps = 11/303 (3%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y++   +G G F +V              K +   ++    Q  +  EI IL    H +
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC-VPEETAKHFMKQLAAGLQVLRDNN 131
           I+ LH+  E   +L +I E+  G D+   I      + E     ++ Q+   LQ L  +N
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           + H D++P+N++      ++ +KI +FG AR L+P      L  +P Y APE+ Q     
Sbjct: 123 IGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D+WS+G +++ L++G  PF      Q+++NI+ A         K +S +  D   +L
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 252 LRRNPVERLTFEEFFNHPFLSQ------TQPDQVFRSRMFSRSADDFPFYESKSVRDVAE 305
           L +    R+T  E   HP+L Q      T+  +  + R +  +          S   ++ 
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301

Query: 306 SSQ 308
              
Sbjct: 302 GGA 304

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (635), Expect = 1e-78
 Identities = 69/308 (22%), Positives = 138/308 (44%), Gaps = 46/308 (14%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D+    ++G+G+  VV+   H+  G  +A K I +  +   ++  ++ E+ +L   N P+
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPY 65

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NN 131
           I+  +      G++ + +E+  GG L   +++ G +PE+        +  GL  LR+ + 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           ++HRD+KP N+L+ +  +   +K+ DFG +  L    +A +  G+  YM+PE +Q   Y 
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYS 181

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQL---LQNIVKATELHFPP------------- 235
            ++D+WS+G  L ++  G+ P    +  +L       V+      PP             
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 236 ------------------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
                                    + + S + +D   K L +NP ER   ++   H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 272 SQTQPDQV 279
            ++  ++V
Sbjct: 302 KRSDAEEV 309

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 2e-76
 Identities = 86/277 (31%), Positives = 140/277 (50%), Gaps = 5/277 (1%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----LQESLMSEIFILKRI 68
            Y  G ++GSG F+VV   R +  G + A K I   R         +E +  E+ ILK I
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
            HP++I LH++ E    + LILE   GG+L  ++     + EE A  F+KQ+  G+  L 
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAA-LKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQL 187
              + H DLKP+N++L   +     +KI DFG A  +      + + G+P ++APEI+  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 188 QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           +    +AD+WS+G I + L++G +PF G  + + L N+               SA  KD 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 248 CQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFRSRM 284
            ++LL ++P +R+T ++   HP++      Q   S  
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAW 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 1e-75
 Identities = 87/318 (27%), Positives = 151/318 (47%), Gaps = 22/318 (6%)

Query: 7   RGRVVGDY-LVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
           +  ++ DY +  + +G G    V    ++    + A+K +       +       E+ + 
Sbjct: 6   KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELH 58

Query: 66  KRI-NHPHIIRLHDIIEVP----GKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMK 118
            R    PHI+R+ D+ E        L +++E   GG+L   IQ  G     E  A   MK
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPL 178
            +   +Q L   N+ HRD+KP+NLL  +   NA LK+ DFGFA+         T C +P 
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

Query: 179 YMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI---VKATELHFP- 234
           Y+APE++  +KYD   D+WS+G I++ L+ G  PF  ++ + +   +   ++  +  FP 
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD---QVFRSRMFSRSADD 291
           P+   +S + K L + LL+  P +R+T  EF NHP++ Q+       +  SR+     + 
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298

Query: 292 FPFYESKSVRDVAESSQD 309
           +   + +    +A    D
Sbjct: 299 WEDVKEEMTSALATMRVD 316

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  238 bits (609), Expect = 7e-75
 Identities = 97/325 (29%), Positives = 168/325 (51%), Gaps = 24/325 (7%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHP 71
           D+ + R +G+GSF  V   R R +G   AMK +    + + K  E    E  +L  + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            IIR+    +   ++ +I++Y +GG+L   +++    P   AK +  ++   L+ L   +
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           +I+RDLKP+N+LL   D N  +KI DFGFA+ +       TLCG+P Y+APE++  + Y+
Sbjct: 125 IIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYN 179

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D WS G ++++++ G TPF  SN ++  + I+ A EL FPP     + D KDL  +L
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPF---FNEDVKDLLSRL 235

Query: 252 LRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRDVAES 306
           + R+  +RL       E+  NHP+  +   +++    +          YE    +   ++
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI-------ETPYEPPIQQGQGDT 288

Query: 307 SQDDCLPFFLDDDSSGPEGSPSFSK 331
           SQ D   +  +D + G +G   ++ 
Sbjct: 289 SQFD--KYPEEDINYGVQGEDPYAD 311

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (607), Expect = 2e-74
 Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 11/276 (3%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGR-LNKKLQESLMSEIFILKR-INH 70
           D+++ + +G GSF  V+ A  +      A+K +     L     E  M E  +L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 71  PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDN 130
           P +  +    +    L  ++EY  GGDL  +IQ         A  +  ++  GLQ L   
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQK 189
            +++RDLK  N+L    D +  +KIADFG  +          T CG+P Y+APEI+  QK
Sbjct: 123 GIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 190 YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
           Y+   D WS G +L++++ G++PF G ++ +L  +I       +P     L  + KDL  
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRW---LEKEAKDLLV 235

Query: 250 KLLRRNPVERLTFE-EFFNHPFLSQTQPDQVFRSRM 284
           KL  R P +RL    +   HP   +   +++ R  +
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 6e-71
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 21/270 (7%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQ----ESLMSEIFILKR 67
             Y VG  +GSG F  V+          VA+K +   R++   +      +  E+ +LK+
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 68  INHPH--IIRLHDIIEVPGKLHLILEYCKGG-DLSMYIQRHGCVPEETAKHFMKQLAAGL 124
           ++     +IRL D  E P    LILE  +   DL  +I   G + EE A+ F  Q+   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 125 QVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI 184
           +   +  ++HRD+K +N+L+  D +   LK+ DFG    L+         G+ +Y  PE 
Sbjct: 124 RHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEW 180

Query: 185 MQLQKYDAK-ADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD 243
           ++  +Y  + A +WS+G +L+ +V G  PF    +I   Q       + F      +S++
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ-------VFFRQR---VSSE 230

Query: 244 CKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           C+ L +  L   P +R TFEE  NHP++  
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 2e-70
 Identities = 68/267 (25%), Positives = 127/267 (47%), Gaps = 18/267 (6%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
           G   VG++IGSGSF  V+  +      +VA+K + +     +  ++  +E+ +L++  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDN 130
           +I+          +L ++ ++C+G  L  ++                +Q A G+  L   
Sbjct: 65  NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL---QPRGLAETLCGSPLYMAPEIMQL 187
           ++IHRDLK  N+ L    ++  +KI DFG A            E L GS L+MAPE++++
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 188 QK---YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI---LS 241
           Q    Y  ++D+++ G +L++L+TG+ P++  N    +  +V    L  P  +K+     
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-SPDLSKVRSNCP 239

Query: 242 ADCKDLCQKLLRRNPVERLTFEEFFNH 268
              K L  + L++   ER  F +    
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-69
 Identities = 74/279 (26%), Positives = 137/279 (49%), Gaps = 14/279 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHP 71
           D+   + +G G+F  V   R +  G   AMK +    +  K      ++E  +L+   HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +  L    +   +L  ++EY  GG+L  ++ R     EE A+ +  ++ + L+ L   +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-LAETLCGSPLYMAPEIMQLQKY 190
           +++RD+K +NL+L   D +  +KI DFG  +     G   +T CG+P Y+APE+++   Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
               D W +G ++++++ G+ PF   +  +L + I+   E+ FP     LS + K L   
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRT---LSPEAKSLLAG 238

Query: 251 LLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           LL+++P +RL       +E   H F        V + ++
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  220 bits (561), Expect = 3e-68
 Identities = 61/266 (22%), Positives = 111/266 (41%), Gaps = 6/266 (2%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINH 70
             Y +G  +G G  S V  AR      +VA+K +      +         E      +NH
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 71  PHIIRLHDIIEVPGK----LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQV 126
           P I+ ++D  E         ++++EY  G  L   +   G +  + A   +      L  
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 127 LRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG-FARSLQPRGLAETLCGSPLYMAPEIM 185
              N +IHRD+KP N+++   +    +        A S         + G+  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 186 QLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
           +    DA++D++S+G +L++++TG+ PFTG + + +    V+   +      + LSAD  
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 246 DLCQKLLRRNPVERLTFEEFFNHPFL 271
            +  K L +NP  R           +
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-67
 Identities = 59/271 (21%), Positives = 128/271 (47%), Gaps = 17/271 (6%)

Query: 18  RQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
           +++GSG+F  V    +++      VA+K +     +  L++ L++E  +++++++P+I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHR 135
           +  I E      L++E  + G L+ Y+Q++  V ++     + Q++ G++ L ++N +HR
Sbjct: 73  MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 136 DLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGSPLYMAPEIMQLQKYD 191
           DL  +N+LL T       KI+DFG +++L+                 + APE +   K+ 
Sbjct: 132 DLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 192 AKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK 250
           +K+D+WS G ++++  + G+ P+ G    ++   + K   +  P        +  DL   
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG---CPREMYDLMNL 245

Query: 251 LLRRNPVERLTFEE---FFNHPFLSQTQPDQ 278
               +   R  F        + +        
Sbjct: 246 CWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  221 bits (563), Expect = 2e-67
 Identities = 84/326 (25%), Positives = 143/326 (43%), Gaps = 24/326 (7%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLM----SEIFILKRI 68
           D+ V R IG G F  V+  R    G   AMK +   R+  K  E+L       + ++   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           + P I+ +      P KL  IL+   GGDL  ++ +HG   E   + +  ++  GL+ + 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQ 188
           +  +++RDLKP N+LL   D++  ++I+D G A     +    +  G+  YMAPE++Q  
Sbjct: 125 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 180

Query: 189 K-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
             YD+ AD +S+G +LF+L+ G +PF         +       +         S + + L
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF-SPELRSL 239

Query: 248 CQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRMFSRSADDFPFYESKSVRD 302
            + LL+R+   RL       +E    PF        VF  +         P        +
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP------PLIP--PRGE 291

Query: 303 VAESSQDDCLPFFLDDDSSGPEGSPS 328
           V  +   D +  F ++D+ G +   S
Sbjct: 292 VNAADAFD-IGSFDEEDTKGIKLLDS 316

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 5e-67
 Identities = 56/260 (21%), Positives = 120/260 (46%), Gaps = 18/260 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +  + + IG G F  V    +R  G +VA+K I     N    ++ ++E  ++ ++ H +
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61

Query: 73  IIRLHD-IIEVPGKLHLILEYCKGGDLSMYIQRHGC--VPEETAKHFMKQLAAGLQVLRD 129
           +++L   I+E  G L+++ EY   G L  Y++  G   +  +    F   +   ++ L  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQK 189
           NN +HRDL  +N+L+    ++   K++DFG  +        +T      + APE ++ +K
Sbjct: 122 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK 176

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           +  K+D+WS G +L+++ + G+ P+       ++  + K  ++  P           ++ 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG---CPPAVYEVM 233

Query: 249 QKLLRRNPVERLTFEEFFNH 268
           +     +   R +F +    
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-66
 Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 47/308 (15%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
             V  Y    +IG G+F  V+ ARHR  G +VA+K++ M    +    + + EI IL+ +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 69  NHPHIIRLHDIIEVP--------GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQL 120
            H +++ L +I            G ++L+ ++C+     +             K  M+ L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 121 AAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE-----TLCG 175
             GL  +  N ++HRD+K  N+L+     +  LK+ADFG AR+      ++         
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 176 SPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP 234
           +  Y  PE++  ++ Y    DLW  G I+ ++ T      G+ +   L  I +       
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL-CGSIT 242

Query: 235 PD-----------------------------AKILSADCKDLCQKLLRRNPVERLTFEEF 265
           P+                             A +      DL  KLL  +P +R+  ++ 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 266 FNHPFLSQ 273
            NH F   
Sbjct: 303 LNHDFFWS 310

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 3e-65
 Identities = 53/260 (20%), Positives = 116/260 (44%), Gaps = 14/260 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D    +++G+G F VV + + R    +VA+K I   +     ++  + E  ++  ++H  
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEK 60

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           +++L+ +      + +I EY   G L  Y+ +       +      K +   ++ L    
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQK 189
            +HRDL  +N L+   +D   +K++DFG +R +       +        +  PE++   K
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           + +K+D+W+ G +++++ + GK P+      +  ++I +   L+ P  A   S     + 
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA---SEKVYTIM 234

Query: 249 QKLLRRNPVERLTFEEFFNH 268
                    ER TF+   ++
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 5e-65
 Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 32/283 (11%)

Query: 20  IGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK---LQESLMSEIFILKRINHPHIIRL 76
           +G G F+ V+ AR +     VA+K+I +G  ++    +  + + EI +L+ ++HP+II L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 77  HDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRD 136
            D       + L+ ++ +     +       +     K +M     GL+ L  + ++HRD
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125

Query: 137 LKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPE-IMQLQKYDAKA 194
           LKP NLLL   D+N  LK+ADFG A+S   P         +  Y APE +   + Y    
Sbjct: 126 LKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 195 DLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TELHFPPDAKI----------- 239
           D+W+VG IL +L+       G + +  L  I +     TE  +P    +           
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 240 ---------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                       D  DL Q L   NP  R+T  +     + S 
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  210 bits (536), Expect = 1e-64
 Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 31/288 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y    +IG G++ VV+ A++  +G   A+K+I + + ++ +  + + EI ILK + H +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I++L+D+I    +L L+ E+       +     G +   TAK F+ QL  G+    D  +
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPE-IMQLQKY 190
           +HRDLKPQNLL+  + +   LKIADFG AR+   P         +  Y AP+ +M  +KY
Sbjct: 122 LHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 191 DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD-------------- 236
               D+WSVG I  ++V G   F G ++   L  I +        +              
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 237 -----------AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                       K L     DL  K+L+ +P +R+T ++   H +  +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 4e-64
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 31/289 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           ++    +IG G++ VV+ AR+++ G  VA+K+I +    + +  + + EI +LK +NHP+
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 73  IIRLHDIIEVPGKLHLILEYC-KGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
           I++L D+I    KL+L+ E+  +     M       +P    K ++ QL  GL     + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSL-QPRGLAETLCGSPLYMAPEIMQLQKY 190
           ++HRDLKPQNLL+   +   A+K+ADFG AR+   P         +  Y APEI+   KY
Sbjct: 123 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 191 -DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT-----------------ELH 232
                D+WS+G I  ++VT +  F G ++I  L  I +                   +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 233 FPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
           FP  A+         L  D + L  ++L  +P +R++ +    HPF   
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (539), Expect = 4e-64
 Identities = 79/278 (28%), Positives = 148/278 (53%), Gaps = 15/278 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHP 71
            +   + +G+GSF  V   +H+  G   AMK +   ++ K K  E  ++E  IL+ +N P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 72  HIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN 131
            +++L    +    L++++EY  GG++  +++R G   E  A+ +  Q+    + L   +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYD 191
           LI+RDLKP+NLL+        +++ DFGFA+ ++ R    TLCG+P  +APEI+  + Y+
Sbjct: 162 LIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYN 216

Query: 192 AKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQKL 251
              D W++G +++++  G  PF     IQ+ + IV   ++ FP      S+D KDL + L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSH---FSSDLKDLLRNL 272

Query: 252 LRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
           L+ +  +R         +  NH + + T    +++ ++
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-63
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 36/299 (12%)

Query: 6   GRGRVVGDYLVGRQIGSGSFSVVWHARHRVH-GTEVAMKEIAMGRLNKKLQESLMSEIFI 64
           G  R    Y    +IG G++  V+ AR   + G  VA+K + +    + +  S + E+ +
Sbjct: 1   GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60

Query: 65  LKRI---NHPHIIRLHDIIEVP-----GKLHLILEYCKGGDLS-MYIQRHGCVPEETAKH 115
           L+ +    HP+++RL D+  V       KL L+ E+      + +       VP ET K 
Sbjct: 61  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120

Query: 116 FMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCG 175
            M QL  GL  L  + ++HRDLKPQN+L+ +       K+ADFG AR    +    ++  
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVV 177

Query: 176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA----TEL 231
           +  Y APE++    Y    DLWSVG I  ++   K  F GS+ +  L  I+       E 
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 232 HFPPDAKI-------------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFL 271
            +P D  +                   +    KDL  K L  NP +R++     +HP+ 
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-63
 Identities = 64/270 (23%), Positives = 129/270 (47%), Gaps = 18/270 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
              +  ++G+G F  VW   +    T+VA+K +  G ++    ++ ++E  ++K++ H  
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVP--EETAKHFMKQLAAGLQVLRDN 130
           ++RL+ ++     +++I EY + G L  +++    +            Q+A G+  + + 
Sbjct: 70  LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG--LAETLCGSPLYMAPEIMQLQ 188
           N IHRDL+  N+L+         KIADFG AR ++       E       + APE +   
Sbjct: 129 NYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
            +  K+D+WS G +L ++VT G+ P+ G    +++QN+ +   +  P +      +   L
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN---CPEELYQL 242

Query: 248 CQKLLRRNPVERLTFEEFFN--HPFLSQTQ 275
            +   +  P +R TF+   +    F + T+
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 2e-63
 Identities = 88/323 (27%), Positives = 136/323 (42%), Gaps = 44/323 (13%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y   + IG+GSF VV+ A+    G  VA+K++       + +     E+ I+++++H +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCN 74

Query: 73  IIRLHDIIEVPGK------LHLILEYCKGGDLSM---YIQRHGCVPEETAKHFMKQLAAG 123
           I+RL       G+      L+L+L+Y       +   Y +    +P    K +M QL   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 124 LQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP- 182
           L  +    + HRD+KPQNLLL  D D A LK+ DFG A+ L       +   S  Y AP 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA-------------- 228
            I     Y +  D+WS G +L +L+ G+  F G + +  L  I+K               
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 229 --TELHFPPDAKI---------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD 277
             TE  FP                 +   LC +LL   P  RLT  E   H F  + +  
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 278 QVFR-SRMFSRSADDFPFYESKS 299
            V   +   + +  +F   E  S
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSS 335

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 2e-63
 Identities = 57/260 (21%), Positives = 121/260 (46%), Gaps = 14/260 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           +    ++IGSG F +V       +  +VA+K I   R     +E  + E  ++ +++HP 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 61

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV-PEETAKHFMKQLAAGLQVLRDNN 131
           +++L+ +      + L+ E+ + G LS Y++    +   ET       +  G+  L +  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQK 189
           +IHRDL  +N L+    +N  +K++DFG  R +       +        + +PE+    +
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 190 YDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC 248
           Y +K+D+WS G +++++ + GK P+   +  +++++I     L+ P   ++ S     + 
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIM 235

Query: 249 QKLLRRNPVERLTFEEFFNH 268
               +  P +R  F      
Sbjct: 236 NHCWKERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 3e-63
 Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 18/272 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
              +  ++G G F  VW        T VA+K +   +      E+ + E  ++K++ H  
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVP--EETAKHFMKQLAAGLQVLRDN 130
           +++L+ ++     ++++ EY   G L  +++                 Q+A+G+  +   
Sbjct: 74  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--AETLCGSPLYMAPEIMQLQ 188
           N +HRDL+  N+L+    +N   K+ADFG AR ++       +       + APE     
Sbjct: 133 NYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           ++  K+D+WS G +L +L T G+ P+ G    ++L  + +   +  PP+         DL
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE---CPESLHDL 246

Query: 248 CQKLLRRNPVERLTFEEF--FNHPFLSQTQPD 277
             +  R+ P ER TFE    F   + + T+P 
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 6e-63
 Identities = 81/300 (27%), Positives = 144/300 (48%), Gaps = 20/300 (6%)

Query: 2   SQATGRGRVVG--DYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRL--NKKL 54
           +  TG    VG  ++ + + +G+G++  V+  R       G   AMK +    +    K 
Sbjct: 12  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71

Query: 55  QESLMSEIFILKRINH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETA 113
            E   +E  +L+ I   P ++ LH   +   KLHLIL+Y  GG+L  ++ +     E   
Sbjct: 72  TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET- 172
           + ++ ++   L+ L    +I+RD+K +N+LL   D N  + + DFG ++           
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAY 188

Query: 173 -LCGSPLYMAPEIMQLQK--YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT 229
             CG+  YMAP+I++     +D   D WS+G ++++L+TG +PFT   +      I +  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248

Query: 230 ELHFPPDAKILSADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM 284
               PP  + +SA  KDL Q+LL ++P +RL       +E   H F  +   D +   ++
Sbjct: 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 6e-62
 Identities = 60/272 (22%), Positives = 123/272 (45%), Gaps = 19/272 (6%)

Query: 18  RQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIR 75
            ++G G+F  V    +R+     +VA+K +  G   K   E +M E  I+ ++++P+I+R
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 76  LHDIIEVPGKLHLILEYCKGGDLSMYI-QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIH 134
           L  + +    L L++E   GG L  ++  +   +P       + Q++ G++ L + N +H
Sbjct: 74  LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132

Query: 135 RDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL----CGSPLYMAPEIMQLQKY 190
           RDL  +N+LL    +    KI+DFG +++L       T          + APE +  +K+
Sbjct: 133 RDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 191 DAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ 249
            +++D+WS G  +++ ++ G+ P+      +++  I +   +  PP+      +   L  
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---CPPELYALMS 246

Query: 250 KLLRRNPVERLTFEE---FFNHPFLSQTQPDQ 278
                   +R  F          + S     +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-61
 Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 19/297 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRI 68
           ++   + +GSG+F  V+       G +V +  +A+  L +    K  + ++ E +++  +
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASV 68

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           ++PH+ RL  I        +      G  L    +    +  +   ++  Q+A G+  L 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIM 185
           D  L+HRDL  +N+L+        +KI DFG A+ L        AE       +MA E +
Sbjct: 129 DRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 186 QLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC 244
             + Y  ++D+WS G  +++L+T G  P+ G    ++   + K   L  PP     + D 
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI---CTIDV 242

Query: 245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR----SRMFSRSADDFPFYES 297
             +  K    +   R  F E           P +        RM   S  D  FY +
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 299

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 3e-61
 Identities = 87/300 (29%), Positives = 134/300 (44%), Gaps = 42/300 (14%)

Query: 11  VGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           VG  Y     IG G++ +V  A   V+   VA+K+I+    ++   +  + EI IL R  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR 64

Query: 70  HPHIIRLHDIIEVP----GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           H +II ++DII  P     K   ++ +  G DL   ++    +  +   +F+ Q+  GL+
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLK 123

Query: 126 VLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP----RGLAETLCGSPLYMA 181
            +   N++HRDLKP NLLL   +    LKI DFG AR   P     G       +  Y A
Sbjct: 124 YIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 182 PEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA------------ 228
           PEIM     Y    D+WSVG IL ++++ +  F G + +  L +I+              
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 229 -------TELHFPPDAKI--------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                    L  P   K+          +   DL  K+L  NP +R+  E+   HP+L Q
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (514), Expect = 4e-61
 Identities = 59/289 (20%), Positives = 100/289 (34%), Gaps = 21/289 (7%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           RV   Y +GR+IGSGSF  ++       G EVA+K   +    K     L  E  I K +
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMM 59

Query: 69  NHPHIIR-LHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
                I  +           +++E        ++         +T      Q+ + ++ +
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL--------AETLCGSPLY 179
              N IHRD+KP N L+        + I DFG A+  +             + L G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 180 MAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI 239
            +       +   + DL S+G +L     G  P+ G       Q   + +E       ++
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 240 LSADC----KDLCQKLLRRNPVERLTFE---EFFNHPFLSQ-TQPDQVF 280
           L                     ++  +    + F + F  Q    D VF
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (512), Expect = 7e-61
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 18/263 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTE---VAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
              + + IG+G F  V     ++ G     VA+K +  G   K+ ++  +SE  I+ + +
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFD 85

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMY-IQRHGCVPEETAKHFMKQLAAGLQVLR 128
           HP++I L  ++     + +I E+ + G L  +  Q  G          ++ +AAG++ L 
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL------CGSPLYMAP 182
           D N +HRDL  +N+L+   + N   K++DFG +R L+      T            + AP
Sbjct: 146 DMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS 241
           E +Q +K+ + +D+WS G +++++++ G+ P+       ++  I +   L  P D     
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD---CP 259

Query: 242 ADCKDLCQKLLRRNPVERLTFEE 264
           +    L     +++   R  F +
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQ 282

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 8e-61
 Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 31/292 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y    +IG G++  V+ A++R     VA+K + +   ++ +  S + EI +LK + H +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNL 132
           I+RLHD++    KL L+ E+C       +   +G +  E  K F+ QL  GL      N+
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 133 IHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP--EIMQLQKY 190
           +HRDLKPQNLL+  + +    K+A+FG AR+        +     L+  P   +   + Y
Sbjct: 123 LHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 191 DAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVKA----TELHFPPDAKI------ 239
               D+WS G I  +L     P F G++    L+ I +     TE  +P   K+      
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 240 ---------------LSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP 276
                          L+A  +DL Q LL+ NPV+R++ EE   HP+ S   P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 4e-60
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 27/272 (9%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGT--EVAMKEIAMGRLNKKLQESLMSEIFILKRI-N 69
           D      IG G+F  V  AR +  G   + A+K +     +K        E+ +L ++ +
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGH 69

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH----------------GCVPEETA 113
           HP+II L    E  G L+L +EY   G+L  ++++                   +  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 114 KHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETL 173
            HF   +A G+  L     IHRDL  +N+L+    +N   KIADFG +R  +        
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELH 232
                +MA E +    Y   +D+WS G +L+++V+ G TP+ G    +L + + +   L 
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 233 FPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
            P +      +  DL ++  R  P ER +F +
Sbjct: 247 KPLN---CDDEVYDLMRQCWREKPYERPSFAQ 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (504), Expect = 8e-60
 Identities = 59/257 (22%), Positives = 119/257 (46%), Gaps = 14/257 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
           D  +  ++G G +  V+    + +   VA+K +   + +    E  + E  ++K I HP+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 73  IIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDN 130
           +++L  +       ++I E+   G+L  Y++      V      +   Q+++ ++ L   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 131 NLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQLQ 188
           N IHRDL  +N L+    +N  +K+ADFG +R +                + APE +   
Sbjct: 135 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 189 KYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL 247
           K+  K+D+W+ G +L+++ T G +P+ G +  Q+ + + K   +  P           +L
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG---CPEKVYEL 248

Query: 248 CQKLLRRNPVERLTFEE 264
            +   + NP +R +F E
Sbjct: 249 MRACWQWNPSDRPSFAE 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-59
 Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 37/288 (12%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL----QESLMSEIFILKRI 68
           +   G+ +GSG+F  V +A            ++A+  L +K     +E+LMSE+ ++ ++
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH---------------------- 105
            +H +I+ L     + G ++LI EYC  GDL  Y++                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 106 -GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL 164
              +  E    F  Q+A G++ L   + +HRDL  +N+L+        +KI DFG AR +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI 214

Query: 165 QPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQ 220
                  +         +MAPE +    Y  K+D+WS G +L+++ + G  P+ G     
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 221 LLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
               +++             + +   + Q     +  +R +F    + 
Sbjct: 275 NFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-59
 Identities = 69/262 (26%), Positives = 118/262 (45%), Gaps = 16/262 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRV---HGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRI 68
           D  +  ++G GSF VV              VA+K +    L++ +  +  + E+  +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVL 127
           +H ++IRL+ ++  P  + ++ E    G L   +++H G     T   +  Q+A G+  L
Sbjct: 69  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG----LAETLCGSPLYMAPE 183
                IHRDL  +NLLL T D    +KI DFG  R+L        + E       + APE
Sbjct: 128 ESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
            ++ + +   +D W  G  L+++ T G+ P+ G N  Q+L  I K  E    P  +    
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--LPRPEDCPQ 242

Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
           D  ++  +     P +R TF  
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVA 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-59
 Identities = 61/263 (23%), Positives = 111/263 (42%), Gaps = 15/263 (5%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
              +GR IG G F  V    +         VA+K       +  ++E  + E   +++ +
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFD 66

Query: 70  HPHIIRLHDIIEVPGKLHLILEYCKGGDL-SMYIQRHGCVPEETAKHFMKQLAAGLQVLR 128
           HPHI++L  +I     + +I+E C  G+L S    R   +   +   +  QL+  L  L 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 129 DNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET--LCGSPLYMAPEIMQ 186
               +HRD+  +N+L+     N  +K+ DFG +R ++     +         +MAPE + 
Sbjct: 126 SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            +++ + +D+W  G  +++++  G  PF G     ++  I     L  PP+         
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN---CPPTLY 239

Query: 246 DLCQKLLRRNPVERLTFEEFFNH 268
            L  K    +P  R  F E    
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  197 bits (501), Expect = 6e-59
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 48/296 (16%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HP 71
           DY + R++G G +S V+ A +  +  +V +K      L    ++ +  EI IL+ +   P
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENLRGGP 90

Query: 72  HIIRLHDIIEVPGK--LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD 129
           +II L DI++ P      L+ E+    D     Q    + +   + +M ++   L     
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 147

Query: 130 NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQ-LQ 188
             ++HRD+KP N+++  D ++  L++ D+G A    P         S  +  PE++   Q
Sbjct: 148 MGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 189 KYDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKA------------------- 228
            YD   D+WS+G +L  ++  K PF  G +    L  I K                    
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 229 --------------TELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPF 270
                                +  ++S +  D   KLLR +   RLT  E   HP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-58
 Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 41/294 (13%)

Query: 14  YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
           Y   + +GSG++  V  A     G +VA+K++     ++   +    E+ +LK + H ++
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 74  IRLHDIIEVPGKL------HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           I L D+      L      +L++ +   G     + +H  + E+  +  + Q+  GL+ +
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPE-IMQ 186
               +IHRDLKP NL +   +++  LKI DFG AR             +  Y APE I+ 
Sbjct: 138 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN 192

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----------------- 229
             +Y    D+WSVG I+ +++TGKT F GS+ +  L+ I+K T                 
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 230 ----------ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                     +  F       S    +L +K+L  +  +R+T  E   HP+   
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 5e-57
 Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 39/294 (13%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH 72
            Y     +GSG++  V  A     G  VA+K+++    +    +    E+ +LK + H +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 73  IIRLHDIIEVPGKLH-----LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           +I L D+      L       ++ +  G D    I +   + ++  +  + Q+  GL+ +
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAPEI-MQ 186
              ++IHRDLKP NL     +++  LKI DFG AR             +  Y APEI + 
Sbjct: 138 HSADIIHRDLKPSNLA---VNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192

Query: 187 LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----------------- 229
              Y+   D+WSVG I+ +L+TG+T F G++ I  L+ I++                   
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 230 ----------ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ 273
                     +++F       +    DL +K+L  +  +R+T  +   H + +Q
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  191 bits (485), Expect = 6e-57
 Identities = 54/291 (18%), Positives = 103/291 (35%), Gaps = 24/291 (8%)

Query: 10  VVGD-YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
           VVG  Y VGR+IG GSF V++   + ++  +VA+K        +     L  E    K +
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLL 57

Query: 69  NH-PHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
                I  ++   +      L+++        +          +T     KQ+ A +Q +
Sbjct: 58  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 128 RDNNLIHRDLKPQNLLLCTDDD--NAALKIADFGFARSLQPRG--------LAETLCGSP 177
            + +L++RD+KP N L+   +      + + DFG  +  +             + L G+ 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 178 LYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDA 237
            YM+      ++   + DL ++G +    + G  P+ G       Q   +  E       
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 238 KILSADC----KDLCQKLLRRNPVERLTFE---EFFNHPFLS-QTQPDQVF 280
           + L A                       ++     F+       T  D+ F
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-57
 Identities = 69/309 (22%), Positives = 126/309 (40%), Gaps = 50/309 (16%)

Query: 9   RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI 68
            V+  Y   + IGSG+  +V  A   V    VA+K+++    N+   +    E+ ++K +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 69  NHPHIIRLHDI------IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAA 122
           NH +II L ++      +E    ++L++E        +          E   + + Q+  
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLC 130

Query: 123 GLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLYMAP 182
           G++ L    +IHRDLKP N        +  LKI DFG AR+     +      +  Y AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSN---IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 183 EIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD------ 236
           E++    Y    D+WSVG I+ ++V  K  F G + I     +++      P        
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 237 --------------------------------AKILSADCKDLCQKLLRRNPVERLTFEE 264
                                            K+ ++  +DL  K+L  +P +R++ ++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 265 FFNHPFLSQ 273
              HP+++ 
Sbjct: 308 ALQHPYINV 316

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 9e-57
 Identities = 60/285 (21%), Positives = 119/285 (41%), Gaps = 40/285 (14%)

Query: 13  DYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
           +    R IG G+F  V+ AR          T VA+K +     +  +Q     E  ++  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAE 72

Query: 68  INHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHG--------------------- 106
            ++P+I++L  +  V   + L+ EY   GDL+ +++                        
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 107 ---CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS 163
               +         +Q+AAG+  L +   +HRDL  +N L+    +N  +KIADFG +R+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRN 189

Query: 164 LQPRGLAE---TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQI 219
           +      +          +M PE +   +Y  ++D+W+ G +L+++ + G  P+ G    
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 220 QLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +++  +     L  P +      +  +L +    + P +R +F  
Sbjct: 250 EVIYYVRDGNILACPEN---CPLELYNLMRLCWSKLPADRPSFCS 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-55
 Identities = 57/285 (20%), Positives = 119/285 (41%), Gaps = 30/285 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRI 68
              + R++G GSF +V+    +    +     +A+  +N+    + +   ++E  ++K  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCV----------PEETAKHFMK 118
           N  H++RL  ++       +I+E    GDL  Y++                         
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 119 QLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL---AETLCG 175
           ++A G+  L  N  +HRDL  +N ++    ++  +KI DFG  R +              
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 176 SPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFP 234
              +M+PE ++   +   +D+WS G +L+++ T  + P+ G +  Q+L+ +++   L  P
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN------HPFLSQ 273
            +         +L +   + NP  R +F E  +       P   +
Sbjct: 258 DN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-54
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 29/277 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHR-------VHGTEVAMKEIAMGRLNKKLQESLMSEIFIL 65
             ++G+ +G G+F  V  A             T+VA+K +      K L + L+SE+ ++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMM 72

Query: 66  KRI-NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC----------------V 108
           K I  H +II L       G L++I+EY   G+L  Y+Q                    +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 109 PEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG 168
             +       Q+A G++ L     IHRDL  +N+L+  D+               +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVK 227
                     +MAPE +  + Y  ++D+WS G +L+++ T G +P+ G    +L + + +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 228 ATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
              +  P +    + +   + +      P +R TF++
Sbjct: 253 GHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQ 286

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-53
 Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 18/263 (6%)

Query: 17  GRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI 73
              IG G F  V+H     +       A+K +       ++ +  ++E  I+K  +HP++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 90

Query: 74  IRLHDI-IEVPGKLHLILEYCKGGDLSMYIQRHGCVPEE-TAKHFMKQLAAGLQVLRDNN 131
           + L  I +   G   ++L Y K GDL  +I+     P       F  Q+A G++ L    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 132 LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLC-----GSPLYMAPEIMQ 186
            +HRDL  +N +L   D+   +K+ADFG AR +  +                +MA E +Q
Sbjct: 151 FVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 187 LQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK 245
            QK+  K+D+WS G +L++L+T G  P+   N   +   +++   L  P           
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLY 264

Query: 246 DLCQKLLRRNPVERLTFEEFFNH 268
           ++  K        R +F E  + 
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSR 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-52
 Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 32/279 (11%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRI 68
               G+ +G+G+F  V  A         A   +A+  L        +E+LMSE+ +L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 69  -NHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGC------------------VP 109
            NH +I+ L     + G   +I EYC  GDL  +++R                     + 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 110 EETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG- 168
            E    F  Q+A G+  L   N IHRDL  +N+LL         KI DFG AR ++    
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKNDSN 200

Query: 169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNI 225
             +         +MAPE +    Y  ++D+WS G  L++L +  +  + G         +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 226 VKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEE 264
           +K  E       +   A+  D+ +     +P++R TF++
Sbjct: 261 IK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-51
 Identities = 60/262 (22%), Positives = 120/262 (45%), Gaps = 17/262 (6%)

Query: 13  DYLVGRQIGSGSFSVVWHARHRVHGTE----VAMKEIAMGRLNKKLQESLMSEIFILKRI 68
                + IG+G F  V+    +    +    VA+K +  G   K+  +  + E  I+ + 
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQF 66

Query: 69  NHPHIIRLHDIIEVPGKLHLILEYCKGGD-LSMYIQRHGCVPEETAKHFMKQLAAGLQVL 127
           +H +IIRL  +I     + +I EY + G       ++ G          ++ +AAG++ L
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 128 RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAET----LCGSPLYMAPE 183
            + N +HRDL  +N+L+   + N   K++DFG +R L+    A            + APE
Sbjct: 127 ANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 184 IMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA 242
            +  +K+ + +D+WS G ++++++T G+ P+   +  ++++ I     L  P D     +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD---CPS 240

Query: 243 DCKDLCQKLLRRNPVERLTFEE 264
               L  +  ++    R  F +
Sbjct: 241 AIYQLMMQCWQQERARRPKFAD 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 7e-51
 Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 50/296 (16%)

Query: 10  VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN 69
           +    ++   IG G F  VW  + R  G EVA+K  +        +E+   EI+    + 
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREA---EIYQTVMLR 55

Query: 70  HPHIIRLHDIIEVPG----KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQ 125
           H +I+              +L L+ +Y + G L  Y+ R+  V  E         A+GL 
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLA 114

Query: 126 VL--------RDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-----LAET 172
            L            + HRDLK +N+L+     N    IAD G A                
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNH 171

Query: 173 LCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ------ 220
             G+  YMAPE++         +   +AD++++G + +++    +        Q      
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231

Query: 221 --------LLQNIVKATELHFPPDAKILSADC----KDLCQKLLRRNPVERLTFEE 264
                    ++ +V   +L      +  S +       + ++    N   RLT   
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 7e-48
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 31/282 (10%)

Query: 13  DYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR 67
              +G+ +G G+F  V  A             VA+K +  G  + + +  +     ++  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 68  INHPHIIRLHDIIEVPG-KLHLILEYCKGGDLSMYIQRHG----------------CVPE 110
            +H +++ L      PG  L +I+E+CK G+LS Y++                    +  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 111 ETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-- 168
           E    +  Q+A G++ L     IHRDL  +N+LL    +   +KI DFG AR +      
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY 190

Query: 169 -LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIV 226
                      +MAPE +  + Y  ++D+WS G +L+++ +   +P+ G    +     +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250

Query: 227 KATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH 268
           K       PD    + +            P +R TF E   H
Sbjct: 251 KEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  166 bits (421), Expect = 4e-47
 Identities = 78/346 (22%), Positives = 130/346 (37%), Gaps = 67/346 (19%)

Query: 12  GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHP 71
             Y++ R++G G FS VW A+  V+ T VAMK +   R +K   E+   EI +L+R+N  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDA 69

Query: 72  -----------HIIRLHDIIEV--PGKLHLILEYCKGG---DLSMYIQRHGCVPEETAKH 115
                      HI++L D      P  +H+++ +   G      +    H  +P    K 
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 116 FMKQLAAGLQVLRDN-NLIHRDLKPQNLLLCTDDDNAAL-KIADFGFARSLQPRGLAETL 173
             KQL  GL  +     +IH D+KP+N+L+   D    L +I       +          
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 174 CGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNI-------- 225
             +  Y +PE++    +   AD+WS   ++F+L+TG   F         ++         
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 226 --------------------------VKATELHFPPDAKIL----------SADCKDLCQ 249
                                        ++L F P   +L          + +  D   
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 250 KLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR--SRMFSRSADDFP 293
            +L+ +P +R       NHP+L  T   +  R   R    S  D P
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIP 355

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 99.5 bits (247), Expect = 1e-24
 Identities = 27/206 (13%), Positives = 64/206 (31%), Gaps = 44/206 (21%)

Query: 16  VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKK----------------LQESLM 59
           +G+ +G G  S V++        E  +K   +G  + K                   S  
Sbjct: 4   IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 60  SEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQ 119
           +E   L+++    + +++          +++E           +    V  E     +  
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEG----NAVLMELI-------DAKELYRVRVENPDEVLDM 111

Query: 120 LAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAETLCGSPLY 179
           +   +       ++H DL   N+L+        + I DF  +  +          G    
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEE-------GWREI 160

Query: 180 MAPEIMQL-----QKYDAKADLWSVG 200
           +  ++  +     + Y  + D+ S  
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	575
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.33
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.88
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.62
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.48
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.72

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-59  Score=485.32  Aligned_cols=264  Identities=33%  Similarity=0.573  Sum_probs=220.8

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++++++.+||
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34566999999999999999999999999999999998765433 24567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+...++++.+||+|||+++......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999999999998899999999999999999999999999999999999999776678899999999999877777


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ...+.+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+....+.+.......+....+++++++||
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  244 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI  244 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence            77788999999999999999999999999999999999999999999999998888887654333344457899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      .+||.+||.+|||++|+++||||+.
T Consensus       245 ~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         245 RHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=474.63  Aligned_cols=255  Identities=32%  Similarity=0.605  Sum_probs=231.5

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+++.+|||
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            689999999999999999999999999999999997654322 2345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999998999999999999999999999999999999999999999   77789999999999765433 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+.+..+.+. ...+|.   .+++++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTFPD---FVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCT---TSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCc---cCCHHHHHHHH
Confidence            45678999999999999999999999999999999999999999999998888887765 334443   58999999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +||++||.+|||++|+|+||||+.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999963

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-60  Score=478.05  Aligned_cols=260  Identities=30%  Similarity=0.499  Sum_probs=224.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++...... +..+.+.+|+.+|++++||||+++++++.+++.+|||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            367899999999999999999999999999999999876432 3345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC--
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR--  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~--  167 (575)
                      ||||+||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+...  
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence            9999999999999888899999999999999999999999999999999999999   67788999999999876432  


Q ss_pred             -CCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                       ....+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+............... ........++++++
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~  237 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPL  237 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHHHH
Confidence             34556899999999999998876 5779999999999999999999987665443333333322 22333457899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||.+||++||.+|||++|+++||||++.
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            99999999999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-59  Score=477.85  Aligned_cols=267  Identities=31%  Similarity=0.575  Sum_probs=237.1

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ...-++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++++||||++++++|++.+.+
T Consensus         4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred             CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence            44557899999999999999999999999999999999865432 22345688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      |||||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+..
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC-
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceeccc
Confidence            9999999999999999999999999999999999999999999999999999999999   7778999999999987643


Q ss_pred             C---CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          167 R---GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       167 ~---~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      .   ....+.+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+++.++.+. ...+|.   .++++
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~  236 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDFPE---KFFPK  236 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCT---TCCHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-CCCCCc---cCCHH
Confidence            2   2345678999999999999999999999999999999999999999999999988888766 344443   58999


Q ss_pred             HHHHHHHhhccCCCCCCCHHH------HHcCCCCCCCCchhhhh
Q 043425          244 CKDLCQKLLRRNPVERLTFEE------FFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~e------iL~Hpff~~~~~~~~~~  281 (575)
                      +++||++||++||.+|||++|      +++||||+.++|+.+.+
T Consensus       237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence            999999999999999999987      68999999999887654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-58  Score=484.28  Aligned_cols=266  Identities=29%  Similarity=0.537  Sum_probs=240.2

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .+.++++|+++++||+|+||.||+|+++.+|+.||||++....  ....+.+.+|+.+|++++||||+++++++++.+.+
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3567899999999999999999999999999999999997653  34456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~-~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||||||+||+|.+++. ..+.+++..++.++.||+.||+|||++|||||||||+|||+..+ .++.+||+|||+++.+.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence            99999999999999985 44679999999999999999999999999999999999999432 35789999999999888


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+........+.....++++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77777889999999999999999999999999999999999999999999999999988877643333333457899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      +||++||++||.+|||++|+|+||||+...
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=473.66  Aligned_cols=272  Identities=32%  Similarity=0.548  Sum_probs=236.6

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      +-++|+++++||+|+||+||+|+++.+|+.||||++.+.....    ...+.+.+|+.+|++++||||++++++|++.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4466999999999999999999999999999999998755432    234678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC-CCCcEEEccccccccc
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD-DNAALKIADFGFARSL  164 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd-~~g~vKL~DFGla~~~  164 (575)
                      +|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+..++ ....+||+|||++...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999999888999999999999999999999999999999999999995432 2346999999999988


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .......+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+......+.....++.++
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  247 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  247 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence            77777778899999999999999999999999999999999999999999999999888887664322222235689999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCCchhhhh
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPDQVFR  281 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~~~~~  281 (575)
                      ++||++||++||.+|||++|+++||||+...+.+...
T Consensus       248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l~  284 (293)
T d1jksa_         248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS  284 (293)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTCC--------
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhhc
Confidence            9999999999999999999999999999877665544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=483.04  Aligned_cols=268  Identities=27%  Similarity=0.558  Sum_probs=243.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++||||++++++|++.+.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            467999999999999999999999999999999999865432 2234668899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-C
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-R  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~  167 (575)
                      |||||+||+|.+++.+.+.++|..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.... .
T Consensus        83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred             ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999   7778999999999987643 4


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ....+.|||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+..++++.+... ...+|.   .+++++++|
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-~~~~p~---~~s~~~~dl  235 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPR---TLSPEAKSL  235 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHHHHH
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-CCCCCc---cCCHHHHHH
Confidence            4566789999999999999999999999999999999999999999999999888887765 345554   589999999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          248 CQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       248 I~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      |++||++||.+|+     +++|+++||||..++|+.+..+..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~  277 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCC
Confidence            9999999999999     499999999999999888766544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=472.01  Aligned_cols=257  Identities=28%  Similarity=0.543  Sum_probs=231.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -++|+++++||+|+||+||+|+++.+|+.||||++.......  .+.+.+|+.+|++++||||+++++++.+++.+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            457999999999999999999999999999999998764432  356899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      |||+||+|.+++.+ +.+++..++.+++||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+... ..
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccccc
Confidence            99999999998865 579999999999999999999999999999999999999   66788999999999877543 34


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+.......+ .....++.++++||.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHHHHHHHH
Confidence            5677899999999999999999999999999999999999999999998888877776644333 233568999999999


Q ss_pred             HhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          250 KLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       250 k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||.+||.+|||++|+|+||||+..
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=466.86  Aligned_cols=255  Identities=32%  Similarity=0.590  Sum_probs=219.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV--PGKLHL   88 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~--~~~l~L   88 (575)
                      .++|++++.||+|+||+||+|+++.+|+.||||++......+...+.+.+|+.+|++++||||+++++++.+  .+.+||
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999999887777777889999999999999999999999854  566899


Q ss_pred             EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccccccCCceeeecCCCCCcEEEcccc
Q 043425           89 ILEYCKGGDLSMYIQR----HGCVPEETAKHFMKQLAAGLQVLRDNN-----LIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~----~~~lse~~i~~i~~QLl~aL~~LH~~g-----IvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                      |||||+||+|.+++.+    ++.+++..++.++.||+.||+|||++|     ||||||||+|||+   +.++.+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeecc
Confidence            9999999999999864    367999999999999999999999976     9999999999999   777899999999


Q ss_pred             cccccCCC-CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          160 FARSLQPR-GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       160 la~~~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      +++.+... ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++...+.+.....++   .
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~---~  236 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---Y  236 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---T
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---c
Confidence            99887543 3456789999999999999999999999999999999999999999999999988888776543333   3


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcCCCC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNHPFL  271 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff  271 (575)
                      .+++++++||++||.+||.+|||++|+++|||+
T Consensus       237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            589999999999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-58  Score=481.02  Aligned_cols=265  Identities=29%  Similarity=0.525  Sum_probs=238.9

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      .|.+.++|+++++||+|+||.||+|+++.+|+.||||++.+..  ......+.+|+.+|++++||||++++++|++++.+
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3667888999999999999999999999999999999998653  33456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      |||||||+||+|.+++...+ ++++..++.++.||+.||+|||++|||||||||+|||+.. ...+.+||+|||+|+.+.
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecC
Confidence            99999999999999876554 6999999999999999999999999999999999999932 245789999999999988


Q ss_pred             CCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                      ......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+............++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            87778889999999999999999999999999999999999999999999999999888877643322333457899999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                      +||++||++||.+|||++|+|+||||+..
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=460.93  Aligned_cols=253  Identities=26%  Similarity=0.495  Sum_probs=220.8

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV----PGKLHLI   89 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~----~~~l~LV   89 (575)
                      |++.++||+|+||+||+|.++.+|..||+|++..........+.+.+|+++|++++||||++++++++.    ...+|||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            478889999999999999999999999999998877777777889999999999999999999999865    3568999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNN--LIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~g--IvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||+.  ++++.+||+|||+|+... .
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~-~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-A  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC-T
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc-C
Confidence            999999999999999899999999999999999999999998  99999999999993  346789999999997543 3


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhccCCCCCChhcccHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQ-LLQNIVKATELHFPPDAKILSADCKD  246 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~-~l~~i~~~~~~~~p~~~~~ls~el~d  246 (575)
                      ....+.+||+.|||||++.+ +|+.++|||||||++|+|++|+.||.+..... +.+.+.....  .+......++++++
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKE  244 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHHHHH
Confidence            34567899999999999864 69999999999999999999999998765444 4444443321  11222457889999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLS  272 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~  272 (575)
                      ||.+||.+||++|||++|+|+||||+
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=468.52  Aligned_cols=258  Identities=29%  Similarity=0.492  Sum_probs=228.6

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      +.|+++++||+|+||.||+|+++.+|+.||||++.....  +..+.+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            469999999999999999999999999999999986532  334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CC
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GL  169 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~  169 (575)
                      ||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+..... ..
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHH
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCccc
Confidence            9999999999765 4579999999999999999999999999999999999999   67788999999999765332 23


Q ss_pred             cccccCCCCCCChHHHh-----hccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          170 AETLCGSPLYMAPEIMQ-----LQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~-----~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..+.+||+.|+|||++.     ...|+.++|||||||++|+|++|++||.+.+..+.+.++.+.....+ .....+++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHH
Confidence            45678999999999984     56689999999999999999999999999998888888887654332 3335689999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ++||++||++||.+|||++|+++||||+...
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999997543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-57  Score=470.85  Aligned_cols=265  Identities=33%  Similarity=0.636  Sum_probs=240.3

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57899999999999999999999999999999999764332 12346688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           90 LEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      ||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence            9999999999999999999999999999999999999999999999999999999   77889999999999876543  


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHH
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQ  249 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~  249 (575)
                      ..+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.. ..+|+   .++++++++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~---~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPP---FFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCT---TSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCC---CCCHHHHHHHH
Confidence            456899999999999999999999999999999999999999999999999988888763 34443   58999999999


Q ss_pred             HhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          250 KLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       250 k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      +||.+||.+|+     |++++++||||+++.|+.+..+..
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~  273 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI  273 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence            99999999996     999999999999999988765443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=479.01  Aligned_cols=259  Identities=26%  Similarity=0.531  Sum_probs=221.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -++|+++++||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999998653 3445567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||+|+.+... .
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~-~  159 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  159 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-T
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC-c
Confidence            999999999999998999999999999999999999997 599999999999999   77789999999999876432 3


Q ss_pred             cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHH--------------------------
Q 043425          170 AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQ--------------------------  223 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~--------------------------  223 (575)
                      ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...                          
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            456899999999999999999999999999999999999999998765332111                          


Q ss_pred             ----------------HHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCc
Q 043425          224 ----------------NIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQP  276 (575)
Q Consensus       224 ----------------~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~  276 (575)
                                      .+........+  ...++.++++||.+||++||.+|||++|+|+||||++..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                            11111111111  1246899999999999999999999999999999976543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-57  Score=473.34  Aligned_cols=266  Identities=30%  Similarity=0.572  Sum_probs=240.7

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+++|+++++||+|+||.||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++...+.+++
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            468999999999999999999999999999999999764322 1234568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+... 
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc-
Confidence            99999999999999999999999999999999999999999999999999999999   77789999999999876543 


Q ss_pred             CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          169 LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                       ..+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+...++..+.... ..++   ..+++++.+||
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p---~~~s~~~~~li  269 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFP---SHFSSDLKDLL  269 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC---TTCCHHHHHHH
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CCCC---ccCCHHHHHHH
Confidence             456889999999999999999999999999999999999999999999999888887763 3333   35899999999


Q ss_pred             HHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          249 QKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       249 ~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      ++||.+||.+|+     |++|+++||||+.++|+.+.....
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~  310 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV  310 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCC
Confidence            999999999995     999999999999999988876544

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-56  Score=454.76  Aligned_cols=260  Identities=33%  Similarity=0.589  Sum_probs=235.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-------HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-------KKLQESLMSEIFILKRIN-HPHIIRLHDIIEV   82 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-------~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~   82 (575)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+....       +...+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999999999999999999876432       234456889999999997 9999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           83 PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        83 ~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      ++.+|||||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence            99999999999999999999999999999999999999999999999999999999999999   778899999999999


Q ss_pred             ccCCCCCcccccCCCCCCChHHHhh------ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 043425          163 SLQPRGLAETLCGSPLYMAPEIMQL------QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPD  236 (575)
Q Consensus       163 ~~~~~~~~~~~~GT~~Y~APEvl~~------~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~  236 (575)
                      ...........+||+.|+|||++..      ..|+.++||||+||++|+|++|+.||.+.+.....+.+.++......+.
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8877666777899999999999864      3467889999999999999999999999999998888887754333334


Q ss_pred             hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          237 AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       237 ~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ...+++++++||++||++||.+|||++|+|+||||++
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            4679999999999999999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-57  Score=463.85  Aligned_cols=255  Identities=27%  Similarity=0.477  Sum_probs=229.6

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK-KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .|+++++||+|+||+||+|+++.+|+.||||++....... ...+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999999999999999998765543 445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCCcc
Q 043425           92 YCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGLAE  171 (575)
Q Consensus        92 y~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~~~  171 (575)
                      ||.||+|..++..++.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.....   ..
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---~~  169 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---AN  169 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC---CC
Confidence            99999998888888899999999999999999999999999999999999999   6778999999999986543   34


Q ss_pred             cccCCCCCCChHHHhh---ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQL---QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLC  248 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~---~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI  248 (575)
                      ..+||+.|||||++.+   ..|+.++|||||||++|+|++|..||.+.+..+.+..+.......++.  ..+++++++||
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~~~li  247 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYFRNFV  247 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--TTSCHHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCCCHHHHHHH
Confidence            5789999999999864   468999999999999999999999999999888888887765443332  35899999999


Q ss_pred             HHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          249 QKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       249 ~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      .+||++||.+|||++|+|+||||....
T Consensus       248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         248 DSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            999999999999999999999997643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-57  Score=467.28  Aligned_cols=260  Identities=28%  Similarity=0.485  Sum_probs=234.7

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      .+.++|+++++||+|+||+||+|.++.+|+.||||++.+..   .....+.+|+.+|+.++||||++++++|++.+.+||
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            35688999999999999999999999999999999997653   334568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||||+||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+.. +....+||+|||+++.....
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccC
Confidence            999999999999998765 7999999999999999999999999999999999999943 24468999999999988777


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC-ChhcccHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP-DAKILSADCKD  246 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~-~~~~ls~el~d  246 (575)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+... .++. ....+++++++
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCHHHHTTSCHHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCChhhccCCCHHHHH
Confidence            777788999999999999999999999999999999999999999999999999988887643 3332 22468999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          247 LCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       247 LI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      ||++||.+||.+|||++|+++||||++
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            999999999999999999999999965

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.7e-56  Score=468.40  Aligned_cols=270  Identities=29%  Similarity=0.482  Sum_probs=228.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHH-HHHH---HHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKL-QESL---MSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~-~~~i---~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      .+++|+++++||+|+||.||+|+++.+|+.||||++.+....... ...+   .+|+.+++.++||||++++++|...+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            468999999999999999999999999999999999765432211 1223   345677778899999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      +|||||||+||+|.+++.+++.+++..++.++.||+.||+|||++|||||||||+|||+   +..+.+||+|||+|+.+.
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999   777899999999998765


Q ss_pred             CCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          166 PRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       166 ~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .. .....+||+.|+|||++.. ..|+.++|||||||+||+|++|+.||.+.+...... +.+......+.....+++++
T Consensus       159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHH
T ss_pred             CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHH
Confidence            44 3456789999999999964 579999999999999999999999998765433322 22221111122224689999


Q ss_pred             HHHHHHhhccCCCCCCC-----HHHHHcCCCCCCCCchhhhhhcc
Q 043425          245 KDLCQKLLRRNPVERLT-----FEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpT-----a~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      ++||.+||.+||.+|||     ++|+++||||+.+.|..+.....
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~  281 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY  281 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCC
Confidence            99999999999999999     79999999999999988776544

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=462.35  Aligned_cols=266  Identities=30%  Similarity=0.552  Sum_probs=235.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC-HHHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN-KKLQESLMSEIFILK-RINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~-~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.+.... ....+.+..|..++. .++||||+++++++.+++.+||
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            57899999999999999999999999999999999764321 122345667777664 6899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-
Q 043425           89 ILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-  167 (575)
                      |||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++..... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence            99999999999999999999999999999999999999999999999999999999   77889999999999876543 


Q ss_pred             CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          168 GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       168 ~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+++..+... .+.+|.   .+++++++|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~p~---~~s~~~~dl  233 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPR---WLEKEAKDL  233 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCT---TSCHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCc---cCCHHHHHH
Confidence            3445578999999999999999999999999999999999999999999999988887765 334443   589999999


Q ss_pred             HHHhhccCCCCCCCHH-HHHcCCCCCCCCchhhhhhc
Q 043425          248 CQKLLRRNPVERLTFE-EFFNHPFLSQTQPDQVFRSR  283 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~-eiL~Hpff~~~~~~~~~~~~  283 (575)
                      |++||++||.+|||+. |+++||||+++.++.+.+..
T Consensus       234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~  270 (320)
T d1xjda_         234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKE  270 (320)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTC
T ss_pred             HHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcC
Confidence            9999999999999995 89999999999888765543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=463.62  Aligned_cols=260  Identities=32%  Similarity=0.554  Sum_probs=222.5

Q ss_pred             CCeeecCEEEEE-EecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe--
Q 043425            7 RGRVVGDYLVGR-QIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKR-INHPHIIRLHDIIEV--   82 (575)
Q Consensus         7 ~g~~v~~Y~i~~-~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~~~~~--   82 (575)
                      .+.++++|++.. .||+|+||.||+|+++.+|+.||||++...       ..+.+|+.++.+ ++||||++++++|++  
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            466889999875 599999999999999999999999999753       246789998755 589999999999976  


Q ss_pred             --CCEEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccc
Q 043425           83 --PGKLHLILEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        83 --~~~l~LVmEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                        ...+|||||||+||+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46799999999999999999875  36999999999999999999999999999999999999976666788999999


Q ss_pred             ccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh---ccCCCCC
Q 043425          159 GFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKA---TELHFPP  235 (575)
Q Consensus       159 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~---~~~~~p~  235 (575)
                      |+|+...........+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+.......+...   ....+|.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            9999887777778889999999999999999999999999999999999999999887655544433332   2233343


Q ss_pred             C-hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          236 D-AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       236 ~-~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      . ...+++++++||++||++||.+|||++|+++||||.+
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            2 3568999999999999999999999999999999965

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=442.59  Aligned_cols=261  Identities=30%  Similarity=0.520  Sum_probs=219.9

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|+++++||+|+||.||+|+++.+|+.||||++..........+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            47899999999999999999999999999999999776554445577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC-CC
Q 043425           91 EYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP-RG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~-~~  168 (575)
                      ||+.++.+...... .+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.... ..
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence            99976544433333 3569999999999999999999999999999999999999   7778999999999987654 34


Q ss_pred             CcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCC------------
Q 043425          169 LAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPP------------  235 (575)
Q Consensus       169 ~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~------------  235 (575)
                      .....+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+..+.+........            
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            4556789999999999877665 788999999999999999999999999888877766532111000            


Q ss_pred             -------------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          236 -------------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       236 -------------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                   ....++.++++||++||++||.+|||++|+++||||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                         012467899999999999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=447.34  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=218.2

Q ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 043425           16 VGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK---KLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEY   92 (575)
Q Consensus        16 i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy   92 (575)
                      .+++||+|+||+||+|+++.+|+.||||++.......   ...+.+.+|+.+|++++||||+++++++...+.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4689999999999999999999999999997654322   2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC-CCcc
Q 043425           93 CKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR-GLAE  171 (575)
Q Consensus        93 ~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~-~~~~  171 (575)
                      |.|+++..++...+.+++..++.+++||+.||+|||++||+||||||+|||+   +..+.+||+|||+++..... ....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCccccc
Confidence            9998888777777789999999999999999999999999999999999999   77889999999999876543 3445


Q ss_pred             cccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC----------------
Q 043425          172 TLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP----------------  234 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p----------------  234 (575)
                      +.+||+.|+|||++.. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.......                
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            6789999999999865 46899999999999999999999999999999988887764221100                


Q ss_pred             ---CC-----hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 ---PD-----AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 ---~~-----~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                         ..     ...+++++++||++||++||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence               00     12467899999999999999999999999999999753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-55  Score=444.44  Aligned_cols=266  Identities=30%  Similarity=0.475  Sum_probs=224.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCC-CcEEEEEEeecCccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVH-GTEVAMKEIAMGRLNKKLQESLMSEIFILKRI---NHPHIIRLHDIIEV   82 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~t-g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~~~~~   82 (575)
                      ..+..++|+++++||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.|   +||||++++++|..
T Consensus         2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             CCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            456778999999999999999999999765 67799999976544433334466777777665   79999999999853


Q ss_pred             -----CCEEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEc
Q 043425           83 -----PGKLHLILEYCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIA  156 (575)
Q Consensus        83 -----~~~l~LVmEy~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~  156 (575)
                           ...++++|||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||+   +..+.+||+
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~  158 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA  158 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeec
Confidence                 3478999999988777655443 3569999999999999999999999999999999999999   777899999


Q ss_pred             ccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC---
Q 043425          157 DFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF---  233 (575)
Q Consensus       157 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~---  233 (575)
                      |||+++...........+||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+..+.+..+.+......   
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            99999877666677788999999999999999999999999999999999999999999999888887765321110   


Q ss_pred             --------------------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          234 --------------------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       234 --------------------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                          ......+++++++||++||.+||.+|||++|+|+||||+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                                001134688999999999999999999999999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=437.50  Aligned_cols=252  Identities=30%  Similarity=0.551  Sum_probs=217.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCH----HHHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNK----KLQESLMSEIFILKRIN--HPHIIRLHDIIEVPG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~~~~~~~   84 (575)
                      -++|+++++||+|+||+||+|+++.+|+.||||++.+.....    .....+.+|+.+|++++  ||||+++++++++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999999999999999998654332    11233568999999987  899999999999999


Q ss_pred             EEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 KLHLILEYCKG-GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 ~l~LVmEy~~G-gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      .+++||||+.+ +++.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||+.  .+.+.+||+|||+|+.
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECcccccee
Confidence            99999999976 68899998889999999999999999999999999999999999999993  2457899999999986


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccC-CcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKY-DAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y-~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+      .+.+. ...++.   .+++
T Consensus       161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~~~---~~s~  229 (273)
T d1xwsa_         161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQ---RVSS  229 (273)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSS---CCCH
T ss_pred             ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-ccCCCC---CCCH
Confidence            543 34557899999999999988776 567999999999999999999998642      23333 333443   5899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                      ++++||++||.+||++|||++|+++||||++..
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-53  Score=430.44  Aligned_cols=259  Identities=26%  Similarity=0.430  Sum_probs=218.6

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCcc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRL-NKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG--   84 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~--   84 (575)
                      ..+.++|++++.||+|+||.||+|+++.+|+.||||++.+... +....+.+.+|+.+|+.++||||+++++++...+  
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            3456779999999999999999999999999999999987654 3455677999999999999999999999987643  


Q ss_pred             --EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425           85 --KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus        85 --~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                        .+|||||||+|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.++|+|||.+.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence              489999999999999999999999999999999999999999999999999999999999   667789999999987


Q ss_pred             ccCCC----CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          163 SLQPR----GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       163 ~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      .....    ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+...........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            55332    23456789999999999999999999999999999999999999999999988888877764433223335


Q ss_pred             cccHHHHHHHHHhhccCCCCCC-CHHHHHcCCC
Q 043425          239 ILSADCKDLCQKLLRRNPVERL-TFEEFFNHPF  270 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~Rp-Ta~eiL~Hpf  270 (575)
                      .+++++++||.+||.+||.+|| |+++++ |+|
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l  271 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMR-ADL  271 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHH
Confidence            6899999999999999999999 566654 444

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-53  Score=431.61  Aligned_cols=259  Identities=31%  Similarity=0.494  Sum_probs=221.4

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|+++++||+|+||+||+|+++ +|+.||||++..........+.+.+|+.+|++++||||+++++++...+..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            368999999999999999999997 8899999999876554444567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      ||+.++.+..+....+.+++..++.++.||+.||+|||+.|||||||||+|||+   +.++.+||+|||++....... .
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence            999988888887778899999999999999999999999999999999999999   777899999999998765433 3


Q ss_pred             cccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC---------------
Q 043425          170 AETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF---------------  233 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~---------------  233 (575)
                      ....+|++.|+|||++... .++.++|||||||++|+|++|++||.+.+..+.+.++.+......               
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            4556799999999998754 568999999999999999999999999998888777664321110               


Q ss_pred             ----------CCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          234 ----------PPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       234 ----------p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                                ......+++++++||++||.+||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      0011346789999999999999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=433.98  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=221.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-----   82 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-----   82 (575)
                      ...+++|+++++||+|+||+||+|+++.+|+.||||++......+.....+.+|+.+|+.++||||+++++++..     
T Consensus         6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            456899999999999999999999999999999999997766555555678899999999999999999998854     


Q ss_pred             ---CCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccc
Q 043425           83 ---PGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFG  159 (575)
Q Consensus        83 ---~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFG  159 (575)
                         .+.+|+||||+.++.+..+......+++..++.+++||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg  162 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG  162 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCT
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecc
Confidence               34689999999888777666666789999999999999999999999999999999999999   677899999999


Q ss_pred             cccccCC-----CCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC
Q 043425          160 FARSLQP-----RGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF  233 (575)
Q Consensus       160 la~~~~~-----~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~  233 (575)
                      +++.+..     .....+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+.+......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9976543     2234457899999999998765 689999999999999999999999999998888777665432221


Q ss_pred             CCCh----------------------------hcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCC
Q 043425          234 PPDA----------------------------KILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQ  273 (575)
Q Consensus       234 p~~~----------------------------~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~  273 (575)
                      +...                            ...++++++||.+||.+||++|||++|+|+||||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            1110                            113668899999999999999999999999999974

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-53  Score=427.75  Aligned_cols=247  Identities=23%  Similarity=0.440  Sum_probs=212.8

Q ss_pred             EEecccCCeEEEEEEEcC--CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 043425           18 RQIGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILEYCKG   95 (575)
Q Consensus        18 ~~LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmEy~~G   95 (575)
                      ++||+|+||.||+|.++.  +++.||||++..........+.+.+|+.+|++++||||++++++++.+ ..+||||||+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            479999999999998653  567899999976655556677899999999999999999999999754 57899999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC----cc
Q 043425           96 GDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL----AE  171 (575)
Q Consensus        96 gsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~----~~  171 (575)
                      |+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+.....    ..
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccccc
Confidence            9999999998999999999999999999999999999999999999999   6678999999999987654332    23


Q ss_pred             cccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHHHHH
Q 043425          172 TLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDLCQK  250 (575)
Q Consensus       172 ~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k  250 (575)
                      ...||+.|+|||++....|+.++|||||||++|||++ |.+||.+.+..++...+.++..+..|.   .+++++.+||.+
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~~~~~~li~~  245 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---GCPREMYDLMNL  245 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---TCCHHHHHHHHH
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---ccCHHHHHHHHH
Confidence            4579999999999999999999999999999999997 899999999888888887765555443   578999999999


Q ss_pred             hhccCCCCCCCHHHH---HcCCCC
Q 043425          251 LLRRNPVERLTFEEF---FNHPFL  271 (575)
Q Consensus       251 ~L~~DP~~RpTa~ei---L~Hpff  271 (575)
                      ||..||.+|||++++   |+|+|+
T Consensus       246 cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         246 CWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999998   456554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=419.24  Aligned_cols=247  Identities=23%  Similarity=0.492  Sum_probs=210.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|+++++||+|+||.||+|+++ +++.||||++.......   +.+.+|+.++++++||||+++++++..++.+++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            47999999999999999999987 67889999998655443   468999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           92 YCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        92 y~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      ||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-----------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce
Confidence            99999999998755 568999999999999999999999999999999999999   7778999999999987654332 


Q ss_pred             -cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          170 -AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       170 -~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       .....||+.|+|||++....|+.++|||||||++|||++ |.+||...+..+++..+..+.....|.   ..++++.+|
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~---~~~~~l~~l  234 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---LASTHVYQI  234 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT---TSCHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc---ccCHHHHHH
Confidence             334679999999999999999999999999999999998 678888888888888887765544443   578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcC
Q 043425          248 CQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~H  268 (575)
                      |.+||+.||++|||++|+++|
T Consensus       235 i~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-52  Score=426.96  Aligned_cols=252  Identities=24%  Similarity=0.445  Sum_probs=210.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCc---EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGT---EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~---~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ..++|++.++||+|+||+||+|+++.+|+   .||||.+.... .....+.+.+|+.+|++++|||||++++++..++.+
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            35789999999999999999999987665   58888876543 445567799999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           87 HLILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      ++|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEcc
Confidence            9999999999999988764 579999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCCc------ccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChh
Q 043425          166 PRGLA------ETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAK  238 (575)
Q Consensus       166 ~~~~~------~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~  238 (575)
                      .....      ....||+.|||||++....|+.++|||||||+||||++ |.+||.+.+..+++..+.++.....+   .
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~  256 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP---M  256 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---c
Confidence            43221      22468999999999999999999999999999999998 89999999999888888776544433   3


Q ss_pred             cccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          239 ILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       239 ~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .++.++.+||.+||++||.+|||+.|++++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            578999999999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-52  Score=424.84  Aligned_cols=249  Identities=23%  Similarity=0.409  Sum_probs=216.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LV   89 (575)
                      .-.+|+++++||+|+||+||+|.++.+|+.||||++..+...   .+++.+|+.+|++++||||+++++++.+++.++||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            346899999999999999999999999999999999765443   34688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           90 LEYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||++|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCC
Confidence            9999999999999764  578999999999999999999999999999999999999   67789999999999876544


Q ss_pred             CC--cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCC-CCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 GL--AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTP-FTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~~--~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~P-F~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      ..  .....||+.|+|||++.+..|+.++|||||||++|+|++|..| |.+.+..++.+.+........+   ..++.++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  245 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP---EGCPEKV  245 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC---ccchHHH
Confidence            32  2334689999999999999999999999999999999996555 5566666665555554443333   3588999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHc
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ++||.+||+.||.+|||++|+++
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=417.61  Aligned_cols=261  Identities=32%  Similarity=0.541  Sum_probs=226.7

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      +++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++......++|+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            36899999999999999999999999999999999877666667788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC-C
Q 043425           91 EYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG-L  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~-~  169 (575)
                      |++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+   +..+.+||+|||.++...... .
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence            999999999999988999999999999999999999999999999999999999   667789999999998775433 3


Q ss_pred             cccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhccCC---------------
Q 043425          170 AETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPF-TGSNQIQLLQNIVKATELH---------------  232 (575)
Q Consensus       170 ~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF-~~~~~~~~l~~i~~~~~~~---------------  232 (575)
                      .....+++.|+|||++.... ++.++|||||||++|+|++|+.|| .+.+..+.+..+.......               
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            44556788999999987665 689999999999999999999885 5556666666554322111               


Q ss_pred             ----------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 ----------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 ----------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                .......+++++++||++||++||.+|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                      111123568899999999999999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=435.53  Aligned_cols=272  Identities=29%  Similarity=0.498  Sum_probs=230.3

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEc---CCCcEEEEEEeecCccC--HHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeC
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHR---VHGTEVAMKEIAMGRLN--KKLQESLMSEIFILKRINH-PHIIRLHDIIEVP   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~---~tg~~vAVK~i~~~~~~--~~~~~~i~~Ei~iL~~L~H-pnIv~l~~~~~~~   83 (575)
                      .+++|+++++||+|+||.||+|++.   .+|+.||||++++....  ....+.+.+|+.+|++++| |||+++++++++.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            4588999999999999999999974   47999999998765431  2234567899999999977 8999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      ..+++||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence            9999999999999999999999999999999999999999999999999999999999999   7778999999999987


Q ss_pred             cCC--CCCcccccCCCCCCChHHHhhc--cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCCCChhc
Q 043425          164 LQP--RGLAETLCGSPLYMAPEIMQLQ--KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFPPDAKI  239 (575)
Q Consensus       164 ~~~--~~~~~~~~GT~~Y~APEvl~~~--~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~  239 (575)
                      +..  .....+.+|++.|+|||++...  .++.++|||||||+||+|++|..||.+.+.......+.+......++....
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            643  3334567899999999999764  467899999999999999999999988765555444444322222222346


Q ss_pred             ccHHHHHHHHHhhccCCCCCC-----CHHHHHcCCCCCCCCchhhhhhcc
Q 043425          240 LSADCKDLCQKLLRRNPVERL-----TFEEFFNHPFLSQTQPDQVFRSRM  284 (575)
Q Consensus       240 ls~el~dLI~k~L~~DP~~Rp-----Ta~eiL~Hpff~~~~~~~~~~~~~  284 (575)
                      +++++++||++||++||.+||     |++|+++||||+++.++.+..+..
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~  308 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV  308 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCC
Confidence            899999999999999999999     589999999999998887766443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=426.58  Aligned_cols=251  Identities=26%  Similarity=0.460  Sum_probs=210.2

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -++|.++++||+|+||+||+|+.+   ..||||++.......+..+.+.+|+.+|++++||||+++++++. .+.++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            467999999999999999999754   36999999877666666778999999999999999999999874 55689999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC--
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR--  167 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~--  167 (575)
                      |||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccccCC
Confidence            999999999999754 579999999999999999999999999999999999999   67789999999999765432  


Q ss_pred             -CCcccccCCCCCCChHHHhhc---cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccC--CCCCChhccc
Q 043425          168 -GLAETLCGSPLYMAPEIMQLQ---KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATEL--HFPPDAKILS  241 (575)
Q Consensus       168 -~~~~~~~GT~~Y~APEvl~~~---~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~--~~p~~~~~ls  241 (575)
                       ......+||+.|||||++...   .|+.++|||||||+||||++|+.||.+.+....+..+......  ..+.....++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence             234567899999999999643   5889999999999999999999999987766655544443221  1122234678


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +++.+||.+||..||.+|||++|++++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=419.94  Aligned_cols=251  Identities=25%  Similarity=0.488  Sum_probs=218.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      -.+|+++++||+|+||.||+|.++ ++..||||++.......   +.+.+|+.+|++++|||||++++++. .+.++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEE
Confidence            368999999999999999999986 67899999997654433   46899999999999999999999875 45679999


Q ss_pred             eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQRH--GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~--~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+....
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence            999999999977533  369999999999999999999999999999999999999   778899999999998875443


Q ss_pred             --CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                        ......||+.|+|||++....|+.++|||||||++|||++ |.+||...+..+.+..+.++.....|   ..++.++.
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  240 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNCPEELY  240 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHH
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---ccChHHHH
Confidence              3345679999999999999999999999999999999999 56777788888888887776554444   35889999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc--CCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN--HPFLS  272 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~--Hpff~  272 (575)
                      +||++||+.||++|||++|+++  |+||+
T Consensus       241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999988  67764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-51  Score=425.42  Aligned_cols=258  Identities=26%  Similarity=0.462  Sum_probs=217.0

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVP--GKL   86 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~l   86 (575)
                      ..++|+++++||+|+||+||+|+++.+|+.||||+++...     .+.+.+|+.+|+.+. ||||++++++|...  ..+
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            4578999999999999999999999999999999997542     345789999999995 99999999999754  569


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      ++|||||.+++|..+.   +.+++..++.+++||+.||+|||++||+||||||+|||+.  .+++.+||+|||+|+....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999998763   4699999999999999999999999999999999999994  2345799999999998877


Q ss_pred             CCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHhc------------cC-
Q 043425          167 RGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQ-IQLLQNIVKAT------------EL-  231 (575)
Q Consensus       167 ~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~-~~~l~~i~~~~------------~~-  231 (575)
                      .......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||..... ......+.+..            .. 
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            7777788999999999998765 579999999999999999999999976543 22222222100            00 


Q ss_pred             --------------------CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCCch
Q 043425          232 --------------------HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQPD  277 (575)
Q Consensus       232 --------------------~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~~~  277 (575)
                                          ........+++++++||++||++||.+|||++|+|+||||+.+.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                                0111224578999999999999999999999999999999987664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=431.37  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=212.9

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCc-----EEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGT-----EVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~-----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~   85 (575)
                      ++|+++++||+|+||+||+|+++.+++     .||+|.+.... .......+.+|+.+|.++ +|||||++++++...+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            579999999999999999999876543     69999886543 333456788999999998 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCce
Q 043425           86 LHLILEYCKGGDLSMYIQRH-----------------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNL  142 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~-----------------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNI  142 (575)
                      +|||||||+||+|.+++...                       +.+++..++.++.||+.||+|||++|||||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            99999999999999999754                       2489999999999999999999999999999999999


Q ss_pred             eeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCH
Q 043425          143 LLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQ  218 (575)
Q Consensus       143 Ll~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~  218 (575)
                      |+   +.++.+||+|||+|+......   ...+.+||+.|||||++....|+.++|||||||+||||++ |.+||.+.+.
T Consensus       196 ll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         196 LV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99   677899999999998764433   2345678999999999999999999999999999999997 8999998776


Q ss_pred             HHHHHHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          219 IQLLQNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       219 ~~~l~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ...+..+++.. .+..|   ..+++++++||.+||++||++|||++||++|
T Consensus       273 ~~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66666555543 22223   3578999999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=422.60  Aligned_cols=252  Identities=23%  Similarity=0.459  Sum_probs=218.7

Q ss_pred             cCEEEEEE-ecccCCeEEEEEEEcC--CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQ-IGSGSFSVVWHARHRV--HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~-LG~GaFG~Vy~a~~~~--tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ++|.+.+. ||+|+||.||+|.++.  ++..||||+++... .....+.+.+|+.+|++++|||||+++++++. +.+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            46888884 9999999999998764  45579999997643 45556789999999999999999999999875 45899


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      |||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccccc
Confidence            99999999999997654 579999999999999999999999999999999999999   56778999999999876543


Q ss_pred             CC----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          168 GL----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       168 ~~----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ..    ....+||+.|+|||++....|+.++|||||||++|||++ |..||.+.+..++...+.++..+..|+   .+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~~  239 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---ECPP  239 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---TCCH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---cCCH
Confidence            32    334679999999999999999999999999999999998 999999998888888887776555554   5889


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHH---HcCCCC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEF---FNHPFL  271 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~ei---L~Hpff  271 (575)
                      ++.+||.+||..||++|||+.+|   |+|+|+
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999888   566665

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=430.06  Aligned_cols=259  Identities=29%  Similarity=0.495  Sum_probs=218.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG-----   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~-----   84 (575)
                      +-++|+++++||+|+||+||+|.++.+|+.||||++.+........+.+.+|+.+|+.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            567899999999999999999999999999999999877667777788999999999999999999999997654     


Q ss_pred             -EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           85 -KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        85 -~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                       .+|+||||| |++|..+++ ++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence             579999999 677877765 4679999999999999999999999999999999999999   7788999999999987


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhc-cCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC----------
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQ-KYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH----------  232 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~-~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~----------  232 (575)
                      ....  ....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+.......          
T Consensus       171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            6433  4567899999999998764 56899999999999999999999999998877766555422110          


Q ss_pred             -----------------CCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCCC
Q 043425          233 -----------------FPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQTQ  275 (575)
Q Consensus       233 -----------------~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~~  275 (575)
                                       +......+++++++||.+||.+||.+|||++|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             1111234688999999999999999999999999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=429.85  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=216.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP------G   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~------~   84 (575)
                      .-+|..+++||+|+||+||+|+++.+|+.||||++..+..      ...+|+.+|++++||||++++++|...      .
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3479999999999999999999999999999999976532      134799999999999999999998543      3


Q ss_pred             EEEEEEeecCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCC-CCcEEEccccc
Q 043425           85 KLHLILEYCKGGDLSMYI---QRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDD-NAALKIADFGF  160 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l---~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~-~g~vKL~DFGl  160 (575)
                      .+|||||||+++.+..+.   .....+++..++.+++||+.||+|||++||+||||||+|||+   +. +..+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeEecccc
Confidence            589999999876443332   345679999999999999999999999999999999999999   43 35899999999


Q ss_pred             ccccCCCCCcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---------
Q 043425          161 ARSLQPRGLAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATE---------  230 (575)
Q Consensus       161 a~~~~~~~~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~---------  230 (575)
                      ++.........+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+...         
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            998877777778899999999999865 5789999999999999999999999999998888777654211         


Q ss_pred             -------CCCCC---------ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          231 -------LHFPP---------DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       231 -------~~~p~---------~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                             ..++.         ....+++++++||.+||.+||.+|||+.|+|+||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                   11111         113478899999999999999999999999999999765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=415.29  Aligned_cols=247  Identities=21%  Similarity=0.432  Sum_probs=221.8

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLILE   91 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVmE   91 (575)
                      .+|+++++||+|+||+||+|+++ ++..||||++.+.....   +.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            57899999999999999999986 78899999998766543   468999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC-
Q 043425           92 YCKGGDLSMYIQR-HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL-  169 (575)
Q Consensus        92 y~~GgsL~~~l~~-~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~-  169 (575)
                      |+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++....... 
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce
Confidence            9999999999764 4579999999999999999999999999999999999999   7788999999999987654433 


Q ss_pred             -cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHHHH
Q 043425          170 -AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCKDL  247 (575)
Q Consensus       170 -~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~dL  247 (575)
                       ....+||+.|+|||++....|+.++|||||||++|||++ |+.||.+.+..++...+.++.....|   ...+.++.+|
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~l  233 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYTI  233 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHHHH
Confidence             334679999999999999999999999999999999998 89999999999988888776554444   3578999999


Q ss_pred             HHHhhccCCCCCCCHHHHHcC
Q 043425          248 CQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       248 I~k~L~~DP~~RpTa~eiL~H  268 (575)
                      |++||+.||.+|||++++++|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=429.94  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=211.5

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe------C
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV------P   83 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~------~   83 (575)
                      +..+|+++++||+|+||+||+|+++.+|+.||||++.....+......+.+|+.+|+.++||||++++++|..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            4578999999999999999999999999999999998877677777789999999999999999999999953      3


Q ss_pred             CEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccc
Q 043425           84 GKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARS  163 (575)
Q Consensus        84 ~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~  163 (575)
                      +.+|+|||||.|+ +.+.+  ...+++..++.+++||+.||+|||++||+||||||+|||+   +.++.+|++|||+++.
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  168 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred             ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhc
Confidence            6899999999765 44444  3579999999999999999999999999999999999999   6678899999999988


Q ss_pred             cCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCCC---------
Q 043425          164 LQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHFP---------  234 (575)
Q Consensus       164 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~p---------  234 (575)
                      ..........+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+.......+........+         
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            77766777889999999999999999999999999999999999999999999887777666542211100         


Q ss_pred             --------------------------CC---hhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          235 --------------------------PD---AKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       235 --------------------------~~---~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                                ..   ....++++++||++||.+||.+|||++|+|+||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                                      00   12356789999999999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=411.61  Aligned_cols=249  Identities=24%  Similarity=0.468  Sum_probs=208.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCC---CcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVH---GTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~t---g~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~L   88 (575)
                      ++|++++.||+|+||.||+|++..+   +..||||.+... ......+.+.+|+.+|++++||||+++++++. .+.+|+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            5799999999999999999998754   356888887543 34556678999999999999999999999985 567899


Q ss_pred             EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheeccCC
Confidence            99999999999987654 579999999999999999999999999999999999999   66678999999999876543


Q ss_pred             C--CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHH
Q 043425          168 G--LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADC  244 (575)
Q Consensus       168 ~--~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el  244 (575)
                      .  .....+||+.|+|||++....|+.++|||||||++|||++ |.+||.+.+..+++..+..+....+++   .+++++
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~---~~~~~~  238 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---NCPPTL  238 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT---TCCHHH
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCCHHH
Confidence            2  2345678999999999999999999999999999999998 899999999999888888775554443   589999


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHcC
Q 043425          245 KDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       245 ~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+||.+||+.||.+|||++||++|
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999886

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-51  Score=423.91  Aligned_cols=260  Identities=32%  Similarity=0.508  Sum_probs=213.9

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----K   85 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----~   85 (575)
                      +..+|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++....    .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            3457999999999999999999999999999999997644 3455667899999999999999999999986543    2


Q ss_pred             EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccC
Q 043425           86 LHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQ  165 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~  165 (575)
                      .+++++|+.||+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+|||+   +..+.+||+|||++....
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             eEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence            34444566699999999754 69999999999999999999999999999999999999   777899999999998654


Q ss_pred             CCC----CcccccCCCCCCChHHHhh-ccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCC--------
Q 043425          166 PRG----LAETLCGSPLYMAPEIMQL-QKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELH--------  232 (575)
Q Consensus       166 ~~~----~~~~~~GT~~Y~APEvl~~-~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~--------  232 (575)
                      ...    .....+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.+..+............        
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            332    3456789999999999854 567889999999999999999999999988776665544321110        


Q ss_pred             -----------CC--------CChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          233 -----------FP--------PDAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       233 -----------~p--------~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                 .+        .....+++++++||.+||++||.+|||++|+|+||||.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                       00        0113467899999999999999999999999999999765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=422.81  Aligned_cols=259  Identities=28%  Similarity=0.424  Sum_probs=219.1

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVP-----G   84 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~-----~   84 (575)
                      +-++|+++++||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+|+.++||||+++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            34689999999999999999999999999999999987766666677889999999999999999999998643     2


Q ss_pred             EEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           85 KLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      ..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||++...
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence            34666777889999999864 579999999999999999999999999999999999999   77789999999999765


Q ss_pred             CCCCCcccccCCCCCCChHHHhhcc-CCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhccCCC----------
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQK-YDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKATELHF----------  233 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~-y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~~~~~----------  233 (575)
                      .  ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.+......          
T Consensus       172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence            3  2345678999999999987665 58899999999999999999999999998887777765422110          


Q ss_pred             ------------CC-----ChhcccHHHHHHHHHhhccCCCCCCCHHHHHcCCCCCCC
Q 043425          234 ------------PP-----DAKILSADCKDLCQKLLRRNPVERLTFEEFFNHPFLSQT  274 (575)
Q Consensus       234 ------------p~-----~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~Hpff~~~  274 (575)
                                  +.     ....+++++++||++||++||.+|||++|+|+||||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                        00     012468899999999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=410.11  Aligned_cols=253  Identities=25%  Similarity=0.468  Sum_probs=213.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLHLIL   90 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~LVm   90 (575)
                      .++|++++.||+|+||.||+|+++. +..||||++.......   +.+.+|+.+|++++|||||++++++. .+.+++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence            4789999999999999999999874 4679999997665433   56899999999999999999999985 45689999


Q ss_pred             eecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCC
Q 043425           91 EYCKGGDLSMYIQR--HGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRG  168 (575)
Q Consensus        91 Ey~~GgsL~~~l~~--~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~  168 (575)
                      |||++|+|..++..  .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence            99999999988753  4579999999999999999999999999999999999999   677899999999998764433


Q ss_pred             --CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHHHH
Q 043425          169 --LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSADCK  245 (575)
Q Consensus       169 --~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~el~  245 (575)
                        .....+||+.|+|||++....++.++|||||||++|||++ |.+||.+....+++..+.+......+   ..++++++
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~  244 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---PECPESLH  244 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTSCHHHH
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---cccCHHHH
Confidence              2334679999999999999999999999999999999999 56667777888888777766544443   45889999


Q ss_pred             HHHHHhhccCCCCCCCHHHHHc--CCCCCCC
Q 043425          246 DLCQKLLRRNPVERLTFEEFFN--HPFLSQT  274 (575)
Q Consensus       246 dLI~k~L~~DP~~RpTa~eiL~--Hpff~~~  274 (575)
                      +||.+||+.||++||+++++++  ++||+..
T Consensus       245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999999988  8888654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=406.76  Aligned_cols=249  Identities=23%  Similarity=0.418  Sum_probs=209.1

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCC----cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHG----TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg----~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ..|.+.++||+|+||.||+|.++.++    ..||||++.... ..+....+.+|+.+|++++|||||++++++...+.++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            46999999999999999999987655    479999997543 4455667899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +|||||.++++.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcccC
Confidence            999999999999988655 579999999999999999999999999999999999999   7788999999999987644


Q ss_pred             CC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          167 RG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       167 ~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ..    ......||+.|+|||++....|+.++|||||||++|||++| .+||.+.+..+++..+..+.....+   ..++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~  239 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---MDCP  239 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTCB
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc---hhhH
Confidence            32    22345789999999999999999999999999999999985 5666777777777777666544444   3578


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++.+||.+||..||++|||+.|+++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=414.30  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=210.4

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcCCCc----EEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRVHGT----EVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~tg~----~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      .+|+++++||+|+||+||+|.+..+|+    .||+|.+.... ..+..+.+.+|+.+|++++|||||++++++.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            569999999999999999999988876    47777775432 233456789999999999999999999999765 567


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +++||+.+|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+++....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceeccc
Confidence            888999999999888765 579999999999999999999999999999999999999   6678899999999987654


Q ss_pred             CCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccH
Q 043425          167 RGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSA  242 (575)
Q Consensus       167 ~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~  242 (575)
                      ...   .....||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+.+..++...+.++..+..|   ..++.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p---~~~~~  240 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PICTI  240 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC---TTBCH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---cccCH
Confidence            332   334578999999999999999999999999999999998 89999998888877777766554444   35889


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          243 DCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       243 el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      ++.+||.+||..||.+|||+.|+++|
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            99999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=412.37  Aligned_cols=251  Identities=28%  Similarity=0.458  Sum_probs=216.6

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcE--EEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTE--VAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~--vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~~l~   87 (575)
                      .++|+++++||+|+||+||+|+++.+|..  ||||.+.... ..+..+.+.+|+.+|+++ +||||+++++++...+.++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            46899999999999999999999988875  5667665432 333456789999999998 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCC
Q 043425           88 LILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNA  151 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g  151 (575)
                      |||||++||+|.+++++.                ..+++..+..++.||+.||.|||++||+||||||+|||+   +..+
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999999754                568999999999999999999999999999999999999   7778


Q ss_pred             cEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcc
Q 043425          152 ALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATE  230 (575)
Q Consensus       152 ~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~  230 (575)
                      .+||+|||+++...........+||+.|+|||.+....|+.++|||||||++|||++| .+||.+.+..++...+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            9999999999876665555677899999999999999999999999999999999996 468999998888888776654


Q ss_pred             CCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          231 LHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       231 ~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +..+   ..+++++++||.+||+.||++|||++|+++|
T Consensus       245 ~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 LEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433   3589999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=406.69  Aligned_cols=249  Identities=24%  Similarity=0.428  Sum_probs=218.0

Q ss_pred             cCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKL   86 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l   86 (575)
                      ++|+++++||+|+||+||+|+.+     .+++.||||++.... ..+..+.+.+|+.+|+.++||||+++++++...+..
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            57999999999999999999975     356899999987543 455667899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCce
Q 043425           87 HLILEYCKGGDLSMYIQRHG------------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNL  142 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~------------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNI  142 (575)
                      ++||||+++|+|.+++....                        .+++..+..++.||+.||+|||++|||||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            99999999999999996532                        388999999999999999999999999999999999


Q ss_pred             eeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCC-CCCCCCCH
Q 043425          143 LLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGK-TPFTGSNQ  218 (575)
Q Consensus       143 Ll~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~-~PF~~~~~  218 (575)
                      |+   +.++.+||+|||+++......   ...+.+||+.|+|||++....|+.++|||||||++|||++|. +||.+.+.
T Consensus       172 Ll---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         172 LV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99   677899999999998664332   334578999999999999999999999999999999999985 78999999


Q ss_pred             HHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          219 IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       219 ~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .+.+..+.++.....|   ..+++++.+||.+||+.||.+|||+.||++
T Consensus       249 ~e~~~~v~~~~~~~~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9988887776543333   458899999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=403.48  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=216.7

Q ss_pred             CCeeecCEEEEEEecccCCeEEEEEEEcCCC-------cEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 043425            7 RGRVVGDYLVGRQIGSGSFSVVWHARHRVHG-------TEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHD   78 (575)
Q Consensus         7 ~g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg-------~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~   78 (575)
                      +.--.++|+++++||+|+||.||+|++..++       ..||||++.... ..+....+.+|...+.++ +||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            3444579999999999999999999976544       479999997654 445556788999988887 7999999999


Q ss_pred             EEEeCCEEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCce
Q 043425           79 IIEVPGKLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNL  142 (575)
Q Consensus        79 ~~~~~~~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNI  142 (575)
                      ++.+++.+++|||||++|+|.+++...                ..+++..+..++.||+.||+|||++|||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            999999999999999999999999754                3489999999999999999999999999999999999


Q ss_pred             eeecCCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCH
Q 043425          143 LLCTDDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQ  218 (575)
Q Consensus       143 Ll~~dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~  218 (575)
                      |+   +.++.+||+|||+++......   .....+||+.|+|||++.++.|+.++|||||||++|+|++ |.+||.+.+.
T Consensus       167 Ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         167 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99   777899999999998765433   3345789999999999999999999999999999999998 7999999998


Q ss_pred             HHHHHHHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          219 IQLLQNIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       219 ~~~l~~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++...+..+..+..|.   .+++++++||.+||++||.+|||+.|+++
T Consensus       244 ~~~~~~i~~~~~~~~p~---~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTTCCCCCCS---SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCc---cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88887777665554443   57899999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=404.17  Aligned_cols=250  Identities=28%  Similarity=0.460  Sum_probs=201.3

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CC
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEV-PG   84 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~-~~   84 (575)
                      ++|+++++||+|+||.||+|.+..     +++.||||++.... .....+.+.+|..++.++ +|+||+.+++++.. .+
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            679999999999999999999754     45789999987543 334456677888887776 68899999998755 45


Q ss_pred             EEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCC
Q 043425           85 KLHLILEYCKGGDLSMYIQRH----------------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDD  148 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~----------------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd  148 (575)
                      .+++|||||+||+|.+++...                ..+++..+..++.||+.||+|||++|||||||||+|||+   +
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---C
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---C
Confidence            689999999999999999753                348899999999999999999999999999999999999   6


Q ss_pred             CCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHH-
Q 043425          149 DNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQ-  223 (575)
Q Consensus       149 ~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~-  223 (575)
                      .++.+||+|||+|+......   .....+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+....+.+. 
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            77899999999998654332   33457899999999999999999999999999999999986 57888766544444 


Q ss_pred             HHHHhccCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          224 NIVKATELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       224 ~i~~~~~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      .+.++.....|   ..+++++++||.+||+.||.+|||++|+++|
T Consensus       249 ~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44444333333   3588999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=401.94  Aligned_cols=247  Identities=22%  Similarity=0.433  Sum_probs=209.3

Q ss_pred             CeeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 043425            8 GRVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIE-VPGKL   86 (575)
Q Consensus         8 g~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~-~~~~l   86 (575)
                      .-..++|+++++||+|+||.||+|+++  |..||||+++.+.    ..+.+.+|+.++++++||||+++++++. ..+.+
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            345678999999999999999999985  8899999997643    3356889999999999999999999884 45668


Q ss_pred             EEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEccccccccc
Q 043425           87 HLILEYCKGGDLSMYIQRHG--CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSL  164 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~--~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~  164 (575)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceec
Confidence            99999999999999996543  58999999999999999999999999999999999999   77889999999999865


Q ss_pred             CCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          165 QPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       165 ~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                      ...  ....++|+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..++...+.++..+.++.   .++++
T Consensus       154 ~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~---~~~~~  228 (262)
T d1byga_         154 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD---GCPPA  228 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT---TCCHH
T ss_pred             CCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHH
Confidence            432  345678999999999999999999999999999999998 799999998888888887665555543   57899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+||++||+.||.+|||+.+++++
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=399.70  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=204.2

Q ss_pred             cCEEEEEEecccCCeEEEEEEEcC-CC--cEEEEEEeecCccC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 043425           12 GDYLVGRQIGSGSFSVVWHARHRV-HG--TEVAMKEIAMGRLN-KKLQESLMSEIFILKRINHPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus        12 ~~Y~i~~~LG~GaFG~Vy~a~~~~-tg--~~vAVK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~l~   87 (575)
                      ++|++++.||+|+||.||+|+... ++  ..||||++.+.... .+..+.+.+|+.+|++++||||+++++++.+ +.++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            569999999999999999998653 33  46899998765443 3445679999999999999999999999965 4678


Q ss_pred             EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCC
Q 043425           88 LILEYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQP  166 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~  166 (575)
                      +|||||++|+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhccc
Confidence            999999999999887654 579999999999999999999999999999999999999   5567899999999987654


Q ss_pred             CC----CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhccCCCCCChhccc
Q 043425          167 RG----LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLLQNIVKATELHFPPDAKILS  241 (575)
Q Consensus       167 ~~----~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l~~i~~~~~~~~p~~~~~ls  241 (575)
                      ..    .....+|++.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+.+...  .++....++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~  241 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDCP  241 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--CCCCCTTCC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC--CCCCccccc
Confidence            33    2334568889999999999999999999999999999998 8999999999998888776532  222334689


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          242 ADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       242 ~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .++++||.+||.+||++|||++||++
T Consensus       242 ~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-48  Score=395.60  Aligned_cols=257  Identities=21%  Similarity=0.255  Sum_probs=206.2

Q ss_pred             eecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 043425           10 VVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-IIRLHDIIEVPGKLHL   88 (575)
Q Consensus        10 ~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~l~L   88 (575)
                      +.++|+++++||+|+||+||+|++..+|+.||||++......    ..+..|+++++.++|+| |+.+.+++...+..++
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            345799999999999999999999999999999998765432    34678999999998766 5566677788899999


Q ss_pred             EEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCC
Q 043425           89 ILEYCKGGDLSMYIQ-RHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPR  167 (575)
Q Consensus        89 VmEy~~GgsL~~~l~-~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~  167 (575)
                      ||||+ +++|...+. ..+.+++..+..++.|++.||+|||++||+||||||+|||+...+.+..+||+|||+|+.+...
T Consensus        81 vme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99999 556666554 4568999999999999999999999999999999999999966666778999999999876543


Q ss_pred             C--------CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----cCCCCC
Q 043425          168 G--------LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQIQLLQNIVKAT----ELHFPP  235 (575)
Q Consensus       168 ~--------~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~~~l~~i~~~~----~~~~p~  235 (575)
                      .        ...+.+||+.|||||++.+.+|+.++|||||||++|+|++|.+||.+.........+.+..    ....+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  239 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence            2        2345789999999999999999999999999999999999999998876554443332211    111111


Q ss_pred             ChhcccHHHHHHHHHhhccCCCCCCCHHHH---HcCCCC
Q 043425          236 DAKILSADCKDLCQKLLRRNPVERLTFEEF---FNHPFL  271 (575)
Q Consensus       236 ~~~~ls~el~dLI~k~L~~DP~~RpTa~ei---L~Hpff  271 (575)
                      ....+++++.+||.+||..||.+||+++++   |+|+|.
T Consensus       240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            124578999999999999999999998755   556553

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=399.18  Aligned_cols=250  Identities=23%  Similarity=0.406  Sum_probs=220.1

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcC-----CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRV-----HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPGK   85 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~-----tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~~   85 (575)
                      -++|.++++||+|+||+||+|.++.     ++..||||+++... ..+....+.+|+.++++++||||+++++++...+.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            4789999999999999999998863     46789999997543 44556678999999999999999999999998899


Q ss_pred             EEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEE
Q 043425           86 LHLILEYCKGGDLSMYIQRH----------GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKI  155 (575)
Q Consensus        86 l~LVmEy~~GgsL~~~l~~~----------~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL  155 (575)
                      .++|||||++|+|.+++...          ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEE
Confidence            99999999999999998643          246889999999999999999999999999999999999   78889999


Q ss_pred             cccccccccCCCCC---cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhC-CCCCCCCCHHHHHHHHHHhccC
Q 043425          156 ADFGFARSLQPRGL---AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTG-KTPFTGSNQIQLLQNIVKATEL  231 (575)
Q Consensus       156 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG-~~PF~~~~~~~~l~~i~~~~~~  231 (575)
                      +|||+++.......   ....+||+.|+|||.+.+..|+.++||||||+++|||++| .+||.+.+..+.+..+.++...
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999987644332   3345789999999999999999999999999999999998 5899999999998888876544


Q ss_pred             CCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          232 HFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       232 ~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..|   ..++..+.+||.+||+.||.+|||++++++
T Consensus       255 ~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         255 DKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            433   357899999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=397.21  Aligned_cols=250  Identities=29%  Similarity=0.466  Sum_probs=215.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEc-----CCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHR-----VHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRI-NHPHIIRLHDIIEVPG   84 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~-----~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~~~~~~~   84 (575)
                      .++|+++++||+|+||.||+|+++     .+++.||||++.... .......+.+|+.+++.+ +|||||++++++...+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            378999999999999999999863     467899999997654 344556789999999999 6999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeec
Q 043425           85 KLHLILEYCKGGDLSMYIQRHG------------------CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCT  146 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~~l~~~~------------------~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~  146 (575)
                      .++||||||+||+|.+++.+..                  .+++..+..++.||+.||+|||++|||||||||+|||+  
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--  178 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--  178 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--
Confidence            9999999999999999997643                  58999999999999999999999999999999999999  


Q ss_pred             CCCCCcEEEcccccccccCCCC---CcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHh-CCCCCCCCCHHHHH
Q 043425          147 DDDNAALKIADFGFARSLQPRG---LAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVT-GKTPFTGSNQIQLL  222 (575)
Q Consensus       147 dd~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLlt-G~~PF~~~~~~~~l  222 (575)
                       +..+.+||+|||+++......   .....+||+.|+|||++....++.++|||||||++|+|++ |.+||.+.+..+.+
T Consensus       179 -~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         179 -THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             -ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             -cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             677899999999998765432   2344689999999999999999999999999999999998 77778777766666


Q ss_pred             HHHHHhc-cCCCCCChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          223 QNIVKAT-ELHFPPDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       223 ~~i~~~~-~~~~p~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      ..+++.. ....+   ..++.++.+||.+||++||.+|||++||++
T Consensus       258 ~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5555442 22222   357899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=386.73  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             EEEEEecccCCeEEEEEEEcCCC---cEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 043425           15 LVGRQIGSGSFSVVWHARHRVHG---TEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEV-PGKLHLIL   90 (575)
Q Consensus        15 ~i~~~LG~GaFG~Vy~a~~~~tg---~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~-~~~l~LVm   90 (575)
                      .+.++||+|+||+||+|++..++   ..||||++++. ......+.+.+|+.+|++++||||+++++++.. ++.+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            34689999999999999987643   36899998753 345566789999999999999999999998765 56899999


Q ss_pred             eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcccccccccCCCCC
Q 043425           91 EYCKGGDLSMYIQRH-GCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIADFGFARSLQPRGL  169 (575)
Q Consensus        91 Ey~~GgsL~~~l~~~-~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~~~~~~~~  169 (575)
                      |||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence            999999999998754 457788999999999999999999999999999999999   7788999999999987644322


Q ss_pred             -----cccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCC-CCHHHHHHHHHHhccCCCCCChhcccHH
Q 043425          170 -----AETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTG-SNQIQLLQNIVKATELHFPPDAKILSAD  243 (575)
Q Consensus       170 -----~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~-~~~~~~l~~i~~~~~~~~p~~~~~ls~e  243 (575)
                           .....||+.|+|||++....++.++||||||+++|||++|..||.. .+..+....+..+..+..|   ..++++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p---~~~~~~  262 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPDP  262 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---TTCCHH
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---ccCcHH
Confidence                 2235689999999999999999999999999999999997766654 4444555666666544444   357899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          244 CKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       244 l~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                      +.+||.+||..||++||++.|+++|
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-46  Score=380.28  Aligned_cols=252  Identities=19%  Similarity=0.244  Sum_probs=209.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-PHIIRLHDIIEVPGKLHLI   89 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~~~~~~~~l~LV   89 (575)
                      .++|+++++||+|+||+||+|++..+|+.||||++......    ..+.+|+++++.|.| +||+.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            45799999999999999999999999999999998764322    346789999999976 8999999999999999999


Q ss_pred             EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecC--CCCCcEEEcccccccccCC
Q 043425           90 LEYCKGGDLSMYIQRHG-CVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTD--DDNAALKIADFGFARSLQP  166 (575)
Q Consensus        90 mEy~~GgsL~~~l~~~~-~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~d--d~~g~vKL~DFGla~~~~~  166 (575)
                      |||+ |++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||+..+  ...+.+||+|||+|+.+..
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 789999987654 79999999999999999999999999999999999999643  2357899999999987543


Q ss_pred             C--------CCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhccCCC-C
Q 043425          167 R--------GLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSN---QIQLLQNIVKATELHF-P  234 (575)
Q Consensus       167 ~--------~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~---~~~~l~~i~~~~~~~~-p  234 (575)
                      .        ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+..   .......+........ +
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            2        12445789999999999999999999999999999999999999998653   3333334433222111 1


Q ss_pred             CChhcccHHHHHHHHHhhccCCCCCCCHHHHHc
Q 043425          235 PDAKILSADCKDLCQKLLRRNPVERLTFEEFFN  267 (575)
Q Consensus       235 ~~~~~ls~el~dLI~k~L~~DP~~RpTa~eiL~  267 (575)
                      .....+++++.+++..|+..+|.+||+++.+.+
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111357899999999999999999999887754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=379.17  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             ecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----EE
Q 043425           11 VGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHIIRLHDIIEVPG----KL   86 (575)
Q Consensus        11 v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~~~~~~~----~l   86 (575)
                      ..+|.+.++||+|+||.||+|++  +|+.||||++..+.   ........|+..+..++||||+++++++...+    .+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            45799999999999999999986  59999999986542   21222234555566789999999999986543    68


Q ss_pred             EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--------CCcccccccCCceeeecCCCCCcEEEccc
Q 043425           87 HLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD--------NNLIHRDLKPQNLLLCTDDDNAALKIADF  158 (575)
Q Consensus        87 ~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~--------~gIvHrDLKPeNILl~~dd~~g~vKL~DF  158 (575)
                      |+|||||++|+|.+++++. .+++..+..++.|++.||.|||.        +|||||||||+|||+   +.++.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence            9999999999999999865 68999999999999999999996        699999999999999   77889999999


Q ss_pred             ccccccCCCC-----CcccccCCCCCCChHHHhhc------cCCcccccchhhHHHHHHHhCCCCCCCCC----------
Q 043425          159 GFARSLQPRG-----LAETLCGSPLYMAPEIMQLQ------KYDAKADLWSVGAILFQLVTGKTPFTGSN----------  217 (575)
Q Consensus       159 Gla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~------~y~~kaDIWSLGviLyeLltG~~PF~~~~----------  217 (575)
                      |+++......     .....+||+.|+|||++...      .++.++|||||||+||||++|.+||....          
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            9998764432     23457899999999998754      36778999999999999999988774321          


Q ss_pred             ----HHHHHHHHHHhcc--CCCCCCh--hcccHHHHHHHHHhhccCCCCCCCHHHHHcC
Q 043425          218 ----QIQLLQNIVKATE--LHFPPDA--KILSADCKDLCQKLLRRNPVERLTFEEFFNH  268 (575)
Q Consensus       218 ----~~~~l~~i~~~~~--~~~p~~~--~~ls~el~dLI~k~L~~DP~~RpTa~eiL~H  268 (575)
                          ....+........  +.++...  .....++.+|+.+||..||.+|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                1122222222211  2222221  1234568999999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.6e-44  Score=371.26  Aligned_cols=263  Identities=28%  Similarity=0.453  Sum_probs=202.3

Q ss_pred             CCeee--cCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-----------CCCc
Q 043425            7 RGRVV--GDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-----------HPHI   73 (575)
Q Consensus         7 ~g~~v--~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnI   73 (575)
                      .|...  ++|+++++||+|+||+||+|+++.+|+.||||++.+..   ...+.+.+|+.+++.++           |+||
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            36654  46999999999999999999999999999999997643   33456778898888774           5789


Q ss_pred             ceEEEEEE--eCCEEEEEEeecCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccccccCCceeeecC
Q 043425           74 IRLHDIIE--VPGKLHLILEYCKGGDLSMYI---QRHGCVPEETAKHFMKQLAAGLQVLRD-NNLIHRDLKPQNLLLCTD  147 (575)
Q Consensus        74 v~l~~~~~--~~~~l~LVmEy~~GgsL~~~l---~~~~~lse~~i~~i~~QLl~aL~~LH~-~gIvHrDLKPeNILl~~d  147 (575)
                      +++++++.  .....+++|+++..+......   .....+++..++.++.||+.||+|||+ .||+||||||+|||+..+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            99998874  446777888777665433332   233579999999999999999999998 899999999999999543


Q ss_pred             CCC---CcEEEcccccccccCCCCCcccccCCCCCCChHHHhhccCCcccccchhhHHHHHHHhCCCCCCCCCHH-----
Q 043425          148 DDN---AALKIADFGFARSLQPRGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGKTPFTGSNQI-----  219 (575)
Q Consensus       148 d~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~kaDIWSLGviLyeLltG~~PF~~~~~~-----  219 (575)
                      +..   ..+||+|||.+.....  .....+||+.|+|||++....|+.++|||||||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            322   3599999999976543  345678999999999999999999999999999999999999999754321     


Q ss_pred             -HHHHHHHHhccC-----------------------CC---------------CCChhcccHHHHHHHHHhhccCCCCCC
Q 043425          220 -QLLQNIVKATEL-----------------------HF---------------PPDAKILSADCKDLCQKLLRRNPVERL  260 (575)
Q Consensus       220 -~~l~~i~~~~~~-----------------------~~---------------p~~~~~ls~el~dLI~k~L~~DP~~Rp  260 (575)
                       ..+.........                       ..               .......++++++||.+||.+||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             112111111000                       00               001123567899999999999999999


Q ss_pred             CHHHHHcCCCCCCC
Q 043425          261 TFEEFFNHPFLSQT  274 (575)
Q Consensus       261 Ta~eiL~Hpff~~~  274 (575)
                      |++|+|+||||++.
T Consensus       321 ta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         321 DAGGLVNHPWLKDT  334 (362)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhcCcccCCC
Confidence            99999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=7.6e-25  Score=207.88  Aligned_cols=167  Identities=17%  Similarity=0.217  Sum_probs=123.5

Q ss_pred             EEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccC----------------HHHHHHHHHHHHHHHhCCCCCcceEE
Q 043425           14 YLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLN----------------KKLQESLMSEIFILKRINHPHIIRLH   77 (575)
Q Consensus        14 Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~----------------~~~~~~i~~Ei~iL~~L~HpnIv~l~   77 (575)
                      |.++++||+|+||+||+|.+. +|+.||||++......                .........|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468999999999999999986 7999999987532110                11123456788999999999999988


Q ss_pred             EEEEeCCEEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhCCcccccccCCceeeecCCCCCcEEEcc
Q 043425           78 DIIEVPGKLHLILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRDNNLIHRDLKPQNLLLCTDDDNAALKIAD  157 (575)
Q Consensus        78 ~~~~~~~~l~LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~~gIvHrDLKPeNILl~~dd~~g~vKL~D  157 (575)
                      ++.  .  .+++|||++++.+..       +++..+..++.||+.+|.|||++||+||||||+|||+.   + ..++|+|
T Consensus        81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~~~liD  145 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EGIWIID  145 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TEEEECC
T ss_pred             Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CCEEEEE
Confidence            663  2  279999998865432       45666788999999999999999999999999999993   3 3489999


Q ss_pred             cccccccCCCCCcccccCCCCCCCh--HH---HhhccCCcccccchhhHHH
Q 043425          158 FGFARSLQPRGLAETLCGSPLYMAP--EI---MQLQKYDAKADLWSVGAIL  203 (575)
Q Consensus       158 FGla~~~~~~~~~~~~~GT~~Y~AP--Ev---l~~~~y~~kaDIWSLGviL  203 (575)
                      ||+|..........       |...  +.   +-...|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99997654322110       1111  10   1246788999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.33  E-value=5.3e-07  Score=86.45  Aligned_cols=142  Identities=12%  Similarity=0.147  Sum_probs=94.5

Q ss_pred             eeecCEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 043425            9 RVVGDYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRIN-HPHIIRLHDIIEVPGKLH   87 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~~~~~~~~l~   87 (575)
                      ..+..|++.+..+.++.+.||++.  ..+..+++|.........  ...+.+|...+..+. +--+.+++.+...++..+
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            456678888776666678999885  357778889876442211  223567888887774 333678888888899999


Q ss_pred             EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 043425           88 LILEYCKGGDLSMYIQRHGCVPEETAKHFMKQLAAGLQVLRD--------------------------------------  129 (575)
Q Consensus        88 LVmEy~~GgsL~~~l~~~~~lse~~i~~i~~QLl~aL~~LH~--------------------------------------  129 (575)
                      +||++++|..+.......     .....++.++...+..||+                                      
T Consensus        87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence            999999998876543211     1112233333333333332                                      


Q ss_pred             ---------------C------CcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          130 ---------------N------NLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       130 ---------------~------gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                                     .      .++|+|+.|.|||+   ++++.+-|+||+.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred             ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhcc
Confidence                           1      27899999999999   454556699999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.88  E-value=1.5e-05  Score=75.68  Aligned_cols=83  Identities=20%  Similarity=0.183  Sum_probs=56.5

Q ss_pred             eeecCEEEEEEecccC-CeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCE
Q 043425            9 RVVGDYLVGRQIGSGS-FSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH--PHIIRLHDIIEVPGK   85 (575)
Q Consensus         9 ~~v~~Y~i~~~LG~Ga-FG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~~~~~~~~   85 (575)
                      ..+..+.+. .+..|. -+.||+.... .+..+++|.......     ..+..|...|+.+..  -.+.+++.+...++.
T Consensus         8 ~~l~g~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~   80 (255)
T d1nd4a_           8 ERLFGYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGR   80 (255)
T ss_dssp             TTTTTCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             HhccCCceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence            334455554 444444 4789988754 577788997654322     235677777776643  336778888888889


Q ss_pred             EEEEEeecCCCCH
Q 043425           86 LHLILEYCKGGDL   98 (575)
Q Consensus        86 l~LVmEy~~GgsL   98 (575)
                      .++||++++|.++
T Consensus        81 ~~~v~~~i~G~~~   93 (255)
T d1nd4a_          81 DWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEECCSSEET
T ss_pred             eEEEEEeeecccc
Confidence            9999999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.62  E-value=7.2e-05  Score=76.62  Aligned_cols=79  Identities=16%  Similarity=0.137  Sum_probs=48.6

Q ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEeecC-ccCH----HHHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRVHGTEVAMKEIAMG-RLNK----KLQESLMSEIFILKRIN-H--PHIIRLHDIIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~-~~~~----~~~~~i~~Ei~iL~~L~-H--pnIv~l~~~~~~~~~l~L   88 (575)
                      .+.||.|..-.||++.+..+|+.++||.-... +...    ....+...|..+|+.+. +  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            56799999999999998878889999964321 1000    01123456787777653 2  345666654  3455678


Q ss_pred             EEeecCCCC
Q 043425           89 ILEYCKGGD   97 (575)
Q Consensus        89 VmEy~~Ggs   97 (575)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.48  E-value=0.0042  Score=61.14  Aligned_cols=67  Identities=9%  Similarity=0.166  Sum_probs=44.1

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCC-----cceE--EEEEEeCCEEEEEEeecCCC
Q 043425           26 SVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPH-----IIRL--HDIIEVPGKLHLILEYCKGG   96 (575)
Q Consensus        26 G~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-----Iv~l--~~~~~~~~~l~LVmEy~~Gg   96 (575)
                      =.||++... +|..|++|+.......   .+++..|...+..|...+     .+..  -..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479998865 7899999998654433   245677888877763211     1111  11345678899999999873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.01  E-value=0.0061  Score=61.56  Aligned_cols=74  Identities=19%  Similarity=0.265  Sum_probs=49.7

Q ss_pred             EEEecccCCeEEEEEEEcC-------CCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 043425           17 GRQIGSGSFSVVWHARHRV-------HGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINHPHI-IRLHDIIEVPGKLHL   88 (575)
Q Consensus        17 ~~~LG~GaFG~Vy~a~~~~-------tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~~~~~~~~l~L   88 (575)
                      +++|+.|-.=.+|++....       .+..|.+++..... ..   ....+|..+++.+.-.++ .++++++.  +  .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ce
Confidence            4678878888999998653       34678888775321 11   234578888888754444 57777763  3  58


Q ss_pred             EEeecCCCCH
Q 043425           89 ILEYCKGGDL   98 (575)
Q Consensus        89 VmEy~~GgsL   98 (575)
                      |+||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.72  E-value=0.013  Score=56.70  Aligned_cols=141  Identities=13%  Similarity=0.117  Sum_probs=73.9

Q ss_pred             CEEEEEEecccCCeEEEEEEEcCCCcEEEEEEeecCccCHHHHHHHHHHHHHHHhCCC-----CCcceEE---EEEEeCC
Q 043425           13 DYLVGRQIGSGSFSVVWHARHRVHGTEVAMKEIAMGRLNKKLQESLMSEIFILKRINH-----PHIIRLH---DIIEVPG   84 (575)
Q Consensus        13 ~Y~i~~~LG~GaFG~Vy~a~~~~tg~~vAVK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-----pnIv~l~---~~~~~~~   84 (575)
                      ...-.+.|..|--=+.|++...  +..|++|++....    ....+..|+.++..|..     |..+...   .+....+
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~   92 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG   92 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred             CceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence            3333455666766788998755  3459999986432    12334556666666532     2222211   0123456


Q ss_pred             EEEEEEeecCCCCHHH-----------HH---HHc---------CC------------------CCHHHHHHHHHHHHHH
Q 043425           85 KLHLILEYCKGGDLSM-----------YI---QRH---------GC------------------VPEETAKHFMKQLAAG  123 (575)
Q Consensus        85 ~l~LVmEy~~GgsL~~-----------~l---~~~---------~~------------------lse~~i~~i~~QLl~a  123 (575)
                      ....++.++.|.....           .+   +..         ..                  .........+..+...
T Consensus        93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  172 (316)
T d2ppqa1          93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY  172 (316)
T ss_dssp             EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred             ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence            6777787777643211           00   000         00                  0111112223333333


Q ss_pred             HHHHhh----CCcccccccCCceeeecCCCCCcEEEccccccc
Q 043425          124 LQVLRD----NNLIHRDLKPQNLLLCTDDDNAALKIADFGFAR  162 (575)
Q Consensus       124 L~~LH~----~gIvHrDLKPeNILl~~dd~~g~vKL~DFGla~  162 (575)
                      +...+.    .|+||+|+.+.||++   +.+...-|+||+.+.
T Consensus       173 ~~~~~~~~L~~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         173 LAAHWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             hhccCccccccccccCCcchhhhhc---ccccceeEecccccc
Confidence            333332    379999999999999   555556899999874